PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Dam, AHDM; Koscinski, I; Kremer, JAM; Moutou, C; Jaeger, AS; Oudakker, AR; Tournaye, H; Charlet, N; Lagier-Tourenne, C; van Bokhoven, H; Viville, S				Dam, Anika H. D. M.; Koscinski, Isabelle; Kremer, Jan A. M.; Moutou, Celine; Jaeger, Anne-Sophie; Oudakker, Astrid R.; Tournaye, Herman; Charlet, Nicolas; lagier-Tourenne, Clotilde; van Bokhoven, Hans; Viville, Stephane			Homozygous mutation in SPATA16 is associated with male infertility in human globozoospermia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ROUND-HEADED SPERMATOZOA; MICE LACKING; ACROSOME FORMATION; GOLGI PROTEIN; IDENTIFICATION; HRB	Globozoospermia is a rare (incidence <0.1% in male infertile patients) form of teratozoospermia, mainly characterized by round-headed spermatozoa that lack an acrosome. It originates from a disturbed spermiogenesis, which is expected to be induced by a genetic factor. Several family cases and recessive mouse models with the same phenotype support this expectation. In this study, we present a consanguineous family with three affected brothers, in whom we have identified a homozygous mutation in the spermatogenesis-specific gene SPATA16. This is the first example of a nonsyndromic male infertility condition in humans caused by an autosomal gene defect, and it could also mean that the identification of other partners like SPATA16 could elucidate acrosome formation.	Radboud Univ Nijmegen Med Ctr, Ctr Reprod, Dept Obstet & Gynecol, NL-6500 HB Nijmegen, Netherlands; Radboud Univ Nijmegen Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Syndicat Inter Hosp Communaute Urbaine Strasbourg, Serv Biol Reprod, Ctr Med Chirurg & Obstet, Schiltigheim, France; Inst Genet & Biol Mol Cellulaire, Dept Dev Biol, Illkirch Graffenstaden, France; Univ Strasbourg, Fac Med, CHU Strasbourg, Strasbourg, France; Dutch Speaking Brussels Free Univ, Ctr Reprod Med, Brussels, Belgium	Radboud University Nijmegen; Radboud University Nijmegen; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Vrije Universiteit Brussel	Kremer, JAM (corresponding author), Radboud Univ Nijmegen Med Ctr, Ctr Reprod, Dept Obstet & Gynecol, 791 Obstet & Gynecol,POB 9101, NL-6500 HB Nijmegen, Netherlands.	j.kremer@obgyn.umcn.nl	Kremer, J.A.M./H-8063-2014; Charlet-Berguerand, Nicolas/GZM-6636-2022; lagier-Tourenne, Clotilde/ABE-6303-2020; Bokhoven, J.H.L.M. van van/H-8015-2014; van Bokhoven, Hans/D-8764-2012; Charlet-Berguerand, Nicolas/I-6727-2016; Oudakker, Astrid/AAB-7890-2019	Kremer, J.A.M./0000-0002-0495-0201; Charlet-Berguerand, Nicolas/0000-0002-4423-4920; lagier-Tourenne, Clotilde/0000-0002-3058-8322; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Charlet-Berguerand, Nicolas/0000-0002-4423-4920; Viville, Stephane/0000-0002-5088-3003; Tournaye, Herman/0000-0002-9863-9309				Baralle D, 2005, J MED GENET, V42, P737, DOI 10.1136/jmg.2004.029538; Christensen GL, 2006, J ANDROL, V27, P11, DOI 10.2164/jandrol.05087; DALE B, 1994, FERTIL STERIL, V61, P336; Dam AHDM, 2007, HUM REPROD UPDATE, V13, P63, DOI 10.1093/humupd/dml047; Escalier D, 2003, MOL REPROD DEV, V66, P190, DOI 10.1002/mrd.10346; FLORKEGERLOFF S, 1984, ANDROLOGIA, V16, P187; Forch P, 2000, MOL CELL, V6, P1089, DOI 10.1016/S1097-2765(00)00107-6; HOLSTEIN AF, 1973, DEUT MED WOCHENSCHR, V98, P61, DOI 10.1055/s-0028-1106747; Kang-Decker N, 2001, SCIENCE, V294, P1531, DOI 10.1126/science.1063665; Kilani Z, 2004, FERTIL STERIL, V82, P1436, DOI 10.1016/j.fertnstert.2004.03.064; Lu L, 2006, ASIAN J ANDROL, V8, P53, DOI 10.1111/j.1745-7262.2006.00089.x; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; Pirrello O, 2005, HUM REPROD, V20, P1314, DOI 10.1093/humrep/deh799; Sen CGS, 1971, ANDROLOGIA, V3, P117, DOI [DOI 10.1111/J.1439-0272.1971.TB02106.X, 10.1111/j.1439-0272.1971.tb02106.x.]; Smith DF, 2004, CELL STRESS CHAPERON, V9, P109, DOI 10.1379/CSC-31.1; TREISMAN R, 1983, NATURE, V302, P591, DOI 10.1038/302591a0; WIERINGA B, 1983, NATURE, V301, P38, DOI 10.1038/301038a0; World Health Organization, 1999, WHO LAB MANUAL EXAMI, V4th; Xu M, 2003, MOL HUM REPROD, V9, P9, DOI 10.1093/molehr/gag005; Xu X, 1999, NAT GENET, V23, P118, DOI 10.1038/12729; Yao RJ, 2002, P NATL ACAD SCI USA, V99, P11211, DOI 10.1073/pnas.162027899	21	195	216	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2007	81	4					813	820		10.1086/521314	http://dx.doi.org/10.1086/521314			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	208GK	17847006	Green Published, Bronze			2022-12-18	WOS:000249307600022
J	Woods, CG; Cox, J; Springell, K; Hampshire, DJ; Mohamed, MD; McKibbin, M; Stern, R; Raymond, FL; Sandford, R; Sharif, SM; Karbani, G; Ahmed, M; Bond, J; Clayton, D; Inglehearn, CF				Woods, CG; Cox, J; Springell, K; Hampshire, DJ; Mohamed, MD; McKibbin, M; Stern, R; Raymond, FL; Sandford, R; Sharif, SM; Karbani, G; Ahmed, M; Bond, J; Clayton, D; Inglehearn, CF			Quantification of homozygosity in consanguineous individuals with autosomal recessive disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAP; CHILDREN; HUMANS	Individuals born of consanguineous union have segments of their genomes that are homozygous as a result of inheriting identical ancestral genomic segments through both parents. One consequence of this is an increased incidence of recessive disease within these sibships. Theoretical calculations predict that 6% (1/16) of the genome of a child of first cousins will be homozygous and that the average homozygous segment will be 20 cM in size. We assessed whether these predictions held true in populations that have preferred consanguineous marriage for many generations. We found that in individuals with a recessive disease whose parents were first cousins, on average, 11% of their genomes were homozygous (n range 5%-20%), with each individual bearing 20 homozygous segments exceeding 3 cM (n =38 range of number of homozygous segments 7-32), and that the size of the homon zygous segment associated with recessive disease was 26 cM (n = 100 range 5-70 cM). These data imply that prolonged parental inbreeding has led to a background level of homozygosity increased similar to 5% over and above that predicted by simple models of consanguinity. This has important clinical and research implications.	Univ Cambridge, Dept Med Genet, Cambridge Inst Med Res, Cambridge CB2 2XY, England; Univ Leeds, Sect Ophthalmol & Neurosci, Inst Mol Med Epidemiol & Canc Res, Leeds, W Yorkshire, England; St Jamess Univ Hosp, Dept Clin Genet, Leeds, W Yorkshire, England	University of Cambridge; University of Leeds; Saint James's University Hospital; University of Leeds	Woods, CG (corresponding author), Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Hills Rd, Cambridge CB2 2XY, England.	cw347@cam.ac.uk	woods, christopher g/A-1361-2010; Hampshire, Daniel/Q-3540-2019; Inglehearn, Chris/GYD-9783-2022; Cox, James/R-1910-2016		Wellcome Trust [06424, 073477, 073243, 057964, 062444] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AHMAD WIU, 1994, J PUBLIC HEALTH MED, V16, P423, DOI 10.1093/oxfordjournals.pubmed.a043023; AlGazali LI, 1997, J BIOSOC SCI, V29, P491, DOI 10.1017/S0021932097004914; Audinarayana N, 2000, SOC BIOL, V47, P189; Bittles AH, 2001, CLIN GENET, V60, P89, DOI 10.1034/j.1399-0004.2001.600201.x; BOUCHER W, 1988, J MATH BIOL, V26, P57, DOI 10.1007/BF00280172; Broman KW, 1999, AM J HUM GENET, V65, P1493, DOI 10.1086/302661; Bundey Sarah, 1993, European Journal of Human Genetics, V1, P206; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; DARR A, 1988, J MED GENET, V25, P186, DOI 10.1136/jmg.25.3.186; Guy R, 2001, CHILD CARE HLTH DEV, V27, P173, DOI 10.1046/j.1365-2214.2001.00165.x; Hoodfar E, 1996, J MED GENET, V33, P212, DOI 10.1136/jmg.33.3.212; JABER L, 1992, AM J MED GENET, V44, P1, DOI 10.1002/ajmg.1320440102; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Miano MG, 2000, AM J HUM GENET, V67, P1348, DOI 10.1016/S0002-9297(07)62966-8; Ober C, 1999, AM J HUM GENET, V64, P225, DOI 10.1086/302198; SMITH CAB, 1974, ANN HUM GENET, V37, P377, DOI 10.1111/j.1469-1809.1974.tb01844.x; VOGEL F, 1997, HUMAN GENETICS PROBL, P482; Woods CG, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.016873; Wright AF, 1997, GENETIC MAPPING OF DISEASE GENES, P255	20	195	198	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2006	78	5					889	896		10.1086/503875	http://dx.doi.org/10.1086/503875			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032EH	16642444	Green Published, Bronze			2022-12-18	WOS:000236756200015
J	Kong, X; Murphy, K; Raj, T; He, C; White, PS; Matise, TC				Kong, X; Murphy, K; Raj, T; He, C; White, PS; Matise, TC			A combined linkage-physical map of the human genome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECOMBINATION; PROGRAM; PCR	We have constructed de novo a high-resolution genetic map that includes the largest set, to our knowledge, of polymorphic markers (N = 14,759) for which genotype data are publicly available; that combines genotype data from both the Centre d'Etude du Polymorphisme Humain (CEPH) and deCODE pedigrees; that incorporates single-nucleotide polymorphisms; and that also incorporates sequence-based positional information. The position of all markers on our map is corroborated by both genomic sequence and recombination-based data. This specific combination of features maximizes marker inclusion, coverage, and resolution, making this map uniquely suitable as a comprehensive resource for determining genetic map information (order and distances) for any large set of polymorphic markers.	Rutgers State Univ, Dept Genet, Piscataway, NJ 08840 USA; Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA	Rutgers State University New Brunswick; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Matise, TC (corresponding author), Rutgers State Univ, Dept Genet, 604 Allison Rd, Piscataway, NJ 08840 USA.	matise@biology.rutgers.edu	Raj, Towfique/ABD-7620-2021		NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R29HG001691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060240] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG01691] Funding Source: Medline; NIMH NIH HHS [MH60240] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BAHLO M, 2004, BIOINFORMATICS  0624; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Kennedy GC, 2003, NAT BIOTECHNOL, V21, P1233, DOI 10.1038/nbt869; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; KONG X, 2004, BIOINFORMATICS  0916; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Matise TC, 2003, AM J HUM GENET, V73, P271, DOI 10.1086/377137; Matise TC, 1999, AM J HUM GENET, V65, pA435; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Murphy K, 2004, BIOINFORMATICS, V20, P588, DOI 10.1093/bioinformatics/btg466; Murray SS, 2004, NAT METHODS, V1, P113, DOI 10.1038/NMETH712; Nievergelt CM, 2004, GENOME RES, V14, P1199, DOI 10.1101/gr.1475304; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Schuler GD, 1997, GENOME RES, V7, P541, DOI 10.1101/gr.7.5.541	16	195	201	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2004	75	6					1143	1148		10.1086/426405	http://dx.doi.org/10.1086/426405			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867TW	15486828	Bronze, Green Published			2022-12-18	WOS:000224866400020
J	Zhou, XP; Waite, KA; Pilarski, R; Hampel, H; Fernandez, MJ; Bos, C; Dasouki, M; Feldman, GL; Greenberg, LA; Ivanovich, J; Matloff, E; Patterson, A; Pierpont, ME; Russo, D; Nassif, NT; Eng, C				Zhou, XP; Waite, KA; Pilarski, R; Hampel, H; Fernandez, MJ; Bos, C; Dasouki, M; Feldman, GL; Greenberg, LA; Ivanovich, J; Matloff, E; Patterson, A; Pierpont, ME; Russo, D; Nassif, NT; Eng, C			Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BANNAYAN-ZONANA-SYNDROME; TUMOR-SUPPRESSOR GENE; COWDEN-DISEASE; FEATURES; PATIENT; PHOSPHORYLATION; TRANSCRIPTION; DEGRADATION; POLYPOSIS; STABILITY	Germline intragenic mutations in PTEN are associated with 80% of patients with Cowden syndrome ( CS) and 60% of patients with Bannayan-Riley-Ruvalcaba syndrome (BRRS). The underlying genetic causes remain to be determined in a considerable proportion of classic CS and BRRS without a polymerase chain reaction (PCR)detectable PTEN mutation. We hypothesized that gross gene deletions and mutations in the PTEN promoter might alternatively account for a subset of apparently mutation-negative patients with CS and BRRS. Using real time and multiplex PCR techniques, we identified three germline hemizygous PTEN deletions in 122 apparently mutation-negative patients with classic CS (N=95) or BRRS (N=27). Fine mapping suggested that one deletion encompassed the whole gene and the other two included exon 1 and encompassed exons 1-5 of PTEN, respectively. Two patients with the deletion were diagnosed with BRRS, and one patient with the deletion was diagnosed with BRRS/CS overlap ( features of both). Thus 3 (11%) of 27 patients with BRRS or BRRS/CS-overlap had PTEN deletions. Analysis of the PTEN promoter revealed nine cases (7.4%) harboring heterozygous germline mutations. All nine had classic CS, representing almost 10% of all subjects with CS. Eight had breast cancers and/or benign breast tumors but, otherwise, oligo-organ involvement. PTEN protein analysis, from one deletion-positive and five PTEN-promoter-mutation -positive samples, revealed a 50% reduction in protein and multiple bands of immunoreactive protein, respectively. In contrast, control samples showed only the expected band. Further, an elevated level of phosphorylated Akt was detected in the five promoter-mutation - positive samples, compared with controls, indicating an absence of or marked reduction in functional PTEN. These data suggest that patients with BRRS and CS without PCR-detected intragenic PTEN mutations be offered clinical deletion analysis and promoter-mutation analysis, respectively.	Ohio State Univ, Human Canc Genet Program, Ctr Comprehens Canc, Columbus, OH 43210 USA; Ohio State Univ, Clin Canc Genet Program, Ctr Comprehens Canc, Columbus, OH 43210 USA; Ohio State Univ, Dept Internal Med, Div Human Genet, Columbus, OH 43210 USA; Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Div Human Canc Genet, Columbus, OH 43210 USA; Ferguson Inherited Colon Canc Registry, Grand Rapids, MI USA; Childrens Mercy Hosp, Div Genet, Kansas City, MO 64108 USA; Wayne State Univ, Sch Med, Detroit Med Ctr, Karmanos Canc Ctr Inst, Detroit, MI USA; Stamford Hosp, Bennett Canc Ctr, Canc Genet Program, Stamford, CT USA; Washington Univ, Sch Med, Pediat Clin, St Louis, MO USA; Yale Canc Ctr, Dept Genet, New Haven, CT USA; Univ Texas, SW Med Ctr, Dallas, TX USA; Univ Minnesota, Minneapolis, MN USA; Childrens Hosp, St Paul, MN USA; NYP Columbia Presbyterian Hosp, Canc Genet Program, New York, NY USA; Univ New S Wales, Liverpool Hosp, SW Sydney Clin Sch, Canc Res Labs, Liverpool, Merseyside, England; Univ Cambridge, Canc Res UK Human Canc Genet Res Grp, Cambridge, England	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Children's Mercy Hospital; Detroit Medical Center; Wayne State University; Stamford Hospital; Washington University (WUSTL); Yale University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Minnesota System; University of Minnesota Twin Cities; Children's Hospitals & Clinics of Minnesota; NewYork-Presbyterian Hospital; University of Cambridge	Eng, C (corresponding author), Ohio State Univ, Human Canc Genet Program, Ctr Comprehens Canc, 420 W 12th Ave,Suite 690 TMRF, Columbus, OH 43210 USA.		Nassif, Najah T/G-6214-2012; Pilarski, Robert/X-3256-2019; Pilarski, Robert/E-3871-2011; Waite, Kristin/AAB-1031-2021	Nassif, Najah T/0000-0003-2675-8322; Eng, Charis/0000-0002-3693-5145	NCI NIH HHS [P30 CA016058, P30CA16058] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahmed SF, 2000, J CLIN ENDOCR METAB, V85, P658, DOI 10.1210/jc.85.2.658; Arch EM, 1997, AM J MED GENET, V71, P489, DOI 10.1002/(SICI)1096-8628(19970905)71:4<489::AID-AJMG24>3.0.CO;2-B; Eng C, 2000, J MED GENET, V37, P828, DOI 10.1136/jmg.37.11.828; GORLIN RJ, 1992, AM J MED GENET, V44, P307, DOI 10.1002/ajmg.1320440309; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Marsh DJ, 1998, HUM MOL GENET, V7, P507, DOI 10.1093/hmg/7.3.507; Marsh DJ, 1997, NAT GENET, V16, P333, DOI 10.1038/ng0897-333; Marsh DJ, 1999, HUM MOL GENET, V8, P1461, DOI 10.1093/hmg/8.8.1461; Nelen MR, 1996, NAT GENET, V13, P114, DOI 10.1038/ng0596-114; Patel L, 2001, CURR BIOL, V11, P764, DOI 10.1016/S0960-9822(01)00225-1; Reardon W, 2001, J MED GENET, V38, P820, DOI 10.1136/jmg.38.12.820; Sheng XY, 2002, BIOCHEM BIOPH RES CO, V292, P422, DOI 10.1006/bbrc.2002.6662; Sieber OM, 2002, P NATL ACAD SCI USA, V99, P2954, DOI 10.1073/pnas.042699199; Smith JM, 2002, J MED GENET, V39, P937, DOI 10.1136/jmg.39.12.937; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Tsuchiya KD, 1998, GENE CHROMOSOME CANC, V21, P113, DOI 10.1002/(SICI)1098-2264(199802)21:2<113::AID-GCC6>3.0.CO;2-3; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124; Waite KA, 2002, AM J HUM GENET, V70, P829, DOI 10.1086/340026; Waite KA, 2003, HUM MOL GENET, V12, P679, DOI 10.1093/hmg/ddg069; Weng LP, 2001, HUM MOL GENET, V10, P605, DOI 10.1093/hmg/10.6.605; Zhou XP, 2000, AM J PATHOL, V157, P1123, DOI 10.1016/S0002-9440(10)64627-5; Zhou XP, 2000, HUM MOL GENET, V9, P765, DOI 10.1093/hmg/9.5.765; Zhou XP, 2001, LANCET, V358, P210, DOI 10.1016/S0140-6736(01)05412-5	25	195	204	0	11	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2003	73	2					404	411		10.1086/377109	http://dx.doi.org/10.1086/377109			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	702KW	12844284	Bronze, Green Published, Green Submitted			2022-12-18	WOS:000184223900017
J	Ericson, KG; Fadeel, B; Nilsson-Ardnor, S; Soderhall, C; Samuelsson, A; Janka, G; Schneider, M; Gurgey, A; Yalman, N; Revesz, T; Egeler, RM; Jahnukainen, K; Storm-Mathiesen, I; Haraldsson, A; Poole, J; de Saint Basile, G; Nordenskjold, M; Henter, JI				Ericson, KG; Fadeel, B; Nilsson-Ardnor, S; Soderhall, C; Samuelsson, A; Janka, G; Schneider, M; Gurgey, A; Yalman, N; Revesz, T; Egeler, RM; Jahnukainen, K; Storm-Mathiesen, I; Haraldsson, A; Poole, J; de Saint Basile, G; Nordenskjold, M; Henter, JI			Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BONE-MARROW TRANSPLANTATION; KILLER-CELL-FUNCTION; FAS LIGAND; HYPERCYTOKINEMIA; ACTIVATION; DONORS	Familial hemophagocytic lymphohistiocytosis (FHL) is an autosomal recessive disease of early childhood characterized by nonmalignant accumulation and multivisceral infiltration of activated T lymphocytes and histiocytes (macrophages). Cytotoxic T and natural killer (NK) cell activity is markedly reduced or absent in these patients, and mutations in a lytic granule constituent, perforin, were recently identified in a number of FHL individuals. Here, we report a comprehensive survey of 34 additional patients with FHL for mutations in the coding region of the perforin gene and the relative frequency of perforin mutations in FHL. Perforin mutations were identified in 7 of the 34 families investigated. Six children were homozygous for the mutations, and one patient was a compound heterozygote. Four novel mutations were detected: one nonsense, two missense, and one deletion of one amino acid. In four families, a previously reported mutation at codon 374, causing a premature stop codon, was identified, and, therefore, this is the most common perforin mutation identified so far in FHL patients. We found perforin mutations in 20% of all FHL patients investigated (7/34), with a somewhat higher prevalence, similar to 30% (6/20), in children whose parents originated from Turkey. No other correlation between the type of mutation and the phenotype of the patients was evident from the present study. Our combined results from mutational analysis of 34 families and linkage analysis of a subset of consanguineous families indicate that perforin mutations account for 20%-40% of the FHL cases and the FHL 1 locus on chromosome 9 for similar to 10%, whereas the major part of the FHL cases are caused by mutations in not-yet-identified genes.	Karolinska Hosp, Dept Pediat Hematol & Oncol, Childhood Canc Res Unit, S-10401 Stockholm, Sweden; Karolinska Inst, Dept Mol Med, Stockholm, Sweden; Karolinska Inst, Inst Environm Med, Div Toxicol, S-10401 Stockholm, Sweden; Umea Univ Hosp, Dept Clin Genet, S-90185 Umea, Sweden; Childrens Univ Hosp, Dept Hematol & Oncol, Hamburg, Germany; Univ Ulm, Ulm, Germany; Hacettepe Univ, Dept Pediat Hematol, Ankara, Turkey; Istanbul Sch Med, Dept Pediat Oncol, Istanbul, Turkey; Wilhelmina Hosp Children, Dept Haematol, Utrecht, Netherlands; Leiden Univ, Med Ctr, Dept Pediat, Leiden, Netherlands; Univ Turku, Dept Pediat, Turku, Finland; Univ Oslo, Natl Hosp, Dept Pediat, Oslo, Norway; Univ Hosp, Dept Paediat, Reykjavik, Iceland; Johannesburg Hosp, Dept Paediat Haematol Oncol, Johannesburg, South Africa; Hop Necker Enfants Malad, INSERM, Unite Rech Dev Normal & Pathol Syst Immunitaire, U429, Paris, France	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Umea University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ulm University; Hacettepe University; Istanbul University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Turku; University of Oslo; National Hospital Norway; Landspitali National University Hospital; University of Witwatersrand; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Henter, JI (corresponding author), Karolinska Hosp, Dept Pediat Hematol & Oncol, Childhood Canc Res Unit Q605, S-17176 Stockholm, Sweden.	jan-inge.henter@kbh.ki.se	Söderhäll, Cilla/E-3940-2012; YALMAN, NEVİN/AAD-6122-2020; de Saint Basile, Genevieve/G-9731-2017	Söderhäll, Cilla/0000-0002-8397-3080; de Saint Basile, Genevieve/0000-0002-1913-5269; Nordenskjold, Magnus/0000-0002-4974-425X; Henter, Jan-Inge/0000-0002-0629-2126; Horne, AnnaCarin/0000-0002-2878-4463; Haraldsson, Asgeir/0000-0001-5364-7877				ARICO M, 1988, ARCH DIS CHILD, V63, P292, DOI 10.1136/adc.63.3.292; Darmon AJ, 1998, CRIT REV IMMUNOL, V18, P255, DOI 10.1615/CritRevImmunol.v18.i3.50; DARMON AJ, 1995, NATURE, V377, P446, DOI 10.1038/377446a0; Dufourcq-Lagelouse R, 1999, INT J MOL MED, V4, P127; Dufourcq-Lagelouse R, 1999, AM J HUM GENET, V64, P172, DOI 10.1086/302194; Durken M, 1999, BRIT J HAEMATOL, V106, P1052, DOI 10.1046/j.1365-2141.1999.01625.x; Egeler RM, 1996, J PEDIAT HEMATOL ONC, V18, P340, DOI 10.1097/00043426-199611000-00002; EIFE R, 1989, PEDIATR HEMAT ONCOL, V6, P265, DOI 10.3109/08880018909034296; Fadeel B, 1999, BRIT J HAEMATOL, V106, P406, DOI 10.1046/j.1365-2141.1999.01538.x; FUJIWARA F, 1993, AM J PEDIAT HEMATOL, V15, P92; Graham GE, 2000, PEDIATR RES, V48, P227, DOI 10.1203/00006450-200008000-00017; Hasegawa D, 1998, BLOOD, V91, P2793, DOI 10.1182/blood.V91.8.2793.2793_2793_2799; HENTER JI, 1991, BLOOD, V78, P2918, DOI 10.1182/blood.V78.11.2918.2918; Henter JI, 1998, HEMATOL ONCOL CLIN N, V12, P417, DOI 10.1016/S0889-8588(05)70520-7; Henter JI, 1997, MED PEDIATR ONCOL, V28, P342, DOI 10.1002/(SICI)1096-911X(199705)28:5<342::AID-MPO3>3.0.CO;2-H; HENTER JI, 1991, SEMIN ONCOL, V18, P29; Imashuku S, 1996, BRIT J HAEMATOL, V93, P803, DOI 10.1046/j.1365-2141.1996.d01-1727.x; Jabado N, 1997, BLOOD, V90, P4743, DOI 10.1182/blood.V90.12.4743.4743_4743_4748; JANKA GE, 1983, EUR J PEDIATR, V140, P221, DOI 10.1007/BF00443367; LICHTENHELD MG, 1988, NATURE, V335, P448, DOI 10.1038/335448a0; LICHTENHELD MG, 1989, J IMMUNOL, V143, P4267; LIU CC, 1995, IMMUNOL TODAY, V16, P194, DOI 10.1016/0167-5699(95)80121-9; Lowin B, 1995, Curr Top Microbiol Immunol, V198, P1; Matloubian M, 1999, J VIROL, V73, P2527, DOI 10.1128/JVI.73.3.2527-2536.1999; Ohadi M, 1999, AM J HUM GENET, V64, P165, DOI 10.1086/302187; PEREZ N, 1984, J PEDIATR-US, V104, P569, DOI 10.1016/S0022-3476(84)80549-1; PODACK ER, 1992, CURR TOP MICROBIOL, V178, P175; SHINKAI Y, 1989, IMMUNOGENETICS, V30, P452, DOI 10.1007/BF02421177; Stepp SE, 1999, SCIENCE, V286, P1957, DOI 10.1126/science.286.5446.1957; Sullivan KE, 1998, PEDIATR RES, V44, P465, DOI 10.1203/00006450-199810000-00001; TAKAHASHI T, 1994, INT IMMUNOL, V6, P1567, DOI 10.1093/intimm/6.10.1567; TSCHOPP J, 1990, ANNU REV IMMUNOL, V8, P279, DOI 10.1146/annurev.immunol.8.1.279; Yasukawa M, 2000, BLOOD, V95, P2352, DOI 10.1182/blood.V95.7.2352.007k40_2352_2355	33	195	199	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2001	68	3					590	597		10.1086/318796	http://dx.doi.org/10.1086/318796			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	402ND	11179007	Bronze, Green Published			2022-12-18	WOS:000166994200004
J	Bassi, MT; Manzoni, M; Monti, E; Pizzo, MT; Ballabio, A; Borsani, G				Bassi, MT; Manzoni, M; Monti, E; Pizzo, MT; Ballabio, A; Borsani, G			Cloning of the gene encoding a novel integral membrane protein, mucolipidin - and identification of the two major founder mutations causing mucolipidosis type IV	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CAPACITATIVE CALCIUM-ENTRY; ABNORMAL TRANSPORT; SKIN FIBROBLASTS; SEQUENCES; DATABASE; STORAGE; DISEASE; FAMILY; DBEST; TRP	Mucolipidosis type IV (MLIV) is an autosomal recessive lysosomal storage disorder characterized by severe psychomotor retardation and ophthalmologic abnormalities, including corneal opacity, retinal degeneration, and strabismus. Unlike the situation in other lysosomal disorders, the accumulation of heterogeneous storage material observed in MLIV does not result from a block in the catabolic pathways but is due to an ill-defined transport defect in the late steps of endocytosis. With the aim of cloning the MLIV gene, we searched in the 19p13.2-13.3 region, where the locus previously had been assigned by linkage mapping. In this region, we have identified a novel gene that is mutated in all patients with MLIV who were enrolled in our study. One patient was homozygous for the splice-acceptor mutation, and another was homozygous for a deletion removing the first six exons of the gene. In addition, four compound heterozygotes for these two mutations were identified. Haplotype analysis indicates that we have identified the two major founder mutations, which account for >95% of MLIV chromosomes in Ashkenazi Jewish patients. The gene, ML4, encodes a protein named "mucolipidin," which localizes on the plasma membrane and, in the carboxy-terminal region, shows homologies to polycystin-2, the product of the polycystic kidney disease 2 gene (PKD2) and to the family of transient receptor potential Ca2+ channels. Mucolipidin is likely to play an important role in endocytosis.	Telethon Inst Genet & Med, TIGEM, I-80131 Naples, Italy; Univ Vita & Salute San Raffaele, Milan, Italy; Univ Brescia, Dept Biomed Sci & Biotechnol, Brescia, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Vita-Salute San Raffaele University; University of Brescia	Borsani, G (corresponding author), Telethon Inst Genet & Med, TIGEM, Via Pietro Castellino 111,San Raffaele Biomed Sci, I-80131 Naples, Italy.		Bassi, Maria Teresa T/A-3517-2014; BALLABIO, Andrea/AAL-2672-2020; Borsani, Giuseppe/B-1709-2010	Bassi, Maria Teresa T/0000-0002-8236-1197; BALLABIO, Andrea/0000-0003-1381-4604; Borsani, Giuseppe/0000-0003-0110-1148; MONTI, Eugenio/0000-0002-4742-7445	Telethon [TGM06S01] Funding Source: Medline	Telethon(Fondazione Telethon)		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMIR N, 1987, PEDIATRICS, V79, P953; Banfi S, 1998, TRENDS GENET, V14, P80, DOI 10.1016/S0168-9525(97)01354-1; Bargal R, 2000, NAT GENET, V26, P118, DOI 10.1038/79095; BARGAL R, 1988, J INHERIT METAB DIS, V11, P144, DOI 10.1007/BF01799863; Bargal R, 1997, J INHERIT METAB DIS, V20, P625, DOI 10.1023/A:1005362123443; BARGAL R, 1989, CLIN CHIM ACTA, V181, P167, DOI 10.1016/0009-8981(89)90184-8; BERMAN ER, 1974, J PEDIATR-US, V84, P519, DOI 10.1016/S0022-3476(74)80671-2; Birnbaumer L, 1996, P NATL ACAD SCI USA, V93, P15195, DOI 10.1073/pnas.93.26.15195; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Borsani G, 1998, HUM MOL GENET, V7, P1641, DOI 10.1093/hmg/7.10.1641; Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; Charron AJ, 2000, J CELL BIOL, V149, P111, DOI 10.1083/jcb.149.1.111; Chen CS, 1998, P NATL ACAD SCI USA, V95, P6373, DOI 10.1073/pnas.95.11.6373; FOLKERTH RD, 1995, J NEUROPATH EXP NEUR, V54, P154, DOI 10.1097/00005072-199503000-00002; GOLDIN E, 1995, PEDIATR RES, V37, P687, DOI 10.1203/00006450-199506000-00003; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Maasch C, 2000, FASEB J, V14, P1653, DOI 10.1096/fj.14.11.1653; MARCK C, 1988, NUCLEIC ACIDS RES, V16, P1829, DOI 10.1093/nar/16.5.1829; Pryor PR, 2000, J CELL BIOL, V149, P1053, DOI 10.1083/jcb.149.5.1053; Putney JW, 1999, BIOESSAYS, V21, P38; Raas-Rothschild A, 1999, EUR J HUM GENET, V7, P496, DOI 10.1038/sj.ejhg.5200277; Sambrook J, 1989, MOL CLONING LAB MANU; Slaugenhaupt SA, 1999, AM J HUM GENET, V65, P773, DOI 10.1086/302549; TELLEZNAGEL I, 1976, ARCH NEUROL-CHICAGO, V33, P828, DOI 10.1001/archneur.1976.00500120032005; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turgeman D, 1996, BIOCHEM MOL MED, V59, P33, DOI 10.1006/bmme.1996.0061; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7	30	195	204	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2000	67	5					1110	1120		10.1016/S0002-9297(07)62941-3	http://dx.doi.org/10.1016/S0002-9297(07)62941-3			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	369WW	11013137	Green Published, Bronze			2022-12-18	WOS:000165091600008
J	Toh, S; Wada, M; Uchiumi, T; Inokuchi, A; Makino, Y; Horie, Y; Adachi, Y; Sakisaka, S; Kuwano, M				Toh, S; Wada, M; Uchiumi, T; Inokuchi, A; Makino, Y; Horie, Y; Adachi, Y; Sakisaka, S; Kuwano, M			Genomic structure of the canalicular multispecific organic anion-transporter gene (MRP2/cMOAT) and mutations in the ATP-binding-cassette region in Dubin-Johnson syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIDRUG-RESISTANCE PROTEIN; CONJUGATE EXPORT PUMP; CANCER CELL-LINES; MEMBRANE TOPOLOGY; CYSTIC-FIBROSIS; RATS; MRP; ORGANIZATION; HEPATOCYTES; EXPRESSION	Dubin-Johnson syndrome (DJS) is an autosomal recessive disease characterized by conjugated hyperbilirubinemia. Previous studies of the defects in the human canalicular multispecific organic anion transporter gene (MRP2/cMOAT) in patients with DJS have suggested that the gene defects are responsible for DJS. In this study, we determined the exon/intron structure of the human MRP2/cMOAT gene and further characterized mutations in patients with DJS. The human MRP2/cMOAT gene contains 32 exons, and it has a structure that is highly conserved with that of another ATP-binding-cassette gene, that for a multidrug resistance-associated protein. We then identified three mutations, including two novel ones. All mutations identified to date are in the cytoplasmic domain, which includes the two ATP-binding cassettes and the linker region, or adjacent putative transmembrane domain. Our results confirm that MRP2/cMOAT is the gene responsible for DJS. The finding that mutations are concentrated in the first ATP-binding-cassette domain strongly suggests that a disruption of this region is a critical route to loss of function.	Kyushu Univ, Sch Med, Dept Biochem, Fukuoka 8128582, Japan; Shimane Med Univ, Dept Surg 2, Izumo, Shimane 693, Japan; Tottori Univ, Sch Med, Dept Internal Med 2, Yonago, Tottori 683, Japan; Mie Univ, Sch Med, Dept Internal Med 3, Tsu, Mie, Japan; Kurume Univ, Sch Med, Dept Med 2, Kurume, Fukuoka 830, Japan	Kyushu University; Shimane University; Tottori University; Mie University; Kurume University	Wada, M (corresponding author), Kyushu Univ, Sch Med, Dept Biochem, Maidashi 3-1-1, Fukuoka 8128582, Japan.							Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; Buchler M, 1996, J BIOL CHEM, V271, P15091; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Deeley RG, 1997, SEMIN CANCER BIOL, V8, P193, DOI 10.1006/scbi.1997.0070; DORK T, 1994, HUM GENET, V94, P533; DUBIN IN, 1954, MEDICINE, V33, P155, DOI 10.1097/00005792-195409000-00001; ELFERINK RPJO, 1990, AM J PHYSIOL, V258, pG699, DOI 10.1152/ajpgi.1990.258.5.G699; ELFERINK RPJO, 1995, BBA-REV BIOMEMBRANES, V1241, P215, DOI 10.1016/0304-4157(95)00006-D; Farrell GC, 1997, J GASTROEN HEPATOL, V12, pS242, DOI 10.1111/j.1440-1746.1997.tb00507.x; FRANK M, 1990, HEPATO-GASTROENTEROL, V37, P147; Gottesman MM, 1995, ANNU REV GENET, V29, P607, DOI 10.1146/annurev.ge.29.120195.003135; Grant CE, 1997, GENOMICS, V45, P368, DOI 10.1006/geno.1997.4950; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hipfner DR, 1997, J BIOL CHEM, V272, P23623, DOI 10.1074/jbc.272.38.23623; Ito K, 1997, AM J PHYSIOL-GASTR L, V272, pG16, DOI 10.1152/ajpgi.1997.272.1.G16; Kartenbeck J, 1996, HEPATOLOGY, V23, P1061; Keppler D, 1997, BIOL CHEM, V378, P787; KITAMURA T, 1990, P NATL ACAD SCI USA, V87, P3557, DOI 10.1073/pnas.87.9.3557; KONDO T, 1974, JPN J HUM GENET, V18, P378; Kool M, 1997, CANCER RES, V57, P3537; Loe DW, 1996, J BIOL CHEM, V271, P9675, DOI 10.1074/jbc.271.16.9675; Paulusma CC, 1997, HEPATOLOGY, V25, P1539, DOI 10.1002/hep.510250635; Paulusma CC, 1996, SCIENCE, V271, P1126, DOI 10.1126/science.271.5252.1126; Sasabe H, 1998, J PHARMACOL EXP THER, V284, P1033; SHANI M, 1970, QJM, V39, P549; SPRINZ H, 1954, ANN INTERN MED, V41, P952, DOI 10.7326/0003-4819-41-5-952; Taguchi Y, 1997, BIOCHEMISTRY-US, V36, P8883, DOI 10.1021/bi970553v; Takino T, 1977, Nihon Shokakibyo Gakkai Zasshi, V74, P1518; Taniguchi K, 1996, CANCER RES, V56, P4124; Tusnady GE, 1997, FEBS LETT, V402, P1, DOI 10.1016/S0014-5793(96)01478-0; Vogel F., 1997, HUMAN GENETICS PROBL; Wada M, 1998, HUM MOL GENET, V7, P203, DOI 10.1093/hmg/7.2.203; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R	34	195	206	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1999	64	3					739	746		10.1086/302292	http://dx.doi.org/10.1086/302292			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	177HN	10053008	Green Published, Bronze			2022-12-18	WOS:000079204700011
J	Friedman, LS; Gayther, SA; Kurosaki, T; Gordon, D; Noble, B; Casey, G; Ponder, BAJ; AntonCulver, H				Friedman, LS; Gayther, SA; Kurosaki, T; Gordon, D; Noble, B; Casey, G; Ponder, BAJ; AntonCulver, H			Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OVARIAN-CANCER; SUSCEPTIBILITY GENE; FAMILIAL BREAST; LINKAGE; RISK; MEN	A population-based series of 54 male breast cancer cases from Southern California were analyzed for germ-line mutations in the inherited breast/ovarian cancer genes, BRCA1 and BRCA2. Nine (17%) of the patients had a family history of breast and/or ovarian cancer in at least one first-degree relative. A further seven (13%) of the patients reported breast/ovarian cancer in at least one second-degree relative and in no first-degree relatives. No germ-line BRCA1 mutations were found. Two male breast cancer patients (4% of the total) were found to carry novel truncating mutations in the BRCA2 gene. Only one of the two male breast cancer patients carrying a BRCA2 mutation had a family history of cancer, with one case of ovarian cancer in a first-degree relative. The remaining eight cases (89%) of male breast cancer with a family history of breast/ovarian cancer in first-degree relatives remain unaccounted for by mutations in either the BRCA1 gene or the BRCA2 gene.	UNIV CALIF IRVINE,DEPT MED,DIV EPIDEMIOL,IRVINE,CA 92717; CLEVELAND CLIN RES INST,CLEVELAND,OH	University of California System; University of California Irvine; Cleveland Clinic Foundation	Friedman, LS (corresponding author), UNIV CAMBRIDGE,ADDENBROOKES HOSP,CRC,HUMAN CANC GENET RES GRP,BOX 238,LEVEL 3 LABS BLOCK,CAMBRIDGE CB2 2QQ,ENGLAND.				NCI NIH HHS [CA 58860] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA058860, U01CA058860] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AntonCulver H, 1996, GENET EPIDEMIOL, V13, P193, DOI 10.1002/(SICI)1098-2272(1996)13:2<193::AID-GEPI5>3.0.CO;2-9; ANTONCULVER H, 1996, INT GEN EP SOC M RIO; CLAUS EB, 1991, AM J HUM GENET, V48, P232; Couch FJ, 1996, NAT GENET, V13, P123, DOI 10.1038/ng0596-123; EASTON DF, 1993, AM J HUM GENET, V52, P678; FRIEND S, 1995, NAT GENET, V11, P238, DOI 10.1038/ng1195-238; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; GAYTHER SA, IN PRESS NAT GENET; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HECHT JR, 1994, AM J CLIN PATHOL, V102, pS25; HOGERVORST FBL, 1995, NAT GENET, V10, P208, DOI 10.1038/ng0695-208; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; NEWMAN B, 1988, P NATL ACAD SCI USA, V85, P3044, DOI 10.1073/pnas.85.9.3044; OLSSON H, 1993, CANCER, V71, P1273, DOI 10.1002/1097-0142(19930215)71:4<1273::AID-CNCR2820710417>3.0.CO;2-P; Phelan CM, 1996, NAT GENET, V13, P120, DOI 10.1038/ng0596-120; ROSENBLATT KA, 1991, JNCI-J NATL CANCER I, V83, P849, DOI 10.1093/jnci/83.12.849; SASCO AJ, 1993, INT J CANCER, V53, P538, DOI 10.1002/ijc.2910530403; STRUEWING JP, 1995, AM J HUM GENET, V57, P1; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Teng DHF, 1996, NAT GENET, V13, P241, DOI 10.1038/ng0696-241; Thorlacius S, 1996, NAT GENET, V13, P117, DOI 10.1038/ng0596-117; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	23	195	199	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1997	60	2					313	319						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WE931	9012404				2022-12-18	WOS:A1997WE93100010
J	Francks, C; Paracchini, S; Smith, SD; Richardson, AJ; Scerri, TS; Cardon, LR; Marlow, AJ; MacPhie, IL; Walter, J; Pennington, BF; Fisher, SE; Olson, RK; DeFries, JC; Stein, JF; Monaco, AP				Francks, C; Paracchini, S; Smith, SD; Richardson, AJ; Scerri, TS; Cardon, LR; Marlow, AJ; MacPhie, IL; Walter, J; Pennington, BF; Fisher, SE; Olson, RK; DeFries, JC; Stein, JF; Monaco, AP			A 77-kilobase region of chromosome 6p22.2 is associated with dyslexia in families from the United Kingdom and from the United States	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUANTITATIVE-TRAIT LOCUS; COMPLEX COGNITIVE TRAIT; READING-DISABILITY; DEVELOPMENTAL DYSLEXIA; ENVIRONMENTAL-INFLUENCES; LINKAGE DISEQUILIBRIUM; 6P INFLUENCES; GENE; PROTEIN; SUSCEPTIBILITY	Several quantitative trait loci (QTLs) that influence developmental dyslexia ( reading disability [RD]) have been mapped to chromosome regions by linkage analysis. The most consistently replicated area of linkage is on chromosome 6p23-21.3. We used association analysis in 223 siblings from the United Kingdom to identify an underlying QTL on 6p22.2. Our association study implicates a 77-kb region spanning the gene TTRAP and the first four exons of the neighboring uncharacterized gene KIAA0319. The region of association is also directly upstream of a third gene, THEM2. We found evidence of these associations in a second sample of siblings from the United Kingdom, as well as in an independent sample of twin-based sibships from Colorado. One main RD risk haplotype that has a frequency of similar to12% was found in both the U. K. and U. S. samples. The haplotype is not distinguished by any protein-coding polymorphisms, and, therefore, the functional variation may relate to gene expression. The QTL influences a broad range of reading-related cognitive abilities but has no significant impact on general cognitive performance in these samples. In addition, the QTL effect may be largely limited to the severe range of reading disability.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Oxford, Dept Physiol, Oxford OX3 7BN, England; Univ Nebraska, Med Ctr, Dept Pediat, Omaha, NE USA; Univ Denver, Dept Psychol, Denver, CO 80208 USA; Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Nebraska System; University of Nebraska Medical Center; University of Denver; University of Colorado System; University of Colorado Boulder	Monaco, AP (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	anthony.monaco@well.ox.ac.uk	Paracchini, Silvia/AAU-6813-2021; Francks, Clyde/AGU-8875-2022; Fisher, Simon E./E-9130-2012; Monaco, Anthony P/A-4495-2010; Francks, Clyde/E-1384-2012	Paracchini, Silvia/0000-0001-9934-8602; Fisher, Simon E./0000-0002-3132-1996; Monaco, Anthony P/0000-0001-7480-3197; Francks, Clyde/0000-0002-9098-890X; Richardson, Alex/0000-0001-5650-4409	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD027802] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD011681] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-27802, HD-11681, P50 HD027802] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; CARDON LR, 1995, SCIENCE, V268, P1553, DOI 10.1126/science.7777847; CARDON LR, 1994, SCIENCE, V266, P276, DOI 10.1126/science.7939663; CASTLES A, 1993, COGNITION, V47, P149, DOI 10.1016/0010-0277(93)90003-E; Deffenbacher KE, 2004, HUM GENET, V115, P128, DOI 10.1007/s00439-004-1126-6; DEFRIES JC, 1987, NATURE, V329, P537, DOI 10.1038/329537a0; Fisher SE, 1999, AM J HUM GENET, V64, P146, DOI 10.1086/302190; Fisher SE, 2002, NAT REV NEUROSCI, V3, P767, DOI 10.1038/nrn936; Fisher SE, 2002, NAT GENET, V30, P86, DOI 10.1038/ng792; FISHER SE, IN PRESS COGNITION; Francks C, 2002, LANCET NEUROL, V1, P483, DOI 10.1016/S1474-4422(02)00221-1; Fridmacher V, 2003, J NEUROSCI, V23, P9403; Gayan J, 1999, AM J HUM GENET, V64, P157, DOI 10.1086/302191; Gayan J, 2003, J EXP CHILD PSYCHOL, V84, P97, DOI 10.1016/S0022-0965(02)00181-9; Gayan J, 2001, DEV NEUROPSYCHOL, V20, P483, DOI 10.1207/S15326942DN2002_3; Goldberg TE, 2004, TRENDS COGN SCI, V8, P325, DOI 10.1016/j.tics.2004.05.011; Grigorenko EL, 2000, AM J HUM GENET, V66, P715, DOI 10.1086/302755; Grigorenko EL, 1997, AM J HUM GENET, V60, P27; Kaplan DE, 2002, AM J HUM GENET, V70, P1287, DOI 10.1086/340449; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lee BH, 2003, VIRUS RES, V98, P83, DOI 10.1016/j.virusres.2003.09.001; Londin ER, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-25; Marlow AJ, 2003, AM J HUM GENET, V72, P561, DOI 10.1086/368201; Marlow AJ, 2001, BEHAV GENET, V31, P219, DOI 10.1023/A:1010209629021; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Paterson SJ, 1999, SCIENCE, V286, P2355, DOI 10.1126/science.286.5448.2355; Paulesu E, 2001, SCIENCE, V291, P2165, DOI 10.1126/science.1057179; Pei HP, 2003, ONCOGENE, V22, P2699, DOI 10.1038/sj.onc.1206374; PENNINGTON BF, 1997, AM J HUM GENET, V60, P27; PETTERSSON F, IN PRESS BIOINFORMAT; Pype S, 2000, J BIOL CHEM, V275, P18586, DOI 10.1074/jbc.M000531200; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Rohde K, 2001, HUM MUTAT, V17, P289, DOI 10.1002/humu.26; SCERRI TS, IN PRESS J MED GENET; SMITH SD, 1996, DYSLEXIA OTHER SPECI; Streets AJ, 2003, J AM SOC NEPHROL, V14, P1804, DOI 10.1097/01.ASN.0000076075.49819.9B; Taipale M, 2003, P NATL ACAD SCI USA, V100, P11553, DOI 10.1073/pnas.1833911100; THOMSON ME, 1982, BRIT J PSYCHOL, V73, P461, DOI 10.1111/j.2044-8295.1982.tb01828.x; Turic D, 2003, MOL PSYCHIATR, V8, P176, DOI 10.1038/sj.mp.4001216; WIGG KG, 2004, IN PRESS MOL PSYCHIA; Zhang YM, 2003, NAT GENET, V34, P181, DOI 10.1038/ng1166	44	194	200	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2004	75	6					1046	1058		10.1086/426404	http://dx.doi.org/10.1086/426404			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867TW	15514892	Bronze, Green Published			2022-12-18	WOS:000224866400009
J	Ware, SM; Peng, JL; Zhu, LR; Fernbach, S; Colicos, S; Casey, B; Towbin, J; Belmont, JW				Ware, SM; Peng, JL; Zhu, LR; Fernbach, S; Colicos, S; Casey, B; Towbin, J; Belmont, JW			Identification and functional analysis of ZIC3 mutations in heterotaxy and related congenital heart defects	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LEFT-RIGHT AXIS; LEFT-RIGHT ASYMMETRY; EXTRACARDIAC ANOMALIES; SITUS ABNORMALITIES; GREAT-ARTERIES; GLI PROTEINS; GENE; TRANSPOSITION; LATERALITY; CFC1	Mutations in the zinc finger transcription factor ZIC3 cause X-linked heterotaxy and have also been identified in patients with isolated congenital heart disease (CHD). To determine the relative contribution of ZIC3 mutations to both heterotaxy and isolated CHD, we screened the coding region of ZIC3 in 194 unrelated patients, including 61 patients with classic heterotaxy, 93 patients with heart defects characteristic of heterotaxy, and 11 patients with situs inversus totalis. Five novel ZIC3 mutations in three classic heterotaxy kindreds and two sporadic CHD cases were identified. None of these alleles was found in 97 ethnically matched control samples. On the basis of these analyses, we conclude that the phenotypic spectrum of ZIC3 mutations should be expanded to include affected females and CHD not typical for heterotaxy. This screening of a cohort of patients with sporadic heterotaxy indicates that ZIC3 mutations account for similar to1% of affected individuals. Missense and nonsense mutations were found in the highly conserved zinc finger - binding domain and in the N-terminal protein domain. Functional analysis of all currently known ZIC3 point mutations indicates that mutations in the putative zinc finger DNA binding domain and in the N-terminal domain result in loss of reporter gene transactivation. It is surprising that transfection studies demonstrate aberrant cytoplasmic localization resulting from mutations between amino acids 253-323 of the ZIC3 protein, indicating that the pathogenesis of a subset of ZIC3 mutations results at least in part from failure of appropriate nuclear localization. These results further expand the phenotypic and genotypic spectrum of ZIC3 mutations and provide initial mechanistic insight into their functional consequences.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Cardiol Sect, Houston, TX 77030 USA; Childrens & Womens Ctr, Vancouver, BC, Canada	Baylor College of Medicine; Baylor College of Medicine	Belmont, JW (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.		Belmont, John/AAH-6084-2021; Ware, Stephanie M./AAF-5577-2020; Belmont, John W/AAI-2494-2019; Towbin, Jeffrey A./J-5595-2019	Belmont, John W/0000-0001-7409-3578; Towbin, Jeffrey A./0000-0002-6585-714X	NHLBI NIH HHS [P01 HL067155, HL67355, HL067155, K08 HL067355] Funding Source: Medline; NICHD NIH HHS [HD41648, K12 HD041648, HD39056, R01 HD039056] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD041648] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL067155, K08HL067355] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aylsworth AS, 2001, AM J MED GENET, V101, P345, DOI 10.1002/ajmg.1219.abs; Bamford RN, 2000, NAT GENET, V26, P365, DOI 10.1038/81695; Bisgrove BW, 2003, ANNU REV GENOM HUM G, V4, P1, DOI 10.1146/annurev.genom.4.070802.110428; Burdine RD, 2000, GENE DEV, V14, P763; CASEY B, 1993, NAT GENET, V5, P403, DOI 10.1038/ng1293-403; CASEY B, 1999, HEART DEV, P479; FERENCZ C, 1997, DEFECTS LATERALITY L; Ferrero GB, 1997, AM J HUM GENET, V61, P395, DOI 10.1086/514857; Gebbia M, 1997, NAT GENET, V17, P305, DOI 10.1038/ng1197-305; Goldmuntz E, 2002, AM J HUM GENET, V70, P776, DOI 10.1086/339079; Gutgesell HP., 1998, SCI PRACT PEDIAT CAR, V1280, P1539; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Kitaguchi T, 2000, DEVELOPMENT, V127, P4787; Kosaki K, 1999, AM J HUM GENET, V64, P712, DOI 10.1086/302289; Kosaki R, 1999, AM J MED GENET, V82, P70, DOI 10.1002/(SICI)1096-8628(19990101)82:1<70::AID-AJMG14>3.0.CO;2-Y; Koyabu Y, 2001, J BIOL CHEM, V276, P6889, DOI 10.1074/jbc.C000773200; Lin AE, 2000, GENET MED, V2, P157, DOI 10.1097/00125817-200005000-00002; Megarbane A, 2000, EUR J HUM GENET, V8, P704, DOI 10.1038/sj.ejhg.5200526; Mercola M, 1999, SEMIN CELL DEV BIOL, V10, P109, DOI 10.1006/scdb.1998.0280; Mercola M, 2001, ANNU REV CELL DEV BI, V17, P779, DOI 10.1146/annurev.cellbio.17.1.779; Mizugishi K, 2001, J BIOL CHEM, V276, P2180, DOI 10.1074/jbc.M004430200; PEOPLES WM, 1983, PEDIATR CARDIOL, V4, P129, DOI 10.1007/BF02076338; PHOON CK, 1994, AM J CARDIOL, V73, P581, DOI 10.1016/0002-9149(94)90338-7; Purandare SM, 2002, DEVELOPMENT, V129, P2293; Robinson SW, 2003, AM J HUM GENET, V72, P1047, DOI 10.1086/374319; Ticho BS, 2000, AM J CARDIOL, V85, P729, DOI 10.1016/S0002-9149(99)00849-8; UEMURA H, 1995, AM J CARDIOL, V76, P846, DOI 10.1016/S0002-9149(99)80243-4; VANPRAAGH S, 1990, DEV CARDIOLOGY MORPH; WARE S, 2003, INBORN ERRORS DEV MO; Watanabe Y, 2002, J MED GENET, V39, P807, DOI 10.1136/jmg.39.11.807	30	194	202	1	12	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2004	74	1					93	105		10.1086/380998	http://dx.doi.org/10.1086/380998			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	759DR	14681828	Bronze, Green Published			2022-12-18	WOS:000187723500009
J	Arking, DE; Becker, DM; Yanek, LR; Fallin, D; Judge, DP; Moy, TF; Becker, LC; Dietz, HC				Arking, DE; Becker, DM; Yanek, LR; Fallin, D; Judge, DP; Moy, TF; Becker, LC; Dietz, HC			KLOTHO allele status and the risk of early-onset occult coronary artery disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; HEART-DISEASE; ENDOTHELIAL DYSFUNCTION; DOWN-REGULATION; ANGIOTENSIN-II; GENE; EXPRESSION; TOMOGRAPHY; PROTECTS; MOUSE	We previously identified a functional variant of KLOTHO (termed "KL-VS"), which harbors two amino acid substitutions in complete linkage disequilibrium and is associated with reduced human longevity when in homozygosity. Klotho-deficient mice display extensive arteriosclerosis when fed a normal diet, suggesting a potent genetic predisposition. To determine whether klotho influences atherosclerotic risk in humans, we performed cross-sectional studies to assess the association between the KL-VS allele and occult coronary artery disease ( CAD) in two independent samples of apparently healthy siblings of individuals with early-onset (age <60 years) CAD ( SIBS-I [N = 520] and SIBS-II [N = 436]). Occult CAD was defined as the occurrence of a reversible perfusion defect during exercise thallium scintigraphy and/or as an abnormal result of an exercise electrocardiogram (SIBS-I, n = 97; SIBS-II, n = 56). In SIBS-I, the KL-VS allele conferred a relative odds of 1.90 ( 95% confidence interval 1.21-2.98) for occult CAD, after adjusting for familial intraclass correlations (P < .005). Logistic regression modeling, incorporating known CAD risk factors, demonstrated that the KL-VS allele is an independent risk factor (P < .019) and that the imposed risk of KL-VS allele status is influenced by modifiable risk factors. Hypertension (P < .022) and increasing high-density lipoprotein cholesterol (HDL-C) levels (P < .004) mask or reduce the risk conferred by the KL-VS allele, respectively, whereas current smoking (P < .004) increases the risk. Remarkably concordant effects of the KL-VS allele and modifying factors on the risk of occult CAD were seen in SIBS- II. These results demonstrate that the KL-VS allele is an independent risk factor for occult CAD in two independent high-risk samples. Modifiable risk factors, including hypertension, smoking status, and HDL-C level, appear to influence the risk imposed by this allele.	Johns Hopkins Univ, Sch Med, Mckusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Ctr Hlth Promot, Div Internal Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Div Cardiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Epidemiol, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Howard Hughes Medical Institute; Johns Hopkins University	Dietz, HC (corresponding author), Johns Hopkins Univ, Sch Med, Mckusick Nathans Inst Genet Med, 720 Rutland Ave,Ross Bldg,Room 858, Baltimore, MD 21205 USA.			Judge, Daniel/0000-0002-3407-0248	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041135] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR00052, M01 RR000052] Funding Source: Medline; NHLBI NIH HHS [R01 HL049762] Funding Source: Medline; NIAMS NIH HHS [R01 AR041135, AR41135] Funding Source: Medline; NINR NIH HHS [NR0224] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		Ahijevych K, 1999, Nicotine Tob Res, V1 Suppl 2, pS59; Aizawa H, 1998, BIOCHEM BIOPH RES CO, V249, P865, DOI 10.1006/bbrc.1998.9246; *AM HEART ASS, 1990, HUM BLOOD PRESS DET, P2460; Arking DE, 2002, P NATL ACAD SCI USA, V99, P856, DOI 10.1073/pnas.022484299; Becker DM, 1998, AM J CARDIOL, V82, P1046, DOI 10.1016/S0002-9149(98)00553-0; Blumenthal RS, 1996, CIRCULATION, V93, P915, DOI 10.1161/01.CIR.93.5.915; Brunner HR, 2001, AM J CARDIOL, V87, p3C; Clark Luther T., 1999, American Journal of Medicine, V107, p22S; Denke MA, 2000, JAMA-J AM MED ASSOC, V284, P2740, DOI 10.1001/jama.284.21.2740; FINTEL DJ, 1989, J AM COLL CARDIOL, V13, P600, DOI 10.1016/0735-1097(89)90600-1; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Fukino K, 2002, BIOCHEM BIOPH RES CO, V293, P332, DOI 10.1016/S0006-291X(02)00216-4; Gavras I, 2002, J HUM HYPERTENS, V16, pS2, DOI 10.1038/sj.jhh.1001392; Hines LM, 2001, NEW ENGL J MED, V344, P549, DOI 10.1056/NEJM200102223440802; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kuvin JT, 2002, AM HEART J, V144, P165, DOI 10.1067/mhj.2002.123145; LIANG KY, 1993, ANNU REV PUBL HEALTH, V14, P43, DOI 10.1146/annurev.pu.14.050193.000355; MCCOMBS RJ, 1994, NEW ENGL J MED, V331, P706, DOI 10.1056/NEJM199409153311104; Mitani H, 2002, HYPERTENSION, V39, P838, DOI 10.1161/01.HYP.0000013734.33441.EA; Morabia A, 2001, PREV MED, V32, P82, DOI 10.1006/pmed.2000.0779; Nagai R, 2000, CELL MOL LIFE SCI, V57, P738, DOI 10.1007/s000180050038; Ordovas JM, 1999, P NUTR SOC, V58, P171, DOI 10.1079/PNS19990023; Saito Y, 2000, BIOCHEM BIOPH RES CO, V276, P767, DOI 10.1006/bbrc.2000.3470; Saito Y, 1998, BIOCHEM BIOPH RES CO, V248, P324, DOI 10.1006/bbrc.1998.8943; SCHILDKRAUT JM, 1989, AM J CARDIOL, V64, P555, DOI 10.1016/0002-9149(89)90477-3; SHEA S, 1984, J AM COLL CARDIOL, V4, P793, DOI 10.1016/S0735-1097(84)80408-8; Shiraki-Iida T, 2000, J GENE MED, V2, P233, DOI 10.1002/1521-2254(200007/08)2:4<233::AID-JGM110>3.0.CO;2-5; Talmud PJ, 2000, ATHEROSCLEROSIS, V149, P75, DOI 10.1016/S0021-9150(99)00309-3; Woods Malaika N., 2001, Ethnicity and Disease, V11, P532; Yuhanna IS, 2001, NAT MED, V7, P853, DOI 10.1038/89986	30	194	210	0	10	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2003	72	5					1154	1161		10.1086/375035	http://dx.doi.org/10.1086/375035			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671PZ	12669274	Green Published, Bronze			2022-12-18	WOS:000182474400008
J	Stoneking, M				Stoneking, M			Hypervariable sites in the mtDNA control region are mutational hotspots	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; SUBSTITUTION RATE VARIATION; RECOMBINATION; HETEROPLASMY	Hypervariable sites in human mtDNA are readily identified in evolutionary studies and are usually assumed to represent mutational hotspots. Recently, an alternative hypothesis was proposed that holds that hypervariable sites may instead reflect ancient mtDNA mutations that have been "shuffled" among different lineages via recombination. These hypotheses can be tested by examining the evolutionary rates for sites at which new mtDNA mutations are observed; if hypervariable sites are mutational hotspots, then newly arisen mtDNA mutations should occur preferentially at hypervariable sites. Results of this study show that both germline and somatic mtDNA mutations occur preferentially at hypervariable sites, which supports the view that hypervariable sites are indeed mutational hotspots.	Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany	Max Planck Society	Stoneking, M (corresponding author), Max Planck Inst Evolutionary Anthropol, Inselstr 22, D-04103 Leipzig, Germany.	stoneking@eva.mpg.de						ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Awadalla P, 1999, SCIENCE, V286, P2524, DOI 10.1126/science.286.5449.2524; AWADALLA P, 2000, SCIENCE, V288, P1931; Bendall KE, 1996, AM J HUM GENET, V59, P1276; Bendall KE, 1997, AM J HUM GENET, V61, P1303, DOI 10.1086/301636; COMAS D, 1995, GENOME RES, V5, P89, DOI 10.1101/gr.5.1.89; Excoffier L, 1999, MOL BIOL EVOL, V16, P1357, DOI 10.1093/oxfordjournals.molbev.a026046; Eyre-Walker A, 1999, P ROY SOC B-BIOL SCI, V266, P477, DOI 10.1098/rspb.1999.0662; Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017; Hagelberg E, 2000, P ROY SOC B-BIOL SCI, V267, P1595, DOI 10.1098/rspb.2000.1183; Hagelberg E, 1999, P ROY SOC B-BIOL SCI, V266, P485, DOI 10.1098/rspb.1999.0663; HASEGAWA M, 1993, J MOL EVOL, V37, P347, DOI 10.1007/BF00178865; Huhne J, 1998, INT J LEGAL MED, V112, P27, DOI 10.1007/s004140050193; Jazin E, 1998, NAT GENET, V18, P109, DOI 10.1038/ng0298-109; Jorde L B, 2000, Science, V288, P1931; Kivisild T, 2000, Science, V288, P1931; Macaulay V, 1999, P ROY SOC B-BIOL SCI, V266, P2037, DOI 10.1098/rspb.1999.0883; Meyer S, 1999, GENETICS, V152, P1103; Parsons TJ, 1997, NAT GENET, V15, P363, DOI 10.1038/ng0497-363; Sharma A, 2000, SCIENCE, V288, P977; Siguroardottir S, 2000, AM J HUM GENET, V66, P1599, DOI 10.1086/302902; Tully LA, 2000, AM J HUM GENET, V67, P432, DOI 10.1086/302996; WAKELEY J, 1993, J MOL EVOL, V37, P613; Wilson MR, 1997, HUM GENET, V100, P167, DOI 10.1007/s004390050485	24	194	209	3	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4					1029	1032		10.1086/303092	http://dx.doi.org/10.1086/303092			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	360DL	10968778	Green Published, Bronze			2022-12-18	WOS:000089651100030
J	Stone, AC; Stoneking, M				Stone, AC; Stoneking, M			mtDNA analysis of a prehistoric Oneota population: Implications for the peopling of the new world	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; ANCIENT DNA; AMERINDIAN POPULATION; AMERICAN POPULATIONS; NATIVE-AMERICANS; GENETIC-EVIDENCE; CONTROL REGION; SEQUENCES; POLYMORPHISM; DIVERSITY	mtDNA was successfully extracted from 108 individuals from the Norris Farms Oneota, a prehistoric Native American population, to compare the mtDNA diversity from a pre-Columbian population with contemporary Native American and Asian mtDNA lineages and to examine hypotheses about the peopling of the New World. Haplogroup and hypervariable region I sequence data indicate that the lineages from haplogroups A, B, C, and D are the most common among Native Americans but that they were not the only lineages brought into the New World from Asia. The mtDNA evidence does not support the three-wave hypothesis of migration into the New World but rather suggests a single "wave" of people with considerable mtDNA diversity that exhibits a signature of expansion 23,000-37,000 years ago.	Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Stone, AC (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Lab Mol Systemat & Evolut, 310 Biol Sci W, Tucson, AZ 85721 USA.	acstone@u.arizona.edu	Stone, Anne C/B-5719-2009	Stone, Anne/0000-0001-8021-8314				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; [Anonymous], 1993, MEGA MOL EVOLUTIONAR; ArisBrosou S, 1996, MOL BIOL EVOL, V13, P494, DOI 10.1093/oxfordjournals.molbev.a025610; BAILLIET G, 1994, AM J HUM GENET, V55, P27; BALLINGER SW, 1992, GENETICS, V130, P139; BANDELT HJ, 1995, GENETICS, V141, P743; BATISTA O, 1995, HUM MOL GENET, V4, P921, DOI 10.1093/hmg/4.5.921; BENDALL KE, 1995, AM J HUM GENET, V57, P248; Bonatto SL, 1997, P NATL ACAD SCI USA, V94, P1866, DOI 10.1073/pnas.94.5.1866; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CHOU Q, 1992, NUCLEIC ACIDS RES, V20, P1717, DOI 10.1093/nar/20.7.1717; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; Easton RD, 1996, AM J HUM GENET, V59, P213; EXCOFFIER L, 1992, GENETICS, V131, P479; Forster P, 1996, AM J HUM GENET, V59, P935; Fox CL, 1996, HUM BIOL, V68, P855; GINTHER C, 1993, EXS, V67, P211; Greenberg J. H, 1987, LANGUAGE AM; GREENBERG JH, 1986, CURR ANTHROPOL, V27, P477, DOI 10.1086/203472; HAGELBERG E, 1991, P ROY SOC B-BIOL SCI, V244, P45, DOI 10.1098/rspb.1991.0049; Handt O, 1996, AM J HUM GENET, V59, P368; HANDT O, 1995, THESIS L MAXIMILLIAN; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; HASEGAWA M, 1993, J MOL EVOL, V37, P347, DOI 10.1007/BF00178865; HAUSWIRTH WW, 1994, EXPERIENTIA, V50, P585, DOI 10.1007/BF01921729; Horai S, 1996, AM J HUM GENET, V59, P579; HORAI S, 1993, MOL BIOL EVOL, V10, P23; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; HORAI S, 1990, AM J HUM GENET, V46, P828; HOSS M, 1993, NUCLEIC ACIDS RES, V21, P3913, DOI 10.1093/nar/21.16.3913; KOLMAN CJ, 1995, GENETICS, V140, P275; Kolman CJ, 1996, GENETICS, V142, P1321; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Lahermo P, 1996, AM J HUM GENET, V58, P1309; LUM JK, 1994, HUM BIOL, V66, P567; Merriwether DA, 1996, MOL PHYLOGENET EVOL, V5, P241, DOI 10.1006/mpev.1996.0017; Merriwether DA, 1996, AM J HUM GENET, V59, P204; MERRIWETHER DA, 1995, AM J PHYS ANTHROPOL, V98, P411, DOI 10.1002/ajpa.1330980404; MILNER GR, 1989, AM J PHYS ANTHROPOL, V80, P49, DOI 10.1002/ajpa.1330800107; MORIN PA, 1994, SCIENCE, V265, P1193, DOI 10.1126/science.7915048; PAABO S, 1989, P NATL ACAD SCI USA, V86, P1939, DOI 10.1073/pnas.86.6.1939; PAABO S, 1988, NUCLEIC ACIDS RES, V16, P9775, DOI 10.1093/nar/16.20.9775; Parr RL, 1996, AM J PHYS ANTHROPOL, V99, P507; REDD AJ, 1995, MOL BIOL EVOL, V12, P604; Richards M, 1996, AM J HUM GENET, V59, P185; RICHARDS MB, 1995, J ARCHAEOL SCI, V22, P291, DOI 10.1006/jasc.1995.0031; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANTOS M, 1994, HUM BIOL, V66, P963; SANTURE SK, 1990, 45 ILL STAT MUS; SCHNEIDER S, 1997, ARLEQUIN EXPLORATORY; SCHURR TG, 1990, AM J HUM GENET, V46, P613; SHERRY ST, 1994, HUM BIOL, V66, P761; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; SLATKIN M, 1991, GENETICS, V129, P555; STONE AC, 1993, AM J PHYS ANTHROPOL, V92, P463, DOI 10.1002/ajpa.1330920405; Stone AC, 1996, AM J PHYS ANTHROPOL, V99, P231; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; Strimmer K., 1997, PUZZLE MAXIMUM LIKEL; Szathmary Emoke J. E., 1993, EVOL ANTHROPOL, V1, P202; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; TAMURA K, 1997, MEBOOT; Thornton R., 1987, AM INDIAN HOLOCAUST; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; TORRONI A, 1995, AM J HUM GENET, V56, P1234; TORRONI A, 1994, AM J HUM GENET, V54, P303; TORRONI A, 1994, P NATL ACAD SCI USA, V91, P1158, DOI 10.1073/pnas.91.3.1158; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; Turner C G 2nd, 1984, Acta Anthropogenet, V8, P23; UBELAKER DH, 1988, AM J PHYS ANTHROPOL, V77, P289, DOI 10.1002/ajpa.1330770302; UBELAKER DH, 1992, HUM BIOL, V64, P361; VIGILANT L, 1989, P NATL ACAD SCI USA, V86, P9350, DOI 10.1073/pnas.86.23.9350; VIGILANT L, 1990, THESIS U CALIFORNIA; WAKELEY J, 1993, J MOL EVOL, V37, P613; WALLACE DC, 1985, AM J PHYS ANTHROPOL, V68, P149, DOI 10.1002/ajpa.1330680202; WALLACE DC, 1992, HUM BIOL, V64, P403; Ward RH, 1996, AM J HUM BIOL, V8, P317, DOI 10.1002/(SICI)1520-6300(1996)8:3<317::AID-AJHB2>3.0.CO;2-X; WARD RH, 1993, P NATL ACAD SCI USA, V90, P10663, DOI 10.1073/pnas.90.22.10663; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; Watson E, 1996, AM J HUM GENET, V59, P437; WRISCHNIK LA, 1987, NUCLEIC ACIDS RES, V15, P529, DOI 10.1093/nar/15.2.529	85	194	200	1	101	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1998	62	5					1153	1170		10.1086/301838	http://dx.doi.org/10.1086/301838			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZL922	9545408	Bronze, Green Published			2022-12-18	WOS:000073487000021
J	Shapria, SK; McCaskill, C; Northrup, H; Spikes, AS; Elder, FFB; Sutton, VR; Korenberg, JR; Greenberg, F; Shaffer, LG				Shapria, SK; McCaskill, C; Northrup, H; Spikes, AS; Elder, FFB; Sutton, VR; Korenberg, JR; Greenberg, F; Shaffer, LG			Chromosome 1p36 deletions: The clinical phenotype and molecular characterization of a common newly delineated syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TERMINAL DELETION; DIAGNOSIS; CONFIRMATION; CONSEQUENCES; MONOSOMY; FEATURES; DISTAL; REGION; DNA; 5P	Deletions of the distal short arm of chromosome 1 (1p36) represent a common, newly delineated deletion syndrome, characterized by moderate to severe psychomotor retardation, seizures, growth delay, and dysmorphic features. Previous cytogenetic underascertainment of this chromosomal deletion has made it difficult to characterize the clinical and molecular aspects of the syndrome. Recent advances in cytogenetic technology, particularly FISH, have greatly improved the ability to identify 1p36 deletions and have allowed a clearer definition of the clinical phenotype and molecular characteristics of this syndrome. We have identified 14 patients with chromosome 1p36 deletions and have assessed the frequency of each phenotypic feature and clinical manifestation in the 13 patients with pure 1p36 deletions. The physical extent and parental origin of each deletion were determined by use of FISH probes an cytogenetic preparations and by analysis of polymorphic DNA markers in the patients and their available parents. Clinical examinations revealed that the most common features and medical problems in patients with this deletion syndrome include large anterior fontanelle (100%), motor delay/hypotonia (32%), moderate to severe mental retardation (92%), growth delay (85%), pointed chin (80%), eye/vision problems (75%), seizures (72%), flat nasal bridge (65%), clinodactyly and/or short fifth finger(s) (64%), low-set ear(s) (53%), ear asymmetry (57%), hearing deficits (56%), abusive behavior (56%), thickened ear helices (53%), and deep-set eyes (50%). FISH and DNA polymorphism analysis showed that there is no uniform region of deletion but, rather, a spectrum of different deletion sizes with a common minimal region of deletion overlap.	BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; UNIV TEXAS,SCH MED,DEPT PATHOL,HOUSTON,TX 77030; UNIV TEXAS,SCH MED,DEPT PEDIAT,HOUSTON,TX 77030; CEDARS SINAI MED CTR,DIV MED GENET,LOS ANGELES,CA 90048; NIH,NATL CTR HUMAN GENOME RES,BETHESDA,MD 20892	Baylor College of Medicine; University of Texas System; University of Texas System; Cedars Sinai Medical Center; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Shapria, SK (corresponding author), BAYLOR COLL MED,DEPT MOL & HUMAN GENET,1 BAYLOR PLAZA,HOUSTON,TX 77030, USA.							BARBI G, 1992, AM J MED GENET, V43, P722, DOI 10.1002/ajmg.1320430414; BIEGEL JA, 1993, AM J HUM GENET, V52, P176; BUNNELL BA, 1990, P NATL ACAD SCI USA, V87, P7467, DOI 10.1073/pnas.87.19.7467; BURN J, 1995, DEVELOPMENTAL MECHANISMS OF HEART DISEASE, P559; BUROKER N, 1987, HUM GENET, V77, P175, DOI 10.1007/BF00272388; BUTLER MG, 1990, AM J MED GENET, V35, P319, DOI 10.1002/ajmg.1320350306; CHURCH DM, 1995, AM J HUM GENET, V56, P1162; DESANGLES F, 1983, ANN GENET-PARIS, V26, P53; GERSH M, 1995, AM J HUM GENET, V56, P1404; HAIN D, 1980, AUST PAEDIATR J, V16, P196; Jensen SJ, 1997, GENOMICS, V42, P126, DOI 10.1006/geno.1997.4714; KEPPLERNOREUIL KM, 1995, J MED GENET, V32, P619, DOI 10.1136/jmg.32.8.619; KORENBERG JR, 1994, P NATL ACAD SCI USA, V91, P4997, DOI 10.1073/pnas.91.11.4997; LEAO JC, 1967, J AMER MED ASSOC, V202, P434, DOI 10.1001/jama.202.5.434; LEJEUNE J, 1963, CR HEBD ACAD SCI, V257, P3098; LUDECKE HJ, 1995, HUM MOL GENET, V4, P31, DOI 10.1093/hmg/4.1.31; MAGENIS R E, 1987, American Journal of Human Genetics, V41, pA130; NIEBUHR E, 1978, HUM GENET, V44, P227, DOI 10.1007/BF00394291; Ning Y, 1996, NAT GENET, V14, P86, DOI 10.1038/ng0996-86; REISH O, 1995, AM J MED GENET, V59, P467, DOI 10.1002/ajmg.1320590413; Sandlin C. J., 1995, American Journal of Human Genetics, V57, pA125; SHAFFER LG, 1993, AM J MED GENET, V47, P383, DOI 10.1002/ajmg.1320470317; SHAFFER LG, 1994, AM J HUM GENET, V55, P968; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; SPENCE JE, 1987, HUM GENET, V76, P5; STEELE MW, 1984, CLIN GENET, V25, P59; WARGOWSKI D, 1991, AM J HUM GENET, V49, P278; WATT JL, 1986, HUMAN CYTOGENETICS P, P39; WENGER SL, 1988, J MED GENET, V25, P263, DOI 10.1136/jmg.25.4.263; WEXLER P, 1991, AM J HUM GENET, V49, P278; WOLF U, 1965, HUMANGENETIK, V1, P397; YUNIS E, 1981, HUM GENET, V56, P279, DOI 10.1007/BF00274679	32	194	196	0	12	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1997	61	3					642	650		10.1086/515520	http://dx.doi.org/10.1086/515520			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XY523	9326330	Bronze, Green Published			2022-12-18	WOS:A1997XY52300022
J	YU, S; MULLEY, J; LOESCH, D; TURNER, G; DONNELLY, A; GEDEON, A; HILLEN, D; KREMER, E; LYNCH, M; PRITCHARD, M; SUTHERLAND, GR; RICHARDS, RI				YU, S; MULLEY, J; LOESCH, D; TURNER, G; DONNELLY, A; GEDEON, A; HILLEN, D; KREMER, E; LYNCH, M; PRITCHARD, M; SUTHERLAND, GR; RICHARDS, RI			FRAGILE-X SYNDROME - UNIQUE GENETICS OF THE HERITABLE UNSTABLE ELEMENT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEGREGATION ANALYSIS; MUSCULAR-DYSTROPHY; HUMAN DNA; CHROMOSOME; LOCUS	The fragile site at Xq27.3 is an unstable microsatellite repeat, p(CCG)n. In fragile-X syndrome pedigrees, this sequence exhibits variable amplification, the length of which correlates with fragile-site expression. There is a direct relationship between increased p(CCG)n copy number and propensity for instability: individuals having large amplifications exhibit somatic variation due to increased instability. The instability of the p(CCG)n repeat, when transmitted through affected pedigrees, explains the unusual segregation patterns of fragile-X phenotype, referred to as the Sherman paradox. All individuals of fragile-X genotype were found (where testing was possible) to have a parent with amplified p(CCG)n repeat, indicating that few, if any, cases of fragile-X syndrome are not familial.	ADELAIDE CHILDRENS HOSP INC,DEPT CYTOGENET & MOLEC GENET,ADELAIDE,SA 5006,AUSTRALIA; LA TROBE UNIV,DEPT PSYCHOL,BUNDOORA,VIC 3083,AUSTRALIA; PRINCE WALES CHILDRENS HOSP,DEPT GENET,SYDNEY,AUSTRALIA	La Trobe University			Kremer, Eric J/D-3734-2013; Gedeon, Agi/G-7890-2011; Richards, Robert/ABE-6423-2020; Sutherland, Grant Robert/D-2606-2012	Kremer, EJ/0000-0001-6114-7530; Loesch, Danuta/0000-0002-2180-2606; Richards, Robert Ian/0000-0002-5978-6453				BELL MV, 1991, CELL, V64, P861, DOI 10.1016/0092-8674(91)90514-Y; BODRUG SE, 1987, SCIENCE, V237, P1620, DOI 10.1126/science.3629260; CHAMBERLAIN JS, 1988, NUCLEIC ACIDS RES, V16, P11141, DOI 10.1093/nar/16.23.11141; DRACOPOLI NC, 1991, GENOMICS, V9, P686, DOI 10.1016/0888-7543(91)90362-I; FU YH, 1991, CELL, V67, P1; GONZALEZ IL, 1985, P NATL ACAD SCI USA, V82, P7666, DOI 10.1073/pnas.82.22.7666; KOGAN SC, 1987, NEW ENGL J MED, V317, P985, DOI 10.1056/NEJM198710153171603; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; LAIRD CD, 1987, GENETICS, V117, P587; MULLEY JC, 1987, AM J MED GENET, V27, P435, DOI 10.1002/ajmg.1320270222; OBERLE I, 1991, SCIENCE, V252, P1087; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; RICHARDS RI, 1991, J MED GENET, V28, P818, DOI 10.1136/jmg.28.12.818; RICHARDS RI, 1991, AM J HUM GENET, V48, P1051; SHERMAN SL, 1985, HUM GENET, V69, P289, DOI 10.1007/BF00291644; SHERMAN SL, 1984, ANN HUM GENET, V48, P21, DOI 10.1111/j.1469-1809.1984.tb00830.x; SHERMAN SL, 1986, HUM GENET, V72, P123; Sutherland G, 1985, FRAGILE SITES HUMAN; SUTHERLAND GR, 1985, TRENDS GENET, V1, P108, DOI 10.1016/0168-9525(85)90042-3; SUTHERLAND GR, 1990, CLIN GENET, V37, P167; SUTHERLAND GR, 1991, NEW ENGL J MED, V325, P1720, DOI 10.1056/NEJM199112123252407; SUTHERLAND GR, 1991, LANCET, V338, P289, DOI 10.1016/0140-6736(91)90426-P; SUTHERS GK, 1991, GENOMICS, V9, P37, DOI 10.1016/0888-7543(91)90218-4; SUTHERS GK, 1991, AM J HUM GENET, V48, P460; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; VINCENT A, 1991, NATURE, V349, P624, DOI 10.1038/349624a0; WEBER JL, 1989, AM J HUM GENET, V44, P388; WYMAN AR, 1980, P NATL ACAD SCI-BIOL, V77, P6754, DOI 10.1073/pnas.77.11.6754; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179; ZHU QS, 1990, NUCLEIC ACIDS RES, V18, P7119, DOI 10.1093/nar/18.23.7119	30	194	199	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1992	50	5					968	980						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HR473	1570846				2022-12-18	WOS:A1992HR47300010
J	SUTHERLAND, GR				SUTHERLAND, GR			HERITABLE FRAGILE SITES ON HUMAN-CHROMOSOMES .2. DISTRIBUTION, PHENOTYPIC EFFECTS, AND CYTOGENETICS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											SUTHERLAND, GR (corresponding author), ADELAIDE CHILDRENS HOSP,DEPT HISTOPATHOL,CYTOGENET UNIT,N ADELAIDE 5006,S AUSTRALIA,AUSTRALIA.		Sutherland, Grant Robert/D-2606-2012					BERG JM, 1969, LANCET, V1, P531; Brogger A, 1968, Tidsskr Nor Laegeforen, V88, P1741; BUHLER EM, 1970, HUMANGENETIK, V9, P97, DOI 10.1007/BF00696019; CONEN PE, 1966, AM J DIS CHILD, V112, P429, DOI 10.1001/archpedi.1966.02090140101009; DAY EJ, 1967, LANCET, V2, P1307; DEKABAN A, 1965, J NUCL MED, V6, P740; DRETS ME, 1970, CYTOGENETICS, V9, P333, DOI 10.1159/000130103; EMERIT I, 1967, CIRCULATION, V36, P886, DOI 10.1161/01.CIR.36.6.886; FERGUSONSMITH MA, 1973, ANN GENET-PARIS, V16, P29; FERGUSONSMITH MA, 1977, REC ADELAIDE CHILD H, V1, P278; FORD C E, 1973, P98; FRACCARO M, 1971, ANN GENET-PARIS, V14, P149; FRACCARO M, 1972, CHROMOSOMES TODAY, V3, P138; GERALD PS, 1970, HUMAN POPULATION CYT, P143; GIRAUD F, 1976, HUM GENET, V34, P125, DOI 10.1007/BF00278880; HARVEY J, 1977, J MED GENET, V14, P46, DOI 10.1136/jmg.14.1.46; JACOBS PA, 1974, NATURE, V249, P164, DOI 10.1038/249164a0; LEJEUNE J, 1968, CR ACAD SCI D NAT, V266, P24; LUBS HA, 1969, AM J HUM GENET, V21, P231; MAGENIS RE, 1970, SCIENCE, V170, P85, DOI 10.1126/science.170.3953.85; NOEL B, 1977, EXP CELL RES, V104, P423, DOI 10.1016/0014-4827(77)90107-0; POPE JH, 1968, INT J CANCER, V3, P857, DOI 10.1002/ijc.2910030619; REEVES BR, 1970, HUMANGENETIK, V8, P295, DOI 10.1007/BF00280327; SAVAGE JRK, 1977, NATURE, V270, P513, DOI 10.1038/270513a0; SCHMID E, 1969, NATURE, V221, P387, DOI 10.1038/221387a0; SCHMID W, 1969, HUMANGENETIK, V7, P22, DOI 10.1007/BF00278689; SUTHERLAND GR, 1977, SCIENCE, V197, P265, DOI 10.1126/science.877551; SUTHERLAND GR, 1979, AM J HUM GENET, V31, P125; TARTAGLIA AP, 1966, AM J MED, V41, P990, DOI 10.1016/0002-9343(66)90056-8; WHITE MJD, AUST J ZOOL, V14, P1027; WILLIAMS AJ, 1976, J MENT DEFIC RES, V21, P227	31	194	195	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1979	31	2					136	148						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GZ386	453198				2022-12-18	WOS:A1979GZ38600005
J	Lapunzina, P; Aglan, M; Temtamy, S; Caparros-Martin, JA; Valencia, M; Leton, R; Martinez-Glez, V; Elhossini, R; Amr, K; Vilaboa, N; Ruiz-Perez, VL				Lapunzina, Pablo; Aglan, Mona; Temtamy, Samia; Caparros-Martin, Jose A.; Valencia, Maria; Leton, Rocio; Martinez-Glez, Victor; Elhossini, Rasha; Amr, Khalda; Vilaboa, Nuria; Ruiz-Perez, Victor L.			Identification of a Frameshift Mutation in Osterix in a Patient with Recessive Osteogenesis Imperfecta	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BONE-MINERAL DENSITY; ZINC-FINGER; DNA RECOGNITION; DEFICIENCY; EXPRESSION; VARIANTS; PROTEIN; GROWTH; GENE; SP7	Osteogenesis imperfecta, or "brittle bone disease," is a type collagen-related condition associated with osteoporosis and increased risk of bone fractures. Using a combination of homozygosity mapping and candidate gene approach, we have identified a homozygous single base pair deletion (c.1052delA) in SP7/Osterix (OSX) in an Egyptian child with recessive osteogenesis imperfecta. The clinical findings from this patient include recurrent fractures, mild bone deformities, delayed tooth eruption, normal hearing, and white sclera. OSX encodes a transcription factor containing three Cys2-His2 zinc-finger DNA-binding domains at its C terminus, which, in mice, has been shown to be essential for bone formation. The frameshift caused by the c.1052delA deletion removes the last 81 amino acids of the protein, including the third zinc-finger motif. This finding adds another locus to the spectrum of genes associated with osteogenesis imperfecta and reveals that SP7/OSX also plays a key role in human bone development.	[Lapunzina, Pablo; Caparros-Martin, Jose A.; Valencia, Maria; Leton, Rocio; Martinez-Glez, Victor; Ruiz-Perez, Victor L.] CIBERER, Madrid 28046, Spain; [Lapunzina, Pablo; Martinez-Glez, Victor] Univ Autonoma Madrid, Hosp Univ La Paz IdiPaz, Inst Genet Med & Mol, Madrid 28046, Spain; [Aglan, Mona; Temtamy, Samia; Elhossini, Rasha; Amr, Khalda] Natl Res Ctr, Human Genet & Genome Res Div, Cairo 12311, Egypt; [Caparros-Martin, Jose A.; Valencia, Maria; Leton, Rocio; Ruiz-Perez, Victor L.] Univ Autonoma Madrid, CSIC, Inst Invest Biomed, Madrid 28029, Spain; [Vilaboa, Nuria] Hosp Univ La Paz IdiPaz, Unidad Invest, Madrid 28046, Spain; [Vilaboa, Nuria] CIBERBBN, Madrid 28046, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Autonomous University of Madrid; Hospital Universitario La Paz; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Hospital Universitario La Paz; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN	Ruiz-Perez, VL (corresponding author), CIBERER, Madrid 28046, Spain.	vlruiz@iib.uam.es	Vilaboa, Nuria/L-1727-2014; Leton, Rocio/AAD-7896-2020; Caparros-Martin, José/L-4470-2014; Ruiz-Perez, Victor L/K-6066-2014; Martinez-Glez, Victor/E-2344-2011; Vilaboa, Nuria/S-2794-2019; Lapunzina, Pablo/L-7075-2014	Caparros-Martin, José/0000-0003-1214-4952; Ruiz-Perez, Victor L/0000-0003-0635-3619; Martinez-Glez, Victor/0000-0002-4680-881X; Vilaboa, Nuria/0000-0003-4473-4498; Lapunzina, Pablo/0000-0002-6324-4825; Amr, Khalda/0000-0001-8472-5911; temtamy, samia/0000-0002-6452-823X; aglan, mona/0000-0002-0908-0639	Biomedical Network Research Centre on Rare Diseases (CIBERER); Spanish Ministry of Science and Innovation [SAF-62291]; Ramon Areces Foundation	Biomedical Network Research Centre on Rare Diseases (CIBERER); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ramon Areces Foundation	We thank the patient and his family for their contribution to this research. This work was funded by the Biomedical Network Research Centre on Rare Diseases (CIBERER), the Spanish Ministry of Science and Innovation (SAF-62291), and the Ramon Areces Foundation. We are grateful to Judith Goodship for the critical reading of the manuscript.	Alanay Y, 2010, AM J HUM GENET, V86, P551, DOI 10.1016/j.ajhg.2010.02.022; Baek WY, 2010, BONE, V46, P920, DOI 10.1016/j.bone.2009.12.007; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; BYERS PH, 1992, ANNU REV MED, V43, P269, DOI 10.1146/annurev.me.43.020192.001413; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; CHOO Y, 1994, P NATL ACAD SCI USA, V91, P11168, DOI 10.1073/pnas.91.23.11168; Christiansen HE, 2010, AM J HUM GENET, V86, P389, DOI 10.1016/j.ajhg.2010.01.034; Drogemuller C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000579; Gao YG, 2004, GENE, V341, P101, DOI 10.1016/j.gene.2004.05.026; Ishikawa Y, 2009, J BIOL CHEM, V284, P17641, DOI 10.1074/jbc.M109.007070; Krane SM, 2008, AMINO ACIDS, V35, P703, DOI 10.1007/s00726-008-0073-2; Milona M, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-43; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; NARDELLI J, 1992, NUCLEIC ACIDS RES, V20, P4137, DOI 10.1093/nar/20.16.4137; NARDELLI J, 1991, NATURE, V349, P175, DOI 10.1038/349175a0; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; Styrkarsdottir U, 2009, NAT GENET, V41, P15, DOI 10.1038/ng.284; Suske G, 2005, GENOMICS, V85, P551, DOI 10.1016/j.ygeno.2005.01.005; Timpson NJ, 2009, HUM MOL GENET, V18, P1510, DOI 10.1093/hmg/ddp052; Uno Y, 2001, BIOCHEMISTRY-US, V40, P1787, DOI 10.1021/bi0023596; van Dijk FS, 2009, AM J HUM GENET, V85, P521, DOI 10.1016/j.ajhg.2009.09.001; Warner LE, 1998, NAT GENET, V18, P382, DOI 10.1038/ng0498-382; Yokono M, 1998, BIOCHEMISTRY-US, V37, P6824, DOI 10.1021/bi9727646	28	193	210	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 9	2010	87	1					110	114		10.1016/j.ajhg.2010.05.016	http://dx.doi.org/10.1016/j.ajhg.2010.05.016			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	627HD	20579626	Green Published, Bronze			2022-12-18	WOS:000280029200011
J	Levy-Litan, V; Hershkovitz, E; Avizov, L; Leventhal, N; Bercovich, D; Chalifa-Caspi, V; Manor, E; Buriakovsky, S; Hadad, Y; Goding, J; Parvari, R				Levy-Litan, Varda; Hershkovitz, Eli; Avizov, Luba; Leventhal, Neta; Bercovich, Dani; Chalifa-Caspi, Vered; Manor, Esther; Buriakovsky, Sophia; Hadad, Yair; Goding, James; Parvari, Ruti			Autosomal-Recessive Hypophosphatemic Rickets Is Associated with an Inactivation Mutation in the ENPP1 Gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ARTERIAL CALCIFICATION; LYSOPHOSPHOLIPASE-D; PC-1; PHOSPHODIESTERASE; AUTOTAXIN; LESSONS; PROTEIN; GROWTH; ENZYME	Human disorders of phosphate (Pi) handling and hypophosphatemic rickets have been shown to result from mutations in PHEX, FGF23, and DWP1, presenting as X-linked recessive, autosomal-dominant, and autosomal-recessive patterns, respectively. We present the identification of an inactivating mutation in the ecto-nucteotide pyrophosphatase/phospliodiesterase I (ENPP1) gene causing autosomal-recessive hypophosphatemic rickets (AMR) with phosphaturia by positional cloning. ENPP1 generates inorganic pyrophosphate (PPi), an essential physiologic inhibitor of calcification, and previously described inactivating mutations in this gene were shown to cause aberrant ectopic calcification disorders, whereas no aberrant calcifications were present in our patients. Our surprising result Suggests a different pathway involved in the generation of ARHR and possible additional functions for ENPP1.	[Levy-Litan, Varda; Avizov, Luba; Manor, Esther; Buriakovsky, Sophia; Parvari, Ruti] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Dev Genet & Virol, IL-84105 Beer Sheva, Israel; [Hershkovitz, Eli; Leventhal, Neta] Soroka Med Ctr, Pediat Endocrinol & Metab Unit, IL-84101 Beer Sheva, Israel; [Bercovich, Dani] Migal Galilee Technol Ctr, IL-11016 Kiryat Shmona, Israel; [Bercovich, Dani] Tel Hai Acad Coll, IL-11016 Kiryat Shmona, Israel; [Chalifa-Caspi, Vered; Parvari, Ruti] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Manor, Esther] Soroka Med Ctr, Inst Genet, IL-84105 Beer Sheva, Israel; [Hadad, Yair] Hebrew Univ Jerusalem, Fac Agr Food & Environm Qual Sci, IL-76100 Rehovot, Israel; [Goding, James] Monash Univ, Dept Physiol, Clayton, Vic 3800, Australia	Ben Gurion University; Ben Gurion University; Soroka Medical Center; Tel Hai Academy College; Ben Gurion University; Ben Gurion University; Soroka Medical Center; Hebrew University of Jerusalem; Monash University	Parvari, R (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Dev Genet & Virol, IL-84105 Beer Sheva, Israel.	ruthi@bgu.ac.il	Herskowitz, eli/F-1922-2012	Herskowitz, eli/0000-0003-1624-1960; Chalifa-Caspi, Vered/0000-0001-6030-5816	Israeli Ministry of Health	Israeli Ministry of Health	We wish to thank the family members for their collaboration. We thank El-Ad David Amir and Ofer Bartal for their contribution to the development of KinSNP. This study was funded in part by a grant from the Israeli Ministry of Health to R.P and E.H.	BELLI SI, 1994, EUR J BIOCHEM, V226, P433, DOI 10.1111/j.1432-1033.1994.tb20068.x; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bercovich D, 2003, GENET TEST, V7, P189, DOI 10.1089/109065703322537197; Ciana G, 2006, EUR J PEDIATR, V165, P258, DOI 10.1007/s00431-005-0035-6; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; FRANCIS F, 1995, NAT GENET, V11, P130, DOI 10.1038/ng1095-130; Goding JW, 2003, BBA-MOL BASIS DIS, V1638, P1, DOI 10.1016/S0925-4439(03)00058-9; HARAHAP AR, 1988, J IMMUNOL, V141, P2317; KELLY SJ, 1975, BIOCHEM BIOPH RES CO, V66, P316, DOI 10.1016/S0006-291X(75)80330-5; Koller DL, 2008, J BONE MINER RES, V23, P41, DOI 10.1359/JBMR.071001; Lorenz-Depiereux B, 2006, NAT GENET, V38, P1248, DOI 10.1038/ng1868; Okawa A, 1998, MAMM GENOME, V9, P155, DOI 10.1007/s003359900707; Peltonen L, 2006, HUM MOL GENET, V15, pR67, DOI 10.1093/hmg/ddl060; Rutsch F, 2005, JOINT BONE SPINE, V72, P110, DOI 10.1016/j.jbspin.2004.05.014; Rutsch F, 2003, NAT GENET, V34, P379, DOI 10.1038/ng1221; Sali A.F.J.M., 1999, ECTO ATPASES RELATED, P267; Schiavi SC, 2006, NAT GENET, V38, P1230, DOI 10.1038/ng1106-1230; Solan JL, 1996, J BONE MINER RES, V11, P183; Terkeltaub RA, 2001, AM J PHYSIOL-CELL PH, V281, pC1, DOI 10.1152/ajpcell.2001.281.1.C1; Terkeltaub Robert, 2006, Purinergic Signal, V2, P371, DOI 10.1007/s11302-005-5304-3; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Yamazaki Y, 2002, J CLIN ENDOCR METAB, V87, P4957, DOI 10.1210/jc.2002-021105	24	193	205	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 12	2010	86	2					273	278		10.1016/j.ajhg.2010.01.010	http://dx.doi.org/10.1016/j.ajhg.2010.01.010			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	556ZS	20137772	Bronze, Green Published			2022-12-18	WOS:000274637200018
J	Spiteri, E; Konopka, G; Coppola, G; Bomar, J; Oldham, M; Ou, J; Vernes, SC; Fisher, SE; Ren, B; Geschwind, DH				Spiteri, Elizabeth; Konopka, Genevieve; Coppola, Giovanni; Bomar, Jamee; Oldham, Michael; Ou, Jing; Vernes, Sonja C.; Fisher, Simon E.; Ren, Bing; Geschwind, Daniel H.			Identification of the transcriptional targets of FOXP2, a gene linked to speech and language, in developing human brain	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE LOCATION; BIPOLAR-I-DISORDER; CCK-AR GENE; RECEPTOR GENE; ACCELERATED EVOLUTION; INCREASED EXPRESSION; POSSIBLE ASSOCIATION; INT-1 PROTOONCOGENE; NEURITE OUTGROWTH; PREFRONTAL CORTEX	Mutations in FOXP2, a member of the forkhead family of transcription factor genes, are the only known cause of developmental speech and language disorders in humans. To date, there are no known targets of human FOXP2 in the nervous system. The identification of FOXP2 targets in the developing human brain, therefore, provides a unique tool with which to explore the development of human language and speech. Here, we define FOXP2 targets in human basal ganglia (BG) and inferior frontal cortex (IFC) by use of chromatin immunoprecipitation followed by microarray analysis (ChIP-chip) and validate the functional regulation of targets in vitro. ChIP-chip identified 285 FOXP2 targets in fetal human brain; statistically significant overlap of targets in BG and IFC indicates a core set of 34 transcriptional targets of FOXP2. We identified targets specific to IFC or BG that were not observed in lung, suggesting important regional and tissue differences in FOXP2 activity. Many target genes are known to play critical roles in specific aspects of central nervous system patterning or development, such as neurite outgrowth, as well as plasticity. Subsets of the FOXP2 transcriptional targets are either under positive selection in humans or differentially expressed between human and chimpanzee brain. This is the first ChIP-chip study to use human brain tissue, making the FOXP2-target genes identified in these studies important to understanding the pathways regulating speech and language in the developing human brain. These data provide the first insight into the functional network of genes directly regulated by FOXP2 in human brain and by evolutionary comparisons, highlighting genes likely to be involved in the development of human higher-order cognitive processes.	Univ Calif Los Angeles, Reed Neurol Res Ctr, Dept Neurol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst, Dept Human Genet, Los Angeles, CA USA; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Oxford; Wellcome Centre for Human Genetics; Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Geschwind, DH (corresponding author), Univ Calif Los Angeles, Reed Neurol Res Ctr, Dept Neurol, 710 Westwood Plaza,Rm 1-145, Los Angeles, CA 90095 USA.	Dhg@ucla.edu	Vernes, Sonja/E-8454-2012; Fisher, Simon E./E-9130-2012	Vernes, Sonja/0000-0003-0305-4584; Fisher, Simon E./0000-0002-3132-1996; Konopka, Genevieve/0000-0002-3363-7302	NICHD NIH HHS [N01-HD-4-3368, T32 HD007032, T32HD007032, N01-HD-4-3383] Funding Source: Medline; NIGMS NIH HHS [T32 GM008243, T32GM008243] Funding Source: Medline; NIMH NIH HHS [R21 MH075028, R21MH075028] Funding Source: Medline; Autism Speaks [AS1309] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH075028] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Autism Speaks; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Arion D, 2007, BIOL PSYCHIAT, V62, P711, DOI 10.1016/j.biopsych.2006.12.021; Beima KM, 2006, J BIOL CHEM, V281, P11992, DOI 10.1074/jbc.M513613200; Bel-Vialar S, 2002, DEVELOPMENT, V129, P5103; Belton E, 2003, HUM BRAIN MAPP, V18, P194, DOI 10.1002/hbm.10093; Benes FM, 2007, P NATL ACAD SCI USA, V104, P10164, DOI 10.1073/pnas.0703806104; Caceres M, 2003, P NATL ACAD SCI USA, V100, P13030, DOI 10.1073/pnas.2135499100; Corballis MC, 2004, TRENDS COGN SCI, V8, P95, DOI 10.1016/j.tics.2004.01.007; Crespi BJ, 2007, TRENDS ECOL EVOL, V22, P174, DOI 10.1016/j.tree.2007.01.007; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dorus S, 2004, CELL, V119, P1027, DOI 10.1016/j.cell.2004.11.040; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Fallin MD, 2005, AM J HUM GENET, V77, P918, DOI 10.1086/497703; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; GALABURDA AM, 1978, SCIENCE, V199, P852, DOI 10.1126/science.341314; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Geschwind DH, 2002, P NATL ACAD SCI USA, V99, P3176, DOI 10.1073/pnas.052494999; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Goodman M, 2005, TRENDS GENET, V21, P511, DOI 10.1016/j.tig.2005.06.012; Grossman LI, 2004, TRENDS GENET, V20, P578, DOI 10.1016/j.tig.2004.09.002; HASHIMOTO T, 2007, ALTERATIONS GABA REL; Hobson SA, 2006, J NEUROCHEM, V99, P1000, DOI 10.1111/j.1471-4159.2006.04143.x; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Ivins JK, 2000, J NEUROSCI, V20, P6551, DOI 10.1523/JNEUROSCI.20-17-06551.2000; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Khaitovich P, 2004, GENOME RES, V14, P1462, DOI 10.1101/gr.2538704; Kim TH, 2005, ONCOGENE, V24, P597, DOI 10.1038/sj.onc.1208237; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; Lai CSL, 2003, BRAIN, V126, P2455, DOI 10.1093/brain/awg247; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Le-Niculescu H, 2007, AM J MED GENET B, V144B, P129, DOI 10.1002/ajmg.b.30481; Li SR, 2004, MOL CELL BIOL, V24, P809, DOI 10.1128/MCB.24.2.809-822.2004; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; MacDermot KD, 2005, AM J HUM GENET, V76, P1074, DOI 10.1086/430841; Mansour HA, 2006, GENES BRAIN BEHAV, V5, P150, DOI 10.1111/j.1601-183X.2005.00147.x; Marczyk G. R., 2003, INT J FORENSIC MENT, V2, P7, DOI DOI 10.1080/14999013.2003.10471175; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; MCALLISTER CG, 1989, ARCH GEN PSYCHIAT, V46, P890; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Miller CL, 2004, NEUROBIOL DIS, V15, P618, DOI 10.1016/j.nbd.2003.12.015; Minato T, 2007, PSYCHIAT GENET, V17, P117, DOI 10.1097/YPG.0b013e328011c02e; Miyaoka T, 1999, SCHIZOPHR RES, V38, P1, DOI 10.1016/S0920-9964(98)00179-0; Noble EP, 2003, AM J MED GENET B, V116B, P103, DOI 10.1002/ajmg.b.10005; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Oldham MC, 2006, GENES BRAIN BEHAV, V5, P54, DOI 10.1111/j.1601-183X.2006.00195.x; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Ooashi N, 2005, J CELL BIOL, V170, P1159, DOI 10.1083/jcb.200503157; Perrone L, 2000, BIOCHEM BIOPH RES CO, V275, P203, DOI 10.1006/bbrc.2000.3232; Porteous DJ, 2006, TRENDS MOL MED, V12, P255, DOI 10.1016/j.molmed.2006.04.009; Preuss TM, 2004, NAT REV GENET, V5, P850, DOI 10.1038/nrg1469; Prince VE, 1998, DEV GENES EVOL, V208, P517, DOI 10.1007/s004270050210; Printz DJ, 1999, BIOL PSYCHIAT, V46, P110, DOI 10.1016/S0006-3223(98)00307-2; Qu M, 2007, AM J MED GENET B, V144B, P266, DOI 10.1002/ajmg.b.30322; Reif A, 2006, MOL PSYCHIATR, V11, P286, DOI 10.1038/sj.mp.4001779; Ren B, 2004, METHOD ENZYMOL, V376, P304; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Sanjuan J, 2006, PSYCHIAT GENET, V16, P67, DOI 10.1097/01.ypg.0000185029.35558.bb; Sanjuan J, 2004, EUR PSYCHIAT, V19, P349, DOI 10.1016/j.eurpsy.2004.06.015; Schmidt TR, 2002, GENE, V286, P13, DOI 10.1016/S0378-1119(01)00800-9; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shinkai T, 2002, MOL PSYCHIATR, V7, P560, DOI 10.1038/sj.mp.4001041; Shu WG, 2001, J BIOL CHEM, V276, P27488, DOI 10.1074/jbc.M100636200; Smith MD, 1997, J BIOL CHEM, V272, P1382, DOI 10.1074/jbc.272.2.1382; Stroud JC, 2006, STRUCTURE, V14, P159, DOI 10.1016/j.str.2005.10.005; Sullivan SA, 2001, DEV BIOL, V232, P439, DOI 10.1006/dbio.2001.0191; Sun T, 2005, SCIENCE, V308, P1794, DOI 10.1126/science.1110324; Tachikawa H, 2000, AM J MED GENET, V96, P141, DOI 10.1002/(SICI)1096-8628(20000403)96:2<141::AID-AJMG3>3.0.CO;2-R; Takase K, 2001, SCHIZOPHR RES, V52, P161, DOI 10.1016/S0920-9964(00)00191-2; Teramitsu I, 2004, J NEUROSCI, V24, P3152, DOI 10.1523/JNEUROSCI.5589-03.2004; Teramitsu I, 2006, J NEUROSCI, V26, P7390, DOI 10.1523/JNEUROSCI.1662-06.2006; Terzic J, 1999, INT J DEV BIOL, V43, P501; Thomas EA, 2001, P NATL ACAD SCI USA, V98, P4066, DOI 10.1073/pnas.071056198; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; Toirac I, 2007, PSYCHIAT GENET, V17, P47, DOI 10.1097/YPG.0b013e3280298292; Toyota T, 2004, HUM MOL GENET, V13, P551, DOI 10.1093/hmg/ddh047; Trivier E, 1996, NATURE, V384, P567, DOI 10.1038/384567a0; Vernes SC, 2007, AM J HUM GENET, V81, P1232, DOI 10.1086/522238; Vernes SC, 2006, HUM MOL GENET, V15, P3154, DOI 10.1093/hmg/ddl392; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang B, 2003, J BIOL CHEM, V278, P24259, DOI 10.1074/jbc.M207174200; Wang Z, 2002, AM J MED GENET, V114, P479, DOI 10.1002/ajmg.10408; Watkins KE, 2002, BRAIN, V125, P452, DOI 10.1093/brain/awf058; Watkins KE, 2002, BRAIN, V125, P465, DOI 10.1093/brain/awf057; Watkins KE, 1999, AM J HUM GENET, V65, P1215, DOI 10.1086/302631; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Yang Q, 2000, BIOCHEM J, V345, P335, DOI 10.1042/0264-6021:3450335; Zeniou M, 2002, HUM MOL GENET, V11, P2929, DOI 10.1093/hmg/11.23.2929; Zhang JZ, 2002, GENETICS, V162, P1825; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563	93	193	202	1	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2007	81	6					1144	1157		10.1086/522237	http://dx.doi.org/10.1086/522237			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233NY	17999357	Bronze, Green Submitted, Green Published			2022-12-18	WOS:000251098800003
J	Helgadottir, A; Gretarsdottir, S; St Clair, D; Manolescu, A; Cheung, J; Thorleifsson, G; Pasdar, A; Grant, SFA; Whalley, LJ; Hakonarson, H; Thorsteinsdottir, U; Kong, A; Gulcher, J; Stefansson, K; MacLeod, MJ				Helgadottir, A; Gretarsdottir, S; St Clair, D; Manolescu, A; Cheung, J; Thorleifsson, G; Pasdar, A; Grant, SFA; Whalley, LJ; Hakonarson, H; Thorsteinsdottir, U; Kong, A; Gulcher, J; Stefansson, K; MacLeod, MJ			Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							C-REACTIVE PROTEIN; ISCHEMIC-STROKE; CHILDHOOD INTELLIGENCE; GAELIC ANCESTRY; CONFERS RISK; ATHEROSCLEROSIS; INFLAMMATION; IDENTIFICATION; HOMOCYSTEINE; DISEASE	Cardiovascular diseases, including myocardial infarction (MI) and stroke, most often occur on the background of atherosclerosis, a condition attributed to the interactions between multiple genetic and environmental risk factors. We recently reported a linkage and association study of MI and stroke that yielded a genetic variant, HapA, in the gene encoding 5-lipoxygenase-activating protein (ALOX5AP), that associates with both diseases in Iceland. We also described another ALOX5AP variant, HapB, that associates with MI in England. To further assess the contribution of the ALOX5AP variants to cardiovascular diseases in a population outside Iceland, we genotyped seven single-nucleotide polymorphisms that define both HapA and HapB from 450 patients with ischemic stroke and 710 controls from Aberdeenshire, Scotland. The Icelandic at-risk haplotype, HapA, had significantly greater frequency in Scottish patients than in controls. The carrier frequency in patients and controls was 33.4% and 26.4%, respectively, which resulted in a relative risk of 1.36, under the assumption of a multiplicative model (P = .007). We did not detect association between HapB and ischemic stroke in the Scottish cohort. However, we observed that HapB was overrepresented in male patients. This replication of haplotype association with stroke in a population outside Iceland further supports a role for ALOX5AP in cardiovascular diseases.	deCODE Genet Inc, IS-101 Reykjavik, Iceland; Univ Aberdeen, Sch Med, Aberdeen AB9 2ZD, Scotland; Aberdeen Royal Infirm, Aberdeen, Scotland	University of Aberdeen; University of Aberdeen	Stefansson, K (corresponding author), deCODE Genet Inc, Sturlugata 8, IS-101 Reykjavik, Iceland.	kstefans@decode.is	Manolescu, Andrei/G-4565-2014; St Clair, David/AAN-2412-2021; Stefansson, Kari/AAE-7187-2019; whalley, lawrence j/E-9019-2011	Manolescu, Andrei/0000-0002-0713-4664; Macleod, Mary Joan/0000-0003-2115-8184; Pasdar, Alireza/0000-0002-7864-9729				Aboderin I., 2002, LIFE COURSE PERSPECT; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P443, DOI 10.1161/hq0302.105593; *AM HEART ASS, 2002, HEART DIS STROK STAT; Chen XN, 1999, GENOME RES, V9, P492; Danesh J, 2000, BMJ-BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199; Deary IJ, 2004, J PERS SOC PSYCHOL, V86, P130, DOI 10.1037/0022-3514.86.1.130; Di Napoli M, 2001, STROKE, V32, P917, DOI 10.1161/01.STR.32.4.917; DIXON RAF, 1990, NATURE, V343, P282, DOI 10.1038/343282a0; Duthie SJ, 2002, AM J CLIN NUTR, V75, P908, DOI 10.1093/ajcn/75.5.908; Dwyer JH, 2004, NEW ENGL J MED, V350, P29, DOI 10.1056/NEJMoa025079; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Helgadottir A, 2004, NAT GENET, V36, P233, DOI 10.1038/ng1311; Helgason A, 2000, AM J HUM GENET, V67, P697, DOI 10.1086/303046; Helgason A, 2001, AM J HUM GENET, V68, P723, DOI 10.1086/318785; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; MacLeod MJ, 1999, NEUROLOGY, V53, P418, DOI 10.1212/WNL.53.2.418; Mehrabian M, 2002, CIRC RES, V91, P120, DOI 10.1161/01.RES.0000028008.99774.7F; Meiklejohn DJ, 2001, STROKE, V32, P57, DOI 10.1161/01.STR.32.1.57; MILLER DK, 1990, NATURE, V343, P278, DOI 10.1038/343278a0; Ridker PM, 1998, CIRCULATION, V98, P731, DOI 10.1161/01.CIR.98.8.731; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Spanbroek R, 2003, P NATL ACAD SCI USA, V100, P1238, DOI 10.1073/pnas.242716099; Stefansson H, 2003, AM J HUM GENET, V72, P83, DOI 10.1086/345442; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; Whalley LJ, 2004, AM J CLIN NUTR, V80, P1650, DOI 10.1093/ajcn/80.6.1650	28	193	213	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2005	76	3					505	509		10.1086/428066	http://dx.doi.org/10.1086/428066			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	895HO	15640973	Green Published, Bronze			2022-12-18	WOS:000226851900012
J	Miyamura, Y; Suzuki, T; Kono, M; Inagaki, K; Ito, S; Suzuki, N; Tomita, Y				Miyamura, Y; Suzuki, T; Kono, M; Inagaki, K; Ito, S; Suzuki, N; Tomita, Y			Mutations of the RNA-specific adenosine deaminase gene (DSRAD) are involved in dyschromatosis symmetrica hereditaria	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							UNWINDING ACTIVITY; LINKAGE ANALYSIS; PROTOONCOGENE; LOCUS; ADAR1	Dyschromatosis symmetrica hereditaria (DSH) ( also called "reticulate acropigmentation of Dohi") is a pigmentary genodermatosis of autosomal dominant inheritance characterized by a mixture of hyperpigmented and hypopigmented macules distributed on the dorsal aspects of the hands and feet. To determine the gene responsible for this disease, we performed a genomewide search in three families with DSH and mapped the DSH locus to chromosome 1q21.3. The mutations involved in causing DSH have been identified in the gene that encodes double-stranded RNA-specific adenosine deaminase (DSRAD) as the disease gene.	Nagoya Univ, Grad Sch Med, Dept Dermatol, Showa Ku, Nagoya, Aichi 4668550, Japan	Nagoya University	Tomita, Y (corresponding author), Nagoya Univ, Grad Sch Med, Dept Dermatol, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.		Kono, Michihiro/I-1238-2012	Kono, Michihiro/0000-0003-2639-1583				BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; FLEISCHMAN RA, 1991, P NATL ACAD SCI USA, V88, P10885, DOI 10.1073/pnas.88.23.10885; GIEBEL LB, 1991, P NATL ACAD SCI USA, V88, P8696, DOI 10.1073/pnas.88.19.8696; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; Kono M, 2000, J DERMATOL SCI, V22, P88, DOI 10.1016/S0923-1811(99)00050-X; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; NISHIKAWA S, 1991, EMBO J, V10, P2111, DOI 10.1002/j.1460-2075.1991.tb07744.x; OCONNELL MA, 1995, MOL CELL BIOL, V15, P1389; Oyama M, 1999, BRIT J DERMATOL, V140, P491; PATRIZI A, 1994, ACTA DERM-VENEREOL, V74, P135; Polson AG, 1996, NATURE, V380, P454; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; TOYAMA I, 1910, JPN J DERMATOL UROL, V10, P644; TOYAMA I, 1929, JPN J DERMATOL, V29, P95; WAGNER RW, 1989, P NATL ACAD SCI USA, V86, P2647, DOI 10.1073/pnas.86.8.2647; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765; WANG Y, 1995, J MOL BIOL, V254, P184, DOI 10.1006/jmbi.1995.0610; Xing QH, 2003, AM J HUM GENET, V73, P377, DOI 10.1086/377007; Yang JH, 2003, IMMUNOLOGY, V109, P15, DOI 10.1046/j.1365-2567.2003.01598.x; Zhang XJ, 2003, J INVEST DERMATOL, V120, P776, DOI 10.1046/j.1523-1747.2003.12130.x	24	193	234	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2003	73	3					693	699		10.1086/378209	http://dx.doi.org/10.1086/378209			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	718FG	12916015	Bronze, Green Published			2022-12-18	WOS:000185134000025
J	van Swieten, JC; Brusse, E; de Graaf, BM; Krieger, E; van de Graaf, R; de Koning, I; Maat-Kievit, A; Leegwater, P; Dooijes, D; Oostra, BA; Heutink, P				van Swieten, JC; Brusse, E; de Graaf, BM; Krieger, E; van de Graaf, R; de Koning, I; Maat-Kievit, A; Leegwater, P; Dooijes, D; Oostra, BA; Heutink, P			A mutation in the fibroblast growth factor 14 gene is associated with autosomal dominant cerebral ataxia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPINOCEREBELLAR ATAXIA; TRINUCLEOTIDE-REPEAT; HOMOLOGOUS FACTORS; EXPANSION; POLYGLUTAMINE; CEREBELLAR; BINDING; REGION; DNA	Hereditary spinocerebellar ataxias (SCAs) are a clinically and genetically heterogeneous group of neurodegenerative disorders for which greater than or equal to14 different genetic loci have been identified. In some SCA types, expanded tri- or pentanucleotide repeats have been identified, and the length of these expansions correlates with the age at onset and with the severity of the clinical phenotype. In several other SCA types, no genetic defect has yet been identified. We describe a large, three-generation family with early-onset tremor, dyskinesia, and slowly progressive cerebellar ataxia, not associated with any of the known SCA loci, and a mutation in the fibroblast growth factor 14 (FGF14) gene on chromosome 13q34. Our observations are in accordance with the occurrence of ataxia and paroxysmal dyskinesia in Fgf14-knockout mice. As indicated by protein modeling, the amino acid change from phenylalanine to serine at position 145 is predicted to reduce the stability of the protein. The present FGF14 mutation represents a novel gene defect involved in the neurodegeneration of cerebellum and basal ganglia.	Erasmus MC, Dept Neurol, NL-3000 CA Rotterdam, Netherlands; Erasmus MC, Dept Clin Genet, NL-3000 CA Rotterdam, Netherlands; Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, Nijmegen, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen	van Swieten, JC (corresponding author), Erasmus MC, Dept Neurol, POB 2040, NL-3000 CA Rotterdam, Netherlands.	vanswieten@neur.azr.nl	maat-kievit, anneke/C-7483-2013; Kievit, Anneke/O-8830-2014	Heutink, Peter/0000-0001-5218-1737; Leegwater, Peter/0000-0002-4100-015X; van Swieten, John/0000-0001-6278-6844				De Vos S, 2001, BIOCHEMISTRY-US, V40, P10140, DOI 10.1021/bi010565n; Gwinn-Hardy K, 2000, NEUROLOGY, V55, P800, DOI 10.1212/WNL.55.6.800; Hecht HJ, 2001, ACTA CRYSTALLOGR D, V57, P378, DOI 10.1107/S0907444900020813; Holmes SE, 1999, NAT GENET, V23, P391, DOI 10.1038/70493; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Juvonen V, 2000, ANN NEUROL, V48, P354, DOI 10.1002/1531-8249(200009)48:3<354::AID-ANA10>3.0.CO;2-A; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Koob MD, 1999, NAT GENET, V21, P379, DOI 10.1038/7710; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Matsuura T, 2000, NAT GENET, V26, P191, DOI 10.1038/79911; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Munoz-Sanjuan I, 2000, J BIOL CHEM, V275, P2589, DOI 10.1074/jbc.275.4.2589; Nakamura K, 2001, HUM MOL GENET, V10, P1441, DOI 10.1093/hmg/10.14.1441; O'Hearn E, 2001, NEUROLOGY, V56, P299, DOI 10.1212/WNL.56.3.299; Ornitz DM, 2001, GENOME BIOL, V2; Rasmussen A, 2001, ANN NEUROL, V50, P234, DOI 10.1002/ana.1081; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Smallwood PM, 1996, P NATL ACAD SCI USA, V93, P9850, DOI 10.1073/pnas.93.18.9850; Sobrido MJ, 2001, NEUROLOGY, V57, P1310, DOI 10.1212/WNL.57.7.1310; Vincent JB, 2000, AM J HUM GENET, V66, P819, DOI 10.1086/302803; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang Q, 2000, MECH DEVELOP, V90, P283, DOI 10.1016/S0925-4773(99)00241-5; Wang Q, 2002, NEURON, V35, P25, DOI 10.1016/S0896-6273(02)00744-4; WEBER JL, 1989, AM J HUM GENET, V44, P388; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Zoghbi HY, 1999, CURR OPIN NEUROBIOL, V9, P566, DOI 10.1016/S0959-4388(99)00013-6	27	193	208	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2003	72	1					191	199		10.1086/345488	http://dx.doi.org/10.1086/345488			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	631VE	12489043	Bronze, Green Published			2022-12-18	WOS:000180186800020
J	Zhang, K; Calabrese, P; Nordborg, M; Sun, FZ				Zhang, K; Calabrese, P; Nordborg, M; Sun, FZ			Haplotype block structure and its applications to association studies: Power and study designs	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; COMMON DISEASE GENES; LINKAGE DISEQUILIBRIUM; HUMAN GENOME; TRANSMISSION/DISEQUILIBRIUM TESTS; MARKERS; POPULATION; IDENTIFICATION; RECOMBINATION; INFERENCE	Recent studies have shown that the human genome has a haplotype block structure, such that it can be divided into discrete blocks of limited haplotype diversity. In each block, a small fraction of single-nucleotide polymorphisms (SNPs), referred to as "tag SNPs," can be used to distinguish a large fraction of the haplotypes. These tag SNPs can potentially be extremely useful for association studies, in that it may not be necessary to genotype all SNPs; however, this depends on how much power is lost. Here we develop a simulation study to quantitatively assess the power loss for a variety of study designs, including case-control designs and case-parental control designs. First, a number of data sets containing case-parental or case-control samples are generated on the basis of a disease model. Second, a small fraction of case and control individuals in each data set are genotyped at all the loci, and a dynamic programming algorithm is used to determine the haplotype blocks and the tag SNPs based on the genotypes of the sampled individuals. Third, the statistical power of tests was evaluated on the basis of three kinds of data: (1) all of the SNPs and the corresponding haplotypes, (2) the tag SNPs and the corresponding haplotypes, and (3) the same number of randomly chosen SNPs as the number of tag SNPs and the corresponding haplotypes. We study the power of different association tests with a variety of disease models and block-partitioning criteria. Our study indicates that the genotyping efforts can be significantly reduced by the tag SNPs, without much loss of power. Depending on the specific haplotype block-partitioning algorithm and the disease model, when the identified tag SNPs are only 25% of all the SNPs, the power is reduced by only 4%, on average, compared with a power loss of 12% when the same number of randomly chosen SNPs is used in a two-locus haplotype analysis. When the identified tag SNPs are 14% of all the SNPs, the power is reduced by 9%, compared with a power loss of 21% when the same number of randomly chosen SNPs is used in a two-locus haplotype analysis. Our study also indicates that haplotype-based analysis can be much more powerful than marker-by-marker analysis.	Univ So Calif, Dept Sci Biol, Mol & Computat Biol Program, Los Angeles, CA 90089 USA	University of Southern California	Sun, FZ (corresponding author), Univ So Calif, Dept Sci Biol, Mol & Computat Biol Program, 1042 W 36th Place,DRB-288, Los Angeles, CA 90089 USA.		Sun, Fengzhu/G-4373-2010	Sun, Fengzhu/0000-0002-8552-043X; Nordborg, Magnus/0000-0001-7178-9748	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK053392] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK53392] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CLARK AG, 1990, MOL BIOL EVOL, V7, P111; Clayton D, 1999, AM J HUM GENET, V65, P1161, DOI 10.1086/302566; Cleves MA, 1997, GENET EPIDEMIOL, V14, P337, DOI 10.1002/(SICI)1098-2272(1997)14:4<337::AID-GEPI1>3.3.CO;2-S; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Dawson E, 2002, NATURE, V418, P544, DOI 10.1038/nature00864; Douglas JA, 2001, NAT GENET, V28, P361, DOI 10.1038/ng582; Dudbridge F, 2000, AM J HUM GENET, V66, P2009, DOI 10.1086/302915; Dunning AM, 2000, AM J HUM GENET, V67, P1544, DOI 10.1086/316906; Eisenbarth I, 2001, HUM MOL GENET, V10, P2833, DOI 10.1093/hmg/10.24.2833; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Griffiths R., 1997, PROGR POPULATION GEN, P257; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; KAPLAN N, 1985, THEOR POPUL BIOL, V28, P382, DOI 10.1016/0040-5809(85)90036-X; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; LONG JC, 1995, AM J HUM GENET, V56, P799; McIntyre LM, 2000, GENET EPIDEMIOL, V19, P18, DOI 10.1002/1098-2272(200007)19:1<18::AID-GEPI2>3.0.CO;2-Y; MichalatosBeloin S, 1996, NUCLEIC ACIDS RES, V24, P4841, DOI 10.1093/nar/24.23.4841; Niu TH, 2002, AM J HUM GENET, V70, P157, DOI 10.1086/338446; Nordborg M, 2002, TRENDS GENET, V18, P83, DOI 10.1016/S0168-9525(02)02557-X; OLSON JM, 1994, AM J HUM GENET, V55, P574; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Taillon-Miller P, 2000, NAT GENET, V25, P324, DOI 10.1038/77100; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Zhang K, 2002, P NATL ACAD SCI USA, V99, P7335, DOI 10.1073/pnas.102186799; Zhao HY, 2000, AM J HUM GENET, V67, P936, DOI 10.1086/303073	35	193	211	1	9	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2002	71	6					1386	1394		10.1086/344780	http://dx.doi.org/10.1086/344780			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621KD	12439824	Green Published, Bronze			2022-12-18	WOS:000179586800012
J	Osier, MV; Pakstis, AJ; Soodyall, H; Comas, D; Goldman, D; Odunsi, A; Okonofua, F; Parnas, J; Schulz, LO; Bertranpetit, J; Bonne-Tamir, B; Lu, RB; Kidd, JR; Kidd, KK				Osier, MV; Pakstis, AJ; Soodyall, H; Comas, D; Goldman, D; Odunsi, A; Okonofua, F; Parnas, J; Schulz, LO; Bertranpetit, J; Bonne-Tamir, B; Lu, RB; Kidd, JR; Kidd, KK			A global perspective on genetic variation at the ADH genes reveals unusual patterns of linkage disequilibrium and diversity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LIVER ALCOHOL-DEHYDROGENASE; COMMON DISEASE GENES; METABOLIZING GENES; IBERIAN PENINSULA; HUMAN GENOME; POLYMORPHISMS; ALLELE; LOCUS; MEN; POPULATIONS	Variants of different Class I alcohol dehydrogenase (ADH) genes have been shown to be associated with an effect that is protective against alcoholism. Previous work from our laboratory has shown that the two sites showing the association are in linkage disequilibrium and has identified the ADH1B Arg47His site as causative, with the ADH1C Ile349Val site showing association only because of the disequilibrium. Here, we describe an initial study of the nature of linkage disequilibrium and genetic variation, in population samples from different regions of the world, in a larger segment of the ADH cluster (including the three Class I ADH genes and ADH7). Linkage disequilibrium across similar to40 kb of the Class I ADH cluster is moderate to strong in all population samples that we studied. We observed nominally significant pairwise linkage disequilibrium, in some populations, between the ADH7 site and some Class I ADH sites, at moderate values and at a molecular distance as great as 100 kb. Our data indicate (1) that most ADH-alcoholism association studies have failed to consider many sites in the ADH cluster that may harbor etiologically significant alleles and (2) that the relevance of the various ADH sites will be population dependent. Some individual sites in the Class I ADH cluster show values that are among F-st the highest seen among several dozen unlinked sites that were studied in the same subset of populations. The high values can be attributed to the discrepant frequencies of specific alleles in eastern Asia relative to those Fst in other regions of the world. These alleles are part of a single haplotype that exists at high (>65%) frequency only in the eastern-Asian samples. It seems unlikely that this haplotype, which is rare or unobserved in other populations, reached such high frequency because of random genetic drift alone.	Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; S African Inst Med Res, Human Genom Divers & Dis Res Unit, ZA-2000 Johannesburg, South Africa; Univ Witwatersrand, Johannesburg, South Africa; Univ Pompeu Fabra, Fac Ciencies Salut & Vida, Dept Ciencies Expt & Salut, Barcelona, Spain; NIAAA, Neurogenet Lab, Rockville, MD 20852 USA; Roswell Pk Canc Inst, Dept Gynecol Oncol, Buffalo, NY 14263 USA; Univ Benin, Fac Med, Dept Gynecol & Obstet, Benin, Nigeria; Univ Copenhagen, Hvidovre Hosp, Dept Psychiat, DK-2650 Hvidovre, Denmark; Univ Wisconsin, Milwaukee, WI 53201 USA; Tel Aviv Univ, Sackler Sch Med, Dept Genet, IL-69978 Tel Aviv, Israel; Natl Def Med Ctr, Triserv Gen Hosp, Dept Psychiat, Taipei, Taiwan	Yale University; University of Witwatersrand; Pompeu Fabra University; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Roswell Park Cancer Institute; University of Benin; University of Copenhagen; University of Wisconsin System; University of Wisconsin Milwaukee; Tel Aviv University; Sackler Faculty of Medicine; National Defense Medical Center; Tri-Service General Hospital	Kidd, KK (corresponding author), Yale Univ, Sch Med, Dept Genet, SHM I-351333 Cedar St, New Haven, CT 06520 USA.		Majid, Salma/AAT-2616-2020; Okonofua, Friday/AAB-9703-2021; Comas, David/D-5382-2014; Goldman, David/F-9772-2010; Bertranpetit, Jaume/F-8550-2012	Majid, Salma/0000-0002-1724-5405; Comas, David/0000-0002-5075-0956; Goldman, David/0000-0002-1724-5405; Bertranpetit, Jaume/0000-0003-0100-0590	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA009379, Z01AA000281, Z01AA000302, Z01AA000019] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA09379, R01 AA009379] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Bosch E, 2001, AM J HUM GENET, V68, P1019, DOI 10.1086/319521; BOSRON WF, 1979, BIOCHEM BIOPH RES CO, V91, P1549, DOI 10.1016/0006-291X(79)91241-5; BOSRON WF, 1983, BIOCHEM GENET, V21, P735, DOI 10.1007/BF00498920; CARR LG, 1989, ALCOHOL CLIN EXP RES, V13, P594, DOI 10.1111/j.1530-0277.1989.tb00383.x; Chen WJ, 1996, BRIT J PSYCHIAT, V168, P762, DOI 10.1192/bjp.168.6.762; Comas D, 2000, HUM GENET, V107, P312, DOI 10.1007/s004390000370; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Edenberg HJ, 2000, PROG NUCLEIC ACID RE, V64, P295, DOI 10.1016/S0079-6603(00)64008-4; EDENBERG HJ, 1997, COMPREHENSIVE TOXICO, V3, P119; EDMAN K, 1992, HUM GENET, V90, P395; GOEDDE HW, 1992, HUM GENET, V88, P344; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; Iyengar S, 1998, DNA SEQUENCE, V8, P317, DOI 10.3109/10425179809034076; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Kidd JR, 2000, AM J HUM GENET, V66, P1882, DOI 10.1086/302952; Kidd KK, 1998, HUM GENET, V103, P211, DOI 10.1007/s004390050809; Kidd KK, 1996, ALCOHOL CLIN EXP RES, V20, P697, DOI 10.1111/j.1530-0277.1996.tb01674.x; KIDD KK, 1974, EVOLUTION, V28, P381, DOI [10.2307/2407159, 10.1111/j.1558-5646.1974.tb00759.x]; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; LEWONTIN RC, 1964, GENETICS, V49, P49; Li TK, 2001, ALCOHOL CLIN EXP RES, V25, P136, DOI 10.1111/j.1530-0277.2001.tb02138.x; Long JC, 1998, AM J MED GENET, V81, P216, DOI 10.1002/(SICI)1096-8628(19980508)81:3<216::AID-AJMG2>3.0.CO;2-U; MURRAY JC, 1987, HUM GENET, V76, P274; Neumark YD, 1998, J STUD ALCOHOL, V59, P133, DOI 10.15288/jsa.1998.59.133; Osier M, 1999, AM J HUM GENET, V64, P1147, DOI 10.1086/302317; Osier MV, 2001, NUCLEIC ACIDS RES, V29, P317, DOI 10.1093/nar/29.1.317; Pakstis AJ, 2000, AM J HUM GENET, V67, P24; PAKSTIS AJ, 2002, AM J PHYS ANTHR S34, V117, P121; Peterson RJ, 1999, GENOME RES, V9, P844, DOI 10.1101/gr.9.9.844; POUPON RE, 1992, HEPATOLOGY, V15, P1017, DOI 10.1002/hep.1840150608; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Reich T, 1998, AM J MED GENET, V81, P207, DOI 10.1002/(SICI)1096-8628(19980508)81:3<207::AID-AJMG1>3.3.CO;2-X; Shen YC, 1997, ALCOHOL CLIN EXP RES, V21, P1272, DOI 10.1111/j.1530-0277.1997.tb04448.x; SMITH M, 1986, ADV HUM GENET, V15, P249; Tanaka F, 1997, ALCOHOL CLIN EXP RES, V21, P596, DOI 10.1111/j.1530-0277.1997.tb03808.x; Templeton AR, 2000, GENETICS, V156, P1259; THOMASSON HR, 1994, ALCOHOL CLIN EXP RES, V18, P640, DOI 10.1111/j.1530-0277.1994.tb00923.x; THOMASSON HR, 1991, AM J HUM GENET, V48, P677; Tishkoff SA, 1998, AM J HUM GENET, V62, P1389, DOI 10.1086/301861; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; Wall TL, 1997, ALCOHOL ALCOHOLISM, V32, P129; Wright S., 1969, THEORY GENE FREQUENC, V2, P520; XU Y, 1988, Genomics, V2, P209, DOI 10.1016/0888-7543(88)90004-3; Zhao H, 1999, ANN HUM GENET, V63, P167, DOI 10.1046/j.1469-1809.1999.6320167.x	45	193	206	0	18	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2002	71	1					84	99		10.1086/341290	http://dx.doi.org/10.1086/341290			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	564GY	12050823	Green Published, Bronze			2022-12-18	WOS:000176307700009
J	Pfaff, CL; Parra, EJ; Bonilla, C; Hiester, K; McKeigue, PM; Kamboh, MI; Hutchinson, RG; Ferrell, RE; Boerwinkle, E; Shriver, MD				Pfaff, CL; Parra, EJ; Bonilla, C; Hiester, K; McKeigue, PM; Kamboh, MI; Hutchinson, RG; Ferrell, RE; Boerwinkle, E; Shriver, MD			Population structure in admired populations: Effect of admixture dynamics on the pattern of linkage disequilibrium	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAPPING GENES; ADMIXED POPULATIONS; ETHNIC-DIFFERENCES; DISEASE RISK; MARKERS; DRIFT	Gene now between genetically distinct populations creates linkage disequilibrium (admixture linkage disequilibrium [ALD]) among all loci (linked and unlinked) that have different allele frequencies in the founding populations, We have explored the distribution of ALD by using computer simulation of two extreme models of admixture: the hybrid-isolation (HI) model, in which admixture occurs in a single generation, and the continuous-gene-flow (CGF) model, in which admixture occurs at a steady rate in every generation. Linkage disequilibrium patterns in African American population samples from Jackson, MS, and from coastal South Carolina resemble patterns observed in the simulated CGF populations, in two respects. First, significant association between two loci (FY and AT3) separated by 22 cM was detected in both samples. The retention of ALD over relatively large (>10 cM) chromosomal segments is characteristic of a CGF pattern of admixture but not of an HI pattern. Second, significant associations were also detected between many pairs of unlinked loci, as observed in the CGF simulation results but not in the simulated HI populations. Such a high rate of association between unlinked markers in these populations could result in false-positive linkage signals in an admixture-mapping study. However, we demonstrate that by conditioning on parental admixture, we can distinguish between true linkage and association resulting from shared ancestry. Therefore, populations with a CGF history of admixture not only are appropriate for admixture mapping but also have greater power for detection of linkage disequilibrium over large chromosomal regions than do populations that have experienced a pattern of admixture more similar to the HI model, if methods are employed that detect and adjust for disequilibrium caused by continuous admixture.	Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London, England; Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA; Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA; Univ Texas, Ctr Human Genet, Houston, TX USA; Univ Texas, Inst Mol Med, Houston, TX USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of London; London School of Hygiene & Tropical Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Mississippi; University of Mississippi Medical Center; University of Texas System; University of Texas System	Shriver, MD (corresponding author), Penn State Univ, Dept Anthropol, 409 Carpenter Bldg, University Pk, PA 16802 USA.		Bonilla, Carolina/U-9263-2018; Parra, Esteban J/A-4957-2008	Bonilla, Carolina/0000-0002-9972-6383; Kamboh, M. Ilyas/0000-0002-3453-1438; Shriver, Mark/0000-0003-0006-0479; parra, esteban J/0000-0002-2057-8577	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044672] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053958] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG002154, HG02154] Funding Source: Medline; NHLBI NIH HHS [HL44672] Funding Source: Medline; NIDDK NIH HHS [R01 DK053958, DK53958] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Boehnke M, 2000, NAT GENET, V25, P246, DOI 10.1038/76980; BRISCOE D, 1994, J HERED, V85, P59; Camp NJ, 1997, AM J HUM GENET, V61, P1424, DOI 10.1086/301648; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; Eaves IA, 2000, NAT GENET, V25, P320; EWENS WJ, 1995, AM J HUM GENET, V57, P455; Hamblin MT, 2000, AM J HUM GENET, V66, P1669, DOI 10.1086/302879; Laan M, 1998, AM J HUM GENET, V63, P654, DOI 10.1086/301972; Lautenberger JA, 2000, AM J HUM GENET, V66, P969, DOI 10.1086/302820; LONG JC, 1991, GENETICS, V127, P417; LONG JC, 1995, AM J HUM GENET, V56, P799; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; McKeigue PM, 2000, ANN HUM GENET, V64, P171, DOI 10.1017/S0003480000008022; McKeigue PM, 1997, AM J HUM GENET, V60, P188; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; PARRA EJ, IN PRESS AM J PHYS A; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Shriver MD, 1997, AM J HUM GENET, V60, P957; Sokal R. R., 1995, BIOMETRY PRINCIPLES; STEPHENS JC, 1994, AM J HUM GENET, V55, P809; Taillon-Miller P, 2000, NAT GENET, V25, P324, DOI 10.1038/77100; Terwilliger JD, 1998, CURR OPIN BIOTECH, V9, P578, DOI 10.1016/S0958-1669(98)80135-3; Terwilliger JD, 1998, HUM HERED, V48, P138, DOI 10.1159/000022794	24	193	200	0	7	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2001	68	1					198	207		10.1086/316935	http://dx.doi.org/10.1086/316935			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	392FG	11112661	Bronze, Green Published			2022-12-18	WOS:000166399900018
J	Young, TL; Ronan, SM; Alvear, AB; Wildenberg, SC; Oetting, WS; Atwood, LD; Wilkin, DJ; King, RA				Young, TL; Ronan, SM; Alvear, AB; Wildenberg, SC; Oetting, WS; Atwood, LD; Wilkin, DJ; King, RA			A second locus for familial high myopia maps to chromosome 12q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN GENOME; SULFATE PROTEOGLYCAN; LINKAGE; COLLAGEN; LOCALIZATION; DECORIN; LUMICAN	dMyopia, or nearsightedness, is the most common eye disorder worldwide. "Pathologic" high myopia, or myopia of less than or equal to -6.00 diopters, predisposes individuals to retinal detachment, macular degeneration, cataract, or glaucoma. A locus for autosomal dominant pathologic high myopia has been mapped to 18p11.31. We now report significant linkage of high myopia to at second locus at the 12q21-23 region in a large German/Italian family. The family had no clinical evidence of connective-tissue abnormalities or glaucoma. The average age at diagnosis of myopia was 5.9 years. The average spherical-component refractive error for the affected individuals was -9.47 diopters. Markers flanking or intragenic to the genes for the 18p locus, Stickler syndromes type I and II (12q13.1-q13.3 and 6p21.3), Marfan syndrome (15q21.1), and juvenile glaucoma (chromosome 1q21-q31) showed no linkage to the myopia in this family The maximum LOD score with two-point linkage analysis in this pedigree was 3.85 at a recombination fraction of .0010, for markers D12S1706 and D12S327. Recombination events identified markers D12S1684 and D12S1605 as flanking markers that define a 30.1-cM interval on chromosome 12q21-23, for the second myopia gene. These results confirm genetic heterogeneity of myopia. The identification of this gene may provide insight into the pathophysiology of myopia and eye development.	Univ Minnesota, Dept Ophthalmol, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA; Univ Minnesota, Div Epidemiol, Minneapolis, MN 55455 USA; Natl Human Genome Res Inst, Med Genet Branch, NIH, Bethesda, MD USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Young, TL (corresponding author), Univ Minnesota, Dept Ophthalmol, Box 493,420 Delaware St, Minneapolis, MN 55455 USA.							BIANCO P, 1990, J HISTOCHEM CYTOCHEM, V38, P1549, DOI 10.1177/38.11.2212616; CHAKRAVARTI S, 1995, GENOMICS, V27, P481, DOI 10.1006/geno.1995.1080; Curtin BJ, 1985, THE MYOPIAS, V1; Deere M, 1996, GENOMICS, V38, P399, DOI 10.1006/geno.1996.0643; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FASMAN KH, 1994, NUCLEIC ACIDS RES, V22, P3462, DOI 10.1093/nar/22.17.3462; Flach Florence, 1942, JOUR HEREDITY, V33, P456; FRANCESCHETTI A, 1953, J GENET HUM, V2, P283; Francois J., 1961, HEREDITY OPHTHALMOLO; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HEDBOM E, 1989, J BIOL CHEM, V264, P6898; HEDLUND H, 1994, MATRIX BIOL, V14, P227, DOI 10.1016/0945-053X(94)90186-4; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; *NAT ADV COUNC, 1993, STRAB AMBL VIS PROC; Nowacki PM, 1998, NUCLEIC ACIDS RES, V26, P220, DOI 10.1093/nar/26.1.220; Rada JA, 1997, INVEST OPHTH VIS SCI, V38, P1740; RADA JA, 1993, EXP EYE RES, V56, P635, DOI 10.1006/exer.1993.1081; SCHWARTZ M, 1990, CLIN GENET, V38, P281; SORSBY A, 1962, VISION RES, V2, P309, DOI 10.1016/0042-6989(62)90039-1; SPERDUTO RD, 1983, ARCH OPHTHALMOL-CHIC, V101, P405, DOI 10.1001/archopht.1983.01040010405011; Stewart EA, 1997, GENOME RES, V7, P422, DOI 10.1101/gr.7.5.422; Young TL, 1998, AM J HUM GENET, V63, P109, DOI 10.1086/301907	23	193	213	0	16	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1998	63	5					1419	1424		10.1086/302111	http://dx.doi.org/10.1086/302111			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	138QZ	9792869	Bronze, Green Published			2022-12-18	WOS:000076985200018
J	Bione, S; Sala, C; Manzini, C; Arrigo, G; Zuffardi, O; Banfi, S; Borsani, G; Jonveaux, P; Philippe, C; Zuccotti, M; Ballabio, A; Toniolo, D				Bione, S; Sala, C; Manzini, C; Arrigo, G; Zuffardi, O; Banfi, S; Borsani, G; Jonveaux, P; Philippe, C; Zuccotti, M; Ballabio, A; Toniolo, D			A human homologue of the Drosophila melanogaster diaphanous gene is disrupted in a patient with premature ovarian failure: Evidence for conserved function in oogenesis and implications for human sterility	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LIMB DEFORMITY GENE; HUMAN X-CHROMOSOME; REGION; IDENTIFICATION; CHOROIDEREMIA; TRANSCRIPTS; FORMINS; LOCUS	Premature ovarian failure (POF) is a defect of ovarian development and is characterized by primary or secondary amenorrhea, with elevated levels of serum gonadotropins, or by early menopause. The disorder has been attributed to various causes, including rearrangements of a large "critical region" in the long arm of the X chromosome. Here we report identification, in a family with POF, of a gene that is disrupted by a breakpoint. The gene is the human homologue of the Drosophila melanogaster diaphanous gene; mutated alleles of this gene affect spermatogenesis or oogenesis and lead to sterility. The protein (DIA) encoded by the human gene (DIA) is the first human member of the growing FH1/FH2 protein family. Members of this protein family affect cytokinesis and other actin-mediated morphogenetic processes that are required in early steps of development. We propose that the human DLA gene is one of the genes responsible for POF and that it affects the cell divisions that lead to ovarian follicle formation.	CNR, Inst Genet Biochem & Evolut, I-27100 Pavia, Italy; Univ Pavia, Inst Gen Biol & Med Genet, I-27100 Pavia, Italy; Univ Pavia, Dept Anim Biol, I-27100 Pavia, Italy; Hosp San Raffaele, Dipartimento Biotecnol, Milan, Italy; Hosp San Raffaele, Lab Cytogenet, Milan, Italy; Telethon Inst Genet & Med, Milan, Italy; Univ Nancy Hosp, Genet Lab, Nancy, France	Consiglio Nazionale delle Ricerche (CNR); University of Pavia; University of Pavia; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); CHU de Nancy	Toniolo, D (corresponding author), CNR, Inst Genet Biochem & Evolut, Via Abbiategrasso 207, I-27100 Pavia, Italy.		BALLABIO, Andrea/AAL-2672-2020; Banfi, Sandro/K-3963-2018; Sala, Cinzia Felicita/AAN-1900-2020; Borsani, Giuseppe/B-1709-2010; Toniolo, Daniela/AAE-2969-2019	BALLABIO, Andrea/0000-0003-1381-4604; Banfi, Sandro/0000-0002-6541-8833; Borsani, Giuseppe/0000-0003-0110-1148; Toniolo, Daniela/0000-0001-9545-6032; zuffardi, orsetta/0000-0002-1466-4559; Bione, Silvia/0000-0002-3924-4606; Manzini, M. Chiara/0000-0001-7175-1096; PHILIPPE, Christophe/0000-0001-7098-6520	Telethon [TGM97000, TGM06S01, E.0297] Funding Source: Medline	Telethon(Fondazione Telethon)		AITTOMAKI K, 1995, CELL, V82, P959, DOI 10.1016/0092-8674(95)90275-9; Banfi S, 1996, NAT GENET, V13, P167, DOI 10.1038/ng0696-167; BIONE S, 1993, P NATL ACAD SCI USA, V90, P10977, DOI 10.1073/pnas.90.23.10977; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; CASTRILLON DH, 1994, DEVELOPMENT, V120, P3367; Chan DC, 1996, J BIOL CHEM, V271, P23472, DOI 10.1074/jbc.271.38.23472; Chang F, 1997, J CELL BIOL, V137, P169, DOI 10.1083/jcb.137.1.169; COULAM CB, 1982, FERTIL STERIL, V38, P645; EMMONS S, 1995, GENE DEV, V9, P2482, DOI 10.1101/gad.9.20.2482; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; Harris SD, 1997, EMBO J, V16, P3474, DOI 10.1093/emboj/16.12.3474; Imamura H, 1997, EMBO J, V16, P2745, DOI 10.1093/emboj/16.10.2745; Kohno H, 1996, EMBO J, V15, P6060, DOI 10.1002/j.1460-2075.1996.tb00994.x; Lynch ED, 1997, SCIENCE, V278, P1315, DOI 10.1126/science.278.5341.1315; MAAS RL, 1990, NATURE, V346, P853, DOI 10.1038/346853a0; MERRY DE, 1989, AM J HUM GENET, V45, P530; PETERSEN J, 1995, MOL CELL BIOL, V15, P3697; PHILIPPE C, 1993, GENOMICS, V17, P147, DOI 10.1006/geno.1993.1296; POWELL CM, 1994, AM J MED GENET, V52, P19, DOI 10.1002/ajmg.1320520105; ROSSI E, 1994, GENOMICS, V24, P34, DOI 10.1006/geno.1994.1579; Sala C, 1997, GENOMICS, V40, P123, DOI 10.1006/geno.1996.4542; TAKAI Y, 1995, TRENDS BIOCHEM SCI, V20, P227, DOI 10.1016/S0968-0004(00)89022-2; THERMAN E, 1990, HUM GENET, V85, P455; VANDERMAAREL SM, 1995, EUR J HUM GENET, V3, P207; VASSALLI JD, 1995, CURR BIOL, V5, P476, DOI 10.1016/S0960-9822(95)00095-9; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; WOYCHIK RP, 1990, NATURE, V346, P850, DOI 10.1038/346850a0	27	193	209	0	4	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1998	62	3					533	541		10.1086/301761	http://dx.doi.org/10.1086/301761			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZF407	9497258	Green Published, Bronze			2022-12-18	WOS:000072894400006
J	SCHAID, DJ; SOMMER, SS				SCHAID, DJ; SOMMER, SS			COMPARISON OF STATISTICS FOR CANDIDATE-GENE ASSOCIATION STUDIES USING CASES AND PARENTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HAPLOTYPE-RELATIVE-RISK; PREDISPOSITION; DISEASE; HRR	Studies of association between candidate genes and disease can be designed to use cases with disease, and in place of nonrelated controls, their parents. The advantage of this design is the elimination of spurious differences due to ethnic differences between cases and nonrelated controls. However, several statistical methods of analysis have been proposed in the literature, and the choice of analysis is not always clear. We review some of the statistical methods currently developed and present two new statistical methods aimed at specific genetic hypotheses of dominance and recessivity of the candidate gene. These new methods can be more powerful than other current methods, as demonstrated by simulations. The basis of these new statistical methods is a likelihood approach. The advantage of the likelihood framework is that regression models can be developed to assess genotype-environment interactions, as well as the relative contribution that alleles at the candidate-gene locus make to the relative risk (RR) of disease. This latter development allows testing of (1) whether interactions between alleles exist, on the scale of log RR, and (2) whether alleles originating from the mother or father of a case impart different risks, i.e., genomic imprinting.	MAYO CLIN & MAYO FDN,DEPT MED GENET,ROCHESTER,MN 55905; MAYO CLIN & MAYO FDN,DEPT BIOCHEM & MOLEC BIOL,ROCHESTER,MN 55905	Mayo Clinic; Mayo Clinic	SCHAID, DJ (corresponding author), MAYO CLIN & MAYO FDN,DEPT HLTH SCI RES,BIOSTAT SECT,7 HARWICK,ROCHESTER,MN 55905, USA.				NIMH NIH HHS [R01 MH44762] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Breslow N, 1980, STATISTICAL METHODS, V32; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; GART JJ, 1983, BIOMETRICS, V39, P781, DOI 10.2307/2531109; KHOURY MJ, 1994, AM J HUM GENET, V55, P414; KNAPP M, 1993, AM J HUM GENET, V52, P1085; OTT J, 1989, GENET EPIDEMIOL, V6, P127, DOI 10.1002/gepi.1370060124; RAO CR, 1973, LINEAR STATISTICAL I; RUBINSTEIN P, 1981, HUM IMMUNOL, V3, P384; SCHAID DJ, 1993, AM J HUM GENET, V53, P1114; SOBELL JL, 1992, GENOMICS, V12, P1, DOI 10.1016/0888-7543(92)90398-C; SOBELL JL, 1993, AM J MED GENET, V48, P28, DOI 10.1002/ajmg.1320480108; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096	13	193	204	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1994	55	2					402	409						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NZ336	8037216				2022-12-18	WOS:A1994NZ33600023
J	REIS, A; DITTRICH, B; GREGER, V; BUITING, K; LALANDE, M; GILLESSENKAESBACH, G; ANVRET, M; HORSTHEMKE, B				REIS, A; DITTRICH, B; GREGER, V; BUITING, K; LALANDE, M; GILLESSENKAESBACH, G; ANVRET, M; HORSTHEMKE, B			IMPRINTING MUTATIONS SUGGESTED BY ABNORMAL DNA METHYLATION PATTERNS IN FAMILIAL ANGELMAN AND PRADER-WILLI SYNDROMES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISM; PARENTAL ORIGIN; CHROMOSOME-15 DELETION; D15S11 LOCUS; REGION; GENE; INHERITANCE; EXPRESSION; 15Q11-13; 15Q	The D15S9 and D15S63 Loci in the Prader-Willi/Angelman syndrome region on chromosome 15 are subject to parent-of-origin-specific DNA methylation. We have found two Prader-Willi syndrome families in which the patients carry a maternal methylation imprint on the paternal chromosome. In one of these families, the patients have a small deletion encompassing the gene for the small nuclear ribonucleoprotein polypeptide N, which maps 130 kb telomeric to D15S63. Furthermore, we have identified a pair of nondeletion Angelman syndrome sibs and two isolated Angelman syndrome patients who carry a paternal methylation imprint on the maternal chromosome, These Angelman and Prader-Willi syndrome patients may have a defect in the imprinting process in 15q11-13. We propose a model in which a cis-acting mutation prevents the resetting of the imprinting signal in the germ line and thus disturbs the expression of imprinted genes in this region.	UNIV ESSEN GESAMTHSCH KLINIKUM,INST HUMAN GENET,D-45122 ESSEN,GERMANY; FREE UNIV BERLIN,INST HUMAN GENET,W-1000 BERLIN,GERMANY; HARVARD UNIV,SCH MED,HOWARD HUGHES MED INST,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DIV GENET,BOSTON,MA; KAROLINSKA HOSP,DEPT CLIN GENET,S-10401 STOCKHOLM,SWEDEN	University of Duisburg Essen; Free University of Berlin; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Karolinska Institutet; Karolinska University Hospital			Reis, André/D-2309-2009	Reis, André/0000-0002-6301-6363; Greger, Valerie/0000-0001-7716-3973				ANGELMAN H, 1965, DEV MED CHILD NEUROL, V7, P681; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BUITING K, 1993, HUM MOL GENET, V2, P1991; BUTLER MG, 1983, LANCET, V1, P1285; CLAYTONSMITH J, 1992, AM J MED GENET, V44, P256, DOI 10.1002/ajmg.1320440236; DITTRICH B, 1993, HUM MOL GENET, V2, P1995, DOI 10.1093/hmg/2.12.1995; DITTRICH B, 1992, HUM GENET, V90, P313; DITTRICH B, 1993, HUM MOL GENET, V2, P1509, DOI 10.1093/hmg/2.9.1509; DRISCOLL DJ, 1992, GENOMICS, V13, P917, DOI 10.1016/0888-7543(92)90001-9; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; FOREJT J, 1992, CELL, V70, P443, DOI 10.1016/0092-8674(92)90168-C; GLENN CC, 1993, HUM MOL GENET, V2, P2001, DOI 10.1093/hmg/2.12.2001; GLENN CC, 1993, HUM MOL GENET, V2, P1377, DOI 10.1093/hmg/2.9.1377; HAMABE J, 1990, NUCLEIC ACIDS RES, V18, P5579, DOI 10.1093/nar/18.18.5579; HAMABE J, 1991, AM J MED GENET, V41, P64, DOI 10.1002/ajmg.1320410117; KAPLAN LC, 1987, AM J MED GENET, V28, P45, DOI 10.1002/ajmg.1320280107; KENNERKNECHT I, 1992, CLIN GENET, V41, P303; KITSBERG D, 1993, NATURE, V364, P459, DOI 10.1038/364459a0; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; KNOLL JHM, 1993, HUM MOL GENET, V2, P183, DOI 10.1093/hmg/2.2.183; Kuwano Akira, 1992, Human Molecular Genetics, V1, P417, DOI 10.1093/hmg/1.6.417; LAIRD CD, 1987, GENETICS, V117, P587; LEDBETTER DH, 1981, NEW ENGL J MED, V304, P325, DOI 10.1056/NEJM198102053040604; MAGENIS RE, 1987, AM J MED GENET, V28, P829, DOI 10.1002/ajmg.1320280407; MALCOLM S, 1991, LANCET, V337, P694, DOI 10.1016/0140-6736(91)90278-W; MEIJERSHEIJBOER EJ, 1992, J MED GENET, V29, P853, DOI 10.1136/jmg.29.12.853; MUTIRANGURA A, 1993, HUM MOL GENET, V2, P143, DOI 10.1093/hmg/2.2.143; MUTIRANGURA A, 1992, HUM MOL GENET, V1, P67, DOI 10.1093/hmg/1.1.67; Mutirangura A., 1992, Human Molecular Genetics, V1, P139, DOI 10.1093/hmg/1.2.139-a; NICHOLLS RD, 1989, AM J MED GENET, V33, P66, DOI 10.1002/ajmg.1320330109; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; NICHOLLS RD, 1989, NUCLEIC ACIDS RES, V17, P10140, DOI 10.1093/nar/17.23.10140; ORSTAVIK KH, 1992, AM J MED GENET, V44, P534; OZCELIK T, 1992, NAT GENET, V2, P265, DOI 10.1038/ng1292-265; Prader A., 1956, SCHWEIZ MED WSCHR, V86, P1260, DOI DOI 10.1007/978-3-642-47669-3_24; REIS A, 1993, LANCET, V341, P122, DOI 10.1016/0140-6736(93)92606-T; SAITOH S, 1992, LANCET, V339, P366, DOI 10.1016/0140-6736(92)91686-3; WAGSTAFF J, 1993, AM J HUM GENET, V53, P105; WAGSTAFF J, 1992, NAT GENET, V1, P291, DOI 10.1038/ng0792-291	39	193	194	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1994	54	5					741	747						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NH394	8178815				2022-12-18	WOS:A1994NH39400002
J	Asselbergs, FW; Guo, YR; van Iperen, EPA; Sivapalaratnam, S; Tragante, V; Lanktree, MB; Lange, LA; Almoguera, B; Appelman, YE; Barnard, J; Baumert, J; Beitelshees, AL; Bhangale, TR; Chen, YDI; Gaunt, TR; Gong, Y; Hopewell, JC; Johnson, T; Kleber, ME; Langaee, TY; Li, MY; Li, YR; Liu, KA; McDonough, CW; Meijs, ME; Middelberg, RPS; Musunuru, K; Nelson, CP; O'Connell, JR; Padmanabhan, S; Pankow, JS; Pankratz, N; Rafelt, S; Rajagopalan, R; Romaine, SPR; Schork, NJ; Shaffer, J; Shen, HQ; Smith, EN; Tischfield, SE; van der Most, PJ; van Vliet-Ostaptchouk, JV; Verweij, N; Volcik, KA; Zhang, L; Bailey, KR; Bailey, KM; Bauer, F; Boer, JMA; Braund, PS; Burt, A; Burton, PR; Buxbaum, SG; Chen, W; Cooper-DeHoff, RM; Cupples, LA; deJong, JS; Delles, C; Duggan, D; Fornage, M; Furlong, CE; Glazer, N; Gums, JG; Hastie, C; Holmes, MV; Illig, T; Kirkland, SA; Kivimaki, M; Klein, R; Klein, BE; Kooperberg, C; Kottke-Marchant, K; Kumari, M; LaCroix, AZ; Mallela, L; Murugesan, G; Ordovas, J; Ouwehand, WH; Post, WS; Saxena, R; Scharnagl, H; Schreiner, PJ; Shah, T; Shields, DC; Shimbo, D; Srinivasan, SR; Stolk, RP; Swerdlow, DI; Taylor, HA; Topo, EJ; Toskala, E; van Pelt, JL; van Setten, J; Yusuf, S; Whittaker, JC; Zwinderman, AH; Anand, SS; Balmforth, AJ; Berenson, GS; Bezzina, CR; Boehm, BO; Boerwinkle, E; Casas, JP; Caulfield, MJ; Clarke, R; Connell, JM; Cruickshanks, KJ; Davidson, KW; Day, INM; de Bakker, PIW; Doevendans, PA; Dominiczak, AE; Hall, AS; Hartman, CA; Hengstenberg, C; Hillege, HL; Hofker, MH; Humphries, SE; Jarvik, GP; Johnson, JA; Kaess, BM; Kathiresan, S; Koenig, W; Lawlor, DA; Maerz, W; Melander, O; Mitchell, BD; Montgomery, GW; Munroe, PB; Murray, SS; Newhouse, SJ; Onland-Moret, NC; Poulter, N; Psaty, B; Redline, S; Rich, SS; Rotter, JI; Schunkert, H; Sever, P; Shuldiner, AR; Silverstein, RL; Stanton, A; Thorand, B; Trip, MD; Tsai, MY; van der Harst, P; van der Schoot, E; van der Schouw, YT; Verschuren, WMM; Watkins, H; Wilde, AAM; Wolffenbuttel, BHR; Whitfield, JB; Hovingh, GK; Ballantyne, CM; Wijmenga, C; Reilly, MP; Martin, NG; Wilson, JG; Rader, DJ; Samani, NJ; Reiner, AP; Hegele, RA; Kastelein, JJP; Hingorani, AD; Talmud, PJ; Hakonarson, H; Elbers, CC; Keating, BJ; Drenos, F				Asselbergs, Folkert W.; Guo, Yiran; van Iperen, Erik P. A.; Sivapalaratnam, Suthesh; Tragante, Vinicius; Lanktree, Matthew B.; Lange, Leslie A.; Almoguera, Berta; Appelman, Yolande E.; Barnard, John; Baumert, Jens; Beitelshees, Amber L.; Bhangale, Tushar R.; Chen, Yii-Der Ida; Gaunt, Tom R.; Gong, Yan; Hopewell, Jemma C.; Johnson, Toby; Kleber, Marcus E.; Langaee, Taimour Y.; Li, Mingyao; Li, Yun R.; Liu, Kiang; McDonough, Caitrin W.; Meijs, Matthijs El.; Middelberg, Rita P. S.; Musunuru, Kiran; Nelson, Christopher P.; O'Connell, Jeffery R.; Padmanabhan, Sandosh; Pankow, James S.; Pankratz, Nathan; Rafelt, Suzanne; Rajagopalan, Ramakrishnan; Romaine, Simon P. R.; Schork, Nicholas J.; Shaffer, Jonathan; Shen, Haiqing; Smith, Erin N.; Tischfield, Sam E.; van der Most, Peter J.; van Vliet-Ostaptchouk, Jana V.; Verweij, Niek; Volcik, Kelly A.; Zhang, Li; Bailey, Kent R.; Bailey, Kristian M.; Bauer, Florianne; Boer, Jolanda M. A.; Braund, Peter S.; Burt, Amber; Burton, Paul R.; Buxbaum, Sarah G.; Chen, Wei; Cooper-DeHoff, Rhonda M.; Cupples, L. Adrienne; deJong, Jonas S.; Delles, Christian; Duggan, David; Fornage, Myriam; Furlong, Clement E.; Glazer, Nicole; Gums, John G.; Hastie, Claire; Holmes, Michael V.; Illig, Thomas; Kirkland, Susan A.; Kivimaki, Mika; Klein, Ronald; Klein, Barbara E.; Kooperberg, Charles; Kottke-Marchant, Kandice; Kumari, Meena; LaCroix, Andrea Z.; Mallela, Laya; Murugesan, Gurunathan; Ordovas, Jose; Ouwehand, Willem H.; Post, Wendy S.; Saxena, Richa; Scharnagl, Hubert; Schreiner, Pamela J.; Shah, Tina; Shields, Denis C.; Shimbo, Daichi; Srinivasan, Sathanur R.; Stolk, Ronald P.; Swerdlow, Daniel I.; Taylor, Herman A., Jr.; Topo, Eric J.; Toskala, Elina; van Pelt, Joost L.; van Setten, Jessica; Yusuf, Salim; Whittaker, John C.; Zwinderman, A. H.; Anand, Sonia S.; Balmforth, Anthony J.; Berenson, Gerald S.; Bezzina, Connie R.; Boehm, Bernhard O.; Boerwinkle, Eric; Casas, Juan P.; Caulfield, Mark J.; Clarke, Robert; Connell, John M.; Cruickshanks, Karen J.; Davidson, Karina W.; Day, Ian N. M.; de Bakker, Paul I. W.; Doevendans, Pieter A.; Dominiczak, Anna E.; Hall, Alistair S.; Hartman, Catharina A.; Hengstenberg, Christian; Hillege, Hans L.; Hofker, Marten H.; Humphries, Steve E.; Jarvik, Gail P.; Johnson, Julie A.; Kaess, Bernhard M.; Kathiresan, Sekar; Koenig, Wolfgang; Lawlor, Debbie A.; Maerz, Winfried; Melander, Olle; Mitchell, Braxton D.; Montgomery, Grant W.; Munroe, Patricia B.; Murray, Sarah S.; Newhouse, Stephen J.; Onland-Moret, N. Charlotte; Poulter, Neil; Psaty, Bruce; Redline, Susan; Rich, Stephen S.; Rotter, Jerome I.; Schunkert, Heribert; Sever, Peter; Shuldiner, Alan R.; Silverstein, Roy L.; Stanton, Alice; Thorand, Barbara; Trip, Mieke D.; Tsai, Michael Y.; van der Harst, Pim; van der Schoot, Ellen; van der Schouw, Yvonne T.; Verschuren, W. M. Monique; Watkins, Hugh; Wilde, Arthur A. M.; Wolffenbuttel, Bruce H. R.; Whitfield, John B.; Hovingh, G. Kees; Ballantyne, Christie M.; Wijmenga, Cisca; Reilly, Muredach P.; Martin, Nicholas G.; Wilson, James G.; Rader, Daniel J.; Samani, Nilesh J.; Reiner, Alex P.; Hegele, Robert A.; Kastelein, John J. P.; Hingorani, Aroon D.; Talmud, Philippa J.; Hakonarson, Hakon; Elbers, Clara C.; Keating, Brendan J.; Drenos, Fotios		LifeLines Cohort Study	Large-Scale Gene-Centric Meta-analysis across 32 Studies Identifies Multiple Lipid Loci	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-HEART-DISEASE; FAMILIAL HYPERCHOLESTEROLEMIA; APOLIPOPROTEIN B-100; MISSING HERITABILITY; PLASMA TRIGLYCERIDES; QUANTITATIVE TRAITS; STATISTICAL-MODEL; COMPLEX TRAITS	Genome-wide association studies (GWASs) have identified many SNPs underlying variations in plasma-lipid levels. We explore whether additional loci associated with plasma-lipid phenotypes, such as high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), and triglycerides (TGs), can be identified by a dense gene-centric approach. Our meta-analysis of 32 studies in 66,240 individuals of European ancestry was based on the custom similar to 50,000 SNP genotyping array (the ITMAT-Broad-CARe array) covering similar to 2,000 candidate genes. SNP-lipid associations were replicated either in a cohort comprising an additional 24,736 samples or within the Global Lipid Genetic Consortium. We identified four, six, ten, and four unreported SNPs in established lipid genes for HDL-C, LDL-C, TC, and TGs, respectively. We also identified several lipid-related SNPs in previously unreported genes: DGAT2, HCAR2, GPIHBP1, PPARG, and FTO for HDL-C; SOCS3, APOH, SPTY2D1, BRCA2, and VLDLR for LDL-C; SOCS3, UGT1A1, BRCA2, UBE3B, FCGR2A, CHUK, and INSIG2 for TC; and SERPINF2, C4B, GCK, GATA4, INSR, and LPAL2 for TGs. The proportion of explained phenotypic variance in the subset of studies providing individual-level data was 9.9% for HDL-C, 9.5% for LDL-C, 10.3% for TC, and 8.0% for TGs. This large meta-analysis of lipid phenotypes with the use of a dense gene-centric approach identified multiple SNPs not previously described in established lipid genes and several previously unknown loci. The explained phenotypic variance from this approach was comparable to that from a meta-analysis of GWAS data, suggesting that a focused genotyping approach can further increase the understanding of heritability of plasma lipids.	[Guo, Yiran; Almoguera, Berta; Li, Yun R.; Mallela, Laya; Toskala, Elina; Hakonarson, Hakon; Keating, Brendan J.] Childrens Hosp Philadelphia, Abramson Res Ctr, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Asselbergs, Folkert W.; Tragante, Vinicius; Meijs, Matthijs El.; Doevendans, Pieter A.] Univ Med Ctr Utrecht, Dept Cardiol, Div Heart & Lungs, NL-3508 GA Utrecht, Netherlands; [Asselbergs, Folkert W.; Bauer, Florianne; de Bakker, Paul I. W.; Onland-Moret, N. Charlotte; van der Schouw, Yvonne T.; Elbers, Clara C.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; [Asselbergs, Folkert W.; Tragante, Vinicius; van Setten, Jessica] Univ Med Ctr Utrecht, Dept Med Genet, NL-3584 CX Utrecht, Netherlands; [Guo, Yiran] BGI Shenzhen, Shenzhen 518083, Peoples R China; [van Iperen, Erik P. A.] Durrer Ctr Cardiogenet Res, NL-1105 AZ Amsterdam, Netherlands; [van Iperen, Erik P. A.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [Sivapalaratnam, Suthesh; Hovingh, G. Kees] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Lanktree, Matthew B.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Med, London, ON N6A 3K6, Canada; [Lanktree, Matthew B.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Biochem, London, ON N6A 3K6, Canada; [Lange, Leslie A.] Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC 27514 USA; [Appelman, Yolande E.] Vrije Univ Amsterdam Med Ctr, Dept Cardiol, NL-1081 HV Amsterdam, Netherlands; [Barnard, John; Zhang, Li] Cleveland Clin, Lerner Res Inst, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA; [Baumert, Jens; Thorand, Barbara] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, D-85764 Neuherberg, Germany; [Beitelshees, Amber L.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Bhangale, Tushar R.] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Chen, Yii-Der Ida; Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Gaunt, Tom R.; Day, Ian N. M.; Lawlor, Debbie A.] Univ Bristol, Sch Social & Community Med, Ctr Causal Anal Translat Epidemiol, MRC, Bristol BS8 2BN, Avon, England; [Gong, Yan; Langaee, Taimour Y.; McDonough, Caitrin W.; Cooper-DeHoff, Rhonda M.; Johnson, Julie A.] Univ Florida, Dept Pharmacotherapy & Translat Res, Gainesville, FL 32603 USA; [Gong, Yan; Langaee, Taimour Y.; McDonough, Caitrin W.; Cooper-DeHoff, Rhonda M.; Johnson, Julie A.] Univ Florida, Ctr Pharmacogen, Gainesville, FL 32603 USA; [Hopewell, Jemma C.; Clarke, Robert] Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7BN, England; [Johnson, Toby; Caulfield, Mark J.; Munroe, Patricia B.; Newhouse, Stephen J.] Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, Barts & London Genome Ctr, London EC1M 6BQ, England; [Kleber, Marcus E.] LURIC Study, D-79098 Freiburg, Germany; [Kleber, Marcus E.; Maerz, Winfried] Heidelberg Univ, Med Fac Mannheim, Mannheim Inst Publ Hlth Social & Prevent Med, D-68167 Mannheim, Germany; [Li, Mingyao; Reilly, Muredach P.; Rader, Daniel J.] Univ Penn, Perelman Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Liu, Kiang] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Middelberg, Rita P. S.; Montgomery, Grant W.; Whitfield, John B.; Martin, Nicholas G.] Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [Middelberg, Rita P. S.] Prince Charles Hosp, Dept Med, Chermside, Qld 4032, Australia; [Musunuru, Kiran; de Bakker, Paul I. W.; Kathiresan, Sekar] Broad Inst MIT & Harvard, Cambridge, MA 02141 USA; [Musunuru, Kiran; Kathiresan, Sekar] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Musunuru, Kiran; de Bakker, Paul I. W.; Kathiresan, Sekar] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Nelson, Christopher P.; Rafelt, Suzanne; Braund, Peter S.; Samani, Nilesh J.] Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [O'Connell, Jeffery R.; Shen, Haiqing; Mitchell, Braxton D.; Shuldiner, Alan R.] Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [Padmanabhan, Sandosh; Delles, Christian; Hastie, Claire; Dominiczak, Anna E.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, BHF Glasgow Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland; [Pankow, James S.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Pankratz, Nathan; Tsai, Michael Y.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Rajagopalan, Ramakrishnan; Burt, Amber; Furlong, Clement E.; Jarvik, Gail P.] Univ Washington, Div Med Genet, Dept Med, Seattle, WA 98195 USA; [Rajagopalan, Ramakrishnan; Furlong, Clement E.; Jarvik, Gail P.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Romaine, Simon P. R.; Bailey, Kristian M.; Balmforth, Anthony J.; Hall, Alistair S.] Univ Leeds, Leeds Inst Genet Hlth & Therapeut, Leeds LS2 9JT, W Yorkshire, England; [Schork, Nicholas J.; Topo, Eric J.; Murray, Sarah S.] Scripps Res Inst, La Jolla, CA 92037 USA; [Schork, Nicholas J.; Topo, Eric J.; Murray, Sarah S.] Scripps Translat Sci Inst, La Jolla, CA 92037 USA; [Shaffer, Jonathan; Shimbo, Daichi] Columbia Univ, Dept Med, Ctr Behav Cardiovasc Hlth, New York, NY 10032 USA; [Smith, Erin N.] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA USA; [Smith, Erin N.] Univ Calif San Diego, Sch Med, Radys Childrens Hosp, La Jolla, CA USA; [Tischfield, Sam E.] Weill Cornell Med Coll, Triinst Training Program Computat Biol & Med, New York, NY 10065 USA; [van der Most, Peter J.; Stolk, Ronald P.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9700 RB Groningen, Netherlands; [van Vliet-Ostaptchouk, Jana V.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Med Biol Div,Mol Genet Lab, NL-9700 RB Groningen, Netherlands; [van Vliet-Ostaptchouk, Jana V.; Wolffenbuttel, Bruce H. R.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, NL-9700 RB Groningen, Netherlands; [Verweij, Niek; Hillege, Hans L.; van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, NL-9700 RB Groningen, Netherlands; [Verweij, Niek; Hillege, Hans L.; Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Volcik, Kelly A.] Univ Texas Hlth Sci Ctr, Sch Publ Hlth, Ctr Human Genet, Div Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA; [Bailey, Kent R.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Bauer, Florianne; Elbers, Clara C.] Univ Med Ctr Utrecht, Dept Med Genet, Complex Genet Sect, NL-3584 CG Utrecht, Netherlands; [Boer, Jolanda M. A.; Verschuren, W. M. Monique] Natl Inst Publ Hlth & Environm, NL-3721 MA Bilthoven, Netherlands; [Burton, Paul R.] Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, Leics, England; [Buxbaum, Sarah G.] Jackson State Univ, Jackson Heart Study, Jackson, MS 39217 USA; [Buxbaum, Sarah G.] Jackson State Univ, Sch Hlth Sci, Dept Epidemiol & Biostat, Jackson, MS 39217 USA; [Chen, Wei; Berenson, Gerald S.] Tulane Univ, Dept Epidemiol, New Orleans, LA 70118 USA; [Cupples, L. Adrienne; Glazer, Nicole] Boston Univ, Boston, MA 02215 USA; [Cupples, L. Adrienne] NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; [deJong, Jonas S.; Bezzina, Connie R.; Wilde, Arthur A. M.] Univ Amsterdam, Acad Med Ctr, Dept Clin & Expt Cardiol, Heart Failure Res Ctr, NL-1105 AZ Amsterdam, Netherlands; [Duggan, David] Translat Genom Res Inst, Phoenix, AZ 85004 USA; [Fornage, Myriam; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Gums, John G.] Univ Florida, Dept Pharmacotherapy & Translat Res, Gainesville, FL 32607 USA; [Gums, John G.] Univ Florida, Dept Community Hlth & Family Med, Gainesville, FL 32607 USA; [Holmes, Michael V.; Kivimaki, Mika; Kumari, Meena; Shah, Tina; Casas, Juan P.; Hingorani, Aroon D.] UCL, Inst Epidemiol & Hlth Care, Res Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Illig, Thomas] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, D-85764 Neuherberg, Germany; [Illig, Thomas] Hannover Med Sch, Hannover Unified Biobank, D-30625 Hannover, Germany; [Kirkland, Susan A.] Dalhousie Univ, Dept Med, Halifax, NS B3H 1V7, Canada; [Kirkland, Susan A.] Dalhousie Univ, Dept Epidemiol & Community Hlth, Halifax, NS B3H 1V7, Canada; [Klein, Ronald; Klein, Barbara E.; Cruickshanks, Karen J.] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI 53706 USA; [Kooperberg, Charles; LaCroix, Andrea Z.; Reiner, Alex P.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; [Kottke-Marchant, Kandice; Murugesan, Gurunathan] Cleveland Clin, Pathol & Lab Med Inst, Cleveland, OH 44195 USA; [Ordovas, Jose] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Ouwehand, Willem H.] Univ Cambridge, Dept Haematol, Cambridge CB10 1SA, England; [Ouwehand, Willem H.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Post, Wendy S.] Johns Hopkins Univ, Dept Med, Div Cardiol, Baltimore, MD 21205 USA; [Saxena, Richa] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Saxena, Richa] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Scharnagl, Hubert] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, A-8036 Graz, Austria; [Schreiner, Pamela J.] Univ Minnesota, Sch Publ Hlth, Minneapolis, MN 55455 USA; [Shields, Denis C.] Natl Univ Ireland Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 4, Ireland; [Srinivasan, Sathanur R.] Tulane Univ, Dept Epidemiol, New Orleans, LA 70118 USA; [Swerdlow, Daniel I.] UCL, Inst Epidemiol & Hlth Care, Res Dept Epidemiol & Publ Hlth, Genet Epidemiol Grp, London WC1E 6BT, England; [Taylor, Herman A., Jr.] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39217 USA; [van Pelt, Joost L.] Univ Groningen, Univ Med Ctr Groningen, Lab Ctr, NL-9713 GZ Groningen, Netherlands; [Yusuf, Salim; Anand, Sonia S.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada; [Whittaker, John C.] GlaxoSmithKline, Stevenage SG1 2NY, Herts, England; [Whittaker, John C.] Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England; [Zwinderman, A. H.] Acad Med Ctr, Department Clin Epidemiol Biostat & Bioinformat, NL-1100 DE Amsterdam, Netherlands; [LifeLines Cohort Study] Univ Groningen, Univ Med Ctr Groningen, LifeLines Cohort Study, NL-9700 RB Groningen, Netherlands; [Bezzina, Connie R.] Univ Amsterdam, Acad Med Ctr, Mol & Expt Cardiol Grp, NL-1105 AZ Amsterdam, Netherlands; [Boehm, Bernhard O.] Univ Hosp, Dept Med, Dept Internal Med, D-89069 Ulm, Germany; [Casas, Juan P.] Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England; [Connell, John M.] Univ Dundee, Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland; [Davidson, Karina W.] Columbia Univ, Dept Med, New York, NY 10027 USA; [Davidson, Karina W.] Columbia Univ, Dept Psychiat, New York, NY 10027 USA; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Med Genet, NL-3508 GA Utrecht, Netherlands; [Hartman, Catharina A.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, NL-9700 AR Groningen, Netherlands; [Hengstenberg, Christian; Kaess, Bernhard M.] Univ Regensburg, Klin & Poliklin Innere Med 2, D-93042 Regensburg, Germany; [Hofker, Marten H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Med Biol Sect, NL-9700 RB Groningen, Netherlands; [Humphries, Steve E.; Talmud, Philippa J.; Drenos, Fotios] UCL, Fac Populat Hlth Sci, Inst Cardiovasc Sci, Ctr Cardiovasc Genet, London WC1E 6JF, England; [Koenig, Wolfgang] Univ Ulm, Med Ctr, Dept Internal Med Cardiol 2, D-89081 Ulm, Germany; [Maerz, Winfried] Synlab Acad, D-68165 Mannheim, Germany; [Melander, Olle] Malmo Univ Hosp, Clin Res Ctr, SE-20502 Malmo, Sweden; [Onland-Moret, N. Charlotte] Univ Med Ctr Utrecht, Dept Med Genet, Complex Genet Sect, NL-3508 GA Utrecht, Netherlands; [Poulter, Neil; Sever, Peter] Univ London Imperial Coll Sci Technol & Med, Int Ctr Circulatory Hlth, London W2 1PG, England; [Psaty, Bruce] Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98195 USA; [Psaty, Bruce] Univ Washington, Cardiovasc Hlth Res Unit, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce] Univ Washington, Cardiovasc Hlth Res Unit, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA 98109 USA; [Redline, Susan] Univ Hosp Cleveland, Case Med Ctr, Cleveland, OH 44106 USA; [Redline, Susan] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA; [Schunkert, Heribert] Med Univ Lubeck, Med Klin 2, D-23562 Lubeck, Germany; [Shuldiner, Alan R.] Vet Adm Med Ctr, Geriatr Res & Educ Clin Ctr, Baltimore, MD 21201 USA; [Silverstein, Roy L.] Case Western Reserve Univ, Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; [Silverstein, Roy L.] Case Western Reserve Univ, Cleveland Clin, Lerner Res Inst, Dept Mol Med, Cleveland, OH 44195 USA; [Stanton, Alice] Royal Coll Surgeons Ireland, Dublin 2, Ireland; [Trip, Mieke D.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands; [van der Schoot, Ellen] Sanquin, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands; [Watkins, Hugh] Univ Oxford, Wellcome Trust Ctr Human Genet, Dept Cardiovasc Med, Oxford OX3 7BN, England; [Ballantyne, Christie M.] Baylor Coll Med, Houston, TX 77030 USA; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA; [Samani, Nilesh J.] Glenfield Gen Hosp, Natl Inst Hlth, Res Leicester Cardiovasc Biomed Res Unit, Leicester LE3 9QP, Leics, England; [Hegele, Robert A.] Univ Western Ontario, Robarts Res Inst, London, ON N6A 5K8, Canada; [Kastelein, John J. P.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Beijing Genomics Institute (BGI); University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Western University (University of Western Ontario); Western University (University of Western Ontario); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Cleveland Clinic Foundation; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University System of Maryland; University of Maryland Baltimore; Roche Holding; Genentech; Cedars Sinai Medical Center; University of Bristol; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Oxford; University of London; Queen Mary University London; Ruprecht Karls University Heidelberg; University of Pennsylvania; Pennsylvania Medicine; Northwestern University; Feinberg School of Medicine; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; Prince Charles Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University System of Maryland; University of Maryland Baltimore; University of Glasgow; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Leeds; Scripps Research Institute; Scripps Research Institute; Columbia University; University of California System; University of California San Diego; University of California System; University of California San Diego; Cornell University; University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Mayo Clinic; Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment; University of Leicester; Jackson State University; Jackson State University; Tulane University; Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Amsterdam; Academic Medical Center Amsterdam; Translational Genomics Research Institute; University of Texas System; University of Texas Health Science Center Houston; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of London; University College London; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Hannover Medical School; Dalhousie University; Dalhousie University; University of Wisconsin System; University of Wisconsin Madison; Fred Hutchinson Cancer Center; Cleveland Clinic Foundation; Tufts University; United States Department of Agriculture (USDA); University of Cambridge; Wellcome Trust Sanger Institute; Johns Hopkins University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Medical University of Graz; University of Minnesota System; University of Minnesota Twin Cities; University College Dublin; Tulane University; University of London; University College London; University of Mississippi; University of Mississippi Medical Center; University of Groningen; McMaster University; Population Health Research Institute; GlaxoSmithKline; University of London; London School of Hygiene & Tropical Medicine; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam; Ulm University; University of London; London School of Hygiene & Tropical Medicine; University of Dundee; Columbia University; Columbia University; Utrecht University; Utrecht University Medical Center; University of Groningen; University of Regensburg; University of Groningen; University of London; University College London; Ulm University; SYNLAB Group; Lund University; Skane University Hospital; Utrecht University; Utrecht University Medical Center; Imperial College London; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; Case Western Reserve University; University Hospitals of Cleveland; Case Western Reserve University; University of Virginia; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Royal College of Surgeons - Ireland; University of Amsterdam; Academic Medical Center Amsterdam; University of Oxford; Wellcome Centre for Human Genetics; Baylor College of Medicine; University of Mississippi; University of Mississippi Medical Center; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Western University (University of Western Ontario); University of Amsterdam; Academic Medical Center Amsterdam	Keating, BJ (corresponding author), Childrens Hosp Philadelphia, Abramson Res Ctr, Ctr Appl Genom, Philadelphia, PA 19104 USA.	bkeating@mail.med.upenn.edu; f.drenos@ucl.ac.uk	de Bakker, Paul IW/B-8730-2009; Stanton, Alice V/F-4697-2012; Martin, Nicholas/R-9235-2019; Hegele, Robert/G-3301-2011; Ballantyne, Christie/A-6599-2008; Verweij, Niek/ABC-6249-2021; Dominiczak, Anna F/P-9390-2017; Buxbaum, Sarah G./E-1970-2013; Padmanabhan, Sandosh/S-3963-2016; Wijmenga, Cisca/D-2173-2009; van der Schouw, Yvonne T./F-8327-2014; Jarvik, Gail P/N-6476-2014; Swerdlow, Daniel/A-3497-2009; Davidson, Karina/GWC-0996-2022; Verweij, Niek/A-4499-2017; Thorand, Barbara/B-5349-2014; Montgomery, Grant W/B-7148-2008; Guo, Yiran/H-4120-2011; Hegele, Robert/AAF-6482-2020; Kastelein, John/AAF-7950-2020; Gaunt, Tom R/O-3918-2014; Onland-Moret, N. Charlotte/G-9185-2011; Saxena, Richa/AAG-7279-2020; Rotter, Jerome/AAY-6598-2021; Hall, Alistair/K-1953-2019; Stolk, Ronald P/B-2341-2013; Mitchell, Braxton/CAF-0876-2022; Kivimaki, Mika/B-3607-2012; Boehm, Bernhard Otto/F-8750-2015; Wijmenga, Cisca/AAE-7719-2019; Lanktree, Matthew Bruce/I-9790-2019; Rajagopalan, Ramakrishnan/I-4349-2019; Asselbergs, Folkert W./ABD-6752-2021; Davidson, Karina/AAG-2388-2019; Wolffenbuttel, Bruce/A-8419-2011; Newhouse, Stephen J/C-9330-2011; Hengstenberg, Christian/U-5485-2019; Whittaker, John C/B-8609-2012; Hemingway, Harry/C-1219-2009; Ordovas, Jose/B-8727-2013; Rajagopalan, Ramakrishnan/Q-9018-2016; Franke, Lude/P-7036-2016	de Bakker, Paul IW/0000-0001-7735-7858; Martin, Nicholas/0000-0003-4069-8020; Verweij, Niek/0000-0002-4303-7685; Dominiczak, Anna F/0000-0003-4913-3608; Buxbaum, Sarah G./0000-0002-4886-3564; van der Schouw, Yvonne T./0000-0002-4605-435X; Jarvik, Gail P/0000-0002-6710-8708; Swerdlow, Daniel/0000-0002-7946-3459; Davidson, Karina/0000-0002-9162-477X; Thorand, Barbara/0000-0002-8416-6440; Montgomery, Grant W/0000-0002-4140-8139; Hegele, Robert/0000-0003-2861-5325; Gaunt, Tom R/0000-0003-0924-3247; Onland-Moret, N. Charlotte/0000-0002-2360-913X; Stolk, Ronald P/0000-0002-0518-1205; Kivimaki, Mika/0000-0002-4699-5627; Wijmenga, Cisca/0000-0002-5635-1614; Lanktree, Matthew Bruce/0000-0002-5750-6286; Asselbergs, Folkert W./0000-0002-1692-8669; Davidson, Karina/0000-0002-9162-477X; Wolffenbuttel, Bruce/0000-0001-9262-6921; Newhouse, Stephen J/0000-0002-1843-9842; Whittaker, John C/0000-0002-3529-2379; Caulfield, Mark/0000-0001-9295-3594; Humphries, Stephen E/0000-0002-8221-6547; Melander, Olle/0000-0002-2581-484X; Ouwehand, Willem/0000-0002-7744-1790; Munroe, Patricia/0000-0002-4176-2947; Kirkland, Susan/0000-0002-8182-2369; Klein, Ronald/0000-0002-4428-6237; s, hema/0000-0002-3440-9475; Schork, Nicholas/0000-0003-0920-5013; Rich, Stephen/0000-0003-3872-7793; Topol, Eric/0000-0002-1478-4729; Cupples, L. Adrienne/0000-0003-0273-7965; Stanton, Alice/0000-0002-4961-165X; Johnson, Toby/0000-0002-5998-3270; Hopewell, Jemma/0000-0002-3870-8018; Kleber, Marcus/0000-0003-0663-7275; McDonough, Caitrin/0000-0001-6393-7288; Reilly, Muredach/0000-0002-3035-9386; Hall, Alistair/0000-0003-0306-7887; Hemingway, Harry/0000-0003-2279-0624; Drenos, Fotios/0000-0003-2469-5516; Mitchell, Braxton/0000-0003-4920-4744; van Vliet-Ostaptchouk, Jana/0000-0002-7943-3153; Ballantyne, Christie/0000-0002-6432-1730; Glazer, Nicole/0000-0002-6397-609X; Ordovas, Jose/0000-0002-7581-5680; Rajagopalan, Ramakrishnan/0000-0002-5751-9239; Pankow, James/0000-0001-7076-483X; Padmanabhan, Sandosh/0000-0003-3869-5808; Franke, Lude/0000-0002-5159-8802; Li, Yun Rose/0000-0002-8077-4975; Lawlor, Debbie A/0000-0002-6793-2262; Yusuf, Salim/0000-0003-4776-5601; Whitfield, John/0000-0002-1103-0876; Pankratz, Nathan/0000-0001-5958-693X; Talmud, Philippa/0000-0002-5560-1933; Hingorani, Aroon/0000-0001-8365-0081; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Kumari, Meena/0000-0001-9716-1035; Saxena, Richa/0000-0003-2233-1065; Shah, Tina/0000-0001-7724-7210; Nelson, Christopher/0000-0001-8025-2897; van Iperen, Erik/0000-0001-7107-3168; Schreiner, Pamela/0000-0002-9920-6257; Shuldiner, Alan/0000-0001-9921-4305; Koenig, Wolfgang/0000-0002-2064-9603; Tsai, Michael/0000-0001-7553-3408; Watkins, Hugh/0000-0002-5287-9016; van Pelt, Joost/0000-0001-5538-1806; Bezzina, Connie/0000-0002-0633-3514; Shields, Denis/0000-0003-4015-2474	MRC [G9521010, G0802432, MC_U137686857] Funding Source: UKRI; National Institute for Health Research [NF-SI-0508-10116] Funding Source: researchfish; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS006516] Funding Source: NIH RePORTER; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085086, N01HC005187, N01HC095160, N01HC055222, N01HC085079, N01HC025195, N01HC055015, N01HC095167, N01HC095163, N01HC055022, N01HC055016, N01HC095162, N01HC095169, N01HC095100, N01HC055020, N01HC055018, N01HC048049, N01HC095159, N01HC045134, N01HC035129, N01HC095095, N01HC048048, N01HC095164, N01HC055021, N01HC055019, N01HC095165, N01HC048047, N01HC085081, N01HC075150, N01HC085082, N01HC095161, N01HC048050, N01HC085085, N01HC095168, N01HC015103, N01HC085080, N01HC085083, N01HC095166, N01HC085084] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD062783, R03HD061437] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124, UL1TR000135, UL1TR000064, UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025774, UL1RR025005] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [U10EY006594] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059367, R01HL091099, U01HL072515, R01HL071205, P50HL081011, K24HL084034, P01HL088117, R01HL092577, R01HL088119, R01HL076784, R01HL105756, R01HL036310, R01HL087641, R01HL067406, R01HL086694, U01HL080295] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072488, P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM074492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016592, R01AG013196, R01AG028321, R37AG013196, R01AG021917, R01AG018728, R37AG011099, R01AG011099] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006899] Funding Source: NIH RePORTER; AHRQ HHS [HS06516] Funding Source: Medline; British Heart Foundation [CH/98001, RG/2001004, PG/07/132/24256, RG/07/005/23633, PG/02/128, RG/08/008, PG/07/133/24260, RG/10/12/28456, PG/07/131/24254, CH/03/001, RG/08/008/25291, SP/08/005/25115, SP/07/007/23671] Funding Source: Medline; Intramural NIH HHS Funding Source: Medline; Medical Research Council [G9521010, MC_U137686857, G9521010D, G0802432] Funding Source: Medline; NCATS NIH HHS [UL1 TR000135, UL1 TR000064, UL1 TR000124, UL1 TR000454] Funding Source: Medline; NCI NIH HHS [P30 CA015704] Funding Source: Medline; NCRR NIH HHS [UL1RR025005, UL1 RR025774] Funding Source: Medline; NEI NIH HHS [U10EY06594] Funding Source: Medline; NHGRI NIH HHS [U01HG004402] Funding Source: Medline; NHLBI NIH HHS [R01HL086694, R01-HL-071205, N01-HC-45205, N01-HC-75150, N01-HC-55222, N01-HC-55021, N01-HC-85079, N01-HC-95161, U01 HL72515, N01-HC-95159, U01-HL-080295, R01 HL67406, N01-HC-48049, N01-HC-95167, N01-HC-35129, N01-HC-95162, N01-HC-95166, N01-HC-85085, N01-HC-05187, K24 HL084034, N01-HC-55020, R01 HL105756, N01-HC-55016, N01-HC-48050, N01-HC-95100, N01-HC-85080, N01-HC-45204, N01-HC-85086, N01-HC-95168, N01-HC-85084, N01-HC-15103, P01 HL088117, N01-HC-85081, N01-HC-55022, N01-HC-48047, R01-HL-076784, N01-HC-95160, N01-HC-25195, N01-HC-85083, N01-HC-55018, R01 HL088119, N01-HC-48048, R01HL59367, N01-HC-45134, N01-HC-55019, HL36310, R01-HL-092577, N01-HC-95163, N01-HC-85082, N01-HC-95165, R01 HL091099, N01-HC-95095, R01HL087641, N01-HC-55015, N01-HC-95169, P50HL81011, N01-HC-95164] Funding Source: Medline; NIA NIH HHS [R01 AG021917, R01-AG-028321, R01 AG18728, R01AG021917, AG-16592, R01 AG016592, R37AG11099, AG13196, R01 AG011099, R37 AG011099] Funding Source: Medline; NICHD NIH HHS [HD-061437, HD-062783] Funding Source: Medline; NIDDK NIH HHS [P30 DK063491, P30 DK072488] Funding Source: Medline; NIGMS NIH HHS [U01-GM074492, U01 GM074492] Funding Source: Medline; NIMHD NIH HHS [P20 MD006899] Funding Source: Medline; Wellcome Trust [090532] Funding Source: Medline; Department of Health Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); British Heart Foundation(British Heart Foundation); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Wellcome Trust(Wellcome Trust); Department of Health		Abecasis Group, 2012, EX CHIP DES; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anagnostopoulou KK, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-24; Arsenault BJ, 2011, NAT REV CARDIOL, V8, P197, DOI 10.1038/nrcardio.2010.223; Austin MA, 2004, AM J EPIDEMIOL, V160, P421, DOI 10.1093/aje/kwh237; Bacanu SA, 2002, GENET EPIDEMIOL, V22, P78, DOI 10.1002/gepi.1045; Barter P, 2000, ARTERIOSCL THROM VAS, V20, P2029, DOI 10.1161/01.ATV.20.9.2029; Barter PJ, 2003, ARTERIOSCL THROM VAS, V23, P160, DOI 10.1161/01.ATV.0000054658.91146.64; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Butterworth AS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002260; Buyske S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035651; Cappola TP, 2010, CIRC-CARDIOVASC GENE, V3, P147, DOI 10.1161/CIRCGENETICS.109.898395; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; de Ferranti SD, 2012, MED CLIN N AM, V96, P141, DOI 10.1016/j.mcna.2012.01.011; Deo RC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000342; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Dieter MZ, 2004, COMP BIOCHEM PHYS C, V139, P209, DOI 10.1016/j.cca.2004.11.002; Duan LP, 2006, AM J PHYSIOL-GASTR L, V290, pG269, DOI 10.1152/ajpgi.00172.2005; Fox ER, 2011, HUM MOL GENET, V20, P2273, DOI 10.1093/hmg/ddr092; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Hazard SE, 2007, PFLUG ARCH EUR J PHY, V453, P745, DOI 10.1007/s00424-005-0040-7; Hegele RA, 2009, NAT REV GENET, V10, P109, DOI 10.1038/nrg2481; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Holmes MV, 2011, NAT REV CARDIOL, V8, P207, DOI 10.1038/nrcardio.2011.6; Hunter J. E, 1990, METHODS META ANAL CO; Illumina, 2010, GEN RAR VAR SIM AN A; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Johnson T, 2011, AM J HUM GENET, V89, P688, DOI 10.1016/j.ajhg.2011.10.013; Kaess BM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014529; Kamboh MI, 2000, ATHEROSCLEROSIS, V152, P193, DOI 10.1016/S0021-9150(99)00459-1; Kantarci OH, 2004, NEUROLOGY, V62, P811, DOI 10.1212/01.WNL.0000113721.83287.83; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Lamina C, 2011, ATHEROSCLEROSIS, V219, P698, DOI 10.1016/j.atherosclerosis.2011.08.044; Lancaster JM, 1996, NAT GENET, V13, P238, DOI 10.1038/ng0696-238; Lanktree MB, 2011, AM J HUM GENET, V88, P6, DOI 10.1016/j.ajhg.2010.11.007; Lanktree MB, 2009, J LIPID RES, V50, P1487, DOI 10.1194/jlr.P900008-JLR200; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Leigh SEA, 2008, ANN HUM GENET, V72, P485, DOI 10.1111/j.1469-1809.2008.00436.x; Lo KS, 2011, HUM GENET, V129, P307, DOI 10.1007/s00439-010-0925-1; Loos RJF, 2008, OBES REV, V9, P246, DOI 10.1111/j.1467-789X.2008.00481.x; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marmot M, 2005, INT J EPIDEMIOL, V34, P251, DOI 10.1093/ije/dyh372; Matthan NR, 2008, ARTERIOSCL THROM VAS, V28, P1838, DOI 10.1161/ATVBAHA.108.163931; MYANT NB, 1993, ATHEROSCLEROSIS, V104, P1, DOI 10.1016/0021-9150(93)90171-P; PATTINSON NR, 1991, GASTROENTEROLOGY, V101, P1339, DOI 10.1016/0016-5085(91)90086-Z; Pearson TA, 2008, JAMA-J AM MED ASSOC, V299, P1335, DOI 10.1001/jama.299.11.1335; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Saxena R, 2012, AM J HUM GENET, V90, P410, DOI 10.1016/j.ajhg.2011.12.022; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Shuldiner AR, 2010, NATURE, V466, P703, DOI 10.1038/466703a; Slatkin M, 2009, GENETICS, V182, P845, DOI 10.1534/genetics.109.102798; Smith AJP, 2010, HUM MOL GENET, V19, P3936, DOI 10.1093/hmg/ddq308; SORIA LF, 1989, P NATL ACAD SCI USA, V86, P587, DOI 10.1073/pnas.86.2.587; Stromberg Anna, 2003, Eur J Cardiovasc Nurs, V2, P7; Talmud PJ, 2009, AM J HUM GENET, V85, P628, DOI 10.1016/j.ajhg.2009.10.014; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thompson JR, 2011, BRIEF BIOINFORM, V12, P259, DOI 10.1093/bib/bbr020; TYBJAERGHANSEN A, 1992, ATHEROSCLEROSIS, V96, P91, DOI 10.1016/0021-9150(92)90056-M; van Dijk KW, 2004, CURR OPIN LIPIDOL, V15, P239, DOI [10.1097/01.mol.00001300096.77252.1f, 10.1097/00041433-200406000-00002]; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Viljoen A, 2010, DRUG HEALTHC PATIENT, V2, P61; Walford GA, 2012, DIABETOLOGIA, V55, P331, DOI 10.1007/s00125-011-2353-8; Weiss LA, 2006, NAT GENET, V38, P218, DOI 10.1038/ng1726; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wise A, 2003, J BIOL CHEM, V278, P9869, DOI 10.1074/jbc.M210695200; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	76	192	193	0	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 2	2012	91	5					823	838		10.1016/j.ajhg.2012.08.032	http://dx.doi.org/10.1016/j.ajhg.2012.08.032			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	036FI	23063622	hybrid, Green Published			2022-12-18	WOS:000311011400005
J	Chartier-Harlin, MC; Dachsel, JC; Vilarino-Guell, C; Lincoln, SJ; Lepretre, F; Hulihan, MM; Kachergus, J; Milnerwood, AJ; Tapia, L; Song, MS; Le Rhun, E; Mutez, E; Larvor, L; Duflot, A; Vanbesien-Mailliot, C; Kreisler, A; Ross, OA; Nishioka, K; Soto-Ortolaza, AI; Cobb, SA; Melrose, HL; Behrouz, B; Keeling, BH; Bacon, JA; Hentati, E; Williams, L; Yanagiya, A; Sonenberg, N; Lockhart, PJ; Zubair, AC; Uitti, RJ; Aasly, JO; Krygowska-Wajs, A; Opala, G; Wszolek, ZK; Frigerio, R; Maraganore, DM; Gosal, D; Lynch, T; Hutchinson, M; Bentivoglio, AR; Valente, EM; Nicholso, WC; Pankratz, N; Foroud, T; Gibson, RA; Hentati, F; Dickson, DW; Destee, A; Farrer, MJ				Chartier-Harlin, Marie-Christine; Dachsel, Justus C.; Vilarino-Gueell, Carles; Lincoln, Sarah J.; Lepretre, Frederic; Hulihan, Mary M.; Kachergus, Jennifer; Milnerwood, Austen J.; Tapia, Lucia; Song, Mee-Sook; Le Rhun, Emilie; Mutez, Eugenie; Larvor, Lydie; Duflot, Aurelie; Vanbesien-Mailliot, Christel; Kreisler, Alexandre; Ross, Owen A.; Nishioka, Kenya; Soto-Ortolaza, Alexandra I.; Cobb, Stephanie A.; Melrose, Heather L.; Behrouz, Bahareh; Keeling, Brett H.; Bacon, Justin A.; Hentati, Emna; Williams, Lindsey; Yanagiya, Akiko; Sonenberg, Nahum; Lockhart, Paul J.; Zubair, Abba C.; Uitti, Ryan J.; Aasly, Jan O.; Krygowska-Wajs, Anna; Opala, Grzegorz; Wszolek, Zbigniew K.; Frigerio, Roberta; Maraganore, Demetrius M.; Gosal, David; Lynch, Tim; Hutchinson, Michael; Bentivoglio, Anna Rita; Valente, Enza Maria; Nicholso, William C.; Pankratz, Nathan; Foroud, Tatiana; Gibson, Rachel A.; Hentati, Faycal; Dickson, Dennis W.; Destee, Alain; Farrer, Matthew J.			Translation Initiator EIF4G1 Mutations in Familial Parkinson Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DIAGNOSTIC-CRITERIA; PROTEIN-SYNTHESIS; ALPHA-SYNUCLEIN; MTOR; PATHOGENESIS; INHIBITION; MECHANISMS	Genome-wide analysis of a multi-incident family with autosomal-dominant parkinsonism has implicated a locus on chromosomal region 3q26-q28. Linkage and disease segregation is explained by a missense mutation c.3614G>A (p.Arg1205His) in eukaryotic translation initiation factor 4-gamma (EIF4G1). Subsequent sequence and genotype analysis identified EIF4G1 c.1505C>T (p.Ala502Val), c.2056G>T (p.Gly686Cys), c.3490A>C (p.Ser1164Arg), c.3589C>T (p.Arg1197Trp) and c.3614G>A (p.Arg1205His) substitutions in affected subjects with familial parkinsonism and idiopathic Lewy body disease but not in control subjects. Despite different countries of origin, persons with EIF4G1 c.1505C>T (p.Ala502Val) or c.3614G>A (p.Arg1205His) mutations appear to share haplotypes consistent with ancestral founders. eIF4G1 p.Ala502Val and p.Arg1205His disrupt eIF4E or eIF3E binding, although the wild-type protein does not, and render mutant cells more vulnerable to reactive oxidative species. EIF4G1 mutations implicate mRNA translation initiation in familial parkinsonism and highlight a convergent pathway for monogenic, toxin and perhaps virally-induced Parkinson disease.	[Dachsel, Justus C.; Lincoln, Sarah J.; Hulihan, Mary M.; Kachergus, Jennifer; Ross, Owen A.; Nishioka, Kenya; Soto-Ortolaza, Alexandra I.; Cobb, Stephanie A.; Melrose, Heather L.; Behrouz, Bahareh; Keeling, Brett H.; Bacon, Justin A.; Hentati, Emna; Williams, Lindsey; Uitti, Ryan J.; Wszolek, Zbigniew K.; Dickson, Dennis W.; Farrer, Matthew J.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; [Dachsel, Justus C.; Lincoln, Sarah J.; Hulihan, Mary M.; Kachergus, Jennifer; Ross, Owen A.; Nishioka, Kenya; Soto-Ortolaza, Alexandra I.; Cobb, Stephanie A.; Melrose, Heather L.; Behrouz, Bahareh; Keeling, Brett H.; Bacon, Justin A.; Hentati, Emna; Williams, Lindsey; Uitti, Ryan J.; Wszolek, Zbigniew K.; Dickson, Dennis W.; Farrer, Matthew J.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Chartier-Harlin, Marie-Christine; Lepretre, Frederic; Mutez, Eugenie; Larvor, Lydie; Duflot, Aurelie; Vanbesien-Mailliot, Christel; Kreisler, Alexandre; Destee, Alain] Univ Lille Nord France, F-59000 Lille, France; [Chartier-Harlin, Marie-Christine; Lepretre, Frederic; Mutez, Eugenie; Larvor, Lydie; Duflot, Aurelie; Vanbesien-Mailliot, Christel; Kreisler, Alexandre; Destee, Alain] IFR114 IMPRT, F-59000 Lille, France; [Chartier-Harlin, Marie-Christine; Lepretre, Frederic; Mutez, Eugenie; Larvor, Lydie; Duflot, Aurelie; Vanbesien-Mailliot, Christel; Kreisler, Alexandre; Destee, Alain] IRCL, INSERM, UMR837, F-59045 Lille, France; [Vilarino-Gueell, Carles; Milnerwood, Austen J.; Tapia, Lucia; Song, Mee-Sook; Farrer, Matthew J.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 2B5, Canada; [Le Rhun, Emilie; Mutez, Eugenie; Kreisler, Alexandre; Destee, Alain] Ctr Hosp Reg Univ Lille CHRU, Dept Neurol & Movement Disorders, F-59000 Lille, France; [Vanbesien-Mailliot, Christel] USTL, Dept Neurosci, F-59655 Villeneuve Dascq, France; [Yanagiya, Akiko; Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ H3A 3R1, Canada; [Yanagiya, Akiko; Sonenberg, Nahum] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 3R1, Canada; [Lockhart, Paul J.] Murdoch Childrens Res Inst, Bruce Lefroy Ctr Genet Hlth Res, Parkville, Vic 3052, Australia; [Zubair, Abba C.] Mayo Clin, Dept Lab Med & Pathol, Jacksonville, FL 32224 USA; [Aasly, Jan O.] St Olavs Hosp, Dept Neurol, N-7006 Trondheim, Norway; [Krygowska-Wajs, Anna] Jagiellonian Univ, Coll Med, Dept Neurol, PL-31358 Krakow, Poland; [Opala, Grzegorz] Med Univ Silesia, Dept Neurol Aging Degenerat & Cerebrovasc Disorde, PL-40055 Katowice, Poland; [Frigerio, Roberta; Maraganore, Demetrius M.] Mayo Clin, Dept Neurol, Rochester, MN 55909 USA; [Gosal, David; Lynch, Tim] Mater Misericordiae Univ Hosp, Dublin Neurol Inst, Dublin 7, Ireland; [Lynch, Tim] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 4, Ireland; [Hutchinson, Michael] St Vincents Univ Hosp, Dept Neurol, Dublin 4, Ireland; [Bentivoglio, Anna Rita] Catholic Univ, Inst Neurol, I-00168 Rome, Italy; [Valente, Enza Maria] Ist Ricovero & Cura Carattere Sci IRCCS Casa Soll, Mendel Lab, I-71013 San Giovanni Rotondo, Italy; [Valente, Enza Maria] Univ Messina, Dept Med & Surg Pediat Sci, I-98124 Messina, Italy; [Nicholso, William C.] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Pankratz, Nathan; Foroud, Tatiana] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Gibson, Rachel A.] GlaxoSmithKline Inc, Res & Dev, Greenford CM19 5AW, Hammersmith, England; [Hentati, Faycal] Inst Natl Neurol, Serv Neurol, Tunis 1007, Tunisia	Mayo Clinic; Mayo Clinic; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); University of British Columbia; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; McGill University; McGill University; Murdoch Children's Research Institute; Mayo Clinic; Norwegian University of Science & Technology (NTNU); Jagiellonian University; Collegium Medicum Jagiellonian University; Medical University Silesia; Mayo Clinic; Mater Misericordiae University Hospital; University College Dublin; University College Dublin; University College Dublin; Saint Vincent's University Hospital; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; University of Messina; Cincinnati Children's Hospital Medical Center; Indiana University System; Indiana University-Purdue University Indianapolis; GlaxoSmithKline; Universite de Tunis-El-Manar; Institut National de Neurologie	Farrer, MJ (corresponding author), Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA.	mfarrer@can.ubc.ca	Vilarino-Guell, Carles/D-8628-2011; Chartier-Harlin, Marie-Christine/L-4527-2018; Ross, Owen/D-7573-2013; Mutez, Eugenie/T-4834-2018; LICEND, CEMND/F-1296-2015; Bentivoglio, Anna Rita/K-3752-2018; Nishioka, Kenya/T-8014-2019; Valente, Enza Maria/G-2942-2017; Lockhart, Paul J/E-7753-2011; hutchinson, michael/H-3508-2019; Wszolek, Zbigniew K./AAB-1431-2019; Milnerwood, Austen J/D-5280-2009; Lynch, Timothy/M-1316-2019	Vilarino-Guell, Carles/0000-0002-5612-5940; Chartier-Harlin, Marie-Christine/0000-0001-6416-6526; Mutez, Eugenie/0000-0002-5947-0432; Valente, Enza Maria/0000-0002-0600-6820; Lockhart, Paul J/0000-0003-2531-8413; Pankratz, Nathan/0000-0001-5958-693X; Yanagiya, Akiko/0000-0002-5553-0311; Dickson, Dennis W/0000-0001-7189-7917; hutchinson, michael/0000-0002-8675-1723; Gibson, Rachel/0000-0002-1338-1290; Ross, Owen/0000-0003-4813-756X; Bentivoglio, Anna Rita/0000-0002-9663-095X; Le Rhun, Emilie/0000-0002-9408-3278; lepretre, frederic/0000-0002-5249-3930; VANBESIEN-MAILLIOT, Christel/0000-0003-3693-9418; Farrer, Matthew/0000-0003-1159-5321	CHR de Lille, Universite Lille 2, Inserm, French Ministry [1994/, 2002/1918, 2005/1914]; Association France Parkinson; Fondation de France [2004-013306, 2011-00016815]; Fondation de la Recherche Medicate; Program for Research in Third Level Institutions (PRTLI); Italian Ministry of Health; Parkinson Study Group; Institute of Neurology, Tunis; Michael J. Fox Foundation; GlaxoSmithKline (GSK); NIH National Institute of Neurological Disorders and Stroke [NS40256, NS072187, 2R01 ES10751]; Canada Excellence Research Chairs program;  [R01NS37167]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS072187, R01NS037167, P50NS040256] Funding Source: NIH RePORTER	CHR de Lille, Universite Lille 2, Inserm, French Ministry(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association France Parkinson; Fondation de France(Fondation de France); Fondation de la Recherche Medicate; Program for Research in Third Level Institutions (PRTLI); Italian Ministry of Health(Ministry of Health, Italy); Parkinson Study Group; Institute of Neurology, Tunis; Michael J. Fox Foundation; GlaxoSmithKline (GSK)(GlaxoSmithKline); NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Canada Excellence Research Chairs program(Canada Research Chairs); ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank subjects who generously participated in this study. We also thank the many clinicians who have contributed to the follow-up of family P30 over the past 15 years, including Estelle Becquet, Serge Brique, Delphine Prince, Xavier Douay, and Nawal Waucquier. We acknowledge the laboratory support of Clotilde Levecque, Vincent Mouroux, Pierre Semaille, and Trevor Tyson. Studies in France would not have been possible without financial support from CHR de Lille, Universite Lille 2, Inserm, French Ministry Hospital Clinical Research Programs (PHRCs) (1994/, 2002/1918, 2005/1914), Association France Parkinson (2005), Fondation de France 2004-013306, 2011-00016815, Fondation de la Recherche Medicate (2006), PPF (synucleotheque 2005-2009), the two Centres de Resources Biologiques (IPL-Lille, CHRU-Lille) and their scientific committee (A.D., M.-C.C.-H., Philippe Amouyel, Florence Pasquier, Regis Bordet). Studies in Ireland were supported by the Program for Research in Third Level Institutions (PRTLI). Studies in Italy were supported by the Italian Ministry of Health (Ricerca Corrente 2011, Ricerca Finalizzata, Giovani Ricercatori). Studies in the PROGENI sample were supported by R01NS37167 and the Parkinson Study Group. Clinicogenetic studies in Tunisia were funded in part by the Institute of Neurology, Tunis, and the Michael J. Fox Foundation. GlaxoSmithKline (GSK) funded and provided a subset of the Tunisian case:control samples and associated phenotypic data, and we gratefully acknowledge the PD Programme Team, most notably Tina Stapleton and Carole Stapleton for sample management. We thank James Weber and NIH National Heart, Lung, and Blood Institute/Marshfield Medical Research Foundation for genome-wide genotyping (genotyping award to M.J.F). Studies performed at Mayo Clinic were financed by NIH National Institute of Neurological Disorders and Stroke (Morris K. Udall Parkinson's Disease Research Center of Excellence; P50 #NS40256 #NS072187; M.J.F., Z.K.W., D.W.D.), 2R01 ES10751 (D.M.M.), the Michael J. Fox Foundation (M.J.F.) and a Herb Geist gift for Lewy body research (M.J.F.). We thank Alice McKinney for supplementary Figure S3. This research was undertaken, in part, thanks to funding from the Canada Excellence Research Chairs program (M.J.F.; C.V.-G.). In addition, Leading Edge Endowment Funds provided by the Province of British Columbia, Life Labs and Genome BC support the Dr. Donald Rix BC Leadership Chair (M.J.F.). The authors (J.O.A., D.W.D., M.J.F., D.M.M.) declare provisional patents relevant to Parkinson's disease, but not to EIF4G1. Royalties have been obtained from licensing related to alpha-synuclein (Alnylam Pharmaceuticals [M.J.F, D.M.M.], Isis Pharmaceuticals [M.J.F.])) and leucine-rich repeat kinase 2 (J.O.A., D.W.D., M.J.F., Z.K.W.) but no conflict of interest is declared.	[Anonymous], POLYPHEN; Bueler H, 2009, EXP NEUROL, V218, P235, DOI 10.1016/j.expneurol.2009.03.006; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Dickson DW, 2009, LANCET NEUROL, V8, P1150, DOI 10.1016/S1474-4422(09)70238-8; Farrer M, 2000, MOVEMENT DISORD, V15, P1075, DOI 10.1002/1531-8257(200011)15:6<1075::AID-MDS1004>3.0.CO;2-2; Gehrke S, 2010, NATURE, V466, P637, DOI 10.1038/nature09191; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Hardy J, 2010, NEURON, V68, P201, DOI 10.1016/j.neuron.2010.10.014; Hawkes CH, 2009, ANN NY ACAD SCI, V1170, P615, DOI 10.1111/j.1749-6632.2009.04365.x; Kong X, 2005, BIOINFORMATICS, V21, P557, DOI 10.1093/bioinformatics/bti024; LeFebvre AK, 2006, J BIOL CHEM, V281, P22917, DOI 10.1074/jbc.M605418200; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Prevot D, 2003, BIOL CELL, V95, P141, DOI 10.1016/S0248-4900(03)00031-5; Ramirez-Valle F, 2008, J CELL BIOL, V181, P293, DOI 10.1083/jcb.200710215; Santini E, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000308; Scheper GC, 2007, NAT REV GENET, V8, P711, DOI 10.1038/nrg2142; Silvera D, 2009, NAT CELL BIOL, V11, P903, DOI 10.1038/ncb1900; Sobel E, 2001, HUM HERED, V52, P121, DOI 10.1159/000053366; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tain LS, 2009, NAT NEUROSCI, V12, P1129, DOI 10.1038/nn.2372; Vilarino-Guell C, 2011, AM J HUM GENET, V89, P162, DOI 10.1016/j.ajhg.2011.06.001; Yanagiya A, 2009, MOL CELL BIOL, V29, P1661, DOI 10.1128/MCB.01187-08; Zhou C, 2008, ANN NY ACAD SCI, V1147, P93, DOI 10.1196/annals.1427.023; UCSC HUMAN GENOME BR; REFSEQ; DBSNP HOMEPAGE; MAP O MAT GENOTYPE D; HUMAN POLYMORPHISM S; GENETHON; HAPLOVIEW	33	192	195	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP 9	2011	89	3					398	406		10.1016/j.ajhg.2011.08.009	http://dx.doi.org/10.1016/j.ajhg.2011.08.009			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	820XQ	21907011	Green Published, Bronze			2022-12-18	WOS:000294939800004
J	Ferrari, SL; Deutsch, S; Choudhury, U; Chevalley, T; Bonjour, JP; Dermitzakis, ET; Rizzoli, R; Antonarakis, SE				Ferrari, SL; Deutsch, S; Choudhury, U; Chevalley, T; Bonjour, JP; Dermitzakis, ET; Rizzoli, R; Antonarakis, SE			Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MINERAL DENSITY; PROMOTER POLYMORPHISMS; PREPUBERTAL GIRLS; DIETARY CALCIUM; FRACTURE RISK; LINKAGE; WOMEN; OSTEOPOROSIS; AGE; MEN	Stature, bone size, and bone mass are interrelated traits with high heritability, but the major genes that govern these phenotypes remain unknown. Independent genomewide quantitative-trait locus studies have suggested a locus for bone-mineral density and stature at chromosome 11q12-13, a region harboring the low-density lipoprotein receptor-related protein 5 (LRP5) gene. Mutations in the LRP5 gene were recently implicated in osteoporosis-pseudoglioma and "high-bone-mass" syndromes. To test whether polymorphisms in the LRP5 gene contribute to bone-mass determination in the general population, we studied a cross-sectional cohort of 889 healthy whites of both sexes. Significant associations were found for a missense substitution in exon 9 (c.2047G-->A) with lumbar spine (LS)-bone-mineral content (BMC) (P = .0032), with bone area (P = .0014), and with stature (P = .0062). The associations were observed mainly in adult men, in whom LRP5 polymorphisms accounted for less than or equal to15% of the traits' variances. Results of haplotype analysis of five single-nucleotide polymorphisms in the LRP5 region suggest that additional genetic variation within the locus might also contribute to bone-mass and size determination. To confirm our results, we investigated whether LRP5 haplotypes were associated with 1-year gain in vertebral bone mass and size in 386 prepubertal children. Significant associations were observed for changes in BMC (P = .0348) and bone area (P = .0286) in males but not females, independently supporting our observations of a mostly male-specific effect, as seen in the adults. Together, these results suggest that LRP5 variants significantly contribute to LS-bone-mass and size determination in men by influencing vertebral bone growth during childhood.	Univ Hosp Geneva, Div Bone Dis, Dept Rehabil & Geriatr, WHO Collaborating Ctr Osteoporosis & Bone Dis, CH-1211 Geneva, Switzerland; Univ Geneva, Sch Med, Div Med Genet, CH-1211 Geneva 4, Switzerland	University of Geneva; World Health Organization; University of Geneva	Ferrari, SL (corresponding author), Univ Hosp Geneva, Div Bone Dis, Dept Rehabil & Geriatr, WHO Collaborating Ctr Osteoporosis & Bone Dis, 21 Rue Micheli du Crest, CH-1211 Geneva, Switzerland.	serge.ferrari@medecine.unige.ch	Ferrari, Serge/ABD-2730-2020; Antonarakis, Stylianos E/N-8866-2014; Chevalley, Thierry/AAQ-1412-2021; Dermitzakis, Emmanouil/B-7687-2013	Ferrari, Serge/0000-0002-1372-4417; Antonarakis, Stylianos E/0000-0001-8907-5823; Chevalley, Thierry/0000-0003-3338-1148; Deutsch, Samuel/0000-0001-9456-7101				Albagha OME, 2002, HUM MOL GENET, V11, P2289, DOI 10.1093/hmg/11.19.2289; BONJOUR JP, 1991, J CLIN ENDOCR METAB, V73, P555, DOI 10.1210/jcem-73-3-555; Bonjour JP, 1997, J CLIN INVEST, V99, P1287, DOI 10.1172/JCI119287; Bonjour JP, 2001, LANCET, V358, P1208, DOI 10.1016/S0140-6736(01)06342-5; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Carn G, 2002, J CLIN ENDOCR METAB, V87, P3819, DOI 10.1210/jc.87.8.3819; Duan YB, 2001, J BONE MINER RES, V16, P2267, DOI 10.1359/jbmr.2001.16.12.2267; Duan YB, 2001, J BONE MINER RES, V16, P2276, DOI 10.1359/jbmr.2001.16.12.2276; Eisman JA, 1999, ENDOCR REV, V20, P788, DOI 10.1210/er.20.6.788; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Ferrari S, 1998, J BONE MINER RES, V13, P925, DOI 10.1359/jbmr.1998.13.6.925; Ferrari S, 1999, J CLIN ENDOCR METAB, V84, P2043, DOI 10.1210/jc.84.6.2043; Ferrari S, 1998, J CLIN ENDOCR METAB, V83, P358, DOI 10.1210/jc.83.2.358; Ferrari Serge, 1999, Current Opinion in Rheumatology, V11, P294, DOI 10.1097/00002281-199907000-00013; Ferrari SL, 2004, J BONE MINER RES, V19, P552, DOI 10.1359/JBMR.040103; Ferrari SL, 1998, J BONE MINER RES, V13, P363, DOI 10.1359/jbmr.1998.13.3.363; Ferrari SL, 2003, J CLIN ENDOCR METAB, V88, P255, DOI 10.1210/jc.2002-020092; GARNIERGERE P, 1992, J HERED, V83, P239, DOI 10.1093/oxfordjournals.jhered.a111204; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hey PJ, 1998, GENE, V216, P103, DOI 10.1016/S0378-1119(98)00311-4; Hirschhorn JN, 2001, AM J HUM GENET, V69, P106, DOI 10.1086/321287; Kanis JA, 2002, LANCET, V359, P1929, DOI 10.1016/S0140-6736(02)08761-5; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Khosla S, 2001, J CLIN ENDOCR METAB, V86, P3555, DOI 10.1210/jc.86.8.3555; Koller DL, 1998, J BONE MINER RES, V13, P1903, DOI 10.1359/jbmr.1998.13.12.1903; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Livshits G, 2002, OSTEOPOROSIS INT, V13, P461, DOI 10.1007/s001980200055; Nieters A, 2002, EUR J NUTR, V41, P210, DOI 10.1007/s00394-002-0378-y; Niu TH, 2002, AM J HUM GENET, V70, P157, DOI 10.1086/338446; Okubo Minoru, 2002, Hum Mutat, V19, P186, DOI 10.1002/humu.9012; Orwoll ES, 2001, J BONE MINER RES, V16, P1962, DOI 10.1359/jbmr.2001.16.11.1962; Patel MS, 2002, NEW ENGL J MED, V346, P1572, DOI 10.1056/NEJM200205163462011; Peacock M, 2002, ENDOCR REV, V23, P303, DOI 10.1210/er.23.3.303; Perola M, 2001, AM J HUM GENET, V69, P117, DOI 10.1086/321286; Pritchard JK, 2000, GENETICS, V155, P945; Quinton ND, 2001, HUM GENET, V108, P233, DOI 10.1007/s004390100468; Rizzoli R, 1999, OSTEOPOROSIS INT, V9, P17, DOI 10.1007/PL00004155; RIZZOLI R, 1997, LANCET, V349, pSI20; Ronaghi M, 2001, GENOME RES, V11, P3, DOI 10.1101/gr.11.1.3; Rozas J, 1995, COMPUT APPL BIOSCI, V11, P621; Sankoh AJ, 1997, STAT MED, V16, P2529, DOI 10.1002/(SICI)1097-0258(19971130)16:22<2529::AID-SIM692>3.0.CO;2-J; Seeman E, 2002, LANCET, V359, P1841, DOI 10.1016/S0140-6736(02)08706-8; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; THEINTZ G, 1992, J CLIN ENDOCR METAB, V75, P1060, DOI 10.1210/jc.75.4.1060; Twells RCJ, 2003, HUM GENET, V113, P99, DOI 10.1007/s00439-003-0940-6; van der Sluis IM, 2003, CALCIFIED TISSUE INT, V73, P332, DOI 10.1007/s00223-002-2130-2; van Meurs JBJ, 2003, HUM MOL GENET, V12, P1745, DOI 10.1093/hmg/ddg176; Van Wesenbeeck L, 2003, AM J HUM GENET, V72, P763, DOI 10.1086/368277; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59	49	192	209	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2004	74	5					866	875		10.1086/420771	http://dx.doi.org/10.1086/420771			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	813SF	15077203	Green Published, Bronze			2022-12-18	WOS:000220926100008
J	Bakker, SC; van der Meulen, EM; Buitelaar, JK; Sandkuijl, LA; Pauls, DL; Monsuur, AJ; van't Slot, R; Minderaa, RB; Gunning, WB; Pearson, PL; Sinke, RJ				Bakker, SC; van der Meulen, EM; Buitelaar, JK; Sandkuijl, LA; Pauls, DL; Monsuur, AJ; van't Slot, R; Minderaa, RB; Gunning, WB; Pearson, PL; Sinke, RJ			A whole-genome scan in 164 Dutch sib pairs with attention-deficit/hyperactivity disorder: Suggestive evidence for linkage on chromosomes 7p and 15q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEFICIT HYPERACTIVITY DISORDER; DOPAMINE TRANSPORTER GENE; AUTISTIC DISORDER; SUSCEPTIBILITY LOCI; READING-DISABILITY; RECEPTOR GENE; ASSOCIATION; CHILDREN; ADHD; POLYMORPHISMS	A genome scan was performed on 164 Dutch affected sib pairs (ASPs) with attention-deficit/hyperactivity disorder (ADHD). All subjects were white and of Dutch descent and were phenotyped according to criteria set out in the Diagnostic and Statistical Manual Of Mental Disorders, 4th edition. Initially, a narrow phenotype was defined, in which all the sib pairs met the full ADHD criteria (117 ASPs). In a broad phenotype, additional sib pairs were included, in which one child had an autistic-spectrum disorder but also met the full ADHD criteria (164 ASPs). A set of 402 polymorphic microsatellite markers with an average intermarker distance of 10 cM was genotyped and analyzed using the Mapmaker/sibs program. Regions with multipoint maximum likelihood scores (MLSs) >11.5 in both phenotypes were fine mapped with additional markers. This genome scan indicated several regions of interest, two of which showed suggestive evidence for linkage. The most promising chromosome region was located at 15q, with an MLS of 3.54 under the broad phenotype definition. This region was previously implicated in reading disability and autism. In addition, MLSs of 3.04 and 2.05 were found for chromosome regions 7p and 9q in the narrow phenotype. Except for a region on chromosome 5, no overlap was found with regions mentioned in the only other independent genome scan in ADHD reported to date.	Univ Med Ctr, Dept Med Genet, NL-3508 AB Utrecht, Netherlands; Univ Med Ctr, Dept Child & Adolescent Psychiat, NL-3508 AB Utrecht, Netherlands; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Psychiat & Neurodev Genet Unit, Boston, MA USA; Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Child & Adolescent Psychiat, Groningen, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Child & Adolescent Psychiat, NL-1105 AZ Amsterdam, Netherlands; Leiden Univ, Dept Med Stat, Med Ctr, NL-2300 RA Leiden, Netherlands; Univ Med Ctr Nijmegen, Dept Psychiat, Nijmegen, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen	Bakker, SC (corresponding author), Univ Med Ctr, Dept Med Genet, KC 04-084-2,POB 85090, NL-3508 AB Utrecht, Netherlands.	s.c.bakker@med.uu.nl	Buitelaar, J.K./AAY-7522-2020; Sinke, Richard J/A-1462-2009; Buitelaar, Jan K/E-4584-2012	Buitelaar, Jan K/0000-0001-8288-7757				Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Achenbach T M, 2000, Pediatr Rev, V21, P265, DOI 10.1542/pir.21-8-265; Altmuller J, 2001, AM J HUM GENET, V69, P936, DOI 10.1086/324069; Aman MG, 2000, J AUTISM DEV DISORD, V30, P451, DOI 10.1023/A:1005559725475; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; Angold A, 1999, J CHILD PSYCHOL PSYC, V40, P57, DOI 10.1017/S0021963098003448; Arnold LE, 1996, J ABNORM CHILD PSYCH, V24, P555, DOI 10.1007/BF01670100; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Barr CL, 2002, AM J MED GENET, V114, P810; Barr CL, 2001, BIOL PSYCHIAT, V49, P333, DOI 10.1016/S0006-3223(00)01053-2; Biederman J, 1998, J CLIN PSYCHIAT, V59, P4; BIEDERMAN J, 1992, ARCH GEN PSYCHIAT, V49, P728; Buitelaar JK, 2002, HYPERACTIVITY ATTENT, P30; Clark T, 1999, EUR CHILD ADOLES PSY, V8, P50, DOI 10.1007/s007870050083; Cohen NJ, 2000, J CHILD PSYCHOL PSYC, V41, P353, DOI 10.1111/1469-7610.00619; Collaborative Linkage Study of Autism, 2001, Am J Med Genet, V105, P609; Cook EH, 1997, AM J HUM GENET, V60, P928; COOK EH, 1995, AM J HUM GENET, V56, P993; CORDELL HJ, 1995, ANN HUM GENET, V59, P435, DOI 10.1111/j.1469-1809.1995.tb00761.x; Daly G, 1999, MOL PSYCHIATR, V4, P192, DOI 10.1038/sj.mp.4000510; Daly MJ, 1996, NAT GENET, V14, P131, DOI 10.1038/ng1096-131; Ernst M, 1999, AM J PSYCHIAT, V156, P1209; Faraone SV, 2001, AM J PSYCHIAT, V158, P1052, DOI 10.1176/appi.ajp.158.7.1052; Fisher SE, 2002, AM J HUM GENET, V70, P1183, DOI 10.1086/340112; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; Gaub M, 1997, J AM ACAD CHILD PSY, V36, P1036, DOI 10.1097/00004583-199708000-00011; Gill M, 1997, MOL PSYCHIATR, V2, P311, DOI 10.1038/sj.mp.4000290; GOYETTE CH, 1978, J ABNORM CHILD PSYCH, V6, P221, DOI 10.1007/BF00919127; Grigorenko EL, 1997, AM J HUM GENET, V60, P27; Gutknecht L, 2001, BEHAV GENET, V31, P113, DOI 10.1023/A:1010218227600; Hawi Z, 2001, MOL PSYCHIATR, V6, P420, DOI 10.1038/sj.mp.4000903; HOLMANS P, 1993, AM J HUM GENET, V52, P362; Holmes J, 2000, MOL PSYCHIATR, V5, P523, DOI 10.1038/sj.mp.4000751; JASELSKIS CA, 1992, J CLIN PSYCHOPHARM, V12, P322; Jorm AF, 2001, AM J MED GENET, V105, P346, DOI 10.1002/ajmg.1355; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kotler M, 2000, AM J MED GENET, V96, P278, DOI 10.1002/1096-8628(20000612)96:3<278::AID-AJMG8>3.0.CO;2-R; Kovac I, 2001, J COMMUN DISORD, V34, P339, DOI 10.1016/S0021-9924(01)00054-5; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LECKMAN JF, 1982, ARCH GEN PSYCHIAT, V39, P879; Levy F, 1997, J AM ACAD CHILD PSY, V36, P737, DOI 10.1097/00004583-199706000-00009; Luteijn EF, 2000, EUR CHILD ADOLES PSY, V9, P168, DOI 10.1007/s007870070040; Maher BS, 2002, PSYCHIATR GENET, V12, P207, DOI 10.1097/00041444-200212000-00003; Morris DW, 2000, HUM MOL GENET, V9, P843, DOI 10.1093/hmg/9.5.843; Noterdaeme M, 2001, EUR CHILD ADOLES PSY, V10, P58, DOI 10.1007/s007870170048; Nothen MM, 1999, EUR CHILD ADOLES PSY, V8, P56; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Ogdie MN, 2003, AM J HUM GENET, V72, P1268, DOI 10.1086/375139; Palmer K J, 1999, Drugs R D, V1, P9, DOI 10.2165/00126839-199901010-00002; Philippe A, 1999, HUM MOL GENET, V8, P805, DOI 10.1093/hmg/8.5.805; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; ROGENESS GA, 1989, PSYCHIAT RES, V27, P241, DOI 10.1016/0165-1781(89)90140-6; Roman T, 2002, AM J MED GENET, V114, P154, DOI 10.1002/ajmg.10194; Roman T, 2001, AM J MED GENET, V105, P471, DOI 10.1002/ajmg.1408; Schmidt LA, 2001, PSYCHIATR GENET, V11, P25, DOI 10.1097/00041444-200103000-00005; Schroer RJ, 1998, AM J MED GENET, V76, P327, DOI 10.1002/(SICI)1096-8628(19980401)76:4<327::AID-AJMG8>3.0.CO;2-M; Shaffer D, 2000, J AM ACAD CHILD PSY, V39, P28, DOI 10.1097/00004583-200001000-00014; Shao YJ, 2003, AM J HUM GENET, V72, P539, DOI 10.1086/367846; Smalley SL, 1997, AM J HUM GENET, V60, P1276, DOI 10.1086/515485; Smalley SL, 2002, AM J HUM GENET, V71, P959, DOI 10.1086/342732; Spencer T, 1998, J CLIN PSYCHIAT, V59, P59; Waldman ID, 1998, AM J HUM GENET, V63, P1767, DOI 10.1086/302132; Wechsler D., 2008, WECHSLER PRESCHOOL P, V3rd; Wechsler D., 1974, WISC R MANUAL WECHSL; Wigg K, 2002, AM J PSYCHIAT, V159, P1046, DOI 10.1176/appi.ajp.159.6.1046; Willcutt EG, 2002, AM J MED GENET, V114, P260, DOI 10.1002/ajmg.10205; Wolpert CM, 2000, AM J MED GENET, V96, P365, DOI 10.1002/1096-8628(20000612)96:3<365::AID-AJMG25>3.0.CO;2-X	68	192	201	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2003	72	5					1251	1260		10.1086/375143	http://dx.doi.org/10.1086/375143			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	671PZ	12679898	Green Published, Bronze			2022-12-18	WOS:000182474400016
J	Roetto, A; Totaro, A; Cazzola, M; Cicilano, M; Bosio, S; D'Ascola, G; Carella, M; Zelante, L; Kelly, AL; Cox, TM; Gasparini, P; Camaschella, C				Roetto, A; Totaro, A; Cazzola, M; Cicilano, M; Bosio, S; D'Ascola, G; Carella, M; Zelante, L; Kelly, AL; Cox, TM; Gasparini, P; Camaschella, C			Juvenile hemochromatosis locus maps to chromosome 1q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY HEMOCHROMATOSIS; TRANSFERRIN RECEPTOR; IDIOPATHIC HEMOCHROMATOSIS; GENE-PRODUCT; PROTEIN; CD1; EXPRESSION; MOLECULES; DISTINCT; DISORDER	Juvenile hemochromatosis (JH) is an autosomal recessive disorder that leads to severe iron loading in the 2d to 3d decade of life. Affected members in families with JH do not show linkage to chromosome 6p and do not have mutations in the HFE gene that lead to the common hereditary hemochromatosis. In this study we performed a genomewide search to map the JH locus in nine families: six consanguineous and three with multiple affected patients. This strategy allowed us to identify the JH locus on the long arm of chromosome 1. A maximum LOD score of 5.75 at a recombination fraction of 0 was detected with marker D1S498, and a LOD score of 5.16 at a recombination fraction of 0 was detected for marker D1S2344. Homozygosity mapping in consanguineous families defined the limits of the candidate region in an similar to 4-cM interval between markers D1S442 and D1S2347. Analysis of genes mapped in this interval excluded obvious candidates. The JH locus does not correspond to the chromosomal localization of any known gene involved in iron metabolism. These findings provide a means to recognize, at an early age, patients in affected families. They also provide a starting point for the identification of the affected gene by positional cloning.	Univ Turin, Dipartimento Sci Clin & Biol, Turin, Italy; IRCCS CSS San Giovanni Rotondo, Foggia, Italy; Univ Pavia, Policlin San Matteo, IRCCS, Dipartimento Med Interna & Oncol, I-27100 Pavia, Italy; Osped Reggio Calabria, Ctr Microcitemie, Reggio Calabria, Italy; Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England	University of Turin; IRCCS Fondazione San Matteo; University of Pavia; University of Cambridge	Camaschella, C (corresponding author), Univ Turin, Dipartimento Sci Clin & Biol, Azienda Osped San Luigi, I-10043 Turin, Italy.		Carella, Massimo/A-2804-2014; Camaschella, Clara/A-3289-2015; Cazzola, Mario/AAQ-8854-2021; Roetto, Antonella/K-4731-2016; Gasparini, Paolo/B-6173-2014	Carella, Massimo/0000-0002-6830-6829; Cazzola, Mario/0000-0001-6984-8817; Gasparini, Paolo/0000-0002-0859-0856; ROETTO, Antonella/0000-0003-1188-7375	Telethon [E.0679] Funding Source: Medline	Telethon(Fondazione Telethon)		Camaschella C, 1997, HAEMATOLOGICA, V82, P77; Camaschella C, 1998, BAILLIERE CLIN GASTR, V12, P227, DOI 10.1016/S0950-3528(98)90132-4; Camaschella C, 1997, EUR J HUM GENET, V5, P371, DOI 10.1159/000484794; CAMASCHELLA C, IN PRESS HEPATOLOGY; Carella M, 1997, AM J HUM GENET, V60, P828; Cazzola M, 1998, BLOOD, V92, P2979, DOI 10.1182/blood.V92.8.2979; CAZZOLA M, 1983, HUM GENET, V65, P149, DOI 10.1007/BF00286653; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Feder JN, 1998, P NATL ACAD SCI USA, V95, P1472, DOI 10.1073/pnas.95.4.1472; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HADDY TB, 1988, AM J PEDIAT HEMATOL, V10, P23; Kasai K, 1997, CLIN EXP IMMUNOL, V109, P317, DOI 10.1046/j.1365-2249.1997.3661267.x; Kelly AL, 1998, QJM-INT J MED, V91, P607, DOI 10.1093/qjmed/91.9.607; LAMON JM, 1979, GASTROENTEROLOGY, V76, P178; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Lebron JA, 1998, CELL, V93, P111, DOI 10.1016/S0092-8674(00)81151-4; OTT J, 1992, HUMAN GENETIC LINKAG, P13; Parkkila S, 1997, P NATL ACAD SCI USA, V94, P13198, DOI 10.1073/pnas.94.24.13198; Piperno A, 1996, HEPATOLOGY, V24, P43, DOI 10.1002/hep.510240109; Porcelli SA, 1998, IMMUNOL TODAY, V19, P362, DOI 10.1016/S0167-5699(98)01289-4; Powell W.L., 1994, IRON METABOLISM HLTH; Sambrook J, 1989, MOL CLONING LAB MANU, V1-3; Wilson IA, 1998, CURR OPIN IMMUNOL, V10, P67, DOI 10.1016/S0952-7915(98)80034-4	24	192	196	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1999	64	5					1388	1393		10.1086/302379	http://dx.doi.org/10.1086/302379			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192RP	10205270	Green Published, Bronze			2022-12-18	WOS:000080093000017
J	Glenn, CC; Saitoh, S; Jong, MTC; Filbrandt, MM; Surti, U; Driscoll, DJ; Nicholls, RD				Glenn, CC; Saitoh, S; Jong, MTC; Filbrandt, MM; Surti, U; Driscoll, DJ; Nicholls, RD			Gene structure, DNA methylation, and imprinted expression of the human SNRPN gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRADER-WILLI SYNDROME; NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE; ANGELMAN SYNDROMES; MOLECULAR DIAGNOSIS; UNIPARENTAL DISOMY; SPLICING PROTEIN; PARENTAL ORIGIN; XIST GENE; CDNA; CHROMOSOME-15	The human SNRPN(small nuclear ribonucleoprotein polypeptide N) gene is one of a gene family that encode proteins involved in pre-mRNA splicing and maps to the smallest deletion region involved in the Prader-Willi syndrome (PWS) within chromosome 15q11-q13. Paternal only expression of SNRPN has previously been demonstrated by use of cell lines from PWS patients (maternal allele only) and Angelman syndrome (AS) patients (paternal allele only). We have characterized two previously unidentified 5' exons of the SNRPN gene and demonstrate that exons -1 and 0 are included in the full-length transcript. This gene is expressed in a wide range of somatic tissues and at high, approximately equal levels in all regions of the brain. Both the first exon of SNRPN (exon -1) and the putative transcription start site are embedded within a CpG island. This CpG island is extensively methylated on the repressed maternal allele and is unmethylated on the expressed paternal allele, in a wide range of fetal and adult somatic cells. This provides a quick and highly reliable diagnostic assay for PWS and AS, which is based on DNA-methylation analysis that has been tested on >100 patients in a variety of tissues. Conversely, several CpG sites similar to 22 kb down stream of the transcription start site in intron 5 are preferentially methylated on the expressed paternal allele in somatic tissues and male germ cells, whereas these same sites are unmethylated in fetal oocytes. These findings are consistent with a key role for DNA methylation in the imprinted inheritance and subsequent gene expression of the human SNRPN gene.	UNIV FLORIDA,DEPT PEDIAT,DIV GENET,COLL MED,RC PHILIPS RES & EDUC UNIT,GAINESVILLE,FL 32610; UNIV FLORIDA,COLL MED,DEPT MOLEC GENET & MICROBIOL,GAINESVILLE,FL; UNIV FLORIDA,COLL MED,CTR MAMMALIAN GENET,GAINESVILLE,FL; UNIV HOSP CLEVELAND,CTR HUMAN GENET,CLEVELAND,OH; UNIV PITTSBURGH,MAGEE WOMENS HOSP,DEPT PATHOL & GENET,PITTSBURGH,PA 15213	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University Hospitals of Cleveland; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh				Saitoh, Shinji/0000-0001-6911-3351	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD031491] Funding Source: NIH RePORTER; NICHD NIH HHS [HD31491] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BARR JA, 1995, MAMM GENOME, V6, P405, DOI 10.1007/BF00355641; BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; BUITING K, 1993, HUM MOL GENET, V2, P1991; CATTANACH BM, 1992, NAT GENET, V2, P270, DOI 10.1038/ng1292-270; DITTRICH B, 1993, HUM MOL GENET, V2, P1995, DOI 10.1093/hmg/2.12.1995; DITTRICH B, 1992, HUM GENET, V90, P313; Driscoll D J, 1994, Mol Genet Med, V4, P37; DRISCOLL DJ, 1992, GENOMICS, V13, P917, DOI 10.1016/0888-7543(92)90001-9; DRISCOLL DJ, 1990, SOMAT CELL MOLEC GEN, V16, P267, DOI 10.1007/BF01233363; FISCHELGHODSIAN N, 1987, NUCLEIC ACIDS RES, V15, P9215, DOI 10.1093/nar/15.22.9215; GABRIEL J, 1994, HUM MOL GENET, V3, P1912, DOI 10.1093/hmg/3.10.1912; GLENN CC, 1993, HUM MOL GENET, V2, P2001, DOI 10.1093/hmg/2.12.2001; GLENN CC, 1993, HUM MOL GENET, V2, P1377, DOI 10.1093/hmg/2.9.1377; GRIMALDI K, 1993, DEV BIOL, V156, P319, DOI 10.1006/dbio.1993.1080; HALL BD, 1972, J PEDIATR-US, V81, P286, DOI 10.1016/S0022-3476(72)80297-X; HOLM VA, 1993, PEDIATRICS, V91, P398; HORN DA, 1992, MOL BRAIN RES, V16, P13, DOI 10.1016/0169-328X(92)90188-H; HUNTRISS JD, 1994, MOL BIOL REP, V20, P19, DOI 10.1007/BF00999851; Jong M. T. C., 1994, American Journal of Human Genetics, V55, pA29; KHAN AS, 1992, NAT GENET, V2, P180, DOI 10.1038/ng1192-180; KNEBELMANN B, 1995, HUM MOL GENET, V4, P675, DOI 10.1093/hmg/4.4.675; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; LEFF SE, 1992, NAT GENET, V2, P259, DOI 10.1038/ng1292-259; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; LI S, 1989, P NATL ACAD SCI USA, V86, P9778, DOI 10.1073/pnas.86.24.9778; MAGENIS RE, 1990, AM J MED GENET, V35, P333, DOI 10.1002/ajmg.1320350307; MALCOLM S, 1991, LANCET, V337, P694, DOI 10.1016/0140-6736(91)90278-W; MASCARI MJ, 1992, NEW ENGL J MED, V326, P1599, DOI 10.1056/NEJM199206113262404; MCALLISTER G, 1989, EMBO J, V8, P1177, DOI 10.1002/j.1460-2075.1989.tb03489.x; MCALLISTER G, 1988, P NATL ACAD SCI USA, V85, P5296, DOI 10.1073/pnas.85.14.5296; MCDANIEL LD, 1992, P NATL ACAD SCI USA, V89, P7968, DOI 10.1073/pnas.89.17.7968; MITCHELL GA, 1991, P NATL ACAD SCI USA, V88, P815, DOI 10.1073/pnas.88.3.815; MOWERYRUSHTON PA, IN PRESS AM J MED GE; MUTTER GL, 1993, AM J HUM GENET, V53, P1096; NAKAO M, 1994, HUM MOL GENET, V3, P309, DOI 10.1093/hmg/3.2.309; NICHOLLS RD, 1989, AM J MED GENET, V33, P66, DOI 10.1002/ajmg.1320330109; NICHOLLS RD, 1992, ANN NEUROL, V32, P512, DOI 10.1002/ana.410320406; NICHOLLS RD, 1993, CURR OPIN GENET DEV, V3, P445, DOI 10.1016/0959-437X(93)90119-A; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; OHOSONE Y, 1989, P NATL ACAD SCI USA, V86, P4249, DOI 10.1073/pnas.86.11.4249; OZCELIK T, 1992, NAT GENET, V2, P265, DOI 10.1038/ng1292-265; REED ML, 1994, NAT GENET, V6, P163, DOI 10.1038/ng0294-163; ROBINSON WP, 1991, AM J HUM GENET, V49, P1219; ROKEACH LA, 1989, J BIOL CHEM, V264, P5024; Sambrook J., 1989, MOL CLONING LAB MANU; SCHMAUSS C, 1989, NUCLEIC ACIDS RES, V17, P1733, DOI 10.1093/nar/17.4.1733; SCHMAUSS C, 1990, J BIOL CHEM, V265, P10733; SCHMAUSS C, 1992, J BIOL CHEM, V267, P8521; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; TREMBLAY KD, 1995, NAT GENET, V9, P407, DOI 10.1038/ng0495-407; VANDAM A, 1989, EMBO J, V8, P3853, DOI 10.1002/j.1460-2075.1989.tb08563.x; WEVRICK R, 1994, HUM MOL GENET, V3, P1877, DOI 10.1093/hmg/3.10.1877; WILLIAMS CA, 1990, AM J MED GENET, V35, P350, DOI 10.1002/ajmg.1320350308; WILLIAMS CA, 1995, AM J MED GENET, V56, P237, DOI 10.1002/ajmg.1320560224; ZACKOWSKI JL, 1993, AM J MED GENET, V46, P7, DOI 10.1002/ajmg.1320460104	59	192	196	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1996	58	2					335	346						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TR791	8571960				2022-12-18	WOS:A1996TR79100010
J	NIJBROEK, G; SOOD, S; MCINTOSH, I; FRANCOMANO, CA; BULL, E; PEREIRA, L; RAMIREZ, F; PYERITZ, RE; DIETZ, HC				NIJBROEK, G; SOOD, S; MCINTOSH, I; FRANCOMANO, CA; BULL, E; PEREIRA, L; RAMIREZ, F; PYERITZ, RE; DIETZ, HC			15 NOVEL FBN1 MUTATIONS CAUSING MARFAN-SYNDROME DETECTED BY HETERODUPLEX ANALYSIS OF GENOMIC AMPLICONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EPIDERMAL GROWTH-FACTOR; 2ND INTERNATIONAL-SYMPOSIUM; EGF-LIKE DOMAINS; CALCIUM-BINDING; NONSENSE MUTATIONS; CONNECTIVE-TISSUE; MISSENSE MUTATION; FIBRILLIN GENES; SYNDROME LOCUS; SEQUENCE	Mutations in the gene encoding fibrillin-1 (FBN1), a component of the extracellular microfibril, cause the Marfan syndrome (MFS). This statement is supported by the observations that the classic Marfan phenotype cosegregates with intragenic and/or flanking marker alleles in all families tested and that a significant number of FBN1 mutations have been identified in affected individuals. We have now devised a method to screen the entire coding sequence and flanking splice junctions of FBN1. On completion for a panel of nine probands with classic MFS, six new mutations were identified that accounted for disease in seven (78%) of nine patients. Nine additional new mutations have been characterized in the early stages of a larger screening project. These 15 mutations were equally distributed throughout the gene and, with one exception, were specific to single families. One-third of mutations created premature termination codons, and 6 of 15 substituted residues with putative significance for calcium binding to epidermal growth factor (EGF)-like domains. Mutations causing severe and rapidly progressive disease that presents in the neonatal period can occur in a larger region of the gene than previously demonstrated, and the nature of the mutation is as important a determinant as its location, in predisposing to this phenotype.	JOHNS HOPKINS UNIV,SCH MED,CTR MED GENET,DEPT PEDIAT,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,CTR MED GENET,DEPT MED,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,CTR MED GENET,DEPT MOLEC BIOL & GENET,BALTIMORE,MD 21205; NIH,NATL CTR HUMAN GENOME RES,BETHESDA,MD 20892; MT SINAI SCH MED,BROOKDALE CTR MOLEC BIOL,NEW YORK,NY; ALLEGHENY SINGER RES INST,DEPT HUMAN GENET,PITTSBURGH,PA 15212	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Icahn School of Medicine at Mount Sinai			Pyeritz, Reed/A-1364-2010		NHLBI NIH HHS [HL-35877, HL-02815] Funding Source: Medline; NIAMS NIH HHS [AR-41135] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035877, K08HL002815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041135] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AOYAMA T, 1993, HUM MOL GENET, V2, P2135, DOI 10.1093/hmg/2.12.2135; AOYAMA T, 1994, J CLIN INVEST, V94, P130, DOI 10.1172/JCI117298; BEIGHTON P, 1988, AM J MED GENET, V29, P581, DOI 10.1002/ajmg.1320290316; BYERS PH, 1993, HUM MUTAT, V2, P80, DOI 10.1002/humu.1380020203; CHENG J, 1990, Molecular and Cellular Biology, V10, P5215; COLLOD G, 1994, NAT GENET, V8, P264, DOI 10.1038/ng1194-264; COOKE RM, 1987, NATURE, V327, P339, DOI 10.1038/327339a0; CORSON GM, 1993, GENOMICS, V17, P476, DOI 10.1006/geno.1993.1350; DAHLBACK B, 1990, J BIOL CHEM, V265, P18481; DIETZ H, 1995, NAT GENET, V9, P228, DOI 10.1038/ng0395-228; Dietz Harry C., 1992, Human Mutation, V1, P366, DOI 10.1002/humu.1380010504; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; DIETZ HC, 1992, J CLIN INVEST, V89, P1674, DOI 10.1172/JCI115766; DIETZ HC, 1991, GENOMICS, V9, P355, DOI 10.1016/0888-7543(91)90264-F; DIETZ HC, 1993, GENOMICS, V17, P468, DOI 10.1006/geno.1993.1349; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; ELDADAH ZA, 1995, J CLIN INVEST, V95, P874, DOI 10.1172/JCI117737; GODFREY M, 1993, AM J HUM GENET, V53, P472; GODFREY M, 1990, AM J HUM GENET, V46, P652; HANDFORD PA, 1991, NATURE, V351, P164, DOI 10.1038/351164a0; HAYWARD C, 1994, HUM MUTAT, V3, P159, DOI 10.1002/humu.1380030212; HAYWARD C, 1994, HUM MOL GENET, V3, P373, DOI 10.1093/hmg/3.2.373; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; HEWETT D, 1994, AM J HUM GENET, V55, P447; HEWETT DR, 1994, J MED GENET, V31, P338, DOI 10.1136/jmg.31.4.338; HEWETT DR, 1993, HUM MOL GENET, V2, P475, DOI 10.1093/hmg/2.4.475; HOLLISTER DW, 1990, NEW ENGL J MED, V323, P152, DOI 10.1056/NEJM199007193230303; KAINULAINEN K, 1992, P NATL ACAD SCI USA, V89, P5917, DOI 10.1073/pnas.89.13.5917; KAINULAINEN K, 1990, NEW ENGL J MED, V323, P935, DOI 10.1056/NEJM199010043231402; KAINULAINEN K, 1991, AM J HUM GENET, V49, P662; KAINULAINEN K, 1994, NAT GENET, V6, P64, DOI 10.1038/ng0194-64; KARTTUNEN L, 1994, AM J HUM GENET, V55, P1083; KIELTY CM, 1994, MATRIX BIOL, V14, P191, DOI 10.1016/0945-053X(94)90008-6; LEE B, 1991, NATURE, V352, P330, DOI 10.1038/352330a0; MASLEN CL, 1991, NATURE, V352, P334, DOI 10.1038/352334a0; MILEWICZ DM, 1994, AM J HUM GENET, V54, P447; MILEWICZ DM, 1992, J CLIN INVEST, V89, P79, DOI 10.1172/JCI115589; Mosher Deane F., 1992, Current Opinion in Cell Biology, V4, P810, DOI 10.1016/0955-0674(92)90104-K; PEREIRA L, 1993, HUM MOL GENET, V2, P961, DOI 10.1093/hmg/2.7.961; PEREIRA L, 1994, NEW ENGL J MED, V331, P148, DOI 10.1056/NEJM199407213310302; PIERSALL LD, 1994, HUM MOL GENET, V3, P1013, DOI 10.1093/hmg/3.6.1013; PYERITZ RE, 1993, AM J MED GENET, V47, P127, DOI 10.1002/ajmg.1320470131; RAVNIKGLAVAC M, 1994, HUM MOL GENET, V3, P801, DOI 10.1093/hmg/3.5.801; SAKAI LY, 1991, J BIOL CHEM, V266, P14763; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; SARFARAZI M, 1992, J MED GENET, V29, P75, DOI 10.1136/jmg.29.2.75; SELANDERSUNNERH.M, 1992, J BIOL CHEM, V0267; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; STAHLHALLENGREN C, 1994, J CLIN INVEST, V94, P709, DOI 10.1172/JCI117389; STENFLO J, 1988, J BIOL CHEM, V263, P21; SYKES B, 1993, NAT GENET, V3, P99, DOI 10.1038/ng0293-99; TSIPOURAS P, 1991, P NATL ACAD SCI USA, V88, P4486, DOI 10.1073/pnas.88.10.4486; TSIPOURAS P, 1992, NEW ENGL J MED, V326, P905, DOI 10.1056/NEJM199204023261401; TYNAN K, 1993, HUM MOL GENET, V2, P1813, DOI 10.1093/hmg/2.11.1813; URLAUB G, 1989, MOL CELL BIOL, V9, P2868, DOI 10.1128/MCB.9.7.2868; WU YS, 1995, CHEM BIOL, V2, P91, DOI 10.1016/1074-5521(95)90281-3	56	192	200	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1995	57	1					8	21						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RE629	7611299				2022-12-18	WOS:A1995RE62900002
J	RISCH, N; REICH, EW; WISHNICK, MM; MCCARTHY, JG				RISCH, N; REICH, EW; WISHNICK, MM; MCCARTHY, JG			SPONTANEOUS MUTATION AND PARENTAL AGE IN HUMANS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510; NYU,DIV GENET,NEW YORK,NY 10003; NYU,INST RECONSTRUCT PLAST SURG,NEW YORK,NY 10003	Yale University; New York University; New York University	RISCH, N (corresponding author), YALE UNIV,SCH MED,DEPT EPIDEMIOL & PUBL HLTH,60 COLL ST,POB 3333,NEW HAVEN,CT 06510, USA.				NICHD NIH HHS [HD00648] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K04HD000648] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BLANK CE, 1960, ANN HUM GENET, V24, P151; CAROTHERS AD, 1986, J MED GENET, V23, P227, DOI 10.1136/jmg.23.3.227; Cohen M M Jr, 1975, Birth Defects Orig Artic Ser, V11, P137; CONNOR JM, 1979, J MED GENET, V16, P147; Feller W., 1968, INTRO PROBABILITY TH, V1; JONES KL, 1975, J PEDIATR-US, V86, P84, DOI 10.1016/S0022-3476(75)80709-8; KAPLAN EB, 1972, I STAT MIMEO SER, V823; MURDOCH JL, 1972, ANN HUM GENET, V35, P331, DOI 10.1111/j.1469-1809.1957.tb01406.x; MURDOCH JL, 1970, ANN HUM GENET, V33, P227, DOI 10.1111/j.1469-1809.1970.tb01648.x; PELLIE C, 1973, HUMANGENETIK, V20, P59, DOI 10.1007/BF00280877; Penrose LS, 1933, J GENET, V27, P219, DOI 10.1007/BF02984413; PENROSE LS, 1955, LANCET, V2, P312; RICCARDI VM, 1984, AM J MED GENET, V18, P169, DOI 10.1002/ajmg.1320180121; RISCH N, 1986, AM J HUM GENET, V39, P68; ROGERS JG, 1979, J MED GENET, V16, P147, DOI 10.1136/jmg.16.2.147; SERGEYEV AS, 1975, HUMANGENETIK, V28, P129, DOI 10.1007/BF00735745; SMITH CAB, 1972, ANN HUM GENET, V35, P337, DOI 10.1111/j.1469-1809.1957.tb01407.x; STEVENSON AC, 1957, AM J HUM GENET, V9, P81; TUNTE W, 1967, HUMANGENETIK, V4, P320, DOI 10.1007/BF00285740; VOGEL F, 1975, ADV HUM GENET, V5, P223; VOGEL F, 1956, Z MENSCH VERERB KONS, V33, P470; VOGEL F, 1964, GENETICS TODAY, P833; Weinberg W., 1912, ARCH RASSEN U GESEL, V9, P710	23	192	196	0	10	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1987	41	2					218	248						31	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	J7575	3618593				2022-12-18	WOS:A1987J757500012
J	CAVENEE, W; LEACH, R; MOHANDAS, T; PEARSON, P; WHITE, R				CAVENEE, W; LEACH, R; MOHANDAS, T; PEARSON, P; WHITE, R			ISOLATION AND REGIONAL LOCALIZATION OF DNA SEGMENTS REVEALING POLYMORPHIC LOCI FROM HUMAN CHROMOSOME-13	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV UTAH,SCH MED,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84132; UNIV UTAH,SCH MED,DEPT CELLULAR VIRAL & MOLEC BIOL,SALT LAKE CITY,UT 84132; UNIV CALIF LOS ANGELES,LOS ANGELES CTY HARBOR MED CTR,DIV MED GENET,TORRANCE,CA 90509; LEIDEN STATE UNIV,DEPT HUMAN GENET,2312 AV LEIDEN,NETHERLANDS	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Leiden University; Leiden University - Excl LUMC				Leach, Robin/0000-0002-3201-5579	NCI NIH HHS [CA-06232] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BALABANMALENBAUM G, 1981, CANCER GENET CYTOGEN, V3, P243, DOI 10.1016/0165-4608(81)90091-1; BARKER DB, 1984, CELL; BENEDICT WF, 1983, SCIENCE, V219, P973, DOI 10.1126/science.6336308; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; COMINGS DE, 1973, P NATL ACAD SCI USA, V70, P3324, DOI 10.1073/pnas.70.12.3324; DAVIES KE, 1981, NATURE, V293, P374, DOI 10.1038/293374a0; FRANCKE U, 1976, CYTOGENET CELL GENET, V16, P131, DOI 10.1159/000130573; GUSELLA JF, 1980, P NATL ACAD SCI-BIOL, V77, P2829, DOI 10.1073/pnas.77.5.2829; Hohn B, 1979, Methods Enzymol, V68, P299; KNUDSON AG, 1978, SEMIN ONCOL, V5, P57; KRUMLAUFF, 1982, P NATL ACAD SCI, V79, P2971; McKusick V.A., 1983, MENDELIAN INHERITANC; MOHANDAS T, 1980, CYTOGENET CELL GENET, V28, P116, DOI 10.1159/000131519; MOHANDAS T, 1979, P NATL ACAD SCI USA, V76, P5779, DOI 10.1073/pnas.76.11.5779; MOTEGI T, 1982, HUM GENET, V61, P95, DOI 10.1007/BF00274194; RIVERA H, 1981, HUM GENET, V59, P211, DOI 10.1007/BF00283666; SKOLNICK MH, 1982, CYTOGENET CELL GENET, V32, P194, DOI 10.1159/000131699; SPARKES RS, 1983, SCIENCE, V219, P971, DOI 10.1126/science.6823558; STRONG LC, 1981, SCIENCE, V213, P1501, DOI 10.1126/science.7280668; WHITE RL, 1983, BANBURY REPORT, V14, P235; WYMAN AR, 1980, P NATL ACAD SCI-BIOL, V77, P6754, DOI 10.1073/pnas.77.11.6754; YUNIS JJ, 1978, AM J DIS CHILD, V132, P161, DOI 10.1001/archpedi.1978.02120270059012	22	192	197	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	1					10	24						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	SC430	6320640				2022-12-18	WOS:A1984SC43000002
J	KIRKMAN, HN; HENDRICKSON, EM				KIRKMAN, HN; HENDRICKSON, EM			SEX-LINKED ELECTROPHORETIC DIFFERENCE IN GLUCOSE-6-PHOSPHATE DEHYDROGENASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ADAM A, 1961, NATURE, V189, P686, DOI 10.1038/189686a0; BEUTLER E, 1962, P NATL ACAD SCI USA, V48, P9, DOI 10.1073/pnas.48.1.9; BOYER SH, 1962, P NATL ACAD SCI USA, V48, P1868, DOI 10.1073/pnas.48.10.1868; BOYER SH, 1962, J CLIN INVEST, V41, P1347; CHILDS B, 1958, B JOHNS HOPKINS HOSP, V102, P21; DONNELL GN, 1960, PEDIATRICS, V25, P572; GROSS RT, 1958, J CLIN INVEST, V37, P1176, DOI 10.1172/JCI103707; KEMPTHORNE O, 1957, GENETIC STATISTICS, P171; KIRKMAN HN, 1961, AM J DIS CHILD, V102, P313, DOI 10.1001/archpedi.1961.02080010315006; KIRKMAN HN, 1962, J BIOL CHEM, V237, P2364; KIRKMAN HN, 1960, P NATL ACAD SCI USA, V46, P938, DOI 10.1073/pnas.46.7.938; KIRKMAN HN, 1962, AM J DIS CHILD, V104, P566; KIRKMAN HN, 1961, 128 M AM ASS ADV SCI; KIRKMAN HN, 1961, SOUTH MED J, V54, P1431; LARIZZA P, 1960, ARCH HAEMAT PAVIA, V45, P129; LARIZZA P, 1960, ARCH HAEMAT PAVIA, V45, P1; MARKS PA, 1962, NATURE, V194, P454, DOI 10.1038/194454a0; MARKS PA, 1961, J BIOL CHEM, V236, P10; MARKS PA, 1959, NATURE, V183, P1266, DOI 10.1038/1831266b0; PORTER IH, 1962, NATURE, V193, P506, DOI 10.1038/193506a0; PORTER IH, 1961, 2 P INT C HUM GEN RO; SINISCALCO M, 1961, NATURE, V190, P1179, DOI 10.1038/1901179a0; SMITHIES O, 1959, BIOCHEM J, V71, P585, DOI 10.1042/bj0710585; SNEDECOR GW, 1956, STATISTICAL METHODS, P221; SZEINBERG A, 1958, BLOOD, V13, P1043, DOI 10.1182/blood.V13.11.1043.1043; TAKAHARA S, 1960, J CLIN INVEST, V39, P610, DOI 10.1172/JCI104075; TARLOV AR, 1962, ARCH INTERN MED, V109, P209, DOI 10.1001/archinte.1962.03620140081013; WELLS IC, 1951, J BIOL CHEM, V188, P65	28	192	192	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1963	15	3					241	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2967A	14033020				2022-12-18	WOS:A19632967A00005
J	Carpenter, ML; Buenrostro, JD; Valdiosera, C; Schroeder, H; Allentoft, ME; Sikora, M; Rasmussen, M; Gravel, S; Guillen, S; Nekhrizov, G; Leshtakov, K; Dimitrova, D; Theodossiev, N; Pettener, D; Luiselli, D; Sandoval, K; Moreno-Estrada, A; Li, YR; Wang, J; Gilbert, MTP; Willerslev, E; Greenleaf, WJ; Bustamante, CD				Carpenter, Meredith L.; Buenrostro, Jason D.; Valdiosera, Cristina; Schroeder, Hannes; Allentoft, Morten E.; Sikora, Martin; Rasmussen, Morten; Gravel, Simon; Guillen, Sonia; Nekhrizov, Georgi; Leshtakov, Krasimir; Dimitrova, Diana; Theodossiev, Nikola; Pettener, Davide; Luiselli, Donata; Sandoval, Karla; Moreno-Estrada, Andres; Li, Yingrui; Wang, Jun; Gilbert, M. Thomas P.; Willerslev, Eske; Greenleaf, William J.; Bustamante, Carlos D.			Pulling out the 1%: Whole-Genome Capture for the Targeted Enrichment of Ancient DNA Sequencing Libraries	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; NEANDERTHAL GENOME; HUNTER-GATHERERS; HYBRID SELECTION; CAVE; DAMAGE	Most ancient specimens contain very low levels of endogenous DNA, precluding the shotgun sequencing of many interesting samples because of cost. Ancient DNA (aDNA) libraries often contain <1% endogenous DNA, with the majority of sequencing capacity taken up by environmental DNA. Here we present a capture-based method for enriching the endogenous component of aDNA sequencing libraries. By using biotinylated RNA baits transcribed from genomic DNA libraries, we are able to capture DNA fragments from across the human genome. We demonstrate this method on libraries created from four Iron Age and Bronze Age human teeth from Bulgaria, as well as bone samples from seven Peruvian mummies and a Bronze Age hair sample from Denmark. Prior to capture, shotgun sequencing of these libraries yielded an average of 1.2% of reads mapping to the human genome (including duplicates). After capture, this fraction increased substantially, with up to 59% of reads mapped to human and enrichment ranging from 6- to 159-fold. Furthermore, we maintained coverage of the majority of regions sequenced in the precapture library. Intersection with the 1000 Genomes Project reference panel yielded an average of 50,723 SNPs (range 3,062-147,243) for the postcapture libraries sequenced with 1 million reads, compared with 13,280 SNPs (range 217-73,266) for the precapture libraries, increasing resolution in population genetic analyses. Our whole-genome capture approach makes it less costly to sequence aDNA from specimens containing very low levels of endogenous DNA, enabling the analysis of larger numbers of samples.	[Carpenter, Meredith L.; Buenrostro, Jason D.; Sikora, Martin; Sandoval, Karla; Moreno-Estrada, Andres; Greenleaf, William J.; Bustamante, Carlos D.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Valdiosera, Cristina; Schroeder, Hannes; Allentoft, Morten E.; Rasmussen, Morten; Gilbert, M. Thomas P.; Willerslev, Eske] Nat Hist Museum Denmark, Ctr GeoGenet, DK-1350 Copenhagen, Denmark; [Valdiosera, Cristina] La Trobe Univ, Fac Humanities & Social Sci, Dept Archaeol Environm & Community Planning, Melbourne, Vic 3086, Australia; [Gravel, Simon] McGill Univ, Dept Human Genet, Montreal, PQ H3A 0G1, Canada; [Gravel, Simon] McGill Univ, Genome Quebec Innovat Ctr, Montreal, PQ H3A 0G1, Canada; [Guillen, Sonia] Ctr Mallqui, Lima 27, Peru; [Nekhrizov, Georgi; Dimitrova, Diana] Bulgarian Acad Sci, Natl Inst Archaeol, Sofia 1000, Bulgaria; [Leshtakov, Krasimir; Theodossiev, Nikola] Sofia Univ St Kliment Ohridski, Dept Archaeol, Sofia 1504, Bulgaria; [Pettener, Davide; Luiselli, Donata] Univ Bologna, Dipartimento Sci Biol Geol & Ambientali BiGeA, I-40126 Bologna, Italy; [Li, Yingrui; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Wang, Jun] King Abdulaziz Univ, Jeddah 21589, Saudi Arabia; [Wang, Jun] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Wang, Jun] Macau Univ Sci & Technol, Taipa 999078, Macau, Peoples R China; [Gilbert, M. Thomas P.] Murdoch Univ, Ancient DNA Lab, Perth, WA 6150, Australia	Stanford University; La Trobe University; McGill University; McGill University; Bulgarian Academy of Sciences; University of Sofia; University of Bologna; Beijing Genomics Institute (BGI); King Abdulaziz University; University of Copenhagen; Macau University of Science & Technology; Murdoch University	Greenleaf, WJ (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	wjg@stanford.edu; cdbustam@stanford.edu	Wang, Jun/A-7261-2013; Willerslev, Eske/A-9619-2011; Schroeder, Hannes/B-9444-2015; Sikora, Martin/C-8609-2015; Dimitrova, Diana/AAE-3843-2019; Moreno-Estrada, Andres/R-3950-2017; Gilbert, Marcus TP/A-8936-2013; Li, Yingrui/K-1064-2015; Willerslev, Eske/AAA-5686-2019; Pettener, Davide/E-1576-2017; Moreno-Estrada, Andres/AAP-4657-2021; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Willerslev, Eske/0000-0002-7081-6748; Schroeder, Hannes/0000-0002-6743-0270; Sikora, Martin/0000-0003-2818-8319; Moreno-Estrada, Andres/0000-0001-8329-8292; Gilbert, Marcus TP/0000-0002-5805-7195; Moreno-Estrada, Andres/0000-0001-8329-8292; Wang, Jun/0000-0002-2113-5874; Wang, Jun/0000-0002-8540-8931; Allentoft, Morten/0000-0003-4424-3568; Valdiosera, Cristina/0000-0003-4948-2226; Carpenter, Meredith/0000-0002-9798-9374; Bustamante, Carlos D./0000-0002-4187-7920; Sandoval, Karla/0000-0002-6175-2463	National Institutes of Health [HG005715, HG003220]; NRSA Postdoctoral Fellowship (NHGRI); European Research Council under the European Union [269442]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG007342, U01HG005715] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA Postdoctoral Fellowship (NHGRI); European Research Council under the European Union(European Research Council (ERC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors would like to thank members of the C.D.B. lab, especially P. Underhill and S. Shringarpure, for helpful discussion, and M.C. Yee and A. Adams for assistance with experiments. Support for this work was provided by National Institutes of Health grants HG005715 and HG003220 and an NRSA Postdoctoral Fellowship (NHGRI) to M.L.C. The sample M4 was obtained and DNA extracted as part of "The Rise" project funded by the European Research Council under the European Union's Seventh Framework programme (FP/2007-2013)/ERC Grant Agreement n. 269442 - THE RISE. Portions of this manuscript are subject to one or more patents pending. C.D.B. consults for Personalis, Inc., Ancestry.com, Invitae (formerly Locus Development), and the 23andMe.com project "Roots into the Future." None of these entities played any role in the design of the research or interpretation of the results presented here.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; [Anonymous], ACTA ARCHAEOLOGICA, V77, P190; Avila-Arcos MC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00074; Birx H. James, 2006, ENCY ANTHR, P469; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Burbano HA, 2010, SCIENCE, V328, P723, DOI 10.1126/science.1188046; Dabney J, 2013, P NATL ACAD SCI USA, V110, P15758, DOI 10.1073/pnas.1314445110; Dimitrova D., 2012, TUMULI GRAVES STATUS, P77; Fehren-Schmitz L, 2011, ANN HUM GENET, V75, P266, DOI 10.1111/j.1469-1809.2010.00620.x; Fu QM, 2013, P NATL ACAD SCI USA, V110, P2223, DOI 10.1073/pnas.1221359110; Gansauge MT, 2013, NAT PROTOC, V8, P737, DOI 10.1038/nprot.2013.038; Gilbert MTP, 2007, SCIENCE, V317, P1927, DOI 10.1126/science.1146971; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Good JM, 2013, MOL BIOL EVOL, V30, P964, DOI 10.1093/molbev/mst005; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Guillen S., 2012, PREHISTOIRE AUTRES P, P321; Jonsson H, 2013, BIOINFORMATICS, V29, P1682, DOI 10.1093/bioinformatics/btt193; Karachanak S, 2012, INT J LEGAL MED, V126, P497, DOI 10.1007/s00414-011-0589-y; Keller A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1701; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Leshtakov K., 2010, NEKROPOL KASNATA BRO, P22; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Maricic T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014004; Melnikov A, 2011, GENOME BIOL, V12, DOI [10.1186/gb-2011-12-8-R73, 10.1186/gb-2011-12-8-r73]; Meyer M., 2010, COLD SPRING HARB PRO; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Nekhrizov G., 2012, AN IR AG 7 P 7 AN IR, P177; Nekhrizov G., 2009, NEKROPOL RANNATA ZHE, P266; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Sanchez-Ouinto F, 2012, CURR BIOL, V22, P1494, DOI 10.1016/j.cub.2012.06.005; Skoglund P, 2013, J ARCHAEOL SCI, V40, P4477, DOI 10.1016/j.jas.2013.07.004; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; Yang DY, 1998, AM J PHYS ANTHROPOL, V105, P539, DOI 10.1002/(SICI)1096-8644(199804)105:4<539::AID-AJPA10>3.0.CO;2-1; Zhidkov I, 2011, MITOCHONDRION, V11, P924, DOI 10.1016/j.mito.2011.08.005	44	191	209	3	96	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 7	2013	93	5					852	864		10.1016/j.ajhg.2013.10.002	http://dx.doi.org/10.1016/j.ajhg.2013.10.002			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252HU	24568772	Green Published, hybrid			2022-12-18	WOS:000326996600006
J	Olbrich, H; Schmidts, M; Werner, C; Onoufriadis, A; Loges, NT; Raidt, J; Banki, NF; Shoemark, A; Burgoyne, T; Al Turki, S; Hurles, ME; Kohler, G; Schroeder, J; Nurnberg, G; Nurnberg, P; Chung, EMK; Reinhardt, R; Marthin, JK; Nielsen, KG; Mitchison, HM; Omran, H				Olbrich, Heike; Schmidts, Miriam; Werner, Claudius; Onoufriadis, Alexandros; Loges, Niki T.; Raidt, Johanna; Banki, Nora Fanni; Shoemark, Amelia; Burgoyne, Tom; Al Turki, Saeed; Hurles, Matthew E.; Koehler, Gabriele; Schroeder, Josef; Nuernberg, Gudrun; Nuernberg, Peter; Chung, Eddie M. K.; Reinhardt, Richard; Marthin, June K.; Nielsen, Kim G.; Mitchison, Hannah M.; Omran, Heymut		UK10K Consortium	Recessive HYDIN Mutations Cause Primary Ciliary Dyskinesia without Randomization of Left-Right Body Asymmetry	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OF-FUNCTION MUTATIONS; GENE-PRODUCT; MICE LACKING; PROTEIN; DEFECTS; HYDROCEPHALUS; COMPLEX; FLOW; DNA; DYSFUNCTION	Primary ciliary dyskinesia (PCD) is a genetically heterogeneous recessive disorder characterized by defective cilia and flagella motility. Chronic destructive-airway disease is caused by abnormal respiratory-tract mucociliary clearance. Abnormal propulsion of sperm flagella contributes to male infertility. Genetic defects in most individuals affected by PCD cause randomization of left-right body asymmetry; approximately half show situs inversus or situs ambiguous. Almost 70 years after the hy3 mouse possessing Hydin mutations was described as a recessive hydrocephalus model, we report HYDIN mutations in PCD-affected persons without hydrocephalus. By homozygosity mapping, we identified a PCD-associated locus, chromosomal region 16q21-q23, which contains HYDIN. However, a nearly identical 360 kb paralogous segment (HYDIN2) in chromosomal region 1q21.1 complicated mutational analysis. In three affected German siblings linked to HYDIN, we identified homozygous c.3985G>T mutations that affect an evolutionary conserved splice acceptor site and that subsequently cause aberrantly spliced transcripts predicting premature protein termination in respiratory cells. Parallel whole-exome sequencing identified a homozygous nonsense HYDIN mutation, c.922A>T (p.Lys307(star)), in six individuals from three Faroe Island PCD-affected families that all carried an 8.8 Mb shared haplotype across HYDIN, indicating an ancestral founder mutation in this isolated population. We demonstrate by electron microscopy tomography that, consistent with the effects of loss-of-function mutations, HYDIN mutant respiratory cilia lack the C2b projection of the central pair (CP) apparatus; similar findings were reported in Hydin-deficient Chlamydomonas and mice. High-speed videomicroscopy demonstrated markedly reduced beating amplitudes of respiratory cilia and stiff sperm flagella. Like the hy3 mouse model, all nine PCD-affected persons had normal body composition because nodal cilia function is apparently not dependent on the function of the CP apparatus.	[Olbrich, Heike; Werner, Claudius; Loges, Niki T.; Raidt, Johanna; Omran, Heymut] Univ Childrens Hosp Muenster, Dept Gen Pediat, D-48149 Munster, Germany; [Schmidts, Miriam; Onoufriadis, Alexandros; Mitchison, Hannah M.] UCL, Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; [Banki, Nora Fanni] Semmelweis Univ, Dept Pediat, H-1085 Budapest, Hungary; [Shoemark, Amelia; Burgoyne, Tom] Royal Brompton & Harefield NHS Trust, Dept Paediat Resp Med, London, England; [Al Turki, Saeed; Hurles, Matthew E.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Koehler, Gabriele] Univ Childrens Hosp Muenster, Dept Pathol, D-48149 Munster, Germany; [Schroeder, Josef] Univ Regensburg, Dept Pathol, D-93053 Regensburg, Germany; [Nuernberg, Gudrun; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Nuernberg, Gudrun; Nuernberg, Peter] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Nuernberg, Gudrun; Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Chung, Eddie M. K.] Univ London Univ Coll, Gen & Adolescent Paediat Unit, Inst Child Hlth, London WC1E 6JJ, England; [Reinhardt, Richard] Max Planck Inst Plant Breeding Res, Genome Ctr Cologne, D-50829 Cologne, Germany; [Marthin, June K.; Nielsen, Kim G.] Copenhagen Univ Hosp, Cyst Fibrosis Ctr, DK-2100 Copenhagen, Denmark; [Marthin, June K.; Nielsen, Kim G.] Copenhagen Univ Hosp, Pediat Pulm Serv, DK-2100 Copenhagen, Denmark	University of Munster; University of London; University College London; Semmelweis University; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital; Wellcome Trust Sanger Institute; University of Munster; University of Regensburg; University of Cologne; University of Cologne; University of Cologne; University of London; University College London; Max Planck Society; University of Copenhagen; University of Copenhagen	Omran, H (corresponding author), Univ Childrens Hosp Muenster, Dept Gen Pediat, D-48149 Munster, Germany.	h.mitchison@ucl.ac.uk; heymut.omran@ukrnuenster.de	Pinheiro, Maísa/E-7424-2012; Nielsen, KG/AAE-6575-2020; Burgoyne, Thomas/HCI-9054-2022; Shoemark, Amelia/I-4068-2019; Schmidts, Miriam/A-3777-2012; Scambler, Peter/C-4998-2008	Nielsen, KG/0000-0001-5906-9449; Burgoyne, Thomas/0000-0002-8428-720X; Shoemark, Amelia/0000-0001-7360-6060; Schmidts, Miriam/0000-0002-1714-6749; Reinhardt, Richard/0000-0001-9376-2132; Savage, David Bousfield/0000-0002-7857-7032; Semple, Robert Kenneth/0000-0001-6539-3069; Mitchison, Hannah/0000-0002-3163-6293; Raidt, Johanna/0000-0002-1571-2647; Kelly, Kirsten/0000-0003-4234-543X; Omran, Heymut/0000-0003-0282-6765; Walter, Klaudia/0000-0003-4448-0301; Scambler, Peter/0000-0002-1487-4628; Futema, Marta/0000-0002-2120-2088	Wellcome Trust; Newlife Foundation for Disabled Children and Action Medical Research; Kindness for Kids Foundation; Deutsche Forschungsgemeinschaft [DFG Om 6/4, GRK 1104, SFB 592]; Cell Dynamics and Disease graduate program; European Community's SYSCILIA project; National Institute for Health Research [NF-SI-0510-10268] Funding Source: researchfish; Action Medical Research [1773] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Newlife Foundation for Disabled Children and Action Medical Research; Kindness for Kids Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cell Dynamics and Disease graduate program; European Community's SYSCILIA project; National Institute for Health Research(National Institute for Health Research (NIHR)); Action Medical Research	We are grateful to the affected persons and their families for their participation in this study. We thank the German patient support group "Kartagener Syndrom und Primaere Ciliaere Dyskinesie e.V." We thank Angelina Heer, Martina Herting, Denise Nergenau, Carmen Kopp, and Dinu Antony for excellent technical assistance. The UK10K project (http://www.uk10k.org/) is funded by the Wellcome Trust. Contributing investigators of the UK10K project are listed in the Supplemental Data. H.M.M. thanks R. Mark Gardiner and Maggie Meeks for originating the Faroe Island project and Peter J. Scambler and Philip L. Beales for their work on the UK10K project. This work was supported by grants from the Newlife Foundation for Disabled Children and Action Medical Research (to H.M.M.), the Kindness for Kids Foundation, Deutsche Forschungsgemeinschaft (DFG Om 6/4), GRK 1104, SFB 592, and the Cell Dynamics and Disease graduate program, as well as the European Community's SYSCILIA project (to H.O.). The manuscript has been seen and approved by all authors.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; Barbato A, 2009, EUR RESPIR J, V34, P1264, DOI 10.1183/09031936.00176608; Bartoloni L, 2002, P NATL ACAD SCI USA, V99, P10282, DOI 10.1073/pnas.152337699; Becker-Heck A, 2011, NAT GENET, V43, P79, DOI 10.1038/ng.727; Budny B, 2006, HUM GENET, V120, P171, DOI 10.1007/s00439-006-0210-5; Castleman VH, 2009, AM J HUM GENET, V84, P197, DOI 10.1016/j.ajhg.2009.01.011; Chilvers MA, 2003, J ALLERGY CLIN IMMUN, V112, P518, DOI 10.1067/mai.2003.1701; Davy BE, 2003, HUM MOL GENET, V12, P1163, DOI 10.1093/hmg/ddg122; Dawe HR, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-33; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; DiBella LM, 2004, MOL BIOL CELL, V15, P4633, DOI 10.1091/mbc.E04-06-0461; DiPetrillo CG, 2010, J CELL BIOL, V189, P601, DOI 10.1083/jcb.200912009; Doggett NA, 2006, GENOMICS, V88, P762, DOI 10.1016/j.ygeno.2006.07.012; Duquesnoy P, 2009, AM J HUM GENET, V85, P890, DOI 10.1016/j.ajhg.2009.11.008; Duriez B, 2007, P NATL ACAD SCI USA, V104, P3336, DOI 10.1073/pnas.0611405104; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Ibanez-Tallon I, 2004, HUM MOL GENET, V13, P2133, DOI 10.1093/hmg/ddh219; Jeganathan D, 2004, J MED GENET, V41, P233, DOI 10.1136/jmg.2003.014084; Kennedy MP, 2007, CIRCULATION, V115, P2814, DOI 10.1161/CIRCULATIONAHA.106.649038; Kuehni CE, 2010, EUR RESPIR J, V36, P1248, DOI 10.1183/09031936.00001010; Lechtreck KF, 2008, J CELL BIOL, V180, P633, DOI 10.1083/jcb.200710162; Lechtreck KF, 2007, J CELL BIOL, V176, P473, DOI 10.1083/jcb.200611115; Lee L, 2008, MOL CELL BIOL, V28, P949, DOI 10.1128/MCB.00354-07; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loges NT, 2008, AM J HUM GENET, V83, P547, DOI 10.1016/j.ajhg.2008.10.001; Loges NT, 2009, AM J HUM GENET, V85, P883, DOI 10.1016/j.ajhg.2009.10.018; Marthin JK, 2011, EUR RESPIR J, V37, P559, DOI 10.1183/09031936.00032610; Mateos-Corral D, 2011, J PEDIATR-US, V159, P420, DOI 10.1016/j.jpeds.2011.03.007; Mazor M, 2011, AM J HUM GENET, V88, P599, DOI 10.1016/j.ajhg.2011.03.018; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Merveille AC, 2011, NAT GENET, V43, P72, DOI 10.1038/ng.726; Mitchison HM, 2012, NAT GENET, V44, P381, DOI 10.1038/ng.1106; Moore A, 2006, J MED GENET, V43, P326, DOI 10.1136/jmg.2005.034868; Nagarkatti-Gude DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020625; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; Panizzi JR, 2012, NAT GENET, V44, P714, DOI 10.1038/ng.2277; Pennarun G, 1999, AM J HUM GENET, V65, P1508, DOI 10.1086/302683; Rashid S, 2006, MOL REPROD DEV, V73, P784, DOI 10.1002/mrd.20475; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; Satir P, 2008, CURR TOP DEV BIOL, V85, P63, DOI 10.1016/S0070-2153(08)00803-X; Schwabe GC, 2008, HUM MUTAT, V29, P289, DOI 10.1002/humu.20656; Sisson JH, 2003, J MICROSC-OXFORD, V211, P103, DOI 10.1046/j.1365-2818.2003.01209.x; Smith EF, 1997, MOL BIOL CELL, V8, P455, DOI 10.1091/mbc.8.3.455; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; Zariwala MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/annurev.physiol.69.040705.141301	54	191	197	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 5	2012	91	4					672	684		10.1016/j.ajhg.2012.08.016	http://dx.doi.org/10.1016/j.ajhg.2012.08.016			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	017CU	23022101	Green Published, hybrid, Green Submitted			2022-12-18	WOS:000309568500009
J	Cameron, JM; Janer, A; Levandovskiy, V; MacKay, N; Rouault, TA; Tong, WH; Ogilvie, I; Shoubridge, EA; Robinson, BH				Cameron, Jessie M.; Janer, Alexandre; Levandovskiy, Valeriy; MacKay, Nevena; Rouault, Tracey A.; Tong, Wing-Hang; Ogilvie, Isla; Shoubridge, Eric A.; Robinson, Brian H.			Mutations in Iron-Sulfur Cluster Scaffold Genes NFU1 and BOLA3 Cause a Fatal Deficiency of Multiple Respiratory Chain and 2-Oxoacid Dehydrogenase Enzymes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEIN-INTERACTION MAP; ESCHERICHIA-COLI; LIPOYL SYNTHASE; SUCCINATE-DEHYDROGENASE; COMPLEX; ACONITASE; IDENTIFICATION; BIOSYNTHESIS; BIOGENESIS; EXPRESSION	Severe combined deficiency of the 2-oxoacid dehydrogenases, associated with a defect in lipoate synthesis and accompanied by defects in complexes I, II, and III of the mitochondrial respiratory chain, is a rare autosomal recessive syndrome with no obvious causative gene defect. A candidate locus for this syndrome was mapped to chromosomal region 2p14 by microcell-mediated chromosome transfer in two unrelated families. Unexpectedly, analysis of genes in this area identified mutations in two different genes, both of which are involved in [Fe-S] cluster biogenesis. A homozygous missense mutation, c.545G>A, near the splice donor of exon 6 in NFU1 predicting a p.Arg182Gln substitution was found in one of the families. The mutation results in abnormal mRNA splicing of exon 6, and no mature protein could be detected in fibroblast mitochondria. A single base-pair duplication c.123dupA was identified in BOLA3 in the second family, causing a frame shift that produces a premature stop codon (p.Glu42Argfs*13). Transduction of fibroblast lines with retroviral vectors expressing the mitochondrial, but not the cytosolic isoform of NFU1 and with isoform 1, but not isoform 2 of BOLA3 restored both respiratory chain function and oxoacid dehydrogenase complexes. NFU1 was previously proposed to be an alternative scaffold to ISCU for the biogenesis of [Fe-S] centers in mitochondria, and the function of BOLA3 was previously unknown. Our results demonstrate that both play essential roles in the production of [Fe-S] centers for the normal maturation of lipoate-containing 2-oxoacid dehydrogenases, and for the assembly of the respiratory chain complexes.	[Cameron, Jessie M.; Levandovskiy, Valeriy; MacKay, Nevena; Robinson, Brian H.] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Janer, Alexandre; Ogilvie, Isla; Shoubridge, Eric A.] McGill Univ, Dept Human Genet, Montreal, PQ H3A 2B4, Canada; [Janer, Alexandre; Ogilvie, Isla; Shoubridge, Eric A.] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; [Rouault, Tracey A.; Tong, Wing-Hang] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Mol Med, NIH, Bethesda, MD 20892 USA; [Robinson, Brian H.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Robinson, Brian H.] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McGill University; McGill University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Toronto; University of Toronto	Robinson, BH (corresponding author), Hosp Sick Children, Res Inst, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	bhr@sickkids.ca	janer, alexandre/AAV-3192-2021		MitoMarch for Kirkland; Canadian Institutes of Health Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008814] Funding Source: NIH RePORTER	MitoMarch for Kirkland; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank "MitoMarch for Kirkland" and the Canadian Institutes of Health Research (E.A.S.) for funding this project. E.A.S. is an International Scholar of the Howard Hughes Medical Institute. The authors declare no conflict of interests.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ALDEA M, 1988, J BACTERIOL, V170, P5169, DOI 10.1128/jb.170.11.5169-5176.1988; Antonicka H, 2006, HUM MOL GENET, V15, P1835, DOI 10.1093/hmg/ddl106; Antonicka H, 2010, AM J HUM GENET, V87, P115, DOI 10.1016/j.ajhg.2010.06.004; Bych K, 2008, EMBO J, V27, P1736, DOI 10.1038/emboj.2008.98; Cameron JM, 2004, AM J MED GENET A, V131A, P59, DOI 10.1002/ajmg.a.30287; Cicchillo RM, 2004, BIOCHEMISTRY-US, V43, P6378, DOI 10.1021/bi049528x; Cicchillo RM, 2005, J AM CHEM SOC, V127, P2860, DOI 10.1021/ja042428u; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Gelling C, 2008, MOL CELL BIOL, V28, P1851, DOI 10.1128/MCB.01963-07; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; HALL RE, 1993, J CLIN INVEST, V92, P2660, DOI 10.1172/JCI116882; HALLER RG, 1991, J CLIN INVEST, V88, P1197, DOI 10.1172/JCI115422; Huynen MA, 2005, FEBS LETT, V579, P591, DOI 10.1016/j.febslet.2004.11.111; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Kerr D. S., 1996, ALPHA KETO ACID DEHY, P249; Lill R, 2006, BBA-MOL CELL RES, V1763, P652, DOI 10.1016/j.bbamcr.2006.05.011; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Lissens W, 2000, HUM MUTAT, V15, P209, DOI 10.1002/(SICI)1098-1004(200003)15:3<209::AID-HUMU1>3.0.CO;2-K; Lochmuller H, 1999, EXP CELL RES, V248, P186, DOI 10.1006/excr.1999.4407; Loiseau L, 2007, P NATL ACAD SCI USA, V104, P13626, DOI 10.1073/pnas.0705829104; Maj MC, 2005, J CLIN ENDOCR METAB, V90, P4101, DOI 10.1210/jc.2005-0123; Miller JR, 2000, BIOCHEMISTRY-US, V39, P15166, DOI 10.1021/bi002060n; Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012; Nishio K, 2000, J BIOL CHEM, V275, P22615, DOI 10.1074/jbc.C000279200; Onder O, 2006, MOL CELL PROTEOMICS, V5, P1426, DOI 10.1074/mcp.M600099-MCP200; Pitkanen S, 1996, BIOCHEM MOL MED, V59, P134, DOI 10.1006/bmme.1996.0078; Robinson BH, 2001, METABOLIC MOL BASES, P2275; Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008; Santos JM, 1999, MOL MICROBIOL, V32, P789, DOI 10.1046/j.1365-2958.1999.01397.x; Seyda A, 2001, AM J HUM GENET, V68, P386, DOI 10.1086/318196; Sheftel AD, 2009, MOL CELL BIOL, V29, P6059, DOI 10.1128/MCB.00817-09; Tong WH, 2003, P NATL ACAD SCI USA, V100, P9762, DOI 10.1073/pnas.1732541100	33	191	203	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 7	2011	89	4					486	495		10.1016/j.ajhg.2011.08.011	http://dx.doi.org/10.1016/j.ajhg.2011.08.011			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	834HV	21944046	Bronze, Green Published			2022-12-18	WOS:000295951300003
J	Bakrania, P; Efthymiou, M; Klein, JC; Salt, A; Bunyan, DJ; Wyatt, A; Ponting, CP; Martin, A; Williams, S; Lindley, V; Gilmore, J; Restori, M; Robson, AG; Neveu, MM; Holder, GE; Collin, JRO; Robinson, DO; Farndon, P; Johansen-Berg, H; Gerrelli, D; Ragge, NK				Bakrania, Preeti; Efthymiou, Maria; Klein, Johannes C.; Salt, Alison; Bunyan, David J.; Wyatt, Alex; Ponting, Chris P.; Martin, Angela; Williams, Steven; Lindley, Victoria; Gilmore, Joanne; Restori, Marie; Robson, Anthony G.; Neveu, Magella M.; Holder, Graham E.; Collin, J. Richard O.; Robinson, David O.; Farndon, Peter; Johansen-Berg, Heidi; Gerrelli, Dianne; Ragge, Nicola K.			Mutations in BMP4 cause eye, brain, and digit developmental anomalies: Overlap between the BMP4 and hedgehog signaling pathways	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SONIC-HEDGEHOG; GORLIN-SYNDROME; PATCHED GENE; CLEFT-PALATE; ANOPHTHALMIA; LIMB; PITUITARY; DELETION; SHH; EXPRESSION	Developmental ocular malformations, including anophthalmia-microphthalmia (AM), are heterogeneous disorders with frequent sporadic or non-Mendelian inheritance. Recurrent interstitial deletions of 14q22-q23 have been associated with AM, sometimes with poly/syndactyly and hypopituitarism. We identify two further cases of AM (one with associated pituitary anomalies) with a 14q22-q23 deletion. Using a positional candidate gene approach, we analyzed the BMP4 (Bone Morphogenetic Protein-4) gene and identified a frame-shift mutation (c.226del2, p.S76fs104X) that segregated with AM, retinal dystrophy, myopia, brain anomalies, and polydactyly in a family and a nonconservative missense mutation (c.278A -> G, p.E93G) in a highly conserved base in another family. MR imaging and tractography in the c.226del2 proband revealed a primary brain developmental disorder affecting thalamostriatal and callosal pathways, also present in the affected grandmother. Using in situ hybridization in human embryos, we demonstrate expression of BMP4 in optic vesicle, developing retina and lens, pituitary region, and digits strongly supporting BMP4 as a causative gene for AM, pituitary, and poly/syndactyly. Because BMP4 interacts with HH signaling genes in animals, we evaluated gene expression in human embryos and demonstrate cotemporal and cospatial expression of BMP4 and HH signaling genes. We also identified four cases, some of whom had retinal dystrophy, with "low-penetrant" mutations in both BMP4 and HH signaling genes: SHH (Sonic Hedgehog) or PTCH1 (Patched). We propose that BMP4 is a major gene for AM and/or retinal dystrophy and brain anomalies and may be a candidate gene for myopia and poly/syndactyly. Our finding of low-penetrant variants in BMP4 and HH signaling partners is suggestive of an interaction between the two pathways in humans.	[Bakrania, Preeti; Wyatt, Alex; Ponting, Chris P.; Martin, Angela; Ragge, Nicola K.] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3QX, England; [Efthymiou, Maria; Gerrelli, Dianne] UCL, Inst Child Hlth, London WC1N 1EH, England; [Klein, Johannes C.; Johansen-Berg, Heidi] Univ Oxford, John Radcliffe Hosp, Oxford Ctr Magnet Resonance Imaging Brain, Oxford OX3 9DU, England; [Salt, Alison; Restori, Marie; Robson, Anthony G.; Neveu, Magella M.; Holder, Graham E.; Collin, J. Richard O.; Ragge, Nicola K.] Moorfields Eye Hosp, London EC1V 2PD, England; [Salt, Alison] Great Ormond St Hosp Sick Children, Wolfson Ctr, London WC1N 2AP, England; [Bunyan, David J.] Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury SP2 8BJ, Wilts, England; [Bunyan, David J.; Robinson, David O.] Univ Southampton, Sch Med, Human Genet Div, Southampton SO16 6YD, Hants, England; [Ponting, Chris P.] Univ Oxford, Dept Physiol Anat & Genet, MRC Funct Genet Unit, Oxford OX1 3QX, England; [Williams, Steven] Sheffield Childrens NHS Fdn Trust, Sheffield Reg Cytogenet Serv, Sheffield S10 2TH, S Yorkshire, England; [Lindley, Victoria; Farndon, Peter] Birmingham Womens Hosp, W Midlands Reg Genet Serv, Birmingham B15 2TG, W Midlands, England; [Gilmore, Joanne] Inst Neurol, N East Thames Reg Cytogenet Serv, London WC11 3BG, England; [Ragge, Nicola K.] Birmingham Childrens Hosp, Dept Ophthalmol, Birmingham B4 6NH, W Midlands, England	University of Oxford; University of London; University College London; University of Oxford; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Salisbury District Hospital; University of Southampton; University of Oxford; Sheffield Children's NHS Foundation Trust; Birmingham Women's Hospital; University of London; University College London; University of Birmingham	Ragge, NK (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, S Pk Rd, Oxford OX1 3QX, England.	nicky.ragge@dpag.ox.ac.uk	Ponting, Chris/AAV-2621-2021; Williams, Steve C/D-6979-2011	Williams, Steve C/0000-0003-4299-1941; Martin, Angela/0000-0001-6196-0409; Robson, Anthony/0000-0002-8391-6123; Ponting, Chris/0000-0003-0202-7816; Johansen-Berg, Heidi/0000-0002-4134-9730	MRC [G9826762, MC_U137761446, G9900837] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/B/16313] Funding Source: Medline; Medical Research Council [G9826762, MC_U137761446, G9900837] Funding Source: Medline; Wellcome Trust [078204] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Ahmad ME, 2003, AM J MED GENET A, V120A, P117, DOI 10.1002/ajmg.a.10146; Aijaz S, 2004, INVEST OPHTH VIS SCI, V45, P3871, DOI 10.1167/iovs.04-0641; Altaba ARI, 1999, DEVELOPMENT, V126, P3205; Bakrania P, 2007, BRIT J OPHTHALMOL, V91, P1471, DOI 10.1136/bjo.2007.117929; Behesti H, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-62; Behrens TEJ, 2006, NEUROIMAGE, V30, P220, DOI 10.1016/j.neuroimage.2005.09.036; Belloni E, 1996, NAT GENET, V14, P353, DOI 10.1038/ng1196-353; BENNETT CP, 1991, J MED GENET, V28, P280, DOI 10.1136/jmg.28.4.280; Blauwkamp MN, 2007, HEARING RES, V225, P71, DOI 10.1016/j.heares.2006.12.010; BRICKELL PM, 1989, BIOESSAYS, V11, P145, DOI 10.1002/bies.950110508; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chang B, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-18; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; CLEMENTI M, 1992, TERATOLOGY, V46, P551, DOI 10.1002/tera.1420460604; Cohen MM, 2003, AM J MED GENET A, V123A, P5, DOI 10.1002/ajmg.a.20495; Dakubo GD, 2003, DEVELOPMENT, V130, P2967, DOI 10.1242/dev.00515; Drossopoulou G, 2000, DEVELOPMENT, V127, P1337; Dubourg C, 2004, HUM MUTAT, V24, P43, DOI 10.1002/humu.20056; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Dunn NR, 1997, DEV BIOL, V188, P235, DOI 10.1006/dbio.1997.8664; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eimon PM, 1999, DEV BIOL, V216, P29, DOI 10.1006/dbio.1999.9496; ELLIOTT J, 1993, J MED GENET, V30, P251, DOI 10.1136/jmg.30.3.251; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; Furuta Y, 1998, GENE DEV, V12, P3764, DOI 10.1101/gad.12.23.3764; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Gould DB, 2004, INT J DEV BIOL, V48, P1015, DOI 10.1387/ijdb.041865dg; Guha U, 2002, DEV BIOL, V249, P108, DOI 10.1006/dbio.2002.0752; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Haraguchi R, 2001, DEVELOPMENT, V128, P4241; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Hjalt TA, 2000, DEV DYNAM, V218, P195, DOI 10.1002/(SICI)1097-0177(200005)218:1<195::AID-DVDY17>3.0.CO;2-C; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Holder GE, 2006, ESSENT OPHTHALMOL, P133; Holder GE, 2007, DOC OPHTHALMOL, V114, P111, DOI 10.1007/s10633-007-9053-1; HUI CC, 1994, DEV BIOL, V162, P402, DOI 10.1006/dbio.1994.1097; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; Idrees F, 2006, AM J MED GENET B, V141B, P184, DOI 10.1002/ajmg.b.30237; Johansen-Berg H, 2005, CEREB CORTEX, V15, P31, DOI 10.1093/cercor/bhh105; Kawai S, 2001, BONE, V29, P54, DOI 10.1016/S8756-3282(01)00470-7; Lai CSL, 2003, BRAIN, V126, P2455, DOI 10.1093/brain/awg247; Lemyre E, 1998, AM J MED GENET, V77, P162, DOI 10.1002/(SICI)1096-8628(19980501)77:2<162::AID-AJMG10>3.0.CO;2-L; Lin DH, 2007, DEV DYNAM, V236, P1307, DOI 10.1002/dvdy.21127; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Lopez-Rios J, 1999, MECH DEVELOP, V83, P155, DOI 10.1016/S0925-4773(99)00017-9; Marmor MF, 2004, DOC OPHTHALMOL, V108, P107, DOI 10.1023/B:DOOP.0000036793.44912.45; Morcillo J, 2006, DEVELOPMENT, V133, P3179, DOI 10.1242/dev.02493; Morrison D, 2002, J MED GENET, V39, P16, DOI 10.1136/jmg.39.1.16; Motoyama Jun, 2006, Congenital Anomalies, V46, P123, DOI 10.1111/j.1741-4520.2006.00114.x; Nolen LD, 2006, AM J MED GENET A, V140A, P1711, DOI 10.1002/ajmg.a.31335; Omi M, 2005, DEV DYNAM, V233, P288, DOI 10.1002/dvdy.20353; Panman L, 2003, J ANAT, V202, P3, DOI 10.1046/j.1469-7580.2003.00138.x; PHADKE SR, 1994, J MED GENET, V31, P960, DOI 10.1136/jmg.31.12.960; Pizette S, 1999, DEVELOPMENT, V126, P883; Qi YC, 2002, TRENDS NEUROSCI, V25, P223, DOI 10.1016/S0166-2236(02)02145-8; Ragge NK, 2005, AM J HUM GENET, V76, P1008, DOI 10.1086/430721; Ragge NK, 2005, BRIT J OPHTHALMOL, V89, P988, DOI 10.1136/bjo.2004.061390; Ragge NK, 2005, AM J MED GENET A, V135A, P1, DOI 10.1002/ajmg.a.30642; Schimmenti LA, 2003, AM J MED GENET A, V116A, P215, DOI 10.1002/ajmg.a.10884; Scott A, 2007, AM J OPHTHALMOL, V143, P346, DOI 10.1016/j.ajo.2006.09.022; Selever J, 2004, DEV BIOL, V276, P268, DOI 10.1016/j.ydbio.2004.08.024; Tang MK, 2000, DEV BIOL, V218, P89, DOI 10.1006/dbio.1999.9578; Tobin JL, 2007, PEDIATR NEPHROL, V22, P926, DOI 10.1007/s00467-007-0435-0; Wawersik S, 2000, HUM MOL GENET, V9, P917, DOI 10.1093/hmg/9.6.917; Wicking C, 1997, AM J MED GENET, V73, P304; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Yeyati PL, 2007, PLOS GENET, V3, P431, DOI 10.1371/journal.pgen.0030043; Zarei M, 2006, J ANAT, V209, P311, DOI 10.1111/j.1469-7580.2006.00615.x; Zhang XM, 2001, DEV BIOL, V233, P271, DOI 10.1006/dbio.2000.0195; Zhang ZY, 2002, DEVELOPMENT, V129, P4135	73	191	195	3	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2008	82	2					304	319		10.1016/j.ajhg.2007.09.023	http://dx.doi.org/10.1016/j.ajhg.2007.09.023			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NN	18252212	Green Published, Bronze			2022-12-18	WOS:000253223900004
J	RANEN, NG; STINE, OC; ABBOTT, MH; SHERR, M; CODORI, AM; FRANZ, ML; CHAO, NI; CHUNG, AS; PLEASANT, N; CALLAHAN, C; KASCH, LM; GHAFFARI, M; CHASE, GA; KAZAZIAN, HH; BRANDT, J; FOLSTEIN, SE; ROSS, CA				RANEN, NG; STINE, OC; ABBOTT, MH; SHERR, M; CODORI, AM; FRANZ, ML; CHAO, NI; CHUNG, AS; PLEASANT, N; CALLAHAN, C; KASCH, LM; GHAFFARI, M; CHASE, GA; KAZAZIAN, HH; BRANDT, J; FOLSTEIN, SE; ROSS, CA			ANTICIPATION AND INSTABILITY OF IT-15 (CAG)(N) REPEATS IN PARENT-OFFSPRING PAIRS WITH HUNTINGTON DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRINUCLEOTIDE CAG REPEAT; BULBAR MUSCULAR-ATROPHY; SPINOCEREBELLAR ATAXIA; AFFECTIVE-DISORDER; MOLECULAR ANALYSIS; CLINICAL-FEATURES; ONSET AGE; LENGTH; INHERITANCE; GENES	Huntington disease (HD) is an autosomal dominant degenerative disorder caused by an expanded and unstable trinucleotide repeat (CAG)n in a gene (IT-15) on chromosome 4. HD exhibits genetic anticipation-earlier onset in successive generations within a pedigree. From a population-based clinical sample, we ascertained parent-offspring pairs with expanded alleles, to examine the intergenerational behavior of the trinucleotide repeat and its relationship to anticipation. We find that the change in repeat length with paternal transmission is significantly correlated with the change in age at onset between the father and offspring. When expanded triplet repeats of affected parents are separated by median repeat length, we find that the longer paternal and maternal repeats are both more unstable on transmission. However, unlike in paternal transmission, in which longer expanded repeats display greater net expansion than do shorter expanded repeats, in maternal transmission there is no mean change in repeat length for either longer or shorter expanded repeats. We also confirmed the inverse relationship between repeat length and age at onset, the higher frequency of juvenile-onset cases arising from paternal transmission, anticipation as a phenomenon of paternal transmission, and greater expansion of the trinucleotide repeat with paternal transmission. Stepwise multiple regression indicates that, in addition to repeat length of offspring, age at onset of affected parent and sex of affected parent contribute significantly to the variance in age at onset of the offspring. Thus, in addition to triplet repeat length, other factors, which could act as environmental factors, genetic factors, or both, contribute to age at onset. Our data establish that further expansion of paternal repeats within the affected range provides a biological basis of anticipation in HD.	JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21287; JOHNS HOPKINS UNIV,SCH MED,DEPT MED,BALTIMORE,MD 21287; JOHNS HOPKINS UNIV,SCH PUBL HLTH,DEPT MENTAL HYG,BALTIMORE,MD; GEORGETOWN UNIV,MED CTR,BIOSTAT CONSULT SERV,WASHINGTON,DC 20007; TUFTS UNIV,SCH MED,DEPT PSYCHIAT,BOSTON,MA 02111; UNIV PENN,SCH MED,DEPT GENET,PHILADELPHIA,PA 19104	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Maryland Department of Health & Mental Hygiene; Georgetown University; Tufts University; University of Pennsylvania	RANEN, NG (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT PSYCHIAT,MEYER 2-181,600 N WOLFE ST,BALTIMORE,MD 21287, USA.		Ross, Christopher A/H-8395-2013	Brandt, Jason/0000-0001-7381-6244	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH046034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016375] Funding Source: NIH RePORTER; NIMH NIH HHS [MH46034] Funding Source: Medline; NINDS NIH HHS [P01 NS16375] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; BASSETT AS, 1994, AM J HUM GENET, V54, P864; Biancalana V., 1992, Human Molecular Genetics, V1, P255, DOI 10.1093/hmg/1.4.255; BIRD ED, 1974, ANN HUM GENET, V37, P255, DOI 10.1111/j.1469-1809.1974.tb01833.x; BOEHNKE M, 1983, AM J HUM GENET, V35, P845; BRACKENRIDGE CJ, 1971, CLIN GENET, V7, P267; BRUYN GW, 1969, EXCERPTA MED, P666; CHUNG AS, 1995, THESIS J HOPKINS U S; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; DIAZ GO, 1990, NEUROLOGY, V40, P1369, DOI 10.1212/WNL.40.9.1369; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; FARRER LA, 1984, AM J MED GENET, V18, P115, DOI 10.1002/ajmg.1320180115; FARRER LA, 1985, AM J HUM GENET, V37, P350; FOLSTEIN SE, 1987, AM J HUM GENET, V41, P168; FOLSTEIN SE, 1985, SCIENCE, V229, P776, DOI 10.1126/science.2992086; FOLSTEIN SE, 1983, PSYCHOL MED, V13, P45, DOI 10.1017/S0033291700050054; FOLSTEIN SE, 1989, HUNTINGTONS DISEASE; FOLSTEIN SE, 1983, PSYCHOL MED, V15, P357; Folstein SE, 1984, J NEUROGENET, V1, P175, DOI 10.3109/01677068409107083; GIACOMELLI F, 1971, J HISTOCHEM CYTOCHEM, V19, P426, DOI 10.1177/19.7.426; GOLDBERG YP, 1993, NAT GENET, V5, P174, DOI 10.1038/ng1093-174; HAINES JL, 1984, NEUROLOGY, V34, P1542, DOI 10.1212/WNL.34.12.1542; HARPER PS, 1992, AM J HUM GENET, V51, P10; JODICE C, 1994, AM J HUM GENET, V54, P959; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; KREMER B, 1994, NEW ENGL J MED, V330, P1401, DOI 10.1056/NEJM199405193302001; LASPADA AR, 1992, NAT GENET, V2, P301, DOI 10.1038/ng1292-301; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LI SH, 1993, GENOMICS, V16, P572, DOI 10.1006/geno.1993.1232; MCINNIS MG, 1993, AM J HUM GENET, V53, P385; MCINNIS MG, 1994, AM J HUM GENET, V55, P590; MERRITT AD, 1969, PROGR NEUROGENETICS, P645; MYERS RH, 1982, AM J HUM GENET, V34, P481; MYERS RH, 1985, AM J HUM GENET, V37, P511; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PENROSE LS, 1948, ANN EUGENIC, V14, P125; PETRONIS A, 1994, AM J HUM GENET, V55, P589; PULST SM, 1993, NAT GENET, V5, P8, DOI 10.1038/ng0993-8c; RANUM LPW, 1994, AM J HUM GENET, V55, P244; RANUM LPW, 1994, NAT GENET, V8, P280, DOI 10.1038/ng1194-280; RIDLEY RM, 1991, J MED GENET, V28, P224, DOI 10.1136/jmg.28.4.224; RIDLEY RM, 1988, J MED GENET, V25, P589, DOI 10.1136/jmg.25.9.589; ROSS CA, 1993, TRENDS NEUROSCI, V16, P254, DOI 10.1016/0166-2236(93)90175-L; Sambrook J., 1989, MOL CLONING LAB MANU; SHERMAN SL, 1985, HUM GENET, V69, P289, DOI 10.1007/BF00291644; SMITH JK, 1958, NEUROLOGY, V8, P205, DOI 10.1212/WNL.8.3.205; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; SQUITIERI F, 1994, HUM MOL GENET, V3, P2103, DOI 10.1093/hmg/3.12.2103; STINE OC, 1993, HUM MOL GENET, V2, P1547, DOI 10.1093/hmg/2.10.1547; TAKIYAMA Y, 1994, NEUROLOGY, V44, P1302, DOI 10.1212/WNL.44.7.1302; TELENIUS H, 1995, HUM MOL GENET, V4, P189, DOI 10.1093/hmg/4.2.189; TELENIUS H, 1993, HUM MOL GENET, V2, P1535, DOI 10.1093/hmg/2.10.1535; TROTTIER Y, 1994, J MED GENET, V31, P377, DOI 10.1136/jmg.31.5.377; TYLER A, 1983, J BIOSOC SCI, V15, P127, DOI 10.1017/S0021932000014413; WEXLER N, 1983, NATURE, V326, P194; 1993, CELL, V72, P971	58	191	197	0	10	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1995	57	3					593	602						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR605	7668287				2022-12-18	WOS:A1995RR60500008
J	MCMAHON, FJ; STINE, OC; MEYERS, DA; SIMPSON, SG; DEPAULO, JR				MCMAHON, FJ; STINE, OC; MEYERS, DA; SIMPSON, SG; DEPAULO, JR			PATTERNS OF MATERNAL TRANSMISSION IN BIPOLAR AFFECTIVE-DISORDER	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MANIC-DEPRESSIVE ILLNESS; FAMILY HISTORY METHOD; GENETIC TRANSMISSION; MITOCHONDRIAL-DNA; INHERITANCE; MODELS; TRAITS; PSYCHOSES; INTERVIEW; DIAGNOSIS	The mode of inheritance of bipolar affective disorder (BPAD) appears complex, and non-Mendelian models of inheritance have been postulated. Two non-Mendelian phenomena, genomic imprinting and mitochondrial inheritance, may contribute to the complex inheritance pattern seen in BPAD. Both imprinting and mitochondrial inheritance share the feature of differential expression of the phenotype, depending on the parent of origin. In this study we tested the hypothesis of a parent-of-origin effect on the transmission of BPAD. We examined the frequency and risk of affective disorder among relatives in a sample of 31 families ascertained through treated probands with BPAD and selected for the presence of affected phenotypes in only one parental lineage. Three specific comparisons were performed: (1) the observed frequency of transmitting mothers versus transmitting fathers; (2) the observed frequency and lifetime risk of BPAD among the maternal versus the paternal relatives of probands; and (3) the observed frequency and lifetime risk of BPAD for the offspring of affected mothers compared with the offspring of affected fathers. We observed a higher than expected frequency of affected mothers (P < .04), a 2.3-2.8-fold increased risk of illness for maternal relatives (P < .006), and a 1.3-2.5-fold increased risk of illness for the offspring of affected mothers (P < .017). In seven enlarged pedigrees, fathers repeatedly failed to transmit the affected phenotype to daughters or sons. Taken together, these findings indicate a maternal effect in the transmission of BPAD susceptibility and suggest that molecular studies of mtDNA and imprinted DNA are warranted in patients with BPAD.	JOHNS HOPKINS UNIV, SCH MED, DEPT PSYCHIAT & BEHAV SCI, BALTIMORE, MD USA	Johns Hopkins University			McMahon, Francis J/A-7290-2009	McMahon, Francis J/0000-0002-9469-305X; DePaulo, J Raymond/0000-0001-9221-9226				ANDREASEN NC, 1977, ARCH GEN PSYCHIAT, V34, P1229; ANGST J, 1980, HUM GENET, V55, P237, DOI 10.1007/BF00291773; AUSTIN KD, 1992, PEDIATR CLIN N AM, V39, P335; BARON M, 1981, ARCH GEN PSYCHIAT, V38, P79; BERTELSEN A, 1977, BRIT J PSYCHIAT, V130, P330, DOI 10.1192/bjp.130.4.330; BROWN MD, 1992, GENETICS, V130, P163; BU XD, 1991, P NATL ACAD SCI USA, V88, P8198, DOI 10.1073/pnas.88.18.8198; BU XD, 1992, GENET EPIDEMIOL, V9, P27, DOI 10.1002/gepi.1370090105; CANNINGS C, 1977, CLIN GENET, V12, P208; CIAFALONI E, 1991, NEUROLOGY, V41, P1663, DOI 10.1212/WNL.41.10.1663; COX DR, 1964, J ROY STAT SOC B, V26, P103; DUNNER DL, 1975, ARCH GEN PSYCHIAT, V32, P1134; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; FEINBERG AP, 1993, NAT GENET, V4, P110, DOI 10.1038/ng0693-110; FLINT J, 1992, PSYCHOL MED, V22, P5, DOI 10.1017/S0033291700032669; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; GERSHON ES, 1984, ARCH GEN PSYCHIAT, V41, P173; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; GOETZL U, 1974, ARCH GEN PSYCHIAT, V31, P665; HALL JG, 1990, AM J HUM GENET, V46, P857; HELZER JE, 1974, ARCH GEN PSYCHIAT, V31, P73; KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403; Lee E.T., 1992, STATISTICAL METHODS; Leonhard K, 1957, AUFTEILUNG ENDOGENEN; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MCINNIS MG, 1993, AM J HUM GENET, V53, P385; MENDLEWICZ J, 1973, BRIT J PSYCHIAT, V122, P31, DOI 10.1192/bjp.122.1.31; MENDLEWICZ J, 1977, NATURE, V268, P327, DOI 10.1038/268327a0; MENDLEWICZ J, 1974, AM J HUM GENET, V26, P692; MERIKANGAS KR, 1982, ARCH GEN PSYCHIAT, V39, P1173; NICHOLLS RD, 1994, AM J HUM GENET, V54, P733; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; ORVASCHEL H, 1982, J AFFECT DISORDERS, V4, P49, DOI 10.1016/0165-0327(82)90019-2; PERRIS C, 1971, BRIT J PSYCHIAT, V118, P207, DOI 10.1192/bjp.118.543.207; PERRIS C, 1966, ACTA PSYCHIAT SCAND, VS 42, P58; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; PRICE RA, 1985, J PSYCHIAT RES, V19, P533, DOI 10.1016/0022-3956(85)90071-8; REICH T, 1972, ANN HUM GENET, V36, P163, DOI 10.1111/j.1469-1809.1972.tb00767.x; REICH T, 1969, AM J PSYCHIAT, V1245, P64; REIK W, 1989, TRENDS GENET, V5, P331, DOI 10.1016/0168-9525(89)90138-8; SCHORK NJ, 1993, AM J HUM GENET, V53, P1320; SIMPSON SG, 1992, AM J PSYCHIAT, V149, P1660; SLATER E, 1971, BRIT J PSYCHIAT, V118, P215, DOI 10.1192/bjp.118.543.215; SMERALDI E, 1977, ACTA PSYCHIAT SCAND, V56, P382, DOI 10.1111/j.1600-0447.1977.tb06679.x; SMERALDI E, 1981, J AFFECT DISORDERS, V3, P173, DOI 10.1016/0165-0327(81)90042-2; Spitzer R.L., 1975, RES DIAGNOSTIC CRITE, V2; STEWART J B, 1990, Medical Science Research, V18, P265; SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856; SUZUKI T, 1990, NEURORADIOLOGY, V32, P74, DOI 10.1007/BF00593949; TRZEBIATOWSKATRZECIAK O, 1977, BRIT J PSYCHIAT, V131, P478, DOI 10.1192/bjp.131.5.478; WALLACE DC, 1970, BRAIN, V93, P121, DOI 10.1093/brain/93.1.121; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523; WEISSMAN MM, 1984, J AM ACAD CHILD PSY, V23, P78, DOI 10.1097/00004583-198401000-00011; WEISSMAN MM, 1991, PSYCHIATRIC DISORDER; ZAHNWAXLER C, 1984, AM J PSYCHIAT, V141, P236	56	191	201	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1995	56	6					1277	1286						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	RA794	7762550				2022-12-18	WOS:A1995RA79400004
J	KRUGLYAK, L; LANDER, ES				KRUGLYAK, L; LANDER, ES			HIGH-RESOLUTION GENETIC-MAPPING OR COMPLEX TRAITS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE STRATEGIES; MODELS	Positional cloning requires high-resolution genetic mapping. To plan a positional cloning project, one needs to know how many informative meioses will be required to narrow the search for a disease gene to an acceptably small region. For a simple Mendelian trait studied with linkage analysis, the answer is straightforward. In this paper, we address the situation of a complex trait studied with affected-relative-pair methods. We derive mathematical formulas for the size of an appropriate confidence region, as a function of the relative risk attributable to the gene. Using these results, we provide graphs showing the number of relative pairs required to narrow the gene hunt to an interval of a given size. For example, we show that localizing a gene to 1 cM requires a median of 200 sib pairs for a locus causing a fivefold increased risk to an offspring and 700 sib pairs for a locus causing a twofold increased risk. We discuss the implications of these results for the positional cloning of genes underlying complex traits.	MIT,WHITEHEAD INST BIOMED RES,CAMBRIDGE CTR 9,CAMBRIDGE,MA 02142; MIT,DEPT BIOL,CAMBRIDGE,MA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)								BERRETTINI WH, 1994, P NATL ACAD SCI USA, V91, P5918, DOI 10.1073/pnas.91.13.5918; BOEHNKE M, 1994, AM J HUM GENET, V55, P379; FEINGOLD E, 1993, AM J HUM GENET, V53, P234; FEINGOLD E, 1993, J APPL PROBAB, V30, P766, DOI 10.2307/3214511; Feller W, 1970, INTRO PROBABILITY TH, V1; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LANGE K, 1985, AM J HUM GENET, V37, P853; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P222; SIEGMUND D, 1988, INT STAT REV, V56, P31, DOI 10.2307/1403360	11	191	194	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1995	56	5					1212	1223						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QU586	7726179				2022-12-18	WOS:A1995QU58600026
J	ZHANG, YH; SHIELDS, T; CRENSHAW, T; HAO, Y; MOULTON, T; TYCKO, B				ZHANG, YH; SHIELDS, T; CRENSHAW, T; HAO, Y; MOULTON, T; TYCKO, B			IMPRINTING OF HUMAN H19 - ALLELE-SPECIFIC CPG METHYLATION, LOSS OF THE ACTIVE ALLELE IN WILMS-TUMOR, AND POTENTIAL FOR SOMATIC ALLELE SWITCHING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRAGILE-X-SYNDROME; DNA METHYLATION; DETERMINES METHYLATION; MOLECULAR MECHANISM; MOUSE EMBRYOGENESIS; PATERNAL GENOMES; GENE-EXPRESSION; TRANSGENIC MICE; CHROMOSOME; PROMOTERS	Genomic imprinting and monoallelic gene expression appear to play a role in human genetic disease and tumorigenesis. The human H19 gene, at chromosome 11p15, has previously been shown to be monoallelically expressed. Since CpG methylation has been implicated in imprinting, we analyzed methylation of H19 DNA. In fetal and adult organs the transcriptionally silent H19 allele was extensively hypermethylated through the entire gene and its promoter, and, consistent with a functional role for DNA methylation, expression of an H19 promoter-reporter construct was inhibited by in vitro methylation. Gynogenetic ovarian teratomas were found to contain only hypomethylated H19 DNA, suggesting that the expressed H19 allele might be maternal. This was confirmed by analysis of 11p15 polymorphisms in a patient with Wilms tumor. The tumor had lost the maternal 11p15, and H19 expression in the normal kidney was exclusively from this allele. Imprinting of human H19 appears to be susceptible to tissue-specific modulation in somatic development; in one individual, cerebellar cells were found to express only the otherwise silent allele. Implications of these findings for the role of DNA methylation in imprinting and for H19 as a candidate imprinted tumor-suppressor gene are discussed.	COLUMBIA UNIV,DEPT PATHOL,DIV NEUROPATHOL,NEW YORK,NY 10027; COLUMBIA UNIV,DEPT PATHOL,DIV ONCOL,NEW YORK,NY 10027; COLUMBIA UNIV,DEPT PEDIAT,DIV PEDIAT HEMATOL ONCOL,NEW YORK,NY 10027; COLUMBIA UNIV COLL PHYS & SURG,NEW YORK,NY 10032	Columbia University; Columbia University; Columbia University; Columbia University								BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BELL MV, 1991, CELL, V64, P861, DOI 10.1016/0092-8674(91)90514-Y; BIRD A, 1992, CELL, V70, P5, DOI 10.1016/0092-8674(92)90526-I; BOYES J, 1991, CELL, V64, P1123, DOI 10.1016/0092-8674(91)90267-3; BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; BRUNKOW ME, 1991, GENE DEV, V5, P1092, DOI 10.1101/gad.5.6.1092; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; CEDAR H, 1988, CELL, V53, P3, DOI 10.1016/0092-8674(88)90479-5; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; DYNAN WS, 1989, TRENDS GENET, V5, P35, DOI 10.1016/0168-9525(89)90016-4; FOREJT J, 1992, CELL, V70, P443, DOI 10.1016/0092-8674(92)90168-C; FRANK D, 1991, NATURE, V351, P239, DOI 10.1038/351239a0; HADCHOUEL M, 1987, NATURE, V329, P454, DOI 10.1038/329454a0; HALL JG, 1990, AM J HUM GENET, V46, P857; HAN DKM, 1992, CIRC RES, V71, P711, DOI 10.1161/01.RES.71.3.711; HOWLETT SK, 1991, DEVELOPMENT, V113, P119; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; LAIRD CD, 1991, AM J MED GENET, V38, P391, DOI 10.1002/ajmg.1320380247; LAIRD CD, 1987, GENETICS, V117, P587; LEFF SE, 1992, NAT GENET, V2, P259, DOI 10.1038/ng1292-259; LEIBOVITCH MP, 1991, BIOCH BIOPHYSICAL RE, V14, P1241; LINDER D, 1975, NEW ENGL J MED, V292, P63, DOI 10.1056/NEJM197501092920202; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; MEEHAN RR, 1989, CELL, V58, P499, DOI 10.1016/0092-8674(89)90430-3; MONK M, 1987, DEVELOPMENT, V99, P371; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; OHLSSON R, IN PRESS NATURE GENE; PACHNIS V, 1988, EMBO J, V7, P673, DOI 10.1002/j.1460-2075.1988.tb02862.x; PAL N, 1990, ONCOGENE, V5, P1665; POIRIER F, 1991, DEVELOPMENT, V113, P1105; PONCE MR, 1992, NUCLEIC ACIDS RES, V20, P623, DOI 10.1093/nar/20.3.623; RACHMILEWITZ J, 1992, MOL REPROD DEV, V32, P196, DOI 10.1002/mrd.1080320303; RACHMILEWITZ J, 1992, FEBS LETT, V309, P25, DOI 10.1016/0014-5793(92)80731-U; REIK W, 1987, NATURE, V328, P248, DOI 10.1038/328248a0; RIGGS AD, 1992, TRENDS GENET, V8, P169, DOI 10.1016/0168-9525(92)90219-T; Sambrook J., 1989, MOL CLONING LAB MANU; SANFORD JP, 1987, GENE DEV, V1, P1039, DOI 10.1101/gad.1.10.1039; SAPIENZA C, 1989, DEVELOPMENT, V107, P165; SAPIENZA C, 1987, NATURE, V328, P251, DOI 10.1038/328251a0; SASAKI H, 1992, GENE DEV, V6, P1843, DOI 10.1101/gad.6.10.1843; SCHROEDER WT, 1987, AM J HUM GENET, V40, P413; SCRABLE H, 1989, P NATL ACAD SCI USA, V86, P7480, DOI 10.1073/pnas.86.19.7480; SEARLE AG, 1978, CYTOGENET CELL GENET, V20, P282, DOI 10.1159/000130859; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; SUSSENBACH JS, 1989, PROG GROWTH FACTOR R, V1, P38; SWAIN JL, 1987, CELL, V50, P719, DOI 10.1016/0092-8674(87)90330-8; TOTH M, 1989, P NATL ACAD SCI USA, V86, P3728, DOI 10.1073/pnas.86.10.3728; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WILES MV, 1988, DEVELOPMENT, V104, P403; WILLIAMS JC, 1989, LANCET, V1, P283; YOOWARREN H, 1988, MOL CELL BIOL, V8, P4707, DOI 10.1128/MCB.8.11.4707; ZEMEL S, 1992, NAT GENET, V2, P61, DOI 10.1038/ng0992-61; ZHANG YH, 1992, NAT GENET, V1, P40, DOI 10.1038/ng0492-40	57	191	199	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1993	53	1					113	124						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ385	8391213				2022-12-18	WOS:A1993LJ38500015
J	ROMMENS, J; KEREM, BS; GREER, W; CHANG, P; TSUI, LC; RAY, P				ROMMENS, J; KEREM, BS; GREER, W; CHANG, P; TSUI, LC; RAY, P			RAPID NONRADIOACTIVE DETECTION OF THE MAJOR CYSTIC-FIBROSIS MUTATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									UNIV TORONTO,HOSP SICK CHILDREN,DEPT MED GENET,TORONTO M5G 1X8,ONTARIO,CANADA; UNIV TORONTO,HOSP SICK CHILDREN,DEPT MED BIOPHYS,TORONTO M5G 1X8,ONTARIO,CANADA; MCMASTER UNIV,DEPT PEDIAT,HAMILTON L8S 4L8,ONTARIO,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University	ROMMENS, J (corresponding author), UNIV TORONTO,HOSP SICK CHILDREN,DEPT GENET,TORONTO M5G 1X8,ONTARIO,CANADA.		Tsui, Lap-chee/A-1081-2010					KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; NAGAMINE CM, 1989, AM J HUM GENET, V45, P337; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657	3	191	193	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1990	46	2					395	396						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CM938	2301405				2022-12-18	WOS:A1990CM93800023
J	Deardorff, MA; Wilde, JJ; Albrecht, M; Dickinson, E; Tennstedt, S; Braunholz, D; Monnich, M; Yan, YQ; Xu, WZ; Gil-Rodriguez, MC; Clark, D; Hakonarson, H; Halbach, S; Michelis, LD; Rampuria, A; Rossier, E; Spranger, S; Van Maldergem, L; Lynch, SA; Gillessen-Kaesbach, G; Ludecke, HJ; Ramsay, RG; McKay, MJ; Krantz, ID; Xu, HL; Horsfield, JA; Kaiser, FJ				Deardorff, Matthew A.; Wilde, Jonathan J.; Albrecht, Melanie; Dickinson, Emma; Tennstedt, Stephanie; Braunholz, Diana; Moennich, Maren; Yan, Yuqian; Xu, Weizhen; Concepcion Gil-Rodriguez, Maria; Clark, Dinah; Hakonarson, Hakon; Halbach, Sara; Michelis, Laura Daniela; Rampuria, Abhinav; Rossier, Eva; Spranger, Stephanie; Van Maldergem, Lionel; Lynch, Sally Ann; Gillessen-Kaesbach, Gabriele; Luedecke, Hermann-Josef; Ramsay, Robert G.; McKay, Michael J.; Krantz, Ian D.; Xu, Huiling; Horsfield, Julia A.; Kaiser, Frank J.			RAD21 Mutations Cause a Human Cohesinopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SISTER-CHROMATID COHESION; DE-LANGE-SYNDROME; DOUBLE-STRAND-BREAK; RADIOSENSITIVE CANCER-PATIENTS; NIPPED-B; MENTAL-RETARDATION; VERTEBRATE CELLS; ROBERTS-SYNDROME; GENE-EXPRESSION; HUMAN HOMOLOG	The evolutionarily conserved cohesin complex was originally described for its role in regulating sister-chromatid cohesion during mitosis and meiosis. Cohesin and its regulatory proteins have been implicated in several human developmental disorders, including Cornelia de Lange (CdLS) and Roberts syndromes. Here we show that human mutations in the integral cohesin structural protein RAD21 result in a congenital phenotype consistent with a "cohesinopathy." Children with RAD21 mutations display growth retardation, minor skeletal anomalies, and facial features that overlap findings in individuals with CdLS. Notably, unlike children with mutations in NIPBL, SMC1A, or SMC3, these individuals have much milder cognitive impairment than those with classical CdLS. Mechanistically, these mutations act at the RAD21 interface with the other cohesin proteins STAG2 and SMC1A, impair cellular DNA damage response, and disrupt transcription in a zebrafish model. Our data suggest that, compared to loss-of-function mutations, dominant missense mutations result in more severe functional defects and cause worse structural and cognitive clinical findings. These results underscore the essential role of RAD21 in eukaryotes and emphasize the need for further understanding of the role of cohesin in human development.	[Deardorff, Matthew A.; Wilde, Jonathan J.; Clark, Dinah; Hakonarson, Hakon; Michelis, Laura Daniela; Rampuria, Abhinav; Krantz, Ian D.] Childrens Hosp Philadelphia, Div Genet, Philadelphia, PA 19104 USA; [Deardorff, Matthew A.; Hakonarson, Hakon; Krantz, Ian D.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Albrecht, Melanie; Braunholz, Diana; Xu, Weizhen; Concepcion Gil-Rodriguez, Maria; Gillessen-Kaesbach, Gabriele; Kaiser, Frank J.] Med Univ Lubeck, Inst Humangenet Lubeck, D-23538 Lubeck, Germany; [Dickinson, Emma; Moennich, Maren; Horsfield, Julia A.] Univ Otago, Dunedin Sch Med, Dept Pathol, Dunedin 9054, New Zealand; [Tennstedt, Stephanie] Med Univ Lubeck, Med Klin 2, D-23538 Lubeck, Germany; [Yan, Yuqian; Ramsay, Robert G.; Xu, Huiling] Peter MacCallum Canc Ctr, Div Res, Melbourne, Vic 3002, Australia; [Xu, Weizhen] Zhejiang Canc Res Inst, Hangzhou 310058, Zhejiang, Peoples R China; [Concepcion Gil-Rodriguez, Maria] Univ Zaragoza, Sch Med, Unit Clin Genet & Funct Genom, E-50009 Zaragoza, Spain; [Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Halbach, Sara] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Rossier, Eva] Genetikum, D-70174 Stuttgart, Germany; [Spranger, Stephanie] Praxis Humangenet, D-28205 Bremen, Germany; [Van Maldergem, Lionel] Univ Franche Comte, Ctr Genet Humaine, F-25030 Besancon, France; [Lynch, Sally Ann] Our Ladys Childrens Hosp, Natl Ctr Med Genet, Dublin 12, Ireland; [Luedecke, Hermann-Josef] Univ Duisburg Essen, Inst Human Genet, D-45122 Essen, Germany; [Ramsay, Robert G.; Xu, Huiling] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Fac Med & Dent Sci, Parkville, Vic 3000, Australia; [Ramsay, Robert G.; Xu, Huiling] Univ Melbourne, Fac Med & Dent Sci, Dept Pathol, Parkville, Vic 3000, Australia; [McKay, Michael J.] N Coast Canc Inst, Lismore, NSW 2480, Australia; [McKay, Michael J.] Univ Sydney, Sch Med, Sydney, NSW 2006, Australia	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Lubeck; University of Otago; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; Peter Maccallum Cancer Center; Zhejiang Cancer Hospital; University of Zaragoza; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Chicago; Universite de Franche-Comte; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; University of Duisburg Essen; Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne; University of Sydney	Deardorff, MA (corresponding author), Childrens Hosp Philadelphia, Div Genet, Philadelphia, PA 19104 USA.	deardorff@email.chop.edu; frank.kaiser@uk-sh.de	Yan, Yuqian/AAU-5681-2020; Horsfield, Julia A/B-5091-2012; Ramsay, Robert G/C-3291-2015; Tennstedt, Stephanie/F-3637-2018; McKay, Michael/ABA-9029-2021; Van Maldergem, Lionel/G-9849-2017; Van Maldergem, Lionel/O-3242-2019	Horsfield, Julia A/0000-0002-9536-7790; Ramsay, Robert G/0000-0001-5003-0433; Tennstedt, Stephanie/0000-0001-9063-3087; Van Maldergem, Lionel/0000-0001-8880-5214; Van Maldergem, Lionel/0000-0001-8880-5214; Lynch, Sally Ann/0000-0003-3540-1333; Wilde, Jonathan/0000-0002-0800-8854	National Institutes of Health from the National Institute of Child Health and Human Development [NICHD] [K08HD055488, P01 HD052860]; USA CdLS Foundation; Children's Hospital of Philadelphia; Cancer Council Victoria Australia [081219]; Australian National Health and Medical Research Council [1007659]; Marsden grant [UOO0713]; New Zealand Lottery Health Research; Spanish Ministerio de Sanidad [PI091422]; University of Lubeck, Germany; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD052860] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD055488] Funding Source: NIH RePORTER	National Institutes of Health from the National Institute of Child Health and Human Development [NICHD]; USA CdLS Foundation; Children's Hospital of Philadelphia; Cancer Council Victoria Australia(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Marsden grant(Royal Society of New ZealandMarsden Fund (NZ)); New Zealand Lottery Health Research; Spanish Ministerio de Sanidad(Spanish Government); University of Lubeck, Germany; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We are exceptionally grateful to the children and families who participated in this study as well as to the referring physicians and colleagues who have contributed samples and clinical information. We thank Maninder Kaur and Melanie Hullings for technical assistance and Pavel Lobachevsky and Goli Mostoufi-Moab for assistance with statistical analysis of the radiation-survival experiments. We are indebted to the continued support of the USA and International Cornelia de Lange Syndrome Foundations. This work was supported by National Institutes of Health grants K08HD055488 (from the National Institute of Child Health and Human Development [NICHD] to M.A.D.), P01 HD052860 (from the NICHD to I.D.K.), research grants from the USA CdLS Foundation, institutional funds from the Children's Hospital of Philadelphia, Cancer Council Victoria Australia grant 081219 (to H.X. and M.J.M.), Australian National Health and Medical Research Council project grant 1007659 (to R.G.R., H.X., and M.J.M.), Marsden grant UOO0713 (to E.D., M.M., and J.H.), funds from New Zealand Lottery Health Research (to E.D., MM., and J.H.), Spanish Ministerio de Sanidad grant PI091422 (to M.C.G.-R.), and intramural funding of the University of Lubeck, Germany ("Schwerpunktprogramm: Medizinische Genetik," to F.J.K. and G.G.-K.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bauerschmidt C, 2010, NUCLEIC ACIDS RES, V38, P477, DOI 10.1093/nar/gkp976; BIRKENBIHL RP, 1992, NUCLEIC ACIDS RES, V20, P6605, DOI 10.1093/nar/20.24.6605; Canudas S, 2009, J CELL BIOL, V187, P165, DOI 10.1083/jcb.200903096; Deardorff M.A., 2010, GENE REV; Deardorff MA, 2007, AM J HUM GENET, V80, P485, DOI 10.1086/511888; Dhawan A, 2009, CELL BIOL TOXICOL, V25, P5, DOI 10.1007/s10565-008-9072-z; Dodson H, 2009, NUCLEIC ACIDS RES, V37, P6054, DOI 10.1093/nar/gkp684; Dorsett D, 2011, CURR OPIN GENET DEV, V21, P199, DOI 10.1016/j.gde.2011.01.018; Dorsett D, 2009, CHROMOSOME RES, V17, P185, DOI 10.1007/s10577-009-9022-5; Eddy S R, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P114; Fenech M, 2000, MUTAT RES-FUND MOL M, V455, P81, DOI 10.1016/S0027-5107(00)00065-8; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Horsfield JA, 2007, DEVELOPMENT, V134, P2639, DOI 10.1242/dev.002485; Hou FJ, 2005, MOL BIOL CELL, V16, P3908, DOI 10.1091/mbc.E04-12-1063; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kalev-Zylinska ML, 2002, DEVELOPMENT, V129, P2015; Kawauchi S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000650; Kim HS, 2010, EMBO J, V29, P3544, DOI 10.1038/emboj.2010.217; Krantz ID, 2004, NAT GENET, V36, P631, DOI 10.1038/ng1364; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Krieger E, 2006, J MOL GRAPH MODEL, V25, P481, DOI 10.1016/j.jmgm.2006.02.009; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Liu JL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000119; Losada A, 2000, J CELL BIOL, V150, P405, DOI 10.1083/jcb.150.3.405; Lovelock PK, 2007, BREAST CANCER RES TR, V104, P257, DOI 10.1007/s10549-006-9415-5; LUDECKE HJ, 1991, AM J HUM GENET, V49, P1197; Mannini L, 2010, HUM MUTAT, V31, P623, DOI 10.1002/humu.21252; McBrien J, 2008, AM J MED GENET A, V146A, P1587, DOI 10.1002/ajmg.a.32347; McKay MJ, 1996, GENOMICS, V36, P305, DOI 10.1006/geno.1996.0466; Misulovin Z, 2008, CHROMOSOMA, V117, P89, DOI 10.1007/s00412-007-0129-1; Momeni P, 2000, NAT GENET, V24, P71, DOI 10.1038/71717; Musio A, 2006, NAT GENET, V38, P528, DOI 10.1038/ng1779; Musio A, 2005, HUM MOL GENET, V14, P525, DOI 10.1093/hmg/ddi049; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Revenkova E, 2009, HUM MOL GENET, V18, P418, DOI 10.1093/hmg/ddn369; Rhodes JM, 2011, MOL CANCER RES, V9, P1587, DOI 10.1158/1541-7786.MCR-11-0382; Rohatgi S, 2010, AM J MED GENET A, V152A, P1641, DOI 10.1002/ajmg.a.33441; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; Schule B, 2005, AM J HUM GENET, V77, P1117, DOI 10.1086/498695; Severin DM, 2001, INT J RADIAT ONCOL, V50, P1323, DOI 10.1016/S0360-3016(01)01608-X; Shaikh TH, 2009, GENOME RES, V19, P1682, DOI 10.1101/gr.083501.108; Shintomi K, 2009, GENE DEV, V23, P2224, DOI 10.1101/gad.1844309; Sjogren C, 2001, CURR BIOL, V11, P991, DOI 10.1016/S0960-9822(01)00271-8; Sonoda E, 2001, DEV CELL, V1, P759, DOI 10.1016/S1534-5807(01)00088-0; Sprung CN, 2005, CLIN CANCER RES, V11, P6352, DOI 10.1158/1078-0432.CCR-04-1931; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Thomas P, 2003, MUTAGENESIS, V18, P187, DOI 10.1093/mutage/18.2.187; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Vass S, 2003, CURR BIOL, V13, P208, DOI 10.1016/S0960-9822(03)00047-2; Vega H, 2005, NAT GENET, V37, P468, DOI 10.1038/ng1548; Vrouwe MG, 2007, HUM MOL GENET, V16, P1478, DOI 10.1093/hmg/ddm098; Waizenegger IC, 2000, CELL, V103, P399, DOI 10.1016/S0092-8674(00)00132-X; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Watrin E, 2006, CURR BIOL, V16, P863, DOI 10.1016/j.cub.2006.03.049; Watrin E, 2009, EMBO J, V28, P2625, DOI 10.1038/emboj.2009.202; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE, P385; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Wojewodzka M, 2002, MUTAT RES-GEN TOX EN, V518, P9, DOI 10.1016/S1383-5718(02)00070-0; Wuyts W, 2002, AM J MED GENET, V113, P326, DOI 10.1002/ajmg.10845; Xu HL, 2011, NAT REV CANCER, V11, P199, DOI 10.1038/nrc3018; Xu HL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012112	69	190	195	2	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 8	2012	90	6					1014	1027		10.1016/j.ajhg.2012.04.019	http://dx.doi.org/10.1016/j.ajhg.2012.04.019			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	958TC	22633399	Bronze, Green Published			2022-12-18	WOS:000305262600007
J	Noskova, L; Stranecky, V; Hartmannova, H; Pristoupilova, A; Baresova, V; Ivanek, R; Hulkova, H; Jahnova, H; van der Zee, J; Staropoli, JF; Sims, KB; Tyynela, J; Van Broeckhoven, C; Nijssen, PCG; Mole, SE; Elleder, M; Kmoch, S				Noskova, Lenka; Stranecky, Viktor; Hartmannova, Hana; Pristoupilova, Anna; Baresova, Veronika; Ivanek, Robert; Hulkova, Helena; Jahnova, Helena; van der Zee, Julie; Staropoli, John F.; Sims, Katherine B.; Tyynela, Jaana; Van Broeckhoven, Christine; Nijssen, Peter C. G.; Mole, Sara E.; Elleder, Milan; Kmoch, Stanislav			Mutations in DNAJC5, Encoding Cysteine-String Protein Alpha, Cause Autosomal-Dominant Adult-Onset Neuronal Ceroid Lipofuscinosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CSP-ALPHA; KUFS-DISEASE; COMPLEX; FORM; PALMITOYLATION; COLOCALIZATION; DOMAIN	Autosomal-dominant adult-onset neuronal ceroid lipofuscinosis (ANCL) is characterized by accumulation of autofluorescent storage material in neural tissues and neurodegeneration and has an age of onset in the third decade of life or later. The genetic and molecular basis of the disease has remained unknown for many years. We carried out linkage mapping, gene-expression analysis, exome sequencing, and candidate-gene sequencing in affected individuals from 20 families and/or individuals with simplex cases; we identified in five individuals one of two disease-causing mutations, c.346_348delCTC and c.344T>G, in DNAJC5 encoding cysteine-string protein alpha (CSP alpha). These mutations-causing a deletion, p.Leu116del, and an amino acid exchange, p.Leu115Arg, respectively-are located within the cysteine-string domain of the protein and affect both palmitoylation-dependent sorting and the amount of CSP alpha in neuronal cells. The resulting depletion of functional CSP alpha might cause in parallel the presynaptic dysfunction and the progressive neurodegeneration observed in affected individuals and lysosomal accumulation of misfolded and proteolysis-resistant proteins in the form of characteristic ceroid deposits in neurons. Our work represents an important step in the genetic dissection of a genetically heterogeneous group of ANCLs. It also confirms a neuroprotective role for CSP alpha in humans and demonstrates the need for detailed investigation of CSP alpha in the neuronal ceroid lipofuscinoses and other neurodegenerative diseases presenting with neuronal protein aggregation.	[Noskova, Lenka; Stranecky, Viktor; Hartmannova, Hana; Pristoupilova, Anna; Baresova, Veronika; Ivanek, Robert; Hulkova, Helena; Jahnova, Helena; Elleder, Milan; Kmoch, Stanislav] Charles Univ Prague, Fac Med 1, Inst Inherited Metab Disorders, Prague 12000, Czech Republic; [Noskova, Lenka; Stranecky, Viktor; Hartmannova, Hana; Pristoupilova, Anna; Baresova, Veronika; Ivanek, Robert; Elleder, Milan; Kmoch, Stanislav] Charles Univ Prague, Fac Med 1, Ctr Appl Genom, Prague 12000, Czech Republic; [van der Zee, Julie; Van Broeckhoven, Christine] VIB, Neurodegenerat Brain Dis Grp, Dept Mol Genet, B-2610 Antwerp, Belgium; [van der Zee, Julie; Van Broeckhoven, Christine] Univ Antwerp, Inst Born Bunge, Neurogenet Lab, B-2610 Antwerp, Belgium; [Staropoli, John F.; Sims, Katherine B.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Staropoli, John F.; Sims, Katherine B.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Tyynela, Jaana] Univ Helsinki, Inst Biomed Biochem & Dev Biol, FIN-00014 Helsinki, Finland; [Nijssen, Peter C. G.] St Elizabeth Hosp, Dept Neurol, NL-5022 Tilburg, Netherlands; [Mole, Sara E.] UCL, MRC Lab Mol Cell Biol, Inst Child Hlth, London WC1E 6BT, England; [Mole, Sara E.] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England	Charles University Prague; Charles University Prague; Flanders Institute for Biotechnology (VIB); University of Antwerp; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Helsinki; MRC Laboratory Molecular Biology; University of London; University College London; University of London; University College London	Kmoch, S (corresponding author), Charles Univ Prague, Fac Med 1, Inst Inherited Metab Disorders, Prague 12000, Czech Republic.	skmoch@lf1.cuni.cz	Kmoch, Stanislav/C-1575-2010; Pristoupilova, Anna/F-4990-2017; Van Broeckhoven, Christine/M-7853-2019; Jahnova, Helena/O-1794-2017; Stranecky, Viktor/I-8524-2017; Baresova, Veronika/H-4931-2017; Noskova, Lenka/F-6564-2017; Van Broeckhoven, Christine/G-8362-2017; Hartmannova, Hana/H-4735-2017; Ivanek, Robert/A-8852-2008	Kmoch, Stanislav/0000-0002-6239-707X; Pristoupilova, Anna/0000-0003-0047-9405; Van Broeckhoven, Christine/0000-0003-0183-7665; Jahnova, Helena/0000-0002-6019-7648; Stranecky, Viktor/0000-0002-2599-6479; Baresova, Veronika/0000-0001-8989-6090; Noskova, Lenka/0000-0001-7011-4327; Van Broeckhoven, Christine/0000-0003-0183-7665; Hartmannova, Hana/0000-0001-7787-832X; Ivanek, Robert/0000-0002-8403-056X; Mole, Sara/0000-0003-4385-4957	Grant Agency of Charles University of Prague [299911]; Ministry of Education of the Czech Republic [1M6837805002, MSM0021620806]; Belgian Science Policy Office Interuniversity Attraction Poles [P6/43]; Flemish Government Methusalem Excellence; Research Foundation Flanders; Batten Disease Support and Research Association	Grant Agency of Charles University of Prague; Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Belgian Science Policy Office Interuniversity Attraction Poles; Flemish Government Methusalem Excellence; Research Foundation Flanders(FWO); Batten Disease Support and Research Association	This work was supported by the Grant Agency of Charles University of Prague (project 299911), the Ministry of Education of the Czech Republic (projects 1M6837805002 and MSM0021620806), Belgian Science Policy Office Interuniversity Attraction Poles program P6/43, Flemish Government Methusalem Excellence grant, Research Foundation Flanders (J.v.d.Z, postdoctoral fellowship), and the Batten Disease Support and Research Association. We thank clinical colleagues and families who contributed samples used in this study, especially John Morris and Joanne Porter (UCL563), David Sleat and the late Krystyna Wisniewski (UCL519), and Aristotle Siakotos (UCL328).	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Arsov T, 2011, AM J HUM GENET, V88, P566, DOI 10.1016/j.ajhg.2011.04.004; BOEHME DH, 1971, BRAIN, V94, P745, DOI 10.1093/brain/94.4.745; Burgoyne RD, 2011, NAT CELL BIOL, V13, P8, DOI 10.1038/ncb0111-8; Burneo JG, 2003, EPILEPSIA, V44, P841, DOI 10.1046/j.1528-1157.2003.39802.x; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Chamberlain LH, 1998, BIOCHEM J, V335, P205, DOI 10.1042/bj3350205; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; FERRER I, 1980, J NEUROL, V222, P183, DOI 10.1007/BF00313117; Garcia-Junco-Clemente P, 2010, J NEUROSCI, V30, P7377, DOI 10.1523/JNEUROSCI.0924-10.2010; Gibbs SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004595; Greaves J, 2008, J BIOL CHEM, V283, P25014, DOI 10.1074/jbc.M802140200; Greaves J, 2006, MOL BIOL CELL, V17, P4748, DOI 10.1091/mbc.E06-03-0183; Jiang HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005280; Johnson JN, 2010, BIOCHEM CELL BIOL, V88, P157, DOI [10.1139/O09-124, 10.1139/o09-124]; Josephson SA, 2001, J NEUROL SCI, V188, P51, DOI 10.1016/S0022-510X(01)00546-9; Landmann L, 2002, J MICROSC-OXFORD, V208, P134, DOI 10.1046/j.1365-2818.2002.01068.x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; MOLE SE, 2010, NEURONAL CEROID LIPO; Nijssen PCG, 2009, CLIN NEUROPHYSIOL, V120, P1782, DOI 10.1016/j.clinph.2009.07.042; Nijssen PCG, 2003, BRAIN PATHOL, V13, P574; Nijssen PCG, 2002, MOVEMENT DISORD, V17, P482, DOI 10.1002/mds.10104; Palmer D.N., 2011, NEURONAL CEROID LIPO, V2nd ed., DOI [10.1093/med/9780199590018.003.0018, DOI 10.1093/MED/9780199590018.003.0018]; Poet M, 2006, P NATL ACAD SCI USA, V103, P13854, DOI 10.1073/pnas.0606137103; Reif A, 2003, J NEUROL NEUROSUR PS, V74, P385, DOI 10.1136/jnnp.74.3.385; ROSALESHERNANDE.A, 2009, GUT, V14, P71; Sakisaka T, 2002, EMBO J, V21, P6125, DOI 10.1093/emboj/cdf603; Schmitz F, 2006, P NATL ACAD SCI USA, V103, P2926, DOI 10.1073/pnas.0510060103; Sharma M, 2011, NAT CELL BIOL, V13, P30, DOI 10.1038/ncb2131; Sims KB, 2011, NEW ENGL J MED, V364, P1062, DOI 10.1056/NEJMcpc1013927; Swayne LA, 2003, BIOCHEM BIOPH RES CO, V300, P921, DOI 10.1016/S0006-291X(02)02964-9; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; Xu FL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011045; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297	35	190	198	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 12	2011	89	2					241	252		10.1016/j.ajhg.2011.07.003	http://dx.doi.org/10.1016/j.ajhg.2011.07.003			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	810TA	21820099	Green Published, hybrid			2022-12-18	WOS:000294148800004
J	Emison, ES; Garcia-Barcelo, M; Grice, EA; Lantieri, F; Amiel, J; Burzynski, G; Fernandez, RM; Hao, L; Kashuk, C; West, K; Miao, XP; Tam, PKH; Griseri, P; Ceccherini, I; Pelet, A; Jannot, AS; de Pontual, L; Henrion-Caude, A; Lyonnet, S; Verheij, JBGM; Hofstra, RMW; Antinolo, G; Borrego, S; McCallion, AS; Chakravarti, A				Emison, Eileen Sproat; Garcia-Barcelo, Merce; Grice, Elizabeth A.; Lantieri, Francesca; Amiel, Jeanne; Burzynski, Grzegorz; Fernandez, Raquel M.; Hao, Li; Kashuk, Carl; West, Kristen; Miao, Xiaoping; Tam, Paul K. H.; Griseri, Paola; Ceccherini, Isabella; Pelet, Anna; Jannot, Anne-Sophie; de Pontual, Loic; Henrion-Caude, Alexandra; Lyonnet, Stanislas; Verheij, Joke B. G. M.; Hofstra, Robert M. W.; Antinolo, Guillermo; Borrego, Salud; McCallion, Andrew S.; Chakravarti, Aravinda			Differential Contributions of Rare and Common, Coding and Noncoding Ret Mutations to Multifactorial Hirschsprung Disease Liability	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSCRIPTION FACTOR SOX10; LINKAGE DISEQUILIBRIUM; GENE-EXPRESSION; C-RET; PROTOONCOGENE; ENHANCER; DNA; ASSOCIATION; HAPLOTYPE; PROTEIN	The major gene for Hirschsprung disease (HSCR) encodes the receptor tyrosine kinase RET. In a study of 690 European- and 192 Chinese-descent probands and their parents or controls, we demonstrate the ubiquity of a >4-fold susceptibility from a C -> T allele (rs2435357: p = 3.9 x 10(-43) in European ancestry; p = 1.1 x 10(-21) in Chinese samples) that probably arose once within the intronic RET enhancer MCS+9.7. With in vitro assays, we now show that the T variant disrupts a SOX10 binding site within MCS+9.7 that compromises RET transactivation. The T allele, with a control frequency of 20%-30%/47% and case frequency of 54%-62%/88% in European/Chinese-ancestry individuals, is involved in all forms of HSCR. It is marginally associated with proband gender (p = 0.13) and significantly so with length of aganglionosis (p = 7.6 x 10(-5)) and familiality (p = 6.2 x 10(-4)). The enhancer variant is more frequent in the common forms of male, short-segment, and simplex families whereas multiple, rare, coding mutations are the norm in the less common and more severe forms of female, long-segment, and multiplex families. The T variant also increases penetrance in patients with rare RET coding mutations. Thus, both rare and common mutations, individually and together, make contributions to the risk of HSCR. The distribution of RET variants in diverse HSCR patients suggests a "cellular-recessive" genetic model where both RET alleles' function is compromised. The RET allelic series, and its genotype-phenotype correlations, shows that success in variant identification in complex disorders may strongly depend on which patients are studied.	[Emison, Eileen Sproat; Grice, Elizabeth A.; Hao, Li; Kashuk, Carl; West, Kristen; McCallion, Andrew S.; Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, Ctr Complex Dis Genom, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Garcia-Barcelo, Merce; Miao, Xiaoping; Tam, Paul K. H.] Univ Hong Kong, Dept Surg, Pokfulam, Hong Kong, Peoples R China; [Lantieri, Francesca] Univ Genoa, Dept Hlth Sci, Biostat Unit, I-16126 Genoa, Italy; [Lantieri, Francesca; Griseri, Paola; Ceccherini, Isabella] Ist Giannina Gaslini, Mol Genet Lab, I-16147 Genoa, Italy; [Amiel, Jeanne; Pelet, Anna; Jannot, Anne-Sophie; de Pontual, Loic; Henrion-Caude, Alexandra; Lyonnet, Stanislas] Univ Paris 05, Fac Med, Dept Genet, F-75006 Paris, France; [Amiel, Jeanne; Pelet, Anna; Jannot, Anne-Sophie; de Pontual, Loic; Henrion-Caude, Alexandra; Lyonnet, Stanislas] Hop Necker Enfants Malad, AP HP, INSERM, U781, F-78743 Paris, France; [Burzynski, Grzegorz; Verheij, Joke B. G. M.; Hofstra, Robert M. W.] Univ Groningen, Dept Med Genet, NL-9700 Groningen, Netherlands; [Fernandez, Raquel M.; Antinolo, Guillermo; Borrego, Salud] Hosp Univ Virgen Rocio, Unidad Gest Clin Genet Reprod & Med Fetal, Seville 41013, Spain; [Fernandez, Raquel M.; Antinolo, Guillermo; Borrego, Salud] ISCIII, CIBERER, Seville 41013, Spain; [Jannot, Anne-Sophie] INSERM, U535, F-94817 Villejuif, France	Johns Hopkins University; University of Hong Kong; University of Genoa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Genoa; IRCCS Istituto Giannina Gaslini; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Groningen; Virgen del Rocio University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Institut National de la Sante et de la Recherche Medicale (Inserm)	Chakravarti, A (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Complex Dis Genom, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.	aravinda@jhmi.edu	Lyonnet, Stanislas/H-5483-2017; amiel, jeanne/AGX-1124-2022; griseri, paola/AAJ-4823-2020; IBIS, REPRODUCCION/P-3399-2015; IBIS, GENETICA/P-3384-2015; Caude, Alexandra A Henrion/I-2778-2016; amiel, jeanne/H-3501-2017; Borrego, Salud/M-6314-2015; Ceccherini, Isabella/P-8195-2014; Burzynski, Grzegorz M/D-2800-2009; miao, xiaoping/C-4336-2011; /C-4405-2009	Lyonnet, Stanislas/0000-0001-5426-9417; Caude, Alexandra A Henrion/0000-0002-8170-2260; amiel, jeanne/0000-0001-5973-4728; Ceccherini, Isabella/0000-0001-8732-1955; miao, xiaoping/0000-0002-6818-9722; Grice, Elizabeth/0000-0003-3939-2200; PELET, Anastella/0000-0002-8353-1725; Antinolo Gil, Guillermo/0000-0002-2113-074X; Hofstra, Robert/0000-0001-7498-3829; DE PONTUAL, LOIC/0000-0002-3123-0453; Jannot, Anne-Sophie/0000-0002-8001-8539; /0000-0001-6231-3035	(USA) National Institutes of Health [HD28088, GM71648]; "Holes for Hirschsprung"; (Italy) Italian Telethon [GGP04257]; European "E-Rare" program-Istituto Superiore di Sanita (Italy) [PI071315]; (France) ANR; FRM (Fondation pour la Recherche Medicale); Hong Kong Research Grant Council [HKU 765407]; (Netherlands) NWO [901-04-225]; Bernoulle Foundation; Ubbo Emmius Foundation; Fondo de Investigacion Sanitaria, Spain [PI070080]; Consejeria de Educacion Ciencia Y Empresa de la Junta de Andalucia [CTS2590]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD028088] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062972] Funding Source: NIH RePORTER	(USA) National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); "Holes for Hirschsprung"; (Italy) Italian Telethon(Fondazione Telethon); European "E-Rare" program-Istituto Superiore di Sanita (Italy); (France) ANR(French National Research Agency (ANR)); FRM (Fondation pour la Recherche Medicale)(Fondation pour la Recherche Medicale); Hong Kong Research Grant Council(Hong Kong Research Grants Council); (Netherlands) NWO(Netherlands Organization for Scientific Research (NWO)Netherlands Government); Bernoulle Foundation; Ubbo Emmius Foundation; Fondo de Investigacion Sanitaria, Spain; Consejeria de Educacion Ciencia Y Empresa de la Junta de Andalucia(Junta de Andalucia); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We wish to thank the numerous patients, their families, and the referring physicians across the world that have participated in studies of Hirschsprung disease in our laboratories over the past 20 years, and the numerous laboratory members who have contributed to discussion of these results. This study is a contribution from The International Hirschsprung Disease Consortium. Grant support is as follows: (USA) National Institutes of Health, HD28088 to A.C. and GM71648 to A.S.M.; and the "Holes for Hirschsprung" fundraiser to A.C.; (Italy) Italian Telethon (GGP04257) and European "E-Rare" program-Istituto Superiore di Sanita (Italy) to I.C.; (France) ANR (Eranet and Maladies Rares Grants) and FRM (Fondation pour la Recherche Medicale) to S.L.; (Hong Kong) HKU 765407 from the Hong Kong Research Grant Council to M.G.-B. and P.K.H.T.; (Netherlands) NWO (no. 901-04-225) Bernoulle Foundation and Ubbo Emmius Foundation to R.M.W.H.; and (Spain) Fondo de Investigacion Sanitaria, Spain (PI070080), European E:Rare program (PI071315), and Consejeria de Educacion Ciencia Y Empresa de la Junta de Andalucia (CTS2590) to S.B. Author contributions are as follows. (USA) A.C. designed the study and ascertained families; E.S.E. and K.W. performed all genotyping; L.H. and E.S.E. performed DNA sequence analysis; E.A.G. and A.S.M. designed and performed the functional enhancer biological analyses; C.K., E.S.E., and A.C. conducted statistical analysis of the data; and E.S.E., A.S.M., and A.C. participated in data interpretation and writing the manuscript. We gratefully acknowledge the work of Erick Kaufmann, Jennifer (Scott) Bubb, Maura Kenton, Julie Albertus, and Courtney Nichols in family ascertainment. (Italy) F.L. and I.C. ascertained families; F.L. conducted statistical analysis of data; and F.L., P.G., and I.C. participated in data interpretation and editing the manuscript. (France) J.A., A.P., and L.d.P. performed DNA sequencing; A.-S.J. conducted statistical analyses of data; and J.A. and S.L. participated in the study design, data interpretation, and ascertainment of families. (Hong Kong) M.G.-B. and X.M. performed DNA sequencing and genotyping of the sporadic Chinese HSCR patients and control samples; M.G.-B. conducted statistical analysis of data, and together with P.K.H.T., data interpretation; and P.K.H.T. ascertained all Chinese HSCR patients. (Netherlands) G.B. performed all genotyping; R.M.W.H. participated in data interpretation and manuscript editing; and J.B.G.M.V. was involved in ascertaining families. (Spain) S.B. and G.A. ascertained Spanish HSCR families; R.M.F. performed DNA sequencing for mutation detection; and R.M.F., G.A., and S.B. participated in manuscript editing.	Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Altenburg E, 1920, GENETICS, V5, P1; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; Arnold S, 2009, HUM MUTAT, V30, P771, DOI 10.1002/humu.20944; BADNER JA, 1990, AM J HUM GENET, V46, P568; BODIAN M, 1963, ANN HUM GENET, V26, P261, DOI 10.1111/j.1469-1809.1963.tb01983.x; Boon CJE, 2008, AM J HUM GENET, V82, P516, DOI 10.1016/j.ajhg.2007.11.007; Borrego S, 1999, J MED GENET, V36, P771, DOI 10.1136/jmg.36.10.771; CARTER CO, 1969, BRIT MED BULL, V25, P52, DOI 10.1093/oxfordjournals.bmb.a070671; CHAKRAVARTI A, 2001, METABOLIC MOL BASES, P6231; DENNY P, 1992, EMBO J, V11, P3705, DOI 10.1002/j.1460-2075.1992.tb05455.x; EDERY P, 1994, NATURE, V367, P378, DOI 10.1038/367378a0; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Fitze G, 1999, AM J HUM GENET, V65, P1469, DOI 10.1086/302618; Gabriel SB, 2002, NAT GENET, V31, P89, DOI 10.1038/ng868; Garcia-Barcelo M, 2005, HUM MOL GENET, V14, P191, DOI 10.1093/hmg/ddi015; Garcia-Barcelo MM, 2003, J MED GENET, V40; Grice EA, 2005, HUM MOL GENET, V14, P3837, DOI 10.1093/hmg/ddi408; Griseri P, 2005, HUM MUTAT, V25, P189, DOI 10.1002/humu.20135; HARLEY VR, 1994, NUCLEIC ACIDS RES, V22, P1500, DOI 10.1093/nar/22.8.1500; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Kanai Y, 1996, J CELL BIOL, V133, P667, DOI 10.1083/jcb.133.3.667; Kashuk CS, 2005, P NATL ACAD SCI USA, V102, P8949, DOI 10.1073/pnas.0503259102; Kato M, 2000, MOL BIOL CELL, V11, P93, DOI 10.1091/mbc.11.1.93; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Lang D, 2003, HUM MOL GENET, V12, P937, DOI 10.1093/hmg/ddg107; Lang D, 2000, J CLIN INVEST, V106, P963, DOI 10.1172/JCI10828; McCallion AS, 2003, P NATL ACAD SCI USA, V100, P1826, DOI 10.1073/pnas.0337540100; Mertin S, 1999, NUCLEIC ACIDS RES, V27, P1359, DOI 10.1093/nar/27.5.1359; PASINI B, 1995, NAT GENET, V10, P35, DOI 10.1038/ng0595-35; Peirano RI, 2000, NUCLEIC ACIDS RES, V28, P3047, DOI 10.1093/nar/28.16.3047; Peirano RI, 2000, MOL CELL BIOL, V20, P3198, DOI 10.1128/MCB.20.9.3198-3209.2000; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; PULITI A, 1993, CYTOGENET CELL GENET, V63, P102, DOI 10.1159/000133510; ROMEO G, 1994, NATURE, V367, P377, DOI 10.1038/367377a0; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Simpson MJ, 2007, DEV BIOL, V302, P553, DOI 10.1016/j.ydbio.2006.10.017; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217	43	190	193	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 9	2010	87	1					60	74		10.1016/j.ajhg.2010.06.007	http://dx.doi.org/10.1016/j.ajhg.2010.06.007			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	627HD	20598273	Green Published, Bronze			2022-12-18	WOS:000280029200006
J	Prior, TW; Krainer, AR; Hua, Y; Swoboda, KJ; Snyder, PC; Bridgeman, SJ; Burghes, AHM; Kissel, JT				Prior, Thomas W.; Krainer, Adrian R.; Hua, Yimin; Swoboda, Kathryn J.; Snyder, Pamela C.; Bridgeman, Scott J.; Burghes, Arthur H. M.; Kissel, John T.			A Positive Modifier of Spinal Muscular Atrophy in the SMN2 Gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MOLECULAR ANALYSIS; IDENTIFICATION; PHENOTYPE; PREDICTION; INCLUSION; CARRIERS; ENHANCER; COPIES	Spinal muscular atrophy (SMA) is a common autosomal-recessive motor neuron disease caused by the homozygous loss of the SMN1 gene. A nearly identical gene, SMN2, has been shown to decrease the severity of SMA in a dose-dependent manner. However SMN2 is not the sole phenotypic modifier, because there are discrepant SMA cases in which the SMN2 copy number does not explain the clinical phenotype. This report describes three unrelated SMA patients who possessed SMN2 copy numbers that did not correlate with the observed mild clinical phenotypes. A single base substitution in SMN2, c.859G>C,, was identified in exon 7 in the patients' DNA. We now show that the change creates a new exonic splicing enhancer element and increases the amount of full-length transcripts, thus resulting in the less severe phenotypes. This demonstrates that the c.859G>C substitution is a positive modifier of the SMA phenotype and that not all SMN2 genes are equivalent. We have shown not only that the SMA phenotype is modified by the number of SMN2 genes but that SMN2 sequence variations can also affect the disease severity.	[Prior, Thomas W.; Snyder, Pamela C.; Bridgeman, Scott J.] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Krainer, Adrian R.; Hua, Yimin] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Swoboda, Kathryn J.] Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT 84132 USA; [Swoboda, Kathryn J.] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT 84132 USA; [Prior, Thomas W.; Burghes, Arthur H. M.; Kissel, John T.] Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA; [Burghes, Arthur H. M.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Cold Spring Harbor Laboratory; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Prior, TW (corresponding author), Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA.	thomas.prior@osumc.edu	; Hua, Yimin/U-6911-2018	Swoboda, Kathryn/0000-0002-4593-6342; Hua, Yimin/0000-0003-0905-7989; Burghes, Arthur/0000-0001-9031-1555; Krainer, Adrian/0000-0001-9024-9501	National Institute of General Medical Sciences [R01-GM42699]; Public Health Services [UL1-RR025764, C06-RR11234]; NIH [R01-HD054599-01]; National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD054599] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR011234, UL1RR025755, UL1RR025764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042699] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Public Health Services(United States Department of Health & Human ServicesUnited States Public Health Service); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to all SMA families for their kind support and to all clinicians for their help in providing blood samples. We thank Michelle Hastings for sharing her unpublished data. This research was supported by grants from Families of SMA. A.R.K. and Y.H. acknowledge support from grant R01-GM42699 from the National Institute of General Medical Sciences. K.J.S. received support from the Public Health Services Research Grant, no. UL1-RR025764 and C06-RR11234, from the National Center for Research Resources, by the NIH grant R01-HD054599-01 from the National Institute of Child Health and Human Development.	Brahe C, 2005, EUR J HUM GENET, V13, P256, DOI 10.1038/sj.ejhg.5201320; Brichta L, 2006, ANN NEUROL, V59, P970, DOI 10.1002/ana.20836; BURGHES AHM, 1994, HUM GENET, V93, P305, DOI 10.1007/BF00212028; Campbell L, 1997, AM J HUM GENET, V61, P40, DOI 10.1086/513886; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; Hofmann Y, 2000, P NATL ACAD SCI USA, V97, P9618, DOI 10.1073/pnas.160181697; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Hua Y, 2004, CELL MOL LIFE SCI, V61, P2658, DOI 10.1007/s00018-004-4300-z; Hua YM, 2007, PLOS BIOL, V5, P729, DOI 10.1371/journal.pbio.0050073; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lorson CL, 2000, HUM MOL GENET, V9, P259, DOI 10.1093/hmg/9.2.259; Mailman MD, 2002, GENET MED, V4, P20, DOI 10.1097/00125817-200201000-00004; MATH E, 2006, NUCLEIC ACIDS RES, V34, P17; McAndrew PE, 1997, AM J HUM GENET, V60, P1411, DOI 10.1086/515465; Monani UR, 2000, HUM MOL GENET, V9, P2451, DOI 10.1093/hmg/9.16.2451; MUNSAT TL, 1992, NEUROMUSCULAR DISORD, V2, P423, DOI 10.1016/S0960-8966(06)80015-5; Oprea GE, 2008, SCIENCE, V320, P524, DOI 10.1126/science.1155085; PEARN J, 1978, J MED GENET, V15, P409, DOI 10.1136/jmg.15.6.409; Prior TW, 2004, AM J MED GENET A, V130A, P307, DOI 10.1002/ajmg.a.30251; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Swoboda KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005268; Velasco E, 1996, HUM MOL GENET, V5, P257, DOI 10.1093/hmg/5.2.257; Wirth B, 1999, AM J HUM GENET, V64, P1340, DOI 10.1086/302369; Wolstencroft EC, 2005, HUM MOL GENET, V14, P1199, DOI 10.1093/hmg/ddi131; ZERRES K, 1995, ARCH NEUROL-CHICAGO, V52, P518, DOI 10.1001/archneur.1995.00540290108025	29	190	201	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 11	2009	85	3					408	413		10.1016/j.ajhg.2009.08.002	http://dx.doi.org/10.1016/j.ajhg.2009.08.002			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	497ZN	19716110	Green Published, Bronze			2022-12-18	WOS:000270104500010
J	Tanaka, T; Scheet, P; Giusti, B; Bandinelli, S; Piras, MG; Usala, G; Lai, S; Mulas, A; Corsi, AM; Vestrini, A; Sofi, F; Gori, AM; Abbate, R; Guralnik, J; Singleton, A; Abecasis, GR; Schlessinger, D; Uda, M; Ferrucci, L				Tanaka, Toshiko; Scheet, Paul; Giusti, Betti; Bandinelli, Stelfania; Piras, Maria Grazia; Usala, Gianluca; Lai, Sandra; Mulas, Antonella; Corsi, Anna Maria; Vestrini, Anna; Sofi, Francesco; Gori, Anna Maria; Abbate, Rosanna; Guralnik, Jack; Singleton, Andrew; Abecasis, Goncalo R.; Schlessinger, David; Uda, Manuela; Ferrucci, Luigi			Genome-wide Association Study of Vitamin B6, Vitamin B12, Folate, and Homocysteine Blood Concentrations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CORONARY-HEART-DISEASE; NEURAL-TUBE DEFECTS; ALKALINE-PHOSPHATASE GENE; ONE-CARBON METABOLISM; HELICOBACTER-PYLORI; CARDIOVASCULAR-DISEASE; VASCULAR-DISEASE; DNA METHYLATION; SYNAPTOTAGMIN-I; COMMON MUTATION	The B vitamins are components of one-carbon metabolism (OCM) that contribute to DNA synthesis and methylation. Homocysteine, a by-product of OCM, has been associated with coronary heart disease, stroke and neurological disease. To investigate genetic factors that affect circulating vitamin B6, vitamin B12, folate and homocysteine, a genome-wide association analysis was conducted in the InCHIANTI (N = 1175), SardiNIA (N = 1115), and BLSA (N = 640) studies. The top loci were replicated in an independent sample of 687 participants in the Progetto Nutrizione study. Polymorphisms in the ALPL gene (rs4654748, p = 8.30 x 10(-18)) were associated with vitamin B6 and FUT2 (rs6022662, p = 2.83 x 10(-20)) with vitamin B12 serum levels. The association of MTHFR, a gene consistently associated with homocysteine, was confirmed in this meta-analysis. The ALPL gene likely influences the catabolism of vitamin B6 while FUT2 interferes with absorption of vitamin B12. These findings highlight mechanisms that affect vitamin B6, vitamin B12 and homocysteine serum levels.	[Tanaka, Toshiko] Medstar Res Inst, Baltimore, MD 21250 USA; [Tanaka, Toshiko; Ferrucci, Luigi] NIA, Clin Res Branch, Baltimore, MD 21250 USA; [Scheet, Paul] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Giusti, Betti; Vestrini, Anna; Sofi, Francesco; Gori, Anna Maria; Abbate, Rosanna] Univ Florence, Dept Med & Surg Crit Care, I-50134 Florence, Italy; [Bandinelli, Stelfania] ASF, Geriatr Unit, I-50125 Florence, Italy; [Piras, Maria Grazia; Usala, Gianluca; Lai, Sandra; Mulas, Antonella; Uda, Manuela] CNR, Ist Neurogenet & Neurofarmacol, I-09042 Cagliari, Italy; [Corsi, Anna Maria] Tuscany Reg Hlth Agcy, I-50134 Florence, Italy; [Gori, Anna Maria] IRCCS, Fdn Don Carlo Gnocchi, Ctr S Maria Ulivi, I-50134 Florence, Italy; [Guralnik, Jack] NIA, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Singleton, Andrew] NIA, Neurogenet Lab, Bethesda, MD 20892 USA; [Abecasis, Goncalo R.] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Schlessinger, David] NIA, Gerontol Res Ctr, Baltimore, MD 21250 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Texas System; UTMD Anderson Cancer Center; University of Florence; Consiglio Nazionale delle Ricerche (CNR); IRCCS Fondazione Don Carlo Gnocchi Onlus; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Tanaka, T (corresponding author), Medstar Res Inst, Baltimore, MD 21250 USA.	tanakato@mail.nih.gov	Singleton, Andrew B/C-3010-2009; Uda, Manuela/AAC-2645-2019; Giusti, Betti/K-6978-2016; Sofi, Francesco/W-4610-2019; Abecasis, Goncalo R/B-7840-2010; Lai, Sandra/AAY-4176-2020; Mulas, Antonella/B-4231-2015; Sofi, Francesco/J-3941-2016; Gori, annamaria.gori@unifi.it/K-6077-2016; piras, maria grazia/P-2061-2018	Uda, Manuela/0000-0002-4890-6456; Giusti, Betti/0000-0002-8708-9444; Sofi, Francesco/0000-0001-7113-7424; Sofi, Francesco/0000-0001-7113-7424; Abecasis, Goncalo/0000-0003-1509-1825; Gori, annamaria.gori@unifi.it/0000-0001-6857-5861; Mulas, Antonella/0000-0002-6856-1483; piras, maria grazia/0000-0001-9004-0900	Italian Ministry of Health [ICS110.1/RF97.71]; U.S. National Institute on Aging [263 MD 9164, 263 MD 821336, N.1-AG-1-1, N.1-AG-1-2111, N01-AG-5-0002]; National Institute on Aging, National Institutes of Health (NIH), Baltimore, Maryland; MedStar Research Institute; NIA [NO1-AG-1-2109]; Genopolis government FIRB [RBLA038RMA_008]; NATIONAL INSTITUTE ON AGING [ZIAAG000971, ZIAAG000965, ZIAAG001050, N01AG012111, ZIAAG000675, ZIAAG000015] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD009164] Funding Source: NIH RePORTER	Italian Ministry of Health(Ministry of Health, Italy); U.S. National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Aging, National Institutes of Health (NIH), Baltimore, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MedStar Research Institute; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Genopolis government FIRB; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The InCHIANTI study baseline (1998-2000) was supported as a "targeted project" (ICS110.1/RF97.71) by the Italian Ministry of Health and in part by the U.S. National Institute on Aging (Contracts: 263 MD 9164 and 263 MD 821336); the InCHIANTI Follow-up 1 (2001-2003) was funded by the U.S. National Institute on Aging (Contracts: N.1-AG-1-1 and N.1-AG-1-2111); the InCHIANTI Follow-ups 2 and 3 studies (2004-2010) were financed by the U.S. National Institute on Aging(Contract: N01-AG-5-0002). BLSA and InCHIANTI were supported in part by the Intramural Research Program of the National Institute on Aging, National Institutes of Health (NIH), Baltimore, Maryland. A portion of that support was through a R&D contract with MedStar Research Institute. The SardiNIA team was supported by Contract NO1-AG-1-2109 from the NIA. The replication experiments were supported by a grant from Genopolis government FIRB project (RBLA038RMA_008).	ANDERSON BB, 1980, GUT, V21, P192, DOI 10.1136/gut.21.3.192; Beaudin Anna E., 2007, Birth Defects Research, V81, P183, DOI 10.1002/bdrc.20100; BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146; Botto LD, 1999, NEW ENGL J MED, V341, P1509, DOI 10.1056/NEJM199911113412006; CARMEL R, 1994, DIGEST DIS SCI, V39, P309, DOI 10.1007/BF02090202; Choi SW, 2005, BRIT J NUTR, V93, P31, DOI 10.1079/BJN20041283; Choi SW, 2003, J NUTR, V133, P1206, DOI 10.1093/jn/133.4.1206; DALY LE, 1995, JAMA-J AM MED ASSOC, V274, P1698, DOI 10.1001/jama.274.21.1698; de Bree A, 2003, ATHEROSCLEROSIS, V166, P369, DOI 10.1016/S0021-9150(02)00373-8; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Ferrucci L, 2000, J AM GERIATR SOC, V48, P1618, DOI 10.1111/j.1532-5415.2000.tb03873.x; Fredriksen A, 2007, HUM MUTAT, V28, P856, DOI 10.1002/humu.20522; Friso S, 2004, AM J CLIN NUTR, V79, P992; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Giovannucci E, 1998, ANN INTERN MED, V129, P517, DOI 10.7326/0003-4819-129-7-199810010-00002; Haggarty P, 2007, P NUTR SOC, V66, P539, DOI 10.1017/S0029665107005861; Hazra A, 2008, NAT GENET, V40, P1160, DOI 10.1038/ng.210; HENTHORN PS, 1992, P NATL ACAD SCI USA, V89, P9924, DOI 10.1073/pnas.89.20.9924; Ikehara Y, 2001, CANCER EPIDEM BIOMAR, V10, P971; Jang HR, 2005, J NUTR, V135, p2967S, DOI 10.1093/jn/135.12.2967S; Kaptan K, 2000, ARCH INTERN MED, V160, P1349, DOI 10.1001/archinte.160.9.1349; KELLY RJ, 1995, J BIOL CHEM, V270, P4640, DOI 10.1074/jbc.270.9.4640; Klerk M, 2002, JAMA-J AM MED ASSOC, V288, P2023, DOI 10.1001/jama.288.16.2023; Lewis SJ, 2005, BMJ-BRIT MED J, V331, P1053, DOI 10.1136/bmj.38611.658947.55; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Mason JB, 2003, J NUTR, V133, p941S, DOI 10.1093/jn/133.3.941S; McCully KS, 2007, AM J CLIN NUTR, V86, p1563S, DOI 10.1093/ajcn/86.5.1563S; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Mornet E, 2000, HUM MUTAT, V15, P309, DOI 10.1002/(SICI)1098-1004(200004)15:4<309::AID-HUMU2>3.0.CO;2-C; Okuda H, 2007, FEBS LETT, V581, P4754, DOI 10.1016/j.febslet.2007.08.075; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Rimm EB, 1998, JAMA-J AM MED ASSOC, V279, P359, DOI 10.1001/jama.279.5.359; SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693; Serpa J, 2004, BIOCHEM J, V383, P469, DOI 10.1042/BJ20040803; Sharp L, 2004, AM J EPIDEMIOL, V159, P423, DOI 10.1093/aje/kwh066; Shock NW., 1984, NORMAL HUMAN AGING B; Sofi F, 2005, EUR J CLIN NUTR, V59, P584, DOI 10.1038/sj.ejcn.1602112; Splaver A, 2004, AM HEART J, V148, P34, DOI 10.1016/j.ahj.2004.02.004; Tanner SM, 2005, P NATL ACAD SCI USA, V102, P4130, DOI 10.1073/pnas.0500517102; Tanner SM, 2004, HUM MUTAT, V23, P327, DOI 10.1002/humu.20014; Tavani A, 2004, EUR J CLIN NUTR, V58, P1266, DOI 10.1038/sj.ejcn.1601960; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202; Watkins W M, 1980, Adv Hum Genet, V10, P1; Yang QH, 2008, AM J CLIN NUTR, V88, P232, DOI 10.1093/ajcn/88.1.232; Yuan X, 2008, AM J HUM GENET, V83, P520, DOI 10.1016/j.ajhg.2008.09.012; Zhu D, 2007, BIOCHEM BIOPH RES CO, V361, P922, DOI 10.1016/j.bbrc.2007.07.083; BMJ, V316, P894	48	190	200	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR 10	2009	84	4					477	482		10.1016/j.ajhg.2009.02.011	http://dx.doi.org/10.1016/j.ajhg.2009.02.011			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	433VB	19303062	Green Published, Bronze			2022-12-18	WOS:000265232800006
J	Baala, L; Audollent, S; Martinovic, J; Ozilou, C; Babron, MC; Sivanandamoorthy, S; Saunier, S; Salomon, R; Gonzales, M; Rattenberry, E; Esculpavit, C; Toutain, A; Moraine, C; Parent, P; Marcorelles, P; Dauge, MC; Roume, J; Le Merrer, M; Meiner, V; Meir, K; Menez, F; Beaufrere, AM; Francannet, C; Tantau, J; Sinico, M; Dumez, Y; MacDonald, F; Munnich, A; Lyonnet, S; Gubler, MC; Genin, E; Johnson, CA; Vekemans, M; Encha-Razavi, F; Attie-Bitach, T				Baala, Lekbir; Audollent, Sophie; Martinovic, Jelena; Ozilou, Catherine; Babron, Marie-Claude; Sivanandamoorthy, Sivanthiny; Saunier, Sophie; Salomon, Remi; Gonzales, Marie; Rattenberry, Eleanor; Esculpavit, Chantal; Toutain, Annick; Moraine, Claude; Parent, Philippe; Marcorelles, Pascale; Dauge, Marie-Christine; Roume, Joelle; Le Merrer, Martine; Meiner, Vardiella; Meir, Karen; Menez, Francoise; Beaufrere, Anne-Marie; Francannet, Christine; Tantau, Julia; Sinico, Martine; Dumez, Yves; MacDonald, Fiona; Munnich, Arnold; Lyonnet, Stanislas; Gubler, Marie-Claire; Genin, Emmanuelle; Johnson, Colin A.; Vekemans, Michel; Encha-Razavi, Ferechte; Attie-Bitach, Tania			Pleiotropic effects of CEP290 (NPHP6) mutations extend to Meckel syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BARDET-BIEDL-SYNDROME; SYNDROME-RELATED DISORDERS; JOUBERT-SYNDROME; GRUBER-SYNDROME; CENTROSOMAL PROTEIN; GENE; NEPHRONOPHTHISIS; MALFORMATIONS; FAMILIES; LOCUS	Meckel syndrome (MKS) is a rare autosomal recessive lethal condition characterized by central nervous system malformations, polydactyly, multicystic kidney dysplasia, and ductal changes of the liver. Three loci have been mapped ( MKS1-MKS3), and two genes have been identified (MKS1/FLJ20345 and MKS3/TMEM67), whereas the gene at the MKS2 locus remains unknown. To identify new MKS loci, a genomewide linkage scan was performed using 10-cM-resolution microsatellite markers in eight families. The highest heterogeneity LOD score was obtained for chromosome 12, in an interval containing CEP290, a gene recently identified as causative of Joubert syndrome (JS) and isolated Leber congenital amaurosis. In view of our recent findings of allelism, at the MKS3 locus, between these two disorders, CEP290 was considered a candidate, and homozygous or compound heterozygous truncating mutations were identified in four families. Sequencing of additional cases identified CEP290 mutations in two fetuses with MKS and in four families presenting a cerebro-reno-digital syndrome, with a phenotype overlapping MKS and JS, further demonstrating that MKS and JS can be variable expressions of the same ciliopathy. These data identify a fourth locus for MKS ( MKS4) and the CEP290 gene as responsible for MKS.	Hop Necker Enfants Malad, Dept Genet, F-75743 Paris 15, France; Hop Necker Enfants Malad, Serv Maternite, F-75743 Paris, France; Univ Paris 05, INSERM, U781, F-75270 Paris 06, France; Univ Paris 05, INSERM, U574, F-75270 Paris 06, France; Hop Armand Trousseau, Serv Genet & Embryol Med, Paris, France; Hop Bichat, Serv Anat Pathol, F-75877 Paris, France; Hop Robert Debre, Serv Biol Dev, F-75019 Paris, France; Hop St Vincent de Paul, AP HP, Serv Anatomopathol, F-75674 Paris, France; INSERM, U535, F-94800 Villejuif, France; Univ Paris Sud, F-94800 Villejuif, France; Birmingham Womens Hosp, W Midlands Reg Genet, Birmingham, W Midlands, England; CHU Tours, Hop Bretonneau, Serv Genet, F-37033 Tours, France; Hop Morvan, CHRU, Dept Pediat & Genet Med, Brest, France; Hop Morvan, CHRU, Lab Anatomophathol, Brest, France; Ctr Hosp Intercommunal, St Germain En Laye, France; Hadassah Univ Hosp, Dept Human Genet & Pathol, IL-91120 Jerusalem, Israel; Hop Hotel Dieu, Serv Anat Pathol, Clermont Ferrand, France; Hop Hotel Dieu, Serv Genet Med, Clermont Ferrand, France; Ctr Hosp Intercommunal Creteil, Serv Anatomopathol, Creteil, France; St James Univ Hosp, Leeds Inst Mol Med, Sect Ophthalmol & Neurosci, Leeds, W Yorkshire, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Birmingham Women's Hospital; CHU Tours; CHU Brest; Universite de Bretagne Occidentale; CHU Brest; Universite de Bretagne Occidentale; Hebrew University of Jerusalem; CHU Clermont Ferrand; CHU Clermont Ferrand; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Saint James's University Hospital; University of Leeds	Attie-Bitach, T (corresponding author), Hop Necker Enfants Malad, Dept Genet, 149 Rue Sevres, F-75743 Paris 15, France.	tania.attie@necker.fr	ATTIE-BITACH, Tania/K-1453-2017; Lyonnet, Stanislas/H-5483-2017; Saunier, Sophie/G-6044-2015; Genin, Emmanuelle/C-4974-2013	ATTIE-BITACH, Tania/0000-0002-1155-3626; Lyonnet, Stanislas/0000-0001-5426-9417; Saunier, Sophie/0000-0002-1069-0047; Genin, Emmanuelle/0000-0003-4117-2813; Gubler, Marie-Claire/0000-0002-3526-5661; Babron, Marie-Claude/0000-0002-4100-0299; Toutain, Annick/0000-0002-5999-5300	NINDS NIH HHS [R01 NS039818, R01 NS039818-09] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039818] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; AHDABBARMADA M, 1990, J NEUROPATH EXP NEUR, V49, P610, DOI 10.1097/00005072-199011000-00007; Baala L, 2007, AM J HUM GENET, V80, P186, DOI 10.1086/510499; Badano JL, 2006, NATURE, V439, P326, DOI 10.1038/nature04370; Dawe HR, 2007, HUM MOL GENET, V16, P173, DOI 10.1093/hmg/ddl459; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; JOUBERT M, 1968, NEUROLOGY, V18, P302; Karmous-Benailly H, 2005, AM J HUM GENET, V76, P493, DOI 10.1086/428679; Katsanis N, 2004, HUM MOL GENET, V13, pR65, DOI 10.1093/hmg/ddh092; Keeler LC, 2003, AM J HUM GENET, V73, P656, DOI 10.1086/378206; Khaddour Rana, 2007, Hum Mutat, V28, P523, DOI 10.1002/humu.9489; Kyttala M, 2006, NAT GENET, V38, P155, DOI 10.1038/ng1714; Parisi MA, 2004, AM J HUM GENET, V75, P82, DOI 10.1086/421846; Patel S, 2002, AM J NEURORADIOL, V23, P1074; Perrault Isabelle, 2007, Hum Mutat, V28, P416, DOI 10.1002/humu.9485; Roume J, 1998, AM J HUM GENET, V63, P1095, DOI 10.1086/302062; Saar K, 1999, AM J HUM GENET, V65, P1666, DOI 10.1086/302655; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Smith UM, 2006, NAT GENET, V38, P191, DOI 10.1038/ng1713; Tory K, 2007, J AM SOC NEPHROL, V18, P1566, DOI 10.1681/ASN.2006101164; Valente EM, 2003, AM J HUM GENET, V73, P663, DOI 10.1086/378241; Valente EM, 2005, ANN NEUROL, V57, P513, DOI 10.1002/ana.20422; Valente EM, 2006, ANN NEUROL, V59, P527, DOI 10.1002/ana.20749; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; Woods CG, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.016873	26	190	199	0	8	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2007	81	1					170	179		10.1086/519494	http://dx.doi.org/10.1086/519494			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	175UO	17564974	Bronze, Green Published			2022-12-18	WOS:000247039700016
J	Bastiaens, MT; ter Huurne, JAC; Kielich, C; Gruis, NA; Westendorp, RGJ; Vermeer, BJ; Bavinck, NJB				Bastiaens, MT; ter Huurne, JAC; Kielich, C; Gruis, NA; Westendorp, RGJ; Vermeer, BJ; Bavinck, NJB		Leiden Skin Canc Study Team	Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MELANOCYTE-STIMULATING HORMONE; ALPHA-MSH; HUMAN PIGMENTATION; POINT MUTATIONS; ULTRAVIOLET-B; KERATINOCYTES; EXPRESSION; PEPTIDES; CELLS; PROOPIOMELANOCORTIN	Melanocortin-1 receptor (MC1R) gene variants are associated with fair skin and red hair and, independently of these, with cutaneous malignant melanoma. The association of MC1R gene variants with nonmelanoma skin cancer is largely unknown. A total of 838 subjects were included in the present study: 453 patients with nonmelanoma skin cancer and 385 subjects with no skin cancer. The coding sequence of the human MC1R gene was tested using single-stranded conformation polymorphism analysis followed by sequencing of unknown variants. Risk of skin cancer dependent on the various MC1R gene variants was estimated using the exposure odds ratio. We investigated whether subjects with MC1R variant alleles were at increased risk of developing nonmelanoma skin cancer and, if so, whether this increased risk was mediated by fair skin and red hair. A total of 27 MC1R gene variants were found. The number of carriers of one, two, or three MC1R gene variants was 379 (45.2%), 208 (24.8%), and 7 (0.9%), respectively. A strong association between MC1R gene variants and fair skin and red hair was established, especially the variants Arg151Cys and Arg160Trp (P<.0001). Carriers of two variant alleles were at increased risk for developing cutaneous squamous cell carcinoma (odds ratio 3.77; 95% confidence interval [CI] 2.11-6.78), nodular basal cell carcinoma (odds ratio 2.26; 95% CI 1.45-3.52), and superficial multifocal basal cell carcinoma (odds ratio 3.43; 95% CI 1.92-6.15), compared with carriers of two wild-type alleles. Carriers of one variant allele had half the risk. The highest relative risks of nonmelanoma skin cancer were found in carriers of the Asp84Glu, His260Pro, and Asp294His variant alleles, and the risk was only slightly lower for carriers of the Val60Leu, Val92Met, Arg142His, Arg151Cys, and Arg160Trp variant alleles. When subjects were stratified by skin type and hair color, analysis showed that these factors did not materially change the relative risks. These findings indicate that MC1R gene variants are important independent risk factors for nonmelanoma skin cancer.	Leiden Univ, Med Ctr, Dept Dermatol, NL-2300 RC Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Bavinck, NJB (corresponding author), Leiden Univ, Med Ctr, Dept Dermatol, POB 9600, NL-2300 RC Leiden, Netherlands.	Dermatol@euronet.nl	Feltkamp, Mariet/A-3788-2010	Feltkamp, Mariet/0000-0001-5993-9846; Gruis, Nelleke/0000-0002-5210-9150				Abdel-Malek Z, 1999, ANN NY ACAD SCI, V885, P117; Bastiaens MT, 1998, J INVEST DERMATOL, V110, P880, DOI 10.1046/j.1523-1747.1998.00217.x; BLISS JM, 1995, INT J CANCER, V62, P367, DOI 10.1002/ijc.2910620402; Box NF, 1997, HUM MOL GENET, V6, P1891, DOI 10.1093/hmg/6.11.1891; CHAKRABORTY A, 1995, J INVEST DERMATOL, V105, P655, DOI 10.1111/1523-1747.ep12324134; CHAKRABORTY A, 1993, J CELL PHYSIOL, V157, P344, DOI 10.1002/jcp.1041570218; Chakraborty AK, 1999, J INVEST DERMATOL, V112, P853, DOI 10.1046/j.1523-1747.1999.00608.x; Chakraborty AK, 1996, BBA-MOL CELL RES, V1313, P130, DOI 10.1016/0167-4889(96)00063-8; CHAKRABORTY AK, 1999, ANN NY ACAD SCI, V855, P100; Cone RD, 1996, RECENT PROG HORM RES, V51, P287; DELUCA M, 1993, J CELL SCI, V105, P1079; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Flanagan N, 2000, HUM MOL GENET, V9, P2531, DOI 10.1093/hmg/9.17.2531; FRANDBERG PA, 1994, BIOCHEM BIOPH RES CO, V202, P1266, DOI 10.1006/bbrc.1994.2067; Frandberg PA, 1998, BIOCHEM BIOPH RES CO, V245, P490, DOI 10.1006/bbrc.1998.8459; GANTZ I, 1993, J BIOL CHEM, V268, P8246; Healy E, 1999, J INVEST DERMATOL, V112, P512, DOI 10.1046/j.1523-1747.1999.00554.x; HUNT G, 1995, J INVEST DERMATOL, V104, P83, DOI 10.1111/1523-1747.ep12613565; ICHIIJONES F, 1999, CLIN CHIM ACTA, V282, P125; Kalden DH, 1999, ANN NY ACAD SCI, V885, P254; Koppula SV, 1997, HUM MUTAT, V9, P30, DOI 10.1002/(SICI)1098-1004(1997)9:1<30::AID-HUMU5>3.3.CO;2-5; KRICKER A, 1994, CANCER CAUSE CONTROL, V5, P367, DOI 10.1007/BF01804988; KRICKER A, 1991, INT J CANCER, V48, P650, DOI 10.1002/ijc.2910480504; Luger TA, 1998, ANN NY ACAD SCI, V840, P381, DOI 10.1111/j.1749-6632.1998.tb09577.x; Luger TA, 1999, ANN NY ACAD SCI, V885, P209; Luger TA, 1997, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 2, NO 1, AUGUST 1997, P87, DOI 10.1038/jidsymp.1997.17; LUNEC J, 1990, PATHOBIOLOGY, V58, P193, DOI 10.1159/000163583; LUNEC J, 1992, MELANOMA RES, V2, P5, DOI 10.1097/00008390-199205000-00002; MAGENIS RE, 1994, MAMM GENOME, V5, P503, DOI 10.1007/BF00369320; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MOUNTJOY KG, 1992, SCIENCE, V257, P1248, DOI 10.1126/science.1325670; Orel L, 1997, J INVEST DERMATOL, V108, P401, DOI 10.1111/1523-1747.ep12289699; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; Palmer JS, 2000, AM J HUM GENET, V66, P176, DOI 10.1086/302711; PRESTON DS, 1992, NEW ENGL J MED, V327, P1649, DOI 10.1056/NEJM199212033272307; RANADIVE NS, 1986, J INVEST DERMATOL, V86, P303, DOI 10.1111/1523-1747.ep12285496; Rees JL, 1997, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 2, NO 1, AUGUST 1997, P94, DOI 10.1038/jidsymp.1997.18; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; Schioth HB, 1999, BIOCHEM BIOPH RES CO, V260, P488, DOI 10.1006/bbrc.1999.0935; Shackelford RE, 2000, FREE RADICAL BIO MED, V28, P1387, DOI 10.1016/S0891-5849(00)00224-0; SLOMINSKI A, 1991, J INVEST DERMATOL, V97, P747, DOI 10.1111/1523-1747.ep12484829; Smith R, 1998, J INVEST DERMATOL, V111, P119, DOI 10.1046/j.1523-1747.1998.00252.x; Suzuki I, 1996, ENDOCRINOLOGY, V137, P1627, DOI 10.1210/en.137.5.1627; Thody AJ, 1998, PIGM CELL RES, V11, P265, DOI 10.1111/j.1600-0749.1998.tb00735.x; THODY AJ, 1991, J INVEST DERMATOL, V97, P340, DOI 10.1111/1523-1747.ep12480680; Valverde P, 1996, HUM MOL GENET, V5, P1663, DOI 10.1093/hmg/5.10.1663; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; Wintzen M, 1996, J INVEST DERMATOL, V106, P3, DOI 10.1111/1523-1747.ep12326950	48	190	197	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2001	68	4					884	894		10.1086/319500	http://dx.doi.org/10.1086/319500			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	414KQ	11254446	Bronze, Green Published			2022-12-18	WOS:000167666000010
J	Satten, GA; Flanders, WD; Yang, QH				Satten, GA; Flanders, WD; Yang, QH			Accounting for unmeasured population substructure in case-control studies of genetic association using a novel latent-class model	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSMISSION DISEQUILIBRIUM TEST; LINKAGE DISEQUILIBRIUM; DIABETES-MELLITUS; MARKERS; STRATIFICATION; SUBDIVISION; POWER	We propose a novel latent-class approach to detect and account for population stratification in a case-control study of association between a candidate gene and a disease. In our approach, population substructure is detected and accounted for using data on additional loci that are in linkage equilibrium within subpopulations but have alleles that vary in frequency between subpopulations. We have tested our approach using simulated data based on allele frequencies in 12 short tandem repeat (STR) loci in four populations in Argentina.	Ctr Dis Control & Prevent, Atlanta, GA 30341 USA; Emory Univ, Dept Epidemiol, Atlanta, GA 30322 USA	Centers for Disease Control & Prevention - USA; Emory University	Satten, GA (corresponding author), Ctr Dis Control & Prevent, Mailstop F-50,4770 Buford Highway, Atlanta, GA 30341 USA.	GSatten@cdc.gov		Satten, Glen/0000-0001-7275-5371				[Anonymous], 1994, VITAL HLTH STAT, V32, P1, DOI DOI 10.1136/BMJ.L42; Bacanu SA, 2000, AM J HUM GENET, V66, P1933, DOI 10.1086/302929; Collins HE, 2000, AM J HUM GENET, V67, P25; Daly MB, 2000, J NATL CANCER I, V92, P452, DOI 10.1093/jnci/92.6.452; DEAN M, 1994, AM J HUM GENET, V55, P788; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Devlin B, 2000, Biostatistics, V1, P369, DOI 10.1093/biostatistics/1.4.369; *DNA FOR SCI, 1996, UPD EV FOR DNA EV; Efron B, 1998, INTRO BOOTSTRAP; EWENS WJ, 1995, AM J HUM GENET, V57, P455; Kleinbaum D.G., 1982, EPIDEMIOLOGIC RES PR; KNOWLER WC, 1988, AM J HUM GENET, V43, P520; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LI CC, 1969, ANN HUM GENET, V33, P23, DOI 10.1111/j.1469-1809.1969.tb01625.x; Morton NE, 1998, P NATL ACAD SCI USA, V95, P11389, DOI 10.1073/pnas.95.19.11389; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Pritchard JK, 2000, GENETICS, V155, P945; Risch N, 1998, GENOME RES, V8, P1273, DOI 10.1101/gr.8.12.1273; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Sala A, 1998, HUM BIOL, V70, P937; Sala A, 1999, ELECTROPHORESIS, V20, P1733, DOI 10.1002/(SICI)1522-2683(19990101)20:8<1733::AID-ELPS1733>3.0.CO;2-X; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; SELF SG, 1991, BIOMETRICS, V47, P53, DOI 10.2307/2532495; Shriver MD, 1997, AM J HUM GENET, V60, P957; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; STEPHENS JC, 1994, AM J HUM GENET, V55, P809; Sun FZ, 1999, AM J EPIDEMIOL, V150, P97; Surguchov AP, 1996, ARTERIOSCL THROM VAS, V16, P941, DOI 10.1161/01.ATV.16.8.941; Wacholder S, 2000, J NATL CANCER I, V92, P1151, DOI 10.1093/jnci/92.14.1151; [No title captured]	34	190	195	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2001	68	2					466	477		10.1086/318195	http://dx.doi.org/10.1086/318195			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	394LD	11170894	Green Published, Bronze			2022-12-18	WOS:000166524800016
J	Hampe, J; Shaw, SH; Saiz, R; Leysens, N; Lantermann, A; Mascheretti, S; Lynch, NJ; MacPherson, AJS; Bridger, S; van Deventer, S; Stokkers, P; Morin, P; Mirza, MM; Forbes, A; Lennard-Jones, JE; Mathew, CG; Curran, ME; Schreiber, S				Hampe, J; Shaw, SH; Saiz, R; Leysens, N; Lantermann, A; Mascheretti, S; Lynch, NJ; MacPherson, AJS; Bridger, S; van Deventer, S; Stokkers, P; Morin, P; Mirza, MM; Forbes, A; Lennard-Jones, JE; Mathew, CG; Curran, ME; Schreiber, S			Linkage of inflammatory bowel disease to human chromosome 6p	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NECROSIS-FACTOR-ALPHA; CROHNS-DISEASE; SUSCEPTIBILITY LOCI; ULCERATIVE-COLITIS; HLA ANTIGENS; HISTOCOMPATIBILITY COMPLEX; PROMOTER REGION; HUMAN GENOME; BETA GENE; POLYMORPHISM	Inflammatory bowel disease (IBD) is characterized by a chronic relapsing intestinal inflammation. IBD is subdivided into Crohn disease and ulcerative colitis phenotypes. Given the immunologic dysregulation in LED, the human-leukocyte-antigen region on chromosome 6p is of significant interest. Previous association and linkage analysis has provided conflicting evidence as to the existence of an IBD-susceptibility locus in this region. Here we report on a two-stage linkage and association analysis of both a basic population of 353 affected sibling pairs (ASPs) and an extension of this population to 428 white ASPs of northern European extraction. Twenty-eight microsatellite markers on chromosome 6 were genotyped. A peak multipoint LOD score of 4.2 was observed, at D6S461, for the IBD phenotype. A transmission/disequilibrium test (TDT) result of P=.006 was detected for D6S426 in the basic population and was confirmed in the extended cohort (P = .004; 97 vs. 56 transmissions). The subphenotypes of Crohn disease, ulcerative colitis, and mixed IBD contributed equally to this linkage, suggesting a general role for the chromosome 6 locus in IBD. Analysis of five single-nucleotide polymorphisms in the TNFA and LTA genes did not reveal evidence for association of these important candidate genes with IBD. In summary, we provide firm linkage evidence for an IBD-susceptibility locus on chromosome Gp and demonstrate that TNFA and LTA are unlikely to be susceptibility loci for IBD.	Univ Kiel, Dept Med 1, D-24105 Kiel, Germany; Axys Pharmaceut Inc, La Jolla, CA USA; Kings Coll London, Sch Med, London WC2R 2LS, England; Guys Hosp, Guys Kings & St Thomass Sch Med, Div Med & Mol Genet, London SE1 9RT, England; Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; St Marks Hosp, Harrow, Middx, England	University of Kiel; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Amsterdam; Academic Medical Center Amsterdam; Imperial College London	Schreiber, S (corresponding author), Univ Kiel, Dept Med 1, Schittenhelmstr 12, D-24105 Kiel, Germany.	S.Schreiber@mucosa.de	Hampe, Jochen/A-2555-2010; Morin, Phillip A/E-9515-2010; Mathew, Christopher G/G-3434-2015	Hampe, Jochen/0000-0002-2421-6127; Mathew, Christopher G/0000-0003-4178-1838; Lynch, Nicholas/0000-0003-3803-3329; Forbes, Alastair/0000-0001-7416-9843; Morin, Phillip/0000-0002-3279-1519				Becker KG, 1998, P NATL ACAD SCI USA, V95, P9979, DOI 10.1073/pnas.95.17.9979; BERGLOONEN EMVD, 1977, J IMMUNOGENET, V4, P167; BIEMOND I, 1986, GUT, V27, P934, DOI 10.1136/gut.27.8.934; Bouma G, 1999, CLIN EXP IMMUNOL, V115, P294, DOI 10.1046/j.1365-2249.1999.00797.x; Bouma G, 1996, CLIN EXP IMMUNOL, V103, P391, DOI 10.1111/j.1365-2249.1996.tb08292.x; Cho JH, 1998, P NATL ACAD SCI USA, V95, P7502, DOI 10.1073/pnas.95.13.7502; Concannon P, 1998, NAT GENET, V19, P292, DOI 10.1038/985; Curran ME, 1998, GASTROENTEROLOGY, V115, P1066, DOI 10.1016/S0016-5085(98)70075-7; DELPRE G, 1980, GASTROENTEROLOGY, V78, P1452; FERENCIK S, 1992, EUR J IMMUNOGENET, V19, P425, DOI 10.1111/j.1744-313X.1992.tb00086.x; Forcione DG, 1996, P NATL ACAD SCI USA, V93, P5094, DOI 10.1073/pnas.93.10.5094; FUJITA K, 1984, J CLIN LAB IMMUNOL, V14, P99; GLEESON MH, 1972, GUT, V13, P438, DOI 10.1136/gut.13.6.438; HALL J, 1997, CURRENT PROTOCOLS HU, V2; HAMILTON SR, 1987, INT J COLORECTAL DIS, V2, P113, DOI 10.1007/BF01647703; Hampe J, 1999, AM J HUM GENET, V64, P808, DOI 10.1086/302294; Hampe J, 1998, INT J COLORECTAL DIS, V13, P260, DOI 10.1007/s003840050173; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; HUGOT JP, 1994, AM J MED GENET, V52, P207, DOI 10.1002/ajmg.1320520216; Idury RM, 1997, GENOME RES, V7, P1104, DOI 10.1101/gr.7.11.1104; Kroeger KM, 1997, MOL IMMUNOL, V34, P391, DOI 10.1016/S0161-5890(97)00052-7; Kruglyak L, 1996, AM J HUM GENET, V58, P1092; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; LIVAK KJ, 1995, PCR METH APPL, V4, P357; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; MCGUIRE W, 1994, NATURE, V371, P508, DOI 10.1038/371508a0; MESSER G, 1991, J EXP MED, V173, P209, DOI 10.1084/jem.173.1.209; Nadel S, 1996, J INFECT DIS, V174, P878, DOI 10.1093/infdis/174.4.878; Nair RP, 1997, HUM MOL GENET, V6, P1349, DOI 10.1093/hmg/6.8.1349; NAKAJIMA A, 1995, GASTROENTEROLOGY, V109, P1462, DOI 10.1016/0016-5085(95)90631-2; OLAVESEN MG, IN PRESS IMMUNOGENET; PARTANEN J, 1988, SCAND J IMMUNOL, V28, P313, DOI 10.1111/j.1365-3083.1988.tb01454.x; Perri F, 1998, ITAL J GASTROENTEROL, V30, P56; Plevy SE, 1996, GASTROENTEROLOGY, V110, P1053, DOI 10.1053/gast.1996.v110.pm8612993; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P928, DOI 10.1056/NEJM199109263251306; Probert CSJ, 1996, INT J COLORECTAL DIS, V11, P25, DOI 10.1007/BF00418851; PURRMANN J, 1985, Z GASTROENTEROL, V23, P432; Roussomoustakaki M, 1997, GASTROENTEROLOGY, V112, P1845, DOI 10.1053/gast.1997.v112.pm9178675; RUSSELL AS, 1975, AM J DIG DIS, V20, P359, DOI 10.1007/BF01237793; Satsangi J, 1996, LANCET, V347, P1212, DOI 10.1016/S0140-6736(96)90734-5; Satsangi J, 1996, NAT GENET, V14, P199, DOI 10.1038/ng1096-199; Schreiber S, 1999, LANCET, V353, P459, DOI 10.1016/S0140-6736(98)03339-X; Shivananda S, 1996, GUT, V39, P690, DOI 10.1136/gut.39.5.690; Silverberg M, 1999, GASTROENTEROLOGY, V116, pA820; SMOLEN JS, 1982, GASTROENTEROLOGY, V82, P34; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; TOYODA H, 1993, GASTROENTEROLOGY, V104, P741, DOI 10.1016/0016-5085(93)91009-7; TRUELOVE SC, 1976, GUT, V17, P192, DOI 10.1136/gut.17.3.192; Uyar FA, 1998, EUR J IMMUNOGENET, V25, P293, DOI 10.1046/j.1365-2370.1998.00104.x; Weissensteiner T, 1997, IMMUNOGENETICS, V47, P6, DOI 10.1007/s002510050320; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195; Yang H, 1999, GUT, V44, P519, DOI 10.1136/gut.44.4.519	55	190	194	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1999	65	6					1647	1655		10.1086/302677	http://dx.doi.org/10.1086/302677			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	266CF	10577918	Bronze, Green Published			2022-12-18	WOS:000084282500019
J	Flanigan, K; Gardner, K; Alderson, K; Galster, B; Otterud, B; Leppert, MF; Kaplan, C; Ptacek, LJ				Flanigan, K; Gardner, K; Alderson, K; Galster, B; Otterud, B; Leppert, MF; Kaplan, C; Ptacek, LJ			Autosomal dominant spinocerebellar ataxia with sensory axonal neuropathy (SCA4): Clinical description and genetic localization to chromosome 16q22.1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TOCOPHEROL-TRANSFER PROTEIN; MACHADO-JOSEPH DISEASE; CEREBELLAR-ATAXIA; CAG REPEAT; EXPANSION; LINKAGE; LOCUS; TRINUCLEOTIDE; DEGENERATION; FAMILIES	The hereditary ataxias represent a clinically and genetically heterogeneous group of neurodegenerative disorders. Various classification schemes based on clinical criteria are being replaced as molecular characterization of the ataxias proceeds; so far, seven distinct autosomal dominant hereditary ataxias have been genetically mapped in the human genome. We report linkage to chromosome 16q22.1 for one of these genes (SCA4) in a five-generation family with an autosomal dominant, late-onset spinocerebellar ataxia; the gene is tightly linked to the microsatellite marker D16S397 (LOD score = 5.93 at theta = .00). In addition, we present clinical and electrophysiological data regarding the distinct and previously unreported phenotype consisting of ataxia with the invariant presence of a prominent axonal sensory neuropathy.	UNIV UTAH,MED CTR,DEPT NEUROL,SALT LAKE CITY,UT; UNIV UTAH,MED CTR,DEPT HUMAN GENET,SALT LAKE CITY,UT; UNIV UTAH,MED CTR,PROGRAM HUMAN MOL BIOL & GENET,SALT LAKE CITY,UT; UNIV UTAH,MED CTR,PROGRAM NEUROSCI,SALT LAKE CITY,UT; VET AFFAIRS MED CTR,SALT LAKE CITY,UT 84148	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Veterans Health Administration (VHA)			Kaplan, Craig/AAO-4500-2021	Kaplan, Craig/0000-0002-7518-695X; Flanigan, Kevin/0000-0001-6440-3376	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K11HD000940] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000367] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR00064] Funding Source: Medline; NHGRI NIH HHS [8 RO1 HG00367] Funding Source: Medline; NICHD NIH HHS [K11 HD00940] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AUBURGER G, 1990, AM J HUM GENET, V46, P1163; BANFI S, 1994, NAT GENET, V7, P513, DOI 10.1038/ng0894-513; BENOMAR A, 1995, NAT GENET, V10, P84, DOI 10.1038/ng0595-84; BIEMOND A, 1954, Rev Neurol (Paris), V91, P3; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; COUTINHO P, 1978, NEUROLOGY, V28, P703, DOI 10.1212/WNL.28.7.703; DIAZ GO, 1990, NEUROLOGY, V40, P1369, DOI 10.1212/WNL.40.9.1369; DUBOURG O, 1995, ANN NEUROL, V37, P176, DOI 10.1002/ana.410370207; GARDNER K, 1994, NEUROLOGY, V44, pA361; GISPERT S, 1993, NAT GENET, V4, P295, DOI 10.1038/ng0793-295; GIUNTI P, 1994, BRAIN, V117, P645, DOI 10.1093/brain/117.4.645; GOTODA T, 1995, NEW ENGL J MED, V333, P1313, DOI 10.1056/NEJM199511163332003; GOUW LG, 1995, NAT GENET, V10, P89, DOI 10.1038/ng0595-89; Greenfield JG, 1954, SPINOCEREBELLAR DEGE; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HARDING A, 1984, HEREDITARY ATAXIAS R; HARDING AE, 1993, ADV NEUROL, V61, P1; Holmes G, 1907, BRAIN, V30, P545; Junck L, 1996, NEUROLOGY, V46, P4, DOI 10.1212/WNL.46.1.4; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KLANKE CA, 1995, GENOMICS, V25, P615, DOI 10.1016/0888-7543(95)80002-4; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KONIGSMARK BW, 1970, MEDICINE, V49, P227, DOI 10.1097/00005792-197005000-00003; LATHROP GM, 1985, AM J HUM GENET, V37, P482; Marie P., 1893, SEM MED PARIS, V13, P444; MATILLA T, 1995, ANN NEUROL, V38, P68, DOI 10.1002/ana.410380113; MCLEOD JG, 1981, MUSCLE NERVE, V4, P51, DOI 10.1002/mus.880040110; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; OUAHCHI K, 1995, NAT GENET, V9, P141, DOI 10.1038/ng0295-141; PTACEK LJ, 1991, AM J HUM GENET, V49, P378; RANUM LPW, 1991, AM J HUM GENET, V49, P31; RANUM LPW, 1994, NAT GENET, V8, P280, DOI 10.1038/ng1194-280; ROSENBERG RN, 1995, NEUROLOGY, V45, P1; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SCHUT JW, 1950, ARCH NEURO PSYCHIATR, V63, P535, DOI 10.1001/archneurpsyc.1950.02310220002001; SERVADIO A, 1995, NAT GENET, V10, P95; Wadia N H, 1984, Adv Neurol, V41, P149; WADIA NH, 1971, BRAIN, V94, P359, DOI 10.1093/brain/94.2.359; ZOGHBI HY, 1988, ANN NEUROL, V23, P580, DOI 10.1002/ana.410230609; ZOGHBI HY, 1991, AM J HUM GENET, V49, P23	41	190	192	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1996	59	2					392	399						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VM288	8755926				2022-12-18	WOS:A1996VM28800015
J	LEWIS, TB; LEACH, RJ; WARD, K; OCONNELL, P; RYAN, SG				LEWIS, TB; LEACH, RJ; WARD, K; OCONNELL, P; RYAN, SG			GENETIC-HETEROGENEITY IN BENIGN FAMILIAL NEONATAL CONVULSIONS - IDENTIFICATION OF A NEW LOCUS ON CHROMOSOME-8Q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE; FRAGMENTS; EPILEPSY; SEIZURES	The syndrome of benign familial neonatal convulsions (BFNC) is a rare autosomal dominant disorder characterized by unprovoked seizures in the first few weeks of life. One locus for BFNC has been mapped to chromosome 20 in several pedigrees, but we have excluded linkage to chromosome 20 in one large kindred. In order to identify this novel BFNC locus, dinucleotide repeat markers distributed throughout the genome were used to screen this family. Maximum pairwise LOD scores of 4.43 were obtained with markers D8S284 and D8S256 on chromosome 8q. Multipoint analysis placed the BFNC locus in the interval spanned by D8S198-D8S274. This study establishes the presence of a new BFNC locus and confirms genetic heterogeneity of this disorder.	UNIV TEXAS,HLTH SCI CTR,DEPT PEDIAT,7703 FLOYD CURL DR,SAN ANTONIO,TX 78284; UNIV TEXAS,HLTH SCI CTR,DEPT PATHOL,SAN ANTONIO,TX 78284; UNIV TEXAS,HLTH SCI CTR,DEPT CELLULAR & STRUCT BIOL,SAN ANTONIO,TX 78284; UNIV UTAH,SCH MED,DEPT OBSTET & GYNECOL,SALT LAKE CITY,UT 84112	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Utah System of Higher Education; University of Utah				Leach, Robin/0000-0002-3201-5579	NHGRI NIH HHS [HG00470] Funding Source: Medline; NIA NIH HHS [AG00165-05] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000470] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ANDERMANN E, 1982, GENETIC BASIS EPILEP, P103; ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; ANNEGERS JF, 1982, NEUROLOGY, V32, P174, DOI 10.1212/WNL.32.2.174; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; DOBRESCU O, 1982, CAN J NEUROL SCI, V9, P345, DOI 10.1017/S0317167100044188; DONISKELLER H, 1991, CYTOGENET CELL GENET, V58, P382, DOI 10.1159/000133168; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GARDINER RM, 1990, J MED GENET, V27, P537, DOI 10.1136/jmg.27.9.537; KAPLAN RE, 1983, AM J MED GENET, V16, P595, DOI 10.1002/ajmg.1320160417; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEPPERT M, 1989, NATURE, V337, P647, DOI 10.1038/337647a0; MALAFOSSE A, 1992, HUM GENET, V89, P54, DOI 10.1007/BF00207042; McKusick V.A., 1992, MENDELIAN INHERITANC; MILES DK, 1990, J CLIN NEUROPHYSIOL, V7, P369, DOI 10.1097/00004691-199007000-00004; OTT J, 1978, ANN HUM GENET, V42, P225; POLYMEROPOULOS MH, 1992, HUM MOL GENET, V1, P65, DOI 10.1093/hmg/1.1.65; QUATTLEBAUM TG, 1979, J PEDIATR-US, V95, P257; RETT A., 1964, WIENER KLIN WOCHEWSCH, V76, P609; RYAN SG, 1991, ANN NEUROL, V29, P469, DOI 10.1002/ana.410290504; Shevell M I, 1986, Pediatr Neurol, V2, P272, DOI 10.1016/0887-8994(86)90018-4; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STEINBRUECK T, 1992, SCIENCE, V258, P67; TIBBLES JAR, 1980, DEV MED CHILD NEUROL, V22, P664; WEBER JL, 1991, GENOMICS, V11, P695, DOI 10.1016/0888-7543(91)90077-R; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; ZONANA J, 1984, AM J MED GENET, V18, P455, DOI 10.1002/ajmg.1320180315	26	190	195	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1993	53	3					670	675						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LU559	8102508				2022-12-18	WOS:A1993LU55900011
J	GLASS, B; LI, CC				GLASS, B; LI, CC			THE DYNAMICS OF RACIAL INTERMIXTURE - AN ANALYSIS BASED ON THE AMERICAN NEGRO	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ARMATTOE REG, 1950, MED WORLD       0825; BARNICOT NA, 1950, ANN EUGENIC, V15, P248; BERNSTEIN F, 1931, GEOGRAPHISCHE VERTEI, P227; BESSIS M, 1947, CR SOC BIOL, V141, P1119; BOYD WC, 1950, COLD SPRING HARB SYM, V15, P233, DOI 10.1101/SQB.1950.015.01.025; BOYD WC, 1950, GENETICS RACES MAN, P418; BOYD WILLIAM C., 1939, TABULAE BIOL, V17, P113; Boyd WC, 1939, AM J PHYS ANTHROPOL, V25, P215, DOI 10.1002/ajpa.1330250234; da Silva EM, 1949, AM J PHYS ANTHROP-NE, V7, P575, DOI 10.1002/ajpa.1330070412; da Silva EM, 1948, AM J PHYS ANTHROP-NE, V6, P423, DOI 10.1002/ajpa.1330060412; DONEGANI JA, 1950, HEREDITY, V4, P377, DOI 10.1038/hdy.1950.30; DUBLIN LI, 1925, J AM STATIST ASS SEP, P334; GLASS B, 1950, AM J HUM GENET, V2, P269; Haldane JBS, 1942, ANN EUGEN, V11, P333; LAUGHLIN WS, CITED INDIRECTLY; LEE B. F., 1934, OHIO JOUR SCI, V34, P337; LEVINE P, 1945, NATURE, V156, P418, DOI 10.1038/156418a0; MORGANTI G, 1948, SANGUE, V21, P181; MURRAY J, 1946, BRIT J EXP PATHOL, V27, P102; NEEL JV, 1951, GENETICS, V36, P84; Ottensooser F., 1944, REV BRASIL BIOL, V4, P531; RACE RR, 1948, BLOOD, V3, P689; SHAPIRO M, 1951, S Afr Med J, V25, P165; SNYDER LAURENCE H., 1932, OHIO JOUR SCI, V32, P436; STEVANS W. L., 1952, HUMAN BIOL, V24, P12; UNGER LJ, 1946, AM J CLIN PATHOL, V16, P498, DOI 10.1093/ajcp/16.8.498; VANLOGHEM JJ, 1949, REV HEMATOL, V4, P173; Wiener AS, 1944, AM J PHYS ANTHROP-NE, V2, P187, DOI 10.1002/ajpa.1330020206; Wiener AS, 1942, SCIENCE, V96, P407, DOI 10.1126/science.96.2496.407; WIENER AS, 1943, BLOOD GROUPS TRANSFU; 1948, VITAL STATISTICS 2, P168	31	190	192	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1953	5	1					1	20						20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XW629	13050606				2022-12-18	WOS:A1953XW62900001
J	Xi, ZR; Zinman, L; Moreno, D; Schymick, J; Liang, Y; Sato, C; Zheng, YL; Ghani, M; Dib, S; Keith, J; Robertson, J; Rogaeva, E				Xi, Zhengrui; Zinman, Lorne; Moreno, Danielle; Schymick, Jennifer; Liang, Yan; Sato, Christine; Zheng, Yonglan; Ghani, Mandi; Dib, Samar; Keith, Julia; Robertson, Janice; Rogaeva, Ekaterina			Hypermethylation of the CpG Island Near the G(4)C(2) Repeat in ALS with a C9orf72 Expansion	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; AGE-OF-ONSET; DNA METHYLATION; HEXANUCLEOTIDE REPEAT; MYOTONIC-DYSTROPHY; FRAGILE-X; REDUCES EXPRESSION; EPIGENETIC CHANGES; FRATAXIN GENE; CAG REPEAT	The G(4)C(2) repeat expansion in C9orf72 is the most common known cause of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). We tested the hypothesis that the repeat expansion causes aberrant CpG methylation near the G(4)C(2) repeat, which could be responsible for the downregulation of gene expression. We investigated the CpG methylation profile by two methods using genomic DNA from the blood of individuals with ALS (37 expansion carriers and 64 noncarriers), normal controls (n = 76), and family members of 7 ALS probands with the expansion. We report that hypermethylation of the CpG island 5' of the G(4)C(2) repeat is associated with the presence of the expansion (p < 0.0001). A higher degree of methylation was significantly correlated with a shorter disease duration (p < 0.01), associated with familial ALS (p = 0.009) and segregated with the expansion in 7 investigated families. Notably, we did not detect methylation for either normal or intermediate alleles (up to 43 repeats), bringing to question the current cutoff of 30 repeats for pathological alleles. Our study raises several important questions for the future investigation of large data sets, such as whether the degree of methylation corresponds to clinical presentation (ALS versus FTLD).	[Xi, Zhengrui; Moreno, Danielle; Schymick, Jennifer; Liang, Yan; Sato, Christine; Ghani, Mandi; Dib, Samar; Robertson, Janice; Rogaeva, Ekaterina] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada; [Zinman, Lorne; Keith, Julia] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Zheng, Yonglan] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Rogaeva, Ekaterina] Univ Toronto, Div Neurol, Dept Med, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Chicago; University of Toronto	Rogaeva, E (corresponding author), Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, 6 Queens Pk Crescent West, Toronto, ON M5S 3H2, Canada.	ekaterina.rogaeva@utoronto.ca	Zheng, Yonglan/O-4112-2019; Zheng, Yonglan/C-4236-2011	Zheng, Yonglan/0000-0001-6597-7072; Ghani, Mahdi/0000-0001-6455-7199	W. Garfield Weston Foundation; Ontario Research Fund	W. Garfield Weston Foundation; Ontario Research Fund	This work was supported by the W. Garfield Weston Foundation and Ontario Research Fund (E.R., J.R.).	Al-Mahdawi S, 2008, HUM MOL GENET, V17, P735, DOI 10.1093/hmg/ddm346; ALLEN RC, 1992, AM J HUM GENET, V51, P1229; [Anonymous], 1994, J Neurol Neurosurg Psychiatry, V57, P416; Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; BELL MV, 1991, CELL, V64, P861, DOI 10.1016/0092-8674(91)90514-Y; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Castaldo I, 2008, J MED GENET, V45, P808, DOI 10.1136/jmg.2008.058594; Castel AL, 2011, HUM MOL GENET, V20, P1, DOI 10.1093/hmg/ddq427; Coon EA, 2013, AMYOTROPH LAT SCL FR, V14, P132, DOI 10.3109/17482968.2012.724075; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Evans-Galea MV, 2012, ANN NEUROL, V71, P487, DOI 10.1002/ana.22671; Filla A, 1996, AM J HUM GENET, V59, P554; Gijselinck I, 2012, LANCET NEUROL, V11, P54, DOI 10.1016/S1474-4422(11)70261-7; Greene E, 2007, NUCLEIC ACIDS RES, V35, P3383, DOI 10.1093/nar/gkm271; Hughes AJ, 2001, NEUROLOGY, V57, P1497, DOI 10.1212/WNL.57.8.1497; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jiang MH, 2010, LAB INVEST, V90, P282, DOI 10.1038/labinvest.2009.132; Klesert TR, 1997, NAT GENET, V16, P402, DOI 10.1038/ng0897-402; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Korade-Mirnics Z, 1999, HUM MOL GENET, V8, P1017, DOI 10.1093/hmg/8.6.1017; Lee JM, 2012, NEUROLOGY, V78, P690, DOI 10.1212/WNL.0b013e318249f683; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Murray ME, 2011, ACTA NEUROPATHOL, V122, P673, DOI 10.1007/s00401-011-0907-y; Nagase H, 2008, FEBS J, V275, P1617, DOI 10.1111/j.1742-4658.2008.06330.x; Parrish RR, 2012, CURR PROTOC NEUROSCI; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; Rademakers R, 2012, LANCET NEUROL, V11, P297, DOI 10.1016/S1474-4422(12)70046-7; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; ROGAEV EI, 1994, GENOMICS, V22, P340, DOI 10.1006/geno.1994.1393; Sabatelli M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.02.011; Smith BN, 2013, EUR J HUM GENET, V21, P102, DOI 10.1038/ejhg.2012.98; Stewart H, 2012, ACTA NEUROPATHOL, V123, P409, DOI 10.1007/s00401-011-0937-5; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; Takada LT, 2012, ARCH NEUROL-CHICAGO, V69, P1149, DOI 10.1001/archneurol.2012.650; Tassone F, 2007, AM J MED GENET B, V144B, P566, DOI 10.1002/ajmg.b.30482; Thornton CA, 1997, NAT GENET, V16, P407, DOI 10.1038/ng0897-407; Xi ZR, 2012, ARCH NEUROL-CHICAGO, V69, P1583, DOI 10.1001/archneurol.2012.2016	40	189	190	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 6	2013	92	6					981	989		10.1016/j.ajhg.2013.04.017	http://dx.doi.org/10.1016/j.ajhg.2013.04.017			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164MX	23731538	Green Published, Bronze			2022-12-18	WOS:000320415300015
J	Srinivasan, A; Bianchi, DW; Huang, H; Sehnert, AJ; Rava, RP				Srinivasan, Anupama; Bianchi, Diana W.; Huang, Hui; Sehnert, Amy J.; Rava, Richard P.			Noninvasive Detection of Fetal Subchromosome Abnormalities via Deep Sequencing of Maternal Plasma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRENATAL-DIAGNOSIS; CHROMOSOMAL MICROARRAY; DNA; ANEUPLOIDY; STATEMENT	The purpose of this study was to determine the deep sequencing and analytic conditions needed to detect fetal subchromosome abnormalities across the genome from a maternal blood sample. Cell-free (cf) DNA was isolated from the plasma of 11 pregnant women carrying fetuses with subchromosomal duplications and deletions, translocations, mosaicism, and trisomy 20 diagnosed by metaphase karyotype. Massively parallel sequencing (MPS) was performed with 25-mer tags at approximately 10(9) tags per sample and mapped to reference human genome assembly hg19. Tags were counted and normalized to fixed genome bin sizes of 1 Mb or 100 kb to detect statistically distinct copy-number changes compared to the reference. All seven cases of microdeletions, duplications, translocations, and the trisomy 20 were detected blindly by MPS, including a microdeletion as small as 300 kb. In two of these cases in which the metaphase karyotype showed additional material of unknown origin, MPS identified both the translocation breakpoint and the chromosomal origin of the additional material. In the four mosaic cases, the subchromosomal abnormality was not demonstrated by MPS. This work shows that in nonmosaic cases, it is possible to obtain a fetal molecular karyotype by MPS of maternal plasma cfDNA that is equivalent to a chromosome microarray and in some cases is better than a metaphase karyotype. This approach combines the advantage of enhanced fetal genomic resolution with the improved safety of a noninvasive maternal blood test.	[Srinivasan, Anupama; Huang, Hui; Sehnert, Amy J.; Rava, Richard P.] Verinata Hlth Inc, Redwood City, CA 94063 USA; [Bianchi, Diana W.] Tufts Med Ctr, Mother Infant Res Inst, Boston, MA 02111 USA; [Bianchi, Diana W.] Tufts Univ, Sch Med, Boston, MA 02111 USA	Tufts Medical Center; Tufts University	Rava, RP (corresponding author), Verinata Hlth Inc, Redwood City, CA 94063 USA.	rrava@verinata.com			Verinata Health	Verinata Health	The authors wish to acknowledge the help of the coinvestigators in the MELISSA trial in acquiring samples. A.S., H.H., A.J.S., and R.P.R. are employees of Verinata Health, Inc. D.W.B. is the chair of the Clinical Advisory Board of Verinata Health, and for this position she receives an honorarium and equity options. She also has a sponsored research grant from Verinata Health that is administered through Tufts Medical Center.	American College of Obstetricians and Gynecologists Committee on Genetics, 2012, Obstet Gynecol, V120, P1532, DOI 10.1097/01.AOG.0000423819.85283.f4; Bianchi DW, 2012, NAT MED, V18, P1041, DOI 10.1038/nm.2829; Bianchi DW, 2012, OBSTET GYNECOL, V119, P890, DOI 10.1097/AOG.0b013e31824fb482; Chen CP, 2003, PRENATAL DIAG, V23, P85, DOI 10.1002/pd.524; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Fan HC, 2007, ANAL CHEM, V79, P7576, DOI 10.1021/ac0709394; Fan HC, 2012, NATURE, V487, P320, DOI 10.1038/nature11251; Fan HC, 2010, CLIN CHEM, V56, P1279, DOI 10.1373/clinchem.2010.144188; Howarth KD, 2011, GENOME RES, V21, P525, DOI 10.1101/gr.114116.110; Jensen TJ, 2012, CLIN CHEM, V58, P1148, DOI 10.1373/clinchem.2011.180794; Kitzman JO, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004323; Lo YMD, 2007, P NATL ACAD SCI USA, V104, P13116, DOI 10.1073/pnas.0705765104; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Novelli A, 2012, ULTRASOUND OBST GYN, V39, P384, DOI 10.1002/uog.11092; Peters D, 2011, NEW ENGL J MED, V365, P1847, DOI 10.1056/NEJMc1106975; Sehnert AJ, 2011, CLIN CHEM, V57, P1042, DOI 10.1373/clinchem.2011.165910; Vetro A, 2012, HUM MUTAT, V33, P923, DOI 10.1002/humu.22050; Wapner RJ, 2012, NEW ENGL J MED, V367, P2175, DOI 10.1056/NEJMoa1203382	21	189	247	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 7	2013	92	2					167	176		10.1016/j.ajhg.2012.12.006	http://dx.doi.org/10.1016/j.ajhg.2012.12.006			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	093GL	23313373	Green Published, hybrid			2022-12-18	WOS:000315179600001
J	Shields, DC; Kirke, PN; Mills, JL; Ramsbottom, D; Molloy, AM; Burke, H; Weir, DG; Scott, JM; Whitehead, AS				Shields, DC; Kirke, PN; Mills, JL; Ramsbottom, D; Molloy, AM; Burke, H; Weir, DG; Scott, JM; Whitehead, AS			The "thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							METHYLENE TETRAHYDROFOLATE REDUCTASE; SPINA-BIFIDA; 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE; HOMOCYSTEINE METABOLISM; LINKAGE DISEQUILIBRIUM; METHIONINE SYNTHASE; TRANSMISSION TEST; VASCULAR-DISEASE; COMMON MUTATION; FOLATE STATUS	Recent reports have implicated the "thermolabile" (T) variant of methylenetetrahydrofolate reductase (MTHFR) in the causation of folate-dependent neural tube defects (NTDs). We report herein the largest genetic study of NTD cases (n = 271) and families (n = 218) to date, establishing that, in Ireland, the "TT" genotype is found in 18.8% of cases versus 8.3% of controls (odds ratio 2.57; confidence interval [CI] 1.48-4.45; P=.0005). The maternal and paternal TT genotypes have intermediate frequencies of 13.8% and 11.9%, respectively, indicating that the predominant MTHFR-related genetic effect acts via the TT genotype of the developing embryo. Analysis of the 218 family triads of mother, father, and affected child with log-linear models supports this interpretation, providing significant evidence that the case TT genotype is associated with NTDs (P =.02) but no evidence of a maternal TT genotypic effect (P =.83). The log-linear model predicted that the risk of NTDs conferred by the case TT genotype is 1.61 (CI 1.06-2.46), consistent with the paramount importance of the case TT genotype in determining risk. There is no compelling evidence for more than a modest additional risk conferred by a maternal TT genotype. These results favor a biological model of MTHFR-related NTD pathogenesis in which suboptimal maternal folate status imposes biochemical stress on the developing embryo, a stress it is ill-equipped to tolerate if it has a TT genotype.	Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Expt Therapeut, Philadelphia, PA 19104 USA; NICHHD, Bethesda, MD 20892 USA; Univ Dublin Trinity Coll, Dept Genet, Dublin 2, Ireland; Univ Dublin Trinity Coll, Dept Clin Med, Dublin 2, Ireland; Univ Dublin Trinity Coll, Dept Biochem, Dublin 2, Ireland; Univ Dublin Trinity Coll, Hlth Res Board, Dublin 2, Ireland; Royal Coll Surg Ireland, Dept Clin Pharmacol, Dublin 2, Ireland	University of Pennsylvania; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; Health Research Board - Ireland; Trinity College Dublin; Royal College of Surgeons - Ireland	Whitehead, AS (corresponding author), Univ Penn, Sch Med, Dept Pharmacol, 3620 Hamilton Walk, Philadelphia, PA 19104 USA.	aswhitehead@pharm.med.upenn.edu		Shields, Denis/0000-0003-4015-2474; Molloy, Anne/0000-0002-1688-9049; Mills, James/0000-0003-4496-332X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD002502] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD002502] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Christensen B, 1997, AM J HUM GENET, V61, pA150; *CTR DIS CONTR PRE, 1989, MMWR MORBID MORTAL W, V38, P264; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; DALY LE, 1995, JAMA-J AM MED ASSOC, V274, P1698, DOI 10.1001/jama.274.21.1698; deFranchis R, 1995, LANCET, V346, P1703, DOI 10.1016/S0140-6736(95)92865-0; ENGBERSEN AMT, 1995, AM J HUM GENET, V56, P142; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; GOYETTE P, 1994, NAT GENET, V7, P195, DOI 10.1038/ng0694-195; Harmon DL, 1996, QJM-MON J ASSOC PHYS, V89, P571; Jacques PF, 1996, CIRCULATION, V93, P7, DOI 10.1161/01.CIR.93.1.7; KANG SS, 1988, METABOLISM, V37, P611, DOI 10.1016/0026-0495(88)90076-5; KELSEY JL, 1986, METHODS OBSERVATIONA; KIRKE PN, 1993, Q J MED, V86, P703; Kirke PN, 1996, LANCET, V348, P1037, DOI 10.1016/S0140-6736(05)64971-9; Koch MC, 1998, EUR J PEDIATR, V157, P487, DOI 10.1007/s004310050860; Little J., 1992, EPIDEMIOLOGY CONTROL, P677; Little J., 1992, EPIDEMIOLOGY CONTROL, P604; MILLS JL, 1995, LANCET, V345, P149, DOI 10.1016/S0140-6736(95)90165-5; Mitchell LE, 1997, AM J HUM GENET, V60, P1006; Molloy AM, 1998, AM J MED GENET, V78, P155, DOI 10.1002/(SICI)1096-8628(19980630)78:2<155::AID-AJMG11>3.3.CO;2-Z; Molloy AM, 1997, LANCET, V349, P1591, DOI 10.1016/S0140-6736(96)12049-3; Mornet E, 1997, HUM GENET, V100, P512, DOI 10.1007/s004390050544; Morrison K, 1997, J MED GENET, V34, P958, DOI 10.1136/jmg.34.11.958; Ou CY, 1996, AM J MED GENET, V63, P610, DOI 10.1002/(SICI)1096-8628(19960628)63:4<610::AID-AJMG15>3.3.CO;2-Y; Papapetrou C, 1996, LANCET, V348, P58, DOI 10.1016/S0140-6736(05)64382-6; Ramsbottom D, 1997, CLIN GENET, V51, P39; ROSENBLATT DS, 1989, METABOLIC BASIS INHE, P2049; Rosenquist TH, 1996, P NATL ACAD SCI USA, V93, P15227, DOI 10.1073/pnas.93.26.15227; SCHAID DJ, 1994, AM J HUM GENET, V55, P402; Schaid DJ, 1996, GENET EPIDEMIOL, V13, P423, DOI 10.1002/(SICI)1098-2272(1996)13:5<423::AID-GEPI1>3.0.CO;2-3; Scott J, 1994, ESSAYS BIOCHEM, V28, P63; Speer MC, 1997, NEUROGENETICS, V1, P149, DOI 10.1007/s100480050022; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; STEEGERSTHEUNISSEN RPM, 1994, METABOLISM, V43, P1475, DOI 10.1016/0026-0495(94)90004-3; STEEGERSTHEUNISSEN RPM, 1991, NEW ENGL J MED, V324, P199; vanderPut NMJ, 1997, QJM-INT J MED, V90, P511, DOI 10.1093/qjmed/90.8.511; VANDERPUT NMJ, 1995, LANCET, V346, P1070, DOI 10.1016/S0140-6736(95)91743-8; vanderPut NMJ, 1997, QJM-MON J ASSOC PHYS, V90, P111, DOI 10.1093/qjmed/90.2.111; vanderPut NMJ, 1996, J MOL MED, V74, P691, DOI 10.1007/s001090050073; WALD N, 1991, LANCET, V338, P131; Weinberg CR, 1998, AM J HUM GENET, V62, P969, DOI 10.1086/301802; WHITEHEAD AS, 1995, QJM-MON J ASSOC PHYS, V88, P763; Wilcken DEL, 1996, LANCET, V347, P340, DOI 10.1016/S0140-6736(96)90526-7	43	189	195	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1999	64	4					1045	1055		10.1086/302310	http://dx.doi.org/10.1086/302310			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184UV	10090889	Green Published, Bronze			2022-12-18	WOS:000079632900015
J	Ohta, T; Gray, TA; Rogan, PK; Buiting, K; Gabriel, JM; Saitoh, S; Muralidhar, B; Bilienska, B; Krajewska-Walasek, M; Driscoll, DJ; Horsthemke, B; Butler, MG; Nicholls, RD				Ohta, T; Gray, TA; Rogan, PK; Buiting, K; Gabriel, JM; Saitoh, S; Muralidhar, B; Bilienska, B; Krajewska-Walasek, M; Driscoll, DJ; Horsthemke, B; Butler, MG; Nicholls, RD			Imprinting-mutation mechanisms in Prader-Willi syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN SNRPN GENE; DNA METHYLATION; MOLECULAR DIAGNOSIS; CHROMOSOME REGION; ANGELMAN-SYNDROME; CPG ISLAND; EXPRESSION; 15Q11-Q13; DELETION; PROTEIN	Microdeletions of a region termed the "imprinting center" (IC) in chromosome 15q11-q13 have been identified in several families with Prader-Willi syndrome (PWS) or Angelman syndrome who show epigenetic inheritance for this region that is consistent with a mutation in the imprinting process. The IC controls resetting of parental imprints in 15q11-q13 during gametogenesis. We have identified a larger series of cases of familial PWS, including one case with a deletion of only 7.5 kb, that narrows the PWS critical region to <4.3 kb spanning the SNRPN gene CpG island and exon 1. Identification of a strong DNase I hypersensitive site, specific for the paternal allele, and six evolutionarily conserved (human-mouse) sequences that are potential transcription-factor binding sites is consistent with this region defining the SNRPN gene promoter. These findings suggest that promoter elements at SNRPN play a key role in the initiation of imprint switching during spermatogenesis. We also identified three patients with sporadic PWS who have an imprinting mutation (IM) and no detectable mutation in the IC. An inherited 15q11-q13 mutation or a trans-factor gene mutation are unlikely; thus, the disease in these patients may arise from a developmental or stochastic failure to switch the maternal-to-paternal imprint during parental spermatogenesis. These studies allow a better understanding of a novel mechanism of human disease, since the epigenetic effect of an IM in the parental germ line determines the phenotypic effect in the patient.	Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Ctr Human Genet, Cleveland, OH 44106 USA; Allegheny Univ Hlth Sci, Dept Human Genet, Pittsburgh, PA USA; Univ Essen Gesamthsch Klinikum, Inst Human Genet, D-4300 Essen, Germany; Hokkaido Univ, Sch Med, Dept Pediat, Sapporo, Hokkaido 060, Japan; Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; Childrens Mem Hlth Inst, Dept Genet, Warsaw, Poland; Univ Florida, Coll Med, Dept Pediat, Div Genet,RC Philips Unit, Gainesville, FL USA	Case Western Reserve University; University Hospitals of Cleveland; University of Duisburg Essen; Hokkaido University; Vanderbilt University; Children's Memorial Health Institute; State University System of Florida; University of Florida	Nicholls, RD (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet, 10900 Euclid Ave, Cleveland, OH 44106 USA.		Rogan, Peter/B-9845-2017	Rogan, Peter/0000-0003-2070-5254; Saitoh, Shinji/0000-0001-6911-3351; Krajewska-Walasek, Malgorzata/0000-0001-8721-210X	NICHD NIH HHS [HD31491] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD031491] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; Buiting K, 1998, AM J HUM GENET, V63, P170, DOI 10.1086/301935; Buiting K, 1997, GENOMICS, V40, P132, DOI 10.1006/geno.1996.4571; BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; Burger J, 1997, AM J HUM GENET, V61, P88, DOI 10.1086/513900; Butler MG, 1996, AM J MED GENET, V65, P137, DOI 10.1002/(SICI)1096-8628(19961016)65:2<137::AID-AJMG11>3.0.CO;2-R; Cassidy SB, 1997, J MED GENET, V34, P917, DOI 10.1136/jmg.34.11.917; CHOI ORB, 1988, CELL, V55, P17, DOI 10.1016/0092-8674(88)90005-0; CLAYTONSMITH J, 1992, J MED GENET, V29, P412, DOI 10.1136/jmg.29.6.412; CROSSLEY M, 1993, CURR OPIN GENET DEV, V3, P232, DOI 10.1016/0959-437X(93)90028-N; Dillon N, 1997, MOL CELL, V1, P131, DOI 10.1016/S1097-2765(00)80014-3; DITTRICH B, 1993, HUM MOL GENET, V2, P1995, DOI 10.1093/hmg/2.12.1995; Dittrich B, 1996, NAT GENET, V14, P163, DOI 10.1038/ng1096-163; DRISCOLL DJ, 1992, GENOMICS, V13, P917, DOI 10.1016/0888-7543(92)90001-9; FEINBERG AP, 1994, COLD SPRING HARB SYM, V59, P357, DOI 10.1101/SQB.1994.059.01.040; Gabriel JM, 1998, MAMM GENOME, V9, P788, DOI 10.1007/s003359900868; GLENN CC, 1993, HUM MOL GENET, V2, P1377, DOI 10.1093/hmg/2.9.1377; Glenn CC, 1996, AM J HUM GENET, V58, P335; GRIMALDI K, 1993, DEV BIOL, V156, P319, DOI 10.1006/dbio.1993.1080; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; GUMUCIO DL, 1992, MOL CELL BIOL, V12, P4919, DOI 10.1128/MCB.12.11.4919; HARRINGTON MA, 1988, P NATL ACAD SCI USA, V85, P2066, DOI 10.1073/pnas.85.7.2066; Hudgins L, 1998, GENET MED, V1, P49; Huq AHMM, 1997, GENOME RES, V7, P642, DOI 10.1101/gr.7.6.642; Ishikawa T, 1996, AM J MED GENET, V62, P350, DOI 10.1002/(SICI)1096-8628(19960424)62:4<350::AID-AJMG6>3.0.CO;2-V; JONG MTC, IN PRESS HUM MOL GEN; Lau AW, 1997, AM J HUM GENET, V61, P1353, DOI 10.1086/301651; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Lyko F, 1998, P NATL ACAD SCI USA, V95, P1698, DOI 10.1073/pnas.95.4.1698; Malzac P, 1998, AM J HUM GENET, V62, P1353, DOI 10.1086/301877; MASCARI MJ, 1992, NEW ENGL J MED, V326, P1599, DOI 10.1056/NEJM199206113262404; MITTWOCH U, 1992, HUM GENET, V89, P467, DOI 10.1007/BF00219168; MUTIRANGURA A, 1993, GENOMICS, V18, P546, DOI 10.1016/S0888-7543(11)80011-X; Nicholls RD, 1998, TRENDS GENET, V14, P194, DOI 10.1016/S0168-9525(98)01432-2; Ohta T, 1999, AM J HUM GENET, V64, P385, DOI 10.1086/302232; Paro R., 1996, EPIGENETIC MECH GENE, P507; Reik W, 1997, TRENDS GENET, V13, P330, DOI 10.1016/S0168-9525(97)01200-6; REIS A, 1994, AM J HUM GENET, V54, P741; Rougeulle C, 1998, NAT GENET, V19, P15, DOI 10.1038/ng0598-15; Saitoh S, 1997, AM J MED GENET, V68, P195, DOI 10.1002/(SICI)1096-8628(19970120)68:2<195::AID-AJMG15>3.3.CO;2-T; Saitoh S, 1996, P NATL ACAD SCI USA, V93, P7811, DOI 10.1073/pnas.93.15.7811; SCHMAUSS C, 1992, J BIOL CHEM, V267, P8521; SCHOENHERR CJ, 1995, CURR OPIN NEUROBIOL, V5, P566, DOI 10.1016/0959-4388(95)80060-3; Schumacher A, 1998, NAT GENET, V19, P324, DOI 10.1038/1211; Shemer R, 1997, P NATL ACAD SCI USA, V94, P10267, DOI 10.1073/pnas.94.19.10267; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; Teshima I, 1996, Am J Med Genet, V62, P217; Tilghman SM, 1998, NAT GENET, V18, P206, DOI 10.1038/ng0398-206; WEVRICK R, 1994, HUM MOL GENET, V3, P1877, DOI 10.1093/hmg/3.10.1877; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631; Yang T, 1998, NAT GENET, V19, P25, DOI 10.1038/ng0598-25	51	189	195	0	12	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1999	64	2					397	413		10.1086/302233	http://dx.doi.org/10.1086/302233			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	169HA	9973278	Green Published, Bronze			2022-12-18	WOS:000078740600010
J	Goodman, M				Goodman, M			The genomic record of humankind's evolutionary roots	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GAMMA-GLOBIN GENE; FETAL EXPRESSION PATTERN; NEW-WORLD MONKEYS; HEMOGLOBIN; SEQUENCES; PRIMATES; FAMILY; ORDER; CIS		Wayne State Univ, Dept Anat & Cell Biol, Sch Med, Detroit, MI 48201 USA	Wayne State University	Goodman, M (corresponding author), Wayne State Univ, Dept Anat & Cell Biol, Sch Med, 540 E Canfield Ave, Detroit, MI 48201 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033940] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL33940] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bailey WJ, 1992, MOL PHYLOGENET EVOL, V1, P97, DOI 10.1016/1055-7903(92)90024-B; BARRIE PA, 1981, J MOL BIOL, V149, P319, DOI 10.1016/0022-2836(81)90476-9; Bunn HF, 1986, HEMOGLOBIN MOL GENET; Chiu CH, 1997, GENE, V205, P47, DOI 10.1016/S0378-1119(97)00476-9; CHIU CH, IN PRESS J EXP ZOOL; COLLINS FS, 1984, PROG NUCLEIC ACID RE, V31, P315, DOI 10.1016/S0079-6603(08)60382-7; Cooper SJB, 1996, MOL BIOL EVOL, V13, P1012, DOI 10.1093/oxfordjournals.molbev.a025651; DEWAAL FBM, 1995, SCI AM, V272, P82, DOI 10.1038/scientificamerican0395-82; FITCH DHA, 1991, P NATL ACAD SCI USA, V88, P7396, DOI 10.1073/pnas.88.16.7396; Fouts R., 1997, NEXT KIN; Gibbons A, 1998, SCIENCE, V281, P1432, DOI 10.1126/science.281.5382.1432; Goodman M, 1998, MOL PHYLOGENET EVOL, V9, P585, DOI 10.1006/mpev.1998.0495; GOODMAN M, 1984, J MOL BIOL, V180, P803, DOI 10.1016/0022-2836(84)90258-4; GOODMAN M, IN PRESS EVOLUTIONAR; GOODMAN M, 1996, GENE FAMILIES STRUCT, P43; Groves Colin P., 1993, P243; Gumucio DL, 1996, MOL PHYLOGENET EVOL, V5, P18, DOI 10.1006/mpev.1996.0004; GUMUCIO DL, 1994, J BIOL CHEM, V269, P15371; HANSCOMBE O, 1991, GENE DEV, V5, P1387, DOI 10.1101/gad.5.8.1387; Hardison R, 1997, GENE, V205, P73, DOI 10.1016/S0378-1119(97)00474-5; Hennig W, 1999, PHYLOGENETIC SYSTEMA; JANE SM, 1992, EMBO J, V11, P2961, DOI 10.1002/j.1460-2075.1992.tb05366.x; Jefferies R. P. S., 1979, ORIGIN MAJOR INVERTE, P443; Johnson RM, 1996, J BIOL CHEM, V271, P14684, DOI 10.1074/jbc.271.25.14684; KOOP BF, 1988, P NATL ACAD SCI USA, V85, P3893, DOI 10.1073/pnas.85.11.3893; Martin R.D., 1990, PRIMATE ORIGINS EVOL; McConkey EH, 1997, TRENDS GENET, V13, P350, DOI 10.1016/S0168-9525(97)01226-2; McGrew WC, 1992, CHIMPANZEE MAT CULTU; McGrew WC, 1997, GREAT APE SOC; MEIRELES CMM, 1995, P NATL ACAD SCI USA, V92, P2607, DOI 10.1073/pnas.92.7.2607; PETERSON KR, 1993, MOL CELL BIOL, V13, P4836, DOI 10.1128/MCB.13.8.4836; Romer A.S., 1962, VERTEBRATE BODY; Savage-Rumbaugh S., 1994, KANZI APE BRINK HUMA; Schimenti JC, 1999, AM J HUM GENET, V64, P40, DOI 10.1086/302220; SMIT AFA, 1995, J MOL BIOL, V246, P401, DOI 10.1006/jmbi.1994.0095; TAGLE DA, 1988, J MOL BIOL, V203, P439, DOI 10.1016/0022-2836(88)90011-3; TomHon C, 1997, J BIOL CHEM, V272, P14062, DOI 10.1074/jbc.272.22.14062; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0	38	189	202	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1999	64	1					31	39		10.1086/302218	http://dx.doi.org/10.1086/302218			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164RM	9915940	Green Published, Bronze			2022-12-18	WOS:000078477400006
J	PETERSEN, DD; MCKINNEY, CE; IKEYA, K; SMITH, HH; BALE, AE; MCBRIDE, OW; NEBERT, DW				PETERSEN, DD; MCKINNEY, CE; IKEYA, K; SMITH, HH; BALE, AE; MCBRIDE, OW; NEBERT, DW			HUMAN CYPIAI GENE - COSEGREGATION OF THE ENZYME INDUCIBILITY PHENOTYPE AND AN RFLP	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ARYL-HYDROCARBON HYDROXYLASE; CULTURED HUMAN-LYMPHOCYTES; MESSENGER-RNA; LUNG-CANCER; CDNA PROBE; DNA; CHROMOSOME-15; SEQUENCE; CYTOCHROME-P1-450; LOCUS	The human CYP1A1 (cytochrome P1 450) gene encodes an enzyme involved in the activation of procarcinogens, such as benzo[a]pyrene, to the ultimate reactive intermediate. Approximately 10% of the human population exhibit high CYP1A1 inducibility, and Kouri et al. reported that the high-inducibility phenotype might be at greater risk than low-inducibility individuals for cigarette smoke-induced bronchogenic carcinoma. In one 3-generation family of 15 individuals, we show here that the high-CYP1A1-inducibility phenotype segregates concordantly with an infrequent polymorphic site located 450 bases downstream from the CYP1A1 gene. Our findings are consistent with the study of Kawajiri et al., who demonstrated an association between this polymorphism and an increased incidence of squamous-cell lung cancer. Our data suggest that the CYP1A1 structural gene, or a region near this gene, might be correlated with the inducibility phenotype.	UNIV CINCINNATI,MED CTR,DEPT ENVIRONM HLTH,CINCINNATI,OH 45267; NICHHD,DEV PHARMACOL LAB,BETHESDA,MD 20892; NCI,BIOCHEM LAB,BETHESDA,MD 20892	University of Cincinnati; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)								ATLAS SA, 1976, CANCER RES, V36, P4619; BALE AE, 1987, CYTOGENET CELL GENET, V46, P574; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; DENISON MS, 1988, J BIOL CHEM, V263, P17221; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FUJISAWASEHARA A, 1988, P NATL ACAD SCI USA, V85, P5859, DOI 10.1073/pnas.85.16.5859; GONZALEZ FJ, 1990, TRENDS GENET, V6, P182, DOI 10.1016/0168-9525(90)90174-5; GUSTAFSON S, 1987, ANAL BIOCHEM, V165, P294, DOI 10.1016/0003-2697(87)90272-7; HAUGEN A, 1990, NUCLEIC ACIDS RES, V18, P3114, DOI 10.1093/nar/18.10.3114; HILDEBRAND CE, 1985, NUCLEIC ACIDS RES, V13, P2009, DOI 10.1093/nar/13.6.2009; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; HINES RN, 1988, CARCINOGENESIS, V9, P1599, DOI 10.1093/carcin/9.9.1599; IKEYA K, 1989, MOL ENDOCRINOL, V3, P1399, DOI 10.1210/mend-3-9-1399; JAISWAL AK, 1985, NUCLEIC ACIDS RES, V13, P4503, DOI 10.1093/nar/13.12.4503; JAISWAL AK, 1985, SCIENCE, V228, P80, DOI 10.1126/science.3838385; JAISWAL AK, 1986, NUCLEIC ACIDS RES, V14, P4376, DOI 10.1093/nar/14.10.4376; KAWAJIRI K, 1986, EUR J BIOCHEM, V159, P219, DOI 10.1111/j.1432-1033.1986.tb09857.x; KAWAJIRI K, 1990, FEBS LETT, V263, P131, DOI 10.1016/0014-5793(90)80721-T; KELLERMANN G, 1973, NEW ENGL J MED, V289, P934, DOI 10.1056/NEJM197311012891802; KOURI RE, 1979, J ENVIRON PATHOL TOX, V2, P1079; KOURI RE, 1974, LIFE SCI, V15, P1585, DOI 10.1016/0024-3205(74)90324-5; KOURI RE, 1982, CANCER RES, V42, P5030; KOURI RE, 1979, 3RD P INT S DET PREV, P1659; LEITERSDORF E, 1989, AM J HUM GENET, V44, P409; LENCH N, 1988, LANCET, V1, P1356; MCBRIDE OW, 1986, P NATL ACAD SCI USA, V83, P130, DOI 10.1073/pnas.83.1.130; Nebert D W, 1978, Methods Enzymol, V52, P226; NEBERT DW, 1987, ANNU REV BIOCHEM, V56, P945, DOI 10.1146/annurev.biochem.56.1.945; NEBERT DW, 1991, DNA CELL BIOL, V10, P1, DOI 10.1089/dna.1991.10.1; NEBERT DW, 1989, INT J BIOCHEM, V21, P243, DOI 10.1016/0020-711X(89)90182-1; NEBERT DW, 1989, CRIT REV TOXICOL, V20, P153, DOI 10.3109/10408448909017908; NEBERT DW, 1988, PHENOTYPIC VARIATION, P45; QUATTROCHI LC, 1986, P NATL ACAD SCI USA, V83, P6731, DOI 10.1073/pnas.83.18.6731; SCHUSTR I, CYTOCHROME P450 BIOC; SPURR NK, 1987, NUCLEIC ACIDS RES, V15, P5901, DOI 10.1093/nar/15.14.5901	35	189	191	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1991	48	4					720	725						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK478	1707592				2022-12-18	WOS:A1991FK47800011
J	VANDERWOUDE, A				VANDERWOUDE, A			FISTULA-LABII INFERIORIS CONGENITA AND ITS ASSOCIATION WITH CLEFT LIP AND PALATE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Davis WB, 1935, SURG GYNECOL OBSTET, V61, P201; De Nancrede CBG, 1912, ANN SURG, V56, P400, DOI 10.1097/00000658-191209000-00003; Demarquay JN, 1845, GAZMED PARIS, V13, P52; FOGHANDERSEN P, 1943, SAERTRYK TANDLAEGEBL; GURNEY CE, 1940, W J SURG, V48, P753; LUDY JB, 1938, N INT CLIN, V3, P75; MASON ML, 1940, SURG GYNECOL OBSTET, V70, P12; Murray J Jardine, 1860, Br Foreign Med Chir Rev, V26, P502; SHEARER WL, 1918, NAT DENT ASS, V5, P1103; STRAITH CL, 1943, JAMA-J AM MED ASSOC, V123, P693; TEST A. R., 1947, JOUR ORAL SURG, V5, P292	11	189	190	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1954	6	2					244	256						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YB733	13158329				2022-12-18	WOS:A1954YB73300005
J	Medland, SE; Nyholt, DR; Painter, JN; McEvoy, BP; Mcrae, AF; Zhu, G; Gordon, SD; Ferreira, MAR; Wright, MJ; Henders, AK; Campbell, MJ; Duffy, DL; Hansell, NK; Macgregor, S; Slutske, WS; Heath, AC; Montgomery, GW; Martin, NG				Medland, Sarah E.; Nyholt, Dale R.; Painter, Jodie N.; McEvoy, Brian P.; McRae, Allan F.; Zhu, Gu; Gordon, Scott D.; Ferreira, Manuel A. R.; Wright, Margaret J.; Henders, Anjali K.; Campbell, Megan J.; Duffy, David L.; Hansell, Narelle K.; Macgregor, Stuart; Slutske, Wendy S.; Heath, Andrew C.; Montgomery, Grant W.; Martin, Nicholas G.			Common Variants in the Trichohyalin Gene Are Associated with Straight Hair in Europeans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INVOLUCRIN GENE; POLYMORPHISM; LINKAGE; PROTEIN; HERITABILITY; CURLINESS; SELECTION; KERATIN; REGION; CDKN2A	Hair morphology is highly differentiated between populations and among people of European ancestry. Whereas hair morphology in East Asian populations has been studied extensively, relatively little is known about the genetics of this trait in Europeans. We performed a genome-wide association scan for hair morphology (straight, wavy curly) in three Australian samples of European descent. All three samples showed evidence of association implicating the Trichohyalin gene (TCHH), which is expressed in the developing inner root sheath of the hair follicle, and explaining similar to 6% of variance (p 1.5 x 10(-31)). These variants are at their highest frequency in Northern Europeans, paralleling the distribution of the straight-hair EDAR variant in Asian populations.	[Medland, Sarah E.; Nyholt, Dale R.; Painter, Jodie N.; McEvoy, Brian P.; McRae, Allan F.; Zhu, Gu; Gordon, Scott D.; Ferreira, Manuel A. R.; Wright, Margaret J.; Henders, Anjali K.; Campbell, Megan J.; Duffy, David L.; Hansell, Narelle K.; Macgregor, Stuart; Montgomery, Grant W.; Martin, Nicholas G.] Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [Slutske, Wendy S.] Univ Missouri, Columbia, MO 65211 USA; [Heath, Andrew C.] Washington Univ, Sch Med, St Louis, MO 63110 USA	QIMR Berghofer Medical Research Institute; University of Missouri System; University of Missouri Columbia; Washington University (WUSTL)	Medland, SE (corresponding author), Queensland Inst Med Res, Brisbane, Qld 4029, Australia.	sarahme@qimr.edu.au	Medland, Sarah/AAT-7595-2020; Wright, Margaret Jane/A-4560-2016; Painter, Jodie N/AAC-6332-2019; Duffy, David/B-7392-2013; MacGregor, Stuart/C-6442-2009; Montgomery, Grant/B-7148-2008; McRae, Allan/J-2644-2014; Henders, Anjali/E-3126-2017; Ferreira, Manuel/D-3609-2013; Nyholt, Dale/J-3174-2017	Medland, Sarah/0000-0003-1382-380X; Wright, Margaret Jane/0000-0001-7133-4970; Painter, Jodie N/0000-0002-4992-2458; Martin, Nicholas/0000-0003-4069-8020; Duffy, David/0000-0001-7227-632X; Gordon, Scott/0000-0001-7623-328X; MacGregor, Stuart/0000-0001-6731-8142; Hansell, Narelle/0000-0002-8229-9741; Montgomery, Grant/0000-0002-4140-8139; McRae, Allan/0000-0001-5286-5485; Henders, Anjali/0000-0003-3672-1451; Campbell, Megan/0000-0002-6056-6140; Ferreira, Manuel/0000-0001-9059-1825; Nyholt, Dale/0000-0001-7159-3040	Australian National Health and Medical Research Council [241944, 339462, 389927, 389875, 389891, 389892, 389938, 442915, 442981, 496739, 552485, 552498]; Australian Research Council [A7960034, A79906588, A79801419, DP0770096, DP0212016, DP0343921]; FP-S GenomEUtwin Project [QLG2-CT-2002-01254]; U.S. National Institutes of Health (NIH) [AA07535, AA10248, AA13320, AA13321, AA13326, AA14041, MH66206]; Netherlands Scientific Organization [NWO 480-05-003]; National Health and Medical Research Council (NHMRC); NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013320, R01AA007535, R01AA013321, R01AA014041, R01AA013326] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); FP-S GenomEUtwin Project; U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Scientific Organization; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank the twins and their families for their participation. We also thank Dixie Statham, Ann Eldridge, Marlene Grace, Kerrie McAloney (sample collection); Lisa Bowdler, Steven Crooks (DNA processing); David Smyth, Harry Beeby, and Daniel Park (IT support). Funding was provided by the Australian National Health and Medical Research Council (241944, 339462, 389927, 389875, 389891, 389892, 389938, 442915, 442981, 496739, 552485, 552498), the Australian Research Council (A7960034, A79906588, A79801419, DP0770096, DP0212016, DP0343921), the FP-S GenomEUtwin Project (QLG2-CT-2002-01254), and the U.S. National Institutes of Health (NIH grants AA07535, AA10248, AA13320, AA13321, AA13326, AA14041, MH66206). A portion of the genotyping on which this study was based (Illumina 370K scans on 4300 individuals) was carried out at the Center for Inherited Disease Research, Baltimore (CIDR), through an access award to our late colleague Dr. Richard Todd (Psychiatry, Washington University School of Medicine, St Louis). Statistical analyses were carried out on the Genetic Cluster Computer, which is financially supported by the Netherlands Scientific Organization (NWO 480-05-003). S.E.M., D.R.N., A.F.M., M.A.R.F., S.M., D.L.D., and G.W.M. are supported by the National Health and Medical Research Council (NHMRC) Fellowship Scheme.	Adaimy L, 2007, AM J HUM GENET, V81, P821, DOI 10.1086/520064; Chernova OF, 2006, BIOL BULL+, V33, P43, DOI 10.1134/S1062359006010067; DJIAN P, 1995, AM J HUM GENET, V56, P1367; Duffy DL, 2007, AM J HUM GENET, V80, P241, DOI 10.1086/510885; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; FIETZ MJ, 1993, J CELL BIOL, V121, P855, DOI 10.1083/jcb.121.4.855; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fujimoto A, 2008, HUM MOL GENET, V17, P835, DOI 10.1093/hmg/ddm355; Fujimoto A, 2009, J HUM GENET, V54, P461, DOI 10.1038/jhg.2009.61; Hansell NK, 2008, TWIN RES HUM GENET, V11, P287, DOI 10.1375/twin.11.3.287; LEE SC, 1993, J BIOL CHEM, V268, P12164; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Loussouarn G, 2007, INT J DERMATOL, V46, P2, DOI 10.1111/j.1365-4632.2007.03453.x; McLaren RJ, 1997, MAMM GENOME, V8, P938, DOI 10.1007/s003359900616; Medland SE, 2009, TWIN RES HUM GENET, V12, P514, DOI 10.1375/twin.12.5.514; Neale M.C.C.L., 2013, METHODOLOGY GENETIC, V67, DOI DOI 10.1007/978-94-015-8018-2; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Shriver Mark D, 2004, Hum Genomics, V1, P274; Stadtman ER, 2003, ANTIOXID REDOX SIGN, V5, P577, DOI 10.1089/152308603770310239; Sturm RA, 2008, AM J HUM GENET, V82, P424, DOI 10.1016/j.ajhg.2007.11.005; Thibaut S, 2007, INT J DERMATOL, V46, P7, DOI 10.1111/j.1365-4632.2007.03454.x; URQUHART A, 1993, AM J HUM GENET, V53, P279; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Zhu G, 1999, AM J HUM GENET, V65, P483, DOI 10.1086/302494; Zhu G, 2007, EUR J HUM GENET, V15, P94, DOI 10.1038/sj.ejhg.5201729	29	188	193	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 13	2009	85	5					750	755		10.1016/j.ajhg.2009.10.009	http://dx.doi.org/10.1016/j.ajhg.2009.10.009			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	521JH	19896111	Bronze, Green Published			2022-12-18	WOS:000271916500023
J	Schumacher, J; Anthoni, H; Dahdouh, F; Konig, IR; Hillmer, AM; Kluck, N; Manthey, M; Plume, E; Warnke, A; Remschmidt, H; Hulsmann, J; Cichon, S; Lindgren, CM; Propping, P; Zucchelli, M; Ziegler, A; Peyrard-Janvid, M; Schulte-Korne, G; Nothen, MM; Kere, J				Schumacher, J; Anthoni, H; Dahdouh, F; Konig, IR; Hillmer, AM; Kluck, N; Manthey, M; Plume, E; Warnke, A; Remschmidt, H; Hulsmann, J; Cichon, S; Lindgren, CM; Propping, P; Zucchelli, M; Ziegler, A; Peyrard-Janvid, M; Schulte-Korne, G; Nothen, MM; Kere, J			Strong genetic evidence of DCDC2 as a susceptibility gene for dyslexia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUANTITATIVE-TRAIT LOCUS; CHROMOSOME 6P INFLUENCES; GENOTYPE RELATIVE RISKS; DEVELOPMENTAL DYSLEXIA; READING-DISABILITY; CONFIDENCE-INTERVALS; CANDIDATE-GENE; ASSOCIATION; LINKAGE; DISEQUILIBRIUM	We searched for linkage disequilibrium (LD) in 137 triads with dyslexia, using markers that span the most-replicated dyslexia susceptibility region on 6p21-p22, and found association between the disease and markers within the VMP/DCDC2/KAAG1 locus. Detailed refinement of the LD region, involving sequencing and genotyping of additional markers, showed significant association within DCDC2 in single-marker and haplotype analyses. The association appeared to be strongest in severely affected patients. In a second step, the study was extended to include an independent sample of 239 triads with dyslexia, in which the association-in particular, with the severe phenotype of dyslexia-was confirmed. Our expression data showed that DCDC2, which contains a doublecortin homology domain that is possibly involved in cortical neuron migration, is expressed in the fetal and adult CNS, which-together with the hypothesized protein function- is in accordance with findings in dyslexic patients with abnormal neuronal migration and maturation.	Univ Bonn, Inst Human Genet, D-53111 Bonn, Germany; Univ Bonn, Dept Genom, Life & Brain Ctr, D-53111 Bonn, Germany; Karolinska Inst, Clin Res Ctr, Stockholm, Sweden; Novum, Dept Biosci, Stockholm, Sweden; Univ Hosp Schleswig Holstein, Inst Med Biometry & Stat, Lubeck, Germany; Univ Wurzburg, Dept Child & Adolesent Psychiat, Wurzburg, Germany; Univ Marburg, Dept Child & Adolesent Psychiat & Psychotherapy, Marburg, Germany; Univ Helsinki, Dept Med Genet, Helsinki, Finland	University of Bonn; University of Bonn; Karolinska Institutet; Karolinska Institutet; University of Kiel; Schleswig Holstein University Hospital; University of Wurzburg; Philipps University Marburg; University of Helsinki	Schumacher, J (corresponding author), Univ Bonn, Inst Human Genet, Wilhelmstr 31, D-53111 Bonn, Germany.	johannes.schumacher@uni-bonn.de	Cichon, Sven/B-9618-2014; Hillmer, Axel M/N-2927-2014; Hillmer, Axel M/B-7485-2015; Schumacher, Johannes/F-4970-2015; Cichon, Sven/H-8803-2013; Schulte-Körne, Gerd/AAI-4828-2021; Nöthen, Markus/B-2027-2009; Kere, Juha/A-9179-2008; Kere, Juha/AAX-9117-2021; König, Inke R/A-4544-2009; Ziegler, Andreas/G-4246-2012	Cichon, Sven/0000-0002-9475-086X; Hillmer, Axel M/0000-0002-3381-7266; Hillmer, Axel M/0000-0002-3381-7266; Schumacher, Johannes/0000-0001-9217-6457; Cichon, Sven/0000-0002-9475-086X; Schulte-Körne, Gerd/0000-0002-9960-1572; Nöthen, Markus/0000-0002-8770-2464; Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; König, Inke R/0000-0003-0504-6465; Lindgren, Cecilia/0000-0002-4903-9374; Ziegler, Andreas/0000-0002-8386-5397	NCRR NIH HHS [P41 RR003655, RR03655] Funding Source: Medline; Wellcome Trust [090532] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; CARDON LR, 1994, SCIENCE, V266, P276, DOI 10.1126/science.7939663; Cope N, 2005, AM J HUM GENET, V76, P581, DOI 10.1086/429131; Deffenbacher KE, 2004, HUM GENET, V115, P128, DOI 10.1007/s00439-004-1126-6; Demonet JF, 2004, LANCET, V363, P1451, DOI 10.1016/S0140-6736(04)16106-0; DENCKLA M B, 1974, Cortex, V10, P186; Dilling H, 1991, INT CLASSIFICATION M; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Fisher SE, 1999, AM J HUM GENET, V64, P146, DOI 10.1086/302190; Francks C, 2004, AM J HUM GENET, V75, P1046, DOI 10.1086/426404; Franke D, 2005, HUM HERED, V60, P81, DOI 10.1159/000088528; Gayan J, 1999, AM J HUM GENET, V64, P157, DOI 10.1086/302191; Grigorenko EL, 2000, AM J HUM GENET, V66, P715, DOI 10.1086/302755; Grigorenko EL, 2003, AM J MED GENET B, V118B, P89, DOI 10.1002/ajmg.b.10032; Grigorenko EL, 1997, AM J HUM GENET, V60, P27; Kaplan DE, 2002, AM J HUM GENET, V70, P1287, DOI 10.1086/340449; Katusic SK, 2001, MAYO CLIN PROC, V76, P1081, DOI 10.4065/76.11.1081; Landerl K., 1997, SLRT SALZBURGER LESE; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Rabinowitz D, 1997, HUM HERED, V47, P342, DOI 10.1159/000154433; Rutter M, 2004, JAMA-J AM MED ASSOC, V291, P2007, DOI 10.1001/jama.291.16.2007; Scherag A, 2002, HUM HERED, V54, P210, DOI 10.1159/000070666; Schulte-Korne G, 2001, Z KINDER JUG-PSYCH, V29, P113, DOI 10.1024//1422-4917.29.2.113; SchulteKorne G, 1996, J CHILD PSYCHOL PSYC, V37, P817, DOI 10.1111/j.1469-7610.1996.tb01477.x; Schultz JE, 1998, IEEE SOFTWARE, V15, P63, DOI 10.1109/52.676742; SCHUMACHER J, 2005, J NEURAL TRANSM; Spielman RS, 1996, AM J HUM GENET, V59, P983; Unnewehr S, 1995, KINDER DIPS DIAGNOST; Wei RH, 1997, GRUNDINTELLIGENZTEST; WEISS RH, 1998, GRUNDINTELLIGENZTES; Willcutt EG, 2002, AM J MED GENET, V114, P260, DOI 10.1002/ajmg.10205; Ziegler A, 2005, HUM HERED, V59, P136, DOI 10.1159/000085572	32	188	201	0	17	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2006	78	1					52	62		10.1086/498992	http://dx.doi.org/10.1086/498992			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	993CN	16385449	Green Published, Bronze			2022-12-18	WOS:000233930400006
J	Brody, LC; Conley, M; Cox, C; Kirke, PN; McKeever, MP; Mills, JL; Molloy, AM; O'Leary, VB; Parle-McDermott, A; Scott, JM; Swanson, DA				Brody, LC; Conley, M; Cox, C; Kirke, PN; McKeever, MP; Mills, JL; Molloy, AM; O'Leary, VB; Parle-McDermott, A; Scott, JM; Swanson, DA			A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: Report of the birth defects research group	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEHYDROGENASE-METHENYLTETRAHYDROFOLATE-CYCLOHYDROLASE; 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE GENE; SPINA-BIFIDA; FORMYLTETRAHYDROFOLATE SYNTHETASE; THERMOLABILE VARIANT; SACCHAROMYCES-CEREVISIAE; TURKISH PATIENTS; C677T MUTATION; FOLATE LEVELS; MTHFR GENE	Women who take folic acid periconceptionally reduce their risk of having a child with a neural tube defect (NTD) by >50%. A variant form of methylenetetrahydrofolate reductase (MTHFR) (677C-->T) is a known risk factor for NTDs, but the prevalence of the risk genotype explains only a small portion of the protective effect of folic acid. This has prompted the search for additional NTD-associated variants in folate-metabolism enzymes. We have analyzed five potential single-nucleotide polymorphisms (SNPs) in the cytoplasmic, nicotinamide adenine dinucleotide phosphate-dependent, trifunctional enzyme methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase (MTHFD1) for an association with NTDs in the Irish population. One SNP, R653Q, in this gene appears to be associated with NTD risk. We observed an excess of the MTHFD1 "Q" allele in the mothers of children with NTD, compared with control individuals. This excess was driven by the overrepresentation of QQ homozygotes in the mothers of children with NTD compared with control individuals (odds ratio 1.52 [95% confidence interval 1.16-1.99], P=.003). We conclude that genetic variation in the MTHFD1 gene is associated with an increase in the genetically determined risk that a woman will bear a child with NTD and that the gene may be associated with decreased embryo survival.	Univ Dublin Trinity Coll, Dept Biochem, Dublin 2, Ireland; Univ Dublin Trinity Coll, Dept Clin Med, Dublin 2, Ireland; Univ Dublin Trinity Coll, Child Hlth Epidemiol Div, Hlth Res Board, Dublin 2, Ireland; NICHHD, Genome Technol Branch, NHGRI, NIH, Bethesda, MD 20892 USA; NICHHD, Div Epidemiol Stat & Prevent Res, NIH, Bethesda, MD 20892 USA	Trinity College Dublin; Trinity College Dublin; Health Research Board - Ireland; Trinity College Dublin; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Parle-McDermott, A (corresponding author), Univ Dublin Trinity Coll, Dept Biochem, Dublin 2, Ireland.			Mills, James/0000-0003-4496-332X; Molloy, Anne/0000-0002-1688-9049; O'Leary, Valerie/0000-0003-1171-9830	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD002502] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD002502] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000167, Z01HG000167] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Akar N, 1999, ACTA HAEMATOL-BASEL, V102, P199, DOI 10.1159/000041015; BARLOWE CK, 1990, MOL CELL BIOL, V10, P5679, DOI 10.1128/MCB.10.11.5679; BARLOWE CK, 1989, BIOCHEMISTRY-US, V28, P2099, DOI 10.1021/bi00431a020; Boduroglu K, 1999, J CHILD NEUROL, V14, P159, DOI 10.1177/088307389901400305; Botto LD, 2000, AM J EPIDEMIOL, V151, P862; Christensen B, 1999, AM J MED GENET, V84, P151, DOI 10.1002/(SICI)1096-8628(19990521)84:2<151::AID-AJMG12>3.0.CO;2-T; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; DALY LE, 1995, JAMA-J AM MED ASSOC, V274, P1698, DOI 10.1001/jama.274.21.1698; de Franchis R, 1998, J MED GENET, V35, P1009, DOI 10.1136/jmg.35.12.1009; Elwood J. M., 1992, EPIDEMIOLOGY CONTROL; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Gelineau-van Waes J, 2001, Semin Pediatr Neurol, V8, P160, DOI 10.1053/spen.2001.26449; Hol FA, 1998, CLIN GENET, V53, P119; HUM DW, 1988, J BIOL CHEM, V263, P15946; ITALIANO C, 1991, GENOMICS, V10, P1073, DOI 10.1016/0888-7543(91)90201-O; KANG SS, 1988, METABOLISM, V37, P611, DOI 10.1016/0026-0495(88)90076-5; KIRKE PN, 1993, Q J MED, V86, P703; Koch MC, 1998, EUR J PEDIATR, V157, P487, DOI 10.1007/s004310050860; Labuda D, 2002, AM J HUM GENET, V71, P193, DOI 10.1086/341345; Lucock M, 2000, MOL GENET METAB, V71, P121, DOI 10.1006/mgme.2000.3027; Melvin EC, 2000, PEDIATR NEUROSURG, V32, P1, DOI 10.1159/000028889; MILLS JL, 1995, LANCET, V345, P149, DOI 10.1016/S0140-6736(95)90165-5; Molloy AM, 1997, LANCET, V349, P1591, DOI 10.1016/S0140-6736(96)12049-3; Mornet E, 1997, HUM GENET, V100, P512, DOI 10.1007/s004390050544; Ou CY, 1996, AM J MED GENET, V63, P610, DOI 10.1002/(SICI)1096-8628(19960628)63:4<610::AID-AJMG15>3.3.CO;2-Y; Papapetrou C, 1996, LANCET, V348, P58, DOI 10.1016/S0140-6736(05)64382-6; Schaid DJ, 1999, GENET EPIDEMIOL, V16, P250, DOI 10.1002/(SICI)1098-2272(1999)16:3<250::AID-GEPI2>3.0.CO;2-T; SCOTT JM, 1994, CIBA F SYMP, V181, P180; Scott J, 1994, ESSAYS BIOCHEM, V28, P63; Shaw GM, 1998, AM J EPIDEMIOL, V148, P30, DOI 10.1093/oxfordjournals.aje.a009555; Shields DC, 1999, AM J HUM GENET, V64, P1045, DOI 10.1086/302310; Speer MC, 1997, NEUROGENETICS, V1, P149, DOI 10.1007/s100480050022; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; VANDERPUT NMJ, 1995, LANCET, V346, P1070, DOI 10.1016/S0140-6736(95)91743-8; WALD N, 1991, LANCET, V338, P131; Weinberg CR, 1998, AM J HUM GENET, V62, P969, DOI 10.1086/301802; Weitkamp LR, 1998, LANCET, V351, P1554, DOI 10.1016/S0140-6736(05)61119-1; West MG, 1996, BIOCHEMISTRY-US, V35, P3122, DOI 10.1021/bi952713d; WHITEHEAD AS, 1995, QJM-MON J ASSOC PHYS, V88, P763	39	188	196	0	7	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2002	71	5					1207	1215		10.1086/344213	http://dx.doi.org/10.1086/344213			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	609CD	12384833	Green Published, Bronze			2022-12-18	WOS:000178884300020
J	Qamar, R; Ayub, Q; Mohyuddin, A; Helgason, A; Mazhar, K; Mansoor, A; Zerjal, T; Tyler-Smith, C; Mehdi, SQ				Qamar, R; Ayub, Q; Mohyuddin, A; Helgason, A; Mazhar, K; Mansoor, A; Zerjal, T; Tyler-Smith, C; Mehdi, SQ			Y-chromosomal DNA variation in Pakistan	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HAPLOTYPES; MICROSATELLITE; POPULATIONS; POLYMORPHISMS; INSERTION; NETWORKS; LINEAGE; ORIGIN	Eighteen binary polymorphisms and 16 multiallelic, short-tandem-repeat (STR) loci from the nonrecombining portion of the human Y chromosome were typed in 718 male subjects belonging to 12 ethnic groups of Pakistan. These identified 11 stable haplogroups and 503 combination binary marker/STR haplotypes. Haplogroup frequencies were generally similar to those in neighboring geographical areas, and the Pakistani populations speaking a language isolate (the Burushos), a Dravidian language (the Brahui), or a Sino-Tibetan language (the Balti) resembled the Indo-European-speaking majority. Nevertheless, median-joining networks of haplotypes revealed considerable substructuring of Y variation within Pakistan, with many populations showing distinct clusters of haplotypes. These patterns can be accounted for by a common pool of Y lineages, with substantial isolation between populations and drift in the smaller ones. Few comparative genetic or historical data are available for most populations, but the results can be compared with oral traditions about origins. The Y data support the well-established origin of the Parsis in Iran, the suggested descent of the Hazaras from Genghis Khan's army, and the origin of the Negroid Makrani in Africa, but do not support traditions of Tibetan, Syrian, Greek, or Jewish origins for other populations.	Univ Oxford, Dept Biochem, Canc Res Campaign, Chromosome Mol Biol Grp, Oxford OX1 3QU, England; Dr AQ Khan Res Labs, Biomed & Genet Engn Div, Islamabad, Pakistan; Univ Oxford, Inst Biol Anthropol, Oxford OX1 3QU, England; deCODE Genet, Reykjavik, Iceland	University of Oxford; University of Oxford	Tyler-Smith, C (corresponding author), Univ Oxford, Dept Biochem, Canc Res Campaign, Chromosome Mol Biol Grp, S Parks Rd, Oxford OX1 3QU, England.		qamar, raheel/D-4543-2012; Mehdi, Syed Qasim/L-2385-2015; Qamar, Raheel/G-3355-2015; Helgason, Agnar/K-1522-2015; zerjal, tatiana/AAO-9473-2020	Ayub, Qasim/0000-0003-3291-0917; Helgason, Agnar/0000-0002-8545-3767				AHMAD AKN, 1952, JESUS HEAVEN EARTH; Ayub Q, 2000, Nucleic Acids Res, V28, pe8, DOI 10.1093/nar/28.2.e8; BACKSTROM PC, 1992, SOCIOLINGUISTIC SURV, V2, P3; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BELLEW HW, 1998, ENQUIRY ETHNOGRAPHY; Bellew HW, 1979, RACES AFGHANISTAN; Bergen AW, 1999, ANN HUM GENET, V63, P63, DOI 10.1046/j.1469-1809.1999.6310063.x; Bianchi NO, 1997, AM J PHYS ANTHROPOL, V102, P79; Biddulph John, 1880, TRIBES HINDOO KOOSH; Burton Richard, 1851, SINDH RACES INHABIT, V1st; Caroe Olaf., 1958, THE PATHANS; CASANOVA M, 1985, SCIENCE, V230, P1403, DOI 10.1126/science.2999986; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; DALES GF, 1991, FORGOTTEN CITIES IND, P129; Decker K. D., 1992, SOCIOLINGUISTIC SURV, V5; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; Grimes BF, 1992, ETHNOLOGUE LANGUAGES; HAMMER MF, 1994, MOL BIOL EVOL, V11, P749; Hammer MF, 2000, P NATL ACAD SCI USA, V97, P6769, DOI 10.1073/pnas.100115997; HAMMER MF, 1995, AM J HUM GENET, V56, P951; Hammer MF, 2001, MOL BIOL EVOL, V18, P1189, DOI 10.1093/oxfordjournals.molbev.a003906; Helgason A, 2000, AM J HUM GENET, V67, P697, DOI 10.1086/303046; Hughes-Buller R., 1991, IMPERIAL GAZETTEER I; Hussain J., 1997, HIST PEOPLES PAKISTA; IBBETSON D, 1883, PANJAB CASTES; Jarrige Jean-Francois, 1991, FORGOTTEN CITIES IND, P34; Jobling MA, 2000, TRENDS GENET, V16, P356, DOI 10.1016/S0168-9525(00)02057-6; Karafet TM, 1999, AM J HUM GENET, V64, P817, DOI 10.1086/302282; Kayser M, 2000, AM J HUM GENET, V66, P1580, DOI 10.1086/302905; Kwok C, 1996, J MED GENET, V33, P465, DOI 10.1136/jmg.33.6.465; LONG JC, 1991, GENETICS, V127, P417; MATHIAS N, 1994, HUM MOL GENET, V3, P115, DOI 10.1093/hmg/3.1.115; Mehdi SQ, 1999, GENOMIC DIVERSITY, P83; Mohyuddin A, 2001, FORENSIC SCI INT, V118, P141, DOI 10.1016/S0379-0738(01)00382-6; NANAVUTTY P, 1997, PARSIS; PANDYA A, 1998, IND J HUM GENET, V4, P52; Qamar R, 1999, HUM BIOL, V71, P745; Quddus Syed Abdul, 1990, TRIBAL BALUCHISTAN; Quintana-Murci L, 2001, AM J HUM GENET, V68, P537, DOI 10.1086/318200; ROBERTS DF, 1965, HUM BIOL, V37, P38; Robertson GS, 1896, KAFIRS HINDU KUSH; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Santos FR, 2000, HUM MOL GENET, V9, P421, DOI 10.1093/hmg/9.3.421; Santos FR, 1999, AM J HUM GENET, V64, P619, DOI 10.1086/302242; SANTOS FR, 1999, METHODS TOOLS BIOSCI, P133; Schneider S., 1997, ARLEQUIN VER 1 1 SOF; SEIELSTAD MT, 1994, HUM MOL GENET, V3, P2159; Shinka T, 1999, J HUM GENET, V44, P240, DOI 10.1007/s100380050151; Thomas MG, 1999, HUM GENET, V105, P577, DOI 10.1007/s004390051148; Tyler-Smith C, 1999, GENOMIC DIVERSITY, P65; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; WHITFIELD LS, 1995, NATURE, V378, P379, DOI 10.1038/378379a0; Wilson IJ, 1998, GENETICS, V150, P499; Wolpert Stanley, 2000, NEW HIST INDIA; Young FW, 1996, STAT COMPUTING ENV S, ps207; Zerjal T, 1997, AM J HUM GENET, V60, P1174; Zerjal T, 2001, MOL BIOL EVOL, V18, P1077, DOI 10.1093/oxfordjournals.molbev.a003879	59	188	193	0	8	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2002	70	5					1107	1124		10.1086/339929	http://dx.doi.org/10.1086/339929			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	541XT	11898125	Bronze, Green Published			2022-12-18	WOS:000175012400004
J	Barcellos, LF; Klitz, W; Field, LL; Tobias, R; Bowcock, AM; Wilson, R; Nelson, MP; Nagatomi, J; Thomson, G				Barcellos, LF; Klitz, W; Field, LL; Tobias, R; Bowcock, AM; Wilson, R; Nelson, MP; Nagatomi, J; Thomson, G			Association mapping of disease loci, by use of a pooled DNA genomic screen	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEPENDENT DIABETES-MELLITUS; HAPLOTYPE-RELATIVE-RISK; CLASS-II REGION; LINKAGE DISEQUILIBRIUM; SUSCEPTIBILITY GENES; MULTIPLE-SCLEROSIS; MICROSATELLITE MARKERS; WIDE SEARCH; COMPLEX; POPULATION	Genomic screening to map disease loci by association requires automation, pooling of DNA samples, and 3,000-6,000 highly polymorphic, evenly spaced microsatellite markers. Case-control samples can be used in an initial screen, followed by family-based data to confirm marker associations. Association mapping is relevant to genetic studies of complex diseases in which linkage analysis may be less effective and to cases in which multigenerational data are difficult to obtain, including rare or late-onset conditions and infectious diseases. The method can also be used effectively to follow up and confirm regions identified in linkage studies or to investigate candidate disease loci. Study designs can incorporate disease heterogeneity and interaction effects by appropriate subdivision of samples before screening. Here we report use of pooled DNA amplifications-the accurate determination of marker-disease associations for both case-control and nuclear family-based data-including application of correction methods for stutter artifact and preferential amplification, These issues, combined with a discussion of both statistical power and experimental design to define the necessary requirements for detecting of disease loci while virtually eliminating false positives, suggest the feasibility and efficiency of association mapping using pooled DNA screening.	UNIV CALIF BERKELEY, DEPT INTEGRAT BIOL, BERKELEY, CA 94720 USA; UNIV CALGARY, DEPT MED GENET, CALGARY, AB, CANADA; UNIV TEXAS, SW MED CTR, DEPT PEDIAT, DALLAS, TX USA	University of California System; University of California Berkeley; University of Calgary; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas				Bowcock, Anne/0000-0001-8691-9090	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035326, R01GM056688] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR43177] Funding Source: Medline; NIGMS NIH HHS [GM56688, GM35326] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Antonarakis S. E., 1996, American Journal of Human Genetics, V59, pA210; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; Birch DE, 1996, NATURE, V381, P445, DOI 10.1038/381445a0; Bowcock A. M., 1996, P1454; BOWCOCK AM, 1994, AM J HUM GENET, V54, P79; CARMI R, 1995, HUM MOL GENET, V4, P9, DOI 10.1093/hmg/4.1.9; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; COOPER DN, 1992, ANN MED, V24, P29, DOI 10.3109/07853899209164142; COPEMAN JB, 1995, NAT GENET, V9, P80, DOI 10.1038/ng0195-80; Cornelis F., 1996, American Journal of Human Genetics, V59, pA215; Cox DR, 1996, NAT GENET, V12, P117, DOI 10.1038/ng0296-117; COX NJ, 1988, AM J HUM GENET, V42, P167; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Ebers GC, 1996, NAT GENET, V13, P472, DOI 10.1038/ng0896-472; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Field L. Leigh, 1994, American Journal of Human Genetics, V55, pA347; FIELD LL, 1994, NAT GENET, V8, P189, DOI 10.1038/ng1094-189; Field LL, 1996, GENOMICS, V33, P1, DOI 10.1006/geno.1996.0153; Freimer NB, 1996, AM J MED GENET, V67, P254, DOI 10.1002/(SICI)1096-8628(19960531)67:3<254::AID-AJMG3>3.0.CO;2-N; FRIEDMAN LS, 1995, AM J HUM GENET, V57, P1284; GOTTESMAN MM, 1994, PREV MED, V23, P591, DOI 10.1006/pmed.1994.1094; GUYER M, 1992, SCIENCE, V258, P67; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; Haines JL, 1996, NAT GENET, V13, P469, DOI 10.1038/ng0896-469; HANAUER A, 1990, AM J HUM GENET, V46, P133; Hanis CL, 1996, NAT GENET, V13, P161, DOI 10.1038/ng0696-161; HARLEY HG, 1991, AM J HUM GENET, V49, P68; HASHIMOTO L, 1994, NATURE, V371, P161, DOI 10.1038/371161a0; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HEDRICK PW, 1994, AM NAT, V143, P945, DOI 10.1086/285643; JAZWINSKA EC, 1993, AM J HUM GENET, V53, P347; JORDE LB, 1994, AM J HUM GENET, V54, P884; KARVONEN M, 1993, DIABETOLOGIA, V36, P883, DOI 10.1007/BF02374468; KLITZ W, 1994, AM J HUM GENET, V54, P497; KLITZ W, 1995, AM J HUM GENET, V57, P1436; KLITZ W, 1992, EVOL BIOL, V26, P35; KNAPP M, 1993, AM J HUM GENET, V52, P1085; KOBAYASHI H, 1995, HUM GENET, V95, P483; Kuokkanen S, 1996, NAT GENET, V13, P477, DOI 10.1038/ng0896-477; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LERNER TJ, 1994, AM J HUM GENET, V54, P88; Luo DF, 1996, HUM MOL GENET, V5, P693, DOI 10.1093/hmg/5.5.693; Mckusick V.A., 1994, MENDELIAN INHERITANC; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; NEPOM GT, 1991, ANNU REV IMMUNOL, V9, P493; Nystuen A, 1996, HUM MOL GENET, V5, P525, DOI 10.1093/hmg/5.4.525; OTT J, 1989, GENET EPIDEMIOL, V6, P127, DOI 10.1002/gepi.1370060124; Ott J., 1991, ANAL HUMAN GENETIC L; OTT J, 1991, STAT PROPERTIES HAPL; OWERBACH D, 1995, DIABETES, V44, P132, DOI 10.2337/diabetes.44.1.132; OZELIUS LJ, 1992, AM J HUM GENET, V50, P619; PERLIN MW, 1995, AM J HUM GENET, V57, P1199; POUND SE, 1992, J MED GENET, V29, P247, DOI 10.1136/jmg.29.4.247; PUERS C, 1993, AM J HUM GENET, V53, P953; RAHACHOWDHURY R, 1995, HUM MOL GENET, V4, P1869, DOI 10.1093/hmg/4.10.1869; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sawcer S, 1996, NAT GENET, V13, P464, DOI 10.1038/ng0896-464; Schaid DJ, 1996, GENET EPIDEMIOL, V13, P423, DOI 10.1002/(SICI)1098-2272(1996)13:5<423::AID-GEPI1>3.0.CO;2-3; Scott DA, 1996, AM J HUM GENET, V59, P385; SHEFFIELD VC, 1995, CURR OPIN GENET DEV, V5, P335, DOI 10.1016/0959-437X(95)80048-4; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; Sheffield VC, 1996, NAT GENET, V12, P424, DOI 10.1038/ng0496-424; SKRAASTAD MI, 1992, AM J HUM GENET, V51, P730; SMITH JR, 1995, GENOME RES, V5, P312, DOI 10.1101/gr.5.3.312; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Taylor BA, 1996, GENOMICS, V34, P389, DOI 10.1006/geno.1996.0302; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; THOMSON G, 1989, GENET EPIDEMIOL, V6, P155, DOI 10.1002/gepi.1370060129; THOMSON G, 1995, AM J HUM GENET, V57, P474; THOMSON G, 1977, GENETICS, V85, P753; THOMSON G, 1995, AM J HUM GENET, V57, P487; TIWARI JL, 1985, HLA DISEASE ASS; Todd JA, 1996, HUM MOL GENET, V5, P1443, DOI 10.1093/hmg/5.Supplement_1.1443; WATKINS WS, 1994, AM J HUM GENET, V55, P348; WEEKS DE, 1995, TRENDS GENET, V11, P513, DOI 10.1016/S0168-9525(00)89163-5; WEIR BS, 1989, PROG CLIN BIOL RES, V329, P81; WEISS KM, 1993, GENETIC VARIATION HU, P180; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	80	188	207	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1997	61	3					734	747		10.1086/515512	http://dx.doi.org/10.1086/515512			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XY523	9326338	Green Published, Bronze			2022-12-18	WOS:A1997XY52300030
J	Motulsky, AG				Motulsky, AG			Nutritional ecogenetics: Homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							CORONARY-ARTERY DISEASE; THERMOLABILE METHYLENETETRAHYDROFOLATE REDUCTASE; RISK FACTOR; HOMOCYSTINURIA		UNIV WASHINGTON,DEPT GENET,SEATTLE,WA 98195	University of Washington; University of Washington Seattle	Motulsky, AG (corresponding author), UNIV WASHINGTON,DEPT MED,BOX 356423,SEATTLE,WA 98195, USA.							BOERS GHJ, 1985, NEW ENGL J MED, V313, P709, DOI 10.1056/NEJM198509193131201; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; BOUSHEY CJ, IN PRESS INT C HOMOC; CLARKE R, 1991, NEW ENGL J MED, V324, P1149, DOI 10.1056/NEJM199104253241701; ENGBERSEN AMT, 1995, AM J HUM GENET, V56, P142; FENTON WA, 1995, METABOLIC MOL BASES, P3129; FROSST P, 1995, NAT GENET, V7, P195; GARTLER SM, 1981, P NATL ACAD SCI-BIOL, V78, P1916, DOI 10.1073/pnas.78.3.1916; GOYETTE P, 1994, NAT GENET, V7, P195, DOI 10.1038/ng0694-195; KANG SS, 1988, METABOLISM, V37, P611, DOI 10.1016/0026-0495(88)90076-5; KANG SS, 1988, AM J HUM GENET, V43, P414; KANG SS, 1991, AM J HUM GENET, V48, P536; KANG SS, 1993, CIRCULATION, V88, P1463, DOI 10.1161/01.CIR.88.4.1463; Kluijtmans LAJ, 1996, AM J HUM GENET, V58, P35; KLUIJTMANS LAJ, 1995, HUM GENET, V96, P249, DOI 10.1007/BF00207394; KOZICH V, 1995, HUM MOL GENET, V4, P623, DOI 10.1093/hmg/4.4.623; MCCULLY KS, 1969, AM J PATHOL, V56, P111; MILLS JL, 1995, LANCET, V345, P149, DOI 10.1016/S0140-6736(95)90165-5; Mudd S.H., 1995, METABOLIC MOL BASES, V1, P1279; MUDD SH, 1981, AM J HUM GENET, V33, P883; Rosenblatt DS., 1995, METABOLIC MOL BASES, P3111; Rozen R., 1995, American Journal of Human Genetics, V57, pA250; Savage D.G., 1995, FOLATE HLTH DIS, V1st, P237; VANDERPUT, 1995, LANCET, V356, P1070; WHITEHEAD AS, 1994, METHIONINE METABOLIS, P79; WILCKEN DEL, 1976, J CLIN INVEST, V57, P1079, DOI 10.1172/JCI108350; Willet W. C., 1990, NUTRITIONAL EPIDEMIO, P341; 1992, MMWR-MORBID MORTAL W, V41, P1	28	188	199	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1996	58	1					17	20						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TL697	8554053				2022-12-18	WOS:A1996TL69700004
J	FURLONG, CE; RICHTER, RJ; SEIDEL, SL; MOTULSKY, AG				FURLONG, CE; RICHTER, RJ; SEIDEL, SL; MOTULSKY, AG			ROLE OF GENETIC-POLYMORPHISM OF HUMAN-PLASMA PARAOXONASE ARYLESTERASE IN HYDROLYSIS OF THE INSECTICIDE METABOLITES CHLORPYRIFOS OXON AND PARAOXON	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WASHINGTON,CTR INHERITED DIS,FACHBEREICH GENET,SEATTLE,WA 98195; UNIV WASHINGTON,CHARLES A DANA PROGRAM GENET & ENVIRONM HLTH,SEATTLE,WA 98195	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	FURLONG, CE (corresponding author), UNIV WASHINGTON,CTR INHERITED DIS,DEPT MED,DIV MED GENET,RG-25,SEATTLE,WA 98195, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM015253] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-15253] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEAUDET A, 1986, AM J HUM GENET, V39, P681; BIGGS AI, 1954, T FARADAY SOC, V50, P800, DOI 10.1039/tf9545000800; CARROCIAMPI G, 1981, CAN J PHYSIOL PHARM, V59, P904, DOI 10.1139/y81-138; ECKERSON HW, 1983, AM J HUM GENET, V35, P214; ECKERSON HW, 1983, AM J HUM GENET, V35, P1126; EIBERG H, 1985, CLIN GENET, V28, P265; EIBERG H, 1981, ANN HUM GENET, V45, P323, DOI 10.1111/j.1469-1809.1981.tb00345.x; GELDMACH.M, 1969, ARCH TOXIKOL, V25, P223; GELDMACHERVONMALLINCKRODT M, 1979, HUM GENET, V50, P313, DOI 10.1007/BF00399398; KALOW W, 1957, CAN J BIOCHEM PHYS, V35, P1305; KITCHEN BJ, 1973, BIOCHEM J, V135, P93, DOI 10.1042/bj1350093; KRISCH K, 1968, Z KLIN CHEM KLIN BIO, V6, P41; LADU BN, 1986, ANN BIOL CLIN-PARIS, V44, P369; MUELLER RF, 1983, AM J HUM GENET, V35, P393; NEILSEN A, 1986, CLIN GENET, V30, P41; NOLAN RJ, 1984, TOXICOL APPL PHARM, V73, P8, DOI 10.1016/0041-008X(84)90046-2; ORTIGOZAFERADO J, 1984, AM J HUM GENET, V36, P295; PLAYFER JR, 1976, J MED GENET, V13, P337, DOI 10.1136/jmg.13.5.337; SULTATOS LG, 1985, J PHARMACOL EXP THER, V232, P624; ZACH R, 1974, COMP BIOCH PHYSL, V48, P427	20	188	195	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1988	43	3					230	238						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	P8841	2458038				2022-12-18	WOS:A1988P884100002
J	SIMON, M; LEMIGNON, L; FAUCHET, R; YAOUANQ, J; DAVID, V; EDAN, G; BOUREL, M				SIMON, M; LEMIGNON, L; FAUCHET, R; YAOUANQ, J; DAVID, V; EDAN, G; BOUREL, M			A STUDY OF 609 HLA HAPLOTYPES MARKING FOR THE HEMOCHROMATOSIS GENE - (1) MAPPING OF THE GENE NEAR THE HLA-A LOCUS AND CHARACTERS REQUIRED TO DEFINE A HETEROZYGOUS POPULATION AND (2) HYPOTHESIS CONCERNING THE UNDERLYING CAUSE OF HEMOCHROMATOSIS-HLA ASSOCIATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CHU RENNES, MED CLIN B, F-35000 RENNES, FRANCE; CHU RENNES, CTR REG TRANSFUS SANGUINE, F-35000 RENNES, FRANCE; CHU RENNES, BIOCHIM LAB B, F-35000 RENNES, FRANCE; CHU RENNES, MED CLIN A, F-35000 RENNES, FRANCE	CHU Rennes; CHU Rennes; CHU Rennes; CHU Rennes								ALPER CA, 1972, J EXP MED, V135, P68, DOI 10.1084/jem.135.1.68; BOMFORD A, 1977, LANCET, V1, P327; BREGMAN H, 1980, LANCET, V2, P882; COLOMBO M, 1983, AM J CLIN PATHOL, V80, P499, DOI 10.1093/ajcp/80.4.499; DADONE MM, 1982, AM J CLIN PATHOL, V78, P196, DOI 10.1093/ajcp/78.2.196; DAUSSET J, 1978, TISSUE ANTIGENS, V12, P297, DOI 10.1111/j.1399-0039.1978.tb01337.x; DAVID V, 1986, HUM GENET, V74, P113, DOI 10.1007/BF00282073; DEMIGUEL E, 1985, J RHEUMATOL, V12, P634; DORAN TJ, 1981, HUM IMMUNOL, V2, P191, DOI 10.1016/0198-8859(81)90011-2; DYRSZKA H, 1978, GASTROENTEROLOGY, V75, P555; EDWARDS CQ, 1982, CLIN HAEMATOL, V11, P411; EDWARDS CQ, 1981, PROG HEMATOL, V12, P43; FAUCHET R, 1982, THESIS U PARIS; GOMEZ E, 1984, NEPHRON, V36, P106, DOI 10.1159/000183127; GOMEZ E, 1981, LANCET, V1, P836; HENKE J, 1978, Z IMMUNITATSFORSCH, V154, P41, DOI 10.1016/S0340-904X(78)80057-8; KRAVITZ K, 1979, AM J HUM GENET, V31, P601; KUHNL P, 1978, TISSUE ANTIGENS, V12, P398, DOI 10.1111/j.1399-0039.1978.tb01350.x; KUNTZ BME, 1981, LANCET, V1, P155; LALOUEL JM, 1985, AM J HUM GENET, V37, P700; LAUKENS P, 1978, GASTROENTEROLOGY, V74, P1351; LEMIGNON L, 1983, CLIN GENET, V24, P171; LEMIGNON L, 1982, THESIS FM RENNES REN; LESAGE GD, 1983, GASTROENTEROLOGY, V84, P1471; LIPINSKI M, 1978, TISSUE ANTIGENS, V11, P471, DOI 10.1111/j.1399-0039.1978.tb01286.x; LLORENTE L, 1980, ARCH DERMATOL RES, V269, P209, DOI 10.1007/BF00406542; MCCARTHY D, 1979, IRISH J MED SCI, V148, P168, DOI 10.1007/BF02938074; Meera Khan P, 1976, Hum Genet, V34, P53; MILMAN N, 1985, DAN MED BULL, V32, P262; MITTAL KK, 1968, TRANSPLANTATION, V6, P913, DOI 10.1097/00007890-196811000-00006; MULLERWIEFEL DE, 1981, P EUR DIAL TRANS, V18, P524; PIPERNO A, 1986, J CLIN PATHOL, V39, P125, DOI 10.1136/jcp.39.2.125; RITTER B, 1984, HUM GENET, V68, P62, DOI 10.1007/BF00293874; SADDI R, 1981, TISSUE ANTIGENS, V17, P473; SCHATTENKIRCHNER M, 1983, KLIN WOCHENSCHR, V61, P1199, DOI 10.1007/BF01537431; SCHWARTZ D, 1963, METHODES STATISTIQUE; SHEWAN WG, 1976, BMJ-BRIT MED J, V1, P281, DOI 10.1136/bmj.1.6004.281-b; Simon M, 1980, Prog Med Genet, V4, P135; SIMON M, 1977, NEW ENGL J MED, V297, P1017, DOI 10.1056/NEJM197711102971901; SIMON M, 1974, NOUV PRESSE MED, V4, P1432; SIMON M, 1976, GUT, V17, P332, DOI 10.1136/gut.17.5.332; SIMON M, 1985, BRIT J HAEMATOL, V60, P1, DOI 10.1111/j.1365-2141.1985.tb07379.x; SIMON M, 1981, HLA ENDOCRINE METABO, P291; SIMON M, 1985, SEP EUR IR CLUB M AM; TACCONEGALLUCI M, 1983, C EUROPEAN DIALYSIS; WALTERS JM, 1975, BMJ-BRIT MED J, V4, P520, DOI 10.1136/bmj.4.5995.520-b	46	188	194	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1987	41	2					89	105						17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	J7575	3475981				2022-12-18	WOS:A1987J757500001
J	Heron, SE; Grinton, BE; Kivity, S; Afawi, Z; Zuberi, SM; Hughes, JN; Pridmore, C; Hodgson, BL; Iona, X; Sadleir, LG; Pelekanos, J; Herlenius, E; Goldberg-Stern, H; Bassan, H; Haan, E; Korczyn, AD; Gardner, AE; Corbett, MA; Gecz, J; Thomas, PQ; Mulley, JC; Berkovic, SF; Scheffer, IE; Dibbens, LM				Heron, Sarah E.; Grinton, Bronwyn E.; Kivity, Sara; Afawi, Zaid; Zuberi, Sameer M.; Hughes, James N.; Pridmore, Clair; Hodgson, Bree L.; Iona, Xenia; Sadleir, Lynette G.; Pelekanos, James; Herlenius, Eric; Goldberg-Stern, Hadassa; Bassan, Haim; Haan, Eric; Korczyn, Amos D.; Gardner, Alison E.; Corbett, Mark A.; Gecz, Jozef; Thomas, Paul Q.; Mulley, John C.; Berkovic, Samuel F.; Scheffer, Ingrid E.; Dibbens, Leanne M.			PRRT2 Mutations Cause Benign Familial Infantile Epilepsy and Infantile Convulsions with Choreoathetosis Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMOSOME 16P12-Q12; FEBRILE SEIZURES; LINKAGE; DYSKINESIA; ONSET; LOCUS	Benign familial infantile epilepsy (BFIE) is a self-limited seizure disorder that occurs in infancy and has autosomal-dominant inheritance. We have identified heterozygous mutations in PRRT2, which encodes proline-rich transmembrane protein 2, in 14 of 17 families (82%) affected by BFIE, indicating that PRRT2 mutations are the most frequent cause of this disorder. We also report PRRT2 mutations in five of six (83%) families affected by infantile convulsions and choreoathetosis (ICCA) syndrome, a familial syndrome in which infantile seizures and an adolescent-onset movement disorder, paroxysmal kinesigenic choreoathetosis (PKC), co-occur. These findings show that mutations in PRRT2 cause both epilepsy and a movement disorder. Furthermore, PRRT2 mutations elicit pleiotropy in terms of both age of expression (infancy versus later childhood) and anatomical substrate (cortex versus basal ganglia).	[Grinton, Bronwyn E.; Pelekanos, James; Berkovic, Samuel F.; Scheffer, Ingrid E.] Univ Melbourne, Dept Med, Epilepsy Res Ctr, Heidelberg, Vic 3084, Australia; [Heron, Sarah E.; Hodgson, Bree L.; Iona, Xenia; Dibbens, Leanne M.] Univ S Australia, Sch Pharm & Med Sci, Epilepsy Res Program, Adelaide, SA 5000, Australia; [Kivity, Sara; Goldberg-Stern, Hadassa] Schneider Childrens Med Ctr Israel, IL-49202 Petah Tiqwa, Israel; [Afawi, Zaid; Korczyn, Amos D.] Tel Aviv Univ, IL-69978 Tel Aviv, Israel; [Zuberi, Sameer M.] Royal Hosp Sick Children, Fraser Allander Neurosci Unit, Paediat Neurosci Res Grp, Glasgow G3 8SJ, Lanark, Scotland; [Hughes, James N.; Gecz, Jozef; Thomas, Paul Q.; Mulley, John C.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia; [Pridmore, Clair] Womens & Childrens Hosp, Dept Neurol, Adelaide, SA 5006, Australia; [Sadleir, Lynette G.] Univ Otago, Dept Paediat, Wellington 6242, New Zealand; [Pelekanos, James] Univ Queensland, Acad Discipline Paediat & Child Hlth, Brisbane, Qld 4072, Australia; [Herlenius, Eric] Karolinska Inst, Astrid Lindgren Childrens Hosp, Neonatal Res Unit, Dept Womens & Childrens Hlth, SE-17177 Stockholm, Sweden; [Bassan, Haim] Tel Aviv Sourasky Med Ctr, Dana Childrens Hosp, Pediat Neurol & Dev Unit, IL-64239 Tel Aviv, Israel; [Haan, Eric] Womens & Childrens Hosp, SA Pathol, S Australian Clin Genet Serv, Adelaide, SA 5006, Australia; [Gardner, Alison E.; Corbett, Mark A.; Gecz, Jozef] Womens & Childrens Hosp, SA Pathol, Neurogenet Program, Adelaide, SA 5006, Australia; [Gecz, Jozef; Mulley, John C.] Univ Adelaide, Sch Paediat & Reprod Hlth, Adelaide, SA 5005, Australia; [Mulley, John C.] Womens & Childrens Hosp, SA Pathol, Dept Med Genet, Adelaide, SA 5006, Australia; [Scheffer, Ingrid E.] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Parkville, Vic 3052, Australia; [Scheffer, Ingrid E.] Univ Melbourne, Royal Childrens Hosp, Florey Neurosci Inst, Parkville, Vic 3052, Australia	University of Melbourne; University of South Australia; Tel Aviv University; University of Glasgow; University of Adelaide; Womens & Childrens Hospital Australia; University of Otago; University of Queensland; Karolinska Institutet; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; SA Pathology; SA Pathology; University of Adelaide; SA Pathology; Royal Children's Hospital Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; Royal Children's Hospital Melbourne; University of Melbourne	Berkovic, SF (corresponding author), Univ Melbourne, Dept Med, Epilepsy Res Ctr, Heidelberg, Vic 3084, Australia.	samuelfb@unimelb.edu.au	Afawi, Zaid/AAE-7848-2022; Heron, Sarah/F-4222-2013; Herlenius, Eric/B-7260-2008; Gecz, Jozef/X-3469-2019; Thomas, Paul Q/K-4497-2012; Korczyn, Amos D/C-3461-2017; jiang, yu/HGU-0029-2022; Scheffer, Ingrid E/G-1668-2013; Corbett, Mark/A-8063-2010; Grinton, Bronwyn/L-7142-2013	Heron, Sarah/0000-0001-8759-6748; Herlenius, Eric/0000-0002-6859-0620; Gecz, Jozef/0000-0002-7884-6861; Korczyn, Amos D/0000-0003-0125-2579; Scheffer, Ingrid E/0000-0002-2311-2174; Corbett, Mark/0000-0001-9298-3072; Dibbens, Leanne/0000-0002-5824-3342; Berkovic, Samuel/0000-0003-4580-841X; Ringstedt, Thomas/0000-0003-0294-9351; Grinton, Bronwyn/0000-0003-4880-2486; Sadleir, Lynette/0000-0002-5355-7115	National Health and Medical Research Council of Australia [628952, 466671, 508043, 1006110, 1016715]; SA Pathology	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); SA Pathology	We thank the patients and their families for their participation and cooperation in our research. We would like to thank Marta Bayly and Bev Johns for technical assistance. This work was supported by the National Health and Medical Research Council of Australia (Program Grant 628952 to S.F.B., I.E.S., L.M.D., P.Q.T., and J.G., Australia Fellowship 466671 to S.F.B., Senior Research Fellowship 508043 to J.G., Practitioner Fellowship 1006110 to I.E.S., and Training Fellowship 1016715 to S.E.H.) and SA Pathology. P.Q.T. is a Pfizer Australia Research Fellow. L.M.D. is an MS McLeod Research Fellow.	Callenbach PMC, 2005, CLIN GENET, V67, P517, DOI 10.1111/j.1399-0004.2005.00445.x; Caraballo R, 2001, AM J HUM GENET, V68, P788, DOI 10.1086/318805; Chen WJ, 2011, NAT GENET, V43, P1252, DOI 10.1038/ng.1008; Corbett MA, 2011, AM J HUM GENET, V88, P657, DOI 10.1016/j.ajhg.2011.04.011; Corbett MA, 2010, AM J HUM GENET, V87, P371, DOI 10.1016/j.ajhg.2010.08.001; Crompton DE, 2009, LANCET NEUROL, V8, P370, DOI 10.1016/S1474-4422(09)70059-6; Dibbens LM, 2008, NAT GENET, V40, P776, DOI 10.1038/ng.149; Guipponi M, 1997, HUM MOL GENET, V6, P473, DOI 10.1093/hmg/6.3.473; Heron S.E., 2011, CLIN GENETIC ASPECTS, P95; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Li HY, 2008, CLIN GENET, V74, P490, DOI 10.1111/j.1399-0004.2008.01092.x; Mullen SA, 2010, NEUROLOGY, V75, P432, DOI 10.1212/WNL.0b013e3181eb58b4; Mulley JC, 2011, EPILEPSIA, V52, P649, DOI 10.1111/j.1528-1167.2010.02953.x; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; REUTENS DC, 1992, EPILEPSIA, V33, P1065, DOI 10.1111/j.1528-1157.1992.tb01760.x; Rochette J, 2008, J MED GENET, V45, P773, DOI 10.1136/jmg.2008.059519; Rochette J, 2010, EPILEPTIC DISORD, V12, P199, DOI 10.1684/epd.2010.0328; Roll P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013750; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Striano P, 2006, EPILEPSIA, V47, P1029, DOI 10.1111/j.1528-1167.2006.00521.x; Suls A, 2008, BRAIN, V131, P1831, DOI 10.1093/brain/awn113; Szepetowski P, 1997, AM J HUM GENET, V61, P889, DOI 10.1086/514877; Wallace RH, 2001, NAT GENET, V28, P49, DOI 10.1038/88259; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252; Weber YG, 2004, EPILEPSIA, V45, P601, DOI 10.1111/j.0013-9580.2004.48203.x; Weber YG, 2008, EPILEPSIA, V49, P1959, DOI 10.1111/j.1528-1167.2008.01646.x	26	187	212	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 13	2012	90	1					152	160		10.1016/j.ajhg.2011.12.003	http://dx.doi.org/10.1016/j.ajhg.2011.12.003			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	880LR	22243967	Bronze, Green Published			2022-12-18	WOS:000299409100016
J	Mosse, YP; Laudenslager, M; Khazi, D; Carlisle, AJ; Winter, CL; Rappaport, E; Maris, JM				Mosse, YP; Laudenslager, M; Khazi, D; Carlisle, AJ; Winter, CL; Rappaport, E; Maris, JM			Germline PHOX2B mutation in hereditary neuroblastoma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							CENTRAL-HYPOVENTILATION-SYNDROME; HOMEOBOX GENE PHOX2B; NEUROCRISTOPATHY; DISEASE		Childrens Hosp Philadelphia, Div Oncol, Abramson Pediat Res Ctr 902A, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; Univ Penn, Abramson Canc Ctr, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Maris, JM (corresponding author), Childrens Hosp Philadelphia, Div Oncol, Abramson Pediat Res Ctr 902A, 3516 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	maris@email.chop.edu	Rappaport, Eric/GRO-4051-2022		NCI NIH HHS [R01-CA78545, R01 CA078545] Funding Source: Medline; NCRR NIH HHS [M01 RR000240, M01-RR00240] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA078545] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000240] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Amiel J, 2003, NAT GENET, V33, P459, DOI 10.1038/ng1130; Brunet JF, 2002, CURR OPIN GENET DEV, V12, P435, DOI 10.1016/S0959-437X(02)00322-2; Gabriel SB, 2002, NAT GENET, V31, P89, DOI 10.1038/ng868; GAISIE G, 1979, PEDIATR RADIOL, V8, P161, DOI 10.1007/BF00973826; Maris JM, 1999, J CLIN ONCOL, V17, P2264, DOI 10.1200/JCO.1999.17.7.2264; Maris JM, 2002, CANCER RES, V62, P6651; Matera I, 2004, J MED GENET, V41, P373, DOI 10.1136/jmg.2003.015412; Nemecek ER, 2003, J PEDIAT HEMATOL ONC, V25, P159, DOI 10.1097/00043426-200302000-00015; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Perri P, 2002, ANN NY ACAD SCI, V963, P74; Trochet D, 2004, AM J HUM GENET, V74, P761, DOI 10.1086/383253; Weese-Mayer DE, 2003, AM J MED GENET A, V123A, P267, DOI 10.1002/ajmg.a.20527	12	187	193	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2004	75	4					727	730		10.1086/424530	http://dx.doi.org/10.1086/424530			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	850SZ	15338462	Green Published, Bronze			2022-12-18	WOS:000223634100024
J	Parisi, MA; Bennett, CL; Eckert, ML; Dobyns, WB; Gleeson, JG; Shaw, DWW; McDonald, R; Eddy, A; Chance, PF; Glass, IA				Parisi, MA; Bennett, CL; Eckert, ML; Dobyns, WB; Gleeson, JG; Shaw, DWW; McDonald, R; Eddy, A; Chance, PF; Glass, IA			The NPHP1 gene deletion associated with juvenile nephronophthisis is present in a subset of individuals with Joubert syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OCULAR MOTOR APRAXIA; ABNORMAL EYE-MOVEMENTS; BARDET-BIEDL-SYNDROME; MOLAR TOOTH SIGN; SYNDROME TYPE-B; CEREBELLAR VERMIS; HOMOZYGOUS DELETIONS; EPISODIC HYPERPNEA; CLINICAL-FEATURES; PROTEIN	Joubert syndrome (JS) is an autosomal recessive multisystem disease characterized by cerebellar vermis hypoplasia with prominent superior cerebellar peduncles (the "molar tooth sign" [MTS] on axial magnetic resonance imaging), mental retardation, hypotonia, irregular breathing pattern, and eye-movement abnormalities. Some individuals with JS have retinal dystrophy and/or progressive renal failure characterized by nephronophthisis (NPHP). Thus far, no mutations in the known NPHP genes, particularly the homozygous deletion of NPHP1 at 2q13, have been identified in subjects with JS. A cohort of 25 subjects with JS and either renal and/or retinal complications and 2 subjects with only juvenile NPHP were screened for mutations in the NPHP1 gene by standard methods. Two siblings affected with a mild form of JS were found to have a homozygous deletion of the NPHP1 gene identical, by mapping, to that in subjects with NPHP alone. A control subject with NPHP and with a homozygous NPHP1 deletion was also identified, retrospectively, as having a mild MTS and borderline intelligence. The NPHP1 deletion represents the first molecular defect associated with JS in a subset of mildly affected subjects. Cerebellar malformations consistent with the MTS may be relatively common in patients with juvenile NPHP without classic symptoms of JS.	Univ Washington, Sch Med, Dept Pediat, Div Genet & Dev Med, Seattle, WA 98195 USA; Univ Washington, Dept Pediat, Div Nephrol, Seattle, WA 98195 USA; Univ Washington, Dept Radiol, Seattle, WA 98195 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; Univ Calif San Diego, Dept Neurosci, Div Pediat Neurol, San Diego, CA 92103 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Chicago; University of Chicago; University of Chicago; University of California System; University of California San Diego	Parisi, MA (corresponding author), Univ Washington, Sch Med, Dept Pediat, Div Genet & Dev Med, Box 356320,1959 NE Pacific St, Seattle, WA 98195 USA.	mparisi@u.washington.edu	Dobyns, William/AAI-2768-2020; Dobyns, William Brian/ABC-6525-2021; Chance, Phillip/AAX-5826-2020	Dobyns, William/0000-0002-7681-2844; Eddy, Allison/0000-0002-3560-7510; Bennett, CRAIG/0000-0002-5847-1687	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS045832, R01NS052455] Funding Source: NIH RePORTER; NINDS NIH HHS [K23 NS045832, K23 NS45832, R01 NS052455] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANTIGNAC C, 1998, CLIN NEPHROL, P2417; Apostolou T, 2001, NEPHROL DIAL TRANSPL, V16, P2412, DOI 10.1093/ndt/16.12.2412; Beales PL, 2003, AM J HUM GENET, V72, P1187, DOI 10.1086/375178; Bennett C. L., 2003, Current Genomics, V4, P123, DOI 10.2174/1389202033350083; Betz R, 2000, J PEDIATR-US, V136, P828, DOI 10.1067/mpd.2000.106225; BOLTSHAUSER E, 1977, NEUROPADIATRIE, V8, P57, DOI 10.1055/s-0028-1091505; Caridi G, 1998, AM J KIDNEY DIS, V32, P1059, DOI 10.1016/S0272-6386(98)70083-6; Caridi G, 2001, CONTRIB NEPHROL, V136, P57; Chance PF, 1999, J CHILD NEUROL, V14, P660, DOI 10.1177/088307389901401007; de Marco MD, 2001, J BIOL CHEM, V276, P23009; DEKABAN AS, 1969, AM J OPHTHALMOL, V68, P1029, DOI 10.1016/0002-9394(69)93443-6; Gleeson JG, 2004, AM J MED GENET A, V125A, P125, DOI 10.1002/ajmg.a.20437; Heninger E, 2001, AM J KIDNEY DIS, V37, P1131, DOI 10.1053/ajkd.2001.24514; Hildebrandt F, 1998, PEDIATR NEPHROL, V12, P16, DOI 10.1007/s004670050394; Hildebrandt F, 1997, KIDNEY INT, V51, P261, DOI 10.1038/ki.1997.31; Hildebrandt F, 1997, NAT GENET, V17, P149, DOI 10.1038/ng1097-149; Hildebrandt F, 2001, KIDNEY INT, V59, P434, DOI 10.1046/j.1523-1755.2001.059002434.x; Johnson CA, 2003, J MED GENET, V40, P311, DOI 10.1136/jmg.40.5.311; JOUBERT M, 1969, NEUROLOGY, V19, P813, DOI 10.1212/WNL.19.9.813; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Keeler LC, 2003, AM J HUM GENET, V73, P656, DOI 10.1086/378206; KING MD, 1984, ARCH DIS CHILD, V59, P709, DOI 10.1136/adc.59.8.709; Konrad M, 1996, HUM MOL GENET, V5, P367, DOI 10.1093/hmg/5.3.367; LOKEN AC, 1961, ACTA PAEDIATR, V50, P177, DOI 10.1111/j.1651-2227.1961.tb08037.x; Maria BL, 1999, J CHILD NEUROL, V14, P583, DOI 10.1177/088307389901400906; Maria BL, 1997, J CHILD NEUROL, V12, P423, DOI 10.1177/088307389701200703; Maria BL, 1999, J CHILD NEUROL, V14, P368, DOI 10.1177/088307389901400605; Mollet G, 2002, NAT GENET, V32, P300, DOI 10.1038/ng996; Nothwang HG, 1998, GENOMICS, V47, P276, DOI 10.1006/geno.1997.5102; Olbrich H, 2003, NAT GENET, V34, P455, DOI 10.1038/ng1216; Otto E, 2002, AM J HUM GENET, V71, P1161, DOI 10.1086/344395; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; PARISI MA, 2003, GENE REV GENETESTS G; Saar K, 1999, AM J HUM GENET, V65, P1666, DOI 10.1086/302655; SARAIVA JM, 1992, AM J MED GENET, V43, P726, DOI 10.1002/ajmg.1320430415; Sargent MA, 1997, AM J NEURORADIOL, V18, P1915; Satran D, 1999, AM J MED GENET, V86, P459; Saunier S, 2000, AM J HUM GENET, V66, P778, DOI 10.1086/302819; Saunier S, 1997, HUM MOL GENET, V6, P2317, DOI 10.1093/hmg/6.13.2317; SAUNIER S, 1997, AM J HUM GENET, V61, P346; SENIOR B, 1961, AM J OPHTHALMOL, V52, P625, DOI 10.1016/0002-9394(61)90147-7; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Takano K, 2003, PEDIATR NEUROL, V28, P142, DOI 10.1016/S0887-8994(02)00619-7; Tusa RJ, 1999, J CHILD NEUROL, V14, P621, DOI 10.1177/088307389901401001; Valente EM, 2003, AM J HUM GENET, V73, P663, DOI 10.1086/378241; VASSELLA F, 1972, DEV MED CHILD NEUROL, V14, P788; Watnick T, 2003, NAT GENET, V34, P355, DOI 10.1038/ng0803-355; WHITSEL EA, 1995, AM J NEURORADIOL, V16, P831; Woo DDL, 1997, J CLIN INVEST, V100, P1934, DOI 10.1172/JCI119724	49	187	191	0	13	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2004	75	1					82	91		10.1086/421846	http://dx.doi.org/10.1086/421846			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	829FG	15138899	Green Published, Bronze			2022-12-18	WOS:000222031300010
J	Leutenegger, AL; Prum, B; Genin, E; Verny, C; Lemainque, A; Clerget-Darpoux, F; Thompson, EA				Leutenegger, AL; Prum, B; Genin, E; Verny, C; Lemainque, A; Clerget-Darpoux, F; Thompson, EA			Estimation of the inbreeding coefficient through use of genomic data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HOMOZYGOSITY; INFERENCE; PEDIGREES; DESCENT	Many linkage studies are performed in inbred populations, either small isolated populations or large populations with a long tradition of marriages between relatives. In such populations, there exist very complex genealogies with unknown loops. Therefore, the true inbreeding coefficient of an individual is often unknown. Good estimators of the inbreeding coefficient (f) are important, since it has been shown that underestimation of f may lead to false linkage conclusions. When an individual is genotyped for markers spanning the whole genome, it should be possible to use this genomic information to estimate that individual's f. To do so, we propose a maximum-likelihood method that takes marker dependencies into account through a hidden Markov model. This methodology also allows us to infer the full probability distribution of the identity-by-descent (IBD) status of the two alleles of an individual at each marker along the genome ( posterior IBD probabilities) and provides a variance for the estimates. We simulate a full genome scan mimicking the true autosomal genome for ( 1) a first-cousin pedigree and ( 2) a quadruple-second-cousin pedigree. In both cases, we find that our method accurately estimates f for different marker maps. We also find that the proportion of genome IBD in an individual with a given genealogy is very variable. The approach is illustrated with data from a study of demyelinating autosomal recessive Charcot-Marie-Tooth disease.	Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Univ Washington, Dept Stat, Seattle, WA 98195 USA; INSERM, U535, Unite Rech Genet Epidemiol & Struct Populat Humai, Villejuif, France; CNRS, Lab Stat & Genome, UMR 8071, Evry, France; Ctr Natl Genotypage, Evry, France; Hop La Pitie Salpetriere, INSERM, U289, Paris, France	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Leutenegger, AL (corresponding author), Univ Washington, Dept Biostat, Box 357232, Seattle, WA 98195 USA.		Genin, Emmanuelle/C-4974-2013; Leutenegger, Anne-Louise/B-5597-2009; Clerget-Darpoux, Francoise/I-4825-2017	Genin, Emmanuelle/0000-0003-4117-2813; Leutenegger, Anne-Louise/0000-0002-1302-4357; Clerget-Darpoux, Francoise/0000-0003-4816-6619				Abney M, 2002, AM J HUM GENET, V70, P920, DOI 10.1086/339705; BAUM LE, 1970, ANN MATH STAT, V41, P164, DOI 10.1214/aoms/1177697196; Baum LE, 1972, INEQUALITIES, V3, P1; Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; BOUCHE P, 1983, J NEUROL SCI, V61, P389, DOI 10.1016/0022-510X(83)90172-7; Broman KW, 1999, AM J HUM GENET, V65, P1493, DOI 10.1086/302661; Charcot JM, 1886, REV MED-PARIS, V6, P97; Epstein MP, 2000, AM J HUM GENET, V67, P1219, DOI 10.1016/S0002-9297(07)62952-8; HARDING AE, 1980, J MED GENET, V17, P329, DOI 10.1136/jmg.17.5.329; LALOUEL JM, 1979, 14 U UT DEP MED BIOP; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Leutenegger AL, 2002, GENET EPIDEMIOL, V23, P413, DOI 10.1002/gepi.10190; LOUIS TA, 1982, J ROY STAT SOC B MET, V44, P226; Malecot G, 1948, MATH HEREDITE; Miano MG, 2000, AM J HUM GENET, V67, P1348, DOI 10.1016/S0002-9297(07)62966-8; RISCH N, 1989, GENET EPIDEMIOL, V6, P143, DOI 10.1002/gepi.1370060127; STAM P, 1980, GENET RES, V35, P131, DOI 10.1017/S0016672300014002; Sundberg R., 1974, SCAND J STAT, V1, P49; Thompson E. A., 1994, P 1994 INT C INT FDN, P498; THOMPSON EA, 1988, IMA J MATH APPL MED, V5, P261; TOOTH H, 1886, THESIS CAMBRIDGE U C	21	187	197	0	26	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2003	73	3					516	523		10.1086/378207	http://dx.doi.org/10.1086/378207			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	718FG	12900793	Green Published, Bronze			2022-12-18	WOS:000185134000005
J	Bingham, C; Bulman, MP; Ellard, S; Allen, LIS; Lipkin, GW; van't Hoff, WG; Woolf, AS; Rizzoni, G; Novelli, G; Nicholls, AJ; Hattersley, AT				Bingham, C; Bulman, MP; Ellard, S; Allen, LIS; Lipkin, GW; van't Hoff, WG; Woolf, AS; Rizzoni, G; Novelli, G; Nicholls, AJ; Hattersley, AT			Mutations in the hepatocyte nuclear factor-1 beta gene are associated with familial hypoplastic glomerulocystic kidney disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOMINANT INHERITANCE; FRAMESHIFT MUTATION; RENAL DYSFUNCTION; FACTOR 1-BETA; COMMON-CAUSE; ENTITY; YOUNG; TRANSCRIPTION; HETERODIMERS; UK	Familial glomerulocystic kidney disease (GCKD) is a dominantly inherited condition characterized by glomerular cysts and variable renal size and function; the molecular genetic etiology is unknown. Mutations in the gene encoding hepatocyte nuclear factor (HNF)-1 beta have been associated with early-onset diabetes and nondiabetic renal disease-particularly renal cystic disease. We investigated a possible role for the HNF-1 beta gene in four unrelated GCKD families and identified mutations in two families: a nonsense mutation in exon 1 (E101X) and a frameshift mutation in exon 2 (P159fsdelT). The family members with HNF-1 beta gene mutations had hypoplastic GCKD and early-onset diabetes or impaired glucose tolerance. We conclude that there is genetic heterogeneity in familial GCKD and that the hypoplastic subtype is a part of the clinical spectrum of the renal cysts and diabetes syndrome that is associated with HNF-1 beta mutations.	Univ Exeter, Sch Postgrad Med & Hlth Sci, Dept Vasc Med & Diabet Res, Exeter, Devon, England; Queen Elizabeth Hosp, Dept Nephrol, Birmingham, W Midlands, England; UCL, Inst Child Hlth, NephroUrol Unit, London WC1E 6BT, England; Bambino Gesu Childrens Hosp & Res Inst, Div Nephrol & Dialysis, Rome, Italy; Univ Roma Tor Vergata, Dipartimento Biopatol & Diagnost Immagini, Sez Genet, Rome, Italy	University of Exeter; University of Birmingham; University of London; University College London; IRCCS Bambino Gesu; University of Rome Tor Vergata	Hattersley, AT (corresponding author), Sch Postgrad Med & Hlth Sci, Dept Diabet & Vasc Med, Barrack Rd, Exeter EX2 5AX, Devon, England.	A.T.Hattersley@exeter.ac.uk	Woolf, Adrian S./AAZ-1075-2020; Novelli, Giuseppe/GQB-3329-2022; Novelli, Giuseppe/T-8822-2019; Novelli, Giuseppe/A-5195-2013	Woolf, Adrian S./0000-0001-5541-1358; Novelli, Giuseppe/0000-0002-7781-602X; Novelli, Giuseppe/0000-0002-7781-602X; Hattersley, Andrew/0000-0001-5620-473X; Ellard, Sian/0000-0002-7620-5526				Attar R, 1998, AM J PATHOL, V152, P1225; Beards F, 1998, DIABETES, V47, P1152, DOI 10.2337/diabetes.47.7.1152; BERNSTEIN J, 1993, PEDIATR NEPHROL, V7, P464, DOI 10.1007/BF00857576; Bingham C, 2000, KIDNEY INT, V57, P898, DOI 10.1046/j.1523-1755.2000.057003898.x; Feather SA, 1997, NEPHROL DIAL TRANSPL, V12, P1354, DOI 10.1093/ndt/12.7.1354; Frayling TM, 1997, DIABETES, V46, P720, DOI 10.2337/diabetes.46.4.720; Hattersley AT, 1998, DIABETIC MED, V15, P15, DOI 10.1002/(SICI)1096-9136(199801)15:1<15::AID-DIA562>3.0.CO;2-M; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; KAPLAN BS, 1989, AM J MED GENET, V34, P569, DOI 10.1002/ajmg.1320340423; LAZZARO D, 1992, DEVELOPMENT, V114, P469; Lindner TH, 1999, HUM MOL GENET, V8, P2001, DOI 10.1093/hmg/8.11.2001; MELNICK SC, 1984, J CLIN PATHOL, V37, P494, DOI 10.1136/jcp.37.5.494; MENDEL DB, 1991, GENE DEV, V5, P1042, DOI 10.1101/gad.5.6.1042; Mesoraca A., 1996, Journal of the American Society of Nephrology, V7, P1338; Nishigori H, 1998, DIABETES, V47, P1354, DOI 10.2337/diabetes.47.8.1354; REYCAMPOS J, 1991, EMBO J, V10, P1445, DOI 10.1002/j.1460-2075.1991.tb07665.x; RIZZONI G, 1982, CLIN NEPHROL, V18, P263; Sharp CK, 1997, J AM SOC NEPHROL, V8, P77; Weng JP, 2000, DIABETOLOGIA, V43, P131; Wild W, 2000, P NATL ACAD SCI USA, V97, P4695, DOI 10.1073/pnas.080010897	20	187	202	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2001	68	1					219	224		10.1086/316945	http://dx.doi.org/10.1086/316945			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	392FG	11085914	Green Published, Bronze			2022-12-18	WOS:000166399900021
J	Amos-Landgraf, JM; Ji, YG; Gottlieb, W; Depinet, T; Wandstrat, AE; Cassidy, SB; Driscoll, DJ; Rogan, PK; Schwartz, S; Nicholls, RD				Amos-Landgraf, JM; Ji, YG; Gottlieb, W; Depinet, T; Wandstrat, AE; Cassidy, SB; Driscoll, DJ; Rogan, PK; Schwartz, S; Nicholls, RD			Chromosome breakage in the Prader-Willi and Angelman syndromes involves recombination between large, transcribed repeats at proximal and distal breakpoints	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DE-NOVO DUPLICATION; DISEASE TYPE 1A; HOMOLOGOUS RECOMBINATION; MOLECULAR CHARACTERIZATION; DELETION BREAKPOINTS; HYDROCARBON EXPOSURE; CHROMATID EXCHANGE; 7Q11.23 DELETIONS; PARENTAL ORIGIN; REGION 15Q11-13	Prader-Willi syndrome (PWS) and Angelman syndrome (AS) are distinct neurobehavioral disorders that most often arise from a 4-Mb deletion of chromosome 15q11-q13 during paternal or maternal gametogenesis, respectively. At a de novo frequency of similar to.67-1/10,000 births, these deletions represent a common structural chromosome change in the human genome. To elucidate the mechanism underlying these events, we characterized the regions that contain two proximal breakpoint clusters and a distal cluster. Novel DNA sequences potentially associated with the breakpoints were positionally cloned from YACs within or near these regions. Analyses of rodent-human somatic-cell hybrids, YAC contigs, and FISH of normal or rearranged chromosomes 15 identified duplicated sequences (the END repeats) at or near the breakpoints. The END-repeat units are derived from large genomic duplications of a novel gene (HERC2), many copies of which are transcriptionally active in germline tissues. One of five PWS/AS patients analyzed to date has an identifiable, rearranged HERC2 transcript derived from the deletion event. We postulate that the END repeats nanking 15q11-q13 mediate homologous recombination resulting in deletion. Furthermore, we propose that active transcription of these repeats in male and female germ cells may facilitate the homologous recombination process.	Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Ctr Human Genet, Cleveland, OH 44106 USA; Univ Florida, Coll Med, Dept Pediat, RC Philips Unit,Div Genet, Gainesville, FL USA; Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL USA; Childrens Mercy Hosp, Sect Med Genet & Mol Med, Kansas City, MO 64108 USA	Case Western Reserve University; University Hospitals of Cleveland; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Children's Mercy Hospital	Nicholls, RD (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet, 10900 Euclid Ave, Cleveland, OH 44106 USA.	rxn19@po.cwru.edu	Amos-Landgraf, James/K-9288-2013; Rogan, Peter/B-9845-2017	Amos-Landgraf, James/0000-0003-2535-7746; Rogan, Peter/0000-0003-2070-5254	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008613] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM08613] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akefeldt A, 1995, DEV MED CHILD NEUROL, V37, P1101; Bachl J, 1998, P NATL ACAD SCI USA, V95, P2396, DOI 10.1073/pnas.95.5.2396; Baumer A, 1998, HUM MOL GENET, V7, P887, DOI 10.1093/hmg/7.5.887; Blair IP, 1996, AM J HUM GENET, V58, P472; Bort S, 1997, AM J HUM GENET, V60, P230; BREUKEL C, 1990, NUCLEIC ACIDS RES, V18, P3097, DOI 10.1093/nar/18.10.3097; Browne CE, 1997, AM J HUM GENET, V61, P1342, DOI 10.1086/301624; BUITING K, 1992, P NATL ACAD SCI USA, V89, P5457, DOI 10.1073/pnas.89.12.5457; Buiting K, 1998, CYTOGENET CELL GENET, V81, P247, DOI 10.1159/000015039; BUTLER MG, 1990, AM J MED GENET, V35, P319, DOI 10.1002/ajmg.1320350306; Carro N, 1997, SPECTROSC-INT J, V13, P61; Cassidy SB, 1997, J MED GENET, V34, P917, DOI 10.1136/jmg.34.11.917; Cassidy SB, 1996, AM J MED GENET, V64, P6; CASSIDY SB, 1989, AM J HUM GENET, V44, P806; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; CHENG CH, 1994, INT J HEAT FLUID FL, V15, P11, DOI 10.1016/0142-727X(94)90026-4; CHRISTIAN SI, 1995, AM J HUM GENET, V57, P40; Christian SL, 1998, GENOME RES, V8, P146, DOI 10.1101/gr.8.2.146; CLAYTONSMITH J, 1992, J MED GENET, V29, P412, DOI 10.1136/jmg.29.6.412; CLAYTONSMITH J, 1993, J MED GENET, V30, P529, DOI 10.1136/jmg.30.6.529; CLAYTONSMITH J, 1993, AM J MED GENET, V47, P683, DOI 10.1002/ajmg.1320470519; CROLLA JA, 1995, HUM GENET, V95, P161; Dutly F, 1996, HUM MOL GENET, V5, P1893, DOI 10.1093/hmg/5.12.1893; Edelmann L, 1999, AM J HUM GENET, V64, P1076, DOI 10.1086/302343; Eichler EE, 1998, GENOME RES, V8, P758, DOI 10.1101/gr.8.8.758; Gabriel JM, 1998, P NATL ACAD SCI USA, V95, P14857, DOI 10.1073/pnas.95.25.14857; Gray TA, 1999, P NATL ACAD SCI USA, V96, P5616, DOI 10.1073/pnas.96.10.5616; HEISKANEN M, 1995, GENOMICS, V30, P31, DOI 10.1006/geno.1995.0005; Huang B, 1997, HUM GENET, V99, P11; Ji YG, 1999, HUM MOL GENET, V8, P533, DOI 10.1093/hmg/8.3.533; Jong MTC, 1999, HUM MOL GENET, V8, P783, DOI 10.1093/hmg/8.5.783; Jurado LAP, 1998, HUM MOL GENET, V7, P325, DOI 10.1093/hmg/7.3.325; Juyal RC, 1996, AM J HUM GENET, V58, P998; Klein S, 1996, NAT GENET, V13, P481, DOI 10.1038/ng0896-481; KNOLL JHM, 1990, AM J HUM GENET, V47, P149; Kuwano Akira, 1992, Human Molecular Genetics, V1, P417, DOI 10.1093/hmg/1.6.417; Lehman AL, 1998, P NATL ACAD SCI USA, V95, P9436, DOI 10.1073/pnas.95.16.9436; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Malzac P, 1998, AM J HUM GENET, V62, P1353, DOI 10.1086/301877; Maquat LE, 1996, AM J HUM GENET, V59, P279; MASCARI MJ, 1992, NEW ENGL J MED, V326, P1599, DOI 10.1056/NEJM199206113262404; MCDANIEL LD, 1992, P NATL ACAD SCI USA, V89, P7968, DOI 10.1073/pnas.89.17.7968; Nicholls RD, 1998, TRENDS GENET, V14, P194, DOI 10.1016/S0168-9525(98)01432-2; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; NICKOLOFF JA, 1992, MOL CELL BIOL, V12, P5311, DOI 10.1128/MCB.12.12.5311; NICOLAS A, 1989, NATURE, V338, P35, DOI 10.1038/338035a0; Osborne LR, 1997, GENOMICS, V45, P402, DOI 10.1006/geno.1997.4923; PALAU F, 1993, HUM MOL GENET, V2, P2031, DOI 10.1093/hmg/2.12.2031; Purandare SM, 1997, GENOME RES, V7, P773, DOI 10.1101/gr.7.8.773; Repetto GR, 1998, AM J MED GENET, V79, P82, DOI 10.1002/(SICI)1096-8628(19980901)79:2<82::AID-AJMG2>3.0.CO;2-P; RINCHIK EM, 1995, P NATL ACAD SCI USA, V92, P6394, DOI 10.1073/pnas.92.14.6394; Robinson Wendy P., 1993, European Journal of Human Genetics, V1, P37; Robinson WP, 1998, J MED GENET, V35, P130, DOI 10.1136/jmg.35.2.130; ROBINSON WP, 1993, HUM GENET, V91, P181; SACHS RK, 1995, P NATL ACAD SCI USA, V92, P2710, DOI 10.1073/pnas.92.7.2710; SCHIESTL RH, 1994, SCIENCE, V266, P1573, DOI 10.1126/science.7985029; SCHINZEL AA, 1994, J MED GENET, V31, P798, DOI 10.1136/jmg.31.10.798; Spritz RA, 1997, AM J MED GENET, V71, P57, DOI 10.1002/(SICI)1096-8628(19970711)71:1<57::AID-AJMG11>3.0.CO;2-U; Stavnezer J, 1996, CURR OPIN IMMUNOL, V8, P199, DOI 10.1016/S0952-7915(96)80058-6; STRAKOWSKI SM, 1987, LANCET, V2, P1458; Sullivan BA, 1996, AM J HUM GENET, V59, P167; Sun YM, 1996, HUM MOL GENET, V5, P517, DOI 10.1093/hmg/5.4.517; TANTRAVAHI U, 1989, AM J MED GENET, V33, P78, DOI 10.1002/ajmg.1320330110; Urban Z, 1996, AM J HUM GENET, V59, P958; VOELKELMEIMAN K, 1987, CELL, V48, P1071, DOI 10.1016/0092-8674(87)90714-8; WALKOWICZ M, IN PRESS MAMM GENOME; Wandstrat AE, 1998, AM J HUM GENET, V62, P925, DOI 10.1086/301777; WEBB T, 1994, J MED GENET, V31, P585, DOI 10.1136/jmg.31.8.585; WILLARD HF, 1984, HUM GENET, V66, P272, DOI 10.1007/BF00286615; Wirth B, 1997, AM J HUM GENET, V61, P1102, DOI 10.1086/301608; WU TC, 1994, SCIENCE, V263, P515, DOI 10.1126/science.8290959; ZACKOWSKI JL, 1993, AM J MED GENET, V46, P7, DOI 10.1002/ajmg.1320460104	72	187	192	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1999	65	2					370	386		10.1086/302510	http://dx.doi.org/10.1086/302510			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	223JA	10417280	Green Published, Bronze			2022-12-18	WOS:000081836900013
J	Geschwind, DH; Perlman, S; Figueroa, CP; Treiman, LJ; Pulst, SM				Geschwind, DH; Perlman, S; Figueroa, CP; Treiman, LJ; Pulst, SM			The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MACHADO-JOSEPH-DISEASE; CAG REPEAT; DENTATORUBROPALLIDOLUYSIAN ATROPHY; HUNTINGTONS-DISEASE; SOMATIC MOSAICISM; DREW FAMILY; EXPANSION; LOCUS; SCA2; ONSET	The dominant cerebellar ataxias (ADCAs) represent a clinically and genetically heterogeneous group of disorders linked by progressive deterioration in balance and coordination. The utility of genetic classification of the ADCAs has been highlighted by the striking variability in clinical phenotype observed within families and the overlap in clinical phenotype observed between those with different genotypes. The recent demonstration that spinocerebellar ataxia type 2 (SCA2) is caused by a CAG repeat expansion within the ataxin-2 gene has allowed us to determine the frequency of SCA2 compared with SCA1, SCA3/Machado-Joseph disease (MJD), and dentatorubropallidoluysian atrophy (DRPLA) in patients with sporadic and inherited ataxia. SCA2 accounts for 13% of patients with ADCA (without retinal degeneration), intermediate between SCA1 and SCA3/MJD, which account for 6% and 23%, respectively. Together, SCA1, SCA2, and SCA3/MJD constitute >40% of the mutations leading to ADCA I in our population. No patient without a family history of ataxia, or with a pure cerebellar or spastic syndrome, tested positive for SCA1, SCA2, or SCA3. No overlap in ataxin-2 allele size between normal and disease chromosomes, or intermediate-sized alleles, were observed. Repeat length correlated inversely with age at onset, accounting for similar to 80% of the variability in onset age. Haplotype analysis provided no evidence for a single founder chromosome, and diverse ethnic origins were observed among SCA2 kindreds. In addition, a wide spectrum of clinical phenotypes was observed among SCA2 patients, including typical mild dominant ataxia, the MJD phenotype with facial fasciculations and lid retraction, and early-onset ataxia with a rapid course, chorea, and dementia.	UNIV CALIF LOS ANGELES,SCH MED,CEDARS SINAI MED CTR,ROSE MOSS LAB PARKINSONS & NEURODEGENER DIS,LOS ANGELES,CA; UNIV CALIF LOS ANGELES,SCH MED,CEDARS SINAI MED CTR,DIV NEUROL,LOS ANGELES,CA; VET ADM WADSWORTH HOSP CTR,DEPT NEUROL,LOS ANGELES,CA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Geschwind, DH (corresponding author), UNIV CALIF LOS ANGELES,SCH MED,REED NEUROL RES CTR,DEPT NEUROL,710 WESTWOOD PLAZA,LOS ANGELES,CA 90095, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS033123, R01NS033123, R37NS033123] Funding Source: NIH RePORTER; NINDS NIH HHS [NS33123-012A, NS011849] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BANFI S, 1994, NAT GENET, V7, P513, DOI 10.1038/ng0894-513; BELAL S, 1994, NEUROLOGY, V44, P1423, DOI 10.1212/WNL.44.8.1423; BENOMAR A, 1995, NAT GENET, V10, P84, DOI 10.1038/ng0595-84; BURKE JR, 1994, NAT GENET, V7, P521, DOI 10.1038/ng0894-521; CANCEL G, 1995, AM J MED GENET, V60, P382, DOI 10.1002/ajmg.1320600507; CANCEL G, 1995, AM J HUM GENET, V57, P809; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; DIAZ GO, 1990, NEUROLOGY, V40, P1369, DOI 10.1212/WNL.40.9.1369; DUBOURG O, 1995, ANN NEUROL, V37, P176, DOI 10.1002/ana.410370207; DURR A, 1993, BRAIN, V116, P1497, DOI 10.1093/brain/116.6.1497; DURR A, 1995, CLIN NEUROSCI, V3, P12; Durr A, 1995, BRAIN, V118, P1573, DOI 10.1093/brain/118.6.1573; Flanigan K, 1996, AM J HUM GENET, V59, P392; GACY AM, 1995, CELL, V81, P533; GISPERT S, 1993, NAT GENET, V4, P295, DOI 10.1038/ng0793-295; GIUNTI P, 1994, BRAIN, V117, P645, DOI 10.1093/brain/117.4.645; GIUNTI P, 1995, BRAIN, V118, P1077, DOI 10.1093/brain/118.5.1077; HARDING AE, 1993, ADV NEUROL, V61, P1; HARDING AE, 1982, BRAIN, V105, P1, DOI 10.1093/brain/105.1.1; Higgins JJ, 1996, NEUROLOGY, V46, P208, DOI 10.1212/WNL.46.1.208; Imbert G, 1996, NAT GENET, V14, P285, DOI 10.1038/ng1196-285; Lezin A, 1996, HUM GENET, V97, P671; Lindblad K., 1996, American Journal of Human Genetics, V59, pA269; MACIEL P, 1995, AM J HUM GENET, V57, P54; Maruyama H, 1996, HUM GENET, V97, P591; MCMURRAY CT, 1995, CHROMOSOMA, V104, P2; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; Nechiporuk A, 1996, NEUROLOGY, V46, P1731, DOI 10.1212/WNL.46.6.1731; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PULST SM, 1993, NAT GENET, V5, P8, DOI 10.1038/ng0993-8c; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; RANUM LPW, 1994, AM J HUM GENET, V55, P244; RANUM LPW, 1995, AM J HUM GENET, V57, P603; RANUM LPW, 1994, NAT GENET, V8, P280, DOI 10.1038/ng1194-280; ROSENBERG RN, 1990, NEUROLOGY, V40, P1329, DOI 10.1212/WNL.40.9.1329; ROSENBERG RN, 1995, NEUROLOGY, V45, P1; Rubinsztein DC, 1996, AM J HUM GENET, V59, P16; Sanpei K, 1996, NAT GENET, V14, P277, DOI 10.1038/ng1196-277; Sasaki H, 1993, Rinsho Shinkeigaku, V33, P1285; SCHOLS L, 1995, HUM MOL GENET, V4, P1001, DOI 10.1093/hmg/4.6.1001; Silveira I, 1996, NEUROLOGY, V46, P214, DOI 10.1212/WNL.46.1.214; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; STEVANIN G, 1995, AM J HUM GENET, V57, P1247; STEVANIN G, 1996, AM J HUM GENET S, V59, pA286; SUDARSKY L, 1995, CLIN NEUROSCI, V3, P17; SUTTON J, IN PRESS NEUROLOGY; TELENIUS H, 1995, HUM MOL GENET, V4, P189, DOI 10.1093/hmg/4.2.189; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; TWELLS R, 1994, HUM MOL GENET, V3, P177, DOI 10.1093/hmg/3.1.177; UENO S, 1995, HUM MOL GENET, V4, P663, DOI 10.1093/hmg/4.4.663; WARNER TT, 1994, MOVEMENT DISORD, V9, P289, DOI 10.1002/mds.870090302; WATKINS WS, 1995, HUM MOL GENET, V4, P1485, DOI 10.1093/hmg/4.9.1485	52	187	191	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1997	60	4					842	850						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WT614	9106530				2022-12-18	WOS:A1997WT61400013
J	Nebert, DW				Nebert, DW			Polymorphisms in drug-metabolizing enzymes: What is their clinical relevance and why do they exist?	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							GENETIC-DIFFERENCES; FURANOCOUMARINS; PHEROMONE; EVOLUTION; OXIDATION; TOXICITY; GROWTH; CANCER; RISK		UNIV CINCINNATI,MED CTR,DEPT PEDIAT,CTR ENVIRONM GENET,CINCINNATI,OH 45267	University System of Ohio; University of Cincinnati	Nebert, DW (corresponding author), UNIV CINCINNATI,MED CTR,DEPT ENVIRONM HLTH,CTR ENVIRONM GENET,3223 EDEN AVE,POB 670056,CINCINNATI,OH 45267, USA.				NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008147, R01ES006321, R01ES006811] Funding Source: NIH RePORTER; NIEHS NIH HHS [R01 ES06321, R01 ES06811, R01 ES08147] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AMBROSONE CB, 1996, JAMA-J AM MED ASSOC, V276, P1474; BERENBAUM M, 1981, SCIENCE, V212, P927, DOI 10.1126/science.212.4497.927; BIGELOW SW, 1989, BIOCHEM PHARMACOL, V38, P3565, DOI 10.1016/0006-2952(89)90129-9; BRYANT JP, 1983, SCIENCE, V222, P1023, DOI 10.1126/science.222.4627.1023; BYERS JA, 1983, SCIENCE, V220, P624, DOI 10.1126/science.220.4597.624; CAIRNS J, 1988, NATURE, V335, P142, DOI 10.1038/335142a0; Daly AK, 1996, PHARMACOGENETICS, V6, P193, DOI 10.1097/00008571-199606000-00001; DIAMOND JM, 1987, NATURE, V329, P487, DOI 10.1038/329487a0; diTomaso E, 1996, NATURE, V382, P677, DOI 10.1038/382677a0; GIBSON RW, 1983, NATURE, V302, P608, DOI 10.1038/302608a0; GONZALEZ FJ, 1994, CLIN PHARMACOKINET, V26, P59, DOI 10.2165/00003088-199426010-00005; GONZALEZ FJ, 1990, TRENDS GENET, V6, P182, DOI 10.1016/0168-9525(90)90174-5; HINKLE G, 1994, SCIENCE, V266, P1695, DOI 10.1126/science.7992052; IDLE JR, 1979, DRUG METAB REV, V9, P301, DOI 10.3109/03602537908993896; Kalow W., 1994, ADV DRUG RES, V23, P1; LEWALTER J, 1985, INT ARCH OCC ENV HEA, V56, P179, DOI 10.1007/BF00396596; MA RL, 1994, ARCH BIOCHEM BIOPHYS, V310, P332, DOI 10.1006/abbi.1994.1175; MCCLEARN GE, 1973, BEHAV GENET, V3, P409; METCALF RL, 1991, P NATL ACAD SCI USA, V88, P1869, DOI 10.1073/pnas.88.5.1869; MEYER UA, 1994, P NATL ACAD SCI USA, V91, P1983, DOI 10.1073/pnas.91.6.1983; Nebert D W, 1994, Prog Liver Dis, V12, P63; NEBERT D W, 1990, P469; NEBERT DW, 1990, NATURE, V347, P709, DOI 10.1038/347709a0; NEBERT DW, 1991, HEPATOLOGY, V14, P398, DOI 10.1002/hep.1840140232; NEBERT DW, 1991, MOL ENDOCRINOL, V5, P1203, DOI 10.1210/mend-5-9-1203; NEBERT DW, 1994, BIOCHEM PHARMACOL, V47, P25, DOI 10.1016/0006-2952(94)90434-0; Nebert DW, 1996, DNA CELL BIOL, V15, P273, DOI 10.1089/dna.1996.15.273; NEBERT DW, 1991, CANCER CELL-MON REV, V3, P93; NEI M, 1986, ETHNIC DIFFERENCES R, P21; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; PARKER LS, 1994, AM J HUM GENET, V54, P137; PETRANYI G, 1984, SCIENCE, V224, P1239, DOI 10.1126/science.6547247; ROTTER JI, 1987, NATURE, V329, P289, DOI 10.1038/329289a0; Sachse C, 1997, AM J HUM GENET, V60, P284; VATSIS KP, 1995, PHARMACOGENETICS, V5, P1, DOI 10.1097/00008571-199502000-00001	35	187	200	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1997	60	2					265	271						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WE931	9012398				2022-12-18	WOS:A1997WE93100004
J	GUTTENBACH, M; KOSCHORZ, B; BERNTHALER, U; GRIMM, T; SCHMID, M				GUTTENBACH, M; KOSCHORZ, B; BERNTHALER, U; GRIMM, T; SCHMID, M			SEX-CHROMOSOME LOSS AND AGING - IN-SITU HYBRIDIZATION STUDIES ON HUMAN INTERPHASE NUCLEI	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN Y-CHROMOSOME; HUMAN X-CHROMOSOME; CULTURED LYMPHOCYTES; REPEATED SEQUENCE; REPETITIVE DNA; ANEUPLOIDY; AGE; WOMEN; CELLS; DIVISION	A total of 1,000 lymphocyte interphase nuclei per proband from 90 females and 138 males age 1 wk to 93 years were analyzed by in situ hybridization for loss of the X and Y chromosomes, respectively. Both sex chromosomes showed an age-dependent loss. In males, Y hypoploidy was very low up to age 15 years (0.05%) but continuously increased to a frequency of 1.34% in men age 76-80 years. Tn females, the baseline level for X chromosome loss is much higher than that seen for the Y chromosome in males. Even prepubertal females show a rate of X chromosome loss, on the order of 1.5%-2.5%, rising to similar to 4.5%-5% in women older than 75 years. Dividing the female probands into three biological age groups on the basis of sex hormone function (<13 years, 13-51 years, and >51 years), a significant correlation of X chromosome loss versus age could clearly be demonstrated in women beyond age 51 years. Females age 51-91 years showed monosomy X at a rate from 3.2% to 5.1%. In contrast to sex chromosomal loss, the frequency of autosomal monosomies does not change during the course of aging: Chromosome 1 and chromosome 17 monosomic cells were found with a constant incidence of 1.2% and 1%, respectively. These data also indicate that autosome loss in interphase nuclei is not a function of chromosome size.	UNIV WURZBURG, BIOZENTRUM, INST HUMAN GENET, D-97074 WURZBURG, GERMANY	University of Wurzburg								ABRUZZO MA, 1985, CYTOGENET CELL GENET, V39, P275, DOI 10.1159/000132157; COOKE H, 1976, NATURE, V262, P182, DOI 10.1038/262182a0; COOKE HJ, 1979, NUCLEIC ACIDS RES, V6, P3177, DOI 10.1093/nar/6.10.3177; COOKE HJ, 1982, CHROMOSOMA, V87, P491, DOI 10.1007/BF00333470; Court Brown WM, 1966, CHROMOSOME STUDIES A; DOMINGUEZSTEGLICH M, 1992, CYTOGENET CELL GENET, V60, P138, DOI 10.1159/000133324; Draper N.R., 1981, APPL REGRESSION ANAL, Vsecond, DOI DOI 10.1002/9781118625590; FENECH M, 1985, MUTAT RES, V148, P99, DOI 10.1016/0027-5107(85)90212-X; FITZGERALD PH, 1975, ANN HUM GENET, V38, P417, DOI 10.1111/j.1469-1809.1975.tb00631.x; FITZGERALD PH, 1977, HUM GENET, V39, P329, DOI 10.1007/BF00295428; FORD JH, 1985, AM J HUM GENET, V37, P973; GALLOWAY SM, 1978, CYTOGENET CELL GENET, V20, P78, DOI 10.1159/000130842; GANGULY BB, 1993, MUTAT RES, V295, P135; GUTTENBACH M, 1994, HUM GENET, V94, P295; HANDO JC, 1994, CHROMOSOMA, V103, P186, DOI 10.1007/s004120050023; HORSMAN DE, 1987, AM J MED GENET, V28, P981, DOI 10.1002/ajmg.1320280425; HUNTER S, 1993, GENE CHROMOSOME CANC, V8, P172, DOI 10.1002/gcc.2870080306; JACOBS PA, 1963, NATURE, V197, P1080, DOI 10.1038/1971080a0; JACOBS PA, 1961, NATURE, V191, P1178, DOI 10.1038/1911178a0; JARVIK LF, 1976, HUM GENET, V33, P17, DOI 10.1007/BF00447282; KORMANNBORTOLOTTO MH, 1993, GERONTOLOGY, V39, P1; NAKAGOME Y, 1984, AM J HUM GENET, V36, P398; NEURATH P, 1970, NATURE, V225, P281, DOI 10.1038/225281a0; NOWINSKI GP, 1990, AM J HUM GENET, V46, P1101; PERCY ME, 1993, AM J MED GENET, V45, P584, DOI 10.1002/ajmg.1320450513; RICHARD F, 1993, MUTAT RES, V295, P71, DOI 10.1016/0921-8734(93)90003-L; RISKE CB, 1994, CANCER GENET CYTOGEN, V72, P44, DOI 10.1016/0165-4608(94)90108-2; SCHMID M, 1990, GENOMICS, V6, P212, DOI 10.1016/0888-7543(90)90559-D; VAZIRI H, 1993, AM J HUM GENET, V52, P661; WENGER SL, 1984, AM J MED GENET, V19, P715, DOI 10.1002/ajmg.1320190411; WHEELER WJ, 1986, MUTAT RES, V171, P31, DOI 10.1016/0165-1218(86)90006-6; WILLARD HF, 1983, NUCLEIC ACIDS RES, V11, P2017, DOI 10.1093/nar/11.7.2017; YANG TP, 1982, P NATL ACAD SCI-BIOL, V79, P6593, DOI 10.1073/pnas.79.21.6593; 1992, GENES CHROMOSOM CANC, V5, P83	34	187	196	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1995	57	5					1143	1150						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TA449	7485166				2022-12-18	WOS:A1995TA44900022
J	PAYAMI, H; JOE, S; FARID, NR; STENSZKY, V; CHAN, SH; YEO, PPB; CHEAH, JS; THOMSON, G				PAYAMI, H; JOE, S; FARID, NR; STENSZKY, V; CHAN, SH; YEO, PPB; CHEAH, JS; THOMSON, G			RELATIVE PREDISPOSITIONAL EFFECTS (RPES) OF MARKER ALLELES WITH DISEASE - HLA-DR ALLELES AND GRAVES-DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF BERKELEY, DEPT GENET, BERKELEY, CA 94720 USA; MEM UNIV NEWFOUNDLAND, MED CTR, THYROID RES LAB, St John A1C 5S7, NEWFOUNDLAND, CANADA; BLOOD TRANSFUS CTR, BEM, HUNGARY; NATL UNIV SINGAPORE, FAC MED, WHO, CTR IMMUNOL, SINGAPORE 0511, SINGAPORE	University of California System; University of California Berkeley; National University of Singapore; World Health Organization	PAYAMI, H (corresponding author), OREGON HLTH SCI UNIV, DEPT MED GENET, L103, 3181 SW SAM JACKSON PK RD, PORTLAND, OR 97201 USA.		Chan, Soh Ha/B-6709-2009		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD012731] Funding Source: NIH RePORTER; NICHD NIH HHS [HD12731] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALLANNIC H, 1980, J CLIN ENDOCR METAB, V51, P863, DOI 10.1210/jcem-51-4-863; ALLANNIC H, 1983, ACTA ENDOCRINOL-COP, V102, P57, DOI 10.1530/acta.0.1020057; BECH K, 1977, ACTA ENDOCRINOL-COP, V86, P510, DOI 10.1530/acta.0.0860510; BERTRAMS J, 1984, HISTOCOMPATIBILITY T, P348; CHAN SH, 1980, TISSUE ANTIGENS, V16, P258; FARID NR, 1979, J CLIN INVEST, V63, P108, DOI 10.1172/JCI109263; FARID NR, 1980, TISSUE ANTIGENS, V16, P23; FARID NR, 1986, MOL BIOL MED, V3, P85; FARID NR, 1980, TISSUE ANTIGENS, V15, P492; FARID NR, 1981, HLA ENDOCRINE METABO, P145; FRECKER M, AUTOIMMUNITY, V1, P307; HODGE SE, 1981, AM J HUM GENET, V33, P381; LOUIS EJ, 1983, ANN HUM GENET, V47, P225, DOI 10.1111/j.1469-1809.1983.tb00991.x; MCMICHAEL A, 1975, HISTOCOMPATIBILITY T, P769; MOTRO U, 1985, GENETICS, V110, P525; RAFFOUX C, 1979, TISSUE ANTIGENS, V14, P274; SCHLEUSENER H, 1983, J CLIN ENDOCR METAB, V56, P781, DOI 10.1210/jcem-56-4-781; STENSZKY V, 1986, MOL BIOL MED, V3, P53; STENSZKY V, 1983, CLIN INVEST MED, V6, P181; THOMSON G, 1989, GENET EPIDEMIOL, V6, P155, DOI 10.1002/gepi.1370060129; THOMSON G, 1988, AM J HUM GENET, V43, P799; THOMSON G, 1986, GENET EPIDEMIOL, P363; THOMSON G, 1984, AM J HUM GENET, V36, P1309; TIAN D, 1986, HLA ASIA OCEANIA 198, P764; TORFS CP, 1986, AM J HUM GENET, V38, P170; TORFS CP, 1983, THESIS U CALIFORNIA; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x	27	187	187	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1989	45	4					541	546						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AW395	2491013				2022-12-18	WOS:A1989AW39500007
J	GENUARDI, M; TSIHIRA, H; ANDERSON, DE; SAUNDERS, GF				GENUARDI, M; TSIHIRA, H; ANDERSON, DE; SAUNDERS, GF			DISTAL DELETION OF CHROMOSOME-IP IN DUCTAL CARCINOMA OF THE BREAST	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT BIOCHEM & MOLEC BIOL,BOX 117,HOUSTON,TX 77030; UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT MOLEC GENET,HOUSTON,TX 77030	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center			Genuardi, Maurizio/K-3049-2018; , Otto/P-4127-2018	Genuardi, Maurizio/0000-0002-7410-8351; , Otto/0000-0003-2101-4105	NATIONAL CANCER INSTITUTE [R01CA029614] Funding Source: NIH RePORTER; NCI NIH HHS [CA 29614] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALI IU, 1987, SCIENCE, V238, P185, DOI 10.1126/science.3659909; ANDERSON DE, 1985, CYTOGENET CELL GENET, V40, P568; ANDERSON DE, 1977, CANCER-AM CANCER SOC, V40, P1855, DOI 10.1002/1097-0142(197710)40:4+<1855::AID-CNCR2820400814>3.0.CO;2-1; BISHOP DT, 1988, GENET EPIDEMIOL, V5, P151, DOI 10.1002/gepi.1370050303; BODMER WF, 1987, NATURE, V328, P614, DOI 10.1038/328614a0; BUROKER N, 1987, HUM GENET, V77, P175, DOI 10.1007/BF00272388; DAO DD, 1987, AM J HUM GENET, V41, P202; DARBY JK, 1985, AM J HUM GENET, V37, P52; DRACOPOLI NC, 1988, AM J HUM GENET, V43, P462; DUNN JM, 1988, SCIENCE, V241, P1797, DOI 10.1126/science.3175621; ESCOT C, 1986, P NATL ACAD SCI USA, V83, P4834, DOI 10.1073/pnas.83.13.4834; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FUNG YKT, 1987, SCIENCE, V236, P1657, DOI 10.1126/science.2885916; GENUARDI M, 1988, IMMUNOGENETICS, V28, P53, DOI 10.1007/BF00372530; GILBERT F, 1984, CANCER RES, V44, P5444; GREENE MH, 1983, P NATL ACAD SCI-BIOL, V80, P6071, DOI 10.1073/pnas.80.19.6071; GRUNDY P, 1988, NATURE, V336, P374, DOI 10.1038/336374a0; HUFF V, 1988, NATURE, V336, P377, DOI 10.1038/336377a0; JEFFREYS AJ, 1988, NATURE, V332, P278, DOI 10.1038/332278a0; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; JEFFREYS AJ, 1987, NUCLEIC ACIDS RES, V15, P2823, DOI 10.1093/nar/15.7.2823; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; KOVACS G, 1978, INT J CANCER, V21, P688, DOI 10.1002/ijc.2910210604; LARSSON C, 1988, NATURE, V332, P85, DOI 10.1038/332085a0; LAW DJ, 1988, SCIENCE, V241, P961, DOI 10.1126/science.2841761; LEE EYHP, 1988, SCIENCE, V241, P218, DOI 10.1126/science.3388033; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; LOWLER ML, 1986, CYTOGENET CELL GENET, V43, P103; LUNDBERG C, 1987, P NATL ACAD SCI USA, V84, P2372, DOI 10.1073/pnas.84.8.2372; LYNCH HT, 1986, CANCER GENET CYTOGEN, V22, P369, DOI 10.1016/0165-4608(86)90032-4; MARS WM, IN PRESS CANCER DETE; MATHEW CGP, 1987, NATURE, V328, P524, DOI 10.1038/328524a0; MATHEW CGP, 1987, NATURE, V328, P527, DOI 10.1038/328527a0; MORSE B, 1988, NATURE, V333, P87, DOI 10.1038/333087a0; NAKAMURA Y, 1987, NUCLEIC ACIDS RES, V15, P2537, DOI 10.1093/nar/15.6.2537; NAU MM, 1985, NATURE, V318, P69, DOI 10.1038/318069a0; NEWMAN B, 1988, P NATL ACAD SCI USA, V85, P3044, DOI 10.1073/pnas.85.9.3044; Nordenskjold M, 1988, Important Adv Oncol, P83; OCONNELL P, 1989, GENOMICS, V4, P12, DOI 10.1016/0888-7543(89)90308-X; PATHAK S, 1980, CANCER GENET CYTOGEN, V1, P281, DOI 10.1016/0165-4608(80)90025-4; PROCHOWNIK EV, 1983, J BIOL CHEM, V258, P8389; RODGERS CS, 1984, CANCER GENET CYTOGEN, V13, P95, DOI 10.1016/0165-4608(84)90052-9; ROULEAU GA, 1987, NATURE, V329, P246, DOI 10.1038/329246a0; SCHWARTZ AG, 1985, JNCI-J NATL CANCER I, V75, P665; SCRABLE HJ, 1987, NATURE, V329, P645, DOI 10.1038/329645a0; SEIZINGER BR, 1988, NATURE, V332, P268, DOI 10.1038/332268a0; SEIZINGER BR, 1987, P NATL ACAD SCI USA, V84, P5419, DOI 10.1073/pnas.84.15.5419; SIMPSON NE, 1987, NATURE, V328, P528, DOI 10.1038/328528a0; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; STOLER A, 1985, P NATL ACAD SCI USA, V82, P570, DOI 10.1073/pnas.82.2.570; TANG A, 1988, SCIENCE, V242, P236; TOGUCHIDA J, 1988, CANCER RES, V48, P3939; ULLRICH A, 1983, NATURE, V303, P821, DOI 10.1038/303821a0; WEICHSELBAUM RR, 1988, P NATL ACAD SCI USA, V85, P2106, DOI 10.1073/pnas.85.7.2106; YOKOTA J, 1987, P NATL ACAD SCI USA, V84, P9252, DOI 10.1073/pnas.84.24.9252	56	187	189	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1989	45	1					73	82						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AE779	2545098				2022-12-18	WOS:A1989AE77900009
J	Keupp, K; Beleggia, F; Kayserili, H; Barnes, AM; Steiner, M; Semler, O; Fischer, B; Yigit, G; Janda, CY; Becker, J; Breer, S; Altunoglu, U; Grunhagen, J; Krawitz, P; Hecht, J; Schinke, T; Makareeva, E; Lausch, E; Cankaya, T; Caparros-Martin, JA; Lapunzina, P; Temtamy, S; Aglan, M; Zabel, B; Eysel, P; Koerber, F; Leikin, S; Garcia, KC; Netzer, C; Schonau, E; Ruiz-Perez, VL; Mundlos, S; Amling, M; Kornak, U; Marini, J; Wollnik, B				Keupp, Katharina; Beleggia, Filippo; Kayserili, Hulya; Barnes, Aileen M.; Steiner, Magdalena; Semler, Oliver; Fischer, Bjoern; Yigit, Goekhan; Janda, Claudia Y.; Becker, Jutta; Breer, Stefan; Altunoglu, Umut; Gruenhagen, Johannes; Krawitz, Peter; Hecht, Jochen; Schinke, Thorsten; Makareeva, Elena; Lausch, Ekkehart; Cankaya, Tufan; Caparros-Martin, Jose A.; Lapunzina, Pablo; Temtamy, Samia; Aglan, Mona; Zabel, Bernhard; Eysel, Peer; Koerber, Friederike; Leikin, Sergey; Garcia, K. Christopher; Netzer, Christian; Schoenau, Eckhard; Ruiz-Perez, Victor L.; Mundlos, Stefan; Amling, Michael; Kornak, Uwe; Marini, Joan; Wollnik, Bernd			Mutations in WNT1 Cause Different Forms of Bone Fragility	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECESSIVE OSTEOGENESIS IMPERFECTA; OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME; MINERAL DENSITY; IN-VIVO; IDENTIFICATION; PROTOONCOGENE; METAANALYSIS; DISORDERS; FRACTURE; REVEALS	We report that hypofunctional alleles of WNT1 cause autosomal-recessive osteogenesis imperfecta, a congenital disorder characterized by reduced bone mass and recurrent fractures. In consanguineous families, we identified five homozygous mutations in WNT1: one frameshift mutation, two missense mutations, one splice-site mutation, and one nonsense mutation. In addition, in a family affected by dominantly inherited early-onset osteoporosis, a heterozygous WNT1 missense mutation was identified in affected individuals. Initial functional analysis revealed that altered WNT1 proteins fail to activate canonical LRP5-mediated WNT-regulated beta-catenin signaling. Furthermore, osteoblasts cultured in vitro showed enhanced Wnt1 expression with advancing differentiation, indicating a role of WNT1 in osteoblast function and bone development. Our finding that homozygous and heterozygous variants in WNT1 predispose to low-bone-mass phenotypes might advance the development of more effective therapeutic strategies for congenital forms of bone fragility, as well as for common forms of age-related osteoporosis.	[Keupp, Katharina; Beleggia, Filippo; Yigit, Goekhan; Becker, Jutta; Netzer, Christian; Wollnik, Bernd] Univ Cologne, Univ Hosp Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Keupp, Katharina; Beleggia, Filippo; Yigit, Goekhan; Wollnik, Bernd] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Keupp, Katharina; Beleggia, Filippo; Yigit, Goekhan; Wollnik, Bernd] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Kayserili, Hulya; Altunoglu, Umut] Istanbul Univ, Istanbul Fac Med, Dept Med Genet, TR-34093 Istanbul, Turkey; [Barnes, Aileen M.; Marini, Joan] NICHHD, Bone & Extracellular Matrix Branch, NIH, Bethesda, MD 20892 USA; [Steiner, Magdalena; Fischer, Bjoern; Gruenhagen, Johannes; Krawitz, Peter; Mundlos, Stefan; Kornak, Uwe] Charite, Inst Med Genet & Human Genet, D-13353 Berlin, Germany; [Semler, Oliver; Schoenau, Eckhard] Univ Cologne, Childrens Hosp, D-50931 Cologne, Germany; [Janda, Claudia Y.; Garcia, K. Christopher] Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Janda, Claudia Y.; Garcia, K. Christopher] Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Biol Struct, Stanford, CA 94305 USA; [Breer, Stefan; Schinke, Thorsten; Amling, Michael] Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech, D-20246 Hamburg, Germany; [Hecht, Jochen] Berlin Brandenburg Ctr Regenerat Therapies, D-13353 Berlin, Germany; [Makareeva, Elena; Leikin, Sergey] NICHHD, Sect Phys Biochem, NIH, Bethesda, MD 20892 USA; [Lausch, Ekkehart; Zabel, Bernhard] Univ Freiburg, Childrens Hosp, Div Genet, D-79106 Freiburg, Germany; [Cankaya, Tufan] Dokuz Eylul Univ, Fac Med, Dept Med Genet, TR-35210 Izmir, Turkey; [Caparros-Martin, Jose A.; Ruiz-Perez, Victor L.] CSIC, Inst Invest Biomed, E-28029 Madrid, Spain; [Caparros-Martin, Jose A.; Ruiz-Perez, Victor L.] Univ Autonoma Madrid, Madrid 28029, Spain; [Caparros-Martin, Jose A.; Lapunzina, Pablo; Ruiz-Perez, Victor L.] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras, Madrid 28029, Spain; [Lapunzina, Pablo] Univ Autonoma Madrid, Inst Genet Med & Mol, Inst Invest Hosp Univ La Paz, Madrid 28046, Spain; [Temtamy, Samia; Aglan, Mona] Natl Res Ctr, Human Genet & Genome Res Div, Cairo 12311, Egypt; [Eysel, Peer] Univ Cologne, Dept Orthopaed & Traumat Surg, D-50931 Cologne, Germany; [Koerber, Friederike] Univ Cologne, Dept Radiol, D-50931 Cologne, Germany; [Mundlos, Stefan; Kornak, Uwe] Max Planck Inst Mol Genet, D-14195 Berlin, Germany	University of Cologne; University of Cologne; University of Cologne; Istanbul University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Cologne; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Freiburg; Dokuz Eylul University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Autonomous University of Madrid; Hospital Universitario La Paz; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); University of Cologne; University of Cologne; Max Planck Society	Kornak, U (corresponding author), Charite, Inst Med Genet & Human Genet, D-13353 Berlin, Germany.	uwe.kornak@charite.de; bwollnik@uni-koeln.de	Caparros-Martin, José/L-4470-2014; Beleggia, Filippo/S-8481-2018; Fischer-Zirnsak, Björn/D-7487-2013; Kayserili, Hülya/AAA-5593-2021; Mundlos, Stefan/ABH-9585-2020; Wollnik, Bernd/GRY-6062-2022; Leikin, Sergey/A-5518-2008; Ruiz-Perez, Victor L/K-6066-2014; Makareeva, Elena/F-5183-2011; Krawitz, Peter M/F-3142-2012; Lapunzina, Pablo/L-7075-2014	Caparros-Martin, José/0000-0003-1214-4952; Fischer-Zirnsak, Björn/0000-0002-1075-7571; Kayserili, Hülya/0000-0003-0376-499X; Wollnik, Bernd/0000-0003-2589-0364; Leikin, Sergey/0000-0001-7095-0739; Ruiz-Perez, Victor L/0000-0003-0635-3619; Makareeva, Elena/0000-0002-5815-0760; Krawitz, Peter M/0000-0002-3194-8625; Beleggia, Filippo/0000-0003-0234-7094; temtamy, samia/0000-0002-6452-823X; Lapunzina, Pablo/0000-0002-6324-4825; Semler, Oliver/0000-0003-0029-7556; Altunoglu, Umut/0000-0002-3172-5368; aglan, mona/0000-0002-0908-0639; Mundlos, Stefan/0000-0002-9788-3166	German Federal Ministry of Education and Research [01GM1211A, 01GM1109C, 01EC1006A]; TUBITAK [112S398]; National Institute of Child Health and Human Development (National Institutes of Health); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000256] Funding Source: NIH RePORTER	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); National Institute of Child Health and Human Development (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We are grateful to all family members who participated in this study, to Esther Milz for excellent technical assistance, and to Karin Boss for critically reading the manuscript. We want to thank Claus-Eric Ott for help with cDNAs and Boi-Dinh Chung-Ueck for kindly providing expression vectors. This work was supported by German Federal Ministry of Education and Research grants 01GM1211A (E-RARE network CRANIRARE-2), 01GM1109C (national rare disease network Forschungsverbund Ausgewahlter Craniofacialer Entwicklungsstorungen) to B.W., and 01EC1006A (Molecular Pathogenesis of Osteoporosis) to U.K. and S.M., by TUBITAK grant 112S398 (E-RARE network CRANIRARE-2) to H.K., and by National Institute of Child Health and Human Development (National Institutes of Health) Intramural Research Program funding to S.L. and J.C.M. M.S. holds a Doc female forte scholarship from Austria and is a member of the Berlin-Brandenburg School for Regenerative Therapies.	Ai MR, 2005, AM J HUM GENET, V77, P741, DOI 10.1086/497706; Alanay Y, 2010, AM J HUM GENET, V86, P551, DOI 10.1016/j.ajhg.2010.02.022; Asharani PV, 2012, AM J HUM GENET, V90, P661, DOI 10.1016/j.ajhg.2012.02.026; Bazan JF, 2012, DEV CELL, V23, P227, DOI 10.1016/j.devcel.2012.07.011; Becker J, 2011, AM J HUM GENET, V88, P362, DOI 10.1016/j.ajhg.2011.01.015; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Boutroy S, 2005, J CLIN ENDOCR METAB, V90, P6508, DOI 10.1210/jc.2005-1258; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Christiansen HE, 2010, AM J HUM GENET, V86, P389, DOI 10.1016/j.ajhg.2010.01.034; Ellisor D, 2012, DEV BIOL, V372, P249, DOI 10.1016/j.ydbio.2012.09.019; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Forlino A, 2011, NAT REV ENDOCRINOL, V7, P540, DOI 10.1038/nrendo.2011.81; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Kamphans T, 2012, BIOINFORMATICS, V28, P2515, DOI 10.1093/bioinformatics/bts462; Laine CM, 2011, EUR J HUM GENET, V19, P875, DOI 10.1038/ejhg.2011.42; Lapunzina P, 2010, AM J HUM GENET, V87, P110, DOI 10.1016/j.ajhg.2010.05.016; Liu GZ, 2009, J CELL BIOL, V185, P67, DOI 10.1083/jcb.200810137; Mann V, 2003, BONE, V32, P711, DOI 10.1016/S8756-3282(03)00087-5; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; Martinez-Glez V, 2012, HUM MUTAT, V33, P343, DOI 10.1002/humu.21647; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Monroe DG, 2012, GENE, V492, P1, DOI 10.1016/j.gene.2011.10.044; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Perdu B, 2010, CRIT REV EUKAR GENE, V20, P195, DOI 10.1615/CritRevEukarGeneExpr.v20.i3.20; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Raisz LG, 1999, CLIN CHEM, V45, P1353; Ralston SH, 2010, ENDOCR REV, V31, P629, DOI 10.1210/er.2009-0044; Shaheen R, 2012, J MED GENET, V49, P630, DOI 10.1136/jmedgenet-2012-101142; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; THOMAS KR, 1991, CELL, V67, P969, DOI 10.1016/0092-8674(91)90369-A; Puig-Hervas MT, 2012, HUM MUTAT, V33, P1444, DOI 10.1002/humu.22133; van Dijk FS, 2009, AM J HUM GENET, V85, P521, DOI 10.1016/j.ajhg.2009.09.001; Zheng HF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002745	36	186	195	1	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR 4	2013	92	4					565	574		10.1016/j.ajhg.2013.02.010	http://dx.doi.org/10.1016/j.ajhg.2013.02.010			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	124FR	23499309	Bronze, Green Published			2022-12-18	WOS:000317449700008
J	Hill, C; Soares, P; Mormina, M; Macaulay, V; Clarke, D; Blumbach, PB; Vizuete-Forster, M; Forster, P; Bulbeck, D; Oppenheimer, S; Richards, M				Hill, Catherine; Soares, Pedro; Mormina, Maru; Macaulay, Vincent; Clarke, Dougie; Blumbach, Petya B.; Vizuete-Forster, Matthieu; Forster, Peter; Bulbeck, David; Oppenheimer, Stephen; Richards, Martin			A mitochondrial stratigraphy for island southeast Asia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA CONTROL REGION; POLYNESIAN ORIGINS; MTDNA VARIATION; ETHNIC POPULATIONS; GENETIC-EVIDENCE; SEQUENCE; POLYMORPHISM; EVOLUTION; LINEAGES; INSIGHTS	Island Southeast Asia (ISEA) was first colonized by modern humans at least 45,000 years ago, but the extent to which the modern inhabitants trace their ancestry to the first settlers is a matter of debate. It is widely held, in both archaeology and linguistics, that they are largely descended from a second wave of dispersal, proto-Austronesian-speaking agriculturalists who originated in China and spread to Taiwan similar to 5,500 years ago. From there, they are thought to have dispersed into ISEA similar to 4,000 years ago, assimilating the indigenous populations. Here, we demonstrate that mitochondrial DNA diversity in the region is extremely high and includes a large number of indigenous clades. Only a fraction of these date back to the time of first settlement, and the majority appear to mark dispersals in the late-Pleistocene or early-Holocene epoch most likely triggered by postglacial flooding. There are much closer genetic links to Taiwan than to the mainland, but most of these probably predated the mid-Holocene "Out of Taiwan" event as traditionally envisioned. Only similar to 20% at most of modern mitochondrial DNAs in ISEA could be linked to such an event, suggesting that, if an agriculturalist migration did take place, it was demographically minor, at least with regard to the involvement of women.	Univ Leeds, Fac Biol Sci, Inst Integrat & Comparat Biol, Leeds LS2 9JT, W Yorkshire, England; Univ Glasgow, Dept Stat, Glasgow, Lanark, Scotland; Univ Huddersfield, Dept Chem & Biol Sci, Huddersfield HD1 3DH, W Yorkshire, England; Univ Cambridge, McDonald Inst Archaeol Res, Cambridge, England; Australian Natl Univ, Sch Archaeol & Anthropol, Canberra, ACT, Australia; Univ Oxford, Dept Anthropol, Oxford, England	University of Leeds; University of Glasgow; University of Huddersfield; University of Cambridge; Australian National University; University of Oxford	Richards, M (corresponding author), Univ Leeds, Fac Biol Sci, Inst Integrat & Comparat Biol, LC Miall Bldg, Leeds LS2 9JT, W Yorkshire, England.	m.b.richards@leeds.ac.uk	Mormina, Maru/HGC-2853-2022; Soares, Pedro A/G-9422-2011	Soares, Pedro A/0000-0002-2807-690X; RICHARDS, MARTIN/0000-0003-3118-0967; Mormina, Maru/0000-0002-5836-8989; Clarke, Douglas/0000-0001-7281-8766				Anderson A., 2005, J AUSTRONESIAN STUDI, V1, P25; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 2002, AM J HUM GENET, V71, P1150, DOI 10.1086/344397; BARKER G, 2002, P PREHIST SOC, V68, P147, DOI [10.1017/s0079497x00001481, DOI 10.1017/S0079497X00001481]; Bellwood P., 1997, PREHISTORY INDO MALA, VRevised; Bellwood P., 1992, ASIAN PERSPECT, V31, P161; Bellwood P., 2002, EXAMINING FARMING LA, P275; Bellwood P., 2005, 1 FARMERS ORIGINS AG; Betty DJ, 1996, AM J HUM GENET, V58, P428; Bird MI, 2005, QUATERNARY SCI REV, V24, P2228, DOI 10.1016/j.quascirev.2005.04.004; BLUST R, 1996, PREHISTORIC SETTLEME, P28; Capelli C, 2001, AM J HUM GENET, V68, P432, DOI 10.1086/318205; Comas D, 1998, AM J HUM GENET, V63, P1824, DOI 10.1086/302133; Detroit F, 2004, CR PALEVOL, V3, P705, DOI 10.1016/j.crpv.2004.06.004; DETROIT F, 2006, AUSTRONESIAN DIASPOR; EESINK G, 2005, PAPUAN PASTS CULTURA, P185; Forster P, 1996, AM J HUM GENET, V59, P935; Friedlaender J, 2005, MOL BIOL EVOL, V22, P1506, DOI 10.1093/molbev/msi142; Fucharoen G, 2001, J HUM GENET, V46, P115, DOI 10.1007/s100380170098; Greenhill S, 2005, EVOLUTION CULTURAL D, P31; HERTZBERG M, 1989, AM J HUM GENET, V44, P504; Hill C, 2006, MOL BIOL EVOL, V23, P2480, DOI 10.1093/molbev/msl124; Horai S, 1996, AM J HUM GENET, V59, P579; HORAI S, 1990, AM J HUM GENET, V46, P828; Hunt CO, 2005, QUATERNARY RES, V64, P460, DOI 10.1016/j.yqres.2005.08.010; Hurles ME, 2002, GENETICS, V160, P289; Kayser M, 2000, CURR BIOL, V10, P1237, DOI 10.1016/S0960-9822(00)00734-X; Kayser M, 2003, AM J HUM GENET, V72, P281, DOI 10.1086/346065; Kayser M, 2001, AM J HUM GENET, V68, P173, DOI 10.1086/316949; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996; Kolman CJ, 1996, GENETICS, V142, P1321; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Lee SD, 1997, FORENSIC SCI INT, V87, P99, DOI 10.1016/S0379-0738(97)02114-2; LUM JK, 1994, HUM BIOL, V66, P567; Lum JK, 1998, AM J HUM GENET, V63, P613, DOI 10.1086/301949; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; MEACHAM W, 1984, ASIAN PERSPECT, V26, P89; MELTON T, 1995, AM J HUM GENET, V57, P403; Melton T, 1998, AM J HUM GENET, V63, P1807, DOI 10.1086/302131; Nishimaki Y, 1999, Leg Med (Tokyo), V1, P238, DOI 10.1016/S1344-6223(99)80044-3; Oota H, 2001, HUM BIOL, V73, P225, DOI 10.1353/hub.2001.0023; Oppenheimer SJ, 2001, NATURE, V410, P166, DOI 10.1038/35065520; OPPENHEIMER SJ, 1998, EDEN E; Oppenheimer Stephen, 2001, Science Progress, V84, P157, DOI 10.3184/003685001783238989; Pawley A., 2002, EXAMINING LANGUAGE F, P251; Pfeiffer H, 1998, INT J LEGAL MED, V111, P309, DOI 10.1007/s004140050177; Pierson MJ, 2006, MOL BIOL EVOL, V23, P1966, DOI 10.1093/molbev/msl063; Prasad BVR, 2001, HUM BIOL, V73, P715; Qian YP, 2001, J HUM GENET, V46, P211, DOI 10.1007/s100380170091; REDD AJ, 1995, MOL BIOL EVOL, V12, P604; Richards M, 1998, AM J HUM GENET, V63, P1234, DOI 10.1086/302043; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 2002, AM J HUM GENET, V71, P1168, DOI 10.1086/342930; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; SCHUTLER R, 1975, ARCHAEOL PHYS ANTHR, V10, P81; SCNEIDER S, 2000, ARLEQUIN SOFTWARE PO; Seo Y, 1998, FORENSIC SCI INT, V97, P155, DOI 10.1016/S0379-0738(98)00153-4; Solheim W.G., 2006, ARCHAEOLOGY CULTURE; SOLHEIM WG, 1994, HIST HUMANITY, V1, P468; Spriggs M., 2003, REV ARCHAEOLOGY, V24, P57; Su B, 2000, P NATL ACAD SCI USA, V97, P8225, DOI 10.1073/pnas.97.15.8225; SYKES B, 1995, AM J HUM GENET, V57, P1463; Szabo K, 2004, WORLD ARCHAEOL, V36, P621, DOI 10.1080/0043824042000303809; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; Terrell JE, 1997, ANTIQUITY, V71, P548, DOI 10.1017/S0003598X0008532X; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; Trejaut JA, 2005, PLOS BIOL, V3, P1362, DOI 10.1371/journal.pbio.0030247; Trivedi R, 2006, J HUM GENET, V51, P217, DOI 10.1007/s10038-005-0349-2; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Wen B, 2004, NATURE, V431, P302, DOI 10.1038/nature02878; Wen B, 2005, MOL BIOL EVOL, V22, P725, DOI 10.1093/molbev/msi055; WOLFF J, 1995, I HIST PHILOLOGY S S, V3; Yao YG, 2002, AM J PHYS ANTHROPOL, V118, P63, DOI 10.1002/ajpa.10052; Yao YG, 2002, J HUM GENET, V47, P311, DOI 10.1007/s100380200042; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; ZAINUDDIN Z, 2003, PROG FORENSIC GENET, V10, P428; Zeitoun Elizabeth, 1999, SELECTED PAPERS 8 IN, P31	79	186	194	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2007	80	1					29	43		10.1086/510412	http://dx.doi.org/10.1086/510412			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	120RG	17160892	Green Published, Bronze			2022-12-18	WOS:000243102500004
J	Groman, JD; Hefferon, TW; Casals, T; Bassas, LS; Estivill, X; Des Georges, M; Guittard, C; Koudova, M; Fallin, MD; Nemeth, K; Fekete, G; Kadasi, L; Friedman, K; Schwarz, M; Bombieri, C; Pignatti, PF; Kanavakis, E; Tzetis, M; Schwartz, M; Novelli, G; D'Apice, MR; Sobczynska-Tomaszewska, A; Bal, J; Stuhrmann, M; Macek, M; Claustres, M; Cutting, GR				Groman, JD; Hefferon, TW; Casals, T; Bassas, LS; Estivill, X; Des Georges, M; Guittard, C; Koudova, M; Fallin, MD; Nemeth, K; Fekete, G; Kadasi, L; Friedman, K; Schwarz, M; Bombieri, C; Pignatti, PF; Kanavakis, E; Tzetis, M; Schwartz, M; Novelli, G; D'Apice, MR; Sobczynska-Tomaszewska, A; Bal, J; Stuhrmann, M; Macek, M; Claustres, M; Cutting, GR			Variation in a repeat sequence determines whether a common variant of the cystic fibrosis transmembrane conductance regulator gene is pathogenic or benign	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CFTR GENE; CONGENITAL ABSENCE; VAS-DEFERENS; EXON-9	An abbreviated tract of five thymidines (5T) in intron 8 of the cystic fibrosis transmembrane conductance regulator ( CFTR) gene is found in similar to 10% of individuals in the general population. When found in trans with a severe CFTR mutation, 5T can result in male infertility, nonclassic cystic fibrosis, or a normal phenotype. To test whether the number of TG repeats adjacent to 5T influences disease penetrance, we determined TG repeat number in 98 patients with male infertility due to congenital absence of the vas deferens, 9 patients with nonclassic CF, and 27 unaffected individuals ( fertile men). Each of the individuals in this study had a severe CFTR mutation on one CFTR gene and 5T on the other. Of the unaffected individuals, 78% ( 21 of 27) had 5T adjacent to 11 TG repeats, compared with 9% ( 10 of 107) of affected individuals. Conversely, 91% ( 97 of 107) of affected individuals had 12 or 13 TG repeats, versus only 22% ( 6 of 27) of unaffected individuals (P < .00001). Those individuals with 5T adjacent to either 12 or 13 TG repeats were substantially more likely to exhibit an abnormal phenotype than those with 5T adjacent to 11 TG repeats ( odds ratio 34.0, 95% CI 11.1 - 103.7, P < .00001). Thus, determination of TG repeat number will allow for more accurate prediction of benign versus pathogenic 5T alleles.	Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Training Program Human Genet, Baltimore, MD 21287 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; Hosp Duran & Reynals, Inst Recerca Oncol, Med & Mol Genet Ctr, Barcelona, Spain; Fundacio Puigvert, Inst Urol, Barcelona, Spain; Ctr Regulacio Genom, Genes & Dis Program, Barcelona, Spain; CHU Montpellier, IURC, Genet Mol Lab, Montpellier, France; Charles Univ, Sch Med 2, Cyst Fibrosis Ctr, Inst Biol & Med Genet, Prague, Czech Republic; Charles Univ, Univ Hosp Motol, Prague, Czech Republic; Semmelweis Univ, Dept Pediat, Budapest, Hungary; Slovak Acad Sci, Inst Mol Physiol & Genet, Bratislava 83334, Slovakia; Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA; Royal Manchester Childrens Hosp, Genet Mol Lab, Manchester M27 1HA, Lancs, England; Univ Verona, Dept Mother & Child, Sect Biol & Genet, I-37100 Verona, Italy; Univ Athens, St Sophias Childrens Hosp, Dept Med Genet, Athens, Greece; Rigshosp, Dept Clin Genet, DK-2100 Copenhagen, Denmark; Univ Roma Tor Vergata, Dipartimento Biopatol & Diagnost Immagini, Rome, Italy; Inst Mother & Child Hlth, Dept Med Genet, Warsaw, Poland; Hannover Med Sch, Inst Humangenet, Hannover, Germany	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; Fundacio Puigvert; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Universite de Montpellier; CHU de Montpellier; Charles University Prague; Charles University Prague; Motol University Hospital; Semmelweis University; Slovak Academy of Sciences; University of North Carolina; University of North Carolina Chapel Hill; Royal Manchester Children's Hospital; University of Verona; National & Kapodistrian University of Athens; Rigshospitalet; University of Copenhagen; University of Rome Tor Vergata; Hannover Medical School	Cutting, GR (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Training Program Human Genet, CMSC 9-125,600 N Wolfe St, Baltimore, MD 21287 USA.		Novelli, Giuseppe/T-8822-2019; Novelli, Giuseppe/A-5195-2013; Casals, Teresa/K-4587-2012; Kadasi, Ludevit/A-4677-2013; Estivill, Xavier/A-3125-2013; Novelli, Giuseppe/GQB-3329-2022; Estivill, Xavier/E-2957-2012; Tzetis, Maria/K-5220-2012; Bal, Jerzy/V-1129-2019	Novelli, Giuseppe/0000-0002-7781-602X; Casals, Teresa/0000-0001-6078-2823; Estivill, Xavier/0000-0002-0723-2256; Novelli, Giuseppe/0000-0002-7781-602X; Tzetis, Maria/0000-0002-6810-2922; Bal, Jerzy/0000-0001-7638-5128; D'Apice, Maria Rosaria/0000-0002-8467-5667	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK044003, R01DK044003] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL68927, R01 HL068927] Funding Source: Medline; NIDDK NIH HHS [R37 DK044003, R01 DK044003, DK44003] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CHILLON M, 1995, NEW ENGL J MED, V332, P1475, DOI 10.1056/NEJM199506013322204; CHU CS, 1993, NAT GENET, V3, P151, DOI 10.1038/ng0293-151; Cuppens H, 1998, J CLIN INVEST, V101, P487, DOI 10.1172/JCI639; de Meeus A, 1998, J MED GENET, V35, P594, DOI 10.1136/jmg.35.7.594; HEFFERON TW, IN PRESS P NATL ACAD; Niksic M, 1999, HUM MOL GENET, V8, P2339, DOI 10.1093/hmg/8.13.2339; Noone PG, 2000, AM J RESP CRIT CARE, V162, P1919, DOI 10.1164/ajrccm.162.5.2003160; Rosenstein BJ, 1998, J PEDIATR-US, V132, P589, DOI 10.1016/S0022-3476(98)70344-0; Strom CM, 2002, GENET MED, V4, P289, DOI 10.1097/00125817-200207000-00007; ZIELENSKI J, 1995, AM J HUM GENET, V57, P958	10	186	197	1	12	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2004	74	1					176	179		10.1086/381001	http://dx.doi.org/10.1086/381001			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	759DR	14685937	Green Published, Bronze			2022-12-18	WOS:000187723500017
J	Beales, PL; Badano, JL; Ross, AJ; Ansley, SJ; Hoskins, BE; Kirsten, B; Mein, CA; Froguel, P; Scambler, PJ; Lewis, RA; Lupski, JR; Katsanis, N				Beales, PL; Badano, JL; Ross, AJ; Ansley, SJ; Hoskins, BE; Kirsten, B; Mein, CA; Froguel, P; Scambler, PJ; Lewis, RA; Lupski, JR; Katsanis, N			Genetic interaction of BBS1 mutations with alleles at other BBS loci can result in non-Mendelian Bardet-Biedl syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN OBESITY SYNDROME; MCKUSICK-KAUFMAN-SYNDROME; TRIALLELIC INHERITANCE; CHROMOSOME 16Q; IDENTIFICATION; LINKAGE; FAMILIES; INTERVAL; DISEASES; PROTEIN	Bardet-Biedl syndrome is a genetically and clinically heterogeneous disorder caused by mutations in at least seven loci (BBS1-7), five of which are cloned (BBS1, BBS2, BBS4, BBS6, and BBS7). Genetic and mutational analyses have indicated that, in some families, a combination of three mutant alleles at two loci (triallelic inheritance) is necessary for pathogenesis. To date, four of the five known BBS loci have been implicated in this mode of oligogenic disease transmission. We present a comprehensive analysis of the spectrum, distribution, and involvement in non-Mendelian trait transmission of mutant alleles in BBS1, the most common BBS locus. Analyses of 259 independent families segregating a BBS phenotype indicate that BBS1 participates in complex inheritance and that, in different families, mutations in BBS1 can interact genetically with mutations at each of the other known BBS genes, as well as at unknown loci, to cause the phenotype. Consistent with this model, we identified homozygous M390R alleles, the most frequent BBS1 mutation, in asymptomatic individuals in two families. Moreover, our statistical analyses indicate that the prevalence of the M390R allele in the general population is consistent with an oligogenic rather than a recessive model of disease transmission. The distribution of BBS oligogenic alleles also indicates that all BBS loci might interact genetically with each other, but some genes, especially BBS2 and BBS6, are more likely to participate in triallelic inheritance, suggesting a variable ability of the BBS proteins to interact genetically with each other.	Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21287 USA; UCL, Mol Med Unit, Inst Child Hlth, London, England; Barts & London Queen Marys Sch Med & Dent, Genome Ctr, Barts & London, London, England; Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21218 USA; Inst Pasteur, CNR, Inst Biol, F-59019 Lille, France; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Johns Hopkins University; University of London; University College London; University of London; Queen Mary University London; Johns Hopkins University; Johns Hopkins Medicine; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Katsanis, N (corresponding author), Johns Hopkins Univ, McKusick Nathans Inst Genet Med, 600 N Wolfe St,2-127 Jefferson St Bldg, Baltimore, MD 21287 USA.	katsanis@jhmi.edu	FROGUEL, Philippe/O-6799-2017; Scambler, Peter/AAZ-6026-2020; Beales, Philip L/C-7367-2009; Katsanis, Nicholas/E-1837-2012; Scambler, Peter J/C-4998-2008	FROGUEL, Philippe/0000-0003-2972-0784; Scambler, Peter/0000-0002-1487-4628; Scambler, Peter J/0000-0002-1487-4628; Katsanis, Nicholas/0000-0002-2480-0171; Mein, Charles/0000-0003-0811-9658; Badano, Jose/0000-0002-0706-8652	MRC [G0000477] Funding Source: UKRI; NATIONAL EYE INSTITUTE [R01EY013255] Funding Source: NIH RePORTER; Medical Research Council [G0000477] Funding Source: Medline; NEI NIH HHS [R01 EY013255, R01 EY13255] Funding Source: Medline; NICHD NIH HHS [R01 HD04260] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDERSON KL, 1997, J RARE DIS, V3, P5; Badano JL, 2002, NAT REV GENET, V3, P779, DOI 10.1038/nrg910; Badano JL, 2003, AM J HUM GENET, V72, P650, DOI 10.1086/368204; Beales PL, 1999, J MED GENET, V36, P437; Beales PL, 1997, J MED GENET, V34, P92, DOI 10.1136/jmg.34.2.92; Beales PL, 2001, AM J HUM GENET, V68, P606, DOI 10.1086/318794; Bolk S, 2000, P NATL ACAD SCI USA, V97, P268, DOI 10.1073/pnas.97.1.268; Bruford EA, 1997, GENOMICS, V41, P93, DOI 10.1006/geno.1997.4613; CARMI R, 1995, HUM MOL GENET, V4, P9, DOI 10.1093/hmg/4.1.9; CROFT JB, 1995, AM J MED GENET, V55, P12, DOI 10.1002/ajmg.1320550105; GREEN JS, 1989, NEW ENGL J MED, V321, P1002, DOI 10.1056/NEJM198910123211503; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Katsanis N, 1998, GENOMICS, V47, P294, DOI 10.1006/geno.1997.5115; Katsanis N, 1999, AM J HUM GENET, V65, P1672, DOI 10.1086/302684; Katsanis N, 2002, AM J HUM GENET, V71, P22, DOI 10.1086/341031; Katsanis N, 2001, HUM MOL GENET, V10, P2293, DOI 10.1093/hmg/10.20.2293; Katsanis N, 2000, NAT GENET, V26, P67, DOI 10.1038/79201; KLEIN D, 1969, J NEUROL SCI, V9, P479, DOI 10.1016/0022-510X(69)90091-4; KWITEKBLACK AE, 1993, NAT GENET, V5, P392, DOI 10.1038/ng1293-392; LEPPERT M, 1994, NAT GENET, V7, P108, DOI 10.1038/ng0594-108; Ming JE, 2002, AM J HUM GENET, V71, P1017, DOI 10.1086/344412; Mykytyn K, 2003, AM J HUM GENET, V72, P429, DOI 10.1086/346172; Mykytyn K, 2002, NAT GENET, V31, P435, DOI 10.1038/ng935; Mykytyn K, 2001, NAT GENET, V28, P188, DOI 10.1038/88925; Nishimura DY, 2001, HUM MOL GENET, V10, P865, DOI 10.1093/hmg/10.8.865; Ramoz N, 2002, NAT GENET, V32, P579, DOI 10.1038/ng1044; SCHACHAT AP, 1982, ARCH OPHTHALMOL-CHIC, V100, P285; SHEFFIELD VC, 1994, HUM MOL GENET, V3, P1331, DOI 10.1093/hmg/3.8.1331; Slavotinek AM, 2000, NAT GENET, V26, P15, DOI 10.1038/79116; Slavotinek AM, 2002, HUM GENET, V110, P561, DOI 10.1007/s00439-002-0733-3; Stone DL, 2000, NAT GENET, V25, P79, DOI 10.1038/75637; Wang Q, 2001, Ophthalmic Genet, V22, P133, DOI 10.1076/opge.22.3.133.2224; Young TL, 1999, AM J HUM GENET, V64, P900, DOI 10.1086/302301; Young TL, 1999, AM J HUM GENET, V65, P1680, DOI 10.1086/302686	34	186	194	1	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2003	72	5					1187	1199		10.1086/375178	http://dx.doi.org/10.1086/375178			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671PZ	12677556	Green Published, Bronze			2022-12-18	WOS:000182474400011
J	Visapaa, I; Fellman, V; Vesa, J; Dasvarma, A; Hutton, JL; Kumar, V; Payne, GS; Makarow, M; Van Coster, R; Taylor, RW; Turnbull, DM; Suomalainen, A; Peltonen, L				Visapaa, I; Fellman, V; Vesa, J; Dasvarma, A; Hutton, JL; Kumar, V; Payne, GS; Makarow, M; Van Coster, R; Taylor, RW; Turnbull, DM; Suomalainen, A; Peltonen, L			GRACILE syndrome, a lethal metabolic disorder with iron overload, is caused by a point mutation in BCS1L	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYTOCHROME-B GENE; MITOCHONDRIAL RESPIRATORY-CHAIN; COMPLEX-III DEFICIENCY; SACCHAROMYCES-CEREVISIAE; LACTIC-ACIDOSIS; PROTEIN; DNA; IDENTIFICATION; EXPRESSION; DISEASE	GRACILE (growth retardation, aminoaciduria, cholestasis, iron overload, lactacidosis, and early death) syndrome is a recessively inherited lethal disease characterized by fetal growth retardation, lactic acidosis, aminoaciduria, cholestasis, and abnormalities in iron metabolism. We previously localized the causative gene to a 1.5-cM region on chromosome 2q33-37. In the present study, we report the molecular defect causing this metabolic disorder, by identifying a homozygous missense mutation that results in an S78G amino acid change in the BCS1L gene in Finnish patients with GRACILE syndrome, as well as five different mutations in three British infants. BCS1L, a mitochondrial inner-membrane protein, is a chaperone necessary for the assembly of mitochondrial respiratory chain complex III. Pulse-chase experiments performed in COS-1 cells indicated that the S78G amino acid change results in instability of the polypeptide, and yeast complementation studies revealed a functional defect in the mutated BCS1L protein. Four different mutations in the BCS1L gene have been reported elsewhere, in Turkish patients with a distinctly different phenotype. Interestingly, the British and Turkish patients had complex III deficiency, whereas in the Finnish patients with GRACILE syndrome complex III activity was within the normal range, implying that BCS1L has another cellular function that is uncharacterized but essential and is putatively involved in iron metabolism.	Natl Publ Hlth Inst, Dept Mol Med, Biomedicum, FIN-00290 Helsinki, Finland; Univ Calif Los Angeles, Sch Med, Dept Human Genet, Los Angeles, CA USA; Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA USA; Univ Helsinki, Dept Med Genet, Helsinki, Finland; Univ Helsinki, Inst Biotechnol, Helsinki, Finland; Univ Helsinki, Dept Neurol, Helsinki, Finland; Univ Helsinki, Programme Neurosci, Helsinki, Finland; Univ Helsinki, Cent Hosp, Hosp Children & Adolescents, Helsinki, Finland; Murdoch Childrens Res Inst, Melbourne, Vic, Australia; Ghent Univ Hosp, Dept Pediat, Ghent, Belgium; Univ Newcastle Upon Tyne, Dept Neurol, Newcastle Upon Tyne, Tyne & Wear, England	Finland National Institute for Health & Welfare; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Murdoch Children's Research Institute; Ghent University; Ghent University Hospital; Newcastle University - UK	Peltonen, L (corresponding author), Natl Publ Hlth Inst, Dept Mol Med, Biomedicum, Haartmaninkatu 8,POB 104, FIN-00290 Helsinki, Finland.			Suomalainen-Wartiovaara, Anu/0000-0003-4833-5195				ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404; BIRCHMACHIN MA, 1989, PEDIATR RES, V25, P553, DOI 10.1203/00006450-198905000-00025; Cruciat CM, 1999, EMBO J, V18, P5226, DOI 10.1093/emboj/18.19.5226; de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706; Fellman V, 2002, ACTA OBSTET GYN SCAN, V81, P398, DOI 10.1034/j.1600-0412.2001.810504.x; Fellman V, 1998, LANCET, V351, P490, DOI 10.1016/S0140-6736(97)09272-6; Folsch H, 1996, EMBO J, V15, P479, DOI 10.1002/j.1460-2075.1996.tb00380.x; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Keightley JA, 2000, AM J HUM GENET, V67, P1400, DOI 10.1086/316900; Legros F, 2001, EUR J HUM GENET, V9, P510, DOI 10.1038/sj.ejhg.5200678; MAJANDER A, 1995, J NEUROL SCI, V134, P95, DOI 10.1016/0022-510X(95)00225-5; Marchler-Bauer A, 2002, NUCLEIC ACIDS RES, V30, P281, DOI 10.1093/nar/30.1.281; Mitsuhashi N, 2000, J BIOL CHEM, V275, P17536, DOI 10.1074/jbc.275.23.17536; MORRIS AAM, 1995, PEDIATR NEPHROL, V9, P407, DOI 10.1007/BF00866711; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; Muhlenhoff U, 2000, BBA-BIOENERGETICS, V1459, P370, DOI 10.1016/S0005-2728(00)00174-2; NOBREGA FG, 1992, EMBO J, V11, P3821, DOI 10.1002/j.1460-2075.1992.tb05474.x; NORIO R, 1973, ANN CLIN RES, V5, P109; Papadopoulou LC, 1999, NAT GENET, V23, P333; Pastinen T, 2001, HUM MOL GENET, V10, P2961, DOI 10.1093/hmg/10.26.2961; Peltonen L, 1999, HUM MOL GENET, V8, P1913, DOI 10.1093/hmg/8.10.1913; Petruzzella V, 1998, GENOMICS, V54, P494, DOI 10.1006/geno.1998.5580; Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798; Rapola J, 2002, PEDIATR PATHOL MOL M, V21, P183, DOI 10.1080/15227950252852087; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; SIKORSKI RS, 1989, GENETICS, V122, P19; SYVANEN AC, 1993, AM J HUM GENET, V52, P46; Visapaa I, 1998, AM J HUM GENET, V63, P1396, DOI 10.1086/302123; Visapaa I, 2002, AM J MED GENET, V109, P202, DOI 10.1002/ajmg.10331; Wibrand F, 2001, ANN NEUROL, V50, P540, DOI 10.1002/ana.1224	31	186	193	0	11	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2002	71	4					863	876		10.1086/342773	http://dx.doi.org/10.1086/342773			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	604HT	12215968	Bronze, Green Published			2022-12-18	WOS:000178613800014
J	Kohl, S; Baumann, B; Rosenberg, T; Kellner, U; Lorenz, B; Vadala, M; Jacobson, SG; Wissinger, B				Kohl, S; Baumann, B; Rosenberg, T; Kellner, U; Lorenz, B; Vadala, M; Jacobson, SG; Wissinger, B			Mutations in the cone photoreceptor G-protein alpha-subunit gene GNAT2 in patients with achromatopsia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TOTAL COLOURBLINDNESS; ROD TRANSDUCIN; DISEASE; CHANNEL	Achromatopsia is an autosomal recessively inherited visual disorder that is present from birth and that features the absence of color discrimination. We here report the identification of five independent families with achromatopsia that segregate protein-truncation mutations in the GNAT2 gene, located on chromosome 1p13. GNAT2 encodes the cone photoreceptor-specific alpha-subunit of transducin, a G-protein of the phototransduction cascade, which couples to the visual pigment(s). Our results demonstrate that GNAT2 is the third gene implicated in achromatopsia.	Univ Tubingen, Augenklin, Mol Genet Lab, D-72076 Tubingen, Germany; Natl Eye Clin Visually Impaired, Copenhagen, Denmark; Free Univ Berlin, Univ Klinikum Benjamin Franklin, D-1000 Berlin, Germany; Univ Regensburg Klinikum, Dept Pediat Ophthalmol & Ophthalmogenet, Regensburg, Germany; Univ Palermo, Clin Oculist, Palermo, Italy; Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Regensburg; University of Palermo; University of Pennsylvania; Pennsylvania Medicine	Wissinger, B (corresponding author), Univ Tubingen, Augenklin, Mol Genet Lab, Morgenstelle 15, D-72076 Tubingen, Germany.		Vadalà, Maria/AAT-1084-2021	Jacobson, Samuel/0000-0003-2122-169X; VADALA', Maria/0000-0002-2726-698X; Kohl, Susanne/0000-0002-6438-6331				BLATT C, 1988, P NATL ACAD SCI USA, V85, P7642, DOI 10.1073/pnas.85.20.7642; Cai K, 2001, P NATL ACAD SCI USA, V98, P4877, DOI 10.1073/pnas.051632898; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; den Dunnen JT, 2001, HUM GENET, V109, P121, DOI 10.1007/s004390100505; Dryja TP, 1996, NAT GENET, V13, P358, DOI 10.1038/ng0796-358; Francois J., 1961, HEREDITY OPHTHALMOLO; GERBER S, 1995, HUM GENET, V95, P382; Kohl S, 1998, NAT GENET, V19, P257, DOI 10.1038/935; Kohl S, 2000, HUM MOL GENET, V9, P2107, DOI 10.1093/hmg/9.14.2107; KUBO M, 1991, FEBS LETT, V291, P245, DOI 10.1016/0014-5793(91)81294-I; LEREA CL, 1986, SCIENCE, V234, P77, DOI 10.1126/science.3529395; LEREA CL, 1989, NEURON, V3, P367, DOI 10.1016/0896-6273(89)90261-4; MAGOVCEVIC I, 1995, GENOMICS, V25, P288, DOI 10.1016/0888-7543(95)80139-D; MORRIS TA, 1993, GENOMICS, V17, P442, DOI 10.1006/geno.1993.1345; Muller F, 1998, NATURWISSENSCHAFTEN, V85, P49, DOI 10.1007/s001140050453; Sundin OH, 2000, NAT GENET, V25, P289, DOI 10.1038/77162; Wissinger B, 2001, AM J HUM GENET, V69, P722, DOI 10.1086/323613	17	186	195	0	28	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2002	71	2					422	425		10.1086/341835	http://dx.doi.org/10.1086/341835			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	575ZE	12077706	Bronze, Green Published			2022-12-18	WOS:000176977700021
J	Berry, R; Schroeder, JJ; French, AJ; McDonnell, SK; Peterson, BJ; Cunningham, JM; Thibodeau, SN; Schaid, DJ				Berry, R; Schroeder, JJ; French, AJ; McDonnell, SK; Peterson, BJ; Cunningham, JM; Thibodeau, SN; Schaid, DJ			Evidence for a prostate cancer-susceptibillty locus on chromosome 20	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; LINKAGE ANALYSIS; FAMILY HISTORY; HIGH-RISK; GENE; 1Q42.2-43; 1Q; INHERITANCE; CARCINOMAS; PATTERNS	Recent studies suggest that hereditary prostate cancer is a complex disease involving multiple susceptibility genes and variable phenotypic expression, While conducting a genomewide search on 162 North American families with greater than or equal to 3 members affected with prostate cancer (PRCA), we found evidence for linkage to chromosome 20q13 with two-point parametric LOD scores >1 at multiple sites, with the highest two-point LOD score of 2.69 for marker D20S196. The maximum multipoint NPL score for the entire data set was 3.02 (P =.002) at D20S887, On the basis of findings from previous reports, families were stratified by the presence (n = 116) or absence (n = 46) of male-to-male transmission, average age of diagnosis (<66 pears, n = 73; greater than or equal to 66 years, n = 89), and number of affected individuals (<5, n = 101; greater than or equal to 5, n = 61) for further analysis. The strongest evidence of linkage was evident with the pedigrees having <5 family members affected with prostate cancer (multipoint NPL 3.22, P=.00079), a later average age of diagnosis (multipoint NPL 3.40, P=.0006), and no male-to-male transmission (multipoint NPL 3.94, P =.00007). The group of patients having all three of these characteristics (n = 19) had a multipoint NPL score of 3.63 (P =.0001). These results demonstrate evidence for a PRCA susceptibility locus in a subset of families that is distinct from the groups more likely to be linked to previously identified loci.	Mayo Clin & Mayo Fdn, Dept Lab Med & Pathol, Genet Lab, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Thibodeau, SN (corresponding author), Mayo Clin & Mayo Fdn, Dept Lab Med & Pathol, Genet Lab, HI 970,200 1st St SW, Rochester, MN 55905 USA.			McDonnell, Shannon/0000-0001-6201-369X	NCI NIH HHS [P30 CA015083, R01 CA072818, N01 CA015083, CA72818] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA015083, R01CA072818] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Berry R, 2000, AM J HUM GENET, V66, P539, DOI 10.1086/302771; Berthon P, 1998, AM J HUM GENET, V62, P1416, DOI 10.1086/301879; Bockmuhl U, 1997, CANCER RES, V57, P5213; Cannon L., 1982, CANCER SURV, V1, P47; CARTER BS, 1990, PROSTATE, V16, P187, DOI 10.1002/pros.2990160302; CARTER BS, 1992, P NATL ACAD SCI USA, V89, P3367, DOI 10.1073/pnas.89.8.3367; Cooney KA, 1997, J NATL CANCER I, V89, P955, DOI 10.1093/jnci/89.13.955; Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; Eeles RA, 1998, AM J HUM GENET, V62, P653, DOI 10.1086/301745; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Gibbs M, 1999, AM J HUM GENET, V64, P776, DOI 10.1086/302287; Gibbs M, 1999, AM J HUM GENET, V64, P1087, DOI 10.1086/302342; GOLDGAR DE, 1994, J NATL CANCER I, V86, P1600, DOI 10.1093/jnci/86.21.1600; Gray MD, 1997, NAT GENET, V17, P100, DOI 10.1038/ng0997-100; Gronberg H, 1997, CANCER RES, V57, P4707; HALL JG, 1990, AM J HUM GENET, V46, P857; Hayward BE, 1998, P NATL ACAD SCI USA, V95, P15475, DOI 10.1073/pnas.95.26.15475; Hsieh CL, 1997, J NATL CANCER I, V89, P1893, DOI 10.1093/jnci/89.24.1893; IWABUCHI H, 1995, CANCER RES, V55, P6172; KALLIONIEMI A, 1994, P NATL ACAD SCI USA, V91, P2156, DOI 10.1073/pnas.91.6.2156; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; KOSARY CL, 1995, NIH PUBL; Lange EM, 1999, CLIN CANCER RES, V5, P4013; MCINDOE RA, 1997, AM J HUM GENET, V61, P3247; MEIKLE AW, 1982, J CLIN ENDOCR METAB, V54, P1104, DOI 10.1210/jcem-54-6-1104; MOHAPATRA G, 1995, GENE CHROMOSOME CANC, V13, P86, DOI 10.1002/gcc.2870130203; MONROE KR, 1995, NAT MED, V1, P827, DOI 10.1038/nm0895-827; Neuhausen SL, 1999, HUM MOL GENET, V8, P2437, DOI 10.1093/hmg/8.13.2437; Ott J, 1996, NATURE, V379, P772, DOI 10.1038/379772a0; Peters J, 1999, P NATL ACAD SCI USA, V96, P3830, DOI 10.1073/pnas.96.7.3830; RISCH N, 1992, HUM HERED, V42, P77, DOI 10.1159/000154047; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Schaid DJ, 1998, AM J HUM GENET, V62, P1425, DOI 10.1086/301862; SCHLEGEL J, 1995, CANCER RES, V55, P6002; SEARLE AG, 1989, ANN HUM GENET, V53, P89, DOI 10.1111/j.1469-1809.1989.tb01777.x; Smith SL, 1996, J NEUROTRAUM, V13, P1, DOI 10.1089/neu.1996.13.1; SolinasToldo S, 1996, CANCER RES, V56, P3803; SPITZ MR, 1991, J UROLOGY, V146, P1305, DOI 10.1016/S0022-5347(17)38074-6; STEINBERG GD, 1990, PROSTATE, V17, P337, DOI 10.1002/pros.2990170409; Suarez BK, 2000, AM J HUM GENET, V66, P933, DOI 10.1086/302818; Weinstein LS, 1999, TRENDS ENDOCRIN MET, V10, P81, DOI 10.1016/S1043-2760(98)00124-6; Whittemore AS, 1999, AM J HUM GENET, V65, P254, DOI 10.1086/302457; WHITTEMORE AS, 1995, AM J EPIDEMIOL, V141, P732, DOI 10.1093/oxfordjournals.aje.a117495; WOOLF CM, 1960, CANCER, V13, P739, DOI 10.1002/1097-0142(196007/08)13:4<739::AID-CNCR2820130414>3.0.CO;2-E; Xu JF, 1998, NAT GENET, V20, P175, DOI 10.1038/2477; Xu JF, 2000, AM J HUM GENET, V66, P945, DOI 10.1086/302807	47	186	187	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2000	67	1					82	91		10.1086/302994	http://dx.doi.org/10.1086/302994			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	347JY	10820130	Green Published, Bronze			2022-12-18	WOS:000088926900011
J	Osier, M; Pakstis, AJ; Kidd, JR; Lee, JF; Yin, SJ; Ko, HC; Edenberg, HJ; Lu, RB; Kidd, KK				Osier, M; Pakstis, AJ; Kidd, JR; Lee, JF; Yin, SJ; Ko, HC; Edenberg, HJ; Lu, RB; Kidd, KK			Linkage disequilibrium at the ADH2 and ADH3 loci and risk of alcoholism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALDEHYDE DEHYDROGENASE GENOTYPES; TAIWANESE POPULATIONS; PLASMINOGEN-ACTIVATOR; METABOLIZING GENES; CELL-LINES; DRD2 LOCUS; POLYMORPHISM; EVOLUTION; ALLELE; MEN	Two of the three class I alcohol dehydrogenase (ADH) genes (ADH2 and ADH3) encode known functional variants that act on alcohol with different efficiencies. Variants at both these genes have been implicated in alcoholism in some populations because allele frequencies differ between alcoholics and controls. Specifically, controls have higher frequencies of the variants with higher V-max (ADH2*2 and ADH3*1). In samples both of alcoholics and of controls from three Taiwanese populations (Chinese, Ami, and Atayal) we found significant pairwise disequilibrium for all comparisons of the two functional polymorphisms and a third, presumably neutral, intronic polymorphism in ADH2. The class I ADH genes all lie within 80 kb on chromosome 4; thus, variants are not inherited independently, and haplotypes must be analyzed when evaluating the risk of alcoholism. In the Taiwanese Chinese we found that, only among those chromosomes containing the ADH3*1 variant (high V-max), the proportions of chromosomes with ADH2*1 (low V-max) and those with ADH2*2 (high V-max) are significantly different between alcoholics and controls (p < 10(-5)) The proportions of chromosomes with ADH3*1 and those with ADH3*2 are not significantly different between alcoholics and controls, on a constant ADH2 background (with ADH2*1, P = .83; with ADH2*2, P = .53). Thus, the observed differences in the frequency of the functional polymorphism at ADH3, between alcoholics and controls, can be accounted for by the disequilibrium with ADH2 in this population.	Yale Univ, Sch Med, Dept Human Genet, New Haven, CT 06520 USA; Natl Def Med Ctr, Tri Serv Gen Hosp, Dept Psychiat, Taipei, Taiwan; Natl Def Med Ctr, Inst Med Sci, Taipei, Taiwan; Natl Def Med Ctr, Dept Biochem, Taipei, Taiwan; Mil Psychiat Ctr, Taipei, Taiwan; Natl Cheng Kung Univ, Coll Med, Grad Inst Behav Med, Tainan 70101, Taiwan; Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA	Yale University; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; National Cheng Kung University; Indiana University System; Indiana University-Purdue University Indianapolis	Kidd, KK (corresponding author), Yale Univ, Sch Med, Dept Human Genet, 333 Cedar St,SHM I-353, New Haven, CT 06520 USA.	kidd@biomed.med.yale.edu		Edenberg, Howard/0000-0003-0344-9690	NIAAA NIH HHS [AA09379-05] Funding Source: Medline; NIMH NIH HHS [MH39239, MH30929] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH030929, P50MH030929, R37MH039239, R01MH039239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA009379] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; Antonarakis SE, 1998, HUM MUTAT, V11, P1; APA, 1987, DIAGN STAT MAN MENT, V3rd; Bowcock A M, 1987, Gene Geogr, V1, P47; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; Bullido MJ, 1998, NAT GENET, V18, P69, DOI 10.1038/ng0198-69; BURNELL JC, 1987, BIOCHEM BIOPH RES CO, V146, P1227, DOI 10.1016/0006-291X(87)90779-0; Calafell F, 1998, EUR J HUM GENET, V6, P38, DOI 10.1038/sj.ejhg.5200151; CASTIGLIONE CM, 1995, AM J HUM GENET, V57, P1445; Chang FM, 1996, HUM GENET, V98, P91, DOI 10.1007/s004390050166; Chang FM, 1997, BIOL PSYCHIAT, V41, P394, DOI 10.1016/S0006-3223(96)00248-X; CHAO YC, 1994, HEPATOLOGY, V19, P360, DOI 10.1002/hep.1840190214; Chen WJ, 1996, BRIT J PSYCHIAT, V168, P762, DOI 10.1192/bjp.168.6.762; Chen WJ, 1997, BIOL PSYCHIAT, V41, P703, DOI 10.1016/S0006-3223(96)00072-8; COUZIGOU P, 1990, ALCOHOL ALCOHOLISM, V25, P623, DOI 10.1093/oxfordjournals.alcalc.a045058; Edenberg H. J, 1997, BIOTRANSFORMATION, V3, P119; EDENBERG HJ, 1991, GENETIC BASIS ALCOHO, P165; EDMAN K, 1992, HUM GENET, V90, P395; GOEDDE HW, 1992, HUM GENET, V88, P344; GOLDMAN D, 1993, ALCOHOL CLIN EXP RES, V17, P199, DOI 10.1111/j.1530-0277.1993.tb00749.x; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; IKUTA T, 1986, P NATL ACAD SCI USA, V83, P634, DOI 10.1073/pnas.83.3.634; Kidd KK, 1998, HUM GENET, V103, P211, DOI 10.1007/s004390050809; LEE JF, IN PRESS ALCOHOL CLI; LEWONTIN RC, 1964, GENETICS, V49, P49; Lu RB, 1996, BIOL PSYCHIAT, V39, P419, DOI 10.1016/0006-3223(95)00182-4; Mountain JL, 1997, AM J HUM GENET, V61, P705, DOI 10.1086/515510; Neumark YD, 1998, J STUD ALCOHOL, V59, P133, DOI 10.15288/jsa.1998.59.133; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; PRICE RA, 1992, INT J OBESITY, V16, P851; RIESS O, 1994, HUM GENET, V94, P1, DOI 10.1007/BF02272834; SAMBROOK J, 1986, MOL BIOL MED, V3, P459; SCHURR TG, 1990, AM J HUM GENET, V46, P613; Shen YC, 1997, ALCOHOL CLIN EXP RES, V21, P1272, DOI 10.1111/j.1530-0277.1997.tb04448.x; SMITH M, 1986, ADV HUM GENET, V15, P249; Tanaka F, 1997, ALCOHOL CLIN EXP RES, V21, P596, DOI 10.1111/j.1530-0277.1997.tb03808.x; THOMASSON HR, 1994, ALCOHOL CLIN EXP RES, V18, P640, DOI 10.1111/j.1530-0277.1994.tb00923.x; THOMASSON HR, 1991, AM J HUM GENET, V48, P677; Tishkoff SA, 1996, HUM GENET, V97, P759; Tishkoff SA, 1998, AM J HUM GENET, V62, P1389, DOI 10.1086/301861; Valdes AM, 1997, AM J HUM GENET, V60, P703; Wall TL, 1997, ALCOHOL ALCOHOLISM, V32, P129; WALZER C, 1993, ELECTROPHORESIS, V14, P566, DOI 10.1002/elps.1150140189; WHITFIELD JB, IN PRESS ALCOHOL CLI; WILLARD HF, 1985, CYTOGENET CELL GENET, V40, P360, DOI 10.1159/000132180; YASUNAMI M, 1990, GENOMICS, V7, P152, DOI 10.1016/0888-7543(90)90535-3; ZOOSSMANNDISKIN A, 1991, ISRAEL J MED SCI, V27, P245	47	186	194	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1999	64	4					1147	1157		10.1086/302317	http://dx.doi.org/10.1086/302317			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184UV	10090900	Green Published, Bronze			2022-12-18	WOS:000079632900026
J	Oldridge, M; Zackai, EH; McDonald-McGinn, DM; Iseki, S; Morriss-Kay, GM; Twigg, RF; Johnson, D; Wall, SA; Jiang, W; Theda, C; Jabs, EW; Wilkie, AOM				Oldridge, M; Zackai, EH; McDonald-McGinn, DM; Iseki, S; Morriss-Kay, GM; Twigg, RF; Johnson, D; Wall, SA; Jiang, W; Theda, C; Jabs, EW; Wilkie, AOM			De novo Alu-element insertions in FGFR2 identify a distinct pathological basis for Apert syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GROWTH-FACTOR RECEPTOR-2; LIGAND-BINDING SPECIFICITY; PFEIFFER-SYNDROME; DEVELOPMENT SUGGESTS; MUTATIONS; GENE; EXPRESSION; SEQUENCE; RNA; CRANIOSYNOSTOSIS	Apert syndrome, one of five craniosynostosis syndromes caused by allelic mutations of fibroblast growth-factor receptor 2 (FGFR2), is characterized by symmetrical bony syndactyly of the hands and feet. We have analyzed 260 unrelated patients, all but 2 of whom have missense mutations in exon 7, which affect a dipeptide in the linker region between the second and third immunoglobulin-like domains. Hence, the molecular mechanism of Apert syndrome is exquisitely specific. FGFR2 mutations in the remaining two patients are distinct in position and nature. Surprisingly, each patient harbors an Alu-element insertion of similar to 360 bp, in one case just upstream of exon 9 and in the other case within exon 9 itself. The insertions are likely to be pathological, because they have arisen de novo; in both cases this occurred on the paternal chromosome. FGFR2 is present in alternatively spliced isoforms characterized by either the IIIb (exon 8) or IIIc (exon 3) domains (keratinocyte growth-factor receptor [KGFR] and bacterially expressed kinase, respectively), which are differentially expressed in mouse limbs on embryonic day 13. Splicing of exon 9 was examined in RNA extracted from fibroblasts and keratinocytes from one patient with an Alu insertion and two patients with Pfeiffer syndrome who had nucleotide substitutions of the exon 9 acceptor splice site. Ectopic expression of KGFR in the fibroblast lines correlated with the severity of limb abnormalities. This provides the first genetic evidence that signaling through KGFR causes syndactyly in Apert syndrome.	John Radcliffe Hosp, Inst Mol Med, Oxford OX3 9DS, England; Univ Oxford, Dept Human Anat & Genet, Oxford OX1 2JD, England; Radcliffe Infirm NHS Trust, Oxford Craniofacial Unit, Oxford, England; Childrens Hosp Philadelphia, Clin Genet Ctr, Philadelphia, PA 19104 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA	University of Oxford; University of Oxford; Radcliffe Infirmary; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Wilkie, AOM (corresponding author), John Radcliffe Hosp, Inst Mol Med, Oxford OX3 9DS, England.		Wilkie, Andrew/AAC-3820-2020; Jiang, Wen G./AAF-1876-2020; McDonald-McGinn, Donna/L-8643-2019; Theda, Christiane/M-2263-2019; jiang, wen/GYI-9662-2022	Wilkie, Andrew/0000-0002-2972-5481; Jiang, Wen G./0000-0002-3283-1111; Theda, Christiane/0000-0001-7577-6004; McDonald-McGinn, Donna/0000-0003-4077-250X; Jiang, Wen/0000-0002-3916-8826; Jabs, Ethylin/0000-0001-8983-5466; Twigg, Stephen/0000-0001-5024-049X	NCRR NIH HHS [RR00052] Funding Source: Medline; NIDCR NIH HHS [R01 DE11441] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011441] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Abdelhak S, 1997, HUM MOL GENET, V6, P2247, DOI 10.1093/hmg/6.13.2247; Anderson J, 1998, HUM MOL GENET, V7, P1475, DOI 10.1093/hmg/7.9.1475; Anderson PJ, 1998, J CRANIOFAC SURG, V9, P83, DOI 10.1097/00001665-199801000-00018; BATZER MA, 1995, J MOL BIOL, V247, P418, DOI 10.1006/jmbi.1994.0150; Batzer MA, 1996, J MOL EVOL, V42, P3, DOI 10.1007/BF00163204; Bellus GA, 1996, NAT GENET, V14, P174, DOI 10.1038/ng1096-174; Boeke JD, 1997, NAT GENET, V16, P6, DOI 10.1038/ng0597-6; Carstens RP, 1998, MOL CELL BIOL, V18, P2205, DOI 10.1128/MCB.18.4.2205; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DEININGER PL, 1995, IMPACT SHORT INTERSP, P43; DelGatto F, 1997, MOL CELL BIOL, V17, P5106, DOI 10.1128/MCB.17.9.5106; DELL KR, 1992, J BIOL CHEM, V267, P21225; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DIONNE CA, 1990, EMBO J, V9, P2685, DOI 10.1002/j.1460-2075.1990.tb07454.x; ESCOBAR V, 1977, CLIN GENET, V12, P169; FINCH PW, 1995, DEV DYNAM, V203, P223, DOI 10.1002/aja.1002030210; GILBERT E, 1993, MOL CELL BIOL, V13, P5461, DOI 10.1128/MCB.13.9.5461; Gorlin RJ, 1990, SYNDROMES HEAD NECK, P519; Halling KC, 1997, AM J HUM GENET, V61, pA67; Hu MCT, 1998, MOL CELL BIOL, V18, P6063, DOI 10.1128/MCB.18.10.6063; HUGHES AE, 1998, AM J HUM GENET S, V63, pA183; Iseki S, 1997, DEVELOPMENT, V124, P3375; JANICIC N, 1995, AM J HUM GENET, V56, P880; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; Johnston CL, 1995, J BIOL CHEM, V270, P30643, DOI 10.1074/jbc.270.51.30643; Jurka J, 1997, P NATL ACAD SCI USA, V94, P1872, DOI 10.1073/pnas.94.5.1872; KATOH M, 1992, P NATL ACAD SCI USA, V89, P2960, DOI 10.1073/pnas.89.7.2960; LAJEUNIE E, 1995, NAT GENET, V9, P108, DOI 10.1038/ng0295-108; Lester Tracy, 1997, Journal of Medical Genetics, V34, pS81; MAKALOWSKI W, 1994, TRENDS GENET, V10, P188, DOI 10.1016/0168-9525(94)90254-2; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; MASON IJ, 1994, MECH DEVELOP, V45, P15, DOI 10.1016/0925-4773(94)90050-7; MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246; Miki Y, 1996, NAT GENET, V13, P245, DOI 10.1038/ng0696-245; Moloney DM, 1996, NAT GENET, V13, P48, DOI 10.1038/ng0596-48; MUENKE M, 1994, NAT GENET, V8, P269, DOI 10.1038/ng1194-269; MURATANI K, 1991, P NATL ACAD SCI USA, V88, P11315, DOI 10.1073/pnas.88.24.11315; Neilson KM, 1996, J BIOL CHEM, V271, P25049, DOI 10.1074/jbc.271.40.25049; Ohbayashi N, 1998, J BIOL CHEM, V273, P18161, DOI 10.1074/jbc.273.29.18161; Ohuchi H, 1997, DEVELOPMENT, V124, P2235; Oldridge M, 1997, HUM MOL GENET, V6, P137, DOI 10.1093/hmg/6.1.137; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; ORRURTREGER A, 1993, DEV BIOL, V158, P475, DOI 10.1006/dbio.1993.1205; PARK WJ, 1995, AM J HUM GENET, V57, P321; Passos-Bueno MR, 1998, J MED GENET, V35, P677, DOI 10.1136/jmg.35.8.677; PassosBueno MR, 1997, AM J MED GENET, V71, P243, DOI 10.1002/(SICI)1096-8628(19970808)71:2<243::AID-AJMG27>3.0.CO;2-D; Przylepa KA, 1996, NAT GENET, V13, P492, DOI 10.1038/ng0896-492; Robertson SC, 1998, P NATL ACAD SCI USA, V95, P4567, DOI 10.1073/pnas.95.8.4567; SCHELL U, 1995, HUM MOL GENET, V4, P323, DOI 10.1093/hmg/4.3.323; Schmid CW, 1996, PROG NUCLEIC ACID RE, V53, P283, DOI 10.1016/S0079-6603(08)60148-8; Slaney SF, 1996, AM J HUM GENET, V58, P923; SPIVAKKROIZMAN T, 1994, CELL, V79, P1015, DOI 10.1016/0092-8674(94)90032-9; Twigg SRF, 1998, HUM MOL GENET, V7, P685, DOI 10.1093/hmg/7.4.685; UPTON J, 1991, CLIN PLAST SURG, V18, P321; UPTON J, 1991, CLIN PLASTIC SURG, V18; Vidaud Dominique, 1993, European Journal of Human Genetics, V1, P30; WALLACE MR, 1991, NATURE, V353, P864, DOI 10.1038/353864a0; Wilkie AOM, 1997, HUM MOL GENET, V6, P1647, DOI 10.1093/hmg/6.10.1647; WILKIE AOM, 1995, NAT GENET, V9, P165, DOI 10.1038/ng0295-165; Xu XL, 1998, DEVELOPMENT, V125, P753	60	186	193	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1999	64	2					446	461		10.1086/302245	http://dx.doi.org/10.1086/302245			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	169HA	9973282	Green Published, Bronze			2022-12-18	WOS:000078740600014
J	Gilad, S; Chessa, L; Khosravi, R; Russell, P; Galanty, Y; Piane, M; Gatti, RA; Jorgensen, TJ; Shiloh, Y; Bar-Shira, A				Gilad, S; Chessa, L; Khosravi, R; Russell, P; Galanty, Y; Piane, M; Gatti, RA; Jorgensen, TJ; Shiloh, Y; Bar-Shira, A			Genotype-phenotype relationships in ataxia-telangiectasia and variants	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CELL-CYCLE CHECKPOINTS; ATM GENE; WITHOUT-TELANGIECTASIA; MUTATIONS; RADIOSENSITIVITY; RADIATION; SENSITIVITY; DEFICIENCY; ANOMALIES; DISTINCT	Ataxia-telangiectasia (A-T) is an autosomal recessive disorder characterized by cerebellar degeneration, immunodeficiency, chromosomal instability, radiosensitivity, and cancer predisposition. A-T cells are sensitive to ionizing radiation and radiomimetic chemicals and fail to activate cell-cycle checkpoints after treatment with these agents. The responsible gene, ATM, encodes a large protein kinase with a phosphatidylinositol 3-kinase-like domain. The typical A-T phenotype is caused, in most cases, by null ATM alleles that truncate or severely destabilize the ATM protein. Rare patients with milder manifestations of the clinical or cellular characteristics of the disease have been reported and have been designated "A-T variants." A special variant form of AT is A-T-Fresno which combines a typical A-T phenotype with microcephaly and mental retardation. The possible association of these syndromes with ATM is both important for understanding their molecular basis and essential for counseling and diagnostic purposes. We quantified ATM-protein levels in six A-T variants, and we searched their ATM genes for mutations. Cell lines from these patients exhibited considerable variability in radiosensitivity while showing the typical radioresistant DNA synthesis of A-T cells. Unlike classical A-T patients, these patients exhibited 1%-17% of the normal level of ATM. The underlying ATM genotypes were either homozygous for mutations expected to produce mild phenotypes or compound heterozygotes for a mild and a severe mutation. An A-(Fresno) cell line was found devoid of the ATM protein and homozygous for a severe ATM mutation. We conclude that certain "A-T variant" phenotypes represent ATM mutations, including some of those without telangiectasia. Our findings extend the range of phenotypes associated with ATM mutations.	Tel Aviv Univ, Sackler Sch Med, Dept Human Genet, IL-69978 Ramat Aviv, Israel; Univ Rome La Sapienza, Dipartimento Med Sperimentale, I-00185 Rome, Italy; Georgetown Univ, Med Ctr, Vincent T Lombardi Canc Res Ctr, Dept Radiat Med, Washington, DC 20007 USA; Univ Calif Los Angeles, Sch Med, Dept Pathol, Los Angeles, CA 90024 USA	Tel Aviv University; Sackler Faculty of Medicine; Sapienza University Rome; Georgetown University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Shiloh, Y (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Human Genet, IL-69978 Ramat Aviv, Israel.			PIANE, Maria/0000-0001-8569-247X; Galanty, Yaron/0000-0001-7167-9004	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031763] Funding Source: NIH RePORTER; NINDS NIH HHS [NS31763] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANTOCCIA A, 1995, MUTAGENESIS, V10, P523, DOI 10.1093/mutage/10.6.523; Antonarakis SE, 1998, HUM MUTAT, V11, P1; Baumer A, 1996, HUM GENET, V98, P246, DOI 10.1007/s004390050202; Beamish H, 1996, J BIOL CHEM, V271, P20486, DOI 10.1074/jbc.271.34.20486; BEAMISH H, 1994, INT J RADIAT BIOL, V65, P175, DOI 10.1080/09553009414550211; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Brown KD, 1997, P NATL ACAD SCI USA, V94, P1840, DOI 10.1073/pnas.94.5.1840; BUNDEY S, 1994, INT J RADIAT BIOL, V66, pS23; Byrd PJ, 1996, HUM MOL GENET, V5, P145, DOI 10.1093/hmg/5.1.145; BYRNE E, 1984, J NEUROL SCI, V66, P307, DOI 10.1016/0022-510X(84)90019-4; Chen G, 1996, J BIOL CHEM, V271, P33693, DOI 10.1074/jbc.271.52.33693; CHEN PC, 1978, NATURE, V274, P484, DOI 10.1038/274484a0; CHESSA L, 1992, AM J MED GENET, V42, P741, DOI 10.1002/ajmg.1320420524; CHESSA L, 1989, CLIN GENET, V37, P297; CHESSA L, 1986, P 7 INT C HUM GEN BE, P696; Concannon P, 1997, HUM MUTAT, V10, P100, DOI 10.1002/(SICI)1098-1004(1997)10:2<100::AID-HUMU2>3.0.CO;2-O; CURRY CJR, 1989, AM J HUM GENET, V45, P270; DEGRAAF AS, 1994, CLIN NEUROL NEUROSUR, V97, P1; DEJONGE J, 1988, CLIN NEUROL NEUROSUR, V90, P279, DOI 10.1016/0303-8467(88)90038-8; FIORILLI M, 1984, HUM GENET, V70, P274; FRIEDMAN JH, 1993, MOVEMENT DISORD, V8, P223, DOI 10.1002/mds.870080222; GATTI RA, 1988, NATURE, V336, P577, DOI 10.1038/336577a0; GATTI RA, 1996, METABOLIC BASIS INHE; Gilad S, 1998, HUM MUTAT, V11, P69, DOI 10.1002/(SICI)1098-1004(1998)11:1<69::AID-HUMU11>3.3.CO;2-P; Gilad S, 1996, HUM MOL GENET, V5, P2033, DOI 10.1093/hmg/5.12.2033; Gilad S, 1996, HUM MOL GENET, V5, P433, DOI 10.1093/hmg/5.4.433; GRAVEL RA, 1995, METABOLIC MOL BASES, P2839; Guttler F, 1996, EUR J PEDIATR, V155, pS6, DOI 10.1007/PL00014253; Hoekstra MF, 1997, CURR OPIN GENET DEV, V7, P170, DOI 10.1016/S0959-437X(97)80125-6; HOULDSWORTH J, 1980, NUCLEIC ACIDS RES, V8, P3709, DOI 10.1093/nar/8.16.3709; Jorgensen TJ, 1996, INT J RADIAT BIOL, V69, P527, DOI 10.1080/095530096145535; Khanna KK, 1997, J BIOL CHEM, V272, P9489; Lakin ND, 1996, ONCOGENE, V13, P2707; LANGE E, 1995, AM J HUM GENET, V57, P112; LANZI G, 1992, EUR NEUROL, V32, P121, DOI 10.1159/000116807; Lavin MF, 1997, ANNU REV IMMUNOL, V15, P177, DOI 10.1146/annurev.immunol.15.1.177; LITTLEFIELD LG, 1981, CYTOGENET CELL GENET, V31, P203, DOI 10.1159/000131650; Maquat LE, 1996, AM J HUM GENET, V59, P279; MASERATI E, 1988, CLIN GENET, V34, P283; McConville CM, 1996, AM J HUM GENET, V59, P320; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; PAINTER RB, 1980, P NATL ACAD SCI-BIOL, V77, P7315, DOI 10.1073/pnas.77.12.7315; ROIFMAN CM, 1985, ATAXIA TELANGIECTASI, P273; Rotman G, 1997, CANCER SURV, V29, P285; Saar K, 1997, AM J HUM GENET, V60, P605; SANAL O, 1993, NATO ASI SERIES H, V77, P183; Savitsky K, 1997, NUCLEIC ACIDS RES, V25, P1678, DOI 10.1093/nar/25.9.1678; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SAVITSKY K, 1995, HUM MOL GENET, V4, P2025, DOI 10.1093/hmg/4.11.2025; Sedgwick R, 1991, HDB CLIN NEUROLOGY, P347; Shiloh Y, 1996, J CLIN IMMUNOL, V16, P254, DOI 10.1007/BF01541389; Shiloh Y, 1997, ANNU REV GENET, V31, P635, DOI 10.1146/annurev.genet.31.1.635; SHILOH Y, 1995, EUR J HUM GENET, V3, P116; STANKLER L, 1973, BRIT J DERMATOL, V88, P187; STELL R, 1989, MOVEMENT DISORD, V4, P320, DOI 10.1002/mds.870040405; STUMM M, 1995, AM J HUM GENET, V57, P960; TAYLOR AMR, 1987, J MED GENET, V24, P669, DOI 10.1136/jmg.24.11.669; TAYLOR AMR, 1993, NATO ASI SER H, V77, P3209; TAYLOR AMR, 1997, 7 AT TEL WORKSH CLER; Telatar M, 1996, AM J HUM GENET, V59, P40; THACKER J, 1994, INT J RADIAT BIOL, V66, pS87; Uziel T, 1996, GENOMICS, V33, P317, DOI 10.1006/geno.1996.0201; Vorechovsky I, 1996, EUR J HUM GENET, V4, P352; Watters D, 1997, ONCOGENE, V14, P1911, DOI 10.1038/sj.onc.1201037; WEEMAES CMR, 1994, INT J RADIAT BIOL, V66, pS185; WEGNER RD, IN PRESS PRIMARY IMM; WILLEMS PJ, 1993, AM J MED GENET, V45, P777, DOI 10.1002/ajmg.1320450624; Wright J, 1996, AM J HUM GENET, V59, P839; YING KL, 1981, CANCER GENET CYTOGEN, V4, P311, DOI 10.1016/0165-4608(81)90027-3; Ziv Y, 1997, ONCOGENE, V15, P159, DOI 10.1038/sj.onc.1201319; ZIV Y, 1995, SOMAT CELL MOLEC GEN, V21, P99, DOI 10.1007/BF02255785; ZIV Y, 1989, MUTAT RES, V210, P211	72	186	188	0	6	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1998	62	3					551	561		10.1086/301755	http://dx.doi.org/10.1086/301755			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZF407	9497252	Green Published, hybrid			2022-12-18	WOS:000072894400008
J	Brown, MD; Sun, FZ; Wallace, DC				Brown, MD; Sun, FZ; Wallace, DC			Clustering of Caucasian Leber hereditary optic neuropathy patients containing the 11778 or 14484 mutations on an mtDNA lineage	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA MUTATIONS; PHYLOGENETIC ANALYSIS; COMPLEX-I; PEDIGREES; SPECTRUM; FAMILIES; FEATURES	Leber hereditary optic neuropathy (LHON) is a type of blindness caused by mtDNA mutations. Three LHON mtDNA mutations at nucleotide positions 3460, 11778, and 14484 are specific for LHON and account for 90% of worldwide cases and are thus designated as ''primary'' LHON mutations. Fifteen other ''secondary'' LHON mtDNA mutations have been identified, but their pathogenicity is unclear. mtDNA haplotype and phylogenetic analysis of the primary LHON mutations in North American Caucasian patients and controls has shown that, unlike the 3460 and 11778 mutations, which are distributed throughout the European-derived (Caucasian) mtDNA phylogeny, patients containing the 14484 mutation tended to be associated with European mtDNA haplotype J. To investigate this apparent clustering, we performed chi(2)-based statistical analyses to compare the distribution of LHON patients on the Caucasian phylogenetic tree. Our results indicate that, unlike the 3460 and 11778 mutations, the 14484 mutation was not distributed on the phylogeny in proportion to the frequencies of the major Caucasian mtDNA haplogroups found in North America. The 14484 mutation was next shown to occur on the haplogroup J background more frequently that expected, consistent with the observation that similar to 75% of worldwide 14484-positive LHON patients occur in association with haplogroup J. The 11778 mutation also exhibited a moderate clustering on haplogroup J. These observations were supported by statistical analysis using all available mutation frequencies reported in the literature. This paper thus illustrates the potential importance of genetic background in certain mtDNA-based diseases, speculates on a pathogenic role for a subset of LHON secondary mutations and their interaction with primary mutations, and provides support for a polygenic model for LHON expression in some cases.			Brown, MD (corresponding author), EMORY UNIV,SCH MED,DEPT GENET & MOL MED,ATLANTA,GA 30322, USA.		Sun, Fengzhu/G-4373-2010	Sun, Fengzhu/0000-0002-8552-043X	NATIONAL EYE INSTITUTE [R29EY011305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021328] Funding Source: NIH RePORTER; NEI NIH HHS [EY11305] Funding Source: Medline; NIGMS NIH HHS [GM46915] Funding Source: Medline; NINDS NIH HHS [NS21328] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BROWN MD, 1994, CLIN NEUROSCI, V2, P138; BROWN MD, 1992, GENETICS, V130, P163; BROWN MD, 1995, HUM MUTAT, V6, P311, DOI 10.1002/humu.1380060405; HARDING AE, 1995, AM J HUM GENET, V57, P77; HOWELL N, 1994, CLIN NEUROSCI, V2, P130; HOWELL N, 1995, GENETICS, V140, P285; HUOPONEN K, 1993, HUM GENET, V92, P379, DOI 10.1007/BF01247339; JOHNS DR, 1992, BIOCHEM BIOPH RES CO, V187, P1551, DOI 10.1016/0006-291X(92)90479-5; JOHNS DR, 1991, BIOCHEM BIOPH RES CO, V174, P1324, DOI 10.1016/0006-291X(91)91567-V; JOHNS DR, 1993, ARCH OPHTHALMOL-CHIC, V111, P495, DOI 10.1001/archopht.1993.01090040087038; MACKEY DA, 1992, AUST NZ J OPHTHALMOL, V20, P177, DOI 10.1111/j.1442-9071.1992.tb00937.x; NEWMAN NJ, 1993, ARCH NEUROL-CHICAGO, V50, P540, DOI 10.1001/archneur.1993.00540050082021; OBERMAIERKUSSER B, 1994, AM J HUM GENET, V55, P1063; OOSTRA RJ, 1994, J MED GENET, V31, P280, DOI 10.1136/jmg.31.4.280; OOSTRA RJ, 1994, HUM GENET, V94, P265, DOI 10.1007/BF00208281; RIORDANEVA P, 1995, BRAIN, V118, P319, DOI 10.1093/brain/118.2.319; SHAM PC, 1995, ANN HUM GENET, V59, P97, DOI 10.1111/j.1469-1809.1995.tb01608.x; TORRONI A, 1994, AM J HUM GENET, V55, P760	18	186	202	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1997	60	2					381	387						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WE931	9012411				2022-12-18	WOS:A1997WE93100017
J	BEUTLER, E; NGUYEN, NJ; HENNEBERGER, MW; SMOLEC, JM; MCPHERSON, RA; WEST, C; GELBART, T				BEUTLER, E; NGUYEN, NJ; HENNEBERGER, MW; SMOLEC, JM; MCPHERSON, RA; WEST, C; GELBART, T			GAUCHER DISEASE - GENE-FREQUENCIES IN THE ASHKENAZI JEWISH POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							JEWS	DNA from over 2,000 Ashkenazi Jewish subjects has been examined for the four most common Jewish Gaucher disease mutations, which collectively account for about 96% of the disease-producing alleles in Jewish patients. This population survey has made possible the estimation of gene frequencies for these alleles. Eighty-seven of 1,528 individuals were heterozygous for the 1226G (N370S) mutation, and four presumably well persons were homozygous for this mutation. The gene frequency for the 1226G allele was calculated to be .0311, and when these data were pooled with those obtained previously from another 593 Jewish subjects, a gene frequency of .032 with a standard error of .004 was found. Among 2,305 normal subjects, 10 were found to be heterozygous for the 84GG allele, giving a gene frequency of .00217 with a standard error of .00096. No examples of the IVS2(+1) mutation were found among 1,256 samples screened, and no 1448C (L444P) mutations were found among 1,528 samples examined. Examination of the distribution of Gaucher disease gene frequencies in the general population shows that the ratio of 1226G mutations to 84GG mutations is higher than that in the patient population. This is presumed to be due to the fact that homozygotes for the 1226G mutation often have late-onset discase or no significant clinical manifestations at all. To bring the gene frequency in the patient population into conformity with the gene frequency in the general population, nearly two-thirds of persons with a Gaucher disease genotype would be missing from the patient population, presumably because their clinical manifestations were very mild.	SCRIPPS IMMUNOL REFERENCE LAB, SAN DIEGO, CA USA	Scripps Research Institute	BEUTLER, E (corresponding author), SCRIPPS RES INST, DEPT MOLEC & EXPTL MED, 10666 N TORREY PINES RD, LA JOLLA, CA 92037 USA.				NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036639] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00833] Funding Source: Medline; NIDDK NIH HHS [DK36639] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BEUTLER E, 1992, BLOOD, V79, P1662; BEUTLER E, 1991, NEW ENGL J MED, V325, P1354; BEUTLER E, 1992, SCIENCE, V256, P794, DOI 10.1126/science.1589760; FRIED K, 1973, ISRAEL J MED SCI, V9, P1396; FRIED K, 1958, 4TH B RES COUNC IS B, V7, P213; GRABOWSKI GA, 1982, GAUCHER DISEASE CENT, P573; Kolodny EH, 1982, GAUCHER DISEASE CENT, P33; MATOTH Y, 1987, AM J MED GENET, V27, P561; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI [10.1016/0307-4412(91), DOI 10.1016/0307-4412(91)]; ZIMRAN A, 1991, AM J HUM GENET, V49, P855	10	186	191	0	11	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1993	52	1					85	88						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KK908	8434610				2022-12-18	WOS:A1993KK90800010
J	Tang, H; Coram, M; Wang, P; Zhu, XF; Risch, N				Tang, Hua; Coram, Marc; Wang, Pei; Zhu, Xiaofeng; Risch, Neil			Reconstructing genetic ancestry blocks in admixed individuals	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HIDDEN MARKOV-MODELS; PROBABILISTIC FUNCTIONS; MAXIMUM-LIKELIHOOD; STATISTICAL TESTS; ADMIXTURE; INFERENCE; LINKAGE; DISEASE; LOCI; POPULATIONS	A chromosome in an individual of recently admixed ancestry resembles a mosaic of chromosomal segments, or ancestry blocks, each derived from a particular ancestral population. We consider the problem of inferring ancestry along the chromosomes in an admixed individual and thereby delineating the ancestry blocks. Using a simple population model, we infer gene-flow history in each individual. Compared with existing methods, which are based on a hidden Markov model, the Markov-hidden Markov model ( MHMM) we propose has the advantage of accounting for the background linkage disequilibrium ( LD) that exists in ancestral populations. When there are more than two ancestral groups, we allow each ancestral population to admix at a different time in history. We use simulations to illustrate the accuracy of the inferred ancestry as well as the importance of modeling the background LD; not accounting for background LD between markers may mislead us to false inferences about mixed ancestry in an indigenous population. The MHMM makes it possible to identify genomic blocks of a particular ancestry by use of any high-density single- nucleotide polymorphism panel. One application of our method is to perform admixture mapping without genotyping special ancestry-informative-marker panels.	Fred Hutchinson Canc Res Ctr, Dept Publ Hlth Sci, Seattle, WA 98109 USA; Univ Chicago, Dept Stat, Chicago, IL 60637 USA; Loyola Univ, Dept Prevent Med & Epidemiol, Med Ctr, Maywood, IL 60153 USA; Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA	Fred Hutchinson Cancer Center; University of Chicago; Loyola University Chicago; University of California System; University of California San Francisco	Tang, H (corresponding author), Fred Hutchinson Canc Res Ctr, Dept Publ Hlth Sci, 1100 Fairview Ave N,M2-B500, Seattle, WA 98109 USA.	huatang@fhcrc.org	Zhu, Xiaofeng/O-6874-2019	Wang, Pei/0000-0002-6890-6453; Zhu, Xiaofeng/0000-0003-0037-411X; Coram, Marc/0000-0002-8877-2501	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073059] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG003054, R01 HG003054] Funding Source: Medline; NIGMS NIH HHS [R01 GM073059, GM073059] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; BAUM LE, 1966, ANN MATH STAT, V37, P1554, DOI 10.1214/aoms/1177699147; BAUM LE, 1970, ANN MATH STAT, V41, P164, DOI 10.1214/aoms/1177697196; Cappe O., 2005, SPR S STAT; CLARK AG, 1990, MOL BIOL EVOL, V7, P111; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Fallin D, 2000, AM J HUM GENET, V67, P947, DOI 10.1086/303069; Falush D, 2003, GENETICS, V164, P1567; Felsenstein J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/oxfordjournals.molbev.a025575; Fridlyand J, 2004, J MULTIVARIATE ANAL, V90, P132, DOI 10.1016/j.jmva.2004.02.008; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; Hoggart CJ, 2004, AM J HUM GENET, V74, P965, DOI 10.1086/420855; Hughey R, 1996, COMPUT APPL BIOSCI, V12, P95; KARLIN S, 1975, 1 COURSE STOCHASTIC, P152; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LONG JC, 1991, GENETICS, V127, P417; LONG JC, 1995, AM J HUM GENET, V56, P799; McKeigue PM, 2000, GENET EPIDEMIOL, V19, P464, DOI 10.1002/1098-2272(200012)19:4<464::AID-GEPI17>3.0.CO;2-M; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; McPeek MS, 2000, AM J HUM GENET, V66, P1076, DOI 10.1086/302800; Montana G, 2004, AM J HUM GENET, V75, P771, DOI 10.1086/425281; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Pritchard JK, 2000, GENETICS, V155, P945; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Rajeevan H, 2003, NUCLEIC ACIDS RES, V31, P270, DOI 10.1093/nar/gkg043; Reich D, 2005, PHILOS T ROY SOC B, V360, P1605, DOI 10.1098/rstb.2005.1691; RIFE DC, 1954, AM J HUM GENET, V6, P26; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Seldin MF, 2004, GENOME RES, V14, P1076, DOI 10.1101/gr.2165904; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Weiss KM, 2002, TRENDS GENET, V18, P19, DOI 10.1016/S0168-9525(01)02550-1; Zhu XF, 2005, NAT GENET, V37, P177, DOI 10.1038/ng1510; Zhu XF, 2004, AM J HUM GENET, V74, P1136, DOI 10.1086/421329	35	185	201	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2006	79	1					1	12		10.1086/504302	http://dx.doi.org/10.1086/504302			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	053YD	16773560	Bronze, Green Published			2022-12-18	WOS:000238341200001
J	Brant, SR; Panhuysen, CIM; Nicolae, D; Reddy, DM; Bonen, DK; Karaliukas, R; Zhang, LL; Swanson, E; Datta, LW; Moran, T; Ravenhill, G; Duerr, RH; Achkar, JP; Karban, AS; Cho, JH				Brant, SR; Panhuysen, CIM; Nicolae, D; Reddy, DM; Bonen, DK; Karaliukas, R; Zhang, LL; Swanson, E; Datta, LW; Moran, T; Ravenhill, G; Duerr, RH; Achkar, JP; Karban, AS; Cho, JH			MDR1 Ala893 polymorphism is associated with inflammatory bowel disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							P-GLYCOPROTEIN MDR1; GENOME-WIDE SEARCH; BLOOD-BRAIN-BARRIER; MULTIDRUG-RESISTANCE; CROHNS-DISEASE; SUSCEPTIBILITY LOCI; PROVIDES EVIDENCE; C3435T MUTATION; ORAL BIOAVAILABILITY; LINKAGE ANALYSIS	Crohn disease (CD) and ulcerative colitis (UC) are overlapping chronic inflammatory bowel diseases (IBDs). Suggestive evidence for linkage at chromosome 7q has been reported for both CD and UC. Contained within this region is the gene for MDR1 (multidrug resistance), a membrane transport protein for which human polymorphisms have been reported in AIa893Ser/Thr and C3435T that alter pharmacokinetic profiles for a variety of drugs. Because mdr1 knockout mice spontaneously develop colitis, exonic regions were resequenced and tested for IBD association in a large, multicenter North American cohort. Two missense mutations, Asn21Asp and Ala893Ser/Thr, as well as the expression-associated polymorphism C3435T, described elsewhere, were genotyped in the entire cohort. Significant association of Ala893 with IBD was observed by both case-control analysis (P = .002) and the pedigree disequilibrium test (PDT [P = .00020-.00030]) but not for the Asn21Asp or C3435T polymorphisms. Significant association by PDT was observed within the subset with CD (P = .0014-.00090), with similar, nonsignificant trends in a smaller subset with UC. The Ala893Ser/Thr variant is triallelic, and the associated, common allele is Ala893, with undertransmission of the 893Ser (common) and the 893Thr (rare) variants. The Ala893 variant has decreased activity compared with the 893Ser variant; therefore, the association with human IBD is consistent with the murine model of mdr1 deficiency. Taken together, these data support the association of the common Ala893 polymorphism with IBD specifically and, more broadly, provides additional support for its contribution to interindividual pharmacogenetic variation.	Johns Hopkins Univ, Sch Med, Dept Med, Harvey M & Lyn P Meyerhoff Inflammatory Bowel Dis, Baltimore, MD 21231 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Genet Epidemiol, Baltimore, MD USA; Boston Univ, Sch Med, Boston, MA 02118 USA; Univ Chicago Hosp, Dept Stat, Martin Boyer Labs, Gastroenterol Sect, Chicago, IL 60637 USA; Univ Chicago Hosp, Dept Med, Martin Boyer Labs, Gastroenterol Sect, Chicago, IL 60637 USA; Univ Pittsburgh, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA USA; Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; Cleveland Clin Fdn, Dept Gastroenterol, Cleveland, OH 44195 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Boston University; University of Chicago; University of Illinois System; University of Chicago; University of Illinois System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cleveland Clinic Foundation	Cho, JH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Harvey M & Lyn P Meyerhoff Inflammatory Bowel Dis, 1503 E Jefferson St,Room B136, Baltimore, MD 21231 USA.	jcho@medicine.bsd.uchicago.edu	Duerr, Richard H/B-4188-2009	Duerr, Richard H/0000-0001-6586-3905; Nicolae, Dan/0000-0002-0918-4630	NCRR NIH HHS [M01 RR000052, M01 RR000055, RR00055, RR00052] Funding Source: Medline; NIDDK NIH HHS [U01 DK062429, R01 DK55731, U01 DK062422, R01 DK058189, U01 DK62429, R01 DK58189, U01DK062431, R01 DK055731, U01 DK062431, R01 DK060867] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055731, R01DK058189, U01DK062431, U01DK062429, U01DK062422, R01DK060867] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ameyaw MM, 2001, PHARMACOGENETICS, V11, P217, DOI 10.1097/00008571-200104000-00005; Bernal ML, 2003, THER DRUG MONIT, V25, P107, DOI 10.1097/00007691-200302000-00016; Binder V, 1998, DIGEST DIS, V16, P351, DOI 10.1159/000016891; Bonen DK, 2003, GASTROENTEROLOGY, V124, P140, DOI 10.1053/gast.2003.50019; Calado RT, 2002, HAEMATOLOGICA, V87, P564; Cascorbi I, 2001, CLIN PHARMACOL THER, V69, P169, DOI 10.1067/mcp.2001.114164; Chamaillard M, 2003, P NATL ACAD SCI USA, V100, P3455, DOI 10.1073/pnas.0530276100; CHAMBERS TC, 1993, J BIOL CHEM, V268, P4592; Cho JH, 1998, P NATL ACAD SCI USA, V95, P7502, DOI 10.1073/pnas.95.13.7502; CHOI K, 1988, CELL, V53, P519, DOI 10.1016/0092-8674(88)90568-5; Duerr RH, 2000, AM J HUM GENET, V66, P1857, DOI 10.1086/302947; Duffy DL, 1997, AM J HUM GENET, V61, pA197; Farrell RJ, 2000, GASTROENTEROLOGY, V118, P279, DOI 10.1016/S0016-5085(00)70210-1; Furuno T, 2002, PHARMACOGENETICS, V12, P529, DOI 10.1097/00008571-200210000-00004; Germann UA, 1996, J BIOL CHEM, V271, P1708, DOI 10.1074/jbc.271.3.1708; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Hampe J, 1999, AM J HUM GENET, V64, P808, DOI 10.1086/302294; HARDY SP, 1995, EMBO J, V14, P68, DOI 10.1002/j.1460-2075.1995.tb06976.x; HIGGINS CF, 1992, TRENDS BIOCHEM SCI, V17, P18, DOI 10.1016/0968-0004(92)90419-A; Hitzl M, 2001, PHARMACOGENETICS, V11, P293, DOI 10.1097/00008571-200106000-00003; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Johne A, 2002, CLIN PHARMACOL THER, V72, P584, DOI 10.1067/mcp.2002.129196; Jones PM, 1998, J MEMBRANE BIOL, V166, P133, DOI 10.1007/s002329900455; Kim RB, 2001, CLIN PHARMACOL THER, V70, P189, DOI 10.1067/mcp.2001.117412; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Lown KS, 1997, CLIN PHARMACOL THER, V62, P248, DOI 10.1016/S0009-9236(97)90027-8; Ma YH, 1999, INFLAMM BOWEL DIS, V5, P271, DOI 10.1097/00054725-199911000-00005; Markianos K, 2001, AM J HUM GENET, V68, P963, DOI 10.1086/319507; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Nakamura T, 2002, CLIN PHARMACOL THER, V71, P297, DOI 10.1067/mcp.2002.122055; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; ORHOLM M, 1991, NEW ENGL J MED, V324, P84, DOI 10.1056/NEJM199101103240203; Paavola-Sakki P, 2003, EUR J HUM GENET, V11, P112, DOI 10.1038/sj.ejhg.5200936; Panwala CM, 1998, J IMMUNOL, V161, P5733; Peeters M, 1996, GASTROENTEROLOGY, V111, P597, DOI 10.1053/gast.1996.v111.pm8780562; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rioux JD, 2000, AM J HUM GENET, V66, P1863, DOI 10.1086/302913; Satsangi J, 1996, NAT GENET, V14, P199, DOI 10.1038/ng1096-199; Schinkel AH, 1996, J CLIN INVEST, V97, P2517, DOI 10.1172/JCI118699; Schinkel AH, 1997, SEMIN CANCER BIOL, V8, P161, DOI 10.1006/scbi.1997.0068; Schinkel AH, 1997, P NATL ACAD SCI USA, V94, P4028, DOI 10.1073/pnas.94.8.4028; SCHINKEL AH, 1995, J CLIN INVEST, V96, P1698, DOI 10.1172/JCI118214; Schwab M, 2003, GASTROENTEROLOGY, V124, P26, DOI 10.1053/gast.2003.50010; Siddiqui A, 2003, NEW ENGL J MED, V348, P1442, DOI 10.1056/NEJMoa021986; Siegmund W, 2002, CLIN PHARMACOL THER, V72, P572, DOI 10.1067/mcp.2002.127739; Sparreboom A, 1997, P NATL ACAD SCI USA, V94, P2031, DOI 10.1073/pnas.94.5.2031; Subhani J, 1998, GUT, V42, pA40; Thompson NP, 1996, BRIT MED J, V312, P95; TYSK C, 1988, GUT, V29, P990, DOI 10.1136/gut.29.7.990; UEDA K, 1987, P NATL ACAD SCI USA, V84, P3004, DOI 10.1073/pnas.84.9.3004; vanHelvoort A, 1996, CELL, V87, P507, DOI 10.1016/S0092-8674(00)81370-7; Verstuyft C, 2003, EUR J CLIN PHARMACOL, V58, P809, DOI 10.1007/s00228-003-0567-5; WEIR DG, 1996, GENETIC DATA ANAL, V2; Williams CN, 2002, INFLAMM BOWEL DIS, V8, P375, DOI 10.1097/00054725-200211000-00001; Yamakov V, 2002, NAT MATER, V1, P45, DOI 10.1038/nmat700	60	185	193	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2003	73	6					1282	1292		10.1086/379927	http://dx.doi.org/10.1086/379927			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	756PW	14610718	Bronze, Green Published			2022-12-18	WOS:000187491100006
J	Breuer, DK; Yashar, BM; Filippova, E; Hiriyanna, S; Lyons, RH; Mears, AJ; Asaye, B; Acar, C; Vervoort, R; Wright, AF; Musarella, MA; Wheeler, P; MacDonald, I; Iannaccone, A; Birch, D; Hoffman, DR; Fishman, GA; Heckenlively, JR; Jacobson, SG; Sieving, PA; Swaroop, A				Breuer, DK; Yashar, BM; Filippova, E; Hiriyanna, S; Lyons, RH; Mears, AJ; Asaye, B; Acar, C; Vervoort, R; Wright, AF; Musarella, MA; Wheeler, P; MacDonald, I; Iannaccone, A; Birch, D; Hoffman, DR; Fishman, GA; Heckenlively, JR; Jacobson, SG; Sieving, PA; Swaroop, A			A comprehensive mutation analysis of RP2 and RPGR in a north American cohort of families with x-linked retinitis pigmentosa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NUCLEOTIDE-EXCHANGE FACTOR; GTPASE REGULATOR; POSITIONAL CLONING; GENE-THERAPY; PROTEIN; MOUSE; IDENTIFICATION; LINKAGE; LOCUS; LOCALIZATION	X-linked retinitis pigmentosa (XLRP) is a clinically and genetically heterogeneous degenerative disease of the retina. At least five loci have been mapped for XLRP; of these, RP2 and RP3 account for 10%-20% and 70%-90% of genetically identifiable disease, respectively. However, mutations in the respective genes, RP2 and RPGR, were detected in only 10% and 20% of families with XLRP. Mutations in an alternatively spliced RPGR exon, ORF15, have recently been shown to account for 60% of XLRP in a European cohort of 47 families. We have performed, in a North American cohort of 234 families with RP, a comprehensive screen of the RP2 and RPGR (including ORF15) genes and their 5 upstream regions. Of these families, 91 (39%) show definitive X-linked inheritance, an additional 88 (38%) reveal a pattern consistent with X-linked disease, and the remaining 55 (23%) are simplex male patients with RP who had an early onset and/or severe disease. In agreement with the previous studies, we show that mutations in the RP2 gene and in the original 19 RPGR exons are detected in ! 10% and 20% of XLRP probands, respectively. Our studies have revealed RPGR-ORF15 mutations in an additional 30% of 91 well-documented families with X-linked recessive inheritance and in 22% of the total 234 probands analyzed. We suggest that mutations in an as-yet-uncharacterized RPGR exon(s), intronic changes, or another gene in the region might be responsible for the disease in the remainder of this North American cohort. We also discuss the implications of our studies for genetic diagnosis, genotype-phenotype correlations, and gene-based therapy.	Univ Michigan, WK Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48105 USA; Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48105 USA; Univ Michigan, Sequencing Core Facil, Ann Arbor, MI 48105 USA; Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Suny Downstate Med Ctr, Dept Ophthalmol, Brooklyn, NY 11203 USA; Tufts Univ New England Med Ctr, Boston, MA 02111 USA; Univ Alberta, Dept Ophthalmol, Edmonton, AB, Canada; Univ Tennessee, Hlth Sci Ctr, Dept Ophthalmol, Memphis, TN USA; Retina Fdn SW, Dallas, TX USA; Univ Illinois, Chicago, IL USA; Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90024 USA; Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA; NEI, Bethesda, MD 20892 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Edinburgh; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Tufts Medical Center; University of Alberta; University of Tennessee System; University of Tennessee Health Science Center; Retina Foundation of the Southwest; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California Los Angeles; University of Pennsylvania; Pennsylvania Medicine; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Swaroop, A (corresponding author), Univ Michigan, WK Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, 1000 Wall St, Ann Arbor, MI 48105 USA.	swaroop@umich.edu	Acar, Ceren/B-5758-2008; Acar, Ceren/M-2926-2019	Acar, Ceren/0000-0003-1842-9203; Acar, Ceren/0000-0003-1842-9203; Birch, David/0000-0002-6594-2897; Swaroop, Anand/0000-0002-1975-1141; Yashar, Beverly M./0000-0003-0807-3258; Iannaccone, Alessandro/0000-0001-5737-8424; Jacobson, Samuel/0000-0003-2122-169X; MacDonald, Ian/0000-0001-7472-8385	NATIONAL EYE INSTITUTE [R01EY007961, R29EY007961] Funding Source: NIH RePORTER; NEI NIH HHS [EY 05235, F31 EY007003, R01 EY007961, EY 07961, EY 05627, P30 EY007003, R01 EY005235, EY 07003] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ballhausen WG, 2000, ANN NY ACAD SCI, V910, P36; Bennett J, 2000, MOL THER, V1, P501, DOI 10.1006/mthe.2000.0080; Bessant DAR, 2001, CURR OPIN GENET DEV, V11, P307, DOI 10.1016/S0959-437X(00)00195-7; BHATTACHARYA SS, 1984, NATURE, V309, P253, DOI 10.1038/309253a0; BIRD AC, 1975, BRIT J OPHTHALMOL, V59, P177, DOI 10.1136/bjo.59.4.177; Boylan JP, 2000, HUM MOL GENET, V9, P2085, DOI 10.1093/hmg/9.14.2085; BREUER DK, 2001, NEW INSIGHTS RETINAL, P11; Buraczynska M, 1997, AM J HUM GENET, V61, P1287, DOI 10.1086/301646; Chapple JP, 2000, HUM MOL GENET, V9, P1919, DOI 10.1093/hmg/9.13.1919; DRIVAS GT, 1990, MOL CELL BIOL, V10, P1793, DOI 10.1128/MCB.10.4.1793; FISHMAN GA, 1978, ARCH OPHTHALMOL-CHIC, V96, P822, DOI 10.1001/archopht.1978.03910050428005; FISHMAN GA, 1988, ARCH OPHTHALMOL-CHIC, V106, P369; Fujita R, 1997, AM J HUM GENET, V61, P571, DOI 10.1086/515523; Gelehrter TD, 1998, PRINCIPLES MED GENET, V2; Gieser L, 1998, AM J HUM GENET, V63, P1439, DOI 10.1086/302121; Hardcastle AJ, 2000, INVEST OPHTH VIS SCI, V41, P2080; Hardcastle AJ, 1999, AM J HUM GENET, V64, P1210, DOI 10.1086/302325; Hauswirth WW, 2000, INVEST OPHTH VIS SCI, V41, P2821; Hong DH, 2001, J BIOL CHEM, V276, P12091, DOI 10.1074/jbc.M009351200; Hong DH, 2000, P NATL ACAD SCI USA, V97, P3649, DOI 10.1073/pnas.060037497; JACOBSON SG, 1989, EXP EYE RES, V48, P679, DOI 10.1016/0014-4835(89)90009-2; Kirschner R, 1999, HUM MOL GENET, V8, P1571, DOI 10.1093/hmg/8.8.1571; Kirschner R, 2001, HUM GENET, V109, P271, DOI 10.1007/s004390100572; Linari M, 1999, P NATL ACAD SCI USA, V96, P1315, DOI 10.1073/pnas.96.4.1315; MacDonald IM, 1998, OPHTHALMOLOGY, V105, P1637, DOI 10.1016/S0161-6420(98)99031-5; Maslen C, 1997, AM J HUM GENET, V60, P1389, DOI 10.1086/515472; Mears AJ, 2000, AM J HUM GENET, V67, P1000, DOI 10.1086/303091; Mears AJ, 1999, AM J HUM GENET, V64, P897, DOI 10.1086/302298; Meindl A, 1996, NAT GENET, V13, P35, DOI 10.1038/ng0596-35; Miano MG, 2001, HUM MUTAT, V18, P109, DOI 10.1002/humu.1160; Moore W, 2000, MOL BIOTECHNOL, V14, P89, DOI 10.1385/MB:14:2:89; MUSARELLA MA, 1990, GENOMICS, V8, P286, DOI 10.1016/0888-7543(90)90284-2; MUSARELLA MA, 1988, AM J HUM GENET, V43, P484; OHTSUBO M, 1987, GENE DEV, V1, P585, DOI 10.1101/gad.1.6.585; OTT J, 1990, P NATL ACAD SCI USA, V87, P701, DOI 10.1073/pnas.87.2.701; Renault L, 1998, NATURE, V392, P97, DOI 10.1038/32204; Roepman R, 1996, HUM MOL GENET, V5, P1035, DOI 10.1093/hmg/5.7.1035; Roepman R, 2000, HUM MOL GENET, V9, P2095, DOI 10.1093/hmg/9.14.2095; Roepman R, 2000, METHOD ENZYMOL, V316, P688; Schwahn U, 1998, NAT GENET, V19, P327, DOI 10.1038/1214; Schwahn U, 2001, HUM MOL GENET, V10, P1177, DOI 10.1093/hmg/10.11.1177; Sharon D, 2000, INVEST OPHTH VIS SCI, V41, P2712; Sieving P A, 1995, Semin Ophthalmol, V10, P279, DOI 10.3109/08820539509063799; TEAGUE PW, 1994, AM J HUM GENET, V55, P105; Tian GL, 1996, CELL, V86, P287, DOI 10.1016/S0092-8674(00)80100-2; Vervoort R, 2000, NAT GENET, V25, P462, DOI 10.1038/78182; Yan D, 1998, J BIOL CHEM, V273, P19656, DOI 10.1074/jbc.273.31.19656; Yang ZL, 2002, HUM MOL GENET, V11, P605, DOI 10.1093/hmg/11.5.605; Yesim F, 2002, AM J HUM GENET, V70, P1049, DOI 10.1086/339620	49	185	195	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2002	70	6					1545	1554		10.1086/340848	http://dx.doi.org/10.1086/340848			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	549LP	11992260	Green Published, Bronze			2022-12-18	WOS:000175445700015
J	McKeigue, PM				McKeigue, PM			Mapping genes that underlie ethnic differences in disease risk: Methods for detecting linkage in admixed populations, by conditioning on parental admixture	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMANS; TRAITS	Genes that underlie ethnic differences in disease risk can be mapped in affected individuals of mixed descent if the ancestry of the alleles at each marker locus can be assigned to one of the two founding populations. Linkage can be detected by testing for association of the disease with the ancestry of alleles at the marker locus, by conditioning on the admixture (defined as the proportion of genes that have ancestry from the high-risk population) of both parents. With regard to exploiting the effects of admixture, this test is more flexible and powerful than the transmission-disequilibrium test. Under the assumption of a multiplicative model, the statistical power for a given sample size depends only on parental admixture and the risk ratio r between populations that is generated by the locus. The most informative families are those in which mean parental admixture is .2-.7 and in which admixture is similar in both parents. The number of markers required for a genome search depends on the number of generations since admixture and on the information content for ancestry (f) of the markers, defined as a function of allele frequencies in the two founding populations. Simulations using a hidden Markov model suggest that, when admixture has occurred 2-10 generations earlier, a multipoint analysis using 2,000 biallelic markers, with f values of 30%, can extract 70%-90% of the ancestry information for each locus. Sets of such markers could be selected from libraries of single-nucleotide polymorphisms, when these become available.	Univ London London Sch Hyg & Trop Med, Epidemiol Unit, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	McKeigue, PM (corresponding author), Univ London London Sch Hyg & Trop Med, Epidemiol Unit, Keppel St, London WC1E 7HT, England.							BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; EWENS WJ, 1995, AM J HUM GENET, V57, P455; Gelman A, 1996, Stat Methods Med Res, V5, P339, DOI 10.1177/096228029600500402; JORDE LB, 1995, AM J HUM GENET, V57, P523; Kaplan NL, 1998, AM J HUM GENET, V62, P703, DOI 10.1086/301760; KNOWLER WC, 1988, AM J HUM GENET, V43, P520; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LIN S, 1994, ANN HUM GENET, V58, P343, DOI 10.1111/j.1469-1809.1994.tb00731.x; Little RJ, 1987, STAT ANAL MISSING DA; MacDonald I.L., 1997, HIDDEN MARKOV OTHER; McKeigue PM, 1997, AM J HUM GENET, V60, P188; *NAT HUM GEN RES I, 1998, HG98001 RFA NAT HUM; POLONI ES, 1995, ANN HUM GENET, V59, P43, DOI 10.1111/j.1469-1809.1995.tb01605.x; REYNOLDS J, 1983, GENETICS, V105, P767; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sobel E, 1993, Stat Methods Med Res, V2, P263, DOI 10.1177/096228029300200305; THOMPSON EA, 1994, PHILOS T ROY SOC B, V344, P345, DOI 10.1098/rstb.1994.0073; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x; WRIGHT S, 1951, ANN EUGEN, V15, P322	22	185	193	0	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1998	63	1					241	251		10.1086/301908	http://dx.doi.org/10.1086/301908			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZZ726	9634509	Green Published, Bronze			2022-12-18	WOS:000074761000032
J	Berg, JN; Gallione, CJ; Stenzel, TT; Johnson, DW; Allen, WP; Schwartz, CE; Jackson, CE; Porteous, MEM; Marchuk, DA				Berg, JN; Gallione, CJ; Stenzel, TT; Johnson, DW; Allen, WP; Schwartz, CE; Jackson, CE; Porteous, MEM; Marchuk, DA			The activin receptor-like kinase 1 gene: Genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ENDOTHELIAL-CELLS; LOCUS; MAPS; HETEROGENEITY; ORGANIZATION; ENDOGLIN; COMPLEX; LINKAGE	The activin receptor-like kinase 1 gene (ALK-1) is the second locus for the autosomal dominant vascular disease hereditary hemorrhagic telangiectasia (HI-IT). In this paper we present the genomic structure of the ALK-1 gene, a type I serine-threonine kinase receptor expressed predominantly in endothelial cells. The coding region is contained within nine exons, spanning <15 kb of genomic DNA. All introns follow the GT-AG rule, except for intron 6, which has a TAG\gcaag 5' splice junction. The positions of introns in the intracellular domain are almost identical to those of the mouse serine-threonine kinase receptor TSK-7L. By sequencing ALK-1 from genomic DNA, mutations were found in six of six families with HHT either shown to link to chromosome 12q13 or in which linkage of HHT to chromosome 9q33 had been excluded. Mutations were also found in three of six patients from families in which available linkage data were insufficient to allow certainty with regard to the locus involved. The high rate of detection of mutations by genomic sequencing of ALK-1 suggests that this will be a useful diagnostic test for HHT2, particularly where preliminary linkage to chromosome 12q13 can be established. In two cases in which premature termination codons were found in genomic DNA, the mutant mRNA was either not present or present at barely detectable levels. These data suggest that mutations in ALK-1 are functionally null alleles.	DUKE UNIV, MED CTR, DEPT GENET, DURHAM, NC 27710 USA; DUKE UNIV, MED CTR, DEPT PATHOL, DURHAM, NC 27710 USA; UNIV EDINBURGH, DEPT HUMAN GENET, EDINBURGH, MIDLOTHIAN, SCOTLAND; GREENWOOD GENET CTR, GREENWOOD, SC 29646 USA; HENRY FORD HOSP, DEPT MED, DIV CLIN & MOL GENET, DETROIT, MI 48202 USA	Duke University; Duke University; University of Edinburgh; Greenwood Genetic Center; Henry Ford Health System; Henry Ford Hospital				Marchuk, Douglas/0000-0002-3110-6671	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL009349, F32HL009394, R01HL049171] Funding Source: NIH RePORTER; NHLBI NIH HHS [1F32HL09349, 1F32HL09394, HL49171] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARRISANO L, 1993, CELL, V75, P671; Berg JN, 1996, J MED GENET, V33, P256, DOI 10.1136/jmg.33.3.256; BRAVERMAN IM, 1990, J INVEST DERMATOL, V95, P422, DOI 10.1111/1523-1747.ep12555569; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; EBNER R, 1993, SCIENCE, V260, P344; FENG XH, 1995, J BIOL CHEM, V270, P24237, DOI 10.1074/jbc.270.41.24237; GUTTMACHER AE, 1995, NEW ENGL J MED, V333, P918, DOI 10.1056/NEJM199510053331407; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HEUTINK P, 1994, J MED GENET, V31, P933, DOI 10.1136/jmg.31.12.933; IOANNOU PA, 1994, NAT GENET, V6, P84, DOI 10.1038/ng0194-84; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; JOHNSON DW, 1995, GENOME RES, V5, P21, DOI 10.1101/gr.5.1.21; MADRI JA, 1989, ANN NY ACAD SCI, V593, P243; MASAKAZU T, 1988, AM J MED SCI, V295, P545; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; MCALLISTER KA, 1994, J MED GENET, V31, P927, DOI 10.1136/jmg.31.12.927; MCALLISTER KA, 1995, HUM MOL GENET, V4, P1983, DOI 10.1093/hmg/4.10.1983; MCDONALD MT, 1994, NAT GENET, V6, P197, DOI 10.1038/ng0294-197; MERWIN JR, 1990, J CELL PHYSIOL, V142, P117, DOI 10.1002/jcp.1041420115; Niehrs C, 1996, NATURE, V381, P561, DOI 10.1038/381561a0; Piantanida M, 1996, J MED GENET, V33, P441, DOI 10.1136/jmg.33.6.441; PLAUCHU H, 1989, AM J MED GENET, V32, P291, DOI 10.1002/ajmg.1320320302; PORTEOUS MEM, 1994, J MED GENET, V31, P925, DOI 10.1136/jmg.31.12.925; Qian F, 1996, CELL, V87, P979, DOI 10.1016/S0092-8674(00)81793-6; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; SCHMITT J, 1995, BIOCHEM BIOPH RES CO, V213, P211, DOI 10.1006/bbrc.1995.2118; SENAPATHY P, 1990, METHOD ENZYMOL, V183, P252; SHOVLIN CL, 1994, NAT GENET, V6, P205, DOI 10.1038/ng0294-205; TENDIJKE P, 1993, ONCOGENE, V8, P2879; VASE P, 1985, ACTA MED SCAND, V218, P105; VINCENT P, 1995, HUM MOL GENET, V4, P945, DOI 10.1093/hmg/4.5.945; Yamamoto H, 1996, J BIOL CHEM, V271, P16253, DOI 10.1074/jbc.271.27.16253; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0	33	185	201	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1997	61	1					60	67		10.1086/513903	http://dx.doi.org/10.1086/513903			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM728	9245985	Green Published, Bronze			2022-12-18	WOS:A1997XM72800012
J	Vanier, MT; Duthel, S; RodriguezLafrasse, C; Pentchev, P; Carstea, ED				Vanier, MT; Duthel, S; RodriguezLafrasse, C; Pentchev, P; Carstea, ED			Genetic heterogeneity in Niemann-Pick C disease: A study using somatic cell hybridization and linkage analysis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LOW-DENSITY LIPOPROTEIN; CHOLESTEROL ESTERIFICATION; COMPLEMENTATION; FIBROBLASTS; DISRUPTION; METABOLISM; DIAGNOSIS	The primary molecular defect underlying Niemann-Pick C disease (NPC) is still unknown. A wide spectrum of clinical and biochemical phenotypes has previously been documented. Indication of genetic heterogeneity has recently been provided for one patient. In the present study, somatic cell hybridization experiments were carried out on skin fibroblast cultures from 32 unrelated NPC patients covering the range of known clinical and biochemical phenotypes. The criterion for complementation was the restoration of a normal intracellular fluorescent pattern in polykaryons stained with filipin to document cholesterol distribution. Crosses between the various cell lines revealed a major complementation group comprising 27 unrelated patients and a second minor group comprising 5 patients. Linkage analysis in one multiplex family belonging to the minor complementation group showed that the mutated gene does not map to the 18q11-12 region assigned to the major gene. Patients in the first group spanned the whole spectrum of clinical and cellular phenotypes. No consistent clinical or biochemical phenotype was associated with the second complementation group. Three of the five group 2 patients, however, presented with a new rare phenotype associated with severe pulmonary involvement leading to death within the first year of life. No biochemical abnormality specific of either group could be demonstrated with regard to tissue lipid storage pattern, intralysosomal cholesterol storage, and regulation of cholesterol homeostasis. Mutations affecting at least two different genes have thus been shown to underlie NPC. The two gene products may function together or sequentially in a common metabolic pathway affecting intracellular cholesterol transport.	CTR HOSP LYON SUD,LAB FDN GILLET MERIEUX,PIERRE BENITE,FRANCE; NINCDS,DEV & METAB NEUROL BRANCH,MOLEC & CELLULAR PATHOPHYSIOL SECT,BETHESDA,MD 20892	CHU Lyon; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Vanier, MT (corresponding author), FAC MED LYON SUD,LYON SUD SCH MED,DEPT BIOCHEM,CNRS,INSERM,U189,BP 12,F-69921 OULLINS,FRANCE.							ARGOFF CE, 1991, BIOCHIM BIOPHYS ACTA, V1096, P319, DOI 10.1016/0925-4439(91)90068-K; BOWLER LM, 1990, J NEUROSCI RES, V27, P505, DOI 10.1002/jnr.490270411; BRUL S, 1988, J CLIN INVEST, V81, P1710, DOI 10.1172/JCI113510; CADIGAN KM, 1990, J CELL BIOL, V110, P295, DOI 10.1083/jcb.110.2.295; Carstea E. D., 1994, American Journal of Human Genetics, V55, pA182; CARSTEA ED, 1993, P NATL ACAD SCI USA, V90, P2002, DOI 10.1073/pnas.90.5.2002; DAHL NK, 1992, J BIOL CHEM, V267, P4889; DAHL NK, 1994, J LIPID RES, V35, P1839; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Greer W. L., 1995, American Journal of Human Genetics, V57, pA192; MANOCOCHIE IK, 1989, ARCH DIS CHILD, V64, P1391; NELSON PV, 1985, J INHERIT METAB DIS, V8, P95, DOI 10.1007/BF01819286; Pampols T, 1986, An Esp Pediatr, V24, P250; Pentchev P. G., 1995, METABOLIC MOL BASES, P2625; PENTCHEV PG, 1994, BBA-MOL BASIS DIS, V1225, P235, DOI 10.1016/0925-4439(94)90001-9; PIN I, 1990, ARCH FR PEDIATR, V47, P373; POLYMEROPOULOS MH, 1992, GENOMICS, V12, P492, DOI 10.1016/0888-7543(92)90439-Y; RODRIGUEZLAFRASSE C, 1990, BIOCHIM BIOPHYS ACTA, V1043, P123, DOI 10.1016/0005-2760(90)90284-5; Sambrook J., 1989, MOL CLONING LAB MANU; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SCHOFER O, 1995, MONATSSCHR KINDERH, V143, pV171; SIDHU HS, 1993, BIOCHEM CELL BIOL, V71, P467, DOI 10.1139/o93-069; STEINBERG SJ, 1994, J MED GENET, V31, P317, DOI 10.1136/jmg.31.4.317; STRAUB RE, 1993, GENOMICS, V15, P45; Vanier M. T., 1994, American Journal of Human Genetics, V55, pA178; VANIER MT, 1988, CLIN GENET, V33, P331; VANIER MT, 1991, BIOCHIM BIOPHYS ACTA, V1096, P328, DOI 10.1016/0925-4439(91)90069-L; VANIER MT, 1991, DEV NEUROSCI-BASEL, V13, P307, DOI 10.1159/000112178; VANIER MT, 1985, CLIN GENET, V27, P20; VANIER MT, 1983, BIOCHIM BIOPHYS ACTA, V750, P178, DOI 10.1016/0005-2760(83)90218-7; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	31	185	189	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1996	58	1					118	125						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TL697	8554047				2022-12-18	WOS:A1996TL69700015
J	COBBEN, JM; VANDERSTEEGE, G; GROOTSCHOLTEN, P; DEVISSER, M; SCHEFFER, H; BUYS, CHCM				COBBEN, JM; VANDERSTEEGE, G; GROOTSCHOLTEN, P; DEVISSER, M; SCHEFFER, H; BUYS, CHCM			DELETIONS OF THE SURVIVAL MOTOR-NEURON GENE IN UNAFFECTED SIBLINGS OF PATIENTS WITH SPINAL MUSCULAR-ATROPHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FREQUENCY	DNA studies in 103 spinal muscular atrophy (SMA) patients from The Netherlands revealed homozygosity for a survival motor neuron (SMN) deletion in 96 (93%) of 103. Neuronal apoptosis inhibitory protein deletions were found in 38 (37%) of 103 and occurred most frequently in SMA type I. SMN deletions have not yet been described to occur in healthy subjects. In this study, however, four unaffected sibs from two SMA families showed homozygosity for SMN deletions. Homozygosity for an SMN deletion in unaffected persons seems to be very rare. Therefore, demonstration of a homozygous SMN deletion in a clinically presumed SMA patient should be considered as a confirmation of the diagnosis, whether or not SMN is in fact the causal gene for SMA.	UNIV GRONINGEN,DEPT MED GENET,9713 AW GRONINGEN,NETHERLANDS; UNIV AMSTERDAM,ACAD MED CTR,DEPT NEUROL,1105 AZ AMSTERDAM,NETHERLANDS	University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam			Scheffer, Hans/E-4644-2012	Scheffer, Hans/0000-0002-2986-0915				BRZUSTOWICZ LM, 1990, NATURE, V344, P540, DOI 10.1038/344540a0; COBBEN JM, 1993, NEUROMUSCULAR DISORD, V3, P327, DOI 10.1016/0960-8966(93)90026-G; COBBEN JM, 1994, J MED GENET, V31, P242, DOI 10.1136/jmg.31.3.242; Dubowitz V., 1978, MUSCLE DISORDERS CHI, P146; EMERY AEH, 1971, J MED GENET, V8, P481, DOI 10.1136/jmg.8.4.481; GILLIAM TC, 1990, NATURE, V345, P823, DOI 10.1038/345823a0; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; LEWIN B, 1995, CELL, V80, P1, DOI 10.1016/0092-8674(95)90442-5; MELKI J, 1990, NATURE, V344, P767, DOI 10.1038/344767a0; MELKI J, 1994, SCIENCE, V264, P1474, DOI 10.1126/science.7910982; MELKI J, 1990, LANCET, V337, P271; MUNSAT TL, 1992, NEUROMUSCULAR DISORD, V2, P423, DOI 10.1016/S0960-8966(06)80015-5; PEARN J, 1978, J MED GENET, V15, P409, DOI 10.1136/jmg.15.6.409; PEARN JH, 1973, J MED GENET, V10, P260, DOI 10.1136/jmg.10.3.260; RODRIGUES NR, 1995, HUM MOL GENET, V4, P631, DOI 10.1093/hmg/4.4.631; ROY N, 1995, CELL, V80, P167, DOI 10.1016/0092-8674(95)90461-1; RUDNIKSCHONEBORN S, 1994, AM J MED GENET, V51, P70, DOI 10.1002/ajmg.1320510115; SPIEGLER AWJ, 1990, HUM GENET, V85, P211, DOI 10.1007/BF00193198; VANDERSTEEGE G, 1995, LANCET, V345, P985, DOI 10.1016/S0140-6736(95)90732-7	19	185	188	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1995	57	4					805	808						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RV793	7573039				2022-12-18	WOS:A1995RV79300009
J	MELTON, T; PETERSON, R; REDD, AJ; SAHA, N; SOFRO, ASM; MARTINSON, J; STONEKING, M				MELTON, T; PETERSON, R; REDD, AJ; SAHA, N; SOFRO, ASM; MARTINSON, J; STONEKING, M			POLYNESIAN GENETIC AFFINITIES WITH SOUTHEAST-ASIAN POPULATIONS AS IDENTIFIED BY MTDNA ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; 9-BP DELETION; GLOBIN GENES; REARRANGEMENTS; POLYMORPHISM; SEQUENCES	Polynesian generic affinities to populations of Asia were studied using mtDNA markers. A total of 1,037 individuals from 12 populations were screened for a 9-bp deletion in the intergenic region between the COII and tRNA(Lys) genes that approaches fixation in Polynesians. Sequence-specific oligonucleotide probes that identify specific mtDNA control region nucleotide substitutions were used to describe variation in individuals with the 9-bp deletion. The 9-bp deletion was not observed in northern Indians, Bangladeshis, or Pakistanis but was seen at low to moderate frequencies in the nine other Southeast Asian populations. Three substitutions in the control region at positions 16217, 16247, and 16261 have previously been observed at high frequency in Polynesian mtDNAs; this ''Polynesian motif'' was observed in 20% of east Indonesians with the 9-bp deletion but was observed in only one additional individual, mtDNA types related to the Polynesian motif are highest in frequency in the corridor from Taiwan south through the Philippines and east Indonesia, and the highest diversity for these types is in Taiwan. These results are consistent with linguistic evidence of a Taiwanese origin for the proto-Polynesian expansion, which spread throughout Oceania by way of Indonesia.	NIAAA,NEUROGENET LAB,BETHESDA,MD; NATL UNIV SINGAPORE HOSP,DEPT PEDIAT,SINGAPORE,SINGAPORE; GAGJAH MADA UNIV,IUC BIOTECHNOL,YPGYAKARTA,INDONESIA; GAGJAH MADA UNIV,FAC MED,YPGYAKARTA,INDONESIA; UNIV OXFORD,INST MOLEC MED,OXFORD,ENGLAND	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National University of Singapore; Gadjah Mada University; Gadjah Mada University; University of Oxford	MELTON, T (corresponding author), PENN STATE UNIV,DEPT ANTHROPOL,UNIVERSITY PK,PA 16802, USA.			Martinson, Jeremy/0000-0003-4673-7238				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BALLINGER SW, 1992, GENETICS, V130, P139; BELLWOOD P, 1991, SCI AM, V265, P88, DOI 10.1038/scientificamerican0791-88; Bellwood P., 1978, MANS CONQUEST PACIFI; Bellwood P.S., 1989, COLONIZATION PACIFIC, P1; BLUST R, 1988, ASIAN PERSPECT, V26, P45; GROUBE L, 1983, NATURE, V324, P453; HAGELBERG E, 1993, P ROY SOC B-BIOL SCI, V252, P163, DOI 10.1098/rspb.1993.0061; HAGELBERG E, 1994, NATURE, V369, P25, DOI 10.1038/369025a0; HARIHARA S, 1992, HUM BIOL, V64, P161; HERTZBERG M, 1989, AM J HUM GENET, V44, P504; HERTZBERG MS, 1988, AM J HUM GENET, V43, P971; HILL AVS, 1989, COLONIZATION PACIFIC; HORAI S, 1986, HUM GENET, V72, P105; LUM JK, 1994, HUM BIOL, V66, P567; NEI M, 1993, MOL BIOL EVOL, V10, P927; Nei M., 1987, MOL EVOLUTIONARY GEN; OSHAUGHNESSY DF, 1990, AM J HUM GENET, V46, P144; PASSARINO G, 1993, AM J HUM GENET, V53, P609; REDD AJ, 1995, MOL BIOL EVOL, V12, P604; RZHETSKY A, 1995, MOL BIOL EVOL, V12, P163, DOI 10.1093/oxfordjournals.molbev.a040185; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SERJEANTSON SW, 1989, COLONIZATION PACIFIC, P120; SPRIGGS M, 1984, OUT ASIA, P185; STONEKING M, 1992, PHILOS T ROY SOC B, V337, P167, DOI 10.1098/rstb.1992.0094; STONEKING M, 1990, GENETICS, V124, P717; STONEKING M, 1991, AM J HUM GENET, V48, P370; STONEKING M, 1993, EVOLUTIONARY ANTHR, V2, P60; TAJIMA F, 1989, GENETICS, V123, P585; Terrell J., 1986, PREHISTORY PACIFIC I; TRENT RJ, 1986, AM J HUM GENET, V39, P350; TURNER CG, 1987, AM J PHYS ANTHROPOL, V68, P149; VIGILANT L, 1989, P NATL ACAD SCI USA, V86, P9350, DOI 10.1073/pnas.86.23.9350; WHITE JP, 1982, PREHISTORY AUSTR; WICKLER S, 1988, ANTIQUITY, V62, P703, DOI 10.1017/S0003598X00075104; WINICHAGOON P, 1982, NUCLEIC ACIDS RES, V10, P5853, DOI 10.1093/nar/10.19.5853; WRISCHNIK LA, 1987, NUCLEIC ACIDS RES, V15, P529, DOI 10.1093/nar/15.2.529	37	185	194	0	11	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1995	57	2					403	414						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RL771	7668267				2022-12-18	WOS:A1995RL77100024
J	KRUGLYAK, L; DALY, MJ; LANDER, ES				KRUGLYAK, L; DALY, MJ; LANDER, ES			RAPID MULTIPOINT LINKAGE ANALYSIS OF RECESSIVE TRAITS IN NUCLEAR FAMILIES, INCLUDING HOMOZYGOSITY MAPPING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MEDITERRANEAN FEVER; GENE; STRATEGIES; HUMANS	Homozygosity mapping is a powerful strategy for mapping rare recessive traits in children of consanguineous marriages. practical applications of this strategy are currently limited by the inability of conventional linkage analysis software to compute, in reasonable time, multipoint LOD scores for pedigrees with inbreeding loops. We have developed a new algorithm for rapid multipoint likelihood calculations in small pedigrees, including those with inbreeding loops. The running time of the algorithm grows, at most, linearly with the number of loci considered simultaneously. The running time is not sensitive to the presence of inbreeding loops, missing genotype information, and highly polymorphic loci. We have incorporated this algorithm into a software package, MAPMAKER/HOMOZ, that allows very rapid multipoint mapping of disease genes in nuclear families, including homozygosity mapping. Multipoint analysis with dozens of markers can be carried out in minutes on a personal workstation.	MIT, WHITEHEAD INST BIOMED RES, CTR GENOME RES, CAMBRIDGE, MA 02142 USA; MIT, DEPT BIOL, CAMBRIDGE, MA USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)			Daly, Mark J/B-2453-2017	Daly, Mark J/0000-0002-0949-8752	NHGRI NIH HHS [HG00098] Funding Source: Medline	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		AKSENTIJEVICH I, 1993, AM J HUM GENET, V53, P451; AKSENTIJEVICH I, 1993, HUM GENET, V91, P527; BENHAMIDA C, 1993, NAT GENET, V5, P195, DOI 10.1038/ng1093-195; BOEHNKE M, 1991, AM J HUM GENET, V48, P22; BUETOW KH, 1994, NAT GENET, V6, P391, DOI 10.1038/ng0494-391; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; FARRALL M, 1993, NAT GENET, V5, P107, DOI 10.1038/ng1093-107; Garrod AE, 1902, LANCET, V2, P1616; GERMAN J, 1994, P NATL ACAD SCI USA, V91, P6669, DOI 10.1073/pnas.91.14.6669; GOTO M, 1992, NATURE, V355, P735, DOI 10.1038/355735a0; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Nakamura Y, 1988, GENOMICS, V2, P302, DOI 10.1016/0888-7543(88)90018-3; OTT J, 1992, AM J HUM GENET, V51, P283; POLLAK MR, 1993, NAT GENET, V5, P201, DOI 10.1038/ng1093-201; PRAS E, 1992, NEW ENGL J MED, V326, P1509, DOI 10.1056/NEJM199206043262301; SMITH CAB, 1953, J R STAT SOC B, V15, P153; Terwilliger J., 1994, HDB HUMAN GENETIC LI; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	23	185	188	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1995	56	2					519	527						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QF423	7847388				2022-12-18	WOS:A1995QF42300021
J	WISE, CA; GARCIA, CA; DAVIS, SN; ZHANG, HJ; LIU, PT; PATEL, PI; LUPSKI, JR				WISE, CA; GARCIA, CA; DAVIS, SN; ZHANG, HJ; LIU, PT; PATEL, PI; LUPSKI, JR			MOLECULAR ANALYSES OF UNRELATED CHARCOT-MARIE-TOOTH (CMT) DISEASE PATIENTS SUGGEST A HIGH-FREQUENCY OF THE CMT-IA DUPLICATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEUROPATHY TYPE-I; HEREDITARY MOTOR; CHROMOSOME 17P11.2; GENE; LOCUS; MUTATION; LINKAGE; HETEROGENEITY; LOCALIZATION; FAMILIES	Charcot-Marie-Tooth disease (CMT) is the most common inherited peripheral neuropathy. One form of CMT, CMT type 1A, is characterized by uniformly decreased nerve conduction velocities, usually shows autosomal dominant inheritance, and is associated with a large submicroscopic duplication of the p11.2-p12 region of chromosome 17. A cohort of 75 unrelated patients diagnosed clinically with CMT and evaluated by electrophysiological methods were analyzed molecularly for the presence of the CMT1A DNA duplication. Three methodologies were used to assess the duplication: measurement of dosage differences between RFLP alleles, analysis of polymorphic (GT). repeats, and detection of a junction fragment by pulsed-field gel electrophoresis. The CMT1A duplication was found in 68% of the 63 unrelated CMT patients with electrophysiological studies consistent with CMT type 1 (CMT1). The CMT1A duplication was detected as a de novo event in two CMT1 families. Twelve CMT patients who did not have decreased nerve conduction velocities consistent with a diagnosis of CMT type 2 (CMT2) were found not to have the CMT1A duplication. The most informative molecular method was the detection of the CMT1A duplication-specific junction fragment. Given the high frequency of the CMT1A duplication in CMT patients and the high frequency of new mutations, we conclude that a molecular test for the CMT1A DNA duplication is very useful in the differential diagnosis of patients with peripheral neuropathies.	BAYLOR COLL MED,INST MOLEC GENET,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; LOUISIANA STATE UNIV,MED CTR,SCH MED,DEPT NEUROL,NEW ORLEANS,LA 70112; LOUISIANA STATE UNIV,MED CTR,SCH MED,DEPT PATHOL,NEW ORLEANS,LA 70112	Baylor College of Medicine; Baylor College of Medicine; Louisiana State University System; Louisiana State University System				Wise, Carol/0000-0002-6790-2194				BARKER D, 1987, CYTOGENET CELL GENET, V46, P576; BARKER DF, 1989, CYTOGENET CELL GENET, V51, P957; BELLONE E, 1992, J MED GENET, V29, P492; BERGOFFEN J, 1993, AM J HUM GENET, V52, P312; BIRD TD, 1978, CLIN GENET, V14, P43; BIRD TD, 1982, AM J HUM GENET, V34, P388; BRICE A, 1992, J MED GENET, V29, P807, DOI 10.1136/jmg.29.11.807; CHANCE PF, 1990, AM J HUM GENET, V47, P915; CHANCE PF, 1992, NEUROLOGY, V42, P2037, DOI 10.1212/WNL.42.10.2037; CHANCE PF, 1993, NEUROLOGY, V72, P143; Charcot JM, 1886, REV MED-PARIS, V6, P97; Dejerine J J, 1893, COMPTES RENDUS SOC B, V45, P63; DYCK PJ, 1968, ARCH NEUROL-CHICAGO, V18, P619, DOI 10.1001/archneur.1968.00470360041003; DYCK PJ, 1968, ARCH NEUROL-CHICAGO, V18, P603, DOI 10.1001/archneur.1968.00470360025002; DYCK PJ, 1992, PERIPHERAL NEUROPATH, P1094; GARCIA C A, 1990, Neurology, V40, P301; GUZZETTA V, 1992, GENOMICS, V13, P551, DOI 10.1016/0888-7543(92)90124-B; HALLAM PJ, 1992, ANN NEUROL, V31, P570, DOI 10.1002/ana.410310518; HARDING AE, 1980, BRAIN, V103, P259, DOI 10.1093/brain/103.2.259; HOOGENDIJK JE, 1992, LANCET, V339, P1081, DOI 10.1016/0140-6736(92)90668-S; HU XY, 1990, AM J HUM GENET, V46, P682; IONASESCU VV, 1991, AM J HUM GENET, V48, P1075; KAKU DA, IN PRESS NEUROLOGY; Kimura J., 1989, ELECTRODIAGNOSIS DIS, V2nd; LEBO RV, 1991, HUM GENET, V88, P1, DOI 10.1007/BF00204921; LITT M, 1989, AM J HUM GENET, V44, P397; LUPSKI JR, 1993, AM J MED GENET, V45, P92, DOI 10.1002/ajmg.1320450122; LUPSKI JR, 1992, CLIN RES, V40, P645; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; LUPSKI JR, 1992, BRAIN PATHOL, V2, P337, DOI 10.1111/j.1750-3639.1992.tb00710.x; LUPSKI JR, 1991, CURRENT NEUROLOGY, P1; LUUPSKI JR, 1992, NAT GENET, V1, P29; MACMILLAN JC, 1992, J MED GENET, V29, P12, DOI 10.1136/jmg.29.1.12; MATSUNAMI N, 1992, NAT GENET, V1, P176, DOI 10.1038/ng0692-176; MCALPINE PJ, 1990, GENOMICS, V7, P408, DOI 10.1016/0888-7543(90)90175-T; McKusick V.A., 1992, MENDELIAN INHERITANC; MIDDLETONPRICE HR, 1990, AM J HUM GENET, V46, P92; NICHOLSON GA, 1991, NEUROLOGY, V41, P547, DOI 10.1212/WNL.41.4.547; PATEL PI, 1990, AM J HUM GENET, V47, P926; PATEL PI, 1990, AM J HUM GENET, V46, P801; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; RAEYMAEKERS P, 1989, AM J HUM GENET, V45, P953; RAEYMAEKERS P, 1992, J MED GENET, V29, P5, DOI 10.1136/jmg.29.1.5; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; ROA BB, 1993, NEW ENGL J MED, V329, P96, DOI 10.1056/NEJM199307083290205; ROA BB, IN PRESS PHENOTYPIC; SKRE H, 1974, CLIN GENET, V6, P98; SUTHERS GK, 1992, AM J HUM GENET, V50, P887; TIMMERMAN V, 1990, AM J HUM GENET, V47, P680; TIMMERMAN V, 1992, NAT GENET, V1, P171, DOI 10.1038/ng0692-171; Tooth HH, 1886, PERONEAL TYPE PROGRE; UPADHYAYA M, 1993, HUM GENET, V91, P392; VALENTIJN LJ, 1992, NAT GENET, V1, P166, DOI 10.1038/ng0692-166; VANCE JM, 1989, EXP NEUROL, V104, P186, DOI 10.1016/S0014-4886(89)80013-5; VANCE JM, 1991, J MED GENET, V28, P1, DOI 10.1136/jmg.28.1.1; VANCE JM, 1991, GENOMICS, V9, P623, DOI 10.1016/0888-7543(91)90355-I; WEBER JL, 1989, AM J HUM GENET, V44, P388; WRIGHT EC, 1990, GENOMICS, V7, P103, DOI 10.1016/0888-7543(90)90524-X	59	185	189	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1993	53	4					853	863						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LY627	8105684				2022-12-18	WOS:A1993LY62700009
J	YANDELL, DW; DRYJA, TP				YANDELL, DW; DRYJA, TP			DETECTION OF DNA-SEQUENCE POLYMORPHISMS BY ENZYMATIC AMPLIFICATION AND DIRECT GENOMIC SEQUENCING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HARVARD UNIV,SCH MED,DEPT OPHTHALMOL,BOSTON,MA 02115	Harvard University; Harvard Medical School	YANDELL, DW (corresponding author), MASSACHUSETTS EYE & EAR HOSP,HOWE LAB,243 CHARLES ST,BOSTON,MA 02114, USA.				NATIONAL EYE INSTITUTE [R01EY005321, R29EY007573] Funding Source: NIH RePORTER; NEI NIH HHS [EY05321, EY07573] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; AMSELEM S, 1988, AM J HUM GENET, V43, P95; ASMUSSEN MA, 1985, HUM HERED, V35, P129, DOI 10.1159/000153533; BARKER D, 1982, CYTOGENET CELL GENET, V32, P253; BISHOP DT, 1983, AM J HUM GENET, V35, P795; BOEHM TLJ, 1987, CLIN GENET, V32, P349; BOOKSTEIN R, 1988, P NATL ACAD SCI USA, V85, P2210, DOI 10.1073/pnas.85.7.2210; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; COOPER DN, 1988, HUM GENET, V78, P299, DOI 10.1007/BF00291724; COOPER DN, 1984, HUM GENET, V66, P1, DOI 10.1007/BF00275182; COOPER DN, 1985, HUM GENET, V69, P201, DOI 10.1007/BF00293024; DEVOR EJ, 1988, AM J HUM GENET, V42, P179; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; DRMANAC R, 1986, NUCLEIC ACIDS RES, V14, P4691, DOI 10.1093/nar/14.11.4691; DRYJA TP, 1986, P NATL ACAD SCI USA, V83, P7391, DOI 10.1073/pnas.83.19.7391; FEDER J, 1985, AM J HUM GENET, V37, P635; FRIEND SH, 1987, P NATL ACAD SCI USA, V84, P9059, DOI 10.1073/pnas.84.24.9059; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FUNG YKT, 1987, SCIENCE, V236, P1657, DOI 10.1126/science.2885916; HARBOUR JW, 1988, SCIENCE, V241, P353, DOI 10.1126/science.2838909; HOROWITZ JM, 1989, SCIENCE, V243, P937, DOI 10.1126/science.2521957; HUDSON RR, 1982, GENETICS, V100, P711; JEFFREYS AJ, 1979, CELL, V18, P1, DOI 10.1016/0092-8674(79)90348-9; LEE EYHP, 1988, SCIENCE, V241, P218, DOI 10.1126/science.3388033; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; MCGEE TL, 1989, GENE, V80, P119, DOI 10.1016/0378-1119(89)90256-4; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; NEI M, 1988, PHILOS T R SOC B, V319, P615, DOI 10.1098/rstb.1988.0069; Nei M., 1987, MOL EVOLUTIONARY GEN; Nei M., 1975, MOL POPULATION GENET; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SCHUMM JW, 1988, AM J HUM GENET, V42, P143; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; TANG A, 1988, SCIENCE, V242, P263, DOI 10.1126/science.3175651; WAINSCOAT JS, 1986, NATURE, V319, P491, DOI 10.1038/319491a0; WEICHSELBAUM RR, 1988, P NATL ACAD SCI USA, V85, P2106, DOI 10.1073/pnas.85.7.2106; WHITE R, 1985, NATURE, V313, P101, DOI 10.1038/313101a0; WIGGS J, 1988, NEW ENGL J MED, V318, P151, DOI 10.1056/NEJM198801213180305; WONG C, 1987, NATURE, V330, P384, DOI 10.1038/330384a0; YOUSSOUFIAN H, 1988, AM J HUM GENET, V42, P867	42	185	187	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1989	45	4					547	555						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AW395	2577468				2022-12-18	WOS:A1989AW39500008
J	BYERS, PH; TSIPOURAS, P; BONADIO, JF; STARMAN, BJ; SCHWARTZ, RC				BYERS, PH; TSIPOURAS, P; BONADIO, JF; STARMAN, BJ; SCHWARTZ, RC			PERINATAL LETHAL OSTEOGENESIS IMPERFECTA (OI TYPE-II) - A BIOCHEMICALLY HETEROGENEOUS DISORDER USUALLY DUE TO NEW MUTATIONS IN THE GENES FOR TYPE-I COLLAGEN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195; UNIV WASHINGTON,CTR INHERITED DIS,SEATTLE,WA 98195; UNIV CONNECTICUT,CTR HLTH,DEPT PEDIAT,FARMINGTON,CT 06032	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Connecticut	BYERS, PH (corresponding author), UNIV WASHINGTON,DEPT PATHOL,SM-30,SEATTLE,WA 98195, USA.			Byers, Peter H./0000-0001-7786-7030	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR038473, P01AR021557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM015253] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR 38473, AR 21557] Funding Source: Medline; NIGMS NIH HHS [GM 15253] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLANSON JE, 1986, CLIN GENET, V29, P429; BARSH GS, 1981, COLLAGEN REL RES, V1, P543; BARSH GS, 1981, P NATL ACAD SCI-BIOL, V78, P5142, DOI 10.1073/pnas.78.8.5142; BARSH GS, 1985, P NATL ACAD SCI USA, V82, P2870, DOI 10.1073/pnas.82.9.2870; BATEMAN JF, 1986, BIOCHEM J, V240, P699, DOI 10.1042/bj2400699; BATEMAN JF, 1984, BIOCHEM J, V217, P103, DOI 10.1042/bj2170103; BATEMAN JF, 1987, J BIOL CHEM, V262, P7021; BONADIO J, 1985, J BIOL CHEM, V260, P1734; BONADIO J, 1985, NATURE, V316, P363, DOI 10.1038/316363a0; BRADLEY TB, 1980, JOHNS HOPKINS MED J, V146, P236; Byers P.H., 2014, GENETIC METABOLIC DI, P56; BYERS PH, 1984, SEMIN DERMATOL, V3, P257; BYERS PH, 1983, AM J HUM GENET, V35, pA39; BYERS PH, 1984, AM J MED GENET, V17, P429, DOI 10.1002/ajmg.1320170206; BYERS PH, 1987, PRENATAL DIAGNOSIS H, P158; CHU ML, 1985, J BIOL CHEM, V260, P691; CHU ML, 1983, NATURE, V304, P78, DOI 10.1038/304078a0; COHN DH, 1986, P NATL ACAD SCI USA, V83, P6045, DOI 10.1073/pnas.83.16.6045; DAVID TJ, 1972, J MED GENET, V9, P316, DOI 10.1136/jmg.9.3.316; DEWET WJ, 1983, J BIOL CHEM, V258, P7721; EMERY AEH, 1976, METHODOLOGY MED GENE; FRYNS JP, 1983, CLIN GENET, V24, P156; HORWITZ A L, 1985, American Journal of Human Genetics, V37, pA59; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; REED TE, 1955, AM J HUM GENET, V7, P28; RUSSELL WL, 1951, COLD SPRING HARB SYM, V16, P327, DOI 10.1101/SQB.1951.016.01.024; Searle A. G., 1978, Genetic mosaics and chimeras in mammals., P209; SHAPIRO JE, 1982, J PEDIATR-US, V100, P127, DOI 10.1016/S0022-3476(82)80252-7; SILLENCE DO, 1984, AM J MED GENET, V17, P407, DOI 10.1002/ajmg.1320170204; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; SMITH R, 1983, BRITTLE BONE DISEASE; SORIANO P, 1986, CELL, V46, P19, DOI 10.1016/0092-8674(86)90856-1; STEINMANN B, 1984, J BIOL CHEM, V259, P1129; THOMPSON EM, 1987, J MED GENET, V24, P386; WILLIAMS CJ, 1983, J BIOL CHEM, V258, P5915; YOUNG ID, 1980, LANCET, V1, P432	36	185	186	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1988	42	2					237	248						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M3133	3341380				2022-12-18	WOS:A1988M313300004
J	Stuart, PE; Nair, RP; Tsoi, LC; Tejasvi, T; Das, S; Kang, HM; Ellinghaus, E; Chandran, V; Callis-Duffin, K; Ike, R; Li, YM; Wen, XQ; Enerback, C; Gudjonsson, JE; Koks, S; Kingo, K; Esko, T; Mrowietz, U; Reis, A; Wichmann, HE; Gieger, C; Hoffmann, P; Nothen, MM; Winkelmann, J; Kunz, M; Moreta, EG; Mease, PJ; Ritchlin, CT; Bowcock, AM; Krueger, GG; Lim, HW; Weidinger, S; Weichenthal, M; Voorhees, JJ; Rahman, P; Gregersen, PK; Franke, A; Gladman, DD; Abecasis, GR; Elder, JT				Stuart, Philip E.; Nair, Rajan P.; Tsoi, Lam C.; Tejasvi, Trilokraj; Das, Sayantan; Kang, Hyun Min; Ellinghaus, Eva; Chandran, Vinod; Callis-Duffin, Kristina; Ike, Robert; Li, Yanming; Wen, Xiaoquan; Enerback, Charlotta; Gudjonsson, Johann E.; Koks, Sulev; Kingo, Kuelli; Esko, Tonu; Mrowietz, Ulrich; Reis, Andre; Wichmann, H. Erich; Gieger, Christian; Hoffmann, Per; Noethen, Markus M.; Winkelmann, Juliane; Kunz, Manfred; Moreta, Elvia G.; Mease, Philip J.; Ritchlin, Christopher T.; Bowcock, Anne M.; Krueger, Gerald G.; Lim, Henry W.; Weidinger, Stephan; Weichenthal, Michael; Voorhees, John J.; Rahman, Proton; Gregersen, Peter K.; Franke, Andre; Gladman, Dafna D.; Abecasis, Goncalo R.; Elder, James T.			Genome-wide Association Analysis of Psoriatic Arthritis and Cutaneous Psoriasis Reveals Differences in Their Genetic Architecture	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROMOTER POLYMORPHISM TNF-ASTERISK-857; SUSCEPTIBILITY LOCI; CHINESE PATIENTS; HLA ANTIGENS; IDENTIFIES 3; RISK GENES; VARIANTS; METAANALYSIS; DISEASE; COMORBIDITIES	Psoriasis vulgaris (PsV) is a common inflammatory and hyperproliferative skin disease. Up to 30% of people with PsV eventually develop psoriatic arthritis (PsA), an inflammatory musculoskeletal condition. To discern differences in genetic risk factors for PsA and cutaneous-only psoriasis (PsC), we carried out a genome-wide association study (GWAS) of 1,430 PsA case subjects and 1,417 unaffected control subjects. Meta-analysis of this study with three other GWASs and two targeted genotyping studies, encompassing a total of 9,293 PsV case subjects, 3,061 PsA case subjects, 3,110 PsC case subjects, and 13,670 unaffected control subjects of European descent, detected 10 regions associated with PsA and 11 with PsC at genome-wide (GW) significance. Several of these association signals (IFNLR1, IFIH1, NFKBIA for PsA; TNFRSF9, LCE3C/B, TRAF3IP2, IL23A, NFKBIA for PsC) have not previously achieved GW significance. After replication, we also identified a PsV-associated SNP near CDKAL1 (rs4712528, odds ratio [OR] = 1.16, p = 8.4 x 10(-11)). Among identified psoriasis risk variants, three were more strongly associated with PsC than PsA (rs12189871 near HLA-C, p = 5.0 x 10(-19); rs4908742 near TNFRSF9, p = 0.00020; rs10888503 near LCE3A, p = 0.0014), and two were more strongly associated with PsA than PsC (rs12044149 near IL23R, p = 0.00018; rs9321623 near TNFAIP3, p = 0.00022). The PsA-specific variants were independent of previously identified psoriasis variants near IL23R and TNFAIP3. We also found multiple independent susceptibility variants in the IL12B, NOS2, and IFIH1 regions. These results provide insights into the pathogenetic similarities and differences between PsC and PsA.	[Stuart, Philip E.; Nair, Rajan P.; Tsoi, Lam C.; Tejasvi, Trilokraj; Gudjonsson, Johann E.; Voorhees, John J.; Elder, James T.] Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI 48109 USA; [Tsoi, Lam C.; Das, Sayantan; Kang, Hyun Min; Li, Yanming; Wen, Xiaoquan; Abecasis, Goncalo R.] Univ Michigan, Ctr Stat Genet, Dept Biostat, Ann Arbor, MI 48109 USA; [Tsoi, Lam C.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Tejasvi, Trilokraj; Elder, James T.] Ann Arbor Vet Affairs Hosp, Ann Arbor, MI 48105 USA; [Ellinghaus, Eva; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Chandran, Vinod; Gladman, Dafna D.] Univ Toronto, Dept Med, Div Rheumatol, Toronto, ON M5T 2S8, Canada; [Chandran, Vinod; Gladman, Dafna D.] Univ Toronto, Ctr Prognosis Studies Rheumat Dis, Toronto Western Res Inst, Toronto, ON M5T 2S8, Canada; [Callis-Duffin, Kristina; Krueger, Gerald G.] Univ Utah, Dept Dermatol, Salt Lake City, UT 84132 USA; [Ike, Robert] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Enerback, Charlotta] Linkoping Univ, Dept Clin & Expt Med, Div Cell Biol & Dermatol, S-58183 Linkoping, Sweden; [Koks, Sulev] Univ Tartu, Ctr Translat Med, Dept Pathophysiol, EE-50411 Tartu, Estonia; [Koks, Sulev] Univ Tartu, Ctr Translat Genom, EE-50411 Tartu, Estonia; [Koks, Sulev] Estonian Univ Life Sci, Dept Reprod Biol, EE-51014 Tartu, Estonia; [Kingo, Kuelli] Univ Tartu, Tartu Univ Hosp, Dept Dermatol & Venereol, Dermatol Clin, EE-50417 Tartu, Estonia; [Esko, Tonu] Univ Tartu, Estonian Genome Ctr, EE-51010 Tartu, Estonia; [Mrowietz, Ulrich; Weidinger, Stephan; Weichenthal, Michael] Univ Med Ctr Schleswig Holstein, Dept Dermatol, D-24105 Kiel, Germany; [Reis, Andre] Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany; [Wichmann, H. Erich] German Res Ctr Environm Hlth, Helmholtz Zentrum Munich, Inst Epidemiol 1, D-85764 Neuherberg, Germany; [Wichmann, H. Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, D-81377 Munich, Germany; [Wichmann, H. Erich] Tech Univ Munich, Inst Med Stat & Epidemiol, D-80333 Munich, Germany; [Gieger, Christian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, D-85764 Neuherberg, Germany; [Gieger, Christian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, D-85764 Neuherberg, Germany; [Hoffmann, Per; Noethen, Markus M.] Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany; [Hoffmann, Per; Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, Dept Genom, D-53127 Bonn, Germany; [Winkelmann, Juliane] Tech Univ Munich, Klinikum Rechts Isar, Neurol Klin & Poliklin, D-80333 Munich, Germany; [Winkelmann, Juliane] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Neurogenom, D-85764 Neuherberg, Germany; [Kunz, Manfred] Univ Leipzig, Dept Dermatol Venereol & Allergol, D-04103 Leipzig, Germany; [Moreta, Elvia G.] St Paul Rheumatol, Eagan, MN 55121 USA; [Mease, Philip J.] Seattle Rheumatol Associates, Seattle, WA 98122 USA; [Ritchlin, Christopher T.] Univ Rochester, Med Ctr, Allergy Immunol & Rheumatol Div, Rochester, NY 14623 USA; [Bowcock, Anne M.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England; [Lim, Henry W.] Henry Ford Hosp, Dept Dermatol, Detroit, MI 48202 USA; [Rahman, Proton] Mem Univ, St John, NF A1C 5B8, Canada; [Gregersen, Peter K.] North Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY 11030 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Kiel; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Utah System of Higher Education; University of Utah; University of Michigan System; University of Michigan; Linkoping University; University of Tartu; University of Tartu; Estonian University of Life Sciences; University of Tartu; University of Tartu; University of Kiel; Schleswig Holstein University Hospital; University of Erlangen Nuremberg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Bonn; University of Bonn; Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Leipzig University; Seattle Rheumatology Associates; University of Rochester; Imperial College London; Henry Ford Health System; Henry Ford Hospital; Memorial University Newfoundland; Northwell Health	Elder, JT (corresponding author), Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI 48109 USA.	jelder@umich.edu	Ellinghaus, Eva/E-6490-2012; li, yan/GTI-4638-2022; Ike, Robert William/AAC-3582-2021; Koks, Sulev/H-3655-2015; Voorhees, John/AAM-9966-2020; Reis, André/D-2309-2009; Weidinger, Stephan/C-8461-2011; Franke, Andre/B-2151-2010; Lim, HW/GRY-3517-2022; Hoffmann, Per/A-5149-2010; Wichmann, Heinz Erich/AAA-5695-2022; Kingo, Külli/H-3603-2012	Ellinghaus, Eva/0000-0003-2914-3382; Koks, Sulev/0000-0001-6087-6643; Voorhees, John/0000-0003-1856-785X; Reis, André/0000-0002-6301-6363; Weidinger, Stephan/0000-0003-3944-252X; Franke, Andre/0000-0003-1530-5811; Hoffmann, Per/0000-0002-6573-983X; Gieger, Christian/0000-0001-6986-9554; Winkelmann, Juliane/0000-0003-2667-9691; Nothen, Markus/0000-0002-8770-2464; Kingo, Kulli/0000-0001-6301-9612; Tsoi, Lam Cheung/0000-0003-1627-5722; Bowcock, Anne/0000-0001-8691-9090; ritchlin, christopher/0000-0002-2602-1219; Wen, Xiaoquan/0000-0001-8990-2737	Barbara and Neal Henschel Charitable Foundation; NIH [R01AR042742, R01AR050511, R01AR054966, R01AR063611, R01AR065183, R01AR050266]; German Research Foundation; German Ministry of Education and Research (BMBF); Doris Duke Foundation [2013106]; Taubman Medical Research Institute; Estonian Ministry of Education and Research [IUT20-46]; Centre of Translational Genomics of University of Tartu (SP1GVARENG); European Regional Development Fund (Centre of Translational Medicine, University of Tartu); Ann Arbor Veterans Affairs Hospital; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050266, R01AR042742, K08AR060802, R01AR054966, R01AR063611, R01AR065183, R01AR050511] Funding Source: NIH RePORTER	Barbara and Neal Henschel Charitable Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Doris Duke Foundation(Doris Duke Charitable Foundation (DDCF)); Taubman Medical Research Institute; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Centre of Translational Genomics of University of Tartu (SP1GVARENG); European Regional Development Fund (Centre of Translational Medicine, University of Tartu); Ann Arbor Veterans Affairs Hospital; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Soumya Raychaudhuri, Aaron Deutsch, and Yuki Okada for sharing their implementation to calculate the percent variance explained for a multi-allelic variant under a disease liability threshold model. We also thank Fawnda Pellett and Remy Pollock from The Centre for Prognostic Studies in the Rheumatic Diseases in Toronto, Canada, for their expert technical assistance, and the Barbara and Neal Henschel Charitable Foundation for their support of the National Psoriasis Victor Henschel Biobank. This work was supported by awards from the NIH (R01AR042742, R01AR050511, R01AR054966, R01AR063611, and R01AR065183 to J.T.E. and R01AR050266 to A.M.B.) and the German Research Foundation. A.F. and E.E. received infrastructure support through the DFG Clusters of Excellence 306 "Inflammation at Interfaces" and are supported by the German Ministry of Education and Research (BMBF) through the e:Med sysINFLAME grant. J.E.G. was supported by the Doris Duke Foundation (grant #2013106) and the Taubman Medical Research Institute as the Frances and Kenneth Eisenberg Emerging Scholar. The Estonian Psoriasis cohort was supported by institutional research funding IUT20-46 of the Estonian Ministry of Education and Research, by the Centre of Translational Genomics of University of Tartu (SP1GVARENG) and by the European Regional Development Fund (Centre of Translational Medicine, University of Tartu). J.T.E. is supported by the Ann Arbor Veterans Affairs Hospital.	Abecasis G. R., 2010, RELATIVEFINDER COMPU; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; ANANTHAKRISHNAN R, 1973, ARCH DERMATOL FORSCH, V247, P53, DOI 10.1007/BF00595700; ANANTHAKRISHNAN R, 1974, J GENET, V61, P142, DOI 10.1007/BF02984078; Apel M, 2013, ARTHRITIS RHEUM-US, V65, P1224, DOI 10.1002/art.37885; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Bergboer JGM, 2011, AM J PATHOL, V178, P1470, DOI 10.1016/j.ajpath.2010.12.017; Bowes J, 2015, ANN RHEUM DIS, V74, P1882, DOI 10.1136/annrheumdis-2014-207187; Bowes J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7046; Bowes J, 2011, ANN RHEUM DIS, V70, P1016, DOI 10.1136/ard.2010.143123; Bowes J, 2010, ANN RHEUM DIS, V69, P2199, DOI 10.1136/ard.2010.130575; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; BRANDRUP F, 1982, ACTA DERM-VENEREOL, V62, P229; Capon F, 2008, HUM MOL GENET, V17, P1938, DOI 10.1093/hmg/ddn091; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chandran V, 2009, ANN RHEUM DIS, V68, P664, DOI 10.1136/ard.2008.089367; Chandran V, 2014, RHEUMATOLOGY, V53, P233, DOI 10.1093/rheumatology/ket296; Chandran V, 2013, HUM IMMUNOL, V74, P1333, DOI 10.1016/j.humimm.2013.07.014; Chandran V, 2010, J AUTOIMMUN, V34, pJ314, DOI 10.1016/j.jaut.2009.12.001; Chang YT, 2007, BRIT J DERMATOL, V156, P899, DOI 10.1111/j.1365-2133.2007.07820.x; Chiraz BS, 2014, MOL BIOL REP, V41, P4141, DOI 10.1007/s11033-014-3285-4; Coto E., 2010, BMC MED GENET, V11, P45; Coto E, 2011, J INVEST DERMATOL, V131, P1003, DOI 10.1038/jid.2011.14; Das S, 2015, EUR J HUM GENET, V23, P844, DOI 10.1038/ejhg.2014.172; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Docampo E, 2011, ARTHRITIS RHEUM-US, V63, P1860, DOI 10.1002/art.30340; Duffin KC, 2009, J INVEST DERMATOL, V129, P2777, DOI 10.1038/jid.2009.169; DUFFY DL, 1993, J AM ACAD DERMATOL, V29, P428, DOI 10.1016/0190-9622(93)70206-9; Eder L, 2012, ANN RHEUM DIS, V71, P50, DOI 10.1136/ard.2011.155044; Eder L, 2011, ANN RHEUM DIS, V70, P1594, DOI 10.1136/ard.2010.147421; Efron B., 1986, STAT SCI, V1, P54, DOI https://doi.org/10.1214/ss/1177013815; ELDER JT, 1994, ARCH DERMATOL, V130, P216, DOI 10.1001/archderm.130.2.216; Ellinghaus D, 2012, AM J HUM GENET, V90, P636, DOI 10.1016/j.ajhg.2012.02.020; Ellinghaus E, 2012, J INVEST DERMATOL, V132, P1133, DOI 10.1038/jid.2011.415; Ellinghaus E, 2010, NAT GENET, V42, P991, DOI 10.1038/ng.689; FitzGerald O, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0640-3; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Ghosh A, 2008, AM J HUM GENET, V82, P1064, DOI 10.1016/j.ajhg.2008.03.002; Giardina E, 2011, ARTHRITIS RHEUM-US, V63, P3801, DOI 10.1002/art.30591; Gladman D.D., 2005, PSORIASIS PSORI ATIC, P57, DOI 10.1007/3-540-27190-2_7; GLADMAN DD, 1986, J RHEUMATOL, V13, P586; Gonzalez S, 1999, ARTHRITIS RHEUM-US, V42, P1010, DOI 10.1002/1529-0131(199905)42:5<1010::AID-ANR21>3.0.CO;2-H; Grjibovski AM, 2007, J EUR ACAD DERMATOL, V21, P1337, DOI 10.1111/j.1468-3083.2007.02268.x; Ho PYPC, 2008, ANN RHEUM DIS, V67, P677, DOI 10.1136/ard.2007.071399; Hohler T, 2002, ANN RHEUM DIS, V61, P213, DOI 10.1136/ard.61.3.213; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Huffmeier U, 2010, NAT GENET, V42, P996, DOI 10.1038/ng.688; Huffmeier U, 2010, ANN RHEUM DIS, V69, P876, DOI 10.1136/ard.2009.108951; Husted JA, 2011, ARTHRIT CARE RES, V63, P1729, DOI 10.1002/acr.20627; Jamnitski A, 2013, ANN RHEUM DIS, V72, P211, DOI 10.1136/annrheumdis-2011-201194; Julia A, 2012, HUM MOL GENET, V21, P4549, DOI 10.1093/hmg/dds295; Karason A, 2009, RHEUMATOLOGY, V48, P1424, DOI 10.1093/rheumatology/kep243; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kryczek I, 2008, J IMMUNOL, V181, P4733, DOI 10.4049/jimmunol.181.7.4733; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lascorz J, 2005, ANN RHEUM DIS, V64, P951, DOI 10.1136/ard.2004.029157; Li BS, 2014, J INVEST DERMATOL, V134, P1828, DOI 10.1038/jid.2014.28; Li YH, 2009, J INVEST DERMATOL, V129, P629, DOI 10.1038/jid.2008.297; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Lonnberg AS, 2013, BRIT J DERMATOL, V169, P412, DOI 10.1111/bjd.12375; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Menon B, 2014, ARTHRITIS RHEUMATOL, V66, P1272, DOI 10.1002/art.38376; MOLL JMH, 1973, ANN RHEUM DIS, V32, P181, DOI 10.1136/ard.32.3.181; Myers A, 2005, RHEUMATOLOGY, V44, P773, DOI 10.1093/rheumatology/keh589; Nair RP, 2013, J INVEST DERMATOL, V133, pS136; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Ni C, 2014, CLIN COSMET INVESTI, V7, P119, DOI 10.2147/CCID.S44843; Okada Y, 2014, AM J HUM GENET, V95, P162, DOI 10.1016/j.ajhg.2014.07.002; Pratt J., 1987, P 2 INT C STAT, P245; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quaranta M, 2009, GENES IMMUN, V10, P654, DOI 10.1038/gene.2009.51; Queiro R, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2097; Rahman P, 2011, ANN RHEUM DIS, V70, P690, DOI 10.1136/ard.2010.133561; Reich K, 2007, ARTHRITIS RHEUM, V56, P2056, DOI 10.1002/art.22590; Riveira-Munoz E, 2011, J INVEST DERMATOL, V131, P1105, DOI 10.1038/jid.2010.350; Sheng Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5331; So HC, 2011, GENET EPIDEMIOL, V35, P310, DOI 10.1002/gepi.20579; Soto-Sanchez J, 2010, CYTOKINE, V50, P114, DOI 10.1016/j.cyto.2010.01.006; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Strong CD, 2010, HUM MOL GENET, V19, P1453, DOI 10.1093/hmg/ddq019; Stuart PE, 2010, NAT GENET, V42, P1000, DOI 10.1038/ng.693; Sun LD, 2010, NAT GENET, V42, P1005, DOI 10.1038/ng.690; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsoi LC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8001; Tsoi LC, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0570-4; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wen XQ, 2014, ANN APPL STAT, V8, P176, DOI 10.1214/13-AOAS695; Winchester R, 2012, ARTHRITIS RHEUM-US, V64, P1134, DOI 10.1002/art.33415; WOODROW JC, 1985, J MED GENET, V22, P492, DOI 10.1136/jmg.22.6.492; Yang Q, 2013, BRIT J DERMATOL, V168, P1060, DOI 10.1111/bjd.12142; Yeung H, 2013, JAMA DERMATOL, V149, P1173, DOI 10.1001/jamadermatol.2013.5015; Yin XY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7916; Zhang XJ, 2009, NAT GENET, V41, P205, DOI 10.1038/ng.310; Zheng HF, 2011, J DERMATOL SCI, V61, P124, DOI 10.1016/j.jdermsci.2010.12.001; Zhu KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023089; Zuo XB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7793	104	184	195	3	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2015	97	6					816	836		10.1016/j.ajhg.2015.10.019	http://dx.doi.org/10.1016/j.ajhg.2015.10.019			21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DB3UM	26626624	Green Published, Bronze			2022-12-18	WOS:000368437900004
J	Abbasi-Moheb, L; Mertel, S; Gonsior, M; Nouri-Vahid, L; Kahrizi, K; Cirak, S; Wieczorek, D; Motazacker, MM; Esmaeeli-Nieh, S; Cremer, K; Weissmann, R; Tzschach, A; Garshasbi, M; Abedini, SS; Najmabadi, H; Ropers, HH; Sigrist, SJ; Kuss, AW				Abbasi-Moheb, Lia; Mertel, Sara; Gonsior, Melanie; Nouri-Vahid, Leyla; Kahrizi, Kimia; Cirak, Sebahattin; Wieczorek, Dagmar; Motazacker, M. Mahdi; Esmaeeli-Nieh, Sahar; Cremer, Kirsten; Weissmann, Robert; Tzschach, Andreas; Garshasbi, Masoud; Abedini, Seyedeh S.; Najmabadi, Hossein; Ropers, H. Hilger; Sigrist, Stephan J.; Kuss, Andreas W.			Mutations in NSUN2 Cause Autosomal-Recessive Intellectual Disability	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MENTAL-RETARDATION; BINDING-PROTEIN; DROSOPHILA; GENE; REVEALS; FAMILY; IDENTIFICATION; MEMORY; EXPRESSION; GENERATION	With a prevalence between 1 and 3%, hereditary forms of intellectual disability (ID) are among the most important problems in health care. Particularly, autosomal-recessive forms of the disorder have a very heterogeneous molecular basis, and genes with an increased number of disease-causing mutations are not common. Here, we report on three different mutations (two nonsense mutations, c.679C>T [p.Gln227(star)] and c.1114C>T [p.Gln372(star)], as well as one splicing mutation, g.6622224A>C [p.Ile179Argfs(star)192]) that cause a loss of the tRNA-methyltransferase-encoding NSUN2 main transcript in homozygotes. We identified the mutations by sequencing exons and exon-intron boundaries within the genomic region where the linkage intervals of three independent consanguineous families of Iranian and Kurdish origin overlapped with the previously described MRT5 locus. In order to gain further evidence concerning the effect of a loss of NSUN2 on memory and learning, we constructed a Drosophila model by deleting the NSUN2 ortholog, CG6133, and investigated the mutants by using molecular and behavioral approaches. When the Drosophila melanogaster NSUN2 ortholog was deleted, severe short-term-memory (STM) deficits were observed; STM could be rescued by re-expression of the wild-type protein in the nervous system. The humans homozygous for NSUN2 mutations showed an overlapping phenotype consisting of moderate to severe ID and facial dysmorphism (which includes a long face, characteristic eyebrows, a long nose, and a small chin), suggesting that mutations in this gene might even induce a syndromic form of ID. Moreover, our observations from the Drosophila model point toward an evolutionarily conserved role of RNA methylation in normal cognitive development.	[Abbasi-Moheb, Lia; Motazacker, M. Mahdi; Esmaeeli-Nieh, Sahar; Tzschach, Andreas; Garshasbi, Masoud; Ropers, H. Hilger; Kuss, Andreas W.] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Abbasi-Moheb, Lia; Nouri-Vahid, Leyla; Kahrizi, Kimia; Abedini, Seyedeh S.; Najmabadi, Hossein] Univ Social Welf & Rehabil Sci, Genet Res Ctr, Tehran 1985713834, Iran; [Mertel, Sara; Gonsior, Melanie; Sigrist, Stephan J.] Free Univ Berlin, Inst Biol Genet, D-14195 Berlin, Germany; [Cirak, Sebahattin] Great Ormond St Childrens Hosp, Inst Child Hlth, London WC1N 1EH, England; [Wieczorek, Dagmar; Cremer, Kirsten] Univ Klinikum Essen, Inst Humangenet, D-45147 Essen, Germany; [Weissmann, Robert; Kuss, Andreas W.] Univ Med Greifswald, Inst Human Genet, D-17489 Greifswald, Germany; [Weissmann, Robert; Kuss, Andreas W.] Univ Greifswald, Interfac Inst Genet & Funct Genom, D-17489 Greifswald, Germany; [Sigrist, Stephan J.] Charite, NeuroCure Cluster Excellence, D-10117 Berlin, Germany	Max Planck Society; Free University of Berlin; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Duisburg Essen; Greifswald Medical School; Ernst Moritz Arndt Universitat Greifswald; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kuss, AW (corresponding author), Univ Med Greifswald, Inst Human Genet, Fleischmannstr 42-44, D-17489 Greifswald, Germany.	kussa@uni-greifswald.de	Wieczorek, Dagmar/AAU-6008-2021; Kahrizi, Kimia/D-7989-2017; Cirak, Sebahattin/AAZ-6829-2020; Cirak, Sebahattin/AAX-9593-2020; Najmabadi, Hossein/P-8182-2017; Abedini, Seyedeh Sedigheh/AAG-3694-2021; Tzschach, Andreas/I-2648-2019	Wieczorek, Dagmar/0000-0003-2812-6492; Tzschach, Andreas/0000-0002-6840-965X; Najmabadi, Hossein/0000-0002-6084-7778; Abedini, Seyedeh Sedigheh/0000-0003-2671-2295; Kuss, Andreas/0000-0002-9401-4627; Garshasbi, Masoud/0000-0002-5508-7903	Iranian National Science Foundation; Max Planck Innovation Fund; German Federal Ministry of Education and Research [MRNET 01GS08161-2, MRNET 01GS08167]; Deutsche Forschungsgemeinschaft (DFG) [SFB 665, SFB 958, EXC 257]	Iranian National Science Foundation(Iran National Science Foundation (INSF)); Max Planck Innovation Fund; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	We are grateful to the affected individuals and their families for their participation in the study. We thank Martin Schwarzel, Lisa Scheunemann, Antje Richlitzki, Sabrina Scholz, Bettina Lipkowitz, and Marianne Schlicht for expert technical assistance. This work was supported by a grant from the Iranian National Science Foundation, the Max Planck Innovation Fund, and a grant from the German Federal Ministry of Education and Research to H.H.R. (MRNET 01GS08161-2) and D.W. (MRNET 01GS08167). Further support was received from the Deutsche Forschungsgemeinschaft (DFG) through grants (SFB 665, SFB 958, and EXC 257) to S.J.S. H.H.R., H.N., and K.K. participate in the GENCODYS Consortium.	Akbarian S, 2009, BIOL PSYCHIAT, V65, P198, DOI 10.1016/j.biopsych.2008.08.015; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bateman JR, 2006, GENETICS, V173, P769, DOI 10.1534/genetics.106.056945; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Blanco S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002403; Brzezicha B, 2006, NUCLEIC ACIDS RES, V34, P6034, DOI 10.1093/nar/gkl765; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Davis RL, 2011, NEURON, V70, P8, DOI 10.1016/j.neuron.2011.03.012; Freude K, 2004, AM J HUM GENET, V75, P305, DOI 10.1086/422507; Frye M, 2006, CURR BIOL, V16, P971, DOI 10.1016/j.cub.2006.04.027; Garshasbi M, 2006, HUM GENET, V118, P708, DOI 10.1007/s00439-005-0104-y; Garshasbi M, 2008, AM J HUM GENET, V82, P1158, DOI 10.1016/j.ajhg.2008.03.018; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Hong CB, 2003, CANCER RES, V63, P7600; Hu H, 2011, AM J HUM GENET, V89, P407, DOI 10.1016/j.ajhg.2011.08.008; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kahrizi K, 2011, EUR J HUM GENET, V19, P115, DOI 10.1038/ejhg.2010.132; Khan MA, 2012, AM J HUM GENET, V90, P856, DOI 10.1016/j.ajhg.2012.03.023; Kuss AW, 2011, HUM GENET, V129, P141, DOI 10.1007/s00439-010-0907-3; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Mir A, 2009, AM J HUM GENET, V85, P909, DOI 10.1016/j.ajhg.2009.11.009; Moheb LA, 2008, EUR J HUM GENET, V16, P270, DOI 10.1038/sj.ejhg.5201967; Motazacker MM, 2007, AM J HUM GENET, V81, P792, DOI 10.1086/521275; Najmabadi H, 2007, HUM GENET, V121, P43, DOI 10.1007/s00439-006-0292-0; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Plotkin JB, 2004, P NATL ACAD SCI USA, V101, P12588, DOI 10.1073/pnas.0404957101; Ramser J, 2004, J MED GENET, V41, P679, DOI 10.1136/jmg.2004.019000; Richter JD, 2010, BIOCHEM SOC T, V38, P1527, DOI 10.1042/BST0381527; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Ropers HH, 2008, CURR OPIN GENET DEV, V18, P241, DOI 10.1016/j.gde.2008.07.008; Ropers HH, 2010, ANNU REV GENOM HUM G, V11, P161, DOI 10.1146/annurev-genom-082509-141640; Schwaerzel M, 2002, NEURON, V35, P951, DOI 10.1016/S0896-6273(02)00832-2; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Schwaerzel M, 2007, J NEUROSCI, V27, P1229, DOI 10.1523/JNEUROSCI.4622-06.2007; Sigrist SJ, 2003, J NEUROSCI, V23, P6546; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672; Zars T, 2010, LEARN MEMORY, V17, P246, DOI 10.1101/lm.1706110; Zhao XY, 2003, P NATL ACAD SCI USA, V100, P6777, DOI 10.1073/pnas.1131928100; Zschocke J, 2002, J BIOL CHEM, V277, P38772, DOI 10.1074/jbc.M205664200	43	184	190	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 4	2012	90	5					847	855		10.1016/j.ajhg.2012.03.021	http://dx.doi.org/10.1016/j.ajhg.2012.03.021			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	940QG	22541559	Green Published, Bronze			2022-12-18	WOS:000303907500008
J	Denny, JC; Crawford, DC; Ritchie, MD; Bielinski, SJ; Basford, MA; Bradford, Y; Chai, HS; Bastarache, L; Zuvich, R; Peissig, P; Carrell, D; Ramirez, AH; Pathak, J; Wilke, RA; Rasmussen, L; Wang, XM; Pacheco, JA; Kho, AN; Hayes, MG; Weston, N; Matsumoto, M; Kopp, PA; Newton, KM; Jarvik, GP; Li, RL; Manolio, TA; Kullo, IJ; Chute, CG; Chisholm, RL; Larson, EB; McCarty, CA; Masys, DR; Roden, DM; de Andrade, M				Denny, Joshua C.; Crawford, Dana C.; Ritchie, Marylyn D.; Bielinski, Suzette J.; Basford, Melissa A.; Bradford, Yuki; Chai, High Seng; Bastarache, Lisa; Zuvich, Rebecca; Peissig, Peggy; Carrell, David; Ramirez, Andrea H.; Pathak, Jyotishman; Wilke, Russell A.; Rasmussen, Luke; Wang, Xiaoming; Pacheco, Jennifer A.; Kho, Abel N.; Hayes, M. Geoffrey; Weston, Noah; Matsumoto, Martha; Kopp, Peter A.; Newton, Katherine M.; Jarvik, Gail P.; Li, Rongling; Manolio, Teri A.; Kullo, Iftikhar J.; Chute, Christopher G.; Chisholm, Rex L.; Larson, Eric B.; McCarty, Catherine A.; Masys, Daniel R.; Roden, Dan M.; de Andrade, Mariza			Variants Near FOXE1 Are Associated with Hypothyroidism and Other Thyroid Conditions: Using Electronic Medical Records for Genome- and Phenome-wide Studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PHYSICIAN ORDER ENTRY; SERUM TSH; CLEFT-PALATE; SUBCLINICAL HYPOTHYROIDISM; GENETIC SUSCEPTIBILITY; POPULATION; SCAN; LINKAGE; CANCER; HEALTH	We repurposed existing genotypes in DNA biobanks across the Electronic Medical Records and Genomics network to perform a genome-wide association study for primary hypothyroidism, the most common thyroid disease. Electronic selection algorithms incorporating billing codes, laboratory values, text queries, and medication records identified 1317 cases and 5053 controls of European ancestry within five electronic medical records (EMRs); the algorithms' positive predictive values were 92.4% and 98.5% for cases and controls, respectively. Four single-nucleotide polymorphisms (SNPs) in linkage disequilibrium at 9q22 near FOXE1 were associated with hypothyroidism at genome-wide significance, the strongest being rs7850258 (odds ratio [OR] 0.74, p = 3.96 x 10(-9)). This association was replicated in a set of 263 cases and 1616 controls (OR = 0.60, p = 5.7 x 10(-6)). A phenome-wide association study (PheWAS) that was performed on this locus with 13,617 individuals and more than 200,000 patient-years of billing data identified associations with additional phenotypes: thyroiditis (OR = 0.58, p = 1.4 x 10(-5)), nodular (OR = 0.76, p = 3.1 x 10(-5)) and multinodular (OR = 0.69, p = 3.9 x 10(-5)) goiters, and thyrotoxicosis (OR = 0.76, p = 1.5 x 10(-3)), but not Graves disease (OR = 1.03, p = 0.82). Thyroid cancer, previously associated with this locus, was not significantly associated in the PheWAS (OR = 1.29, p = 0.09). The strongest association in the PheWAS was hypothyroidism (OR = 0.76, p = 2.7 x 10(-13)), which had an odds ratio that was nearly identical to that of the curated case-control population in the primary analysis, providing further validation of the PheWAS method. Our findings indicate that EMR-linked genomic data could allow discovery of genes associated with many diseases without additional genotyping cost.	[Denny, Joshua C.; Ritchie, Marylyn D.; Bastarache, Lisa; Masys, Daniel R.] Vanderbilt Univ, Dept Biomed Informat, Nashville, TN 37232 USA; [Denny, Joshua C.; Ramirez, Andrea H.; Wilke, Russell A.; Roden, Dan M.] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA; [Crawford, Dana C.; Ritchie, Marylyn D.; Zuvich, Rebecca] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Ritchie, Marylyn D.; Bradford, Yuki; Zuvich, Rebecca] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37232 USA; [Bielinski, Suzette J.] Mayo Clin, Dept Hlth Sci Res, Div Epidemiol, Rochester, MN 55905 USA; [Basford, Melissa A.; Wang, Xiaoming] Vanderbilt Univ, Res Off, Nashville, TN 37232 USA; [Chai, High Seng; Pathak, Jyotishman; Matsumoto, Martha; Chute, Christopher G.; de Andrade, Mariza] Mayo Clin, Div Biomed Stat & Informat, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Peissig, Peggy; Rasmussen, Luke; Newton, Katherine M.] Marshfield Clin Res Fdn, Biomed Informat Res Ctr, Marshfield, WI 54449 USA; [Carrell, David; Weston, Noah; Larson, Eric B.] Grp Hlth Res Inst, Seattle, WA 98101 USA; [Kho, Abel N.; Hayes, M. Geoffrey; Kopp, Peter A.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Jarvik, Gail P.] Univ Washington, Med Ctr, Dept Med, Seattle, WA 98105 USA; [Li, Rongling; Manolio, Teri A.] Natl Human Genome Res Inst, Off Populat Genom, Bethesda, MD 20892 USA; [Kullo, Iftikhar J.] Mayo Clin, Dept Med, Div Cardiovasc Dis, Rochester, MN 55905 USA; [Pacheco, Jennifer A.; Kopp, Peter A.; Chisholm, Rex L.] Northwestern Univ, Dept Ctr Genet Med, Chicago, IL USA; [McCarty, Catherine A.] Marshfield Clin Res Fdn, Ctr Human Genet, Marshfield, WI 54449 USA; [Roden, Dan M.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Mayo Clinic; Vanderbilt University; Mayo Clinic; Northwestern University; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Mayo Clinic; Northwestern University; Vanderbilt University	Denny, JC (corresponding author), Vanderbilt Univ, Dept Biomed Informat, 221 Kirkland Hall, Nashville, TN 37232 USA.	josh.denny@vanderbilt.edu	Bielinski, Suzette/A-2238-2009; Jarvik, Gail P/N-6476-2014; Roden, Dan/ABD-5412-2021; Crawford, Dana/C-1054-2012; Ritchie, Marylyn/C-1114-2012; Crawford, Dana/O-5578-2019; Chute, Christopher/AAT-8540-2021; Denny, Josh/AAL-3359-2021; Chisholm, Rex/B-3418-2009	Bielinski, Suzette/0000-0002-2905-5430; Jarvik, Gail P/0000-0002-6710-8708; Crawford, Dana/0000-0002-6437-6248; Denny, Josh/0000-0002-3049-7332; Chisholm, Rex/0000-0002-5638-3990; Pacheco, Jennifer/0000-0001-8021-5818; Kopp, Peter A/0000-0001-5980-0529; McCarty, Catherine/0000-0003-1089-0142; Rasmussen, Luke/0000-0002-4497-8049; Hayes, M Geoffrey/0000-0002-4617-3981	National Human Genome Research Institute (NHGRI) [U01-HG-004610, U01-HG-004608, U01-HG-004599, U01-HG-004609, U01-HG-004603]; National Institute of General Medical Sciences (NIGMS); Mayo Foundation, Mayo Clinic Genome-wide Association Study of Venous Thromboembolism from the NHGRI (GENEVA Consortium) [HG-004735]; National Cancer Institute [P50CA102701]; NATIONAL CANCER INSTITUTE [P50CA102701] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004735, U01HG004610, U01HG004603, U01HG004608, U01HG004609, U01HG006375, U01HG004599] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010685] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Mayo Foundation, Mayo Clinic Genome-wide Association Study of Venous Thromboembolism from the NHGRI (GENEVA Consortium); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The eMERGE Network was initiated and funded by the National Human Genome Research Institute (NHGRI) through the following grants: U01-HG-004610 (Group Health Cooperative); U01-HG-004608 (Marshfield Clinic); U01-HG-004599 (Mayo Clinic); U01-HG-004609 (Northwestern University); and U01-HG-004603 (Vanderbilt University, also serving as the Coordinating Center). The National Institute of General Medical Sciences (NIGMS) provided additional funding to the eMERGE Network through these grants. The Mayo Genome Consortia are supported by the Mayo Foundation, Mayo Clinic Genome-wide Association Study of Venous Thromboembolism (HG-004735) from the NHGRI (GENEVA Consortium), and the Mayo Clinic SPORE in Pancreatic Cancer (P50CA102701) from the National Cancer Institute.	Allen EM, 2003, J CLIN ENDOCR METAB, V88, P1292, DOI 10.1210/jc.2002-020634; Ammenwerth E, 2008, J AM MED INFORM ASSN, V15, P585, DOI 10.1197/jamia.M2667; Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; Aoki Y, 2007, THYROID, V17, P1211, DOI 10.1089/thy.2006.0235; Arnaud-Lopez L, 2008, AM J HUM GENET, V82, P1270, DOI 10.1016/j.ajhg.2008.04.019; Ban Y, 2002, CLIN ENDOCRINOL, V57, P81, DOI 10.1046/j.1365-2265.2002.01566.x; Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; Boelaert K, 2010, AM J MED, V123, DOI 10.1016/j.amjmed.2009.06.030; Brix TH, 2000, J CLIN ENDOCR METAB, V85, P536, DOI 10.1210/jc.85.2.536; Buyukasik O, 2011, ENDOKRYNOL POL, V62, P303; Caldwell KL, 2011, THYROID, V21, P419, DOI 10.1089/thy.2010.0077; Carre A, 2007, HUM GENET, V122, P467, DOI 10.1007/s00439-007-0420-5; Clifton-Bligh RJ, 1998, NAT GENET, V19, P399, DOI 10.1038/1294; Criswell LA, 2005, AM J HUM GENET, V76, P561, DOI 10.1086/429096; Dayan CM, 1996, NEW ENGL J MED, V335, P99, DOI 10.1056/NEJM199607113350206; De Felice M, 1998, NAT GENET, V19, P395, DOI 10.1038/1289; Denny JC, 2010, CIRCULATION, V122, P2016, DOI 10.1161/CIRCULATIONAHA.110.948828; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Fagman H, 2011, J MOL ENDOCRINOL, V46, pR33, DOI 10.1677/JME-10-0084; Grady BJ, 2010, BIOCOMPUT-PAC SYM, P315; Gudmundsson J, 2009, NAT GENET, V41, P460, DOI 10.1038/ng.339; Hansen PS, 2006, EUR J ENDOCRINOL, V154, P29, DOI 10.1530/eje.1.02060; Haymart MR, 2009, CLIN ENDOCRINOL, V71, P434, DOI 10.1111/j.1365-2265.2008.03489.x; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Huber G, 2002, J CLIN ENDOCR METAB, V87, P3221, DOI 10.1210/jc.87.7.3221; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; KABADI UM, 1993, ARCH INTERN MED, V153, P957, DOI 10.1001/archinte.153.8.957; Kacem HH, 2003, J CLIN ENDOCR METAB, V88, P2274, DOI 10.1210/jc.2002-021460; Kaushal R, 2006, J AM MED INFORM ASSN, V13, P261, DOI 10.1197/jamia.M1984; Kohane IS, 2011, NAT REV GENET, V12, P417, DOI 10.1038/nrg2999; Kopp PA, 2008, NEW ENGL J MED, V358, P1856, DOI 10.1056/NEJMe0802188; Kullo IJ, 2011, AM J HUM GENET, V89, P131, DOI 10.1016/j.ajhg.2011.05.019; Kullo IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013011; Kurreeman F, 2011, AM J HUM GENET, V88, P57, DOI 10.1016/j.ajhg.2010.12.007; Liao KP, 2010, ARTHRIT CARE RES, V62, P1120, DOI 10.1002/acr.20184; Lowe JK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000365; Marazita ML, 2009, HUM HERED, V68, P151, DOI 10.1159/000224636; MARTINI FH, 2011, HUMAN ANATOMY; McCarty CA, 2007, COMMUNITY GENET, V10, P2, DOI 10.1159/000096274; McCarty Catherine A, 2005, Per Med, V2, P49, DOI 10.1517/17410541.2.1.49; McCarty CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-13; Medici M, 2011, EUR J ENDOCRINOL, V164, P781, DOI 10.1530/EJE-10-1130; Moreno LM, 2009, HUM MOL GENET, V18, P4879, DOI 10.1093/hmg/ddp444; Ortiz L, 1999, J BIOL CHEM, V274, P15213, DOI 10.1074/jbc.274.21.15213; Pacheco Jennifer A, 2009, AMIA Annu Symp Proc, V2009, P497; Panicker V, 2010, AM J HUM GENET, V87, P430, DOI 10.1016/j.ajhg.2010.08.005; Park SM, 2005, J MED GENET, V42, P379, DOI 10.1136/jmg.2004.024158; Pearce EN, 2008, THYROID, V18, P1143, DOI 10.1089/thy.2008.1554; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ritchie MD, 2010, AM J HUM GENET, V86, P560, DOI 10.1016/j.ajhg.2010.03.003; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; SEGAL K, 1985, INT SURG, V70, P205; Stefan M, 2011, J BIOL CHEM, V286, P31168, DOI 10.1074/jbc.M111.247510; Szczepanek E, 2011, HORM RES PAEDIAT, V75, P329, DOI 10.1159/000322874; Takahashi M, 2010, HUM MOL GENET, V19, P2516, DOI 10.1093/hmg/ddq123; Tomer Y, 2010, THYROID, V20, P715, DOI 10.1089/thy.2010.1644; Turner S., 2011, CURR PROTOC HUM GENE, V68; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Van Vliet G, 2003, CLIN GENET, V63, P445; Vanderpump M, 1996, THYROID, P474; Wilke RA, 2011, CLIN PHARMACOL THER, V89, P379, DOI 10.1038/clpt.2010.260; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Zannini M, 1997, EMBO J, V16, P3185, DOI 10.1093/emboj/16.11.3185	67	184	185	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 7	2011	89	4					529	542		10.1016/j.ajhg.2011.09.008	http://dx.doi.org/10.1016/j.ajhg.2011.09.008			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	834HV	21981779	Green Published, Bronze			2022-12-18	WOS:000295951300007
J	Mefford, HC; Clauin, S; Sharp, AJ; Moller, RS; Ullmann, R; Kapur, R; Pinkel, D; Cooper, GM; Ventura, M; Ropers, HH; Tommerup, N; Eichler, EE; Bellanne-Chantelot, C				Mefford, Heather C.; Clauin, Severine; Sharp, Andrew J.; Moller, Rikke S.; Ullmann, Reinhard; Kapur, Raj; Pinkel, Dan; Cooper, Gregory M.; Ventura, Mario; Ropers, H. Hilger; Tommerup, Niels; Eichler, Evan E.; Bellanne-Chantelot, Christine			Recurrent reciprocal genomic Rearrangements of 17q12 are associated with renal disease, diabetes, and epilepsy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COPY-NUMBER; TCF2 GENE; MICRODUPLICATION; ARCHITECTURE; MICROARRAY; ANOMALIES; IMBALANCE; CHILDREN; 22Q11.2; LIM1	Most studies of genomic disorders have focused on patients with cognitive disability and/or peripheral nervous system defects. In an effort to broaden the phenotypic spectrum of this disease model, we assessed 155 autopsy samples from fetuses with well-defined developmental pathologies in regions predisposed to recurrent rearrangement, by array-based comparative genomic hybridization. We found that 6% of fetal material showed evidence of microdeletion or microduplication, including three independent events that likely resulted from unequal crossing-over between segmental duplications. One of the microdeletions, identified in a fetus with multicystic dysplastic kidneys, encompasses the TCF2 gene on 17q12, previously shown to be mutated in maturity-onset diabetes, as well as in a subset of pediatric renal abnormalities. Fine-scale mapping of the breakpoints in different patient cohorts revealed a recurrent 1.5-Mb de novo deletion in individuals with phenotypes that ranged from congenital renal abnormalities to maturity-onset diabetes of the young type 5. We also identified the reciprocal duplication, which appears to be enriched in samples from patients with epilepsy. We describe the first example of a recurrent genomic disorder associated with diabetes.	Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Div Med Genet, Seattle, WA 98195 USA; Childrens Hosp & Reg Med Ctr, Dept Labs, Seattle, WA USA; Howard Hughes Med Inst, Seattle, WA USA; Assistance Publ Hop Paris Pitie Salpetriere, Ctr Mol Genet & Cytogenet, Paris, France; Univ Paris 06, Paris, France; Danish Epilepsy Ctr, Dianalund, Denmark; Wilhelm Johannsen Ctr Funct Genome Res, Copenhagen, Denmark; Max Planck Inst Mol Genet, Berlin, Germany; Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA; Univ Bari, Dept Genet & Microbiol, Bari, Italy	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; Howard Hughes Medical Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Max Planck Society; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Universita degli Studi di Bari Aldo Moro	Eichler, EE (corresponding author), Univ Washington, Dept Genome Sci, 1705 NE Pacific St,Box 355065, Seattle, WA 98195 USA.	eee@gs.washington.edu	Cooper, Gregory/D-6914-2011; Sharp, Andrew/A-5783-2008; Tommerup, Niels/T-8776-2017; Ventura, Mario/E-6420-2011	Cooper, Gregory/0000-0001-5509-9923; Tommerup, Niels/0000-0003-2304-0112; Ventura, Mario/0000-0001-7762-8777; Moller, Rikke S./0000-0002-9664-1448	NHLBI NIH HHS [U01 HL069757] Funding Source: Medline; NICHD NIH HHS [R01 HD043569, HD043569] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043569] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL069757] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bellanne-Chantelot C, 2005, DIABETES, V54, P3126, DOI 10.2337/diabetes.54.11.3126; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; Decramer S, 2007, J AM SOC NEPHROL, V18, P923, DOI 10.1681/ASN.2006091057; Ensenauer RE, 2003, AM J HUM GENET, V73, P1027, DOI 10.1086/378818; Friedman JM, 2006, AM J HUM GENET, V79, P500, DOI 10.1086/507471; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Ishkanian AS, 2004, NAT GENET, V36, P299, DOI 10.1038/ng1307; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; Koolen DA, 2006, NAT GENET, V38, P999, DOI 10.1038/ng1853; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Menten B, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039453; Muller D, 2006, KIDNEY INT, V70, P1656, DOI 10.1038/sj.ki.5001746; Pedersen A, 2005, DEV BIOL, V288, P571, DOI 10.1016/j.ydbio.2005.09.027; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Robin NH, 2005, J PEDIATR-US, V147, P90, DOI 10.1016/j.jpeds.2005.03.007; Rosenberg C, 2006, J MED GENET, V43, P180, DOI 10.1136/jmg.2005.032268; Rozen S, 2000, Methods Mol Biol, V132, P365; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; SHAWLOT W, 1995, NATURE, V374, P425, DOI 10.1038/374425a0; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Ulinski T, 2006, J AM SOC NEPHROL, V17, P497, DOI 10.1681/ASN.2005101040; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; Yobb TM, 2005, AM J HUM GENET, V76, P865, DOI 10.1086/429841	31	184	191	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2007	81	5					1057	1069		10.1086/522591	http://dx.doi.org/10.1086/522591			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	224XE	17924346	Bronze, Green Published			2022-12-18	WOS:000250480900016
J	Newbury, DF; Bonora, E; Lamb, JA; Fisher, SE; Lai, CSL; Baird, G; Jannoun, L; Slonims, V; Stott, CM; Merricks, MJ; Bolton, PF; Bailey, AJ; Monaco, AP				Newbury, DF; Bonora, E; Lamb, JA; Fisher, SE; Lai, CSL; Baird, G; Jannoun, L; Slonims, V; Stott, CM; Merricks, MJ; Bolton, PF; Bailey, AJ; Monaco, AP		Int Molecular Genetic Study Autism	FOXP2 is not a major susceptibility gene for autism or specific language impairment	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILY-HISTORY; SEVERE SPEECH; DISORDER; TWIN; LOCALIZATION; DEFICITS; CHILDREN; 7Q31	The FOXP2 gene, located on human 7q31 (at the SPCH1 locus), encodes a transcription factor containing a polyglutamine tract and a forkhead domain. FOXP2 is mutated in a severe monogenic form of speech and language impairment, segregating within a single large pedigree, and is also disrupted by a translocation in an isolated case. Several studies of autistic disorder have demonstrated linkage to a similar region of 7q (the AUTS1 locus), leading to the proposal that a single genetic factor on 7q31 contributes to both autism and language disorders. In the present study, we directly evaluate the impact of the FOXP2 gene with regard to both complex language impairments and autism, through use of association and mutation screening analyses. We conclude that coding-region variants in FOXP2 do not underlie the AUTS1 linkage and that the gene is unlikely to play a role in autism or more common forms of language impairment.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Guys Hosp, Newccomen Ctr, London SE1 9RT, England; Inst Psychiat, Ctr Social Genet & Dev Psychiat, London, England; Inst Psychiat, Dept Child & Adolescent Psychiat, London, England; Univ Cambridge, Dev Psychiat Sect, Cambridge, England	University of Oxford; Wellcome Centre for Human Genetics; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London; University of Cambridge	Monaco, AP (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	anthony.monaco@well.ox.ac.uk	Fisher, Simon E./E-9130-2012; Monaco, Anthony P/A-4495-2010; Warfield, Simon/B-3352-2009; Bailey, Anthony/J-2860-2014	Fisher, Simon E./0000-0002-3132-1996; Monaco, Anthony P/0000-0001-7480-3197; Warfield, Simon/0000-0002-7659-3880; Bailey, Anthony/0000-0003-4257-972X; Lamb, Janine/0000-0002-7248-0539; Bonora, Elena/0000-0001-6132-7734; Green, Jonathan/0000-0002-0143-181X; BONORA, Enzo/0000-0003-1074-5164	NCRR NIH HHS [M01 RR006022] Funding Source: Medline; NICHD NIH HHS [P01 HD035482] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; [Anonymous], 1987, CLIN DEV MED; Ashley-Koch A, 1999, GENOMICS, V61, P227, DOI 10.1006/geno.1999.5968; Bailey A, 1998, HUM MOL GENET, V7, P571; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Barrett S, 1999, AM J MED GENET, V88, P609; BISHOP DVM, 1994, PHILOS T ROY SOC B, V346, P105, DOI 10.1098/rstb.1994.0134; BISHOP DVM, 1995, DEV MED CHILD NEUROL, V37, P56; Bishop DVM, 1999, J SPEECH LANG HEAR R, V42, P155, DOI 10.1044/jslhr.4201.155; BOLTON P, 1994, J CHILD PSYCHOL PSYC, V35, P877, DOI 10.1111/j.1469-7610.1994.tb02300.x; ContiRamsden G, 1997, J SPEECH LANG HEAR R, V40, P765, DOI 10.1044/jslhr.4004.765; Dunn L. M., 1997, BRIT PICTURE VOCABUL; Fisher SE, 1998, NAT GENET, V18, P168, DOI 10.1038/ng0298-168; FOLSTEIN S, 1977, J CHILD PSYCHOL PSYC, V18, P297, DOI 10.1111/j.1469-7610.1977.tb00443.x; Folstein SE, 2000, AM J HUM GENET, V67, P278, DOI 10.1086/303034; Gathercole S E, 1994, Memory, V2, P103, DOI 10.1080/09658219408258940; Kuklin A, 1997, GENET TEST, V1, P201, DOI 10.1089/gte.1997.1.201; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lai CSL, 2000, AM J HUM GENET, V67, P357, DOI 10.1086/303011; LEWIS BA, 1992, J SPEECH HEAR RES, V35, P1086, DOI 10.1044/jshr.3505.1086; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Mawhood L, 2000, J CHILD PSYCHOL PSYC, V41, P547, DOI 10.1017/S002196309900579X; Mullen E.M., 1995, MULLENS SCALES EARLY; Newbury DF, 2002, AM J HUM GENET, V70, P384; Palferman S, 2001, HUM MOL GENET, V10, P973; Palferman S, 2001, AM J HUM GENET, V69, P570; Philippe A, 1999, HUM MOL GENET, V8, P805, DOI 10.1093/hmg/8.5.805; PICKLES A, 1995, AM J HUM GENET, V57, P717; Rapin I, 1997, NEW ENGL J MED, V337, P97, DOI 10.1056/NEJM199707103370206; Rapin I., 1983, NEUROPSYCHOLOGY LANG, P155; Raven J.C., 1989, STANDARD PROGR MATRI; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; Semel EM, 1992, CLIN EVALUATION LANG; Sparrow SS, 1984, VINELAND ADAPTIVE BE; STEFFENBURG S, 1989, J CHILD PSYCHOL PSYC, V30, P405, DOI 10.1111/j.1469-7610.1989.tb00254.x; Tager-Flusberg H, 2001, MENT RETARD DEV D R, V7, P21; Tomblin JB, 1998, J SPEECH LANG HEAR R, V41, P188, DOI 10.1044/jslhr.4101.188; Tomblin JB, 1996, J SPEECH HEAR RES, V39, P1284, DOI 10.1044/jshr.3906.1284; Vargha-Khadem F, 1998, P NATL ACAD SCI USA, V95, P12695, DOI 10.1073/pnas.95.21.12695; VARGHAKHADEM F, 1995, P NATL ACAD SCI USA, V92, P930, DOI 10.1073/pnas.92.3.930; Vincent JB, 2000, AM J HUM GENET, V67, P510, DOI 10.1086/303005; Warburton P, 2000, AM J MED GENET, V96, P228, DOI 10.1002/(SICI)1096-8628(20000403)96:2<228::AID-AJMG20>3.0.CO;2-G; World Health Organization, 1993, ICD 10 CLASS MENT BE	45	184	187	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2002	70	5					1318	1327		10.1086/339931	http://dx.doi.org/10.1086/339931			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	541XT	11894222	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000175012400021
J	Pogribna, M; Melnyk, S; Pogribny, I; Chango, A; Yi, P; James, SJ				Pogribna, M; Melnyk, S; Pogribny, I; Chango, A; Yi, P; James, SJ			Homocysteine metabolism in children with Down syndrome: In vitro modulation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COULOMETRIC ELECTROCHEMICAL DETECTION; GENE; CHROMOSOME-21; PLASMA; INDIVIDUALS; METHYLATION; TRISOMY-21; HYPOTHESIS; SURVIVAL; DNA	The gene for cystathionine beta -synthase (CBS) is located on chromosome 21 and is overexpressed in children with Down syndrome (DS), or trisomy 21. The dual purpose of the present study was to evaluate the impact of overexpression of the CBS gene on homocysteine metabolism in children with DS and to determine whether the supplementation of trisomy 21 lymphoblasts in vitro with selected nutrients would shift the genetically induced metabolic imbalance. Plasma samples were obtained from 42 children with karyotypically confirmed full trisomy 21 and from 36 normal siblings (mean age 7.4 years). Metabolites involved in homocysteine metabolism were measured and compared to those of normal siblings used as controls. Lymphocyte DNA methylation status was determined as a functional endpoint. The results indicated that plasma levels of homocysteine, methionine, S-adenosylhomocysteine, and S-adenosylmethionine were all significantly decreased in children with DS and that their lymphocyte DNA was hypermethylated relative to that in normal siblings. Plasma levels of cystathionine and cysteine were significantly increased, consistent with an increase in CBS activity. Plasma glutathione levels were significantly reduced in the children with DS and may reflect an increase in oxidative stress due to the overexpression of the superoxide dismutase gene, also located on chromosome 21. The addition of methionine, folinic acid, methyl-B-12, thymidine, or dimethylglycine to the cultured trisomy 21 lymphoblastoid cells improved the metabolic profile in vitro. The increased activity of CBS in children with DS significantly alters homocysteine metabolism such that the folate-dependent resynthesis of methionine is compromised. The decreased availability of homocysteine promotes the well-established "folate trap," creating a functional folate deficiency that may contribute to the metabolic pathology of this complex genetic disorder.	US FDA, Natl Ctr Toxicol Res, Div Biochem Toxicol, Jefferson, AR 72079 USA; Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA	US Food & Drug Administration (FDA); University of Arkansas System; University of Arkansas Medical Sciences	James, SJ (corresponding author), US FDA, Natl Ctr Toxicol Res, Div Biochem Toxicol, 3900 NCTR Rd, Jefferson, AR 72079 USA.	jjames@nctr.fda.gov						Aapola U, 2000, GENOMICS, V65, P293, DOI 10.1006/geno.2000.6168; AUSEBEL FM, 1989, CURRENT PROTOCOLS MO; Brattstrom L, 1998, BMJ-BRIT MED J, V316, P894, DOI 10.1136/bmj.316.7135.894; Brodsky G, 1997, HUM MOL GENET, V6, P2043, DOI 10.1093/hmg/6.12.2043; CHADEFAUX B, 1988, LANCET, V2, P741; CHADEFAUX B, 1985, BIOCHEM BIOPH RES CO, V128, P40, DOI 10.1016/0006-291X(85)91641-9; Epstein C.J., 1995, METABOLIC MOL BASES, P749; GERICKE GS, 1977, S AFR MED J, V51, P369; GERSHOFF SN, 1958, AM J CLIN NUTR, V6, P526, DOI 10.1093/ajcn/6.5.526; Greber-Platzer S, 1999, BIOCHEM BIOPH RES CO, V254, P395, DOI 10.1006/bbrc.1998.9743; Hassold T, 2000, CLIN GENET, V57, P95, DOI 10.1034/j.1399-0004.2000.570201.x; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Iannello RC, 1999, J NEURAL TRANSM-SUPP, P257; Jacob RA, 1999, J NUTR, V129, P712, DOI 10.1093/jn/129.3.712; JANSSON U, 1995, J PEDIATR GASTR NUTR, V21, P443, DOI 10.1097/00005176-199511000-00012; KORENBERG JR, 1994, P NATL ACAD SCI USA, V91, P4997, DOI 10.1073/pnas.91.11.4997; KRIVCHENIA E, 1993, AM J EPIDEMIOL, V137, P815, DOI 10.1093/oxfordjournals.aje.a116743; Kuromitsu J, 1997, MOL CELL BIOL, V17, P707, DOI 10.1128/MCB.17.2.707; LEJEUNE J, 1992, ANN GENET-PARIS, V35, P8; LEJEUNE J, 1990, AM J MED GENET, P20; Melnyk S, 1999, J NUTR BIOCHEM, V10, P490, DOI 10.1016/S0955-2863(99)00033-9; Melnyk S, 2000, CLIN CHEM, V46, P265; Mudd S.H., 1995, METABOLIC MOL BASES, V1, P1279; PEETERS MA, 1995, BRIT J HAEMATOL, V89, P678, DOI 10.1111/j.1365-2141.1995.tb08390.x; PEETERS MA, 1993, J INTELL DISABIL RES, V37, P491; Pogribny I, 1999, BIOCHEM BIOPH RES CO, V262, P624, DOI 10.1006/bbrc.1999.1187; PRIEST DG, 1991, J NATL CANCER I, V83, P1806, DOI 10.1093/jnci/83.24.1806; PUUKKA R, 1986, BIOCHEM MED METAB B, V36, P45, DOI 10.1016/0885-4505(86)90105-2; SACKS B, 1989, J NEUROL NEUROSUR PS, V52, P1294, DOI 10.1136/jnnp.52.11.1294; SCOTT RB, 1994, MECH AGEING DEV, V75, P1, DOI 10.1016/0047-6374(94)90023-X; Smith MDA, 1998, MECH AGEING DEV, V101, P167; Tassone F, 1999, J NEURAL TRANSM-SUPP, P179; Taub JW, 1996, BLOOD, V87, P3395, DOI 10.1182/blood.V87.8.3395.bloodjournal8783395; Torfs CP, 1998, AM J MED GENET, V77, P431, DOI 10.1002/(SICI)1096-8628(19980605)77:5<431::AID-AJMG15>3.0.CO;2-J; UELAND PM, 1990, CANCER CHEMOTH PHARM, V25, P384, DOI 10.1007/BF00686245; WILCKEN DEL, 1983, NEW ENGL J MED, V309, P448, DOI 10.1056/NEJM198308253090802; WISNIEWSKI KE, 1989, CLIN NEUROPATHOL, V8, P55; Yu JW, 1997, P NATL ACAD SCI USA, V94, P6862, DOI 10.1073/pnas.94.13.6862	38	184	191	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2001	69	1					88	95		10.1086/321262	http://dx.doi.org/10.1086/321262			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XM	11391481	Bronze, Green Published			2022-12-18	WOS:000170108100009
J	Zaragoza, MV; Surti, T; Redline, RW; Millie, E; Chakravarti, A; Hassold, TJ				Zaragoza, MV; Surti, T; Redline, RW; Millie, E; Chakravarti, A; Hassold, TJ			Parental origin and phenotype of triploidy in spontaneous abortions: Predominance of diandry and association with the partial hydatidiform mole	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMOSOME; NONDISJUNCTION; FETUSES; MOUSE; SET	The origin of human triploidy is controversial. Early cytogenetic studies found the majority of cases to be paternal in origin; however, recent molecular analyses have challenged these findings, suggesting that digynic triploidy is the most common source of triploidy. To resolve this dispute, we examined 91 cases of human triploid spontaneous abortions to (1) determine the mechanism of origin of the additional haploid set, and (2) assess the effect of origin on the phenotype of the conceptus. Our results indicate that the majority of cases were diandric in origin because of dispermy, whereas the maternally-derived cases mainly originated through errors in meiosis II. Furthermore, our results indicate a complex relationship between phenotype and parental origin: paternally-derived cases predominate among "typical" spontaneous abortions, whereas maternally-derived cases are associated with either early embryonic demise or with relatively late demise involving a well-formed fetus. As the cytogenetic studies relied on analyses of the former type of material and the molecular studies on the latter sources, the discrepancies between the data sets are explained by differences in ascertainment. In studies correlating the origin of the extra haploid set with histological phenotype, we observed an association between paternal-but not maternal-triploidy and the development of partial hydatidiform moles. However, only a proportion of paternally derived cases developed a partial molar phenotype, indicating that the mere presence of two paternal genomes is not sufficient for molar development.	Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Ctr Human Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; Magee Womens Hosp, Dept Genet, Pittsburgh, PA USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Hassold, TJ (corresponding author), Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021341] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD21341] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANGELL RR, 1984, J MED GENET, V21, P39, DOI 10.1136/jmg.21.1.39; ANTONARAKIS SE, 1991, NEW ENGL J MED, V324, P872, DOI 10.1056/NEJM199103283241302; Beatty R. A., 1957, PARTHENOGENESIS POLY; CHAKRAVARTI A, 1987, Genomics, V1, P35, DOI 10.1016/0888-7543(87)90102-9; CHAKRAVARTI A, 1989, AM J HUM GENET, V44, P639; DIETZSCH E, 1995, AM J MED GENET, V58, P360, DOI 10.1002/ajmg.1320580412; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; EPPIG JJ, 1994, DEV BIOL, V164, P1, DOI 10.1006/dbio.1994.1175; FRENCH FE, 1962, PUBLIC HEALTH REP, V77, P835, DOI 10.2307/4591645; FUNAKI K, 1980, CYTOGENET CELL GENET, V28, P158, DOI 10.1159/000131526; HASSOLD T, 1980, ANN HUM GENET, V44, P151, DOI 10.1111/j.1469-1809.1980.tb00955.x; HOFFNER L, 1992, CANCER GENET CYTOGEN, V62, P58, DOI 10.1016/0165-4608(92)90040-F; Hook EB, 1977, POPULATION CYTOGENET, P63; JACOBS PA, 1977, HUM HERED, V27, P59, DOI 10.1159/000152852; Jacobs PA, 1995, ADV GENET, V33, P101, DOI 10.1016/S0065-2660(08)60332-6; JACOBS PA, 1978, ANN HUM GENET, V42, P49, DOI 10.1111/j.1469-1809.1978.tb00930.x; JACOBS PA, 1982, ANN HUM GENET, V46, P223, DOI 10.1111/j.1469-1809.1982.tb00714.x; KAJII T, 1977, NATURE, V268, P633, DOI 10.1038/268633a0; Kono T, 1996, NAT GENET, V13, P91, DOI 10.1038/ng0596-91; LANE SA, 1993, J CLIN PATHOL, V46, P346, DOI 10.1136/jcp.46.4.346; LAWLER SD, 1991, AM J OBSTET GYNECOL, V164, P1270, DOI 10.1016/0002-9378(91)90698-Q; LORBER BJ, 1992, AM J HUM GENET, V51, P1265; MARTIN RH, 1995, AM J HUM GENET, V57, P1395; McFadden DE, 1996, HUM PATHOL, V27, P1018, DOI 10.1016/S0046-8177(96)90277-4; MCFADDEN DE, 1993, HUM GENET, V92, P465, DOI 10.1007/BF00216452; MCFADDEN DE, 1997, MEDIZINISCHE GENET S, V9, P525; McFaden D. E., 1994, Modern Pathology, V7, p5P; MINY P, 1995, AM J MED GENET, V57, P102, DOI 10.1002/ajmg.1320570121; NIEBUHR E, 1974, HUMANGENETIK, V21, P103, DOI 10.1007/BF00281030; Obata Y, 1998, DEVELOPMENT, V125, P1553; PROCTER SE, 1984, CLIN GENET, V26, P46; Redline RW, 1998, HUM PATHOL, V29, P505, DOI 10.1016/S0046-8177(98)90067-3; SHERARD J, 1986, AM J MED GENET, V25, P307, DOI 10.1002/ajmg.1320250216; SZULMAN AE, 1978, AM J OBSTET GYNECOL, V132, P20, DOI 10.1016/0002-9378(78)90792-5; UCHIDA IA, 1985, AM J OBSTET GYNECOL, V151, P65, DOI 10.1016/0002-9378(85)90426-0; Warburton D, 1991, CHROMOSOME ANOMALIES	36	184	196	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2000	66	6					1807	1820		10.1086/302951	http://dx.doi.org/10.1086/302951			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QU	10801385	Green Published, Bronze			2022-12-18	WOS:000088373800009
J	Howell, N; Kubacka, I; Mackey, DA				Howell, N; Kubacka, I; Mackey, DA			How rapidly does the human mitochondrial genome evolve?	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY OPTIC NEUROPATHY; RECENT AFRICAN ORIGIN; D-LOOP REGION; PHYLOGENETIC ANALYSIS; DNA; EVOLUTION; MTDNA; IDENTIFICATION; SEQUENCE; DROSOPHILA	The results of an empirical nucleotide-sequencing approach indicate that the evolution of the human mitochondrial noncoding D-loop is both more rapid and more complex than is revealed by standard phylogenetic approaches. The nucleotide sequence of the D-loop region of the mitochondrial genome was determined for 45 members of a large matrilineal Leber hereditary optic neuropathy pedigree. Two germ-line mutations have arisen in members of one branch of the family, thereby leading to triplasmic descendants with three mitochondrial genotypes. Segregation toward the homoplasmic state can occur within a single generation in some of these descendants, a result that suggests rapid fixation of mitochondrial mutations as a result of developmental bottlenecking. However, slow segregation was observed in other offspring, and therefore no single or simple pattern of segregation can be generalized from the available data. Evidence for rare mtDNA recombination within the D-loop was obtained for one family member. In addition to these germ-line mutations, a somatic mutation was found in the D-loop of one family member. When this genealogical approach was applied to the nucleotide sequences of mitochondrial coding regions, the results again indicated a very rapid rate of evolution.	UNIV TEXAS,MED BRANCH,DEPT HUMAN BIOL CHEM & GENET,GALVESTON,TX 77555; UNIV MELBOURNE,DEPT OPHTHALMOL,MELBOURNE,VIC,AUSTRALIA; UNIV MELBOURNE,DEPT PAEDIAT,MELBOURNE,VIC,AUSTRALIA; UNIV TASMANIA,MENZIES CTR POPULAT HLTH RES,LAUNCESTON,TAS,AUSTRALIA	University of Texas System; University of Texas Medical Branch Galveston; University of Melbourne; University of Melbourne; University of Tasmania	Howell, N (corresponding author), UNIV TEXAS,MED BRANCH,DEPT RADIAT THERAPY,BIOL DIV 0656,GALVESTON,TX 77555, USA.		Mackey, David A/H-5340-2014	Mackey, David A/0000-0001-7914-4709	NEI NIH HHS [R01 EY10758] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010758] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Armour JAL, 1996, NAT GENET, V13, P154, DOI 10.1038/ng0696-154; BALLARD JWO, 1994, GENETICS, V138, P757; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; COMAS D, 1995, GENOME RES, V5, P89, DOI 10.1101/gr.5.1.89; CUMMINGS MP, 1995, MOL BIOL EVOL, V12, P814; Donnelly P, 1995, ANNU REV GENET, V29, P401, DOI 10.1146/annurev.ge.29.120195.002153; Gadaleta G, 1996, J BIOL CHEM, V271, P13537, DOI 10.1074/jbc.271.23.13537; Ghosh SS, 1996, AM J HUM GENET, V58, P325; GILL P, 1994, NAT GENET, V6, P130, DOI 10.1038/ng0294-130; HAMMER MF, 1995, NATURE, V378, P376, DOI 10.1038/378376a0; HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; HOWELL N, 1994, CLIN NEUROSCI, V2, P130; HOWELL N, 1992, HUM GENET, V90, P117; HOWELL N, 1995, GENETICS, V140, P285; HOWELL N, 1991, AM J HUM GENET, V48, P935; HOWELL N, 1991, AM J HUM GENET, V49, P939; Ivanov PL, 1996, NAT GENET, V12, P417, DOI 10.1038/ng0496-417; KOCHER TD, 1991, EVOLUTION OF LIFE, P391; LUNDSTROM R, 1992, P NATL ACAD SCI USA, V89, P5961, DOI 10.1073/pnas.89.13.5961; MACKEY D, 1992, AM J HUM GENET, V51, P1218; MACKEY DA, 1992, AUST NZ J OPHTHALMOL, V20, P177, DOI 10.1111/j.1442-9071.1992.tb00937.x; Nachman MW, 1996, GENETICS, V142, P953; NOBLE W, 1991, MAN, V26, P223, DOI 10.2307/2803830; PAABO S, 1990, J BIOL CHEM, V265, P4718; PENNY D, 1995, MOL BIOL EVOL, V12, P863; PESOLE G, 1992, MOL BIOL EVOL, V9, P587; RAND DM, 1994, GENETICS, V138, P741; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; Ruvolo M, 1996, MOL PHYLOGENET EVOL, V5, P202, DOI 10.1006/mpev.1996.0014; SHERRY ST, 1994, HUM BIOL, V66, P761; STONEKING M, 1992, PHILOS T ROY SOC B, V337, P167, DOI 10.1098/rstb.1992.0094; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; TEMPLETON AR, 1993, AM ANTHROPOL, V95, P51, DOI 10.1525/aa.1993.95.1.02a00030; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; TORRONI A, 1994, P NATL ACAD SCI USA, V91, P1158, DOI 10.1073/pnas.91.3.1158; TORRONI A, 1994, AM J HUM GENET, V55, P760; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WAKELEY J, 1993, J MOL EVOL, V37, P613; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; WHITFIELD LS, 1995, NATURE, V378, P379, DOI 10.1038/378379a0; WILLS C, 1995, EVOLUTION, V49, P593, DOI 10.1111/j.1558-5646.1995.tb02296.x; YANG ZH, 1995, GENETICS, V139, P993	44	184	190	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1996	59	3					501	509						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN625	8751850				2022-12-18	WOS:A1996VN62500003
J	Gong, YQ; Vikkula, M; Boon, L; Liu, J; Beighton, P; Ramesar, R; Peltonen, L; Somer, H; Hirose, T; Dallapiccola, B; DePaepe, A; Swoboda, W; Zabel, B; SupertiFurga, A; Steinmann, B; Brunner, HG; Jans, A; Boles, RG; Adkins, W; vandenBoogaard, MJ; Olsen, BR; Warman, ML				Gong, YQ; Vikkula, M; Boon, L; Liu, J; Beighton, P; Ramesar, R; Peltonen, L; Somer, H; Hirose, T; Dallapiccola, B; DePaepe, A; Swoboda, W; Zabel, B; SupertiFurga, A; Steinmann, B; Brunner, HG; Jans, A; Boles, RG; Adkins, W; vandenBoogaard, MJ; Olsen, BR; Warman, ML			Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12-13	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OSTEOGENESIS IMPERFECTA; MUTATION; LOCUS; GENE; DNA; VITREORETINOPATHY; LINKAGE; ALLELES; MOUSE; 11Q	Osteoporosis-pseudoglioma syndrome (OPS) is an autosomal recessive disorder characterized by severs juvenile-onset osteoporosis and congenital or juvenile-onset blindness. The pathogenic mechanism is not known. Clinical, biochemical, and microscopic analyses suggest that OPS may be a disorder of matrix homeostasis rather than a disorder of matrix structure. Consequently, identification of the OPS gene and its protein product could provide insights regarding common osteoporotic conditions, such as postmenopausal and senile osteoporosis. As a first step toward determining the cause of OPS, we utilized a combination of traditional linkage analysis and homozygosity mapping to assign the OPS locus to chromosome region 11q12-13. Mapping was accomplished by analyzing 16 DNA samples (seven affected individuals) from three different consanguineous kindreds. Studies in 10 additional families narrowed the candidate region, supported locus homogeneity, and did not detect founder effects. The OPS locus maps to a 13-cM interval between D11S1298 and D11S971 and most likely lies in a 3-cM region between GSTP1 and D11S1296. At present, no strong candidate genes colocalize with OPS.	CASE WESTERN RESERVE UNIV,SCH MED,DEPT GENET,BRB 719,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV,UNIV HOSP CLEVELAND,CTR HUMAN GENET,CLEVELAND,OH 44106; HARVARD UNIV,SCH MED,DEPT CELL BIOL,BOSTON,MA 02115; RETINA ASSOCIATES,BOSTON,MA; UNIV CAPE TOWN,SCH MED,DEPT HUMAN GENET,ZA-7925 CAPE TOWN,SOUTH AFRICA; UNIV CAPE TOWN,SCH MED,MRC UNIT MED GENET,ZA-7925 CAPE TOWN,SOUTH AFRICA; NATL PUBL HLTH INST,DEPT HUMAN MOL GENET,HELSINKI,FINLAND; UNIV HELSINKI,DEPT NEUROL,FIN-00014 HELSINKI,FINLAND; UNIV ROMA TOR VERGATA,CTR MED GENET,I-00173 ROME,ITALY; STATE UNIV GHENT,CTR MED GENET,B-9000 GHENT,BELGIUM; LUDWIG BOLTZMANN INST PEDIAT ENDOCRINOL & IMMUNOL,VIENNA,AUSTRIA; UNIV ZURICH,DEPT PEDIAT,DIV METAB & MOL DIS,CH-8006 ZURICH,SWITZERLAND; UNIV MAINZ,DEPT GENET,D-6500 MAINZ,GERMANY; UNIV NIJMEGEN,DEPT HUMAN GENET,NIJMEGEN,NETHERLANDS; CHILDRENS HOSP LOS ANGELES,DIV MED GENET,LOS ANGELES,CA 90027; CENT WISCONSIN CTR DEVELOPMENTALLY DISABLED,MADISON,WI; INST MENTALLY HANDICAPPED,OISTERWIJK,NETHERLANDS; INST MENTALLY HANDICAPPED,BREDA,NETHERLANDS; UNIV UTRECHT,DEPT HUMAN GENET,NL-3508 TC UTRECHT,NETHERLANDS	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Harvard University; Harvard Medical School; University of Cape Town; University of Cape Town; Finland National Institute for Health & Welfare; University of Helsinki; University of Rome Tor Vergata; Ghent University; Ludwig Boltzmann Institute; University of Zurich; Johannes Gutenberg University of Mainz; Radboud University Nijmegen; Children's Hospital Los Angeles; Utrecht University			superti-furga, andrea/E-9162-2015; Boon, Laurence/HCI-3629-2022; Brunner, Han/C-9928-2013; Ramesar, Raj S/I-6941-2015; Vikkula, Miikka/Q-1038-2018; Dallapiccola, Bruno/K-8692-2016	superti-furga, andrea/0000-0002-3543-7531; Ramesar, Raj S/0000-0001-5688-1634; Vikkula, Miikka/0000-0002-6236-338X; Dallapiccola, Bruno/0000-0002-5031-1013	NIAMS NIH HHS [AR36820, AR36819] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR036819, R37AR036820, R37AR036819, R01AR036820] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BEIGHTON P, 1985, CLIN GENET, V28, P69; BENOVIC JL, 1991, FEBS LETT, V283, P122, DOI 10.1016/0014-5793(91)80568-N; BOON LM, 1994, HUM MOL GENET, V3, P1583, DOI 10.1093/hmg/3.9.1583; BRUDE E, 1986, 7 INT C HUM GEN ABST, P35; CALABRESE G, 1994, GENOMICS, V24, P169, DOI 10.1006/geno.1994.1594; DEPAEPE A, 1993, AM J MED GENET, V45, P30, DOI 10.1002/ajmg.1320450110; FRONTALI M, 1985, AM J MED GENET, V22, P35, DOI 10.1002/ajmg.1320220104; HENDRICKSON BA, 1993, GENE, V134, P271, DOI 10.1016/0378-1119(93)90106-D; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEPPERT M, 1994, NAT GENET, V7, P108, DOI 10.1038/ng0594-108; LI Y, 1992, AM J HUM GENET, V51, P749; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506; MARKS SC, 1985, J HERED, V76, P171, DOI 10.1093/oxfordjournals.jhered.a110059; MELTON LJ, 1993, BONE, V14, pS1; MOCHIZUKI H, 1994, HUM MOL GENET, V3, P2265, DOI 10.1093/hmg/3.12.2265; MORRISON NA, 1994, NATURE, V367, P284, DOI 10.1038/367284a0; MURRAY V, 1989, NUCLEIC ACIDS RES, V17, P8889, DOI 10.1093/nar/17.21.8889; NICHOLS BE, 1994, AM J HUM GENET, V54, P95; *OMIM, 1995, ONL MEND INH MAN HUM; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; PEACOCK M, 1995, J BONE MINER RES, V10, P1294; SARAUX H, 1969, ANN OCUL, V202, P1311; SAUVEGRAIN J, 1981, J RADIOL, V62, P537; SMITH CB, 1976, ACTA ORTHOP SCAND, V47, P496, DOI 10.3109/17453677608988727; SOMER H, 1988, J MED GENET, V25, P543, DOI 10.1136/jmg.25.8.543; SPOTILA LD, 1993, AM J HUM GENET, V53, P1715; Stone Edwin M., 1992, Human Molecular Genetics, V1, P685, DOI 10.1093/hmg/1.9.685; SUPERTIFURGA A, 1986, CLIN GENET, V29, P184; SWEET HO, 1991, J HERED, V82, P140, DOI 10.1093/oxfordjournals.jhered.a111048; SWOBODA W, 1988, PEDIATR RADIOL, V18, P399, DOI 10.1007/BF02388045; TAKAHASHI R, 1994, NAT GENET, V7, P79, DOI 10.1038/ng0594-79; VANHEYNINGEN V, 1995, CYTOGENET CELL GENET, V69, P129	33	184	202	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1996	59	1					146	151						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL455	8659519				2022-12-18	WOS:A1996VL45500021
J	PARK, WJ; THEDA, C; MAESTRI, NE; MEYERS, GA; FRYBURG, JS; DUFRESNE, C; COHEN, MM; JABS, EW				PARK, WJ; THEDA, C; MAESTRI, NE; MEYERS, GA; FRYBURG, JS; DUFRESNE, C; COHEN, MM; JABS, EW			ANALYSIS OF PHENOTYPIC FEATURES AND FGFR2 MUTATIONS IN APERT SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECEPTORS; SPECIFICITY; ANOMALIES; GENE	A phenotypic and genotypic survey was conducted on 36 Apert syndrome patients. In all but one patient, an FGFR2 mutation, either S252W or P253R, was found in exon IIIa (exon U or 7). The frequency was 71% and 26%, for the mutations S252W and P253R, respectively. These mutations occur in the linker region between immunoglobulin-like domains II and Iii, which are involved in activation of the receptor by ligand binding and dimerization. The fact that one patient did not have a mutation in the same exon suggests further genetic heterogeneity in Apert syndrome. The frequencies of occurrence or means for measurements of 29 different clinical features (including severity of craniofacial features, syndactyly of the hands and feet, and multisystem involvement) were determined for all patients and for the two subgroups defined by their mutations. Comparison between the subgroups for the different clinical features was performed and suggested no statistically significant differences, These results are not unexpected, because the two common mutations for Apert syndrome alter FGFR2 at adjacent amino acids that are likely to have similar biological, and therefore phenotypic, consequences.	JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT MED,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT SURG,BALTIMORE,MD 21205; UNIV VIRGINIA,DEPT PEDIAT,CHARLOTTESVILLE,VA; GEORGETOWN UNIV,DEPT PLAST SURG,WASHINGTON,DC; FAIRFAX HOSP,CTR FACIAL REHABIL,FAIRFAX,VA; DALHOUSIE UNIV,DEPT ORAL & MAXILLOFACIAL SURG,HALIFAX,NS,CANADA; DALHOUSIE UNIV,DEPT PEDIAT,HALIFAX,NS,CANADA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Virginia; Georgetown University; Inova Fairfax Hospital; Dalhousie University; Dalhousie University			Dufresne, Craig R/B-2172-2019; Theda, Christiane/M-2263-2019	Dufresne, Craig R/0000-0001-6051-348X; Jabs, Ethylin/0000-0001-8983-5466; Theda, Christiane/0000-0001-7577-6004	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE010180, P50DE011131] Funding Source: NIH RePORTER; NICHD NIH HHS [HD24061] Funding Source: Medline; NIDCR NIH HHS [DE10180, DE11131] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ALLANSON JE, 1986, CLIN GENET, V29, P429; Apert E., 1906, B SOC MED PARIS, V23, P1310; BELLUS GA, 1995, AM J HUM GENET, V56, P368; Cohen, 1986, CRANIOSYNOSTOSIS DIA; COHEN MM, 1993, AM J MED GENET, V47, P624, DOI 10.1002/ajmg.1320470509; COHEN MM, 1993, AM J DIS CHILD, V147, P989, DOI 10.1001/archpedi.1993.02160330079025; COHEN MM, 1992, AM J MED GENET, V42, P655, DOI 10.1002/ajmg.1320420505; COHEN MM, 1990, AM J MED GENET, V35, P36, DOI 10.1002/ajmg.1320350108; COHEN MM, 1993, AM J MED GENET, V45, P758, DOI 10.1002/ajmg.1320450618; COHEN MM, IN PRESS AM J MED GE; COHEN MM, 1995, J MED GENET, V56, P82; COHN MS, 1993, CUTIS, V52, P205; DIONNE CA, 1990, EMBO J, V9, P2685, DOI 10.1002/j.1460-2075.1990.tb07454.x; ERICKSON JD, 1974, ANN HUM GENET, V38, P89, DOI 10.1111/j.1469-1809.1974.tb01996.x; GIVOL D, 1992, FASEB J, V6, P3362, DOI 10.1096/fasebj.6.15.1464370; JABS EW, 1994, NAT GENET, V8, P275, DOI 10.1038/ng1194-275; JONES EY, 1992, NATURE, V360, P232, DOI 10.1038/360232a0; LAJEUNIE E, 1995, NAT GENET, V9, P108, DOI 10.1038/ng0295-108; LEWANDA AF, 1993, AM J DIS CHILD, V147, P1306, DOI 10.1001/archpedi.1993.02160360048016; MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246; MUENKE M, 1994, NAT GENET, V8, P269, DOI 10.1038/ng1194-269; MULVIHILL JT, 1995, NAT GENET, V9, P101, DOI 10.1038/ng0295-101; PARK WJ, IN PRESS HUM MOL GEN; REARDON W, 1994, NAT GENET, V8, P98, DOI 10.1038/ng0994-98; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; RUTLAND P, 1995, NAT GENET, V9, P173, DOI 10.1038/ng0295-173; Sambrook J., 1989, MOL CLONING LAB MANU; SCHELL U, 1995, HUM MOL GENET, V4, P323, DOI 10.1093/hmg/4.3.323; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; Sokal R.R., 1981, BIOMETRY PRINCIPLES; TARVORMINA PL, 1995, NAT GENET, V9, P321; UPTON J, 1991, CLIN PLAST SURG, V18, P321; WILKIE AOM, 1995, NAT GENET, V9, P165, DOI 10.1038/ng0295-165	33	184	193	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1995	57	2					321	328						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RL771	7668257				2022-12-18	WOS:A1995RL77100014
J	DOBYNS, WB; CURRY, CJR; HOYME, HE; TURLINGTON, L; LEDBETTER, DH				DOBYNS, WB; CURRY, CJR; HOYME, HE; TURLINGTON, L; LEDBETTER, DH			CLINICAL AND MOLECULAR DIAGNOSIS OF MILLER-DIEKER SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUBMICROSCOPIC DELETIONS; CHROMOSOME REGION	We report results of clinical, cytogenetic, and molecular studies in 27 patients with Miller-Dieker syndrome (MDS) from 25 families. All had severe type I lissencephaly with grossly normal cerebellum and a distinctive facial appearance consisting of prominent forehead, bitemporal hollowing, short nose with upturned nares, protuberant upper lip, thin vermilion border, and small jaw. Several other abnormalities, especially growth deficiency, were frequent but not constant. Chromosome analysis showed deletion of band 17p13 in 14 of 25 MDS probands. RFLP and somatic cell hybrid studies using probes from the 17p13.3 region including pYNZ22 (D17S5), pYNH37 (D17S28), and p144-D6 (D17S34) detected deletions in 19 of 25 probands tested including seven in whom chromosome analysis was normal. When the cytogenetic and molecular data are combined, deletions were detected in 21 of 25 probands. Parental origin of de novo deletions was determined in 11 patients. Paternal origin occurred in seven and maternal origin in four. Our demonstration of cytogenetic or molecular deletions in 21 of 25 MDS probands proves that deletion of a "critical region" comprising two or more genetic loci within band 17p13.3 is the cause of the MDS phenotype. We suspect that the remaining patients have smaller deletions involving the proposed critical region which are not detected with currently available probes.	INDIANA UNIV,SCH MED,DEPT NEUROL,INDIANAPOLIS,IN 46202; INDIANA UNIV,SCH MED,DEPT MED GENET,INDIANAPOLIS,IN 46202; VALLEY CHILDRENS HOSP,DEPT MED GENET,FRESNO,CA; UNIV ARIZONA,HLTH SCI CTR,DEPT PEDIAT,TUCSON,AZ 85721; WASHINGTON UNIV,SCH MED,DEPT OBSTET & GYNECOL,ST LOUIS,MO 63110; BAYLOR UNIV,INST MOLEC GENET,HOUSTON,TX 77030	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of Arizona; University of Arizona Health Sciences; Washington University (WUSTL); Baylor College of Medicine; Baylor University			Dobyns, William Brian/ABC-6525-2021; Dobyns, William/AAI-2768-2020	Dobyns, William/0000-0002-7681-2844; Hoyme, Harold/0000-0002-1979-693X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD020619] Funding Source: NIH RePORTER; NICHD NIH HHS [HD20619] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALVAREZ LA, 1986, NEUROLOGY, V36, P489, DOI 10.1212/WNL.36.4.489; BARTH PG, 1982, BRAIN DEV-JPN, V4, P145, DOI 10.1016/S0387-7604(82)80008-9; DAUBE JR, 1966, NEUROLOGY, V16, P179, DOI 10.1212/WNL.16.2_Part_1.179; DIEKER H, 1969, Birth Defects Original Article Series, V5, P53; DOBYNS W B, 1989, American Journal of Human Genetics, V45, pA44; Dobyns W B, 1987, Birth Defects Orig Artic Ser, V23, P225; DOBYNS WB, 1983, J PEDIATR-US, V102, P552, DOI 10.1016/S0022-3476(83)80183-8; DOBYNS WB, 1984, AM J MED GENET, V18, P509, DOI 10.1002/ajmg.1320180320; DOBYNS WB, 1989, AM J MED GENET, V32, P195, DOI 10.1002/ajmg.1320320213; DOBYNS WB, 1985, AM J MED GENET, V22, P197, DOI 10.1002/ajmg.1320220119; DOBYNS WB, 1989, NEUROL CLIN, V7, P89, DOI 10.1016/S0733-8619(18)30830-2; GARCIA CA, 1978, ARCH NEUROL-CHICAGO, V35, P608, DOI 10.1001/archneur.1978.00500330056011; GREENBERG F, 1986, AM J MED GENET, V23, P853, DOI 10.1002/ajmg.1320230402; HARNDEN DG, 1985, ISCN INT SYSTEM HUMA; LEDBETTER DH, 1989, P NATL ACAD SCI USA, V86, P5136, DOI 10.1073/pnas.86.13.5136; LEDBETTER DH, 1989, METABOLIC BASIS INHE, P343; LEDBETTER SA, 1990, GENOMICS, V7, P264, DOI 10.1016/0888-7543(90)90549-A; MILLER JQ, 1963, NEUROLOGY, V13, P841, DOI 10.1212/WNL.13.10.841; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; PAVONE L, 1990, J CHILD NEUROL, V5, P52, DOI 10.1177/088307389000500113; STRATTON RF, 1984, HUM GENET, V67, P193, DOI 10.1007/BF00273000; van Tuinen P, 1987, Genomics, V1, P374, DOI 10.1016/0888-7543(87)90042-5; VANALLEN M, 1983, J PEDIATR-US, V102, P559; VANTUINEN P, 1988, AM J HUM GENET, V43, P587; WILKINS LE, 1983, J PEDIATR-US, V102, P528, DOI 10.1016/S0022-3476(83)80179-6	25	184	189	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1991	48	3					584	594						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK470	1671808				2022-12-18	WOS:A1991FK47000018
J	MILLER, DA; TANTRAVAHI, R; DEV, VG; MILLER, OJ				MILLER, DA; TANTRAVAHI, R; DEV, VG; MILLER, OJ			FREQUENCY OF SATELLITE ASSOCIATION OF HUMAN-CHROMOSOMES IS CORRELATED WITH AMOUNT OF AG-STAINING OF NUCLEOLUS ORGANIZER REGION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									COLUMBIA UNIV, COLL PHYS & SURG, DEPT HUMAN GENET & DEV, NEW YORK, NY 10032 USA; COLUMBIA UNIV, COLL PHYS & SURG, DEPT OBSTET & GYNECOL, NEW YORK, NY 10032 USA	Columbia University; Columbia University								CASSIDY DM, 1974, DEV BIOL, V41, P84, DOI 10.1016/0012-1606(74)90285-1; CROCE CM, 1977, P NATL ACAD SCI USA, V74, P694, DOI 10.1073/pnas.74.2.694; DITTES H, 1975, HUMANGENETIK, V26, P47, DOI 10.1007/BF00280284; EVANS HJ, 1974, CHROMOSOMA, V48, P405, DOI 10.1007/BF00290996; FERGUS.MA, 1961, LANCET, V1, P638, DOI 10.1016/S0140-6736(61)91655-5; FERGUSON-SMITH M. A., 1964, CYTOGENETICS, V3, P124, DOI 10.1159/000129803; GOODPASTURE C, 1976, AM J HUM GENET, V28, P559; GOODPASTURE C, 1975, CHROMOSOMA, V53, P37, DOI 10.1007/BF00329389; HENDERSON AS, 1972, P NATL ACAD SCI USA, V69, P3394, DOI 10.1073/pnas.69.11.3394; HENDERSON AS, 1973, NATURE, V245, P95, DOI 10.1038/245095b0; HONJO T, 1973, J MOL BIOL, V80, P217, DOI 10.1016/0022-2836(73)90168-X; HOWELL WM, 1976, CHROMOSOMA, V57, P165, DOI 10.1007/BF00292914; HSU TC, 1975, CHROMOSOMA, V53, P25, DOI 10.1007/BF00329388; JACOBS PA, 1976, AM J HUM GENET, V28, P567; MARSHALL CJ, 1975, J CELL SCI, V17, P307; MATTEI JF, 1976, HUM GENET, V34, P185, DOI 10.1007/BF00278887; MILLER DA, 1976, GENETICS, V84, P67; MILLER DA, 1976, EXP CELL RES, V101, P235, DOI 10.1016/0014-4827(76)90373-6; MILLER OJ, 1976, P NATL ACAD SCI USA, V73, P4531, DOI 10.1073/pnas.73.12.4531; PATIL SR, 1971, HUMANGENETIK, V13, P157, DOI 10.1007/BF00295797; SCHMID M, 1974, HUMANGENETIK, V23, P267, DOI 10.1007/BF00272510; TANTRAVAHI R, 1976, CHROMOSOMA, V56, P15, DOI 10.1007/BF00293725; TANTRAVAHI R, IN PRESS; WARBURTON D, 1976, CYTOGENET CELL GENET, V17, P221, DOI 10.1159/000130715; ZANG KD, 1968, CYTOGENETICS, V7, P455, DOI 10.1159/000130006; ZANKL H, 1974, HUMANGENETIK, V23, P259, DOI 10.1007/BF00272509	26	184	185	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1977	29	5					490	502						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DV673	70995				2022-12-18	WOS:A1977DV67300008
J	Weedon, MN; Hastings, R; Caswell, R; Xie, WJ; Paszkiewicz, K; Antoniadi, T; Williams, M; King, C; Greenhalgh, L; Newbury-Ecob, R; Ellard, S				Weedon, Michael N.; Hastings, Robert; Caswell, Richard; Xie, Weijia; Paszkiewicz, Konrad; Antoniadi, Thalia; Williams, Maggie; King, Cath; Greenhalgh, Lynn; Newbury-Ecob, Ruth; Ellard, Sian			Exome Sequencing Identifies a DYNC1H1 Mutation in a Large Pedigree with Dominant Axonal Charcot-Marie-Tooth Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DYNEIN HEAVY-CHAIN; CYTOPLASMIC DYNEIN; GENE	Charcot-Marie-Tooth disease is characterized by length-dependent axonal degeneration with distal sensory loss and weakness, deep-tendon-reflex abnormalities, and skeletal deformities. It is caused by mutations in more than 40 genes. We investigated a four-generation family with 23 members affected by the axonal form (type 2), for which the common causes had been excluded by Sanger sequencing. Exome sequencing of three affected individuals separated by eight meioses identified a single shared novel heterozygous variant, c.917A>G, in DYNC1H1, which encodes the cytoplasmic dynein heavy chain 1 (here, novel refers to a variant that has not been seen in dbSNP131 or the August 2010 release of the 1000 Genomes project). Testing of six additional affected family members showed cosegregation and a maximum LOD score of 3.6. The shared DYNC1H1 gene variant is a missense substitution, p.His306Arg, at a highly conserved residue within the homodimerization domain. Three mouse models with different mutations within this domain have previously been reported with age-related progressive loss of muscle bulk and locomotor ability. Cytoplasmic dynein is a large multisubunit motor protein complex and has a key role in retrograde axonal transport in neurons. Our results highlight the importance of dynein and retrograde axonal transport in neuronal function in humans.	[Weedon, Michael N.; Caswell, Richard; Xie, Weijia; Ellard, Sian] Univ Exeter, Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter EX2 5AD, Devon, England; [Hastings, Robert; King, Cath; Greenhalgh, Lynn; Newbury-Ecob, Ruth] Univ Hosp Bristol Natl Hlth Serv NHS Fdn Trust, St Michaels Hosp, Clin Genet Dept, Bristol BS2 8EG, Avon, England; [Paszkiewicz, Konrad] Univ Exeter, Coll Life & Environm Sci, Exeter Sequencing Serv, Exeter EX2 4SB, Devon, England; [Antoniadi, Thalia; Williams, Maggie] N Bristol NHS Trust, Southmead Hosp, Bristol Genet Lab, Bristol BS10 5NB, Avon, England	University of Exeter; University of Exeter; North Bristol NHS Trust; Southmead Hospital	Ellard, S (corresponding author), Univ Exeter, Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter EX2 5AD, Devon, England.	sian.ellard@rdeft.nhs.uk		Weedon, Michael/0000-0002-6174-6135; Ellard, Sian/0000-0002-7620-5526; Caswell, Richard/0000-0003-0713-4602				Banks GT, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-214; Braunstein KE, 2010, HUM MOL GENET, V19, P4385, DOI 10.1093/hmg/ddq361; Chen XJ, 2007, J NEUROSCI, V27, P14515, DOI 10.1523/JNEUROSCI.4338-07.2007; Courchesne Stephanie L, 2011, PLoS One, V6, pe16753, DOI 10.1371/journal.pone.0016753; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Harada A, 1998, J CELL BIOL, V141, P51, DOI 10.1083/jcb.141.1.51; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Ori-McKenney KM, 2010, NAT CELL BIOL, V12, P1228, DOI 10.1038/ncb2127; Ostergaard P, 2011, J MED GENET, V48, P251, DOI 10.1136/jmg.2010.085563; Patzko A, 2011, CURR NEUROL NEUROSCI, V11, P78, DOI 10.1007/s11910-010-0158-7; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Reid E, 2002, AM J HUM GENET, V71, P1189, DOI 10.1086/344210; Tynan SH, 2000, J BIOL CHEM, V275, P32769, DOI 10.1074/jbc.M001537200; Wang JL, 2010, BRAIN, V133, P3510, DOI 10.1093/brain/awq323; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4	16	183	191	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 12	2011	89	2					308	312		10.1016/j.ajhg.2011.07.002	http://dx.doi.org/10.1016/j.ajhg.2011.07.002			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	810TA	21820100	Green Published, Bronze			2022-12-18	WOS:000294148800011
J	Guan, MX; Yan, QF; Li, XM; Bykhovskaya, Y; Gallo-Teran, J; Hajek, P; Umeda, N; Zhao, H; Garrido, G; Mengesha, E; Suzuki, T; del Castillo, I; Peters, JL; Li, RH; Qian, YP; Wang, XJ; Ballana, E; Shohat, M; Lu, JX; Estivill, X; Watanabe, K; Fischel-Ghodsian, N				Guan, Min-Xin; Yan, Qingfeng; Li, Xiaoming; Bykhovskaya, Yelena; Gallo-Teran, Jaime; Hajek, Petr; Umeda, Noriko; Zhao, Hui; Garrido, Gema; Mengesha, Emebet; Suzuki, Tsutomu; del Castillo, Ignacio; Peters, Jennifer Lynne; Li, Ronghua; Qian, Yaping; Wang, Xinjian; Ballana, Ester; Shohat, Mordechai; Lu, Jianxin; Estivill, Xavier; Watanabe, Kimitsuna; Fischel-Ghodsian, Nathan			Mutation in TRMU related to transfer RNA modification modulates the phenotypic expression of the deafness-associated mitochondrial 12S ribosomal RNA mutations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYNDROMIC HEARING-LOSS; NUCLEAR MODIFIER GENE; PAROMOMYCIN RESISTANCE MUTATION; MATERNALLY INHERITED DEAFNESS; LARGE CHINESE FAMILY; A1555G MUTATION; ESCHERICHIA-COLI; NONSYNDROMIC DEAFNESS; SACCHAROMYCES-CEREVISIAE; C1494T MUTATION	The human mitochondrial 12S ribosomal RNA (rRNA) A1555G mutation has been associated with aminoglycoside-induced and nonsyndromic deafness in many families worldwide. Our previous investigation revealed that the A1555G mutation is a primary factor underlying the development of deafness but is not sufficient to produce a deafness phenotype. However, it has been proposed that nuclear-modifier genes modulate the phenotypic manifestation of the A1555G mutation. Here, we identified the nuclear-modifier gene TRMU, which encodes a highly conserved mitochondrial protein related to transfer RNA (tRNA) modification. Genotyping analysis of TRMU in 613 subjects from 1 Arab-Israeli kindred, 210 European (Italian pedigrees and Spanish pedigrees) families, and 31 Chinese pedigrees carrying the A1555G or the C1494T mutation revealed a missense mutation (G28T) altering an invariant amino acid residue (A10S) in the evolutionarily conserved N-terminal region of the TRMU protein. Interestingly, all 18 Arab-Israeli/Italian-Spanish matrilineal relatives carrying both the TRMU A10S and 12S rRNA A1555G mutations exhibited prelingual profound deafness. Functional analysis showed that this mutation did not affect importation of TRMU precursors into mitochondria. However, the homozygous A10S mutation leads to a marked failure in mitochondrial tRNA metabolisms, specifically reducing the steady-state levels of mitochondrial tRNA. As a consequence, these defects contribute to the impairment of mitochondrial protein synthesis. Resultant biochemical defects aggravate the mitochondrial dysfunction associated with the A1555G mutation, exceeding the threshold for expressing the deafness phenotype. These findings indicate that the mutated TRMU, acting as a modifier factor, modulates the phenotypic manifestation of the deafness-associated 12S rRNA mutations.	Cincinnati Childrens Hosp, Med Ctr, Div & Program Human Genet, Cincinnati, OH 45229 USA; Cincinnati Childrens Hosp, Med Ctr, Ctr Hearing & Deafness Res, Cincinnati, OH 45229 USA; Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Cedars Sinai Med Ctr, Los Angeles, CA USA; Hosp Ramon y Cajal, Unidad Genet Mol, E-28034 Madrid, Spain; CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ Tokyo, Dept Chem & Biotechnol, Tokyo, Japan; Univ Tokyo, Dept Integrated Biosci, Grad Sch Frontier Sci, Tokyo, Japan; Pompeu Fabra Univ, Genes & Dis Program, Ctr Gene Regulat, Barcelona, Spain; Tel Aviv Univ, Sch Med, Dept Pediat & Med Genet, IL-49100 Petah Tiqwa, Israel; Tel Aviv Univ, Sch Med, Basil & Gerald Felsenstein Med Res Ctr, IL-49100 Petah Tiqwa, Israel; Wenzhou Med Coll, Zhejiang Provincial Key Lab Med Genet, Sch Life Sci, Wenzhou, Peoples R China	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Hospital Universitario Ramon y Cajal; California Institute of Technology; University of Tokyo; University of Tokyo; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Tel Aviv University; Tel Aviv University; Wenzhou Medical University	Guan, MX (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Div & Program Human Genet, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	min-xin.guan@chmcc.org	Guix, Ester Ballana/R-4117-2018; Garrido, Gema/ABF-5941-2021; Estivill, Xavier/A-3125-2013; Suzuki, Tsutomu/J-1776-2015; del Castillo, Ignacio/B-4314-2013; Estivill, Xavier/E-2957-2012; yan, qing/GZN-2287-2022	Estivill, Xavier/0000-0002-0723-2256; Suzuki, Tsutomu/0000-0002-9731-1731; del Castillo, Ignacio/0000-0003-1188-3665; Ballana, Ester/0000-0002-5215-7363; Mengesha, Emebet/0000-0001-7830-1557; Guan, Min-Xin/0000-0001-5067-6736	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC004958, R01DC001402, R01DC005230] Funding Source: NIH RePORTER; NIDCD NIH HHS [R03 DC004958, R03DC04958, R01DC05230, R01 DC005230, R01DC01402, R01 DC001402] Funding Source: Medline; NINDS NIH HHS [R01 NS044015, R01NS44015] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson S, 1982, MITOCHONDRIAL GENES, P5; BJORK GR, 1996, ESCHERICHIA COLI SAL, P861; Bregeon D, 2001, GENE DEV, V15, P2295, DOI 10.1101/gad.207701; Bykhovskaya Y, 2004, MOL GENET METAB, V82, P27, DOI 10.1016/j.ymgme.2004.01.020; Bykhovskaya Y, 1998, AM J MED GENET, V77, P421, DOI 10.1002/(SICI)1096-8628(19980605)77:5<421::AID-AJMG13>3.0.CO;2-K; Bykhovskaya Y, 2000, AM J HUM GENET, V66, P1905, DOI 10.1086/302914; Cabedo H, 1999, EMBO J, V18, P7063, DOI 10.1093/emboj/18.24.7063; Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8; Colby G, 1998, J BIOL CHEM, V273, P27945, DOI 10.1074/jbc.273.43.27945; DECOSTER E, 1993, J MOL BIOL, V232, P79, DOI 10.1006/jmbi.1993.1371; del Castillo FJ, 2003, J MED GENET, V40, P632, DOI 10.1136/jmg.40.8.632; DESTASIO EA, 1990, J MOL BIOL, V212, P127, DOI 10.1016/0022-2836(90)90309-A; Estivill X, 1998, AM J HUM GENET, V62, P27, DOI 10.1086/301676; FernandezSilva P, 1997, EMBO J, V16, P1066, DOI 10.1093/emboj/16.5.1066; Fischel-Ghodsian N, 1999, HUM MUTAT, V13, P261, DOI 10.1002/(SICI)1098-1004(1999)13:4<261::AID-HUMU1>3.0.CO;2-W; Green R, 1997, ANNU REV BIOCHEM, V66, P679, DOI 10.1146/annurev.biochem.66.1.679; Guan MX, 2001, HUM MOL GENET, V10, P573, DOI 10.1093/hmg/10.6.573; Guan MX, 2000, HUM MOL GENET, V9, P1787, DOI 10.1093/hmg/9.12.1787; Guan MX, 1998, MOL CELL BIOL, V18, P5868, DOI 10.1128/MCB.18.10.5868; Guan MX, 1996, HUM MOL GENET, V5, P963, DOI 10.1093/hmg/5.7.963; Guan MX, 2004, ANN NY ACAD SCI, V1011, P259, DOI 10.1196/annals.1293.025; Hamasaki K, 1997, BIOCHEMISTRY-US, V36, P12323, DOI 10.1021/bi970962r; HENLEY CM, 1988, AUDIOLOGY, V27, P137; IGLOI GL, 1988, BIOCHEMISTRY-US, V27, P3842, DOI 10.1021/bi00410a048; Kambampati R, 2003, BIOCHEMISTRY-US, V42, P1109, DOI 10.1021/bi026536+; KING MP, 1993, J BIOL CHEM, V268, P10228; Li RH, 2004, AM J MED GENET A, V124A, P113, DOI 10.1002/ajmg.a.20305; Li XM, 2004, NUCLEIC ACIDS RES, V32, P867, DOI 10.1093/nar/gkh226; Li XM, 2002, MOL CELL BIOL, V22, P7701, DOI 10.1128/MCB.22.21.7701-7711.2002; Li XM, 2002, J BIOL CHEM, V277, P27256, DOI 10.1074/jbc.M203267200; Li ZY, 2005, HUM GENET, V117, P9, DOI 10.1007/s00439-005-1276-1; Magalhaes PJ, 1998, MOL BIOL CELL, V9, P2375, DOI 10.1091/mbc.9.9.2375; Matthijs G, 1996, EUR J HUM GENET, V4, P46; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; MORIYA J, 1994, BIOCHEMISTRY-US, V33, P2234, DOI 10.1021/bi00174a033; NEEFS JM, 1991, NUCLEIC ACIDS RES, V19, P1987, DOI 10.1093/nar/19.suppl.1987; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; PUROHIT P, 1994, NATURE, V370, P659, DOI 10.1038/370659a0; SCHNEIDER A, 1994, NUCLEIC ACIDS RES, V22, P3699, DOI 10.1093/nar/22.18.3699; Shigi N, 2002, J BIOL CHEM, V277, P39128, DOI 10.1074/jbc.M207323200; SULLIVAN MA, 1985, J BACTERIOL, V161, P368, DOI 10.1128/JB.161.1.368-376.1985; Suzuki T, 2002, EMBO J, V21, P6581, DOI 10.1093/emboj/cdf656; Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200; WEISSBRUMMER B, 1989, MOL GEN GENET, V217, P362, DOI 10.1007/BF02464905; Yan QF, 2006, BIOCHEM BIOPH RES CO, V342, P1130, DOI 10.1016/j.bbrc.2006.02.078; Yan QF, 2005, J BIOL CHEM, V280, P29151, DOI 10.1074/jbc.M504247200; Yan QF, 2004, BBA-GENE STRUCT EXPR, V1676, P119, DOI 10.1016/j.bbaexp.2003.11.010; Yarian C, 2002, J BIOL CHEM, V277, P16391, DOI 10.1074/jbc.M200253200; Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794; Young WY, 2005, BIOCHEM BIOPH RES CO, V328, P1244, DOI 10.1016/j.bbrc.2005.01.085; Zhao H, 2005, NUCLEIC ACIDS RES, V33, P1132, DOI 10.1093/nar/gki262; Zhao H, 2004, AM J HUM GENET, V74, P139, DOI 10.1086/381133; ZIMMERMANN RA, 1990, RIBOSOME, P331	53	183	213	0	31	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2006	79	2					291	302		10.1086/506389	http://dx.doi.org/10.1086/506389			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	063SR	16826519	Bronze, Green Published			2022-12-18	WOS:000239040400010
J	Brouillard, P; Boon, LM; Mulliken, JB; Enjolras, O; Ghassibe, M; Warman, ML; Tan, OT; Olsen, BR; Vikkula, M				Brouillard, P; Boon, LM; Mulliken, JB; Enjolras, O; Ghassibe, M; Warman, ML; Tan, OT; Olsen, BR; Vikkula, M			Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations ("glomangiomas")	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INHERITED VENOUS MALFORMATIONS; SMOOTH-MUSCLE; TGF-BETA; CELLS; GENE; ANOMALIES; LOCUS; DIFFERENTIATION; HETEROGENEITY; FKBP12	Glomuvenous malformations (GVMs) are cutaneous venous lesions characterized by the presence of smooth-muscle-like glomus cells in the media surrounding distended vascular lumens. We have shown that heritable GVMs link to a 4-6-cM region in chromosome 1p21-22. We also identified linkage disequilibrium that allowed a narrowing of this VMGLOM locus to 1.48 Mb. Herein, we report the identification of the mutated gene, glomulin, localized on the basis of the YAC and PAC maps. An incomplete cDNA sequence for glomulin had previously been designated "FAP48," for "FKBP-associated protein of 48 kD." The complete cDNA for glomulin contains an open reading frame of 1,785 nt encoding a predicted protein of 68 kD. The gene consists of 19 exons in which we identified 14 different germline mutations in patients with GVM. In addition, we found a somatic "second hit" mutation in affected tissue of a patient with an inherited genomic deletion. Since all but one of the mutations result in premature stop codons, and since the localized nature of the lesions could be explained by Knudson's two-hit model, GVMs are likely caused by complete loss of function of glomulin. The abnormal phenotype of vascular smooth-muscle cells (VSMCs) in GVMs suggests that glomulin plays an important role in differentiation of these cells- and, thereby, in vascular morphogenesis-especially in cutaneous veins.	Christian de Duve Inst Cellular Pathol, Lab Human Mol Genet, B-1200 Brussels, Belgium; Catholic Univ Louvain, Ctr Vasc Anomalies, Div Plast Surg, B-1200 Brussels, Belgium; Childrens Hosp, Div Plast Surg, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; Harvard Univ, Sch Dent Med, Harvard Forsyth Dept Oral Biol, Boston, MA 02115 USA; Tufts Univ, Sch Vet Med, Boston, MA 02111 USA; Hop Lariboisiere, F-75475 Paris, France; Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA	Universite Catholique Louvain; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard School of Dental Medicine; Tufts University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Case Western Reserve University	Vikkula, M (corresponding author), Christian de Duve Inst Cellular Pathol, Lab Human Mol Genet, Ave Hippocrate 74 5,BP 75-39, B-1200 Brussels, Belgium.		Ghassibe, Michella/A-7256-2011; BROUILLARD, Pascal/AER-9771-2022; Ghassibe-Sabbagh, Michella/AAG-5710-2019; Vikkula, Miikka/Q-1038-2018; Boon, Laurence/HCI-3629-2022	BROUILLARD, Pascal/0000-0001-9548-8229; Ghassibe-Sabbagh, Michella/0000-0003-2107-9929; Vikkula, Miikka/0000-0002-6236-338X; 				Boon LM, 1999, AM J HUM GENET, V65, P125, DOI 10.1086/302450; BOON LM, 1994, HUM MOL GENET, V3, P1583, DOI 10.1093/hmg/3.9.1583; Brouillard P, 2000, GENOMICS, V67, P96, DOI 10.1006/geno.2000.6232; Calvert JT, 1999, HUM MOL GENET, V8, P1279, DOI 10.1093/hmg/8.7.1279; Calvert JT, 2001, HUM HERED, V51, P180, DOI 10.1159/000053340; Chambraud B, 1996, J BIOL CHEM, V271, P32923, DOI 10.1074/jbc.271.51.32923; Chen YG, 1997, EMBO J, V16, P3866, DOI 10.1093/emboj/16.13.3866; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Enjolras O, 1996, PEDIATR SURG INT, V11, P290, DOI 10.1007/BF00497795; GALLIONE CJ, 1995, J MED GENET, V32, P197, DOI 10.1136/jmg.32.3.197; GOODMAN TF, 1971, ARCH DERMATOL, V103, P11, DOI 10.1001/archderm.103.1.11; GORLIN RJ, 1960, ARCH DERMATOL, V82, P776, DOI 10.1001/archderm.1960.01580050118018; GUPTA RK, 1965, ARCH DERMATOL, V92, P670, DOI 10.1001/archderm.92.6.670; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; Hirschi KK, 1998, J CELL BIOL, V141, P1287; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Irrthum A, 2001, EUR J HUM GENET, V9, P34, DOI 10.1038/sj.ejhg.5200576; KATO N, 1990, Journal of Dermatology (Tokyo), V17, P423; Larsson J, 2001, EMBO J, V20, P1663, DOI 10.1093/emboj/20.7.1663; Miano JM, 2000, J BIOL CHEM, V275, P9814, DOI 10.1074/jbc.275.13.9814; MIETTINEN M, 1983, VIRCHOWS ARCH B, V43, P139, DOI 10.1007/BF02932951; Mulliken J.B., 1988, VASCULAR BIRTHMARKS, P24; NANAEV AK, 1991, CELL TISSUE RES, V266, P535, DOI 10.1007/BF00318595; PEPPER MC, 1977, J INVEST DERMATOL, V68, P111, DOI 10.1111/1523-1747.ep12491672; RUDOLPH R, 1993, ANN PLAS SURG, V30, P183, DOI 10.1097/00000637-199302000-00017; SHIMIZU RT, 1995, J BIOL CHEM, V270, P7631, DOI 10.1074/jbc.270.13.7631; Vikkula M, 1998, TRENDS CARDIOVAS MED, V8, P281, DOI 10.1016/S1050-1738(98)00024-3; Vikkula M, 1996, CELL, V87, P1181, DOI 10.1016/S0092-8674(00)81814-0; Vikkula M, 2001, MATRIX BIOL, V20, P327, DOI 10.1016/S0945-053X(01)00150-0; Yang Y, 1999, DEVELOPMENT, V126, P3027	30	183	188	1	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2002	70	4					866	874		10.1086/339492	http://dx.doi.org/10.1086/339492			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	528PL	11845407	Green Published, Bronze			2022-12-18	WOS:000174252100004
J	Desautels, A; Turecki, G; Montplaisir, J; Sequeira, A; Verner, A; Rouleau, GA				Desautels, A; Turecki, G; Montplaisir, J; Sequeira, A; Verner, A; Rouleau, GA			Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VENTRAL TEGMENTAL AREA; LINKAGE ANALYSIS; CIRCADIAN-RHYTHM; SENSORY SYMPTOMS; COMPUTATIONS; ANTICIPATION; PEDIGREES; SCORES; GENE; RAT	Restless legs syndrome (RLS) is a neurological disorder characterized by leg paresthesia associated with an irresistible urge to move that often interferes with nocturnal sleep, leading to chronic sleep deprivation. To map genes that may play a role in the vulnerability to RLS, a genomewide scan was conducted in a large French-Canadian family. Significant linkage was established on chromosome 12q, for a series of adjacent microsatellite markers with a maximum two-point LOD score of 3.42 (recombination fraction .05; P=6 x 10(-4); autosomal recessive mode of inheritance), whereas multipoint linkage calculations yielded a LOD score of 3.59. Haplotype analysis refined the genetic interval, positioning the RLS- predisposing gene in a 14.71-cM region between D12S1044 and D12S78. These findings represent the first mapping of a locus conferring susceptibility to RLS.	McGill Univ, Montreal Gen Hosp, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada; McGill Univ, Montreal Genome Ctr, Montreal, PQ H3G 1A4, Canada; Douglas Hosp, Res Ctr, Montreal, PQ, Canada; Univ Montreal, Ctr Rech Sci Neurol, Montreal, PQ H3C 3J7, Canada; Hop Sacre Coeur, Ctr Etud Sommeil, Montreal, PQ H4J 1C5, Canada	McGill University; McGill University; McGill University; Universite de Montreal; Universite de Montreal	Rouleau, GA (corresponding author), McGill Univ, Montreal Gen Hosp, Ctr Res Neurosci, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.		Turecki, Gustavo/K-5100-2015; Sequeira, Adolfo/K-7278-2015	Sequeira, Adolfo/0000-0003-3040-1190; Turecki, Gustavo/0000-0003-4075-2736	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037754] Funding Source: NIH RePORTER; NINDS NIH HHS [1R01NS37754-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Desautels A, 2001, NEUROLOGY, V57, P1304, DOI 10.1212/WNL.57.7.1304; Dichgans M, 1996, MOVEMENT DISORD, V11, P87; DUBOVSKY J, 1995, HUM MOL GENET, V4, P449, DOI 10.1093/hmg/4.3.449; Ekbom KA, 1944, ACTA MED SCAND, V118, P197; Ekbom KA, 1945, ACTA MED SCAND, V158, P1; ERVIN GN, 1981, NATURE, V291, P73, DOI 10.1038/291073a0; Hening WA, 1999, SLEEP, V22, P901, DOI 10.1093/sleep/22.7.901; HODGE SE, 1994, GENET EPIDEMIOL, V11, P329, DOI 10.1002/gepi.1370110403; JOHNSON W, 1992, SLEEP RES, V21, P214; KALIVAS PW, 1983, NEUROSCIENCE, V8, P495, DOI 10.1016/0306-4522(83)90195-1; Koike N, 1998, FEBS LETT, V441, P427, DOI 10.1016/S0014-5793(98)01597-X; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LAVIGNE GJ, 1994, SLEEP, V17, P739; Lazzarini A, 1999, MOVEMENT DISORD, V14, P111, DOI 10.1002/1531-8257(199901)14:1<111::AID-MDS1018>3.3.CO;2-0; Marondel I, 1996, GENOMICS, V38, P243, DOI 10.1006/geno.1996.0624; Montplaisir J, 1999, NEUROLOGY, V52, P938, DOI 10.1212/WNL.52.5.938; Montplaisir J, 1997, MOVEMENT DISORD, V12, P61, DOI 10.1002/mds.870120111; Montplaisir J, 2000, PRINCIPLES PRACTICE, P742; Ondo WG, 2000, NEUROLOGY, V55, P1404, DOI 10.1212/WNL.55.9.1404; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Phillips B, 2000, ARCH INTERN MED, V160, P2137, DOI 10.1001/archinte.160.14.2137; QUIRION R, 1985, BRAIN RES, V327, P385, DOI 10.1016/0006-8993(85)91542-2; Sambrook J, 1989, MOL CLONING LAB MANU; Schaffer AA, 1996, HUM HERED, V46, P226, DOI 10.1159/000154358; Sobel E, 1996, AM J HUM GENET, V58, P1323; SZIGETHY E, 1989, J COMP NEUROL, V279, P128, DOI 10.1002/cne.902790111; Trenkwalder C, 1996, MOVEMENT DISORD, V11, P389, DOI 10.1002/mds.870110407; Trenkwalder C, 1999, MOVEMENT DISORD, V14, P102, DOI 10.1002/1531-8257(199901)14:1<102::AID-MDS1017>3.0.CO;2-E; Turjanski N, 1999, NEUROLOGY, V52, P932, DOI 10.1212/WNL.52.5.932; Walters AS, 1996, NEUROLOGY, V46, P92, DOI 10.1212/WNL.46.1.92; WALTERS AS, 1995, MOVEMENT DISORD, V10, P634, DOI 10.1002/mds.870100517; Weeks DE., 1990, AM J HUM GENET, V47, pA203; Winkelmann J, 2001, SLEEP, V24, pA102; Winkelmann J, 2000, SLEEP, V23, P597; Zai C, 2000, Semin Clin Neuropsychiatry, V5, P33	36	183	188	0	7	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2001	69	6					1266	1270		10.1086/324649	http://dx.doi.org/10.1086/324649			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	491AY	11704926	Green Published, Bronze			2022-12-18	WOS:000172086900011
J	Bosch, E; Calafell, F; Comas, D; Oefner, PJ; Underhill, PA; Bertranpetit, J				Bosch, E; Calafell, F; Comas, D; Oefner, PJ; Underhill, PA; Bertranpetit, J			High-resolution analysis of human Y-chromosome variation shows a sharp discontinuity and limited gene flow between northwestern Africa and the Iberian Peninsula	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN-POPULATIONS; DNA POLYMORPHISM; HISTORY; EUROPE; FREQUENCIES; SIMULATION; HAPLOTYPES; INFERENCE; DIVERSITY; DISTANCES	In the present study we have analyzed 44 Y-chromosome biallelic polymorphisms in population samples from northwestern (NW) Africa and the Iberian Peninsula, which allowed us to place each chromosome unequivocally in a phylogenetic tree based on >150 polymorphisms. The most striking results are that contemporary NW African and Iberian populations were found to have originated from distinctly different patrilineages and that the Strait of Gibraltar seems to have acted as a strong (although not complete) barrier to gene flow. In NW African populations, an Upper Paleolithic colonization that probably had its origin in eastern Africa contributed 75% of the current gene pool. In comparison, similar to 78% of contemporary Iberian Y chromosomes originated in an Upper Paleolithic expansion from western Asia, along the northern rim of the Mediterranean basin. Smaller contributions to these gene pools (constituting 13% of Y chromosomes in NW Africa and 10% of Y chromosomes in Iberia) came from the Middle East during the Neolithic and, during subsequent gene flow, from Sub-Saharan to NW Africa. Finally, bidirectional gene flow across the Strait of Gibraltar has been detected: the genetic contribution of European Y chromosomes to the NW African gene pool is estimated at 4%, and NW African populations may have contributed 7% of Iberian Y chromosomes. The Islamic rule of Spain, which began in A.D. 711 and lasted almost 8 centuries, left only a minor contribution to the current Iberian Y-chromosome pool. The high-resolution analysis of the Y chromosome allows us to separate successive migratory components and to precisely quantify each historical layer.	Univ Pompeu Fabra, Fac Ciencies Salut & Vida, Unitat Biol Evolut, Barcelona 08003, Spain; Stanford DNA Sequencing & Technol Ctr, Palo Alto, CA USA; Stanford Univ, Dept Genet, Stanford, CA 94305 USA	Pompeu Fabra University; Stanford University; Stanford University	Bertranpetit, J (corresponding author), Univ Pompeu Fabra, Fac Ciencies Salut & Vida, Unitat Biol Evolut, Doctor Aiguader 80, Barcelona 08003, Spain.		Bertranpetit, Jaume/F-8550-2012; Calafell, Francesc/C-8595-2014; Bosch, Elena/D-8681-2014; Bosch, Elena/N-7603-2019; Comas, David/D-5382-2014	Bertranpetit, Jaume/0000-0003-0100-0590; Calafell, Francesc/0000-0002-1083-9438; Bosch, Elena/0000-0003-2848-103X; Bosch, Elena/0000-0003-2848-103X; Comas, David/0000-0002-5075-0956	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM028428] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 28428] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bahlo M, 2000, THEOR POPUL BIOL, V57, P79, DOI 10.1006/tpbi.1999.1447; BANDELT HJ, 1995, GENETICS, V141, P743; BERTRANPETIT J, 1995, ANN HUM GENET, V59, P63, DOI 10.1111/j.1469-1809.1995.tb01606.x; Bosch E, 2000, EUR J HUM GENET, V8, P360, DOI 10.1038/sj.ejhg.5200464; Bosch E, 1997, HUM BIOL, V69, P295; Bosch E, 1999, AM J HUM GENET, V65, P1623, DOI 10.1086/302676; CALAFELL F, 1994, AM J PHYS ANTHROPOL, V93, P201, DOI 10.1002/ajpa.1330930205; CALAFELL F, 1993, CURR ANTHROPOL, V34, P735, DOI 10.1086/204219; Camps G., 1974, REV MONDES MUSULMANS; CASANOVA M, 1985, SCIENCE, V230, P1403, DOI 10.1126/science.2999986; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Comas D, 2000, HUM GENET, V107, P312, DOI 10.1007/s004390000370; CorteReal HBSM, 1996, ANN HUM GENET, V60, P331, DOI 10.1111/j.1469-1809.1996.tb01196.x; DESANGES J, 1990, GEN HIST AFRICA, P236; DORIT RL, 1995, SCIENCE, V268, P1183, DOI 10.1126/science.7761836; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L., 2000, ARLEQUIN V 2 0 SOFTW; Goldstein DB, 1996, MOL BIOL EVOL, V13, P1213, DOI 10.1093/oxfordjournals.molbev.a025686; GRIFFITHS RC, 1994, STAT SCI, V9, P307, DOI 10.1214/ss/1177010378; HAMMER MF, 1995, AM J HUM GENET, V56, P951; Hammer MF, 1997, GENETICS, V145, P787; Heyer E, 1997, HUM MOL GENET, V6, P799, DOI 10.1093/hmg/6.5.799; Hitti P. K., 1990, ARABS SHORT HIST; Hurles ME, 1999, AM J HUM GENET, V65, P1437, DOI 10.1086/302617; Jobling MA, 1999, HUM MOL GENET, V8, P2117, DOI 10.1093/hmg/8.11.2117; Kandil M, 1999, HUM BIOL, V71, P791; KASULE S, 1998, HIST ATLAS AFRICA; LI WH, 1985, MOL BIOL EVOL, V2, P150; McEvedy C., 1978, ATLAS WORLD POPULATI; Newman J. L., 1995, PEOPLING AFRICA; Pinto F, 1996, ANN HUM GENET, V60, P321, DOI 10.1111/j.1469-1809.1996.tb01195.x; Rando JC, 1998, ANN HUM GENET, V62, P531, DOI 10.1046/j.1469-1809.1998.6260531.x; RENDINE S, 1986, AM NAT, V128, P681, DOI 10.1086/284597; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Salas A, 1998, EUR J HUM GENET, V6, P365, DOI 10.1038/sj.ejhg.5200202; SEIELSTAD MT, 1994, HUM MOL GENET, V3, P2159; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Semino O, 1996, AM J HUM GENET, V59, P964; Shen PD, 2000, P NATL ACAD SCI USA, V97, P7354, DOI 10.1073/pnas.97.13.7354; Simoni L, 1999, HUM BIOL, V71, P399; Thomas MG, 1998, NATURE, V394, P138, DOI 10.1038/28083; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685	44	183	183	0	15	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2001	68	4					1019	1029		10.1086/319521	http://dx.doi.org/10.1086/319521			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	414KQ	11254456	Green Published, Bronze			2022-12-18	WOS:000167666000021
J	Canzian, F; Amati, P; Harach, HR; Kraimps, JL; Lesueur, F; Barbier, J; Levillain, P; Romeo, G; Bonneau, D				Canzian, F; Amati, P; Harach, HR; Kraimps, JL; Lesueur, F; Barbier, J; Levillain, P; Romeo, G; Bonneau, D			A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PAPILLARY CARCINOMA; RECEPTOR GENE; GERMLINE MUTATIONS; LINKAGE ANALYSIS; CANCER; HUMAN-CHROMOSOME-19; DISEASE; GOITER	Familial nonmedullary thyroid cancer (FNMTC) is a clinical entity characterized by a phenotype more aggressive than that of its sporadic counterpart. Families with recurrence of nonmedullary thyroid cancer (NMTC) have been repeatedly reported in the literature, and epidemiological data show a very high relative risk for first-degree relatives of probands with thyroid cancer. The transmission of susceptibility to FNMTC is compatible with autosomal dominant inheritance with reduced penetrance, or with complex inheritance. Cases of benign thyroid disease are often found in FNMTC kindreds. We report both the identification of a new entity of FNMTC and the mapping of the responsible gene, named "TCO" ((t) under bar hyroid tumors with (c) under bar ell (o) under bar xypihilia), in a French pedigree with multiple cases of multinodular goiter and NMTC. TCO was mapped to chromosome 19p13.2 by linkage analysis with a whole-genome panel of microsatellite markers. Interestingly, both the benign and malignant thyroid tumors in this family exhibit some extent of cell oxyphilia, which, until now, had not been described in the FNMTC. These findings suggest that the relatives of patients affected with sporadic NMTC with cell oxyphilia should be carefully investigated.	Int Agcy Res Canc, Unit Genet Canc Susceptibil, F-69372 Lyon 08, France; Gen Med Serv, Poitiers, France; Serv Chirurg Endocrinienne, Poitiers, France; Serv Anat Pathol, Poitiers, France; St Bartholomews Hosp, Dept Histopathol, London, England	World Health Organization; International Agency for Research on Cancer (IARC); University of London; Queen Mary University London	Romeo, G (corresponding author), Int Agcy Res Canc, Unit Genet Canc Susceptibil, 150 Cours Albert Thomas, F-69372 Lyon 08, France.		Lesueur, Fabienne/R-2178-2017; Canzian, Federico/I-2804-2014; Bonneau, Dominique/K-6110-2015	Lesueur, Fabienne/0000-0001-7404-4549; Canzian, Federico/0000-0002-4261-4583				ASHWORTH LK, 1995, NAT GENET, V11, P422, DOI 10.1038/ng1295-422; Bignell GR, 1997, AM J HUM GENET, V61, P1123, DOI 10.1086/301610; BONGARZONE I, 1989, ONCOGENE, V4, P1457; Burgess JR, 1997, J CLIN ENDOCR METAB, V82, P345, DOI 10.1210/jc.82.2.345; Collin GB, 1996, GENOMICS, V37, P125, DOI 10.1006/geno.1996.0529; COOPER DS, 1981, J CLIN ENDOCR METAB, V52, P294, DOI 10.1210/jcem-52-2-294; COUCH RM, 1986, AM J HUM GENET, V39, P811; DIRENZO MF, 1992, ONCOGENE, V7, P2549; DUPREZ L, 1994, NAT GENET, V7, P396, DOI 10.1038/ng0794-396; GOLDGAR DE, 1994, J NATL CANCER I, V86, P1600, DOI 10.1093/jnci/86.21.1600; GORSON D, 1992, THYROID, V2, P131, DOI 10.1089/thy.1992.2.131; GROSSMAN RF, 1995, ARCH SURG-CHICAGO, V130, P892; HARACH HR, 1994, HISTOPATHOLOGY, V25, P549, DOI 10.1111/j.1365-2559.1994.tb01374.x; Katoh R, 1998, J PATHOL, V186, P292; Kraimps JL, 1997, SURGERY, V121, P715, DOI 10.1016/S0039-6060(97)90063-5; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; LOTE K, 1980, CANCER, V46, P1291, DOI 10.1002/1097-0142(19800901)46:5<1291::AID-CNCR2820460534>3.0.CO;2-Q; NAKASHIMA M, 1994, J ENDOCRINOL INVEST, V17, P843, DOI 10.1007/BF03347789; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; OZAKI O, 1988, WORLD J SURG, V12, P565, DOI 10.1007/BF01655453; PARMA J, 1993, NATURE, V365, P649, DOI 10.1038/365649a0; Pasini B, 1996, TRENDS GENET, V12, P138, DOI 10.1016/0168-9525(96)10012-3; STOFFER SS, 1986, AM J MED GENET, V25, P775, DOI 10.1002/ajmg.1320250415	25	183	192	1	7	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1998	63	6					1743	1748		10.1086/302164	http://dx.doi.org/10.1086/302164			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EL	9837827	Green Published, Bronze			2022-12-18	WOS:000077707700020
J	Baharloo, S; Johnston, PA; Service, SK; Gitschier, J; Freimer, NB				Baharloo, S; Johnston, PA; Service, SK; Gitschier, J; Freimer, NB			Absolute pitch: An approach for identification of genetic and nongenetic components	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MECHANISMS; TRAITS	Absolute pitch (AP) is the ability to recognize a pitch, without an external reference, By surveying more than 600 musicians in music conservatories, training programs, and orchestras, we have attempted to dissect the influences of early musical training and genetics on the development of this ability. Early musical training appears to be necessary but nor sufficient for the development of AP. Forty percent of musicians who had begun training at less than or equal to 4 years of age reported AP, whereas only 3% of those who had initiated training at greater than or equal to 9 years of age did so. Self-reported AP possessors were four times more likely to report another AP possessor in their families than were non-AP possessors. These data suggest that both early musical training and genetic predisposition are needed for the development of AP. We developed a simple computer-based acoustical test that has allowed us to subdivide AP possessors into distinct groups, on the basis of their performance, Investigation of individuals who performed extremely well on this test has already led us to identify several families that will be suitable for studies of the genetic basis of AP.	Univ Calif San Francisco, Langley Porter Psychiat Inst, Dept Psychiat, Ctr Neurobiol & Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Keck Ctr Integrat Neurobiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Genet Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Freimer, NB (corresponding author), Univ Calif San Francisco, Langley Porter Psychiat Inst, Dept Psychiat, Ctr Neurobiol & Psychiat, Box 0984,401 Parnassus Ave,Room 68, San Francisco, CA 94143 USA.	nelson@ngl.ucsf.edu						BACHEM A, 1955, J ACOUST SOC AM, V27, P1180, DOI 10.1121/1.1908155; Baggaley J., 1974, PSYCHOL MUSIC, V2, P11, DOI [10.1177/030573567422002?journalCode=poma, DOI 10.1177/030573567422002]; Doupe A J, 1993, Curr Opin Neurobiol, V3, P104, DOI 10.1016/0959-4388(93)90043-X; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Gregersen Peter K., 1996, American Journal of Human Genetics, V59, pA179; KLEIN M, 1984, SCIENCE, V223, P1306, DOI 10.1126/science.223.4642.1306; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; MCINNES LA, 1995, CURR OPIN GENET DEV, V5, P376, DOI 10.1016/0959-437X(95)80054-9; MIYAZAKI K, 1988, PERCEPT PSYCHOPHYS, V44, P501, DOI 10.3758/BF03207484; MIYAZAKI K, 1989, MUSIC PERCEPT, V7, P1; MIYAZAKI K, 1988, H8861 HEAR SCI RES S; NEVILLE HJ, 1991, BRAIN MATURATION COG, P355; OPOLKO F, 1987, MCGILL U MASTER SAMP, V3; PETRAN LA, 1939, MUS TEACH NATL ASS P, V34, P144; PROFITA J, 1988, AM J MED GENET, V29, P763, DOI 10.1002/ajmg.1320290405; Rakowski A., 1987, Archives of Acoustics, V12, P75; Revesz G., 1953, INTRO PSYCHOL MUSIC; SCHLAUG G, 1995, SCIENCE, V267, P699, DOI 10.1126/science.7839149; SERGEANT D, 1969, J RES MUSIC EDUC, V17, P135, DOI 10.2307/3344200; Takahashi JS, 1996, PROG BRAIN RES, V111, P5, DOI 10.1016/S0079-6123(08)60396-9; Takeuchi A. H., 1989, THESIS J HOPKINS U B; TAKEUCHI AH, 1993, PSYCHOL BULL, V113, P345, DOI 10.1037/0033-2909.113.2.345; TAKEUCHI AH, 1991, MUSIC PERCEPT, V9, P27; Ward W.D., 1982, PSYCHOL MUSIC, V2nd ed., P431; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767	26	183	187	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1998	62	2					224	231		10.1086/301704	http://dx.doi.org/10.1086/301704			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA927	9463312	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000072416000004
J	CARLSON, KM; BRACAMONTES, J; JACKSON, CE; CLARK, R; LACROIX, A; WELLS, SA; GOODFELLOW, PJ				CARLSON, KM; BRACAMONTES, J; JACKSON, CE; CLARK, R; LACROIX, A; WELLS, SA; GOODFELLOW, PJ			PARENT-OF-ORIGIN EFFECTS IN MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MEDULLARY-THYROID CARCINOMA; SOMATIC-CELL HYBRIDS; SPORADIC WILMS-TUMOR; PREFERENTIAL MUTATION; HUMAN CHROMOSOME-10; RET PROTOONCOGENE; GENE; RETINOBLASTOMA; ALLELES; CANCER	Multiple endocrine neoplasia type 2B (MEN 2B) is characterized by medullary thyroid carcinoma, pheochromocytomas, mucosal neuromas, ganglioneuromas, and skeletal and ophthalmic abnormalities. It is observed as both inherited and sporadic disease, with an estimated 50% of cases arising de novo. A single point mutation in the catalytic core region of the receptor tyrosine kinase, RET, has been observed in germ-line DNA of MEN 2B patients. We have analyzed 25 cases of de novo disease in order to determine the parental origin of the mutated RET allele. In all cases the new mutation was of paternal origin. We observe a distortion of the sex ratio in both de novo MEN 2B patients and the affected offspring of MEN 2B transmitting males. These results suggest a differential susceptibility of RET to mutation in paternally and maternally derived DNA and a possible role for imprinting of RET during development.	WASHINGTON UNIV,SCH MED,DIV HUMAN MOLEC GENET,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT SURG,DIV GEN SURG,ST LOUIS,MO; HENRY FORD HOSP,DEPT MED,DETROIT,MI; UNIV SO CALIF,CHILDRENS HOSP LOS ANGELES,SCH MED,DEPT PEDIAT,LOS ANGELES,CA; UNIV MONTREAL,HOTEL DIEU MONTREAL,RES CTR,DEPT MED,DIV METAB ENDOCRINOL & NUTR,MONTREAL,PQ,CANADA	Washington University (WUSTL); Washington University (WUSTL); Henry Ford Health System; Henry Ford Hospital; Children's Hospital Los Angeles; University of Southern California; Universite de Montreal			Lacroix, Andre/AAI-5645-2020		NATIONAL CANCER INSTITUTE [P01CA053524, T32CA009621] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000036] Funding Source: NIH RePORTER; NCI NIH HHS [P01CA53524, NCIT32CA09621] Funding Source: Medline; NCRR NIH HHS [M01 RR00036] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		CARLSON KM, 1994, HUM MOL GENET, V3, P1207; CARLSON KM, 1994, P NATL ACAD SCI USA, V91, P1579, DOI 10.1073/pnas.91.4.1579; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; DONISKELLER H, 1993, HUM MOL GENET, V2, P851, DOI 10.1093/hmg/2.7.851; DOU S, 1993, AM J HUM GENET, V53, P1286; DRYJA TP, 1989, NATURE, V339, P556, DOI 10.1038/339556a0; ENG C, 1994, HUM MOL GENET, V3, P237, DOI 10.1093/hmg/3.2.237; FARNDON JR, 1986, BRIT J SURG, V73, P278, DOI 10.1002/bjs.1800730411; GIDDINGS SJ, 1994, NAT GENET, V6, P310, DOI 10.1038/ng0394-310; GOODFELLOW PJ, 1990, SOMAT CELL MOLEC GEN, V16, P163, DOI 10.1007/BF01233046; GOODFELLOW PJ, 1989, ANN HUM GENET, V53, P15, DOI 10.1111/j.1469-1809.1989.tb01118.x; GOSS SJ, 1975, NATURE, V255, P680, DOI 10.1038/255680a0; HAAS OA, 1992, NATURE, V359, P414, DOI 10.1038/359414a0; HOFSTRA RMW, 1994, NATURE, V367, P375, DOI 10.1038/367375a0; HOWE JR, 1992, AM J HUM GENET, V51, P1430; Jackson C E, 1992, Henry Ford Hosp Med J, V40, P232; JADAYEL D, 1990, NATURE, V345, P558; JINNO Y, 1994, NAT GENET, V6, P305, DOI 10.1038/ng0394-305; KALSCHEUER VM, 1993, NAT GENET, V5, P74, DOI 10.1038/ng0993-74; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; KNUDSON AG, 1972, J NATL CANCER I, V48, P313; LAINMORE TC, 1991, GENOMICS, V9, P181; LATHAM KE, 1994, GENE DEV, V8, P290, DOI 10.1101/gad.8.3.290; LEACH RJ, 1990, CELL GROWTH DIFFER, V1, P401; LOVE DR, 1993, HUM MOL GENET, V2, P491, DOI 10.1093/hmg/2.4.491-a; MANNENS M, 1988, HUM GENET, V81, P41, DOI 10.1007/BF00283727; MULLIGAN LM, 1993, NATURE, V363, P458, DOI 10.1038/363458a0; MULLIGAN LM, 1993, NAT GENET, V6, P70; NAUMOVA A, 1994, AM J HUM GENET, V54, P264; NORTON JA, 1979, SURG CLIN N AM, V59, P109; NORUM RA, 1990, GENOMICS, V8, P313, DOI 10.1016/0888-7543(90)90287-5; PAL N, 1990, ONCOGENE, V5, P1665; Penrose LS, 1933, J GENET, V27, P219, DOI 10.1007/BF02984413; PONTECORVO G, 1975, SOMAT CELL GENET, V1, P397, DOI 10.1007/BF01538671; REEVE AE, 1984, NATURE, V309, P174, DOI 10.1038/309174a0; Sambrook J., 1989, MOL CLONING LAB MANU; SCHROEDER WT, 1987, AM J HUM GENET, V40, P413; SCRABLE H, 1989, P NATL ACAD SCI USA, V86, P7480, DOI 10.1073/pnas.86.19.7480; SPECTOR B, 1981, AM J OPHTHALMOL, V911, P204; Srivastava A K, 1992, PCR Methods Appl, V1, P255; STEPHENS K, 1992, HUM GENET, V88, P279; TAKAHASHI M, 1989, ONCOGENE, V4, P805; TAKAHASHI M, 1988, ONCOGENE, V3, P571; TOGUCHIDA J, 1989, NATURE, V338, P156, DOI 10.1038/338156a0; VISARIA PM, 1967, EUGEN QUART, V14, P132, DOI 10.1080/19485565.1967.9987713; VOGEL F, 1985, ADV HUM GENET, V5, P223; ZHU XP, 1989, NATURE, V340, P312, DOI 10.1038/340312a0	47	183	190	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1994	55	6					1076	1082						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB684	7977365				2022-12-18	WOS:A1994QB68400002
J	PUERS, C; HAMMOND, HA; JIN, L; CASKEY, CT; SCHUMM, JW				PUERS, C; HAMMOND, HA; JIN, L; CASKEY, CT; SCHUMM, JW			IDENTIFICATION OF REPEAT SEQUENCE HETEROGENEITY AT THE POLYMORPHIC SHORT TANDEM REPEAT LOCUS HUMTHOI[AATG](N) AND REASSIGNMENT OF ALLELES IN POPULATION ANALYSIS BY USING A LOCUS-SPECIFIC ALLELIC LADDER	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC-VARIATION; POLYACRYLAMIDE-GELS; HUMAN DNA; MARKERS; AMPLIFICATION; FINGERPRINTS	An allelic ladder containing amplified sequences of seven alleles of the polymorphic human tyrosine hydroxylase locus, HUMTH01, was constructed and employed as a standard marker. Sequence analysis of each ladder component indicates that fragments differ by integral multiples of the AATG core repeat sequence characteristic of this locus. Individual alleles are designated ''5'' through ''11,'' according to the number of complete reiterations of the core repeat contained within them. Comparison of the HUMTH01 allelic ladder with DNA samples amplified at this locus revealed core repeat length heterogeneity (i.e., deletions or insertions shorter than one core repeat) within the human population. In particular, a common allele was identified which migrates more quickly than allele 10, but more slowly than allele 9, on electrophoresis through a denaturing polyacrylamide gel. Sequence analysis of this allele, designated ''10-1,'' reveals lack of a single adenine normally present in the seventh copy of the AATG. The allelic ladder was used to reevaluate previously published population data. Results of testing for Hardy-Weinberg equilibrium and population substructure were not altered significantly by these modifications.	PROMEGA CORP,2800 WOODS HOLLOW RD,MADISON,WI 53711; INST FORENS MED,MUNSTER,GERMANY; BAYLOR COLL MED,INST MOLEC GENET,HOUSTON,TX 77030; BAYLOR COLL MED,HOWARD HUGHES MED INST,HOUSTON,TX 77030; UNIV TEXAS,GRAD SCH BIOMED SCI,CTR DEMOG & POPULAT GENET,HOUSTON,TX 77025	Promega Corporation; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; University of Texas System			Jin, Li/C-1468-2009; Jin, Li/M-5063-2019	Jin, Li/0000-0002-4546-2415; 				BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; BECKMANN JS, 1992, GENOMICS, V12, P627, DOI 10.1016/0888-7543(92)90285-Z; Brenner C.H., 1989, INT S HUMAN IDENTIFI, P21; BRINKMANN B, 1992, 3RD P INT S HUM ID, P357; BRUNK CF, 1979, ANAL BIOCHEM, V92, P497, DOI 10.1016/0003-2697(79)90690-0; BUDOWLE B, 1991, AM J HUM GENET, V48, P841; CAROTHERS AM, 1989, BIOTECHNIQUES, V7, P494; CHAKRABORTY R, 1988, AM J HUM GENET, V43, P709; CHAKRABORTY R, 1993, GENETICS, V134, P953; CHAKRABORTY R, 1992, HUM GENET, V88, P267, DOI 10.1007/BF00197257; CHAKRABORTY R, 1992, HUM BIOL, V64, P141; CLARK JM, 1988, NUCLEIC ACIDS RES, V16, P9677, DOI 10.1093/nar/16.20.9677; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; EDWARDS A, 1991, AM J HUM GENET, V49, P746; EDWARDS A, 1991, 2ND P INT S HUM ID M, P31; FRANK R, 1979, NUCLEIC ACIDS RES, V6, P2069, DOI 10.1093/nar/6.6.2069; GILL P, 1985, NATURE, V318, P577, DOI 10.1038/318577a0; JEFFREYS AJ, 1985, NATURE, V316, P76, DOI 10.1038/316076a0; KOBAYASHI Y, 1988, FOCUS, V10, P73; LITT M, 1989, AM J HUM GENET, V44, P397; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; PATEL PI, 1984, SOMAT CELL MOLEC GEN, V10, P483, DOI 10.1007/BF01534853; Sambrook J., 1989, MOL CLONING LAB MANU; Sokal Robert R., 1969, BIOMETRY; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TAUTZ D, 1986, NATURE, V322, P652, DOI 10.1038/322652a0; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; WEBER JL, 1989, AM J HUM GENET, V44, P388; YAP EPH, 1991, NUCLEIC ACIDS RES, V19, P1713, DOI 10.1093/nar/19.7.1713	29	183	195	0	11	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1993	53	4					953	958						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LY627	8105685				2022-12-18	WOS:A1993LY62700021
J	LIN, HJ; HAN, CY; LIN, BK; HARDY, S				LIN, HJ; HAN, CY; LIN, BK; HARDY, S			SLOW ACETYLATOR MUTATIONS IN THE HUMAN POLYMORPHIC N-ACETYLTRANSFERASE GENE IN 786 ASIANS, BLACKS, HISPANICS, AND WHITES - APPLICATION TO METABOLIC EPIDEMIOLOGY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								Our aim was to determine the population frequencies of the major slow acetylator alleles of the polymorphic N-acetyltransferase (NAT2) gene, whose locus maps to chromosome 8. We used allele-specific PCR amplification on 786 dried blood spots obtained from Hong Kong Chinese, U.S. Koreans, U.S. blacks, U.S. Hispanics, Germans, and U.S. whites. Our results show that four slow acetylator alleles can be detected as mutations at positions 481, 590, and 857 in the NAT2 gene. Recognized base substitutions at positions 341 and 803 need not be determined, because they were almost always associated with the 481T mutation. The known mutation at position 282 was strongly associated with the 590A mutation. The 481T, 590A, and 857A mutations accounted for virtually all of the slow acetylator alleles in Asian and white populations. The 857A mutation proved to be an Asiatic allele. The results will be useful in large-scale epidemiologic studies of cancer and other conditions potentially associated with the acetylator polymorphism.	UNIV CALIF LOS ANGELES, SCH MED, DEPT SURG, TISSUE TYPING LAB, LOS ANGELES, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	LIN, HJ (corresponding author), UNIV CALIF LOS ANGELES, HARBOR MED CTR, DIV MED GENET, E4, 1124 W CARSON ST, TORRANCE, CA 90502 USA.							BLUM M, 1991, P NATL ACAD SCI USA, V88, P5237, DOI 10.1073/pnas.88.12.5237; DUFOUR AP, 1964, SCIENCE, V145, P391, DOI 10.1126/science.145.3630.391; ELLARD GA, 1976, CLIN PHARMACOL THER, V19, P610; FISHBEIN E, 1976, ARTHRITIS RHEUM, V19, P796; GRANT DM, 1984, BRIT J CLIN PHARMACO, V17, P459, DOI 10.1111/j.1365-2125.1984.tb02372.x; HAN CY, 1992, NUCLEIC ACIDS RES, V20, P6419, DOI 10.1093/nar/20.23.6419; HARRIS CC, 1991, CANCER RES, V51, pS5023; HEIN DW, 1988, BIOCHIM BIOPHYS ACTA, V948, P37, DOI 10.1016/0304-419X(88)90004-2; JINKS DC, 1989, HUM GENET, V81, P363, DOI 10.1007/BF00283692; KARIM AKMB, 1981, J MED GENET, V18, P325, DOI 10.1136/jmg.18.5.325; KHOURY MJ, 1988, AM J HUM GENET, V42, P89; NEBERT DW, 1991, MUTAT RES, V247, P267, DOI 10.1016/0027-5107(91)90022-G; OHSAKO S, 1990, J BIOL CHEM, V265, P4630; PERERA FP, 1992, NATURE, V360, P256, DOI 10.1038/360256a0; PROBST MR, 1992, CARCINOGENESIS, V13, P1713, DOI 10.1093/carcin/13.10.1713; Roots I, 1992, PHARMACOGENETICS DRU, P815; SCHURR TG, 1990, AM J HUM GENET, V46, P613; SHIBATA DK, 1988, J EXP MED, V167, P225, DOI 10.1084/jem.167.1.225; VATSIS KP, 1991, P NATL ACAD SCI USA, V88, P6333, DOI 10.1073/pnas.88.14.6333; WEBER WW, 1987, ACETYLATOR GENES DRU	20	183	195	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1993	52	4					827	834						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KY059	8460648				2022-12-18	WOS:A1993KY05900023
J	CAVALLIS.LL; FELDMAN, MW				CAVALLIS.LL; FELDMAN, MW			CULTURAL VERSUS BIOLOGICAL INHERITANCE - PHENOTYPIC TRANSMISSION FROM PARENTS TO CHILDREN - THEORY OF EFFECT OF PARENTAL PHENOTYPES ON CHILDRENS PHENOTYPES)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									STANFORD UNIV, DEPT GENET, STANFORD, CA 94305 USA; STANFORD UNIV, DEPT BIOL, STANFORD, CA 94305 USA	Stanford University; Stanford University								BURT C, 1966, BRIT J PSYCHOL, V57, P137, DOI 10.1111/j.2044-8295.1966.tb01014.x; CAVALLISFORZA L, 1973, THEOR POPUL BIOL, V4, P42, DOI 10.1016/0040-5809(73)90005-1; EDWARDS JH, 1969, BRIT MED BULL, V25, P58, DOI 10.1093/oxfordjournals.bmb.a070672; ERLENMEYERKIMLI.L, 1963, SCIENCE, V142, P1477, DOI 10.1126/science.142.3598.1477; FELDMAN M, TO BE PUBLISHED; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; JENSEN AR, 1970, BEHAV GENET, V1, P133; Mather K, 1971, BIOMETRICAL GENETICS; MCCALL RB, 1972, SCIENCE, V178, P1004, DOI 10.1126/science.178.4064.1004; MCCALL RB, 1973, SRCD150 MON; Shields J., 1962, MONOZYGOTIC TWINS BR; WILSON RS, 1972, SCIENCE, V178, P1006; WRIGHT SEWALL, 1931, JOUR AMER STAT ASSOC, V26, P155, DOI 10.2307/2277611	13	183	186	2	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1973	25	6					618	637						20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	R7135	4797967				2022-12-18	WOS:A1973R713500006
J	Nakamura, M; Nishida, N; Kawashima, M; Aiba, Y; Tanaka, A; Yasunami, M; Nakamura, H; Komori, A; Nakamuta, M; Zeniya, M; Hashimoto, E; Ohira, H; Yamamoto, K; Onji, M; Kaneko, S; Honda, M; Yamagiwa, S; Nakao, K; Ichida, T; Takikawa, H; Seike, M; Umemura, T; Ueno, Y; Sakisaka, S; Kikuchi, K; Ebinuma, H; Yamashiki, N; Tamura, S; Sugawara, Y; Mori, A; Yagi, S; Shirabe, K; Taketomi, A; Arai, K; Monoe, K; Ichikawa, T; Taniai, M; Miyake, Y; Kumagi, T; Abe, M; Yoshizawa, K; Joshita, S; Shimoda, S; Honda, K; Takahashi, H; Hirano, K; Takeyama, Y; Harada, K; Migita, K; Ito, M; Yatsuhashi, H; Fukushima, N; Ota, H; Komatsu, T; Saoshiro, T; Ishida, J; Kouno, H; Kouno, H; Yagura, M; Kobayashi, M; Muro, T; Masaki, N; Hirata, K; Watanabe, Y; Nakamura, Y; Shimada, M; Hirashima, N; Komeda, T; Sugi, K; Koga, M; Ario, K; Takesaki, E; Maehara, Y; Uemoto, S; Kokudo, N; Tsubouchi, H; Mizokami, M; Nakanuma, Y; Tokunaga, K; Ishibashi, H				Nakamura, Minoru; Nishida, Nao; Kawashima, Minae; Aiba, Yoshihiro; Tanaka, Atsushi; Yasunami, Michio; Nakamura, Hitomi; Komori, Atsumasai; Nakamuta, Makoto; Zeniya, Mikio; Hashimoto, Etsuko; Ohira, Hiromasa; Yamamoto, Kazuhide; Onji, Morikazu; Kaneko, Shuichi; Honda, Masao; Yamagiwa, Satoshi; Nakao, Kazuhiko; Ichida, Takafumi; Takikawa, Hajime; Seike, Masataka; Umemura, Takeji; Ueno, Yoshiyuki; Sakisaka, Shotaro; Kikuchi, Kentaro; Ebinuma, Hirotoshi; Yamashiki, Noriyo; Tamura, Sumito; Sugawara, Yasuhiko; Mori, Akira; Yagi, Shintaro; Shirabe, Ken; Taketomi, Akinobu; Arai, Kuniaki; Monoe, Kyoko; Ichikawa, Tatsuki; Taniai, Makiko; Miyake, Yasuhiro; Kumagi, Teru; Abe, Masanori; Yoshizawa, Kaname; Joshita, Satoru; Shimoda, Shinji; Honda, Koichi; Takahashi, Hiroki; Hirano, Katsuji; Takeyama, Yasuaki; Harada, Kenichi; Migita, Kiyoshi; Ito, Masahiro; Yatsuhashi, Hiroshi; Fukushima, Nobuyoshi; Ota, Hajime; Komatsu, Tatsuji; Saoshiro, Takeo; Ishida, Jinya; Kouno, Hirotsugu; Kouno, Hirotaka; Yagura, Michiyasu; Kobayashi, Masakazu; Muro, Toyokichi; Masaki, Naohiko; Hirata, Keiichi; Watanabe, Yukio; Nakamura, Yoko; Shimada, Masaaki; Hirashima, Noboru; Komeda, Toshiki; Sugi, Kazuhiro; Koga, Michiaki; Ario, Keisuke; Takesaki, Eiichi; Maehara, Yoshihiko; Uemoto, Shinji; Kokudo, Norihiro; Tsubouchi, Hirohito; Mizokami, Masashi; Nakanuma, Yasuni; Tokunaga, Katsushi; Ishibashi, Hiromi			Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; COACTIVATOR OBF-1; SNP ARRAY; SPI-B; VARIANTS; POLYMORPHISMS; GENERATION; CELLS; INDIVIDUALS	For the identification of susceptibility loci for primary binary cirrhosis (PBC), a genome-wide association study (GWAS) was performed in 963 Japanese individuals (487 PBC cases and 476 healthy controls) and in a subsequent replication study that included 1,402 other Japanese individuals (787 cases and 615 controls). In addition to the most significant susceptibility region, human leukocyte antigen (HLA), we identified two significant susceptibility loci, TNFSF15 (rs4979462) and POU2AF1 (rs4938534) (combined odds ratio [OR] = 1.56, p = 2.84 x 10(-14) for rs4979462, and combined OR = 1.39, p = 2.38 x 10(-8) for rs4938534). Among 21 non-HLA susceptibility loci for PBC identified in GWASs of individuals of European descent, three loci (IL7R, IKZF3, and CD80) showed significant associations (combined p = 3.66 x 10(-8), 3.66 x 10(-9), and 3.04 x 10(-9), respectively) and STAT4 and NFKB1 loci showed suggestive association with PBC (combined p = 1.11 x 10(-6) and 1.42 x 10(-7), respectively) in the Japanese population. These observations indicated the existence of ethnic differences in genetic susceptibility loci to PBC and the importance of TNF signaling and B cell differentiation for the development of PBC in individuals of European descent and Japanese individuals.	[Nakamura, Minoru; Aiba, Yoshihiro; Nakamura, Hitomi; Komori, Atsumasai; Migita, Kiyoshi; Ito, Masahiro; Yatsuhashi, Hiroshi; Ishibashi, Hiromi] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki Med Ctr, Clin Res Ctr,NHO, Omura, Nagasaki 8568562, Japan; [Nakamura, Minoru; Aiba, Yoshihiro; Nakamura, Hitomi; Komori, Atsumasai; Migita, Kiyoshi; Ito, Masahiro; Yatsuhashi, Hiroshi; Ishibashi, Hiromi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Hepatol, Omura, Nagasaki 8568562, Japan; [Nakamura, Minoru; Nakamuta, Makoto; Fukushima, Nobuyoshi; Ota, Hajime; Komatsu, Tatsuji; Saoshiro, Takeo; Ishida, Jinya; Kouno, Hirotsugu; Kouno, Hirotaka; Yagura, Michiyasu; Kobayashi, Masakazu; Muro, Toyokichi; Masaki, Naohiko; Hirata, Keiichi; Watanabe, Yukio; Nakamura, Yoko; Shimada, Masaaki; Hirashima, Noboru; Komeda, Toshiki; Sugi, Kazuhiro; Koga, Michiaki; Ario, Keisuke; Takesaki, Eiichi] NHO Nagasaki Med Ctr, Clin Res Ctr, Headquaters Primary Biliary Cirrhosis Res NHO Stu, Omura, Nagasaki 8568562, Japan; [Nakamura, Minoru] Nagasaki Univ, Grad Sch Biomed Sci, Headquaters Working Grp Gp210,Dept Hepatol, Intractable Liver Dis Res Project Team,Minist Hlt, Omura, Nagasaki 8568562, Japan; [Nishida, Nao; Kawashima, Minae; Tokunaga, Katsushi] Univ Tokyo, Grad Sch Med, Dept Human Genet, Tokyo 1130033, Japan; [Nishida, Nao] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Ichikawa 2728516, Japan; [Tanaka, Atsushi; Takikawa, Hajime] Teikyo Univ, Sch Med, Dept Med, Tokyo 1738605, Japan; [Yasunami, Michio] Nagasaki Univ, Inst Trop Med, Dept Clin Med, Nagasaki 8528523, Japan; [Zeniya, Mikio; Takahashi, Hiroki] Tokyo Jikei Univ, Sch Med, Dept Gastroenterol & Hepatol, Tokyo 1058461, Japan; [Hashimoto, Etsuko; Taniai, Makiko] Tokyo Womens Med Univ, Dept Med & Gastroenterol, Tokyo 1628666, Japan; [Ohira, Hiromasa; Monoe, Kyoko] Fukushima Med Univ, Dept Gastroenterol & Rheumat Dis, Fukushima 9601295, Japan; [Yamamoto, Kazuhide; Miyake, Yasuhiro] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Okayama 7008558, Japan; [Onji, Morikazu; Kumagi, Teru; Abe, Masanori] Ehime Univ, Grad Sch Med, Dept Gastroenterol & Med, Matsuyama, Ehime 7910295, Japan; [Kaneko, Shuichi; Honda, Masao; Arai, Kuniaki] Kanazawa Univ, Grad Sch Med, Dept Gastroenterol, Kanazawa, Ishikawa 9200942, Japan; [Yamagiwa, Satoshi] Niigata Univ, Grad Sch Med & Dent Sci, Div Gastroenterol & Hepatol, Niigata 9518510, Japan; [Nakao, Kazuhiko; Ichikawa, Tatsuki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Gastroenterol & Hepatol, Nagaski 8528501, Japan; [Ichida, Takafumi; Hirano, Katsuji] Juntendo Univ, Shizuoka Hosp, Dept Gastroenterol & Hepatol, Shizuoka 4102295, Japan; [Seike, Masataka; Honda, Koichi] Oita Univ, Fac Med, Dept Internal Med 1, Oita 8795593, Japan; [Umemura, Takeji; Yoshizawa, Kaname; Joshita, Satoru] Shinshu Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Matsumoto, Nagano 3908621, Japan; [Ueno, Yoshiyuki] Tohoku Univ, Grad Sch Med, Div Gastroenterol, Sendai, Miyagi 9808575, Japan; [Sakisaka, Shotaro; Takeyama, Yasuaki] Fukuoka Univ, Sch Med, Dept Gastroenterol & Med, Fukuoka 8140180, Japan; [Kikuchi, Kentaro] Teikyo Univ, Mizonokuchi Hosp, Dept Internal Med, Kawasaki, Kanagawa 2138507, Japan; [Ebinuma, Hirotoshi] Keio Grad Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo 1608582, Japan; [Yamashiki, Noriyo] Univ Tokyo, Organ Transplantat Serv, Tokyo 1138655, Japan; [Tamura, Sumito; Sugawara, Yasuhiko; Kokudo, Norihiro] Univ Tokyo, Grad Sch Med, Dept Surg, Hepatobiliary & Pancreat Surg Div, Tokyo 1138655, Japan; [Tamura, Sumito; Sugawara, Yasuhiko; Kokudo, Norihiro] Univ Tokyo, Grad Sch Med, Dept Surg, Artificial Organ & Transplantat Div, Tokyo 1138655, Japan; [Mori, Akira; Yagi, Shintaro; Uemoto, Shinji; Mizokami, Masashi] Kyoto Univ, Grad Sch Med, Dept Surg, Div Hepatopancreatobiliary Surg & Transplantat, Kyoto 6068507, Japan; Kyushu Univ, Dept Surg & Sci, Grad Sch Med Sci, Fukuoka 8128582, Japan; [Shimoda, Shinji] Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka 8128582, Japan; [Harada, Kenichi; Nakanuma, Yasuni] Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa 9200942, Japan; [Tsubouchi, Hirohito] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Digest & Lifestyle Related Dis, Kagoshima 8908520, Japan	Nagasaki University; Nagasaki University; Nagasaki University; University of Tokyo; National Center for Global Health & Medicine - Japan; Teikyo University; Nagasaki University; Jikei University; Tokyo Women's Medical University; Fukushima Medical University; Okayama University; Ehime University; Kanazawa University; Niigata University; Nagasaki University; Juntendo University; Oita University; Shinshu University; Tohoku University; Fukuoka University; Teikyo University; University of Tokyo; University of Tokyo; University of Tokyo; Kyoto University; Kyushu University; Kyushu University; Kanazawa University; Kagoshima University	Nakamura, M (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki Med Ctr, Clin Res Ctr,NHO, Omura, Nagasaki 8568562, Japan.	nakamuram@nmc.hosp.go.jp	Ueno, Yoshiyuki/R-9242-2019; Yagi, Shintaro/O-4403-2016; Kumagi, Teru/AAS-7427-2021; Joshita, Satoru/K-5679-2019	Ueno, Yoshiyuki/0000-0001-5623-4250; Yagi, Shintaro/0000-0001-7465-5761; Kumagi, Teru/0000-0002-2292-7750; Joshita, Satoru/0000-0002-6364-9654; YAMASHIKI, Noriyo/0000-0002-9274-0000; TAKEYAMA, Yasuaki/0000-0001-7919-4407	Japan Society for the Promotion of Science [20590800, 23591006]; NHO; Ministry of Health, Labor, and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEAT); Grants-in-Aid for Scientific Research [22590344, 24790728, 22133008] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NHO; Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEAT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The study was approved by the ethics committees of Nagasaki Medical Center and all institutes and hospitals throughout Japan that participated in this collaborative study. All participants provided written informed consent for participation in this study. This study was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (#20590800, #23591006) to M.N., by a Grant-in-Aid for Clinical Research from the NHO to M. Nakamura, by a grant from the Research Program of Intractable Disease provided by the Ministry of Health, Labor, and Welfare of Japan to HI., and by a grant for Scientific Research on Innovative Areas (Genome Science) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEAT) to K.T. We thank Yoriko Mawatari, Megumi Sageshima, Yuko Ogasawara, Natsumi Baba, and Rieko Hayashi (University of Tokyo) for technical assistance. We also thank Shinya Nagaoka and Seigo Abiru (NHO Nagasaki Medical Center, Omura, Japan) and Shigeki Hayashi, Hiroshi Mano, Yukio Ohara, Haruhiro Yamashita, Kouki Matsushita, Takeaki Sato, Tsutomu Yamashita, Masahiko Takahashi, Tetsuo Yamamoto, Hironori Sakai, Michio Kato, Fuji Makita, Hitoshi Takaki, and Hideo Nishimura (members of NHOSLJ) for collecting clinical data and blood samples and for obtaining informed consent from PBC cases.	Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bartholdy B, 2006, P NATL ACAD SCI USA, V103, P11665, DOI 10.1073/pnas.0509430103; Boonstra K, 2012, J HEPATOL, V56, P1181, DOI 10.1016/j.jhep.2011.10.025; Cortes M, 2004, J EXP MED, V199, P209, DOI 10.1084/jem.20031571; David-Fung ES, 2006, IMMUNOL REV, V209, P212, DOI 10.1111/j.0105-2896.2006.00355.x; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Garrett-Sinha LA, 1999, IMMUNITY, V10, P399, DOI 10.1016/S1074-7613(00)80040-0; Hirschfield GM, 2012, GENES IMMUN, V13, P328, DOI 10.1038/gene.2011.89; Hirschfield GM, 2010, NAT GENET, V42, P655, DOI 10.1038/ng.631; Hirschfield GM, 2009, NEW ENGL J MED, V360, P2544, DOI 10.1056/NEJMoa0810440; Hoffmann TJ, 2011, GENOMICS, V98, P79, DOI 10.1016/j.ygeno.2011.04.005; Kakuta Y, 2006, GUT, V55, P1527, DOI 10.1136/gut.2006.100297; Kakuta Y, 2009, HUM MOL GENET, V18, P1089, DOI 10.1093/hmg/ddp005; Kaplan MM, 2005, NEW ENGL J MED, V353, P1261, DOI 10.1056/NEJMra043898; Latiano A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022688; Lindor KD, 2009, HEPATOLOGY, V50, P291, DOI 10.1002/hep.22906; Liu XD, 2010, NAT GENET, V42, P658, DOI 10.1038/ng.627; Lleo A, 2012, J HEPATOL, V56, P731, DOI 10.1016/j.jhep.2011.05.040; Mackall CL, 2011, NAT REV IMMUNOL, V11, P330, DOI 10.1038/nri2970; Mells GF, 2011, NAT GENET, V43, P329, DOI 10.1038/ng.789; Meylan F, 2011, IMMUNOL REV, V244, P188, DOI 10.1111/j.1600-065X.2011.01068.x; Michelsen KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004719; Miyagawa T, 2008, J HUM GENET, V53, P886, DOI 10.1007/s10038-008-0322-y; Nguyen VT, 2000, J BIOL CHEM, V275, P23674, DOI 10.1074/jbc.M002482200; Nishida N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029967; Nishida N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-431; Selmi C, 2004, GASTROENTEROLOGY, V127, P485, DOI 10.1053/j.gastro.2004.05.005; STRUBIN M, 1995, CELL, V80, P497, DOI 10.1016/0092-8674(95)90500-6; Sun J, 2003, J IMMUNOL, V170, P1699, DOI 10.4049/jimmunol.170.4.1699; Thiebaut R, 2009, AM J GASTROENTEROL, V104, P384, DOI 10.1038/ajg.2008.36; Tremelling M, 2008, INFLAMM BOWEL DIS, V14, P733, DOI 10.1002/ibd.20399; Wang K, 2010, HUM MOL GENET, V19, P2059, DOI 10.1093/hmg/ddq078; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Yamazaki K, 2005, HUM MOL GENET, V14, P3499, DOI 10.1093/hmg/ddi379; Yang SK, 2008, AM J GASTROENTEROL, V103, P1437, DOI 10.1111/j.1572-0241.2007.01752.x; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753; Zinovieva E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000528; Zucchelli M, 2011, GUT, V60, P1671, DOI 10.1136/gut.2011.241877; Zuo JX, 2007, J AUTOIMMUN, V29, P87, DOI 10.1016/j.jaut.2007.05.001	39	182	191	1	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT 5	2012	91	4					721	728		10.1016/j.ajhg.2012.08.010	http://dx.doi.org/10.1016/j.ajhg.2012.08.010			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	017CU	23000144	Bronze, Green Published			2022-12-18	WOS:000309568500014
J	Zhong, H; Yang, X; Kaplan, LM; Molony, C; Schadt, EE				Zhong, Hua; Yang, Xia; Kaplan, Lee M.; Molony, Cliona; Schadt, Eric E.			Integrating Pathway Analysis and Genetics of Gene Expression for Genome-wide Association Studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; INSULIN-RESISTANCE; DIABETES-MELLITUS; RISK; CELL; POPULATION; LOCI; STREPTOZOTOCIN; INFLAMMATION; PATHOGENESIS	Genome-wide association studies (GWAS) have achieved great success identifying common genetic variants associated with common human diseases. However, to date, the massive amounts of data generated from GWAS have not been maximally leveraged and integrated with other types of data to identify associations beyond those associations that meet the stringent genome-wide significance threshold. Here, we present a novel approach that leverages information from genetics of gene expression studies to identify biological pathways enriched for expression-associated genetic loci associated with disease in publicly available GWAS results. Specifically, we first identify SNPs in population-based human cohorts that associate with the expression of genes (eSNPs) in the metabolically active tissues liver, subcutaneous adipose, and omental adipose. We then use this functionally annotated set of SNPs to investigate pathways enriched for eSNPs associated with disease in publicly available GWAS data. As an example, we tested 110 pathways from the Kyoto Encylopedia of Genes and Genomes (KEGG) database and identified 16 pathways enriched for genes corresponding to eSNPs that show evidence of association with type 2 diabetes (T2D) in the Wellcome Trust Case Control Consortium (WTCCC) T2D GWAS. We then replicated these findings in the Diabetes Genetics Replication and Meta-analysis (DIAGRAM) study. Many of the pathways identified have been proposed as important candidate pathways for T2D, including the calcium signaling pathway, the PPAR signaling pathway, and TGE-13 signaling. Importantly, we identified other pathways not previously associated with T2D, including the tight junction, complement and coagulation pathway, and antigen processing and presentation pathway. The integration of pathways and eSNPs provides putative functional bridges between GWAS and candidate genes or pathways, thus serving as a potential powerful approach to identifying biological mechanisms underlying GWAS findings.	[Zhong, Hua; Yang, Xia; Molony, Cliona; Schadt, Eric E.] Merck & Co Inc, Seattle, WA 98109 USA; [Zhong, Hua; Yang, Xia; Molony, Cliona; Schadt, Eric E.] Rosetta Inpharmat LLC, Seattle, WA 98109 USA; [Kaplan, Lee M.] Harvard Univ, Sch Med, MGH, Weight Ctr, Boston, MA 02115 USA; [Kaplan, Lee M.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Merck & Company; Merck & Company; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Zhong, H (corresponding author), 1100 Fairview Ave N, Seattle, WA 98109 USA.	judy.zhong@sagebase.org	Califano, Andrea/F-7239-2012		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30 DK043351] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bavamian S, 2007, DIABETES OBES METAB, V9, P118, DOI 10.1111/j.1463-1326.2007.00780.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Das UN, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-35; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Elbers CC, 2009, GENET EPIDEMIOL, V33, P419, DOI 10.1002/gepi.20395; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Engstrom G, 2005, DIABETOLOGIA, V48, P2525, DOI 10.1007/s00125-005-0021-6; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fernandez-Real JM, 2008, TRENDS ENDOCRIN MET, V19, P10, DOI 10.1016/j.tem.2007.10.004; Gabrielsson BG, 2003, OBES RES, V11, P699, DOI 10.1038/oby.2003.100; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Grant S, 2009, CURR DIABETES REP, V9, P157, DOI 10.1007/s11892-009-0026-5; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; Harhaj NS, 2004, INT J BIOCHEM CELL B, V36, P1206, DOI 10.1016/j.biocel.2003.08.007; Hawkins BT, 2007, NEUROSCI LETT, V411, P1, DOI 10.1016/j.neulet.2006.09.010; Hedges L.V., 2014, STAT METHODS META AN; Higai K, 2003, CLIN CHIM ACTA, V329, P117, DOI 10.1016/S0009-8981(02)00427-8; Hodgkin MN, 2008, J ENDOCRINOL, V199, P1, DOI 10.1677/JOE-08-0261; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Itoh N, 2007, AM J PHYSIOL-ENDOC M, V293, pE1069, DOI 10.1152/ajpendo.00182.2007; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanno T, 2002, NEUROSCI RES, V42, P79, DOI 10.1016/S0168-0102(01)00318-2; Kraft P, 2009, NEW ENGL J MED, V360, P1701, DOI 10.1056/NEJMp0810107; Lanner JT, 2008, CURR OPIN PHARMACOL, V8, P339, DOI 10.1016/j.coph.2008.01.006; Levy J, 1999, ENDOCRINE, V10, P1, DOI 10.1385/ENDO:10:1:1; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Liu XQ, 2009, WORLD J GASTROENTERO, V15, P1730, DOI 10.3748/wjg.15.1730; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Miyamoto N, 2007, DIABETOLOGIA, V50, P461, DOI 10.1007/s00125-006-0539-2; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Nishikiori N, 2007, DIABETES, V56, P1333, DOI 10.2337/db06-1431; Perry JRB, 2009, DIABETES, V58, P1463, DOI 10.2337/db08-1378; Poulsen P, 1999, DIABETOLOGIA, V42, P139, DOI 10.1007/s001250051131; Rosenson RS, 2007, AM J CARDIOL, V99, p96B, DOI 10.1016/j.amjcard.2006.11.010; Saltiel AR, 1996, DIABETES, V45, P1661, DOI 10.2337/diabetes.45.12.1661; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; SANVITO F, 1994, DEVELOPMENT, V120, P3451; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Seda O, 2007, PHARMACOGENOMICS, V8, P587, DOI 10.2217/14622416.8.6.587; Semple RK, 2006, J CLIN INVEST, V116, P581, DOI 10.1172/JCI28003; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Smart NG, 2006, PLOS BIOL, V4, P200, DOI 10.1371/journal.pbio.0040039; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Warnberg J, 2006, AM J CLIN NUTR, V84, P505; Watts T, 2005, P NATL ACAD SCI USA, V102, P2916, DOI 10.1073/pnas.0500178102; Witczak CA, 2007, DIABETES, V56, P1403, DOI 10.2337/db06-1230; Wright DC, 2004, DIABETES, V53, P330, DOI 10.2337/diabetes.53.2.330; Yoshikumi Y, 2008, ENDOCR J, V55, P757, DOI 10.1507/endocrj.K08E-017; Yu K, 2009, GENET EPIDEMIOL, V33, P700, DOI 10.1002/gepi.20422; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhong H, 2008, BIOSTATISTICS, V9, P621, DOI 10.1093/biostatistics/kxn001	65	182	189	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 9	2010	86	4					581	591		10.1016/j.ajhg.2010.02.020	http://dx.doi.org/10.1016/j.ajhg.2010.02.020			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	583YP	20346437	Bronze, Green Published			2022-12-18	WOS:000276716800008
J	Nelson, MR; Bryc, K; King, KS; Indap, A; Boyko, AR; Novembre, J; Briley, LP; Maruyama, Y; Waterworth, DM; Waeber, G; Vollenweider, P; Oksenberg, JR; Hauser, SL; Stirnadel, HA; Kooner, JS; Chambers, JC; Jones, B; Mooser, V; Bustamante, CD; Roses, AD; Burns, DK; Ehm, MG; Lail, EH				Nelson, Matthew R.; Bryc, Katarzyna; King, Karen S.; Indap, Amit; Boyko, Adam R.; Novembre, John; Briley, Linda P.; Maruyama, Yuka; Waterworth, Dawn M.; Waeber, Gerard; Vollenweider, Peter; Oksenberg, Jorge R.; Hauser, Stephen L.; Stirnadel, Heide A.; Kooner, Jaspal S.; Chambers, John C.; Jones, Brendan; Mooser, Vincent; Bustamante, Carlos D.; Roses, Allen D.; Burns, Daniel K.; Ehm, Margaret G.; Lail, Eric H.			The population reference sample, POPRES: A resource for population, disease, and pharmacological genetics research	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; COMPLEX TRAITS; HAPLOTYPE; STRATIFICATION; SUSCEPTIBILITY; POLYMORPHISM; INFORMATION; GENOTYPES; VARIANTS	Technological and scientific advances, stemming in large part from the Human Genome and HapMap projects, have made large-scale, genome-wide investigations feasible and cost effective. These advances have the potential to dramatically impact drug discovery and development by identifying genetic factors that contribute to variation in disease risk as well as drug pharmacokinetics, treatment efficacy, and adverse drug reactions. In spite of the technological advancements, successful application in biomedical research Would be limited without access to suitable sample collections. To facilitate exploratory genetics research, we have assembled a DNA resource from a large number of subjects participating in multiple studies throughout the world. This growing resource was initially genotyped with a commercially available genome-wide 500,000 single-nucleotide polymorphism panel. This project includes nearly 6,000 subjects of African-American, East Asian, South Asian, Mexican, and European origin. Seven informative axes of variation identified via principal-component analysis (PCA) of these data confirm the overall integrity of the data and highlight important features of the genetic structure of diverse populations. The potential value of such extensively genotyped collections is illustrated by selection of genetically matched population controls in a genome-wide analysis of abacavir-associated hypersensitivity reaction. We find that matching based on country of origin, identity-by-state distance, and multidimensional PCA do similarly well to control the type I error rate. The genotype and demographic data from this reference sample are freely available through the NCBI database of Genotypes and Phenotypes (dbGaP).	[Nelson, Matthew R.; King, Karen S.; Briley, Linda P.; Maruyama, Yuka; Jones, Brendan; Roses, Allen D.; Burns, Daniel K.; Ehm, Margaret G.; Lail, Eric H.] GlaxoSmithKline Inc, Res Triangle Pk, NC 27709 USA; [Bryc, Katarzyna; Indap, Amit; Boyko, Adam R.; Bustamante, Carlos D.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Novembre, John] Univ Calif Los Angeles, Interdepartmental Program Bioinformat, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; [Novembre, John] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Waterworth, Dawn M.; Mooser, Vincent] GlaxoSmithKline Inc, King Of Prussia, PA 19406 USA; [Waeber, Gerard; Vollenweider, Peter] CHU Vaudois, Dept Internal Med, CH-1011 Lausanne, Switzerland; [Oksenberg, Jorge R.; Hauser, Stephen L.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Stirnadel, Heide A.] GlaxoSmithKline Inc, Harlow CM19 5AW, Essex, England; [Kooner, Jaspal S.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LY, England; [Chambers, John C.] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England	GlaxoSmithKline; Cornell University; University of California System; University of California Los Angeles; University of Chicago; GlaxoSmithKline; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of California System; University of California San Francisco; GlaxoSmithKline; Imperial College London; Imperial College London	Nelson, MR (corresponding author), GlaxoSmithKline Inc, Res Triangle Pk, NC 27709 USA.	matthew.r.nelson@gsk.com	Colaus, PsyColaus/K-6607-2013; Novembre, John/G-1339-2011	Waeber, Gerard/0000-0003-4193-788X; Indap, Amit/0000-0002-3322-4735; Bustamante, Carlos D./0000-0002-4187-7920	National Institutes of Health [RO1 NS046297]; National Multiple Sclerosis Society [RG3060C8]; GlaxoSmithKline; MRC [G0601966, G0700931] Funding Source: UKRI; Medical Research Council [G0700931, G0601966] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046297] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); GlaxoSmithKline(GlaxoSmithKline); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Clive E. Bowman, Michael Klotsman, Ann Marie McNeill, David P. Yarnall, Ross Haggart, Steve Haneline, Kelley Johansson, Devon Kelly, Devi Smart, Sarah Tate, Jill Ratchford, and Mike Lawson at GlaxoSmithKline for their many contributions to the development of the POPRES resource. We thank Arlene Hughes and Bill Spreen at GlaxoSmithKline for their work on pharmacogenetics research into abacavir-associated hypersensitivity reaction. We gratefully acknowledge Yolande Barreau, AnneLise Bastian, Binasa Ramic, Martine Moranville, Martine Baumer, Marcy Sagette, Jeanne Ecoffey, and Sylvie Mermoud for their roles in the CoLaus data collection. The CoLaus study was supported by research grants from GlaxoSmithKline and from the Faculty of Biology and Medicine of Lausanne, Switzerland. We thank Anna We thank Robin Lincoln at UCSF for expert specimen management. Recruitment of the UCSF African American samples was funded by grants from the National Institutes of Health (RO1 NS046297) and National Multiple Sclerosis Society (RG3060C8). All genotyping for this study was funded by GlaxoSmithKline, of which several authors are employees.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bauchet M, 2007, AM J HUM GENET, V80, P948, DOI 10.1086/513477; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen JW, 2000, GENOME RES, V10, P549, DOI 10.1101/gr.10.4.549; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Hinds DA, 2004, AM J HUM GENET, V74, P317, DOI 10.1086/381716; *INT C HARM, 2008, FED REGISTER, V78, P19074; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Kooner JS, 2008, NAT GENET, V40, P149, DOI 10.1038/ng.2007.61; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; Luca D, 2008, AM J HUM GENET, V82, P453, DOI 10.1016/j.ajhg.2007.11.003; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Manolio TA, 2007, NAT GENET, V39, P1045, DOI 10.1038/ng2127; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; NELSON MR, 2008, PHARMACOGEN IN PRESS; NOVEMBRE J, 2008, NATURE IN PRESS; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; Oksenberg JR, 2004, AM J HUM GENET, V74, P160, DOI 10.1086/380997; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Thiers FA, 2008, NAT REV DRUG DISCOV, V7, P13, DOI 10.1038/nrd2441; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702	33	182	191	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP 12	2008	83	3					347	358		10.1016/j.ajhg.2008.08.005	http://dx.doi.org/10.1016/j.ajhg.2008.08.005			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	349TW	18760391	Green Published, Bronze			2022-12-18	WOS:000259307200006
J	Jeanpierre, C; Denamur, E; Henry, I; Cabanis, MO; Luce, S; Cecille, A; Elion, J; Peuchmaur, M; Loirat, C; Niaudet, P; Gubler, MC; Junien, C				Jeanpierre, C; Denamur, E; Henry, I; Cabanis, MO; Luce, S; Cecille, A; Elion, J; Peuchmaur, M; Loirat, C; Niaudet, P; Gubler, MC; Junien, C			Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DENYS-DRASH SYNDROME; WILMS-TUMOR SUPPRESSOR; DNA-BINDING SPECIFICITY; SUBNUCLEAR LOCALIZATION; GONADAL-DYSGENESIS; POINT MUTATIONS; GENE-PRODUCT; TRANSCRIPTION; PROTEIN; ABNORMALITIES	Constitutional mutations of the WT1 gene, encoding a zinc-finger transcription factor involved in renal and gonadal development, are found in most patients with Denys-Drash syndrome (DDS), or diffuse mesangial sclerosis (DMS) associated with pseudohermaphroditism and/or Wilms tumor (WT). Most mutations in DDS patients lie in exon 8 or exon 9, encoding zinc finger 2 or zinc finger 3, respectively, with a hot spot (R394W) in exon 9. We analyzed a series of 24 patients, 10 with isolated DMS (IDMS), 10 with DDS, and 4 with urogenital abnormalities and/or WT. We report WT1 heterozygous mutations in 16 patients, 4 of whom presented with IDMS. One male and two female IDMS patients with WT1 mutations underwent normal puberty. Two mutations associated with IDMS are different from those described in DDS patients. No WT1 mutations were detected in the six other IDMS patients, suggesting genetic heterogeneity of this disease. We analyzed genotype/phenotype correlations, on the basis of the constitution of a WT1 mutation database of 84 germline mutations, to compare the distribution and type of mutations, according to the different symptoms. This demonstrated (1) the association between mutations in exons 8 and 9 and DMS; (2) among patients with DMS, a higher frequency of exon 8 mutations among 46,XY patients with female phenotype than among 46,XY patients with sexual ambiguity or male phenotype; and (3) statistically significant evidence that mutations in exons 8 and 9 preferentially affect amino acids with different functions.	Univ Rene Descartes, Hop Necker Enfants Malad, INSERM,U383, Clin Maurice Lamy, F-75743 Paris, France; Univ Rene Descartes, Hop Necker Enfants Malad, INSERM,U423, F-75743 Paris, France; Univ Rene Descartes, Hop Necker Enfants Malad, Serv Nephrol Pediat, F-75743 Paris, France; Hop Robert Debre, INSERM, U458, F-75019 Paris, France; Hop Robert Debre, Biochim Genet Lab, F-75019 Paris, France; Hop Robert Debre, Lab Anatopathol, F-75019 Paris, France; Hop Robert Debre, Serv Nephrol Pediat, F-75019 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Jeanpierre, C (corresponding author), Univ Rene Descartes, Hop Necker Enfants Malad, INSERM,U383, Clin Maurice Lamy, 149 Rue Sevres, F-75743 Paris, France.		Jeanpierre, cecile/H-3770-2017; Elion, Jacques/A-1048-2014	Jeanpierre, cecile/0000-0002-3463-5907; Elion, Jacques/0000-0002-8407-1783; Gubler, Marie-Claire/0000-0002-3526-5661; LUCE, Sandrine/0000-0002-9519-333X				AKASAKA Y, 1993, FEBS LETT, V317, P39, DOI 10.1016/0014-5793(93)81487-K; Baird Paul N., 1992, Human Molecular Genetics, V1, P301, DOI 10.1093/hmg/1.5.301; Barbaux S, 1997, NAT GENET, V17, P467, DOI 10.1038/ng1297-467; BARDEESY N, 1994, GENOMICS, V21, P663, DOI 10.1006/geno.1994.1333; Baylin SB, 1997, SCIENCE, V277, P1948, DOI 10.1126/science.277.5334.1948; BEAUDET AL, 1993, HUM MUTAT, V2, P245, DOI 10.1002/humu.1380020402; BICKMORE WA, 1992, SCIENCE, V257, P235, DOI 10.1126/science.1321494; COPPES MJ, 1992, CANCER RES, V52, P6125; COPPES MJ, 1993, FASEB J, V7, P886, DOI 10.1096/fasebj.7.10.8393819; DENYS P, 1967, ARCH FR PEDIATR, V24, P729; DRASH A, 1970, J PEDIATR-US, V76, P585, DOI 10.1016/S0022-3476(70)80409-7; DRUMMOND IA, 1994, MOL CELL BIOL, V14, P3800, DOI 10.1128/MCB.14.6.3800; DRUMMOND IA, 1992, SCIENCE, V257, P674, DOI 10.1126/science.1323141; Englert C, 1995, P NATL ACAD SCI USA, V92, P11960, DOI 10.1073/pnas.92.26.11960; HABER DA, 1991, P NATL ACAD SCI USA, V88, P9618, DOI 10.1073/pnas.88.21.9618; Habib R, 1993, Adv Nephrol Necker Hosp, V22, P43; HUFF V, 1995, AM J HUM GENET, V56, P84; Huff V, 1996, MED PEDIATR ONCOL, V27, P408, DOI 10.1002/(SICI)1096-911X(199611)27:5<408::AID-MPO4>3.0.CO;2-Q; JADRESIC L, 1990, J PEDIATR-US, V117, P717, DOI 10.1016/S0022-3476(05)83327-X; Jeanpierre C, 1998, NUCLEIC ACIDS RES, V26, P271, DOI 10.1093/nar/26.1.271; JINNO Y, 1994, NAT GENET, V6, P305, DOI 10.1038/ng0394-305; Kaplinsky C, 1996, GENOMICS, V38, P451, DOI 10.1006/geno.1996.0655; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; LARSSON SH, 1995, CELL, V81, P391, DOI 10.1016/0092-8674(95)90392-5; Little M, 1997, HUM MUTAT, V9, P209, DOI 10.1002/(SICI)1098-1004(1997)9:3<209::AID-HUMU2>3.0.CO;2-2; LITTLE M, 1995, HUM MOL GENET, V4, P351, DOI 10.1093/hmg/4.3.351; LITTLE MH, 1992, P NATL ACAD SCI USA, V89, P4791, DOI 10.1073/pnas.89.11.4791; Mitsuya K, 1997, HUM MOL GENET, V6, P2243, DOI 10.1093/hmg/6.13.2243; MOFFETT P, 1995, P NATL ACAD SCI USA, V92, P11105, DOI 10.1073/pnas.92.24.11105; NORDENSKJOLD A, 1995, HUM GENET, V96, P102, DOI 10.1007/BF00214195; NORDENSKJOLD A, 1995, INT J CANCER, V63, P516, DOI 10.1002/ijc.2910630410; OGAWA O, 1993, HUM MOL GENET, V2, P203, DOI 10.1093/hmg/2.2.203; PELLETIER J, 1991, NATURE, V353, P431, DOI 10.1038/353431a0; PRITCHARDJONES K, 1990, NATURE, V346, P194, DOI 10.1038/346194a0; Renshaw J, 1997, GENE CHROMOSOME CANC, V19, P256, DOI 10.1002/(SICI)1098-2264(199708)19:4<256::AID-GCC8>3.0.CO;2-W; RUPPRECHT HD, 1994, J BIOL CHEM, V269, P6198; SCHMITT K, 1995, EUR J PEDIATR, V154, P577, DOI 10.1007/s004310050346; Schumacher V, 1997, P NATL ACAD SCI USA, V94, P3972, DOI 10.1073/pnas.94.8.3972; TADOKORO K, 1993, HUM MOL GENET, V2, P2205, DOI 10.1093/hmg/2.12.2205; WANG ZY, 1995, ONCOGENE, V10, P415; WANG ZY, 1993, J BIOL CHEM, V268, P9172; WANG ZY, 1992, J BIOL CHEM, V267, P21999	42	182	194	0	3	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1998	62	4					824	833		10.1086/301806	http://dx.doi.org/10.1086/301806			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZM197	9529364	Bronze, Green Published			2022-12-18	WOS:000073514400013
J	Bolduc, V; Marlow, G; Boycott, KM; Saleki, K; Inoue, H; Kroon, J; Itakura, M; Robitaille, Y; Parent, L; Baas, F; Mizuta, K; Kamata, N; Richard, I; Linssen, WHJP; Mahjneh, I; de Visser, M; Bashir, R; Brais, B				Bolduc, Veronique; Marlow, Gareth; Boycott, Kym M.; Saleki, Khalil; Inoue, Hiroshi; Kroon, Johan; Itakura, Mitsuo; Robitaille, Yves; Parent, Lucie; Baas, Frank; Mizuta, Kuniko; Kamata, Nobuyuki; Richard, Isabelle; Linssen, Wim H. J. P.; Mahjneh, Ibrahim; de Visser, Marianne; Bashir, Rumaisa; Brais, Bernard			Recessive Mutations in the Putative Calcium-Activated Chloride Channel Anoctamin 5 Cause Proximal LGMD2L and Distal MMD3 Muscular Dystrophies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEFECTIVE MEMBRANE REPAIR; TRANSMEMBRANE PROTEIN; MIYOSHI MYOPATHY; DYSFERLIN; GENE; TMEM16A; EXPRESSION; MANAGEMENT; COMPLEX; CLONING	The recently described human anion channel Anoctamin (ANO) protein family comprises at least ten members, many of which have been shown to correspond to calcium-activated chloride channels. To date, the only reported human mutations in this family of genes are dominant mutations in ANO5 (TMEM16E, GDD1) in the rare skeletal disorder gnathodiaphyseal dysplasia. We have identified recessive Mutations in ANO5 that result in a proximal limb-girdle Muscular dystrophy (LGMD2L) in three French Canadian families and in a distal non-dysferlin Miyoshi myopathy (MMD3) in Dutch and Finnish families. These mutations consist of a splice site, one base pair duplication shared by French Canadian and Dutch cases, and two missense mutations. The splice site and the duplication mutations introduce premature-termination codons and consequently trigger nonsense-mediated mRNA decay, suggesting an underlining loss-of-function mechanism. The LGMD2L phenotype is characterized by proximal weakness, with prominent asymmetrical quadriceps femoris and biceps brachii atrophy. The MMD3 phenotype is associated with distal weakness, of calf muscles in particular. With the use of electron microscopy, multifocal sarcolemmal lesions were observed in both phenotypes. The phenotypic heterogeneity associated with ANO5 mutations is reminiscent of that observed with Dysferlin (DYSF) mutations that can cause both LGMD2B and Miyoshi myopathy (MMD1). In one MMD3-affected individual, defective membrane repair was documented on fibroblasts by membrane-resealing ability assays, as observed in dysferlinopathies. Though the function of the ANO5 protein is still unknown, its Putative calcium-activated chloride channel function may lead to important insights into the role of deficient skeletal muscle membrane repair in muscular dystrophies.	[Bolduc, Veronique; Brais, Bernard] Univ Montreal, Ctr Hosp, Ctr Rech, Lab Neurogenet Motricite, Montreal, PQ H2L 4M1, Canada; [Marlow, Gareth; Saleki, Khalil; Kroon, Johan; Bashir, Rumaisa] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England; [Boycott, Kym M.] Childrens Hosp Eastern Ontario, Dept Genet, Ottawa, ON K1H 8L1, Canada; [Inoue, Hiroshi; Itakura, Mitsuo] Univ Tokushima, Inst Genome Res, Tokushima 7708503, Japan; [Robitaille, Yves] CHU St Justine, Montreal, PQ H3T 1C5, Canada; [Parent, Lucie] Univ Montreal, Grp Etud Prot Membranaires, Dept Physiol, Montreal, PQ H3C 3J7, Canada; [Baas, Frank] Acad Med Ctr, Dept Neurogenet, NL-1005 AZ Amsterdam, Netherlands; [de Visser, Marianne] Acad Med Ctr, Dept Neurol, NL-1005 AZ Amsterdam, Netherlands; [Mizuta, Kuniko; Kamata, Nobuyuki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Oral & Maxillofacial Surg, Div Cervicognathostomatol, Hiroshima 7348553, Japan; [Richard, Isabelle] CNRS, UMR8587, LAMBE, F-91000 Evry, France; [Linssen, Wim H. J. P.] Sint Lucas Andreas Hosp, Dept Neurol, NL-1061 AE Amsterdam, Netherlands; [Mahjneh, Ibrahim] Univ Oulu, Dept Neurol, Oulu 90029, Finland; [Mahjneh, Ibrahim] MHSO Hosp, Pietarsaari 68601, Finland	Universite de Montreal; Durham University; University of Ottawa; Children's Hospital of Eastern Ontario; Tokushima University; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Hiroshima University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; CEA; CY Cergy Paris Universite; Sint Lucas Andreas Hospital; University of Oulu	Brais, B (corresponding author), Univ Montreal, Ctr Hosp, Ctr Rech, Lab Neurogenet Motricite, Montreal, PQ H2L 4M1, Canada.	bernard.brais@umontreal.ca	Baas, Frank/F-9574-2010; Richard, isabelle/J-8298-2013; Kroon, Johan Theodorus Maria/S-8415-2019; Brais, Bernard/Y-3910-2019; Bolduc, Veronique/AAO-9523-2021	Baas, Frank/0000-0003-3912-5428; Kroon, Johan Theodorus Maria/0000-0003-2086-6074; Mahjneh, Ibrahim/0000-0002-0752-9949; Marlow, Gareth/0000-0002-7608-9086	Muscular Dystrophy Association of United States [MDA 4001, MDA131863]; Muscular Dystrophy Campaign (UK); Jain Foundation; Canadian Institutes of Health Research (CIHR)	Muscular Dystrophy Association of United States(Muscular Dystrophy Association); Muscular Dystrophy Campaign (UK)(Muscular Dystrophy Association); Jain Foundation; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	We are grateful to all the patients and their family for their participation in this study. Special thanks to Professor Louise F. Charron for her original referral. We thank Dr. Anna-Kaisa Anttonen (Department of Genetics, University of Helsinki, Finland) for extracting the DNA from the Finnish family and Prof. Anna-Elina Lehesjoki (Folkhalsan Institute of Genetics, University of Helsinki, Finland) who carried mutation testing in controls. We thank Dr. Guy A. Rouleau for providing CEPH controls. We would also like to thank the Sequencing and Genotyping platforms of the McGill University/Genome Quebec Innovation Centre, and the Sequencing Facility at Durham University. Many thanks to the Genome Quebec and Universite de Sherbrooke RNomics Centre who carried out the qPCR for the NMD assays, in particular Philippe Thibault. This study was supported by the Muscular Dystrophy Association of United States (MDA 4001 and MDA131863), Muscular Dystrophy Campaign (UK), and the Jain Foundation. V.B. is a recipient of a Canadian Institutes of Health Research (CIHR) scholarship.	Allikian MJ, 2007, TRAFFIC, V8, P177, DOI 10.1111/j.1600-0854.2006.00519.x; Almaca J, 2009, J BIOL CHEM, V284, P28571, DOI 10.1074/jbc.M109.010074; Ampong Beryl N, 2005, Acta Myol, V24, P134; Andoni UJ, 2008, NEUROL INDIA, V56, P289; Aromataris EC, 2006, CLIN EXP PHARMACOL P, V33, P1118, DOI 10.1111/j.1440-1681.2006.04502.x; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Brogna S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/nsmb.1550; Cai CX, 2009, J BIOL CHEM, V284, P15894, DOI 10.1074/jbc.M109.009589; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Carr IM, 2006, HUM MUTAT, V27, P1041, DOI 10.1002/humu.20383; Cenacchi G, 2005, J CLIN PATHOL, V58, P190, DOI 10.1136/jcp.2004.018978; Cohn RD, 2000, MUSCLE NERVE, V23, P1456, DOI 10.1002/1097-4598(200010)23:10<1456::AID-MUS2>3.3.CO;2-K; Fein A, 2005, J GEN PHYSIOL, V126, P151, DOI 10.1085/jgp.200509294; Galindo BE, 2005, INT J MOL MED, V16, P919; Glover L, 2007, TRAFFIC, V8, P785, DOI 10.1111/j.1600-0854.2007.00573.x; Guglieri M, 2008, CURR OPIN NEUROL, V21, P576, DOI 10.1097/WCO.0b013e32830efdc2; Han R, 2007, CURR OPIN CELL BIOL, V19, P409, DOI 10.1016/j.ceb.2007.07.001; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Hartzell HC, 2009, J PHYSIOL-LONDON, V587, P2127, DOI 10.1113/jphysiol.2008.163709; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hernandez-Deviez DJ, 2008, J BIOL CHEM, V283, P6476, DOI 10.1074/jbc.M708776200; Huang YC, 2007, FASEB J, V21, P732, DOI 10.1096/fj.06-6628com; Jaiswal JK, 2007, TRAFFIC, V8, P77, DOI 10.1111/j.1600-0854.2006.00505.x; Jarry J, 2007, BRAIN, V130, P368, DOI 10.1093/brain/awl270; Klinge L, 2007, FASEB J, V21, P1768, DOI 10.1096/fj.06-7659com; Kourie JI, 1996, AM J PHYSIOL-CELL PH, V270, pC1675, DOI 10.1152/ajpcell.1996.270.6.C1675; Lennon NJ, 2003, J BIOL CHEM, V278, P50466, DOI 10.1074/jbc.M307247200; Linssen WHJP, 1998, NEUROMUSCULAR DISORD, V8, P317, DOI 10.1016/S0960-8966(98)00020-0; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Malicdan MCV, 2008, NEUROL INDIA, V56, P314; McNeil AK, 2006, J BIOL CHEM, V281, P35202, DOI 10.1074/jbc.M606406200; McNeil PL, 2005, NAT REV MOL CELL BIO, V6, P499, DOI 10.1038/nrm1665; Mizuta K, 2007, BIOCHEM BIOPH RES CO, V357, P126, DOI 10.1016/j.bbrc.2007.03.108; Norwood F, 2007, EUR J NEUROL, V14, P1305, DOI 10.1111/j.1468-1331.2007.01979.x; Ousingsawat J, 2009, J BIOL CHEM, V284, P28698, DOI 10.1074/jbc.M109.012120; Rock JR, 2008, DEV DYNAM, V237, P2566, DOI 10.1002/dvdy.21676; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Selcen D, 2001, NEUROLOGY, V56, P1472, DOI 10.1212/WNL.56.11.1472; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Stohr H, 2009, J NEUROSCI, V29, P6809, DOI 10.1523/JNEUROSCI.5546-08.2009; Tsutsumi S, 2005, BIOCHEM BIOPH RES CO, V331, P1099, DOI 10.1016/j.bbrc.2005.03.226; Tsutsumi S, 2004, AM J HUM GENET, V74, P1255, DOI 10.1086/421527; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313	46	181	188	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 12	2010	86	2					213	221		10.1016/j.ajhg.2009.12.013	http://dx.doi.org/10.1016/j.ajhg.2009.12.013			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	556ZS	20096397	Green Published, Bronze			2022-12-18	WOS:000274637200010
J	Tosic, M; Ott, J; Barral, S; Bovet, P; Deppen, P; Gheorghita, F; Matthey, ML; Parnas, J; Preisig, M; Saraga, M; Solida, A; Timm, S; Wang, AG; Werge, T; Cuenod, M; Do, KQ				Tosic, Mirjana; Ott, Jurg; Barral, Sandra; Bovet, Pierre; Deppen, Patricia; Gheorghita, Fulvia; Matthey, Marie-Louise; Parnas, Josef; Preisig, Martin; Saraga, Michael; Solida, Alessandra; Timm, Sally; Wang, August G.; Werge, Thomas; Cuenod, Michel; Do, Kim Quang			Schizophrenia and oxidative stress: Glutamate cysteine ligase modifier as a susceptibility gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOPAMINE UPTAKE INHIBITION; GLUTATHIONE DEFICIT; CEREBROSPINAL-FLUID; PREFRONTAL CORTEX; SUBUNIT GENE; POLYMORPHISM; RELEVANCE; MODEL; NEURONS; RATS	Oxidative stress could be involved in the pathophysiology of schizophrenia, a major psychiatric disorder. Glutathione (GSH), a redox regulator, is decreased in patients' cerebrospinal fluid and prefrontal cortex. The gene of the key GSH-synthesizing enzyme, glutamate cysteine ligase modifier (GCLM) subunit, is strongly associated with schizophrenia in two case-control studies and in one family study. GCLM gene expression is decreased in patients' fibroblasts. Thus, GSH metabolism dysfunction is proposed as one of the vulnerability factors for schizophrenia.	Univ Lausanne Hosp, Ctr Psychiat Neurosci, Lausanne, Switzerland; Univ Lausanne Hosp, Dept Psychiat, Lausanne, Switzerland; Univ Copenhagen, Hvidovre Hosp, Dept Psychiat, DK-2650 Hvidovre, Denmark; Rockefeller Univ, Lab State Genet, New York, NY 10021 USA; Frederiksberg Univ Hosp, Dept Psychiat, Frederiksberg, Denmark; Univ Copenhagen, Dept Psychiat, HS Amager Hosp, Copenhagen, Denmark; S Sct Hans Hosp, Roskilde, Denmark	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Copenhagen; Rockefeller University; University of Copenhagen	Tosic, M (corresponding author), Univ Lausanne, CHU Vaudois, Ctr Psychiat Neurosci, CH-1008 Lausanne, Switzerland.	Mirjana.Tosic@chuv.ch	Saraga, Michael/AAN-5803-2020; Werge, Thomas/G-7263-2012; Do, Kim Q./G-6694-2016; Preisig, Martin/H-3441-2016	Saraga, Michael/0000-0003-2836-3770; Do, Kim Q./0000-0003-1968-1646; Wang, August G./0000-0003-4518-0466; Preisig, Martin/0000-0001-5689-4259	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH044292, R37MH044292] Funding Source: NIH RePORTER; NIMH NIH HHS [MH44292, R37 MH044292, R01 MH044292] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Altar CA, 2005, BIOL PSYCHIAT, V58, P85, DOI 10.1016/j.biopsych.2005.03.031; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; Arinami T, 2005, AM J HUM GENET, V77, P937, DOI 10.1086/498122; Cabungcal JH, 2006, NEUROBIOL DIS, V22, P624, DOI 10.1016/j.nbd.2006.01.003; Cabungcal JH, 2004, SCHIZOPHR RES, V67, P118; Castagne V, 2004, NEUROSCIENCE, V123, P821, DOI 10.1016/j.neuroscience.2003.11.012; Castagne V, 2004, NEUROBIOL DIS, V15, P93, DOI 10.1016/j.nbd.2003.09.005; Chen Y, 2005, J BIOL CHEM, V280, P33766, DOI 10.1074/jbc.M504604200; Choi YB, 2000, CELL MOL LIFE SCI, V57, P1535, DOI 10.1007/PL00000638; Coyle JT, 2004, INT REV NEUROBIOL, V59, P491; Do KQ, 2000, EUR J NEUROSCI, V12, P3721, DOI 10.1046/j.1460-9568.2000.00229.x; DO KQ, 1995, J NEUROCHEM, V65, P2652, DOI 10.1046/j.1471-4159.1995.65062652.x; Grima G, 2003, SCHIZOPHR RES, V62, P213, DOI 10.1016/S0920-9964(02)00405-X; GYSIN R, 2005, 36 ANN M SOC NEUR NO; Harada S, 2001, BIOCHEM BIOPH RES CO, V281, P267, DOI 10.1006/bbrc.2001.4347; Harrison PJ, 2003, LANCET, V361, P417, DOI 10.1016/S0140-6736(03)12379-3; Herken H, 2001, MOL PSYCHIATR, V6, P66, DOI 10.1038/sj.mp.4000789; HUANG CS, 1993, J BIOL CHEM, V268, P19675; HUANG CS, 1993, J BIOL CHEM, V268, P20578; KOHR G, 1994, NEURON, V12, P1031, DOI 10.1016/0896-6273(94)90311-5; Kolluri N, 2005, AM J PSYCHIAT, V162, P1200, DOI 10.1176/appi.ajp.162.6.1200; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Mahadik SP, 1996, SCHIZOPHR RES, V19, P1, DOI 10.1016/0920-9964(95)00049-6; Marchbanks RM, 2003, SCHIZOPHR RES, V65, P33, DOI 10.1016/S0920-9964(03)00011-2; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Nakamura S, 2002, CIRCULATION, V105, P2968, DOI 10.1161/01.CIR.0000019739.66514.1E; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; Olney JW, 1999, J PSYCHIAT RES, V33, P523, DOI 10.1016/S0022-3956(99)00029-1; Pae CU, 2004, PSYCHIAT GENET, V14, P147, DOI 10.1097/00041444-200409000-00005; Pae CU, 2003, PROG NEURO-PSYCHOPH, V27, P519, DOI 10.1016/S0278-5846(03)00043-5; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; Pulver AE, 2000, MOL PSYCHIATR, V5, P650, DOI 10.1038/sj.mp.4000814; Rabinovic AD, 1998, J NEUROCHEM, V71, P2071; Rodi CP, 2002, BIOTECHNIQUES, P62; Shinkai T, 2004, PSYCHIAT GENET, V14, P177, DOI 10.1097/00041444-200409000-00012; Steullet P, 2006, NEUROSCIENCE, V137, P807, DOI 10.1016/j.neuroscience.2005.10.014; Tsuang M, 2000, BIOL PSYCHIAT, V47, P210, DOI 10.1016/S0006-3223(99)00289-9; Tsuchiya K, 1995, GENOMICS, V30, P630, DOI 10.1006/geno.1995.1293; Yang Y, 2002, J BIOL CHEM, V277, P49446, DOI 10.1074/jbc.M209372200; Yao JK, 2006, DIS MARKERS, V22, P83, DOI 10.1155/2006/248387	41	181	189	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2006	79	3					586	592		10.1086/507566	http://dx.doi.org/10.1086/507566			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	074RY	16909399	Bronze, Green Published			2022-12-18	WOS:000239830700023
J	Johnston, JJ; Olivos-Glander, I; Killoran, C; Elson, E; Turner, JT; Peters, KF; Abbott, MH; Aughton, DJ; Aylsworth, AS; Bamshad, MJ; Booth, C; Curry, CJ; David, A; Dinulos, MB; Flannery, DB; Fox, MA; Graham, JM; Grange, DK; Guttmacher, AE; Hannibal, MC; Henn, W; Hennekam, RCM; Holmes, LB; Hoyme, HE; Leppig, KA; Lin, AE; MacLeod, P; Manchester, DK; Marcelis, C; Mazzanti, L; McCann, E; McDonald, MT; Mendelsohn, NJ; Moeschler, JB; Moghaddam, B; Neri, G; Newbury-Ecob, R; Pagon, RA; Phillips, JA; Sadler, LS; Stoler, JM; Tilstra, D; Vockley, CMW; Zackai, EH; Zadeh, TM; Brueton, L; Black, GCM; Biesecker, LG				Johnston, JJ; Olivos-Glander, I; Killoran, C; Elson, E; Turner, JT; Peters, KF; Abbott, MH; Aughton, DJ; Aylsworth, AS; Bamshad, MJ; Booth, C; Curry, CJ; David, A; Dinulos, MB; Flannery, DB; Fox, MA; Graham, JM; Grange, DK; Guttmacher, AE; Hannibal, MC; Henn, W; Hennekam, RCM; Holmes, LB; Hoyme, HE; Leppig, KA; Lin, AE; MacLeod, P; Manchester, DK; Marcelis, C; Mazzanti, L; McCann, E; McDonald, MT; Mendelsohn, NJ; Moeschler, JB; Moghaddam, B; Neri, G; Newbury-Ecob, R; Pagon, RA; Phillips, JA; Sadler, LS; Stoler, JM; Tilstra, D; Vockley, CMW; Zackai, EH; Zadeh, TM; Brueton, L; Black, GCM; Biesecker, LG			Molecular and clinical analyses of Greig cephalopolysyndactyly and Pallister-Hall syndromes: Robust phenotype prediction from the type and position of GLI3 mutations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTERSTITIAL DELETION; HYPOTHALAMIC HAMARTOMA; ACROCALLOSAL SYNDROME; POINT MUTATIONS; FAMILIES; DISEASE; MICRODELETION; DELINEATION; ANOMALIES; SPECTRUM	Mutations in the GLI3 zinc-finger transcription factor gene cause Greig cephalopolysyndactyly syndrome (GCPS) and Pallister-Hall syndrome (PHS), which are variable but distinct clinical entities. We hypothesized that GLI3 mutations that predict a truncated functional repressor protein cause PHS and that functional haploinsufficiency of GLI3 causes GCPS. To test these hypotheses, we screened patients with PHS and GCPS for GLI3 mutations. The patient group consisted of 135 individuals: 89 patients with GCPS and 46 patients with PHS. We detected 47 pathological mutations ( among 60 probands); when these were combined with previously published mutations, two genotype- phenotype correlations were evident. First, GCPS was caused by many types of alterations, including translocations, large deletions, exonic deletions and duplications, small in-frame deletions, and missense, frameshift/ nonsense, and splicing mutations. In contrast, PHS was caused only by frameshift/ nonsense and splicing mutations. Second, among the frameshift/ nonsense mutations, there was a clear genotype- phenotype correlation. Mutations in the first third of the gene ( from open reading frame [ORF] nucleotides [nt] 1 - 1997) caused GCPS, and mutations in the second third of the gene ( from ORF nt 1998 - 3481) caused primarily PHS. Surprisingly, there were 12 mutations in patients with GCPS in the 3' third of the gene ( after ORF nt 3481), and no patients with PHS had mutations in this region. These results demonstrate a robust correlation of genotype and phenotype for GLI3 mutations and strongly support the hypothesis that these two allelic disorders have distinct modes of pathogenesis.	NHGRI, NIH, Bethesda, MD 20892 USA; Cent Manchester Univ Hosp, Natl Hlth Serv Trust, St Marys Hosp, Dept Clin Genet, Manchester, Lancs, England; Manchester Childrens Univ Hosp, Natl Hlth Serv Trust, St Marys Hosp, Dept Clin Genet, Manchester, Lancs, England; Penn State Univ, Ctr Dev & Hlth Genet, University Pk, PA 16802 USA; Penn State Univ, Dept Biobehav Hlth, University Pk, PA 16802 USA; Baltimore Huntington Dis Ctr, Dept Psychiat, Baltimore, MD USA; William Beaumont Hosp, Dept Pediat, Div Genet, Royal Oak, MI 48072 USA; Univ N Carolina, Dept Pediat, Chapel Hill, NC USA; Univ N Carolina, Dept Genet, Chapel Hill, NC USA; Univ Utah, Hlth Sci Ctr, Eccles Inst Human Genet, Salt Lake City, UT USA; Lutheran Gen Hosp, Park Ridge, IL 60068 USA; Univ Calif, Fresno, CA USA; Ctr Hosp Univ, Serv Genet, Nantes, France; Dartmouth Coll, Childrens Hosp, Div Genet & Child Dev, Lebanon, NH 03756 USA; Dartmouth Hitchcock Med Ctr, Dept Pediat, Lebanon, NH 03766 USA; Med Coll Georgia, Dept Pediat, Augusta, GA 30912 USA; Univ Calif Los Angeles, David Geffen Sch Med, Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA USA; St Louis Childrens Hosp, Dept Pediat, Div Med Genet, St Louis, MO 63110 USA; Univ Washington, Childrens Hosp Reg Med Ctr, Div Genet & Dev Med, Seattle, WA 98195 USA; Univ Washington, Childrens Hosp Reg Med Ctr, Dept Pediat, Seattle, WA 98195 USA; Grp Hlth Cooperat Puget Sound, Genet Serv, Seattle, WA 98121 USA; Univ Saarland, Inst Humangenet, Homburg, Germany; Univ Amsterdam, Childrens Acad Med Ctr, Div Emma Childrens Hosp, Amsterdam, Netherlands; Massachusetts Gen Hosp, Genet & Teratol Unit, Boston, MA 02114 USA; Stanford Univ, Sch Med, Dept Pediat, Div Med Genet, Stanford, CA 94305 USA; Natl Birth Defects Ctr, Waltham, MA USA; Victoria Gen Hosp, Med Genet Sect, Victoria, BC, Canada; Childrens Hosp, Denver, CO 80218 USA; Univ Med Ctr Nijmegen, Dept Clin Genet, Nijmegen, Netherlands; SantOrsola Malpighi Hosp, Dept Pediat, Bologna, Italy; Royal Liverpool Childrens Hosp, Dept Clin Genet, Liverpool L7 7DG, Merseyside, England; Duke Univ, Med Ctr, Div Med Genet, Durham, NC USA; Childrens Hosp & Clin, Minneapolis, MN USA; Univ Oklahoma, Schusterman Ctr, HA Chapman Inst, Tulsa, OK USA; Univ Cattolica, Inst Med Genet, Rome, Italy; St Michaels Hosp, Dept Clin Genet, Bristol, Avon, England; Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; Childrens Hosp, Dept Pediat, Div Genet, Buffalo, NY 14222 USA; CentraCare Clin, Dept Pediat, St Cloud, MN USA; Mayo Fdn, Dept Med Genet, Rochester, MN USA; Childrens Hosp Philadelphia, Div Human Genet & Mol Biol, Philadelphia, PA 19104 USA; Genet Ctr, Orange, CA USA; Kennedy Galton Ctr, Dept Clin Genet, London, England	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Manchester; University of Manchester; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Beaumont Health; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Utah System of Higher Education; University of Utah; Nantes Universite; CHU de Nantes; Dartmouth College; Dartmouth College; University System of Georgia; Augusta University; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; St. Louis Children's Hospital; Washington University (WUSTL); Seattle Children's Hospital; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Group Health Cooperative; Saarland University; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Harvard University; Massachusetts General Hospital; Stanford University; University of Victoria; Children's Hospital Colorado; Radboud University Nijmegen; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; Duke University; Children's Hospitals & Clinics of Minnesota; University of Oklahoma System; University of Oklahoma - Tulsa; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Vanderbilt University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Mayo Clinic; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Johnston, JJ (corresponding author), NHGRI, NIH, Bldg 49 Room 4B75,MSC4472,9000 Rockville Pike, Bethesda, MD 20892 USA.	jjohnsto@mail.nih.gov	Henn, Wolfram/AAU-1608-2020; Graham, John M./J-1429-2019; Flannery, David/O-6719-2019; Marcelis, C.L.M./L-4504-2015; Biesecker, Leslie/AAG-2526-2021; Black, Graeme/K-7374-2015	Marcelis, C.L.M./0000-0001-7095-4641; Black, Graeme/0000-0001-8727-6592; Hannibal, Mark/0000-0002-9077-3837; Hoyme, Harold/0000-0002-1979-693X; mazzanti, laura/0000-0002-7670-6494; Clement, Emma/0000-0002-5562-6276	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG200328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008243] Funding Source: NIH RePORTER; NICHD NIH HHS [HD22657-11, P01 HD022657] Funding Source: Medline; NIGMS NIH HHS [GM08243, T32 GM008243] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altaba ARI, 1999, DEVELOPMENT, V126, P3205; BARAITSER M, 1983, CLIN GENET, V24, P257; BIANCHI DW, 1981, CLIN GENET, V19, P456; Biesecker LG, 1996, AM J MED GENET, V65, P76, DOI 10.1002/(SICI)1096-8628(19961002)65:1<76::AID-AJMG12>3.0.CO;2-O; Biesecker LG, 1997, NAT GENET, V17, P259, DOI 10.1038/ng1197-259; BIESECKER LG, 2004, GENEREVIEWS GENETEST; BIESECKER LG, 2003, GENEREVIEWS GENETEST; Bose J, 2002, HUM MOL GENET, V11, P1129, DOI 10.1093/hmg/11.9.1129; Debeer P, 2003, AM J MED GENET A, V120A, P49, DOI 10.1002/ajmg.a.20018; Driess S, 2003, Hum Genet, V112, P103; Elson E, 2002, J MED GENET, V39, P804, DOI 10.1136/jmg.39.11.804; Freese K, 2003, Hum Genet, V112, P103; FRIEZ MJ, 2000, P GREENWOOD GENET CT, V19, P51; Galasso C, 2001, AM J MED GENET, V99, P128, DOI 10.1002/1096-8628(2001)9999:9999<::AID-AJMG1128>3.0.CO;2-S; Gorlin RJ, 2001, SYNDROMES HEAD NECK, P995; Haynes JH, 2003, J PEDIATR SURG, V38, P1411, DOI 10.1016/S0022-3468(03)00411-1; Iacobazzi V, 2001, CYTOGENET CELL GENET, V93, P40, DOI 10.1159/000056945; Johnston JJ, 2003, AM J MED GENET A, V123A, P236, DOI 10.1002/ajmg.a.20318; Jones K. L., 1997, SMITHS RECOGNIZABLE; Kalff-Suske M, 2004, Hum Genet, V114, P403; Kalff-Suske M, 1999, HUM MOL GENET, V8, P1769, DOI 10.1093/hmg/8.9.1769; KALFFSUSKE M, 2000, HUM GENET, V107, P203; KALFFSUSKE M, 2000, HUM GENET, V107, P204; Kang S, 1997, NAT GENET, V15, P266, DOI 10.1038/ng0397-266; Kang SM, 1997, J MED GENET, V34, P441, DOI 10.1136/jmg.34.6.441; Killoran CE, 2000, CLIN GENET, V58, P28, DOI 10.1034/j.1399-0004.2000.580105.x; Kremer S, 2003, EPILEPTIC DISORD, V5, P27; Kroisel PM, 2001, AM J MED GENET, V102, P243, DOI 10.1002/ajmg.1443; LOW M, 1995, CLIN GENET, V48, P209; MARKS K, 1985, J MED GENET, V22, P316, DOI 10.1136/jmg.22.4.316; Ng D, 2004, AM J MED GENET A, V124A, P296, DOI 10.1002/ajmg.a.20338; Ondrey F, 2000, AM J MED GENET, V94, P64, DOI 10.1002/1096-8628(20000904)94:1<64::AID-AJMG13>3.0.CO;2-D; PELZ L, 1986, HELV PAEDIATR ACTA, V41, P381; PETTIGREW AL, 1991, HUM GENET, V87, P452; Radhakrishna U, 1999, AM J HUM GENET, V65, P645, DOI 10.1086/302557; Radhakrishna U, 1997, NAT GENET, V17, P269, DOI 10.1038/ng1197-269; RIDLER MAC, 1977, CLIN GENET, V12, P213; RUPPERT JM, 1990, MOL CELL BIOL, V10, P5408, DOI 10.1128/MCB.10.10.5408; Stevenson RE, 1993, HUMAN MALFORMATIONS, V2; Stroh B, 1999, INT J PEDIATR OTORHI, V47, P81, DOI 10.1016/S0165-5876(98)00165-7; TOMMERUP N, 1983, AM J MED GENET, V16, P313, DOI 10.1002/ajmg.1320160304; Turner C, 2003, HUM GENET, V112, P303, DOI 10.1007/s00439-002-0892-2; VERLOES A, 1995, J MED GENET, V32, P605, DOI 10.1136/jmg.32.8.605; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; WAGNER K, 1990, GENOMICS, V8, P487, DOI 10.1016/0888-7543(90)90035-S; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wild A, 1997, HUM MOL GENET, V6, P1979, DOI 10.1093/hmg/6.11.1979; Williams PG, 1997, CLIN GENET, V52, P436; Zucchini S, 1998, J PEDIATR ENDOCR MET, V11, P35	49	181	188	0	10	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2005	76	4					609	622		10.1086/429346	http://dx.doi.org/10.1086/429346			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	904RS	15739154	Bronze, Green Published			2022-12-18	WOS:000227516000007
J	De Raedt, T; Brems, H; Wolkenstein, P; Vidaud, D; Pilotti, S; Perrone, F; Mautner, V; Frahm, S; Sciot, R; Legius, E				De Raedt, T; Brems, H; Wolkenstein, P; Vidaud, D; Pilotti, S; Perrone, F; Mautner, V; Frahm, S; Sciot, R; Legius, E			Elevated risk for MPNST in NF1 microdeletion patients	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NERVE SHEATH TUMORS; NEUROFIBROMATOSIS TYPE-1; GENE DELETIONS; PHENOTYPE	An NF1 microdeletion is the single most commonly reported mutation in individuals with neurofibromatosis type 1 (NF1). Individuals with an NF1 microdeletion have, as a group, more neurofibromas at a younger age than the group of all individuals with NF1. We report that NF1 microdeletion individuals additionally have a substantially higher lifetime risk for the development of malignant peripheral nerve sheath tumors than individuals with NF1 who do not have an NF1 microdeletion. This should be taken into account in the medical follow-up of individuals with an NF1 microdeletion.	Catholic Univ Louvain, Dept Human Genet, B-3000 Louvain, Belgium; Catholic Univ Louvain, Dept Pathol, B-3000 Louvain, Belgium; Hop Henri Mondor, Dept Dermatol, F-94010 Creteil, France; Genet Mol Lab, Upres, France; Ist Nazl Studio & Cura Tumori, Dept Pathol, Unit Expt Mol Pathol, I-20133 Milan, Italy; Klinikum Nord, Dept Neurol, Hamburg, Germany; Univ Hamburg, Hosp Eppendorf, Dept Neurosurg, Lab Brain Tumor Biol, D-20246 Hamburg, Germany	Universite Catholique Louvain; Universite Catholique Louvain; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Fondazione IRCCS Istituto Nazionale Tumori Milan; Klinikum Nurnberg Nord; University of Hamburg	Legius, E (corresponding author), Catholic Univ Louvain, Dept Human Genet, Herestr 49, B-3000 Louvain, Belgium.	Eric.Legius@med.kuleuven.ac.be	Brems, Hilde/AAN-4075-2020; Legius, Eric/H-1735-2011; De Raedt, Thomas/AAC-3172-2021; VIDAUD, Dominique/O-7357-2017; Perrone, Federica/S-6171-2016	Perrone, Federica/0000-0003-4406-8245; De Raedt, Thomas/0000-0002-7492-851X; sciot, raf/0000-0003-2244-5839				[Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; Birindelli S, 2001, LAB INVEST, V81, P833, DOI 10.1038/labinvest.3780293; Clementi M, 1996, ANN GENET-PARIS, V39, P92; Cnossen MH, 1997, HUM MUTAT, V9, P458, DOI 10.1002/(SICI)1098-1004(1997)9:5<458::AID-HUMU13>3.0.CO;2-1; Correa CL, 2000, AM J HUM GENET, V66, P1969, DOI 10.1086/302920; Correa CL, 1999, HUM MUTAT, V14, P387, DOI 10.1002/(SICI)1098-1004(199911)14:5<387::AID-HUMU4>3.0.CO;2-4; Dorschner MO, 2000, HUM MOL GENET, V9, P35, DOI 10.1093/hmg/9.1.35; Evans DGR, 2002, J MED GENET, V39, P311, DOI 10.1136/jmg.39.5.311; GREAGER JA, 1992, AM J SURG, V163, P440, DOI 10.1016/0002-9610(92)90050-2; Huson SHR, 1994, NEUROFIBROMATOSES PA; HUSON SM, 1989, J MED GENET, V26, P704, DOI 10.1136/jmg.26.11.704; KAYES LM, 1994, AM J HUM GENET, V54, P424; Leppig KA, 1997, AM J MED GENET, V73, P197, DOI 10.1002/(SICI)1096-8628(1997)73:2<197::AID-AJMG17>3.0.CO;2-P; Leroy K, 2001, ARCH DERMATOL, V137, P908; Lopez-Correa C, 2001, HUM MOL GENET, V10, P1387, DOI 10.1093/hmg/10.13.1387; Rasmussen SA, 1998, J MED GENET, V35, P468, DOI 10.1136/jmg.35.6.468; Tonsgard JH, 1997, AM J MED GENET, V73, P80, DOI 10.1002/(SICI)1096-8628(19971128)73:1<80::AID-AJMG16>3.0.CO;2-N; WU BL, 1995, AM J MED GENET, V59, P528, DOI 10.1002/ajmg.1320590427; Wu BL, 1997, AM J MED GENET, V69, P98, DOI 10.1002/(SICI)1096-8628(19970303)69:1<98::AID-AJMG19>3.0.CO;2-J; Wu RN, 1999, GENE CHROMOSOME CANC, V26, P376, DOI 10.1002/(SICI)1098-2264(199912)26:4<376::AID-GCC13>3.3.CO;2-F	20	181	190	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2003	72	5					1288	1292		10.1086/374821	http://dx.doi.org/10.1086/374821			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671PZ	12660952	Green Published, Bronze			2022-12-18	WOS:000182474400021
J	Howell, N; Smejkal, CB; Mackey, DA; Chinnery, PF; Turnbull, DM; Herrnstadt, C				Howell, N; Smejkal, CB; Mackey, DA; Chinnery, PF; Turnbull, DM; Herrnstadt, C			The pedigree rate of sequence divergence in the human mitochondrial genome: There is a difference between phylogenetic and pedigree rates	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY OPTIC NEUROPATHY; MTDNA CONTROL REGION; DEEP-ROOTING PEDIGREES; SUBSTITUTION RATE; MUTATION-RATE; NUCLEOTIDE SUBSTITUTION; Y-CHROMOSOME; HOT-SPOTS; DNA; HETEROPLASMY	We have extended our previous analysis of the pedigree rate of control-region divergence in the human mitochondrial genome. One new germline mutation in the mitochondrial DNA (mtDNA) control region was detected among 185 transmission events (generations) from five Leber hereditary optic neuropathy (LHON) pedigrees. Pooling the LHON pedigree analyses yields a control-region divergence rate of 1.0 mutation/bp/10(6) years (Myr). When the results from eight published studies that used a similar approach were pooled with the LHON pedigree studies, totaling >2,600 transmission events, a pedigree divergence rate of 0.95 mutations/bp/Myr for the control region was obtained with a 99.5% confidence interval of 0.53-1.57. Taken together, the cumulative results support the original conclusion that the pedigree divergence rate for the control region is similar to10-fold higher than that obtained with phylogenetic analyses. There is no evidence that any one factor explains this discrepancy, and the possible roles of mutational hotspots (rate heterogeneity), selection, and random genetic drift and the limitations of phylogenetic approaches to deal with high levels of homoplasy are discussed. In addition, we have extended our pedigree analysis of divergence in the mtDNA coding region. Finally, divergence of complete mtDNA sequences was analyzed in two tissues, white blood cells and skeletal muscle, from each of 17 individuals. In three of these individuals, there were four instances in which an mtDNA mutation was found in one tissue but not in the other. These results are discussed in terms of the occurrence of somatic mtDNA mutations.	MitoKor, San Diego, CA 92121 USA; Univ Texas, Med Branch, Dept Radiat Oncol, Galveston, TX 77550 USA; Univ Texas, Med Branch, Dept Human Biol Chem & Genet, Galveston, TX 77550 USA; Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic 3002, Australia; Newcastle Univ, Dept Neurol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; Newcastle University - UK	Howell, N (corresponding author), MitoKor, 11494 Sorrento Valley Rd, San Diego, CA 92121 USA.	howelln@mitokor.com	Mackey, David A/H-5340-2014	Mackey, David A/0000-0001-7914-4709; Chinnery, Patrick/0000-0002-7065-6617				Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 2001, ANN HUM GENET, V65, P549, DOI 10.1017/S0003480001008892; Bendall KE, 1996, AM J HUM GENET, V59, P1276; Cavelier L, 2000, HUM GENET, V107, P45, DOI 10.1007/s004390050009; Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X; Denver DR, 2000, SCIENCE, V289, P2342, DOI 10.1126/science.289.5488.2342; DONNELLY P, 1991, STAT SCI, V6, P277; Excoffier L, 1999, MOL BIOL EVOL, V16, P1357, DOI 10.1093/oxfordjournals.molbev.a026046; Gerber AS, 2001, ANNU REV GENET, V35, P539, DOI 10.1146/annurev.genet.35.102401.091106; HASEGAWA M, 1993, J MOL EVOL, V37, P347, DOI 10.1007/BF00178865; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Herrnstadt C, 2002, MUTAT RES-FUND MOL M, V501, P19, DOI 10.1016/S0027-5107(01)00304-9; HEYER E, 1995, AM J HUM GENET, V56, P1450; Heyer E, 1997, HUM MOL GENET, V6, P799, DOI 10.1093/hmg/6.5.799; Heyer E, 2001, AM J HUM GENET, V69, P1113, DOI 10.1086/324024; Howell N, 1997, AM J HUM GENET, V61, P986; Howell N, 1998, AM J HUM GENET, V62, P196, DOI 10.1086/301675; Howell N, 2000, AM J HUM GENET, V66, P1589, DOI 10.1086/302910; Howell N, 1996, AM J HUM GENET, V59, P501; HOWELL N, 1995, GENETICS, V140, P285; HOWELL N, 1991, AM J HUM GENET, V48, P935; Howell N, 1998, AM J HUM GENET, V63, P1220, DOI 10.1086/302049; HOWELL N, 1994, AM J HUM GENET, V55, P203; Howell N, 2000, Hum Reprod, V15 Suppl 2, P235; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; JANSEN RPS, 2000, HUM REPROD S2, V15; Jazin E, 1998, NAT GENET, V18, P109, DOI 10.1038/ng0298-109; Kayser M, 2000, AM J HUM GENET, V66, P1580, DOI 10.1086/302905; Lambert DM, 2002, SCIENCE, V295, P2270, DOI 10.1126/science.1068105; Macaulay VA, 1997, AM J HUM GENET, V61, P983; MACKEY DA, 1992, AUST NZ J OPHTHALMOL, V20, P177, DOI 10.1111/j.1442-9071.1992.tb00937.x; Meyer S, 1999, GENETICS, V152, P1103; Mumm S, 1997, AM J HUM GENET, V60, P153; Paabo S, 1996, AM J HUM GENET, V59, P493; Parsons TJ, 1997, NAT GENET, V15, P363, DOI 10.1038/ng0497-363; Parsons TJ, 1998, NAT GENET, V18, P110; Rand DM, 2001, ANNU REV ECOL SYST, V32, P415, DOI 10.1146/annurev.ecolsys.32.081501.114109; Rannala B, 2001, HUM MUTAT, V18, P87, DOI 10.1002/humu.1158; Relethford JH, 2001, P NATL ACAD SCI USA, V98, P390, DOI 10.1073/pnas.98.2.390; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Siguroardottir S, 2000, AM J HUM GENET, V66, P1599, DOI 10.1086/302902; Soodyall H, 1997, AM J PHYS ANTHROPOL, V104, P157, DOI 10.1002/(SICI)1096-8644(199710)104:2<157::AID-AJPA2>3.0.CO;2-W; STONEKING M, 1992, PHILOS T ROY SOC B, V337, P167, DOI 10.1098/rstb.1992.0094; Tamura K, 2000, GENE, V259, P189, DOI 10.1016/S0378-1119(00)00443-1; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; Tully LA, 2000, AM J HUM GENET, V67, P432, DOI 10.1086/302996; WALLACE DC, 1970, BRAIN, V93, P121, DOI 10.1093/brain/93.1.121; Zavolan M, 2001, CURR OPIN GENET DEV, V11, P612, DOI 10.1016/S0959-437X(00)00242-2	50	181	184	0	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2003	72	3					659	670		10.1086/368264	http://dx.doi.org/10.1086/368264			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	648LJ	12571803	Green Published, Bronze			2022-12-18	WOS:000181152600015
J	Rosenberg, N; Murata, M; Ikeda, Y; Opare-Sem, O; Zivelin, A; Geffen, E; Seligsohn, U				Rosenberg, N; Murata, M; Ikeda, Y; Opare-Sem, O; Zivelin, A; Geffen, E; Seligsohn, U			The frequent 5,10-methylenetetrahydrofolate reductase C677T polymorphism is associated with a common haplotype in whites, Japanese, and Africans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							THERMOLABILE METHYLENETETRAHYDROFOLATE REDUCTASE; RISK FACTOR; FOLATE-DEFICIENCY; VASCULAR-DISEASE; MUTATION; GENE; HYPERHOMOCYSTEINEMIA; METAANALYSIS; DISORDERS; PREGNANCY	The common 5,10-methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism causes decreased activity of this enzyme and can be associated with mild-to-moderate hyperhomocysteinemia in homozygotes, particularly when there is folic acid deficiency, as well as with vascular dementia, arterial thrombosis, venous thrombosis, neural-tube defects, and fetal loss. When folic acid intake is sufficient, homozygotes for MTHFR 677T appear to be protected against colon cancer and acute lymphatic leukemia, and fetuses bearing this genotype have an augmented survival. The distribution of MTHFR 677T is worldwide, but its frequency in different populations varies extensively. In the present study, we addressed the question of whether the MTHFR 677T alteration has an ancestral origin or has occurred repeatedly. We analyzed the frequency distribution of the previously described polymorphism A1298C in exon 7 and of three intronic dimorphisms, in white Israelis (Jews and Arabs), Japanese, and Ghanaian Africans. The 677T allele was, remarkably, associated with one haplotype, G-T-A-C, in white and Japanese homozygotes. Among the Africans, analysis of maximum likelihood also disclosed an association with the G-T-A-C haplotype, although none of the 174 subjects examined was homozygous for MTHFR 677T. These results suggest that the MTHFR 677T alteration occurred on a founder haplotype that may have had a selective advantage.	Chaim Sheba Med Ctr, Inst Thrombosis & Hemostasis, IL-52621 Tel Hashomer, Israel; Keio Univ, Sch Med, Tokyo, Japan; Univ Sci & Technol, Sch Med Sci, Kumasi, Ghana; Tel Aviv Univ, Fac Life Sci, Inst Nat Conservat Res, IL-69978 Tel Aviv, Israel	Chaim Sheba Medical Center; Keio University; Kwame Nkrumah University Science & Technology; Tel Aviv University	Seligsohn, U (corresponding author), Chaim Sheba Med Ctr, Inst Thrombosis & Hemostasis, IL-52621 Tel Hashomer, Israel.							Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290, DOI 10.1073/pnas.94.7.3290; Botto LD, 2000, AM J EPIDEMIOL, V151, P862; Brattstrom L, 1998, CIRCULATION, V98, P2520, DOI 10.1161/01.CIR.98.23.2520; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Gemmati D, 1999, ARTERIOSCL THROM VAS, V19, P1761, DOI 10.1161/01.ATV.19.7.1761; Goyette P, 1998, MAMM GENOME, V9, P652, DOI 10.1007/s003359900838; GOYETTE P, 1994, NAT GENET, V7, P195, DOI 10.1038/ng0694-195; Gris JC, 1999, THROMB HAEMOSTASIS, V81, P891; Hegele RA, 1997, LANCET, V349, P1221, DOI 10.1016/S0140-6736(05)62414-2; Isotalo PA, 2000, AM J HUM GENET, V67, P986, DOI 10.1086/303082; LANGMAN LJ, 2002, INABIS 98 5 INT WORL; Ma J, 1997, CANCER RES, V57, P1098; Munoz-Moran E, 1998, LANCET, V352, P1120, DOI 10.1016/S0140-6736(05)79761-0; Nelen WLDM, 1997, LANCET, V350, P861, DOI 10.1016/S0140-6736(97)24038-9; Pepe G, 1998, AM J HUM GENET, V63, P917, DOI 10.1086/302015; Rosenblatt DS, 1999, SEMIN HEMATOL, V36, P19; Rosenblatt DS, 2001, METABOLIC MOL BASES, P3897; Seligsohn U, 1997, THROMB HAEMOSTASIS, V78, P297; Skibola CF, 1999, P NATL ACAD SCI USA, V96, P12810, DOI 10.1073/pnas.96.22.12810; Sonoda A, 2000, STROKE, V31, P493, DOI 10.1161/01.STR.31.2.493; vanderPut NMJ, 1997, QJM-MON J ASSOC PHYS, V90, P111, DOI 10.1093/qjmed/90.2.111; Weisberg I, 1998, MOL GENET METAB, V64, P169, DOI 10.1006/mgme.1998.2714; Wiemels JL, 2001, P NATL ACAD SCI USA, V98, P4004, DOI 10.1073/pnas.061408298; WOUTERS MGAJ, 1993, FERTIL STERIL, V60, P820; Yoo JH, 2000, ARTERIOSCL THROM VAS, V20, P1921, DOI 10.1161/01.ATV.20.8.1921	26	181	195	0	12	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2002	70	3					758	762		10.1086/338932	http://dx.doi.org/10.1086/338932			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	522DG	11781870	Bronze, Green Published			2022-12-18	WOS:000173880000018
J	Zhou, XP; Woodford-Richens, K; Lehtonen, R; Kurose, K; Aldred, M; Hampel, H; Launonen, V; Virta, S; Pilarski, R; Salovaara, R; Bodmer, WF; Conrad, BA; Dunlop, M; Hodgson, SV; Iwama, T; Jarvinen, H; Kellokumpu, I; Kim, JC; Leggett, B; Markie, D; Mecklin, JP; Neale, K; Phillips, R; Piris, J; Rozen, P; Houlston, RS; Aaltonen, LA; Tomlinson, IPM; Eng, C				Zhou, XP; Woodford-Richens, K; Lehtonen, R; Kurose, K; Aldred, M; Hampel, H; Launonen, V; Virta, S; Pilarski, R; Salovaara, R; Bodmer, WF; Conrad, BA; Dunlop, M; Hodgson, SV; Iwama, T; Jarvinen, H; Kellokumpu, I; Kim, JC; Leggett, B; Markie, D; Mecklin, JP; Neale, K; Phillips, R; Piris, J; Rozen, P; Houlston, RS; Aaltonen, LA; Tomlinson, IPM; Eng, C			Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PEUTZ-JEGHERS-SYNDROME; PTEN MUTATION; ZONANA-SYNDROME; GENE; DISEASE; DELETION; SPECTRUM; 10Q22-23; CANCER; KINASE	Juvenile polyposis syndrome (JPS) is an inherited hamartomatous-polyposis syndrome with a risk for colon cancer. JPS is a clinical diagnosis by exclusion, and, before susceptibility genes were identified, JPS could easily be confused with other inherited hamartoma syndromes, such as Bannayan-Riley-Ruvalcaba syndrome (BRRS) and Cowden syndrome (CS). Germline mutations of MADH4 (SMAD4) have been described in a variable number of probands with JPS. A series of familial and isolated European probands without MADH4 mutations were analyzed for germline mutations in BMPR1A, a member of the transforming growth-factor beta -receptor superfamily, upstream from the SMAD pathway. Overall, 10 (38%) probands were found to have germline BMPR1A mutations, 8 of which resulted in truncated receptors and 2 of which resulted in missense alterations (C124R and C376Y). Almost all available component tumors from mutation-positive cases showed loss of heterozygosity (LOH) in the BMPR1A region, whereas those from mutation-negative cases did not. One proband with CS/CS-like phenotype was also found to have a germline BMPR1A missense mutation (A338D). Thus, germline BMPR1A mutations cause a significant proportion of cases of JPS and might define a small subset of cases of CS/BRRS with specific colonic phenotype.	Ohio State Univ, Human Canc Genet Program, Ctr Comprehens Canc, Columbus, OH 43210 USA; Ohio State Univ, Clin Canc Genet Program, Ctr Comprehens Canc, Columbus, OH 43210 USA; Ohio State Univ, Dept Internal Med, Div Human Genet, Columbus, OH 43210 USA; Imperial Canc Res Fund, Mol & Populat Genet Lab, London, England; Guys Hosp, United Med Sch, Dept Med Genet, London, England; Guys Hosp, United Dent Sch, Dept Med Genet, London, England; St Thomas Hosp, United Dent Sch, Dept Med Genet, London, England; St Thomas Hosp, United Med Sch, Dept Med Genet, London, England; Univ Helsinki, Dept Pathol, FIN-00014 Helsinki, Finland; Univ Helsinki, Dept Med Genet, Haartman Inst, FIN-00014 Helsinki, Finland; Helsinki Univ Cent Hosp, Dept Surg 2, Helsinki, Finland; Univ Oxford, Inst Mol Med, Imperial Canc Res Fund, Immunogenet Lab, Oxford OX1 2JD, England; John Radcliffe Hosp, Dept Pathol, Oxford OX3 9DU, England; United Hosp, St Paul, MN USA; Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Ctr Polyposis & Intestinal Dis, Tokyo, Japan; Jyvaskyla Cent Hosp, Dept Surg, Jyvaskyla, Finland; Univ Ulsan, Coll Med, Dept Pediat, Seoul, South Korea; Asan Inst, Seoul, South Korea; Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld 4029, Australia; Dunedin Sch Med, Dept Pathol, Genet Mol Lab, Dunedin, New Zealand; St Marks Hosp, Polyposis Registry, Harrow, Middx, England; Tel Aviv Univ, Dept Gastroenterol, IL-69978 Tel Aviv, Israel; Inst Canc Res, Sect Canc Genet, Surrey, England; Univ Cambridge, Canc Res Campaign, Human Canc Genet Res Grp, Cambridge CB2 1TN, England	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Cancer Research UK; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Oxford; University of Oxford; University of Edinburgh; Central Finland Central Hospital; University of Ulsan; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; University of Otago; Imperial College London; Tel Aviv University; University of London; Institute of Cancer Research - UK; CRUK Cambridge Institute; University of Cambridge	Eng, C (corresponding author), Ohio State Univ, Human Canc Genet Program, Ctr Comprehens Canc, 420 W 12th Ave,Suite 690 TMRF, Columbus, OH 43210 USA.	eng-1@medctr.osu.edu	Pilarski, Robert/X-3256-2019; Dunlop, Malcolm G/F-1973-2011; Aaltonen, Lauri/A-5375-2010; Markie, David/I-7893-2019; Pilarski, Robert/E-3871-2011; Leggett, Barbara A/D-3579-2011; Mecklin, Jukka-Pekka/AAB-5378-2020; Mecklin, Jukka-Pekka/AAC-9650-2019	Dunlop, Malcolm G/0000-0002-3033-5851; Aaltonen, Lauri/0000-0001-6839-4286; Mecklin, Jukka-Pekka/0000-0003-4895-2249; Bodmer, Walter/0000-0001-6244-9792; Markie, David/0000-0001-5452-9194; Lehtonen, Rainer Juhani/0000-0002-8343-0318; Eng, Charis/0000-0002-3693-5145; Houlston, Richard/0000-0002-5268-0242; Leggett, Barbara/0000-0003-2062-7380	NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA016058, P30CA16058] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bevan S, 1999, GUT, V45, P406, DOI 10.1136/gut.45.3.406; Boardman LA, 1998, ANN INTERN MED, V128, P896, DOI 10.7326/0003-4819-128-11-199806010-00004; Dahia PM, 2000, J MED GENET, V37, P715, DOI 10.1136/jmg.37.9.715; Eng C, 1998, AM J HUM GENET, V62, P1020, DOI 10.1086/301847; Eng C, 2001, NAT GENET, V28, P105, DOI 10.1038/88802; Eng C, 2001, ANNU REV MED, V52, P371, DOI 10.1146/annurev.med.52.1.371; Eng C, 2000, J MED GENET, V37, P828, DOI 10.1136/jmg.37.11.828; ENG C, 2001, METABOLIC MOL BASES, V1, P979; Friedl W, 1999, GENE CHROMOSOME CANC, V25, P403, DOI 10.1002/(SICI)1098-2264(199908)25:4<403::AID-GCC15>3.0.CO;2-P; GORLIN RJ, 1992, AM J MED GENET, V44, P307, DOI 10.1002/ajmg.1320440309; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Houlston R, 1998, HUM MOL GENET, V7, P1907, DOI 10.1093/hmg/7.12.1907; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; Howe JR, 2001, NAT GENET, V28, P184, DOI 10.1038/88919; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Kinzler KW, 1998, SCIENCE, V280, P1036, DOI 10.1126/science.280.5366.1036; Kirsch T, 2000, NAT STRUCT BIOL, V7, P492; Kurose K, 1999, AM J HUM GENET, V64, P308, DOI 10.1086/302207; Marsh DJ, 1998, J MED GENET, V35, P881, DOI 10.1136/jmg.35.11.881; Marsh DJ, 1997, CANCER RES, V57, P5017; Marsh DJ, 1998, GENE CHROMOSOME CANC, V21, P61, DOI 10.1002/(SICI)1098-2264(199801)21:1<61::AID-GCC8>3.0.CO;2-6; Marsh DJ, 1998, HUM MOL GENET, V7, P507, DOI 10.1093/hmg/7.3.507; Marsh DJ, 1997, NAT GENET, V16, P333, DOI 10.1038/ng0897-333; Marsh DJ, 1999, HUM MOL GENET, V8, P1461, DOI 10.1093/hmg/8.8.1461; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; MATHEW CGP, 1987, NATURE, V328, P527, DOI 10.1038/328527a0; Mutter GL, 2000, JNCI-J NATL CANCER I, V92, P924, DOI 10.1093/jnci/92.11.924; Nelen MR, 1996, NAT GENET, V13, P114, DOI 10.1038/ng0596-114; Olschwang S, 1998, NAT GENET, V18, P12, DOI 10.1038/ng0198-12; Roth S, 1999, GENE CHROMOSOME CANC, V26, P54, DOI 10.1002/(SICI)1098-2264(199909)26:1<54::AID-GCC8>3.0.CO;2-D; Tsuchiya KD, 1998, GENE CHROMOSOME CANC, V21, P113, DOI 10.1002/(SICI)1098-2264(199802)21:2<113::AID-GCC6>3.0.CO;2-3; Weber HC, 1998, GASTROENTEROLOGY, V114, pA702, DOI 10.1016/S0016-5085(98)82880-1; Woodford-Richens K, 2000, GUT, V46, P656, DOI 10.1136/gut.46.5.656; Woodford-Richens K, 2000, CANCER RES, V60, P2477; WOODFORDRICHENS KL, IN PRESS AM J PATHOL	35	181	192	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2001	69	4					704	711		10.1086/323703	http://dx.doi.org/10.1086/323703			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	472WP	11536076	Green Published, Bronze			2022-12-18	WOS:000171008200004
J	Karafet, T; Xu, LP; Du, RF; Wang, W; Feng, S; Wells, RS; Redd, AJ; Zegura, SL; Hammer, MF				Karafet, T; Xu, LP; Du, RF; Wang, W; Feng, S; Wells, RS; Redd, AJ; Zegura, SL; Hammer, MF			Paternal population history of east Asia: Sources, patterns, and microevolutionary processes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CLADISTIC-ANALYSIS; SEQUENCE VARIATION; HAPLOTYPES; EVOLUTIONARY; AFRICA; DIFFERENTIATION; FREQUENCIES; LANGUAGES; DISTANCE; ORIGINS	Asia has served as a focal point for human migration during much of the Late Pleistocene and Holocene. Clarification of East Asia's role as a source and/or transit point for human dispersals requires that this region's own settlement history be understood. To this end, we examined variation at 52 polymorphic sites on the nonrecombining portion of the Y chromosome (NRY) in 1,383 unrelated males, representing 25 populations from southern East Asia (SEAS), northern East Asia (NEAS), and central Asia (CAS). The polymorphisms defined 45 global haplogroups, 28 of which were present in these three regions. Although heterozygosity levels were similar in all three regions, the average pairwise difference among haplogroups was noticeably smaller in SEAS. Multidimensional scaling analysis indicated a general separation of SEAS versus NEAS and CAS populations, and analysis of molecular variance produced very different values of ST in NEAS and SEAS populations. In spatial autocorrelation analyses, the overall correlogram exhibited a clinal pattern; however, the NEAS populations showed evidence of both isolation by distance and ancient clines, whereas there was no evidence of structure in SEAS populations. Nested cladistic analysis demonstrated that population history events and ongoing demographic processes both contributed to the contrasting patterns of NRY variation in NEAS and SEAS. We conclude that the peopling of East Asia was more complex than earlier models had proposedthat is, a multilayered, multidirectional, and multidisciplinary framework is necessary. For instance, in addition to the previously recognized genetic and dental dispersal signals from SEAS to NEAS populations, CAS has made a significant contribution to the contemporary gene pool of NEAS, and the Sino-Tibetan expansion has left traces of a genetic trail from northern to southern China.	Univ Arizona, Lab Mol Systematics, Tucson, AZ USA; Univ Arizona, Dept Anthropol, Tucson, AZ USA; Inst Cytol & Genet, Lab Human Mol & Evolut Genet, Novosibirsk, Russia; Chinese Acad Sci, Inst Genet, Beijing, Peoples R China; City Univ Hong Kong, Dept Elect Engn, Kowloon, Peoples R China; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX1 2JD, England	University of Arizona; University of Arizona; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Chinese Academy of Sciences; City University of Hong Kong; University of Oxford; Wellcome Centre for Human Genetics	Hammer, MF (corresponding author), Univ Arizona, Lab Mol Systematics, Tucson, AZ USA.	mhammer@u.arizona.edu	Wang, Wen/AAP-9873-2020	Wang, William S-Y./0000-0001-6153-8240	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053566, R29GM053566] Funding Source: NIH RePORTER; NIGMS NIH HHS [R29 GM053566, GM-53566-06, R01 GM053566] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ammermann A.J., 1984, NEOLITHIC TRANSITION; BARBUJANI G, 1994, AM J PHYS ANTHROPOL, V95, P137, DOI 10.1002/ajpa.1330950203; Barbujani G, 2000, HUM BIOL, V72, P133; BARBUJANI G, 1993, P NATL ACAD SCI USA, V90, P4670, DOI 10.1073/pnas.90.10.4670; BARBUJANI G, 1991, AM J HUM GENET, V48, P398; BARBUJANI G, 1995, AM J PHYS ANTHROPOL, V96, P109, DOI 10.1002/ajpa.1330960202; BERTORELLE G, 1995, GENETICS, V140, P811; CAVALLISFORZA LL, 1992, P NATL ACAD SCI USA, V89, P5620, DOI 10.1073/pnas.89.12.5620; CAVALLISFORZA LL, 1994, HIST GEOGRAPHY HUM; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; de Ceuninck ID, 2000, EUR J HUM GENET, V8, P750, DOI 10.1038/sj.ejhg.5200519; Ding YC, 2000, P NATL ACAD SCI USA, V97, P14003, DOI 10.1073/pnas.240441297; Endler J.A., 1977, Monographs in Population Biology, pi; EXCOFFIER L, 1991, HUM BIOL, V63, P273; FIX AG, 1999, MIGRATION COLONIZAT; GAMBLE C, 1993, TIMEWALKERS PREHIST; Hammer MF, 2000, P NATL ACAD SCI USA, V97, P6769, DOI 10.1073/pnas.100115997; Hammer MF, 1998, MOL BIOL EVOL, V15, P427, DOI 10.1093/oxfordjournals.molbev.a025939; Hammer MF, 2001, MOL BIOL EVOL, V18, P1189, DOI 10.1093/oxfordjournals.molbev.a003906; Hammer Michael F., 1996, Evolutionary Anthropology, V5, P116, DOI 10.1002/(SICI)1520-6505(1996)5:4<116::AID-EVAN2>3.0.CO;2-E; JORDE LB, 1980, GENETIC STRUCTURE, P135; Karafet TM, 1999, AM J HUM GENET, V64, P817, DOI 10.1086/302282; KIMURA M, 1964, GENETICS, V49, P561; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Kuzmin YV, 1998, J WORLD PREHIST, V12, P1, DOI 10.1023/A:1022431307503; Lahr MM, 1998, YEARB PHYS ANTHROPOL, V41, P137; MANTEL N, 1967, CANCER RES, V27, P209; MATSUMOTO H, 1988, HUM GENET, V80, P207, DOI 10.1007/BF01790088; MORTON NE, 1973, GENET STRUCTURE POP; NEI M, 1993, MOL BIOL EVOL, V10, P927; NEI M, 1987, MOL EVOL GENET; Poloni ES, 1997, AM J HUM GENET, V61, P1015, DOI 10.1086/301602; Przeworski M, 2000, TRENDS GENET, V16, P296, DOI 10.1016/S0168-9525(00)02030-8; Qian YP, 2000, HUM GENET, V106, P453, DOI 10.1007/s004390000259; Renfrew C, 1991, CAMB ARCHAEOL J, V1, P3, DOI DOI 10.1017/S0959774300000238; Rohlf F.J., 1998, NTSYS PC NUMERICAL T; Rousset F, 1997, GENETICS, V145, P1219; RUHLEN M, 1992, SFI S SCI C, V11, P159; SCHNEIDER S, 1998, ARLEQUIN SOFTWARE; Shen PD, 2000, P NATL ACAD SCI USA, V97, P7354, DOI 10.1073/pnas.97.13.7354; SLATKIN M, 1990, GENETICS, V126, P249; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; SOKAL RR, 1989, AM J PHYS ANTHROPOL, V80, P267, DOI 10.1002/ajpa.1330800302; SOKAL RR, 1978, BIOL J LINN SOC, V10, P229, DOI 10.1111/j.1095-8312.1978.tb00014.x; SOLKAL RR, 1979, ECOL PARAMETERS INFE, P167; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Su B, 2000, HUM GENET, V107, P582, DOI 10.1007/s004390000406; Sugimoto C, 1997, P NATL ACAD SCI USA, V94, P9191, DOI 10.1073/pnas.94.17.9191; TEMPLETON AR, 1995, GENETICS, V140, P767; TEMPLETON AR, 1993, GENETICS, V134, P659; Templeton AR, 1998, AM ANTHROPOL, V100, P632, DOI 10.1525/aa.1998.100.3.632; TURNER CG, 1990, AM J PHYS ANTHROPOL, V82, P295, DOI 10.1002/ajpa.1330820308; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Wright S, 1943, GENETICS, V28, P114; Yermanos, 1968, MATH HEREDITY; ZEGURA SL, 1995, J QUANTIT ANTHR, V5, P171; ZHAO T, 1989, HUM GENET, V83, P101, DOI 10.1007/BF00286699	57	181	201	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2001	69	3					615	+		10.1086/323299	http://dx.doi.org/10.1086/323299			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	459VD	11481588	Bronze, Green Published			2022-12-18	WOS:000170271400013
J	Guichard, C; Harricane, MC; Lafitte, JJ; Godard, P; Zaegel, M; Tack, V; Lalau, G; Bouvagnet, P				Guichard, C; Harricane, MC; Lafitte, JJ; Godard, P; Zaegel, M; Tack, V; Lalau, G; Bouvagnet, P			Axonemal dynein intermediate-chain gene (DNAI1) mutations result in situs inversus and primary ciliary dyskinesia (Kartagener syndrome)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LEFT-RIGHT ASYMMETRY; OF-FUNCTION MUTATIONS; MICE; MOUSE; INV; ABNORMALITIES; LATERALITY; DEFECTS; TESTIS; FLOW	Kartagener syndrome (KS) is a trilogy of symptoms (nasal polyps, bronchiectasis, and situs inversus totalis) that is associated with ultrastructural anomalies of cilia of epithelial cells covering the upper and lower respiratory tracts and spermatozoa flagellae. The axonemal dynein intermediate-chain gene 1 (DNAI1), which has been demonstrated to be responsible for a case of primary ciliary dyskinesia (PCD) without situs inversus, was screened for mutation in a series of 34 patients with KS. We identified compound heterozygous DNAI1 gene defects in three independent patients and in two of their siblings who presented with PCD and situs solitus (i.e., normal position of inner organs). Strikingly, these five patients share one mutant allele (splice defect), which is identical to one of the mutant DNAI1 alleles found in the patient with PCD, reported elsewhere. Finally, this study demonstrates a link between ciliary function and situs determination, since compound mutation heterozygosity in DNAI1 results in PCD with situs solitus or situs inversus (KS).	Univ Lyon 1, Fac Med Pharm, Lab Genet Mol Humaine, Equipe Accueil 3088, F-69373 Lyon 8, France; Hop Cardiol, Lyon, France; Ctr Rech Biochim Macromol, CNRS, UPR 1086, Montpellier, France; Univ Montpellier I, Montpellier, France; Hop A Villeneuve, Serv Malad Resp, Montpellier, France; Hop Albert Calmette, Biochim Lab, Lille, France; Hop Albert Calmette, Dept Pneumol, Lille, France; Ctr Hosp, Calais, France; Hop Fontenoy, Serv Pneumol, Chartres, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille	Bouvagnet, P (corresponding author), Univ Lyon 1, Fac Med Pharm, Lab Genet Mol Humaine, Equipe Accueil 3088, 8 Ave Rockefeller, F-69373 Lyon 8, France.	pbouv@rockefeller.univ-lyon1.fr						Afzelius B A, 2000, Acta Otorhinolaryngol Belg, V54, P287; Afzelius BA, 1999, INT J DEV BIOL, V43, P283; Bamford RN, 2000, NAT GENET, V26, P365, DOI 10.1038/81695; Blair DF, 1992, CURR OPIN GENET DEV, V2, P756, DOI 10.1016/S0959-437X(05)80136-4; Blouin JL, 2000, EUR J HUM GENET, V8, P109, DOI 10.1038/sj.ejhg.5200429; Brody SL, 2000, AM J RESP CELL MOL, V23, P45, DOI 10.1165/ajrcmb.23.1.4070; BRYAN JHD, 1977, CELL TISSUE RES, V180, P187, DOI 10.1007/BF00231951; Chapelin C, 1997, FEBS LETT, V412, P325, DOI 10.1016/S0014-5793(97)00800-4; Chen JC, 1998, J CLIN INVEST, V102, P1077, DOI 10.1172/JCI4786; Gebbia M, 1997, NAT GENET, V17, P305, DOI 10.1038/ng1197-305; Jorissen M, 2000, Acta Otorhinolaryngol Belg, V54, P357; Jorissen M, 2000, Acta Otorhinolaryngol Belg, V54, P343; Kartagener M., 1933, BEITR KLIN ERFORSCH, V83, P489, DOI DOI 10.1007/BF02141468; Kosaki K, 1999, AM J HUM GENET, V64, P712, DOI 10.1086/302289; Kosaki R, 1999, AM J MED GENET, V82, P70, DOI 10.1002/(SICI)1096-8628(19990101)82:1<70::AID-AJMG14>3.0.CO;2-Y; Maiti AK, 2000, CYTOGENET CELL GENET, V90, P119, DOI 10.1159/000015645; Maiti AK, 2000, EUR J HUM GENET, V8, P923, DOI 10.1038/sj.ejhg.5200555; Milisav I, 1996, MAMM GENOME, V7, P667, DOI 10.1007/s003359900202; Mochizuki T, 1998, NATURE, V395, P177, DOI 10.1038/26006; Morgan D, 1998, NAT GENET, V20, P149, DOI 10.1038/2450; Neesen J, 1997, GENE, V200, P193, DOI 10.1016/S0378-1119(97)00417-4; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Noone PG, 1999, AM J MED GENET, V82, P155, DOI 10.1002/(SICI)1096-8628(19990115)82:2<155::AID-AJMG11>3.0.CO;2-T; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; Pennarun G, 1999, AM J HUM GENET, V65, P1508, DOI 10.1086/302683; Porter ME, 1996, CURR OPIN CELL BIOL, V8, P10, DOI 10.1016/S0955-0674(96)80042-1; Shingyoji C, 1998, NATURE, V393, P711, DOI 10.1038/31520; Siewert A.K., 1904, BERLIN KLIN WOCHEN S, V41, P139; Supp DM, 1999, DEVELOPMENT, V126, P5495; Supp DM, 1997, NATURE, V389, P963, DOI 10.1038/40140; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; VALLEE R, 1993, P NATL ACAD SCI USA, V90, P8769, DOI 10.1073/pnas.90.19.8769; Vaughan KT, 1996, GENOMICS, V36, P29, DOI 10.1006/geno.1996.0422; WAITE DA, 1981, CHEST, V80, P896, DOI 10.1378/chest.80.6.896; WITMAN G B, 1992, Current Opinion in Cell Biology, V4, P74	35	181	192	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2001	68	4					1030	1035		10.1086/319511	http://dx.doi.org/10.1086/319511			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	414KQ	11231901	Bronze, Green Published			2022-12-18	WOS:000167666000022
J	Roberts, SA; Spreadborough, AR; Bulman, B; Barber, JBP; Evans, DGR; Scott, D				Roberts, SA; Spreadborough, AR; Bulman, B; Barber, JBP; Evans, DGR; Scott, D			Heritability of cellular radiosensitivity: A marker of low-penetrance predisposition genes in breast cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA-REPAIR PROFICIENCY; ATAXIA-TELANGIECTASIA; UNIFIED MODEL; MUTATIONS; FAMILIES; LOCUS	Many inherited: cancer-prone conditions show an elevated sensitivity to the induction of chromosome damage in cells exposed to ionizing radiation, indicative-of defects in the processing of DNA damage. We earlier found that 40% of patients with breast cancer and 5%-10% of controls showed evidence of enhanced chromosomal radiosensitivity-and that this sensitivity was not age related. We suggested that this could be a marker of cancer-predisposing genes of low penetrance. To further test this hypothesis, we have studied the heritability of radiosensitivity in families of patients with breast cancer. Of 37 first-degree relatives of 16 sensitive patients, 23 (62%) were themselves sensitive, compared with 1 (7%) of 15 first-degree relatives of four patients with normal responses. The distribution of radiosensitivities among the family members showed a trimodal distribution, suggesting the presence of a limited number of major genes determining radiosensitivity. Segregation analysis of 95 family members showed clear evidence of heritability of radiosensitivity, with a single major gene accounting for 82% of the variance between family members. The two alleles combine in an additive (codominant) manner, giving complete heterozygote expression. A better fit was obtained to a model that includes a second, rarer gene with a similar, additive effect on radiosensitivity, but the data are clearly consistent with a range of models. Novel genes involved in predisposition to breast cancer can now be sought through linkage studies using this quantitative trait.	Christie Hosp NHS Trust, Paterson Inst Canc Res, Canc Res Campaign, Biomath & Comp Unit, Manchester M20 4BX, Lancs, England; Christie Hosp NHS Trust, Paterson Inst Canc Res, Mol Genet Sect, Manchester M20 4BX, Lancs, England	Christie NHS Foundation Trust; Christie Hospital; Paterson Institute for Cancer Research; Christie NHS Foundation Trust; Christie Hospital; Paterson Institute for Cancer Research	Roberts, SA (corresponding author), Christie Hosp NHS Trust, Paterson Inst Canc Res, Canc Res Campaign, Biomath & Comp Unit, Manchester M20 4BX, Lancs, England.	sroberts@picr.man.ac.uk	Evans, D Gareth/AAB-4308-2022	Evans, D Gareth/0000-0002-8482-5784				Athma P, 1996, CANCER GENET CYTOGEN, V92, P130, DOI 10.1016/S0165-4608(96)00328-7; Bernhard EJ, 1998, CANCER RES, V58, P1754; Bishop DT, 1997, NAT GENET, V15, P226, DOI 10.1038/ng0397-226; DEMENAIS F, 1986, AM J HUM GENET, V38, P228; EASTON DF, 1994, INT J RADIAT BIOL, V66, pS177, DOI 10.1080/09553009414552011; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; GOLDGAR DE, 1996, GENETIC PREDISPOSITI; HASSTEDT S, 1981, PAP PEDIGREE ANAL PA; HASSTEDT SJ, 1993, GENET EPIDEMIOL, V10, P145, DOI 10.1002/gepi.1370100302; HELZLSOUER KJ, 1995, INT J CANCER, V64, P14, DOI 10.1002/ijc.2910640105; Helzlsouer KJ, 1996, J NATL CANCER I, V88, P754, DOI 10.1093/jnci/88.11.754; *INT COMM RAD PROT, 1999, ANN ICRP, V28, P1; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; KRONTIRIS TG, 1993, NEW ENGL J MED, V329, P517, DOI 10.1056/NEJM199308193290801; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; MORTON NE, 1974, AM J HUM GENET, V26, P318; Parshad R, 1996, BRIT J CANCER, V74, P1, DOI 10.1038/bjc.1996.307; Patel RK, 1997, INT J CANCER, V73, P20, DOI 10.1002/(SICI)1097-0215(19970926)73:1<20::AID-IJC4>3.0.CO;2-3; Price EA, 1997, SOMAT CELL MOLEC GEN, V23, P237, DOI 10.1007/BF02674415; SCOTT D, 1994, LANCET, V344, P1444, DOI 10.1016/S0140-6736(94)90615-7; Scott D, 1999, INT J RADIAT BIOL, V75, P1, DOI 10.1080/095530099140744; SU LN, 1992, INT J RADIAT BIOL, V62, P201, DOI 10.1080/09553009214552021; SWIFT M, 1987, NEW ENGL J MED, V316, P1289, DOI 10.1056/NEJM198705213162101; TAYLOR AMR, 1975, NATURE, V258, P427, DOI 10.1038/258427a0; TAYLOR AMR, 1983, RAD INDUCED CHROMOSO, P167; TEARE MD, 1994, BRIT J CANCER, V70, P102, DOI 10.1038/bjc.1994.257; THOMPSON EA, 1979, GENETIC ANAL COMMON; Varley JM, 1997, BRIT J CANCER, V76, P1, DOI 10.1038/bjc.1997.328	29	181	183	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1999	65	3					784	794		10.1086/302544	http://dx.doi.org/10.1086/302544			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233KQ	10441587	Bronze, Green Published			2022-12-18	WOS:000082426400025
J	Shih, JC; Thompson, RF				Shih, JC; Thompson, RF			Monoamine oxidase in neuropsychiatry and behavior	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							A-DEFICIENT MICE; AGGRESSIVE-BEHAVIOR; MAO-A; GENETIC ASSOCIATION; STRESS-RESPONSE; MOLECULAR-BASIS; NORRIE DISEASE; B GENES; DISORDER; PROMOTER		Univ So Calif, Dept Mol Pharmacol & Toxicol, Pharmaceut Sci Ctr, Los Angeles, CA 90033 USA; Univ So Calif, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA; Univ So Calif, Program Neurosci, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California	Shih, JC (corresponding author), Univ So Calif, Dept Mol Pharmacol & Toxicol, Pharmaceut Sci Ctr, Room 528, Los Angeles, CA 90033 USA.				NIMH NIH HHS [R01 MH37020, R37 MH39085, K05 MH00795] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH037020, R37MH039085, Z01MH000795] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BACH AWJ, 1988, P NATL ACAD SCI USA, V85, P4934, DOI 10.1073/pnas.85.13.4934; BERGER W, 1992, NAT GENET, V1, P199, DOI 10.1038/ng0692-199; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; BRUNNER HG, 1993, AM J HUM GENET, V52, P1032; Camarena B, 1998, PSYCHIATR GENET, V8, P255, DOI 10.1097/00041444-199808040-00010; Cases O, 1996, NEURON, V16, P297, DOI 10.1016/S0896-6273(00)80048-3; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; Cases O, 1998, J NEUROSCI, V18, P6914; CHEN ZY, 1992, GENOMICS, V14, P75, DOI 10.1016/S0888-7543(05)80286-1; CHEN ZY, 1995, HUM MOL GENET, V4, P1729, DOI 10.1093/hmg/4.suppl_1.1729; Coron B, 1996, PSYCHIAT RES, V62, P221, DOI 10.1016/0165-1781(96)02933-2; CRADDOCK N, 1995, AM J MED GENET, V60, P322, DOI 10.1002/ajmg.1320600412; Deckert J, 1999, HUM MOL GENET, V8, P621, DOI 10.1093/hmg/8.4.621; DEVOR EJ, 1993, AM J MED GENET, V48, P209, DOI 10.1002/ajmg.1320480407; DeVries AC, 1997, J NEUROENDOCRINOL, V9, P363, DOI 10.1046/j.1365-2826.1997.t01-1-00589.x; Fowler JS, 1996, NATURE, V379, P733, DOI 10.1038/379733a0; Fowler JS, 1996, P NATL ACAD SCI USA, V93, P14065, DOI 10.1073/pnas.93.24.14065; Gade R, 1998, MOL PSYCHIATR, V3, P50, DOI 10.1038/sj.mp.4000326; Gogos JA, 1998, P NATL ACAD SCI USA, V95, P9991, DOI 10.1073/pnas.95.17.9991; GRIMSBY J, 1991, P NATL ACAD SCI USA, V88, P3637, DOI 10.1073/pnas.88.9.3637; Grimsby J, 1997, NAT GENET, V17, P206, DOI 10.1038/ng1097-206; HOLSCHNEIDER DP, 1998, PSYCHOPHARMACOLOGY 4; Hsu YPP, 1996, AM J PSYCHIAT, V153, P1209; JOHNSTON JP, 1968, BIOCHEM PHARMACOL, V17, P1285, DOI 10.1016/0006-2952(68)90066-X; Kim JJ, 1997, P NATL ACAD SCI USA, V94, P5929, DOI 10.1073/pnas.94.11.5929; Knoll J, 1972, Adv Biochem Psychopharmacol, V5, P393; Kriegsfeld LJ, 1997, BRAIN RES, V769, P66, DOI 10.1016/S0006-8993(97)00688-4; Ledent C, 1997, NATURE, V388, P674, DOI 10.1038/41771; Lenders JWM, 1996, J CLIN INVEST, V97, P1010, DOI 10.1172/JCI118492; LEYSEN JE, 1988, J PHARMACOL EXP THER, V244, P310; LIM LCC, 1995, AM J MED GENET, V60, P325, DOI 10.1002/ajmg.1320600413; LINNOILA M, 1983, BIOL PSYCHIAT, V18, P513; LU RB, 1999, 1999 WORLD C PSYCH G; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; MICZEK KA, 1994, NEUROSCI BIOBEHAV R, V18, P97, DOI 10.1016/0149-7634(94)90040-X; Muramatsu T, 1997, AM J MED GENET, V74, P494, DOI 10.1002/(SICI)1096-8628(19970919)74:5<494::AID-AJMG7>3.0.CO;2-O; O'Donovan MC, 1999, AM J HUM GENET, V65, P587, DOI 10.1086/302560; Ogawa S, 1996, ANN NY ACAD SCI, V794, P384, DOI 10.1111/j.1749-6632.1996.tb32549.x; Oreland L., 1993, MONOAMINE OXIDASE BA, P219; PARSIAN A, 1995, AM J MED GENET, V60, P409, DOI 10.1002/ajmg.1320600511; Parsian A, 1997, AM J MED GENET, V74, P475, DOI 10.1002/(SICI)1096-8628(19970919)74:5<475::AID-AJMG3>3.0.CO;2-N; Ramboz S, 1996, BEHAV BRAIN RES, V73, P305; Reich T, 1999, AM J HUM GENET, V65, P599, DOI 10.1086/302561; ROTH BL, 1987, J NEUROCHEM, V49, P1833, DOI 10.1111/j.1471-4159.1987.tb02444.x; Sabol SZ, 1998, HUM GENET, V103, P273, DOI 10.1007/s004390050816; SHI Y, 1998, NEUROSCIENCE, V24, P1922; SHIH JC, 1991, NEUROPSYCHOPHARMACOL, V4, P1; Shih JC, 1999, ANNU REV NEUROSCI, V22, P197, DOI 10.1146/annurev.neuro.22.1.197; SHIH JC, IN PRESS BRAIN RES; Simpson GM, 1999, NEUROPSYCHOPHARMACOL, V20, P392, DOI 10.1016/S0893-133X(98)00119-5; SIMS KB, 1989, NEURON, V2, P1069, DOI 10.1016/0896-6273(89)90231-6; Vanyukov MM, 1995, PSYCHIAT RES, V59, P35, DOI 10.1016/0165-1781(95)02719-X; Voncken JW, 1998, INT J MOL MED, V2, P577; Zhu QS, 1997, J NEUROCHEM, V69, P1368; ZHU QS, 1994, J NEUROSCI, V14, P7393; ZHU QS, 1992, J NEUROSCI, V12, P4437	56	181	187	0	16	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1999	65	3					593	598		10.1086/302562	http://dx.doi.org/10.1086/302562			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233KQ	10441564	Green Published, Bronze			2022-12-18	WOS:000082426400002
J	Sarfarazi, M; Child, A; Stoilova, D; Brice, G; Desai, T; Trifan, OC; Poinoosawmy, D; Crick, RP				Sarfarazi, M; Child, A; Stoilova, D; Brice, G; Desai, T; Trifan, OC; Poinoosawmy, D; Crick, RP			Localization of the fourth locus (GLC1E) for adult-onset primary open-angle glaucoma to the 10p15-p14 region	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LASER TOMOGRAPHIC SCANNER; LOW-TENSION GLAUCOMA; OPTIC-NERVE HEAD; HUMAN GENOME; FIELD PROGRESSION; LINKAGE; BUPHTHALMOS; MAPS; DNA	One of the major causes of blindness is primary open-angle glaucoma, which affects millions of elderly people worldwide. Genetic studies have so far mapped three loci for the adult-onset form of this condition to the 2cen-q13, 3q21-q24, and 8q23 regions. Herein, we report the localization of a fourth locus, to the 10p15-p14 region, in one large British family with a classical form of normal-tension open-angle glaucoma. Of the 42 meioses genotyped in this pedigree, 39 subjects(lb affected) inherited a haplotype compatible with their prior clinical designation, whereas the remaining 3 were classified as unknown. Although a maximum LOD score of 10.00 at a recombination fraction of theta = .00 was obtained with D10S1216, 21 other markers provided significant values, varying between 3.77 and 9.70. When only the affected meioses of this kindred were analyzed, LOD scores remained statistically significant, ranging from 3.16 (D10S527) to 3.57 (D10S506). Two critical recombinational events in the affected subjects positioned this new locus to a region of similar to 21 cM, flanked by D10S1729 and D10S1664. However, an additional recombination in a 59-year-old unaffected female suggests that this locus resides between D10S585 (or D10S1172) and D10S1664, within a genetic distance of 5-11 cM. However, the latter minimum region must be taken cautiously, because the incomplete penetrance has previously been documented for this group of eye conditions. A partial list of genes that positionally are considered as candidates includes NET1, PRKCT, ITIH2, IL2RA, IL15RA, IT1H2, hGATA3, the mRNA for open reading frame KIAA0019, and the gene for D123 protein.	Univ Connecticut, Ctr Hlth, Dept Surg, Surg Res Ctr,Mol Ophthalm Genet Lab, Farmington, CT 06030 USA; Univ London St Georges Hosp, Sch Med, Dept Cardiol Sci, London, England; Moorfields Eye Hosp, Glaucoma Unit, London, England; Kings Hosp, Int Glaucoma Assoc, London, England	University of Connecticut; St Georges University London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Sarfarazi, M (corresponding author), Univ Connecticut, Ctr Hlth, Dept Surg, Surg Res Ctr,Mol Ophthalm Genet Lab, 263 Farmington Ave, Farmington, CT 06030 USA.	msarfara@cortex.uchc.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR006192] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY009947] Funding Source: NIH RePORTER; NCRR NIH HHS [M01RR-06192] Funding Source: Medline; NEI NIH HHS [EY-09947] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adam MF, 1997, HUM MOL GENET, V6, P2091, DOI 10.1093/hmg/6.12.2091; ADAMSON D, 1995, AM J HUM GENET, V57, P619; Akarsu AN, 1996, HUM MOL GENET, V5, P1199, DOI 10.1093/hmg/5.8.1199; Avramopoulos D, 1996, J MED GENET, V33, P1043, DOI 10.1136/jmg.33.12.1043; BAEZ KA, 1995, BRIT J OPHTHALMOL, V79, P125, DOI 10.1136/bjo.79.2.125; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; BECHTOILLE A, 1997, PERIMETRY UPDATE 199, P157; BENNETT SR, 1989, AM J OPHTHALMOL, V108, P238, DOI 10.1016/0002-9394(89)90112-8; Crabb D, 1997, PERIMETRY UPDATE 199, P301; CRICK RP, 1974, LANCET, V1, P205; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DREHER AW, 1991, AM J OPHTHALMOL, V111, P221, DOI 10.1016/S0002-9394(14)72263-9; DRYJA TP, 1995, HUM MOL GENET, V4, P1739, DOI 10.1093/hmg/4.suppl_1.1739; FASMAN KH, 1994, NUCLEIC ACIDS RES, V22, P3462, DOI 10.1093/nar/22.17.3462; Fitzke FW, 1996, BRIT J OPHTHALMOL, V80, P40, DOI 10.1136/bjo.80.1.40; FRANCOIS J, 1966, AM J OPHTHALMOL, V61, P652, DOI 10.1016/0002-9394(66)91201-3; GEBHARD W, 1988, FEBS LETT, V229, P63, DOI 10.1016/0014-5793(88)80798-1; GROSSKREUTZ C, 1994, INT OPHTHALMOL CLIN, V34, P173, DOI 10.1097/00004397-199403430-00016; HITCHINGS RA, 1992, BRIT J OPHTHALMOL, V76, P494, DOI 10.1136/bjo.76.8.494; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; Jay B, 1970, Trans Ophthalmol Soc U K, V90, P161; JOHNSON AT, 1996, GLAUCOMAS, V2, P39; JOHNSON CA, 1993, ARCH OPHTHALMOL-CHIC, V111, P645, DOI 10.1001/archopht.1993.01090050079034; Kobayashi H, 1996, J BIOL CHEM, V271, P11362, DOI 10.1074/jbc.271.19.11362; KORTH M, 1993, GRAEF ARCH CLIN EXP, V231, P84, DOI 10.1007/BF00920218; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LESKE MC, 1983, AM J EPIDEMIOL, V118, P166, DOI 10.1093/oxfordjournals.aje.a113626; LICHTER PR, 1994, AM J OPHTHALMOL, V117, P706, DOI 10.1016/S0002-9394(14)70314-9; MOORE D, 1994, CURRENT PROTOCOLS MO; NETLAND PA, 1993, INT OPHTHALMOL CLIN, V33, P101, DOI 10.1097/00004397-199303320-00011; Quigley HA, 1997, INVEST OPHTH VIS SCI, V38, P83; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; QUIGLEY HA, 1993, NEW ENGL J MED, V328, P1097, DOI 10.1056/NEJM199304153281507; Raymond V, 1997, AM J HUM GENET, V60, P272; Richards JE, 1996, OPHTHALMOLOGY, V103, P1035, DOI 10.1016/S0161-6420(96)30570-8; Sarfarazi M, 1997, HUM MOL GENET, V6, P1667, DOI 10.1093/hmg/6.10.1667; SARFARAZI M, 1995, GENOMICS, V30, P171, DOI 10.1006/geno.1995.9888; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SHEFFIELD VC, 1993, NAT GENET, V4, P47, DOI 10.1038/ng0593-47; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; Shields M, 1996, GLAUCOMAS, V2, P717; Stoilov I, 1997, HUM MOL GENET, V6, P641, DOI 10.1093/hmg/6.4.641; Stoilova D, 1996, GENOMICS, V36, P142, DOI 10.1006/geno.1996.0434; Stoilova D, 1997, OPHTHALMIC GENET, V18, P109, DOI 10.3109/13816819709057124; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; THYLEFORS B, 1994, B WORLD HEALTH ORGAN, V72, P323; TIELSCH JM, 1991, JAMA-J AM MED ASSOC, V266, P369, DOI 10.1001/jama.266.3.369; TRIFAN OC, IN PRESS AM J OPHTHA; WEINREB RN, 1989, INT OPHTHALMOL, V13, P25, DOI 10.1007/BF02028633; WERNER EB, 1996, GLAUCOMAS, V2, P769; Wilson RM., 1996, GLAUCOMAS, P753; Wirtz MK, 1997, AM J HUM GENET, V60, P296; YU TC, 1991, INVEST OPHTH VIS SCI, V32, P2779	53	181	208	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1998	62	3					641	652		10.1086/301767	http://dx.doi.org/10.1086/301767			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZF407	9497264	Bronze, Green Published			2022-12-18	WOS:000072894400018
J	Martin, ER; Kaplan, NL; Weir, BS				Martin, ER; Kaplan, NL; Weir, BS			Tests for linkage and association in nuclear families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISEQUILIBRIUM	The transmission/disequilibrium test (TDT) originally was introduced to test for linkage between a genetic marker and a disease-susceptibility locus, in the presence of association. Recently, the TDT has been used to test for association in the presence of linkage. The motivation for this is that linkage analysis typically identifies large candidate regions, and further refinement is necessary before a search for the disease gene is begun, on the molecular level. Evidence of association and linkage may indicate which markers in the region are closest to a disease locus. As a test of linkage, transmissions from heterozygous parents to all of their affected children can be included in the TDT; however, the TDT is a valid chi(2) test of association only if transmissions to unrelated affected children are used in the analysis. If the sample contains independent nuclear families with multiple affected children, then one procedure that has been used to test for association is to select randomly a single affected child from each sibship and to apply the TDT to those data. As an alternative, we propose two statistics that use data from all of the affected children. The statistics give valid chi(2) tests Of the null hypothesis of no association or no linkage and generally are more powerful than the TDT with a single, randomly chosen, affected child from each family.	N CAROLINA STATE UNIV,DEPT STAT,PROGRAM STAT GENET,RALEIGH,NC	University of North Carolina; North Carolina State University	Martin, ER (corresponding author), NIEHS,BIOSTAT BRANCH,POB 12233,RES TRIANGLE PK,NC 27709, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM045344, T32GM008443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023360] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM08443, P01 GM45344] Funding Source: Medline; NINDS NIH HHS [R01 NS23360] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CLEVES MA, IN PRESS GENET EPIDE; COPEMAN JB, 1995, NAT GENET, V9, P80, DOI 10.1038/ng0195-80; Kaplan NL, 1997, AM J HUM GENET, V60, P691; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Wang SB, 1996, AM J HUM GENET, V59, P731; [No title captured]	7	181	187	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1997	61	2					439	448		10.1086/514860	http://dx.doi.org/10.1086/514860			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XX701	9311750	Green Published, Bronze			2022-12-18	WOS:A1997XX70100023
J	TANZI, RE; VAULA, G; ROMANO, DM; MORTILLA, M; HUANG, TL; TUPLER, RG; WASCO, W; HYMAN, BT; HAINES, JL; JENKINS, BJ; KALAITSIDAKI, M; WARREN, AC; MCINNIS, MC; ANTONARAKIS, SE; KARLINSKY, H; PERCY, ME; CONNOR, L; GROWDON, J; CRAPPERMCLACHLAN, DR; GUSELLA, JF; STGEORGEHYSLOP, PH				TANZI, RE; VAULA, G; ROMANO, DM; MORTILLA, M; HUANG, TL; TUPLER, RG; WASCO, W; HYMAN, BT; HAINES, JL; JENKINS, BJ; KALAITSIDAKI, M; WARREN, AC; MCINNIS, MC; ANTONARAKIS, SE; KARLINSKY, H; PERCY, ME; CONNOR, L; GROWDON, J; CRAPPERMCLACHLAN, DR; GUSELLA, JF; STGEORGEHYSLOP, PH			ASSESSMENT OF AMYLOID BETA-PROTEIN PRECURSOR GENE-MUTATIONS IN A LARGE SET OF FAMILIAL AND SPORADIC ALZHEIMER-DISEASE CASES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY CEREBRAL-HEMORRHAGE; LINKAGE ANALYSIS; CHROMOSOME-21; DUTCH; CDNA; MARKERS; DEFECT; EXONS; LOCUS	A genetic locus associated with familial Alzheimer disease (FAD) and a candidate gene, APP, encoding the amyloid protein precursor have both been assigned previously to chromosome 21, and, in a few FAD families, mutations of APP have been detected. However, obligate crossovers between APP and FAD have also been reported in several FAD pedigrees, including FAD4, a large kindred showing highly suggestive evidence for linkage of the disorder to chromosome 21. In case the apparent APP crossover in FAD4 actually represented an intragenic recombination event or segregation of different mutations in different family branches, we have performed a more detailed assessment of APP as a candidate gene in this family. The entire coding region of the APP gene was sequenced for FAD4 and for FAD1, a second large kindred. No mutations were found, indicating that, in at least one chromosome 21-linked FAD pedigree, the gene defect is not accounted for by a mutation in the known coding region of the APP gene. A total of 25 well-characterized early- and late-onset FAD pedigrees were typed for genetic linkage to APP, to assess the percentage of FAD families predicted to carry mutations in the APP gene. None of the FAD families yielded positive lod scores at a recombination fraction of 0.0. To estimate the overall prevalence of FAD-associated mutations in the beta-A4 domain of APP, we sequenced exons 16 and 17 in 30 (20 early- and 10 late-onset) FAD kindreds and in 11 sporadic AD cases, and we screened 56 FAD kindreds and 81 cases of sporadic AD for the presence of the originally reported FAD-associated mutation, APP717 Val --> Ile (by BclI digestion). No APP gene mutations were found in any of the FAD families or sporadic-AD samples examined in this study, suggesting that the mutations in exons 16 and 17 are a rare cause of FAD. Overall, these data suggest that APP gene mutations account for a very small portion of FAD.	MASSACHUSETTS GEN HOSP, DEPT NEUROL, MOLEC NEUROGENET LAB, BOSTON, MA 02114 USA; HARVARD UNIV, SCH MED, PROGRAM NEUROSCI, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DEPT GENET, BOSTON, MA 02115 USA; UNIV TORONTO, DEPT MED, TORONTO M5S 1A1, ONTARIO, CANADA; UNIV TORONTO, DEPT NEUROL, TORONTO M5S 1A1, ONTARIO, CANADA; UNIV TORONTO, DEPT PSYCHIAT, TORONTO M5S 1A1, ONTARIO, CANADA; UNIV TORONTO, SURREY PL CTR OBSTET & GYNECOL, TORONTO M5S 1A1, ONTARIO, CANADA; JOHNS HOPKINS UNIV, SCH MED, CTR MED GENET, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT PSYCHIAT, BALTIMORE, MD 21205 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Toronto; University of Toronto; University of Toronto; University of Toronto; Johns Hopkins University; Johns Hopkins University			Tanzi, Rudolph/AAE-9622-2019; Mortilla, Marzia/AAV-5525-2020; Antonarakis, Stylianos E/N-8866-2014; Haines, Jonathan/C-3374-2012; Tupler, Rossella/C-9500-2015; KALAITZIDAKI, MARIANNA/GRX-6580-2022	Tanzi, Rudolph/0000-0002-7032-1454; Antonarakis, Stylianos E/0000-0001-8907-5823; Haines, Jonathan/0000-0002-4351-4728; Tupler, Rossella/0000-0002-3797-1789; KALAITZIDAKI, MARIANNA/0000-0003-4073-1230	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG008487, R29AG008487] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00317] Funding Source: Medline; NIA NIH HHS [AG08487] Funding Source: Medline; NINDS NIH HHS [NS30428] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CHARTIERHARLIN MC, 1991, NEUROSCI LETT, V129, P134, DOI 10.1016/0304-3940(91)90738-F; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; CRAWFORD F, 1991, NEUROSCI LETT, V133, P1, DOI 10.1016/0304-3940(91)90042-R; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOATE AM, 1989, LANCET, V1, P352; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; HARDY J, 1991, LANCET, V337, P1342; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KITAGUCHI N, 1988, NATURE, V331, P530, DOI 10.1038/331530a0; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEMAIRE HG, 1989, NUCLEIC ACIDS RES, V17, P517, DOI 10.1093/nar/17.2.517; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; LUCOTTE E, 1991, NATURE, V351, P530; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; NARUSE S, 1991, LANCET, V337, P978, DOI 10.1016/0140-6736(91)91612-X; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; PERICAKVANCE MA, 1988, EXP NEUROL, V102, P271, DOI 10.1016/0014-4886(88)90220-8; PERICAKVANCE MA, 1992, AM J HUM GENET S, V49; PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0; ROBAKIS NK, 1987, P NATL ACAD SCI USA, V84, P4190, DOI 10.1073/pnas.84.12.4190; SCHELLENBERG GD, 1991, AM J HUM GENET, V49, P511; SCHELLENBERG GD, 1988, SCIENCE, V241, P1507, DOI 10.1126/science.3420406; SCHELLENBERG GD, 1991, AM J HUM GENET, V48, P563; SCHELLENBERG GD, AM J HUM GENET S, V49, pA2811; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; STGEORGEHYSLOP PH, 1990, NATURE, V347, P194, DOI 10.1038/347194a0; Tanzi R E, 1991, Curr Opin Neurobiol, V1, P455, DOI 10.1016/0959-4388(91)90069-J; TANZI RE, 1987, NATURE, V329, P156, DOI 10.1038/329156a0; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; TANZI RE, 1991, J BIOL CHEM, V266, P20579; TANZI RE, 1988, NATURE, V331, P528, DOI 10.1038/331528a0; TANZI RE, 1991, AM J HUM GENET, V49, P507; TERRY RD, 1983, ANN NEUROL, V14, P497, DOI 10.1002/ana.410140502; VAN BROECKHOVEN C, 1987, NATURE, V329, P153; VAN BROECKHOVEN C, 1990, SCIENCE, V248, P1120, DOI 10.1126/science.1971458; VANBROECKHOVEN C, 1988, AM J HUM GENET S, V43, pA205; VANDUIJN CM, 1991, LANCET, V337, P978, DOI 10.1016/0140-6736(91)91611-W; VANDUINEN SG, 1987, P NATL ACAD SCI USA, V84, P5991; WARREN AC, UNPUB HIGHLY POLYMOR; YOSHIKAI S, 1990, GENE, V87, P257, DOI 10.1016/0378-1119(90)90310-N; YOSHIOKA K, 1991, BIOCHEM BIOPH RES CO, V178, P1141, DOI 10.1016/0006-291X(91)91011-Z	42	181	185	0	8	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1992	51	2					273	282						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JF776	1642228				2022-12-18	WOS:A1992JF77600006
J	LUDWIG, EH; FRIEDL, W; MCCARTHY, BJ				LUDWIG, EH; FRIEDL, W; MCCARTHY, BJ			HIGH-RESOLUTION ANALYSIS OF A HYPERVARIABLE REGION IN THE HUMAN APOLIPOPROTEIN-B GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF SAN FRANCISCO,CARDIOL RES INST,GLADSTONE FDN LABS CARDIOVASC DIS,POB 40608,SAN FRANCISCO,CA 94140; LANDESKRANKENANSTALTEN SALZBURG,A-5020 SALZBURG,AUSTRIA	University of California System; University of California San Francisco; The J David Gladstone Institutes					NHLBI NIH HHS [HL 38781] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038781] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALI S, 1988, NUCLEIC ACIDS RES, V16, P8487, DOI 10.1093/nar/16.17.8487; BELL GI, 1982, NATURE, V295, P31, DOI 10.1038/295031a0; BERG K, 1986, CLIN GENET, V30, P515; BLACKHART BD, 1986, J BIOL CHEM, V261, P5364; BOERWINKLE E, 1989, P NATL ACAD SCI USA, V86, P212, DOI 10.1073/pnas.86.1.212; HEGELE RA, 1986, NEW ENGL J MED, V315, P1509, DOI 10.1056/NEJM198612113152403; HUANG LS, 1987, J BIOL CHEM, V262, P8952; JARMAN AP, 1988, AM J HUM GENET, V43, P249; JARMAN AP, 1986, EMBO J, V5, P1857, DOI 10.1002/j.1460-2075.1986.tb04437.x; JEFFREYS AJ, 1988, NUCLEIC ACIDS RES, V16, P10953, DOI 10.1093/nar/16.23.10953; JEFFREYS AJ, 1988, NATURE, V332, P278, DOI 10.1038/332278a0; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; JENNER K, 1988, ATHEROSCLEROSIS, V69, P39, DOI 10.1016/0021-9150(88)90287-0; KNOTT TJ, 1986, NUCLEIC ACIDS RES, V14, P9215, DOI 10.1093/nar/14.22.9215; LUDWIG EH, 1987, DNA-J MOLEC CELL BIO, V6, P363, DOI 10.1089/dna.1987.6.363; LUSIS AJ, 1988, J LIPID RES, V29, P397; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; PAULWEBER B, IN PRESS ARTERIOSCLE; RAPACZ J, 1986, SCIENCE, V234, P1573, DOI 10.1126/science.3787263; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SORIA LF, 1989, P NATL ACAD SCI USA, V86, P587, DOI 10.1073/pnas.86.2.587; STOKER NG, 1985, NUCLEIC ACIDS RES, V13, P4613, DOI 10.1093/nar/13.13.4613; WEISGRABER KH, 1988, P NATL ACAD SCI USA, V85, P9758, DOI 10.1073/pnas.85.24.9758	24	181	186	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1989	45	3					458	464						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AN879	2773938				2022-12-18	WOS:A1989AN87900015
J	Wooderchak-Donahue, WL; McDonald, J; O'Fallon, B; Upton, PD; Li, W; Roman, BL; Young, S; Plant, P; Fulop, GT; Langa, C; Morrell, NW; Botella, LM; Bernabeu, C; Stevenson, DA; Runo, JR; Bayrak-Toydemir, P				Wooderchak-Donahue, Whitney L.; McDonald, Jamie; O'Fallon, Brendan; Upton, Paul D.; Li, Wei; Roman, Beth L.; Young, Sarah; Plant, Parker; Fueloep, Gyula T.; Langa, Carmen; Morrell, Nicholas W.; Botella, Luisa M.; Bernabeu, Carmelo; Stevenson, David A.; Runo, James R.; Bayrak-Toydemir, Pinar			BMP9 Mutations Cause a Vascular-Anomaly Syndrome with Phenotypic Overlap with Hereditary Hemorrhagic Telangiectasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							KINASE 1 ALK1; RASA1 MUTATIONS; ARTERIOVENOUS-MALFORMATIONS; ENDOTHELIAL-CELLS; WEBER-SYNDROME; ZEBRAFISH; CAPILLARY; IDENTIFICATION; RECEPTORS; LOCUS	Hereditary hemorrhagic telangiectasia (HHT), the most common inherited vascular disorder, is caused by mutations in genes involved in the transforming growth factor beta (TGF-beta) signaling pathway (ENG, ACVRL1, and SMAD4). Yet, approximately 15% of individuals with clinical features of HHT do not have mutations in these genes, suggesting that there are undiscovered mutations in other genes for HHT and possibly vascular disorders with overlapping phenotypes. The genetic etiology for 191 unrelated individuals clinically suspected to have HHT was investigated with the use of exome and Sanger sequencing; these individuals had no mutations in ENG, ACVEL1, and SMAD4. Mutations in BMP9 (also known as GDF2) were identified in three unrelated probands. These three individuals had epistaxis and dermal lesions that were described as telangiectases but whose location and appearance resembled lesions described in some individuals with RASA1-related disorders (capillary malformation-arteriovenous malformation syndrome). Analyses of the variant proteins suggested that mutations negatively affect protein processing and/or function, and a bmp9-deficient zebrafish model demonstrated that BMP9 is involved in angiogenesis. These data confirm a genetic cause of a vascular-anomaly syndrome that has phenotypic overlap with HHT.	[Wooderchak-Donahue, Whitney L.; O'Fallon, Brendan; Plant, Parker; Bayrak-Toydemir, Pinar] Associated Reg & Univ Pathologists Inst Clin & Ex, Salt Lake City, UT 84108 USA; [McDonald, Jamie; Bayrak-Toydemir, Pinar] Univ Utah, Dept Pathol, Salt Lake City, UT 84108 USA; [Upton, Paul D.; Li, Wei; Morrell, Nicholas W.] Univ Cambridge, Sch Clin Med, Dept Med, Addenbrookes Hosp, Cambridge CB2 0QQ, England; [Roman, Beth L.; Young, Sarah] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Fueloep, Gyula T.; Langa, Carmen; Botella, Luisa M.; Bernabeu, Carmelo] CSIC, Ctr Invest Biol, Madrid 28040, Spain; [Fueloep, Gyula T.; Langa, Carmen; Botella, Luisa M.; Bernabeu, Carmelo] Ctr Invest Biomed Red Enfermed Raras, Madrid 28040, Spain; [Stevenson, David A.] Univ Utah, Div Med Genet, Dept Pediat, Salt Lake City, UT 84108 USA; [Runo, James R.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Madison, WI 53792 USA	Utah System of Higher Education; University of Utah; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Utah System of Higher Education; University of Utah; University of Wisconsin System; University of Wisconsin Madison	Bayrak-Toydemir, P (corresponding author), Associated Reg & Univ Pathologists Inst Clin & Ex, Salt Lake City, UT 84108 USA.	pinar.bayrak-toydemir@aruplab.com	Bernabeu, Carmelo/L-3226-2014; Bernabeu, Carmelo/P-4662-2019; Botella, Luisa M/L-1392-2014; Young, Sarah/E-2883-2014	Bernabeu, Carmelo/0000-0002-1563-6162; Bernabeu, Carmelo/0000-0002-1563-6162; Young, Sarah/0000-0002-8301-5106; Morrell, Nicholas/0000-0001-5700-9792; Roman, Beth/0000-0002-1250-1705	Associated Regional and University Pathologists Institute for Clinical and Experimental Pathology; National Institutes of Health [HL079108]; British Heart Foundation [RG/08/002/24718]; Ministerio de Economia y Competitividad of Spain [SAF2010-19222]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079108] Funding Source: NIH RePORTER; British Heart Foundation [PG/12/54/29734, RG/13/4/30107] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10174] Funding Source: researchfish	Associated Regional and University Pathologists Institute for Clinical and Experimental Pathology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); Ministerio de Economia y Competitividad of Spain(Spanish Government); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank the families and individuals who participated in this study. This work was funded by the Associated Regional and University Pathologists Institute for Clinical and Experimental Pathology, a National Institutes of Health grant R01 (HL079108 to B.L.R.), a British Heart Foundation Programme grant (RG/08/002/24718 to N.W.M), and the Ministerio de Economia y Competitividad of Spain (SAF2010-19222 to C.B.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029948; Bidart M, 2012, CELL MOL LIFE SCI, V69, P313, DOI 10.1007/s00018-011-0751-1; Boon LM, 2005, CURR OPIN GENET DEV, V15, P265, DOI 10.1016/j.gde.2005.03.004; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Castonguay R, 2011, J BIOL CHEM, V286, P30034, DOI 10.1074/jbc.M111.260133; Choi J, 2007, DEV BIOL, V304, P735, DOI 10.1016/j.ydbio.2007.01.023; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Corti P, 2011, DEVELOPMENT, V138, P1573, DOI 10.1242/dev.060467; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Eerola I, 2003, AM J HUM GENET, V73, P1240, DOI 10.1086/379793; Fernandez-L A, 2006, CLIN MED RES, V4, P66, DOI 10.3121/cmr.4.1.66; Gallione CJ, 2004, LANCET, V363, P852, DOI 10.1016/S0140-6736(04)15732-2; Garber M, 2009, BIOINFORMATICS, V25, pI54, DOI 10.1093/bioinformatics/btp190; Gedge F, 2007, J MOL DIAGN, V9, P258, DOI 10.2353/jmoldx.2007.060117; Hershkovitz D, 2008, BRIT J DERMATOL, V158, P1035, DOI 10.1111/j.1365-2133.2008.08493.x; JOHNSON DW, 1995, GENOME RES, V5, P21, DOI 10.1101/gr.5.1.21; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; MCDONALD MT, 1994, NAT GENET, V6, P197, DOI 10.1038/ng0294-197; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Revencu N, 2008, HUM MUTAT, V29, P959, DOI 10.1002/humu.20746; Ricard N, 2012, BLOOD, V119, P6162, DOI 10.1182/blood-2012-01-407593; Richards-Yutz J, 2010, HUM GENET, V128, P61, DOI 10.1007/s00439-010-0825-4; Roman BL, 2002, DEVELOPMENT, V129, P3009; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P; Townson SA, 2012, J BIOL CHEM, V287, P27313, DOI 10.1074/jbc.M112.377960; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Young K, 2012, BLOOD, V120, P4263, DOI 10.1182/blood-2012-07-440784	34	180	192	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 5	2013	93	3					530	537		10.1016/j.ajhg.2013.07.004	http://dx.doi.org/10.1016/j.ajhg.2013.07.004			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	297QB	23972370	Green Published, Bronze			2022-12-18	WOS:000330268900012
J	Piton, A; Redin, C; Mandel, JL				Piton, Amelie; Redin, Claire; Mandel, Jean-Louis			XLID-Causing Mutations and Associated Genes Challenged in Light of Data From Large-Scale Human Exome Sequencing	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKED MENTAL-RETARDATION; UBIQUITIN LIGASE HUWE1; INTELLECTUAL DISABILITY; MONOAMINE-OXIDASE; X-CHROMOSOME; MISSENSE MUTATION; CANDIDATE GENE; FRAGILE-X; FUNCTIONAL IMPACT; AGTR2 MUTATIONS	Because of the unbalanced sex ratio (1.3-1.4 to 1) observed in intellectual disability (ID) and the identification of large ID-affected families showing X-linked segregation, much attention has been focused on the genetics of X-linked ID (XLID). Mutations causing monogenic XLID have now been reported in over 100 genes, most of which are commonly included in XLID diagnostic gene panels. Nonetheless, the boundary between true mutations and rare non-disease-causing variants often remains elusive. The sequencing of a large number of control X chromosomes, required for avoiding false-positive results, was not systematically possible in the past. Such information is now available thanks to large-scale sequencing projects such as the National Heart, Lung, and Blood (NHLBI) Exome Sequencing Project, which provides variation information on 10,563 X chromosomes from the general population. We used this NHLBI cohort to systematically reassess the implication of 106 genes proposed to be involved in monogenic forms of XLID. We particularly question the implication in XLID of ten of them (AGTR2, MAGT1, ZNF674, SRPX2, ATP6AP2, ARHGEF6, NXF5, ZCCHC12, ZNF41, and ZNF81), in which truncating variants or previously published mutations are observed at a relatively high frequency within this cohort. We also highlight 15 other genes (CCDC22, CLIC2, CNKSR2, FRMPD4, HCFC1, IGBP1, KIAA2022, KLF8, MAOA, NAA10, NLGN3, RPL10, SHROOM4, ZDHHC15, and ZNF261) for which replication studies are warranted. We propose that similar reassessment of reported mutations (and genes) with the use of data from large-scale human exome sequencing would be relevant for a wide range of other genetic diseases.	[Piton, Amelie; Redin, Claire; Mandel, Jean-Louis] Univ Strasbourg, Inst Natl Sante & Rech Med,U964, Ctr Natl Rech Sci Unite Mixte Rech 7104, Inst Genet & Biol Mol & Cellulaire,Dept Translat, F-67404 Illkirch Graffenstaden, France; [Piton, Amelie; Redin, Claire; Mandel, Jean-Louis] Coll France, Chaire Genet Humaine, F-75231 Paris 05, France; [Mandel, Jean-Louis] Hop Univ Strasbourg, Lab Diagnost Genet, F-67091 Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; PSL Research University Paris; College de France; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Piton, A (corresponding author), Univ Strasbourg, Inst Natl Sante & Rech Med,U964, Ctr Natl Rech Sci Unite Mixte Rech 7104, Inst Genet & Biol Mol & Cellulaire,Dept Translat, F-67404 Illkirch Graffenstaden, France.	piton@igbmc.fr; jlmandel@igbmc.fr	Mandel, Jean Louis/Q-2668-2016; Piton, Amelie/F-1201-2013	Mandel, Jean Louis/0000-0002-0535-6589; Piton, Amelie/0000-0003-0408-7468	Fondation Jerome Lejeune; Agence de Biomedecine; Fondation pour la Recherche Medicale; APLM; Groupement d'Interet Economique - Centre Europeen de Recherche en Biologie et en Medecine	Fondation Jerome Lejeune; Agence de Biomedecine; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); APLM; Groupement d'Interet Economique - Centre Europeen de Recherche en Biologie et en Medecine	We thank Stephanie Le Gras and Jean Muller for bioinformatics assistance and more particularly for helping download data from the National Heart, Lung, and Blood Institute Exome Sequencing Project Exome Variant Server. Our work on intellectual disability genetics is supported by grants from the Fondation Jerome Lejeune and the Agence de Biomedecine, a postdoctoral fellowship from the Fondation pour la Recherche Medicale to A.P., and a student fellowship from the APLM and Groupement d'Interet Economique - Centre Europeen de Recherche en Biologie et en Medecine to C.R.	Alesi V, 2012, GENE, V505, P384, DOI 10.1016/j.gene.2012.05.031; Andreasen C, 2013, EUR J HUM GENET; Bedoyan JK, 2012, J MED GENET, V49, P332, DOI 10.1136/jmedgenet-2011-100575; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Biancalana V, 2004, AM J MED GENET A, V129A, P218, DOI 10.1002/ajmg.a.30237; Bienvenu T, 2003, J MED GENET, V40, P357, DOI 10.1136/jmg.40.5.357; Bortolato M, 2013, INT J NEUROPSYCHOPH, V16, P869, DOI 10.1017/S1461145712000715; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; BRUNNER HG, 1993, AM J HUM GENET, V52, P1032; Cantagrel V, 2004, J MED GENET, V41, P736, DOI 10.1136/jmg.2004.021626; Chen CP, 2011, TAIWAN J OBSTET GYNE, V50, P339, DOI 10.1016/j.tjog.2011.01.018; Chiocchetti A, 2011, AM J MED GENET A, V155A, P1472, DOI 10.1002/ajmg.a.33977; Cho G, 2008, AM J MED GENET A, V146A, P2644, DOI 10.1002/ajmg.a.32472; Coffee B, 2009, AM J HUM GENET, V85, P503, DOI 10.1016/j.ajhg.2009.09.007; COLLINS FA, 1992, AM J MED GENET, V42, P127, DOI 10.1002/ajmg.1320420126; D'Arca D, 2010, P NATL ACAD SCI USA, V107, P5875, DOI 10.1073/pnas.0912874107; DAHL N, 1995, AM J HUM GENET, V56, P1108; de Brouwer APM, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9482; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Delphin N, 2012, EUR J HUM GENET, V20, P352, DOI 10.1038/ejhg.2011.217; El-Hattab AW, 2011, CLIN GENET, V79, P531, DOI 10.1111/j.1399-0004.2010.01496.x; Ellison JW, 2013, ANNU REV MED, V64, P441, DOI 10.1146/annurev-med-042711-140053; Erdmann J, 2004, HUM GENET, V114, P396, DOI 10.1007/s00439-003-1076-4; Fassio A, 2011, HUM MOL GENET, V20, P2297, DOI 10.1093/hmg/ddr122; Filges I, 2011, CLIN GENET, V79, P79, DOI 10.1111/j.1399-0004.2010.01590.x; Frints SGM, 2002, CLIN GENET, V62, P423, DOI 10.1034/j.1399-0004.2002.620601.x; Frints SGM, 2003, AM J MED GENET A, V119A, P367, DOI 10.1002/ajmg.a.20195; Froyen G, 2008, AM J HUM GENET, V82, P432, DOI 10.1016/j.ajhg.2007.11.002; Froyen G, 2007, HUM MUTAT, V28, P1034, DOI 10.1002/humu.20564; Froyen G, 2012, AM J HUM GENET, V91, P252, DOI 10.1016/j.ajhg.2012.06.010; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Garcia CC, 2004, J MED GENET, V41, P183, DOI 10.1136/jmg.2003.013680; Garshasbi M, 2011, AM J MED GENET A, V155A, P1976, DOI 10.1002/ajmg.a.34077; Gecz J, 2009, TRENDS GENET, V25, P308, DOI 10.1016/j.tig.2009.05.002; Graham JM, 2003, AM J MED GENET A, V123A, P37, DOI 10.1002/ajmg.a.20504; Grillo L, 2010, EUR J MED GENET, V53, P113, DOI 10.1016/j.ejmg.2010.01.001; Haavik J, 2008, HUM MUTAT, V29, P891, DOI 10.1002/humu.20700; Hagens O, 2006, HUM GENET, V118, P578, DOI 10.1007/s00439-005-0072-2; HODGSON SV, 1987, HUM GENET, V75, P286, DOI 10.1007/BF00281076; Honda S, 2010, J HUM GENET, V55, P590, DOI 10.1038/jhg.2010.74; Houge G, 2011, MOL SYNDROMOL, V2, P60, DOI 10.1159/000335159; Huang DH, 2005, AM J MED GENET A, V139A, P243, DOI 10.1002/ajmg.a.31022; Huang LL, 2012, AM J HUM GENET, V91, P694, DOI 10.1016/j.ajhg.2012.08.011; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jun L, 2001, CURR BIOL, V11, P1381, DOI 10.1016/S0960-9822(01)00419-5; Kalscheuer V.M., 2013, J MED GENET; Kaufman L, 2010, J NEURODEV DISORD, V2, P182, DOI 10.1007/s11689-010-9055-2; Klauck SM, 2006, MOL PSYCHIATR, V11, P1073, DOI 10.1038/sj.mp.4001883; Kleefstra T, 2004, J MED GENET, V41, P394, DOI 10.1136/jmg.2003.016972; Kutsche K, 2000, NAT GENET, V26, P247, DOI 10.1038/80002; Lebel RR, 2002, CLIN GENET, V61, P139, DOI 10.1034/j.1399-0004.2002.610209.x; LENK U, 1994, NEUROMUSCULAR DISORD, V4, P411, DOI 10.1016/0960-8966(94)90080-9; Leonard H, 2002, MENT RETARD DEV D R, V8, P117, DOI 10.1002/mrdd.10031; Lescai F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051292; Li FY, 2011, MAGNESIUM RES, V24, pS109, DOI 10.1684/mrh.2011.0286; Liang GSL, 2005, ANN NEUROL, V57, P749, DOI 10.1002/ana.20459; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lossi AM, 2002, J MED GENET, V39, P113, DOI 10.1136/jmg.39.2.113; Lubs HA, 2012, AM J HUM GENET, V90, P579, DOI 10.1016/j.ajhg.2012.02.018; Lugtenberg D, 2006, AM J HUM GENET, V78, P265, DOI 10.1086/500306; Madrigal I, 2007, GENET MED, V9, P117, DOI 10.1097/GIM.0b013e318031206e; Madrigal I, 2010, J HUM GENET, V55, P822, DOI 10.1038/jhg.2010.119; Mansouri MR, 2005, EUR J HUM GENET, V13, P970, DOI 10.1038/sj.ejhg.5201445; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Maul B, 2008, J MOL MED, V86, P563, DOI 10.1007/s00109-008-0316-4; Molinari F, 2008, AM J HUM GENET, V82, P1150, DOI 10.1016/j.ajhg.2008.03.021; Nava C, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.102; Noor A, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001267; O'Leary RE, 2012, EUR J MED GENET, V55, P349, DOI 10.1016/j.ejmg.2012.01.007; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Piton A, 2011, MOL PSYCHIATR, V16, P867, DOI 10.1038/mp.2010.54; Potluri P, 2009, MOL GENET METAB, V96, P189, DOI 10.1016/j.ymgme.2008.12.004; Ramakers GJA, 2012, HUM MOL GENET, V21, P268, DOI 10.1093/hmg/ddr457; Ramaswamy V, 2010, PEDIATR NEUROL, V43, P209, DOI 10.1016/j.pediatrneurol.2010.04.016; Ramser J, 2005, HUM MOL GENET, V14, P1019, DOI 10.1093/hmg/ddi094; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Roll P, 2006, HUM MOL GENET, V15, P1195, DOI 10.1093/hmg/ddl035; Rope AF, 2011, AM J HUM GENET, V89, P28, DOI 10.1016/j.ajhg.2011.05.017; Ropers HH, 2010, ANNU REV GENOM HUM G, V11, P161, DOI 10.1146/annurev-genom-082509-141640; Royer-Zemmour B, 2008, HUM MOL GENET, V17, P3617, DOI 10.1093/hmg/ddn256; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Shoichet SA, 2003, AM J HUM GENET, V73, P1341, DOI 10.1086/380309; Swaminathan GJ, 2012, HUM MOL GENET, V21, pR37, DOI 10.1093/hmg/dds362; Takeshita E, 2012, BRAIN DEV-JPN, V34, P776, DOI 10.1016/j.braindev.2011.12.010; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; TURNER G, 1994, AM J MED GENET, V51, P575, DOI 10.1002/ajmg.1320510456; Unger S, 2007, AM J MED GENET A, V143A, P1876, DOI 10.1002/ajmg.a.31751; vanderMaarel SM, 1996, HUM MOL GENET, V5, P887, DOI 10.1093/hmg/5.7.887; Vervoort VS, 2002, SCIENCE, V296, P2401; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Voineagu I, 2012, MOL PSYCHIATR, V17, P4, DOI 10.1038/mp.2011.95; Whibley AC, 2010, AM J HUM GENET, V87, P173, DOI 10.1016/j.ajhg.2010.06.017; Witham S, 2011, PROTEINS, V79, P2444, DOI 10.1002/prot.23065; Ylisaukko-oja T, 2004, HUM GENET, V114, P211, DOI 10.1007/s00439-003-1048-8; Zemni R, 2000, NAT GENET, V24, P167, DOI 10.1038/72829; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727; Zhao X, 2009, DEV CELL, V17, P210, DOI 10.1016/j.devcel.2009.07.009	100	180	189	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 8	2013	93	2					368	383		10.1016/j.ajhg.2013.06.013	http://dx.doi.org/10.1016/j.ajhg.2013.06.013			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	202AP	23871722	Green Published, Bronze			2022-12-18	WOS:000323186200017
J	Kobayashi, H; Abe, K; Matsuura, T; Ikeda, Y; Hitomi, T; Akechi, Y; Habu, T; Liu, WY; Okuda, H; Koizumi, A				Kobayashi, Hatasu; Abe, Koji; Matsuura, Tohru; Ikeda, Yoshio; Hitomi, Toshiaki; Akechi, Yuji; Habu, Toshiyuki; Liu, Wanyang; Okuda, Hiroko; Koizumi, Akio			Expansion of Intronic GGCCTG Hexanucleotide Repeat in NOP56 Causes SCA36, a Type of Spinocerebellar Ataxia Accompanied by Motor Neuron Involvement	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOMINANT CEREBELLAR ATAXIAS; CLINICAL-FEATURES; NEURODEGENERATION; PCR	Autosomal-dominant spinocerebellar ataxias (SCAs) are a heterogeneous group of neurodegenerative disorders. In this study, we performed genetic analysis of a unique form of SCA (SCA36) that is accompanied by motor neuron involvement. Genome-wide linkage analysis and subsequent fine mapping for three unrelated Japanese families in a cohort of SCA cases, in whom molecular diagnosis had never been performed, mapped the disease locus to the region of a 1.8 Mb stretch (LOD score of 4.60) on 20p13 (D20S906-D20S193) harboring 37 genes with definitive open reading frames. We sequenced 33 of these and observed a large expansion of an intronic GGCCTG hexanucleotide repeat in NOP56 and an unregistered missense variant (Phe265Leu) in C20orf194, but we found no mutations in PDYN and TGM6. The expansion showed complete segregation with the SCA phenotype in family studies, whereas Phe265Leu in C20orf194 did not. Screening of the expansions in the SCA cohort cases revealed four additional occurrences, but none were revealed in the cohort of 27 Alzheimer disease cases, 154 amyotrophic lateral sclerosis cases, or 300 controls. In total, nine unrelated cases were found in 251 cohort SCA patients (3.6%). A founder haplotype was confirmed in these cases. RNA foci formation was detected in lymphoblastoid cells from affected subjects by fluorescence in situ hybridization. Double staining and gel-shift assay showed that (GGCCUG)n binds the RNA-binding protein SRSF2 but that (CUG)(6) does not. In addition, transcription of MIR1292, a neighboring miRNA, was significantly decreased in lymphoblastoid cells of SCA patients. Our finding suggests that SCA36 is caused by hexanucleotide repeat expansions through RNA gain of function.	[Kobayashi, Hatasu; Hitomi, Toshiaki; Liu, Wanyang; Okuda, Hiroko; Koizumi, Akio] Kyoto Univ, Grad Sch Med, Dept Hlth & Environm Sci, Kyoto, Japan; [Abe, Koji; Matsuura, Tohru; Ikeda, Yoshio; Akechi, Yuji] Okayama Univ, Dept Neurol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Habu, Toshiyuki] Kyoto Univ, Ctr Radiat Biol, Kyoto 606, Japan	Kyoto University; Okayama University; Kyoto University	Koizumi, A (corresponding author), Kyoto Univ, Grad Sch Med, Dept Hlth & Environm Sci, Kyoto, Japan.	koizumi.akio.5v@kyoto-u.ac.jp	Habu, Toshiyuki/ABC-6644-2021; Kobayashi, Hatasu/R-8012-2019	Habu, Toshiyuki/0000-0003-4131-3938; Kobayashi, Hatasu/0000-0002-5664-6869	Grants-in-Aid for Scientific Research [10J05192, 23590741] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Bakalkin G, 2010, AM J HUM GENET, V87, P593, DOI 10.1016/j.ajhg.2010.10.001; Cagnoli C, 2004, J MOL DIAGN, V6, P96, DOI 10.1016/S1525-1578(10)60496-5; Daughters RS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000600; Eacker SM, 2009, NAT REV NEUROSCI, V10, P837, DOI 10.1038/nrn2726; HARDING AE, 1982, BRAIN, V105, P1, DOI 10.1093/brain/105.1.1; Hashikata H, 2010, STROKE, V41, P1138, DOI 10.1161/STROKEAHA.109.576694; Hebert SS, 2009, TRENDS NEUROSCI, V32, P199, DOI 10.1016/j.tins.2008.12.003; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lechertier T, 2009, EXP CELL RES, V315, P928, DOI 10.1016/j.yexcr.2009.01.016; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Matilla-Duenas A, 2010, CEREBELLUM, V9, P148, DOI 10.1007/s12311-009-0144-2; Matsuura T, 2002, ANN NEUROL, V51, P271, DOI 10.1002/ana.10049; Nutini M, 2011, NEUROPHARMACOLOGY, V60, P1200, DOI 10.1016/j.neuropharm.2010.11.001; Ohta Y, 2007, INTERNAL MED, V46, P751, DOI 10.2169/internalmedicine.46.6261; Sanelli T, 2007, J NEUROL SCI, V256, P39, DOI 10.1016/j.jns.2007.02.018; Sato N, 2009, AM J HUM GENET, V85, P544, DOI 10.1016/j.ajhg.2009.09.019; Schols L, 2004, LANCET NEUROL, V3, P291, DOI 10.1016/S1474-4422(04)00737-9; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Todd PK, 2010, ANN NEUROL, V67, P291, DOI 10.1002/ana.21948; TSUZUKI K, 2005, GLUTAMATE RECEPTORS; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang JL, 2010, BRAIN, V133, P3510, DOI 10.1093/brain/awq323; Warner JP, 1996, J MED GENET, V33, P1022, DOI 10.1136/jmg.33.12.1022; White MC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000984; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006; TARGET SCAN HUMAN 5; ESEFINDER 3 0	28	180	190	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL 15	2011	89	1					121	130		10.1016/j.ajhg.2011.05.015	http://dx.doi.org/10.1016/j.ajhg.2011.05.015			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	796HF	21683323	Bronze, Green Published			2022-12-18	WOS:000293041700010
J	Baala, L; Romano, S; Khaddour, R; Saunier, S; Smith, UM; Audollent, S; Ozilou, C; Faivre, L; Laurent, N; Foliguet, B; Munnich, A; Lyonnet, S; Salomon, R; Encha-Razavi, F; Gubler, MC; Boddaert, N; de Lonlay, P; Johnson, CA; Vekemans, M; Antignac, C; Attie-Bitach, T				Baala, Lekbir; Romano, Stephane; Khaddour, Rana; Saunier, Sophie; Smith, Ursula M.; Audollent, Sophie; Ozilou, Catherine; Faivre, Laurence; Laurent, Nicole; Foliguet, Bernard; Munnich, Arnold; Lyonnet, Stanislas; Salomon, Remi; Encha-Razavi, Ferechte; Gubler, Marie-Claire; Boddaert, Nathalie; de Lonlay, Pascale; Johnson, Colin A.; Vekemans, Michel; Antignac, Corinne; Attie-Bitach, Tania			The Meckel-Gruber syndrome gene, MKS3, is mutated in Joubert syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYNDROME-RELATED DISORDERS; DANDY-WALKER MALFORMATION; BARDET-BIEDL-SYNDROME; MOLAR TOOTH SIGN; HEPATIC-FIBROSIS; AHI1 GENE; JUVENILE NEPHRONOPHTHISIS; CENTROSOMAL PROTEIN; KIDNEY-DISEASE; PRIMARY CILIA	Joubert syndrome (JS) is an autosomal recessive disorder characterized by cerebellar vermis hypoplasia associated with hypotonia, developmental delay, abnormal respiratory patterns, and abnormal eye movements. The association of retinal dystrophy and renal anomalies defines JS type B. JS is a genetically heterogeneous condition with mutations in two genes, AHI1 and CEP290, identified to date. In addition, NPHP1 deletions identical to those that cause juvenile nephronophthisis have been identified in a subset of patients with a mild form of cerebellar and brainstem anomaly. Occipital encephalocele and/or polydactyly have occasionally been reported in some patients with JS, and these phenotypic features can also be observed in Meckel-Gruber syndrome (MKS). MKS is a rare, autosomal recessive lethal condition characterized by central nervous system malformations ( typically, occipital meningoencephalocele), postaxial polydactyly, multicystic kidney dysplasia, and ductal proliferation in the portal area of the liver. Since there is obvious phenotypic overlap between JS and MKS, we hypothesized that mutations in the recently identified MKS genes, MKS1 on chromosome 17q and MKS3 on 8q, may be a cause of JS. After mutation analysis of MKS1 and MKS3 in a series of patients with JS (n = 22), we identified MKS3 mutations in four patients with JS, thus defining MKS3 as the sixth JS locus (JBTS6). No MKS1 mutations were identified in this series, suggesting that the allelism is restricted to MKS3.	Hop Necker Enfants Malad, Dept Genet, Assistance Publ Hop Paris, F-75743 Paris 15, France; Hop Necker Enfants Malad, Serv Radiol Pediat, Assistance Publ Hop Paris, F-75743 Paris 15, France; Univ Paris 05, INSERM, U781, Hop Necker Enfants Malad, Paris 5, France; Univ Paris 05, INSERM, U574, Hop Necker Enfants Malad, Paris 5, France; Hop Necker Enfants Malad, Dept Pediat, Assistance Publ Hop Paris, F-75743 Paris 15, France; Univ Birmingham, Sect Med & Mol Genet, Dept Paediat & Child Hlth, Sch Med, Birmingham B15 2TT, W Midlands, England; CHU Dijon, Dijon, France; Lab Biol Reprod & Dev Matern Nancy, Nancy, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; University of Birmingham; CHU Dijon Bourgogne	Attie-Bitach, T (corresponding author), Hop Necker Enfants Malad, Dept Genet, Assistance Publ Hop Paris, 149 Rue Sevres, F-75743 Paris 15, France.	tania.attie@necker.fr	Lyonnet, Stanislas/H-5483-2017; ANTIGNAC, Corinne/H-8945-2017; Saunier, Sophie/G-6044-2015; ATTIE-BITACH, Tania/K-1453-2017; boddaert, nathalie/GWV-2865-2022	Lyonnet, Stanislas/0000-0001-5426-9417; ANTIGNAC, Corinne/0000-0002-9934-4940; Saunier, Sophie/0000-0002-1069-0047; ATTIE-BITACH, Tania/0000-0002-1155-3626; boddaert, nathalie/0000-0003-0991-7774; Gubler, Marie-Claire/0000-0002-3526-5661; Faivre, Laurence/0000-0001-9770-444X				AHDABBARMADA M, 1990, J NEUROPATH EXP NEUR, V49, P610, DOI 10.1097/00005072-199011000-00007; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Badano JL, 2006, NATURE, V439, P326, DOI 10.1038/nature04370; Badano JL, 2003, HUM MOL GENET, V12, P1651, DOI 10.1093/hmg/ddg188; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Balci S, 2004, TURKISH J PEDIATR, V46, P283; Caridi G, 2006, KIDNEY INT, V70, P1342, DOI 10.1038/sj.ki.5001768; CASAMASSIMA AC, 1987, AM J MED GENET, V26, P321, DOI 10.1002/ajmg.1320260211; Castori M, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.027375; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Dixon-Salazar T, 2004, AM J HUM GENET, V75, P979, DOI 10.1086/425985; EGGER J, 1982, J NEUROL NEUROSUR PS, V45, P737, DOI 10.1136/jnnp.45.8.737; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; Fuchs JL, 2004, CELL BIOL INT, V28, P111, DOI 10.1016/j.cellbi.2003.11.008; Gattone VH, 2004, ANAT REC PART A, V277A, P384, DOI 10.1002/ar.a.20022; GENUARDI M, 1993, AM J MED GENET, V47, P50, DOI 10.1002/ajmg.1320470111; Gleeson JG, 2004, AM J MED GENET A, V125A, P125, DOI 10.1002/ajmg.a.20437; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Johnson CA, 2003, J MED GENET, V40, P311, DOI 10.1136/jmg.40.5.311; JOUBERT M, 1968, NEUROLOGY, V18, P302; Karmous-Benailly H, 2005, AM J HUM GENET, V76, P493, DOI 10.1086/428679; Katsanis N, 2001, HUM MOL GENET, V10, P2293, DOI 10.1093/hmg/10.20.2293; Keeler LC, 2003, AM J HUM GENET, V73, P656, DOI 10.1086/378206; Kyttala M, 2006, NAT GENET, V38, P155, DOI 10.1038/ng1714; LEWIS SME, 1994, AM J MED GENET, V52, P419, DOI 10.1002/ajmg.1320520406; LOWRY RB, 1983, AM J MED GENET, V14, P417, DOI 10.1002/ajmg.1320140303; Moerman P., 1993, Genetic Counseling, V4, P97; Mollet G, 2002, NAT GENET, V32, P300, DOI 10.1038/ng996; Olbrich H, 2003, NAT GENET, V34, P455, DOI 10.1038/ng1216; Otto EA, 2005, NAT GENET, V37, P282, DOI 10.1038/ng1520; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; PAETAU A, 1985, CLIN NEUROPATHOL, V4, P56; Parisi MA, 2004, AM J HUM GENET, V75, P82, DOI 10.1086/421846; Patel S, 2002, AM J NEURORADIOL, V23, P1074; PIERQUIN G, 1989, AM J MED GENET, V33, P483, DOI 10.1002/ajmg.1320330414; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Raynes HR, 1999, J CHILD NEUROL, V14, P649, DOI 10.1177/088307389901401005; Romano S, 2006, NEUROPEDIATRICS, V37, P42, DOI 10.1055/s-2006-923838; Roume J, 1998, AM J HUM GENET, V63, P1095, DOI 10.1086/302062; Saar K, 1999, AM J HUM GENET, V65, P1666, DOI 10.1086/302655; SALONEN R, 1984, AM J MED GENET, V18, P671, DOI 10.1002/ajmg.1320180414; Satran D, 1999, AM J MED GENET, V86, P459; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; SCHURIG V, 1980, AM J MED GENET, V5, P373, DOI 10.1002/ajmg.1320050408; Silverstein DM, 1997, PEDIATR NEPHROL, V11, P746, DOI 10.1007/s004670050381; Smith UM, 2006, NAT GENET, V38, P191, DOI 10.1038/ng1713; Ueno Naoto, 2003, Birth Defects Research, V69, P318, DOI 10.1002/bdrc.10029; Utsch B, 2006, PEDIATR NEPHROL, V21, P32, DOI 10.1007/s00467-005-2054-y; Valente EM, 2003, AM J HUM GENET, V73, P663, DOI 10.1086/378241; Valente EM, 2005, ANN NEUROL, V57, P513, DOI 10.1002/ana.20422; Valente EM, 2006, ANN NEUROL, V59, P527, DOI 10.1002/ana.20749; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; VANDORP DB, 1991, AM J MED GENET, V40, P100, DOI 10.1002/ajmg.1320400121; Yachnis AT, 1999, J CHILD NEUROL, V14, P655, DOI 10.1177/088307389901401006	54	180	182	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2007	80	1					186	194		10.1086/510499	http://dx.doi.org/10.1086/510499			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	120RG	17160906	Bronze, Green Published			2022-12-18	WOS:000243102500018
J	Osawa, H; Yamada, K; Onuma, H; Murakami, A; Ochi, M; Kawata, H; Nishimiya, T; Niiya, T; Shimizu, I; Nishida, W; Hashiramoto, M; Kanatsuka, A; Fujii, Y; Ohashi, J; Makino, H				Osawa, H; Yamada, K; Onuma, H; Murakami, A; Ochi, M; Kawata, H; Nishimiya, T; Niiya, T; Shimizu, I; Nishida, W; Hashiramoto, M; Kanatsuka, A; Fujii, Y; Ohashi, J; Makino, H			The G/G genotype of a resistin single-nucleotide polymorphism at-420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SP FAMILY-MEMBERS; STIMULATE TRANSCRIPTION; HAPLOTYPE FREQUENCIES; RECOMBINANT RESISTIN; GLUCOSE-METABOLISM; INSULIN-RESISTANCE; SYSTEMATIC SEARCH; GENE; EXPRESSION; OBESITY	Insulin resistance is a major cause of type 2 diabetes mellitus (T2DM). Resistin, an adipocyte-secreted hormone, antagonizes insulin. Transgenic mice that overexpress the resistin gene (Retn) in adipose tissue are insulin-resistant, whereas Retn (-/-) mice show lower fasting blood glucose, suggesting that the altered Retn promoter function could cause diabetes. To determine the role of RETN in human T2DM, we analyzed polymorphisms in its 5' flanking region. We found that the -420G/G genotype was associated with T2DM (397 cases and 406 controls) (P = .008; adjusted odds ratio = 1.97 [by logistic regression analysis]) and could accelerate the onset of disease by 4.9 years (P = .006 [by multiple regression analysis]). Meta-analysis of 1,888 cases and 1,648 controls confirmed this association (P = .013). Linkage disequilibrium analysis revealed that the -420G/ G genotype itself was a primary variant determining T2DM susceptibility. Functionally, Sp1 and Sp3 transcription factors bound specifically to the susceptible DNA element that included -420G. Overexpression of Sp1 or Sp3 enhanced RETN promoter activity with -420G in Drosophila Schneider line 2 cells that lacked endogenous Sp family members. Consistent with these findings, fasting serum resistin levels were higher in subjects with T2DM who carried the -420G/G genotype. Therefore, the specific recognition of -420G by Sp1/3 increases RETN promoter activity, leading to enhanced serum resistin levels, thereby inducing human T2DM.	Ehime Univ, Sch Med, Dept Lab Med, Shigenobu, Ehime 7910295, Japan; Ehime Prefectural Hosp, Matsuyama, Ehime, Japan; Univ Fukui, Fac Med Sci, Dept Biochem, Fukui 910, Japan; Chiba Cent Med Ctr, Ctr Diabet, Chiba, Japan; Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo, Japan; Univ Tokyo, Grad Sch Med, Sch Int Hlth, Dept Human Genet, Tokyo, Japan	Ehime University; Ehime Prefectural Central Hospital; University of Fukui; Japan Science & Technology Agency (JST); University of Tokyo	Makino, H (corresponding author), Ehime Univ, Sch Med, Dept Lab Med, Shigenobu, Ehime 7910295, Japan.	hidemak@m.ehime-u.ac.jp	OHASHI, JUN/G-5907-2015					Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Banerjee RR, 2004, SCIENCE, V303, P1195, DOI 10.1126/science.1092341; Bouwman P, 2002, MOL CELL ENDOCRINOL, V195, P27, DOI 10.1016/S0303-7207(02)00221-6; Cho YM, 2004, DIABETOLOGIA, V47, P559, DOI 10.1007/s00125-003-1319-x; COUREY AJ, 1989, CELL, V59, P827, DOI 10.1016/0092-8674(89)90606-5; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; DINOCERA PP, 1983, P NATL ACAD SCI-BIOL, V80, P7095; Dooley KA, 1998, J BIOL CHEM, V273, P1349, DOI 10.1074/jbc.273.3.1349; Engert JC, 2002, DIABETES, V51, P1629, DOI 10.2337/diabetes.51.5.1629; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Fallin D, 2001, GENOME RES, V11, P143, DOI 10.1101/gr.148401; Fujinami A, 2004, CLIN CHIM ACTA, V339, P57, DOI 10.1016/j.cccn.2003.09.009; Gavin JR, 1999, DIABETES CARE, V22, pS5; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Kikkawa E, 2001, J BIOCHEM-TOKYO, V130, P885, DOI 10.1093/oxfordjournals.jbchem.a003062; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lee JH, 2003, J CLIN ENDOCR METAB, V88, P4848, DOI 10.1210/jc.2003-030519; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Ma XW, 2002, J CLIN ENDOCR METAB, V87, P4407, DOI 10.1210/jc.2002-020109; McCarthy MI, 2002, AM J PHYSIOL-ENDOC M, V283, pE217, DOI 10.1152/ajpendo.00099.2002; McTernan PG, 2003, J CLIN ENDOCR METAB, V88, P6098, DOI 10.1210/jc.2003-030898; Nagaev I, 2001, BIOCHEM BIOPH RES CO, V285, P561, DOI 10.1006/bbrc.2001.5173; Omi K, 2003, AM J HUM GENET, V72, P364, DOI 10.1086/346091; Osawa H, 2003, DIABETES, V52, P562, DOI 10.2337/diabetes.52.2.562; Osawa H, 2002, DIABETES, V51, P863, DOI 10.2337/diabetes.51.3.863; Patel SD, 2004, SCIENCE, V304, P1154, DOI 10.1126/science.1093466; Pravenec M, 2003, J BIOL CHEM, V278, P45209, DOI 10.1074/jbc.M304869200; Rajala MW, 2003, J CLIN INVEST, V111, P225, DOI 10.1172/JCI200316521; Savage DB, 2001, DIABETES, V50, P2199, DOI 10.2337/diabetes.50.10.2199; Shou ZF, 2003, GENE, V302, P83, DOI 10.1016/S0378-1119(02)01093-4; Smith SR, 2003, DIABETES, V52, P1611, DOI 10.2337/diabetes.52.7.1611; Steppan CM, 2004, J INTERN MED, V255, P439, DOI 10.1111/j.1365-2796.2004.01306.x; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Tokuhiro S, 2003, NAT GENET, V35, P341, DOI 10.1038/ng1267; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Yamada K, 1997, BIOCHEM J, V324, P917, DOI 10.1042/bj3240917; Yamada K, 1997, IEEE IND ELEC, P4, DOI 10.1109/IECON.1997.670904; Yamada K, 2000, J BIOL CHEM, V275, P18129, DOI 10.1074/jbc.M001543200	41	180	188	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2004	75	4					678	686		10.1086/424761	http://dx.doi.org/10.1086/424761			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	850SZ	15338456	Green Published, Bronze			2022-12-18	WOS:000223634100014
J	Angell, R				Angell, R			First-meiotic-division nondisjunction in human oocytes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MATERNAL AGE; MEIOSIS-I; REDUCED RECOMBINATION; TRISOMY FORMATION; FEMALE MICE; CHROMOSOME; MECHANISM; CHIASMA; ORIGIN	Reject oocytes from in vitro-fertilization patients are currently the only practical source of human oocyte material available for meiotic studies in women. Two hundred clearly analyzable second meiotic (MII) metaphase oocytes from 116 patients were examined for evidence of first meiotic (MI) division errors. The chromosome results, in which 67% of oocytes had a normal 23,X chromosome complement but none had an extra whole chromosome, cast doubt on the relevance, to human oocytes, of those theories of nondisjunction that propose that both chromosomes of the bivalent fail to disjoin at MI so that both move to one pole and result in an additional whole chromosome at MII metaphase. The only class of abnormality found in the MII oocytes had single chromatids (half-chromosomes) replacing whole chromosomes. Analysis of the chromosomally abnormal oocytes revealed an extremely close correlation with data on trisomies in spontaneous abortions, with respect to chromosome distribution, frequency, and maternal age, and indicated the likelihood of the chromatid abnormalities being the MI-division nondisjunction products that lead to trisomy formation after fertilization. The most likely derivation of the abnormalities is through a form of misdivision process usually associated with univalents, in which the centromeres divide precociously at MI, instead of MII, division. In the light of recent data that show that altered recombination patterns of the affected chromosomes are a key feature of most MI-division trisomies, the oocyte data imply that the vulnerable meiotic configurations arising from altered recombination patterns are processed as functional univalents in older women. Preliminary evidence from MI-metaphase oocytes supports this view.			Angell, R (corresponding author), UNIV EDINBURGH,DEPT OBSTET & GYNAECOL,37 CHALMERS ST,EDINBURGH EH3 9EW,MIDLOTHIAN,SCOTLAND.				Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANGELL RR, 1991, HUM GENET, V86, P383; ANGELL RR, 1994, CYTOGENET CELL GENET, V65, P194, DOI 10.1159/000133631; ANGELL RR, 1993, HUM REPROD, V8, P1047, DOI 10.1093/oxfordjournals.humrep.a138190; ANGELL RR, 1995, CYTOGENET CELL GENET, V69, P266, DOI 10.1159/000133977; Dailey T, 1996, AM J HUM GENET, V59, P176; Darlington C. D., 1937, RECENT ADV CYTOLOGY; FISHER JM, 1995, AM J HUM GENET, V56, P669; HASSOLD T, 1995, AM J HUM GENET, V57, P867; HASSOLD T, 1984, AM J HUM GENET, V36, P1349; HASSOLD TJ, 1984, ANNU REV GENET, V18, P69, DOI 10.1146/annurev.genet.18.1.69; HENDERSON SA, 1968, NATURE, V218, P22, DOI 10.1038/218022a0; HULTEN M, 1974, HEREDITAS, V76, P55; HUNT P, 1995, HUM MOL GENET, V4, P2007, DOI 10.1093/hmg/4.11.2007; Jacobs P A, 1992, Oxf Rev Reprod Biol, V14, P47; Jagiello G., 1976, CHROMOSOM TODAY, V5, P43; KAMIGUCHI Y, 1993, HUM GENET, V90, P533; Lamb NE, 1996, NAT GENET, V14, P400, DOI 10.1038/ng1296-400; LUTHARDT FW, 1973, CYTOGENET CELL GENET, V12, P68, DOI 10.1159/000130440; MITTELMAN F, 1995, ISCN INT SYSTEM HUMA; Munne S, 1995, HUM REPROD, V10, P1015; NAVOT D, 1991, LANCET, V337, P1375, DOI 10.1016/0140-6736(91)93060-M; POLANI P, 1982, HUM GENET, V62, P277, DOI 10.1007/BF00333536; POLANI PE, 1976, CYTOGENET CELL GENET, V16, P505, DOI 10.1159/000130668; POLANI PE, 1981, TRISOMY, V21, P111; RIEGER R, 1968, GLOSSARY GENETICS CY; RISCH N, 1986, AM J HUM GENET, V39, P68; ROBINSON WP, 1993, AM J HUM GENET, V53, P740; Sasaki, 1983, RAD INDUCED CHROMOSO, P411; SHERMAN SL, 1991, AM J HUM GENET, V49, P608; SHERMAN SL, 1994, HUM MOL GENET, V3, P1529, DOI 10.1093/hmg/3.9.1529; SPEED RM, 1977, CHROMOSOMA, V64, P241, DOI 10.1007/BF00328080; SUGAWARA S, 1983, CYTOGENET CELL GENET, V35, P34, DOI 10.1159/000131833; Sumner AT, 1990, CHROMOSOME BANDING, P155; WARBURTON D, 1980, HUMAN EMBRYONIC FETA, P261; White MJD., 1954, ANIMAL CYTOLOGY EVOL, V2; Wilson EB., 1925, CELL DEV HEREDITY, V3rd edition; Yoon PW, 1996, AM J HUM GENET, V58, P628; 1991, LANCET, V338, P285	38	180	184	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1997	61	1					23	32		10.1086/513890	http://dx.doi.org/10.1086/513890			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM728	9245981	Green Published, Bronze			2022-12-18	WOS:A1997XM72800008
J	MUNNE, S; GRIFO, J; COHEN, J; WEIER, HUG				MUNNE, S; GRIFO, J; COHEN, J; WEIER, HUG			CHROMOSOME-ABNORMALITIES IN HUMAN ARRESTED PREIMPLANTATION EMBRYOS - A MULTIPLE-PROBE FISH STUDY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FLUORESCENT INSITU HYBRIDIZATION; CYTOGENETIC ANALYSIS; HUMAN BLASTOMERES; HUMAN PREEMBRYOS; INVITRO; CELLS; FERTILIZATION; IMPLANTATION; MICROSCOPY; ANEUPLOIDY	Numerical chromosome abnormalities were studied in single blastomeres from arrested or otherwise morphologically abnormal human preimplantation embryos. A 6-h FISH procedure with fluorochrome-labeled DNA probes was developed to determine numerical abnormalities of chromosomes X, Y, and 18. The three chromosomes were stained and detected simultaneously in 571 blastomeres from 131 embryos. Successful analysis including biopsy, fixation, and FISH analysis was achieved in 86.5% of all blastomeres. The procedure described here offers a reliable alternative to sexing of embryos by PCR and allows simultaneous ploidy assessment. For the three chromosomes tested, numerical aberrations were found in 56.5% of the embryos. Most abnormal embryos were polyploid or mosaics, and 6.1% were aneuploid for gonosomes or chromosome 18. Extrapolation of these results to all human chromosomes suggests that the majority of abnormally developing and arrested human embryos carry numerical chromosome abnormalities.	UNIV CALIF SAN FRANCISCO,SCH MED,DEPT LAB MED,DIV MOLEC CYTOMETRY,SAN FRANCISCO,CA; UNIV CALIF BERKELEY,LAWRENCE BERKELEY LAB,DIV LIFE SCI,BERKELEY,CA 94720	University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	MUNNE, S (corresponding author), CORNELL UNIV,NEW YORK HOSP,MED CTR,DEPT OBSTET & GYNECOL,CTR REPROD MED & INFERTIL,NEW YORK,NY 10021, USA.			Munne, Santiago/0000-0002-1088-5565; Grifo, James/0000-0003-0439-2374				ARTLEY JK, 1992, HUM REPROD, V7, P1014, DOI 10.1093/oxfordjournals.humrep.a137761; ARTLEY JK, 1993, ASSISTED REPROD REV, V3, P13; BENKHALIFA M, 1993, HUM REPROD, V8, P895, DOI 10.1093/oxfordjournals.humrep.a138162; BOLTON VN, 1989, J IN VITRO FERTIL EM, V6, P30, DOI 10.1007/BF01134578; BONGSO A, 1991, FERTIL STERIL, V56, P66; BRAUDE P, 1988, NATURE, V332, P459, DOI 10.1038/332459a0; COHEN J, 1992, HUM REPROD, V7, P685, DOI 10.1093/oxfordjournals.humrep.a137720; DAUWERSE JG, 1992, HUM MOL GENET, V1, P593, DOI 10.1093/hmg/1.8.593; DREWS M, 1992, FERTIL STERIL S, V58, pS39; GORDON JW, 1986, J EXP ZOOL, V239, P347, DOI 10.1002/jez.1402390306; GRIFFIN DK, 1992, HUM GENET, V89, P18, DOI 10.1007/BF00207035; GRIFO JA, 1992, JAMA-J AM MED ASSOC, V268, P727, DOI 10.1001/jama.268.6.727; HANDYSIDE AH, 1989, LANCET, V1, P347; HASSOLD T, 1985, HUM GENET, V70, P11, DOI 10.1007/BF00389450; HOPMAN AHN, 1988, HISTOCHEMISTRY, V89, P307, DOI 10.1007/BF00500631; JACOBS PA, 1977, AM J EPIDEMIOL, V105, P180, DOI 10.1093/oxfordjournals.aje.a112374; JENKINS RB, 1992, BLOOD, V79, P3307; JOHNSON GD, 1981, J IMMUNOL METHODS, V43, P349, DOI 10.1016/0022-1759(81)90183-6; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; LAURIE DA, 1985, ANN HUM GENET, V49, P189, DOI 10.1111/j.1469-1809.1985.tb01693.x; LAWITTS JA, 1991, BIOL REPROD, V45, P245, DOI 10.1095/biolreprod45.2.245; MARTIN RH, 1990, CYTOGENET CELL GENET, V53, P103, DOI 10.1159/000132905; MENEZO YJR, 1990, BIOL REPROD, V42, P301, DOI 10.1095/biolreprod42.2.301; MUNNE S, 1993, HUM REPROD, V8, P2185, DOI 10.1093/oxfordjournals.humrep.a138001; MUNNE S, 1993, HUM REPROD, V8, P1120, DOI 10.1093/oxfordjournals.humrep.a138204; MUNNE S, 1993, J ASSIST REPROD GEN, V10, P82, DOI 10.1007/BF01204446; MUNNE S, IN PRESS HUMAN REPRO; NEDERLOF PM, 1992, CYTOMETRY, V13, P839, DOI 10.1002/cyto.990130806; Papadopoulus G., 1988, HUM REPROD, V4, P91; PIETERS MHEC, 1990, CYTOGENET CELL GENET, V53, P15, DOI 10.1159/000132886; PIETERS MHEC, 1992, J ASSIST REPROD GEN, V9, P68, DOI 10.1007/BF01204118; PINKEL D, 1986, COLD SPRING HARB SYM, V51, P151, DOI 10.1101/SQB.1986.051.01.018; PLACHOT M, 1987, HUM REPROD, V2, P29, DOI 10.1093/oxfordjournals.humrep.a136484; PLACHOT M, 1988, HUM REPROD, V3, P627, DOI 10.1093/oxfordjournals.humrep.a136758; SCHRURS BM, 1993, HUM REPROD, V8, P296, DOI 10.1093/oxfordjournals.humrep.a138040; STROM CM, 1991, J IN VITRO FERTIL EM, V8, P225, DOI 10.1007/BF01130810; TARKOWSKI AK, 1966, CYTOGENETICS, V5, P394, DOI 10.1159/000129914; TELFORD NA, 1990, MOL REPROD DEV, V26, P90, DOI 10.1002/mrd.1080260113; VEEK LL, 1991, ATLAS HUMAN OOCYTE E, V2, P167; Warburton D, 1986, PERINATAL GENETICS D, P133; WEST JD, 1988, HUM REPROD, V3, P1010, DOI 10.1093/oxfordjournals.humrep.a136814; WIEMER KE, 1989, HUM REPROD, V4, P595, DOI 10.1093/oxfordjournals.humrep.a136949; WINSTON NJ, 1991, HUM REPROD, V6, P17, DOI 10.1093/oxfordjournals.humrep.a137253; 1992, FERTIL STERIL, V57, P15	44	180	182	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1994	55	1					150	159						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NW461	8023843				2022-12-18	WOS:A1994NW46100021
J	SHOSHANI, T; AUGARTEN, A; GAZIT, E; BASHAN, N; YAHAV, Y; RIVLIN, Y; TAL, A; SERET, H; YAAR, L; KEREM, E; KEREM, BS				SHOSHANI, T; AUGARTEN, A; GAZIT, E; BASHAN, N; YAHAV, Y; RIVLIN, Y; TAL, A; SERET, H; YAAR, L; KEREM, E; KEREM, BS			ASSOCIATION OF A NONSENSE MUTATION (W1282X), THE MOST COMMON MUTATION IN THE ASHKENAZI JEWISH CYSTIC-FIBROSIS PATIENTS IN ISRAEL, WITH PRESENTATION OF SEVERE DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							STEROID 21-HYDROXYLASE DEFICIENCY; ENZYMATIC AMPLIFICATION; GENE; IDENTIFICATION; DNA; METABOLISM; PHENOTYPE; DIAGNOSIS	Only about 30% of the cystic fibrosis chromosomes in the Israeli cystic fibrosis patient populations carry the major CF mutation (DELTA-F508). Since different Jewish ethnic groups tended to live as closed isolates until recent times, high frequencies of specific mutations are expected among the remainder cystic fibrosis chromosomes of these ethnic groups. Genetic factors appear to influence the severity of the disease. It is therefore expected that different mutations will be associated with either severe or mild phenotype. Direct genomic sequencing of exons included in the two nucleotide-binding folds of the putative CFTR protein was performed on 119 Israeli cystic fibrosis patients from 97 families. One sequence alteration which is expected to create a termination at residue 1282 (W1282X) was found in 63 chromosomes. Of 95 chromosomes, 57 (60%) are of Ashkenazi origin. Together with the DELTA-F508 (23% in this group), G542X, N1303K, and 1717-1G --> A mutations, the identification of 92% of cystic fibrosis chromosomes of Ashkenazi origin becomes possible. Patients homozygous for the W1282X mutation (n = 16) and patients heterozygous for the DELTA-F508 and W1282X mutations (n = 22) had similarly severe disease, reflected by pancreatic insufficiency, high incidence of meconium ileus (37% and 27%, respectively), early age at diagnosis, poor nutritional status, and variable pulmonary function. In conclusion, the W1282X mutation is the most common cystic fibrosis mutation in the Ashkenazi Jewish patient population in Israel. This nonsense mutation is associated with presentation of severe disease.	HEBREW UNIV JERUSALEM,INST LIFE SCI,DEPT GENET,IL-91904 JERUSALEM,ISRAEL; TECHNION ISRAEL INST TECHNOL,CARMEL HOSP,SCH MED,DEPT PEDIAT,HAIFA,ISRAEL; NEGEV UNIV,SOROKA MED CTR,DEPT PEDIAT,BEER SHEVA,ISRAEL; TEL AVIV UNIV,CHAIM SHEBA MED CTR,SACKLER SCH MED,DEPT PEDIAT,TEL HASHOMER,ISRAEL; HEBREW UNIV JERUSALEM,BIKUR CHOLIM HOSP,HADASSAH MED SCH,DEPT PEDIAT,JERUSALEM,ISRAEL; TEL AVIV UNIV,CHAIM SHEBA MED CTR,SACKLER SCH MED,TISSUE TYPING LAB,TEL HASHOMER,ISRAEL	Hebrew University of Jerusalem; Clalit Health Services; Carmel Medical Center; Technion Israel Institute of Technology; Ben Gurion University; Soroka Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Hebrew University of Jerusalem; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine			Tal, Asher/B-4286-2012	Tal, Asher/0000-0002-5670-8804				ADAMS JG, 1990, SEMIN HEMATOL, V27, P229; ANDERSON MP, 1991, SCIENCE, V251, P670; BASERGA SJ, 1988, P NATL ACAD SCI USA, V85, P2056, DOI 10.1073/pnas.85.7.2056; Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; CUTTING GR, 1990, NEW ENGL J MED, V323, P1517; Cystic Fibrosis Genetic Anal Consortium, 1990, AM J HUM GENET, V47, P354; DAAR IO, 1988, MOL CELL BIOL, V8, P802, DOI 10.1128/MCB.8.2.802; DEAN M, 1990, CELL, V61, P863, DOI 10.1016/0092-8674(90)90196-L; DURIE PR, 1986, PEDIATR RES, V20, P209, DOI 10.1203/00006450-198603000-00002; GASPARINI P, 1991, GENOMICS, V10, P193, DOI 10.1016/0888-7543(91)90500-E; GITSCHIER J, 1986, SCIENCE, V232, P1415, DOI 10.1126/science.3012775; GLOBERMAN H, 1988, J CLIN INVEST, V82, P139, DOI 10.1172/JCI113562; GUILLERMIT H, 1990, HUM GENET, V85, P450, DOI 10.1007/BF02428306; IANNUZZI MC, 1991, AM J HUM GENET, V48, P227; IVASCHENKO TE, 1991, GENOMICS, V10, P298, DOI 10.1016/0888-7543(91)90517-I; KARTNER N, 1991, CELL, V64, P681, DOI 10.1016/0092-8674(91)90498-N; KEREM BS, 1990, P NATL ACAD SCI USA, V87, P8447, DOI 10.1073/pnas.87.21.8447; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KEREM BS, 1989, AM J HUM GENET, V44, P827; KEREM E, 1990, NEW ENGL J MED, V323, P1517, DOI 10.1056/NEJM199011293232203; KEREM E, 1989, J PEDIATR-US, V114, P767, DOI 10.1016/S0022-3476(89)80134-9; KOBAYASHI K, 1990, AM J HUM GENET, V47, P611; LEMNA WK, 1990, NEW ENGL J MED, V322, P291, DOI 10.1056/NEJM199002013220503; LERER I, 1990, HUM GENET, V416, P85; LIM SK, 1989, EMBO J, V8, P2613, DOI 10.1002/j.1460-2075.1989.tb08401.x; OSBORNE L, 1991, AM J HUM GENET, V48, P608; Polgar G, 1971, PULMONARY FUNCTION T; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS J, 1990, AM J HUM GENET, V46, P395; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; ROTH C, 1971, KETER JERUSALEM, V3, P719; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANTIS G, 1990, LANCET, V335, P1426, DOI 10.1016/0140-6736(90)91448-J; TANNER JM, 1966, ARCH DIS CHILD, V41, P454, DOI 10.1136/adc.41.219.454; TSUI LC, 1985, SCIENCE, V230, P1045; VANDEKAMER JH, 1949, J BIOL CHEM, V177, P347; VIDAUD M, 1990, HUM GENET, V85, P446, DOI 10.1007/BF02428305; WHITE MB, 1991, GENOMICS, V10, P266, DOI 10.1016/0888-7543(91)90510-L; WHITE MB, 1990, NATURE, V344, P665, DOI 10.1038/344665a0; WHITE PC, 1989, ENDOCR RES, V15, P239, DOI 10.1080/07435808909039099; WINSHIP PR, 1989, NUCLEIC ACIDS RES, V17, P1266, DOI 10.1093/nar/17.3.1266; ZIELENSKI J, 1991, GENOMICS, V10, P229, DOI 10.1016/0888-7543(91)90504-8; ZIELENSKI J, 1991, GENOMICS, V10, P214, DOI 10.1016/0888-7543(91)90503-7; [No title captured]	46	180	180	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1992	50	1					222	228						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HA040	1370365				2022-12-18	WOS:A1992HA04000024
J	CRAIGHOLMES, AP; MOORE, FB; SHAW, MW				CRAIGHOLMES, AP; MOORE, FB; SHAW, MW			POLYMORPHISM OF HUMAN C-BAND HETEROCHROMATIN .1. FREQUENCY OF VARIANTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TEXAS, MD ANDERSON HOSP & TUMOR INST, HOUSTON, TX 77025 USA; UNIV TEXAS, GRAD SCH BIOMED SCI, DEPT BIOL, HOUSTON, TX 77025 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System								ARRIGHI FE, 1971, CYTOGENETICS, V10, P81, DOI 10.1159/000130130; ARRIGHI FE, 1971, EXPERIENTIA, V27, P964, DOI 10.1007/BF02135776; CASPERSSON T, 1971, HEREDITAS-GENETISK A, V67, P89; CHEN TR, 1971, CHROMOSOMA, V34, P51, DOI 10.1007/BF00285516; CRAIGHOLMES AP, 1971, SCIENCE, V174, P702, DOI 10.1126/science.174.4010.702; DRETS ME, 1971, P NATL ACAD SCI USA, V68, P2073, DOI 10.1073/pnas.68.9.2073; EVANS HJ, 1971, CHROMOSOMA, V35, P310, DOI 10.1007/BF00326281; FLAMM WG, 1972, INT REV CYTOL, V32, P1, DOI 10.1016/S0074-7696(08)60337-X; HSU TC, 1972, P NATL ACAD SCI USA, V69, P1464, DOI 10.1073/pnas.69.6.1464; HSU TC, 1971, CHROMOSOMA, V34, P73, DOI 10.1007/BF00285517; JONES KW, 1971, NATURE-NEW BIOL, V233, P268, DOI 10.1038/newbio233268a0; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; Parker Don F., IN PRESS, P75; SAUNDERS GF, 1972, NATURE-NEW BIOL, V236, P244, DOI 10.1038/newbio236244a0; SAUNDERS GF, 1972, J MOL BIOL, V63, P323, DOI 10.1016/0022-2836(72)90430-5; STUBBLEFIELD E, IN PRESS	17	180	182	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1973	25	2					181	192						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	P0622	4120239				2022-12-18	WOS:A1973P062200007
J	Hughes, AE; Bradley, DT; Campbell, M; Lechner, J; Dash, DP; Simpson, DA; Willoughby, CE				Hughes, Anne E.; Bradley, Declan T.; Campbell, Malcolm; Lechner, Judith; Dash, Durga P.; Simpson, David A.; Willoughby, Colin E.			Mutation Altering the miR-184 Seed Region Causes Familial Keratoconus with Cataract	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE; POPULATION; APOPTOSIS; SHIP2; LOCUS; VSX1; EYE	MicroRNAs (miRNAs) bind to complementary sequences within the 3' untranslated region (UTR) of mRNAs from hundreds of target genes, leading either to mRNA degradation or suppression of translation. We found that a mutation in the seed region of miR-184 (MIR184) is responsible for familial severe keratoconus combined with early-onset anterior polar cataract by deep sequencing of a linkage region known to contain the mutation. The mutant form fails to compete with miR-205 (MIR205) for overlapping target sites on the 3' UTRs of INPPL1 and ITGB4. Although these target genes and miR-205 are expressed widely, the phenotype is restricted to the cornea and lens because of the very high expression of miR-184 in these tissues. Our finding highlights the tissue specificity of a gene network regulated by a miRNA. Awareness of the important function of miRNAs could aid identification of susceptibility genes and new therapeutic targets for treatment of both rare and common diseases.	[Hughes, Anne E.; Bradley, Declan T.; Campbell, Malcolm] Queens Univ Belfast, Royal Victoria Hosp, Ctr Publ Hlth, Belfast BT12 6BN, Antrim, North Ireland; [Lechner, Judith; Dash, Durga P.; Simpson, David A.; Willoughby, Colin E.] Queens Univ Belfast, Royal Victoria Hosp, Ctr Vis & Vasc Sci, Belfast BT12 6BA, Antrim, North Ireland	Queens University Belfast; Queens University Belfast	Hughes, AE (corresponding author), Queens Univ Belfast, Royal Victoria Hosp, Ctr Publ Hlth, Grosvenor Rd, Belfast BT12 6BN, Antrim, North Ireland.	a.hughes@qub.ac.uk	Bradley, Declan/AFN-7904-2022; Bradley, Declan T/AFO-1353-2022; Hughes, Anne/A-1307-2012; Lechner, Judith/GQH-8616-2022	Bradley, Declan/0000-0003-1468-1823; Willoughby, Colin/0000-0002-1246-4166; Simpson, David/0000-0003-0157-1211	Northern Ireland Research and Development Office [4.46]; Fight for Sight [1787]; Public Health Agency (Northern Ireland); Public Health Agency [EAT/3976/08] Funding Source: researchfish	Northern Ireland Research and Development Office; Fight for Sight; Public Health Agency (Northern Ireland); Public Health Agency	This work was supported by Northern Ireland Research and Development Office RRG grant 4.46 and Fight for Sight grant 1787. D.T.B. was funded by the Public Health Agency (Northern Ireland). We are grateful for the longstanding interest of the family who participated in the study and to the clinicians who recruited and cared for the family. Bioinformatics work was conducted on the Queen's University of Belfast High Performance Computing Dell cluster.	*1000 GEN, 1000 GEN PROJ; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; [Anonymous], INTEGRATIVE GENOMICS; [Anonymous], MAPPING ASSEMBLY QUA; [Anonymous], SAMTOOLS; [Anonymous], GENOME ANAL TOOLKIT; [Anonymous], BURROWS WHEELER ALIG; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Bremond-Gignac D, 2010, MOL VIS, V16, P1705; DAI E, 2009, OPHTHALMOLOGY, P381; Dash DP, 2010, EYE, V24, P1085, DOI 10.1038/eye.2009.217; Dash D, 2006, MOL VIS, V12, P499; *ENR LAB, 2011, MICROCOSM TARG VERS; Enright AJ, 2004, GENOME BIOL, V5; Ghosheh Faris R., 2008, International Ophthalmology, V28, P147, DOI 10.1007/s10792-007-9177-z; Heon E, 2002, HUM MOL GENET, V11, P1029, DOI 10.1093/hmg/11.9.1029; Hughes AE, 2003, INVEST OPHTH VIS SCI, V44, P5063, DOI 10.1167/iovs.03-0399; Hysi PG, 2010, NAT GENET, V42, P902, DOI 10.1038/ng.664; John B, 2004, PLOS BIOL, V2, pe363, DOI [10.1371/journal.pbio.0020363, DOI 10.1371/J0URNAL.PBI0.0020363]; Karali M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-715; KENNEDY RH, 1986, AM J OPHTHALMOL, V101, P267, DOI 10.1016/0002-9394(86)90817-2; Kim WJ, 1999, EXP EYE RES, V69, P475, DOI 10.1006/exer.1999.0719; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; Meola Nicola, 2009, Pathogenetics, V2, P7, DOI 10.1186/1755-8417-2-7; Meyron-Holtz EG, 2004, SCIENCE, V306, P2087, DOI 10.1126/science.1103786; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; NISHIDA T, 2011, CORNEA, P17; Prasad NK, 2005, J BIOL CHEM, V280, P13129, DOI 10.1074/jbc.M410289200; R Development Core Team, 2009, R LANG ENV STAT COMP; Robichon C, 2006, BBA-MOL CELL BIOL L, V1761, P1107, DOI 10.1016/j.bbalip.2006.07.007; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Ryan D, 2006, MOL VIS, V12, P1175; Wilson SE, 2007, EXP EYE RES, V85, P305, DOI 10.1016/j.exer.2007.06.009; Yu J, 2008, P NATL ACAD SCI USA, V105, P19300, DOI 10.1073/pnas.0803992105; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; GPLOTS; MICROCOSM TARGETS; GENOMIC ANNOTATOR DA; VCFTOOLS	43	179	193	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV 11	2011	89	5					628	633		10.1016/j.ajhg.2011.09.014	http://dx.doi.org/10.1016/j.ajhg.2011.09.014			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	848YD	21996275	Bronze, Green Accepted, Green Published			2022-12-18	WOS:000297090100004
J	Vernes, SC; Spiteri, E; Nicod, J; Groszer, M; Taylor, JM; Davies, KE; Geschwind, DH; Fisher, SE				Vernes, Sonja C.; Spiteri, Elizabeth; Nicod, Jerome; Groszer, Matthias; Taylor, Jennifer M.; Davies, Kay E.; Geschwind, Daniel H.; Fisher, Simon E.			High-throughput analysis of promoter occupancy reveals direct neural targets of FOXP2, a gene mutated in speech and language disorders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSCRIPTION FACTORS; MICE LACKING; INHERITED SPEECH; FORKHEAD-DOMAIN; BINDING; DNA; EXPRESSION; PROTEIN; FAMILY; REPRESSOR	We previously discovered that mutations of the human FOXP2 gene cause a monogenic communication disorder, primarily characterized by difficulties in learning to make coordinated sequences of articulatory gestures that underlie speech. Affected people have deficits in expressive and receptive linguistic processing and display structural and/or functional abnormalities in cortical and subcortical brain regions. FOXP2 provides a unique window into neural processes involved in speech and language. In particular, its role as a transcription factor gene offers powerful functional genomic routes for dissecting critical neurogenetic mechanisms. Here, we employ chromatin immunoprecipitation coupled with promoter microarrays (ChIP-chip) to successfully identify genomic sites that are directly bound by FOXP2 protein in native chromatin of human neuron-like cells. We focus on a subset of downstream targets identified by this approach, showing that altered FOXP2 levels yield significant changes in expression in our cell-based models and that FOXP2 binds in a specific manner to consensus sites within the relevant promoters. Moreover, we demonstrate significant quantitative differences in target expression in embryonic brains of mutant mice, mediated by specific in vivo Foxp2-chromatin interactions. This work represents the first identification and in vivo verification of neural targets regulated by FOXP2. Our data indicate that FOXP2 has dual functionality acting to either repress or activate gene expression at occupied promoters. The identified targets suggest roles in modulating synaptic plasticity, neurodevelopment, neurotransmission, and axon guidance and represent novel entry points into in vivo pathways that may be disturbed in speech and language disorders.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Oxford, Med Res Council Functional Genet Unit, Oxford, England; Univ Calif Los Angeles, Dept Neurol, Program Neurogenet, Los Angeles, CA USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Semel Inst, Los Angeles, CA USA	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Fisher, SE (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	simon.fisher@well.ox.ac.uk	Taylor, Jennifer M/A-1686-2010; Groszer, Matthias/P-6291-2017; Fisher, Simon E./E-9130-2012; Vernes, Sonja/E-8454-2012	Taylor, Jennifer M/0000-0003-4231-0181; Fisher, Simon E./0000-0002-3132-1996; Vernes, Sonja/0000-0003-0305-4584; Groszer, Matthias/0000-0002-6209-305X	Medical Research Council [MC_U137761449] Funding Source: Medline; NIGMS NIH HHS [T32GM008243, T32 GM008243] Funding Source: Medline; NIMH NIH HHS [R21 MH075028, 5R21MH075028] Funding Source: Medline; Wellcome Trust [080971] Funding Source: Medline; Autism Speaks [AS1309] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH075028] Funding Source: NIH RePORTER; MRC [MC_U137761449] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wellcome Trust(Wellcome Trust); Autism Speaks; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abu-Khalil A, 2004, J COMP NEUROL, V474, P276, DOI 10.1002/cne.20112; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailey T.L., 1994, P 2 INT C INT SYST M, V2, P28; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Beima KM, 2006, J BIOL CHEM, V281, P11992, DOI 10.1074/jbc.M513613200; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertram L, 2005, J MED GENET, V42, P857, DOI 10.1136/jmg.2004.024596; Bird AJ, 2004, EMBO J, V23, P1123, DOI 10.1038/sj.emboj.7600122; Breslin MB, 2003, J BIOL CHEM, V278, P38991, DOI 10.1074/jbc.M306795200; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Feuk L, 2006, AM J HUM GENET, V79, P965, DOI 10.1086/508902; Fisher SE, 2006, NAT REV GENET, V7, P9, DOI 10.1038/nrg1747; Fisher SE, 2003, ANNU REV NEUROSCI, V26, P57, DOI 10.1146/annurev.neuro.26.041002.131144; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674; Ishibashi K., 2003, NEPHRON PHYSIOL, V94, P10; Katoh M, 2004, INT J ONCOL, V25, P1495; Kim TH, 2006, ANNU REV GENOM HUM G, V7, P81, DOI 10.1146/annurev.genom.7.080505.115634; Lai CSL, 2003, BRAIN, V126, P2455, DOI 10.1093/brain/awg247; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lehmann OJ, 2003, TRENDS GENET, V19, P339, DOI 10.1016/S0168-9525(03)00111-2; Li SR, 2004, MOL CELL BIOL, V24, P809, DOI 10.1128/MCB.24.2.809-822.2004; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Liegeois F, 2003, NAT NEUROSCI, V6, P1230, DOI 10.1038/nn1138; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lonze BE, 2002, NEURON, V34, P371, DOI 10.1016/S0896-6273(02)00686-4; MacDermot KD, 2005, AM J HUM GENET, V76, P1074, DOI 10.1086/430841; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Oberley MJ, 2003, METHOD ENZYMOL, V371, P577; OVERDIER DG, 1994, MOL CELL BIOL, V14, P2755, DOI 10.1128/MCB.14.4.2755; PAHLMAN S, 1990, ACTA PHYSIOL SCAND, V140, P25; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; Reimer RJ, 2004, PFLUG ARCH EUR J PHY, V447, P629, DOI 10.1007/s00424-003-1087-y; Rudolph D, 1998, P NATL ACAD SCI USA, V95, P4481, DOI 10.1073/pnas.95.8.4481; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Scharff C, 2005, CURR OPIN NEUROBIOL, V15, P694, DOI 10.1016/j.conb.2005.10.004; Schubert LA, 2001, J BIOL CHEM, V276, P37672, DOI 10.1074/jbc.M104521200; Shriberg LD, 2006, J SPEECH LANG HEAR R, V49, P500, DOI 10.1044/1092-4388(2006/038); Smyth G. K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027/MACHINEREADABLECITATION/RIS]; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Spiteri E, 2007, AM J HUM GENET, V81, P1144, DOI 10.1086/522237; Strausberg RL, 2001, J PATHOL, V195, P31, DOI 10.1002/1096-9896(200109)195:1<31::AID-PATH920>3.0.CO;2-W; Stroud JC, 2006, STRUCTURE, V14, P159, DOI 10.1016/j.str.2005.10.005; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; Vernes SC, 2006, HUM MOL GENET, V15, P3154, DOI 10.1093/hmg/ddl392; Wang B, 2003, J BIOL CHEM, V278, P24259, DOI 10.1074/jbc.M207174200; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Washburn BK, 2001, MOL CELL BIOL, V21, P2057, DOI 10.1128/MCB.21.6.2057-2069.2001; Wassink TH, 2004, MENT RETARD DEV D R, V10, P272, DOI 10.1002/mrdd.20041; Watkins KE, 2002, BRAIN, V125, P452, DOI 10.1093/brain/awf058; Watkins KE, 2002, BRAIN, V125, P465, DOI 10.1093/brain/awf057; Wehr R, 1997, DEVELOPMENT, V124, P4447; White SA, 2006, J NEUROSCI, V26, P10376, DOI 10.1523/JNEUROSCI.3379-06.2006; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; YOON JB, 1994, MOL CELL BIOL, V14, P1776, DOI 10.1128/MCB.14.3.1776; Zeesman S, 2006, AM J MED GENET A, V140A, P509, DOI 10.1002/ajmg.a.31110; Zhang B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-16; Zhang JZ, 2002, GENETICS, V162, P1825; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zhou CJ, 2006, NEUROSCIENCE, V142, P1119, DOI 10.1016/j.neuroscience.2006.07.007	61	179	182	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2007	81	6					1232	1250		10.1086/522238	http://dx.doi.org/10.1086/522238			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233NY	17999362	Bronze, Green Published			2022-12-18	WOS:000251098800009
J	Amr, S; Heisey, C; Zhang, M; Xia, XJ; Shows, KH; Ajlouni, K; Pandya, A; Satin, LS; El-Shanti, H; Shiang, R				Amr, Sami; Heisey, Cindy; Zhang, Min; Xia, Xia-Juan; Shows, Kathryn H.; Ajlouni, Kamel; Pandya, Arti; Satin, Leslie S.; El-Shanti, Hatem; Shiang, Rita			A homozygous mutation in a novel zinc-finger protein, ERIS, is responsible for Wolfram syndrome 2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FREE CA2+ CONCENTRATION; PANCREATIC BETA-CELLS; ENDOPLASMIC-RETICULUM; WOLFRAM-SYNDROME; OPTIC ATROPHY; DIABETES-MELLITUS; TRANSMEMBRANE PROTEIN; MISSENSE MUTATION; LUMINAL CALCIUM; GENE	A single missense mutation was identified in a novel, highly conserved zinc-finger gene, ZCD2, in three consanguineous families of Jordanian descent with Wolfram syndrome (WFS). It had been shown that these families did not have mutations in the WFS1 gene (WFS1) but were mapped to the WFS2 locus at 4q22-25. A GrC transversion at nucleotide 109 predicts an amino acid change from glutamic acid to glutamine (E37Q). Although the amino acid is conserved and the mutation is nonsynonymous, the pathogenesis for the disorder is because the mutation also causes aberrant splicing. The mutation was found to disrupt messenger RNA splicing by eliminating exon 2, and it results in the introduction of a premature stop codon. Mutations in WFS1 have also been found to cause low-frequency nonsyndromic hearing loss, progressive hearing loss, and isolated optic atrophy associated with hearing loss. Screening of 377 probands with hearing loss did not identify mutations in the WFS2 gene. The WFS1-encoded protein, Wolframin, is known to localize to the endoplasmic reticulum and plays a role in calcium homeostasis. The ZCD2-encoded protein, ERIS (endoplasmic reticulum intermembrane small protein), is also shown to localize to the endoplasmic reticulum but does not interact directly with Wolframin. Lymphoblastoid cells from affected individuals show a significantly greater rise in intracellular calcium when stimulated with thapsigargin, compared with controls, although no difference was observed in resting concentrations of intracellular calcium.	Virginia Commonwealth Univ, Dept Human Genet, Richmond, VA 23284 USA; Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA; Univ Jordan, Natl Ctr Diabet Endocrinol & Genet, Amman, Jordan; Univ Jordan, Dept Internal Med, Amman, Jordan; Univ Iowa, Childrens Hosp, Dept Pediat, Iowa City, IA USA	Virginia Commonwealth University; Virginia Commonwealth University; University of Jordan; University of Jordan; University of Iowa	Shiang, R (corresponding author), POB 980033, Richmond, VA 23298 USA.	rshiang@vcu.edu	El-Shanti, Hatem/O-5990-2014; EL-SHANTI, HATEM/Q-4932-2016	El-Shanti, Hatem/0000-0001-6230-8316; EL-SHANTI, HATEM/0000-0001-6230-8316; Shows, Kathryn Hanson/0000-0001-5392-6315; Ajlouni, Kamel/0000-0001-5569-6306; Amr, Sami/0000-0003-0927-6057	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046409] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK046409, R01 DK46409RS] Funding Source: Medline; PHS HHS [5P3ONSO47463] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ajlouni K, 2002, AM J MED GENET, V115, P61, DOI 10.1002/ajmg.10345; Al-Sheyyab M, 2001, EUR J PEDIATR, V160, P243, DOI 10.1007/s004310000704; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barrett TG, 1997, EYE, V11, P882, DOI 10.1038/eye.1997.226; BASSANI JWM, 1995, AM J PHYSIOL-CELL PH, V268, pC1313, DOI 10.1152/ajpcell.1995.268.5.C1313; Bespalova IN, 2001, HUM MOL GENET, V10, P2501, DOI 10.1093/hmg/10.22.2501; BLASI C, 1986, DIABETES CARE, V9, P521, DOI 10.2337/diacare.9.5.521; Cann HM, 2002, SCIENCE, V296, P261; CARSON MJ, 1977, AM J DIS CHILD, V131, P1382, DOI 10.1001/archpedi.1977.02120250064010; Collier DA, 1996, AM J HUM GENET, V59, P855; Collins P, 2000, NAT REV NEUROSCI, V1, P4, DOI 10.1038/35036157; Cooper TA, 1997, AM J HUM GENET, V61, P259, DOI 10.1086/514856; CREMERS C W R J, 1977, Acta Paediatrica Scandinavica Supplement, P1; DAVID V, 1993, J BIOL CHEM, V268, P9585; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Eiberg H, 2006, J MED GENET, V43, P435, DOI 10.1136/jmg.2005.034892; El-Shanti H, 2000, AM J HUM GENET, V66, P1229, DOI 10.1086/302858; Fonseca SG, 2005, J BIOL CHEM, V280, P39609, DOI 10.1074/jbc.M507426200; Genis D, 1997, ACTA NEUROPATHOL, V93, P426, DOI 10.1007/s004010050635; Gomez-Zaera M, 2001, MOL GENET METAB, V72, P72, DOI 10.1006/mgme.2000.3107; Guo Q, 1999, NAT MED, V5, P101, DOI 10.1038/4789; Gyorke I, 2004, BIOPHYS J, V86, P2121, DOI 10.1016/S0006-3495(04)74271-X; Gyorke I, 1998, BIOPHYS J, V75, P2801, DOI 10.1016/S0006-3495(98)77723-9; HAN S, 1994, J PHYSIOL-LONDON, V480, P411, DOI 10.1113/jphysiol.1994.sp020371; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Inoue H, 1998, NAT GENET, V20, P143, DOI 10.1038/2441; JOUAVILLE LS, 1995, NATURE, V377, P438, DOI 10.1038/377438a0; Kanner EM, 2002, BIOCHEMISTRY-US, V41, P7707, DOI 10.1021/bi0256882; Khanim F, 2001, HUM MUTAT, V17, P357, DOI 10.1002/humu.1110.abs; KUENZEL EA, 1987, J BIOL CHEM, V262, P9136; KUZNETSOV G, 1992, J BIOL CHEM, V267, P3932; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Leissring MA, 2000, J CELL BIOL, V149, P793, DOI 10.1083/jcb.149.4.793; LODISH HF, 1992, J BIOL CHEM, V267, P12753; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Mackay JP, 1998, TRENDS BIOCHEM SCI, V23, P1, DOI 10.1016/S0968-0004(97)01168-7; Minton JAL, 2003, REV ENDOCR METAB DIS, V4, P53, DOI 10.1023/A:1021875403463; Mogami H, 1998, EMBO J, V17, P435, DOI 10.1093/emboj/17.2.435; ONORATO JJ, 1991, BIOCHEMISTRY-US, V30, P5118, DOI 10.1021/bi00235a002; Osman AA, 2003, J BIOL CHEM, V278, P52755, DOI 10.1074/jbc.M310331200; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Solovyova N, 2002, EMBO J, V21, P622, DOI 10.1093/emboj/21.4.622; Strom TM, 1998, HUM MOL GENET, V7, P2021, DOI 10.1093/hmg/7.13.2021; Takeda K, 2001, HUM MOL GENET, V10, P477, DOI 10.1093/hmg/10.5.477; Takei D, 2006, FEBS LETT, V580, P5635, DOI 10.1016/j.febslet.2006.09.007; Wolfram DJ, 1938, P MAYO CLIN, V13, P715; Yamada T, 2006, HUM MOL GENET, V15, P1600, DOI 10.1093/hmg/ddl081; Yokoyama K, 2002, EMBO J, V21, P83, DOI 10.1093/emboj/21.1.83; Young TL, 2001, HUM MOL GENET, V10, P2509, DOI 10.1093/hmg/10.22.2509; Zhang M, 2003, BIOPHYS J, V84, P2852, DOI 10.1016/S0006-3495(03)70014-9	53	179	184	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2007	81	4					673	683		10.1086/520961	http://dx.doi.org/10.1086/520961			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	208GK	17846994	Green Published, Bronze			2022-12-18	WOS:000249307600010
J	Heuser, A; Plovie, ER; Ellinor, PT; Grossmann, KS; Shin, JT; Wichter, T; Basson, CT; Lerman, BB; Sasse-Klaassen, S; Thierfelder, L; MacRae, CA; Gerull, B				Heuser, Arnd; Plovie, Eva R.; Ellinor, Patrick T.; Grossmann, Katja S.; Shin, Jordan T.; Wichter, Thomas; Basson, Craig T.; Lerman, Bruce B.; Sasse-Klaassen, Sabine; Thierfelder, Ludwig; MacRae, Calum A.; Gerull, Brenda			Mutant desmocollin-2 causes arrhythmogenic right ventricular cardiomyopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CELL-CELL ADHESION; DESMOSOMAL CADHERINS; PALMOPLANTAR KERATODERMA; PLAKOPHILIN-2 MUTATIONS; WOOLLY HAIR; PLAKOGLOBIN; GENE; DYSPLASIA/CARDIOMYOPATHY; DESMOPLAKIN; DYSPLASIA	Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetically heterogeneous heart-muscle disorder characterized by progressive fibrofatty replacement of right ventricular myocardium and an increased risk of sudden cardiac death. Mutations in desmosomal proteins that cause ARVC have been previously described; therefore, we investigated 88 unrelated patients with the disorder for mutations in human desmosomal cadherin desmocollin-2 (DSC2). We identified a heterozygous splice-acceptor-site mutation in intron 5 (c.631-2A -> G) of the DSC2 gene, which led to the use of a cryptic splice-acceptor site and the creation of a downstream premature termination codon. Quantitative analysis of cardiac DSC2 expression in patient specimens revealed a marked reduction in the abundance of the mutant transcript. Morpholino knockdown in zebrafish embryos revealed a requirement for dsc2 in the establishment of the normal myocardial structure and function, with reduced desmosomal plaque area, loss of the desmosome extracellular electron-dense midlines, and associated myocardial contractility defects. These data identify DSC2 mutations as a cause of ARVC in humans and demonstrate that physiologic levels of DSC2 are crucial for normal cardiac desmosome formation, early cardiac morphogenesis, and cardiac function.	Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; Humboldt Univ, Charite, HELIOS Clin GmbH, Franz Volhard Clin,Dept Clin & Mol Cardiol, D-1086 Berlin, Germany; Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; Univ Hosp Munster, Dept Cardiol & Angiol, Munster, Germany; Univ Munster, Inst Arteriosclerosis Res, D-4400 Munster, Germany; Cornell Univ, Weill Med Coll, Dept Med, Greenberg Cardiol Div, Ithaca, NY 14853 USA	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Franz-Volhard Clinical Research Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Munster; University of Munster; Cornell University	Gerull, B (corresponding author), Max Delbruck Ctr Mol Med, Robert Roessle Str 10, D-13092 Berlin, Germany.	b.gerull@mdc-berlin.de		Ellinor, Patrick/0000-0002-2067-0533; Heuser, Arnd/0000-0002-3334-960X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109264] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL109264] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Awad MM, 2006, AM J HUM GENET, V79, P136, DOI 10.1086/504393; Beffagna G, 2005, CARDIOVASC RES, V65, P366, DOI 10.1016/j.cardiores.2004.10.005; Chitaev NA, 1997, J CELL BIOL, V138, P193, DOI 10.1083/jcb.138.1.193; Fontaine G, 1999, ANNU REV MED, V50, P17, DOI 10.1146/annurev.med.50.1.17; Gallicano GI, 1998, J CELL BIOL, V143, P2009, DOI 10.1083/jcb.143.7.2009; Garcia-Gras E, 2006, J CLIN INVEST, V116, P2012, DOI 10.1172/JCI27751; Garrod DR, 2002, CURR OPIN CELL BIOL, V14, P537, DOI 10.1016/S0955-0674(02)00366-6; Gerull B, 2004, NAT GENET, V36, P1162, DOI 10.1038/ng1461; Green KJ, 2000, NAT REV MOL CELL BIO, V1, P208, DOI 10.1038/35043032; Grossmann KS, 2004, J CELL BIOL, V167, P149, DOI 10.1083/jcb.200402096; Hanakawa Y, 2000, J CELL SCI, V113, P1803; Ishii K, 2001, J INVEST DERMATOL, V117, P26, DOI 10.1046/j.0022-202x.2001.01400.x; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Kljuic A, 2003, CELL, V113, P249, DOI 10.1016/S0092-8674(03)00273-3; Ko KS, 2001, J BIOL CHEM, V276, P35967, DOI 10.1074/jbc.M104106200; Kostetskii I, 2005, CIRC RES, V96, P346, DOI 10.1161/01.RES.0000156274.72390.2c; MARCUS FI, 1982, CIRCULATION, V65, P384, DOI 10.1161/01.CIR.65.2.384; MCKENNA WJ, 1994, BRIT HEART J, V71, P215; McKoy G, 2000, LANCET, V355, P2119, DOI 10.1016/S0140-6736(00)02379-5; NAVA A, 1988, J AM COLL CARDIOL, V12, P1222, DOI 10.1016/0735-1097(88)92603-4; Norgett EE, 2000, HUM MOL GENET, V9, P2761, DOI 10.1093/hmg/9.18.2761; North AJ, 1996, P NATL ACAD SCI USA, V93, P7701, DOI 10.1073/pnas.93.15.7701; NUBER UA, 1995, EUR J CELL BIOL, V66, P69; OVERDUIN M, 1995, SCIENCE, V267, P386, DOI 10.1126/science.7824937; Paul M, 2003, Z KARDIOL, V92, P128, DOI 10.1007/s00392-003-0892-9; Pilichou K, 2006, CIRCULATION, V113, P1171, DOI 10.1161/CIRCULATIONAHA.105.583674; Rampazzo A, 2002, AM J HUM GENET, V71, P1200, DOI 10.1086/344208; Rickman L, 1999, HUM MOL GENET, V8, P971, DOI 10.1093/hmg/8.6.971; Ruiz P, 1996, J CELL BIOL, V135, P215, DOI 10.1083/jcb.135.1.215; Sen-Chowdhry S, 2005, J CARDIOVASC ELECTR, V16, P927, DOI 10.1111/j.1540-8167.2005.40842.x; Syrris P, 2006, CIRCULATION, V113, P356, DOI 10.1161/CIRCULATIONAHA.105.561654; THIENE G, 1988, NEW ENGL J MED, V318, P129, DOI 10.1056/NEJM198801213180301; Tiso N, 2001, HUM MOL GENET, V10, P189, DOI 10.1093/hmg/10.3.189; van Tintelen JP, 2006, CIRCULATION, V113, P1650, DOI 10.1161/CIRCULATIONAHA.105.609719; Wlodarska Elzbieta K, 2004, Kardiol Pol, V60, P1	35	179	191	0	6	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2006	79	6					1081	1088		10.1086/509044	http://dx.doi.org/10.1086/509044			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106WB	17186466	Bronze, Green Published			2022-12-18	WOS:000242131600009
J	Wieland, I; Jakubiczka, S; Muschke, P; Cohen, M; Thiele, H; Gerlach, KL; Adams, RH; Wieacker, P				Wieland, I; Jakubiczka, S; Muschke, P; Cohen, M; Thiele, H; Gerlach, KL; Adams, RH; Wieacker, P			Mutations of the ephrin-B1 gene cause craniofrontonasal syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMMISSURAL AXONS; CRYSTAL-STRUCTURE; X-CHROMOSOME; RECEPTOR; EPH; INACTIVATION; INHERITANCE	Craniofrontonasal syndrome (CFNS) is an X-linked craniofacial disorder with an unusual manifestation pattern, in which affected females show multiple skeletal malformations, whereas the genetic defect causes no or only mild abnormalities in male carriers. Recently, we have mapped a gene for CFNS in the pericentromeric region of the X chromosome that contains the EFNB1 gene, which encodes the ephrin-B1 ligand for Eph receptors. Since Efnb1 mutant mice display a spectrum of malformations and an unusual inheritance reminiscent of CFNS, we analyzed the EFNB1 gene in three families with CFNS. In one family, a deletion of exons 2-5 was identified in an obligate carrier male, his mildly affected brother, and in the affected females. In the two other families, missense mutations in EFNB1 were detected that lead to amino acid exchanges P54L and T111I. Both mutations are located in multimerization and receptor-interaction motifs found within the ephrin-B1 extracellular domain. In all cases, mutations were found consistently in obligate male carriers, clinically affected males, and affected heterozygous females. We conclude that mutations in EFNB1 cause CFNS.	Univ Magdeburg, Inst Humangenet, D-39106 Magdeburg, Germany; Univ Magdeburg, Klin Mund Kiefer & Gesichtschirurg, D-39106 Magdeburg, Germany; Kinderzentrum Munchen, Munich, Germany; Univ Halle Wittenberg, Inst Humangenet, Halle Saale, Germany; Canc Res UK London Res Inst, London, England	Otto von Guericke University; Otto von Guericke University; Martin Luther University Halle Wittenberg; Cancer Research UK	Wieacker, P (corresponding author), Univ Klinikum Magdeburg, Leipziger Str 44, D-39120 Magdeburg, Germany.	peter.wieacker@medizin.uni-magdeburg.de	Thiele, Holger/ABE-6792-2020; Adams, Ralf H/AAE-9274-2019	Thiele, Holger/0000-0002-0169-998X; Wieland, Ilse/0000-0002-8017-3029				ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Carrel L, 1999, P NATL ACAD SCI USA, V96, P14440, DOI 10.1073/pnas.96.25.14440; Compagni A, 2003, DEV CELL, V5, P217, DOI 10.1016/S1534-5807(03)00198-9; DEVRIENDT K, 1995, GENET COUNSEL, V6, P361; Feldman GJ, 1997, HUM MOL GENET, V6, P1937, DOI 10.1093/hmg/6.11.1937; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; JOHNSON WG, 1980, AM J HUM GENET, V32, P374; Koolpe M, 2002, J BIOL CHEM, V277, P46974, DOI 10.1074/jbc.M208495200; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Murai KK, 2003, J CELL SCI, V116, P2823, DOI 10.1242/jcs.00625; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; Saavedra D, 1996, AM J MED GENET, V61, P147, DOI 10.1002/(SICI)1096-8628(19960111)61:2<147::AID-AJMG8>3.3.CO;2-9; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; Toth J, 2001, DEV CELL, V1, P83, DOI 10.1016/S1534-5807(01)00002-8; Wieland I, 2002, CYTOGENET GENOME RES, V99, P285, DOI 10.1159/000071605; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515	17	179	186	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2004	74	6					1209	1215		10.1086/421532	http://dx.doi.org/10.1086/421532			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	823ZB	15124102	Green Published, Bronze			2022-12-18	WOS:000221651900013
J	Zhivotovsky, LA; Rosenberg, NA; Feldman, MW				Zhivotovsky, LA; Rosenberg, NA; Feldman, MW			Features of evolution and expansion of modern humans, inferred from genomewide microsatellite markers	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN Y-CHROMOSOME; HUMAN-POPULATION EXPANSION; LINKAGE DISEQUILIBRIUM; GENETIC DISTANCES; SEQUENCE VARIATION; HUMAN DEMOGRAPHY; HIGH-RESOLUTION; DIVERSITY; LOCI; HISTORY	We study data on variation in 52 worldwide populations at 377 autosomal short tandem repeat loci, to infer a demographic history of human populations. Variation at di-, tri-, and tetranucleotide repeat loci is distributed differently, although each class of markers exhibits a decrease of within-population genetic variation in the following order: sub-Saharan Africa, Eurasia, East Asia, Oceania, and America. There is a similar decrease in the frequency of private alleles. With multidimensional scaling, populations belonging to the same major geographic region cluster together, and some regions permit a finer resolution of populations. When a stepwise mutation model is used, a population tree based on T-D estimates of divergence time suggests that the branches leading to the present sub-Saharan African populations of hunter-gatherers were the first to diverge from a common ancestral population (similar to71-142 thousand years ago). The branches corresponding to sub-Saharan African farming populations and those that left Africa diverge next, with subsequent splits of branches for Eurasia, Oceania, East Asia, and America. African hunter-gatherer populations and populations of Oceania and America exhibit no statistically significant signature of growth. The features of population subdivision and growth are discussed in the context of the ancient expansion of modern humans.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Russian Acad Sci, Vavilov Inst Gen Genet, Moscow, Russia; Univ So Calif, Program Mol & Computat Biol, Los Angeles, CA USA	Stanford University; Russian Academy of Sciences; Vavilov Institute of General Genetics; University of Southern California	Feldman, MW (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.		Zhivotovsky, Lev A/A-1351-2012; Peng, Bo/A-6920-2009	Peng, Bo/0000-0001-8225-2284; Rosenberg, Noah/0000-0002-1829-8664	FOGARTY INTERNATIONAL CENTER [R03TW005540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028016, P01GM028428] Funding Source: NIH RePORTER; FIC NIH HHS [1 R03 TW05540, R03 TW005540] Funding Source: Medline; NIGMS NIH HHS [R01 GM028016, GM 28428, P01 GM028428, GM 28016] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barbujani G, 2001, P NATL ACAD SCI USA, V98, P22, DOI 10.1073/pnas.98.1.22; BARTON NH, 1986, HEREDITY, V56, P409, DOI 10.1038/hdy.1986.63; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Cann HM, 2002, SCIENCE, V296, P261; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Cavalli-Sforza L. L., 1986, AFRICAN PYGMIES; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; CAVALLISFORZA LL, 1988, P NATL ACAD SCI USA, V85, P6002, DOI 10.1073/pnas.85.16.6002; Chakraborty R, 1997, P NATL ACAD SCI USA, V94, P1041, DOI 10.1073/pnas.94.3.1041; Chen YS, 2000, AM J HUM GENET, V66, P1362, DOI 10.1086/302848; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; DEKA R, 1995, AM J HUM GENET, V56, P461; Di Rienzo A, 1998, GENETICS, V148, P1269; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Excoffier L, 1999, P NATL ACAD SCI USA, V96, P10597, DOI 10.1073/pnas.96.19.10597; Feldman M.W., 1999, MICROSATELLITES EVOL, P98; Frisse L, 2001, AM J HUM GENET, V69, P831, DOI 10.1086/323612; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gagneux P, 1999, P NATL ACAD SCI USA, V96, P5077, DOI 10.1073/pnas.96.9.5077; Goldstein DB, 1996, MOL BIOL EVOL, V13, P1213, DOI 10.1093/oxfordjournals.molbev.a025686; GOLDSTEIN DB, 1995, P NATL ACAD SCI USA, V92, P6723, DOI 10.1073/pnas.92.15.6723; Gonser R, 2000, GENETICS, V154, P1793; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Ingman M, 2001, NATURE, V410, P611, DOI 10.1038/35069127; Jin L, 2000, ANN HUM GENET, V64, P117, DOI 10.1017/S0003480000008034; Jin L, 1999, P NATL ACAD SCI USA, V96, P3796, DOI 10.1073/pnas.96.7.3796; Jorde LB, 1997, P NATL ACAD SCI USA, V94, P3100, DOI 10.1073/pnas.94.7.3100; Karafet T, 2001, AM J HUM GENET, V69, P615, DOI 10.1086/323299; Kimmel M, 1998, GENETICS, V148, P1921; King JP, 2000, MOL BIOL EVOL, V17, P1859, DOI 10.1093/oxfordjournals.molbev.a026287; Michalakis Y, 1996, GENETICS, V142, P1061; MORAN PAP, 1975, THEOR POPUL BIOL, V8, P318, DOI 10.1016/0040-5809(75)90049-0; NEI M, 1993, MOL BIOL EVOL, V10, P927; PerezLezaun A, 1997, HUM GENET, V99, P1; Pluzhnikov A, 2002, GENETICS, V161, P1209; Pritchard JK, 1999, MOL BIOL EVOL, V16, P1791, DOI 10.1093/oxfordjournals.molbev.a026091; Pritchard JK, 2000, GENETICS, V155, P945; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Reich DE, 1998, P NATL ACAD SCI USA, V95, P8119, DOI 10.1073/pnas.95.14.8119; RELETHFORD JH, 2001, GENETICS SEARCH MODE; Ribeiro-dos-Santos AKC, 2000, HUM HERED, V51, P79, DOI 10.1159/000022962; Rogers AR, 1996, AM J HUM GENET, V58, P1033; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rousset F, 1996, GENETICS, V142, P1357; Semino O, 2002, AM J HUM GENET, V70, P265, DOI 10.1086/338306; Shen PD, 2000, P NATL ACAD SCI USA, V97, P7354, DOI 10.1073/pnas.97.13.7354; SLATKIN M, 1995, GENETICS, V139, P457; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Takezaki N, 1996, GENETICS, V144, P389; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Urbanek M, 1996, MOL BIOL EVOL, V13, P943, DOI 10.1093/oxfordjournals.molbev.a025662; Watkins WS, 2001, AM J HUM GENET, V68, P738, DOI 10.1086/318793; Weber JL, 2001, ADV GENET, V42, P77, DOI 10.1016/S0065-2660(01)42016-5; Weir B., 1996, GENETIC DATA ANAL; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; WOLFRAM S, 1996, MATH BOOK; Yang ZH, 2002, GENETICS, V162, P1811; ZHIVOTOVSKY LA, 1995, P NATL ACAD SCI USA, V92, P11549, DOI 10.1073/pnas.92.25.11549; Zhivotovsky LA, 2001, MOL BIOL EVOL, V18, P2141, DOI 10.1093/oxfordjournals.molbev.a003759; Zhivotovsky LA, 2001, MOL BIOL EVOL, V18, P700, DOI 10.1093/oxfordjournals.molbev.a003852; Zhivotovsky LA, 2000, MOL BIOL EVOL, V17, P757, DOI 10.1093/oxfordjournals.molbev.a026354	63	179	194	0	21	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2003	72	5					1171	1186		10.1086/375120	http://dx.doi.org/10.1086/375120			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671PZ	12690579	Bronze, Green Published			2022-12-18	WOS:000182474400010
J	Frosk, P; Weiler, T; Nylen, E; Sudha, T; Greenberg, CR; Morgan, K; Fujiwara, TM; Wrogemann, K				Frosk, P; Weiler, T; Nylen, E; Sudha, T; Greenberg, CR; Morgan, K; Fujiwara, TM; Wrogemann, K			Limb-girdle muscular dystrophy type 2H associated with mutation in TRIM32, a putative E3-ubiquitin-ligase gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PLASMA PROTEIN-A; DROSOPHILA-BRAIN-TUMOR; MANITOBA HUTTERITES; RING FINGER; PARKIN; DOMAIN; OVEREXPRESSION; UBIQUITINATION; IDENTIFICATION; DESTRUCTION	Limb-girdle muscular dystrophy type 2H (LGMD2H) is a mild autosomal recessive myopathy that was first described in the Manitoba Hutterite population. Previous studies in our laboratory mapped the causative gene for this disease to a 6.5-Mb region in chromosomal region 9q31-33, flanked by D9S302 and D9S1850. We have now used additional families and a panel of 26 microsatellite markers to construct haplotypes. Twelve recombination events that reduced the size of the candidate region to 560 kb were identified or inferred. This region is flanked by D9S1126 and D9S737 and contains at least four genes. Exons of these genes were sequenced in one affected individual, and four sequence variations were identified. The families included in our study and 100 control individuals were tested for these variations. On the basis of our results, the mutation in the tripartite-motif-containing gene (TRIM32) that replaces aspartate with asparagine at position 487 appears to be the causative mutation of LGMD2H. All affected individuals were found to be homozygous for D487N, and this mutation was not found in any of the controls. This mutation occurs in an NHL (named after the proteins NCL1, HT2A, and LIN-41) domain at a position that is highly conserved. NHL domains are known to be involved in protein-protein interactions. Although the function of TRIM32 is unknown, current knowledge of the domain structure of this protein suggests that it may be an E3-ubiquitin ligase. If proven, this represents a new pathogenic mechanism leading to muscular dystrophy.	Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB R3E 0W3, Canada; Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3T 2N2, Canada; McGill Univ, Ctr Human Genet, Montreal, PQ, Canada; McGill Univ, Dept Med, Montreal, PQ, Canada; McGill Univ, Ctr Hlth, Montreal, PQ, Canada	University of Manitoba; University of Manitoba; McGill University; McGill University; McGill University	Wrogemann, K (corresponding author), Univ Manitoba, Dept Biochem & Med Genet, 770 Bannatyne Ave, Winnipeg, MB R3E 0W3, Canada.	K_Wrogemann@Umanitoba.ca	Weiler, Tracey A/D-6646-2017	Weiler, Tracey A/0000-0003-4662-4495; Frosk, Patrick/0000-0002-9673-795X				Antonarakis SE, 1998, HUM MUTAT, V11, P1; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Arama E, 2000, ONCOGENE, V19, P3706, DOI 10.1038/sj.onc.1203706; Barinaga M, 1999, SCIENCE, V286, P223, DOI 10.1126/science.286.5438.223; Bushby KMD, 1999, HUM MOL GENET, V8, P1875, DOI 10.1093/hmg/8.10.1875; Bushby KMD, 1999, BRAIN, V122, P1403, DOI 10.1093/brain/122.8.1403; Conover CA, 1999, J CLIN ENDOCR METAB, V84, P4742, DOI 10.1210/jc.84.12.4742; EDMONDSON JC, 1988, J CELL BIOL, V106, P505, DOI 10.1083/jcb.106.2.505; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; FRIDELL RA, 1995, VIROLOGY, V209, P347, DOI 10.1006/viro.1995.1266; Galbiati F, 2000, P NATL ACAD SCI USA, V97, P9689, DOI 10.1073/pnas.160249097; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; KAPLAN J, 2001, NEUROMUSCULAR DISORD, V11, P323; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lawrence JB, 1999, P NATL ACAD SCI USA, V96, P3149, DOI 10.1073/pnas.96.6.3149; Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762; Liu HX, 1998, GENE DEV, V12, P1998, DOI 10.1101/gad.12.13.1998; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Shen LX, 1999, P NATL ACAD SCI USA, V96, P7871, DOI 10.1073/pnas.96.14.7871; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; SHOKEIR MHK, 1985, AM J MED GENET, V22, P487, DOI 10.1002/ajmg.1320220306; SHOKEIR MHK, 1976, CLIN GENET, V9, P197; SILAHTAROGLU AN, 1993, CYTOGENET CELL GENET, V62, P214, DOI 10.1159/000133479; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Slack FJ, 1998, TRENDS BIOCHEM SCI, V23, P474, DOI 10.1016/S0968-0004(98)01299-7; Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801; Torok M, 2001, DIFFERENTIATION, V67, P63, DOI 10.1046/j.1432-0436.2001.067003063.x; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Weiler T, 1998, AM J HUM GENET, V63, P140, DOI 10.1086/301925; Weiler T, 1997, AM J MED GENET, V72, P363, DOI 10.1002/(SICI)1096-8628(19971031)72:3<363::AID-AJMG22>3.0.CO;2-Q; Zhu XL, 2001, J BIOL CHEM, V276, P21785, DOI 10.1074/jbc.M101877200	33	179	186	1	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2002	70	3					663	672		10.1086/339083	http://dx.doi.org/10.1086/339083			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	522DG	11822024	Bronze, Green Published			2022-12-18	WOS:000173880000010
J	Meloni, I; Bruttini, M; Longo, I; Mari, F; Rizzolio, F; D'Adamo, P; Denvriendt, K; Fryns, JP; Toniolo, D; Renieri, A				Meloni, I; Bruttini, M; Longo, I; Mari, F; Rizzolio, F; D'Adamo, P; Denvriendt, K; Fryns, JP; Toniolo, D; Renieri, A			A mutation in the Rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILY	Heterozygous mutations in the X-linked MECP2 gene cause Rett syndrome, a severe neurodevelopmental disorder of young females. Only one male presenting an MECP2 mutation has been reported; he survived only to age 1 year, suggesting that mutations in MECP2 are male lethal. Here we report a three-generation family in which two affected males showed severe mental retardation and progressive spasticity, previously mapped in Xq27.2-qter. Two obligate carrier females showed either normal or borderline intelligence, simulating an X-linked recessive trait. The two males and the two obligate carrier females presented a mutation in the MECP2 gene, demonstrating that, in males, MECP2 can be responsible for severe mental retardation associated with neurological disorders.	Univ Siena, Policlin Le Scotte, I-53100 Siena, Italy; Katholieke Univ Leuven, Dept Genet, Louvain, Belgium; CNR, Ist Genet Biochim & Evoluzionist, I-27100 Pavia, Italy	University of Siena; KU Leuven; Consiglio Nazionale delle Ricerche (CNR)	Renieri, A (corresponding author), Univ Siena, Policlin Le Scotte, Viale Bracci 2, I-53100 Siena, Italy.		Meloni, Ilaria/R-6627-2018; Renieri, Alessandra/K-5950-2016; Toniolo, Daniela/AAE-2969-2019; Mari, Francesca/E-7737-2012; Rizzolio, Flavio/K-2690-2018; D'Adamo, Patrizia/AAN-3919-2020	Meloni, Ilaria/0000-0002-6255-9761; Renieri, Alessandra/0000-0002-0846-9220; Toniolo, Daniela/0000-0001-9545-6032; Mari, Francesca/0000-0003-1992-1654; Rizzolio, Flavio/0000-0002-3400-4363; D'Adamo, Patrizia/0000-0002-0312-5541; Longo, Ilaria/0000-0003-2056-8763				ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Amir RE, 2000, ANN NEUROL, V47, P670, DOI 10.1002/1531-8249(200005)47:5<670::AID-ANA20>3.3.CO;2-6; Bienvenu T, 2000, HUM MOL GENET, V9, P1377, DOI 10.1093/hmg/9.9.1377; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; Chandler SP, 1999, BIOCHEMISTRY-US, V38, P7008, DOI 10.1021/bi990224y; Cheadle JP, 2000, HUM MOL GENET, V9, P1119, DOI 10.1093/hmg/9.7.1119; Claes S, 1997, CLIN GENET, V52, P155; De Bona C, 2000, EUR J HUM GENET, V8, P325, DOI 10.1038/sj.ejhg.5200473; Huppke P, 2000, HUM MOL GENET, V9, P1369, DOI 10.1093/hmg/9.9.1369; Kim SJ, 2000, HUM MUTAT, V15, P382, DOI 10.1002/(SICI)1098-1004(200004)15:4<382::AID-HUMU16>3.0.CO;2-8; MURPHY DB, 1994, GENOMICS, V21, P551, DOI 10.1006/geno.1994.1313; PEGORARO E, 1994, AM J HUM GENET, V54, P989; Van den Veyver IB, 2000, CURR OPIN GENET DEV, V10, P275, DOI 10.1016/S0959-437X(00)00083-6; Wan MM, 1999, AM J HUM GENET, V65, P1520, DOI 10.1086/302690; Xiang FQ, 2000, J MED GENET, V37, P250, DOI 10.1136/jmg.37.4.250	16	179	188	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4					982	985		10.1086/303078	http://dx.doi.org/10.1086/303078			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	360DL	10986043	Green Published, Bronze			2022-12-18	WOS:000089651100020
J	McPeek, MS; Strahs, A				McPeek, MS; Strahs, A			Assessment of linkage disequilibrium by the decay of haplotype sharing, with application to fine-scale genetic mapping	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MYOCLONUS EPILEPSY EPM1; LIKELIHOOD; MODELS; INTERFERENCE; POPULATIONS; ALLELE	Linkage disequilibrium (LD) is of great interest for gene mapping and the study of population history. We propose a multilocus model for LD, based on the decay of haplotype sharing (DHS). The DHS model is most appropriate when the LD in which one is interested is due to the introduction of a variant on an ancestral haplotype, with recombinations in succeeding generations resulting in preservation of only a small region of the ancestral haplotype around the variant. This is generally the scenario of interest for gene mapping by LD. The DHS parameter is a measure of LD that can be interpreted as the expected genetic distance to which the ancestral haplotype is preserved, or, equivalently, 1/(time in generations to the ancestral haplotype). The method allows for multiple origins of alleles and for mutations, and it takes into account missing observations:and ambiguities in haplotype determination, via a hidden Markov model. Whereas most commonly used measures of LD apply to pairs of loci, the DHS measure is designed for application to the densely mapped haplotype data that are increasingly available. The DHS method explicitly models the dependence among multiple tightly linked loci on a chromosome. When the assumptions about population structure are sufficiently tractable, the estimate of LD is obtained by maximum likelihood. For more-complicated models of population history, we find means and covariances based on the model and solve a quasi-score estimating equation. Simulations show that this approach works extremely well both for estimation of LD and for fine mapping. We apply the DHS method to published data sets for cystic fibrosis and progressive myoclonus epilepsy.	Univ Chicago, Dept Stat, Chicago, IL 60637 USA	University of Chicago	McPeek, MS (corresponding author), Univ Chicago, Dept Stat, S734 S Univ Ave, Chicago, IL 60637 USA.				NHGRI NIH HHS [R29 HG001645] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R29HG001645] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Baum LE, 1972, INEQUALITIES, V3, P1; BENNETT JH, 1954, ANN EUGENIC, V18, P311; Cox D., 1980, POINT PROCESSES; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Devlin B, 1996, GENOMICS, V36, P1, DOI 10.1006/geno.1996.0419; FOSS E, 1993, GENETICS, V133, P681; Graham J, 1998, AM J HUM GENET, V63, P1517, DOI 10.1086/302102; KAPLAN NL, 1995, AM J HUM GENET, V56, P18; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kingman J, 1982, STOCHASTIC PROCESS A, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Lazzeroni LC, 1998, AM J HUM GENET, V62, P159, DOI 10.1086/301678; Lindsay B. G., 1988, CONT MATH, P221, DOI DOI 10.1090/CONM/080/999014; McCullagh P, 1989, GEN LINEAR MODELS, V2nd; MCPEEK MS, 1995, GENETICS, V139, P1031; MORIO R, 1981, BIOCULTURAL ASPECTS, P359; NEVANLINNA HR, 1972, HEREDITAS-GENETISK A, V71, P195; Pennacchio LA, 1996, SCIENCE, V271, P1731, DOI 10.1126/science.271.5256.1731; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Rannala B, 1998, AM J HUM GENET, V62, P459, DOI 10.1086/301709; SLATKIN M, 1972, GENETICS, V72, P157; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; Virtaneva K, 1996, AM J HUM GENET, V58, P1247; WEDDERBURN RWM, 1974, BIOMETRIKA, V61, P439, DOI 10.2307/2334725; Whittemore AS, 1996, AM J HUM GENET, V59, P704; Xiong MM, 1997, AM J HUM GENET, V60, P1513, DOI 10.1086/515475; ZHAO HY, 1995, GENETICS, V139, P1045	28	179	184	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1999	65	3					858	875		10.1086/302537	http://dx.doi.org/10.1086/302537			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233KQ	10445904	Green Published, Bronze			2022-12-18	WOS:000082426400030
J	Hartge, P; Struewing, JP; Wacholder, S; Brody, LC; Tucker, MA				Hartge, P; Struewing, JP; Wacholder, S; Brody, LC; Tucker, MA			The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BREAST-OVARIAN CANCER; FAMILY HISTORY; GERMLINE MUTATIONS; JEWISH INDIVIDUALS; 185DELAG MUTATION; CARRIER FREQUENCY; SEQUENCE-ANALYSIS; GENE BRCA1; RISK; WOMEN	Three founder mutations in the cancer-associated genes BRCA1 and BRCA2 occur frequently enough among Ashkenazi Jews to warrant consideration of genetic testing outside the setting of high-risk families with multiple cases of breast or ovarian cancer. We estimated the prevalence of these founder mutations in BRCA1 and BRCA2 in the general population of Ashkenazi Jews according to age at testing, personal cancer history, and family cancer history. We compared the results of anonymous genetic testing of blood samples obtained in a survey of >5,000 Jewish participants from the Washington, DC, area with personal and family cancer histories obtained from questionnaires completed by the participants. In all subgroups defined by age and cancer history, fewer mutations were found,in this community sample than in clinical series studied to date. For example, 11 (10%) of 109 Jewish women who had been given a diagnosis of breast cancer in their forties carried one of the mutations. The most important predictor of mutation status was a previous diagnosis of breast or ovarian cancer. In men and in women never given a diagnosis of cancer, family history of breast cancer before age 50 years was the strongest predictor. As interest in genetic testing for BRCA1 and BRCA2 in the Jewish community broadens, community-based estimates such as these help guide those seeking and those offering such testing. Even with accurate estimates of the likelihood of carrying a mutation and the likelihood of developing cancer if a mutation is detected, the most vexing clinical problems remain.	NCI, Div Canc Epidemiol & Stat, NIH, Bethesda, MD 20892 USA; NHGRI, Genet & Mol Biol Branch, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Hartge, P (corresponding author), NCI, Div Canc Epidemiol & Stat, NIH, Bldg EPN,Room 443, Bethesda, MD 20892 USA.		Tucker, Margaret A/B-4297-2015; Struewing, Jeffery P/I-7502-2013; Struewing, Jeffery P/C-3221-2008	Struewing, Jeffery P/0000-0002-4848-3334; 	NATIONAL CANCER INSTITUTE [Z01CP010138] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Beller U, 1997, GYNECOL ONCOL, V67, P123, DOI 10.1006/gyno.1997.4844; Berry DA, 1997, J NATL CANCER I, V89, P227, DOI 10.1093/jnci/89.3.227; Breiman L., 1984, CLASSIFICATION REGRE, DOI DOI 10.1201/9781315139470; Couch FJ, 1997, NEW ENGL J MED, V336, P1409, DOI 10.1056/NEJM199705153362002; Fodor FH, 1998, AM J HUM GENET, V63, P45, DOI 10.1086/301903; Frank TS, 1998, J CLIN ONCOL, V16, P2417, DOI 10.1200/JCO.1998.16.7.2417; Gayther SA, 1997, NAT GENET, V15, P103, DOI 10.1038/ng0197-103; Lee JS, 1999, JNCI-J NATL CANCER I, V91, P259, DOI 10.1093/jnci/91.3.259; Lerman C, 1996, JAMA-J AM MED ASSOC, V275, P1885, DOI 10.1001/jama.275.24.1885; LevyLahad E, 1997, AM J HUM GENET, V60, P1059; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Modan B, 1996, JAMA-J AM MED ASSOC, V276, P1823, DOI 10.1001/jama.276.22.1823; Oddoux C, 1996, NAT GENET, V14, P188, DOI 10.1038/ng1096-188; Offit K, 1996, LANCET, V347, P1643, DOI 10.1016/S0140-6736(96)91484-1; Richards CS, 1997, AM J HUM GENET, V60, P1085; ShattuckEidens D, 1997, JAMA-J AM MED ASSOC, V278, P1242, DOI 10.1001/jama.278.15.1242; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Thorlacius S, 1998, LANCET, V352, P1337, DOI 10.1016/S0140-6736(98)03300-5; WACHOLDER S, 1986, AM J EPIDEMIOL, V123, P174, DOI 10.1093/oxfordjournals.aje.a114212; Wacholder S, 1998, AM J EPIDEMIOL, V148, P623, DOI 10.1093/aje/148.7.623; Whittemore AS, 1997, AM J HUM GENET, V60, P496; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	23	179	180	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1999	64	4					963	970		10.1086/302320	http://dx.doi.org/10.1086/302320			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184UV	10090881	Green Published, Bronze			2022-12-18	WOS:000079632900007
J	Lee, JH; Reed, DR; Li, WD; Xu, WZ; Joo, EJ; Kilker, RL; Nanthakumar, E; North, M; Sukul, H; Bell, C; Price, RA				Lee, JH; Reed, DR; Li, WD; Xu, WZ; Joo, EJ; Kilker, RL; Nanthakumar, E; North, M; Sukul, H; Bell, C; Price, RA			Genome scan for human obesity and linkage to markers in 20q13	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN OB GENE; BODY-MASS INDEX; QUANTITATIVE TRAIT LOCUS; SERUM LEPTIN LEVELS; AFFECTED SIB PAIRS; FAT MASS; ADIPOCYTE DIFFERENTIATION; SUSCEPTIBILITY LOCUS; POLYMORPHIC MARKER; DIABETES-MELLITUS	Obesity is a highly prevalent, multigenic trait that predicts increased morbidity and mortality. Here we report results from a genome scan based on 354 markers in 513 members of 92 nuclear families ascertained through extreme obesity and normal body weight. The average marker interval was similar to 10 cM. We examined four correlated obesity phenotypes, including the body-mass index (BMI) (both as a quantitative bait and as a discrete trait with a threshold of BMI greater than or equal to 30 kg/m(2)) and percentage of fat (both as a quantitative bait and as a discrete trait with a threshold of 40%) as assessed by bioelectrical impedance. In the initial stage of the genome scan, four markers in 20q gave positive evidence for linkage, which was consistent across most obesity phenotypes and analytic methods. After saturating 20q with additional markers (25 markers total) in an augmented sample of: 713 members from 124 families, we found linkage to several markers in a region, 20q13, previously implicated in both human and animal studies. Three markers (D20S107, D20S211, and D20S149) in 20q13 had empirical P values (based on Monte Carlo simulations, which controlled for multiple testing) less than or equal to.01 for single-point analysis. In addition, the parametric, affecteds-only analysis for D20S476 yielded a LOD score of 3.06 (P =.00009), and the affected-sib-pair test yielded a LOD score of 3.17 (P =.000067). Multipoint analyses further strengthened and localized these findings, This region includes several plausible candidate genes for obesity. Our results suggest that one or more genes affecting obesity are located in 20q13.	Univ Penn, Ctr Neurobiol & Behav, Dept Psychiat, Philadelphia, PA 19104 USA; Axys Pharmaceut, La Jolla, CA USA	University of Pennsylvania; Pennsylvania Medicine	Price, RA (corresponding author), Univ Penn, Ctr Neurobiol & Behav, Dept Psychiat, 415 Curie Blvd,CRB135B, Philadelphia, PA 19104 USA.		Lee, Joseph H/D-2441-2012	Lee, Joseph H/0000-0002-2000-4821; Li, Wei-Dong/0000-0003-0521-7412; Reed, Danielle/0000-0002-4374-6107	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044073, R01DK048095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC003509] Funding Source: NIH RePORTER; NIDCD NIH HHS [R03DC03509] Funding Source: Medline; NIDDK NIH HHS [R01DK44073, R01DK48095] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allison DB, 1998, GENETICS, V148, P859; ANDERSSON L, 1994, SCIENCE, V263, P1771, DOI 10.1126/science.8134840; BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; Borecki I B, 1994, Obes Res, V2, P213; Borecki IB, 1998, OBES RES, V6, P107, DOI 10.1002/j.1550-8528.1998.tb00323.x; Bowden DW, 1997, DIABETES, V46, P882, DOI 10.2337/diabetes.46.5.882; BRAY GA, 1978, INT J OBESITY, V2, P99; Bray GA, 1986, HDB EATING DISORDERS, P3; Bray MS, 1996, HUM GENET, V98, P590, DOI 10.1007/s004390050265; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; Butler MG, 1997, AM J HUM GENET, V61, pA305; Chagnon YC, 1998, OBES RES, V6, P76, DOI 10.1002/j.1550-8528.1998.tb00318.x; Clement K, 1996, DIABETES, V45, P687, DOI 10.2337/diabetes.45.5.687; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; Comings DE, 1996, MOL PSYCHIATR, V1, P325; COMUZZIE AG, 1995, GENET EPIDEMIOL, V12, P475, DOI 10.1002/gepi.1370120505; Comuzzie AG, 1997, NAT GENET, V15, P273, DOI 10.1038/ng0397-273; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Curtis D, 1996, NAT GENET, V12, P356, DOI 10.1038/ng0496-356; Davis S, 1997, AM J HUM GENET, V61, P1431, DOI 10.1086/301635; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dong ZM, 1997, P NATL ACAD SCI USA, V94, P7526, DOI 10.1073/pnas.94.14.7526; Drigalenko EI, 1997, GENET EPIDEMIOL, V14, P779, DOI 10.1002/(SICI)1098-2272(1997)14:6<779::AID-GEPI36>3.0.CO;2-L; Duggirala R, 1996, AM J HUM GENET, V59, P694; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Fong TM, 1997, BIOCHEM BIOPH RES CO, V237, P629, DOI 10.1006/bbrc.1997.7200; Good DJ, 1997, NAT GENET, V15, P397, DOI 10.1038/ng0497-397; GunayAygun M, 1997, BEHAV GENET, V27, P307, DOI 10.1023/A:1025683829856; Hager J, 1998, INT J OBESITY, V22, P200, DOI 10.1038/sj.ijo.0800567; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Hasstedt SJ, 1997, AM J HUM GENET, V61, P668, DOI 10.1086/515509; HORMAN RA, 1998, AM J HUM GENET, V62, P659; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; JEMAA R, 1995, INT J OBESITY, V19, P270; Ji LN, 1997, DIABETES, V46, P876, DOI 10.2337/diabetes.46.5.876; KNAPP M, 1994, HUM HERED, V44, P44, DOI 10.1159/000154188; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; Kuokkanen S, 1996, NAT GENET, V13, P477, DOI 10.1038/ng0896-477; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lapsys NM, 1997, OBES RES, V5, P430; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Lembertas AV, 1997, J CLIN INVEST, V100, P1240, DOI 10.1172/JCI119637; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; Mailly F, 1997, HUM MUTAT, V10, P465; Mammes O, 1998, DIABETES, V47, P487, DOI 10.2337/diabetes.47.3.487; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; Mehrabian M, 1998, J CLIN INVEST, V101, P2485, DOI 10.1172/JCI1748; Meirhaeghe A, 1998, HUM MOL GENET, V7, P435, DOI 10.1093/hmg/7.3.435; MILLER MW, 1993, GENE DEV, V7, P454, DOI 10.1101/gad.7.3.454; MOLL PP, 1991, AM J HUM GENET, V49, P1243; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Morton NE, 1998, AM J HUM GENET, V62, P690, DOI 10.1086/301741; Norman RA, 1996, DIABETES, V45, P1229, DOI 10.2337/diabetes.45.9.1229; Norman RA, 1997, AM J HUM GENET, V60, P166; Oksanen L, 1997, HUM GENET, V99, P559, DOI 10.1007/s004390050406; Oksanen L, 1997, INT J OBESITY, V21, P489, DOI 10.1038/sj.ijo.0800436; OTT J, 1992, AM J HUM GENET, V51, P283; Peters JM, 1998, NAT GENET, V18, P292, DOI 10.1038/ng0398-292; Pomp D, 1997, BEHAV GENET, V27, P285, DOI 10.1023/A:1025631813018; Pomp D, 1996, TRANSGENIC RES, V5, P13, DOI 10.1007/BF01979918; PRICE RA, 1991, BEHAV GENET, V21, P1, DOI 10.1007/BF01067662; PRICE RA, 1990, HUM BIOL, V62, P747; Price RA, 1998, INT J OBESITY, V22, P406, DOI 10.1038/sj.ijo.0800601; PRICE RA, 1987, AM J PSYCHIAT, V144, P1003; Rao DC, 1998, GENET EPIDEMIOL, V15, P1; Reed DR, 1998, INT J OBESITY, V22, P827, DOI 10.1038/sj.ijo.0800666; Reed DR, 1996, DIABETES, V45, P691, DOI 10.2337/diabetes.45.5.691; Reed DR, 1998, OBES RES, V6, P332, DOI 10.1002/j.1550-8528.1998.tb00360.x; REED DR, 1995, INT J OBESITY, V19, P599; RISCH N, 1991, AM J HUM GENET, V48, P1058; Roth H, 1997, EXP CLIN ENDOCR DIAB, V105, P341, DOI 10.1055/s-0029-1211776; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Shao DL, 1997, J BIOL CHEM, V272, P21473, DOI 10.1074/jbc.272.34.21473; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; Shintani M, 1996, DIABETOLOGIA, V39, P1398, DOI 10.1007/s001250050589; SORENSEN TIA, 1989, BRIT MED J, V298, P87, DOI 10.1136/bmj.298.6666.87; STIRLING B, 1995, DIABETES, V44, P999, DOI 10.2337/diabetes.44.8.999; Strobel A, 1998, NAT GENET, V18, P213, DOI 10.1038/ng0398-213; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; SUAREZ BK, 1984, AM J MED GENET, V18, P135, DOI 10.1002/ajmg.1320180117; Taylor BA, 1996, GENOMICS, V34, P389, DOI 10.1006/geno.1996.0302; Taylor BA, 1997, GENOMICS, V43, P249, DOI 10.1006/geno.1997.4835; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; WEEKS DE, 1990, GENET EPIDEMIOL, V7, P237, DOI 10.1002/gepi.1370070402; WEST DB, 1994, J CLIN INVEST, V94, P1410, DOI 10.1172/JCI117477; WILSON AF, 1993, GENET EPIDEMIOL, V10, P593, DOI 10.1002/gepi.1370100644; WILSON AF, 1991, AM J HUM GENET, V48, P862; Witte JS, 1996, NAT GENET, V12, P355, DOI 10.1038/ng0496-355; Xu W, 1995, Obes Res, V3, P559; Yamada T, 1996, POLYM REACT ENG, V4, P1; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; York B, 1996, MAMM GENOME, V7, P677, DOI 10.1007/s003359900204; Zouali H, 1997, HUM MOL GENET, V6, P1401, DOI 10.1093/hmg/6.9.1401	98	179	182	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1999	64	1					196	209		10.1086/302195	http://dx.doi.org/10.1086/302195			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164RM	9915959	Bronze, Green Published			2022-12-18	WOS:000078477400025
J	Prowse, AH; Webster, AR; Richards, FM; Richard, S; Olschwang, S; Resche, F; Affara, NA; Maher, ER				Prowse, AH; Webster, AR; Richards, FM; Richard, S; Olschwang, S; Resche, F; Affara, NA; Maher, ER			Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUPPRESSOR GENE; RENAL-CARCINOMA; GERMLINE MUTATIONS; DNA METHYLATION; PHEOCHROMOCYTOMA; IDENTIFICATION; ELONGATION; PHENOTYPE; NEOPLASIA; PROTEIN	Von Hippel-Lindau (VHL) disease is a dominantly inherited disorder predisposing to retinal and CNS hemangioblastomas, renal cell carcinoma (RCC), pheochromocytoma, and pancreatic tumors. Interfamilial differences in predisposition to pheochromocytoma reflect allelic heterogeneity such that there is a strong association between missense mutations and risk of pheochromocytoma. We investigated the mechanism of tumorigenesis in VHL disease tumors to determine whether there were differences between tumor types or classes of germ-line mutations. Fifty-three tumors (30 RCCs, 15 hemangioblastomas, 5 pheochromocytomas, and 3 pancreatic tumors) from 33 patients (27 kindreds) with VHL disease were analyzed. Overall, 51% of 45 informative tumors showed loss of heterozygosity (LOH) at the VHL locus. In 11 cases it was possible to distinguish between loss of the wild-type and mutant alleles, and in each case the wild-type allele was lost. LOH was detected in all tumor types and occurred in the presence of both germ-line missense mutations and other types of germline mutation associated with a low risk of pheochromocytoma. Intragenic somatic mutations were detected in three tumors (all hemangioblastomas) and in two of these could be shown to occur in the wild-type allele. This provides the first example of homozygous inactivation of the VHL by small intragenic mutations in this type of tumor. Hypermethylation of the VHL gene was detected in 33% (6/18) of tumors without LOH, including 2 RCCs and 4 hemangioblastomas. Although hypermethylation of the VHL gene has been reported previously in nonfamilial RCC and although methylation of tumor-suppressor genes has been implicated in the pathogenesis of other sporadic cancers, this is the first report of somatic methylation in a familial cancer syndrome.	UNIV CAMBRIDGE, DEPT PATHOL, CAMBRIDGE CB2 1TN, ENGLAND; ADDENBROOKES HOSP, DEPT OPHTHALMOL, CAMBRIDGE, ENGLAND; HOP NECKER ENFANTS MALAD, EPHE, LAB NEUROHISTOL, PARIS, FRANCE; INST CURIE, LAB GENET TUMEURS, PARIS, FRANCE; CHU NANTES, SERV NEUROCHIRURG, F-44035 NANTES 01, FRANCE	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Nantes Universite; CHU de Nantes			MAHER, EAMONN R/A-9507-2008; Olschwang, Sylviane/G-2716-2013; RICHARD, Stéphane/O-1005-2017	MAHER, EAMONN R/0000-0002-6226-6918; Olschwang, Sylviane/0000-0001-7078-3029; RICHARD, Stéphane/0000-0002-9859-9773				ASO T, 1995, SCIENCE, V269, P1439, DOI 10.1126/science.7660129; BRAUCH H, 1995, HUM GENET, V95, P551, DOI 10.1007/BF00223868; CHEN F, 1995, HUM MUTAT, V5, P66, DOI 10.1002/humu.1380050109; CROSSEY PA, 1994, HUM GENET, V93, P53; CROSSEY PA, 1994, HUM MOL GENET, V3, P1303; CROSSEY PA, 1995, J MED GENET, V32, P885, DOI 10.1136/jmg.32.11.885; DECKER HJH, 1994, CANCER GENET CYTOGEN, V77, P1, DOI 10.1016/0165-4608(94)90141-4; DUAN DR, 1995, SCIENCE, V269, P1402, DOI 10.1126/science.7660122; ENG C, 1995, J MED GENET, V32, P934, DOI 10.1136/jmg.32.12.934; FOSTER K, 1994, HUM MOL GENET, V3, P2169, DOI 10.1093/hmg/3.12.2169; Foster K, 1995, EUR J CANCER, V31A, P2392, DOI 10.1016/0959-8049(95)00437-8; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; KANNO H, 1994, CANCER RES, V54, P4845; KIBEL A, 1995, SCIENCE, V269, P1444, DOI 10.1126/science.7660130; LAIRD PW, 1994, HUM MOL GENET, V3, P1487, DOI 10.1093/hmg/3.suppl_1.1487; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; MAHER ER, 1990, Q J MED, V77, P1151, DOI 10.1093/qjmed/77.2.1151; Maher ER, 1996, J MED GENET, V33, P328, DOI 10.1136/jmg.33.4.328; MARSHALL CJ, 1991, CELL, V64, P313, DOI 10.1016/0092-8674(91)90641-B; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; NEUMANN HPH, 1995, JAMA-J AM MED ASSOC, V274, P1149; PAYNE SJ, 1994, HUM MOL GENET, V3, P390, DOI 10.1093/hmg/3.2.390; SEIZINGER BR, 1991, CYTOGENET CELL GENET, V58, P1080, DOI 10.1159/000133722; SEKIDO Y, 1994, ONCOGENE, V9, P1599; SHUIN T, 1994, CANCER RES, V54, P2852	26	179	184	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1997	60	4					765	771						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WT614	9106522				2022-12-18	WOS:A1997WT61400005
J	Turner, TN; Hormozdiari, F; Duyzend, MH; McClymont, SA; Hook, PW; Iossifov, I; Raja, A; Baker, C; Hoekzema, K; Stessman, HA; Zody, MC; Nelson, BJ; Huddleston, J; Sandstrom, R; Smith, JD; Hanna, D; Swanson, JM; Faustman, EM; Bamshad, MJ; Stamatoyannopoulos, J; Nickerson, DA; McCallion, AS; Darnell, R; Eichler, EE				Turner, Tychele N.; Hormozdiari, Fereydoun; Duyzend, Michael H.; McClymont, Sarah A.; Hook, Paul W.; Iossifov, Ivan; Raja, Archana; Baker, Carl; Hoekzema, Kendra; Stessman, Holly A.; Zody, Michael C.; Nelson, Bradley J.; Huddleston, John; Sandstrom, Richard; Smith, Joshua D.; Hanna, David; Swanson, James M.; Faustman, Elaine M.; Bamshad, Michael J.; Stamatoyannopoulos, John; Nickerson, Deborah A.; McCallion, Andrew S.; Darnell, Robert; Eichler, Evan E.			Genome Sequencing of Autism-Affected Families Reveals Disruption of Putative Noncoding Regulatory DNA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COPY-NUMBER VARIATION; DE-NOVO MUTATIONS; WHOLE-GENOME; INTELLECTUAL DISABILITY; PATHWAY MUTATIONS; SPECTRUM; EXOME; DISCOVERY; GENES; RARE	We performed whole-genome sequencing (WGS) of 208 genomes from 53 families affected by simplex autism. For the majority of these families, no copy-number variant (CNV) or candidate de novo gene-disruptive single-nucleotide variant (SNV) had been detected by microarray or whole-exome sequencing (WES). We integrated multiple CNV and SNV analyses and extensive experimental validation to identify additional candidate mutations in eight families. We report that compared to control individuals, probands showed a significant (p = 0.03) enrichment of de novo and private disruptive mutations within fetal CNS DNase I hypersensitive sites (i.e., putative regulatory regions). This effect was only observed within 50 kb of genes that have been previously associated with autism risk, including genes where dosage sensitivity has already been established by recurrent disruptive de novo protein-coding mutations (ARID1B, SCN2A, NR3C2, PRKCA, and DSCAM). In addition, we provide evidence of gene-disruptive CNVs (in DISCI, WNT7A, RBFOX1, and MBD5), as well as smaller de novo CNVs and exon-specific SNVs missed by exome sequencing in neurodevelopmental genes (e.g., CANX, SAE1, and PIK3CA). Our results suggest that the detection of smaller, often multiple CNVs affecting putative regulatory elements might help explain additional risk of simplex autism.	[Turner, Tychele N.; Hormozdiari, Fereydoun; Duyzend, Michael H.; Raja, Archana; Baker, Carl; Hoekzema, Kendra; Stessman, Holly A.; Nelson, Bradley J.; Huddleston, John; Sandstrom, Richard; Smith, Joshua D.; Hanna, David; Bamshad, Michael J.; Stamatoyannopoulos, John; Nickerson, Deborah A.; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [McClymont, Sarah A.; Hook, Paul W.; McCallion, Andrew S.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Iossifov, Ivan] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Iossifov, Ivan; Zody, Michael C.; Darnell, Robert] New York Genome Ctr, New York, NY 10013 USA; [Raja, Archana; Huddleston, John; Darnell, Robert; Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Swanson, James M.] Univ Calif Irvine, Dept Pediat, Irvine, CA 92612 USA; [Faustman, Elaine M.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98105 USA; [Bamshad, Michael J.] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; [Darnell, Robert] Rockefeller Univ, New York, NY 10065 USA	University of Washington; University of Washington Seattle; Johns Hopkins University; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of California System; University of California Irvine; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Rockefeller University	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu	; Darnell, Robert/B-9022-2008	Sandstrom, Richard/0000-0002-3356-1547; Faustman, Elaine/0000-0002-3085-6403; Duyzend, Michael/0000-0002-3941-6447; Hook, Paul/0000-0002-3912-1999; Darnell, Robert/0000-0002-5134-8088; Turner, Tychele/0000-0001-8246-6477; Stessman, Holly/0000-0002-0764-3493	Simons Foundation (SFARI) [336475]; National Institute of Child Health and Development [HHSN267200700021C, HHSN275200800015C, HHSN267200700023C]; National Institute of Neurological Disorders and Stroke [NS062972]; National Institute of General Medical Sciences [5T32GM07814]; National Human Genome Research Institute [2T32HG000035]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083091] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000035, UM1HG008901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266, T32GM007814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062972] Funding Source: NIH RePORTER	Simons Foundation (SFARI); National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank T. Brown for assistance in editing this manuscript. This work was supported by grants from the Simons Foundation (SFARI 336475 to E.E.E.), National Institute of Child Health and Development (HHSN267200700021C to J.M.S.), (HHSN275200800015C and HHSN267200700023C to E.M.F.), National Institute of Neurological Disorders and Stroke (NS062972 to A.S.M.), National Institute of General Medical Sciences (predoctoral training grant 5T32GM07814 to P.W.H.), and National Human Genome Research Institute (postdoctoral training grant 2T32HG000035 to T.N.T.). We also thank Dr. Daniela Witten for advice on statistical testing of regulatory elements and Dr. Bradley Coe for information on CNVs from his previous publication. We thank Natalia Volfovsky, Alex Lash, and Malcolm Mallardi from the Simons Foundation for help with depositing genome data to SFARI Base and Colleen Davis for help with depositing genome data to dbGaP. We are grateful to all of the families at the participating Simons Simplex Collection (SSC) sites, as well as the principal investigators (A. Beaudet, R. Bernier, J. Constantino, E. Cook, E. Fombonne, D. Geschwind, R. Goin-Kochel, E. Hanson, D. Grice, A. Klin, D. Ledbetter, C. Lord, C. Martin, D. Martin, R. Maxim, J. Miles, O. Ousley, K. Pelphrey, B. Peterson, J. Piggot, C. Saulnier, M. State, W. Stone, J. Sutcliffe, C. Walsh, Z. Warren, and E Wijsman). We appreciate receiving access to phenotypic data on Simons Foundation Autism Research Initiative (SFARI) Base. Approved researchers can obtain the SSC population dataset described in this study by applying at SFARI Base (see Web Resources). E.E.E. is an investigator of the Howard Hughes Medical Institute.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Belkadi A, 2015, P NATL ACAD SCI USA, V112, P5473, DOI 10.1073/pnas.1418631112; Bernier R, 2014, CELL, V158, P263, DOI 10.1016/j.cell.2014.06.017; Bill BR, 2013, INT REV NEUROBIOL, V113, P251, DOI 10.1016/B978-0-12-418700-9.00008-3; Bradshaw NJ, 2012, NEUROPHARMACOLOGY, V62, P1230, DOI 10.1016/j.neuropharm.2010.12.027; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Celestino-Soper PBS, 2011, HUM MOL GENET, V20, P4360, DOI 10.1093/hmg/ddr363; Coe BP, 2014, NAT GENET, V46, P1063, DOI 10.1038/ng.3092; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; DEKOK YJM, 1995, HUM MOL GENET, V4, P2145; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; Fogel BL, 2012, HUM MOL GENET, V21, P4171, DOI 10.1093/hmg/dds240; Fromer M, 2012, AM J HUM GENET, V91, P597, DOI 10.1016/j.ajhg.2012.08.005; Fu CL, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn167; Fuerst PG, 2008, NATURE, V451, P470, DOI 10.1038/nature06514; Garrison E, 2012, ARXIV PREPRINT ARXIV; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; Girirajan S, 2013, AM J HUM GENET, V92, P221, DOI 10.1016/j.ajhg.2012.12.016; Girirajan S, 2012, NEW ENGL J MED, V367, P1321, DOI 10.1056/NEJMoa1200395; Girirajan S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002334; Hach F, 2010, NAT METHODS, V7, P576, DOI 10.1038/nmeth0810-576; Handsaker RE, 2011, NAT GENET, V43, P269, DOI 10.1038/ng.768; Henley JM, 2014, PHYSIOL REV, V94, P1249, DOI 10.1152/physrev.00008.2014; Hodge JC, 2014, MOL PSYCHIATR, V19, P368, DOI 10.1038/mp.2013.42; Hormozdiari F, 2011, GENOME RES, V21, P2203, DOI 10.1101/gr.120501.111; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jacquemont S, 2014, AM J HUM GENET, V94, P415, DOI 10.1016/j.ajhg.2014.02.001; Jansen LA, 2015, BRAIN, V138, P1613, DOI 10.1093/brain/awv045; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kilpinen H, 2008, MOL PSYCHIATR, V13, P187, DOI 10.1038/sj.mp.4002031; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Krumm N, 2015, NAT GENET, V47, P582, DOI 10.1038/ng.3303; Krumm N, 2012, GENOME RES, V22, P1525, DOI 10.1101/gr.138115.112; LEFF SE, 1992, NAT GENET, V2, P259, DOI 10.1038/ng1292-259; Lelieveld SH, 2015, HUM MUTAT, V36, P815, DOI 10.1002/humu.22813; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lin MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023356; Lionel AC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002464; Liu YZ, 2014, BIOINFORMATICS, V30, P1830, DOI 10.1093/bioinformatics/btu141; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meynert AM, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-247; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Munz M, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0195-6; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; O'Roak BJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6595; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Oda K, 2008, CANCER RES, V68, P8127, DOI 10.1158/0008-5472.CAN-08-0755; Okuma T, 1999, BIOCHEM BIOPH RES CO, V254, P693, DOI 10.1006/bbrc.1998.9995; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Prasad A, 2012, G3-GENES GENOM GENET, V2, P1665, DOI 10.1534/g3.112.004689; Qu QH, 2013, MOL CELL BIOL, V33, P2551, DOI 10.1128/MCB.00325-13; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Rimmer A, 2014, NAT GENET, V46, P912, DOI 10.1038/ng.3036; Ritchie ME, 2009, BIOINFORMATICS, V25, P2621, DOI 10.1093/bioinformatics/btp470; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; ROCHE AF, 1987, PEDIATRICS, V79, P706; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Scharpf RB, 2011, J STAT SOFTW, V40, P1; Sherry ST, 1999, GENOME RES, V9, P677; STEFFENBURG S, 1989, J CHILD PSYCHOL PSYC, V30, P405, DOI 10.1111/j.1469-7610.1989.tb00254.x; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Talkowski ME, 2011, AM J HUM GENET, V89, P551, DOI 10.1016/j.ajhg.2011.09.011; Thomas DJ, 2007, NUCLEIC ACIDS RES, V35, pD663, DOI 10.1093/nar/gkl1017; Turner TN, 2015, NATURE, V520, P51, DOI 10.1038/nature14186; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wei Q, 2015, BIOINFORMATICS, V31, P1375, DOI 10.1093/bioinformatics/btu839; Whitlock KE, 2000, DEVELOPMENT, V127, P3645; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446; Yuen RKC, 2015, NAT MED, V21, P185, DOI 10.1038/nm.3792; Zhao WW, 2013, MOL CYTOGENET, V6, DOI 10.1186/1755-8166-6-26	84	178	178	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 7	2016	98	1					58	74		10.1016/j.ajhg.2015.11.023	http://dx.doi.org/10.1016/j.ajhg.2015.11.023			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DA8JL	26749308	Green Published, Bronze			2022-12-18	WOS:000368050800005
J	Hoyer, J; Ekici, AB; Endele, S; Popp, B; Zweier, C; Wiesener, A; Wohlleber, E; Dufke, A; Rossier, E; Petsch, C; Zweier, M; Gohring, I; Zink, AM; Rappold, G; Schrock, E; Wieczorek, D; Riess, O; Engels, H; Rauch, A; Reis, A				Hoyer, Juliane; Ekici, Arif B.; Endele, Sabine; Popp, Bernt; Zweier, Christiane; Wiesener, Antje; Wohlleber, Eva; Dufke, Andreas; Rossier, Eva; Petsch, Corinna; Zweier, Markus; Goehring, Ina; Zink, Alexander M.; Rappold, Gudrun; Schroeck, Evelin; Wieczorek, Dagmar; Riess, Olaf; Engels, Hartmut; Rauch, Anita; Reis, Andre			Haploinsufficiency of ARID1B, a Member of the SWI/SNF-A Chromatin-Remodeling Complex, Is a Frequent Cause of Intellectual Disability	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MENTAL-RETARDATION; HISTONE H2B; DEVELOPMENTAL DELAY; MUTATIONS; GENES; EXPRESSION; DISORDERS; SUBUNITS; AUTISM; REGION	Intellectual disability (ID) is a clinically and genetically heterogeneous common condition that remains etiologically unresolved in the majority of cases. Although several hundred diseased genes have been identified in X-linked, autosomal-recessive, or syndromic types of ID, the establishment of an etiological basis remains a difficult task in unspecific, sporadic cases. Just recently, de novo mutations in SYNGAP1, STXBP1, MEF2C, and GRIN2B were reported as relatively common causes of ID in such individuals. On the basis of a patient with severe ID and a 2.5 Mb microdeletion including ARID1B in chromosomal region 6q25, we performed mutational analysis in 887 unselected patients with unexplained ID. In this cohort, we found eight (0.9%) additional de novo nonsense or frameshift mutations predicted to cause haploinsufficiency. Our findings indicate that haploinsufficiency of ARID1B, a member of the SWI/SNF-A chromatin-remodeling complex, is a common cause of ID, and they add to the growing evidence that chromatin-remodeling defects are an important contributor to neurodevelopmental disorders.	[Hoyer, Juliane; Ekici, Arif B.; Endele, Sabine; Popp, Bernt; Zweier, Christiane; Wiesener, Antje; Petsch, Corinna; Zweier, Markus; Goehring, Ina; Rauch, Anita; Reis, Andre] Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany; [Wohlleber, Eva; Zink, Alexander M.; Engels, Hartmut] Univ Bonn, Inst Human Genet, D-53105 Bonn, Germany; [Dufke, Andreas; Rossier, Eva; Riess, Olaf] Univ Tubingen, Inst Human Genet, D-72076 Tubingen, Germany; [Rappold, Gudrun] Heidelberg Univ, Dept Human Mol Genet, D-69120 Heidelberg, Germany; [Schroeck, Evelin] Tech Univ Dresden, Inst Klin Genet, D-01307 Dresden, Germany; [Wieczorek, Dagmar] Univ Klinikum Essen, Inst Humangenet, D-45147 Essen, Germany; [Rauch, Anita] Univ Zurich, Inst Med Genet, CH-8603 Schwerzenbach, Switzerland	University of Erlangen Nuremberg; University of Bonn; Eberhard Karls University of Tubingen; Ruprecht Karls University Heidelberg; Technische Universitat Dresden; University of Duisburg Essen; University of Zurich	Reis, A (corresponding author), Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany.	andre.reis@uk-erlangen.de	Wieczorek, Dagmar/AAU-6008-2021; Rauch, Anita/C-5568-2014; Zweier, Christiane/F-2202-2015; Reis, André/D-2309-2009; Popp, Bernt/M-2157-2019; Ekici, Arif B/C-3971-2013; Zink, Alexander/B-2305-2013	Wieczorek, Dagmar/0000-0003-2812-6492; Rauch, Anita/0000-0003-2930-3163; Zweier, Christiane/0000-0001-8002-2020; Reis, André/0000-0002-6301-6363; Popp, Bernt/0000-0002-3679-1081; Ekici, Arif B/0000-0001-6099-7066; 	German Intellectual Disability Network through German Ministry of Education and Research [01GS08160]	German Intellectual Disability Network through German Ministry of Education and Research	We thank the patients and their families for their cooperation. We also thank Angelika Diem, Petra Rothe, Daniela Schweizer, and Olga Zwenger for the excellent technical support. This study was supported by the German Intellectual Disability Network through a grant from the German Ministry of Education and Research to G.R., E.S., D.W., OR., H.E., A. Rauch, and A. Reis. (01GS08160).	Abou Jamra R, 2011, AM J HUM GENET, V88, P788, DOI 10.1016/j.ajhg.2011.04.019; Backx L, 2011, CYTOGENET GENOME RES, V132, P135, DOI 10.1159/000321577; DAVIE JR, 1994, BIOCHEM BIOPH RES CO, V203, P344, DOI 10.1006/bbrc.1994.2188; Endele S, 2010, NAT GENET, V42, P1021, DOI 10.1038/ng.677; Gecz J, 2009, TRENDS GENET, V25, P308, DOI 10.1016/j.tig.2009.05.002; Halgren C, 2012, CLIN GENET, V82, P248, DOI 10.1111/j.1399-0004.2011.01755.x; Hamdan FF, 2009, ANN NEUROL, V65, P748, DOI 10.1002/ana.21625; Hamdan FF, 2009, NEW ENGL J MED, V360, P599, DOI 10.1056/NEJMoa0805392; Kraft M, 2011, J CLIN INVEST, V121, P3479, DOI 10.1172/JCI43428; Kramer JM, 2009, INT J BIOCHEM CELL B, V41, P96, DOI 10.1016/j.biocel.2008.08.009; Li XS, 2010, MOL CELL BIOL, V30, P1673, DOI 10.1128/MCB.00540-09; Minsky N, 2008, NAT CELL BIOL, V10, P483, DOI 10.1038/ncb1712; Nagamani SCS, 2009, EUR J HUM GENET, V17, P573, DOI 10.1038/ejhg.2008.220; Nagl NG, 2007, EMBO J, V26, P752, DOI 10.1038/sj.emboj.7601541; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Nord AS, 2011, EUR J HUM GENET, V19, P727, DOI 10.1038/ejhg.2011.24; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Rauch A, 2006, AM J MED GENET A, V140A, P2063, DOI 10.1002/ajmg.a.31416; Ropers HH, 2010, ANNU REV GENOM HUM G, V11, P161, DOI 10.1146/annurev-genom-082509-141640; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Wang XM, 2004, BIOCHEM J, V383, P319, DOI 10.1042/BJ20040524; Zweier M, 2010, HUM MUTAT, V31, P722, DOI 10.1002/humu.21253	24	178	187	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 9	2012	90	3					565	572		10.1016/j.ajhg.2012.02.007	http://dx.doi.org/10.1016/j.ajhg.2012.02.007			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911ZI	22405089	Green Accepted, Green Published, Bronze			2022-12-18	WOS:000301762800024
J	Martinelli, S; De Luca, A; Stellacci, E; Rossi, C; Checquolo, S; Lepri, F; Caputo, V; Silvano, M; Buscherini, F; Consoli, F; Ferrara, G; Digilio, MC; Cavaliere, ML; van Hagen, JM; Zampino, G; van der Burgt, I; Ferrero, GB; Mazzanti, L; Screpanti, I; Yntema, HG; Nillesen, WM; Savarirayan, R; Zenker, M; Dallapiccola, B; Gelb, BD; Tartaglia, M				Martinelli, Simone; De Luca, Alessandro; Stellacci, Emilia; Rossi, Cesare; Checquolo, Saula; Lepri, Francesca; Caputo, Viviana; Silvano, Marianna; Buscherini, Francesco; Consoli, Federica; Ferrara, Grazia; Digilio, Maria C.; Cavaliere, Maria L.; van Hagen, Johanna M.; Zampino, Giuseppe; van der Burgt, Ineke; Ferrero, Giovanni B.; Mazzanti, Laura; Screpanti, Isabella; Yntema, Helger G.; Nillesen, Willy M.; Savarirayan, Ravi; Zenker, Martin; Dallapiccola, Bruno; Gelb, Bruce D.; Tartaglia, Marco			Heterozygous Germline Mutations in the CBL Tumor-Suppressor Gene Cause a Noonan Syndrome-like Phenotype	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GAIN-OF-FUNCTION; JUVENILE MYELOMONOCYTIC LEUKEMIA; ACQUIRED UNIPARENTAL DISOMY; ACUTE MYELOID-LEUKEMIA; GROWTH-FACTOR RECEPTOR; C-CBL; EGF RECEPTOR; NEUROFIBROMATOSIS TYPE-1; COSTELLO-SYNDROME; ADAPTER PROTEIN	RAS signaling plays a key role in controlling appropriate cell responses to extracellular stimuli and participates in early and late developmental processes. Although enhanced flow through this pathway has been established as a major contributor to oncogenesis, recent discoveries have revealed that aberrant RAS activation causes a group of clinically related developmental disorders characterized by facial dysmorphism, a wide spectrum of cardiac disease, reduced growth, variable cognitive deficits, ectodermal and musculoskeletal anomalies, and increased risk for certain malignancies. Here, we report that heterozygous germline mutations in CBL, a tumor-suppressor gene that is mutated in myeloid malignancies and encodes a multivalent adaptor protein with E3 ubiquitin ligase activity, can underlie a phenotype with clinical features fitting or partially overlapping Noonan syndrome (NS), the most common condition of this disease family. Independent CBL mutations were identified in two sporadic cases and two families from among 365 unrelated subjects who had NS or suggestive features and were negative for mutations in previously identified disease genes. Phenotypic heterogeneity and variable expressivity were documented. Mutations were missense changes altering evolutionarily conserved residues located in the RING finger domain or the linker connecting this domain to the N-terminal tyrosine kinase binding domain, a known mutational hot spot in myeloid malignancies. Mutations were shown to affect CBL-mediated receptor ubiquitylation and dysregulate signal flow through RAS. These findings document that germline mutations in CBL alter development to cause a clinically variable condition that resembles NS and that possibly predisposes to malignancies.	[Martinelli, Simone; Stellacci, Emilia; Caputo, Viviana; Silvano, Marianna; Tartaglia, Marco] Ist Super Sanita, Dipartimento Ematol Oncol & Med Mol, I-00161 Rome, Italy; [De Luca, Alessandro; Lepri, Francesca; Consoli, Federica] Osped Casa Sollievo Sofferenza, IRCCS, I-71013 San Giovanni Rotondo, Italy; [Rossi, Cesare; Buscherini, Francesco] St Orsola Marcello Malpighi Hosp, Unita Operat Genet Med, I-40138 Bologna, Italy; [Checquolo, Saula; Ferrara, Grazia; Screpanti, Isabella] Univ Roma La Sapienza, Dipartimento Med Sperimentale, I-00161 Rome, Italy; [Digilio, Maria C.; Dallapiccola, Bruno] Bambino Gesu Pediat Hosp, I-00165 Rome, Italy; [Cavaliere, Maria L.] Osped Antonio Cardarelli, Unita Operat Genet Med, I-80131 Naples, Italy; [van Hagen, Johanna M.] Vrije Univ Univ Med Ctr, Dept Human Genet, NL-1007 Amsterdam, Netherlands; [Zampino, Giuseppe] Univ Cattolica Sacro Cuore, Ist Clin Pediat, I-00168 Rome, Italy; [van der Burgt, Ineke; Yntema, Helger G.; Nillesen, Willy M.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 Nijmegen, Netherlands; [Ferrero, Giovanni B.] Univ Turin, Dipartimento Pediat, I-10126 Turin, Italy; [Mazzanti, Laura] Univ Bologna, Dipartimento Pediat, I-40138 Bologna, Italy; [Savarirayan, Ravi] Royal Childrens Hosp, Genet Hlth Serv Victoria, Melbourne, Vic 3052, Australia; [Savarirayan, Ravi] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia; [Zenker, Martin] Univ Hosp, Inst Human Genet, D-39120 Magdeburg, Germany; [Gelb, Bruce D.] Mt Sinai Sch Med, Child Hlth & Dev Inst, New York, NY 10029 USA	Istituto Superiore di Sanita (ISS); IRCCS Casa Sollievo Della Sofferenza; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Sapienza University Rome; IRCCS Bambino Gesu; Antonio Cardarelli Hospital; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Radboud University Nijmegen; University of Turin; University of Bologna; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University Hospital Magdeburg; Icahn School of Medicine at Mount Sinai	Tartaglia, M (corresponding author), Ist Super Sanita, Dipartimento Ematol Oncol & Med Mol, Viale Regina Elena 299, I-00161 Rome, Italy.	mtartaglia@iss.it	Ferrero, Giovanni Battista/K-5265-2018; Martinelli, Simone/J-9432-2018; Zampino, Giuseppe/AAC-2152-2019; Consoli, Federica/B-7747-2017; mazzanti, laura/K-3368-2016; Lepri, Francesca Romana/AAA-6115-2020; Rossi, Cesare/AAC-2083-2022; De Luca, Alessandro/B-2179-2017; stellacci, emilia/J-2747-2014; Tartaglia, Marco/K-2955-2018; Digilio, Maria Cristina/AAI-2434-2019; Yntema, H.G./L-4771-2015; Stellacci, Francesco/B-1990-2008; Dallapiccola, Bruno/K-8692-2016	Ferrero, Giovanni Battista/0000-0002-3793-5788; Martinelli, Simone/0000-0002-5843-419X; Consoli, Federica/0000-0002-8256-586X; Rossi, Cesare/0000-0003-1826-615X; De Luca, Alessandro/0000-0002-4408-8062; stellacci, emilia/0000-0003-0415-3285; Tartaglia, Marco/0000-0001-7736-9672; Stellacci, Francesco/0000-0003-4635-6080; CHECQUOLO, Saula/0000-0001-5109-8392; Lepri, Francesca Romana/0000-0001-5331-0473; Dallapiccola, Bruno/0000-0002-5031-1013; mazzanti, laura/0000-0002-7670-6494	Telethon-Italy [GGP10020]; Associazione Italiana Sindromi di Costello e Cardiofaciocutanea; ERA (European network on Noonan Syndrome and related disorders); Italian Ministry of Health [RC2010]; National Institutes of Health [HL71207]; March of Dimes [FY 07-286]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071207] Funding Source: NIH RePORTER	Telethon-Italy(Fondazione Telethon); Associazione Italiana Sindromi di Costello e Cardiofaciocutanea; ERA (European network on Noonan Syndrome and related disorders); Italian Ministry of Health(Ministry of Health, Italy); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are indebted to the patients and families who participated in the study, the physicians who referred the subjects, Serenella Venanzi (Istituto Superiore di Sanita, Rome, Italy) for experimental support, and Paolo Bazzicalupo and Elia Di Schiavi (Istituto di Genetica e Biofisica "A. Buzzati Traverso," Consiglio Nazionale delle Ricerche, Naples, Italy) for stimulating discussions. This research was funded by grants from Telethon-Italy (GGP10020) and "Associazione Italiana Sindromi di Costello e Cardiofaciocutanea" to M.T., from ERA-Net for research programmes on rare diseases 2009 (European network on Noonan Syndrome and related disorders) to M.T. and M.Z., from the Italian Ministry of Health (RC2010) to F.L., and from the National Institutes of Health (HL71207) and March of Dimes (FY 07-286) to B.D.G.	ALLANSON JE, 1985, AM J MED GENET, V21, P457, DOI 10.1002/ajmg.1320210307; Allanson JE, 2007, AM J MED GENET C, V145C, P274, DOI 10.1002/ajmg.c.30138; Bacher U, 2010, ANN HEMATOL, V89, P643, DOI 10.1007/s00277-010-0920-6; Beier AD, 2009, NEUROLOGIST, V15, P37, DOI 10.1097/NRL.0b013e31817833c4; Brems H, 2009, LANCET ONCOL, V10, P508, DOI 10.1016/S1470-2045(09)70033-6; Caligiuri MA, 2007, BLOOD, V110, P1022, DOI 10.1182/blood-2006-12-061176; Carta C, 2006, AM J HUM GENET, V79, P129, DOI 10.1086/504394; Cirstea IC, 2010, NAT GENET, V42, P27, DOI 10.1038/ng.497; Cordeddu V, 2009, NAT GENET, V41, P1022, DOI 10.1038/ng.425; De Luca A, 2005, AM J HUM GENET, V77, P1092, DOI 10.1086/498454; Dikic I, 2007, EUR J CELL BIOL, V86, P505, DOI 10.1016/j.ejcb.2007.04.005; Duan L, 2003, J BIOL CHEM, V278, P28950, DOI 10.1074/jbc.M304474200; Dunbar AJ, 2008, CANCER RES, V68, P10349, DOI 10.1158/0008-5472.CAN-08-2754; Finkelstein LD, 2000, BIOCHEM J, V345, P385, DOI 10.1042/0264-6021:3450385; Garcia-Guzman M, 2000, ONCOGENE, V19, P4058, DOI 10.1038/sj.onc.1203750; Grand FH, 2009, BLOOD, V113, P6182, DOI 10.1182/blood-2008-12-194548; Gripp KW, 2010, AM J MED GENET A, V152A, P1161, DOI 10.1002/ajmg.a.33391; Grovdal LM, 2004, EXP CELL RES, V300, P388, DOI 10.1016/j.yexcr.2004.07.003; Holder-Espinasse M, 2003, CLIN DYSMORPHOL, V12, P275, DOI 10.1097/00019605-200310000-00013; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kassenbrock CK, 2004, J BIOL CHEM, V279, P28017, DOI 10.1074/jbc.M404114200; Loh ML, 2009, BLOOD, V114, P1859, DOI 10.1182/blood-2009-01-198416; Longva KE, 2002, J CELL BIOL, V156, P843, DOI 10.1083/jcb.200106056; Makishima H, 2009, J CLIN ONCOL, V27, P6109, DOI 10.1200/JCO.2009.23.7503; Moghal N, 2003, DEVELOPMENT, V130, P57, DOI 10.1242/dev.00189; Muramatsu H, 2010, BLOOD, V115, P1969, DOI 10.1182/blood-2009-06-226340; Nava C, 2007, J MED GENET, V44, P763, DOI 10.1136/jmg.2007.050450; NOONAN JA, 1994, CLIN PEDIATR, V33, P548, DOI 10.1177/000992289403300907; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rajalingam K, 2007, BBA-MOL CELL RES, V1773, P1177, DOI 10.1016/j.bbamcr.2007.01.012; Razzaque MA, 2007, NAT GENET, V39, P1013, DOI 10.1038/ng2078; Reindl C, 2009, CLIN CANCER RES, V15, P2238, DOI 10.1158/1078-0432.CCR-08-1325; Roberts AE, 2007, NAT GENET, V39, P70, DOI 10.1038/ng1926; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Sargin B, 2007, BLOOD, V110, P1004, DOI 10.1182/blood-2007-01-066076; Sarkozy A, 2009, HUM MUTAT, V30, P695, DOI 10.1002/humu.20955; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Schubbert S, 2006, NAT GENET, V38, P331, DOI 10.1038/ng1748; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Song JJ, 2010, CELL SIGNAL, V22, P377, DOI 10.1016/j.cellsig.2009.10.007; SUGIMOTO Y, 2010, BR J HAEMAT IN PRESS; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; Tartaglia M, 2004, BLOOD, V104, P307, DOI 10.1182/blood-2003-11-3876; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2010, MOL SYNDROMOL, V1, P2, DOI 10.1159/000276766; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tartaglia M, 2007, NAT GENET, V39, P75, DOI 10.1038/ng1939; Tidyman WE, 2009, CURR OPIN GENET DEV, V19, P230, DOI 10.1016/j.gde.2009.04.001; Tubbs RS, 2004, PEDIATR NEUROL, V30, P278, DOI 10.1016/j.pediatrneurol.2003.09.013; Umebayashi K, 2008, MOL BIOL CELL, V19, P3454, DOI 10.1091/mbc.E07-10-0988; van der Burgt I, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-4; Visser GD, 2005, EXP CELL RES, V311, P281, DOI 10.1016/j.yexcr.2005.09.015; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	54	178	183	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 13	2010	87	2					250	257		10.1016/j.ajhg.2010.06.015	http://dx.doi.org/10.1016/j.ajhg.2010.06.015			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641EG	20619386	Green Published, Bronze			2022-12-18	WOS:000281107000009
J	Flanagan, JM; Popendikyte, V; Pozdniakovaite, N; Sobolev, M; Assadzadeh, A; Schumacher, A; Zangeneh, M; Lau, L; Virtanen, C; Wang, SC; Petronis, A				Flanagan, James M.; Popendikyte, Violeta; Pozdniakovaite, Natalija; Sobolev, Martha; Assadzadeh, Abbas; Schumacher, Axel; Zangeneh, Masood; Lau, Lynette; Virtanen, Carl; Wang, Sun-Chong; Petronis, Arturas			Intra- and interindividual epigenetic variation in human germ cells	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA-METHYLATION; CPG ISLANDS; CHROMOSOME BANDS; CDH13 GENE; CHROMATIN; MOUSE; INHERITANCE; PROMOTER; RISK; AGE	Epigenetics represents a secondary inheritance system that has been poorly investigated in human biology. The objective of this study was to perform a comprehensive analysis of DNA methylation variation between and within the germlines of normal males. First, methylated cytosines were mapped using bisulphite modification-based sequencing in the promoter regions of the following disease genes: presenilins ( PSEN1 and PSEN2), breast cancer ( BRCA1 and BRCA2), myotonic dystrophy ( DM1), and Huntington disease ( HD). Major epigenetic variation was detected within samples, since the majority of sperm cells of the same individual exhibited unique DNA methylation profiles. In the interindividual analysis, 41 of 61 pairwise comparisons revealed distinct DNA methylation profiles ( to 6.8 x 10(-14)). Second, microarray. P = .036 based epigenetic profiling of the same sperm samples was performed using a 12,198-feature CpG island microarray. The microarray analysis has identified numerous DNA methylation-variable positions in the germ cell genome. The largest degree of variation was detected within the promoter CpG islands and pericentromeric satellites among the single-copy DNA fragments and repetitive elements, respectively. A number of genes, such as EED, CTNNA2, CALM1, CDH13, and STMN2, exhibited age-related DNA methylation changes. Finally, allele-specific methylation patterns in CDH13 were detected. This study provides evidence for significant epigenetic variability in human germ cells, which warrants further research to determine whether such epigenetic patterns can be efficiently transmitted across generations and what impact inherited epigenetic individuality may have on phenotypic outcomes in health and disease.	Ctr Addict & Mental Hlth, Krembil Family Epigenet Lab, Toronto, ON M5T 1R8, Canada; Ontario Canc Inst, Microarray Ctr, Toronto, ON M5T 1R8, Canada; Inst Biotechnol, Vilnius, Lithuania	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Vilnius University	Petronis, A (corresponding author), Ctr Addict & Mental Hlth, Krembil Family Epigenet Lab, 250 Coll St, Toronto, ON M5T 1R8, Canada.	arturas_petronis@camh.net	Schumacher, Axel/C-6612-2008; zangeneh, masood/ABH-2565-2020; Petronis, Art/AAD-4491-2019	zangeneh, masood/0000-0002-5038-1089; Flanagan, James/0000-0003-4955-1383				Allegrucci C, 2005, REPRODUCTION, V129, P137, DOI 10.1530/rep.1.00360; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Blewitt ME, 2005, P NATL ACAD SCI USA, V102, P7629, DOI 10.1073/pnas.0409375102; Byrne M, 2003, ARCH GEN PSYCHIAT, V60, P673, DOI 10.1001/archpsyc.60.7.673; Cavalli G, 1998, CELL, V93, P505, DOI 10.1016/S0092-8674(00)81181-2; Cavalli G, 1999, SCIENCE, V286, P955, DOI 10.1126/science.286.5441.955; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Chong SY, 2004, CURR OPIN GENET DEV, V14, P692, DOI 10.1016/j.gde.2004.09.001; Churikov D, 2004, GENOMICS, V84, P745, DOI 10.1016/j.ygeno.2004.06.001; Churikov D, 2004, CYTOGENET GENOME RES, V105, P203, DOI 10.1159/000078190; CRAIG JM, 1993, BIOESSAYS, V15, P349, DOI 10.1002/bies.950150510; Czermin B, 2003, GENETICA, V117, P159, DOI 10.1023/A:1022927725945; Dudoit S, 2002, GENOME BIOL, V3; Furey TS, 2003, HUM MOL GENET, V12, P1037, DOI 10.1093/hmg/ddg113; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gisselsson D, 2005, CHROMOSOMA, V114, P118, DOI 10.1007/s00412-005-0343-7; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hajkova Petra, 2002, Methods Mol Biol, V200, P143; Heisler LE, 2005, NUCLEIC ACIDS RES, V33, P2952, DOI 10.1093/nar/gki582; Henikoff S, 1997, TRENDS GENET, V13, P293, DOI 10.1016/S0168-9525(97)01219-5; Hibi K, 2004, BRIT J CANCER, V90, P1030, DOI 10.1038/sj.bjc.6601647; Hibi K, 2004, BRIT J CANCER, V91, P1139, DOI 10.1038/sj.bjc.6602095; Hitchins M, 2005, GASTROENTEROLOGY, V129, P1392, DOI 10.1053/j.gastro.2005.09.003; HOLMQUIST GP, 1992, AM J HUM GENET, V51, P17; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; JABS EW, 1989, P NATL ACAD SCI USA, V86, P202, DOI 10.1073/pnas.86.1.202; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kaminsky ZA, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni094; Kimmins S, 2005, NATURE, V434, P583, DOI 10.1038/nature03368; Klar AJS, 1998, TRENDS GENET, V14, P299, DOI 10.1016/S0168-9525(98)01535-2; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; Malaspina D, 2001, ARCH GEN PSYCHIAT, V58, P361, DOI 10.1001/archpsyc.58.4.361; Martin DIK, 2005, ANN NY ACAD SCI, V1054, P68, DOI 10.1196/annals.1345.009; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Miniou P, 1997, HUM GENET, V99, P738, DOI 10.1007/s004390050441; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Murrell A, 2004, HUM MOL GENET, V13, P247, DOI 10.1093/hmg/ddh013; Ogama Y, 2004, INT J ONCOL, V25, P685; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Polesskaya OO, 2006, J NEUROSCI RES, V83, P362, DOI 10.1002/jnr.20732; Rakyan V, 2003, CURR BIOL, V13, pR6, DOI 10.1016/S0960-9822(02)01377-5; Rakyan VK, 2004, PLOS BIOL, V2, P2170, DOI 10.1371/journal.pbio.0020405; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Roman-Gomez J, 2003, J CLIN ONCOL, V21, P1472, DOI 10.1200/JCO.2003.08.166; Sakai M, 2004, CANCER SCI, V95, P588, DOI 10.1111/j.1349-7006.2004.tb02491.x; Sandovici I, 2005, HUM MOL GENET, V14, P2135, DOI 10.1093/hmg/ddi218; Scheid OM, 2003, NAT GENET, V34, P450, DOI 10.1038/ng1210; Schumacher A, 2006, NUCLEIC ACIDS RES, V34, P528, DOI 10.1093/nar/gkj461; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Smith A, 2005, MOL BRAIN RES, V135, P225, DOI 10.1016/j.molbrainres.2004.12.025; Suter CM, 2004, NAT GENET, V36, P497, DOI 10.1038/ng1342; TAUBES G, 1995, SCIENCE, V269, P164, DOI 10.1126/science.7618077; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101; Widschwendter A, 2004, INT J CANCER, V109, P163, DOI 10.1002/ijc.11706; Wong AHC, 2005, HUM MOL GENET, V14, pR11, DOI 10.1093/hmg/ddi116; Yamada Y, 2004, GENOME RES, V14, P247, DOI 10.1101/gr.1351604; Yatabe Y, 2001, P NATL ACAD SCI USA, V98, P10839, DOI 10.1073/pnas.191225998; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Zalensky AO, 2002, J BIOL CHEM, V277, P43474, DOI 10.1074/jbc.M206065200; ZOGEL C, 2006, EUR J HUM GENET	71	178	194	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2006	79	1					67	84		10.1086/504729	http://dx.doi.org/10.1086/504729			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	053YD	16773567	Bronze, Green Published			2022-12-18	WOS:000238341200008
J	Yobb, TM; Somerville, MJ; Willatt, L; Firth, HV; Harrison, K; MacKenzie, J; Gallo, N; Morrow, BE; Shaffer, LG; Babcock, M; Chernos, J; Bernier, F; Sprysak, K; Christiansen, J; Haase, S; Elyas, B; Lilley, M; Bamforth, S; McDermid, HE				Yobb, TM; Somerville, MJ; Willatt, L; Firth, HV; Harrison, K; MacKenzie, J; Gallo, N; Morrow, BE; Shaffer, LG; Babcock, M; Chernos, J; Bernier, F; Sprysak, K; Christiansen, J; Haase, S; Elyas, B; Lilley, M; Bamforth, S; McDermid, HE			Microduplication and triplication of 22q11.2: A highly variable syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CAT-EYE SYNDROME; CARDIO-FACIAL SYNDROME; DELETION-SYNDROME; TANDEM DUPLICATION; GENOMIC DISORDERS; CHROMOSOME 22Q11; PROXIMAL 22Q; COPY-NUMBER; MECHANISMS; PHENOTYPE	22q11.2 microduplications of a 3-Mb region surrounded by low-copy repeats should be, theoretically, as frequent as the deletions of this region; however, few microduplications have been reported. We show that the phenotype of these patients with microduplications is extremely diverse, ranging from normal to behavioral abnormalities to multiple defects, only some of which are reminiscent of the 22q11.2 deletion syndrome. This diversity will make ascertainment difficult and will necessitate a rapid-screening method. We demonstrate the utility of four different screening methods. Although all the screening techniques give unique information, the efficiency of real-time polymerase chain reaction allowed the discovery of two 22q11.2 microduplications in a series of 275 females who tested negative for fragile X syndrome, thus widening the phenotypic diversity. Ascertainment of the fragile X negative cohort was twice that of the cohort screened for the 22q11.2 deletion. We also report the first patient with a 22q11.2 triplication and show that this patient's mother carries a 22q11.2 microduplication. We strongly recommend that other family members of patients with 22q11.2 microduplications also be tested, since we found several phenotypically normal parents who were carriers of the chromosomal abnormality.	Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; Univ Alberta, Dept Med Genet, Edmonton, AB T6G 2E9, Canada; Univ Cambridge, Addenbrookes Natl Hlth Serv Trust, Cambridge, England; Univ Cambridge, Dept Med Genet, Cambridge, England; Queens Univ, Dept Pathol, Kingston, ON K7L 3N6, Canada; Queens Univ, Dept Pediat, Kingston, ON K7L 3N6, Canada; Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10467 USA; Washington State Univ, Sch Mol Biosci, Hlth Res & Educ Ctr, Spokane, WA USA; Alberta Childrens Prov Gen Hosp, Dept Med Genet, Calgary, AB, Canada	University of Alberta; University of Alberta; University of Cambridge; University of Cambridge; Queens University - Canada; Queens University - Canada; Yeshiva University; Albert Einstein College of Medicine; Washington State University; Alberta Childrens Hospital; University of Calgary	McDermid, HE (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada.	hmcdermi@ualberta.ca	Bernier, Francois/AAP-2174-2020; Bernier, Francois/V-7150-2018	Bernier, Francois/0000-0001-7063-4269; Morrow, Bernice/0000-0002-8076-4726	NICHD NIH HHS [1 P01 HD39420-01, 5 P01 HD34980-05, P01 HD039420] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD034980, P01HD039420] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Armour JAL, 2002, HUM MUTAT, V20, P325, DOI 10.1002/humu.10133; Armour JAL, 2000, NUCLEIC ACIDS RES, V28, P605, DOI 10.1093/nar/28.2.605; Botto LD, 2003, PEDIATRICS, V112, P101, DOI 10.1542/peds.112.1.101; DiGeorge A, 1965, J PEDIAT, V67, P907, DOI [DOI 10.1016/S0022-3476(65)81796-6, 10.1016/S0022-3476(65)82145-X]; Edelmann L, 1999, HUM MOL GENET, V8, P1157, DOI 10.1093/hmg/8.7.1157; Edelmann L, 1999, AM J HUM GENET, V64, P1076, DOI 10.1086/302343; Ensenauer RE, 2003, AM J HUM GENET, V73, P1027, DOI 10.1086/378818; Funke B, 1999, AM J HUM GENET, V64, P747, DOI 10.1086/302284; Hassed SJ, 2004, CLIN GENET, V65, P400, DOI 10.1111/j.0009-9163.2004.0212.x; KNOLL JHM, 1995, AM J MED GENET, V55, P221, DOI 10.1002/ajmg.1320550214; Kurahashi H, 2000, HUM MOL GENET, V9, P1665, DOI 10.1093/hmg/9.11.1665; LINDSAY EA, 1995, AM J MED GENET, V56, P296, DOI 10.1002/ajmg.1320560316; Mantripragada KK, 2004, INT J MOL MED, V13, P273; MCDERMID HE, 1986, SCIENCE, V232, P646, DOI 10.1126/science.3961499; McDermid HE, 2002, AM J HUM GENET, V70, P1077, DOI 10.1086/340363; McTaggart KE, 1998, CYTOGENET CELL GENET, V81, P222, DOI 10.1159/000015035; Papenhausen PR, 2002, AM J HUM GENET, V71, P302; Potocki L, 2000, NAT GENET, V24, P84, DOI 10.1038/71743; REISS JA, 1985, AM J MED GENET, V20, P165, DOI 10.1002/ajmg.1320200120; Saitta SC, 2004, HUM MOL GENET, V13, P417, DOI 10.1093/hmg/ddh041; Shaffer LG, 2000, ANNU REV GENET, V34, P297, DOI 10.1146/annurev.genet.34.1.297; SHPRINTZEN RJ, 1978, CLEFT PALATE J, V15, P56; SMITH ACM, 1986, AM J MED GENET, V24, P393, DOI 10.1002/ajmg.1320240303; Stankiewicz P, 2002, CURR OPIN GENET DEV, V12, P312, DOI 10.1016/S0959-437X(02)00304-0; Swillen A, 1999, GENET COUNSEL, V10, P79; Thiel CT, 2003, EUR J HUM GENET, V11, P170, DOI 10.1038/sj.ejhg.5200920	26	178	188	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2005	76	5					865	876		10.1086/429841	http://dx.doi.org/10.1086/429841			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	914BB	15800846	Green Published, Bronze			2022-12-18	WOS:000228198300013
J	Trochet, D; O'Brien, LM; Gozal, D; Trang, H; Nordenskjold, A; Laudier, B; Svensson, PJ; Uhrig, S; Cole, T; Munnich, A; Gaultier, C; Lyonnet, S; Amiel, J				Trochet, D; O'Brien, LM; Gozal, D; Trang, H; Nordenskjold, A; Laudier, B; Svensson, PJ; Uhrig, S; Cole, T; Munnich, A; Gaultier, C; Lyonnet, S; Amiel, J			PHOX2B genotype allows for prediction of tumor risk in congenital central hypoventilation syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ONSET CENTRAL-HYPOVENTILATION; HOMEOBOX GENE PHOX2B; HIRSCHSPRUNGS-DISEASE; POLYALANINE EXPANSIONS; MUTATIONS; NEUROBLASTOMA; DIAGNOSIS	The Phox2b gene is necessary for autonomic nervous-system development. Phox2b(-/-) mice die in utero with absent autonomic nervous system circuits, since autonomic nervous system neurons either fail to form or degenerate. We first identified the Phox2b human ortholog, PHOX2B, as the gene underlying congenital central hypoventilation syndrome (CCHS, or Ondine curse), with an autosomal dominant mode of inheritance and de novo mutation at the first generation. We have subsequently shown that heterozygous mutations of PHOX2B may account for several combined or isolated disorders of autonomic nervous-system development - namely, tumors of the sympathetic nervous system (TSNS), such as neuroblastoma and late-onset central hypoventilation syndrome. Here, we report the clinical and molecular assessments of a cohort of 188 probands with CCHS, either isolated or associated with Hirschsprung disease and/or TSNS. The mutation-detection rate was 92.6% (174/188) in our series, and the most prevalent mutation was an in-frame duplication leading to an expansion of +5 to +13 alanines in the 20-alanine stretch at the carboxy terminal of the protein. Such findings suggest PHOX2B mutation screening as a simple and reliable tool for the diagnosis of CCHS, independent of the clinically variable phenotype. In addition, somatic mosaicism was detected in 4.5% of parents. Most interestingly, analysis of genotype-phenotype interactions strongly supports the contention that patients with CCHS who develop malignant TSNS will harbor either a missense or a frameshift heterozygous mutation of the PHOX2B gene. These data further highlight the link between congenital malformations and tumor predisposition when a master gene in development is mutated.	Hop Necker Enfants Malad, Dept Genet, INSERM, U393,Unite Rech Handicaps Genet Enfant, F-75743 Paris 15, France; Birmingham Womens Hosp, Clin Genet Unit, Birmingham, W Midlands, England; Inst Human Genet & Anthropol, Giessen, Germany; Karolinska Hosp, Dept Mol Med, S-10401 Stockholm, Sweden; Univ Louisville, Kosair Childrens Hosp, Res Inst, Dept Pediat, Louisville, KY 40292 USA; Hop Robert Debre, INSERM 9202, Serv Physiol, Ctr Invest Clin, F-75019 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Birmingham Women's Hospital; Karolinska Institutet; Karolinska University Hospital; University of Louisville; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Amiel, J (corresponding author), Hop Necker Enfants Malad, Dept Genet, INSERM, U393,Unite Rech Handicaps Genet Enfant, 149 Rue Sevres, F-75743 Paris 15, France.	amiel@necker.fr	Gozal, David/ABH-3805-2020; Lyonnet, Stanislas/H-5483-2017; Gozal, David/M-9492-2017; amiel, jeanne/AGX-1124-2022; amiel, jeanne/H-3501-2017	Lyonnet, Stanislas/0000-0001-5426-9417; amiel, jeanne/0000-0001-5973-4728; Trochet, Delphine/0000-0002-9216-6117; Nordenskjold, Agneta/0000-0001-6638-4631				Albrecht AN, 2004, HUM MOL GENET, V13, P2351, DOI 10.1093/hmg/ddh277; Amiel J, 2004, HUM MOL GENET, V13, pR235, DOI 10.1093/hmg/ddh251; Amiel J, 2003, NAT GENET, V33, P459, DOI 10.1038/ng1130; Brunet JF, 2002, CURR OPIN GENET DEV, V12, P435, DOI 10.1016/S0959-437X(02)00322-2; Croaker GDH, 1998, ARCH DIS CHILD, V78, P316, DOI 10.1136/adc.78.4.316; Dauger S, 2003, DEVELOPMENT, V130, P6635, DOI 10.1242/dev.00866; Gozal D, 1998, PEDIATR PULM, V26, P273; HADDAD GG, 1978, MEDICINE, V57, P517, DOI 10.1097/00005792-197811000-00003; HAMILTON J, 1989, J MED GENET, V26, P272, DOI 10.1136/jmg.26.4.272; Katz ES, 2000, PEDIATR PULM, V29, P62, DOI 10.1002/(SICI)1099-0496(200001)29:1<62::AID-PPUL10>3.3.CO;2-D; Kerbl R, 1996, EUR J PEDIATR, V155, P977, DOI 10.1007/BF02282890; Matera I, 2004, J MED GENET, V41, P373, DOI 10.1136/jmg.2003.015412; Mosse YP, 2004, AM J HUM GENET, V75, P727, DOI 10.1086/424530; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Rohrer T, 2002, PEDIATR PULM, V33, P71, DOI 10.1002/ppul.10031; Samad OA, 2004, DEVELOPMENT, V131, P4071, DOI 10.1242/dev.01282; Sasaki A, 2003, HUM GENET, V114, P22, DOI 10.1007/s00439-003-1036-z; Trochet D, 2004, AM J HUM GENET, V74, P761, DOI 10.1086/383253; Vanderlaan M, 2004, PEDIATR PULM, V37, P217, DOI 10.1002/ppul.10438; Warren ST, 1997, SCIENCE, V275, P408, DOI 10.1126/science.275.5298.408; Weese-Mayer DE, 2003, AM J MED GENET A, V123A, P267, DOI 10.1002/ajmg.a.20527; Weese-Mayer DE, 1999, AM J RESP CRIT CARE, V160, P368; Yokoyama M, 1999, GENOMICS, V59, P40, DOI 10.1006/geno.1999.5845	23	178	193	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2005	76	3					421	426		10.1086/428366	http://dx.doi.org/10.1086/428366			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	895HO	15657873	Green Published, Bronze			2022-12-18	WOS:000226851900005
J	Dick, DM; Foroud, T; Flury, L; Bowman, ES; Miller, MJ; Rau, NL; Moe, PR; Samavedy, N; El-Mallakh, R; Manji, H; Glitz, DA; Meyer, ET; Smiley, C; Hahn, R; Widmark, C; McKinney, R; Sutton, L; Ballas, C; Grice, D; Berrettini, W; Byerley, W; Coryell, W; DePaulo, R; MacKinnon, DF; Gershon, ES; Kelsoe, JR; McMahon, FJ; McInnis, M; Murphy, DL; Reich, T; Scheftner, W; Nurnberger, JI				Dick, DM; Foroud, T; Flury, L; Bowman, ES; Miller, MJ; Rau, NL; Moe, PR; Samavedy, N; El-Mallakh, R; Manji, H; Glitz, DA; Meyer, ET; Smiley, C; Hahn, R; Widmark, C; McKinney, R; Sutton, L; Ballas, C; Grice, D; Berrettini, W; Byerley, W; Coryell, W; DePaulo, R; MacKinnon, DF; Gershon, ES; Kelsoe, JR; McMahon, FJ; McInnis, M; Murphy, DL; Reich, T; Scheftner, W; Nurnberger, JI			Genomewide linkage analyses of bipolar disorder: A new sample of 250 pedigrees from the National Institute of Mental Health Genetics Initiative	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MANIC-DEPRESSIVE ILLNESS; COMPLEX TRAITS; DNA MARKERS; SCREEN; SCAN; SCHIZOPHRENIA; FAMILIES; CHROMOSOME-11; REPLICATION; ALCOHOLISM	We conducted genomewide linkage analyses on 1,152 individuals from 250 families segregating for bipolar disorder and related affective illnesses. These pedigrees were ascertained at 10 sites in the United States, through a proband with bipolar I affective disorder and a sibling with bipolar I or schizoaffective disorder, bipolar type. Uniform methods of ascertainment and assessment were used at all sites. A 9-cM screen was performed by use of 391 markers, with an average heterozygosity of 0.76. Multipoint, nonparametric linkage analyses were conducted in affected relative pairs. Additionally, simulation analyses were performed to determine genomewide significance levels for this study. Three hierarchical models of affection were analyzed. Significant evidence for linkage (genomewide P < .10) was found on chromosome 17q, with a peak maximum LOD score of 3.63, at the marker D17S928, and on chromosome 6q, with a peak maximum LOD score of 3.61, near the marker D6S1021. These loci met both standard and simulation-based criteria for genomewide significance. Suggestive evidence of linkage was observed in three other regions (genomewide P <.10), on chromosomes 2p, 3q, and 8q. This study, which is based on the largest linkage sample for bipolar disorder analyzed to date, indicates that several genes contribute to bipolar disorder.	Indiana Univ, Sch Med, Inst Psychiat Res, Indianapolis, IN 46202 USA; Univ Louisville, Louisville, KY 40292 USA; NIMH, Mood & Anxiety Program, NIH, US Dept HHS, Bethesda, MD 20892 USA; Wayne State Univ, Detroit, MI USA; Univ Calif Irvine, Irvine, CA USA; Univ Calif San Diego, San Diego, CA 92103 USA; San Diego Vet Affairs Healthcare Syst, San Diego, CA USA; Univ Penn, Philadelphia, PA 19104 USA; Univ Iowa, Iowa City, IA USA; Johns Hopkins Univ, Baltimore, MD USA; Univ Chicago, Chicago, IL 60637 USA; Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA; Washington Univ, St Louis, MO USA	Indiana University System; Indiana University-Purdue University Indianapolis; University of Louisville; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Wayne State University; University of California System; University of California Irvine; University of California System; University of California San Diego; University of Pennsylvania; University of Iowa; Johns Hopkins University; University of Chicago; Rush University; Washington University (WUSTL)	Nurnberger, JI (corresponding author), Indiana Univ, Sch Med, Inst Psychiat Res, 791 Union Dr, Indianapolis, IN 46202 USA.	jnurnber@iupui.edu	MacKinnon, Dean/AAG-6232-2020; McMahon, Francis J/A-7290-2009; Meyer, Eric T./C-1029-2011; Grice, Dorothy E/X-3372-2019	McMahon, Francis J/0000-0002-9469-305X; Meyer, Eric T./0000-0002-1998-7162; Grice, Dorothy E/0000-0002-8833-2549; Nurnberger, John/0000-0002-7674-1767; coryell, william/0000-0003-3989-7276; DePaulo, J Raymond/0000-0001-9221-9226	NHGRI NIH HHS [N01HG65403, N01 HG 65403] Funding Source: Medline; NIAAA NIH HHS [AA 13358, F32 AA013358, AA 00285] Funding Source: Medline; NIMH NIH HHS [R01 MH059567, MH 60068, R01 MH060068, R01 MH059545, R01 MH 59545, MH 59567] Funding Source: Medline; PHS HHS [R01 59553] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002842, Z01MH002237, Z01MH002810] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; American Psychiatric Association DSM-IV, 1994, DSM 4 DIAGN STAT MAN; Badner JA, 2002, MOL PSYCHIATR, V7, P405, DOI 10.1038/sj.mp.4001012; Bennett P, 2002, MOL PSYCHIATR, V7, P189, DOI 10.1038/sj.mp.4000957; BERRETTINI WH, 1994, P NATL ACAD SCI USA, V91, P5918, DOI 10.1073/pnas.91.13.5918; BERTELSEN A, 1979, ORIGIN PREVENTION TR, P227; BOEHNKE M, 1991, AM J HUM GENET, V48, P22; Craddock N, 1999, J MED GENET, V36, P585, DOI 10.1136/jmg.36.8.585; DeteraWadleigh SD, 1997, AM J MED GENET, V74, P254, DOI 10.1002/(SICI)1096-8628(19970531)74:3<254::AID-AJMG4>3.0.CO;2-Q; Dick DM, 2002, AM J MED GENET, V114, P407, DOI 10.1002/ajmg.10380; Edenberg HJ, 1997, AM J MED GENET, V74, P238, DOI 10.1002/(SICI)1096-8628(19970531)74:3<238::AID-AJMG2>3.0.CO;2-M; EGELAND JA, 1987, NATURE, V325, P783, DOI 10.1038/325783a0; FEIGHNER JP, 1972, ARCH GEN PSYCHIAT, V26, P57, DOI 10.1001/archpsyc.1972.01750190059011; Foroud T, 2000, ALCOHOL CLIN EXP RES, V24, P933, DOI 10.1097/00000374-200007000-00001; GERSHON ES, 1988, ARCH GEN PSYCHIAT, V45, P328; Green P., 1990, DOCUMENTATION CRIMAP; Jamison Kay Redfield, 1999, NIGHT FALLS FAST UND; KELSOE JR, 1989, NATURE, V342, P238, DOI 10.1038/342238a0; Kendler KS, 1996, AM J PSYCHIAT, V153, P1534; KENDLER KS, 1992, ARCH GEN PSYCHIAT, V49, P257; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P699; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; MCCABE MS, 1975, ACTA PSYCHIAT SCAND, P13; McInnis MG, 2003, MOL PSYCHIATR, V8, P288, DOI 10.1038/sj.mp.4001277; MCINNIS MG, IN PRESS BIOL PSYCHI; McPeek MS, 2000, AM J HUM GENET, V66, P1076, DOI 10.1086/302800; MENDLEWICZ J, 1977, NATURE, V268, P327, DOI 10.1038/268327a0; NAROD SA, 1995, AM J HUM GENET, V56, P254; Nurnberger J I Jr, 2000, Curr Psychiatry Rep, V2, P147, DOI 10.1007/s11920-000-0060-0; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; Nurnberger JI, 1997, AM J MED GENET, V74, P227, DOI 10.1002/(SICI)1096-8628(19970531)74:3<227::AID-AJMG1>3.0.CO;2-N; Nurnberger Jr JI, 1998, PSYCHIAT GENETICS; Pankratz N, 2002, AM J HUM GENET, V71, P124, DOI 10.1086/341282; Rice JP, 1997, AM J MED GENET, V74, P247, DOI 10.1002/(SICI)1096-8628(19970531)74:3<247::AID-AJMG3>3.0.CO;2-N; Roberts SB, 1999, AM J HUM GENET, V65, P876, DOI 10.1086/302528; Segurado R, 2003, AM J HUM GENET, V73, P49, DOI 10.1086/376547; Stine OC, 1997, AM J MED GENET, V74, P263, DOI 10.1002/(SICI)1096-8628(19970531)74:3<263::AID-AJMG5>3.3.CO;2-S; SUAREZ BK, 1994, GENETIC APPROACHES M; Taylor Levi, 2002, Curr Psychiatry Rep, V4, P130, DOI 10.1007/s11920-002-0046-1; Tsuang M, 1990, GENETICS MOOD DISORD; WENDER PH, 1986, ARCH GEN PSYCHIAT, V43, P923; Williams JT, 1999, AM J HUM GENET, V65, P1148, DOI 10.1086/302571	43	178	180	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2003	73	1					107	114		10.1086/376562	http://dx.doi.org/10.1086/376562			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	696UA	12772088	Bronze, Green Published			2022-12-18	WOS:000183904900010
J	Chen, DH; Brkanac, Z; Verlinde, CLMJ; Tan, XJ; Bylenok, L; Nochlin, D; Matsushita, M; Lipe, H; Wolff, J; Fernandez, M; Cimino, PJ; Bird, TD; Raskind, WH				Chen, DH; Brkanac, Z; Verlinde, CLMJ; Tan, XJ; Bylenok, L; Nochlin, D; Matsushita, M; Lipe, H; Wolff, J; Fernandez, M; Cimino, PJ; Bird, TD; Raskind, WH			Missense mutations in the regulatory domain of PKC gamma: A new mechanism for dominant nonepisodic cerebellar ataxia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEIN-KINASE-C; SCA1 TRANSGENIC MICE; PHORBOL ESTER BINDING; CHROMOSOME 19Q13.4-QTER; MOLECULAR-DYNAMICS; PURKINJE-CELLS; MUTANT MICE; FAMILIES; MULTIPLE; SPINOCEREBELLAR	We report a nonepisodic autosomal dominant (AD) spinocerebellar ataxia (SCA) not caused by a nucleotide repeat expansion that is, to our knowledge, the first such SCA. The AD SCAs currently comprise a group of greater than or equal to16 genetically distinct neurodegenerative conditions, all characterized by progressive incoordination of gait and limbs and by speech and eye-movement disturbances. Six of the nine SCAs for which the genes are known result from CAG expansions that encode polyglutamine tracts. Noncoding CAG, CTG, and ATTCT expansions are responsible for three other SCAs. Approximately 30% of families with SCA do not have linkage to the known loci. We recently mapped the locus for an AD SCA in a family (AT08) to chromosome 19q13.4-qter. A particularly compelling candidate gene, PRKCG, encodes protein kinase C gamma (PKCgamma), a member of a family of serine/threonine kinases. The entire coding region of PRKCG was sequenced in an affected member of family AT08 and in a group of 39 unrelated patients with ataxia not attributable to trinucleotide expansions. Three different nonconservative missense mutations in highly conserved residues in C1, the cysteine-rich region of the protein, were found in family AT08, another familial case, and a sporadic case. The mutations cosegregated with disease in both families. Structural modeling predicts that two of these amino acid substitutions would severely abrogate the zinc-binding or phorbol ester-binding capabilities of the protein. Immunohistochemical studies on cerebellar tissue from an affected member of family AT08 demonstrated reduced staining for both PKCg and ataxin 1 in Purkinje cells, whereas staining for calbindin was preserved. These results strongly support a new mechanism for neuronal cell dysfunction and death in hereditary ataxias and suggest that there may be a common pathway for PKCgamma-related and polyglutamine-related neurodegeneration.	Univ Washington, Dept Med, Sch Med, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Biol Struct, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Neurol, Seattle, WA 98195 USA; Vet Affairs Puget Sound Hlth Care Syst, Geriatr Res, Educ & Clin Ctr, Seattle, WA USA; Vet Affairs Puget Sound Hlth Care Syst, VISN 20 Mental Illness Res, Educ & Clin Ctr, Seattle, WA USA; Ohio State Univ, Dept Med, Columbus, OH 43210 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University System of Ohio; Ohio State University	Raskind, WH (corresponding author), Univ Washington, Dept Med, Sch Med, Box 35-7720, Seattle, WA 98195 USA.		VERLINDE, CHRISTOPHE LMJ/J-5796-2013	VERLINDE, CHRISTOPHE LMJ/0000-0002-7790-3203; Cimino, P.J./0000-0003-0441-4502	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033] Funding Source: NIH RePORTER; NIEHS NIH HHS [P30 ES007033, P30ES07033] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ABELIOVICH A, 1993, CELL, V75, P1263, DOI 10.1016/0092-8674(93)90614-V; Al-Maghtheh M, 1998, AM J HUM GENET, V62, P1248, DOI 10.1086/301819; Barmack NH, 2000, J COMP NEUROL, V427, P235, DOI 10.1002/1096-9861(20001113)427:2<235::AID-CNE6>3.0.CO;2-6; Brkanac Z, 2002, ARCH NEUROL-CHICAGO, V59, P1291, DOI 10.1001/archneur.59.8.1291; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Chen C, 1995, CELL, V83, P1233, DOI 10.1016/0092-8674(95)90148-5; Chen DH, 2002, J NEUROL SCI, V196, P91, DOI 10.1016/S0022-510X(02)00031-X; Clark HB, 1997, J NEUROSCI, V17, P7385; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; COUSSENS L, 1986, SCIENCE, V233, P859, DOI 10.1126/science.3755548; Craig NJ, 2001, NAT NEUROSCI, V4, P1061, DOI 10.1038/nn740; Dryja TP, 1999, AM J HUM GENET, V65, P926, DOI 10.1086/302554; Ho C, 2001, BIOCHEMISTRY-US, V40, P10334, DOI 10.1021/bi002839x; KAZANIETZ MG, 1995, J BIOL CHEM, V270, P21852, DOI 10.1074/jbc.270.37.21852; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; KNOPF JL, 1986, CELL, V46, P491, DOI 10.1016/0092-8674(86)90874-3; Koh JY, 2001, MOL NEUROBIOL, V24, P99, DOI 10.1385/MN:24:1-3:099; Mariotti C, 2001, NEUROL SCI, V22, pS88, DOI 10.1007/s100720100042; Moseley ML, 1998, NEUROLOGY, V51, P1666, DOI 10.1212/WNL.51.6.1666; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Pang YP, 2000, PROTEIN SCI, V9, P1857; Pang YP, 2000, PROTEIN SCI, V9, P2583; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; QUEST AFG, 1994, J BIOL CHEM, V269, P2961; ROSENBERG RN, 1995, NEUROLOGY, V45, P1; SAITO N, 1988, J NEUROSCI, V8, P369; Skinner PJ, 2001, AM J PATHOL, V159, P905, DOI 10.1016/S0002-9440(10)61766-X; TANAKA C, 1994, ANNU REV NEUROSCI, V17, P551, DOI 10.1146/annurev.ne.17.030194.003003; van Swieten JC, 2003, AM J HUM GENET, V72, P191, DOI 10.1086/345488; Xu RX, 1997, BIOCHEMISTRY-US, V36, P10709, DOI 10.1021/bi970833a; Yamashita I, 2000, ANN NEUROL, V48, P156, DOI 10.1002/1531-8249(200008)48:2<156::AID-ANA4>3.0.CO;2-9; Zeidman R, 1999, INT J CANCER, V81, P494, DOI 10.1002/(SICI)1097-0215(19990505)81:3<494::AID-IJC26>3.0.CO;2-L; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X	33	178	188	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2003	72	4					839	849		10.1086/373883	http://dx.doi.org/10.1086/373883			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662WT	12644968	Bronze, Green Published			2022-12-18	WOS:000181972600006
J	Andresen, BS; Dobrowolski, SF; O'Reilly, L; Muenzer, J; McCandless, SE; Frazier, DM; Udvari, S; Bross, P; Knudsen, I; Banas, R; Chace, DH; Engel, P; Naylor, EW; Gregersen, N				Andresen, BS; Dobrowolski, SF; O'Reilly, L; Muenzer, J; McCandless, SE; Frazier, DM; Udvari, S; Bross, P; Knudsen, I; Banas, R; Chace, DH; Engel, P; Naylor, EW; Gregersen, N			Medium-chain Acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-Based prospective screening of newborns differ from those observed in patients with clinical symptoms: Identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article; Proceedings Paper	50th Annual Meeting of the American-Society-for-Human-Genetics	OCT   04, 2000	PHILADELPHIA, PENNSYLVANIA	Amer Soc Human Genet			TANDEM MASS-SPECTROMETRY; BLOOD SPOTS; GENE; DIAGNOSIS; COENZYME; DISEASE; G985; HETEROZYGOSITY; ALLELE; K304E	Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency is the most frequently diagnosed mitochondrial beta -oxidation defect, and it is potentially fatal. Eighty percent of patients are homozygous for a common mutation, 985A -->G, and a further 18% have this mutation in only one disease allele. In addition, a large number of rare disease-causing mutations have been identified and characterized. There is no clear genotype-phenotype correlation. High 985A -->G carrier frequencies in populations of European descent and the usual avoidance of recurrent disease episodes by patients diagnosed with MCAD deficiency who comply with a simple dietary treatment suggest that MCAD deficiency is a candidate in prospective screening of newborns. Therefore, several such screening programs employing analysis of acylcarnitines in blood spots by tandem mass spectrometry (MS/MS) are currently used worldwide. No validation of this method by mutation analysis has yet been reported. We investigated for MCAD mutations in newborns from US populations who had been identified by prospective MS/MS-based screening of 930,078 blood spots. An MCAD-deficiency frequency of 1/15,001 was observed. Our mutation analysis shows that the MS/MS-based method is excellent for detection of MCAD deficiency but that the frequency of the 985A -->G mutant allele in newborns with a positive acylcarnitine profile is much lower than that observed in clinically affected patients. Our identification of a new mutation, 199T -->C, which has never been observed in patients with clinically manifested disease but was present in a large proportion of the acylcarnitine-positive samples, may explain this skewed ratio. Overexpression experiments showed that this is a mild folding mutation that exhibits decreased levels of enzyme activity only under stringent conditions. A carrier frequency of 1/500 in the general population makes the 199T -->C mutation one of the three most prevalent mutations in the enzymes of fatty-acid oxidation.	Arhus Univ Hosp, Res Unit Mol Med, Aarhus, Denmark; Skejby Sygehus, Fac Hlth Sci, DK-8200 Aarhus, Denmark; Aarhus Univ, Inst Human Genet, DK-8000 Aarhus, Denmark; NeoGen Screening, Pittsburgh, PA USA; Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland; Univ N Carolina, Dept Pediat, Chapel Hill, NC USA	Aarhus University; Aarhus University; Aarhus University; University College Dublin; University of North Carolina; University of North Carolina Chapel Hill	Andresen, BS (corresponding author), Skejby Sygehus, Res Unit Mol Med, DK-8200 Aarhus N, Denmark.		Andresen, Brage/D-2515-2012; Bross, Peter/B-7219-2013	Andresen, Brage/0000-0001-7488-3035; Bross, Peter/0000-0001-9526-8525				Andresen B. S., 2000, Journal of Inherited Metabolic Disease, V23, P12; ANDRESEN BS, 1993, AM J HUM GENET, V53, P730; Andresen BS, 1997, HUM MOL GENET, V6, P695, DOI 10.1093/hmg/6.5.695; ANDRESEN BS, 1993, HUM MOL GENET, V2, P488, DOI 10.1093/hmg/2.4.488; ANDRESEN BS, 1999, J INHER METAB DIS S, V22, P136; BEEKMAN RP, 1994, EUR J PEDIATR, V153, P264, DOI 10.1007/s004310050133; Bross P, 1998, PROG NUCLEIC ACID RE, V58, P301; BROSS P, 1995, J BIOL CHEM, V270, P10284, DOI 10.1074/jbc.270.17.10284; BROSS P, 1993, BIOCHIM BIOPHYS ACTA, V1182, P264, DOI 10.1016/0925-4439(93)90068-C; Chace DH, 1997, CLIN CHEM, V43, P2106; Clayton PT, 1998, ARCH DIS CHILD, V79, P109, DOI 10.1136/adc.79.2.109; Den Boer MEJ, 2000, PEDIATR RES, V48, P151, DOI 10.1203/00006450-200008000-00006; GREGERSEN N, 1993, HUM HERED, V43, P342, DOI 10.1159/000154157; GREGERSEN N, 1994, J INHERIT METAB DIS, V17, P169, DOI 10.1007/BF00711614; GREGERSEN N, 1991, CLIN CHIM ACTA, V203, P23, DOI 10.1016/0009-8981(91)90153-4; IAFOLLA AK, 1994, J PEDIATR-US, V124, P409, DOI 10.1016/S0022-3476(94)70363-9; Ibdah JA, 1999, NEW ENGL J MED, V340, P1723, DOI 10.1056/NEJM199906033402204; KELLY DP, 1990, P NATL ACAD SCI USA, V87, P9236, DOI 10.1073/pnas.87.23.9236; KIM JJP, 1993, P NATL ACAD SCI USA, V90, P7523, DOI 10.1073/pnas.90.16.7523; LEHMAN TC, 1990, ANAL BIOCHEM, V186, P280, DOI 10.1016/0003-2697(90)90080-S; LINDNER M, 2000, J INHERIT METAB D S1, V23, pP250; MARSDEN D, 1992, AM J DIS CHILD, V146, P1459, DOI 10.1001/archpedi.1992.02160240069023; MATSUBARA Y, 1991, LANCET, V338, P552, DOI 10.1016/0140-6736(91)91110-G; McCandless SE, 2000, AM J HUM GENET, V67, P10; Pollitt RJ, 1998, ARCH DIS CHILD, V79, P116, DOI 10.1136/adc.79.2.116; RINALDO P, 1988, NEW ENGL J MED, V319, P1308, DOI 10.1056/NEJM198811173192003; ROE CR, 2001, METABOLIC MOL BASES, P2297; RUITENBEEK W, 1995, J NEUROL NEUROSUR PS, V58, P209, DOI 10.1136/jnnp.58.2.209; Tanaka K, 1997, PEDIATR RES, V41, P201, DOI 10.1203/00006450-199702000-00008; VANHOVE JLK, 1993, AM J HUM GENET, V52, P958; WILCKEN B, 1993, ARCH DIS CHILD-FETAL, V69, P292, DOI 10.1136/adc.69.3_Spec_No.292; Yang BZ, 2000, MOL GENET METAB, V69, P259, DOI 10.1006/mgme.2000.2978; YOKOTA I, 1991, AM J HUM GENET, V49, P1280; ZHANG ZF, 1992, BIOCHEMISTRY-US, V31, P81, DOI 10.1021/bi00116a013; ZIADEH R, 1995, PEDIATR RES, V37, P675, DOI 10.1203/00006450-199505000-00021	35	178	194	1	8	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2001	68	6					1408	1418		10.1086/320602	http://dx.doi.org/10.1086/320602			11	Genetics & Heredity	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	439DB	11349232	Green Published, Bronze			2022-12-18	WOS:000169094600011
J	Broeks, A; Urbanus, JHM; Floore, AN; Dahler, EC; Klijn, JGM; Rutgers, EJT; Devilee, P; Russell, NS; van Leeuwen, FE; van't Veer, LJ				Broeks, A; Urbanus, JHM; Floore, AN; Dahler, EC; Klijn, JGM; Rutgers, EJT; Devilee, P; Russell, NS; van Leeuwen, FE; van't Veer, LJ			ATM-heterozygous germline mutations contribute to breast cancer-susceptibility	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ATAXIA-TELANGIECTASIA HETEROZYGOTES; GENE; FAMILIES; RADIOSENSITIVITY; 11Q23.1; RISK; DNA	Approximately 0.5%-1% of the general population has been estimated to be heterozygous for a germline mutation in the ATM gene. Mutations in the ATM gene are responsible for the autosomal recessive disorder ataxia-telangiectasia (A-T) (MIM 208900). The finding that ATM-heterozygotes have an increased relative risk for breast cancer was supported by some studies but not confirmed by others. In view of this discrepancy, we examined the frequency of ATM germline mutations in a selected group of Dutch patients with breast cancer. We have analyzed ATM germline mutations in normal blood lymphocytes, using the protein-truncation test followed by genomic-sequence analysis. A high percentage of ATM germline mutations was demonstrated among patients with sporadic breast cancer. The 82 patients included in this study had developed breast cancer at age <45 and had survived greater than or equal to 5 years (mean 15 years), and in 33 (40%) of the patients a contralateral breast tumor had been diagnosed. Among these patients we identified seven (8.5%) ATM germline mutations, of which five are distinct. One splice-site mutation (IVS10-6T-->G) was detected three times in our series. Four heterozygous carriers were patients with bilateral breast cancer. Our results indicate that the mutations identified in this study are "A-T disease-causing" mutations that might be associated with an increased risk of breast cancer in heterozygotes. We conclude that ATM heterozygotes have an approximately ninefold-increased risk of developing a type of breast cancer characterized by frequent bilateral occurrence, early age at onset, and long-term survival. The specific characteristics of our population of patients may ex-plain why such a high frequency was not found in other series.	Netherlands Canc Inst, Div Expt Therapy, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Dept Epidemiol, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Dept Surg, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Dept Radiotherapy, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Dept Pathol, NL-1066 CX Amsterdam, Netherlands; Dr Daniel den Hoed Canc Ctr, Dept Med Oncol, NL-3008 AE Rotterdam, Netherlands; Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van't Veer, LJ (corresponding author), Netherlands Canc Inst, Div Expt Therapy, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.		DEVILEE, PETER/ABR-2140-2022; Rutgers, Emiel J T/C-5934-2015					Athma P, 1996, CANCER GENET CYTOGEN, V92, P130, DOI 10.1016/S0165-4608(96)00328-7; Broeks A, 1998, HUM MUTAT, V12, P330, DOI 10.1002/(SICI)1098-1004(1998)12:5<330::AID-HUMU6>3.0.CO;2-H; Chen JD, 1998, CANCER RES, V58, P1376; EASTON DF, 1994, INT J RADIAT BIOL, V66, pS177, DOI 10.1080/09553009414552011; FitzGerald MG, 1997, NAT GENET, V15, P307, DOI 10.1038/ng0397-307; GATTI RA, 1991, MEDICINE, V70, P99, DOI 10.1097/00005792-199103000-00003; Gilad S, 1998, AM J HUM GENET, V62, P551, DOI 10.1086/301755; Inskip HM, 1999, BRIT J CANCER, V79, P1304, DOI 10.1038/sj.bjc.6690209; Janin N, 1999, BRIT J CANCER, V80, P1042, DOI 10.1038/sj.bjc.6690460; Laake K, 1999, GENE CHROMOSOME CANC, V25, P212, DOI 10.1002/(SICI)1098-2264(199907)25:3<212::AID-GCC3>3.3.CO;2-7; Laake K, 1997, GENE CHROMOSOME CANC, V18, P175, DOI 10.1002/(SICI)1098-2264(199703)18:3<175::AID-GCC4>3.0.CO;2-Z; Lavin MF, 1996, CURR OPIN IMMUNOL, V8, P459, DOI 10.1016/S0952-7915(96)80030-6; Lavin MF, 1997, ANNU REV IMMUNOL, V15, P177, DOI 10.1146/annurev.immunol.15.1.177; PATERSON MC, 1979, CANCER RES, V39, P3725; Platzer M, 1997, GENOME RES, V7, P592, DOI 10.1101/gr.7.6.592; Sambrook J, 1989, MOL CLONING LAB MANU; Sandoval N, 1999, HUM MOL GENET, V8, P69, DOI 10.1093/hmg/8.1.69; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SEGDWICK RP, 1991, HEREDITARY NEUROPATH, P347; SHILOH Y, 1995, EUR J HUM GENET, V3, P116; SWIFT M, 1987, NEW ENGL J MED, V316, P1289, DOI 10.1056/NEJM198705213162101; SWIFT M, 1991, NEW ENGL J MED, V325, P1831, DOI 10.1056/NEJM199112263252602; Teraoka SN, 1999, AM J HUM GENET, V64, P1617, DOI 10.1086/302418; WEST CML, 1995, INT J RADIAT BIOL, V68, P197, DOI 10.1080/09553009514551101	24	178	185	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					494	500		10.1086/302746	http://dx.doi.org/10.1086/302746			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QL	10677309	Bronze, Green Published			2022-12-18	WOS:000088373100016
J	GILLARD, EF; CHAMBERLAIN, JS; MURPHY, EG; DUFF, CL; SMITH, B; BURGHES, AHM; THOMPSON, MW; SUTHERLAND, J; OSS, I; BODRUG, SE; KLAMUT, HJ; RAY, PN; WORTON, RG				GILLARD, EF; CHAMBERLAIN, JS; MURPHY, EG; DUFF, CL; SMITH, B; BURGHES, AHM; THOMPSON, MW; SUTHERLAND, J; OSS, I; BODRUG, SE; KLAMUT, HJ; RAY, PN; WORTON, RG			MOLECULAR AND PHENOTYPIC ANALYSIS OF PATIENTS WITH DELETIONS WITHIN THE DELETION-RICH REGION OF THE DUCHENNE MUSCULAR-DYSTROPHY (DMD) GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HOSP SICK CHILDREN,DEPT GENET,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA; HOSP SICK CHILDREN,RES INST,TORONTO M5G 1X8,ONTARIO,CANADA; HOSP SICK CHILDREN,DEPT PEDIAT,DIV NEUROL,TORONTO M5G 1X8,ONTARIO,CANADA; UNIV TORONTO,DEPT MED GENET,TORONTO M5S 1A1,ONTARIO,CANADA; UNIV TORONTO,DEPT MED BIOPHYS,TORONTO M5S 1A1,ONTARIO,CANADA; BAYLOR UNIV,INST MOLEC GENET,HOUSTON,TX 77030	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Baylor College of Medicine; Baylor University				Burghes, Arthur/0000-0001-9031-1555; Chamberlain, Jeffrey/0000-0001-5299-0059				ANAND R, 1988, BLOOD, V72, P636; BAUMBACH LL, 1989, NEUROLOGY, V39, P465, DOI 10.1212/WNL.39.4.465; BOYD Y, 1988, CYTOGENET CELL GENET, V48, P28, DOI 10.1159/000132581; BURGHES AHM, 1987, NATURE, V328, P434, DOI 10.1038/328434a0; BURMEISTER M, 1988, Genomics, V2, P189, DOI 10.1016/0888-7543(88)90002-X; CHAMBERLAIN JS, 1988, NUCLEIC ACIDS RES, V16, P11141, DOI 10.1093/nar/16.23.11141; CROSS SH, 1986, GENE, V49, P2; DARRAS BT, 1988, AM J HUM GENET, V43, P620; DARRAS BT, 1988, AM J HUM GENET, V43, P612; DENDUNNEN JT, 1987, NATURE, V329, P640, DOI 10.1038/329640a0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P267; FORREST S M, 1988, Genomics, V2, P109, DOI 10.1016/0888-7543(88)90091-2; FORREST SM, 1987, LANCET, V2, P1294; FORREST SM, 1987, NATURE, V329, P638, DOI 10.1038/329638a0; GILLARD EF, 1987, NUCLEIC ACIDS RES, V15, P3977, DOI 10.1093/nar/15.10.3977; HART K, 1986, J MED GENET, V23, P516, DOI 10.1136/jmg.23.6.516; HART KA, 1987, HUM GENET, V75, P281, DOI 10.1007/BF00281075; HU XY, 1989, AM J HUM GENET, V44, P855; KAZAZIAN HH, 1988, MOL GENETICS MED, P43; KOENIG M, 1989, AM J HUM GENET, V45, P498; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; KUNKEL LM, 1986, NATURE, V322, P73, DOI 10.1038/322073a0; KUNKEL LM, 1985, P NATL ACAD SCI USA, V82, P4778, DOI 10.1073/pnas.82.14.4778; LINDLOF M, 1988, CLIN GENET, V33, P131; MALHOTRA SB, 1988, SCIENCE, V242, P755, DOI 10.1126/science.3055295; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; MONACO AP, 1987, HUM GENET, V75, P221, DOI 10.1007/BF00281063; MONACO AP, 1985, NATURE, V316, P842, DOI 10.1038/316842a0; Orkin S., 1987, MOL BASIS BLOOD DISE, P106; RAY PN, 1985, NATURE, V318, P672, DOI 10.1038/318672a0; READ AP, 1988, HUM GENET, V80, P152, DOI 10.1007/BF00702859; THOMAS NST, 1986, J MED GENET, V23, P509, DOI 10.1136/jmg.23.6.509; VANIN EF, 1983, CELL, V35, P701, DOI 10.1016/0092-8674(83)90103-4; WAPENAAR M C, 1988, Genomics, V2, P101, DOI 10.1016/0888-7543(88)90090-0	36	178	180	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1989	45	4					507	520						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AW395	2491010				2022-12-18	WOS:A1989AW39500004
J	NAGAMINE, CM; CHAN, K; LAU, YFC				NAGAMINE, CM; CHAN, K; LAU, YFC			A PCR ARTIFACT - GENERATION OF HETERODUPLEXES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco	NAGAMINE, CM (corresponding author), UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143, USA.		Lau, Yun-Fai C/E-4465-2014	Lau, Yun-Fai C/0000-0002-9119-7050				NAGAMINE CM, 1989, SCIENCE, V243, P80, DOI 10.1126/science.2563174; NAGAMINE CM, UNPUB EXPRESSION CAN; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; WU HM, 1984, NATURE, V308, P509, DOI 10.1038/308509a0	5	178	193	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1989	45	2					337	339						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AK380	2631699				2022-12-18	WOS:A1989AK38000020
J	STAMATOYANNOPOULOS, G; CHEN, SH; FUKUI, M				STAMATOYANNOPOULOS, G; CHEN, SH; FUKUI, M			LIVER ALCOHOL-DEHYDROGENASE IN JAPANESE - HIGH POPULATION FREQUENCY OF ATYPICAL FORM AND ITS POSSIBLE ROLE IN ALCOHOL SENSITIVITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WASHINGTON, SCH MED, DEPT MED, DIV MED GENET, SEATTLE, WA 98195 USA; UNIV WASHINGTON, SCH MED, DEPT PEDIAT, SEATTLE, WA 98195 USA; OSAKA UNIV, MED SCH, DEPT LEGAL MED, OSAKA, JAPAN	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Osaka University								ASMUSSEN E, 1948, ACTA PHARMACOL TOX, V4, P311; BURITZ G, 1966, BIOCHEM PHARMACOL, V15, P711; DAVIS VE, 1970, SCIENCE, V167, P1005; DEITRICH RA, 1971, MOL PHARMACOL, V7, P301; EDWARDS JA, 1967, CLIN PHARMACOL THER, V8, P824; FEINSTEIN RN, 1972, BIOCHEM BIOPH RES CO, V48, P1140, DOI 10.1016/0006-291X(72)90829-7; FUKUI M, 1972, JAP J LEGAL MED, V26, P46; HALD J, 1948, ACTA PHARMACOL TOX, V4, P305; KORSTEN MA, 1975, NEW ENGL J MED, V292, P386, DOI 10.1056/NEJM197502202920802; LIEBER CS, 1968, SCIENCE, V162, P917, DOI 10.1126/science.162.3856.917; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAJCHROWICZ E, 1965, CAN J BIOCHEM CELL B, V43, P1041, DOI 10.1139/o65-117; ORMEJOHN.WH, 1965, BIOCHEM BIOPH RES CO, V21, P78, DOI 10.1016/0006-291X(65)90429-8; RASKIN NH, 1975, NEW ENGL J MED, V292, P422, DOI 10.1056/NEJM197502202920811; RUBIN E, 1968, SCIENCE, V162, P690, DOI 10.1126/science.162.3854.690; SMITH M, 1973, ANN HUM GENET, V37, P49, DOI 10.1111/j.1469-1809.1973.tb01814.x; SMITH M, 1973, ANN HUM GENET, V36, P401, DOI 10.1111/j.1469-1809.1973.tb00604.x; SMITH M, 1972, ANN HUM GENET, V35, P243, DOI 10.1111/j.1469-1809.1957.tb01398.x; SMITH M, 1971, EUR J BIOCHEM, V24, P251; TRUITT EB, 1971, BIOL ASPECTS ALCOHOL, P212; TRUITT EB, 1971, BIOL ALCOHOL, V1, P161; VONWARTBURG JP, 1965, CAN J BIOCHEM CELL B, V43, P889, DOI 10.1139/o65-102; WARTBURG JP, 1968, ANN NY ACAD SCI, V151, P936; WOLFF PH, 1972, SCIENCE, V175, P449, DOI 10.1126/science.175.4020.449; WOLFF PH, 1973, AM J HUM GENET, V25, P193	25	178	180	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1975	27	6					789	796						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AX924	1200030				2022-12-18	WOS:A1975AX92400010
J	Sato, N; Amino, T; Kobayashi, K; Asakawa, S; Ishiguro, T; Tsunemi, T; Takahashi, M; Matsuura, T; Flanigan, KM; Iwasaki, S; Ishino, F; Saito, Y; Murayama, S; Yoshida, M; Hashizume, Y; Takahashi, Y; Tsuji, S; Shimizu, N; Toda, T; Ishikawa, K; Mizusawa, H				Sato, Nozomu; Amino, Takeshi; Kobayashi, Kazuhiro; Asakawa, Shuichi; Ishiguro, Taro; Tsunemi, Taiji; Takahashi, Makoto; Matsuura, Tohru; Flanigan, Kevin M.; Iwasaki, Sawa; Ishino, Fumitoshi; Saito, Yuko; Murayama, Shigeo; Yoshida, Mari; Hashizume, Yoshio; Takahashi, Yuji; Tsuji, Shoji; Shimizu, Nobuyoshi; Toda, Tatsushi; Ishikawa, Kinya; Mizusawa, Hidehiro			Spinocerebellar Ataxia Type 31 Is Associated with "Inserted" Penta-Nucleotide Repeats Containing (TGGAA)(n)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOMINANT CEREBELLAR-ATAXIA; MYOTONIC-DYSTROPHY TYPE-2; ADCA TYPE-III; FUNCTIONAL-CHARACTERIZATION; HUMAN-CELLS; RNA; GENE; TRANSCRIPTS; DISEASE; LOCUS	Spinocerebellar ataxia type 31 (SCA31) is an adult-onset autosomal-dominant neurodegenerative disorder showing progressive cerebellar ataxia mainly affecting Purkinje cells. The SCA31 critical region was tracked down to a 900 kb interval in chromosome 16q22.1, where the disease shows a strong founder effect. By performing comprehensive Southern blot analysis and BAC- and fosmid-based sequencing, we isolated two genetic changes segregating with SCA31. One was a single-nucleotide change in an intron of the thymidine kinase 2 gene (TK2). However, this did not appear to affect splicing or expression patterns. The other was an insertion, from 2.5-3.8 kb long, consisting of complex penta-nucleotide repeats including a long (TGGAA)(n) stretch. In controls, shorter (1.5-2.0 kb) insertions lacking (TGGAA)(n) were found only rarely. The SCA31 repeat insertion's length inversely correlated with patient age of onset, and an expansion was documented in a single family showing anticipation. The repeat insertion was located in introns of TK2 and BEAN (brain expressed, associated with Nedd4) expressed in the brain and formed RNA foci in the nuclei of patients' Purkinje cells. An electrophoretic mobility-shift assay showed that essential splicing factors, serine/arginine-rich splicing factors SFRS1 and SFRS9, bind to (UGGAA)(n) in vitro. Because (TGGAA)(n) is a characteristic sequence of paracentromeric heterochromatin, we speculate that the insertion might have originated from heterochromatin. SCA31 is important because it exemplifies human diseases associated with "inserted" microsatellite repeats that can expand through transmission. Our finding suggests that the ectopic microsatellite repeat, when transcribed, might cause a disease involving the essential splicing factors.	[Sato, Nozomu; Amino, Takeshi; Ishiguro, Taro; Tsunemi, Taiji; Takahashi, Makoto; Ishikawa, Kinya; Mizusawa, Hidehiro] Tokyo Med & Dent Univ, Grad Sch, Dept Neurol & Neurol Sci, Bunkyo Ku, Tokyo 1138519, Japan; [Amino, Takeshi; Mizusawa, Hidehiro] Minist Educ Sci & Culture, 21st Century Ctr Excellence Program Brain Integra, Tokyo, Japan; [Amino, Takeshi] Tokyo Med & Dent Univ Hosp, Fac Med, Bunkyo Ku, Tokyo 1138519, Japan; [Kobayashi, Kazuhiro; Toda, Tatsushi] Osaka Univ, Div Clin Genet, Dept Med Genet, Grad Sch Med, Suita, Osaka 5650871, Japan; [Asakawa, Shuichi] Keio Univ, Sch Med, Dept Mol Biol, Shinjuku Ku, Tokyo 1608582, Japan; [Matsuura, Tohru] Nagoya Univ, Div Neurogenet & Bioinformat, Ctr Neurol Dis & Canc, Grad Sch Med,Showa Ku, Nagoya, Aichi 4668550, Japan; [Flanigan, Kevin M.] Univ Utah, Dept Neurol, Salt Lake City, UT 84132 USA; [Iwasaki, Sawa; Ishino, Fumitoshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Epigenet, Bunkyo Ku, Tokyo 1138519, Japan; [Saito, Yuko; Murayama, Shigeo] Tokyo Metropolitan Inst Gerontol, Dept Geriatr Neurosci, Itabashi Ku, Tokyo 1730015, Japan; [Yoshida, Mari; Hashizume, Yoshio] Aichi Med Univ, Inst Med Sci Aging, Dept Neuropathol, Nagakute, Aichi 4801195, Japan; [Takahashi, Yuji; Tsuji, Shoji] Univ Tokyo, Dept Neurol, Grad Sch Med, Bunkyo Ku, Tokyo 1138655, Japan; [Shimizu, Nobuyoshi] Keio Univ, Adv Res Ctr Genome Super Power, Tsukuba, Ibaraki 3002611, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Osaka University; Keio University; Nagoya University; Utah System of Higher Education; University of Utah; Tokyo Medical & Dental University (TMDU); Tokyo Metropolitan Institute of Gerontology; Aichi Medical University; University of Tokyo; Keio University	Ishikawa, K (corresponding author), Tokyo Med & Dent Univ, Grad Sch, Dept Neurol & Neurol Sci, Bunkyo Ku, Yushima 1-5-45, Tokyo 1138519, Japan.	pico.nuro@tmd.ac.jp	Kobayashi, Kazuhiro/AAH-8638-2021	Kobayashi, Kazuhiro/0000-0001-7801-147X; Sato, Nozomu/0000-0002-8906-2798; Takahashi, Makoto/0000-0002-2452-0268; Flanigan, Kevin/0000-0001-6440-3376	Health and Labour Sciences Research Grants on Human Genome; Ataxic Diseases; Ministry of Health, Labour and Welfare, Japan; 21st Century COE Program; Brain Integration and its Disorders; Ministry of Education, Science and Culture, Japan	Health and Labour Sciences Research Grants on Human Genome; Ataxic Diseases; Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); 21st Century COE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Brain Integration and its Disorders; Ministry of Education, Science and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We would like to thank the families who participated in this study, as well as Iku Sudo, Minori Kono, and Hideko Uno for their technical assistance. This study was funded by numerous grants, particularly from the Health and Labour Sciences Research Grants on Human Genome (KI) and Ataxic Diseases (HM), Ministry of Health, Labour and Welfare, Japan, and the 21st Century COE Program, Brain Integration and its Disorders, the Ministry of Education, Science and Culture, Japan (HM). We also thank Laura P.W. Ranum (University of Minnesota) and Christopher E. Pearson (Hospital for Sick Children, Toronto) for their advice. We thank Eric Sheldon (Scientific Language Editing Team, Tsukuba, Japan) for proofreading our manuscript.	Amino T, 2007, J HUM GENET, V52, P643, DOI 10.1007/s10038-007-0154-1; Asakawa S, 1997, GENE, V191, P69, DOI 10.1016/S0378-1119(97)00044-9; Bandmann O, 2008, NEUROLOGY, V71, P542, DOI 10.1212/01.wnl.0000323932.90720.55; Barrett MT, 2004, P NATL ACAD SCI USA, V101, P17765, DOI 10.1073/pnas.0407979101; Batzer MA, 1996, J MOL EVOL, V42, P3, DOI 10.1007/BF00163204; BRICE A, 2007, SPINOCEREBELLAR DEGE; Chiodi I, 2004, NUCLEIC ACIDS RES, V32, P4127, DOI 10.1093/nar/gkh759; Cleary JD, 2003, CYTOGENET GENOME RES, V100, P25, DOI 10.1159/000072837; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Flanigan K, 1996, AM J HUM GENET, V59, P392; GRADY DL, 1992, P NATL ACAD SCI USA, V89, P1695, DOI 10.1073/pnas.89.5.1695; Hara K, 2008, NEUROLOGY, V71, P547, DOI 10.1212/01.wnl.0000311277.71046.a0; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Hellenbroich Y, 2006, J NEURAL TRANSM, V113, P829, DOI 10.1007/s00702-005-0362-9; Hellenbroich Y, 2003, J NEUROL, V250, P668, DOI 10.1007/s00415-003-1052-x; Hellenbroich Y, 2008, J NEUROL, V255, P612, DOI 10.1007/s00415-008-0771-4; Ishikawa K, 2005, AM J HUM GENET, V77, P280, DOI 10.1086/432518; Iwahashi CK, 2006, BRAIN, V129, P256, DOI 10.1093/brain/awh650; Jin Honglian, 2008, J Med Dent Sci, V55, P145; Jolly C, 2006, NUCLEIC ACIDS RES, V34, P5508, DOI 10.1093/nar/gkl711; Kanadia RN, 2008, DEVELOPMENT, V135, P3923, DOI 10.1242/dev.024620; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Li M, 2003, J HUM GENET, V48, P111, DOI 10.1007/s100380300017; Liquori CL, 2003, AM J HUM GENET, V73, P849, DOI 10.1086/378720; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Longman D, 2000, EMBO J, V19, P1625, DOI 10.1093/emboj/19.7.1625; Moseley ML, 2006, NAT GENET, V38, P758, DOI 10.1038/ng1827; Nagaoka U, 2000, NEUROLOGY, V54, P1971, DOI 10.1212/WNL.54.10.1971; Ohata T, 2006, J HUM GENET, V51, P461, DOI 10.1007/s10038-006-0385-6; Ouyang Y, 2006, J NEUROL SCI, V247, P180, DOI 10.1016/j.jns.2006.04.009; Owada K, 2005, NEUROLOGY, V65, P629, DOI 10.1212/01.wnl.0000173065.75680.e2; Ranum LPW, 2006, ANNU REV NEUROSCI, V29, P259, DOI 10.1146/annurev.neuro.29.051605.113014; Rizzi N, 2004, MOL BIOL CELL, V15, P543, DOI 10.1091/mbc.E03-07-0487; Rudnicki DD, 2007, ANN NEUROL, V61, P272, DOI 10.1002/ana.21081; Sanford JR, 2009, GENOME RES, V19, P381, DOI 10.1101/gr.082503.108; Scott HS, 2001, NAT GENET, V27, P59, DOI 10.1038/83768; Sengupta Sonali, 2006, RNA Biol, V3, P28; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Tassone Flora, 2004, RNA Biol, V1, P103, DOI 10.4161/rna.1.2.1035; Valgardsdottir R, 2005, MOL BIOL CELL, V16, P2597, DOI 10.1091/mbc.E04-12-1078; Valgardsdottir R, 2008, NUCLEIC ACIDS RES, V36, P423, DOI 10.1093/nar/gkm1056; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	42	177	181	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 13	2009	85	5					544	557		10.1016/j.ajhg.2009.09.019	http://dx.doi.org/10.1016/j.ajhg.2009.09.019			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	521JH	19878914	Green Published, Bronze			2022-12-18	WOS:000271916500003
J	Willatt, L; Cox, J; Barber, J; Cabanas, ED; Collins, A; Donnai, D; FitzPatrick, DR; Maher, E; Martin, H; Parnau, J; Pindar, L; Ramsay, J; Shaw-Smith, C; Sistermans, EA; Tettenborn, M; Trump, D; de Vries, BBA; Walker, K; Raymond, FL				Willatt, L; Cox, J; Barber, J; Cabanas, ED; Collins, A; Donnai, D; FitzPatrick, DR; Maher, E; Martin, H; Parnau, J; Pindar, L; Ramsay, J; Shaw-Smith, C; Sistermans, EA; Tettenborn, M; Trump, D; de Vries, BBA; Walker, K; Raymond, FL			3q29 Microdeletion syndrome: Clinical and molecular characterization of a new syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							UNEXPLAINED MENTAL-RETARDATION; CHROMOSOMAL REARRANGEMENTS; DELETIONS; TELOMERES; MONOSOMY; CHILDREN; PROBES; 1P36	We report the identification of six patients with 3q29 microdeletion syndrome. The clinical phenotype is variable despite an almost identical deletion size. The phenotype includes mild- to- moderate mental retardation, with only slightly dysmorphic facial features that are similar in most patients: a long and narrow face, short philtrum, and high nasal bridge. Autism, gait ataxia, chest- wall deformity, and long and tapering fingers were noted in at least two of six patients. Additional features - including microcephaly, cleft lip and palate, horseshoe kidney and hypospadias, ligamentous laxity, recurrent middle ear infections, and abnormal pigmentation - were observed, but each feature was only found once, in a single patient. The microdeletion is similar to 1.5 Mb in length, with molecular boundaries mapping within the same or adjacent bacterial artificial chromosome ( BAC) clones at either end of the deletion in all patients. The deletion encompasses 22 genes, including PAK2 and DLG1, which are autosomal homologues of two known X- linked mental retardation genes, PAK3 and DLG3. The presence of two nearly identical low- copy repeat sequences in BAC clones on each side of the deletion breakpoint suggests that nonallelic homologous recombination is the likely mechanism of disease causation in this syndrome.	Univ Cambridge, Addenbrookes Hosp, Dept Med Genet, Cambridge Inst Med Res, Cambridge CB2 2XY, England; Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury, Wilts, England; Princess Anne Hosp, Wessex Clin Genet Serv, Southampton, Hants, England; Univ Manchester, Acad Unit Med Genet, Manchester, Lancs, England; St Marys Hosp, Reg Genet Serv, Manchester M13 0JH, Lancs, England; Western Gen Hosp, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Western Gen Hosp, Lothian Reg Genet Serv, Edinburgh EH4 2XU, Midlothian, Scotland; Norfolk & Norwich Hosp, Dept Cytogenet, Norwich NR1 3SR, Norfolk, England; Radboud Univ, Nijmegen Med Ctr, Nijmegen, Netherlands; Frimley Childrens Ctr, Frimley, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Salisbury District Hospital; University of Manchester; University of Manchester; University of Edinburgh; University of Edinburgh; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; Radboud University Nijmegen	Raymond, FL (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med Genet, Cambridge Inst Med Res, Cambridge CB2 2XY, England.	flr24@cam.ac.uk	Sistermans, Erik/B-1109-2009; FitzPatrick, David R/B-8311-2008; Dachs-Cabanas, Elisabet/F-7636-2015; Cox, James/R-1910-2016; FitzPatrick, David R/C-7301-2013	Sistermans, Erik/0000-0001-7187-4563; Dachs-Cabanas, Elisabet/0000-0001-6969-0626; FitzPatrick, David R./0000-0003-4861-969X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aldred MA, 2004, J MED GENET, V41, P433, DOI 10.1136/jmg.2003.017202; Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; de Vries BBA, 2003, J MED GENET, V40, P385, DOI 10.1136/jmg.40.6.385; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; FLINT J, 1995, NAT GENET, V9, P132, DOI 10.1038/ng0295-132; Flint J, 2003, CURR OPIN GENET DEV, V13, P310, DOI 10.1016/S0959-437X(03)00049-2; Heilstedt HA, 2003, AM J HUM GENET, V72, P1200, DOI 10.1086/375179; Knight SJL, 1999, LANCET, V354, P1676, DOI 10.1016/S0140-6736(99)03070-6; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; Koolen DA, 2004, J MED GENET, V41, P892, DOI 10.1136/jmg.2004.023671; LEDBETTER DH, 1981, NEW ENGL J MED, V304, P325, DOI 10.1056/NEJM198102053040604; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; Ning Y, 1996, NAT GENET, V14, P86, DOI 10.1038/ng0996-86; Osborne LR, 2001, NAT GENET, V29, P321, DOI 10.1038/ng753; Rossi E, 2001, J MED GENET, V38, P417, DOI 10.1136/jmg.38.6.417; SCHWARTZ CE, 1988, AM J HUM GENET, V43, P597; Shapria SK, 1997, AM J HUM GENET, V61, P642, DOI 10.1086/515520; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; Slavotinek A, 1999, J MED GENET, V36, P405; Tarpey P, 2004, AM J HUM GENET, V75, P318, DOI 10.1086/422703	20	177	181	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2005	77	1					154	160		10.1086/431653	http://dx.doi.org/10.1086/431653			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	935PP	15918153	Bronze, Green Published			2022-12-18	WOS:000229794500016
J	McDermid, HE; Morrow, BE				McDermid, HE; Morrow, BE			Genomic disorders on 22q11	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							CARDIO-FACIAL-SYNDROME; CAT-EYE SYNDROME; SYNDROME CRITICAL REGION; RECURRENT CONSTITUTIONAL T(11-22); CONGENITAL HEART-DISEASE; DIGEORGE-SYNDROME REGION; 3-1 MEIOTIC DISJUNCTION; EARLY MOUSE DEVELOPMENT; QUAIL-CHICK CHIMERAS; LOW-COPY REPEATS	The 22q11 region is involved in chromosomal rearrangements that lead to altered gene dosage, resulting in genomic disorders that are characterized by mental retardation and/or congenital malformations. Three such disorders-cat-eye syndrome (CES), der(22) syndrome, and velocardiofacial syndrome/DiGeorge syndrome (VCFS/DGS)-are associated with four, three, and one dose, respectively, of parts of 22q11. The critical region for CES lies centromeric to the deletion region of VCFS/DGS, although, in some cases, the extra material in CES extends across the VCFS/DGS region. The der(22) syndrome region overlaps both the CES region and the VCFS/DGS region. Molecular approaches have revealed a set of common chromosome breakpoints that are shared between the three disorders, implicating specific mechanisms that cause these rearrangements. Most VCFS/DGS and CES rearrangements are likely to occur by homologous recombination events between blocks of low-copy repeats (e. g., LCR22), whereas nonhomologous recombination mechanisms lead to the constitutional t(11; 22) translocation. Meiotic nondisjunction events in carriers of the t( 1; 22) translocation can then lead to offspring with der(22) syndrome. The molecular basis of the clinical phenotype of these genomic disorders has also begun to be addressed. Analysis of both the genomic sequence for the 22q11 interval and the orthologous regions in the mouse has identified >24 genes that are shared between VCFS/DGS and der(22) syndrome and has identified 14 putative genes that are shared between CES and der(22) syndrome. The ability to manipulate the mouse genome aids in the identification of candidate genes in these three syndromes. Research on genomic disorders on 22q11 will continue to expand our knowledge of the mechanisms of chromosomal rearrangements and the molecular basis of their phenotypic consequences.	Yeshiva Univ Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10461 USA; Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	Yeshiva University; Albert Einstein College of Medicine; University of Alberta	Morrow, BE (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Mol Genet, 1300 Morris Pk Ave, Bronx, NY 10461 USA.			Morrow, Bernice/0000-0002-8076-4726				Akgun E, 1997, MOL CELL BIOL, V17, P5559, DOI 10.1128/MCB.17.9.5559; Amati F, 1999, EUR J HUM GENET, V7, P903, DOI 10.1038/sj.ejhg.5200399; Bailey JA, 2002, AM J HUM GENET, V70, P83, DOI 10.1086/338458; Baumer A, 1998, HUM MOL GENET, V7, P887, DOI 10.1093/hmg/7.5.887; Berends MJW, 2001, GENET COUNSEL, V12, P23; BOCKMAN DE, 1984, SCIENCE, V223, P498, DOI 10.1126/science.6606851; BOCKMAN DE, 1987, AM J ANAT, V180, P332; BORGAONKAR DS, 1989, CHROMOSOMAL VARIATIO; BUDARF ML, 1995, NAT GENET, V10, P269, DOI 10.1038/ng0795-269; BURN J, 1996, EMERY RIMOINS PRINCI, V1, P767; Carlson C, 1997, AM J HUM GENET, V61, P620, DOI 10.1086/515508; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Charlab R, 2001, GENE, V267, P13, DOI 10.1016/S0378-1119(01)00393-6; Chieffo C, 1997, GENOMICS, V43, P267, DOI 10.1006/geno.1997.4829; CHOW EWC, 1994, AM J MED GENET, V54, P107, DOI 10.1002/ajmg.1320540205; COLLINS JE, 1995, NATURE, V377, P367; COULY GF, 1987, DEV BIOL, V120, P198, DOI 10.1016/0012-1606(87)90118-7; Crolla JA, 1997, AM J MED GENET, V72, P440, DOI 10.1002/(SICI)1096-8628(19971112)72:4<440::AID-AJMG13>3.0.CO;2-R; DELACHAPELLE A, 1981, HUM GENET, V57, P253, DOI 10.1007/BF00278938; DiGeorge A, 1965, J PEDIAT, V67, P907, DOI [DOI 10.1016/S0022-3476(65)81796-6, 10.1016/S0022-3476(65)82145-X]; DRISCOLL DA, 1992, AM J HUM GENET, V50, P924; DRISCOLL DA, 1993, J MED GENET, V30, P813, DOI 10.1136/jmg.30.10.813; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Edelmann L, 1999, HUM MOL GENET, V8, P1157, DOI 10.1093/hmg/8.7.1157; Edelmann L, 1999, AM J HUM GENET, V65, P1608, DOI 10.1086/302689; Edelmann L, 1999, AM J HUM GENET, V64, P1076, DOI 10.1086/302343; Edelmann L, 2001, AM J HUM GENET, V68, P1, DOI 10.1086/316952; Emanuel BS, 2001, NAT REV GENET, V2, P791, DOI 10.1038/35093500; Footz TK, 1998, GENOMICS, V51, P472, DOI 10.1006/geno.1998.5392; Footz TK, 2001, GENOME RES, V11, P1053, DOI 10.1101/gr.154901; FRACCARO M, 1980, HUM GENET, V56, P21, DOI 10.1007/BF00281567; Funke B, 2001, HUM MOL GENET, V10, P2549, DOI 10.1093/hmg/10.22.2549; Funke B, 1999, AM J HUM GENET, V64, P747, DOI 10.1086/302284; GONG W, 2001, J MED GENET, V38, pE1; Guris DL, 2001, NAT GENET, V27, P293, DOI 10.1038/85855; Holmes SE, 1997, HUM MOL GENET, V6, P357, DOI 10.1093/hmg/6.3.357; Jerome LA, 2001, NAT GENET, V27, P286, DOI 10.1038/85845; KehrerSawatzki H, 1997, HUM GENET, V99, P237, DOI 10.1007/s004390050346; Kimber WL, 1999, HUM MOL GENET, V8, P2229, DOI 10.1093/hmg/8.12.2229; KIRBY ML, 1985, ANAT RECORD, V213, P87, DOI 10.1002/ar.1092130112; KIRBY ML, 1983, SCIENCE, V220, P1059, DOI 10.1126/science.6844926; KIRBY ML, 1995, CIRC RES, V77, P211, DOI 10.1161/01.RES.77.2.211; KNOLL JHM, 1995, AM J MED GENET, V55, P221, DOI 10.1002/ajmg.1320550214; Kurahashi H, 2000, AM J HUM GENET, V67, P763, DOI 10.1086/303054; Kurahashi H, 2000, HUM MOL GENET, V9, P1665, DOI 10.1093/hmg/9.11.1665; Kurahashi H, 1996, AM J HUM GENET, V58, P1377; Kurahashi H, 2001, HUM MOL GENET, V10, P2605, DOI 10.1093/hmg/10.23.2605; LAMOUR V, 1995, HUM MOL GENET, V4, P791, DOI 10.1093/hmg/4.5.791; LEVY A, 1995, HUM MOL GENET, V4, P2417, DOI 10.1093/hmg/4.12.2417; Li S, 2000, GENE, V252, P83, DOI 10.1016/S0378-1119(00)00226-2; LIN AE, 1986, CLIN GENET, V29, P269; Lindsay EA, 1998, HUM MOL GENET, V7, P629, DOI 10.1093/hmg/7.4.629; LINDSAY EA, 1993, GENOMICS, V17, P403, DOI 10.1006/geno.1993.1339; Lindsay EA, 2001, NATURE, V410, P97, DOI 10.1038/35065105; Lindsay EA, 1999, NATURE, V401, P379, DOI 10.1038/43900; Lund J, 1999, MAMM GENOME, V10, P438, DOI 10.1007/s003359901019; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; MCDERMID HE, 1986, SCIENCE, V232, P646, DOI 10.1126/science.3961499; McQuade L, 1999, AM J MED GENET, V86, P27, DOI 10.1002/(SICI)1096-8628(19990903)86:1<27::AID-AJMG6>3.0.CO;2-7; McTaggart KE, 1998, CYTOGENET CELL GENET, V81, P222, DOI 10.1159/000015035; MEARS AJ, 1994, AM J HUM GENET, V55, P134; MEARS AJ, 1995, AM J HUM GENET, V57, P667; Merscher S, 2001, CELL, V104, P619, DOI 10.1016/S0092-8674(01)00247-1; MORROW B, 1995, AM J HUM GENET, V56, P1391; Murphy KC, 2001, BRIT J PSYCHIAT, V179, P397, DOI 10.1192/bjp.179.5.397; Murphy KC, 1999, ARCH GEN PSYCHIAT, V56, P940, DOI 10.1001/archpsyc.56.10.940; ODonnell H, 1997, AM J HUM GENET, V60, P1544; Papolos DF, 1996, AM J PSYCHIAT, V153, P1541; PHILLIPS MT, 1987, CIRC RES, V60, P27, DOI 10.1161/01.RES.60.1.27; Pizzuti A, 1997, HUM MOL GENET, V6, P259, DOI 10.1093/hmg/6.2.259; Puech A, 1997, P NATL ACAD SCI USA, V94, P14608, DOI 10.1073/pnas.94.26.14608; PULVER AE, 1994, J NERV MENT DIS, V182, P476, DOI 10.1097/00005053-199408000-00010; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; Rauch A, 1999, AM J HUM GENET, V64, P659, DOI 10.1086/302235; REISS JA, 1985, AM J MED GENET, V20, P165, DOI 10.1002/ajmg.1320200120; Reiter LT, 1996, NAT GENET, V12, P288, DOI 10.1038/ng0396-288; Reiter LT, 1998, AM J HUM GENET, V62, P1023, DOI 10.1086/301827; Riazi MA, 2000, GENOMICS, V64, P277, DOI 10.1006/geno.1999.6099; Roberts C, 1997, HUM MOL GENET, V6, P237, DOI 10.1093/hmg/6.2.237; Roberts C, 2002, MOL CELL BIOL, V22, P2318, DOI 10.1128/MCB.22.7.2318-2328.2002; Saint-Jore B, 1998, HUM MOL GENET, V7, P1841, DOI 10.1093/hmg/7.12.1841; SCAMBLER PJ, 1992, LANCET, V339, P1138, DOI 10.1016/0140-6736(92)90734-K; SCHINZEL A, 1981, HUM GENET, V56, P249, DOI 10.1007/BF00274675; SCHRECK RR, 1977, HUM GENET, V36, P1, DOI 10.1007/BF00390430; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; Shaikh TH, 1999, AM J HUM GENET, V65, P1595, DOI 10.1086/302666; Shprintzen RJ, 2000, MENT RETARD DEV D R, V6, P142, DOI 10.1002/1098-2779(2000)6:2<142::AID-MRDD9>3.0.CO;2-H; SHPRINTZEN RJ, 1978, CLEFT PALATE J, V15, P56; Sutherland HF, 1996, AM J HUM GENET, V59, P23; Swillen A, 1999, GENET COUNSEL, V10, P79; VANDYKE DL, 1977, AM J HUM GENET, V29, P294; VANHOVE JLK, 1992, AM J MED GENET, V44, P24, DOI 10.1002/ajmg.1320440107; Wakamiya M, 1998, HUM MOL GENET, V7, P1835, DOI 10.1093/hmg/7.12.1835; Yamagishi H, 1999, SCIENCE, V283, P1158, DOI 10.1126/science.283.5405.1158; Yu YJ, 2001, NAT REV GENET, V2, P780, DOI 10.1038/35093564; ZACKAI EH, 1980, AM J MED GENET, V7, P507, DOI 10.1002/ajmg.1320070412; Zheng BH, 2000, MOL CELL BIOL, V20, P648, DOI 10.1128/MCB.20.2.648-655.2000; ZUROVEC M, IN PRESS P NATL ACAD	98	177	183	1	6	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2002	70	5					1077	1088		10.1086/340363	http://dx.doi.org/10.1086/340363			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	541XT	11925570	Green Published, Bronze			2022-12-18	WOS:000175012400001
J	HECHT, JT; HOGUE, D; STRONG, LC; HANSEN, MF; BLANTON, SH; WAGNER, M				HECHT, JT; HOGUE, D; STRONG, LC; HANSEN, MF; BLANTON, SH; WAGNER, M			HEREDITARY MULTIPLE EXOSTOSIS AND CHONDROSARCOMA - LINKAGE TO CHROMOSOME-11 AND LOSS OF HETEROZYGOSITY FOR EXT-LINKED MARKERS ON CHROMOSOME-11 AND CHROMOSOME-8	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RHINO-PHALANGEAL SYNDROME; MENTAL-RETARDATION; DELETION; GENE	Hereditary multiple exostosis (EXT) is an autosomal dominant disorder characterized by bony exostoses at the ends of the long bones. Linkage studies have recently suggested that there are three chromosomal locations for EXT genes, 8q24.1 (EXT1), the pericentric region of 11 (EXT2), and 19p (EXT3). As part of a larger study to determine the frequencies of the three EXT types in the United States, we have ascertained a large multigenerational family with EXT and one family member with a chondrosarcoma. This family demonstrated linkage of the disease to chromosome 11 markers. The constitutional and tumor DNAs from the affected family member were compared using short-tandem-repeat markers from chromosomes 8, 11, and 19. Loss of heterozygosity (LOH) in the tumor was observed for chromosome 8 and 11 markers, but chromosome 19 markers were intact. An apparent deletion of the marker D11S303 was observed in constitutional DNA from all affected individuals and in the tumor sample. These results indicate that the EXT2 gene maps to the region containing marker D11S903, which is flanked by markers D11S1355 and D11S1361. Additional constitutional and chondrosarcoma DNA pairs from six unrelated individuals, two of whom had EXT, were similarly analyzed. One tumor from an individual with EXT demonstrated LOH for chromosome 8 markers, and a person with a sporadic chondrosarcoma was found to have tumor-specific LOH and a homozygous deletion of chromosome 11 markers. These findings suggest that EXT genes may be tumor-suppressor genes and that the initiation of tumor development may follow a multistep model.	UNIV TEXAS, MD ANDERSON CANC CTR, HOUSTON, TX 77225 USA; UNIV HOUSTON, HOUSTON, TX USA; BOSTON UNIV, SCH MED, BOSTON, MA 02118 USA; UNIV VIRGINIA, CHARLOTTESVILLE, VA USA	University of Texas System; UTMD Anderson Cancer Center; University of Houston System; University of Houston; Boston University; University of Virginia	HECHT, JT (corresponding author), UNIV TEXAS, SCH MED, DEPT PEDIAT, POB 20708, HOUSTON, TX 77225 USA.		Blanton, Susan Halloran/ABF-1323-2021		NATIONAL CANCER INSTITUTE [R01CA053318, R03CA053318, P01CA034936] Funding Source: NIH RePORTER; NCI NIH HHS [CA53318, CA30929, CA34936] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Blanton S. H., 1994, American Journal of Human Genetics, V55, pA180; BUHLER EM, 1984, AM J MED GENET, V19, P113, DOI 10.1002/ajmg.1320190111; COOK A, 1993, AM J HUM GENET, V53, P71; DRYJA TP, 1989, NATURE, V339, P556, DOI 10.1038/339556a0; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; Jaffe HL, 1943, ARCH PATHOL, V36, P335; LANGER LO, 1984, AM J MED GENET, V19, P81, DOI 10.1002/ajmg.1320190110; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEMERRER M, 1994, HUM MOL GENET, V3, P717, DOI 10.1093/hmg/3.5.717; LEMIEUX N, 1989, CANCER GENET CYTOGEN, V43, P73, DOI 10.1016/0165-4608(89)90129-5; LUCKERTWICKLUND C, 1994, AM J MED GENET, V55, P43; MERTENS F, 1994, GENE CHROMOSOME CANC, V9, P8, DOI 10.1002/gcc.2870090103; OGLE RF, 1991, J MED GENET, V28, P881, DOI 10.1136/jmg.28.12.881; PONDER B, 1988, NATURE, V335, P400, DOI 10.1038/335400a0; Sambrook J., 1989, MOL CLONING LAB MANU; SCHEFFER H, 1991, CANCER GENET CYTOGEN, V53, P45, DOI 10.1016/0165-4608(91)90113-9; SCHMALE GA, 1994, J BONE JOINT SURG AM, V76A, P986, DOI 10.2106/00004623-199407000-00005; SOLOMON L, 1963, J BONE JOINT SURG BR, V45, P292, DOI 10.1302/0301-620X.45B2.292; VOUTSINAS S, 1983, J MED GENET, V20, P345, DOI 10.1136/jmg.20.5.345; WU YQ, 1994, HUM MOL GENET, V3, P167, DOI 10.1093/hmg/3.1.167; YAMAGUCHI T, 1992, CANCER RES, V52, P2419; YAMAMOTO Y, 1989, AM J MED GENET, V32, P133, DOI 10.1002/ajmg.1320320128; YOUNG JL, 1981, NATL CANCER I MONOGR, V57, P96	23	177	188	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1995	56	5					1125	1131						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QU586	7726168				2022-12-18	WOS:A1995QU58600015
J	CONNEALLY, PM				CONNEALLY, PM			HUNTINGTON DISEASE - GENETICS AND EPIDEMIOLOGY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review											CONNEALLY, PM (corresponding author), INDIANA UNIV,DEPT NEUROL,INDIANAPOLIS,IN 46223, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [N01NS092320] Funding Source: NIH RePORTER; NINDS NIH HHS [N01-NS-9-2320] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Avila-Giron R., 1973, ADV NEUROL, V1, P261; BARBEAU A, 1970, LANCET, V2, P937; BARKLEY DS, 1977, ANN NEUROL, V1, P426, DOI 10.1002/ana.410010505; BEEBE GW, 1977, REPORT COMMISSION 1, V3, P224; BELL J, 1934, TREASURY HUMAN INHER, V4; BIRD ED, 1980, ANNU REV PHARMACOL, V20, P533, DOI 10.1146/annurev.pa.20.040180.002533; BOEHNKE M, 1983, AM J HUM GENET, V35, P845; BOLT JMW, 1970, BRIT J PSYCHIAT, V116, P259, DOI 10.1192/bjp.116.532.259; BONILLA E, 1983, NEUROLOGY S2, V33, P86; BRACKENRIDGE CJ, 1979, ACTA NEUROL SCAND, V60, P272; BRACKENRIDGE CJ, 1974, J NEUROL NEUROSUR PS, V37, P297, DOI 10.1136/jnnp.37.3.297; BRACKENRIDGE CJ, 1973, J MED GENET, V10, P333, DOI 10.1136/jmg.10.4.333; BRACKENRIDGE CJ, 1978, ANN HUM GENET, V42, P203, DOI 10.1111/j.1469-1809.1978.tb00652.x; BRACKENRIDGE CJ, 1974, CLIN GENET, V5, P248; BROTHERS CRD, 1964, J NEUROL SCI, V1, P405, DOI 10.1016/0022-510X(64)90110-8; Brothers CRD, 1949, P ROY AUST COLL PHYC, V4, P48; BUNDEY S, 1983, J MED GENET, V20, P76, DOI 10.1136/jmg.20.1.76; BURCH PRJ, 1973, ADV NEUROL, V1, P179; BUTTERFIELD DA, 1977, NATURE, V267, P453, DOI 10.1038/267453a0; Caro A J, 1977, J R Coll Gen Pract, V27, P41; COMINGS DE, 1981, AM J HUM GENET, V33, P166; COMINGS DE, 1981, AM J HUM GENET, V33, P314; COMINGS DE, 1981, AM J HUM GENET, V33, P175; COMINGS DE, 1979, ADV NEUROL, V23, P335; CONNEALLY PM, 1975, MODERN TRENDS HUMAN, P204; CRITCHLEY M, 1973, ADV NEUROL, V1, P13; Critchley M., 1934, J STATE MED, V42, P575; CROSS A, 1983, EUR J PHARMACOL, V88, P223, DOI 10.1016/0014-2999(83)90009-2; CURRIER RD, 1982, NEUROLOGY, V32, P907, DOI 10.1212/WNL.32.8.907; ELSTON RC, 1980, AM J HUM GENET, V32, pA142; FARRER LA, 1984, AM J MED GENET; FINCH CE, 1980, ANN NEUROL, V7, P406, DOI 10.1002/ana.410070503; GOETZ I, 1975, NEW ENGL J MED, V293, P1225, DOI 10.1056/NEJM197512112932403; GOETZ IE, 1981, AM J HUM GENET, V33, P187; GOLDMAN D, 1983, AM J HUM GENET, V35, P827; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; Haldane JBS, 1941, J GENET, V41, P149, DOI 10.1007/BF02983018; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; Haldane JBS, 1938, ANN EUGENIC, V8, P255, DOI 10.1111/j.1469-1809.1938.tb02179.x; HARPER PS, 1979, LANCET, V2, P346; HARRIS H, 1949, ANN EUGENIC, V14, P309, DOI 10.1111/j.1469-1809.1949.tb02420.x; Hattie WH, 1909, AM J INSANITY, V66, P123, DOI 10.1176/ajp.66.1.123; HAYDEN MR, 1982, AM J MED GENET, V11, P135, DOI 10.1002/ajmg.1320110203; HAYDEN MR, 1980, S AFR MED J, V58, P193; HAYDEN MR, 1980, S AFR MED J, V58, P201; Hayden MR., 1981, HUNTINGTONS CHOREA, P45; HAYDEN MR, 1979, THESIS S AFRICA U CA; Heathfield K W, 1971, Guys Hosp Rep, V120, P295; HODGE SE, 1979, CYTOGENET CELL GENET, V25, P164; HOGG JE, 1979, ADV NEUROL, V23, P27; Huntington G., 1872, MED SURG REP, V26, P320; Husquinet H, 1975, Rev Med Liege, V30, P228; HWANG SL, 1980, B NEUROL SOC ROC TAI, V5, P125; JONES M B, 1970, Journal of Medical Genetics, V7, P20, DOI 10.1136/jmg.7.1.20; JONES MB, 1973, ADV NEUROL, V1, P171; KIRK D, 1977, HUM GENET, V36, P143, DOI 10.1007/BF00273252; KISHIMOTO K, 1957, ANN REP RES I ENV ME, V9, P195; KNUTSON AG, 1971, P NATL ACAD SCI USA, V68, P820; KORENYI C, 1972, DIS NERV SYST, V33, P339; KURTZKE JF, 1979, ADV NEUROL, V23, P13; LAKOWICZ JR, 1981, AM J HUM GENET, V33, P155; LEGER JM, 1974, REV MED LIMOGES, V5, P147; MARTIN JB, 1982, NATURE, V229, P205; Marx RN, 1973, ADV NEUROL, V1, P237; MATTSSON B, 1974, THESIS UMEA U; MENKES JH, 1973, NEW ENGL J MED, V288, P856; MERRITT AD, 1969, PROGR NEUROGENETICS, P645; MYERS RH, 1983, LANCET, V1, P208; MYERS RH, 1982, AM J HUM GENET, V34, P481; MYRIANTHOPOULOS NC, 1973, ADV NEUROL, V1, P149; MYRIANTHOPOULOS NTINOS C., 1966, J MED GENET, V3, P298, DOI 10.1136/jmg.3.4.298; Narabayashi H, 1973, ADV NEUROL, V1, P253; NEWCOMBE RG, 1981, ANN HUM GENET, V45, P387, DOI 10.1111/j.1469-1809.1981.tb00352.x; OLIVER JE, 1970, BRIT J PSYCHIAT, V116, P241, DOI 10.1192/bjp.116.532.241; PEARSON JS, 1955, P STAFF M MAYO CLIN, V30, P349; PERICAKVANCE MA, 1978, CYTOGENET CELL GENET, V22, P640, DOI 10.1159/000131042; PERICAKVANCE MA, 1983, AM J MED GENET, V14, P49, DOI 10.1002/ajmg.1320140109; PERICAKVANCE MA, 1979, ADV NEUROL, V23, P59; PETTEGREW JW, 1979, J NEUROCHEM, V33, P905, DOI 10.1111/j.1471-4159.1979.tb09920.x; REED TE, 1959, AM J HUM GENET, V11, P107; REED TE, 1969, SCIENCE, V165, P762, DOI 10.1126/science.165.3895.762; REED TE, 1958, AM J HUM GENET, V10, P201; ROSS RA, 1976, NATURE, V264, P654, DOI 10.1038/264654a0; SCHACHT E, 1961, 2ND P INT C HUM GEN; SCHOENBERG BS, 1979, ADV NEUROL, V23, P1; SCRIMGEOUR EM, 1980, J MED GENET, V17, P197, DOI 10.1136/jmg.17.3.197; SEVERSON JA, 1979, SOC NEUR ABSTR, V5, P11; SHAW M, 1982, J MED GENET, V19, P161, DOI 10.1136/jmg.19.3.161; SHOKEIR MHK, 1975, CLIN GENET, V7, P349; SHOULSON I, 1979, NEUROLOGY, V29, P1, DOI 10.1212/WNL.29.1.1; STEVENS DL, 1976, THESIS U LONDON; Vessie PR, 1932, J NERV MENT DIS, V76, P553, DOI 10.1097/00005053-193212000-00001; Vessie PR, 1939, J CONNECTICUT STATE, V3, P596; VOLKERS WS, 1980, ANN HUM GENET, V44, P75, DOI 10.1111/j.1469-1809.1980.tb00947.x; WALLACE DC, 1976, ANN HUM GENET, V39, P375, DOI 10.1111/j.1469-1809.1976.tb00142.x; WALLACE DC, 1972, MED J AUST, V2, P1275; WALLACE DC, 1979, ADV NEUROL, V23, P73; WENDT G G, 1959, Acta Genet Stat Med, V9, P18; WENDT GC, 1972, ARCH PSYCHIATR NERVE, V201, P298; WENT LN, 1983, ANN HUM GENET, V47, P205, DOI 10.1111/j.1469-1809.1983.tb00989.x; WEXLER NS, 1979, GENETIC COUNCELLING, P190; [No title captured]; [No title captured]	103	177	179	0	10	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	3					506	526						21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	SY119	6233902				2022-12-18	WOS:A1984SY11900002
J	MCGUE, M; GOTTESMAN, II; RAO, DC				MCGUE, M; GOTTESMAN, II; RAO, DC			THE TRANSMISSION OF SCHIZOPHRENIA UNDER A MULTIFACTORIAL THRESHOLD-MODEL	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									WASHINGTON UNIV,SCH MED,DEPT PSYCHIAT,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT GENET,ST LOUIS,MO 63110	Washington University (WUSTL); Washington University (WUSTL)	MCGUE, M (corresponding author), WASHINGTON UNIV,SCH MED,DIV BIOSTAT,ST LOUIS,MO 63110, USA.		G, I/D-8042-2011		NIGMS NIH HHS [GM-28719] Funding Source: Medline; NIMH NIH HHS [MH-31302] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH031302, P30MH031302] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bishop YM., 2007, DISCRETE MULTIVARIAT; Bleuler M, 1978, SCHIZOPHRENIA DISORD; CARTER CL, 1980, HUM HERED, V30, P350, DOI 10.1159/000153156; DEBRAY Q, 1979, HUM HERED, V29, P27, DOI 10.1159/000153012; DEBRAY Q, 1978, NEUROPSYCHOBIOLOGY, V4, P217; ELSTON RC, 1973, SOC BIOL, V20, P276, DOI 10.1080/19485565.1973.9988054; ENDICOTT J, 1982, ARCH GEN PSYCHIATRY, V39, P887; ESSEN-MOLLER E, 1955, Acta Genet Stat Med, V5, P334; ESSENMOLLER E, 1956, ACTA PSYCHIATR NEU S, V100; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; FREMMING K, 1951, 7 OCC PAP EUG LOND; Gottesman I. I., 1972, SCHIZOPHRENIA GENETI; GOTTESMAN II, 1967, P NATL ACAD SCI USA, V58, P199, DOI 10.1073/pnas.58.1.199; HELGASON T, 1964, ACTA PSYCHIAT SCAND, P173; KARLSSON JL, 1982, BRIT J PSYCHIAT, V140, P600, DOI 10.1192/bjp.140.6.600; KETY SS, 1976, SCHIZOPHRENIA BULL, V2, P413, DOI 10.1093/schbul/2.3.413; KIDD KK, 1973, SOC BIOL, V20, P254, DOI 10.1080/19485565.1973.9988051; Kringlen E., 1967, HEREDITY ENV FUNCTIO; MATTHYSSE SW, 1976, AM J PSYCHIAT, V133, P185; MCGUE M, UNPUB CINCINNATI LIP; Morton N.E., 1983, METHODS GENETIC EPID; MORTON NE, 1974, AM J HUM GENET, V26, P489; OROURKE DH, 1982, AM J HUM GENET, V34, P630; PAYKEL ES, 1978, PSYCHOL MED, V8, P245, DOI 10.1017/S003329170001429X; RABKIN JG, 1980, PSYCHOL BULL, V87, P408, DOI 10.1037/0033-2909.87.2.408; RAO DC, 1982, GENET RES, V39, P187, DOI 10.1017/S0016672300020875; RAO DC, 1979, GENET RES, V33, P175, DOI 10.1017/S0016672300018310; RAO DC, 1981, HUM HERED, V31, P325, DOI 10.1159/000153233; RAO DC, 1978, GENETIC EPIDEMIOLOGY, P145; RAO DC, 1983, METHODS HUMAN POPULA; REICH T, 1972, ANN HUM GENET, V36, P153; RICE JP, 1981, PSYCHIAT RES, V4, P301, DOI 10.1016/0165-1781(81)90032-9; Rosanoff AJ, 1911, AM J INSANITY, V68, P221, DOI 10.1176/ajp.68.2.221; SCHOFIELD W, 1959, J ABNORM SOC PSYCH, V59, P216, DOI 10.1037/h0042510; SHIELDS J, 1972, ARCH GEN PSYCHIAT, V27, P725; Shields J, 1982, SCHIZOPHRENIA EPIGEN; SLATER E, 1953, MED RES COUNCIL SPEC, V278; Slater E, 1971, GENETICS MENTAL DISO; SMITH C, 1976, ANN HUM GENET, V39, P281, DOI 10.1111/j.1469-1809.1976.tb00132.x; TSUANG MT, 1982, BRIT J PSYCHIAT, V140, P595, DOI 10.1192/bjp.140.6.595; VAUGHN CE, 1976, BRIT J PSYCHIAT, V129, P125, DOI 10.1192/bjp.129.2.125; ZERBINRUDIN E, 1977, HUMANGENETIK, V2, P446; ZERBINRUDIN E, 1980, PSYCHIATRIE GEGENWAR, V1, P545; Zinkin J., 1950, DEMENTIA PRAECOX GRO	44	177	178	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	6					1161	1178						18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	RU705	6650500				2022-12-18	WOS:A1983RU70500011
J	MORTON, NE; CHUNG, CS				MORTON, NE; CHUNG, CS			FORMAL GENETICS OF MUSCULAR DYSTROPHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BABER RE, 1924, U WISCONSIN STUD SOC, V10; BECKER PE, 1933, DYSTROPHIA MUSCULORU; Bell J, 1943, TREASURY HUMAN INHER, V4, P283; BINET F. E., 1958, ANN HUMAN GENETICS, V22, P144; CHEESEMAN EA, 1958, ANN HUM GENET, V22, P235, DOI 10.1111/j.1469-1809.1958.tb01418.x; CHUNG CS, 1959, AM J HUM GENET, V11, P339; CHUNG CS, ANN HUMAN GENET; CROW JAMES F., 1958, HUMAN BIOL, V30, P1; DEGROUCHY J, 1953, THESIS PARIS; FORD CE, 1959, NATURE, V183, P1030, DOI 10.1038/1831030a0; HALDANE JBS, 1956, ANN HUM GENET, V20, P344; KROOTH RS, 1955, AM J HUM GENET, V7, P325; LAMY MAURICE, 1954, JOUR GENET HUMAINE, V3, P219; LEVISON H, 1951, OP DOMO BIOL HERED H, V26; MORTON NE, 1958, SCIENCE, V127, P79, DOI 10.1126/science.127.3289.79; MORTON NE, 1959, AM J HUM GENET, V11, P1; NEEL JV, 1949, AM J HUM GENET, V1, P156; PARKES AS, 1956, MARSHALLS PHYSL RE 1, V1; PENROSE LS, 1955, LANCET, V2, P312; PHILIP U, 1956, ANN HUM GENET, V21, P155, DOI 10.1111/j.1469-1809.1971.tb00276.x; REED TE, 1955, AM J HUM GENET, V7, P236; SJOVALL B, 1936, ACTA PSYCHIAT NE S10; SMITH CAB, 1958, ANN HUM GENET, V22, P244, DOI 10.1111/j.1469-1809.1958.tb01419.x; STEPHENS FE, 1951, AM J HUM GENET, V3, P111; STEVENSON A. C., 1955, ANN HUMAN GENETICS, V19, P159, DOI 10.1111/j.1469-1809.1955.tb01340.x; STEVENSON AC, 1953, ANN EUGENIC, V18, P50; STEVENSON AC, 1958, ANN HUM GENET, V22, P231, DOI 10.1111/j.1469-1809.1958.tb01417.x; TYLER FH, 1950, ANN INTERN MED, V32, P640, DOI 10.7326/0003-4819-32-4-640; WALTON JN, 1955, ANN HUM GENET, V20, P1, DOI 10.1111/j.1469-1809.1955.tb01274.x	29	177	179	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1959	11	4					360	379						20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF076	14424475				2022-12-18	WOS:A1959WF07600006
J	Shi, H; Kichaev, G; Pasaniuc, B				Shi, Huwenbo; Kichaev, Gleb; Pasaniuc, Bogdan			Contrasting the Genetic Architecture of 30 Complex Traits from Summary Association Data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; RED-BLOOD-CELL; BONE-MINERAL DENSITY; QUANTITATIVE TRAIT; COMMON VARIANTS; HUMAN HEIGHT; HERITABILITY; LOCI; POPULATION; LINKAGE	Variance-component methods that estimate the aggregate contribution of large sets of variants to the heritability of complex traits have yielded important insights into the genetic architecture of common diseases. Here, we introduce methods that estimate the total trait variance explained by the typed variants at a single locus in the genome (local SNP heritability) from genome-wide association study (GWAS) summary data while accounting for linkage disequilibrium among variants. We applied our estimator to ultra-large-scale GWAS summary data of 30 common traits and diseases to gain insights into their local genetic architecture. First, we found that common SNPs have a high contribution to the heritability of all studied traits. Second, we identified traits for which the majority of the SNP heritability can be confined to a small percentage of the genome. Third, we identified GWAS risk loci where the entire locus explains significantly more variance in the trait than the GWAS reported variants. Finally, we identified loci that explain a significant amount of heritability across multiple traits.	[Shi, Huwenbo; Kichaev, Gleb; Pasaniuc, Bogdan] Univ Calif Los Angeles, Bioinformat Interdept Program, Los Angeles, CA 90024 USA; [Pasaniuc, Bogdan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90024 USA; [Pasaniuc, Bogdan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Pasaniuc, B (corresponding author), Univ Calif Los Angeles, Bioinformat Interdept Program, Los Angeles, CA 90024 USA.; Pasaniuc, B (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90024 USA.; Pasaniuc, B (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90024 USA.	pasaniuc@ucla.edu		Pasaniuc, Bogdan/0000-0002-0227-2056				Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Arden NK, 1996, J BONE MINER RES, V11, P530; BenIsrael A., 2003, GEN INVERSES THEORY, V15; Berisa T, 2016, BIOINFORMATICS, V32, P283, DOI 10.1093/bioinformatics/btv546; Boomsma D, 2002, NAT REV GENET, V3, P872, DOI 10.1038/nrg932; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Chen Z, 2013, HUM MOL GENET, V22, P2529, DOI 10.1093/hmg/ddt087; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Cohen RZ, 1999, AM J PSYCHIAT, V156, P1059; Chagas SVD, 2011, PUBLIC HEALTH, V125, P329, DOI 10.1016/j.puhe.2011.02.009; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Elbein SC, 2002, DIABETES, V51, P528, DOI 10.2337/diabetes.51.2.528; Elman R., 2008, ALGEBRAIC GEOMETRIC, V56; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Gamazon ER, 2014, AM J HUM GENET, V95, P477, DOI 10.1016/j.ajhg.2014.09.009; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; Garner C, 2000, BLOOD, V95, P342; Gieger C, 2011, NATURE, V480, P201, DOI 10.1038/nature10659; Golan D, 2014, P NATL ACAD SCI USA, V111, pE5272, DOI 10.1073/pnas.1419064111; Gusev A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003993; HANSEN PC, 1987, BIT, V27, P534, DOI 10.1007/BF01937276; Harney SMJ, 2008, RHEUMATOLOGY, V47, P1761, DOI 10.1093/rheumatology/ken376; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Hemani G, 2013, AM J HUM GENET, V93, P865, DOI 10.1016/j.ajhg.2013.10.005; Hinckley JD, 2013, MOL GENET GENOM MED, V1, P131, DOI 10.1002/mgg3.16; Kichaev G, 2015, AM J HUM GENET, V97, P260, DOI 10.1016/j.ajhg.2015.06.007; Koller DL, 2013, J BONE MINER RES, V28, P547, DOI 10.1002/jbmr.1796; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Lin JP, 2007, AM J HEMATOL, V82, P605, DOI 10.1002/ajh.20868; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Loh PR, 2015, NAT GENET, V47, P1385, DOI 10.1038/ng.3431; Mancuso N, 2016, NAT GENET, V48, P30, DOI 10.1038/ng.3446; McCarthy S., 2015, BIORXIV; Mills GW, 2004, DIABETOLOGIA, V47, P732, DOI 10.1007/s00125-004-1338-2; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Palla L, 2015, AM J HUM GENET, V97, P250, DOI 10.1016/j.ajhg.2015.06.005; Pasaniuc B, 2014, BIOINFORMATICS, V30, P2906, DOI 10.1093/bioinformatics/btu416; Perry JRB, 2014, NATURE, V514, P92, DOI 10.1038/nature13545; Poulsen P, 1999, DIABETOLOGIA, V42, P139, DOI 10.1007/s001250051131; Rasmussen-Torvik LJ, 2007, DIABETIC MED, V24, P1286, DOI 10.1111/j.1464-5491.2007.02271.x; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Simonis-Bik AMC, 2008, TWIN RES HUM GENET, V11, P597, DOI 10.1375/twin.11.6.597; Soranzo N, 2010, DIABETES, V59, P3229, DOI 10.2337/db10-0502; Su Z, 2011, BIOINFORMATICS, V27, P2304, DOI 10.1093/bioinformatics/btr341; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Towne B, 2005, AM J PHYS ANTHROPOL, V128, P210, DOI 10.1002/ajpa.20106; Turner S., 2011, CURR PROTOC HUM GENE, P19; TYSK C, 1988, GUT, V29, P990, DOI 10.1136/gut.29.7.990; van der Harst P, 2012, NATURE, V492, P369, DOI 10.1038/nature11677; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zaitlen N, 2014, NAT GENET, V46, P1356, DOI 10.1038/ng.3139; Zheng HF, 2015, NATURE, V526, P112, DOI 10.1038/nature14878; Zheng HF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002745; Zhou X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003264	65	176	177	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 7	2016	99	1					139	153		10.1016/j.ajhg.2016.05.013	http://dx.doi.org/10.1016/j.ajhg.2016.05.013			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT6TI	27346688	Bronze, Green Submitted, Green Published			2022-12-18	WOS:000381616600011
J	Galinsky, KJ; Bhatia, G; Loh, PR; Georgiev, S; Mukherjee, S; Patterson, NJ; Price, AL				Galinsky, Kevin J.; Bhatia, Gaurav; Loh, Po-Ru; Georgiev, Stoyan; Mukherjee, Sayan; Patterson, Nick J.; Price, Alkes L.			Fast Principal-Component Analysis Reveals Convergent Evolution of ADH1B in Europe and East Asia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECENT POSITIVE SELECTION; WHOLE-GENOME ASSOCIATION; NATURAL-SELECTION; POPULATION-STRUCTURE; ALCOHOL DEPENDENCE; GENETIC SIGNATURES; WIDE ASSOCIATION; LOCAL ADAPTATION; ANCESTRY; VARIANTS	Searching for genetic variants with unusual differentiation between subpopulations is an established approach for identifying signals of natural selection. However, existing methods generally require discrete subpopulations. We introduce a method that infers selection using principal components (PCs) by identifying variants whose differentiation along top PCs is significantly greater than the null distribution of genetic drift. To enable the application of this method to large datasets, we developed the FastPCA software, which employs recent advances in random matrix theory to accurately approximate top PCs while reducing time and memory cost from quadratic to linear in the number of individuals, a computational improvement of many orders of magnitude. We apply FastPCA to a cohort of 54,734 European Americans, identifying 5 distinct subpopulations spanning the top 4 PCs. Using the PC-based test for natural selection, we replicate previously known selected loci and identify three new genome-wide significant signals of selection, including selection in Europeans at ADH1B. The coding variant rs1229984*T has previously been associated to a decreased risk of alcoholism and shown to be under selection in East Asians; we show that it is a rare example of independent evolution on two continents. We also detect selection signals at IGFBP3 and IGH, which have also previously been associated to human disease.	[Galinsky, Kevin J.; Price, Alkes L.] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Galinsky, Kevin J.; Bhatia, Gaurav; Loh, Po-Ru; Patterson, Nick J.; Price, Alkes L.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Bhatia, Gaurav; Loh, Po-Ru; Price, Alkes L.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Georgiev, Stoyan] Google, Palo Alto, CA 94043 USA; [Mukherjee, Sayan] Duke Univ, Dept Stat Sci, Dept Comp Sci, Durham, NC 27708 USA; [Mukherjee, Sayan] Duke Univ, Dept Math, Durham, NC 27708 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard T.H. Chan School of Public Health; Google Incorporated; Duke University; Duke University	Galinsky, KJ; Price, AL (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.; Galinsky, KJ; Price, AL (corresponding author), Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA.; Price, AL (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	galinsky@fas.harvard.edu; aprice@hsph.harvard.edu		Galinsky, Kevin/0000-0003-0311-4938	NIH [R01 HG006399]; NSF [DMS-1209155, DMS-1418261]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG007805, R01HG006399] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We are grateful to D. Reich for helpful discussions and S. Pollack for assistance with FastPCA software. This research was funded by NIH grant R01 HG006399. S.M. is funded by NSF grants DMS-1209155 and DMS-1418261.	Abraham G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093766; Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Ayodo G, 2007, AM J HUM GENET, V81, P234, DOI 10.1086/519221; Banda Y, 2015, GENETICS, V200, P1285, DOI 10.1534/genetics.115.178616; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Bhatia G, 2014, AM J HUM GENET, V95, P437, DOI 10.1016/j.ajhg.2014.08.011; Bhatia G, 2013, GENOME RES, V23, P1514, DOI 10.1101/gr.154831.113; Bhatia G, 2011, AM J HUM GENET, V89, P368, DOI 10.1016/j.ajhg.2011.07.025; Bigham A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001116; Billingsley P., 1995, MEASURE PROBABILITY; Bonhomme M, 2010, GENETICS, V186, P241, DOI 10.1534/genetics.104.117275; Buck D, 2013, ANN NEUROL, V73, P86, DOI 10.1002/ana.23749; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen CY, 2013, BIOINFORMATICS, V29, P1399, DOI 10.1093/bioinformatics/btt144; Chen G.-B., 2015, EIGENGWAS FINDING LO, DOI [http://dx.doi.org/10.1101/023457, DOI 10.1101/023457]; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Duforet-Frebourg N, 2014, MOL BIOL EVOL, V31, P2483, DOI 10.1093/molbev/msu182; Edenberg HJ, 2013, NAT REV GASTRO HEPAT, V10, P487, DOI 10.1038/nrgastro.2013.86; Engelken J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004128; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Foll M, 2014, AM J HUM GENET, V95, P394, DOI 10.1016/j.ajhg.2014.09.002; Fumagalli M, 2015, SCIENCE, V349, P1343, DOI 10.1126/science.aab2319; Galassi M, 2009, GNU SCI LIB REFERENC; Ganesh SK, 2014, AM J HUM GENET, V95, P49, DOI 10.1016/j.ajhg.2014.06.002; Gelernter J, 2014, MOL PSYCHIATR, V19, P41, DOI 10.1038/mp.2013.145; Gunther T, 2013, GENETICS, V195, P205, DOI 10.1534/genetics.113.152462; Gurdasani D, 2015, NATURE, V517, P327, DOI 10.1038/nature13997; Gusev A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003993; Halko N, 2011, SIAM REV, V53, P217, DOI 10.1137/090771806; Halko N, 2011, SIAM J SCI COMPUT, V33, P2580, DOI 10.1137/100804139; Hamblin MT, 2000, AM J HUM GENET, V66, P1669, DOI 10.1086/302879; Han Y, 2007, AM J HUM GENET, V80, P441, DOI 10.1086/512485; Hancock AM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001375; He YG, 2015, GENOME RES, V25, P1903, DOI 10.1101/gr.192336.115; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Karlsson EK, 2014, NAT REV GENET, V15, P379, DOI 10.1038/nrg3734; Key TJ, 2010, LANCET ONCOL, V11, P530, DOI 10.1016/S1470-2045(10)70095-4; Ko A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4983; Ko WY, 2013, AM J HUM GENET, V93, P54, DOI 10.1016/j.ajhg.2013.05.014; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Leslie S, 2015, NATURE, V519, P309, DOI 10.1038/nature14230; LEWONTIN RC, 1973, GENETICS, V74, P175; Li H, 2007, AM J HUM GENET, V81, P842, DOI 10.1086/521201; Li H, 2011, ANN HUM GENET, V75, P497, DOI 10.1111/j.1469-1809.2011.00651.x; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Loan C. F. V., 1996, MATRIX COMPUTATIONS, V3rd; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; Moreno EA, 2014, SCIENCE, V344, P1280; Nelson MR, 2008, AM J HUM GENET, V83, P347, DOI 10.1016/j.ajhg.2008.08.005; Nicholson G, 2002, J ROY STAT SOC B, V64, P695, DOI 10.1111/1467-9868.00357; Nielsen R, 2007, NAT REV GENET, V8, P857, DOI 10.1038/nrg2187; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; Novembre J, 2009, NAT REV GENET, V10, P745, DOI 10.1038/nrg2632; Osier MV, 2002, AM J HUM GENET, V71, P84, DOI 10.1086/341290; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Peter BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003011; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000505; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rokhlin V, 2009, SIAM J MATRIX ANAL A, V31, P1100, DOI 10.1137/080736417; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Scheinfeldt LB, 2013, NAT REV GENET, V14, P692, DOI 10.1038/nrg3604; Schlebusch CM, 2012, SCIENCE, V338, P374, DOI 10.1126/science.1227721; Seldin MF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040005; Shriver Mark D, 2004, Hum Genomics, V1, P274; Suo C, 2012, EUR J HUM GENET, V20, P102, DOI 10.1038/ejhg.2011.139; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Treutlein J, 2014, BIOL PSYCHIAT, V75, pE15, DOI 10.1016/j.biopsych.2013.05.042; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Whitfield JB, 2002, AM J HUM GENET, V71, P1247, DOI 10.1086/344287; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015; Yang J, 2014, NAT GENET, V46, P100, DOI 10.1038/ng.2876; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yang WY, 2012, NAT GENET, V44, P725, DOI 10.1038/ng.2285; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zhu XF, 2015, AM J HUM GENET, V96, P21, DOI 10.1016/j.ajhg.2014.11.011; Zou F, 2010, HUM HERED, V70, P9, DOI 10.1159/000288706	99	176	178	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 3	2016	98	3					456	472		10.1016/j.ajhg.2015.12.022	http://dx.doi.org/10.1016/j.ajhg.2015.12.022			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DG9DN	26924531	Green Submitted, Bronze, Green Published			2022-12-18	WOS:000372383100010
J	Zhu, XF; Feng, T; Tayo, BO; Liang, JJ; Young, JH; Franceschini, N; Smith, JA; Yanek, LR; Sun, YV; Edwards, TL; Chen, W; Nalls, M; Fox, E; Sale, M; Bottinger, E; Rotimi, C; Liu, YM; McKnight, B; Liu, K; Arnett, DK; Chakravati, A; Cooper, RS; Redline, S				Zhu, Xiaofeng; Feng, Tao; Tayo, Bamidele O.; Liang, Jingjing; Young, J. Hunter; Franceschini, Nora; Smith, Jennifer A.; Yanek, Lisa R.; Sun, Yan V.; Edwards, Todd L.; Chen, Wei; Nalls, Mike; Fox, Ervin; Sale, Michele; Bottinger, Erwin; Rotimi, Charles; Liu, Yongmei; McKnight, Barbara; Liu, Kiang; Arnett, Donna K.; Chakravati, Aravinda; Cooper, Richard S.; Redline, Susan		COGENT BP Consortium	Meta-analysis of Correlated Traits via Summary Statistics from GWASs with an Application in Hypertension	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; COMBINING DEPENDENT TESTS; BLOOD-PRESSURE TRAITS; PRINCIPAL-COMPONENTS; SUSCEPTIBILITY LOCI; GENETIC ASSOCIATION; PHENOTYPES; VARIANTS; DISEASE; LINKAGE	Genome-wide association studies (GWASs) have identified many genetic variants underlying complex traits. Many detected genetic loci harbor variants that associate with multiple-even distinct-traits. Most current analysis approaches focus on single traits, even though the final results from multiple traits are evaluated together. Such approaches miss the opportunity to systemically integrate the phenome-wide data available for genetic association analysis. In this study, we propose a general approach that can integrate association evidence from summary statistics of multiple traits, either correlated, independent, continuous, or binary traits, which might come from the same or different studies. We allow for trait heterogeneity effects. Population structure and cryptic relatedness can also be controlled. Our simulations suggest that the proposed method has improved statistical power over single-trait analysis in most of the cases we studied. We applied our method to the Continental Origins and Genetic Epidemiology Network (COGENT) African ancestry samples for three blood pressure traits and identified four loci (CHIC2, HOXA-EVX1, IGFBP1/IGFBP3, and CDH17; p < 5.0 x 10(-8)) associated with hypertension-related traits that were missed by a single-trait analysis in the original report. Six additional loci with suggestive association evidence (p < 5.0 x 10(-7)) were also observed, including CACNA1D and WNT3. Our study strongly suggests that analyzing multiple phenotypes can improve statistical power and that such analysis can be executed with the summary statistics from GWASs. Our method also provides a way to study a cross phenotype (CP) association by using summary statistics from GWASs of multiple phenotypes.	[Zhu, Xiaofeng; Feng, Tao; Liang, Jingjing] Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Feng, Tao] Heilongjiang Univ, Coll Math Sci, Harbin 150080, Peoples R China; [Tayo, Bamidele O.; Cooper, Richard S.] Loyola Univ Chicago, Stritch Sch Med, Dept Publ Hlth Sci, Maywood, IL 60153 USA; [Young, J. Hunter; Yanek, Lisa R.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Franceschini, Nora] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Smith, Jennifer A.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Sun, Yan V.] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Edwards, Todd L.] Vanderbilt Univ, Dept Med, Div Epidemiol, Ctr Human Genet Res, Nashville, TN 37212 USA; [Chen, Wei] Tulane Univ, Tulane Ctr Cardiovasc Hlth, New Orleans, LA 70112 USA; [Nalls, Mike] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Fox, Ervin] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39126 USA; [Sale, Michele] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA; [Bottinger, Erwin] Mt Sinai Sch Med, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Rotimi, Charles] NHGRI, Ctr Res Genom & Global Hlth, Bethesda, MD 20892 USA; [Liu, Yongmei] Wake Forest Sch Med, Dept Epidemiol & Prevent, Winston Salem, NC 27157 USA; [McKnight, Barbara] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Liu, Kiang] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Arnett, Donna K.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA; [Chakravati, Aravinda] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Ctr Complex Dis Genom, Baltimore, MD 21205 USA; [Redline, Susan] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Redline, Susan] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	Case Western Reserve University; Heilongjiang University; Loyola University Chicago; Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; University of Michigan System; University of Michigan; Emory University; Rollins School Public Health; Vanderbilt University; Tulane University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Mississippi; University of Mississippi Medical Center; University of Virginia; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Wake Forest University; University of Washington; University of Washington Seattle; Northwestern University; Feinberg School of Medicine; University of Alabama System; University of Alabama Birmingham; Johns Hopkins University; Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Zhu, XF (corresponding author), Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA.	xiaofeng.zhu@case.edu	Bovet, Pascal/F-4477-2011; Bochud, Murielle/A-3981-2010; Singleton, Andrew B/C-3010-2009; Zhu, Xiaofeng/O-6874-2019; Cushman, Mary/K-1157-2019; Williams, Scott/Q-4812-2019	Bovet, Pascal/0000-0002-0242-4259; Bochud, Murielle/0000-0002-5727-0218; Cushman, Mary/0000-0002-7871-6143; Williams, Scott/0000-0002-4835-9544; Smith, Jennifer Ann/0000-0002-3575-5468; Zhu, Xiaofeng/0000-0003-0037-411X; Adeyemo, Adebowale/0000-0002-3105-3231; Shriner, Daniel/0000-0003-1928-5520	NIH from the National Human Genome Research Institute [HG003054]; National Heart, Lung, and Blood Institute [HL086718, HL053353, HL113338, HL123677]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL121429, R01HL053353, U01HL107446, R01HL086718, R21HL123677, R01HL113338, T32HL007567, R01HL055673] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200362, R01HG003054] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006899] Funding Source: NIH RePORTER	NIH from the National Human Genome Research Institute; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	We are gratefully indebted to Robert C. Elston for his valuable discussions and suggestions that greatly improved the manuscript. The work was supported by the NIH grants HG003054 from the National Human Genome Research Institute and HL086718, HL053353, HL113338, and HL123677 from the National Heart, Lung, and Blood Institute. Funding information for the COGENT BP Consortium is provided in the Supplemental Data.	ALAM K, 1979, SCAND J STAT, V6, P123; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Aschard H, 2014, AM J HUM GENET, V94, P662, DOI 10.1016/j.ajhg.2014.03.016; Azizan EAB, 2013, NAT GENET, V45, P1055, DOI 10.1038/ng.2716; Balakumar P, 2011, HYPERTENS RES, V34, P1161, DOI 10.1038/hr.2011.113; Bhattacharjee S, 2012, AM J HUM GENET, V90, P821, DOI 10.1016/j.ajhg.2012.03.015; Ciullo M, 2006, HUM MOL GENET, V15, P1735, DOI 10.1093/hmg/ddl097; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Franceschini N, 2013, AM J HUM GENET, V93, P545, DOI 10.1016/j.ajhg.2013.07.010; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Ganesh SK, 2014, AM J HUM GENET, V95, P49, DOI 10.1016/j.ajhg.2014.06.002; Heald AH, 2002, DIABETES, V51, P2629, DOI 10.2337/diabetes.51.8.2629; Huang J, 2011, BIOINFORMATICS, V27, P1201, DOI 10.1093/bioinformatics/btr116; Klei L, 2008, GENET EPIDEMIOL, V32, P9, DOI 10.1002/gepi.20257; Lange C, 2003, BIOSTATISTICS, V4, P195, DOI 10.1093/biostatistics/4.2.195; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Li YL, 2011, STAT INTERFACE, V4, P273; Lin DY, 2010, BIOMETRIKA, V97, P321, DOI 10.1093/biomet/asq006; O'Reilly PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034861; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; Ott J, 1999, HUM HERED, V49, P106, DOI 10.1159/000022854; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rajwani A, 2012, DIABETES, V61, P915, DOI 10.2337/db11-0963; Schifano ED, 2013, AM J HUM GENET, V92, P744, DOI 10.1016/j.ajhg.2013.04.004; Skroza N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/983902; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; van der Sluis S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003235; Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922; WEI LJ, 1985, BIOMETRIKA, V72, P359; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Xu X, 2003, BIOSTATISTICS, V4, P223, DOI 10.1093/biostatistics/4.2.223; Yang QO, 2010, GENET EPIDEMIOL, V34, P444, DOI 10.1002/gepi.20497; Zaykin DV, 2002, GENET EPIDEMIOL, V22, P170, DOI 10.1002/gepi.0042; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zhang HP, 2010, J AM STAT ASSOC, V105, P473, DOI 10.1198/jasa.2009.ap08387; Zhou X, 2014, NAT METHODS, V11, P407, DOI [10.1038/NMETH.2848, 10.1038/nmeth.2848]; Zhu XF, 2005, NAT GENET, V37, P177, DOI 10.1038/ng1510; Zhu XF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001244; Zhu XF, 2012, AM J HUM GENET, V91, P965, DOI 10.1016/j.ajhg.2012.05.029	42	176	179	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 8	2015	96	1					21	36		10.1016/j.ajhg.2014.11.011	http://dx.doi.org/10.1016/j.ajhg.2014.11.011			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AY6YE	25500260	Bronze, Green Published			2022-12-18	WOS:000347707800002
J	Popova, T; Hebert, L; Jacquemin, V; Gad, S; Caux-Moncoutier, V; Dubois-d'Enghien, C; Richaudeau, B; Renaudin, X; Sellers, J; Nicolas, A; Sastre-Garau, X; Desjardins, L; Gyapay, G; Raynal, V; Sinilnikova, OM; Andrieu, N; Manie, E; de Pauw, A; Gesta, P; Bonadona, V; Maugard, CM; Penet, C; Avril, MF; Barillot, E; Cabaret, O; Delattre, O; Richard, S; Caron, O; Benfodda, M; Hu, HH; Soufir, N; Bressac-de Paillerets, B; Stoppa-Lyonnet, D; Stern, MH				Popova, Tatiana; Hebert, Lucie; Jacquemin, Virginie; Gad, Sophie; Caux-Moncoutier, Virginie; Dubois-d'Enghien, Catherine; Richaudeau, Benedicte; Renaudin, Xavier; Sellers, Jason; Nicolas, Andre; Sastre-Garau, Xavier; Desjardins, Laurence; Gyapay, Gabor; Raynal, Virginie; Sinilnikova, Olga M.; Andrieu, Nadine; Manie, Elodie; de Pauw, Antoine; Gesta, Paul; Bonadona, Valerie; Maugard, Christine M.; Penet, Clotilde; Avril, Marie-Francoise; Barillot, Emmanuel; Cabaret, Odile; Delattre, Olivier; Richard, Stephane; Caron, Olivier; Benfodda, Meriem; Hu, Hui-Han; Soufir, Nadem; Bressac-de Paillerets, Brigitte; Stoppa-Lyonnet, Dominique; Stern, Marc-Henri			Germline BAP1 Mutations Predispose to Renal Cell Carcinomas	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BRCA1-ASSOCIATED PROTEIN-1; UBIQUITIN HYDROLASE; LUNG ADENOCARCINOMA; SOMATIC MUTATIONS; HEREDITARY CAUSES; BREAST-CANCER; UVEAL; MESOTHELIOMA; MELANOMA; TUMORS	The genetic cause of some familial nonsyndromic renal cell carcinomas (RCC) defined by at least two affected first-degree relatives is unknown. By combining whole-exome sequencing and tumor profiling in a family prone to cases of RCC, we identified a germline BAP1 mutation c.277A>G (p.Thr93Ala) as the probable genetic basis of RCC predisposition. This mutation segregated with all four RCC-affected relatives. Furthermore, BAP1 was found to be inactivated in RCC-affected individuals from this family. No BAP1 mutations were identified in 32 familial cases presenting with only RCC. We then screened for germline BAP1 deleterious mutations in familial aggregations of cancers within the spectrum of the recently described BAP1-associated tumor predisposition syndrome, including uveal melanoma, malignant pleural mesothelioma, and cutaneous melanoma. Among the 11 families that included individuals identified as carrying germline deleterious BAP1 mutations, 6 families presented with 9 RCC-affected individuals, demonstrating a significantly increased risk for RCC. This strongly argues that RCC belongs to the BAP1 syndrome and that BAP1 is a RCC-predisposition gene.	[Popova, Tatiana; Hebert, Lucie; Jacquemin, Virginie; Renaudin, Xavier; Sellers, Jason; Raynal, Virginie; Manie, Elodie; Delattre, Olivier; Stoppa-Lyonnet, Dominique; Stern, Marc-Henri] Inst Curie, INSERM, U830, F-75248 Paris, France; [Gad, Sophie; Richard, Stephane] Inst Cancerol Gustave Roussy, INSERM, U753, Genet Oncol EPHE, F-94805 Villejuif, France; [Gad, Sophie; Richard, Stephane] Hop Bicetre, AP HP, INCa, Ctr Expert Natl Canc Rares PREDIR, F-94276 Le Kremlin Bicetre, France; [Caux-Moncoutier, Virginie; Dubois-d'Enghien, Catherine; Richaudeau, Benedicte; Nicolas, Andre; Sastre-Garau, Xavier; de Pauw, Antoine; Stoppa-Lyonnet, Dominique; Stern, Marc-Henri] Inst Curie, Dept Tumor Biol, F-75248 Paris, France; [Desjardins, Laurence] Inst Curie, Dept Chirurg, F-75248 Paris, France; [Gyapay, Gabor] CEA, GENOSCOPE, Ctr Natl Sequencage, F-91057 Evry, France; [Sinilnikova, Olga M.] Ctr Hosp Univ Lyon, Unite Mixte Genet Constitut Canc Frequents, Ctr Leon Berard, F-69008 Lyon, France; [Sinilnikova, Olga M.] Univ Lyon 1, CNRS, UMR5286, INSERM,U1052,Ctr Rech Cancerol Lyon, F-69008 Lyon, France; [Andrieu, Nadine; Barillot, Emmanuel] Inst Curie, INSERM, U900, F-75248 Paris, France; [Gesta, Paul] Ctr Hosp G Renon, Serv Oncol, F-79021 Niort, France; [Bonadona, Valerie] Univ Lyon 1, CNRS, UMR 5558, F-69622 Villeurbanne, France; [Bonadona, Valerie] Ctr Leon Berard, F-69008 Lyon, France; [Maugard, Christine M.] Nouvel Hop Civil, Lab Diagnost Genet, F-67091 Strasbourg, France; [Penet, Clotilde] Inst Jean Godinot, Unite Oncogenet, F-51056 Reims, France; [Avril, Marie-Francoise] Univ Paris 05, Hop Cochin, APHP, Serv Dermatol, F-75014 Paris, France; [Barillot, Emmanuel] Mines ParisTech, F-77300 Fontainebleau, France; [Cabaret, Odile; Bressac-de Paillerets, Brigitte] Inst Cancerol Gustave Roussy, Serv Genet, F-94805 Villejuif, France; [Cabaret, Odile; Bressac-de Paillerets, Brigitte] INSERM, U946, F-75010 Paris, France; [Caron, Olivier] Inst Cancerol Gustave Roussy, Dept Med, F-94805 Villejuif, France; [Benfodda, Meriem; Hu, Hui-Han; Soufir, Nadem] Hop Xavier Bichat, APHP, Dept Genet, F-75018 Paris, France; [Benfodda, Meriem; Hu, Hui-Han; Soufir, Nadem] Univ Paris 07, St Louis Hosp, INSERM, U976,Skin Res Ctr, F-75010 Paris, France; [Stoppa-Lyonnet, Dominique] Univ Paris 05, F-75270 Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National du Cancer (INCA) France; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; CEA; UDICE-French Research Universities; Universite Paris Saclay; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; UNICANCER; Centre Leon Berard; CHU Strasbourg; UNICANCER; Institut Jean Godinot; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Stern, MH (corresponding author), Inst Curie, INSERM, U830, F-75248 Paris, France.	marc-henri.stem@curie.fr	Lambert, Blandine S/O-6002-2016; Paillerets, Brigitte Bressac-de/D-8954-2018; Stern, Marc-Henri/A-2728-2011; ANDRIEU, Nadine/H-4255-2014; RICHARD, Stéphane/O-1005-2017	Lambert, Blandine S/0000-0002-8429-2404; Paillerets, Brigitte Bressac-de/0000-0003-0245-8608; Stern, Marc-Henri/0000-0002-8100-2272; RICHARD, Stéphane/0000-0002-9859-9773; BARILLOT, Emmanuel/0000-0003-2724-2002; Renaudin, Xavier/0000-0002-2970-6010; Sastre-Garau, Xavier/0000-0001-5992-2083; GAD (LAPITEAU), Sophie/0000-0002-3158-6791; delattre, olivier/0000-0002-8730-2276	Comite de Paris de la Ligue Nationale Contre le Cancer; l'Association pour la Recherche sur le Cancer (ARC); l'Institut National du Cancer (INCa); le Canceropole Region Ile-de-France; Institut Curie Translational department; INCa; Translational department; Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche (MERNT); ARC; Canceropole Ile de France; Region Ile de France	Comite de Paris de la Ligue Nationale Contre le Cancer; l'Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); l'Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); le Canceropole Region Ile-de-France; Institut Curie Translational department; INCa(Institut National du Cancer (INCA) France); Translational department; Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche (MERNT); ARC(Australian Research Council); Canceropole Ile de France(Region Ile-de-France); Region Ile de France(Region Ile-de-France)	We are grateful to the family members who participated in this study. The authors would like to thank S. Chanock, C. Houdayer, A. Vincent-Salomon, and E. Heard for helpful discussions; R. Lebofsky and A. Holmes for reviewing the manuscript; M.C. King, S. Giraud, L. Venat, D. Joly, D. Chauveau, and S. Pipemo-Neumann for access to individual samples; D. Bellanger, O. Mariani, M. de Lichy, M. Mary, A. Riffault, B. Grandchamp, L. Thomas, and M. Belotti for their contributions; M. Sahbatou and E. Genin for initial genetic studies; the NGS (A.N., P. Legoix-Ne) and Sanger (L. Tremolet) platforms; P. Fanen and L. Golmard for help in Exontrap assays; and A. Renier and N. Amirouchene Angelozzi for providing cell lines. This project was supported by grants from Comite de Paris de la Ligue Nationale Contre le Cancer, l'Association pour la Recherche sur le Cancer (ARC), l'Institut National du Cancer (INCa), le Canceropole Region Ile-de-France, and the Institut Curie Translational department. T.P. was supported by INCa, L.H. by the Translational department and the Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche (MERNT), and V.J. by ARC. The NGS platform was supported by grants from Canceropole Ile de France and Region Ile de France. The EMMA technology is dependent on Curie Institute/CNRS/University Pierre et Marie Curie joint patents. D.S.-L. is a shareholder of Fluigent.	Abdel-Rahman MH, 2011, J MED GENET, V48, P856, DOI 10.1136/jmedgenet-2011-100156; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Axwijk PH, 2010, EUR J CLIN INVEST, V40, P433, DOI 10.1111/j.1365-2362.2010.02270.x; Belot A, 2008, REV EPIDEMIOL SANTE, V56, P159, DOI 10.1016/j.respe.2008.03.117; Bott M, 2011, NAT GENET, V43, P668, DOI 10.1038/ng.855; Caux-Moncoutier V, 2011, HUM MUTAT, V32, P325, DOI 10.1002/humu.21414; Coupier I, 2005, FAM CANCER, V4, P273, DOI 10.1007/s10689-005-2833-4; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Goldstein AM, 2011, NAT GENET, V43, P925, DOI 10.1038/ng.956; Guo GW, 2012, NAT GENET, V44, P17, DOI 10.1038/ng.1014; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Misaghi S, 2009, MOL CELL BIOL, V29, P2181, DOI 10.1128/MCB.01517-08; Njauw CNJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035295; Pavlovich CP, 2004, NAT REV CANCER, V4, P381, DOI 10.1038/nrc1364; Pena-LlopiS S, 2012, NAT GENET, V44, P751, DOI 10.1038/ng.2323; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Testa JR, 2011, NAT GENET, V43, P1022, DOI 10.1038/ng.912; Ventii KH, 2008, CANCER RES, V68, P6953, DOI 10.1158/0008-5472.CAN-08-0365; Wadt K, 2012, PIGM CELL MELANOMA R, V25, P815, DOI 10.1111/pcmr.12006; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wiesner T, 2011, NAT GENET, V43, P1018, DOI 10.1038/ng.910; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Woodward ER, 2008, CLIN CANCER RES, V14, P5925, DOI 10.1158/1078-0432.CCR-08-0608	28	176	177	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 6	2013	92	6					974	980		10.1016/j.ajhg.2013.04.012	http://dx.doi.org/10.1016/j.ajhg.2013.04.012			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164MX	23684012	Green Published, Bronze			2022-12-18	WOS:000320415300014
J	Gotz, A; Tyynismaa, H; Euro, L; Ellonen, P; Hyotylainen, T; Ojala, T; Hamalainen, RH; Tommiska, J; Raivio, T; Oresic, M; Karikoski, R; Tammela, O; Simola, KOJ; Paetau, A; Tyni, T; Suomalainen, A				Gotz, Alexandra; Tyynismaa, Henna; Euro, Liliya; Ellonen, Pekka; Hyotylainen, Tuulia; Ojala, Tiina; Hamalainen, Riikka H.; Tommiska, Johanna; Raivio, Taneli; Oresic, Matej; Karikoski, Riitta; Tammela, Outi; Simola, Kalle O. J.; Paetau, Anders; Tyni, Tiina; Suomalainen, Anu			Exome Sequencing Identifies Mitochondrial Alanyl-tRNA Synthetase Mutations in Infantile Mitochondrial Cardiomyopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PURE MYOPATHY; GENE; DEFICIENCY; ALANINE; RECOGNITION; DISORDERS; DISEASE; PATIENT; DESIGN; DOMAIN	Infantile cardiomyopathies are devastating fatal disorders of the neonatal period or the first year of life. Mitochondrial dysfunction is a common cause of this group of diseases, but the underlying gene defects have been characterized in only a minority of cases, because tissue specificity of the manifestation hampers functional cloning and the heterogeneity of causative factors hinders collection of informative family materials. We sequenced the exome of a patient who died at the age of 10 months of hypertrophic mitochondrial cardiomyopathy with combined cardiac respiratory chain complex I and IV deficiency. Rigorous data analysis allowed us to identify a homozygous missense mutation in AARS2, which we showed to encode the mitochondrial alanyl-tRNA synthetase (mtAlaRS). Two siblings from another family, both of whom died perinatally of hypertrophic cardiomyopathy, had the same mutation, compound heterozygous with another missense mutation. Protein structure modeling of mtAlaRS suggested that one of the mutations affected a unique tRNA recognition site in the editing domain, leading to incorrect tRNA aminoacylation, whereas the second mutation severely disturbed the catalytic function, preventing tRNA aminoacylation. We show here that mutations in AARS2 cause perinatal or infantile cardiomyopathy with near-total combined mitochondrial respiratory chain deficiency in the heart. Our results indicate that exome sequencing is a powerful tool for identifying mutations in single patients and allows recognition of the genetic background in single-gene disorders of variable clinical manifestation and tissue-specific disease. Furthermore, we show that mitochondrial disorders extend to prenatal life and are an important cause of early infantile cardiac failure.	[Gotz, Alexandra; Tyynismaa, Henna; Euro, Liliya; Hamalainen, Riikka H.; Tyni, Tiina; Suomalainen, Anu] Univ Helsinki, Res Programs Unit, Biomedicum Helsinki, FIN-00290 Helsinki, Finland; [Ellonen, Pekka; Suomalainen, Anu] Univ Helsinki, Inst Mol Med Finland FIMM, FIN-00290 Helsinki, Finland; [Hyotylainen, Tuulia; Oresic, Matej] VTT Tech Res Ctr Finland, Espoo 02044, Finland; [Ojala, Tiina] Univ Helsinki, Hosp Children & Adolescents, Dept Pediat Cardiol, FIN-00290 Helsinki, Finland; [Tommiska, Johanna; Raivio, Taneli] Univ Helsinki, Dept Physiol, Inst Biomed, FIN-00290 Helsinki, Finland; [Tommiska, Johanna; Raivio, Taneli] Helsinki Univ Cent Hosp, Childrens Hosp, Helsinki 00290, Finland; [Karikoski, Riitta; Paetau, Anders] Univ Helsinki, Dept Pathol, FIN-00290 Helsinki, Finland; [Tammela, Outi] Tampere Univ Hosp, Pediat Res Ctr, Tampere 33521, Finland; [Simola, Kalle O. J.] Tampere Univ Hosp, Dept Pediat, Genet Outpatient Clin, Tampere 33521, Finland; [Tyni, Tiina] Helsinki Univ Cent Hosp, Dept Pediat Neurol, Helsinki 00290, Finland; [Suomalainen, Anu] Helsinki Univ Cent Hosp, Dept Neurol, Helsinki 00290, Finland	University of Helsinki; University of Helsinki; VTT Technical Research Center Finland; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital	Suomalainen, A (corresponding author), Univ Helsinki, Res Programs Unit, Biomedicum Helsinki, FIN-00290 Helsinki, Finland.	anu.wartiovaara@helsinki.fi	Oresic, Matej/K-7673-2016; Tyynismaa, Henna/F-1428-2011; Oresic, Matej/AAV-3978-2020; Martikainen, Riikka/AAR-8397-2020; Hyötyläinen, Tuulia/AAP-6266-2020; Euro, Liliya/F-3808-2015	Oresic, Matej/0000-0002-2856-9165; Martikainen, Riikka/0000-0002-5102-0672; Euro, Liliya/0000-0001-9705-3886; Tyynismaa, Henna/0000-0002-2493-2422; Ellonen, Pekka/0000-0001-6072-0489; Suomalainen-Wartiovaara, Anu/0000-0003-4833-5195; Tommiska, Johanna/0000-0001-7958-8262; Gotz, Alexandra/0000-0001-9737-6861; Raivio, Taneli/0000-0001-5385-434X; Hyotylainen, Tuulia/0000-0002-1389-8302	Jane and Aatos Erkko Foundation; Academy of Finland; Sigrid Juselius Foundation; University of Helsinki; Graduate School of Biotechnology and Molecular Biology; Finnish Cultural Foundation	Jane and Aatos Erkko Foundation; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); University of Helsinki; Graduate School of Biotechnology and Molecular Biology; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	The authors wish to thank Tuula Manninen and Anu Harju for technical assistance and Sanna Marjavaara, Pirjo Isohanni, Uwe Richter, and Brendan Battersby for discussions. This study was supported by the Jane and Aatos Erkko Foundation (to A.S. and T.T.), the Academy of Finland (to H.T. and A.S.), the Sigrid Juselius Foundation, the University of Helsinki (to A.S.), the Graduate School of Biotechnology and Molecular Biology, and the Finnish Cultural Foundation (to A.G.).	Beebe K, 2008, NATURE, V451, P90, DOI 10.1038/nature06454; Belostotsky R, 2011, AM J HUM GENET, V88, P193, DOI 10.1016/j.ajhg.2010.12.010; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; Castillo S, 2011, ANAL CHEM, V83, P3058, DOI 10.1021/ac103308x; Cizkova A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246; Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227; Guo M, 2009, NATURE, V462, P808, DOI 10.1038/nature08612; Guo M, 2009, SCIENCE, V325, P744, DOI 10.1126/science.1174343; Holmgren D, 2003, EUR HEART J, V24, P280, DOI 10.1016/S0195-668X(02)00387-1; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Leary SC, 2009, METHODS MOL BIOL, V554, P143, DOI 10.1007/978-1-59745-521-3_10; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lovato MA, 2001, EMBO J, V20, P4846, DOI 10.1093/emboj/20.17.4846; McFarland R, 2008, NEUROMUSCULAR DISORD, V18, P63, DOI 10.1016/j.nmd.2007.07.007; Papadopoulou LC, 1999, NAT GENET, V23, P333; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001; ROBINSON BH, 1992, BIOCHEM MED METAB B, V48, P122, DOI 10.1016/0885-4505(92)90056-5; Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718; Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013; SCHIMMEL P, 1995, TRENDS BIOCHEM SCI, V20, P333, DOI 10.1016/S0968-0004(00)89067-2; Sokabe M, 2005, P NATL ACAD SCI USA, V102, P11669, DOI 10.1073/pnas.0502119102; Sokabe M, 2009, P NATL ACAD SCI USA, V106, P11028, DOI 10.1073/pnas.0904645106; Spagnolo M, 2001, NEUROMUSCULAR DISORD, V11, P481, DOI 10.1016/S0960-8966(01)00195-X; Suomalainen A, 2000, MOL BIOTECHNOL, V15, P123, DOI 10.1385/MB:15:2:123; Swairjo MA, 2005, P NATL ACAD SCI USA, V102, P988, DOI 10.1073/pnas.0409024102; Swairjo MA, 2004, MOL CELL, V13, P829, DOI 10.1016/S1097-2765(04)00126-1; Swalwell H, 2006, NEUROLOGY, V66, P447, DOI 10.1212/01.wnl.0000196490.36349.83; TANAKA M, 1990, LANCET, V336, P1452, DOI 10.1016/0140-6736(90)93162-I; Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55; Watanabe K, 2010, P JPN ACAD B-PHYS, V86, P11, DOI 10.2183/pjab.86.11; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yaplito-Lee J, 2007, J PEDIATR-US, V150, P407, DOI 10.1016/j.jpeds.2006.12.047	36	176	182	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 13	2011	88	5					635	642		10.1016/j.ajhg.2011.04.006	http://dx.doi.org/10.1016/j.ajhg.2011.04.006			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	767CE	21549344	Green Published, Bronze			2022-12-18	WOS:000290832100012
J	Sanchez-Corral, P; Perez-Caballero, D; Huarte, O; Simckes, AM; Goicoechea, E; Lopez-Trascasa, M; de Cordoba, SR				Sanchez-Corral, P; Perez-Caballero, D; Huarte, O; Simckes, AM; Goicoechea, E; Lopez-Trascasa, M; de Cordoba, SR			Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEMENT FACTOR-H; HEPARIN-BINDING DOMAIN; ALTERNATIVE PATHWAY; MOLECULAR-BASIS; PROTEIN; SITE; IDENTIFICATION; DEFICIENCY; BETA-1H; C3B	Genetic studies have demonstrated the involvement of the complement regulator factor H in nondiarrheal, non-verocytotoxin (i.e., atypical) cases of hemolytic uremic syndrome. Different factor H mutations have been identified in 10%-30% of patients with atypical hemolytic uremic syndrome (aHUS), and most of these mutations alter single amino acids in the C-terminal region of factor H. Although these mutations are considered to be responsible for the disease, the precise role that factor H plays in the pathogenesis of aHUS is unknown. We report here the structural and functional characterization of three different factor H proteins purified from the plasma of patients with aHUS who carry the factor H mutations W1183L, V1197A, or R1210C. Structural anomalies in factor H were found only in R1210C carriers; these individuals show, in their plasma, a characteristic high-molecular-weight factor H protein that results from the covalent interaction between factor H and human serum albumin. Most important, all three aHUS-associated factor H proteins have a normal cofactor activity in the proteolysis of fluid-phase C3b by factor I but show very low binding to surface-bound C3b. This functional impairment was also demonstrated in recombinant mutant factor H proteins expressed in COS7 cells. These data support the hypothesis that patients with aHUS carry a specific dysfunction in the protection of cellular surfaces from complement activation, offering new possibilities to improve diagnosis and develop appropriate therapies.	CSIC, Ctr Invest Biol, Dept Inmunol, Velazquez 144, E-28006 Madrid, Spain; Hosp Univ La Paz, Unidad Inmunol, Madrid, Spain; Univ Missouri, Sch Med, Childrens Mercy Hosp & Clin, Kansas City, MO 64110 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consiglio Nazionale delle Ricerche (CNR); Hospital Universitario La Paz; Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City	de Cordoba, SR (corresponding author), CSIC, Ctr Invest Biol, Dept Inmunol, Velazquez 144, E-28006 Madrid, Spain.	SrdeCordoba@cib.csic.es	de Cordoba, Santiago Rodriguez/K-6727-2014; López-Trascasa, Margarita/L-2699-2014; Goicoechea De Jorge, Elena/L-4580-2016	de Cordoba, Santiago Rodriguez/0000-0001-6401-1874; López-Trascasa, Margarita/0000-0001-8594-282X; Goicoechea De Jorge, Elena/0000-0002-4978-2483				Blackmore TK, 1996, J IMMUNOL, V157, P5422; Blackmore TK, 1998, J IMMUNOL, V160, P3342; Buddles MRH, 2000, AM J HUM GENET, V66, P1721, DOI 10.1086/302877; Caprioli J, 2001, J AM SOC NEPHROL, V12, P297, DOI 10.1681/ASN.V122297; DECORDOBA SR, 1984, J IMMUNOL, V132, P1906; FUJITA T, 1979, J EXP MED, V150, P267, DOI 10.1084/jem.150.2.267; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAURELL A-B, 1971, European Journal of Immunology, V1, P146, DOI 10.1002/eji.1830010215; MERI S, 1990, P NATL ACAD SCI USA, V87, P3982, DOI 10.1073/pnas.87.10.3982; Ohali M, 1998, PEDIATR NEPHROL, V12, P619, DOI 10.1007/s004670050515; PANGBURN MK, 1991, J BIOL CHEM, V266, P16847; PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257; Pangburn MK, 2000, J IMMUNOL, V164, P4742, DOI 10.4049/jimmunol.164.9.4742; Perez-Caballero D, 2001, AM J HUM GENET, V68, P478, DOI 10.1086/318201; Perkins SJ, 2002, J MOL BIOL, V316, P217, DOI 10.1006/jmbi.2001.5337; PICHETTE V, 1994, AM J KIDNEY DIS, V24, P936, DOI 10.1016/S0272-6386(12)81065-1; Pickering MC, 2002, NAT GENET, V31, P424, DOI 10.1038/ng912; Ram S, 1998, J EXP MED, V187, P743, DOI 10.1084/jem.187.5.743; Remuzzi G, 1998, KIDNEY INT, V53, pS54; Remuzzi G, 2002, LANCET, V359, P1671, DOI 10.1016/S0140-6736(02)08560-4; Remuzzi G, 2002, BLOOD, V100, P778, DOI 10.1182/blood-2001-12-0166; Richards A, 2001, AM J HUM GENET, V68, P485, DOI 10.1086/318203; RIPOCHE J, 1988, BIOCHEM J, V249, P593, DOI 10.1042/bj2490593; Rougier N, 1998, J AM SOC NEPHROL, V9, P2318; Sanchez-Corral P, 2000, IMMUNOGENETICS, V51, P366, DOI 10.1007/s002510050631; SANCHEZCORRAL P, 1989, J IMMUNOL METHODS, V122, P105, DOI 10.1016/0022-1759(89)90340-2; Sharma AK, 1996, P NATL ACAD SCI USA, V93, P10996, DOI 10.1073/pnas.93.20.10996; SKRIVER K, 1989, J BIOL CHEM, V264, P3066; THOMPSON RA, 1981, CLIN EXP IMMUNOL, V46, P110; Warwicker P, 1998, KIDNEY INT, V53, P836, DOI 10.1111/j.1523-1755.1998.00824.x; WEILER JM, 1976, P NATL ACAD SCI USA, V73, P3268, DOI 10.1073/pnas.73.9.3268; Zipfel PF, 2001, TRENDS IMMUNOL, V22, P345, DOI 10.1016/S1471-4906(01)01972-X	32	176	182	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2002	71	6					1285	1295		10.1086/344515	http://dx.doi.org/10.1086/344515			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621KD	12424708	Green Published, Bronze			2022-12-18	WOS:000179586800003
J	Machinis, K; Pantel, J; Netchine, I; Leger, J; Camand, OJA; Sobrier, ML; Dastot-Le Moal, F; Duquesnoy, P; Abitbol, M; Czernichow, P; Amselem, S				Machinis, K; Pantel, J; Netchine, I; Leger, J; Camand, OJA; Sobrier, ML; Dastot-Le Moal, F; Duquesnoy, P; Abitbol, M; Czernichow, P; Amselem, S			Syndromic short stature in patients with a germline mutation in the LIM homeobox LHX4	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PITUITARY-HORMONE DEFICIENCY; GENE-EXPRESSION; HOMEODOMAIN; MOUSE; CELLS; GLAND; PIT-1	Studies of genetically engineered flies and mice have revealed the role that orthologs of the human LIM homeobox LHX4 have in the control of motor-neuron-identity assignment and in pituitary development. Remarkably, these mouse strains, which bear a targeted modification of Lhx4 in the heterozygous state, are asymptomatic, whereas homozygous animals die shortly after birth. Nevertheless, we have isolated the human LHX4 gene, as well as the corresponding cDNA sequence, to test whether it could be involved in developmental defects of the human pituitary region. LHX4, which encodes a protein 99% identical to its murine counterpart, consists of six coding exons and spans >45 kb of the q25 region of chromosome 1. We report a family with an LHX4 germline splice-site mutation that results in a disease phenotype characterized by short stature and by pituitary and hindbrain (i.e., cerebellar) defects in combination with abnormalities of the sella turcica of the central skull base. This intronic mutation, which segregates in a dominant and fully penetrant manner over three generations, abolishes normal LHX4 splicing and activates two exonic cryptic splice sites, thereby predicting two different proteins deleted in their homeodomain sequence. These findings, which elucidate the molecular basis of a complex Mendelian disorder, reveal the fundamental pleiotropic role played by a single factor that tightly coordinates brain development and skull shaping during head morphogenesis.	Hop Henri Mondor, INSERM, U468, F-94010 Creteil, France; Hop Henri Mondor, Serv Biochim, F-94010 Creteil, France; CERTO, Fac Necker, Paris, France; Hop Robert Debre, Serv Endocrinol & Diabetol, F-75019 Paris, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Amselem, S (corresponding author), Hop Henri Mondor, INSERM, U468, 51 Ave Marechal Lattre Tassigny, F-94010 Creteil, France.		Pantel, Jacques/C-6563-2014; Sobrier, Marie-Laure/L-4820-2017	Pantel, Jacques/0000-0002-9015-6281; Sobrier, Marie-Laure/0000-0001-6396-100X				Burset M, 2001, NUCLEIC ACIDS RES, V29, P255, DOI 10.1093/nar/29.1.255; COULY G, 1988, DEVELOPMENT, V103, P101; Dattani MT, 1998, NAT GENET, V19, P125, DOI 10.1038/477; Dubois PM, 1997, MICROSC RES TECHNIQ, V39, P98; EAGLESON GW, 1990, J NEUROBIOL, V21, P427, DOI 10.1002/neu.480210305; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.biochem.63.1.487; IKEDA H, 1988, ANAT EMBRYOL, V178, P327, DOI 10.1007/BF00698663; JAPON MA, 1994, J HISTOCHEM CYTOCHEM, V42, P1117, DOI 10.1177/42.8.8027530; Lamolet B, 2001, CELL, V104, P849, DOI 10.1016/S0092-8674(01)00282-3; LI H, 1994, EMBO J, V13, P2876, DOI 10.1002/j.1460-2075.1994.tb06582.x; Meadows J, 2000, J NEUROSURG, V92, P920, DOI 10.3171/jns.2000.92.6.0920; Netchine I, 2000, NAT GENET, V25, P182, DOI 10.1038/76041; OSUMIYAMASHITA N, 1994, DEV BIOL, V164, P409, DOI 10.1006/dbio.1994.1211; Peltonen L, 2001, SCIENCE, V291, P1224, DOI 10.1126/science.291.5507.1224; PFAFFLE RW, 1992, SCIENCE, V257, P1118, DOI 10.1126/science.257.5073.1118; RADOVICK S, 1992, SCIENCE, V257, P1115, DOI 10.1126/science.257.5073.1115; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Sheng HZ, 1997, SCIENCE, V278, P1809, DOI 10.1126/science.278.5344.1809; TATSUMI K, 1992, NAT GENET, V1, P56, DOI 10.1038/ng0492-56; Watkins-Chow DE, 1998, TRENDS GENET, V14, P284, DOI 10.1016/S0168-9525(98)01476-0; Wu W, 1998, NAT GENET, V18, P147, DOI 10.1038/ng0298-147; Yamashita T, 1997, GENOMICS, V44, P144, DOI 10.1006/geno.1997.4852	23	176	183	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2001	69	5					961	968		10.1086/323764	http://dx.doi.org/10.1086/323764			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	479PU	11567216	Green Published, Bronze			2022-12-18	WOS:000171413400004
J	Xu, JF; Meyers, DA; Ober, C; Blumenthal, MN; Mellen, B; Barnes, KC; King, RA; Lester, LA; Howard, TD; Solway, J; Langefeld, CD; Beaty, TH; Rich, SS; Bleecker, ER; Cox, NJ				Xu, JF; Meyers, DA; Ober, C; Blumenthal, MN; Mellen, B; Barnes, KC; King, RA; Lester, LA; Howard, TD; Solway, J; Langefeld, CD; Beaty, TH; Rich, SS; Bleecker, ER; Cox, NJ		Collab Study on Genetics of Asthma	Genomewide screen and identification of gene-gene interactions for asthma-susceptibility loci in three US populations: Collaborative study on the genetics of asthma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; LINKAGE ANALYSIS; WIDE SEARCH; MARKERS; HYPERRESPONSIVENESS; MODELS; TESTS	The genomewide screen to search for asthma-susceptibility loci, in the Collaborative Study on the Genetics of Asthma (CSGA), has been conducted in two stages and includes 266 families (199 nuclear and 67 extended pedigrees) from three U.S. populations: African American, European American, and Hispanic. Evidence for linkage with the asthma phenotype was observed for multiple chromosomal regions, through use of several analytical approaches that facilitated the identification of multiple disease loci. Ethnicity-specific analyses, which allowed for different frequencies of asthma-susceptibility genes in each ethnic population, provided the strongest evidence for linkage at 6p21 in the European American population, at 11q21 in the African American population, and at 1p32 in the Hispanic population. Both the conditional analysis and the affected-sib-pair two-locus analysis provided further evidence for linkage, at 5q31, 8p23, 12q22, and 15q13. Several of these regions have been observed in other genomewide screens and linkage or association studies, for asthma and related phenotypes. These results were used to develop a conceptual model to delineate asthma-susceptibility loci and their genetic interactions, which provides a promising basis for initiation of fine-mapping studies and, ultimately, for gene identification.	Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC 27157 USA; Univ Chicago, Chicago, IL 60637 USA; Univ Minnesota, Minneapolis, MN USA; Johns Hopkins Univ, Baltimore, MD USA	Wake Forest University; Wake Forest Baptist Medical Center; University of Chicago; University of Minnesota System; University of Minnesota Twin Cities; Johns Hopkins University	Meyers, DA (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	dmeyers@wfubmc.edu	Solway, Julian/B-1116-2008	Solway, Julian/0000-0002-0898-8530	NCRR NIH HHS [M01 RR000055, M01 RR000400, MO1 RR00400, MR1 RR00055] Funding Source: Medline; NHLBI NIH HHS [R01 HL049609, HL49602, U01 HL049609, U01 HL049596, N01HV48141, HL49609, HL49612, HL58977, U01 HL049602] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000400, M01RR000055] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL049602, U01HL049596, U01HL049612, U01HL049609, U01HL058977, R01HL049609] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; Barnes KC, 1996, GENOMICS, V37, P41, DOI 10.1006/geno.1996.0518; Bleecker ER, 1999, AM J RESP CRIT CARE, V159, pA645; CHAI H, 1975, J ALLERGY CLIN IMMUN, V56, P323, DOI 10.1016/0091-6749(75)90107-4; CHATHAM M, 1982, CHEST, V82, P15, DOI 10.1378/chest.82.1.15; Clark AG, 2000, EVOL BIOL, V32, P205; COOKSON WOCM, 1989, LANCET, V1, P1292; CORDELL HJ, 1995, AM J HUM GENET, V57, P920; Cordell HJ, 2000, AM J HUM GENET, V66, P1273, DOI 10.1086/302847; COX DR, 1974, THEORETICAL STATISTI, P279; Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; Daniels SE, 1996, NATURE, V383, P247, DOI 10.1038/383247a0; Doull IJM, 1996, AM J RESP CRIT CARE, V153, P1280, DOI 10.1164/ajrccm.153.4.8616554; FARAWAY JJ, 1993, GENET EPIDEMIOL, V10, P75, DOI 10.1002/gepi.1370100108; Farrall M, 1997, GENET EPIDEMIOL, V14, P103, DOI 10.1002/(SICI)1098-2272(1997)14:2<103::AID-GEPI1>3.0.CO;2-8; Goring HHH, 2000, AM J HUM GENET, V67, P218; KNAPP M, 1994, AM J HUM GENET, V55, P1030; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kuida S, 2000, GENOME RES, V10, P49; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Leiter EH, 1998, DIABETES, V47, P1287, DOI 10.2337/diabetes.47.8.1287; Marsh DG, 1997, NAT GENET, V15, P389; MARSH DG, 1994, SCIENCE, V264, P1152, DOI 10.1126/science.8178175; MEYERS DA, 1994, GENOMICS, V23, P464, DOI 10.1006/geno.1994.1524; Ober C, 1998, HUM MOL GENET, V7, P1393, DOI 10.1093/hmg/7.9.1393; Ober C, 2000, CLIN CHEST MED, V21, P245, DOI 10.1016/S0272-5231(05)70264-1; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; POSTMA DS, 1995, NEW ENGL J MED, V333, P894, DOI 10.1056/NEJM199510053331402; Weeks DE., 1990, AM J HUM GENET, V47, pA203; Wjst M, 1999, GENOMICS, V58, P1, DOI 10.1006/geno.1999.5806	32	176	194	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2001	68	6					1437	1446		10.1086/320589	http://dx.doi.org/10.1086/320589			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	439DB	11349227	Bronze, Green Published			2022-12-18	WOS:000169094600014
J	Varley, JM; McGown, G; Thorncroft, M; James, LA; Margison, GP; Forster, G; Evans, DGR; Harris, M; Kelsey, AM; Birch, JM				Varley, JM; McGown, G; Thorncroft, M; James, LA; Margison, GP; Forster, G; Evans, DGR; Harris, M; Kelsey, AM; Birch, JM			Are there low-penetrance TP53 alleles? Evidence from childhood adrenocortical tumors	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LI-FRAUMENI-SYNDROME; GERMLINE P53 MUTATION; SPLICING MUTATION; GENE-MUTATIONS; MILD EXPRESSION; FAMILIES; CANCER; RETINOBLASTOMA; CARCINOMA; DELETION	We have analyzed a panel of 14 cases of childhood adrenocortical tumors unselected for family history and have identified germline TP53 mutations in >80%, making this the highest known incidence of a germline mutation in a tumor-suppressor gene in any cancer. The spectrum of germline TP53 mutations detected is remarkably limited. Analysis of tumor tissue for loss of constitutional heterozygosity, with respect to the germline mutant allele and the occurrence of other somatic TP53 mutations, indicates complex sequences of genetic events in a number of tumors. None of the families had cancer histories that conformed to the criteria for Li-Fraumeni syndrome, but, in some families, we were able to demonstrate thar; the mutation had been inherited. In these families there were gene carriers unaffected in their 40s and 50s, and there were others with relatively late-onset cancers. These data provide evidence that certain TP53 alleles confer relatively low penetrance for predisposition to the development of cancer, and they imply that deleterious TP53 mutations may be more frequent in the population than has been estimated previously Our findings have considerable implications for the clinical management of children with andrenocortical tumors and their parents, in terms of both genetic testing and the early detection and treatment of tumors.	Paterson Inst Canc Res, Mol Genet Sect, CRC, Manchester M20 9BX, Lancs, England; Paterson Inst Canc Res, Sect Genome Damage & Repair, CRC, Manchester M20 9BX, Lancs, England; Royal Manchester Childrens Hosp, Paediat & Familial Canc Res Grp, Pendlebury, England; Royal Manchester Childrens Hosp, Dept Histopathol, Pendlebury, England; St Marys Hosp, Dept Med Genet, Manchester, Lancs, England; Christie Hosp, Dept Histopathol, Manchester, Lancs, England	Paterson Institute for Cancer Research; Paterson Institute for Cancer Research; Royal Manchester Children's Hospital; Royal Manchester Children's Hospital; University of Manchester; Christie NHS Foundation Trust; Christie Hospital	Varley, JM (corresponding author), Paterson Inst Canc Res, Mol Genet Sect, CRC, Wilmslow Rd, Manchester M20 9BX, Lancs, England.		Evans, D Gareth/AAB-4308-2022; Margison, Geoff/E-4146-2019	Evans, D Gareth/0000-0002-8482-5784; 				BARDEESY N, 1994, NAT GENET, V7, P91, DOI 10.1038/ng0594-91; BARTEK J, 1991, ONCOGENE, V6, P1699; Beroud C, 1998, NUCLEIC ACIDS RES, V26, P200, DOI 10.1093/nar/26.1.200; Birch JM, 1998, ONCOGENE, V17, P1061, DOI 10.1038/sj.onc.1202033; BIRCH JM, 1994, BRIT J CANCER, V70, P1176, DOI 10.1038/bjc.1994.468; BIRCH JM, 1994, CANCER RES, V54, P1298; Boyle JM, 1999, BRIT J CANCER, V79, P1657, DOI 10.1038/sj.bjc.6690265; Bremner R, 1997, AM J HUM GENET, V61, P556, DOI 10.1086/515499; CAMPBELL C, 1993, J INVEST DERMATOL, V100, P746, DOI 10.1111/1523-1747.ep12475717; Cowell JK, 1998, ONCOGENE, V16, P3211, DOI 10.1038/sj.onc.1201833; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; DRYJA TP, 1993, AM J HUM GENET, V52, P1122; Felix CA, 1996, BLOOD, V87, P4376, DOI 10.1182/blood.V87.10.4376.bloodjournal87104376; FELIX CA, 1993, ONCOGENE, V8, P1203; Felix CA, 1998, BLOOD, V91, P4451; FREBOURG T, 1995, AM J HUM GENET, V56, P608; Giunta C, 1996, DIAGN MOL PATHOL, V5, P265, DOI 10.1097/00019606-199612000-00007; GRAYSON GH, 1994, AM J PEDIAT HEMATOL, V16, P341; GUTIERREZ MI, 1994, HUM MOL GENET, V3, P2247, DOI 10.1093/hmg/3.12.2247; HAMELIN R, 1994, HUM GENET, V94, P88, DOI 10.1007/BF02272849; Harbour JW, 1998, OPHTHALMOLOGY, V105, P1442, DOI 10.1016/S0161-6420(98)98025-3; Hisada M, 1998, JNCI-J NATL CANCER I, V90, P606, DOI 10.1093/jnci/90.8.606; HORIO Y, 1994, ONCOGENE, V9, P1231; JAMES LA, IN PRESS BR J CANC; LEBIHAN C, 1995, GENET EPIDEMIOL, V12, P13, DOI 10.1002/gepi.1370120103; LI FP, 1988, CANCER RES, V48, P5358; LOHMANN DR, 1994, HUM GENET, V94, P349; LUBBE J, 1995, BRAIN PATHOL, V5, P15, DOI 10.1111/j.1750-3639.1995.tb00572.x; Malkhosyan S, 1996, NATURE, V382, P499, DOI 10.1038/382499a0; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MIDGLEY CA, 1992, J CELL SCI, V101, P183; Moutou C, 1996, CANCER, V78, P1483, DOI 10.1002/(SICI)1097-0142(19961001)78:7<1483::AID-CNCR16>3.0.CO;2-W; Munn KE, 1996, BRIT J CANCER, V74, P1578, DOI 10.1038/bjc.1996.592; ONADIM Z, 1992, P NATL ACAD SCI USA, V89, P6177, DOI 10.1073/pnas.89.13.6177; PARSONS R, 1995, CANCER RES, V55, P5548; Pivnick EK, 1998, J MED GENET, V35, P328, DOI 10.1136/jmg.35.4.328; PONDER B, 1988, NATURE, V335, P400, DOI 10.1038/335400a0; SAMESHIMA Y, 1992, J NATL CANCER I, V84, P703, DOI 10.1093/jnci/84.9.703; Schubert EL, 1997, HUM GENET, V100, P557, DOI 10.1007/s004390050551; Sedlacek Z, 1998, BRIT J CANCER, V77, P1034, DOI 10.1038/bjc.1998.172; SOUSSI T, 1990, ONCOGENE, V5, P945; STOLZENBERG MC, 1994, ONCOGENE, V9, P2799; STRAUSS EA, 1995, CANCER RES, V55, P3237; Varley JM, 1998, ONCOGENE, V16, P3291, DOI 10.1038/sj.onc.1201878; Varley JM, 1997, ONCOGENE, V14, P865, DOI 10.1038/sj.onc.1201041; Varley JM, 1997, CANCER RES, V57, P3245; Varley JM, 1996, CANCER GENET CYTOGEN, V90, P14, DOI 10.1016/0165-4608(96)00059-3; VARLEY JM, 1995, J MED GENET, V32, P946; Vital A, 1998, J NEUROPATH EXP NEUR, V57, P1061, DOI 10.1097/00005072-199811000-00009; WAGNER J, 1994, JNCI-J NATL CANCER I, V86, P1707, DOI 10.1093/jnci/86.22.1707; WARNEFORD SG, 1992, CELL GROWTH DIFFER, V3, P839; WIEDEMANN HR, 1983, EUR J PEDIATR, V141, P129, DOI 10.1007/BF00496807	53	176	177	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1999	65	4					995	1006		10.1086/302575	http://dx.doi.org/10.1086/302575			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	241XW	10486318	Green Published, Bronze			2022-12-18	WOS:000082910000008
J	Dailey, T; Dale, B; Cohen, J; Munne, S				Dailey, T; Dale, B; Cohen, J; Munne, S			Association between nondisjunction and maternal age in meiosis-II human oocytes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMOSOME-ABNORMALITIES; PARENTAL ORIGIN; INVITRO FERTILIZATION; CYTOGENETIC ANALYSIS; TRISOMY FORMATION; EXTRA CHROMOSOME; EMBRYOS; RATES; RECOMBINATION; ANEUPLOIDY	The relationship between advanced maternal age and increased risk of trisomic offspring is well known clinically but not clearly understood at the level of the oocyte. A total of 383 oocytes that failed fertilization from 107 patients undergoing in vitro fertilization were analyzed by FISH using X-, 18-, and 13/21-chromosome probes simultaneously. The corresponding polar bodies were also analyzed in 188 of these oocytes. The chromosomes in the oocyte and first polar body complement each other and provide an internal control to differentiate between aneuploidy and technical errors. Two mechanisms of nondisjunction were determined. First, nondisjunction of bivalent chromosomes resulting in two univalents going to the same pole and, second, nondisjunction by premature chromatid separation (predivision) of univalent chromosomes producing either a balanced (2 + 2) or unbalanced (3 + 1) distribution of chromatids into the first polar body and M-II oocytes. Balanced predivision of chromatids, previously proposed as a major mechanism of aneuploidy, was found to increase significantly with time in culture (P < .005), which suggests that this phenomenon should be interpreted carefully. Unbalanced predivision and classical nondisjunction were unaffected by oocyte aging. In comparing oocytes from women <35 years of age with oocytes from women greater than or equal to 40 years of age, a significant increase (P < .001) in nondisjunction of full dyads was found in the oocytes with analyzable polar bodies and no FISH errors. Premature predivision of chromatids was also found to cause nondisjunction, but it did not increase with maternal age.	ST BARNABAS HOSP, INST REPROD MED & SCI, LIVINGSTON, NJ 10021 USA; CORNELL UNIV, MED CTR, NEW YORK HOSP, NEW YORK, NY USA; STAZ ZOOL ANTON DOHRN, NAPLES, ITALY	Cornell University; NewYork-Presbyterian Hospital; Stazione Zoologica Anton Dohrn di Napoli				Munne, Santiago/0000-0002-1088-5565				ALMEIDA PA, 1993, HUM REPROD, V8, P229, DOI 10.1093/oxfordjournals.humrep.a138028; ANGELL RR, 1991, HUM GENET, V86, P383; ANGELL RR, 1994, CYTOGENET CELL GENET, V65, P194, DOI 10.1159/000133631; ANGELL RR, 1993, HUM REPROD, V8, P1047, DOI 10.1093/oxfordjournals.humrep.a138190; ANTONARAKIS SE, 1993, NAT GENET, V3, P146, DOI 10.1038/ng0293-146; ANTONARAKIS SE, 1991, NEW ENGL J MED, V324, P872, DOI 10.1056/NEJM199103283241302; DELHANTY JDA, 1990, HUM REPROD, V5, P699, DOI 10.1093/oxfordjournals.humrep.a137171; DESUTTER P, 1991, HUM REPROD, V6, P550, DOI 10.1093/oxfordjournals.humrep.a137378; EDIRISINGHE WR, 1992, HUM REPROD, V7, P230, DOI 10.1093/oxfordjournals.humrep.a137623; EICHENLAUBRITTER U, 1988, HUM GENET, V80, P259, DOI 10.1007/BF01790094; FISHER JM, 1995, AM J HUM GENET, V56, P669; GRAS L, 1992, HUM REPROD, V7, P1396, DOI 10.1093/oxfordjournals.humrep.a137581; GUERNERI S, 1987, HUM REPROD, V2, P735, DOI 10.1093/oxfordjournals.humrep.a136623; HASSOLD T, 1988, AM J HUM GENET, V42, P534; HASSOLD T, 1995, AM J HUM GENET, V57, P867; HASSOLD T, 1985, HUM GENET, V70, P11, DOI 10.1007/BF00389450; HASSOLD T, 1987, J MED GENET, V24, P725, DOI 10.1136/jmg.24.12.725; KAMIGUCHI Y, 1993, HUM GENET, V90, P533; MACAS E, 1990, HUM REPROD, V5, P703, DOI 10.1093/oxfordjournals.humrep.a137172; MAY KM, 1990, AM J HUM GENET, V46, P754; MCDONALD M, 1994, HUM MOL GENET, V3, P1365; MORTON NE, 1988, ANN HUM GENET, V52, P227, DOI 10.1111/j.1469-1809.1988.tb01100.x; MUNNE S, 1993, HUM REPROD, V8, P2185, DOI 10.1093/oxfordjournals.humrep.a138001; MUNNE S, 1995, FERTIL STERIL, V64, P382, DOI 10.1016/S0015-0282(16)57739-5; Munne S, 1995, HUM REPROD, V10, P1015; NOTHEN MM, 1993, HUM GENET, V92, P347, DOI 10.1007/BF01247332; PELLESTOR F, 1991, HUM REPROD, V6, P1252, DOI 10.1093/oxfordjournals.humrep.a137522; Plachot M, 1992, Ann Acad Med Singap, V21, P538; PLACHOT M, 1988, HUM REPROD, V3, P125, DOI 10.1093/oxfordjournals.humrep.a136644; RISCH N, 1986, AM J HUM GENET, V39, P68; RODMAN TC, 1971, NATURE, V233, P191, DOI 10.1038/233191a0; SELVA J, 1991, HUM REPROD, V6, P709, DOI 10.1093/oxfordjournals.humrep.a137413; SIMPSON JL, 1987, JAMA-J AM MED ASSOC, V258, P2555, DOI 10.1001/jama.258.18.2555; SIMPSON JL, 1986, CHORIONIC VILLUS SAM, P227; SNIJDERS RJM, 1994, PRENATAL DIAG, V14, P543, DOI 10.1002/pd.1970140706; SZOLLOSI D, 1983, AGING GAMETES THEIR, P93; TARIN JJ, 1991, FERTIL STERIL, V55, P964; TARKOWSKI AK, 1966, CYTOGENETICS, V5, P394, DOI 10.1159/000129914; VANBLERKOM J, 1990, ELEMENTS MAMMALIAN F, P81; Verlinsky Y, 1996, J ASSIST REPROD GEN, V13, P157, DOI 10.1007/BF02072538; Warburton D, 1986, PERINATAL GENETICS D, P133; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401; ZARAGOZA RV, 1994, HUM GENET, V94, P411; 1995, FERTIL STERIL, V64, P13	44	176	180	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1996	59	1					176	184						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL455	8659524				2022-12-18	WOS:A1996VL45500025
J	TSUCHIYA, K; REIJO, R; PAGE, DC; DISTECHE, CM				TSUCHIYA, K; REIJO, R; PAGE, DC; DISTECHE, CM			GONADOBLASTOMA - MOLECULAR DEFINITION OF THE SUSCEPTIBILITY REGION ON THE Y-CHROMOSOME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							46,XY FEMALES; SHORT ARM; DNA; GENE; HYBRIDIZATION; LOCALIZATION; DELETIONS; PROBE; TSPY; MAP	Using sequence-tagged sites we have performed deletion mapping of the Y chromosome in sex-reversed female patients with a Y chromosome and gonadoblastoma. The GBY gene (gonadoblastoma locus on the Y chromosome) was sublocalized to a small region near the centromere of the Y chromosome. We estimate the size of the GBY critical region to be similar to 1-2 Mb. Our analysis also indicates that copies of two dispersed Y-linked gene families, TSPY (testis-specific protein, Y-encoded) and YRRM (Y-chromosome RNA recognition motif) are present in all patients and that copies of TSPY but not YRRM fall within the GBY critical region as formally defined by deletion mapping. Two tumor samples showed expression of both genes and in one patient this expression was limited to a unilateral gonadoblastoma but absent in the contralateral streak gonad. Although our results do not directly implicate TSPY or YRRM in the etiology of the tumor, they raise the issue of whether there is one GBY gene in the critical region or possibly multiple GBY loci dispersed on the Y chromosome.	UNIV WASHINGTON, DEPT PATHOL, SEATTLE, WA 98195 USA; WHITEHEAD INST, HOWARD HUGHES MED INST, CAMBRIDGE, MA 02142 USA; MIT, DEPT BIOL, CAMBRIDGE, MA USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)				Reijo Pera, Renee/0000-0002-6487-1329	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000257] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00257] Funding Source: Medline; NIA NIH HHS [AG00057] Funding Source: Medline; NIGMS NIH HHS [GM46883] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADLER DA, 1991, P NATL ACAD SCI USA, V88, P4592, DOI 10.1073/pnas.88.11.4592; ARNEMANN J, 1987, NUCLEIC ACIDS RES, V15, P8713, DOI 10.1093/nar/15.21.8713; ARNEMANN J, 1991, GENOMICS, V11, P108, DOI 10.1016/0888-7543(91)90107-P; CANTRELL MA, 1989, HUM GENET, V83, P88, DOI 10.1007/BF00274156; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DISTECHE CM, 1986, AM J HUM GENET, V38, P751; DISTECHE CM, 1986, P NATL ACAD SCI USA, V83, P7841, DOI 10.1073/pnas.83.20.7841; FOOTE S, 1992, SCIENCE, V258, P60, DOI 10.1126/science.1359640; HAWKINS JR, 1992, AM J HUM GENET, V51, P979; KAWASAKI ES, 1988, P NATL ACAD SCI USA, V85, P5698, DOI 10.1073/pnas.85.15.5698; MA K, 1993, CELL, V75, P1287, DOI 10.1016/0092-8674(93)90616-X; MAGENIS RE, 1984, J PEDIATR-US, V105, P916, DOI 10.1016/S0022-3476(84)80077-3; MAGENIS RE, 1987, HUM GENET, V75, P228, DOI 10.1007/BF00281064; MANZ E, 1993, GENOMICS, V17, P726, DOI 10.1006/geno.1993.1393; PAGE DC, 1987, DEVELOPMENT, V101, P151; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PETROVIC V, 1992, J MED GENET, V29, P542, DOI 10.1136/jmg.29.8.542; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Sambrook J., 1989, MOL CLONING LAB MANU; SCULLY RE, 1970, CANCER, V25, P1340, DOI 10.1002/1097-0142(197006)25:6<1340::AID-CNCR2820250612>3.0.CO;2-N; TYLERSMITH C, 1993, NAT GENET, V5, P368, DOI 10.1038/ng1293-368; VERGNAUD G, 1986, AM J HUM GENET, V38, P109; VERP MS, 1987, CANCER GENET CYTOGEN, V25, P191, DOI 10.1016/0165-4608(87)90180-4; VOLLRATH D, 1992, SCIENCE, V258, P52, DOI 10.1126/science.1439769; VONLINDERN M, 1992, MOL CELL BIOL, V12, P3346, DOI 10.1128/MCB.12.8.3346; Zhang Julie S., 1992, Human Molecular Genetics, V1, P717, DOI 10.1093/hmg/1.9.717; 1994, WISCONSIN PACKAGE PR	27	176	186	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1995	57	6					1400	1407						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TE655	8533770				2022-12-18	WOS:A1995TE65500018
J	WONG, LJC; ASHIZAWA, T; MONCKTON, DG; CASKEY, CT; RICHARDS, CS				WONG, LJC; ASHIZAWA, T; MONCKTON, DG; CASKEY, CT; RICHARDS, CS			SOMATIC HETEROGENEITY OF THE CTG REPEAT IN MYOTONIC-DYSTROPHY IS AGE AND SIZE-DEPENDENT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRAGILE-X MUTATIONS; UNSTABLE DNA; MONOZYGOTIC TWINS; EXPANSION; GENE; ANTICIPATION; METHYLATION; SEQUENCE; REGION	The most common form of adult muscular dystrophy, myotonic dystrophy (DM), is caused by the abnormal expansion of the CTG repeat, located in the 3' UTR of the DM gene. The expanded-CTG allele often presents as a diffused band on Southern blot analysis, suggesting somatic mosaicism. In order to study the somatic instability of the CTG repeat, we have investigated the dynamics of the size heterogeneity of the CTG expansion. Size heterogeneity is shown as a smear on Southern blot and is measured by the midpeak-width ratio of the expanded allele to the normal sized allele. The ratio is also corrected for compression in the higher-molecular-weight region. It is found that the size heterogeneity of the expanded-CTG repeats, of 173 DM patients, correlates well with the age of the patient (r = .81, P much less than .001). The older patients show larger size variation. This correlation is independent of the sex of either the patient or the transmitting parent. The size heterogeneity of the expansion, based on age groups, is also dependent on the size of the expanded trinucleotide repeat. However, obvious size heterogeneity is not observed in congenital cases, regardless of the size of expansion. Comparison of individual patient samples collected at two different times has confirmed that the degree of size heterogeneity increases with age and has revealed a subtle but definite upward shift in the size of the expanded-CTG allele. The progression of the CTG repeat toward larger expansion with age is further confirmed by small-pool PCR assay that resolved the heterogeneous fragments into discrete bands. This report, for the first time, documents the quantitative measurement of size heterogeneity of CTG-repeat expansion and shows the increasing size and size heterogeneity with age.	BAYLOR COLL MED,DEPT MOLEC & HUMAN GENET,HOUSTON,TX 77030; BAYLOR COLL MED,KLEBERG DNA DIAGNOST LAB,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT NEUROL,HOUSTON,TX 77030; BAYLOR COLL MED,HOWARD HUGHES MED INST,HOUSTON,TX 77030; BAYLOR COLL MED,CTR HUMAN GENOME,HOUSTON,TX 77030	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine			Monckton, Darren/B-4943-2013	Monckton, Darren/0000-0002-8298-8264				ABELIOVICH D, 1993, AM J HUM GENET, V52, P1175; ANVRET M, 1993, HUM MOL GENET, V2, P1397, DOI 10.1093/hmg/2.9.1397; ASHIASLANIDIS C, 1992, NATURE, V355, P548; ASHIZAWA T, 1993, NEUROLOGY, V43, P2674, DOI 10.1212/WNL.43.12.2674; ASHIZAWA T, 1992, NEUROLOGY, V42, P1871; ASHIZAWA T, 1994, AM J HUM GENET, V54, P414; ASHIZAWA T, 1994, NEUROLOGY, V44, P120, DOI 10.1212/WNL.44.1.120; ASHIZAWA T, 1992, NEUROLOGY, V42, P1877; Ashizawa T., 1994, American Journal of Human Genetics, V55, pA210; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BRUNNER HG, 1993, NEW ENGL J MED, V328, P476, DOI 10.1056/NEJM199302183280705; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; DEMUNAIN AL, 1994, ANN NEUROL, V35, P374, DOI 10.1002/ana.410350323; DEVYS D, 1992, AM J MED GENET, V43, P208, DOI 10.1002/ajmg.1320430134; DUBEL JR, 1992, NEUROLOGY, V42, P1815, DOI 10.1212/WNL.42.9.1815; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; HARLEY HG, 1992, LANCET, V339, P1125, DOI 10.1016/0140-6736(92)90729-M; Harper P.S., 1989, MYOTONIC DYSTROPHY; HARPER PS, 1992, AM J HUM GENET, V51, P10; JANSEN G, 1994, AM J HUM GENET, V54, P575; JEFFREYS AJ, 1994, NAT GENET, V6, P136, DOI 10.1038/ng0294-136; KRUYER H, 1994, AM J HUM GENET, V54, P437; LAVEDAN C, 1993, AM J HUM GENET, V52, P875; LAVEDAN C, 1993, LANCET, V341, P236; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MALMGREN H, 1992, AM J MED GENET, V43, P268, DOI 10.1002/ajmg.1320430142; MONCKTON DG, IN PRESS HUM MOL GEN; MULLEY JC, 1993, LANCET, V341, P236, DOI 10.1016/0140-6736(93)90096-Y; REYNIERS E, 1993, NAT GENET, V4, P143, DOI 10.1038/ng0693-143; RICHARDS RI, 1994, NAT GENET, V6, P114, DOI 10.1038/ng0294-114; RICHARDS RI, 1992, CELL, V70, P709, DOI 10.1016/0092-8674(92)90302-S; SHELBOURNE P, 1992, HUM MOL GENET, V1, P467, DOI 10.1093/hmg/1.7.467; TAYLOR HP, 1993, NEUROLOGY, V43, pA280; THORNTON CA, 1994, ANN NEUROL, V35, P104, DOI 10.1002/ana.410350116; WIERINGA B, 1994, HUM MOL GENET, V3, P1, DOI 10.1093/hmg/3.1.1-a; WOHRLE D, 1993, NAT GENET, V4, P140, DOI 10.1038/ng0693-140	37	176	183	0	10	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1995	56	1					114	122						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QC101	7825566				2022-12-18	WOS:A1995QC10100015
J	BAIRD, PA; MACDONALD, EC				BAIRD, PA; MACDONALD, EC			AN EPIDEMIOLOGIC-STUDY OF CONGENITAL-MALFORMATIONS OF THE ANTERIOR ABDOMINAL-WALL IN MORE THAN HALF A MILLION CONSECUTIVE LIVE BIRTHS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MINIS HLTH,BRITISH COLUMBIA HLTH SURVEILLANCE REGISTRY,DIV VITAL STAT,VANCOUVER,BC,CANADA		BAIRD, PA (corresponding author), UNIV BRITISH COLUMBIA,DEPT MED GENET,VANCOUVER V6T 1W5,BC,CANADA.							BALFOUR RP, 1980, LANCET, V1, P317; BROCK DJH, 1976, LANCET, V2, P345; COLLINS DL, 1970, P PAED SURG C MELB, P21; CZEIZEL A, 1979, LANCET, V2, P470; GOODMAN LA, 1971, TECHNOMETRICS, V13, P33, DOI 10.2307/1267074; HUTCHIN P, 1965, SURGERY, V57, P297; IVES E J, 1974, Birth Defects Original Article Series, V10, P127; LOWRY RB, 1975, CAN J PUBLIC HEALTH, V66, P322; MCKEOWN T, 1953, AM J HUM GENET, V5, P168; MOORE TC, 1977, SURGERY, V82, P561; MOORE TC, 1953, SURGERY, V33, P112; NELSON WE, 1979, PEDIATRICS TXB, P1569; NIELSON HB, 1963, DAN MED B, V10, P75; OLEARY CM, 1941, AM J SURG, V52, P38; PAUCOT H, 1936, B SOC OBSTET GYNECOL, V25, P296; RICKETT LK, 1979, BIRTH DEFECTS COMPEN; RICKHAM PP, 1978, NEONATAL SURGERY, P313; RICKHAM PP, 1978, NEONATAL SURGERY; SCHUSTER SR, 1967, SURG GYNECOL OBSTETR, V125, P837; SELLER MJ, 1978, LANCET, V1, P660; VINSON PC, 1977, NEW ENGL J MED, V297, P1351	21	176	179	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1981	33	3					470	478						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LT725	6454342				2022-12-18	WOS:A1981LT72500015
J	Park, JH; Hogrebe, M; Gruneberg, M; DuChesne, I; von der Heiden, AL; Reunert, J; Schlingmann, KP; Boycott, KM; Beaulieu, CL; Mhanni, AA; Innes, AM; Hurtnagel, K; Biskup, S; Gleixner, EM; Kurlemann, G; Fiedler, B; Omran, H; Rutsch, F; Wada, Y; Tsiakas, K; Santer, R; Nebert, DW; Rust, S; Marquardt, T				Park, Julien H.; Hogrebe, Max; Grueneberg, Marianne; DuChesne, Ingrid; von der Heiden, Ava L.; Reunert, Janine; Schlingmann, Karl P.; Boycott, Kym M.; Beaulieu, Chandree L.; Mhanni, Aziz A.; Innes, A. Micheil; Hoertnagel, Konstanze; Biskup, Saskia; Gleixner, Eva M.; Kurlemann, Gerhard; Fiedler, Barbara; Omran, Heymut; Rutsch, Frank; Wada, Yoshinao; Tsiakas, Konstantinos; Santer, Rene; Nebert, Daniel W.; Rust, Stephan; Marquardt, Thorsten			SLC39A8 Deficiency: A Disorder of Manganese Transport and Glycosylation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL DISORDERS; UDP-GALACTOSE; TRANSFERRIN; ZIP8; GALACTOSYLTRANSFERASE; ZINC; ION; BETA-1,4-GALACTOSYLTRANSFERASE-I; HYPERMANGANESEMIA; POLYCYTHEMIA	SLC39A8 is a membrane transporter responsible for manganese uptake into the cell. Via whole-exome sequencing, we studied a child that presented with cranial asymmetry, severe infantile spasms with hypsarrhythmia, and dysproportionate dwarfism. Analysis of transferrin glycosylation revealed severe dysglycosylation corresponding to a type II congenital disorder of glycosylation (CDG) and the blood manganese levels were below the detection limit. The variants c.112G>C (p.Gly38Arg) and c.1019T>A (p.Ile340Asn) were identified in SLC39A8. A second individual with the variants c.97G>A (p.Val33Met) and c.1004G>C (p.Ser335Thr) on the paternal allele and c.610G>T (p.Gly204Cys) on the maternal allele was identified among a group of unresolved case subjects with CDG. These data demonstrate that variants in SLC39A8 impair the function of manganese-dependent enzymes, most notably beta-1,4-galactosyltransferase, a Golgi enzyme essential for biosynthesis of the carbohydrate part of glycoproteins. Impaired galactosylation leads to a severe disorder with deformed skull, severe seizures, short limbs, profound psychomotor retardation, and hearing loss. Oral galactose supplementation is a treatment option and results in complete normalization of glycosylation. SLC39A8 deficiency links a trace element deficiency with inherited glycosylation disorders.	[Park, Julien H.; Hogrebe, Max; Grueneberg, Marianne; DuChesne, Ingrid; von der Heiden, Ava L.; Reunert, Janine; Schlingmann, Karl P.; Kurlemann, Gerhard; Fiedler, Barbara; Omran, Heymut; Rutsch, Frank; Rust, Stephan; Marquardt, Thorsten] Univ Klinikum Munster, Klin & Poliklin Kinder & Jugendmed, Albert Schweitzer Campus 1,Gebaude A 1, D-48149 Munster, Germany; [Boycott, Kym M.; Beaulieu, Chandree L.] Univ Ottawa, Childrens Hosp, Eastern Ontario Res Inst, Ottawa, ON K1H 8L1, Canada; [Mhanni, Aziz A.] Univ Manitoba, Childrens Hosp, Genet & Metab Program, Winnipeg, MB R3A 1S1, Canada; [Mhanni, Aziz A.] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3A 1S1, Canada; [Innes, A. Micheil] Univ Calgary, Dept Med Genet, Calgary, AB T2N 4N1, Canada; [Innes, A. Micheil] Univ Calgary, Alberta Childrens Hosp, Res Inst, Cumming Sch Med, Calgary, AB T2N 4N1, Canada; [Hoertnagel, Konstanze; Biskup, Saskia; Gleixner, Eva M.] CeGaT GmbH, Paul Ehrlich Str 23, D-72076 Tubingen, Germany; [Wada, Yoshinao] Osaka Med Ctr, 840 Murodo Cho, Izumi, Osaka 5941101, Japan; [Wada, Yoshinao] Res Inst Maternal & Child Hlth, 840 Murodo Cho, Izumi, Osaka 5941101, Japan; [Tsiakas, Konstantinos; Santer, Rene] Univ Kinder Klin, UKE, Martinistr 52, D-20246 Hamburg, Germany; [Nebert, Daniel W.] Cincinnati Childrens Hosp, Div Human Genet, Dept Pediat & Mol Dev Biol, Cincinnati, OH 45229 USA; [Nebert, Daniel W.] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA	University of Ottawa; Children's Hospital of Eastern Ontario; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; University of Calgary; Alberta Childrens Hospital; University of Calgary; CeGaT; Osaka Medical Center for Cancer & Cardiovascular Diseases; University of Hamburg; University Medical Center Hamburg-Eppendorf; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Marquardt, T (corresponding author), Univ Klinikum Munster, Klin & Poliklin Kinder & Jugendmed, Albert Schweitzer Campus 1,Gebaude A 1, D-48149 Munster, Germany.	thorsten.marquardt@ukmuenster.de	innes, allan micheil/A-9955-2017	Innes, Micheil/0000-0001-9881-5467; Park, Julien H./0000-0003-2305-9948; Omran, Heymut/0000-0003-0282-6765	NIH [R01 ES010416, P30 ES06096]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010416, P30ES006096] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We are grateful to the families for their support during the conception of this study. This work was supported, in part, by NIH grants R01 ES010416 and P30 ES06096 (to D.W.N.).	[Anonymous], 1988, NUTR REV, V46, P348; Avila Daiana Silva, 2013, Met Ions Life Sci, V13, P199, DOI 10.1007/978-94-007-7500-8_7; BISKUP S, 2010, J LAB MED, V34, P305, DOI DOI 10.1515/JLM.2010.056; Boycott KM, 2015, AM J HUM GENET, V97, P886, DOI 10.1016/j.ajhg.2015.11.002; Dorre K, 2015, J INHERIT METAB DIS, V38, P931, DOI 10.1007/s10545-015-9828-6; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Freeze HH, 2013, J BIOL CHEM, V288, P6936, DOI 10.1074/jbc.R112.429274; Galvez-Peralta M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036055; Guillard M, 2011, CLIN CHEM, V57, P593, DOI 10.1373/clinchem.2010.153635; Guo S, 2001, GLYCOBIOLOGY, V11, P813, DOI 10.1093/glycob/11.10.813; Hansske B, 2002, J CLIN INVEST, V109, P725, DOI 10.1172/JCI200214010; HARRISON SM, 1995, DEVELOPMENT, V121, P2479; He L, 2006, MOL PHARMACOL, V70, P171, DOI 10.1124/mol.106.021521; He Lei, 2009, Human Genomics, V3, P195; Hennet T, 2002, CELL MOL LIFE SCI, V59, P1081, DOI 10.1007/s00018-002-8489-4; Herrera C, 2014, J BIOL INORG CHEM, V19, P869, DOI 10.1007/s00775-014-1118-5; HIDIROGLOU M, 1990, ANN RECH VET, V21, P281; Jaeken J, 2011, J INHERIT METAB DIS, V34, P853, DOI 10.1007/s10545-011-9299-3; Jenkitkasemwong S, 2012, BIOMETALS, V25, P643, DOI 10.1007/s10534-012-9526-x; Keen CL, 1999, NEUROTOXICOLOGY, V20, P213; Kim BJ, 2010, J PHARMACOL EXP THER, V334, P682, DOI 10.1124/jpet.110.166470; Krajewski WW, 2008, J MOL BIOL, V375, P217, DOI 10.1016/j.jmb.2007.10.029; KUHN NJ, 1995, ARCH BIOCHEM BIOPHYS, V320, P24, DOI 10.1006/abbi.1995.1338; KUHN NJ, 1991, EUR J BIOCHEM, V195, P243, DOI 10.1111/j.1432-1033.1991.tb15700.x; Leach R M, 1978, World Rev Nutr Diet, V32, P123; LEACH RM, 1971, FED PROC, V30, P991; Lux AL, 2004, LANCET, V364, P1773, DOI 10.1016/S0140-6736(04)17400-X; Manis FR, 1997, J INHERIT METAB DIS, V20, P549, DOI 10.1023/A:1005357622551; Marquardt T, 2003, EUR J PEDIATR, V162, P359, DOI 10.1007/s00431-002-1136-0; MAURIZI MR, 1987, BIOCHEMISTRY-US, V26, P5023, DOI 10.1021/bi00390a021; Moore-Scott BA, 2007, DEV DYNAM, V236, P1997, DOI 10.1002/dvdy.21204; Ng BG, 2013, AM J HUM GENET, V92, P632, DOI 10.1016/j.ajhg.2013.03.012; Park JH, 2014, CLIN CHIM ACTA, V436, P135, DOI 10.1016/j.cca.2014.05.011; POWELL JT, 1976, J BIOL CHEM, V251, P3645; Quadri M, 2012, AM J HUM GENET, V90, P467, DOI 10.1016/j.ajhg.2012.01.017; Ramakrishnan B, 2006, J MOL BIOL, V357, P1619, DOI 10.1016/j.jmb.2006.01.088; Rivera-Mancia S, 2011, BIOMETALS, V24, P811, DOI 10.1007/s10534-011-9454-1; SCHROEDER HA, 1966, J CHRON DIS, V19, P545, DOI 10.1016/0021-9681(66)90094-4; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Tegtmeyer LC, 2014, NEW ENGL J MED, V370, P533, DOI 10.1056/NEJMoa1206605; Tuschl K, 2013, INT REV NEUROBIOL, V110, P277, DOI 10.1016/B978-0-12-410502-7.00013-2; Tuschl K, 2012, AM J HUM GENET, V90, P457, DOI 10.1016/j.ajhg.2012.01.018; Wang B, 2011, BIOCHEM BIOPH RES CO, V410, P289, DOI 10.1016/j.bbrc.2011.05.134; Wang CY, 2012, J BIOL CHEM, V287, P34032, DOI 10.1074/jbc.M112.367284; WONGVALLE J, 1989, J ANIM SCI, V67, P2409, DOI 10.2527/jas1989.6792409x; Zhu Hao, 2007, Syst Synth Biol, V1, P171, DOI 10.1007/s11693-008-9015-2; Zuhlsdorf A, 2015, CLIN BIOCHEM, V48, P11, DOI 10.1016/j.clinbiochem.2014.09.022	47	175	179	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2015	97	6					894	903		10.1016/j.ajhg.2015.11.003	http://dx.doi.org/10.1016/j.ajhg.2015.11.003			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DB3UM	26637979	Bronze, Green Published			2022-12-18	WOS:000368437900012
J	Gibson, WT; Hood, RL; Zhan, SH; Bulman, DE; Fejes, AP; Moore, R; Mungall, AJ; Eydoux, P; Babul-Hirji, R; An, JH; Marra, MA; Chitayat, D; Boycott, KM; Weaver, DD; Jones, SJM				Gibson, William T.; Hood, Rebecca L.; Zhan, Shing Hei; Bulman, Dennis E.; Fejes, Anthony P.; Moore, Richard; Mungall, Andrew J.; Eydoux, Patrice; Babul-Hirji, Riyana; An, Jianghong; Marra, Marco A.; Chitayat, David; Boycott, Kym M.; Weaver, David D.; Jones, Steven J. M.		FORGE Canada Consortium	Mutations in EZH2 Cause Weaver Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTOSOMAL-DOMINANT INHERITANCE; NSD1 MUTATIONS; DATABASE; SPECTRUM; SIFT; SITE	We used trio-based whole-exome sequencing to analyze two families affected by Weaver syndrome, including one of the original families reported in 1974. Filtering of rare variants in the affected probands against the parental variants identified two different de novo mutations in the enhancer of zeste homolog 2 (EZH2). Sanger sequencing of EZH2 in a third classically-affected proband identified a third de novo mutation in this gene. These data show that mutations in EZH2 cause Weaver syndrome.	[Gibson, William T.; Eydoux, Patrice; Marra, Marco A.; Jones, Steven J. M.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada; [Gibson, William T.] Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada; [Hood, Rebecca L.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Hood, Rebecca L.; Bulman, Dennis E.] Ottawa Hosp, Res Inst, Ottawa, ON K1H 8L6, Canada; [Zhan, Shing Hei; Fejes, Anthony P.; Moore, Richard; Mungall, Andrew J.; An, Jianghong; Marra, Marco A.; Jones, Steven J. M.] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; [Eydoux, Patrice] Childrens & Womens Hlth Ctr British Columbia, Dept Pathol & Lab Med, Cytogenet Lab, Vancouver, BC V5Z 4H4, Canada; [Babul-Hirji, Riyana; Chitayat, David] Univ Toronto, Hosp Sick Children, Div Clin & Metab Genet, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Chitayat, David] Mt Sinai Hosp, Prenatal Diag & Med Genet Program, Dept Obstet & Gynecol, Toronto, ON M5G 1X5, Canada; [Boycott, Kym M.] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada; [Weaver, David D.] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Jones, Steven J. M.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	University of British Columbia; Child & Family Research Institute; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; British Columbia Cancer Agency; BC Women's Hospital & Health Centre; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Ottawa; Children's Hospital of Eastern Ontario; Indiana University System; Indiana University Bloomington; Simon Fraser University	Gibson, WT (corresponding author), Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada.	wtgibson@cfri.ubc.ca	Mungall, Andrew J./U-7067-2018; Marra, Marco A/B-5987-2008; Jones, Steven J/C-3621-2009	Mungall, Andrew J./0000-0002-0905-2742; Marra, Marco A/0000-0001-7146-7175; Jones, Steven J/0000-0003-3394-2208; Gibson, William/0000-0002-6552-402X; Zhan, Shing/0000-0002-6351-8873	Government of Canada through Genome Canada; Canadian Institutes of Health Research (CIHR); Ontario Genomics Institute [OGI-049]; Genome Quebec; Genome British Columbia; CIHR Institute of Genetics; Child and Family Research Institute	Government of Canada through Genome Canada(Genome Canada); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Genomics Institute; Genome Quebec; Genome British Columbia; CIHR Institute of Genetics(Canadian Institutes of Health Research (CIHR)); Child and Family Research Institute	The authors gratefully acknowledge the generosity of the families in providing samples and clinical details for this study. We would like to thank J. Marcadier (Clinical Coordinator) and C. Beaulieu (Project Manager) for their contribution to the infrastructure of the FORGE Canada Consortium. This work was funded by the Government of Canada through Genome Canada, the Canadian Institutes of Health Research (CIHR), and the Ontario Genomics Institute (OGI-049). Additional funding was provided by Genome Quebec and Genome British Columbia. W.T.G. is supported by a Clinician Scientist Phase 2 Award from the CIHR Institute of Genetics and a Clinician Scientist Salary Award from the Child and Family Research Institute. K.M.B. is supported by a Clinical Investigatorship Award from the CIHR Institute of Genetics. S.J.M.J. is a Senior Scholar of the Michael Smith Foundation for Health Research. The FORGE Canada Steering Committee includes Kym Boycott (University of Ottawa), Jan Friedman (University of British Columbia), Jacques Michaud (Universite de Montreal), Francois Bernier (University of Calgary), Michael Brudno (University of Toronto), Bridget Fernandez (Memorial University), Bartha Knoppers (McGill University), Mark Samuels (Universite de Montreal), and Steve Scherer (University of Toronto).	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Basel-Vanagaite L, 2010, AM J MED GENET A, V152A, P383, DOI 10.1002/ajmg.a.33244; Baujat G, 2005, AM J MED GENET C, V137C, P4, DOI 10.1002/ajmg.c.30060; Chen HA, 2009, GENE DEV, V23, P975, DOI 10.1101/gad.1742509; Douglas J, 2003, AM J HUM GENET, V72, P132, DOI 10.1086/345647; Fejes AP, 2011, BIOINFORMATICS, V27, P1155, DOI 10.1093/bioinformatics/btr100; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Fryer A, 1997, J MED GENET, V34, P418, DOI 10.1136/jmg.34.5.418; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jacobs SA, 2002, NAT STRUCT BIOL, V9, P833, DOI 10.1038/nsb861; Juan AH, 2011, GENE DEV, V25, P789, DOI 10.1101/gad.2027911; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Makishima H, 2010, LEUKEMIA, V24, P1799, DOI 10.1038/leu.2010.167; Marth GT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r84; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Proud VK, 1998, AM J MED GENET, V79, P305, DOI 10.1002/(SICI)1096-8628(19981002)79:4<305::AID-AJMG13>3.0.CO;2-V; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Rio M, 2003, J MED GENET, V40, P436, DOI 10.1136/jmg.40.6.436; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; WEAVER DD, 1974, J PEDIATR-US, V84, P547, DOI 10.1016/S0022-3476(74)80675-X; Wu H, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008570, 10.1371/journal.pone.0013316]; Wyngaarden LA, 2011, DEVELOPMENT, V138, P3759, DOI 10.1242/dev.063180; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208	34	175	181	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 13	2012	90	1					110	118		10.1016/j.ajhg.2011.11.018	http://dx.doi.org/10.1016/j.ajhg.2011.11.018			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	880LR	22177091	hybrid, Green Published			2022-12-18	WOS:000299409100011
J	Kwee, LC; Liu, DW; Lin, XH; Ghosh, D; Epstein, MP				Kwee, Lydia Coulter; Liu, Dawei; Lin, Xihong; Ghosh, Debashis; Epstein, Michael P.			A powerful and flexible multilocus association test for quantitative traits	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; GENOME-WIDE ASSOCIATION; LINEAR MIXED MODELS; LINKAGE DISEQUILIBRIUM; UNRELATED INDIVIDUALS; GENETIC ASSOCIATION; SCORE TEST; P-VALUES; HAPLOTYPES; COMPONENTS	Association mapping of complex traits typically employs tagSNP genotype data to identify a trait locus within a region of interest. However, considerable debate exists regarding the most powerful strategy for utilizing such tagSNP data for inference. A popular approach tests each tagSNP within the region individually, but such tests could lose power as a result of incomplete linkage disequilibrium between the genotyped tagSNP and the trait locus. Alternatively, one can jointly test all tagSNPs simultaneously within the region (by using genotypes or haplotypes), but such multivariate tests have large degrees of freedom that can also compromise power. Here, we consider a semiparametric model for quantitative-trait mapping that uses genetic information from multiple tagSNPs simultaneously in analysis but produces a test statistic with reduced degrees of freedom compared to existing multivariate approaches. We fit this model by using a dimension-reducing technique called least-squares kernel machines, which we show is identical to analysis using a specific linear mixed model (which we can fit by using standard software packages like SAS and R). Using simulated SNP data based on real data from the International HapMap Project, we demonstrate that our approach often has superior performance for association mapping of quantitative traits compared to the popular approach of single-tagSNP testing. Our approach is also flexible, because it allows easy modeling of covariates and, if interest exists, high-dimensional interactions among tagSNPs and environmental predictors.	[Epstein, Michael P.] Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA; [Kwee, Lydia Coulter] Emory Univ, Dept Biostat, Atlanta, GA 30322 USA; [Liu, Dawei] Brown Univ, Ctr Stat Sci, Providence, RI 02912 USA; [Lin, Xihong] Harvard Univ, Dept Biostat, Boston, MA 02115 USA; [Ghosh, Debashis] Penn State Univ, Dept Stat, University Pk, PA 16802 USA	Emory University; Emory University; Brown University; Harvard University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Epstein, MP (corresponding author), Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA.	mepstein@genetics.emory.edu		Ghosh, Debashis/0000-0001-6618-1316	NCI NIH HHS [R37 CA076404, CA76404, R29 CA076404, R01 CA076404] Funding Source: Medline; NHGRI NIH HHS [HG003618, R01 HG003618] Funding Source: Medline; NIGMS NIH HHS [T32 GM074909, GM074909] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA076404, R29CA076404, R37CA076404] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM074909] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Allison DB, 1999, AM J HUM GENET, V65, P531, DOI 10.1086/302487; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; AMOS CI, 1994, AM J HUM GENET, V54, P535; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Chen GK, 2007, AM J HUM GENET, V81, P397, DOI 10.1086/519794; Conneely KN, 2007, AM J HUM GENET, V81, P1158, DOI 10.1086/522036; Conti DV, 2003, AM J HUM GENET, V72, P351, DOI 10.1086/346117; Cristianini N., 2000, INTRO SUPPORT VECTOR; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Gauderman WJ, 2007, GENET EPIDEMIOL, V31, P383, DOI 10.1002/gepi.20219; Hung RJ, 2004, CANCER EPIDEM BIOMAR, V13, P1013; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Lin DY, 2005, BIOINFORMATICS, V21, P781, DOI 10.1093/bioinformatics/bti053; Lin XH, 1996, J AM STAT ASSOC, V91, P1007, DOI 10.2307/2291720; Liu D, 2007, BIOMETRICS, V63, P1079, DOI 10.1111/j.1541-0420.2007.00799.x; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Nicolae DL, 2006, GENET EPIDEMIOL, V30, P718, DOI 10.1002/gepi.20182; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Roeder K, 2005, GENET EPIDEMIOL, V28, P207, DOI 10.1002/gepi.20050; Rosenberg PS, 2006, STAT MED, V25, P3134, DOI 10.1002/sim.2407; Ruppert D., 2003, SEMIPARAMETRIC REGRE; Schaid DJ, 2005, AM J HUM GENET, V76, P780, DOI 10.1086/429838; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stram DO, 2004, GENET EPIDEMIOL, V27, P365, DOI 10.1002/gepi.20028; Tzeng JY, 2007, AM J HUM GENET, V81, P927, DOI 10.1086/521558; Tzeng JY, 2006, AM J HUM GENET, V78, P231, DOI 10.1086/500025; Valle T, 1998, DIABETES CARE, V21, P949, DOI 10.2337/diacare.21.6.949; Wang T, 2007, AM J HUM GENET, V80, P353, DOI 10.1086/511312; Wessel J, 2006, AM J HUM GENET, V79, P792, DOI 10.1086/508346; Witte JS, 1997, GENET EPIDEMIOL, V14, P1137, DOI 10.1002/(SICI)1098-2272(1997)14:6<1137::AID-GEPI96>3.0.CO;2-H; Witte JS, 2000, EPIDEMIOLOGY, V11, P684, DOI 10.1097/00001648-200011000-00012; Zaitlen N, 2007, AM J HUM GENET, V80, P683, DOI 10.1086/513109; Zaykin DV, 2002, GENET EPIDEMIOL, V22, P170, DOI 10.1002/gepi.0042; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986; Zhang DW, 2003, BIOSTATISTICS, V4, P57, DOI 10.1093/biostatistics/4.1.57	43	175	182	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2008	82	2					386	397		10.1016/j.ajhg.2007.10.010	http://dx.doi.org/10.1016/j.ajhg.2007.10.010			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NN	18252219	Green Published, Bronze			2022-12-18	WOS:000253223900011
J	Yahya-Graison, EA; Aubert, J; Dauphinot, L; Rivals, I; Prieur, M; Golfier, G; Rossier, J; Personnaz, L; Creau, N; Blehaut, H; Robin, S; Delabar, JM; Potier, MC				Yahya-Graison, E. Ait; Aubert, J.; Dauphinot, L.; Rivals, I.; Prieur, M.; Golfier, G.; Rossier, J.; Personnaz, L.; Creau, N.; Blehaut, H.; Robin, S.; Delabar, J. M.; Potier, M. -C.			Classification of human chromosome 21 gene-expression variations in down syndrome: Impact on disease phenotypes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MOUSE MODEL; TS1CJE MOUSE; MOLECULAR CHARACTERIZATION; CEREBELLAR TRANSCRIPTOME; POSTNATAL-DEVELOPMENT; OVER-EXPRESSION; SYNDROME BRAIN; CHROMOSOME-21; TRISOMY; REGION	Down syndrome caused by chromosome 21 trisomy is the most common genetic cause of mental retardation in humans. Disruption of the phenotype is thought to be the result of gene-dosage imbalance. Variations in chromosome 21 gene expression in Down syndrome were analyzed in lymphoblastoid cells derived from patients and control individuals. Of the 359 genes and predictions displayed on a specifically designed high-content chromosome 21 microarray, one-third were expressed in lymphoblastoid cells. We performed a mixed-model analysis of variance to find genes that are differentially expressed in Down syndrome independent of sex and interindividual variations. In addition, we identified genes with variations between Down syndrome and control samples that were significantly different from the gene-dosage effect (1.5). Microarray data were validated by quantitative polymerase chain reaction. We found that 29% of the expressed chromosome 21 transcripts are overexpressed in Down syndrome and correspond to either genes or open reading frames. Among these, 22% are increased proportional to the gene-dosage effect, and 7% are amplified. The other 71% of expressed sequences are either compensated (56%, with a large proportion of predicted genes and antisense transcripts) or highly variable among individuals (15%). Thus; most of the chromosome 21 transcripts are compensated for the gene-dosage effect. Overexpressed genes are likely to be involved in the Down syndrome phenotype, in contrast to the compensated genes. Highly variable genes could account for phenotypic variations observed in patients. Finally, we show that alternative transcripts belonging to the same gene are similarly regulated in Down syndrome but sense and antisense transcripts are not.	[Yahya-Graison, E. Ait; Dauphinot, L.; Golfier, G.; Rossier, J.; Potier, M. -C.] ESPCI, CNRS, UMR 7637, Neurobiol & Diversite Cellulaire, 10 Rue Vauquelin, F-75005 Paris, France; [Yahya-Graison, E. Ait; Creau, N.; Delabar, J. M.] Univ Paris Diderot, Paris, France; [Aubert, J.; Robin, S.] Inst Natl Agro Paris Grignon, Ecole Natl Genie Rural Eaux & Forets, UMR, Paris, France; [Aubert, J.; Robin, S.] INRA, Paris, France; [Rivals, I.; Personnaz, L.] Hop Necker Enfants Malad, Equipe Stat Appl, Paris, France; [Prieur, M.] Hop Necker Enfants Malad, Cytogenet Serv, Paris, France; [Blehaut, H.] Inst Jerome Lejeune, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; INRAE; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Potier, MC (corresponding author), ESPCI, CNRS, UMR 7637, Neurobiol & Diversite Cellulaire, 10 Rue Vauquelin, F-75005 Paris, France.	marie-claude.potier@espci.fr	AUBERT, Julie/AAJ-8960-2021; AUBERT, Julie/D-9120-2011; Rivals, Isabelle/AAE-7971-2022	AUBERT, Julie/0000-0001-5203-5748; Rivals, Isabelle/0000-0002-8736-7010; Ait Yahya Graison, Emilie/0000-0002-7205-2649; Potier, Marie-Claude/0000-0003-2462-7150				Amano K, 2004, HUM MOL GENET, V13, P1333, DOI 10.1093/hmg/ddh154; Antonio A, 2004, J PROD ANAL, V21, P5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birchler JA, 2005, TRENDS GENET, V21, P219, DOI 10.1016/j.tig.2005.02.010; BIRCHLER JA, 1979, GENETICS, V92, P1211; BRIGAND KL, 2006, NUCLEIC ACIDS RES, V34, pE87; Chen H, 1996, GENOME RES, V6, P747, DOI 10.1101/gr.6.8.747; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Chung IH, 2005, J KOREAN MED SCI, V20, P82, DOI 10.3346/jkms.2005.20.1.82; Dahmane N, 1998, GENOMICS, V48, P12, DOI 10.1006/geno.1997.5146; Dauphinot L, 2005, HUM MOL GENET, V14, P373, DOI 10.1093/hmg/ddi033; Delabar Jean-Maurice, 1993, European Journal of Human Genetics, V1, P114; Deutsch S, 2005, HUM MOL GENET, V14, P3741, DOI 10.1093/hmg/ddi404; DEVLIN RH, 1982, P NATL ACAD SCI-BIOL, V79, P1200, DOI 10.1073/pnas.79.4.1200; EPSTEIN CJ, 1991, AM J HUM GENET, V49, P207; FitzPatrick DR, 2002, HUM MOL GENET, V11, P3249, DOI 10.1093/hmg/11.26.3249; Gardiner K, 2003, GENE, V318, P137, DOI 10.1016/S0378-1119(03)00769-8; Gardiner K, 2006, BEHAV GENET, V36, P439, DOI 10.1007/s10519-006-9051-1; Giannone S, 2004, ANN HUM GENET, V68, P546, DOI 10.1046/j.1529-8817.2003.00123.x; Gross SJ, 2002, AM J OBSTET GYNECOL, V187, P457, DOI 10.1067/mob.2002.123542; GUO M, 1994, SCIENCE, V266, P1999, DOI 10.1126/science.266.5193.1999; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Janel N, 2006, BIOCHEM BIOPH RES CO, V346, P1303, DOI 10.1016/j.bbrc.2006.06.048; Kahlem P, 2004, GENOME RES, V14, P1258, DOI 10.1101/gr.1951304; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; LEJEUNE J, 1959, CR HEBD ACAD SCI, V248, P1721; Li CM, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-24; Lyle R, 2004, GENOME RES, V14, P1268, DOI 10.1101/gr.2090904; Mao R, 2003, GENOMICS, V81, P457, DOI 10.1016/S0888-7543(03)00035-1; Mao R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r107; Nikolaienko E, 2005, GENE, V364, P90, DOI 10.1016/j.gene.2005.07.019; O'Leary DA, 2004, BBA-MOL BASIS DIS, V1739, P81, DOI 10.1016/j.bbadis.2004.09.005; Ohira M, 1997, GENOME RES, V7, P47, DOI 10.1101/gr.7.1.47; Olson LE, 2007, HUM MOL GENET, V16, P774, DOI 10.1093/hmg/ddm022; Pellegrini-Calace M, 2006, BIOINFORMATICS, V22, P775, DOI 10.1093/bioinformatics/btl006; Potier MC, 2006, J NEUROCHEM, V97, P104, DOI 10.1111/j.1471-4159.2005.03624.x; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Reymond A, 2002, GENOMICS, V79, P824, DOI 10.1006/geno.2002.6781; Saran NG, 2003, HUM MOL GENET, V12, P2013, DOI 10.1093/hmg/ddg217; *SAS I, 2000, SAS STAT SOFTW REL 8; Schinzel A., 2001, CATALOGUE UNBALANCED; Shapiro BL, 2001, J NEURAL TRANSM-SUPP, P11; SHERMAN L, 1984, NUCLEIC ACIDS RES, V12, P9349, DOI 10.1093/nar/12.24.9349; SINET PM, 1975, BIOCHEM BIOPH RES CO, V67, P904, DOI 10.1016/0006-291X(75)90762-7; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Storey JD, 2007, AM J HUM GENET, V80, P502, DOI 10.1086/512017; Tang Y, 2004, ANN NEUROL, V56, P808, DOI 10.1002/ana.20291; Wester U, 2006, AM J MED GENET A, V140A, P1164, DOI 10.1002/ajmg.a.31260; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520; Yamada Y, 2004, GENOME RES, V14, P247, DOI 10.1101/gr.1351604	52	175	181	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2007	81	3					475	491		10.1086/520000	http://dx.doi.org/10.1086/520000			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205PX	17701894	Green Published, Bronze			2022-12-18	WOS:000249128200005
J	Stoetzel, C; Muller, J; Laurier, V; Davis, EE; Zaghloul, NA; Vicaire, S; Jacquelin, C; Plewniak, F; Leitch, CC; Sarda, P; Hamel, C; de Ravel, TJL; Lewis, RA; Friederich, E; Thibault, C; Danse, JM; Verloes, A; Bonneau, D; Katsanis, N; Poch, O; Mandel, JL; Dollfus, H				Stoetzel, Corinne; Muller, Jean; Laurier, Virginie; Davis, Erica E.; Zaghloul, Norann A.; Vicaire, Serge; Jacquelin, Cecile; Plewniak, Frederic; Leitch, Carmen C.; Sarda, Pierre; Hamel, Christian; de Ravel, Thomy J. L.; Lewis, Richard Alan; Friederich, Evelyne; Thibault, Christelle; Danse, Jean-Marc; Verloes, Alain; Bonneau, Dominique; Katsanis, Nicholas; Poch, Olivier; Mandel, Jean-Louis; Dollfus, Helene			Identification of a novel BBS gene (BBS12) highlights the major role of a vertebrate-specific branch of chaperonin-related proteins in Bardet-Biedl syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POPULATION; OBESITY; DISSECTION; MUTATIONS; GENOMICS; PROTEOME; COHORT; CCT	Bardet-Biedl syndrome (BBS) is primarily an autosomal recessive ciliopathy characterized by progressive retinal degeneration, obesity, cognitive impairment, polydactyly, and kidney anomalies. The disorder is genetically heterogeneous, with 11 BBS genes identified to date, which account for similar to 70% of affected families. We have combined single-nucleotide polymorphism array homozygosity mapping with in silico analysis to identify a new BBS gene, BBS12. Patients from two Gypsy families were homozygous and haploidentical in a 6-Mb region of chromosome 4q27. FLJ35630 was selected as a candidate gene, because it was predicted to encode a protein with similarity to members of the type II chaperonin superfamily, which includes BBS6 and BBS10. We found pathogenic mutations in both Gypsy families, as well as in 14 other families of various ethnic backgrounds, indicating that BBS12 accounts for similar to 5% of all BBS cases. BBS12 is vertebrate specific and, together with BBS6 and BBS10, defines a novel branch of the type II chaperonin superfamily. These three genes are characterized by unusually rapid evolution and are likely to perform ciliary functions specific to vertebrates that are important in the pathophysiology of the syndrome, and together they account for about one-third of the total BBS mutational load. Consistent with this notion, suppression of each family member in zebrafish yielded gastrulation-movement defects characteristic of other BBS morphants, whereas simultaneous suppression of all three members resulted in severely affected embryos, possibly hinting at partial functional redundancy within this protein family.	CHU Strasbourg, Serv Genet Med, F-67000 Strasbourg, France; CHU Strasbourg, Ctr Reference Affect Genet Ophthalmol, F-67000 Strasbourg, France; Univ Strasbourg, Fac Med, Med Genet Lab, Strasbourg, France; CNRS, INSERM, Unite 596, Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France; Coll France, Illkirch Graffenstaden, France; Ctr Rech Publ Sante, Lab Biol Mol Anal Gen & Modelisat, Luxembourg, Luxembourg; Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD USA; Johns Hopkins Univ, Dept Ophthalmol, Baltimore, MD USA; Johns Hopkins Univ, Dept Mol Biol, Baltimore, MD USA; Johns Hopkins Univ, Dept Genet, Baltimore, MD USA; CHU Hop Arnaud Villeneuve, Serv Genet Med, Montpellier, France; CHU Hop St Eloi, Inst Neurosci Montpellier, Montpellier, France; Univ Hosp Gasthuisberg, Ctr Human Genet, B-3000 Louvain, Belgium; Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; CHU Angers, Serv Genet, Angers, France; Hop Robert Debre, Clin Genet Unit, F-75019 Paris, France	CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; PSL Research University Paris; College de France; Luxembourg Institute of Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; KU Leuven; University Hospital Leuven; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Dollfus, H (corresponding author), Hop Univ Strasbourg, Fac Med, Med Genet Lab, EA 3439, 11 Rue Humann, F-67085 Strasbourg, France.	helene.dollfus@medecine.u-strasbg.fr	/AAK-8500-2021; Muller, Jean/L-7412-2018; Katsanis, Nicholas/E-1837-2012; Bonneau, Dominique/K-6110-2015; VERLOES, Alain/E-7287-2014; Mandel, Jean Louis/Q-2668-2016	Muller, Jean/0000-0002-7682-559X; VERLOES, Alain/0000-0003-4819-0264; Davis, Erica/0000-0002-2412-8397; Katsanis, Nicholas/0000-0002-2480-0171; Dollfus, Helene/0000-0002-2249-895X; Mandel, Jean Louis/0000-0002-0535-6589; de Ravel, Thomy/0000-0002-3361-3781; Thibault-Carpentier, Christelle/0000-0003-1562-1451; Plewniak, Frederic/0000-0001-6534-8786				Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Archibald JM, 2000, MOL BIOL EVOL, V17, P1456, DOI 10.1093/oxfordjournals.molbev.a026246; Badano JL, 2006, NATURE, V439, P326, DOI 10.1038/nature04370; Badano JL, 2003, AM J HUM GENET, V72, P650, DOI 10.1086/368204; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; BAYER JA, 2006, NAT GENET, V38, P674; Beales PL, 1999, J MED GENET, V36, P437; Chiang AP, 2006, P NATL ACAD SCI USA, V103, P6287, DOI 10.1073/pnas.0600158103; Chiang AP, 2004, AM J HUM GENET, V75, P475, DOI 10.1086/423903; Davis EE, 2006, DEV CELL, V11, P9, DOI 10.1016/j.devcel.2006.06.009; Ditzel L, 1998, CELL, V93, P125, DOI 10.1016/S0092-8674(00)81152-6; Fan YL, 2004, NAT GENET, V36, P989, DOI 10.1038/ng1414; FARAG TI, 1988, CLIN GENET, V33, P78; FARAG TI, 1989, CLIN GENET, V36, P463; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; GREEN JS, 1989, NEW ENGL J MED, V321, P1002, DOI 10.1056/NEJM198910123211503; Hichri H, 2005, EUR J HUM GENET, V13, P607, DOI 10.1038/sj.ejhg.5201372; Katsanis N, 2004, HUM MOL GENET, V13, pR65, DOI 10.1093/hmg/ddh092; Katsanis N, 2000, NAT GENET, V26, P67, DOI 10.1038/79201; Kim JC, 2005, J CELL SCI, V118, P1007, DOI 10.1242/jcs.01676; Lecompte O, 2001, GENE, V270, P17, DOI 10.1016/S0378-1119(01)00461-9; LEPPERT M, 1994, NAT GENET, V7, P108, DOI 10.1038/ng0594-108; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Moore SJ, 2005, AM J MED GENET A, V132A, P352, DOI 10.1002/ajmg.a.30406; Mykytyn K, 2001, NAT GENET, V28, P188, DOI 10.1038/88925; Nishimura DY, 2005, AM J HUM GENET, V77, P1021, DOI 10.1086/498323; Nishimura DY, 2001, HUM MOL GENET, V10, P865, DOI 10.1093/hmg/10.8.865; NYKYTYN K, 2002, NAT GENET, V31, P435; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Slavotinek AM, 2000, NAT GENET, V26, P15, DOI 10.1038/79116; Stoetzel C, 2006, NAT GENET, V38, P521, DOI 10.1038/ng1771	31	175	182	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2007	80	1					1	11		10.1086/510256	http://dx.doi.org/10.1086/510256			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	120RG	17160889	Green Published, Bronze			2022-12-18	WOS:000243102500001
J	Longley, MJ; Clark, S; Man, CYW; Hudson, G; Durham, SE; Taylor, RW; Nightingale, S; Turnbull, DM; Copeland, WC; Chinnery, PF				Longley, Matthew J.; Clark, Susanna; Man, Cynthia Yu Wai; Hudson, Gavin; Durham, Steve E.; Taylor, Robert W.; Nightingale, Simon; Turnbull, Douglass M.; Copeland, William C.; Chinnery, Patrick F.			Mutant POLG2 disrupts DNA polymerase gamma subunits and causes progressive external ophthalmoplegia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACCESSORY SUBUNIT; ALPERS-SYNDROME; AUTOSOMAL-DOMINANT; MUTATIONS; BINDING; IDENTIFICATION; DEPLETION; DELETIONS; MUSCLE	DNA polymerase gamma (pol gamma) is required to maintain the genetic integrity of the 16,569-bp human mitochondrial genome (mtDNA). Mutation of the nuclear gene for the catalytic subunit of pol gamma (POLG) has been linked to a wide range of mitochondrial diseases involving mutation, deletion, and depletion of mtDNA. We describe a heterozygous dominant mutation (c.1352G -> A/p.G451E) in POLG2, the gene encoding the p55 accessory subunit of pol gamma, that causes progressive external ophthalmoplegia with multiple mtDNA deletions and cytochrome c oxidase (COX)-deficient muscle fibers. Biochemical characterization of purified, recombinant G451E-substituted p55 protein in vitro revealed incomplete stimulation of the catalytic subunit due to compromised subunit interaction. Although G451E p55 retains a wild-type ability to bind DNA, it fails to enhance the DNA-binding strength of the p140-p55 complex. In vivo, the disease most likely arises through haplotype insufficiency or heterodimerization of the mutated and wild-type proteins, which promote mtDNA deletions by stalling the DNA replication fork. The progressive accumulation of mtDNA deletions causes COX deficiency in muscle fibers and results in the clinical phenotype.	Univ Newcastle Upon Tyne, Sch Med, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Natl Inst Environm Hlth Sci, Mol Genet Lab, NIH, Res Triangle Pk, NC USA; Univ Newcastle Upon Tyne, Inst Human Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Royal Shrewsbury Hosp, Shrewsbury, Salop, England	Newcastle University - UK; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Newcastle University - UK	Chinnery, PF (corresponding author), Univ Newcastle Upon Tyne, Sch Med, Mitochondrial Res Grp, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	P.F.Chinnery@ncl.ac.uk	Copeland, William/C-4242-2019; Hudson, Gavin/E-7117-2017	Copeland, William/0000-0002-0359-0953; Chinnery, Patrick/0000-0002-7065-6617; Hudson, Gavin/0000-0001-7210-2733; Yu-Wai-Man, Cynthia/0000-0003-4868-5187	Intramural NIH HHS Funding Source: Medline; Wellcome Trust [074454] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES065078, Z01ES065078] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Blakely EL, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.011296; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212; Carrodeguas JA, 2000, NUCLEIC ACIDS RES, V28, P1237, DOI 10.1093/nar/28.5.1237; Carrodeguas JA, 2002, J BIOL CHEM, V277, P50008, DOI 10.1074/jbc.M207030200; Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8; Chan SSL, 2005, DNA REPAIR, V4, P1381, DOI 10.1016/j.dnarep.2005.08.010; Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Durham SE, 2005, NEUROLOGY, V65, P453, DOI 10.1212/01.wnl.0000171861.30277.88; Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410; Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805; He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067; HUDSON G, IN PRESS NEUROLOGY; Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455; Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278; Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197; Longley Matthew J, 2002, Methods Mol Biol, V197, P245, DOI 10.1385/1-59259-284-8:245; Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029; Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w; Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079; Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70; Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034; Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83; Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X; Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200	26	175	182	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2006	78	6					1026	1034		10.1086/504303	http://dx.doi.org/10.1086/504303			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	042TZ	16685652	Green Published, Bronze			2022-12-18	WOS:000237553800011
J	Luis, JR; Rowold, DJ; Regueiro, M; Caeiro, B; Cinnioglu, C; Roseman, C; Underhill, PA; Cavalli-Sforza, LL; Herrera, RJ				Luis, JR; Rowold, DJ; Regueiro, M; Caeiro, B; Cinnioglu, C; Roseman, C; Underhill, PA; Cavalli-Sforza, LL; Herrera, RJ			The Levant versus the Horn of Africa: Evidence for bidirectional corridors of human migrations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN Y-CHROMOSOME; ELECTROPHORETICALLY DETECTABLE ALLELES; HIGH-RESOLUTION ANALYSIS; HOMO-SAPIENS-SAPIENS; SUB-SAHARAN AFRICA; HUMAN-POPULATIONS; GENETIC-EVIDENCE; HAPLOTYPES; ORIGINS; EVOLUTION	Paleoanthropological evidence indicates that both the Levantine corridor and the Horn of Africa served, repeatedly, as migratory corridors between Africa and Eurasia. We have begun investigating the roles of these passageways in bidirectional migrations of anatomically modern humans, by analyzing 45 informative biallelic markers as well as 10 microsatellite loci on the nonrecombining region of the Y chromosome (NRY) in 121 and 147 extant males from Oman and northern Egypt, respectively. The present study uncovers three important points concerning these demic movements: (1) The E3b1-M78 and E3b3-M123 lineages, as well as the R1*-M173 lineages, mark gene flow between Egypt and the Levant during the Upper Paleolithic and Mesolithic. (2) In contrast, the Horn of Africa appears to be of minor importance in the human migratory movements between Africa and Eurasia represented by these chromosomes, an observation based on the frequency distributions of E3b*-M35 ( no known downstream mutations) and M173. (3) The areal diffusion patterns of G-M201, J-12f2, the derivative M173 haplogroups, and M2 suggest more recent genetic associations between the Middle East and Africa, involving the Levantine corridor and/or Arab slave routes. Affinities to African groups were also evaluated by determining the NRY haplogroup composition in 434 samples from seven sub-Saharan African populations. Oman and Egypt's NRY frequency distributions appear to be much more similar to those of the Middle East than to any sub-Saharan African population, suggesting a much larger Eurasian genetic component. Finally, the overall phylogeographic profile reveals several clinal patterns and genetic partitions that may indicate source, direction, and relative timing of different waves of dispersals and expansions involving these nine populations.	Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; Univ Santiago de Compostela, Fac Biol, Secc Antropoloxia, Galicia, Spain; Stanford Univ, Dept Genet, Stanford, CA 94305 USA	State University System of Florida; Florida International University; Universidade de Santiago de Compostela; Stanford University	Herrera, RJ (corresponding author), Florida Int Univ, Dept Biol Sci, Univ Pk, Miami, FL 33199 USA.	herrerar@fiu.edu	Roseman, Charles/AAL-6141-2021	Roseman, Charles/0000-0002-4589-0401	NIGMS NIH HHS [GM 08205, GM 61347, R25 GM061347, S06 GM008205] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061347] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson S. E., 1995, BLACK HOLOCAUST BEGI; Bar-Yosef O, 2002, ANNU REV ANTHROPOL, V31, P363, DOI 10.1146/annurev.anthro.31.040402.085416; Bosch E, 2001, AM J HUM GENET, V68, P1019, DOI 10.1086/319521; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CAVALLISFORZA LL, 1993, SCIENCE, V259, P639, DOI 10.1126/science.8430313; Cinnioglu C, 2004, HUM GENET, V114, P127, DOI 10.1007/s00439-003-1031-4; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; EXCOFFIER L, 1992, GENETICS, V131, P479; Goudet J., 2001, CLADISTICS; Hammarlund D, 2002, HOLOCENE, V12, P339, DOI 10.1191/0959683602hl548rp; Hammer MF, 2000, P NATL ACAD SCI USA, V97, P6769, DOI 10.1073/pnas.100115997; Hitti P. K., 1990, ARABS SHORT HIST; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Kayser M, 1997, INT J LEGAL MED, V110, P125, DOI 10.1007/s004140050051; King R, 2002, ANTIQUITY, V76, P707, DOI 10.1017/S0003598X00091158; Kittles RA, 1998, AM J HUM GENET, V62, P1171, DOI 10.1086/301831; Kivisild T, 1999, CURR BIOL, V9, P1331, DOI 10.1016/S0960-9822(00)80057-3; Lahr Marta Mirazon, 1994, Evolutionary Anthropology, V3, P48, DOI 10.1002/evan.1360030206; Lucotte G, 2003, AM J PHYS ANTHROPOL, V121, P63, DOI 10.1002/ajpa.10190; Manni F, 2002, HUM BIOL, V74, P645, DOI 10.1353/hub.2002.0054; Nebel A, 2002, AM J HUM GENET, V70, P1594, DOI 10.1086/340669; Newman JL., 1995, PEOPLING AFRICA GEOG; OHTA T, 1973, GENET RES, V22, P201, DOI 10.1017/S0016672300012994; Passarino G, 1998, AM J HUM GENET, V62, P420, DOI 10.1086/301702; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Richards M, 2003, AM J HUM GENET, V72, P1058, DOI 10.1086/374384; ROHLF F, 2002, NTSYSPC; Rowold DJ, 2000, GENETICA, V108, P57, DOI 10.1023/A:1004099605261; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; Scozzari R, 1999, AM J HUM GENET, V65, P829, DOI 10.1086/302538; Scozzari R, 1997, AM J HUM GENET, V61, P719, DOI 10.1086/515500; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Semino O, 2002, AM J HUM GENET, V70, P265, DOI 10.1086/338306; Stringer C, 2000, NATURE, V405, P24, DOI 10.1038/35011166; Tremblay M, 2000, AM J HUM GENET, V66, P651, DOI 10.1086/302770; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Underhill PA, 2001, HUM MUTAT, V17, P271, DOI 10.1002/humu.23; WEHRHAHN CF, 1975, GENETICS, V80, P375; WILSON I, 2000, BATWING BAYESIAN ANA; Zhivotovsky LA, 2003, AM J HUM GENET, V72, P1171, DOI 10.1086/375120	43	175	177	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2004	74	3					532	544		10.1086/382286	http://dx.doi.org/10.1086/382286			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	801TP	14973781	Green Published, Bronze			2022-12-18	WOS:000220118500019
J	Greco, L; Corazza, G; Babron, MC; Clot, F; Fulchignoni-Lataud, MC; Percopo, S; Zavattari, P; Bouguerra, F; Dib, C; Tosi, R; Troncone, R; Ventura, A; Mantavoni, W; Magazzu, G; Gatti, R; Lazzari, R; Giunta, A; Perri, F; Iacono, G; Cardi, E; de Virgiliis, S; Cataldo, F; De Angelis, G; Musumeci, S; Ferrari, R; Balli, F; Bardella, MT; Volta, U; Catassi, C; Torre, G; Eliaou, JF; Serre, JL; Clerget-Darpoux, F				Greco, L; Corazza, G; Babron, MC; Clot, F; Fulchignoni-Lataud, MC; Percopo, S; Zavattari, P; Bouguerra, F; Dib, C; Tosi, R; Troncone, R; Ventura, A; Mantavoni, W; Magazzu, G; Gatti, R; Lazzari, R; Giunta, A; Perri, F; Iacono, G; Cardi, E; de Virgiliis, S; Cataldo, F; De Angelis, G; Musumeci, S; Ferrari, R; Balli, F; Bardella, MT; Volta, U; Catassi, C; Torre, G; Eliaou, JF; Serre, JL; Clerget-Darpoux, F			Genome search in Celiac disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEX TRAITS; GLUTEN; GENES; MAP	Celiac disease (CD), a malabsorption disorder of: the small intestine, results from ingestion of gluten. The HLA risk factors involved in CD are well known but do not explain the entire genetic susceptibility. To determine the localization of other genetic risk factors, a systematic screening of the genome has been undertaken, The typing information of 281 markers on 110 affected sib pairs and their parents was used to test linkage. Systematic linkage analysis was first performed on 33 pairs in which both sibs had a symptomatic form of CD. Replication of the regions of interest was then carried out on 71 pairs in which one sib had a symptomatic form and the other a silent form of CD. In addition to the HLA loci, our study suggests that a risk factor in 5qter is involved in both forms of CD (symptomatic and silent). Furthermore, a factor on 11qter possibly differentiates the two forms. In contrast, none of the regions recently published was confirmed by the present screening.	Univ Naples Federico II, Dept Pediat, Naples, Italy; INSERM, U155, F-75016 Paris, France; Univ Versailles, Lab Cytogenet & Genet Mol Humaine, F-78000 Versailles, France; Dipartimento Sci Med, Novara, Italy; Hop Enfants, Unite Genet Epidemiol, Tunis, Tunisia; Inst Natl Sante Publ, Tunis, Tunisia; Genethon, Evry, France; CNR, Rome, Italy; Univ Rome La Sapienza, Dept Pediat, Rome, Italy; Univ Pisa, Dept Pediat, Pisa, Italy; Osped Maggiore Bologna, Lab Anal, Bologna, Italy; Univ Bologna, Dept Pediat, Bologna, Italy; Inst Med Semeiot, Bologna, Italy; Univ Messina, Dept Pediat, Messina, Italy; Ist Giannina Gaslini, I-16148 Genoa, Italy; Univ Milan, Dept Pediat, Milan, Italy; Univ Milan, Ist Sci Med, I-20122 Milan, Italy; Univ Palermo, Dept Pediat Cristina, Palermo, Italy; Univ Palermo, Dept Pediat Lancia di Brolo, Palermo, Italy; Univ Cagliari, Ist Clin & Biol Eta Evolut, I-09100 Cagliari, Italy; Univ Parma, Dept Pediat, I-43100 Parma, Italy; Univ Catania, Dept Pediat, Catania, Italy; Univ Florence, Dept Pediat, Florence, Italy; Univ Modena, Dept Pediat, I-41100 Modena, Italy; Univ Ancona, Dept Pediat, Ancona, Italy; Ist Burlo Garofolo, Trieste, Italy; INSERM, U291, Montpellier, France	University of Naples Federico II; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Universite de Tunis-El-Manar; Hopital d'Enfants; Consiglio Nazionale delle Ricerche (CNR); Sapienza University Rome; University of Pisa; AUSL di Bologna; University of Bologna; University of Messina; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Milan; University of Milan; University of Palermo; University of Palermo; University of Cagliari; University of Parma; University of Catania; University of Florence; Universita di Modena e Reggio Emilia; Marche Polytechnic University; IRCCS Burlo Garofolo; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Clerget-Darpoux, F (corresponding author), INSERM, U155, Chateau Longchamp,Bois Boulogne, F-75016 Paris, France.		Corazza, Gino Roberto/K-8500-2016; de'Angelis, Gian Luigi/AAC-7901-2021; Musumeci, Sebastiano Antonino/E-3879-2017; Perri, Francesco/AAF-4659-2020; Clerget-Darpoux, Francoise/I-4825-2017	Corazza, Gino Roberto/0000-0001-9532-0573; de'Angelis, Gian Luigi/0000-0002-8254-6917; Musumeci, Sebastiano Antonino/0000-0002-6865-5367; Perri, Francesco/0000-0001-8314-8016; Volta, Umberto/0000-0003-3405-3808; Magazzu, Giuseppe/0000-0003-2622-4013; Babron, Marie-Claude/0000-0002-4100-0299; Ventura, Alessandro/0000-0002-4657-1760; Clerget-Darpoux, Francoise/0000-0003-4816-6619	Telethon [E.0552] Funding Source: Medline	Telethon(Fondazione Telethon)		BABRON MC, 1997, GENET EPIDEMIOL, V14, pA4; Bouguerra F, 1997, GENET EPIDEMIOL, V14, P413, DOI 10.1002/(SICI)1098-2272(1997)14:4<413::AID-GEPI6>3.0.CO;2-3; CATASSI C, 1994, LANCET, V343, P200, DOI 10.1016/S0140-6736(94)90989-X; CLERGETDARPOUX F, 1997, GENETIC DIVERSITY HL, V2, P718; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; EICHENBAUMVOLIN.S, GENET EPIDEMIOL, V14, P1079; Ginot F, 1996, NUCLEIC ACIDS RES, V24, P540, DOI 10.1093/nar/24.3.540; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HOLMANS P, 1993, AM J HUM GENET, V52, P362; Houlston RS, 1997, HUM MOL GENET, V6, P1335, DOI 10.1093/hmg/6.8.1335; Kruglyak L, 1996, AM J HUM GENET, V58, P1092; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; Maki M, 1997, LANCET, V349, P1755, DOI 10.1016/S0140-6736(96)70237-4; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; MEEUWISSE GW, 1970, ACTA PAEDIATR SCAND, V59, P461; Petronzelli F, 1997, ANN HUM GENET, V61, P307; RISCH N, 1990, AM J HUM GENET, V46, P242; RISCH N, 1987, AM J HUM GENET, V40, P1; RISCH N, 1990, AM J HUM GENET, V46, P223; SOLLID LM, 1993, GASTROENTEROLOGY, V105, P910, DOI 10.1016/0016-5085(93)90912-V; SOLLID LM, 1989, J EXP MED, V169, P345, DOI 10.1084/jem.169.1.345; Troncone R, 1996, PEDIATR CLIN N AM, V43, P355, DOI 10.1016/S0031-3955(05)70410-7; WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909; Zhong F, 1996, NAT GENET, V14, P329, DOI 10.1038/ng1196-329	24	175	178	0	9	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1998	62	3					669	675		10.1086/301754	http://dx.doi.org/10.1086/301754			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZF407	9497251	Bronze, Green Published			2022-12-18	WOS:000072894400021
J	STEPHENS, JC; BRISCOE, D; OBRIEN, SJ				STEPHENS, JC; BRISCOE, D; OBRIEN, SJ			MAPPING BY ADMIXTURE LINKAGE DISEQUILIBRIUM IN HUMAN-POPULATIONS - LIMITS AND GUIDELINES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE; POLYMORPHISMS; LOCI	Certain human hereditary conditions, notably those with low penetrance and those which require an environmental event such as infectious disease exposure, are difficult to localize in pedigree analysis, because of uncertainty in the phenotype of an affected patient's relatives. An approach to locating these genes in human cohort studies would be to use association analysis, which depends on linkage disequilibrium of flanking polymorphic DNA markers. In theory, a high degree of linkage disequilibrium between genes separated by 10-20 cM will be generated and persist in populations that have a history of recent (3-20 generations ago) admixture between genetically differentiated racial groups, such as has occurred in African Americans and Hispanic populations. We have conducted analytic and computer simulations to quantify the effect of genetic, genomic, and population parameters that affect the amount and ascertainment of linkage disequilibrium in populations with a history of genetic admixture. Our goal is to thoroughly explore the ranges of all relevant parameters or factors (e.g., sample size and degree of genetic differentiation between populations) that may be involved in gene localization studies, in hopes of prescribing guidelines for an efficient mapping strategy. The results provide reasonable limits on sample size (200-300 patients), marker number (200-300 in 20-cM intervals), and allele differentiation (loci with allele frequency difference of greater than or equal to .3 between admired parent populations) to produce an efficient approach (>95% ascertainment) for locating genes not easily tracked in human pedigrees.	NCI,FREDERICK CANC RES & DEV CTR,VIRAL CARCINOGENESIS LAB,FREDERICK,MD 21702	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick			OBRIEN, STEPHEN/ABD-1346-2020	OBRIEN, STEPHEN/0000-0001-7857-0757				[Anonymous], 1974, GENETIC BASIS EVOLUT; BEASLEY RP, 1981, LANCET, V2, P1129; BODMER WF, 1986, COLD SPRING HARB SYM, V51, P1; BRISCOE D, 1994, J HERED, V85, P59; BROWN AHD, 1975, THEOR POPUL BIOL, V8, P184, DOI 10.1016/0040-5809(75)90031-3; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; CHAKRABORTY R, 1986, YEARB PHYS ANTHROPOL, V29, P1; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P3071, DOI 10.1073/pnas.85.9.3071; Clegg M. T., 1984, Oxford Surveys in Evolutionary Biology, V1, P160; DEAN M, 1994, AM J HUM GENET, V55, P788; GILBERT DA, 1990, AM J HUM GENET, V47, P499; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KOZAK CA, 1993, GENETIC MAPS LOCUS M; LANDER ES, 1986, COLD SPRING HARB SYM, V51, P49, DOI 10.1101/SQB.1986.051.01.007; LEWONTIN RC, 1960, EVOLUTION, V14, P458, DOI 10.2307/2405995; LITT M, 1989, AM J HUM GENET, V44, P397; McKusick V. A. E., 1991, MENDELIAN INHERITANC; NEI M, 1973, GENETICS, V75, P213; OBRIEN SJ, 1971, NATURE, V230, P335, DOI 10.1038/230335a0; OBRIEN SJ, 1988, TRENDS ECOL EVOL, V3, P254, DOI 10.1016/0169-5347(88)90058-4; PODUSLO SE, 1991, AM J HUM GENET, V49, P106; Risch NJ, 1992, AM J HUM GENET S, V51, P13; Roychoudhury AK, 1988, HUMAN POLYMORPHIC GE; SCHWEDER T, 1982, BIOMETRIKA, V69, P493; STEPHENS JC, 1990, SCIENCE, V250, P237, DOI 10.1126/science.2218527; TODD JA, 1988, NATURE, V333, P710, DOI 10.1038/333710a0; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; Weir, 1990, GENETIC DATA ANAL ME; 1993, CELL, V72, P971	32	175	181	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1994	55	4					809	824						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PJ027	7942858				2022-12-18	WOS:A1994PJ02700023
J	HUFF, V; MIWA, H; HABER, DA; CALL, KM; HOUSMAN, D; STRONG, LC; SAUNDERS, GF				HUFF, V; MIWA, H; HABER, DA; CALL, KM; HOUSMAN, D; STRONG, LC; SAUNDERS, GF			EVIDENCE FOR WTI AS A WILMS-TUMOR (WT) GENE - INTRAGENIC GERMINAL DELETION IN BILATERAL WT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMOSOMAL BAND-11P13; INTERSTITIAL DELETION; BAND 11P13; SHORT ARM; ANIRIDIA; ALLELES; ASSOCIATION; MARKERS; DENOVO	The inactivation of two alleles at a locus on the short arm of chromosome 11 (band 11p13) has been suggested to be critical steps in the development of Wilms tumor (WT), a childhood kidney tumor. Two similar candidate WT cDNA clones (WT33 and LK15) have recently been identified on the basis of both their expression in fetal kidney and their location within the smallest region of overlap of somatic 11p13 deletions in some tumors. These homozygous deletions, however, are large and potentially affect more than one gene. Using a cDNA probe to the candidate gene, we have analyzed DNA from both normal and tumor tissue from WT patients, in an effort to detect rearrangements at this locus. We report here a patient with bilateral WT who is heterozygous for a small (< 11 kb) germinal deletion within this candidate gene. DNA from both tumors is homozygous for this intragenic deletion allele, which, by RNA-PRC sequence analysis, is predicted to encode a protein truncated by 180 amino acids. These data support the identification of this locus as an 11p13 WT gene (WT1) and provide direct molecular data supporting the two-hit mutational model for WT.	UNIV TEXAS,MD ANDERSON CANC CTR,DEPT BIOCHEM & MOLEC BIOL,1515 HOLCOMBE BLVD,HOUSTON,TX 77030; UNIV TEXAS,MD ANDERSON CANC CTR,DEPT EXPTL PEDIAT GENET,HOUSTON,TX 77030; MIT,CTR CANC RES,CAMBRIDGE,MA 02139	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Massachusetts Institute of Technology (MIT)								BRESLOW N, 1988, CANCER RES, V48, P1653; BRESLOW NE, 1982, JNCI-J NATL CANCER I, V68, P429; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; FEARON ER, 1984, NATURE, V309, P176, DOI 10.1038/309176a0; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; GRUNDY P, 1988, NATURE, V336, P374, DOI 10.1038/336374a0; HABER DA, 1990, CELL, V61, P1257, DOI 10.1016/0092-8674(90)90690-G; HENRY I, 1989, P NATL ACAD SCI USA, V86, P3247, DOI 10.1073/pnas.86.9.3247; HITTNER HM, 1979, OPHTHALMOLOGY, V86, P1173; HOLM T, 1988, NUCLEIC ACIDS RES, V16, P4746, DOI 10.1093/nar/16.10.4746; HUFF V, 1988, NATURE, V336, P377, DOI 10.1038/336377a0; HUFF V, 1990, AM J HUM GENET, V47, P155; HUFF V, 1990, HUM GENET, V84, P253; KANEKO Y, 1981, CANCER RES, V41, P4577; KNUDSON AG, 1972, J NATL CANCER I, V48, P313; KOUFOS A, 1984, NATURE, V309, P170, DOI 10.1038/309170a0; KOUSSEFF BG, 1981, J PEDIATR, V96, P676; LAVEDAN C, 1989, CYTOGENET CELL GENET, V50, P70, DOI 10.1159/000132726; MANNENS M, 1988, HUM GENET, V81, P41, DOI 10.1007/BF00283727; MATSUNAGA E, 1981, HUM GENET, V57, P231; NAKAGOME Y, 1985, HUM GENET, V70, P289; ORKIN SH, 1984, NATURE, V309, P172, DOI 10.1038/309172a0; PORTEOUS DJ, 1987, P NATL ACAD SCI USA, V84, P5355, DOI 10.1073/pnas.84.15.5355; PRITCHARDJONES K, 1990, NATURE, V346, P194, DOI 10.1038/346194a0; REEVE AE, 1984, NATURE, V309, P174, DOI 10.1038/309174a0; RICCARDI VM, 1978, PEDIATRICS, V61, P604; SCHROEDER WT, 1987, AM J HUM GENET, V40, P413; SLATER RM, 1982, CANCER GENET CYTOGEN, V5, P237, DOI 10.1016/0165-4608(82)90030-9; STROBEL JR, 1980, AM J MED GENET, V7, P15; VANHEYNINGEN V, 1990, P NATL ACAD SCI USA, V87, P5383, DOI 10.1073/pnas.87.14.5383; YUNIS JJ, 1980, J PEDIATR-US, V96, P1027, DOI 10.1016/S0022-3476(80)80630-5	32	175	176	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1991	48	5					997	1003						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK897	1673293				2022-12-18	WOS:A1991FK89700020
J	LYON, MF				LYON, MF			THE ALLAN,WILLIAM MEMORIAL AWARD ADDRESS - X-CHROMOSOME INACTIVATION AND THE LOCATION AND EXPRESSION OF X-LINKED GENES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											LYON, MF (corresponding author), MRC, RADIOBIOL UNIT, DIDCOT OX11 ORD, OXON, ENGLAND.							AVNER P, 1987, P NATL ACAD SCI USA, V84, P1629, DOI 10.1073/pnas.84.6.1629; BALLABIO A, 1986, HUM GENET, V72, P237, DOI 10.1007/BF00291885; BERNING AK, 1980, J IMMUNOL, V124, P1875; BROCKDORFF N, 1987, NATURE, V328, P166, DOI 10.1038/328166a0; BUCKLE VJ, 1985, CYTOGENET CELL GENET, V40, P594; CARPENTER NJ, 1983, CYTOGENETICS MAMMA B, P211; CATTANACH BM, 1986, J EMBRYOL EXP MORPH, V97, P137; CATTANACH BM, 1974, GENET RES, V23, P291, DOI 10.1017/S0016672300014932; CHANDRA HS, 1975, NATURE, V253, P165, DOI 10.1038/253165a0; CHAPMAN V, 1984, NATURE, V307, P284, DOI 10.1038/307284a0; COOPER DW, 1977, AUST J BIOL SCI, V30, P431, DOI 10.1071/BI9770431; CRAIG IW, 1986, TRENDS GENET, V2, P201, DOI 10.1016/0168-9525(86)90230-1; ENDO S, 1981, JPN J GENET, V56, P349, DOI 10.1266/jjg.56.349; GARDNER RL, 1985, J EMBRYOL EXP MORPH, V88, P349; HAPPLE R, 1983, HUM GENET, V63, P24, DOI 10.1007/BF00285392; HARRISON KB, 1986, CYTOGENET CELL GENET, V41, P163, DOI 10.1159/000132221; HEILIG R, 1987, NATURE, V328, P168, DOI 10.1038/328168a0; HODGSON S, 1986, HUM GENET, V74, P409, DOI 10.1007/BF00280495; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; JOHNSTON PG, 1978, AUST J BIOL SCI, V31, P415, DOI 10.1071/BI9780415; KAUFMAN MH, 1978, NATURE, V271, P547, DOI 10.1038/271547a0; KEITGES E, 1985, NATURE, V315, P226, DOI 10.1038/315226a0; KRATZER PG, 1983, CELL, V33, P37, DOI 10.1016/0092-8674(83)90332-X; KRUMLAUF R, 1986, NATURE, V319, P224, DOI 10.1038/319224a0; KUNKEL LM, 1986, NATURE, V322, P73, DOI 10.1038/322073a0; LISKAY RM, 1980, P NATL ACAD SCI-BIOL, V77, P4895, DOI 10.1073/pnas.77.8.4895; LOCK LF, 1986, MOL CELL BIOL, V6, P914, DOI 10.1128/MCB.6.3.914; LUZZATTO L, 1985, ADV HUM GENET, V14, P217; LYON MARY F., 1966, ADVANCE TERATOLOGY, V1, P25; LYON MF, 1986, P NATL ACAD SCI USA, V83, P4899, DOI 10.1073/pnas.83.13.4899; LYON MF, 1962, AM J HUM GENET, V14, P135; LYON MF, 1986, J EMBRYOL EXP MORPH, V97, P75; LYON MF, 1984, DIFFERENTIATION, V26, P63, DOI 10.1111/j.1432-0436.1984.tb01375.x; Lyon MF, 1986, MOUSE NEWS LETT, V74, P93; LYON MF, 1963, 2ND INT C CONG MALF; MACHLER M, 1986, HUM GENET, V73, P271, DOI 10.1007/BF00401243; MARTIN GR, 1978, NATURE, V271, P329, DOI 10.1038/271329a0; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; MCGRATH J, 1986, J EMBRYOL EXP MORPH, V97, P277; MENSINK EJBM, 1986, HUM GENET, V73, P327, DOI 10.1007/BF00279095; MIGEON BR, 1982, NATURE, V299, P838, DOI 10.1038/299838a0; MIGEON BR, 1985, P NATL ACAD SCI USA, V82, P3390, DOI 10.1073/pnas.82.10.3390; MIGEON BR, 1986, P NATL ACAD SCI USA, V83, P2182, DOI 10.1073/pnas.83.7.2182; MOLLON JD, 1984, PROC R SOC SER B-BIO, V222, P373, DOI 10.1098/rspb.1984.0071; MOLLON JD, 1986, NATURE, V323, P578, DOI 10.1038/323578a0; MONACO AP, 1987, TRENDS GENET, V3, P33, DOI 10.1016/0168-9525(87)90163-6; MONK M, 1979, NATURE, V281, P311, DOI 10.1038/281311a0; MONK M, 1986, BIOESSAYS, V4, P204, DOI 10.1002/bies.950040505; MONK M, 1987, DEVELOPMENT, V99, P371; MULLINS LJ, 1987, MOUSE NEWS LETT, V77, P150; MUNKE M, 1983, EUR J PEDIATR, V141, P8, DOI 10.1007/BF00445661; NEITZ J, 1986, NATURE, V323, P623, DOI 10.1038/323623a0; Ohno S., 1967, SEX CHROMOSOMES SEX; PAPAIOANNOU VE, 1981, GENET RES, V37, P183, DOI 10.1017/S0016672300020152; Perrin J C, 1976, Birth Defects Orig Artic Ser, V12, P267; RASTAN S, 1982, J EMBRYOL EXP MORPH, V71, P11; RASTAN S, 1983, J EMBRYOL EXP MORPH, V78, P1; RASTAN S, 1980, NATURE, V288, P172, DOI 10.1038/288172a0; READ AP, 1986, HUM GENET, V73, P267, DOI 10.1007/BF00401242; RIGGS AD, 1975, CYTOGENET CELL GENET, V14, P9, DOI 10.1159/000130315; Russell L B, 1978, Basic Life Sci, V12, P393; Russell L. B., 1983, Cytogenetics of the mammalian X chromosome. Part A. Basic mechanisms of X chromosome behavior., P205; RUSSELL LB, 1970, GENETICS, V64, P281; RUSSELL LB, 1963, SCIENCE, V140, P976, DOI 10.1126/science.140.3570.976; SAGER R, 1975, SCIENCE, V189, P426, DOI 10.1126/science.1098145; SANFORD J, 1984, NUCLEIC ACIDS RES, V12, P2823, DOI 10.1093/nar/12.6.2823; SANFORD JP, 1985, TRENDS GENET, V1, P89, DOI 10.1016/0168-9525(85)90033-2; Seegmiller J E, 1976, Adv Hum Genet, V6, P75; SHAPIRO LJ, 1985, ADV HUM GENET, V14, P331; SUGAWARA O, 1985, CYTOGENET CELL GENET, V39, P210, DOI 10.1159/000132137; SURANI MAH, 1986, J EMBRYOL EXP MORPH, V97, P123; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; Takagi N., 1978, Genetic mosaics and chimeras in mammals., P341; TAKAGI N, 1980, CHROMOSOMA, V81, P439, DOI 10.1007/BF00368155; TAKAGI N, 1983, EXP CELL RES, V145, P397, DOI 10.1016/0014-4827(83)90018-6; TAKAGI N, 1983, CELL, V34, P1053, DOI 10.1016/0092-8674(83)90563-9; TRAUPE H, 1984, CLIN GENET, V25, P42; TSUKAHARA M, 1985, HUM GENET, V71, P7, DOI 10.1007/BF00295658; WAREHAM KA, 1987, NATURE, V327, P725, DOI 10.1038/327725a0; ZUFFARDI O, 1983, CYTOGENETICS MAMMA B, P193	80	175	176	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1988	42	1					8	16						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	L8697	3276178				2022-12-18	WOS:A1988L869700002
J	Jakkula, E; Leppa, V; Sulonen, AM; Varilo, T; Kallio, S; Kemppinen, A; Purcell, S; Koivisto, K; Tienari, P; Sumelahti, ML; Elovaara, I; Pirttila, T; Reunanen, M; Aromaa, A; Oturai, AB; Sondergaard, HB; Harbo, HF; Mero, IL; Gabriel, SB; Mirel, DB; Hauser, SL; Kappos, L; Polman, C; De Jager, PL; Hafler, DA; Daly, MJ; Palotie, A; Saarela, J; Peltonen, L				Jakkula, Eveliina; Leppa, Virpi; Sulonen, Anna-Maija; Varilo, Teppo; Kallio, Suvi; Kemppinen, Anu; Purcell, Shaun; Koivisto, Keijo; Tienari, Pentti; Sumelahti, Maria-Liisa; Elovaara, Irina; Pirttila, Tuula; Reunanen, Mauri; Aromaa, Arpo; Oturai, Annette Bang; Sondergaard, Helle Bach; Harbo, Hanne F.; Mero, Inger-Lise; Gabriel, Stacey B.; Mirel, Daniel B.; Hauser, Stephen L.; Kappos, Ludwig; Polman, Chris; De Jager, Philip L.; Hafler, David A.; Daly, Mark J.; Palotie, Aarno; Saarela, Janna; Peltonen, Leena			Genome-wide Association Study in a High-Risk Isolate for Multiple Sclerosis Reveals Associated Variants in STAT3 Gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HYPER-IGE SYNDROME; SUSCEPTIBILITY LOCI; FINLAND; REPLICATION; MUTATIONS; RECEPTOR; FAMILIES; DISEASE; CD58; DYSTROGLYCAN	Genetic risk for multiple sclerosis (MS) is thought to involve both common and rare risk alleles. Recent GWAS and subsequent meta-analysis have established the critical role of the HLA locus and identified new common variants associated to MS. These variants have small odds ratios (ORs) and explain only a fraction of the genetic risk. To expose potentially rare, high-impact alleles, we conducted a GWAS of 68 distantly related cases and 136 controls from a high-risk internal isolate of Finland with increased prevalence and familial occurrence of MS. The top 27 loci with 1) < 10(-4) were tested in 711 cases and 1029 controls from Finland, and the top two findings were validated in 3859 cases and 9110 controls from more heterogeneous populations. SNP (rs744166) within the STAT-3 gene was associated to MS (p = 2.75 x 10(-10), OR 0.87, confidence interval 0.83-0.91). The protective haplotype for MS in STAT3 is a risk allele for Crohn disease, implying that STAT3 represents a shared risk locus for at least two autoimmune diseases. This study also demonstrates the potential of special isolated populations in search for variants contributing to complex traits.	[Jakkula, Eveliina; Leppa, Virpi; Sulonen, Anna-Maija; Varilo, Teppo; Kallio, Suvi; Kemppinen, Anu; Palotie, Aarno; Saarela, Janna; Peltonen, Leena] Univ Helsinki, Inst Mol Med Finland, FIN-00290 Helsinki, Finland; [Leppa, Virpi] Univ Helsinki, Helsinki Biomed Grad Sch, FIN-00290 Helsinki, Finland; [Varilo, Teppo; Peltonen, Leena] Univ Helsinki, Dept Med Genet, FIN-00290 Helsinki, Finland; [Tienari, Pentti] Univ Helsinki, Biomedicum Helsinki, Dept Neurol, Neurosci Programme, FIN-00290 Helsinki, Finland; [Jakkula, Eveliina; Leppa, Virpi; Sulonen, Anna-Maija; Varilo, Teppo; Kallio, Suvi; Kemppinen, Anu; Saarela, Janna; Peltonen, Leena] Natl Inst Hlth & Welf, Unit Publ Hlth Genom, Helsinki 00271, Finland; [Aromaa, Arpo] Natl Inst Hlth & Welf, Unit Living Condit Hlth & Wellbeing, Helsinki 00271, Finland; [Jakkula, Eveliina; Purcell, Shaun; Gabriel, Stacey B.; Mirel, Daniel B.; De Jager, Philip L.; Daly, Mark J.; Palotie, Aarno; Peltonen, Leena] MIT & Harvard, Broad Inst, Program Med & Populat Genet & Genet Anal Platform, Cambridge, MA 02142 USA; [Purcell, Shaun; Daly, Mark J.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Koivisto, Keijo] Cent Hosp Seinajoki, Seinajoki 60220, Finland; [Sumelahti, Maria-Liisa] Tampere Univ, Sch Publ Hlth, Tampere 33014, Finland; [Elovaara, Irina] Tampere Univ Hosp, Dept Neurol, Tampere 33521, Finland; [Pirttila, Tuula] Kuopio Univ Hosp, Dept Neurol & Neurosci, Kuopio 70211, Finland; [Reunanen, Mauri] Oulu Univ Hosp, Dept Neurol, Oulu 90014, Finland; [Oturai, Annette Bang; Sondergaard, Helle Bach] Univ Copenhagen Hosp, Rigshosp, Danish Multiple Sclerosis Res Ctr, DK-2100 Copenhagen, Denmark; [Harbo, Hanne F.; Mero, Inger-Lise] Oslo Univ Hosp, Dept Neurol, Ulleval, Norway; [Harbo, Hanne F.; Mero, Inger-Lise] Univ Oslo, N-0407 Oslo, Norway; [Mero, Inger-Lise] Oslo Univ Hosp, Rikshosp, Inst Immunol, N-0027 Oslo, Norway; [Hauser, Stephen L.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Kappos, Ludwig] Univ Basel, Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland; [Kappos, Ludwig] Univ Basel, Univ Basel Hosp, Dept Neuroradiol & Biomed, CH-4031 Basel, Switzerland; [Polman, Chris] Vrije Univ Amsterdam, Med Ctr, Dept Neurol, NL-1085 Amsterdam, Netherlands; [De Jager, Philip L.] Brigham & Womens Hosp, Program Translat NeuroPsychiat Genorn, Boston, MA 02035 USA; [Hafler, David A.] Brigham & Womens Hosp, Dept Neurol, Div Mol Immunol, Boston, MA 02035 USA; [Hafler, David A.] Harvard Univ, Sch Med, Boston, MA 02035 USA; [Hafler, David A.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06520 USA; [Palotie, Aarno; Peltonen, Leena] Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Seinajoki Central Hospital; Tampere University; Tampere University; Tampere University Hospital; Kuopio University Hospital; University of Eastern Finland; University of Oulu; Rigshospitalet; University of Copenhagen; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of California System; University of California San Francisco; University of Basel; University of Basel; Vrije Universiteit Amsterdam; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Yale University; Wellcome Trust Sanger Institute	Peltonen, L (corresponding author), Univ Helsinki, Inst Mol Med Finland, FIN-00290 Helsinki, Finland.	leena@sanger.ac.uk	Hauser, Stephen L/J-2978-2016; Tienari, Pentti J/A-4893-2012; Saarela, Janna S/E-5369-2014; Daly, Mark J/B-2453-2017	Daly, Mark J/0000-0002-0949-8752; Sulonen, Anna-Maija/0000-0002-5518-1975; Palotie, Aarno/0000-0002-2527-5874; Leppa, Virpi/0000-0003-2942-2656; Varilo, Teppo/0000-0002-5839-8854; Saarela, Janna/0000-0002-0853-6219	NCRR NIH HHS [U54 RR020278] Funding Source: Medline; NIMH NIH HHS [R01 MH071425] Funding Source: Medline; NINDS NIH HHS [R01 NS043559, R01 NS 43559] Funding Source: Medline; Wellcome Trust [089061/Z/09/Z] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043559] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Ban M, 2009, EUR J HUM GENET, V17, P1309, DOI 10.1038/ejhg.2009.41; Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Booth DR, 2009, GENES IMMUN, V10, P11, DOI 10.1038/gene.2008.83; Brynedal B, 2009, P NATL ACAD SCI USA, V106, pE58, DOI 10.1073/pnas.0904338106; Carteron C, 2006, J CELL SCI, V119, P898, DOI 10.1242/jcs.02799; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Colognato H, 2002, NAT CELL BIOL, V4, P833, DOI 10.1038/ncb865; Colognato H, 2007, DEVELOPMENT, V134, P1723, DOI 10.1242/dev.02819; Compston A, 1997, J NEUROL NEUROSUR PS, V62, P553, DOI 10.1136/jnnp.62.6.553; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; De Jager PL, 2009, P NATL ACAD SCI USA, V106, P5264, DOI 10.1073/pnas.0813310106; Dyment DA, 2001, NEUROGENETICS, V3, P145, DOI 10.1007/s100480100113; EBERS GC, 1995, NATURE, V377, P150, DOI 10.1038/377150a0; Egwuagu CE, 2009, CYTOKINE, V47, P149, DOI 10.1016/j.cyto.2009.07.003; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Garcia RAG, 2000, P NATL ACAD SCI USA, V97, P3596, DOI 10.1073/pnas.070042497; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Haines JL, 2002, HUM MOL GENET, V11, P2251; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Jakkula E, 2008, AM J HUM GENET, V83, P787, DOI 10.1016/j.ajhg.2008.11.005; JERSILD C, 1972, ACTA NEUROL SCAND, V48, P377; Kallio SP, 2009, HUM MOL GENET, V18, P1670, DOI 10.1093/hmg/ddp073; Kuokkanen S, 1996, NAT GENET, V13, P477, DOI 10.1038/ng0896-477; Kuokkanen S, 1997, AM J HUM GENET, V61, P1379, DOI 10.1086/301637; Lincoln MR, 2005, NAT GENET, V37, P1108, DOI 10.1038/ng1647; Liu XB, 2008, J IMMUNOL, V180, P6070, DOI 10.4049/jimmunol.180.9.6070; Longman C, 2003, HUM MOL GENET, V12, P2853, DOI 10.1093/hmg/ddg307; Lorentzen AR, 2008, J NEUROIMMUNOL, V197, P152, DOI 10.1016/j.jneuroim.2008.04.037; Lundmark F, 2007, J NEUROIMMUNOL, V192, P171, DOI 10.1016/j.jneuroim.2007.08.015; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; MUMFORD CJ, 1994, NEUROLOGY, V44, P11, DOI 10.1212/WNL.44.1.11; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rubio JP, 2008, GENES IMMUN, V9, P624, DOI 10.1038/gene.2008.59; Saarela J, 2002, HUM MOL GENET, V11, P2257, DOI 10.1093/hmg/11.19.2257; Saarela J, 2006, PLOS GENET, V2, P364, DOI 10.1371/journal.pgen.0020042; Stensland HNFR, 2005, J NEUROIMMUNOL, V170, P122, DOI 10.1016/j.jneuroim.2005.08.004; Sulonen AM, 2009, J NEUROIMMUNOL, V206, P86, DOI 10.1016/j.jneuroim.2008.10.005; Sumelahti ML, 2000, NEUROEPIDEMIOLOGY, V19, P67, DOI 10.1159/000026241; Sumelahti ML, 2001, ACTA NEUROL SCAND, V103, P153, DOI 10.1034/j.1600-0404.2001.103003153.x; Tienari Pentti J., 1993, European Journal of Human Genetics, V1, P257; Tienari PJ, 2004, CLIN NEUROL NEUROSUR, V106, P175, DOI 10.1016/j.clineuro.2004.02.009; VARILO T, 1999, AGE MUTATIONS FINNIS; WIKSTROM J, 1975, ACTA NEUROL SCAND, V51, P173, DOI 10.1111/j.1600-0404.1975.tb07598.x; WIKSTROM J, 1975, ACTA NEUROL SCAND, V51, P85; Yeo TW, 2007, ANN NEUROL, V61, P228, DOI 10.1002/ana.21063; Zoledziewska M, 2009, GENES IMMUN, V10, P15, DOI 10.1038/gene.2008.84	54	174	181	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 12	2010	86	2					285	291		10.1016/j.ajhg.2010.01.017	http://dx.doi.org/10.1016/j.ajhg.2010.01.017			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	556ZS	20159113	Green Published, Bronze			2022-12-18	WOS:000274637200020
J	Berkovic, SE; Dibbens, LM; Oshlack, A; Silver, JD; Katerelos, M; Vears, DF; Lullmann-Rauch, R; Blanz, J; Zhang, KW; Stankovich, J; Kalnins, RM; Dowling, JP; Andermann, E; Andermann, F; Faldini, E; D'Hooge, R; Vadlamudi, L; Macdonell, RA; Hodgson, BL; Bayly, MA; Savige, J; Mulley, JC; Smyth, GK; Power, DA; Saftig, P; Bahlo, M				Berkovic, Samuel E.; Dibbens, Leanne M.; Oshlack, Alicia; Silver, Jeremy D.; Katerelos, Marina; Vears, Danya F.; Luellmann-Rauch, Renate; Blanz, Judith; Zhang, Ke Wei; Stankovich, Jim; Kalnins, Renate M.; Dowling, John P.; Andermann, Eva; Andermann, Frederick; Faldini, Enrico; D'Hooge, Rudi; Vadlamudi, Lata; Macdonell, Richard A.; Hodgson, Bree L.; Bayly, Marta A.; Savige, Judy; Mulley, John C.; Smyth, Gordon K.; Power, David A.; Saftig, Paul; Bahlo, Melanie			Array-based gene discovery with three unrelated subjects shows SCARB2/LIMP-2 deficiency causes myoclonus epilepsy and glomerulosclerosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RENAL FAILURE SYNDROME; LINKAGE ANALYSIS; MOUSE MODEL; DISEASE; AUTOPHAGY; MICE; NEURODEGENERATION; IDENTIFICATION; PLEIOTROPY; EXPRESSION	Action myoclonus-renal failure syndrome (AMRF) is an autosomal-recessive disorder with the remarkable combination of focal glomerulosclerosis, frequently with glomerular collapse, and progressive myoclonus epilepsy associated with storage material in the brain. Here, we employed a novel combination of molecular strategies to find the responsible gene and show its effects in an animal model. Utilizing only three unrelated affected individuals and their relatives, we used homozygosity mapping with single-nucleotide polymorphism chips to localize AMRF. We then used microarray-expression analysis to prioritize candidates prior to sequencing. The disorder was mapped to 4q1-21, and microarray-expression analysis identified SCARB2/Limp2, which encodes a lysosomal-membrane protein, as the likely candidate. Mutations in SCARB2/Limp2 were found in all three families used for mapping and subsequently confirmed in two other unrelated AMRF families. The mutations were associated with lack of SCARB2 protein. Reanalysis of an existing Limp2 knockout mouse showed intracellular inclusions in cerebral and cerebellar cortex, and the kidneys showed subtle glomerular changes. This study highlights that recessive genes can be identified with a very small number of subjects. The ancestral lysosomal-membrane protein SCARB2/LIMP-2 is responsible for AMRF. The heterogeneous pathology in the kidney and brain suggests that SCARB2/Limp2 has pleiotropic effects that may be relevant to understanding the pathogenesis of other forms of glomerulosclerosis or collapse and myoclonic epilepsies.	[Berkovic, Samuel E.; Vears, Danya F.; Zhang, Ke Wei; Savige, Judy] Austin Hlth & No Hlth, Dept Med, Heidelberg, Vic 3081, Australia; [Berkovic, Samuel E.; Vears, Danya F.; Vadlamudi, Lata] Univ Melbourne, Epilepsy Res Ctr, Heidelberg West, Vic 3081, Australia; [Berkovic, Samuel E.; Kalnins, Renate M.; Macdonell, Richard A.; Power, David A.] Austin Hlth, Dept Nephrol, Heidelberg, Vic 3081, Australia; [Berkovic, Samuel E.; Kalnins, Renate M.; Macdonell, Richard A.; Power, David A.] Austin Hlth, Dept Nephrol & Anat Pathol, Heidelberg, Vic 3081, Australia; [Dibbens, Leanne M.; Hodgson, Bree L.; Bayly, Marta A.; Mulley, John C.] Womens & Childrens Hosp, Dept Med Genet, Adelaide, SA 5006, Australia; [Oshlack, Alicia; Silver, Jeremy D.; Stankovich, Jim; Smyth, Gordon K.; Bahlo, Melanie] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Silver, Jeremy D.] Univ Melbourne, Dept Math & Stat, Parkville, Vic 3052, Australia; [Katerelos, Marina; Power, David A.] Austin Hlth, Burnett Inst Austin, Heidelberg, Vic 3081, Australia; [Luellmann-Rauch, Renate] Univ Kiel, Inst Anat, D-24098 Kiel, Germany; [Blanz, Judith] Univ Gottingen, Biochem Abt 2, Zentrum Biochem & Mol Zellbiol, D-37073 Gottingen, Germany; [Stankovich, Jim] Univ Tasmania, Menzies Res Inst, Hobart, Tas 7000, Australia; [Dowling, John P.] Alfred Hosp, Dept Anat Pathol, Prahran, Vic 3181, Australia; [Andermann, Eva; Andermann, Frederick] Hosp McGill Univ, Montreal, PQ H3A 2B4, Canada; [Andermann, Eva; Andermann, Frederick] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Faldini, Enrico; D'Hooge, Rudi] Univ Louvain, Lab Biol Psychol, B-3000 Louvain, Belgium; [Mulley, John C.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5081, Australia; [Saftig, Paul] Univ Kiel, Dept Biochem, D-24098 Kiel, Germany; [Dibbens, Leanne M.; Mulley, John C.] Univ Adelaide, Sch Pediat & Reprod Hlth, Adelaide, SA 5081, Australia	Austin Research Institute; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Womens & Childrens Hospital Australia; Walter & Eliza Hall Institute; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Kiel; University of Gottingen; University of Tasmania; Menzies Institute for Medical Research; Florey Institute of Neuroscience & Mental Health; McGill University; University of Adelaide; University of Kiel; University of Adelaide	Berkovic, SE (corresponding author), Austin Hlth & No Hlth, Dept Med, Heidelberg, Vic 3081, Australia.	s.berkovic@unimelb.edu.au	Power, David/AAM-6012-2021; jiang, yu/HGU-0029-2022; Smyth, Gordon/B-5276-2008; Vadlamudi, Lata/F-5044-2010; Bayly, Marta A/F-3977-2013; Oshlack, Alicia/P-6139-2014; Saftig, Paul/A-7966-2010; Silver, Jeremy/Y-4174-2019	Power, David/0000-0003-3983-0581; Smyth, Gordon/0000-0001-9221-2892; Vadlamudi, Lata/0000-0002-8742-0125; Oshlack, Alicia/0000-0001-9788-5690; Silver, Jeremy/0000-0003-1502-6249; Berkovic, Samuel/0000-0003-4580-841X; Savige, Judy/0000-0002-6813-0288; Bahlo, Melanie/0000-0001-5132-0774; Bayly, Marta/0000-0002-6011-4478; Dibbens, Leanne/0000-0002-5824-3342; Stankovich, Jim/0000-0001-9344-7749				Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Alakurtti K, 2005, EUR J HUM GENET, V13, P208, DOI 10.1038/sj.ejhg.5201300; Andermann E, 1986, Adv Neurol, V43, P87; Badhwar A, 2004, BRAIN, V127, P2173, DOI 10.1093/brain/awh263; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERKOVIC SF, 1988, BRAIN, V111, P27, DOI 10.1093/brain/111.1.27; CALVO D, 1995, GENOMICS, V25, P100, DOI 10.1016/0888-7543(95)80114-2; Cao Y, 2006, J BIOL CHEM, V281, P20483, DOI 10.1074/jbc.M602180200; Di XJ, 2005, BIOINFORMATICS, V21, P1958, DOI 10.1093/bioinformatics/bti275; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; FUJITA H, 1992, BIOCHEM BIOPH RES CO, V184, P604, DOI 10.1016/0006-291X(92)90632-U; Gamp AC, 2003, HUM MOL GENET, V12, P631, DOI 10.1093/hmg/ddg062; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; He XL, 2006, GENETICS, V173, P1885, DOI 10.1534/genetics.106.060269; Hinkes B, 2006, NAT GENET, V38, P1397, DOI 10.1038/ng1918; Hodgkin J, 1998, INT J DEV BIOL, V42, P501; Karp CL, 2000, NAT IMMUNOL, V1, P221, DOI 10.1038/79759; Knipper M, 2006, J PHYSIOL-LONDON, V576, P73, DOI 10.1113/jphysiol.2006.116889; Koike M, 2005, AM J PATHOL, V167, P1713, DOI 10.1016/S0002-9440(10)61253-9; Kuronita T, 2002, J CELL SCI, V115, P4117, DOI 10.1242/jcs.00075; Leutenegger AL, 2006, AM J HUM GENET, V79, P62, DOI 10.1086/504640; Martinez-Vicente M, 2007, LANCET NEUROL, V6, P352, DOI 10.1016/S1474-4422(07)70076-5; Mole SE, 2006, EUR J PAEDIATR NEURO, V10, P255, DOI 10.1016/j.ejpn.2006.08.009; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Park JK, 2003, PEDIATR RES, V53, P387, DOI 10.1203/01.PDR.0000049515.79882.94; Pennacchio LA, 1998, NAT GENET, V20, P251, DOI 10.1038/3059; Quaggin SE, 2006, NAT GENET, V38, P1360, DOI 10.1038/ng1206-1360; Reczek D, 2007, CELL, V131, P770, DOI 10.1016/j.cell.2007.10.018; Rothdach AJ, 2001, NERVENARZT, V72, P636, DOI 10.1007/s001150170065; Schroen B, 2007, J EXP MED, V204, P1227, DOI 10.1084/jem.20070145; Shacka JJ, 2007, J NEUROSCI, V27, P2081, DOI 10.1523/JNEUROSCI.5577-06.2007; Shah SN, 2006, CURR OPIN NEPHROL HY, V15, P450, DOI 10.1097/01.mnh.0000232887.58271.67; Shahwan A, 2005, LANCET NEUROL, V4, P239, DOI 10.1016/S1474-4422(05)70043-0; Shannon P, 2002, J NEUROPATH EXP NEUR, V61, P1085, DOI 10.1093/jnen/61.12.1085; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; SMYTH GK, 2004, STAT APPL GENET MOL, V3; Stankovich J, 2005, HUM GENET, V117, P188, DOI 10.1007/s00439-005-1279-y; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; Vadlamudi L, 2006, NEUROLOGY, V67, P1310, DOI 10.1212/01.wnl.0000238424.23177.5e; Vierimaa O, 2006, SCIENCE, V312, P1228, DOI 10.1126/science.1126100; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683	43	174	184	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2008	82	3					673	684		10.1016/j.ajhg.2007.12.019	http://dx.doi.org/10.1016/j.ajhg.2007.12.019			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	275JN	18308289	Green Published, Bronze			2022-12-18	WOS:000254067800012
J	Bondurand, N; Dastot-Le Moal, F; Stanchina, L; Collot, N; Baral, V; Marlin, S; Attie-Bitach, T; Giurgea, I; Skopinski, L; Reardon, W; Toutain, A; Sarda, P; Echaieb, A; Lackmy-Port-Lis, M; Touraine, R; Amiel, J; Goossens, M; Pingault, V				Bondurand, Nadege; Dastot-Le Moal, Florence; Stanchina, Laure; Collot, Nathalie; Baral, Viviane; Marlin, Sandrine; Attie-Bitach, Tania; Giurgea, Irina; Skopinski, Laurent; Reardon, William; Toutain, Annick; Sarda, Pierre; Echaieb, Anis; Lackmy-Port-Lis, Marilyn; Touraine, Renaud; Amiel, Jeanne; Goossens, Michel; Pingault, Veronique			Deletions at the SOX10 gene locus cause Waardenburg syndrome types 2 and 4	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSCRIPTION FACTOR SOX10; CHRONIC INTESTINAL PSEUDOOBSTRUCTION; NEURAL CREST DEVELOPMENT; AUTOSOMAL SEX REVERSAL; OF-THE-LITERATURE; SHAH WS4 SYNDROME; SRY-RELATED GENE; HIRSCHSPRUNG-DISEASE; CAMPOMELIC DYSPLASIA; DOPACHROME-TAUTOMERASE	Waardenburg syndrome (WS) is an auditory-pigmentary disorder that exhibits varying combinations of sensorineural hearing loss and abnormal pigmentation of the hair and skin. Depending on additional symptoms, WS is classified into four subtypes, WS-WS4. Absence of additional features characterizes WS2. The association of facial dysmorphic features defines WS1 and WS3, whereas the association with Hirschsprung disease (aganglionic megacolon) characterizes WS4, also called "Waardenburg-Hirschsprung disease." Mutations within the genes MITF and SNAI2 have been identified in WS2, whereas mutations of EDN3, EDNRB, and SOX10 have been observed in patients with WS4. However, not all cases are explained at the molecular level, which raises the possibility that other genes are involved or that some mutations within the known genes are not detected by commonly used genotyping methods. We used a combination of semiquantitative fluorescent multiplex polymerase chain reaction and fluorescent in situ hybridization to search for SOX10 heterozygous deletions. We describe the first characterization of SOX10 deletions in patients presenting with WS4. We also found SOX10 deletions in WS2 cases, making SOX10 a new gene of WS2. Interestingly, neurological phenotypes reminiscent of that observed in WS4 (PCWH syndrome [peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, WS, and Hirschsprung disease]) were observed in some WS2-affected patients with SOX10 deletions. This study further characterizes the molecular complexity and the close relationship that links the different subtypes of WS.	Hop Henri Mondor, Inst Mondor Rech Biomed, ISERM U841, Dept Genet, Equipe 11,51 Ave Marechal Lattre Tassigny, F-94010 Creteil, France; Univ Paris 12, Fac Med, F-94010 Creteil, France; Hop Paris, Grp Henri Mondor Albert Chenevier, Serv Biochim & Genet, Creteil, France; Univ Paris 05 Descartes, Fac Med, Hop Necker,Serv Genet Med, INSERM U781, F-75270 Paris 06, France; Hop Paris, Paris, France; Our Ladys Hosp Sick Children, Dublin, Ireland; Ctr Hosp Univ, Serv Genet, Tours, France; Ctr Hosp Univ, Serv Genet, Montpellier, France; Ctr Hosp Univ Fort France, Hop Pierre Zobda, Serv Chirurg Infantile, Fort De France, France; Univ Pointe Pitre, Ctr Hosp, Serv Pediat, Pointe A Pitre, Guadeloupe, France; Univ Hop Nord, Ctr Hosp, Serv Genet, St Etienne, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Our Ladys Children Hospital Crumlin; CHU Tours; Universite de Montpellier; CHU de Montpellier; CHU Martinique; CHU Guadeloupe; CHU de St Etienne	Bondurand, N (corresponding author), Hop Henri Mondor, Inst Mondor Rech Biomed, ISERM U841, Dept Genet, Equipe 11,51 Ave Marechal Lattre Tassigny, F-94010 Creteil, France.	nadege.bondurand@creteil.inserm.fr	Bondurand, Nadege/H-4737-2017; Touraine, Renaud/AAV-1605-2020; amiel, jeanne/AGX-1124-2022; ATTIE-BITACH, Tania/K-1453-2017; Giurgea, Irina/AGX-6879-2022; amiel, jeanne/H-3501-2017	Bondurand, Nadege/0000-0002-1531-1544; ATTIE-BITACH, Tania/0000-0002-1155-3626; Giurgea, Irina/0000-0002-5035-2958; amiel, jeanne/0000-0001-5973-4728; Chatrousse, Laure/0000-0001-9180-2794; marlin, sandrine/0000-0002-4115-9806; Toutain, Annick/0000-0002-5999-5300; Reardon, Willie/0000-0001-7329-9179; Pingault, Veronique/0000-0001-7064-0765				Amiel J, 2001, J MED GENET, V38, P729, DOI 10.1136/jmg.38.11.729; Antonellis A, 2006, HUM MOL GENET, V15, P259, DOI 10.1093/hmg/ddi442; ATTIE T, 1995, HUM MOL GENET, V4, P1381, DOI 10.1093/hmg/4.8.1381; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; BOLANDE RP, 1974, HUM PATHOL, V5, P409, DOI 10.1016/S0046-8177(74)80021-3; Bonaglia MC, 2006, J MED GENET, V43, P822, DOI 10.1136/jmg.2005.038604; Bondurand N, 2000, HUM MOL GENET, V9, P1907, DOI 10.1093/hmg/9.13.1907; Bondurand N, 1999, HUM MOL GENET, V8, P1785, DOI 10.1093/hmg/8.9.1785; Bondurand N, 2001, HUM MOL GENET, V10, P2783, DOI 10.1093/hmg/10.24.2783; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Brooks AS, 2005, CLIN GENET, V67, P6, DOI 10.1111/j.1399-0004.2004.00319.x; Chakravarti A, 1996, HUM MOL GENET, V5, P303; de Pontual L, 2007, HUM MUTAT, V28, P790, DOI 10.1002/humu.20517; Edery P, 1996, NAT GENET, V12, P442, DOI 10.1038/ng0496-442; Elworthy S, 2003, DEVELOPMENT, V130, P2809, DOI 10.1242/dev.00461; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Girard M, 2006, FEBS LETT, V580, P1635, DOI 10.1016/j.febslet.2006.02.011; Heath KE, 2001, AM J HUM GENET, V69, P1033, DOI 10.1086/324267; Hofstra RMW, 1996, NAT GENET, V12, P445, DOI 10.1038/ng0496-445; Hong CS, 2005, SEMIN CELL DEV BIOL, V16, P694, DOI 10.1016/j.semcdb.2005.06.005; Houlden H, 2004, ANN NEUROL, V56, P730, DOI 10.1002/ana.20267; Inoue K, 2004, NAT GENET, V36, P361, DOI 10.1038/ng1322; Inoue K, 2002, ANN NEUROL, V52, P836, DOI 10.1002/ana.10404; Inoue K, 1999, ANN NEUROL, V46, P313, DOI 10.1002/1531-8249(199909)46:3<313::AID-ANA6>3.0.CO;2-7; Jiao ZX, 2004, PIGM CELL RES, V17, P352, DOI 10.1111/j.1600-0749.2004.00154.x; Kapur RP, 1999, PEDIATR DEVEL PATHOL, V2, P559, DOI 10.1007/s100249900162; Kellerer S, 2006, DEVELOPMENT, V133, P2875, DOI 10.1242/dev.02477; Kelsh RN, 2006, BIOESSAYS, V28, P788, DOI 10.1002/bies.20445; Kim J, 2003, NEURON, V38, P17, DOI 10.1016/S0896-6273(03)00163-6; Lalwani AK, 2000, AM J HUM GENET, V67, P1121, DOI 10.1016/S0002-9297(07)62942-5; Lang D, 2003, HUM MOL GENET, V12, P937, DOI 10.1093/hmg/ddg107; Lang D, 2000, J CLIN INVEST, V106, P963, DOI 10.1172/JCI10828; Le Douarin NM, 1999, NEURAL CREST; Lee M, 2000, J BIOL CHEM, V275, P37978, DOI 10.1074/jbc.M003816200; Ludwig A, 2004, FEBS LETT, V556, P236, DOI 10.1016/S0014-5793(03)01446-7; Maka M, 2005, DEV BIOL, V277, P155, DOI 10.1016/j.ydbio.2004.09.014; McCallion AS, 2001, PIGM CELL RES, V14, P161, DOI 10.1034/j.1600-0749.2001.140305.x; Moal FDL, 2007, HUM MUTAT, V28, P313, DOI 10.1002/humu.20452; Mollaaghababa R, 2003, ONCOGENE, V22, P3024, DOI 10.1038/sj.onc.1206442; Morgan NV, 2006, NAT GENET, V38, P752, DOI 10.1038/ng1826; Murisier F, 2007, PIGM CELL RES, V20, P173, DOI 10.1111/j.1600-0749.2007.00368.x; Niel F, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.022400; Peirano RI, 2000, NUCLEIC ACIDS RES, V28, P3047, DOI 10.1093/nar/28.16.3047; Peirano RI, 2000, MOL CELL BIOL, V20, P3198, DOI 10.1128/MCB.20.9.3198-3209.2000; Phelan MC, 2001, AM J MED GENET, V101, P91, DOI 10.1002/1096-8628(20010615)101:2<91::AID-AJMG1340>3.0.CO;2-C; Pingault V, 2000, ANN NEUROL, V48, P671, DOI 10.1002/1531-8249(200010)48:4<671::AID-ANA17>3.0.CO;2-8; Pingault V, 2002, HUM GENET, V111, P198, DOI 10.1007/s00439-002-0765-8; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; Pingault V, 2001, J MED GENET, V38, P205, DOI 10.1136/jmg.38.3.205; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; Potterf SB, 2000, HUM GENET, V107, P1, DOI 10.1007/s004390050001; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; Read AP, 1997, J MED GENET, V34, P656, DOI 10.1136/jmg.34.8.656; Sanchez-Martin M, 2002, HUM MOL GENET, V11, P3231, DOI 10.1093/hmg/11.25.3231; Schlierf B, 2002, NUCLEIC ACIDS RES, V30, P5509, DOI 10.1093/nar/gkf690; SHAH KN, 1981, J PEDIATR-US, V99, P432, DOI 10.1016/S0022-3476(81)80339-3; Shahin H, 2006, AM J HUM GENET, V78, P144, DOI 10.1086/499495; Sham MH, 2001, J MED GENET, V38, DOI 10.1136/jmg.38.9.e30; Sock E, 2003, HUM MOL GENET, V12, P1439, DOI 10.1093/hmg/ddg158; Southard-Smith EM, 1999, GENOME RES, V9, P215; Stolt CC, 2002, GENE DEV, V16, P165, DOI 10.1101/gad.215802; TASSABEHJI M, 1994, NAT GENET, V8, P251, DOI 10.1038/ng1194-251; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; Toki F, 2003, PEDIATR SURG INT, V19, P725, DOI 10.1007/s00383-003-1057-7; Touraine RL, 2000, AM J HUM GENET, V66, P1496, DOI 10.1086/302895; TOURAINE RL, 1998, AM J HUM GENET, V63, pA174; Verastegui C, 2000, J BIOL CHEM, V275, P30757, DOI 10.1074/jbc.C000445200; Verheij JBGM, 2006, EUR J PAEDIATR NEURO, V10, P11, DOI 10.1016/j.ejpn.2005.10.004; WAARDENBURG PJ, 1951, AM J HUM GENET, V3, P195; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; Wegner M, 2005, PIGM CELL RES, V18, P74, DOI 10.1111/j.1600-0749.2005.00218.x; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Wong WT, 2007, ARCH OPHTHALMOL-CHIC, V125, P239, DOI 10.1001/archopht.125.2.239; Yau SC, 1996, J MED GENET, V33, P550, DOI 10.1136/jmg.33.7.550; Yokoyama S, 2006, FEBS J, V273, P1805, DOI 10.1111/j.1742-4658.2006.05200.x; Zhu L, 2004, NAT GENET, V36, P732, DOI 10.1038/ng1371	78	174	197	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2007	81	6					1169	1185		10.1086/522090	http://dx.doi.org/10.1086/522090			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233NY	17999358	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000251098800005
J	Achilli, A; Rengo, C; Battaglia, V; Pala, M; Olivieri, A; Fornarino, S; Magri, C; Scozzari, R; Babudri, N; Santachiara-Benerecetti, AS; Bandelt, HJ; Semino, O; Torroni, A				Achilli, A; Rengo, C; Battaglia, V; Pala, M; Olivieri, A; Fornarino, S; Magri, C; Scozzari, R; Babudri, N; Santachiara-Benerecetti, AS; Bandelt, HJ; Semino, O; Torroni, A			Saami and Berbers - An unexpected mitochondrial DNA link	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MTDNA VARIATION; HUMAN-EVOLUTION; POPULATIONS; SEQUENCE; AFRICA; HUMANS; ORIGIN; POOL; WEST	The sequencing of entire human mitochondrial DNAs belonging to haplogroup U reveals that this clade arose shortly after the "out of Africa" exit and rapidly radiated into numerous regionally distinct subclades. Intriguingly, the Saami of Scandinavia and the Berbers of North Africa were found to share an extremely young branch, aged merely similar to 9,000 years. This unexpected finding not only confirms that the Franco-Cantabrian refuge area of southwestern Europe was the source of late-glacial expansions of hunter-gatherers that repopulated northern Europe after the Last Glacial Maximum but also reveals a direct maternal link between those European hunter-gatherer populations and the Berbers.	Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy; Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, Rome, Italy; Univ Perugia, Dipartimento Biol Cellulare & Ambientale, I-06100 Perugia, Italy; Univ Hamburg, Fachbereich Math, Hamburg, Germany	University of Pavia; Sapienza University Rome; University of Perugia; University of Hamburg	Torroni, A (corresponding author), Univ Pavia, Dipartimento Genet & Microbiol, Via Ferrata 1, I-27100 Pavia, Italy.	torroni@ipvgen.unipv.it	OLIVIERI, ANNA/I-9235-2012; Battaglia, Vincenza/F-6950-2017; Torroni, Antonio/E-1557-2011; Achilli, Alessandro/I-9236-2012; Magri, Chiara/I-4691-2017	OLIVIERI, ANNA/0000-0002-3941-8098; Torroni, Antonio/0000-0002-4163-4478; Achilli, Alessandro/0000-0001-6871-3451; Magri, Chiara/0000-0001-9933-8666; SEMINO, Ornella/0000-0002-9675-9403; Pala, Maria/0000-0001-9202-8331				Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Forster P, 2001, MOL BIOL EVOL, V18, P1864, DOI 10.1093/oxfordjournals.molbev.a003728; Forster P, 1996, AM J HUM GENET, V59, P935; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Quintana-Murci L, 2004, AM J HUM GENET, V74, P827, DOI 10.1086/383236; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Rosa A, 2004, ANN HUM GENET, V68, P340, DOI 10.1046/j.1529-8817.2004.00100.x; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; STRINGER CB, 1988, SCIENCE, V239, P1263, DOI 10.1126/science.3125610; Tambets K, 2004, AM J HUM GENET, V74, P661, DOI 10.1086/383203; Torroni A, 1996, GENETICS, V144, P1835; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; WALLACE DC, 1995, AM J HUM GENET, V57, P201	20	174	175	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2005	76	5					883	886		10.1086/430073	http://dx.doi.org/10.1086/430073			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	914BB	15791543	Green Published, Bronze			2022-12-18	WOS:000228198300015
J	Azuma, N; Yamaguchi, Y; Handa, H; Tadokoro, K; Asaka, A; Kawase, E; Yamada, M				Azuma, N; Yamaguchi, Y; Handa, H; Tadokoro, K; Asaka, A; Kawase, E; Yamada, M			Mutations of the PAX6 gene detected in patients with a variety of optic-nerve malformations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PAIRED DOMAIN; MISSENSE MUTATION; EYE; ANIRIDIA; ANOMALIES; REGION; FAMILY; MOUSE	The PAX6 gene is involved in ocular morphogenesis and is expressed in the developing central nervous system and numerous ocular tissues during development. PAX6 mutations have been detected in various ocular anomalies, including aniridia, Peters anomaly, corneal dystrophy, congenital cataracts, and foveal hypoplasia. However, it has not been identified in patients with optic-nerve malformations. Here, we identified novel mutations in eight pedigrees with optic-nerve malformations, including coloboma, morning glory disc anomaly, optic-nerve hypoplasia/aplasia, and persistent hyperplastic primary vitreous. A functional assay demonstrated that each mutation decreased the transcriptional activation potential of PAX6 through the paired DNA-binding domain. PAX6 and PAX2 are each thought to downregulate the expression of the other. Four of the detected mutations affected PAX6-mediated transcriptional repression of the PAX2 promoter in a reporter assay. Because PAX2 gene mutations were detected in papillorenal syndrome, alternation of PAX2 function by PAX6 mutations may affect phenotypic manifestations of optic-nerve malformations.	Natl Ctr Child Hlth & Dev, Dept Ophthalmol, Setagaya Ku, Tokyo 1578535, Japan; Natl Res Inst Child Hlth & Dev, Dept Genet, Tokyo, Japan; Tokyo Inst Technol, Dept Biomol Engn, Frontier Collaborat Res Ctr, Yokohama, Kanagawa 227, Japan	National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; Tokyo Institute of Technology	Azuma, N (corresponding author), Natl Ctr Child Hlth & Dev, Dept Ophthalmol, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.		Yamaguchi, Yuki/B-9390-2015	Yamaguchi, Yuki/0000-0002-0197-614X				Azuma N, 1999, AM J HUM GENET, V65, P656, DOI 10.1086/302529; Azuma N, 1996, NAT GENET, V13, P141, DOI 10.1038/ng0696-141; Brown GC, 1983, CONGENITAL ANOMALIES; Dattani MT, 1998, NAT GENET, V19, P125, DOI 10.1038/477; EPSTEIN J, 1994, J BIOL CHEM, V269, P8355; Gehring WJ, 1996, GENES CELLS, V1, P11, DOI 10.1046/j.1365-2443.1996.11011.x; GLASER T, 1990, SCIENCE, V250, P823, DOI 10.1126/science.2173141; GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232; Hanson I, 1999, HUM MOL GENET, V8, P165, DOI 10.1093/hmg/8.2.165; MACDONALD R, 1995, DEVELOPMENT, V121, P3267; Malandrini A, 2001, CLIN GENET, V60, P151, DOI 10.1034/j.1399-0004.2001.600210.x; MARTHA A, 1994, AM J HUM GENET, V54, P801; Mishra R, 2002, J BIOL CHEM, V277, P49488, DOI 10.1074/jbc.M206478200; Nishina S, 1999, BRIT J OPHTHALMOL, V83, P723, DOI 10.1136/bjo.83.6.723; SANYANUSIN P, 1995, NAT GENET, V9, P358, DOI 10.1038/ng0495-358; Schwarz M, 2000, DEVELOPMENT, V127, P4325; Singh S, 1998, J BIOL CHEM, V273, P21531, DOI 10.1074/jbc.273.34.21531; Sisodiya SM, 2001, NAT GENET, V28, P214, DOI 10.1038/90042; van Heyningen V, 2002, HUM MOL GENET, V11, P1161, DOI 10.1093/hmg/11.10.1161; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Yamaguchi Y, 1997, GENES CELLS, V2, P255, DOI 10.1046/j.1365-2443.1997.1170315.x	21	174	185	0	10	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2003	72	6					1565	1570		10.1086/375555	http://dx.doi.org/10.1086/375555			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	685QV	12721955	Green Published, Bronze			2022-12-18	WOS:000183275500020
J	De Baere, E; Beysen, D; Oley, C; Lorenz, B; Cocquet, J; De Sutter, P; Devriendt, K; Dixon, M; Fellous, M; Fryns, JP; Garza, A; Jonsrud, C; Koivisto, PA; Krause, A; Leroy, BP; Meire, F; Plomp, A; Van Maldergem, L; De Paepe, A; Veitia, R; Messiaen, L				De Baere, E; Beysen, D; Oley, C; Lorenz, B; Cocquet, J; De Sutter, P; Devriendt, K; Dixon, M; Fellous, M; Fryns, JP; Garza, A; Jonsrud, C; Koivisto, PA; Krause, A; Leroy, BP; Meire, F; Plomp, A; Van Maldergem, L; De Paepe, A; Veitia, R; Messiaen, L			FOXL2 and BPES: Mutational hotspots, phenotypic variability, and revision of the genotype-phenotype correlation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EPICANTHUS INVERSUS SYNDROME; BLEPHAROPHIMOSIS; PTOSIS; TRANSLOCATION; GENE; T(3-4)(Q23-P15.2); PATIENT; 3Q23	Blepharophimosis syndrome (BPES), an autosomal dominant syndrome in which an eyelid malformation is associated (type I) or not (type II) with premature ovarian failure (POF), has recently been ascribed to mutations in FOXL2, a putative forkhead transcription factor gene. We previously reported 22 FOXL2 mutations and suggested a preliminary genotype-phenotype correlation. Here, we describe 21 new FOXL2 mutations (16 novel ones) through sequencing of open reading frame, 5' untranslated region, putative core promoter, and fluorescence in situ hybridization analysis. Our study shows the existence of two mutational hotspots: 30% of FOXL2 mutations lead to polyalanine (poly-Ala) expansions, and 13% are a novel out-of-frame duplication. In addition, this is the first study to demonstrate intra- and interfamilial phenotypic variability (both BPES types caused by the same mutation). Furthermore, the present study allows a revision of the current genotype-phenotype correlation, since we found exceptions to it. We assume that for predicted proteins with a truncation before the poly-Ala tract, the risk for development of POF is high. For mutations leading to a truncated or extended protein containing an intact forkhead and poly-Ala tract, no predictions are possible, since some of these mutations lead to both types of BPES, even within the same family. Poly-Ala expansions may lead to BPES type II. For missense mutations, no correlations can be made yet. Microdeletions are associated with mental retardation. We conclude that molecular testing may be carefully used as a predictor for POF risk in a limited number of mutations.	State Univ Ghent Hosp, Dept Med Genet Gynecol & Ophthalmol, B-9000 Ghent, Belgium; Royal Childrens Hosp, Queensland Clin Genet Serv, Brisbane, Qld, Australia; Univ Regensburg Klinikum, Dept Pediat Ophthalmol Strabismol & Ophthalmogene, Regensburg, Germany; Hop Cochin, INSERM, U Reprod & Physiopathol Obstet 361, F-75674 Paris, France; Catholic Univ Louvain, Ctr Human Genet, B-3000 Louvain, Belgium; Univ Manchester, Sch Biol Sci, Manchester, Lancs, England; Grp Transamer Esteril & Fertil, Matamoros, Mexico; Univ Tromso Hosp, Dept Med Genet, N-9012 Tromso, Norway; Tampere Univ Hosp, Dept Clin Genet, Tampere, Finland; Natl Hlth Lab Serv, Dept Human Genet, Johannesburg, South Africa; Univ Amsterdam, Acad Med Ctr, Klin Genet, NL-1105 AZ Amsterdam, Netherlands; Ctr Human Genet, Loverval, Belgium	Ghent University; Ghent University Hospital; Royal Children's Hospital Brisbane; University of Regensburg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Catholique Louvain; University of Manchester; UiT The Arctic University of Tromso; University Hospital of North Norway; Tampere University; Tampere University Hospital; National Health Laboratory Service; University of Amsterdam; Academic Medical Center Amsterdam	De Baere, E (corresponding author), State Univ Ghent Hosp, Dept Med Genet, De Pintelaan 185, B-9000 Ghent, Belgium.		Cocquet, Julie/L-5844-2017; Van Maldergem, Lionel/O-3242-2019; Van Maldergem, Lionel/G-9849-2017; Krause, Amanda/AAQ-7038-2020; De Baere, Elfride/E-7405-2017	Cocquet, Julie/0000-0002-6275-5412; Van Maldergem, Lionel/0000-0001-8880-5214; Van Maldergem, Lionel/0000-0001-8880-5214; Krause, Amanda/0000-0002-7157-0807; De Baere, Elfride/0000-0002-5609-6895; /0000-0002-4903-8232				Amati P, 1996, AM J HUM GENET, V58, P1089; Bell R, 2001, GENET TEST, V5, P335, DOI 10.1089/109065701753617499; BOCCONE L, 1994, AM J MED GENET, V51, P258, DOI 10.1002/ajmg.1320510317; Brocke KS, 2002, HUM MOL GENET, V11, P331, DOI 10.1093/hmg/11.3.331; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Cocquet J, 2002, J MED GENET, V39, P916, DOI 10.1136/jmg.39.12.916; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; De Baere E, 2000, GENOMICS, V68, P296, DOI 10.1006/geno.2000.6304; De Baere E, 2002, J MED GENET, V39, DOI 10.1136/jmg.39.8.e43; De Baere E, 1999, GENOMICS, V57, P70, DOI 10.1006/geno.1999.5747; De Baere E, 2001, HUM MOL GENET, V10, P1591, DOI 10.1093/hmg/10.15.1591; FUKUSHIMA Y, 1991, AM J MED GENET, V40, P485, DOI 10.1002/ajmg.1320400423; HAN KY, 1993, EMBO J, V12, P2723, DOI 10.1002/j.1460-2075.1993.tb05934.x; HARRAR HS, 1995, J MED GENET, V32, P774, DOI 10.1136/jmg.32.10.774; Harris SE, 2002, MOL HUM REPROD, V8, P729, DOI 10.1093/molehr/8.8.729; Kosaki Kenjiro, 2002, Ophthalmic Genet, V23, P43, DOI 10.1076/opge.23.1.43.2202; Pailhoux E, 2001, NAT GENET, V29, P453, DOI 10.1038/ng769; Praphanphoj V, 2000, GENOMICS, V65, P67, DOI 10.1006/geno.2000.6157; Prueitt RL, 2001, NAT GENET, V27, P132, DOI 10.1038/84735; Ramirez-Castro JL, 2002, AM J MED GENET, V113, P47, DOI 10.1002/ajmg.10741; Schibler L, 2000, GENOME RES, V10, P311, DOI 10.1101/gr.10.3.311; SMALL KW, 1995, HUM MOL GENET, V4, P443, DOI 10.1093/hmg/4.3.443; Stromme P, 2002, NAT GENET, V30, P441, DOI 10.1038/ng862; Veitia RA, 2002, BIOESSAYS, V24, P175, DOI 10.1002/bies.10023; WALTER AE, 1994, P NATL ACAD SCI USA, V91, P9218, DOI 10.1073/pnas.91.20.9218; Yamada T, 2001, J HUM GENET, V46, P733, DOI 10.1007/s100380170009; ZLOTOGORA J, 1983, AM J HUM GENET, V35, P1020	27	174	180	0	14	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2003	72	2					478	487		10.1086/346118	http://dx.doi.org/10.1086/346118			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	640GK	12529855	Green Published, Bronze			2022-12-18	WOS:000180680000028
J	Item, CB; Stockler-Ipsiroglu, S; Stromberger, C; Muhl, A; Alessandri, MG; Bianchi, MC; Tosetti, M; Fornai, F; Cioni, G				Item, CB; Stockler-Ipsiroglu, S; Stromberger, C; Muhl, A; Alessandri, MG; Bianchi, MC; Tosetti, M; Fornai, F; Cioni, G			Arginine : glycine amidinotransferase deficiency: The third inborn error of creatine metabolism in humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY; GRADIENT GEL-ELECTROPHORESIS; BRAIN; EXPRESSION; MUTATION; IDENTIFICATION; BIOSYNTHESIS; TRANSPORTER; DIAGNOSIS; CLONING	Arginine: glycine amidinotransferase (AGAT) catalyzes the first step of creatine synthesis, resulting in the formation of guanidinoacetate, which is a substrate for creatine formation. In two female siblings with mental retardation who had brain creatine deficiency that was reversible by means of oral creatine supplementation and had low urinary guanidinoacetate concentrations, AGAT deficiency was identified as a new genetic defect in creatine metabolism. A homozygous G-A transition at nucleotide position 9297, converting a tryptophan codon (TGG) to a stop codon (TAG) at residue 149 (T149X), resulted in undetectable cDNA, as investigated by reverse-transcription PCR, as well as in undetectable AGAT activity, as investigated radiochemically in cultivated skin fibroblasts and in virus-transformed lymphoblasts of the patients. The parents were heterozygous for the mutant allele, with intermediate residual AGAT activities. Recognition and treatment with oral creatine supplements may prevent neurological sequelae in affected patients.	Univ Hosp Vienna, Dept Pediat, A-1090 Vienna, Austria; Gen Hosp Vienna, Vienna, Austria; Univ Pisa, Dept Human Morphol & Appl Biol, Pisa, Italy; Santa Chiara Hosp, Unit Neuroradiol, Pisa, Italy; IRCCS Stella Maris, Lab Neuroimaging, Pisa, Italy	University Hospital Vienna; University of Pisa; Santa Chiara Hospital; IRCCS Fondazione Stella Maris	Stockler-Ipsiroglu, S (corresponding author), Univ Hosp Vienna, Dept Pediat, Wahringerstr 18-20, A-1090 Vienna, Austria.		Alessandrì, Maria Grazia/AAI-6958-2021; Cioni, Giovanni/A-4178-2015; Tosetti, Michela/K-5749-2016; Alessandrì, Maria Grazia/B-2891-2018; FORNAI, FRANCESCO/AAA-5312-2019	Alessandrì, Maria Grazia/0000-0003-3467-8648; Cioni, Giovanni/0000-0002-6526-5566; Tosetti, Michela/0000-0002-2515-7560; Alessandrì, Maria Grazia/0000-0003-3467-8648; FORNAI, FRANCESCO/0000-0002-3883-5084; Stromberger, Carmen/0000-0001-6165-1729				Bianchi MC, 2000, ANN NEUROL, V47, P511; Bodamer OA, 2001, CLIN CHIM ACTA, V308, P173, DOI 10.1016/S0009-8981(01)00480-6; Cecil KM, 2001, ANN NEUROL, V49, P401, DOI 10.1002/ana.79; Cotton RG, 2000, EUR J PEDIATR, V159, pS179, DOI 10.1007/PL00014396; Cotton RGH, 1998, HUM MUTAT, V12, P1, DOI 10.1002/(SICI)1098-1004(1998)12:1<1::AID-HUMU1>3.0.CO;2-M; Ganesan V, 1997, PEDIATR NEUROL, V17, P155, DOI 10.1016/S0887-8994(97)00083-0; GreberPlatzer S, 1997, HUM MUTAT, V10, P49, DOI 10.1002/(SICI)1098-1004(1997)10:1<49::AID-HUMU7>3.0.CO;2-H; GUIMBAL C, 1993, J BIOL CHEM, V268, P8418; GULDBERG P, 1993, NUCLEIC ACIDS RES, V21, P2261, DOI 10.1093/nar/21.9.2261; Humm A, 1997, BIOCHEM J, V322, P771, DOI 10.1042/bj3220771; Hunneman DH, 1997, J INHERIT METAB DIS, V20, P450, DOI 10.1023/A:1005383507547; Ilas J, 2000, CLIN CHIM ACTA, V290, P179, DOI 10.1016/S0009-8981(99)00182-5; Leuzzi V, 2000, NEUROLOGY, V55, P1407, DOI 10.1212/WNL.55.9.1407; Osborn MJ, 1999, HUM GENET, V105, P327, DOI 10.1007/s004390051109; Salomons GS, 2001, AM J HUM GENET, V68, P1497, DOI 10.1086/320595; Schulze A, 1997, J PEDIATR-US, V131, P626, DOI 10.1016/S0022-3476(97)70075-1; SORA I, 1994, BIOCHEM BIOPH RES CO, V204, P419, DOI 10.1006/bbrc.1994.2475; Stockler S, 1997, METABOLISM, V46, P1189, DOI 10.1016/S0026-0495(97)90215-8; Stockler S, 1996, LANCET, V348, P789, DOI 10.1016/S0140-6736(96)04116-5; STOCKLER S, 1994, PEDIATR RES, V36, P409; Stockler S, 1996, AM J HUM GENET, V58, P914; StocklerIpsiroglu S, 1997, J PEDIATR-US, V131, P510; Struys EA, 1998, J PHARMACEUT BIOMED, V18, P659, DOI 10.1016/S0731-7085(98)00280-5; van der Knaap MS, 2000, ANN NEUROL, V47, P540, DOI 10.1002/1531-8249(200004)47:4<540::AID-ANA23>3.0.CO;2-K; VANPILSUM JF, 1972, BIOCHEM J, V126, P325, DOI 10.1042/bj1260325; VONFIGURA K, 2000, METABOLIC MOL BASIS, P1897; Walker J B, 1979, Adv Enzymol Relat Areas Mol Biol, V50, P177	27	174	183	2	5	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2001	69	5					1127	1133		10.1086/323765	http://dx.doi.org/10.1086/323765			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	479PU	11555793	Green Published, Bronze			2022-12-18	WOS:000171413400019
J	Gaffney, PM; Ortmann, WA; Selby, SA; Shark, KB; Ockenden, TC; Rohlf, KE; Walgrave, NL; Boyum, WP; Malmgren, ML; Miller, ME; Kearns, GM; Messner, RP; King, RA; Rich, SS; Behrens, TW				Gaffney, PM; Ortmann, WA; Selby, SA; Shark, KB; Ockenden, TC; Rohlf, KE; Walgrave, NL; Boyum, WP; Malmgren, ML; Miller, ME; Kearns, GM; Messner, RP; King, RA; Rich, SS; Behrens, TW			Genome screening in human systemic lupus erythematosus: Results from a second Minnesota cohort and combined analyses of 187 sib-pair families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INFLAMMATORY BOWEL-DISEASE; LARGE EUROPEAN COHORT; SUSCEPTIBILITY LOCUS; WIDE SEARCH; REVISED CRITERIA; GENETIC-ANALYSIS; COMPLEX TRAITS; LINKAGE; CHROMOSOME-16; CLASSIFICATION	Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by a loss of immunologic tolerance to a multitude of self-antigens. Epidemiological data suggest an important role for genes in the etiology of lupus, and previous genetic studies have implicated the HLA locus, complement genes, and low-affinity IgG (Fc gamma) receptors in SLE pathogenesis. In an effort to identify new susceptibility loci for SLE, we recently reported the results of a genomewide microsatellite marker screen in 105 SLE sib-pair families. By using nonparametric methods, evidence for linkage was found in four intervals: 6p11-21 (near the HLA), 16q13, 14q21-23, and 20p12.3 (LOD scores greater than or equal to 2.0), and weaker evidence in another nine regions. We now report the results of a second complete genome screen in a new cohort of 82 SLE sib-pair families. In the cohort 2 screen, the four best intervals were 7p22 (LOD score 2.87), 7q21 (LOD score 2.40), 10p13 (LOD score 2.24), and 7q36 (LOD score 2.15). Eight additional intervals were identified with LOD scores in the range 1.00-1.67. A combined analysis of MN cohorts 1 and 2 (187 sib-pair families) showed that markers in 6p11-p21 (D6S426, LOD score 4.19) and 16q13 (D16S415, LOD score 3.85) met the criteria for significant linkage. Three intervals (2p15, 7q36, and 1q42) had LOD scores in the range 1.92-2.06, and another 13 intervals had LOD scores in the range of 1.00-1.78 in the combined sample. These data, together with other available gene mapping results in SLE, are beginning to allow a prioritization of genomic intervals for gene discovery efforts in human SLE.	Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; Univ Coll, Dublin, Ireland; Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA	University of Minnesota System; University of Minnesota Twin Cities; University College Dublin; Wake Forest University; Wake Forest Baptist Medical Center	Behrens, TW (corresponding author), Univ Minnesota, Sch Med, Box 334 Mayo,312 Church St SE, Minneapolis, MN 55455 USA.			Rich, Stephen/0000-0003-3872-7793; Gaffney, Patrick/0000-0002-1580-869X	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR001986, K08AR002105] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR/AI43271, K08-AR01986, K08-AR02105] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ARNETT FC, 1997, DUBOIS LUPUS ERYTHEM, P77; Becker KG, 1998, P NATL ACAD SCI USA, V95, P9979, DOI 10.1073/pnas.95.17.9979; BIAS WB, 1986, AM J HUM GENET, V39, P584; BLOCK SR, 1975, AM J MED, V59, P533, DOI 10.1016/0002-9343(75)90261-2; Curran ME, 1998, GASTROENTEROLOGY, V115, P1066, DOI 10.1016/S0016-5085(98)70075-7; Daniels SE, 1996, NATURE, V383, P247, DOI 10.1038/383247a0; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; DEAPEN D, 1992, ARTHRITIS RHEUM, V35, P311; Gaffney PM, 1998, P NATL ACAD SCI USA, V95, P14875, DOI 10.1073/pnas.95.25.14875; Goring HHH, 1997, EUR J HUM GENET, V5, P69, DOI 10.1159/000484736; Hampe J, 1999, AM J HUM GENET, V64, P808, DOI 10.1086/302294; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; HOCHBERG MC, 1997, DUBOIS LUPUS ERYTHEM, P49; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; Kearns GM, 1998, J RHEUMATOL, V25, P482; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Mirza MM, 1998, J MED GENET, V35, P218, DOI 10.1136/jmg.35.3.218; Moser KL, 1998, P NATL ACAD SCI USA, V95, P14869, DOI 10.1073/pnas.95.25.14869; Nair RP, 1997, HUM MOL GENET, V6, P1349, DOI 10.1093/hmg/6.8.1349; NEPOM GT, 1991, ANNU REV IMMUNOL, V9, P493; RISCH N, 1990, AM J HUM GENET, V46, P222; Rothfield N. J., 1985, ARTHRITIS ALLIED CON, P911; Salmon JE, 1996, J CLIN INVEST, V97, P1348, DOI 10.1172/JCI118552; Shai R, 1999, HUM MOL GENET, V8, P639, DOI 10.1093/hmg/8.4.639; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tomer Y, 1998, AM J HUM GENET, V63, P1749, DOI 10.1086/302146; Trembath RC, 1997, HUM MOL GENET, V6, P813, DOI 10.1093/hmg/6.5.813; Tromp G, 1996, AM J HUM GENET, V59, P1097; Tsao BP, 1999, J CLIN INVEST, V103, P1135, DOI 10.1172/JCI5967; Tsao BP, 1997, J CLIN INVEST, V99, P725, DOI 10.1172/JCI119217; Vyse TJ, 1996, CELL, V85, P311, DOI 10.1016/S0092-8674(00)81110-1; Wu JM, 1997, J CLIN INVEST, V100, P1059, DOI 10.1172/JCI119616; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	36	174	190	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					547	556		10.1086/302767	http://dx.doi.org/10.1086/302767			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QL	10677315	Bronze, Green Published			2022-12-18	WOS:000088373100022
J	Goddard, KAB; Hopkins, PJ; Hall, JM; Witte, JS				Goddard, KAB; Hopkins, PJ; Hall, JM; Witte, JS			Linkage disequilibrium and allele-frequency distributions for 114 single-nucleotide polymorphisms in five populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN LIPOPROTEIN-LIPASE; MEXICAN-AMERICANS; MARKERS; ADMIXTURE; DIVERSITY; IDENTIFICATION; LIKELIHOOD; DISEASE; ORIGINS; REGION	Single-nucleotide polymorphisms (SNPs) may be extremely important for deciphering the impact of genetic variation on complex human diseases. The ultimate value of SNPs for linkage and association mapping studies depends in part on the distribution of SNP allele frequencies and intermarker linkage disequilibrium (LD) across populations. Limited information is available about these distributions on a genomewide scale, particularly for LD. Using 114 SNPs from 33 genes, we compared these distributions in five American populations (727 individuals) of African, European, Chinese, Hispanic, and Japanese descent. The allele frequencies were highly correlated across populations but differed by >20% for at least one pair of populations in 35% of SNPs. The correlation in LD was high for some pairs of populations but not for others (e.g., Chinese American or Japanese American vs. any other population). Regardless of population, average minor-allele frequencies were significantly higher for SNPs in noncoding regions (20%-25%) than for SNPs in coding regions (12%-16%). Interestingly, we found that intermarker LD may be strongest with pairs of SNPs in which both markers are nonconservative substitutions, compared to pairs of SNPs where at least one marker is a conservative substitution. These results suggest that population differences and marker location within the gene may be important factors in the selection of SNPs for use in the study of complex disease with linkage or association mapping methods.	Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44109 USA; PPGx Inc, La Jolla, CA USA	Case Western Reserve University	Goddard, KAB (corresponding author), Case Western Reserve Univ, Dept Epidemiol & Biostat, 2500 Metrohlth Dr, Cleveland, OH 44109 USA.		Peng, Bo/A-6920-2009	Peng, Bo/0000-0001-8225-2284	NCI NIH HHS [R29 CA073270, CA73270] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA073270] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bowcock A M, 1991, Gene Geogr, V5, P151; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Cambien F, 1999, AM J HUM GENET, V65, P183, DOI 10.1086/302448; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; CARLSON CS, 1998, AM J HUM GENET, V63, pA284; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CHAKRABORTY R, 1992, AM J HUM GENET, V50, P145; Chapman NH, 1998, AM J HUM GENET, V63, P1872, DOI 10.1086/302139; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; DEAN M, 1994, AM J HUM GENET, V55, P788; Destro-Bisol G, 1999, HUM GENET, V104, P149, DOI 10.1007/s004390050928; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; ELSTON RC, IN PRESS GENET EPIDE; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Goddard KAB, 1996, AM J HUM GENET, V58, P1286; GODDARD KAB, 1999, THESIS U WASHINGTON; GOLDIN LR, 1993, AM J HUM GENET, V53, P908; GOLDIN LR, 1988, GENET EPIDEMIOL, V5, P35, DOI 10.1002/gepi.1370050104; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; HANIS CL, 1991, DIABETES CARE, V14, P618, DOI 10.2337/diacare.14.7.618; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Jorde LB, 1997, P NATL ACAD SCI USA, V94, P3100, DOI 10.1073/pnas.94.7.3100; JORDE LB, 1995, AM J HUM GENET, V57, P523; JORDE LB, 1994, AM J HUM GENET, V54, P884; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kruglyak L, 1997, NAT GENET, V17, P21, DOI 10.1038/ng0997-21; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Lai E, 1998, GENOMICS, V54, P31, DOI 10.1006/geno.1998.5581; LEWONTIN RC, 1995, GENETICS, V140, P377; LONG JC, 1991, AM J PHYS ANTHROPOL, V84, P141, DOI 10.1002/ajpa.1330840204; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; NEI M, 1980, GENET RES, V35, P65, DOI 10.1017/S001667230001394X; NICKERSON DA, 1992, GENOMICS, V12, P377, DOI 10.1016/0888-7543(92)90388-9; NICKERSON DA, 1990, P NATL ACAD SCI USA, V87, P8923, DOI 10.1073/pnas.87.22.8923; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; PEASE AC, 1994, P NATL ACAD SCI USA, V91, P5022, DOI 10.1073/pnas.91.11.5022; PerezLezaun A, 1997, HUM GENET, V99, P1; Relethford JH, 1999, AM J PHYS ANTHROPOL, V108, P251; RISCH N, 1990, AM J HUM GENET, V46, P229; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Slatkin M, 1996, HEREDITY, V76, P377, DOI 10.1038/hdy.1996.55; THOMPSON EA, 1988, AM J HUM GENET, V42, P113; Tseng M, 1998, AM J PHYS ANTHROPOL, V106, P361, DOI 10.1002/(SICI)1096-8644(199807)106:3<361::AID-AJPA8>3.3.CO;2-J; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; WEIR BS, 1996, GENETIC DATA ANAL, V2, P125; Xiong MM, 1999, AM J HUM GENET, V64, P629, DOI 10.1086/302231; Zietkiewicz E, 1997, GENE, V205, P161	48	174	184	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2000	66	1					216	234		10.1086/302727	http://dx.doi.org/10.1086/302727			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279FK	10631153	Green Published, Bronze			2022-12-18	WOS:000085033600024
J	COOK, A; RASKIND, W; BLANTON, SH; PAULI, RM; GREGG, RG; FRANCOMANO, CA; PUFFENBERGER, E; CONRAD, EU; SCHMALE, G; SCHELLENBERG, G; WIJSMAN, E; HECHT, JT; WELLS, D; WAGNER, MJ				COOK, A; RASKIND, W; BLANTON, SH; PAULI, RM; GREGG, RG; FRANCOMANO, CA; PUFFENBERGER, E; CONRAD, EU; SCHMALE, G; SCHELLENBERG, G; WIJSMAN, E; HECHT, JT; WELLS, D; WAGNER, MJ			GENETIC-HETEROGENEITY IN FAMILIES WITH HEREDITARY MULTIPLE EXOSTOSES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DELETION	We have carried out a linkage analysis on 11 families segregating gene(s) for hereditary multiple exostoses (EXT). Four highly informative, short tandem-repeat (STR) markers that have been physically mapped to an interval surrounding the Langer-Giedion chromosomal region (8q24.11-q24.13) were used in a multipoint linkage analysis. Significant evidence for linkage of EXT with genetic heterogeneity was found. A model of heterogeneity with linkage of the disease gene to the STR markers in 70% of the families (with a 95% confidence interval of 26%-96%) produced a maximum LOD score of 8.11, with the most likely position of EXT between D8S85 and D8S199. Thus there are at least two genes that are capable of causing hereditary multiple exostoses, one in the Langer-Giedion region and one at another, unlinked location.	UNIV HOUSTON,DEPT BIOL,HOUSTON,TX 77204; UNIV HOUSTON,INST MOLEC BIOL,HOUSTON,TX 77204; UNIV TEXAS,HLTH SCI CTR,DEPT PEDIAT,HOUSTON,TX 77225; UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT ORTHOPED SURG,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT BIOSTAT,SEATTLE,WA 98195; UNIV VIRGINIA,DEPT PEDIAT,CHARLOTTESVILLE,VA 22903; UNIV WISCONSIN,DEPT PEDIAT,MADISON,WI 53706; UNIV WISCONSIN,DEPT MED GENET,MADISON,WI 53706; UNIV WISCONSIN,WAISMAN CTR MENTAL RETARDAT & HUMAN DEV,MADISON,WI 53706; JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT MED,BALTIMORE,MD 21205	University of Houston System; University of Houston; University of Houston System; University of Houston; University of Texas System; University of Texas Health Science Center Houston; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Virginia; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Johns Hopkins University; Johns Hopkins University			/AAD-2181-2020; Blanton, Susan Halloran/ABF-1323-2021	Gregg, Ronald/0000-0001-5805-224X; Puffenberger, Erik/0000-0002-6388-9148	NCI NIH HHS [CA16448] Funding Source: Medline; NHGRI NIH HHS [HG00373, HG00172] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA016448, R01CA016448] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R55HG000172, R01HG000172, P01HG000373, F32HG000172] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BUHLER EM, 1984, AM J MED GENET, V19, P113, DOI 10.1002/ajmg.1320190111; FRYNS JP, 1986, HUM GENET, V74, P188, DOI 10.1007/BF00282091; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HENNEKAM RCM, 1991, J MED GENET, V28, P262, DOI 10.1136/jmg.28.4.262; KROOTH RS, 1961, AM J HUM GENET, V13, P340; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEMERRER M, 1992, J MED GENET, V29, P713, DOI 10.1136/jmg.29.10.713; LEONE NC, 1987, J HERED, V78, P171, DOI 10.1093/oxfordjournals.jhered.a110351; McKusick VA, 1990, MENDELIAN INHERITANC; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; OGLE RF, 1991, J MED GENET, V28, P881, DOI 10.1136/jmg.28.12.881; Ott J., 1991, ANAL HUMAN GENETIC L; PARRISH JE, 1991, GENOMICS, V11, P54, DOI 10.1016/0888-7543(91)90101-J; SMITH CAB, 1961, 2ND P INT C HUM GEN, V1, P212; SOLOMON L, 1964, AM J HUM GENET, V16, P351; STOCKS P, 1925, TREASURY HUMAN INHER, V3; SUGIURA Y, 1976, JPN J HUM GENET, V21, P149; TOMFOHRED A, 1992, GENOMICS, V14, P144; VOUTSINAS S, 1983, J MED GENET, V20, P345, DOI 10.1136/jmg.20.5.345; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4038, DOI 10.1093/nar/18.13.4038	20	174	186	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1993	53	1					71	79						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ385	8317501				2022-12-18	WOS:A1993LJ38500010
J	Jones, WD; Dafou, D; McEntagart, M; Woollard, WJ; Elmslie, FV; Holder-Espinasse, M; Irving, M; Saggar, AK; Smithson, S; Trembath, RC; Deshpande, C; Simpson, MA				Jones, Wendy D.; Dafou, Dimitra; McEntagart, Meriel; Woollard, Wesley J.; Elmslie, Frances V.; Holder-Espinasse, Muriel; Irving, Melita; Saggar, Anand K.; Smithson, Sarah; Trembath, Richard C.; Deshpande, Charu; Simpson, Michael A.			De Novo Mutations in MLL Cause Wiedemann-Steiner Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							KABUKI SYNDROME; HYPERTRICHOSIS-CUBITI; PROTEIN; GENE; EXPRESSION; LEUKEMIA	Excessive growth of terminal hair around the elbows (hypertrichosis cubit has been reported both in isolation and in association with a variable spectrum of associated phenotypic features. We identified a cohort of six individuals with hypertrichosis cubiti associated with short stature, intellectual disability, and a distinctive facial appearance, consistent with a diagnosis of Wiedemann-Steiner syndrome (WSS). Utilizing a whole-exome sequencing approach, we identified de novo mutations in MLL in five of the six individuals. MLL encodes a histone methyltransferase that regulates chromatin-mediated transcription through the catalysis of methylation of histone H3K4. Each of the five mutations is predicted to result in premature termination of the protein product. Furthermore, we demonstrate that transcripts arising from the mutant alleles are subject to nonsense-mediated decay. These findings define the genetic basis of WSS, provide additional evidence for the role of haploinsufficency of histone-modification enzymes in multiple-congenital-anomaly syndromes, and further illustrate the importance of the regulation of histone modification in development.	[Dafou, Dimitra; Woollard, Wesley J.; Trembath, Richard C.; Simpson, Michael A.] Kings Coll London, Sch Med, Guys Hosp, Div Genet & Mol Med, London SE1 9RT, England; [Jones, Wendy D.; McEntagart, Meriel; Elmslie, Frances V.; Saggar, Anand K.] Univ London, St Georges Hosp, SW Thames Reg Genet Serv, London SW17 0RE, England; [Jones, Wendy D.] Great Ormond St Hosp Sick Children, NE Thames Reg Genet Serv, London WC1N 3JH, England; [Holder-Espinasse, Muriel] CHRU, Serv Genet Clin, Hop Jeanne Flandre, F-59037 Lille, France; [Holder-Espinasse, Muriel; Irving, Melita; Deshpande, Charu] Guys & St Thomas Natl Hlth Serv Fdn Trust, Guys Hosp, London SE1 9RT, England; St Michaels Hosp, Dept Clin Genet, Bristol BS2 8EG, Avon, England; [Trembath, Richard C.] Univ London, Barts & London Sch Med & Dent, London EC1M 6QB, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; St Georges University London; University of London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Universite de Lille - ISITE; CHU Lille; Guy's & St Thomas' NHS Foundation Trust; University of London; Queen Mary University London	Simpson, MA (corresponding author), Kings Coll London, Sch Med, Guys Hosp, Div Genet & Mol Med, London SE1 9RT, England.	michael.simpson@kcl.ac.uk	Simpson, Michael/F-4737-2011; Dafou, Dimitra/N-6094-2015	Simpson, Michael/0000-0002-8539-8753; Dafou, Dimitra/0000-0003-4170-0612; Trembath, Richard/0000-0003-0550-3400	Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre; King's College London; King's College Hospital NHS Foundation Trust; National Institute for Health Research [NF-SI-0507-10379] Funding Source: researchfish	Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); King's College London; King's College Hospital NHS Foundation Trust; National Institute for Health Research(National Institute for Health Research (NIHR))	The authors express their gratitude to the families for participating in this study. The authors also acknowledge support from the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's and St. Thomas' NHS Foundation Trust, in partnership with the King's College London and King's College Hospital NHS Foundation Trust. We thank Alistair Calder (Department of Radiology, Great Ormond Street Hospital for Children, Great Ormond Street, London) for his assistance and expertise in reviewing the radiography.	Banka S, 2012, EUR J HUM GENET, V20, P381, DOI 10.1038/ejhg.2011.220; Butler LH, 1997, BLOOD, V89, P3361, DOI 10.1182/blood.V89.9.3361; Clayton-Smith J, 2011, AM J HUM GENET, V89, P675, DOI 10.1016/j.ajhg.2011.10.008; Cosgrove MS, 2010, FEBS J, V277, P1832, DOI 10.1111/j.1742-4658.2010.07609.x; Ernst P, 2001, MOL CELL BIOL, V21, P2249, DOI 10.1128/MCB.21.7.2249-2258.2001; Hood RL, 2012, AM J HUM GENET, V90, P308, DOI 10.1016/j.ajhg.2011.12.001; Hsieh JJD, 2003, MOL CELL BIOL, V23, P186, DOI 10.1128/MCB.23.1.186-194.2003; Koenig R, 2010, AM J MED GENET A, V152A, P2372, DOI 10.1002/ajmg.a.33587; Lederer D, 2012, AM J HUM GENET, V90, P119, DOI 10.1016/j.ajhg.2011.11.021; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li Y, 2011, HUM GENET, V130, P715, DOI 10.1007/s00439-011-1004-y; Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Paulussen ADC, 2011, HUM MUTAT, V32, pE2018, DOI 10.1002/humu.21416; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Polizzi A, 2005, J PEDIATR ENDOCR MET, V18, P1019; Prasad R, 1997, ONCOGENE, V15, P549, DOI 10.1038/sj.onc.1201211; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Simpson MA, 2012, AM J HUM GENET, V90, P290, DOI 10.1016/j.ajhg.2011.11.024; Steiner CE, 2000, CLIN DYSMORPHOL, V9, P155, DOI 10.1097/00019605-200009020-00021; Visser R, 2002, GENET COUNSEL, V13, P397; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wendelin DS, 2003, J AM ACAD DERMATOL, V48, P161, DOI 10.1067/mjd.2003.100; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0	25	173	183	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 10	2012	91	2					358	364		10.1016/j.ajhg.2012.06.008	http://dx.doi.org/10.1016/j.ajhg.2012.06.008			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	990CN	22795537	Bronze, Green Published			2022-12-18	WOS:000307608700015
J	Hartig, MB; Iuso, A; Haack, T; Kmiec, T; Jurkiewicz, E; Heim, K; Roeber, S; Tarabin, V; Dusi, S; Krajewska-Walasek, M; Jozwiak, S; Hempel, M; Winkelmann, J; Elstner, M; Oexle, K; Klopstock, T; Mueller-Felber, W; Gasser, T; Trenkwalder, C; Tiranti, V; Kretzschmar, H; Schmitz, G; Strom, TM; Meitinger, T; Prokisch, H				Hartig, Monika B.; Iuso, Arcangela; Haack, Tobias; Kmiec, Tomasz; Jurkiewicz, Elzbieta; Heim, Katharina; Roeber, Sigrun; Tarabin, Victoria; Dusi, Sabrina; Krajewska-Walasek, Malgorzata; Jozwiak, Sergiusz; Hempel, Maja; Winkelmann, Juliane; Elstner, Matthias; Oexle, Konrad; Klopstock, Thomas; Mueller-Felber, Wolfgang; Gasser, Thomas; Trenkwalder, Claudia; Tiranti, Valeria; Kretzschmar, Hans; Schmitz, Gerd; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger			Absence of an Orphan Mitochondrial Protein, C19orf12, Causes a Distinct Clinical Subtype of Neurodegeneration with Brain Iron Accumulation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE; MUTATIONS; DYSTONIA; DISEASE; PLA2G6; PANK2	The disease classification neurodegeneration with brain iron accumulation (NBIA) comprises a clinically and genetically heterogeneous group of progressive neurodegenerative disorders characterized by brain iron deposits in the basal ganglia. For about half of the cases, the molecular basis is currently unknown. We used homozygosity mapping followed by candidate gene sequencing to identify a homozygous 11 bp deletion in the orphan gene C19orf12. Mutation screening of 23 ideopathic NBIA index cases revealed two mutated alleles in 18 of them, and one loss-of-function mutation is the most prevalent. We also identified compound heterozygous missense mutations in a case initially diagnosed with Parkinson disease at age 49. Psychiatric signs, optic atrophy, and motor axonal neuropathy were common findings. Compared to the most prevalent NBIA subtype, pantothenate kinase associated neurodegeneration (PKAN), individuals with two C19orf12 mutations were older at age of onset and the disease progressed more slowly. A polyclonal antibody against the predicted membrane spanning protein showed a mitochondrial localization. A histopathological examination in a single autopsy case detected Lewy bodies, tangles, spheroids, and tau pathology. The mitochondrial localization together with the immunohistopathological findings suggests a pathomechanistic overlap with common forms of neurodegenerative disorders.	[Hartig, Monika B.; Haack, Tobias; Hempel, Maja; Winkelmann, Juliane; Oexle, Konrad; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Hartig, Monika B.; Iuso, Arcangela; Haack, Tobias; Heim, Katharina; Hempel, Maja; Winkelmann, Juliane; Elstner, Matthias; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Kmiec, Tomasz; Jozwiak, Sergiusz] Mem Childrens Hlth Inst, Dept Child Neurol, PL-04730 Warsaw, Poland; [Jurkiewicz, Elzbieta] Mem Childrens Hlth Inst, Magnet Resonance Imaging Unit, PL-04730 Warsaw, Poland; [Roeber, Sigrun; Kretzschmar, Hans] Univ Munich, Ctr Neuropathol & Prion Res, D-81377 Munich, Germany; [Tarabin, Victoria; Schmitz, Gerd] Univ Regensburg, Inst Clin Chem & Lab Med, D-93053 Regensburg, Germany; [Dusi, Sabrina; Tiranti, Valeria] Ist Ricovero & Cura, Neurol Inst Carlo Besta, Unit Mol Neurogenet, I-20100 Milan, Italy; [Krajewska-Walasek, Malgorzata] Mem Childrens Hlth Inst, Dept Med Genet, PL-04730 Warsaw, Poland; [Winkelmann, Juliane] Tech Univ Munich, Dept Neurol, D-81675 Munich, Germany; [Elstner, Matthias; Klopstock, Thomas] Univ Munich, Dept Neurol, D-81377 Munich, Germany; [Mueller-Felber, Wolfgang] Univ Munich, Dept Pediat, Dr Von Hauner Childrens Hosp, D-81337 Munich, Germany; [Gasser, Thomas] Hertie Inst Clin Brain Res, Dept Neurodegenerat Dis, D-72076 Tubingen, Germany; [Gasser, Thomas] German Ctr Neurodegenerat Dis, D-72076 Tubingen, Germany; [Trenkwalder, Claudia] Univ Gottingen, D-34128 Kassel, Germany; [Trenkwalder, Claudia] Paracelsus Elena Klin, D-34128 Kassel, Germany	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Regensburg; IRCCS Istituto Neurologico Besta; Technical University of Munich; University of Munich; University of Munich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Gottingen	Meitinger, T (corresponding author), Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany.	meitinger@helmholtz-muenchen.de	Meitinger, Thomas/O-1318-2015; Tiranti, Valeria/AFN-5783-2022; Dusi, Sabrina/H-6561-2016; Tiranti, Valeria/J-8233-2016; Trenkwalder, Claudia/AHD-1232-2022; Prokisch, Holger/N-8964-2013; Trenkwalder, Claudia/ABD-6559-2021; Gasser, Thomas/GNH-5293-2022	Tiranti, Valeria/0000-0002-3584-7338; Dusi, Sabrina/0000-0002-4935-5174; Tiranti, Valeria/0000-0002-3584-7338; Trenkwalder, Claudia/0000-0001-6407-1199; Gasser, Thomas/0000-0002-1069-1146; Krajewska-Walasek, Malgorzata/0000-0001-8721-210X; Jurkiewicz, Elzbieta/0000-0003-4505-8815; Prokisch, Holger/0000-0003-2379-6286; Jozwiak, Sergiusz/0000-0003-3350-6326; Schmitz, Gerd/0000-0002-1325-1007; Meitinger, Thomas/0000-0002-8838-8403; Kmiec, Tomasz/0000-0001-6958-6239; Winkelmann, Juliane/0000-0003-2667-9691; Oexle, Konrad/0000-0001-7447-2252	Helmholtz Association [HA-215]; German National Research Network [01GS08134]; German Network for Mitochondrial Disorders (mitoNET) [01GM0867, 01GM0862]; Systems Biology of Metabotypes (SysMBo) [0315494A]; Deutsche Forschungsgemeinschaft [WI 1820/4-1]; Federal Ministry of Education and Research (BMBF); European-Union [202272]; Italian Foundation AISNAF (Associazione Italiana Sindromi Neurodegenerative Accumulo di Ferro); Mariani Foundation of Milan [R-10-84]	Helmholtz Association(Helmholtz Association); German National Research Network; German Network for Mitochondrial Disorders (mitoNET); Systems Biology of Metabotypes (SysMBo); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European-Union(European Commission); Italian Foundation AISNAF (Associazione Italiana Sindromi Neurodegenerative Accumulo di Ferro); Mariani Foundation of Milan	We are indebted to all individuals and their families donating samples and clinical datasets. We thank I. Gromek, A. Kostera-Pruszczyk, B. Lojszczyk, and B. Chipczynska for their efforts in clinical phenotyping. We gratefully acknowledge the support of R. Hellinger and A. Loschner in genotyping; B. Schmick, K. Junghans, and B. Siegel in expression analysis; and S. Heinisch in bioinformatics analysis. T.M. and H.P. were supported by the Impulse and Networking Fund of the Helmholtz Association in the framework of the Helmholtz Alliance for Mental Health in an Ageing Society (HA-215), the German National Research Network (NGENplus #01GS08134), the German Network for Mitochondrial Disorders (mitoNET 01GM0867), and Systems Biology of Metabotypes (SysMBo #0315494A). T.K. is supported by the German Network for Mitochondrial Disorders (mitoNET #01GM0862). J.W. and K.O. are supported by a grant from the Deutsche Forschungsgemeinschaft (WI 1820/4-1). The Brain-Net is supported by the Federal Ministry of Education and Research (BMBF). Work on primary human adipocytes was supported by the seventh framework program of the European-Union-funded LipidomicNet (proposal 202272). S.D. is supported by Italian Foundation AISNAF (Associazione Italiana Sindromi Neurodegenerative Accumulo di Ferro). The financial support of Mariani Foundation of Milan (grant R-10-84 to V.T.) is gratefully acknowledged.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Edvardson S, 2008, AM J HUM GENET, V83, P643, DOI 10.1016/j.ajhg.2008.10.010; Gregory A, 2011, CURR NEUROL NEUROSCI, V11, P254, DOI 10.1007/s11910-011-0181-3; Hardy J, 2010, NEURON, V68, P201, DOI 10.1016/j.neuron.2010.10.014; Hartig MB, 2006, ANN NEUROL, V59, P248, DOI 10.1002/ana.20771; Hortnagel K, 2003, HUM MOL GENET, V12, P321, DOI 10.1093/hmg/ddg026; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Kruer MC, 2010, ANN NEUROL, V68, P611, DOI 10.1002/ana.22122; LINDSTROM MJ, 1988, J AM STAT ASSOC, V83, P1014; Meisinger C, 2009, AM J HUM GENET, V84, P66, DOI 10.1016/j.ajhg.2008.11.015; Morgan NV, 2006, NAT GENET, V38, P752, DOI 10.1038/ng1826; Paisan-Ruiz C, 2009, ANN NEUROL, V65, P19, DOI 10.1002/ana.21415; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572	15	173	179	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 7	2011	89	4					543	550		10.1016/j.ajhg.2011.09.007	http://dx.doi.org/10.1016/j.ajhg.2011.09.007			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	834HV	21981780	Green Published, Bronze			2022-12-18	WOS:000295951300008
J	Mao, XY; Bigham, AW; Mei, R; Gutierrez, G; Weiss, KM; Brutsaert, TD; Leon-Velarde, F; Moore, LG; Vargas, E; McKeigue, PM; Shriver, MD; Parra, EJ				Mao, Xianyun; Bigham, Abigail W.; Mei, Rui; Gutierrez, Gerardo; Weiss, Ken M.; Brutsaert, Tom D.; Leon-Velarde, Fabiola; Moore, Lorna G.; Vargas, Enrique; McKeigue, Paul M.; Shriver, Mark D.; Parra, Esteban J.			A genomewide admixture mapping panel for hispanic/latino populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MEXICAN-AMERICANS; ADMIXED POPULATIONS; GENETIC ADMIXTURE; UNITED-STATES; DISEASE; AFRICAN; ANCESTRY; DENSITY; LINKAGE; MARKERS	Admixture mapping ( AM) is a promising method for the identification of genetic risk factors for complex traits and diseases showing prevalence differences among populations. Efficient application of this method requires the use of a genomewide panel of ancestry-informative markers (AIMs) to infer the population of origin of chromosomal regions in admixed individuals. Genomewide AM panels with markers showing high frequency differences between West African and European populations are already available for disease-gene discovery in African Americans. However, no such a map is yet available for Hispanic/Latino populations, which are the result of two-way admixture between Native American and European populations or of three-way admixture of Native American, European, and West African populations. Here, we report a genomewide AM panel with 2,120 AIMs showing high frequency differences between Native American and European populations. The average intermarker genetic distance is similar to 1.7 cM. The panel was identified by genotyping, with the Affymetrix GeneChip Human Mapping 500K array, a population sample with European ancestry, a Mesoamerican sample comprising Maya and Nahua from Mexico, and a South American sample comprising Aymara/Quechua from Bolivia and Quechua from Peru. The main criteria for marker selection were both high information content for Native American/European ancestry (measured as the standardized variance of the allele frequencies, also known as "f value") and small frequency differences between the Mesoamerican and South American samples. This genomewide AM panel will make it possible to apply AM approaches in many admixed populations throughout the Americas.	Penn State Univ, Dept Anthropol, University Pk, PA 16801 USA; Affymetrix, Santa Clara, CA USA; SUNY Albany, Dept Anthropol, Albany, NY 12222 USA; Univ Peruana Cayetano Heredia, Dept Ciencias Biol & Fisiol, Lima, Peru; Univ Colorado, Dept Hlth Behav Sci, Denver, CO 80202 USA; Univ Colorado, Dept Anthropol, Denver, CO 80202 USA; Univ Colorado, Hlth Sci Ctr, Denver, CO USA; Univ Mayor San Andres, Inst Boliviano Biol Altura, La Paz, Bolivia; Univ Coll Dublin, Conway Inst, Dublin 2, Ireland; Univ Toronto, Dept Anthropol, Mississauga, ON L5L 1C6, Canada	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Affymetrix; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Universidad Peruana Cayetano Heredia; University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Universidad Mayor de San Andres; University College Dublin; University of Toronto; University Toronto Mississauga	Shriver, MD (corresponding author), Penn State Univ, Dept Anthropol, Carpenter Bldg 409, University Pk, PA 16801 USA.	mds17@psu.edu	Parra, Esteban J/A-4957-2008; mao, xianyun/B-4664-2014	mao, xianyun/0000-0002-1236-4800; parra, esteban J/0000-0002-2057-8577; Leon-Velarde Servetto, Fabiola/0000-0001-8398-2406; Shriver, Mark/0000-0003-0006-0479	NHGRI NIH HHS [HG02154, R01 HG002154] Funding Source: Medline; NHLBI NIH HHS [HL60131, HL07171, T32 HL007171] Funding Source: Medline; PHS HHS [TN01188] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060131] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002154] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Bertoni B, 2003, HUM BIOL, V75, P1, DOI 10.1353/hub.2003.0016; Bonilla C, 2005, AM J PHYS ANTHROPOL, V128, P861, DOI 10.1002/ajpa.20227; Bonilla C, 2004, HUM GENET, V115, P57, DOI 10.1007/s00439-004-1125-7; Bonilla C, 2004, ANN HUM GENET, V68, P139, DOI 10.1046/j.1529-8817.2003.00084.x; Brutsaert TD, 2003, J APPL PHYSIOL, V95, P519, DOI 10.1152/japplphysiol.01088.2002; CHAKRABORTY R, 1993, DNA FINGERPRINTING C, V67, P153; Choudhry S, 2006, HUM GENET, V118, P652, DOI 10.1007/s00439-005-0071-3; Collins-Schramm HE, 2004, HUM GENET, V114, P263, DOI 10.1007/s00439-003-1058-6; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Halder Indrani, 2003, Human Genomics, V1, P52; HANIS CL, 1991, DIABETES CARE, V14, P618, DOI 10.2337/diacare.14.7.618; Hoggart CJ, 2004, AM J HUM GENET, V74, P965, DOI 10.1086/420855; Kong X, 2004, AM J HUM GENET, V75, P1143, DOI 10.1086/426405; Martinez-Marignac VL, 2007, HUM GENET, V120, P807, DOI 10.1007/s00439-006-0273-3; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; McKeigue PM, 2005, AM J HUM GENET, V76, P1, DOI 10.1086/426949; Montana G, 2004, AM J HUM GENET, V75, P771, DOI 10.1086/425281; Nievergelt CM, 2005, CURR HYPERTENS REP, V7, P31, DOI 10.1007/s11906-005-0052-x; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Pfaff CL, 2004, GENET EPIDEMIOL, V26, P305, DOI 10.1002/gepi.10319; Pritchard JK, 2000, GENETICS, V155, P945; Reich D, 2005, NAT GENET, V37, P1113, DOI 10.1038/ng1646; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tang H, 2006, HUM GENET, V119, P624, DOI 10.1007/s00439-006-0175-4; Tian C, 2006, AM J HUM GENET, V79, P640, DOI 10.1086/507954; Tseng M, 1998, AM J PHYS ANTHROPOL, V106, P361, DOI 10.1002/(SICI)1096-8644(199807)106:3<361::AID-AJPA8>3.3.CO;2-J; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Zhang C, 2004, GENET EPIDEMIOL, V27, P225, DOI 10.1002/gepi.20021; Zhu XF, 2005, NAT GENET, V37, P177, DOI 10.1038/ng1510; Zhu XF, 2004, AM J HUM GENET, V74, P1136, DOI 10.1086/421329; Zhu XF, 2006, HUM GENET, V120, P431, DOI 10.1007/s00439-006-0224-z	32	173	180	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2007	80	6					1171	1178		10.1086/518564	http://dx.doi.org/10.1086/518564			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	168WD	17503334	Green Published, Bronze			2022-12-18	WOS:000246553800015
J	McQueen, MB; Devlin, B; Faraone, SV; Nimgaonkar, VL; Sklar, P; Smoller, JW; Jamra, RA; Albus, M; Bacanu, SA; Baron, M; Barrett, TB; Berrettini, W; Blacker, D; Byerley, W; Cichon, S; Coryell, W; Craddock, N; Daly, MJ; DePaulo, JR; Edenberg, HJ; Foroud, T; Gill, M; Gilliam, TC; Hamshere, M; Jones, I; Jones, L; Juo, SH; Kelsoe, JR; Lambert, D; Lange, C; Lerer, B; Liu, JJ; Maier, W; MacKinnon, JD; McInnis, MG; McMahon, FJ; Murphy, DL; Nothen, MM; Nurnberger, JI; Pato, CN; Pato, MT; Potash, JB; Propping, P; Pulver, AE; Rice, JP; Rietschel, M; Scheftner, W; Schumacher, J; Segurado, R; Van Steen, K; Xie, WT; Zandi, PP; Laird, NM				McQueen, MB; Devlin, B; Faraone, SV; Nimgaonkar, VL; Sklar, P; Smoller, JW; Jamra, RA; Albus, M; Bacanu, SA; Baron, M; Barrett, TB; Berrettini, W; Blacker, D; Byerley, W; Cichon, S; Coryell, W; Craddock, N; Daly, MJ; DePaulo, JR; Edenberg, HJ; Foroud, T; Gill, M; Gilliam, TC; Hamshere, M; Jones, I; Jones, L; Juo, SH; Kelsoe, JR; Lambert, D; Lange, C; Lerer, B; Liu, JJ; Maier, W; MacKinnon, JD; McInnis, MG; McMahon, FJ; Murphy, DL; Nothen, MM; Nurnberger, JI; Pato, CN; Pato, MT; Potash, JB; Propping, P; Pulver, AE; Rice, JP; Rietschel, M; Scheftner, W; Schumacher, J; Segurado, R; Van Steen, K; Xie, WT; Zandi, PP; Laird, NM			Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE SCAN; NATIONAL-INSTITUTE; GENETIC HOMOGENEITY; SUGGESTIVE LINKAGE; MANIC-DEPRESSION; POTENTIAL LOCI; PEDIGREES; METAANALYSIS; SCREEN; FAMILIES	Several independent studies and meta-analyses aimed at identifying genomic regions linked to bipolar disorder (BP) have failed to find clear and consistent evidence of linkage regions. Our hypothesis is that combining the original genotype data provides benefits of increased power and control over sources of heterogeneity that outweigh the difficulty and potential pitfalls of the implementation. We conducted a combined analysis using the original genotype data from 11 BP genomewide linkage scans comprising 5,179 individuals from 1,067 families. Heterogeneity among studies was minimized in our analyses by using uniform methods of analysis and a common, standardized marker map and was assessed using novel methods developed for meta-analysis of genome scans. To date, this collaboration is the largest and most comprehensive analysis of linkage samples involving a psychiatric disorder. We demonstrate that combining original genome-scan data is a powerful approach for the elucidation of linkage regions underlying complex disease. Our results establish genomewide significant linkage to BP on chromosomes 6q and 8q, which provides solid information to guide future gene-finding efforts that rely on fine-mapping and association approaches.	Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	McQueen, MB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, 677 Huntington Ave, Boston, MA 02115 USA.	mmcqueen@hsph.harvard.edu	Juo, Suh-Hang/C-9545-2009; McMahon, Francis J/A-7290-2009; Daly, Mark J/B-2453-2017; Jamra, Rami Abou/I-4805-2015; Nöthen, Markus/B-2027-2009; Faraone, Stephen V/O-7239-2018; McQueen, Matthew/X-5845-2019; Faraone, Stephen/AAE-7334-2019; Abou Jamra, Rami/AAC-8192-2019; Cichon, Sven/H-8803-2013; McInnis, Melvin G/F-6963-2012; Cichon, Sven/B-9618-2014; Liu, Jianjun/AAK-4989-2020; Juo, Suh-Hang/A-1765-2010; Jamra, Rami Abou/I-2350-2012; Jones, Ian R/B-4925-2009; Segurado, Ricardo/K-6116-2014	McMahon, Francis J/0000-0002-9469-305X; Daly, Mark J/0000-0002-0949-8752; Jamra, Rami Abou/0000-0002-1542-1399; Nöthen, Markus/0000-0002-8770-2464; Faraone, Stephen V/0000-0002-9217-3982; Faraone, Stephen/0000-0002-9217-3982; Abou Jamra, Rami/0000-0002-1542-1399; Cichon, Sven/0000-0002-9475-086X; McInnis, Melvin G/0000-0002-0375-6247; Cichon, Sven/0000-0002-9475-086X; Liu, Jianjun/0000-0002-3255-3019; Jamra, Rami Abou/0000-0002-1542-1399; Jones, Ian R/0000-0001-5821-5889; Jones, Lisa/0000-0002-5122-8334; coryell, william/0000-0003-3989-7276; DePaulo, J Raymond/0000-0001-9221-9226; Van Steen, Kristel/0000-0001-9868-5033; Nurnberger, John/0000-0002-7674-1767; Segurado, Ricardo/0000-0002-3547-6733; Gill, Michael/0000-0003-0206-5337; Edenberg, Howard/0000-0003-0344-9690; Bacanu, Silviu-Alin/0000-0002-4364-1583	Intramural NIH HHS [Z01 MH002810] Funding Source: Medline; NHGRI NIH HHS [N01HG65403] Funding Source: Medline; NICHD NIH HHS [R01 HD060726] Funding Source: Medline; NIMH NIH HHS [T32-MH017119, MH0667288, R01 MH059553, U01 MH46280, R01 MH59567, R01 MH059533, R01 MH60068, U01 MH46274, R01 MH59553, R01-MH063445, R01 MH059548, R01 MH59533, R01 MH059567, R01 MH59545, R01 MH059535, R01 MH063445, R01 MH063420, R01 MH59602, T32 MH017119, MH63420, R01 MH59535, R01 MH059534, U01 MH46282, 1Z01MH002810-01, R01 MH060068, R01 MH059556, R01 MH059545] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060726] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059535, U01MH046282, R01MH063420, R01MH059553, R01MH059534, Z01MH002810, R01MH063445, R01MH060068, R01MH059545, R01MH059567, R01MH059533, R01MH059602, T32MH017119, R01MH059548, U01MH046274, R01MH059556, U01MH046280] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; APA, 1994, DIAGN STAT MAN MENT; Bacanu SA, 2005, GENET EPIDEMIOL, V28, P24, DOI 10.1002/gepi.20030; Badenhop R, 2002, MOL PSYCHIATR, V7, P851, DOI 10.1038/sj.mp.4001114; Badner JA, 2002, MOL PSYCHIATR, V7, P405, DOI 10.1038/sj.mp.4001012; Baron M, 2002, MOL PSYCHIATR, V7, P342, DOI 10.1038/sj.mp.4000998; Barondes SH, 1999, BIOL PSYCHIAT, V45, P559, DOI 10.1016/S0006-3223(98)00283-2; Bennett P, 2002, MOL PSYCHIATR, V7, P189, DOI 10.1038/sj.mp.4000957; Blackwood DHR, 1996, NAT GENET, V12, P427, DOI 10.1038/ng0496-427; Cichon S, 2001, HUM MOL GENET, V10, P2933, DOI 10.1093/hmg/10.25.2933; COON H, 1993, AM J HUM GENET, V52, P1234; Curtis D, 2003, PSYCHIAT GENET, V13, P77, DOI 10.1097/01.ypg.0000056684.89558.d2; Detera-Wadleigh SD, 1999, P NATL ACAD SCI USA, V96, P5604, DOI 10.1073/pnas.96.10.5604; Dick DM, 2003, AM J HUM GENET, V73, P107, DOI 10.1086/376562; Dick DM, 2002, AM J MED GENET, V114, P407, DOI 10.1002/ajmg.10380; Dizier MH, 2000, ANN HUM GENET, V64, P433, DOI 10.1046/j.1469-1809.2000.6450433.x; Ekholm JM, 2003, HUM MOL GENET, V12, P1907, DOI 10.1093/hmg/ddg199; Elston RC, 2005, AM J HUM GENET, V76, P152, DOI 10.1086/426872; Ewald H, 2002, MOL PSYCHIATR, V7, P734, DOI 10.1038/sj.mp.4001074; Fallin MD, 2004, AM J HUM GENET, V75, P204, DOI 10.1086/422474; Friddle C, 2000, AM J HUM GENET, V66, P205, DOI 10.1086/302697; Garner C, 2001, AM J HUM GENET, V68, P1061, DOI 10.1086/319517; Gu C, 1998, GENET EPIDEMIOL, V15, P609, DOI 10.1002/(SICI)1098-2272(1998)15:6<609::AID-GEPI5>3.0.CO;2-N; HOLMANS P, 1993, AM J HUM GENET, V52, P362; Kelsoe JR, 2001, P NATL ACAD SCI USA, V98, P585, DOI 10.1073/pnas.011358498; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kong X, 2004, AM J HUM GENET, V75, P1143, DOI 10.1086/426405; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Laird N M, 1990, Int J Technol Assess Health Care, V6, P5; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; LAMBERT D, 2005, MOL PSYCHIAT; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Levinson DF, 2003, AM J HUM GENET, V73, P17, DOI 10.1086/376548; Liu J, 2003, MOL PSYCHIATR, V8, P333, DOI 10.1038/sj.mp.4001254; McInnes LA, 1996, P NATL ACAD SCI USA, V93, P13060, DOI 10.1073/pnas.93.23.13060; McInnis MG, 2003, BIOL PSYCHIAT, V54, P1265, DOI 10.1016/j.biopsych.2003.08.001; McInnis MG, 2003, MOL PSYCHIATR, V8, P288, DOI 10.1038/sj.mp.4001277; Middleton FA, 2004, AM J HUM GENET, V74, P886, DOI 10.1086/420775; Morissette J, 1999, AM J MED GENET, V88, P567, DOI 10.1002/(SICI)1096-8628(19991015)88:5<567::AID-AJMG24>3.0.CO;2-8; Nurnberger JI, 1997, AM J MED GENET, V74, P227, DOI 10.1002/(SICI)1096-8628(19970531)74:3<227::AID-AJMG1>3.0.CO;2-N; Park N, 2004, MOL PSYCHIATR, V9, P1091, DOI 10.1038/sj.mp.4001541; Pato CN, 2004, AM J MED GENET B, V127B, P30, DOI 10.1002/ajmg.b.30001; Radhakrishna U, 2001, EUR J HUM GENET, V9, P39, DOI 10.1038/sj.ejhg.5200584; Schulze TG, 2004, BIOL PSYCHIAT, V56, P18, DOI 10.1016/j.biopsych.2004.04.004; Segurado R, 2003, AM J HUM GENET, V73, P49, DOI 10.1086/376547; Simpson SG, 2002, ARCH GEN PSYCHIAT, V59, P736, DOI 10.1001/archpsyc.59.8.736; Smoller JW, 2003, AM J MED GENET C, V123C, P48, DOI 10.1002/ajmg.c.20013; Tsuang M.T., 2000, BIPOLAR DISORDERS 10, P231; Turecki G, 2001, MOL PSYCHIATR, V6, P570, DOI 10.1038/sj.mp.4000888; Venken T, 2005, AM J HUM GENET, V76, P237, DOI 10.1086/427836; Weissman MM, 1996, JAMA-J AM MED ASSOC, V276, P293, DOI 10.1001/jama.276.4.293; Weissman MM, 1991, PSYCHIAT DISORDERS A, P53; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Willour VL, 2003, AM J MED GENET B, V121B, P21, DOI 10.1002/ajmg.b.20051; Wise LH, 1999, ANN HUM GENET, V63, P263, DOI 10.1046/j.1469-1809.1999.6330263.x; Zandi PP, 2003, AM J MED GENET B, V119B, P69, DOI 10.1002/ajmg.b.10063	58	173	179	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2005	77	4					582	595		10.1086/491603	http://dx.doi.org/10.1086/491603			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	967QS	16175504	Bronze, Green Published			2022-12-18	WOS:000232106900006
J	Woods, KS; Cundall, M; Turton, J; Rizotti, K; Mehta, A; Palmer, R; Wong, J; Chong, WK; Al-Zyoud, M; El-Ali, M; Otonkoski, T; Martinez-Barbera, JP; Thomas, PQ; Robinson, IC; Lovell-Badge, R; Woodward, KJ; Dattani, MT				Woods, KS; Cundall, M; Turton, J; Rizotti, K; Mehta, A; Palmer, R; Wong, J; Chong, WK; Al-Zyoud, M; El-Ali, M; Otonkoski, T; Martinez-Barbera, JP; Thomas, PQ; Robinson, IC; Lovell-Badge, R; Woodward, KJ; Dattani, MT			Over- and underdosage of SOX3 is associated with infundibular hypoplasia and hypopituitarism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKED MENTAL-RETARDATION; PITUITARY-HORMONE DEFICIENCY; SEPTO-OPTIC DYSPLASIA; SEX REVERSAL; TESTIS DETERMINATION; MOLECULAR-BASIS; GENE-MUTATIONS; RECEPTOR GENE; ORGANOGENESIS; DUPLICATION	Duplications of Xq26-27 have been implicated in the etiology of X-linked hypopituitarism associated with mental retardation (MR). Additionally, an expansion of a polyalanine tract (by 11 alanines) within the transcription factor SOX3 (Xq27.1) has been reported in patients with growth hormone deficiency and variable learning difficulties. We report a submicroscopic duplication of Xq27.1, the smallest reported to date (685.6 kb), in two siblings with variable hypopituitarism, callosal abnormalities, anterior pituitary hypoplasia (APH), an ectopic posterior pituitary (EPP), and an absent infundibulum. This duplication contains SOX3 and sequences corresponding to two transcripts of unknown function; only Sox3 is expressed in the infundibulum in mice. Next, we identified a novel seven-alanine expansion within a polyalanine tract in SOX3 in a family with panhypopituitarism in three male siblings with an absent infundibulum, severe APH, and EPP. This mutation led to reduced transcriptional activity, with impaired nuclear localization of the mutant protein. We also identified a novel polymorphism (A43T) in SOX3 in another child with hypopituitarism. In contrast to findings in previous studies, there was no evidence of MR or learning difficulties in our patients. We conclude that both over- and underdosage of SOX3 are associated with similar phenotypes, consisting of infundibular hypoplasia and hypopituitarism but not necessarily MR.	UCL, Inst Child Hlth, London Ctr Paediat Endocrinol Biochem Endocrinol, London WC1N 1EH, England; UCL, Inst Child Hlth, Metab Unit, London WC1N 1EH, England; UCL, Inst Child Hlth, Clin & Mol Genet Unit, London WC1N 1EH, England; UCL, Inst Child Hlth, Neural Dev Unit, London WC1N 1EH, England; Natl Inst Med Res, MRC, Div Dev Genet, London NW7 1AA, England; Natl Inst Med Res, MRC, Div Mol Neuroendocrinol, London NW7 1AA, England; Great Ormond St Hosp Sick Children, NE London Reg Cytogenet Lab, London WC1N 3JH, England; Great Ormond St Hosp Sick Children, Dept Neuroradiol, London WC1N 3JH, England; Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; Hamad Med Corp, Dept Paediat Endocrinol, Doha, Qatar; Univ Helsinki, Hosp Children & Adolescents, Helsinki, Finland	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; MRC National Institute for Medical Research; MRC National Institute for Medical Research; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Hamad Medical Corporation; University of Helsinki	Dattani, MT (corresponding author), UCL, Inst Child Hlth, London Ctr Paediat Endocrinol Biochem Endocrinol, 30 Guilford St, London WC1N 1EH, England.	mdattani@ich.ucl.ac.uk	Martinez-Barbera, Juan Pedro/AAE-9284-2020; Thomas, Paul Q/K-4497-2012; Rizzoti, Karine/AAW-1090-2021; DATTANI, MEHUL/C-5401-2008; Otonkoski, Timo/F-1189-2011	Martinez-Barbera, Juan Pedro/0000-0002-5292-7276; Rizzoti, Karine/0000-0003-0711-5452; Lovell-Badge, Robin/0000-0001-9364-4179; Chong, Kling/0000-0002-4335-3864; Woods-Townsend, Kathryn/0000-0003-3376-6988	MRC [MC_U117562207] Funding Source: UKRI; Medical Research Council [MC_U117562207] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Albrecht AN, 2004, HUM MOL GENET, V13, P2351, DOI 10.1093/hmg/ddh277; ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Bienvenu T, 2002, HUM MOL GENET, V11, P981, DOI 10.1093/hmg/11.8.981; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164; Brickman JM, 1999, P NATL ACAD SCI USA, V96, P10679, DOI 10.1073/pnas.96.19.10679; Brickman JM, 2000, DEVELOPMENT, V127, P2303; Brickman JM, 2001, DEVELOPMENT, V128, P5189; Brown LY, 2004, TRENDS GENET, V20, P51, DOI 10.1016/j.tig.2003.11.002; Brown LY, 2001, HUM MOL GENET, V10, P791, DOI 10.1093/hmg/10.8.791; Cohen LE, 2002, ENDOCR REV, V23, P431, DOI 10.1210/er.2001-0030; Collignon J, 1996, DEVELOPMENT, V122, P509; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; Dasen JS, 2001, GENE DEV, V15, P3193, DOI 10.1101/gad.932601; Dasen JS, 2001, ANNU REV NEUROSCI, V24, P327, DOI 10.1146/annurev.neuro.24.1.327; Dattani MT, 2000, CLIN GENET, V57, P337, DOI 10.1034/j.1399-0004.2000.570503.x; Dattani MT, 1998, NAT GENET, V19, P125, DOI 10.1038/477; Ericson J, 1998, DEVELOPMENT, V125, P1005; Eroshkin F, 2002, GENE, V285, P279, DOI 10.1016/S0378-1119(02)00393-1; Goodman FR, 2000, AM J HUM GENET, V67, P197, DOI 10.1086/302961; Hamel BCJ, 1996, AM J MED GENET, V64, P35, DOI 10.1002/(SICI)1096-8628(19960712)64:1<35::AID-AJMG5>3.0.CO;2-Q; Hanson IM, 2003, PEDIATR RES, V54, P791, DOI 10.1203/01.PDR.0000096455.00657.98; Heath KE, 2000, J MED GENET, V37, P272, DOI 10.1136/jmg.37.4.272; Hol FA, 2000, GENOMICS, V69, P174, DOI 10.1006/geno.2000.6327; Huang B, 1999, AM J MED GENET, V87, P349, DOI 10.1002/(SICI)1096-8628(19991203)87:4<349::AID-AJMG13>3.0.CO;2-N; Jordan BK, 2001, AM J HUM GENET, V68, P1102, DOI 10.1086/320125; Koster RW, 2000, MECH DEVELOP, V95, P175, DOI 10.1016/S0925-4773(00)00356-7; LagerstromFermer M, 1997, AM J HUM GENET, V60, P910; Laumonnier F, 2002, AM J HUM GENET, V71, P1450, DOI 10.1086/344661; LAZZARO D, 1991, DEVELOPMENT, V113, P1093; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Lim HN, 2000, HUM GENET, V107, P650, DOI 10.1007/s004390000428; Machinis K, 2001, AM J HUM GENET, V69, P961, DOI 10.1086/323764; Meeks JJ, 2003, NAT GENET, V34, P32, DOI 10.1038/ng1141; Muragaki Y, 1996, SCIENCE, V272, P548, DOI 10.1126/science.272.5261.548; Nakano M, 2001, NAT GENET, V29, P315, DOI 10.1038/ng744; Netchine I, 2000, NAT GENET, V25, P182, DOI 10.1038/76041; Otto F, 2002, HUM MUTAT, V19, P209, DOI 10.1002/humu.10043; PFAFFLE RW, 1992, SCIENCE, V257, P1118, DOI 10.1126/science.257.5073.1118; RADOVICK S, 1992, SCIENCE, V257, P1115, DOI 10.1126/science.257.5073.1115; Raverot G, 2004, J CLIN ENDOCR METAB, V89, P4146, DOI 10.1210/jc.2004-0191; Rizzoti K, 2004, NAT GENET, V36, P247, DOI 10.1038/ng1309; Scully KM, 2002, SCIENCE, V295, P2231, DOI 10.1126/science.1062736; Smith JM, 2004, TRENDS GENET, V20, P4, DOI 10.1016/j.tig.2003.11.007; Solomon NM, 2004, J MED GENET, V41, P669, DOI 10.1136/jmg.2003.016949; Solomon NM, 2002, GENOMICS, V79, P553, DOI 10.1006/geno.2002.6741; Stromme P, 2002, NAT GENET, V30, P441, DOI 10.1038/ng862; Takuma N, 1998, DEVELOPMENT, V125, P4835; Thomas PQ, 2001, HUM MOL GENET, V10, P39, DOI 10.1093/hmg/10.1.39; Uchikawa M, 1999, MECH DEVELOP, V84, P103, DOI 10.1016/S0925-4773(99)00083-0; Vincent MC, 2003, EUR J HUM GENET, V11, P163, DOI 10.1038/sj.ejhg.5200940; Weiss J, 2003, MOL CELL BIOL, V23, P8084, DOI 10.1128/MCB.23.22.8084-8091.2003; Woodward K, 2003, AM J MED GENET A, V118A, P15, DOI 10.1002/ajmg.a.10103; Wu W, 1998, NAT GENET, V18, P147, DOI 10.1038/ng0298-147; Xiang FQ, 2000, J MED GENET, V37, P250, DOI 10.1136/jmg.37.4.250; Zhang C, 2003, DEVELOPMENT, V130, P5609, DOI 10.1242/dev.00798	55	173	183	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2005	76	5					833	849		10.1086/430134	http://dx.doi.org/10.1086/430134			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	914BB	15800844	Green Published, Bronze, Green Accepted			2022-12-18	WOS:000228198300010
J	Chiang, AP; Nishimura, D; Searby, C; Elbedour, K; Carmi, R; Ferguson, AL; Secrist, J; Braun, T; Casavant, T; Stone, EM; Sheffield, VC				Chiang, AP; Nishimura, D; Searby, C; Elbedour, K; Carmi, R; Ferguson, AL; Secrist, J; Braun, T; Casavant, T; Stone, EM; Sheffield, VC			Comparative genomic analysis identifies an ADP-ribosylation factor-like gene as the cause of Bardet-Biedl syndrome (BBS3)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MCKUSICK-KAUFMAN-SYNDROME; HUMAN OBESITY SYNDROME; GTP-BINDING PROTEINS; CHROMOSOME 16Q; DISEASE; NUCLEOTIDE; MUTATIONS; SEQUENCE; COMPLEX; LINKAGE	Bardet-Biedl syndrome (BBS) is a genetically heterogeneous, pleiotropic human disorder characterized by obesity, retinopathy, polydactyly, renal and cardiac malformations, learning disabilities, and hypogenitalism. Eight BBS loci have been mapped, and seven genes have been identified. BBS3 was previously mapped to chromosome 3 by linkage analysis in a large Israeli Bedouin kindred. The rarity of other families mapping to the BBS3 locus has made it difficult to narrow the disease interval sufficiently to identify the gene by positional cloning. We hypothesized that the genomes of model organisms that contained the orthologues to known BBS genes would also likely contain a BBS3 orthologue. Therefore, comparative genomic analysis was performed to prioritize BBS candidate genes for mutation screening. Known BBS proteins were compared with the translated genomes of model organisms to identify a subset of organisms in which these proteins were conserved. By including multiple organisms that have relatively small genome sizes in the analysis, the number of candidate genes was reduced, and a few genes mapping to the BBS3 interval emerged as the best candidates for this disorder. One of these genes, ADP-ribosylation factor-like 6 (ARL6), contains a homozygous stop mutation that segregates completely with the disease in the Bedouin kindred originally used to map the BBS3 locus, identifying this gene as the BBS3 gene. These data illustrate the power of comparative genomic analysis for the study of human disease and identifies a novel BBS gene.	Univ Iowa, Howard Hughes Med Inst, Dept Pediat, Div Med Genet, Iowa City, IA 52242 USA; Univ Iowa, Dept Elect & Comp Engn, Iowa City, IA 52242 USA; Univ Iowa, Dept Ophthalmol, Iowa City, IA 52242 USA; Ben Gurion Univ Negev, Soroka Med Ctr, Inst Genet, IL-84105 Beer Sheva, Israel	Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; Ben Gurion University; Soroka Medical Center	Sheffield, VC (corresponding author), Univ Iowa, Howard Hughes Med Inst, Dept Pediat, Div Med Genet, Iowa City, IA 52242 USA.	val-sheffield@uiowa.edu		Stone, Edwin M./0000-0003-3343-4414; Searby, Charles/0000-0002-8108-8782; Sheffield, Val/0000-0002-6282-0835	NEI NIH HHS [R01 EY011298, R01-EY-11298] Funding Source: Medline; NHLBI NIH HHS [P50-HL-55006, P50 HL055006] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011298] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL055006] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Badano JL, 2003, AM J HUM GENET, V72, P650, DOI 10.1086/368204; BARDET G, 1920, THESIS U PARIS PARIS; Bhamidipati A, 2000, J CELL BIOL, V149, P1087, DOI 10.1083/jcb.149.5.1087; Biedl A., 1922, DEUT MED WOCHENSCHR, V48, P1630; Bruford EA, 1997, GENOMICS, V41, P93, DOI 10.1006/geno.1997.4613; CARMI R, 1995, AM J MED GENET, V59, P199, DOI 10.1002/ajmg.1320590216; Curwen V, 2004, GENOME RES, V14, P942, DOI 10.1101/gr.1858004; ELBEDOUR K, 1994, AM J MED GENET, V52, P164, DOI 10.1002/ajmg.1320520208; FRYDMAN J, 1992, EMBO J, V11, P4767, DOI 10.1002/j.1460-2075.1992.tb05582.x; GREEN JS, 1989, NEW ENGL J MED, V321, P1002, DOI 10.1056/NEJM198910123211503; HARNETT JD, 1988, NEW ENGL J MED, V319, P615, DOI 10.1056/NEJM198809083191005; Ingley E, 1999, FEBS LETT, V459, P69, DOI 10.1016/S0014-5793(99)01188-6; Jacobs S, 1999, FEBS LETT, V456, P384, DOI 10.1016/S0014-5793(99)00759-0; KAHN RA, 1984, J BIOL CHEM, V259, P6228; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Katsanis N, 2000, NAT GENET, V26, P67, DOI 10.1038/79201; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; KWITEKBLACK AE, 1993, NAT GENET, V5, P392, DOI 10.1038/ng1293-392; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Mykytyn K, 2004, P NATL ACAD SCI USA, V101, P8664, DOI 10.1073/pnas.0402354101; Mykytyn K, 2002, NAT GENET, V31, P435, DOI 10.1038/ng935; Mykytyn K, 2001, NAT GENET, V28, P188, DOI 10.1038/88925; Nishimura DY, 2001, HUM MOL GENET, V10, P865, DOI 10.1093/hmg/10.8.865; Pasqualato S, 2002, EMBO REP, V3, P1035, DOI 10.1093/embo-reports/kvf221; PRICE SR, 1988, P NATL ACAD SCI USA, V85, P5488, DOI 10.1073/pnas.85.15.5488; ROBINOW M, 1979, J PEDIATR-US, V94, P776, DOI 10.1016/S0022-3476(79)80155-9; SEWELL JL, 1988, P NATL ACAD SCI USA, V85, P4620, DOI 10.1073/pnas.85.13.4620; SHEFFIELD VC, 1994, HUM MOL GENET, V3, P1331, DOI 10.1093/hmg/3.8.1331; Slavotinek AM, 2000, NAT GENET, V26, P15, DOI 10.1038/79116; Stone DL, 2000, NAT GENET, V25, P79, DOI 10.1038/75637; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	36	173	176	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2004	75	3					475	484		10.1086/423903	http://dx.doi.org/10.1086/423903			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	845VA	15258860	Green Published, Bronze			2022-12-18	WOS:000223272200011
J	Li, AR; Jiao, XD; Munier, FL; Schorderet, DF; Yao, WL; Iwata, F; Hayakawa, M; Kanai, A; Chen, MS; Lewis, RA; Heckenlively, J; Weleber, RG; Traboulsi, EI; Zhang, QJ; Xiao, XS; Kaiser-Kupfer, M; Sergeev, YV; Hejtmancik, JF				Li, AR; Jiao, XD; Munier, FL; Schorderet, DF; Yao, WL; Iwata, F; Hayakawa, M; Kanai, A; Chen, MS; Lewis, RA; Heckenlively, J; Weleber, RG; Traboulsi, EI; Zhang, QJ; Xiao, XS; Kaiser-Kupfer, M; Sergeev, YV; Hejtmancik, JF			Bietti crystalline corneoretinal dystrophy is caused by mutations in the novel gene CYP4V2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IDENTIFICATION; OPTIMIZATION; CONFORMATION; SEQUENCE; LINKAGE; CHINA	Bietti crystalline corneoretinal dystrophy (BCD) is an autosomal recessive retinal dystrophy characterized by multiple glistening intraretinal crystals scattered over the fundus, a characteristic degeneration of the retina, and sclerosis of the choroidal vessels, ultimately resulting in progressive night blindness and constriction of the visual field. The BCD region of chromosome 4q35.1 was refined to an interval flanked centromerically by D4S2924 by linkage and haplotype analysis; mutations were found in the novel CYP450 family member CYP4V2 in 23 of 25 unrelated patients with BCD tested. The CYP4V2 gene, transcribed from 11 exons spanning 19 kb, is expressed widely. Homology to other CYP450 proteins suggests that CYP4V2 may have a role in fatty acid and steroid metabolism, consistent with biochemical studies of patients with BCD.	NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA; Jules Gonin Eye Hosp, Oculgenet Unit, Lausanne, Switzerland; Inst Rech Ophtalmol, Sion, Switzerland; Juntendo Univ, Sch Med, Dept Ophthalmol, Tokyo 113, Japan; Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan; Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; Baylor Coll Med, Dept Human & Mol Genet, Houston, TX 77030 USA; Univ Michigan, Jules Kellogg Eye Ctr, Ann Arbor, MI 48109 USA; Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR USA; Cleveland Clin Fdn, Cleveland, OH 44195 USA; Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangzhou, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Juntendo University; National Taiwan University; National Taiwan University Hospital; Baylor College of Medicine; Baylor College of Medicine; University of Michigan System; University of Michigan; Oregon Health & Science University; Cleveland Clinic Foundation; Sun Yat Sen University	Hejtmancik, JF (corresponding author), NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bldg 10,Room 10B10,10 Ctr Dr,MSC 1860, Bethesda, MD 20892 USA.	f3h@helix.nih.gov	Zhang, Qingjiong/AAR-6331-2021; Traboulsi, Elias/AAY-7443-2020	Zhang, Qingjiong/0000-0001-7508-848X; 	NATIONAL EYE INSTITUTE [Z01EY000272, ZIAEY000272] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ayyagari R, 1996, GENOME RES, V6, P504, DOI 10.1101/gr.6.6.504; Bietti G., 1937, KLIN MBL AUGENHEILK, V99, P737; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; HU DN, 1983, OPHTHALMIC PAED GEN, V2, P39, DOI 10.3109/13816818309007148; HU DN, 1982, AM J MED GENET, V12, P51, DOI 10.1002/ajmg.1320120107; Jiao XD, 2000, AM J HUM GENET, V67, P1309; KAISERKUPFER MI, 1994, AM J OPHTHALMOL, V118, P569, DOI 10.1016/S0002-9394(14)76572-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LEE C, 1991, J MOL BIOL, V217, P373, DOI 10.1016/0022-2836(91)90550-P; LEE C, 1994, J MOL BIOL, V236, P918, DOI 10.1006/jmbi.1994.1198; Lee J, 1998, MOL GENET METAB, V65, P143, DOI 10.1006/mgme.1998.2723; Lee J, 2001, INVEST OPHTH VIS SCI, V42, P1707; LEVITT M, 1992, J MOL BIOL, V226, P507, DOI 10.1016/0022-2836(92)90964-L; MATAFTSI A, IN PRESS RETINA; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Rogan PK, 1998, HUM MUTAT, V12, P153, DOI 10.1002/(SICI)1098-1004(1998)12:3<153::AID-HUMU3>3.3.CO;2-O; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; SMITH RJH, 1989, CYTOGENET CELL GENET, V50, P102, DOI 10.1159/000132733; Welch R B, 1977, Trans Am Ophthalmol Soc, V75, P164; WILSON DJ, 1989, ARCH OPHTHALMOL-CHIC, V107, P213, DOI 10.1001/archopht.1989.01070010219026; [No title captured]	24	173	188	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2004	74	5					817	826		10.1086/383228	http://dx.doi.org/10.1086/383228			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	813SF	15042513	Green Published, Bronze			2022-12-18	WOS:000220926100004
J	Auranen, M; Vanhala, R; Varilo, T; Ayers, K; Kempas, E; Ylisaukko-oja, T; Sinsheimer, JS; Peltonen, L; Jarvela, I				Auranen, M; Vanhala, R; Varilo, T; Ayers, K; Kempas, E; Ylisaukko-oja, T; Sinsheimer, JS; Peltonen, L; Jarvela, I			A genomewide screen for autism-spectrum disorders: Evidence for a major susceptibility locus on chromosome 3q25-27	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECEPTIVE LANGUAGE DISORDER; EARLY ADULT LIFE; WIDE SCAN; FOLLOW-UP; LINKAGE DISEQUILIBRIUM; MULTIPLE-SCLEROSIS; PEDIGREE ANALYSIS; FAMILY-HISTORY; GENOMIC SCREEN; GENE	To identify genetic loci for autism-spectrum disorders, we have performed a two-stage genomewide scan in 38 Finnish families. The detailed clinical examination of all family members revealed infantile autism, but also Asperger syndrome (AS) and developmental dysphasia, in the same set of families. The most significant evidence for linkage was found on chromosome 3q25-27, with a maximum two-point LOD score of 4.31 (Z(max) (dom)) for D3S3037, using infantile autism and AS as an affection status. Six markers flanking over a 5-cM region on 3q gave Z(max) (dom) >3, and a maximum parametric multipoint LOD score (MLS) of 4.81 was obtained in the vicinity of D3S3715 and D3S3037. Association, linkage disequilibrium, and haplotype analyses provided some evidence for shared ancestor alleles on this chromosomal region among affected individuals, especially in the regional subisolate. Additional potential susceptibility loci with two-point LOD scores >2 were observed on chromosomes 1q21-22 and 7q. The region on 1q21-22 overlaps with the previously reported candidate region for infantile autism and schizophrenia, whereas the region on chromosome 7q provided evidence for linkage 58 cM distally from the previously described autism susceptibility locus (AUTS1).	Univ Helsinki, Dept Med Genet, Biomedicum, Helsinki 00290, Finland; Natl Publ Hlth Inst, Dept Mol Med, Helsinki, Finland; Univ Helsinki, Cent Hosp, Mol Genet Lab, Helsinki, Finland; Univ Calif Los Angeles, Sch Med, Dept Biomath, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Sch Med, Dept Human Genet, Los Angeles, CA 90024 USA; Hosp Children & Adolescents, Unit Child Neurol, Helsinki, Finland	University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Peltonen, L (corresponding author), Univ Helsinki, Dept Med Genet, Biomedicum, Haartmanink 8, Helsinki 00290, Finland.	leena.peltonen@ktl.fi	Jarvela, Irma E/L-5836-2013	Jarvela, Irma E/0000-0002-1770-6187; Varilo, Teppo/0000-0002-5839-8854; Ayers, Kristin/0000-0002-4984-5229; Auranen, Mari/0000-0003-3948-7074	NIMH NIH HHS [R01 MH059490, R37 MH059490, MH59490] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH059490, R01MH059490] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ashley-Koch A, 1999, GENOMICS, V61, P227, DOI 10.1006/geno.1999.5968; Auranen M, 2000, MOL PSYCHIATR, V5, P320, DOI 10.1038/sj.mp.4000708; Bailey A, 1998, J AUTISM DEV DISORD, V28, P369, DOI 10.1023/A:1026048320785; Bailey A, 1998, HUM MOL GENET, V7, P571; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Barrett S, 1999, AM J MED GENET, V88, P609; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; BOLTON P, 1994, J CHILD PSYCHOL PSYC, V35, P877, DOI 10.1111/j.1469-7610.1994.tb02300.x; Brzustowicz LM, 2000, SCIENCE, V288, P678, DOI 10.1126/science.288.5466.678; Buxbaum JD, 2001, AM J HUM GENET, V68, P1514, DOI 10.1086/320588; EHLERS S, 1993, J CHILD PSYCHOL PSYC, V34, P1327, DOI 10.1111/j.1469-7610.1993.tb02094.x; Ekelund J, 2000, HUM MOL GENET, V9, P1049, DOI 10.1093/hmg/9.7.1049; Fisher SE, 1998, NAT GENET, V18, P168, DOI 10.1038/ng0298-168; FOLSTEIN S, 1977, J CHILD PSYCHOL PSYC, V18, P297, DOI 10.1111/j.1469-7610.1977.tb00443.x; Folstein SE, 1998, J AUTISM DEV DISORD, V28, P439, DOI 10.1023/A:1026008606672; Fombonne E, 1997, J CHILD PSYCHOL PSYC, V38, P667, DOI 10.1111/j.1469-7610.1997.tb01694.x; Howlin P, 2000, J CHILD PSYCHOL PSYC, V41, P561, DOI 10.1017/S0021963099005806; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; Kuokkanen S, 1996, NAT GENET, V13, P477, DOI 10.1038/ng0896-477; Kuokkanen S, 1997, AM J HUM GENET, V61, P1379, DOI 10.1086/301637; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lai CSL, 2000, AM J HUM GENET, V67, P357, DOI 10.1086/303011; Laitinen T, 2001, NAT GENET, V28, P87, DOI 10.1038/88319; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; Lange K, 2001, AM J HUM GENET, V69, P504; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1986, GENET EPIDEMIOL, V3, P39, DOI 10.1002/gepi.1370030105; Liu JJ, 2001, AM J HUM GENET, V69, P327, DOI 10.1086/321980; Mahtani MM, 1996, NAT GENET, V14, P90, DOI 10.1038/ng0996-90; Mawhood L, 2000, J CHILD PSYCHOL PSYC, V41, P547, DOI 10.1017/S002196309900579X; Murphy M, 2000, PSYCHOL MED, V30, P1411, DOI 10.1017/S0033291799002949; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OTT J, 1986, GENET EPIDEMIOL, P251; Pajukanta P, 1998, NAT GENET, V18, P369, DOI 10.1038/ng0498-369; Palferman S, 2001, HUM MOL GENET, V10, P973; Palferman S, 2001, AM J HUM GENET, V69, P570; PELTOMAKI P, 1993, SCIENCE, V260, P810, DOI 10.1126/science.8484120; Peltonen L, 1999, HUM MOL GENET, V8, P1913, DOI 10.1093/hmg/8.10.1913; Philippe A, 1999, HUM MOL GENET, V8, P805, DOI 10.1093/hmg/8.5.805; Pickles A, 2000, J CHILD PSYCHOL PSYC, V41, P491, DOI 10.1017/S0021963099005557; PIVEN J, 1994, PSYCHOL MED, V24, P783, DOI 10.1017/S0033291700027938; Piven J, 1997, AM J PSYCHIAT, V154, P185; Piven J, 1997, AM J MED GENET, V74, P398, DOI 10.1002/(SICI)1096-8628(19970725)74:4<398::AID-AJMG11>3.0.CO;2-D; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; Shao YJ, 2002, AM J HUM GENET, V70, P1058, DOI 10.1086/339765; Shao YJ, 2002, AM J MED GENET, V114, P99, DOI 10.1002/ajmg.10153; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; Shifman S, 2001, NAT GENET, V28, P309, DOI 10.1038/91060; Sinsheimer JS, 2000, AM J HUM GENET, V66, P1168, DOI 10.1086/302826; Skuse DH, 2000, PEDIATR RES, V47, P9, DOI 10.1203/00006450-200001000-00006; Smalley SL, 1997, AM J HUM GENET, V60, P1276, DOI 10.1086/515485; Sobel E, 1996, AM J HUM GENET, V58, P1323; STEFFENBURG S, 1989, J CHILD PSYCHOL PSYC, V30, P405, DOI 10.1111/j.1469-7610.1989.tb00254.x; Stober G, 2000, AM J HUM GENET, V67, P1201, DOI 10.1086/321183; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; TERWILLIGER JD, 1998, ENCY BIOSTATISTICS, P2279; Varilo T, 1996, AM J HUM GENET, V58, P506; *WHO, 1993, INT CLASS DIS	59	173	180	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2002	71	4					777	790		10.1086/342720	http://dx.doi.org/10.1086/342720			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	604HT	12192642	Green Published, Bronze			2022-12-18	WOS:000178613800007
J	Bartlett, CW; Flax, JF; Logue, MW; Vieland, VJ; Bassett, AS; Tallal, P; Brzustowicz, LM				Bartlett, CW; Flax, JF; Logue, MW; Vieland, VJ; Bassett, AS; Tallal, P; Brzustowicz, LM			A major susceptibility locus for specific language impairment is located on 13q21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUANTITATIVE-TRAIT LOCUS; LINKAGE ANALYSIS; POSTERIOR PROBABILITY; FAMILIAL AGGREGATION; READING-DISABILITY; DETECT LINKAGE; LOD SCORES; CHILDREN; SPEECH; DYSLEXIA	Children who fail to develop language normally-in the absence of explanatory factors such as neurological disorders, hearing impairment, or lack of adequate opportunity-are clinically described as having specific language impairment (SLI). SLI has a prevalence of similar to7% in children entering school and is associated with later difficulties in learning to read. Research indicates that genetic factors are important in the etiology of SLI. Studies have consistently demonstrated that SLI aggregates in families. Increased monozygotic versus dizygotic twin concordance rates indicate that heredity, not just shared environment, is the cause of the familial clustering. We have collected five pedigrees of Celtic ancestry that segregate SLI, and we have conducted genomewide categorical linkage analysis, using model-based LOD score techniques. Analysis was conducted under both dominant and recessive models by use of three phenotypic classifications: clinical diagnosis, language impairment (spoken language quotient ! 85) and reading discrepancy (nonverbal IQ minus non-word reading >15). Chromosome 13 yielded a maximum multipoint LOD score of 3.92 under the recessive reading discrepancy model. Simulation to correct for multiple models and multiple phenotypes indicated that the genomewide empirical P value is <.01. As an alternative measure, we also computed the posterior probability of linkage (PPL), obtaining a PPL of 53% in the same region. One other genomic region yielded suggestive results on chromosome 2 (multipoint LOD score 2.86, genomic P value <.06 under the recessive language impairment model). Our findings underscore the utility of traditional LOD-score-based methods in finding genes for complex diseases, specifically, SLI.	Rutgers State Univ, Nelson Biol Labs, Dept Genet, Piscataway, NJ 08854 USA; Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Psychiat, Newark, NJ 07103 USA; Univ Iowa, Coll Publ Hlth, Dept Biostat, Div Stat Genet, Iowa City, IA USA; Univ Iowa, Coll Med, Dept Psychiat, Iowa City, IA 52242 USA; Univ Toronto, Dept Psychiat, Toronto, ON, Canada; Ctr Addict & Mental Hlth, Schizophrenia Res Program, Queen St Div, Toronto, ON, Canada	Rutgers State University New Brunswick; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Iowa; University of Iowa; University of Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	Bartlett, CW (corresponding author), Rutgers State Univ, Nelson Biol Labs, Dept Genet, Room B318,604 Allison Rd, Piscataway, NJ 08854 USA.	bartlett@axon.rutgers.edu	Bartlett, Christopher/AAD-8813-2022; Bartlett, Christopher/B-4958-2009	Bartlett, Christopher/0000-0001-7837-6348; Bartlett, Christopher/0000-0001-7837-6348; Logue, Mark/0000-0001-9347-7892	NHGRI NIH HHS [N01HG65403] Funding Source: Medline; NIDCD NIH HHS [R01 DC01654] Funding Source: Medline; NIMH NIH HHS [T32 MH014620, 5 T32 MH14620, MH52841, K02-MH01432, R01 MH052841] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052841, T32MH014620, K02MH001432, R55MH052841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001654] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Abreu PC, 1999, AM J HUM GENET, V65, P847, DOI 10.1086/302536; [Anonymous], 1998, WOODCOCK READING MAS; Aram DM, 1991, LANG SPEECH HEAR SER, V22, P84; Bailey A, 1998, HUM MOL GENET, V7, P571; Benasich AA, 1996, INFANT BEHAV DEV, V19, P339, DOI 10.1016/S0163-6383(96)90033-8; Benasich AA, 1999, CLIN DEV MED, P191; Bishop DVM, 1997, BRAIN LANG, V56, P1, DOI 10.1006/brln.1997.1729; BISHOP DVM, 1990, J CHILD PSYCHOL PSYC, V31, P1027, DOI 10.1111/j.1469-7610.1990.tb00844.x; BISHOP DVM, 1994, PHILOS T ROY SOC B, V346, P105, DOI 10.1098/rstb.1994.0134; BISHOP DVM, 1995, DEV MED CHILD NEUROL, V37, P56; Bishop DVM, 2001, PHILOS T R SOC B, V356, P369, DOI 10.1098/rstb.2000.0770; Brzustowicz LM, 2000, SCIENCE, V288, P678, DOI 10.1126/science.288.5466.678; Brzustowicz LM, 1997, AM J HUM GENET, V61, P1388, DOI 10.1086/301623; CARDON LR, 1994, SCIENCE, V266, P276, DOI 10.1126/science.7939663; CATTS HW, 1993, J SPEECH HEAR RES, V36, P948, DOI 10.1044/jshr.3605.948; *CLSA, 2001, AM J MED GENET, V105, P805; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dale PS, 1998, NAT NEUROSCI, V1, P324, DOI 10.1038/1142; DiSimoni F., 1978, TOKEN TEST CHILDREN; ELSTON RC, 1975, ANN HUM GENET, V38, P341, DOI 10.1111/j.1469-1809.1975.tb00619.x; Fagerheim T, 1999, J MED GENET, V36, P664; Fisher SE, 1999, AM J HUM GENET, V64, P146, DOI 10.1086/302190; Fisher SE, 2002, NAT GENET, V30, P86, DOI 10.1038/ng792; Fitch RH, 1997, ANNU REV NEUROSCI, V20, P331, DOI 10.1146/annurev.neuro.20.1.331; Gathercole S E, 1994, Memory, V2, P103, DOI 10.1080/09658219408258940; Gayan J, 1999, AM J HUM GENET, V64, P157, DOI 10.1086/302191; Greenberg DA, 1998, AM J HUM GENET, V63, P870, DOI 10.1086/301997; Grigorenko EL, 1997, AM J HUM GENET, V60, P27; HAMMILL D, 1988, TEST LANGUAGE DEV, V2; Hodge SE, 2001, AM J MED GENET, V105, P62, DOI 10.1002/1096-8628(20010108)105:1<62::AID-AJMG1063>3.0.CO;2-C; Johnston J. R., 1991, LANG SPEECH HEAR SER, V22, P75; Kjelgaard MM, 2001, LANG COGNITIVE PROC, V16, P287, DOI 10.1080/01690960042000058; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Leonard L.B., 1998, CHILDREN SPECIFIC LA; LEONARD LB, 1991, LANG SPEECH HEAR SER, V22, P84; Louis K, 1987, ORAL SPEECH MECH SCR; Morton NE, 1998, AM J HUM GENET, V62, P690, DOI 10.1086/301741; Newbury DF, 2002, AM J HUM GENET, V70, P384; NEWCOMER P, 1988, TEST LANGUAGE DEV, V2; Noone PG, 2001, RESP RES, V2, P328, DOI 10.1186/rr82; PENNINGTON BF, 1992, J LEARN DISABIL-US, V25, P562, DOI 10.1177/002221949202500904; REED MA, 1989, J EXP CHILD PSYCHOL, V48, P270, DOI 10.1016/0022-0965(89)90006-4; Rice ML, 1998, J SPEECH LANG HEAR R, V41, P419, DOI 10.1044/jslhr.4102.419; SCARBOROUGH HS, 1990, J SPEECH HEAR RES, V33, P70, DOI 10.1044/jshr.3301.70; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Snowling M, 2000, J CHILD PSYCHOL PSYC, V41, P587, DOI 10.1111/1469-7610.00651; Snowling MJ, 2001, INT J LANG COMM DIS, V36, P173, DOI 10.1080/13682820010019892; Sobel E, 1996, AM J HUM GENET, V58, P1323; Stothard SE, 1998, J SPEECH LANG HEAR R, V41, P407, DOI 10.1044/jslhr.4102.407; Stromswold K, 1998, HUM BIOL, V70, P297; Talcott JB, 1999, NEUROREPORT, V10, P2045, DOI 10.1097/00001756-199907130-00010; TALLAL P, 1973, NEUROPSYCHOLOGIA, V11, P389, DOI 10.1016/0028-3932(73)90025-0; TALLAL P, 1973, NATURE, V241, P468, DOI 10.1038/241468a0; Tallal P, 2001, J SPEECH LANG HEAR R, V44, P1172, DOI 10.1044/1092-4388(2001/091); TALLAL P, 1989, J SPEECH HEAR DISORD, V54, P167, DOI 10.1044/jshd.5402.167; Terwilliger J., 1994, HDB HUMAN GENETIC LI; TOMBLIN JB, 1992, J SPEECH HEAR RES, V35, P832, DOI 10.1044/jshr.3504.832; TOMBLIN JB, 1989, J SPEECH HEAR DISORD, V54, P287, DOI 10.1044/jshd.5402.287; Tomblin JB, 1998, J SPEECH LANG HEAR R, V41, P188, DOI 10.1044/jslhr.4101.188; Tomblin JB, 1997, J SPEECH LANG HEAR R, V40, P1245, DOI 10.1044/jslhr.4006.1245; VanderLely HKJ, 1996, BRAIN LANG, V52, P484, DOI 10.1006/brln.1996.0026; Vieland VJ, 1998, AM J HUM GENET, V63, P947, DOI 10.1086/302076; Vieland VJ, 2001, HUM HERED, V51, P199, DOI 10.1159/000053343; Wang K, 2000, ANN HUM GENET, V64, P533, DOI 10.1046/j.1469-1809.2000.6460533.x; Wang K, 1999, GENET EPIDEMIOL, V17, pS749; Wechsler D, 1999, WECHSLER ABBREVIATED; Wechsler D., 1974, MANUAL WECHSLER INTE; Wechsler D, 1989, MANUAL WECHSLER PRES; Wechsler D., 1997, WAIS 3 WECHSLER ADUL; Witton C, 1998, CURR BIOL, V8, P791, DOI 10.1016/S0960-9822(98)70320-3; Wright BA, 1997, NATURE, V387, P176, DOI 10.1038/387176a0; Wright BA, 2000, CURR OPIN NEUROBIOL, V10, P482, DOI 10.1016/S0959-4388(00)00119-7; [No title captured]	76	173	177	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2002	71	1					45	55		10.1086/341095	http://dx.doi.org/10.1086/341095			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	564GY	12048648	Green Published, Bronze			2022-12-18	WOS:000176307700005
J	Brzustowicz, LM; Honer, WG; Chow, EWC; Little, D; Hogan, J; Hodgkinson, K; Bassett, AS				Brzustowicz, LM; Honer, WG; Chow, EWC; Little, D; Hogan, J; Hodgkinson, K; Bassett, AS			Linkage of familial schizophrenia to chromosome 13q32	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-LOCUS APPROXIMATIONS; GENOME-WIDE SEARCH; SUSCEPTIBILITY GENES; SUGGESTIVE EVIDENCE; OLIGOGENIC TRAITS; SCAN; CONSORTIUM; PEDIGREES; SYMPTOMS; ADEQUACY	Over the past 4 years, a number of investigators have reported findings suggestive of linkage to schizophrenia, with markers on chromosomes 13q32 and 8p21, with one recent study by Blouin et al. reporting significant linkage to these regions. As part of an ongoing genome scan, we evaluated microsatellite markers spanning chromosomes 8 and 13, for linkage to schizophrenia, in 21 extended Canadian families. Families were analyzed under autosomal dominant and recessive models, with broad and narrow definitions of schizophrenia. All models produced positive LOD scores with markers on 13q, with higher scores under the recessive models. The maximum three-point LOD scores were obtained under the recessive-broad model: 3.92 at recombination fraction (theta) .1 with D13S793, under homogeneity, and 4.42 with alpha=.65 and theta=0 with D13S793, under heterogeneity. Positive LOD scores were also obtained, under all models, for markers on 8p. Although a maximum two-point LOD score of 3.49 was obtained under the dominant-narrow model with D8S136 at theta = 0.1, multipoint analysis with closely flanking markers reduced the maximum LOD score in this region to 2.13. These results provide independent significant evidence of linkage of a schizophrenia-susceptibility locus to markers on 13q32 and support the presence of a second susceptibility locus on 8p21.	Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Psychiat, Newark, NJ 07103 USA; Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; Univ Toronto, Dept Psychiat, Toronto, ON, Canada; Ctr Addict & Mental Hlth, Schizophrenia Res Program, Genet Sect, Toronto, ON, Canada	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of British Columbia; University of Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	Brzustowicz, LM (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.	brzustowicz@axon.rutgers.edu			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH001392] Funding Source: NIH RePORTER; NHGRI NIH HHS [N01HG65403] Funding Source: Medline; NIMH NIH HHS [K08 MH01392] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Barden N, 1998, Psychiatr Genet, V8, P93, DOI 10.1097/00041444-199800820-00013; BASSETT AS, 1993, SCHIZOPHR RES, V11, P9, DOI 10.1016/0920-9964(93)90033-F; BASSETT AS, 1994, AM J HUM GENET, V54, P864; Blouin JL, 1998, NAT GENET, V20, P70, DOI 10.1038/1734; Brzustowicz LM, 1997, AM J HUM GENET, V61, P1388, DOI 10.1086/301623; COON H, 1994, AM J MED GENET, V54, P59, DOI 10.1002/ajmg.1320540111; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Curtis D, 1996, SCHIZOPHR RES, V22, P61; Durner M, 1999, AM J HUM GENET, V64, P281, DOI 10.1086/302181; Faraone SV, 1998, AM J MED GENET, V81, P290, DOI 10.1002/(SICI)1096-8628(19980710)81:4<290::AID-AJMG3>3.0.CO;2-Y; Greenberg DA, 1998, AM J HUM GENET, V63, P870, DOI 10.1086/301997; Hodge SE, 1997, AM J HUM GENET, V60, P217; Kaufmann CA, 1998, AM J MED GENET, V81, P282, DOI 10.1002/(SICI)1096-8628(19980710)81:4<282::AID-AJMG2>3.3.CO;2-R; Kendler KS, 1996, AM J PSYCHIAT, V153, P1534; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1986, GENET EPIDEMIOL, V3, P39, DOI 10.1002/gepi.1370030105; Levinson DF, 1996, AM J MED GENET, V67, P580; Levinson DF, 1998, AM J PSYCHIAT, V155, P741; Lin MW, 1995, PSYCHIATR GENET, V5, P117, DOI 10.1097/00041444-199505030-00004; Lin MW, 1997, HUM GENET, V99, P417, DOI 10.1007/s004390050382; MCGUFFIN P, 1994, BRIT J PSYCHIAT, V164, P593, DOI 10.1192/bjp.164.5.593; MOISES HW, 1995, NAT GENET, V11, P321, DOI 10.1038/ng1195-321; Moldin SO, 1997, NAT GENET, V17, P127, DOI 10.1038/ng1097-127; Morton NE, 1998, AM J HUM GENET, V62, P690, DOI 10.1086/301741; OTT J, 1986, GENET EPIDEMIOL, P251; Ott J., 1991, ANAL HUMAN GENETIC L; PULVER AE, 1995, AM J MED GENET, V60, P252, DOI 10.1002/ajmg.1320600316; Pulver AE, 1996, COLD SPRING HARB SYM, V61, P797; RISCH N, 1992, HUM HERED, V42, P77, DOI 10.1159/000154047; RISCH N, 1991, AM J HUM GENET, V48, P1058; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Shaw SH, 1998, AM J MED GENET, V81, P364, DOI 10.1002/(SICI)1096-8628(19980907)81:5<364::AID-AJMG4>3.0.CO;2-T; Straub RE, 1997, AM J MED GENET, V74, P558; VIELAND VJ, 1992, GENET EPIDEMIOL, V9, P45, DOI 10.1002/gepi.1370090106; VIELAND VJ, 1993, HUM HERED, V43, P329, DOI 10.1159/000154155; WILDENAUER DB, 1998, PSYCHIAT GENET, V8, P57	39	173	178	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1999	65	4					1096	1103		10.1086/302579	http://dx.doi.org/10.1086/302579			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	241XW	10486329	Green Published, Bronze			2022-12-18	WOS:000082910000019
J	Robinson, WP; Barrett, IJ; Bernard, L; Telenius, A; Bernasconi, F; Wilson, RD; Best, RG; HowardPeebles, PN; Langlois, S; Kalousek, DK				Robinson, WP; Barrett, IJ; Bernard, L; Telenius, A; Bernasconi, F; Wilson, RD; Best, RG; HowardPeebles, PN; Langlois, S; Kalousek, DK			Meiotic origin of trisomy in confined placental mosaicism is correlated with presence of fetal uniparental disomy, high levels of trisomy in trophoblast, and increased risk of fetal intrauterine growth restriction	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMOSOMAL MOSAICISM; PRENATAL-DIAGNOSIS; MATERNAL AGE; NONDISJUNCTION; RETARDATION; RECOMBINATION; FREQUENCY; HUMANS	Molecular studies were performed on 101 cases of confined placental mosaicism (CPM) involving autosomal trisomy. The origin of the trisomic cell line was determined in 54 cases (from 51 pregnancies), 47 of which were also analyzed for the presence of uniparental disomy (UPD) in the disomic cell line. An additional 47 cases were analyzed for parental origin in the disomic cell line only. A somatic (postmeiotic) origin of the trisomy was observed in 22 cases and included the majority of cases with CPM for trisomy 2, 7, 8, 10, and 12. Most cases of CPM involving trisomy 9, 16, and 22 were determined to be meiotic. Fetal maternal UPD was found in 17 of 94 informative CPM cases, involving trisomy 2 (1 case), 7 (1 case), 16 (13 cases), and 22 (2 cases). The placental trisomy was of meiotic origin in all 17 cases associated with fetal UPD (P = .00005). A meiotic origin also correlated with the levels of trisomy in cultured chorionic villi samples (CVS) (P = .0002) and trophoblast (P = .00005). Abnormal pregnancy outcome (usually IUGR) correlated with meiotic origin (P = .0003), the presence of fetal UPD (P = 4 x 10(-7)), and the level of trisomy in trophoblast (P = 3 x 10(-7)) but not with the level of trisomy in CVS or term chorion. The good fit of somatic errors with the expected results could have been observed only if few true meiotic errors were misclassified by these methods as a somatic error. These data indicate that molecular determination of origin is a useful predictor of pregnancy outcome, whereas the level of trisomy observed in cultured CVS is not. In addition, UPD for some chromosomes may affect prenatal, but not postnatal, development, possibly indicating that imprinting effects for these chromosomes are confined to placental tissues.	UNIV BRITISH COLUMBIA,DEPT PATHOL,VANCOUVER,BC V57Z 4H4,CANADA; UNIV BRITISH COLUMBIA,DEPT OBSTET,VANCOUVER,BC V57Z 4H4,CANADA; UNIV S CAROLINA,DEPT OBSTET & GYNECOL,COLUMBIA,SC 29208; GENET & IVF INST,FAIRFAX,VA 22039; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,RICHMOND,VA 23298	University of British Columbia; University of British Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Virginia Commonwealth University	Robinson, WP (corresponding author), UNIV BRITISH COLUMBIA,DEPT MED GENET,ROOM 170,950 W 28TH ST,VANCOUVER,BC V57Z 4H4,CANADA.		Robinson, Wendy P/I-9590-2014; Langlois, Sylvie/AAR-7978-2021; Robinson, Wendy/AAB-6420-2020	Robinson, Wendy P/0000-0002-2010-6174; Robinson, Wendy/0000-0002-2010-6174				ANTONARAKIS SE, 1993, NAT GENET, V3, P146, DOI 10.1038/ng0293-146; Bernasconi F, 1996, AM J HUM GENET, V59, P1114; BERNASCONI F, 1996, AM J HUM GENET, V58, pA112; CASSIDY SB, 1992, AM J HUM GENET, V51, P701; Christian SL, 1996, PRENATAL DIAG, V16, P323, DOI 10.1002/(SICI)1097-0223(199604)16:4<323::AID-PD856>3.0.CO;2-5; EGGERDING FA, 1994, AM J HUM GENET, V55, P253; HANSEN WF, IN PRESS PRENAT DIAG; HARRISON K, 1995, AM J MED GENET, V58, P147, DOI 10.1002/ajmg.1320580211; HASSOLD T, 1995, AM J HUM GENET, V57, P867; Henderson KG, 1996, HUM GENET, V97, P650; James RS, 1996, HUM GENET, V97, P283, DOI 10.1007/BF02185754; KALOUSEK DK, 1983, SCIENCE, V221, P665, DOI 10.1126/science.6867735; KALOUSEK DK, 1987, HUM GENET, V77, P163, DOI 10.1007/BF00272385; KALOUSEK DK, 1994, PLACENTA, V15, P219, DOI 10.1016/0143-4004(94)90014-0; KALOUSEK DK, 1989, AM J HUM GENET, V44, P338; Kalousek DK, 1996, AM J MED GENET, V65, P348, DOI 10.1002/(SICI)1096-8628(19961111)65:4<348::AID-AJMG19>3.0.CO;2-U; KALOUSEK DK, 1993, AM J HUM GENET, V52, P8; KALOUSEK DK, 1991, PRENATAL DIAG, V11, P743, DOI 10.1002/pd.1970111002; KALOUSEK DK, 1994, PEDIATR PATHOL, V14, P151, DOI 10.3109/15513819409022034; KALOUSEK DK, 1985, 1ST TRIMESTER FETAL, P130; KOTZOT D, 1995, HUM MOL GENET, V4, P583, DOI 10.1093/hmg/4.4.583; LANGLOIS S, 1995, J MED GENET, V32, P871, DOI 10.1136/jmg.32.11.871; LEDBETTER DH, 1995, HUM MOL GENET, V4, P1757, DOI 10.1093/hmg/4.suppl_1.1757; Meck J. M., 1995, American Journal of Human Genetics, V57, pA120; MIKKELSEN M, 1987, HUM GENET, P596; MINY P, 1991, PRENATAL DIAG, V11, P581, DOI 10.1002/pd.1970110815; PURVISSMITH SG, 1992, AM J HUM GENET, V50, P1348; ROBINSON WP, 1994, AM J HUM GENET, V54, P290; ROBINSON WP, 1993, AM J HUM GENET, V53, P740; ROBINSON WP, 1995, AM J HUM GENET, V56, P444; SCHINZEL AA, 1994, AM J HUM GENET, V54, P21; Shaffer LG, 1996, PRENATAL DIAG, V16, P899, DOI 10.1002/(SICI)1097-0223(199610)16:10<899::AID-PD960>3.0.CO;2-M; SIMONI G, 1994, PRENATAL DIAG, V14, P1185, DOI 10.1002/pd.1970141304; Simoni G, 1985, 1ST TRIMESTER FETAL, P137; WANG BBT, 1993, PRENATAL DIAG, V13, P179, DOI 10.1002/pd.1970130305; Wolstenholme J, 1996, PRENATAL DIAG, V16, P511, DOI 10.1002/(SICI)1097-0223(199606)16:6<511::AID-PD904>3.0.CO;2-8; ZARAGOZA RV, 1994, HUM GENET, V94, P411	37	173	174	0	11	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1997	60	4					917	927						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WT614	9106539				2022-12-18	WOS:A1997WT61400022
J	Wirtz, MK; Samples, JR; Kramer, PL; Rust, K; Topinka, JR; Yount, J; Koler, RD; Acott, TS				Wirtz, MK; Samples, JR; Kramer, PL; Rust, K; Topinka, JR; Yount, J; Koler, RD; Acott, TS			Mapping a gene for adult-onset primary open-angle glaucoma to chromosome 3q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							JUVENILE GLAUCOMA; LINKAGE ANALYSIS; HUMAN GENOME; LOCALIZATION; PROTEOGLYCAN; ASSIGNMENT; IDENTIFICATION; TRINUCLEOTIDE; PREVALENCE; RECEPTOR	Glaucoma is the third-leading cause of blindness in the world, affecting >13.5 million people. Adult-onset primary open-angle glaucoma (POAG) is the most common form of glaucoma in the United States. We present a family in which adult-onset POAG is inherited as an autosomal dominant trait. Twelve affected family members were identified from 44 at-risk individuals. The disease-causing gene was mapped to chromosome 3q21-24, with analysis of recombinant haplotypes suggesting a total inclusion region of 11.1 cM between markers D3S3637 and D3S1744. This is the first report of mapping of an adult-onset POAG gene to chromosome 3q, gene symbol GLC1C.	OREGON HLTH SCI UNIV, CASEY EYE INST, DEPT MOL & MED GENET, PORTLAND, OR 97201 USA; OREGON HLTH SCI UNIV, CASEY EYE INST, DEPT NEUROL, PORTLAND, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Wirtz, MK (corresponding author), OREGON HLTH SCI UNIV, CASEY EYE INST, DEPT OPHTHALMOL, CE RES, 3375 SW TERWILLIGER BLVD, PORTLAND, OR 97201 USA.				NEI NIH HHS [EY03279, EY10555] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY003279, R01EY010555] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADAMSON D, 1995, AM J HUM GENET, V57, P619; ALAKAPEE M, 1990, SOMAT CELL MOLEC GEN, V16, P501, DOI 10.1007/BF01233200; ARMALY MF, 1967, ARCH OPHTHALMOL-CHIC, V78, P35, DOI 10.1001/archopht.1967.00980030037007; BARKER PE, 1989, J IMMUNOL, V142, P283; BENGTSSON B, 1981, BRIT J OPHTHALMOL, V65, P46, DOI 10.1136/bjo.65.1.46; BREVIARIO F, 1992, J BIOL CHEM, V267, P22190; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FRANCOIS J, 1966, AM J OPHTHALMOL, V61, P652, DOI 10.1016/0002-9394(66)91201-3; GASTIER JM, 1995, HUM MOL GENET, V4, P1829, DOI 10.1093/hmg/4.10.1829; GAUGHAN G, 1991, GENOMICS, V11, P455, DOI 10.1016/0888-7543(91)90155-8; GRAFF C, 1995, HUM GENET, V96, P285; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HITCHINGS RA, 1980, BRIT J OPHTHALMOL, V64, P232, DOI 10.1136/bjo.64.4.232; HOLLOWS FC, 1966, BRIT J OPHTHALMOL, V50, P570, DOI 10.1136/bjo.50.10.570; IOZZO RV, 1992, GENOMICS, V14, P845, DOI 10.1016/S0888-7543(05)80103-X; Johnson AT, 1996, OPHTHALMOLOGY, V103, P808; JOHNSON AT, 1996, GLAUCOMAS, V1, P39; KAHN HA, 1980, ARCH OPHTHALMOL-CHIC, V98, P2172, DOI 10.1001/archopht.1980.01020041024003; KALLUNKI P, 1991, GENOMICS, V11, P389, DOI 10.1016/0888-7543(91)90147-7; KELLERMAN L, 1955, AM J OPHTHALMOL, V40, P681, DOI 10.1016/0002-9394(55)91495-1; Kolker AE, 1976, BECKER SHAFFERS DIAG; LAWFORD JB, 1907, R LOND OPHTHALMOL HO, V17, P57; LICHTER PR, 1994, AM J OPHTHALMOL, V117, P706, DOI 10.1016/S0002-9394(14)70314-9; LITT M, 1993, BIOTECHNIQUES, V15, P280; McKusick V.A., 1992, MENDELIAN INHERITANC; MEYER A, 1994, CR ACAD SCI III-VIE, V317, P565; MORISSETTE J, 1995, AM J HUM GENET, V56, P1431; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; NAYLOR SL, 1994, CYTOGENET CELL GENET, V65, P43; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; POHJANPELTO PE, 1974, ACTA OPHTHALMOL, V52, P194; POLLAK MR, 1993, NAT GENET, V5, P201, DOI 10.1038/ng1093-201; POSNER A, 1949, ARCH OPHTHALMOL-CHIC, V41, P125; PULKKINEN L, 1992, CYTOGENET CELL GENET, V60, P107, DOI 10.1159/000133314; RICHARDS JE, 1994, AM J HUM GENET, V54, P62; ROLFS A, 1994, EUR HEART J, V15, P108, DOI 10.1093/eurheartj/15.suppl_D.108; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SHEFFIELD VC, 1993, NAT GENET, V4, P47, DOI 10.1038/ng0593-47; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; Shieds M. B., 1996, GLAUCOMAS, P717; SHIN DH, 1977, ARCH OPHTHALMOL-CHIC, V95, P598; SHIPP MA, 1993, BLOOD, V82, P1052, DOI 10.1182/blood.V82.4.1052.bloodjournal8241052; SIEBURTH D, 1992, GENOMICS, V14, P59, DOI 10.1016/S0888-7543(05)80283-6; SMITH DI, 1995, CYTOGENET CELL GENET, V68, P126; Stoilova D, 1996, GENOMICS, V36, P142, DOI 10.1006/geno.1996.0434; SUZUKAWA K, 1994, BLOOD, V84, P2681; TEIKARI JM, 1987, ACTA OPHTHALMOL, V65, P715; TIELSCH JM, 1994, ARCH OPHTHALMOL-CHIC, V112, P69, DOI 10.1001/archopht.1994.01090130079022; WIGGS JL, 1994, GENOMICS, V21, P299, DOI 10.1006/geno.1994.1269; WIGGS JL, 1995, MOL GENETICS OCULAR, P83; WOLFENSBERGER TJ, 1994, BRIT J OPHTHALMOL, V78, P446, DOI 10.1136/bjo.78.6.446; YANG FM, 1984, P NATL ACAD SCI-BIOL, V81, P2752, DOI 10.1073/pnas.81.9.2752	54	173	192	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1997	60	2					296	304						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WE931	9012402				2022-12-18	WOS:A1997WE93100008
J	Kumar, A; Girimaji, SC; Duvvari, MR; Blanton, SH				Kumar, Arun; Girimaji, Satish C.; Duvvari, Mahesh R.; Blanton, Susan H.			Mutations in STIL, Encoding a Pericentriolar and Centrosomal Protein, Cause Primary Microcephaly	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BRAIN SIZE; ASPM GENE; SIL GENE; MAPS; LOCUS; EXPRESSION; FAMILIES	Primary microcephaly (MCPH) is an autosomal-recessive congenital disorder characterized by smaller-than-normal brain size and mental retardation. MCPH is genetically heterogeneous with six known loci: MCPH1-MCPH6. We report mapping of a novel locus, MCPH7, to chromosome 1p32.3-p33 between markers D1S2797 and D1S417, corresponding to a physical distance of 8.39 Mb. Heterogeneity analysis of 24 families previously excluded from linkage to the six known MCPH loci suggested linkage of five families (20.83%) to the MCPH7 locus. In addition, four families were excluded from linkage to the MCPH7 locus as well as all of the six previously known loci, whereas the remaining 15 families could not be conclusively excluded or included. The combined maximum two-point LOD score for the linked families was 5.96 at marker D1S386 at theta = 0.0. The combined multipoint LOD score was 6.97 between markers D1S2797 and D1S417. Previously, mutations in four genes, MCPH1, CDK5RAP2, ASPM, and CENPJ, that code for centrosomal proteins have been shown to cause this disorder. Three different homozygous mutations in STIL, which codes for a pericentriolar and centrosomal protein, were identified in patients from three of the five families linked to the MCPH7 locus; all are predicted to truncate the STIL protein. Further, another recently ascertained family was homozygous for the same mutation as one of the original families. There was no evidence for a common haplotype. These results suggest that the centrosome and its associated structures are important in the control of neurogenesis in the developing human brain.	[Kumar, Arun; Duvvari, Mahesh R.] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India; [Girimaji, Satish C.] Natl Inst Mental Hlth & Neurosci, Dept Psychiat, Bangalore 560029, Karnataka, India; [Blanton, Susan H.] Univ Miami, Miller Sch Med, Miami Inst Human Genom, Miami, FL 33101 USA	Indian Institute of Science (IISC) - Bangalore; National Institute of Mental Health & Neurosciences - India; University of Miami	Kumar, A (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	karun@mrdg.iisc.ernet.in	Blanton, Susan Halloran/ABF-1323-2021; Kumar, Arun/C-9149-2009	Kumar, Arun/0000-0001-8422-0219; GIRIMAJI, SATISH CHANDRA/0000-0002-6466-6229	Sir Dorabli Tata Center for Tropical Diseases, Bangalore	Sir Dorabli Tata Center for Tropical Diseases, Bangalore	This work was financially supported by the Sir Dorabli Tata Center for Tropical Diseases, Bangalore. We thank L Krishna, M. Markandaya, Sabina Rao, and M.N. Nagashri for their help in patient recruitment and human fetal tissue samples.	Avides MD, 1999, SCIENCE, V283, P1733, DOI 10.1126/science.283.5408.1733; Bond J, 2003, AM J HUM GENET, V73, P1170, DOI 10.1086/379085; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; COWIE V, 1960, J MENT DEFIC RES, V4, P42; GARDINER M, 2006, J ARAB NEONATOLOGY F, V3, P17; Gul A, 2006, NEUROGENETICS, V7, P105, DOI 10.1007/s10048-006-0042-4; Izraeli S, 1999, NATURE, V399, P691, DOI 10.1038/21429; Izraeli S, 1997, CELL GROWTH DIFFER, V8, P1171; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Jackson AP, 1998, AM J HUM GENET, V63, P541, DOI 10.1086/301966; Jamieson CR, 2000, AM J HUM GENET, V67, P1575, DOI 10.1086/316909; Jamieson CR, 1999, AM J HUM GENET, V65, P1465, DOI 10.1086/302640; Jones K. L., 1997, SMITHS RECOGNIZABLE; Karkera JD, 2002, CYTOGENET GENOME RES, V97, P62, DOI 10.1159/000064057; KRAWCZAK M, 1992, HUM GENET, V90, P41; Kumar A, 2004, CLIN GENET, V66, P341, DOI 10.1111/j.1399-0004.2004.00304.x; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Leal GF, 2003, J MED GENET, V40, P540, DOI 10.1136/jmg.40.7.540; Mochida GH, 2001, CURR OPIN NEUROL, V14, P151, DOI 10.1097/00019052-200104000-00003; Moynihan L, 2000, AM J HUM GENET, V66, P724, DOI 10.1086/302777; Pattison L, 2000, AM J HUM GENET, V67, P1578, DOI 10.1086/316910; Pfaff KL, 2007, MOL CELL BIOL, V27, P5887, DOI 10.1128/MCB.00175-07; Roberts E, 1999, EUR J HUM GENET, V7, P815, DOI 10.1038/sj.ejhg.5200385; Roberts E, 2002, J MED GENET, V39, P718, DOI 10.1136/jmg.39.10.718; Smith CM, 2007, NUCLEIC ACIDS RES, V35, pD618, DOI 10.1093/nar/gkl1003; Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930; Zhong XY, 2006, CELL CYCLE, V5, P457, DOI 10.4161/cc.5.4.2481; Zhong XY, 2005, CELL CYCLE, V4, P1227, DOI 10.4161/cc.4.9.2029	30	172	175	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB 13	2009	84	2					286	290		10.1016/j.ajhg.2009.01.017	http://dx.doi.org/10.1016/j.ajhg.2009.01.017			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	413NL	19215732	Green Published, Bronze			2022-12-18	WOS:000263799700019
J	Rainier, S; Bui, M; Mark, E; Thornas, D; Tokarz, D; Ming, L; Delaney, C; Richardson, RJ; Albers, JW; Matsunami, N; Stevens, J; Coon, H; Leppert, M; Fink, JK				Rainier, Shirley; Bui, Melanie; Mark, Erin; Thornas, Donald; Tokarz, Debra; Ming, Lei; Delaney, Colin; Richardson, Rudy J.; Albers, James W.; Matsunami, Nori; Stevens, Jeff; Coon, Hilary; Leppert, Mark; Fink, John K.			Neuropathy target esterase gene mutations cause motor neuron disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPASTIC PARAPLEGIA; LINKAGE ANALYSIS; TROYER-SYNDROME; OUTBREAK; NEURODEGENERATION; PARALYSIS; DOMAIN; BLUES; JAKE	The possibility that organophosphorus (OP) compounds contribute to motor neuron disease (MND) is supported by association of paraoxonase 1 polymorphisms with amyotrophic lateral sclerosis (ALS) and the occurrence of MND in OP compound-induced delayed neuropathy (OPIDN), in which neuropathy target esterase (NTE) is inhibited by organophosphorylation. We evaluated a consanguineous kindred and a genetically unrelated nonconsanguineous kindred in which affected subjects exhibited progressive spastic paraplegia and distal muscle wasting. Affected subjects resembled those with OPIDN and those with Troyer Syndrome due to SPG20/spartin gene mutation (excluded by genetic linkage and SPG20/spartin sequence analysis). Genome-wide analysis suggested linkage to a 22 cM homozygous locus (D19S56S to D19S884, maximum multipoint LOD score 3.28) on chromosome 19p13 to which NTE had been mapped (GenBank AJ004832). NTE was a candidate because of its role in OPIDN and the similarity of our patients to those with OPIDN. Affected subjects in the consanguineous kindred were homozygous for disease-specific NTE mutation c.3034A -> G that disrupted an interspecies conserved residue (MI012V) in NTE's catalytic domain. Affected subjects in the nonconsanguineous family were compound heterozygotes: one allele had c.2669G -> A mutation, which disrupts an interspecies conserved residue in NTE's catalytic domain (R890H), and the other allele had an insertion (c.2946_2947insCAGC) causing frameshift and protein truncation (p.S982fs1019). Disease-specific, nonconserved NTE mutations in unrelated MND patients indicates NTE's importance in maintaining axonal integrity raises the possibility that NTE pathway disturbances contribute to other MNDs including ALS, and supports the role of NTE abnormalities in axonopathy produced by neuropathic OP compounds.	[Rainier, Shirley; Bui, Melanie; Mark, Erin; Thornas, Donald; Tokarz, Debra; Ming, Lei; Delaney, Colin; Richardson, Rudy J.; Albers, James W.; Fink, John K.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Richardson, Rudy J.] Univ Michigan, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA; [Coon, Hilary] Univ Utah, Dept Psychiat, Salt Lake City, UT 84112 USA; [Matsunami, Nori; Stevens, Jeff; Leppert, Mark] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; [Fink, John K.] Ann Arbor Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Fink, JK (corresponding author), Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA.	jkfink@umich.edu	Richardson, Rudy J/B-2030-2008	Richardson, Rudy J/0000-0002-2028-5723; Coon, Hilary/0000-0002-8877-5446; Delaney, Colin E/0000-0001-6880-6973	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045163, R01NS053917] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS045163, R01-NS045163, R01-NS053917, R01 NS053917] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABOUDONIA MB, 1981, ANNU REV PHARMACOL, V21, P511, DOI 10.1146/annurev.pa.21.040181.002455; CROSS HE, 1967, ARCH NEUROL-CHICAGO, V16, P473, DOI 10.1001/archneur.1967.00470230025003; FINK JK, 2007, EMERY RIMOINS PRINCI, P2771; Forshaw PJ, 2001, J NEUROCHEM, V79, P400, DOI 10.1046/j.1471-4159.2001.00562.x; Glynn P, 1999, BIOCHEM J, V344, P625, DOI 10.1042/0264-6021:3440625; Glynn P, 2000, PROG NEUROBIOL, V61, P61, DOI 10.1016/S0301-0082(99)00043-X; INOUE N, 1988, Journal of UOEH, V10, P433; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LOTTI M, 1984, NEUROLOGY, V34, P658, DOI 10.1212/WNL.34.5.658; Lush MJ, 1998, BIOCHEM J, V332, P1; Mehta R S, 1975, J Assoc Physicians India, V23, P133; MORGAN JP, 1978, ARCH NEUROL-CHICAGO, V35, P530, DOI 10.1001/archneur.1978.00500320050011; MORGAN JP, 1976, ANN INTERN MED, V85, P804, DOI 10.7326/0003-4819-85-6-804; Patel H, 2002, NAT GENET, V31, P347, DOI 10.1038/ng937; Sarkar J K, 1974, J Indian Med Assoc, V63, P359; Slowik A, 2006, NEUROLOGY, V67, P766, DOI 10.1212/01.wnl.0000219565.32247.11; SMITH HV, 1959, LANCET, V2, P1019; Sobel E, 2001, HUM HERED, V52, P121, DOI 10.1159/000053366; Sobel E, 1996, AM J HUM GENET, V58, P1323; Sobel E, 2002, AM J HUM GENET, V70, P496, DOI 10.1086/338920; SOROKIN M, 1969, MED J AUSTRALIA, V1, P506, DOI 10.5694/j.1326-5377.1969.tb92252.x; SRIVASTAVA AK, 1990, FOOD CHEM TOXICOL, V28, P303, DOI 10.1016/0278-6915(90)90047-Q; TAYLOR P, 1996, ANTICHOLINESTERASE A; van Tienhoven M, 2002, J BIOL CHEM, V277, P20942, DOI 10.1074/jbc.M200330200; WOOLF AD, 1995, VET HUM TOXICOL, V37, P252	26	172	182	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2008	82	3					780	785		10.1016/j.ajhg.2007.12.018	http://dx.doi.org/10.1016/j.ajhg.2007.12.018			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	275JN	18313024	Bronze, Green Published			2022-12-18	WOS:000254067800023
J	Sparrow, DB; Chapman, G; Wouters, MA; Whittock, NV; Ellard, S; Fatkin, D; Turnpenny, PD; Kusumi, K; Sillence, D; Dunwoodie, SL				Sparrow, DB; Chapman, G; Wouters, MA; Whittock, NV; Ellard, S; Fatkin, D; Turnpenny, PD; Kusumi, K; Sillence, D; Dunwoodie, SL			Mutation of the LUNATIC FRINGE gene in humans causes spondylocostal dysostosis with a severe vertebral phenotype	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							APICAL ECTODERMAL RIDGE; AXIAL SKELETAL DEFECTS; CRYSTAL-STRUCTURE; NOTCH PATHWAY; SCHEMATIC DIAGRAMS; DYNAMIC EXPRESSION; SEQUENCE ALIGNMENT; RADICAL FRINGE; DELTA-HOMOLOG; SEGMENTATION	The spondylocostal dysostoses ( SCDs) are a heterogeneous group of vertebral malsegmentation disorders that arise during embryonic development by a disruption of somitogenesis. Previously, we had identified two genes that cause a subset of autosomal recessive forms of this disease: DLL3 (SCD1) and MESP2 (SCD2). These genes are important components of the Notch signaling pathway, which has multiple roles in development and disease. Here, we have used a candidate-gene approach to identify a mutation in a third Notch pathway gene, LUNATIC FRINGE (LFNG), in a family with autosomal recessive SCD. LFNG encodes a glycosyltransferase that modifies the Notch family of cell-surface receptors, a key step in the regulation of this signaling pathway. A missense mutation was identified in a highly conserved phenylalanine close to the active site of the enzyme. Functional analysis revealed that the mutant LFNG was not localized to the correct compartment of the cell, was unable to modulate Notch signaling in a cell-based assay, and was enzymatically inactive. This represents the first known mutation in the human LFNG gene and reinforces the hypothesis that proper regulation of the Notch signaling pathway is an absolute requirement for the correct patterning of the axial skeleton.	Univ New S Wales, Dev Biol Program, Victor Chang Cardiac Res Inst, Sydney, NSW 2010, Australia; Univ New S Wales, Computat Biol & Bioinformat Program, Victor Chang Cardiac Res Inst, Sydney, NSW 2010, Australia; Univ New S Wales, Sr Bernice Res Program Inherited Heart Dis, Victor Chang Cardiac Res Inst, Sydney, NSW 2010, Australia; Univ New S Wales, St Vincents Hosp, Dept Cardiol, Sydney, NSW 2010, Australia; Univ New S Wales, Fac Med, Sydney, NSW 2010, Australia; Univ New S Wales, Fac Sci, Sydney, NSW 2010, Australia; Childrens Hosp Westmead, Dept Med Genet, Sydney, NSW, Australia; Royal Devon & Exeter Hosp, Dept Clin Genet, Exeter EX2 5DW, Devon, England; Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Div Orthoped Surg, Philadelphia, PA 19104 USA	University of New South Wales Sydney; Victor Chang Cardiac Research Institute; University of New South Wales Sydney; Victor Chang Cardiac Research Institute; University of New South Wales Sydney; Victor Chang Cardiac Research Institute; St Vincents Hospital Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of Sydney; University of Exeter; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Dunwoodie, SL (corresponding author), Univ New S Wales, Dev Biol Program, Victor Chang Cardiac Res Inst, 384 Victoria St, Sydney, NSW 2010, Australia.	s.dunwoodie@victorchang.unsw.edu.au	Chapman, Gavin/A-9534-2012; Sparrow, Duncan/B-3994-2008; Wouters, Merridee/F-4310-2010; Wouters, Merridee/D-2046-2012; Kusumi, Kenro/J-2626-2012; Wouters, Merridee A/G-2481-2015; Dunwoodie, Sally L/M-4019-2018	Chapman, Gavin/0000-0002-3513-723X; Sparrow, Duncan/0000-0002-1141-6613; Kusumi, Kenro/0000-0002-1458-4540; Wouters, Merridee A/0000-0002-2121-912X; Dunwoodie, Sally L/0000-0002-2069-7349; Ellard, Sian/0000-0002-7620-5526				Aulehla A, 1999, DEV BIOL, V207, P49, DOI 10.1006/dbio.1998.9164; Bonafe L, 2003, CLIN GENET, V64, P28, DOI 10.1034/j.1399-0004.2003.00085.x; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Bulman MP, 2000, NAT GENET, V24, P438, DOI 10.1038/74307; Capdevila J, 2001, ANNU REV CELL DEV BI, V17, P87, DOI 10.1146/annurev.cellbio.17.1.87; Charnock SJ, 1999, BIOCHEMISTRY-US, V38, P6380, DOI 10.1021/bi990270y; Chen JH, 2001, P NATL ACAD SCI USA, V98, P13716, DOI 10.1073/pnas.241398098; Cohen B, 1997, NAT GENET, V16, P283, DOI 10.1038/ng0797-283; Collins JS, 2002, AM J HUM GENET, V71, P1251, DOI 10.1086/344344; Correia T, 2003, P NATL ACAD SCI USA, V100, P6404, DOI 10.1073/pnas.1131007100; COUTINHO PM, 1999, GENETICS BIOCH ECOLO, P15; Dahlqvist C, 2003, DEVELOPMENT, V130, P6089, DOI 10.1242/dev.00834; Dunwoodie SL, 2002, DEVELOPMENT, V129, P1795; Dunwoodie SL, 1997, DEVELOPMENT, V124, P3065; Forsberg H, 1998, CURR BIOL, V8, P1027, DOI 10.1016/S0960-9822(07)00424-1; Fritz TA, 2004, P NATL ACAD SCI USA, V101, P15307, DOI 10.1073/pnas.0405657101; Gibbons BJ, 2002, J MOL BIOL, V319, P463, DOI 10.1016/S0022-2836(02)00305-4; Hahn KL, 2005, DEVELOPMENT, V132, P817, DOI 10.1242/dev.01601; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Harper JA, 2003, CLIN GENET, V64, P461, DOI 10.1046/j.1399-0004.2003.00194.x; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; HUTCHINSON EG, 1990, PROTEINS, V8, P203, DOI 10.1002/prot.340080303; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Johnston SH, 1997, DEVELOPMENT, V124, P2245; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kato H, 1997, DEVELOPMENT, V124, P4133; Koch U, 2001, IMMUNITY, V15, P225, DOI 10.1016/S1074-7613(01)00189-3; Kusumi K, 2004, GENESIS, V39, P115, DOI 10.1002/gene.20034; Laufer E, 1997, NATURE, V386, P366, DOI 10.1038/386366a0; Leimeister C, 2003, GENE EXPR PATTERNS, V3, P595, DOI 10.1016/S1567-133X(03)00114-5; Lemm I, 2002, MOL CELL BIOL, V22, P3959, DOI 10.1128/MCB.22.12.3959-3969.2002; Liu J, 2003, PROTEIN SCI, V12, P1418, DOI 10.1110/ps.0302103; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Morales AV, 2002, DEV CELL, V3, P63, DOI 10.1016/S1534-5807(02)00211-3; Moran JL, 1999, NATURE, V399, P742, DOI 10.1038/21560; Munro S, 2000, CURR BIOL, V10, P813, DOI 10.1016/S0960-9822(00)00578-9; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Mustonen T, 2002, DEV BIOL, V248, P281, DOI 10.1006/dbio.2002.0734; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; Pourquie O, 2001, ANNU REV CELL DEV BI, V17, P311, DOI 10.1146/annurev.cellbio.17.1.311; RodriguezEsteban C, 1997, NATURE, V386, P360, DOI 10.1038/386360a0; RUSSELL RB, 1992, PROTEINS, V14, P309, DOI 10.1002/prot.340140216; Saga Y, 1997, GENE DEV, V11, P1827, DOI 10.1101/gad.11.14.1827; Shimizu K, 2001, J BIOL CHEM, V276, P25753, DOI 10.1074/jbc.M103473200; Sparrow DB, 2002, INT J DEV BIOL, V46, P365; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turnpenny PD, 2003, J MED GENET, V40, P333, DOI 10.1136/jmg.40.5.333; van Tuyl M, 2005, AM J PHYSIOL-LUNG C, V288, pL672, DOI 10.1152/ajplung.00247.2004; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Weinmaster G, 2003, ANNU REV CELL DEV BI, V19, P367, DOI 10.1146/annurev.cellbio.19.111301.115434; Whittock NV, 2004, CLIN GENET, V66, P67, DOI 10.1111/j.0009-9163.2004.00272.x; Whittock NV, 2004, AM J HUM GENET, V74, P1249, DOI 10.1086/421053; Zhang N, 2000, CURR BIOL, V10, P659, DOI 10.1016/S0960-9822(00)00522-4; Zhang N, 2002, GENESIS, V33, P21, DOI 10.1002/gene.10081; Zhang NA, 1998, NATURE, V394, P374, DOI 10.1038/28625; Zhang NA, 1999, NATURE, V399, P743, DOI 10.1038/21563	57	172	184	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2006	78	1					28	37		10.1086/498879	http://dx.doi.org/10.1086/498879			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	993CN	16385447	Green Published, Bronze			2022-12-18	WOS:000233930400004
J	Astuto, LM; Bork, JM; Weston, MD; Askew, JW; Fields, RR; Orten, DJ; Ohliger, SJ; Riazuddin, S; Morell, RJ; Khan, S; Riazuddin, S; Kremer, H; van Hauwe, P; Moller, CG; Cremers, CWRJ; Ayuso, C; Heckenlively, JR; Rohrschneider, K; Spandau, U; Greenberg, J; Ramesar, R; Reardon, W; Bitoun, P; Millan, J; Legge, R; Friedman, TB; Kimberling, WJ				Astuto, LM; Bork, JM; Weston, MD; Askew, JW; Fields, RR; Orten, DJ; Ohliger, SJ; Riazuddin, S; Morell, RJ; Khan, S; Riazuddin, S; Kremer, H; van Hauwe, P; Moller, CG; Cremers, CWRJ; Ayuso, C; Heckenlively, JR; Rohrschneider, K; Spandau, U; Greenberg, J; Ramesar, R; Reardon, W; Bitoun, P; Millan, J; Legge, R; Friedman, TB; Kimberling, WJ			CDH23 mutation and phenotype heterogeneity: A profile of 107 diverse families with Usher syndrome and nonsyndromic deafness	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTOSOMAL RECESSIVE DEAFNESS; MYOSIN-VIIA GENE; SYNDROME TYPE 1F; RETINITIS-PIGMENTOSA; PREVALENCE; DFNB12; 1C; 1D	Usher syndrome type I is characterized by congenital hearing loss, retinitis pigmentosa (RP), and variable vestibular areflexia. Usher syndrome type ID, one of seven Usher syndrome type I genetic localizations, have been mapped to a chromosomal interval that overlaps with a nonsyndromic-deafness localization, DFNB12. Mutations in CDH23, a gene that encodes a putative cell-adhesion protein with multiple cadherin-like domains, are responsible for both Usher syndrome and DFNB12 nonsyndromic deafness. Specific CDH23 mutational defects have been identified that differentiate these two phenotypes. Only missense mutations of CDH23 have been observed in families with nonsyndromic deafness, whereas nonsense, frameshift, splice-site, and missense mutations have been identified in families with Usher syndrome. In the present study, a panel of 69 probands with Usher syndrome and 38 probands with recessive nonsyndromic deafness were screened for the presence of mutations in the entire coding region of CDH23, by heteroduplex, single-strand conformation polymorphism, and direct sequence analyses. A total of 36 different CDH23 mutations were detected in 45 families; 33 of these mutations were novel, including 18 missense, 3 nonsense, 5 splicing defects, 5 microdeletions, and 2 insertions. A total of seven mutations were common to more than one family. Numerous exonic and intronic polymorphisms also were detected. Results of ophthalmologic examinations of the patients with nonsyndromic deafness have found asymptomatic RP-like manifestations, indicating that missense mutations may have a subtle effect in the retina. Furthermore, patients with mutations in CDH23 display a wide range of hearing loss and RP phenotypes, differing in severity, age at onset, type, and the presence or absence of vestibular areflexia.	Boys Town Natl Res Hosp, Ctr Study & Treatment Usher Syndrome, Omaha, NE 68131 USA; Univ Nebraska, Med Ctr, Dept Ophthalmol, Omaha, NE USA; Natl Inst Deafness & Other Commun Disorders, Mol Genet Lab, NIH, Rockville, MD USA; Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore, Pakistan; Univ Med Ctr Nijmegen, Dept Otorhinolaryngol, Nijmegen, Netherlands; Univ Med Ctr Nijmegen, Dept Human Genet& Otorhinolaryngol, Nijmegen, Netherlands; Sahlgrens Univ Hosp, Dept Audiol, S-41345 Gothenburg, Sweden; Fdn Jimenez Diaz, Madrid, Spain; Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90024 USA; Heidelberg Univ, Dept Ophthalmol, Heidelberg, Germany; Univ Cape Town, Sch Med, Dept Human Genet, ZA-7925 Cape Town, South Africa; Univ London, Inst Child Hlth, London WC1N 1EH, England; CHU, Paris, France; Hosp Univ La Fe, Genet Unit, Valencia, Spain	Boys Town National Research Hospital; University of Nebraska System; University of Nebraska Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Center of Excellence in Molecular Biology - Pakistan; University of Punjab; Radboud University Nijmegen; Radboud University Nijmegen; Sahlgrenska University Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Ruprecht Karls University Heidelberg; University of Cape Town; University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hospital Universitari i Politecnic La Fe	Kimberling, WJ (corresponding author), Boys Town Natl Res Hosp, Ctr Study & Treatment Usher Syndrome, Omaha, NE 68131 USA.	kimber@boystown.org	Kremer, Hannie/F-5126-2010; Morell, Robert James/Q-2042-2019; Ramesar, Raj S/I-6941-2015; Cremers, C.W.R.J./L-4254-2015	Kremer, Hannie/0000-0002-0841-8693; Ramesar, Raj S/0000-0001-5688-1634; Ayuso, Carmen/0000-0002-9242-7065; Morell, Robert/0000-0003-1537-7356; Bitoun, Pierre/0000-0001-6557-6826; Reardon, Willie/0000-0001-7329-9179; Rohrschneider, Klaus/0000-0003-1996-7935	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000039, Z01DC000048] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 DC000039] Funding Source: Medline; NIDCD NIH HHS [R01 DC 00677-07, P60 DC 00982, 1Z01 DC 00035-05, 1Z01 DC 00039-05, P01 DC 01813, T32 DC000035] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		AHMED ZA, IN PRESS HUM GENET; Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Alagramam KN, 2001, HUM MOL GENET, V10, P1709, DOI 10.1093/hmg/10.16.1709; Astuto LM, 2000, AM J HUM GENET, V67, P1569, DOI 10.1086/316889; Bitner-Glindzicz M, 2000, NAT GENET, V26, P56, DOI 10.1038/79178; BITOUN P, 1991, OPHTHALMIC PAED GEN, V12, P149, DOI 10.3109/13816819109029397; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; BOUGHMAN JA, 1983, J CHRON DIS, V36, P595, DOI 10.1016/0021-9681(83)90147-9; Chaib H, 1996, HUM MOL GENET, V5, P1061, DOI 10.1093/hmg/5.7.1061; GRONDAHL J, 1987, CLIN GENET, V31, P255; Grover S, 1997, OPHTHALMOLOGY, V104, P460, DOI 10.1016/S0161-6420(97)30291-7; Kelley PM, 1998, AM J HUM GENET, V62, P792, DOI 10.1086/301807; Kimberling W J, 1995, J Am Acad Audiol, V6, P63; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; NUUTILA A, 1970, J GENET HUM, V18, P57; TAMAYO ML, 1991, CLIN GENET, V40, P304; VERNON M, 1969, J CHRON DIS, V22, P133, DOI 10.1016/0021-9681(69)90055-1; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; von Brederlow B, 2002, HUM MUTAT, V19, P268, DOI 10.1002/humu.10049; Wayne S, 1996, HUM MOL GENET, V5, P1689, DOI 10.1093/hmg/5.10.1689; Wayne S, 1997, AM J HUM GENET, V61, pA300; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0	25	172	181	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2002	71	2					262	275		10.1086/341558	http://dx.doi.org/10.1086/341558			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	575ZE	12075507	Green Published, Bronze			2022-12-18	WOS:000176977700005
J	Trappe, R; Laccone, F; Cobilanschi, J; Meins, M; Huppke, P; Hanefeld, F; Engel, W				Trappe, R; Laccone, F; Cobilanschi, J; Meins, M; Huppke, P; Hanefeld, F; Engel, W			MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LETHAL OSTEOGENESIS IMPERFECTA; X-CHROMOSOME INACTIVATION; LINKED MENTAL-RETARDATION; I COLLAGEN; PARENTAL MOSAICISM; GENE; MALES; RECURRENCE; NEUROFIBROMATOSIS; SUBSTITUTION	Rett syndrome (RTT) is an X-linked neurodevelopmental disorder that apparently is lethal in male embryos. RTT almost exclusively affects female offspring and, in 99.5% of all cases, is sporadic and due to de novo mutations in the MECP2 gene. Familial cases of RTT are rare and are due to X-chromosomal inheritance from a carrier mother. We analyzed the parental origin of MECP2 mutations in sporadic cases of RTT, by analysis of linkage between the mutation in the MECP2 gene and intronic polymorphisms in 27 families with 15 different mutations, and we found a high predominance of mutations of paternal origin in 26 of 27 cases (P < .001). The paternal origin was independent of type of mutation and was found for single-base exchanges as well as for deletions. Parents were not of especially advanced age. We conclude that de novo mutations in RTT occur almost exclusively on the paternally derived X chromosome and that this is most probably the cause for the high female: male ratio observed in patients with RTT. Affected males recently have been described in a few cases of familial inheritance. Identification of the parental origin may be useful to distinguish between the sporadic form of RTT and a potentially familial form. This distinction will allow geneticists to offer more-specific counseling and discriminate between higher (maternal origin) and lower (paternal origin) recurrence risk.	Univ Gottingen, Inst Human Genet, D-37073 Gottingen, Germany; Specialty Neuropaediat, Dept Paediat, Gottingen, Germany	University of Gottingen	Laccone, F (corresponding author), Univ Gottingen, Inst Human Genet, Heinrich Duker Weg 12, D-37073 Gottingen, Germany.		Trappe, Ralf Ulrich/W-5801-2019; Laccone, Franco A/B-3655-2018; Trappe, Ralf/E-6048-2012	Trappe, Ralf Ulrich/0000-0001-7565-7160; Trappe, Ralf/0000-0001-7565-7160				Amano K, 2000, J HUM GENET, V45, P231, DOI 10.1007/s100380070032; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Amir RE, 2000, ANN NEUROL, V47, P670, DOI 10.1002/1531-8249(200005)47:5<670::AID-ANA20>3.3.CO;2-6; Bienvenu T, 2000, HUM MOL GENET, V9, P1377, DOI 10.1093/hmg/9.9.1377; Bohossian HB, 2000, NATURE, V406, P622, DOI 10.1038/35020557; CARLSON KM, 1994, AM J HUM GENET, V55, P1076; Cheadle JP, 2000, HUM MOL GENET, V9, P1119, DOI 10.1093/hmg/9.7.1119; Clayton-Smith J, 2000, LANCET, V356, P830, DOI 10.1016/S0140-6736(00)02661-1; COHN DH, 1990, AM J HUM GENET, V46, P591; Dragich J, 2000, HUM MOL GENET, V9, P2365, DOI 10.1093/hmg/9.16.2365; Edwards Matthew J., 1992, Human Mutation, V1, P47, DOI 10.1002/humu.1380010108; Glaser RL, 2000, AM J HUM GENET, V66, P768, DOI 10.1086/302831; Goto T, 1998, MICROBIOL MOL BIOL R, V62, P362, DOI 10.1128/MMBR.62.2.362-378.1998; HAGBERG B, 1985, BRAIN DEV-JPN, V7, P372, DOI 10.1016/S0387-7604(85)80048-6; HAGBERG B, 1985, ACTA PAEDIATR SCAND, V74, P405, DOI 10.1111/j.1651-2227.1985.tb10993.x; Huppke P, 2000, HUM MOL GENET, V9, P1369, DOI 10.1093/hmg/9.9.1369; JADAYEL D, 1990, NATURE, V343, P558, DOI 10.1038/343558a0; LAZARO C, 1994, NEW ENGL J MED, V331, P1403, DOI 10.1056/NEJM199411243312102; Meloni I, 2000, AM J HUM GENET, V67, P982, DOI 10.1086/303078; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MOLONEY DM, 1996, NAT GENET, V13, P9; NAMIKAWA C, 1995, HUM GENET, V95, P666; Obata K, 2000, J MED GENET, V37, P608, DOI 10.1136/jmg.37.8.608; Orrico A, 2000, FEBS LETT, V481, P285, DOI 10.1016/S0014-5793(00)01994-3; *STAT BUND WIESB, 1985, STAT JB BUND DTSCH; Tate P, 1996, NAT GENET, V12, P205, DOI 10.1038/ng0296-205; Thomas GH, 1996, AM J HUM GENET, V58, P1364; Villard L, 2000, NEUROLOGY, V55, P1188, DOI 10.1212/WNL.55.8.1188; Wan MM, 1999, AM J HUM GENET, V65, P1520, DOI 10.1086/302690; WETTKESCHAFER R, 1983, HUM GENET, V64, P1, DOI 10.1007/BF00289472; Xiang FQ, 2000, J MED GENET, V37, P250, DOI 10.1136/jmg.37.4.250	31	172	186	0	18	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2001	68	5					1093	1101		10.1086/320109	http://dx.doi.org/10.1086/320109			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	423HZ	11309679	Bronze, Green Published			2022-12-18	WOS:000168171200003
J	de Winter, JP; Leveille, F; van Berkel, CGM; Rooimans, MA; van der Weel, L; Steltenpool, J; Demuth, I; Morgan, NV; Alon, N; Bosnoyan-Collins, L; Lightfoot, J; Leegwater, PA; Waisfisz, Q; Komatsu, K; Arwert, F; Pronk, JC; Mathew, CG; Digweed, M; Buchwald, M; Joenje, H				de Winter, JP; Leveille, F; van Berkel, CGM; Rooimans, MA; van der Weel, L; Steltenpool, J; Demuth, I; Morgan, NV; Alon, N; Bosnoyan-Collins, L; Lightfoot, J; Leegwater, PA; Waisfisz, Q; Komatsu, K; Arwert, F; Pronk, JC; Mathew, CG; Digweed, M; Buchwald, M; Joenje, H			Isolation of a cDNA representing the Fanconi anemia complementation group E gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GROUP-C; PROTEIN; CLONING; MAPS	Fanconi anemia (FA) is an autosomal recessive chromosomal instability syndrome with at least seven different complementation groups, Four FA genes (FANCA, FANCC, FANCF, and FANCG) have been identified, and two other FA genes (FANCD and FANCE) have been mapped. Here we report the identification, by complementation cloning, of the gene mutated in FA complementation group E (FANCE), FANCE has 10 exons and encodes a novel 536-amino acid protein with two potential nuclear localization signals.	Free Univ Amsterdam, Med Ctr, Dept Clin Genet & Human Genet, NL-1081 BT Amsterdam, Netherlands; Free Univ Amsterdam, Med Ctr, Dept Clin Chem, NL-1081 BT Amsterdam, Netherlands; Humboldt Univ, Charite, Inst Human Genet, Berlin, Germany; Guys Hosp, GKT Sch Med, Div Med & Mol Genet, London SE1 9RT, England; Hosp Sick Children, Program Genet & Genom Biol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada; Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Radiat Biol, Hiroshima, Japan	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Hiroshima University	Joenje, H (corresponding author), Free Univ Amsterdam, Med Ctr, Dept Clin Genet & Human Genet, Van der Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.		Demuth, Ilja/ABD-5352-2021; Morgan, Neil V/A-5475-2009; Mathew, Christopher G/G-3434-2015	Demuth, Ilja/0000-0002-4340-2523; Morgan, Neil V/0000-0001-6433-5692; Mathew, Christopher G/0000-0003-4178-1838; Leegwater, Peter/0000-0002-4100-015X; Waisfisz, Quinten/0000-0002-7384-9182	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050131] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL50131] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Apostolou S, 1996, NAT GENET, V14, P324, DOI 10.1038/ng1196-324; AUERBACH AD, 1998, GENETIC BASIS HUMAN, P317; de Winter JP, 2000, NAT GENET, V24, P15, DOI 10.1038/71626; de Winter JP, 1998, NAT GENET, V20, P281, DOI 10.1038/3093; Hejna JA, 2000, AM J HUM GENET, V66, P1540, DOI 10.1086/302896; Hoatlin ME, 1999, BLOOD, V94, P3737, DOI 10.1182/blood.V94.11.3737.423k39_3737_3747; Joenje H, 2000, AM J HUM GENET, V67, P759, DOI 10.1086/303067; Joenje H, 1997, AM J HUM GENET, V61, P940, DOI 10.1086/514881; Kruyt FAE, 1998, BLOOD, V92, P3050, DOI 10.1182/blood.V92.9.3050.421k56_3050_3056; Liu JM, 1999, HUM GENE THER, V10, P2337, DOI 10.1089/10430349950016988; LoTenFoe JR, 1996, NAT GENET, V14, P320, DOI 10.1038/ng1196-320; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Pang QS, 2000, MOL CELL BIOL, V20, P4724, DOI 10.1128/MCB.20.13.4724-4735.2000; STRATHDEE CA, 1992, NATURE, V356, P763, DOI 10.1038/356763a0; Tripodis N, 2000, GENOME RES, V10, P454, DOI 10.1101/gr.10.4.454; Waisfisz Q, 1999, AM J HUM GENET, V64, P1400, DOI 10.1086/302385; WHITNEY M, 1995, NAT GENET, V11, P341, DOI 10.1038/ng1195-341	17	172	175	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2000	67	5					1306	1308		10.1016/S0002-9297(07)62959-0	http://dx.doi.org/10.1016/S0002-9297(07)62959-0			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	369WW	11001585	Green Published, Bronze			2022-12-18	WOS:000165091600026
J	Zhu, G; Duffy, DL; Eldridge, A; Grace, M; Mayne, C; O'Gorman, L; Aitken, JF; Neale, MC; Hayward, NK; Green, AC; Martin, NG				Zhu, G; Duffy, DL; Eldridge, A; Grace, M; Mayne, C; O'Gorman, L; Aitken, JF; Neale, MC; Hayward, NK; Green, AC; Martin, NG			A major quantitative-trait locus for mole density is linked to the familial melanoma gene CDKN2A: A maximum-likelihood combined linkage and association analysis in twins and their sibs	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MELANOCYTIC NEVI; GERMLINE MUTATIONS; VARIANCE-COMPONENTS; CUTANEOUS MELANOMA; COMPLEX TRAITS; PRONE FAMILIES; SUN EXPOSURE; RISK-FACTORS; CDK4; P16	Important risk factors for melanoma are densely clustered melanocytic nevi (common moles) and mutations in the p16 (CDKN2A) gene. Nevi may be subclassified as raised or flat. In our sample, raised nevi were 27% of the total, and the two kinds had a correlation of .33. Correlations for total-nevus count (TNC) in 153 MZ and 199 DZ twin pairs were .94 and .60, respectively, which are compatible with a very-high degree of genetic determination. We hypothesized that some of the genetic variance might be due to variation in the p16 gene. Analysis of linkage to a highly polymorphic marker (D9S942), located close to p16, detected quantitative-trait-loci (QTL) effects accounting for 27% of variance in TNC, rising to 33% if flat but not raised moles were considered. Total heritability was higher for raised (.69) than for flat (.42) moles, but QTL linkage was 0 for raised moles, whereas it accounted for 80% of the heritability of flat moles; additionally, family environment accounted for only 15% of variance in raised versus 46% in flat moles. These findings suggest that raised and flat nevi have very different etiologies. Longer alleles at D9S942 were associated with higher flat-mole counts, and a novel modification to a within-sibship association test showed that this association is genuine and not due to population stratification, although it accounts for only 1% of total variance. Since germline mutations in the exons of CDKN2A are rare, it is likely that variants in the noncoding regions of this gene, or in another gene nearby, are responsible for this major determinant of moliness and, hence, of melanoma risk.	Queensland Inst Med Res, Brisbane, Qld 4029, Australia; Univ Queensland, Joint Genet Program, Brisbane, Qld, Australia; Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA USA	QIMR Berghofer Medical Research Institute; University of Queensland; Virginia Commonwealth University	Martin, NG (corresponding author), Queensland Inst Med Res, PO Royal Brisbane Hosp, Brisbane, Qld 4029, Australia.		hayward, nicholas k/C-1367-2015; Aitken, Joanne F/C-5289-2009; hayward, nick/AAV-8802-2020; Green, Adele C/P-2736-2014; Neale, Michael C/B-1418-2008; Duffy, David L/B-7392-2013; Green, Adele C/B-5324-2011; Neale, Michael/AAD-5056-2020	hayward, nicholas k/0000-0003-4760-1033; Green, Adele C/0000-0002-2753-4841; Duffy, David L/0000-0001-7227-632X; Aitken, Joanne Frances/0000-0001-6859-2186; Martin, Nicholas/0000-0003-4069-8020				Aitken J, 1999, JNCI-J NATL CANCER I, V91, P446, DOI 10.1093/jnci/91.5.446; AITKEN JF, 1994, BRIT J CANCER, V69, P487, DOI 10.1038/bjc.1994.88; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; AMOS CI, 1994, AM J HUM GENET, V54, P535; Boomsma DI, 1996, BEHAV GENET, V26, P161, DOI 10.1007/BF02359893; Briollais L, 1996, GENET EPIDEMIOL, V13, P385, DOI 10.1002/(SICI)1098-2272(1996)13:4<385::AID-GEPI7>3.0.CO;2-3; CANNONALBRIGHT LA, 1994, CANCER RES, V54, P6041; DAVIS NC, 1991, MALIGNANT SKIN TUMOU, P71; DUFFY DL, 1992, CYTOGENET CELL GENET, V59, P194, DOI 10.1159/000133243; EASTON DF, 1991, BRIT J CANCER, V64, P1164, DOI 10.1038/bjc.1991.483; Eaves LJ, 1996, BEHAV GENET, V26, P519, DOI 10.1007/BF02359757; Fulker DW, 1999, AM J HUM GENET, V64, P259, DOI 10.1086/302193; Fulker DW, 1996, BEHAV GENET, V26, P527, DOI 10.1007/BF02359758; GOLDGAR DE, 1991, J NATL CANCER I, V83, P1726, DOI 10.1093/jnci/83.23.1726; GREEN A, 1995, MELANOMA RES, V5, P155, DOI 10.1097/00008390-199506000-00003; GREEN A, 1989, EPIDEMIOL REV, V11, P204, DOI 10.1093/oxfordjournals.epirev.a036037; GRUIS NA, 1995, MELANOMA RES, V5, P169, DOI 10.1097/00008390-199506000-00005; HARRISON SL, 1994, LANCET, V344, P1529, DOI 10.1016/S0140-6736(94)90348-4; Hayward Nicholas K., 1996, Current Opinion in Oncology, V8, P136, DOI 10.1097/00001622-199603000-00011; HAYWARD NK, 1998, INHERITED SUSCEPTIBI, P279; HAYWARD NK, 1998, CURR PRAC MED, V1, P47; Holland EA, 1995, ONCOGENE, V11, P2289; Kamb A, 1994, Nat Genet, V8, P23; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; KELLY JW, 1994, J AM ACAD DERMATOL, V30, P40, DOI 10.1016/S0190-9622(94)70005-2; KRUGLYAK L, 1995, AM J HUM GENET, V56, P1212; LANGE K, 1976, ANN HUM GENET, V39, P485, DOI 10.1111/j.1469-1809.1976.tb00156.x; MACLENNAN R, 1992, J NATL CANCER I, V84, P1427, DOI 10.1093/jnci/84.18.1427; MACLENNAN R, IN PRESS AUSTRALASIA; Martin N, 1997, NAT GENET, V17, P387, DOI 10.1038/ng1297-387; MARTIN NG, 1977, HEREDITY, V38, P79, DOI 10.1038/hdy.1977.9; MARTIN NG, 1987, AM J HUM GENET, V40, P267; McGregor B, 1999, GENET EPIDEMIOL, V16, P40, DOI 10.1002/(SICI)1098-2272(1999)16:1<40::AID-GEPI4>3.3.CO;2-T; Milan T, 1998, BRIT J CANCER, V78, P1516, DOI 10.1038/bjc.1998.716; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Neale M.C.C.L., 2013, METHODOLOGY GENETIC, V67, DOI DOI 10.1007/978-94-015-8018-2; NEALE MC, 1997, MX STAT MODELING; OHTA M, 1994, CANCER RES, V54, P5269; Platz A, 1997, J NATL CANCER I, V89, P697, DOI 10.1093/jnci/89.10.697; Pollock PM, 1996, GENE CHROMOSOME CANC, V15, P77, DOI 10.1002/(SICI)1098-2264(199602)15:2<77::AID-GCC1>3.0.CO;2-0; RANADE K, 1995, NAT GENET, V10, P114, DOI 10.1038/ng0595-114; REYMOND A, 1995, ONCOGENE, V11, P1173; Schmoeckel C, 1997, AM J DERMATOPATH, V19, P31, DOI 10.1097/00000372-199702000-00006; Siemens H., 1924, ZWILLINGSPATHOLOGIE; Soufir N, 1998, HUM MOL GENET, V7, P209, DOI 10.1093/hmg/7.2.209; SWERDLOW AJ, 1987, BRIT J DERMATOL, V117, P137, DOI 10.1111/j.1365-2133.1987.tb04109.x; Worret WI, 1998, AM J DERMATOPATH, V20, P135, DOI 10.1097/00000372-199804000-00005; Zuo L, 1996, NAT GENET, V12, P97, DOI 10.1038/ng0196-97	48	172	173	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1999	65	2					483	492		10.1086/302494	http://dx.doi.org/10.1086/302494			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	223JA	10417291	Green Published, Bronze			2022-12-18	WOS:000081836900024
J	Jackson, CE; Fischer, RE; Hsu, AP; Anderson, SM; Choi, YN; Wang, J; Dale, JK; Fleisher, TA; Middelton, LA; Sneller, MC; Lenardo, MJ; Straus, SE; Puck, JM				Jackson, CE; Fischer, RE; Hsu, AP; Anderson, SM; Choi, YN; Wang, J; Dale, JK; Fleisher, TA; Middelton, LA; Sneller, MC; Lenardo, MJ; Straus, SE; Puck, JM			Autoimmune lymphoproliferative syndrome with defective fas: Genotype influences penetrance	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NECROSIS-FACTOR-ALPHA; SYSTEMIC LUPUS-ERYTHEMATOSUS; GENE POLYMORPHISM; LYMPHOCYTE APOPTOSIS; CELL ACTIVATION; DEATH DOMAIN; MUTATIONS; MICE; DISEASE; EXPRESSION	Autoimmune lymphoproliferative syndrome (ALPS) is a disorder of lymphocyte homeostasis and immunological tolerance. Most patients have a heterozygous mutation in the APT1 gene, which encodes Fas (CD95, APO-1), mediator of an apoptotic pathway crucial to lymphocyte homeostasis. Of 17 unique APT1 mutations in unrelated ALPS probands, 12 (71%) occurred in exons 7-9, which encode the intracellular portion of Fas. In vitro, activated lymphocytes from all 17 patients showed apoptotic defects when exposed to an anti-Fas agonist monoclonal antibody. Similar defects were found in a Fas-negative cell line transfected with cDNAs bearing each of the mutations. In cotransfection experiments, Fas constructs with either intra- or extracellular mutations caused dominant inhibition of apoptosis mediated by wild-type Fas. Two missense Fas variants, not restricted to patients with ALPS, were identified. Variant A(-1)T at the Fas signal-sequence:cleavage site, which mediates;apoptosis less well than wild-type Fas and is partially inhibitory, was present in 13% of African American alleles. Among the ALPS-associated Eas mutants, dominant inhibition of apoptosis was much more pronounced in mutants affecting the intracellular, versus extracellular, portion of the Fas receptor. Mutations causing disruption of the intracellular Fas death domain also showed a higher penetrance of ALPS phenotype features in mutation-bearing relatives. Significant ALPS-related morbidity occurred in 44% of relatives with intracellular mutations, versus 0% of relatives with extracellular mutations. Thus, the location of mutations within APT1 strongly influences the development and the severity of ALPS.	NHGRI, Branch Genet & Mol Biol, NIH, Bethesda, MD 20892 USA; NHGRI, Branch Med Genet, Bethesda, MD 20892 USA; NIAID, Immunol Lab, Bethesda, MD 20892 USA; NIAID, Clin Invest Lab, Bethesda, MD 20892 USA; NIAID, Immunoregulat Lab, Bethesda, MD 20892 USA; NIH, Ctr Clin, Pathol Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Puck, JM (corresponding author), NHGRI, Branch Genet & Mol Biol, NIH, 49 Convent Dr,Bldg 49,Room 3W14, Bethesda, MD 20892 USA.	jpuck@nhgri.nih.gov	Choi, Youngnim/AAL-8140-2020	Choi, Youngnim/0000-0002-6496-5560; Wang, Jin/0000-0002-3116-0838	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000732, Z01AI000732] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARNOLD A, 1990, J CLIN INVEST, V86, P1084, DOI 10.1172/JCI114811; Arnold WJ, 1993, TXB RHEUMATOLOGY, P1429; BEHRMANN I, 1994, EUR J IMMUNOL, V24, P3057, DOI 10.1002/eji.1830241221; Beltinger C, 1998, BLOOD, V91, P3943; Bettinardi A, 1997, BLOOD, V89, P902, DOI 10.1182/blood.V89.3.902; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; CASCINO I, 1995, J IMMUNOL, V154, P2706; CHENG JH, 1995, J IMMUNOL, V154, P1239; COOPER DN, 1995, HUMAN GENE MUTATION; DANIS VA, 1995, CLIN EXP IMMUNOL, V99, P303; DANIS VA, 1995, DIS MARKERS, V12, P127, DOI 10.1155/1994/756247; DAVIDSON WF, 1986, J IMMUNOL, V136, P4075; DAVIGNON JL, 1985, J IMMUNOL, V135, P2423; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; Drappa J, 1996, NEW ENGL J MED, V335, P1643, DOI 10.1056/NEJM199611283352204; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; FIUCCI G, 1994, IMMUNOGENETICS, V39, P437; GALBRAITH GMP, 1995, HUM GENET, V96, P433; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; INAZAWA J, 1992, GENOMICS, V14, P821, DOI 10.1016/S0888-7543(05)80200-9; Infante AJ, 1998, J PEDIATR-US, V133, P629, DOI 10.1016/S0022-3476(98)70102-7; ITO M, 1993, J CLIN INVEST, V91, P2565, DOI 10.1172/JCI116494; IZUI S, 1984, J IMMUNOL, V133, P227; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; Kasahara Y, 1998, INT IMMUNOL, V10, P195, DOI 10.1093/intimm/10.2.195; Kimura M, 1994, Int Rev Immunol, V11, P193, DOI 10.3109/08830189409061727; Landowski TH, 1997, BLOOD, V90, P4266, DOI 10.1182/blood.V90.11.4266.4266_4266_4270; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; LIU CD, 1995, BIOCHEM J, V310, P957, DOI 10.1042/bj3100957; MESSER G, 1994, DERMATOLOGY, V189, P135, DOI 10.1159/000246957; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; OGATA Y, 1993, CELL IMMUNOL, V148, P91, DOI 10.1006/cimm.1993.1093; Papoff G, 1996, J IMMUNOL, V156, P4622; Pensati L, 1997, GASTROENTEROLOGY, V113, P1384, DOI 10.1053/gast.1997.v113.pm9322534; Puck JM, 1997, BLOOD, V89, P1968; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; SARKAR G, 1992, GENOMICS, V13, P441, DOI 10.1016/0888-7543(92)90266-U; SCHUR PH, 1993, TXB RHEUMATOLOGY, P1017; Singh A, 1998, J INTERF CYTOK RES, V18, P439, DOI 10.1089/jir.1998.18.439; SNELLER MC, 1992, J CLIN INVEST, V90, P334, DOI 10.1172/JCI115867; Sneller MC, 1997, BLOOD, V89, P1341, DOI 10.1182/blood.V89.4.1341; Sullivan KE, 1997, ARTHRITIS RHEUM, V40, P2207, DOI 10.1002/art.1780401215; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WATZKE HH, 1991, J CLIN INVEST, V88, P1685, DOI 10.1172/JCI115484; WILSON AG, 1994, EUR J IMMUNOL, V24, P191, DOI 10.1002/eji.1830240130; Yanagawa T, 1996, THYROID, V6, P37, DOI 10.1089/thy.1996.6.37	47	172	176	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1999	64	4					1002	1014		10.1086/302333	http://dx.doi.org/10.1086/302333			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184UV	10090885	Green Published, Bronze			2022-12-18	WOS:000079632900011
J	Brown, MD; Hosseini, SH; Torroni, A; Bandelt, HJ; Allen, JC; Schurr, TG; Scozzari, R; Cruciani, F; Wallace, DC				Brown, MD; Hosseini, SH; Torroni, A; Bandelt, HJ; Allen, JC; Schurr, TG; Scozzari, R; Cruciani, F; Wallace, DC			mtDNA haplogroup X: An ancient link between Europe western Asia and North America?	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA ANALYSIS; CHROMOSOME-SPECIFIC POLYMORPHISMS; NATIVE-AMERICANS; CONTROL REGION; NEW-WORLD; AMERINDIAN POPULATION; ORIGIN; HAPLOTYPES; SEQUENCE; MIGRATIONS	On the basis of comprehensive RFLP analysis, it has been inferred that similar to 97% of Native American mtDNAs belong to one of four major founding mtDNA lineages, designated haplogroups "A"-"D." It has been proposed that a fifth mtDNA haplogroup (haplogroup X) represents a minor founding lineage in Native Americans. Unlike haplogroups A-D, haplogroup X is also found at low frequencies in modern European populations. To investigate the origins, diversity, and continental relationships of this haplogroup, we performed mtDNA high-resolution RFLP and complete control region (CR) sequence analysis on 22 putative Native American haplogroup X and 14 putative European haplogroup X mtDNAs. The results identified a consensus haplogroup X motif that characterizes our European and Native American samples. Among Native Americans, haplogroup X appears to be essentially restricted to northern Amerindian groups, including the Ojibwa, the Nuu-Chah-Nulth, the Sioux, and the Yakima, although we also observed this haplogroup in the Na-Dene-speaking Navajo. Median network analysis indicated that European and Native American haplogroup X mtDNAs, although distinct, nevertheless are distantly related to each other. Time estimates for the arrival of X in North America are 12,000-36,000 years ago, depending on the number of assumed founders, thus supporting the conclusion that the peoples harboring haplogroup X were among the original founders of Native American populations. To date, haplogroup X has not been unambiguously identified in Asia, raising the possibility that some Native American founders were of Caucasian ancestry.	Emory Univ, Sch Med, Ctr Mol Med, Atlanta, GA 30303 USA; Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, I-00185 Rome, Italy; Univ Hamburg, Math Seminar, D-2000 Hamburg, Germany	Emory University; Sapienza University Rome; University of Hamburg	Brown, MD (corresponding author), Emory Univ, Sch Med, Ctr Mol Med, 420B Dental Sch,1462 Clifton Rd, Atlanta, GA 30303 USA.	mdbrown@gmm.gen.emory.edu	Cruciani, Fulvio/G-6105-2012; Schurr, Theodore G/A-1336-2007; Torroni, Antonio/E-1557-2011	Torroni, Antonio/0000-0002-4163-4478; Cruciani, Fulvio/0000-0002-6900-024X; Allen, Jeffrey/0000-0001-9957-6664	NHLBI NIH HHS [HL45572] Funding Source: Medline; NIA NIH HHS [AG10130] Funding Source: Medline; NINDS NIH HHS [NS21328] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010130] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BAILLIET G, 1994, AM J HUM GENET, V55, P27; BALLINGER SW, 1992, GENETICS, V130, P139; BANDELT HJ, 1995, GENETICS, V141, P743; BATISTA O, 1995, HUM MOL GENET, V4, P921, DOI 10.1093/hmg/4.5.921; Bianchi NO, 1997, AM J HUM GENET, V61, P244; Easton RD, 1996, AM J HUM GENET, V59, P213; Forster P, 1996, AM J HUM GENET, V59, P935; FOULDS LR, 1979, J MOL EVOL, V13, P127, DOI 10.1007/BF01732868; GINTHER C, 1993, EXS, V67, P211; GRAVEN L, 1995, MOL BIOL EVOL, V12, P334; HASKELL JL, 1987, SO ATHAPASKAN MIGRAT, P200; Hauswirth William W., 1994, P104; HENDY MD, 1982, MATH BIOSCI, V59, P277, DOI 10.1016/0025-5564(82)90027-X; Horai S, 1996, AM J HUM GENET, V59, P579; HORAI S, 1993, MOL BIOL EVOL, V10, P23; Huoponen K, 1997, EUR J HUM GENET, V5, P25, DOI 10.1159/000484728; IVANOVA AV, 1993, THESIS U NOVOSIBIRSK; KOLMAN CJ, 1995, GENETICS, V140, P275; Kolman CJ, 1996, GENETICS, V142, P1321; Lee SD, 1997, FORENSIC SCI INT, V87, P99, DOI 10.1016/S0379-0738(97)02114-2; MERRIWETHER DA, 1995, AM J PHYS ANTHROPOL, V98, P411, DOI 10.1002/ajpa.1330980404; NEI M, 1983, GENETICS, V105, P207; PIERCY R, 1993, INT J LEGAL MED, V106, P85, DOI 10.1007/BF01225046; REDD AJ, 1995, MOL BIOL EVOL, V12, P604; RibeirodosSantos AKC, 1996, AM J PHYS ANTHROPOL, V101, P29, DOI 10.1002/(SICI)1096-8644(199609)101:1<29::AID-AJPA3>3.0.CO;2-8; SCHELL LM, 1988, YEARB PHYS ANTHROPOL, V31, P1; Scozzari R, 1997, AM J HUM GENET, V60, P241; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; STARIKOVSKAYA YB, 1998, IN PRESS AM J HUM GE, V63; STONE AC, 1993, AM J PHYS ANTHROPOL, V92, P463, DOI 10.1002/ajpa.1330920405; Stone AC, 1998, AM J HUM GENET, V62, P1153, DOI 10.1086/301838; STONEKING M, 1991, AM J HUM GENET, V48, P370; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 1996, GENETICS, V144, P1835; TORRONI A, 1994, P NATL ACAD SCI USA, V91, P1158, DOI 10.1073/pnas.91.3.1158; TORRONI A, 1994, J BIOENERG BIOMEMBR, V26, P261, DOI 10.1007/BF00763098; TORRONI A, 1994, AM J HUM GENET, V55, P760; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; WARD RH, 1993, P NATL ACAD SCI USA, V90, P10663, DOI 10.1073/pnas.90.22.10663; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503	45	172	176	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1998	63	6					1852	1861		10.1086/302155	http://dx.doi.org/10.1086/302155			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Genetics & Heredity	151EL	9837837	Green Published, Bronze			2022-12-18	WOS:000077707700030
J	LUTY, JA; GUO, Z; WILLARD, HF; LEDBETTER, DH; LEDBETTER, S; LITT, M				LUTY, JA; GUO, Z; WILLARD, HF; LEDBETTER, DH; LEDBETTER, S; LITT, M			5 POLYMORPHIC MICROSATELLITE VNTRS ON THE HUMAN X-CHROMOSOME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									OREGON HLTH SCI UNIV, DEPT BIOCHEM, PORTLAND, OR 97201 USA; OREGON HLTH SCI UNIV, DEPT MED GENET, PORTLAND, OR 97201 USA; UNIV TORONTO, DEPT MED GENET, TORONTO M5S 1A1, ONTARIO, CANADA; BAYLOR UNIV, INST MOLEC GENET, HOUSTON, TX 77030 USA	Oregon Health & Science University; Oregon Health & Science University; University of Toronto; Baylor College of Medicine; Baylor University					NICHD NIH HHS [HD20619] Funding Source: Medline; NIGMS NIH HHS [R01-GM32500] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD020619] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032500] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BROWN CJ, 1989, AM J HUM GENET, V44, P264; CHAMBERLAIN JS, 1988, NUCLEIC ACIDS RES, V16, P11141, DOI 10.1093/nar/16.23.11141; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CHURCH GM, 1988, SCIENCE, V240, P185, DOI 10.1126/science.3353714; COOKE HJ, 1985, NATURE, V317, P687, DOI 10.1038/317687a0; COOPER DN, 1985, HUM GENET, V69, P201, DOI 10.1007/BF00293024; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; DRACOPOLI NC, 1988, AM J HUM GENET, V43, P462; DRAYNA D, 1985, SCIENCE, V230, P753, DOI 10.1126/science.4059909; EHRLICH HA, 1989, PCR TECHNOLOGY PRINC; HOFKER MH, 1986, AM J HUM GENET, V39, P438; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LATHROP M, 1988, GENOMICS, V3, P361, DOI 10.1016/0888-7543(88)90128-0; LEDBETTER SA, UNPUB NEW SOMATIC CE; LEPPERT M, 1987, CYTOGENET CELL GENET, V46, P649; LITT M, 1989, CYTOGENET CELL GENET, V51, P1034; LITT M, 1989, AM J HUM GENET, V44, P397; NAKAMURA Y, 1988, GENOMICS, V3, P389, DOI 10.1016/0888-7543(88)90133-4; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P5705, DOI 10.1093/nar/16.12.5705; NAKAMURA Y, 1988, GENOMICS, V3, P342, DOI 10.1016/0888-7543(88)90125-5; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; Nakamura Y, 1988, GENOMICS, V2, P302, DOI 10.1016/0888-7543(88)90018-3; NUSSBAUM RL, 1983, HUM GENET, V64, P148, DOI 10.1007/BF00327113; NUSSBAUM RL, 1986, AM J MED GENET, V23, P457, DOI 10.1002/ajmg.1320230137; OCONNELL P, 1989, GENOMICS, V4, P12, DOI 10.1016/0888-7543(89)90308-X; OCONNELL P, 1988, GENOMICS, V3, P367, DOI 10.1016/0888-7543(88)90129-2; PAABO S, 1989, P NATL ACAD SCI USA, V86, P1939, DOI 10.1073/pnas.86.6.1939; ROULEAU GA, 1989, GENOMICS, V4, P1, DOI 10.1016/0888-7543(89)90306-6; ROYLE NJ, 1988, GENOMICS, V3, P352, DOI 10.1016/0888-7543(88)90127-9; SCOTT AF, 1979, P NATL ACAD SCI USA, V76, P4563, DOI 10.1073/pnas.76.9.4563; SHIBATA DK, 1988, J EXP MED, V167, P225, DOI 10.1084/jem.167.1.225; SMEETS HJM, 1989, HUM GENET, V83, P245, DOI 10.1007/BF00285165; TANZI R E, 1988, Genomics, V3, P129, DOI 10.1016/0888-7543(88)90143-7; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; van Tuinen P, 1987, Genomics, V1, P374, DOI 10.1016/0888-7543(87)90042-5; WEBER JL, 1989, CYTOGENET CELL GENET, V51, P1103; WEBER JL, 1989, AM J HUM GENET, V44, P388; WILLARD HF, 1989, HUM GENET, V81, P234; WILLARD HF, 1986, P NATL ACAD SCI USA, V83, P5611, DOI 10.1073/pnas.83.15.5611	43	172	178	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1990	46	4					776	783						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CW549	2316523				2022-12-18	WOS:A1990CW54900015
J	BEAUDET, A; BOWCOCK, A; BUCHWALD, M; CAVALLISFORZA, L; FARRALL, M; KING, MC; KLINGER, K; LALOUEL, JM; LATHROP, G; NAYLOR, S; OTT, J; TSUI, LC; WAINWRIGHT, B; WATKINS, P; WHITE, R; WILLIAMSON, R				BEAUDET, A; BOWCOCK, A; BUCHWALD, M; CAVALLISFORZA, L; FARRALL, M; KING, MC; KLINGER, K; LALOUEL, JM; LATHROP, G; NAYLOR, S; OTT, J; TSUI, LC; WAINWRIGHT, B; WATKINS, P; WHITE, R; WILLIAMSON, R			LINKAGE OF CYSTIC-FIBROSIS TO 2 TIGHTLY LINKED DNA MARKERS - JOINT REPORT FROM A COLLABORATIVE STUDY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; STANFORD UNIV,DEPT GENET,STANFORD,CA 94305; HOSP SICK CHILDREN,RES INST,DEPT GENET,TORONTO M5G 1X8,ONTARIO,CANADA; UNIV TORONTO,DEPT MED BIOPHYS,TORONTO M5S 1A1,ONTARIO,CANADA; UNIV TORONTO,DEPT MED GENET,TORONTO M5S 1A1,ONTARIO,CANADA; UNIV CALIF BERKELEY,SCH PUBL HLTH,BERKELEY,CA 94720; COLUMBIA UNIV,DEPT PSYCHIAT,NEW YORK,NY 10027; COLUMBIA UNIV,DEPT GENET & DEV,NEW YORK,NY 10027; UNIV TEXAS,HLTH SCI CTR,DEPT CELLULAR & STRUCT BIOL,SAN ANTONIO,TX 78284; UNIV UTAH,SCH MED,DEPT GENET,SALT LAKE CITY,UT 84112; UNIV UTAH,SCH MED,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84112; INTEGRATED GENET INC,FRAMINGHAM,MA 01701	Baylor College of Medicine; Stanford University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of California System; University of California Berkeley; Columbia University; Columbia University; University of Texas System; University of Texas Health San Antonio; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	BEAUDET, A (corresponding author), BAYLOR COLL MED,HOWARD HUGHES MED INST,HOUSTON,TX 77030, USA.		Tsui, Lap-chee/A-1081-2010	Bowcock, Anne/0000-0001-8691-9090; King, Mary-Claire/0000-0001-9426-1743	NCI NIH HHS [CA-27632] Funding Source: Medline; NIADDK NIH HHS [AM-34942] Funding Source: Medline; NIGMS NIH HHS [GM-28428] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM034942] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA027632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM028428] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BODMER WF, 1984, IMMUNOGENETICS ITS A, P263; BOWCOCK AM, 1986, GENETIC ANAL CYSTIC, V39, P699; BUCHWALD M, 1986, CYTOGENET CELL GENET, V41, P234, DOI 10.1159/000132235; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; EIBERG H, 1985, CLIN GENET, V28, P265; EIBERG H, 1985, CYTOGENET CELL GENET, V40, P623; KNOWLTON RG, 1985, NATURE, V318, P380, DOI 10.1038/318380a0; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; OTT J, 1985, ANAL HUMAN GENETIC L; SCAMBLER PJ, 1985, LANCET, V2, P1241; TSUI LC, 1985, SCIENCE, V230, P1054, DOI 10.1126/science.2997931; TSUI LC, 1986, DNA MARKERS, V39, P720; WAINWRIGHT BJ, 1985, NATURE, V318, P384, DOI 10.1038/318384a0; WHITE R, 1985, NATURE, V318, P382, DOI 10.1038/318382a0; WHITE R, 1986, FURTHER LINKAGE DATA, V39, P694	16	172	175	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1986	39	6					681	693						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	F5414	3026171				2022-12-18	WOS:A1986F541400001
J	WOLFF, PH				WOLFF, PH			VASOMOTOR SENSITIVITY TO ALCOHOL IN DIVERSE MONGOLOID POPULATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CHILDRENS HOSP,MED CTR,BOSTON,MA 02115	Harvard University; Boston Children's Hospital								CHAFETZ ME, 1964, NEW ENGL J MED, V271, P297, DOI 10.1056/NEJM196408062710607; Chen KK, 1929, J PHARMACOL EXP THER, V36, P429; COMAS J, 1960, MANUAL PHYSICAL ANTH; DOZIER EP, 1966, Q J STUD ALCOHOL, V27, P72; FENNA D, 1971, CAN MED ASSOC J, V105, P472; GOODMAN LS, 1970, PHARMACOLOGIC BASIS; Harger RN, 1956, ALCOHOLISM, P103; HIMWICH HE, 1956, ALCOHOLISM, P291; MONTAGU MFA, 1960, INTRO PHYSICAL ANTHR; SCOTT JG, 1945, BRIT J OPHTHALMOL, V29, P12, DOI 10.1136/bjo.29.1.12; UNDERHILL RM, 1971, RED MANS AMERICA; WHEELAN RF, 1967, CONTROL PERIPHERAL C; WOLFF PH, 1972, SCIENCE, V175, P449, DOI 10.1126/science.175.4020.449	13	172	175	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1973	25	2					193	199						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	P0622	4689039				2022-12-18	WOS:A1973P062200008
J	Freeze, HH; Chong, JX; Bamshad, MJ; Ng, BG				Freeze, Hudson H.; Chong, Jessica X.; Bamshad, Michael J.; Ng, Bobby G.			Solving Glycosylation Disorders: Fundamental Approaches Reveal Complicated Pathways	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							CONGENITAL MYASTHENIC SYNDROMES; LINKED-N-ACETYLGLUCOSAMINE; ANCHOR-SYNTHESIS PATHWAY; FUCOSYL-TRANSFERASE 1; ALPHA-DYSTROGLYCAN; CAUSE HYPERPHOSPHATASIA; MUSCULAR-DYSTROPHIES; O-MANNOSYLATION; MUTATIONS; NOTCH	Over 100 human genetic disorders result from mutations in glycosylation-related genes. In 2013, a new glycosylation disorder was reported every 17 days. This trend will probably continue given that at least 2% of the human genome encodes glycan-biosynthesis and -recognition proteins. Established biosynthetic pathways provide many candidate genes, but finding unanticipated mutated genes will offer new insights into glycosylation. Simple glycobiomarkers can be used in narrowing the candidates identified by exome and genome sequencing, and those can be validated by glycosylation analysis of serum or cells from affected individuals. Model organisms will expand the understanding of these mutations' impact on glycosylation and pathology. Here, we highlight some recently discovered glycosylation disorders and the barriers, breakthroughs, and surprises they presented. We predict that some glycosylation disorders might occur with greater frequency than current estimates of their prevalence. Moreover, the prevalence of some disorders differs substantially between European and African Americans.	[Freeze, Hudson H.; Ng, Bobby G.] Sanford Burnham Med Res Inst, Human Genet Program, Sanford Childrens Hlth Res Ctr, La Jolla, CA 92037 USA; [Chong, Jessica X.; Bamshad, Michael J.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA	Sanford Burnham Prebys Medical Discovery Institute; University of Washington; University of Washington Seattle	Freeze, HH (corresponding author), Sanford Burnham Med Res Inst, Human Genet Program, Sanford Childrens Hlth Res Ctr, La Jolla, CA 92037 USA.	hudson@sanfordburnham.org	Chong, Jessica/GZH-1625-2022	Chong, Jessica/0000-0002-1616-2448; Freeze, Hudson/0000-0001-6316-0501	Rocket Fund;  [R01DK55615];  [U54HG006493]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006493, UM1HG006493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055615] Funding Source: NIH RePORTER	Rocket Fund; ; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by The Rocket Fund and by R01DK55615 to H.H.F. and U54HG006493 to M.B. We would like to thank Richard Cummings (Emory University) for providing the original glycosylphosphatidylinositol diagram used in Figure 3.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Almeida AM, 2007, NEW ENGL J MED, V356, P1641, DOI 10.1056/NEJMoa063369; Almeida AM, 2006, NAT MED, V12, P846, DOI 10.1038/nm1410; Carrera IA, 2012, AM J MED GENET A, V158A, P2027, DOI 10.1002/ajmg.a.35472; Artayanis-Tsakonas S, 2010, CURR TOP DEV BIOL, V92, P1, DOI 10.1016/S0070-2153(10)92001-2; Artemenko Natalia V, 2012, Methods Mol Biol, V899, P325, DOI 10.1007/978-1-61779-921-1_21; Barone R, 2012, ANN NEUROL, V72, P550, DOI 10.1002/ana.23632; Belaya K, 2012, AM J HUM GENET, V91, P193, DOI 10.1016/j.ajhg.2012.05.022; Bondt A, 2013, J PROTEOME RES, V12, P4522, DOI 10.1021/pr400589m; Cao W, 1998, SCIENCE, V282, P2079, DOI 10.1126/science.282.5396.2079; Chandler K, 2013, MOL CELL PROTEOMICS, V12, P836, DOI 10.1074/mcp.R112.026930; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Cole LA, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-24; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Cossins J, 2013, BRAIN, V136, P944, DOI 10.1093/brain/awt010; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Demaegd D, 2013, P NATL ACAD SCI USA, V110, P6859, DOI 10.1073/pnas.1219871110; Douillard C, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-26; Engel AG, 1999, ARCH NEUROL-CHICAGO, V56, P163, DOI 10.1001/archneur.56.2.163; Engel AG, 2012, ANN NY ACAD SCI, V1275, P54, DOI 10.1111/j.1749-6632.2012.06803.x; Ferguson MAJ, 2009, ESSENTIALS GLYCOBIOL, V2nd, P143; Fischer B, 2012, HUM GENET, V131, P1761, DOI 10.1007/s00439-012-1197-8; Freeze H. H., 2009, ESSENTIALS GLYCOBIOL, P163; Freeze HH, 2009, ESSENTIALS GLYCOBIOL, P47; Freeze HH, 2013, J BIOL CHEM, V288, P6936, DOI 10.1074/jbc.R112.429274; Freeze HH, 2012, LANCET NEUROL, V11, P453, DOI 10.1016/S1474-4422(12)70040-6; Freeze HH, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005371; Freeze HH, 2010, SEMIN CELL DEV BIOL, V21, P655, DOI 10.1016/j.semcdb.2010.03.011; Fujita M, 2012, BBA-MOL CELL BIOL L, V1821, P1050, DOI 10.1016/j.bbalip.2012.01.004; Gao XD, 2005, J BIOL CHEM, V280, P36254, DOI 10.1074/jbc.M507569200; Gao XD, 2004, GLYCOBIOLOGY, V14, P559, DOI 10.1093/glycob/cwh072; Godfrey C, 2011, CURR OPIN GENET DEV, V21, P278, DOI 10.1016/j.gde.2011.02.001; Haeuptle MA, 2009, HUM MUTAT, V30, P1628, DOI 10.1002/humu.21126; Hansen L, 2013, AM J HUM GENET, V92, P575, DOI 10.1016/j.ajhg.2013.03.008; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hayee B, 2011, GLYCOBIOLOGY, V21, P914, DOI 10.1093/glycob/cwr023; Heinonen TYK, 2009, ANN MED, V41, P2, DOI 10.1080/07853890802301975; Hennet T, 2012, BBA-GEN SUBJECTS, V1820, P1306, DOI 10.1016/j.bbagen.2012.02.001; Houlden H, 2013, BRAIN, V136, P692, DOI 10.1093/brain/awt042; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Jae LT, 2013, SCIENCE, V340, P479, DOI 10.1126/science.1233675; Jimenez-Mallebrera C, 2009, BRAIN PATHOL, V19, P596, DOI 10.1111/j.1750-3639.2008.00198.x; Johnston JJ, 2012, AM J HUM GENET, V90, P295, DOI 10.1016/j.ajhg.2011.11.031; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; Kinoshita T, 2013, BBA-MOL CELL RES, V1833, P2473, DOI 10.1016/j.bbamcr.2013.01.027; Kornak U, 2008, NAT GENET, V40, P32, DOI 10.1038/ng.2007.45; Kranz C, 2007, AM J HUM GENET, V80, P433, DOI 10.1086/512130; Krawitz PM, 2013, AM J HUM GENET, V92, P584, DOI 10.1016/j.ajhg.2013.03.011; Krawitz PM, 2012, AM J HUM GENET, V91, P146, DOI 10.1016/j.ajhg.2012.05.004; Krawitz PM, 2010, NAT GENET, V42, P827, DOI 10.1038/ng.653; Kunz S, 2005, J VIROL, V79, P14282, DOI 10.1128/JVI.79.22.14282-14296.2005; Kvarnung M, 2013, J MED GENET, V50, P521, DOI 10.1136/jmedgenet-2013-101654; Lee CL, 2011, J REPROD IMMUNOL, V90, P29, DOI 10.1016/j.jri.2011.04.007; Lefeber DJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002427; Lefeber DJ, 2009, AM J HUM GENET, V85, P76, DOI 10.1016/j.ajhg.2009.06.006; Li M, 2013, AM J HUM GENET, V92, P895, DOI 10.1016/j.ajhg.2013.04.022; Lu JS, 2012, GLYCOBIOLOGY, V22, P504, DOI 10.1093/glycob/cwr162; Maeda Y, 2000, EMBO J, V19, P2475, DOI 10.1093/emboj/19.11.2475; Maeda Y, 2001, EMBO J, V20, P250, DOI 10.1093/emboj/20.1.250; Maeda Y, 2011, PROG LIPID RES, V50, P411, DOI 10.1016/j.plipres.2011.05.002; Manzini MC, 2012, AM J HUM GENET, V91, P541, DOI 10.1016/j.ajhg.2012.07.009; Martin PT, 2007, CURR MOL MED, V7, P417, DOI 10.2174/156652407780831601; Matsuura A, 2008, J BIOL CHEM, V283, P35486, DOI 10.1074/jbc.M806202200; Maydan G, 2011, J MED GENET, V48, P383, DOI 10.1136/jmg.2010.087114; Mefford HC, 2012, NEW ENGL J MED, V367, P1951, DOI 10.1056/NEJMe1211659; Mercuri E, 2012, ANN NEUROL, V72, P9, DOI 10.1002/ana.23548; Muntoni F, 2008, NEUROTHERAPEUTICS, V5, P627, DOI 10.1016/j.nurt.2008.08.005; Muppidi S., 2012, SWAIMANS PEDIAT NEUR, P1549; Murakami Y, 2012, J BIOL CHEM, V287, P6318, DOI 10.1074/jbc.M111.331090; Ng BG, 2013, AM J HUM GENET, V92, P632, DOI 10.1016/j.ajhg.2013.03.012; O'Brien John F, 2005, Semin Pediatr Neurol, V12, P159, DOI 10.1016/j.spen.2005.11.002; Rampal R, 2007, CURR MOL MED, V7, P427, DOI 10.2174/156652407780831593; Rillahan CD, 2011, ANNU REV BIOCHEM, V80, P797, DOI 10.1146/annurev-biochem-061809-152236; Rivinoja A, 2012, ANN MED, V44, P542, DOI 10.3109/07853890.2011.579150; Roscioli T, 2012, NAT GENET, V44, P581, DOI 10.1038/ng.2253; Sakaidani Y, 2012, BIOCHEM BIOPH RES CO, V419, P14, DOI 10.1016/j.bbrc.2012.01.098; Saunders CJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004041; Schollen E, 2000, EUR J HUM GENET, V8, P367, DOI 10.1038/sj.ejhg.5200470; Schuster-Gossler K, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-6; Senderek J, 2011, AM J HUM GENET, V88, P162, DOI 10.1016/j.ajhg.2011.01.008; Shaheen R, 2013, AM J HUM GENET, V92, P598, DOI 10.1016/j.ajhg.2013.02.012; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Stalnaker SH, 2011, CURR OPIN STRUC BIOL, V21, P603, DOI 10.1016/j.sbi.2011.09.001; Stanley P., 2009, ESSENTIALS GLYCOBIOL; Stanley P, 2009, ESSENTIALS GLYCOBIOL, P175; Stanley P, 2010, CURR TOP DEV BIOL, V92, P131, DOI 10.1016/S0070-2153(10)92004-8; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Sturiale L, 2011, J INHERIT METAB DIS, V34, P891, DOI 10.1007/s10545-011-9306-8; Tegtmeyer LC, 2014, NEW ENGL J MED, V370, P533, DOI 10.1056/NEJMoa1206605; Timal S, 2012, HUM MOL GENET, V21, P4151, DOI 10.1093/hmg/dds123; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Varki A., 2009, ESSENTIALS GLYCOBIOL, P1; Vuillaumier-Barrot S, 2012, AM J HUM GENET, V91, P1135, DOI 10.1016/j.ajhg.2012.10.009; WARE RE, 1994, BLOOD, V83, P2418; Willer T, 2012, NAT GENET, V44, P575, DOI 10.1038/ng.2252; Wu XH, 2003, HUM MUTAT, V22, P144, DOI 10.1002/humu.10239; Yan QJ, 2010, AM J PATHOL, V176, P2921, DOI 10.2353/ajpath.2010.090702; Yang AC, 2013, MOL GENET METAB, V110, P345, DOI 10.1016/j.ymgme.2013.06.016; Yang HS, 2013, BIOMARK MED, V7, P99, DOI [10.2217/BMM.12.80, 10.2217/bmm.12.80]; Yao D, 2011, BLOOD, V117, P5652, DOI 10.1182/blood-2010-12-326074; Yoshida-Moriguchi T, 2013, SCIENCE, V341, P896, DOI 10.1126/science.1239951; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512; Zoltowska K, 2013, HUM MOL GENET, V22, P2905, DOI 10.1093/hmg/ddt145	103	171	174	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 6	2014	94	2					161	175		10.1016/j.ajhg.2013.10.024	http://dx.doi.org/10.1016/j.ajhg.2013.10.024			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AA9NF	24507773	Green Published, Bronze			2022-12-18	WOS:000331419500001
J	Giannandrea, M; Bianchi, V; Mignogna, ML; Sirri, A; Carrabino, S; D'Elia, E; Vecellio, M; Russo, S; Cogliati, F; Larizza, L; Ropers, HH; Tzschach, A; Kalscheuer, V; Oehl-Jaschkowitz, B; Skinner, C; Schwartz, CE; Gecz, J; Van Esch, H; Raynaud, M; Chelly, J; de Brouwer, APM; Toniolo, D; D'Adamo, P				Giannandrea, Maila; Bianchi, Veronica; Mignogna, Maria Lidia; Sirri, Alessandra; Carrabino, Salvatore.; D'Elia, Errico; Vecellio, Matteo; Russo, Silvia; Cogliati, Francesca; Larizza, Lidia; Ropers, Hans-Hilger; Tzschach, Andreas; Kalscheuer, Vera; Oehl-Jaschkowitz, Barbara; Skinner, Cindy; Schwartz, Charles E.; Gecz, Jozef; Van Esch, Hilde; Raynaud, Martine; Chelly, Jamel; de Brouwer, Arjan P. M.; Toniolo, Daniela; D'Adamo, Patrizia			Mutations in the Small GTPase Gene RAB39B Are Responsible for X-linked Mental Retardation Associated with Autism, Epilepsy, and Macrocephaly	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANS-GOLGI; PROTEINS; FAMILY; NEUROPATHY; ENDOSOMES; MECHANISM; SUBUNIT; NEURONS; CELLS; MICE	Human Mental Retardation (MR) is a common and highly heterogeneous pediatric disorder affecting around 3% of the general population; at least 21 S X-linked MR (XI,MR) conditions have been described, and mutations have been identified in 83 different genes, encoding proteins with a variety of function, Such as chromatin remodeling, synaptic function, and intracellular trafficking. The small GTPases of the RAB family, which play an essential role in intracellular vesicular trafficking, have been shown to be involved in MR. We report here the identification of mutations in the small GTPase RAB39B gene in two male patients. One mutation in family X (D-23) introduced a stop codon seven amino acids after the start codon (c.21C > A; p.Y7X). A second mutation, in the MRX72 family, altered the 5' splice site (c.215+1 G > A) and normal splicing. Neither instance produced a protein. Mutations segregate with the disease in the families, and in some family members intellectual disabilities were associated with autism spectrum disorder, epileptic seizures, and macrocephaly. We show that RAB39B, a novel RAB GTPase of unknown function, is a neuronal-specific protein that is localized to the Golgi compartment. Its downregulation leads to an alteration in the number and morphology of neurite growth cones and a significant reduction in presynaptic buttons, suggesting that RAB39B is required for synapse formation and maintenance. Our results demonstrate developmental and functional neuronal alteration as a consequence of downregulation of RAB39B and emphasize the critical role of vesicular trafficking in the development of neurons and human intellectual abilities.	[Giannandrea, Maila; Bianchi, Veronica; Mignogna, Maria Lidia; D'Elia, Errico; Vecellio, Matteo; D'Adamo, Patrizia] Ist Sci San Raffaele, Div Neurosci, Dulbecco Telethon Inst, I-20132 Milan, Italy; [Sirri, Alessandra; Carrabino, Salvatore.; Toniolo, Daniela] Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy; [Russo, Silvia; Cogliati, Francesca; Larizza, Lidia] Ist Auxol Italiano, Genet Mol Lab, I-20145 Milan, Italy; [Larizza, Lidia] Univ Milano Polo Osp San Paolo, I-20142 Milan, Italy; [Ropers, Hans-Hilger; Tzschach, Andreas; Kalscheuer, Vera] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Skinner, Cindy; Schwartz, Charles E.] Greenwood Genet Ctr, JC Self Res Inst Human Genet, Greenwood, SC 29646 USA; [Gecz, Jozef] Womens & Childrens Hosp, Adelaide, SA 5006, Australia; [Gecz, Jozef] Univ Adelaide, Dept Paediat, Adelaide, SA 5006, Australia; [Van Esch, Hilde] Katholieke Univ Leuven Hosp, Ctr Human Genet, B-3000 Louvain, Belgium; [Raynaud, Martine] Ctr Hosp Reg Univ Tours, Serv Genet, F-37044 Tours, France; [Raynaud, Martine] INSERM, U930, F-37044 Tours, France; [Chelly, Jamel] Univ Paris 05, Inst Cochin, INSERM, U567, F-75014 Paris, France; [Chelly, Jamel] CNRS, UMR 8104, F-75014 Paris, France; [de Brouwer, Arjan P. M.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Human Genet, NL-6500 Nijmegen, Netherlands; [de Brouwer, Arjan P. M.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6500 Nijmegen, Netherlands; [Toniolo, Daniela] CNR, Inst Mol Genet, I-20182 Pavia, Italy	Fondazione Telethon; Dulbecco Telethon Institute (DTI); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Istituto Auxologico Italiano; Max Planck Society; Greenwood Genetic Center; Womens & Childrens Hospital Australia; University of Adelaide; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Radboud University Nijmegen; Radboud University Nijmegen; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR)	D'Adamo, P (corresponding author), Ist Sci San Raffaele, Div Neurosci, Dulbecco Telethon Inst, I-20132 Milan, Italy.	p.dadamo@hsr.it	Gecz, Jozef/X-3469-2019; Toniolo, Daniela/AAE-2969-2019; Vecellio, Matteo Luca/HGB-6768-2022; de Brouwer, Arjan PM/P-5949-2015; D'Adamo, Patrizia/AAN-3919-2020; Chelly, Jamel/J-7528-2015; Vecellio, Matteo Luca/AAA-9143-2022; Van+Esch, Hilde/AAU-5688-2020; Cogliati, Francesca/AAA-4104-2020; Raynaud, Martine/R-9811-2019; Tzschach, Andreas/I-2648-2019	Gecz, Jozef/0000-0002-7884-6861; Toniolo, Daniela/0000-0001-9545-6032; Vecellio, Matteo Luca/0000-0002-8643-1316; D'Adamo, Patrizia/0000-0002-0312-5541; Chelly, Jamel/0000-0002-0939-8719; Vecellio, Matteo Luca/0000-0002-8643-1316; Cogliati, Francesca/0000-0001-6073-5445; Raynaud, Martine/0000-0002-6888-6480; Tzschach, Andreas/0000-0002-6840-965X; mignogna, maria lidia/0000-0001-9144-6363; Russo, Silvia/0000-0002-5893-0193; s, hema/0000-0002-3440-9475; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Van Esch, Hilde/0000-0002-9604-5726; Kalscheuer, Vera/0000-0001-6898-3259	Telethon, Italy [TCP04015]; Italian Ministry of Research and Health; Vita Salute San Raffaele University, Milan, Italy; National Institute of Child Health and Human Development [HD26202]; South Carolina Department of Disabilities and Special Needs; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD026202] Funding Source: NIH RePORTER	Telethon, Italy(Fondazione Telethon); Italian Ministry of Research and Health; Vita Salute San Raffaele University, Milan, Italy; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); South Carolina Department of Disabilities and Special Needs; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank the Subjects who participated in this study and their parents. We also thank L. Wrabetz and B. Oostra for their helpful discussion, comments, and critical reading of the manuscript,R. Cassinari for graphic support; ALEMBIC for the microscopy technical support; L. Naldini, L. Sergi Sergi for the help in lentiviral production; and A. De Matteis for providing us with a surplus Of antibodies. This work was supported by funding from Telethon, Italy (TCP04015 to P.D.). M.G. is supported by a fellowship from the Italian Ministry of Research and Health (PRIN 2007). V.B. is supported by a Ph.D. fellowship from Vita Salute San Raffaele University, Milan, Italy. This Study was also supported, in part, by grants from the National Institute of Child Health and Human Development (HD26202 to C.E.S.) and the South Carolina Department of Disabilities and Special Needs.	Aligianis IA, 2006, AM J HUM GENET, V78, P702, DOI 10.1086/502681; Aligianis IA, 2005, NAT GENET, V37, P221, DOI 10.1038/ng1517; Amessou M, 2007, J CELL SCI, V120, P1457, DOI 10.1242/jcs.03436; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; Bianchi V, 2009, HUM MOL GENET, V18, P105, DOI 10.1093/hmg/ddn321; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Corbeel L, 2008, EUR J PEDIATR, V167, P723, DOI 10.1007/s00431-008-0740-z; D'Adamo P, 2002, HUM MOL GENET, V11, P2567, DOI 10.1093/hmg/11.21.2567; D'Adamo P, 1998, NAT GENET, V19, P134, DOI 10.1038/487; De Palma M, 2002, METHOD ENZYMOL, V346, P514; Erez H, 2007, J CELL BIOL, V176, P497, DOI 10.1083/jcb.200607098; HERBST DS, 1980, AM J MED GENET, V7, P443, DOI 10.1002/ajmg.1320070406; Houlden H, 2004, ANN NEUROL, V56, P586, DOI 10.1002/ana.20281; Itoh T, 2008, MOL BIOL CELL, V19, P2916, DOI 10.1091/mbc.E07-12-1231; Jenkins D, 2007, AM J HUM GENET, V80, P1162, DOI 10.1086/518047; Khvotchev MV, 2003, J NEUROSCI, V23, P10531; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Pereira-Leal JB, 2000, J MOL BIOL, V301, P1077, DOI 10.1006/jmbi.2000.4010; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Rao DD, 2009, ADV DRUG DELIVER REV, V61, P746, DOI 10.1016/j.addr.2009.04.004; Russo S, 2000, AM J MED GENET, V94, P376, DOI 10.1002/1096-8628(20001023)94:5<376::AID-AJMG6>3.0.CO;2-A; SHOLL DA, 1950, PROC R SOC SER B-BIO, V137, P470, DOI 10.1098/rspb.1950.0056; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Tran THT, 2007, J CELL SCI, V120, P1028, DOI 10.1242/jcs.03387; Verhoeven K, 2003, AM J HUM GENET, V72, P722, DOI 10.1086/367847	26	171	184	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 12	2010	86	2					185	195		10.1016/j.ajhg.2010.01.011	http://dx.doi.org/10.1016/j.ajhg.2010.01.011			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	556ZS	20159109	Green Published, Bronze			2022-12-18	WOS:000274637200008
J	Nicolae, D; Cox, NJ; Lester, LA; Schneider, D; Tan, Z; Billstrand, C; Kuldanek, S; Donfack, J; Kogut, P; Patel, NM; Goodenbour, J; Howard, T; Wolf, R; Koppelman, GH; White, SR; Parry, R; Postma, DS; Meyers, D; Bleecker, ER; Hunt, JS; Solway, J; Ober, C				Nicolae, D; Cox, NJ; Lester, LA; Schneider, D; Tan, Z; Billstrand, C; Kuldanek, S; Donfack, J; Kogut, P; Patel, NM; Goodenbour, J; Howard, T; Wolf, R; Koppelman, GH; White, SR; Parry, R; Postma, DS; Meyers, D; Bleecker, ER; Hunt, JS; Solway, J; Ober, C			Fine mapping and positional candidate studies identify HLA-G as an asthma susceptibility gene on chromosome 6p21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; MATERNAL-FETAL INTERFACE; GENOME-WIDE SEARCH; LINKAGE DISEQUILIBRIUM; FOUNDER POPULATION; EXPRESSION; REGION; CELLS; TRANSPLANTATION; IDENTIFICATION	Asthma affects nearly 14 million people worldwide and has been steadily increasing in frequency for the past 50 years. Although environmental factors clearly influence the onset, progression, and severity of this disease, family and twin studies indicate that genetic variation also influences susceptibility. Linkage of asthma and related phenotypes to chromosome 6p21 has been reported in seven genome screens, making it the most replicated region of the genome. However, because many genes with individually small effects are likely to contribute to risk, identification of asthma susceptibility loci has been challenging. In this study, we present evidence from four independent samples in support of HLA-G as a novel asthma and bronchial hyperresponsiveness susceptibility gene in the human leukocyte antigen region on chromosome 6p21, and we speculate that this gene might contribute to risk for other inflammatory diseases that show linkage to this region.	Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Chicago, Dept Stat, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; Univ Chicago, Dept Obstet & Gynecol, Chicago, IL 60637 USA; Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA; Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Genet, Winston Salem, NC USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Pediat, Winston Salem, NC 27103 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Med, Winston Salem, NC 27103 USA; Univ S Dakota, Dept Med, Sioux Falls, SD USA; Univ Groningen Hosp, Beatrix Childrens Hosp, Groningen, Netherlands; Univ Groningen Hosp, Dept Pulmonol, Groningen, Netherlands	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Kansas; University of Kansas Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; University of South Dakota; University of Groningen; University of Groningen	Ober, C (corresponding author), Univ Chicago, Dept Human Genet, CLSC 507C,920 E 58th St, Chicago, IL 60637 USA.	c-ober@genetics.uchicago.edu	Solway, Julian/B-1116-2008; Koppelman, Gerard/AAG-9187-2020	Solway, Julian/0000-0002-0898-8530; Koppelman, Gerard/0000-0001-8567-3252; Nicolae, Dan/0000-0002-0918-4630; Ober, Carole/0000-0003-4626-9809	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000055] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056399, R01HL066393, R01HL066533, R01HL072414] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR000055] Funding Source: Medline; NHLBI NIH HHS [HL66533, R01 HL066533, HL56399, P50 HL056399, R01 HL066393, R01 HL072414, HL72414, HL66393] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams KM, 2004, JAMA-J AM MED ASSOC, V291, P1127, DOI 10.1001/jama.291.9.1127; BEGOVICH AB, 1992, J IMMUNOL, V148, P249; Bourgain C, 2003, AM J HUM GENET, V73, P612, DOI 10.1086/378208; FUJII T, 1994, J IMMUNOL, V153, P5516; Hunt JS, 2000, HUM IMMUNOL, V61, P1113, DOI 10.1016/S0198-8859(00)00195-6; Jones CA, 2000, ALLERGY, V55, P2, DOI 10.1034/j.1398-9995.2000.00109.x; Kapasi K, 2000, IMMUNOLOGY, V101, P191, DOI 10.1046/j.1365-2567.2000.00109.x; Kenealy SJ, 2003, J NEUROIMMUNOL, V143, P7, DOI [10.1016/j.jneuroim.2003.08.005, 10.1016/j.jneuroim.2003.08.009]; Khosrotehrani K, 2001, J INVEST DERMATOL, V117, P750, DOI 10.1046/j.0022-202x.2001.01487.x; Koppelman GH, 2002, J ALLERGY CLIN IMMUN, V109, P498, DOI 10.1067/mai.2002.122235; Le Bouteiller P, 2003, PLACENTA, V24, pS10, DOI 10.1053/plac.2002.0931; Lester LA, 2001, J ALLERGY CLIN IMMUN, V108, P357, DOI 10.1067/mai.2001.117796; LIN H, 1993, J IMMUNOL, V151, P4562; Marsh DG, 1997, NAT GENET, V15, P389; Martinez FD, 1997, CIBA F SYMP, V206, P233; Mathew CG, 2004, HUM MOL GENET, V13, pR161, DOI 10.1093/hmg/ddh079; Morales PJ, 2003, J IMMUNOL, V171, P6215, DOI 10.4049/jimmunol.171.11.6215; Moreau P, 2003, P NATL ACAD SCI USA, V100, P1191, DOI 10.1073/pnas.0337539100; Mungall AJ, 2003, NATURE, V425, P805, DOI 10.1038/nature02055; Nicolae DL, 2004, BIOMETRICS, V60, P368, DOI 10.1111/j.0006-341X.2004.00181.x; Ober C, 2000, AM J HUM GENET, V67, P1154, DOI 10.1016/S0002-9297(07)62946-2; Ober C, 2003, AM J HUM GENET, V72, P1425, DOI 10.1086/375501; Ober C, 1996, J REPROD IMMUNOL, V32, P111, DOI 10.1016/S0165-0378(96)01000-5; Ober C, 1997, J REPROD IMMUNOL, V36, P1, DOI 10.1016/S0165-0378(97)00062-4; Onno M, 1997, TISSUE ANTIGENS, V49, P356, DOI 10.1111/j.1399-0039.1997.tb02763.x; Osmond C, 2000, ENVIRON HEALTH PERSP, V108, P545, DOI 10.1289/ehp.00108s3545; Pangault C, 2002, HUM IMMUNOL, V63, P83, DOI 10.1016/S0198-8859(01)00373-1; PANHUYSEN CIM, 1995, CLIN EXP ALLERGY, V25, P35, DOI 10.1111/j.1365-2222.1995.tb00418.x; Rouas-Freiss N, 2003, AM J TRANSPLANT, V3, P11, DOI 10.1034/j.1600-6143.2003.30103.x; Soderhall C, 2001, HUM GENET, V109, P129, DOI 10.1007/s004390100556; Stewart CA, 2004, GENOME RES, V14, P1176, DOI 10.1101/gr.2188104; Sun L, 2002, AM J HUM GENET, V70, P399, DOI 10.1086/338660; Torres MI, 2004, INT IMMUNOL, V16, P579, DOI 10.1093/intimm/dxh061; Wiendl H, 2003, HUM IMMUNOL, V64, P1050, DOI 10.1016/j.humimm.2003.07.001; Wright P, 2001, SCHIZOPHR RES, V47, P1, DOI 10.1016/S0920-9964(00)00022-0; Xu JF, 2001, AM J HUM GENET, V68, P1437, DOI 10.1086/320589; Yang YP, 1996, J IMMUNOL, V156, P4224; Zhang WH, 2002, P NATL ACAD SCI USA, V99, P17004, DOI 10.1073/pnas.012672899; Zhang XJ, 2002, J INVEST DERMATOL, V119, P1361, DOI 10.1046/j.1523-1747.2002.19612.x	39	171	190	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2005	76	2					349	357		10.1086/427763	http://dx.doi.org/10.1086/427763			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	886GO	15611928	Green Published, Bronze			2022-12-18	WOS:000226215100020
J	Hammond, CJ; Andrew, T; Mak, YT; Spector, TD				Hammond, CJ; Andrew, T; Mak, YT; Spector, TD			A susceptibility locus for myopia in the normal population is linked to the PAX6 gene region on chromosome 11: A genomewide scan of dizygotic twins	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							REFRACTIVE ERROR; QUANTITATIVE TRAITS; LINKAGE ANALYSIS; EYE; DISEQUILIBRIUM; GROWTH; MAPS; ENVIRONMENT; BLINDNESS	Myopia is a common, complex trait with considerable economic and social impact and, in highly affected individuals, ocular morbidity. We performed a classic twin study of 506 unselected twin pairs and inferred the heritability of refractive error to be 0.89 (95% confidence interval 0.86 - 0.91). A genomewide scan of 221 dizygotic twin pairs, analyzed by use of optimal Haseman-Elston regression methods implemented by use of generalized linear modeling, showed significant linkage (LOD >3.2) to refractive error at four loci, with a maximum LOD score of 6.1 at 40 cM on chromome 11p13. Evidence of linkage at this locus, as well as at the other linkage peaks at chromosomes 3q26 (LOD 3.7), 8p23 (LOD 4.1), and 4q12 (LOD 3.3), remained the same or became stronger after model fit was checked and outliers were downweighted. Examination of potential candidate genes showed the PAX6 gene directly below the highest peak at the 11p13 locus. PAX6 is fundamental to identity and growth of the eye, but reported mutations usually result in catastrophic congenital phenotypes such as aniridia. Haplotype tagging of 17 single-nucleotide polymorphisms (SNPs), which covered the PAX6 gene and had common minor allele frequencies, identified 5 SNPs that explained 0.999 of the haplotype diversity. Linkage and association analysis of the tagging SNPs showed strong evidence of linkage for all markers with a minimum chi(1)(2) of 7.5 (P = .006) but no association. This suggests that PAX6 may play a role in myopia development, possibly because of genetic variation in an upstream promoter or regulator, although no definite association between PAX6 common variants and myopia was demonstrated in this study.	St Thomas Hosp, Twin Res & Genet Epidemiol Unit, London SE1 7EH, England; Princess Royal Univ Hosp, W Kent Eye Ctr, Orpington, England	Guy's & St Thomas' NHS Foundation Trust	Hammond, CJ (corresponding author), St Thomas Hosp, Twin Res & Genet Epidemiol Unit, London SE1 7EH, England.	chammond@btopenworld.com	Spector, Tim D/F-6533-2012; Andrew, Toby/O-8868-2017	Andrew, Toby/0000-0001-8838-4384				Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Abecasis GR, 2000, EUR J HUM GENET, V8, P545, DOI 10.1038/sj.ejhg.5200494; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; Ashery-Padan R, 2001, CURR OPIN CELL BIOL, V13, P706, DOI 10.1016/S0955-0674(00)00274-X; Barber MJ, 2004, GENET EPIDEMIOL, V26, P97, DOI 10.1002/gepi.10299; Dandona R, 2001, B WORLD HEALTH ORGAN, V79, P237; Dermitzakis ET, 2003, SCIENCE, V302, P1033, DOI 10.1126/science.1087047; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dominguez M, 2004, NAT GENET, V36, P31, DOI 10.1038/ng1281; Flitcroft DI, 1998, BRIT J OPHTHALMOL, V82, P210, DOI 10.1136/bjo.82.3.210; GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232; Hammond CJ, 2001, INVEST OPHTH VIS SCI, V42, P1232; HEDRICK PW, 1987, GENETICS, V117, P331; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hung LF, 2000, INVEST OPHTH VIS SCI, V41, P1259; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; Lyhne N, 2001, BRIT J OPHTHALMOL, V85, P1470, DOI 10.1136/bjo.85.12.1470; MARTIN NG, 1975, ANN HUM GENET, V39, P213, DOI 10.1111/j.1469-1809.1975.tb00124.x; Marzani D, 1997, INVEST OPHTH VIS SCI, V38, P1726; Mertz JR, 2000, EXP EYE RES, V70, P519, DOI 10.1006/exer.1999.0813; Mutti DO, 1996, INVEST OPHTH VIS SCI, V37, P952; Mutti DO, 2002, INVEST OPHTH VIS SCI, V43, P3633; Mutti DO, 2002, AM J MED GENET, V112, P355, DOI 10.1002/ajmg.10683; Naiglin L, 2002, J MED GENET, V39, P118, DOI 10.1136/jmg.39.2.118; Neale M.C.C.L., 2013, METHODOLOGY GENETIC, V67, DOI DOI 10.1007/978-94-015-8018-2; NEALE MC, 1997, MX STAT MODELING; NORTON TT, 1994, JAMA-J AM MED ASSOC, V271, P1362; Paluru P, 2003, INVEST OPHTH VIS SCI, V44, P1830, DOI 10.1167/iovs.02-0697; PRITCHARD LE, 1995, HUM MOL GENET, V4, P197, DOI 10.1093/hmg/4.2.197; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; Rosenberg T, 1996, ACTA OPHTHALMOL SCAN, V74, P395; Saw SM, 1996, EPIDEMIOL REV, V18, P175, DOI 10.1093/oxfordjournals.epirev.a017924; Schedl A, 1996, CELL, V86, P71, DOI 10.1016/S0092-8674(00)80078-1; Simpson TI, 2002, BIOESSAYS, V24, P1041, DOI 10.1002/bies.10174; Snieder H, 1997, PSYCHOPHYSIOLOGY, V34, P317, DOI 10.1111/j.1469-8986.1997.tb02402.x; Spector TD, 2002, TWIN RES, V5, P440, DOI 10.1375/twin.5.5.440; Sperduto RD, 1996, ARCH OPHTHALMOL-CHIC, V114, P326; *STAT, 2003, INT STAT UN SEL ED; Tay M T, 1992, Ann Acad Med Singap, V21, P785; van Heyningen V, 2002, HUM MOL GENET, V11, P1161, DOI 10.1093/hmg/11.10.1161; WANG Q, 1994, INVEST OPHTH VIS SCI, V35, P4344; Weale ME, 2003, AM J HUM GENET, V73, P551, DOI 10.1086/378098; Wilson SG, 2003, AM J HUM GENET, V72, P144, DOI 10.1086/345819; Young TL, 1998, AM J HUM GENET, V63, P109, DOI 10.1086/301907; Young TL, 1998, AM J HUM GENET, V63, P1419, DOI 10.1086/302111; ZADNIK K, 1994, JAMA-J AM MED ASSOC, V271, P1323, DOI 10.1001/jama.271.17.1323	49	171	178	0	15	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2004	75	2					294	304		10.1086/423148	http://dx.doi.org/10.1086/423148			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	838GR	15307048	Green Published, Bronze			2022-12-18	WOS:000222702000013
J	Ober, C; Aldrich, CL; Chervoneva, I; Billstrand, C; Rahimov, F; Gray, HL; Hyslop, T				Ober, C; Aldrich, CL; Chervoneva, I; Billstrand, C; Rahimov, F; Gray, HL; Hyslop, T			Variation in the HLA-G promoter region influences miscarriage rates	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CLASS-I MOLECULE; LINKAGE DISEQUILIBRIUM; RECURRENT MISCARRIAGE; DELETION POLYMORPHISM; PROTEIN EXPRESSION; HUMAN TROPHOBLASTS; NEUTRAL EVOLUTION; T-LYMPHOCYTES; CELL-SURFACE; FETAL LOSS	The HLA-G gene is primarily expressed in placental cells that invade the maternal decidua during pregnancy. This gene encodes multiple isoforms that fulfill a variety of functions at the maternal-fetal interface throughout gestation. Recently, a null allele for the most abundant HLA-G isoform was associated with recurrent miscarriage in two independent studies, suggesting that reduced levels of the HLA-G1 protein may compromise successful pregnancy. We initiated the present study to determine whether other polymorphisms that could affect expression levels of HLA-G were associated with fetal loss in women participating in a 15-year prospective study of pregnancy outcome. We genotyped these subjects for 18 single-nucleotide polymorphisms in the 1,300 bp upstream of exon 1, 13 of which were identified as part of this study, as well as for an insertion/deletion (in/del) polymorphism in the 3' untranslated region. The 18 SNPs defined eight unique haplotypes. One polymorphism, -725C/G, was associated with fetal loss, with an increased risk for miscarriage in couples in which both partners carried the -725G allele, compared with couples not carrying this allele (odds ratio 2.76, 95% confidence interval 1.08-7.09; P = .035). Further, the G at nucleotide -725 creates a CpG dinucleotide, and we demonstrate that this CpG site is methylated on -725G alleles. Overall, this study identified extraordinary levels of variation in the 5'-upstream regulatory region of HLA-G and provides evidence for an association between a promoter-region SNP and fetal loss rates, further attesting to the novel features and critical role of this gene in pregnancy.	Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Chicago, Dept Obstet & Gynecol, Chicago, IL 60637 USA; Thomas Jefferson Univ, Biostat Sect, Div Clin Pharmacol, Philadelphia, PA 19107 USA	University of Chicago; University of Chicago; Jefferson University	Ober, C (corresponding author), Univ Chicago, Dept Human Genet, 920 E 58th St,CLSC 507C, Chicago, IL 60637 USA.		Rahimov, Fedik/H-2685-2013	Rahimov, Fedik/0000-0001-6519-7404	NICHD NIH HHS [R01 HD021244, HD21244] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021244] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aldrich C, 2002, HUM IMMUNOL, V63, P405, DOI 10.1016/S0198-8859(02)00377-4; Aldrich C, 2000, J REPROD IMMUNOL, V47, P41, DOI 10.1016/S0165-0378(00)00052-8; Aldrich CL, 2001, MOL HUM REPROD, V7, P1167, DOI 10.1093/molehr/7.12.1167; Bainbridge DRJ, 2000, J REPROD IMMUNOL, V47, P1, DOI 10.1016/S0165-0378(00)00056-5; Bainbridge DRJ, 2000, J REPROD IMMUNOL, V48, P17, DOI 10.1016/S0165-0378(00)00070-X; BOHJANEN PR, 1991, MOL CELL BIOL, V11, P3288, DOI 10.1128/MCB.11.6.3288; Castro MJ, 2000, TISSUE ANTIGENS, V56, P232, DOI 10.1034/j.1399-0039.2000.560305.x; CHRISTIANSEN OB, 1989, TISSUE ANTIGENS, V34, P190, DOI 10.1111/j.1399-0039.1989.tb01736.x; Colonna M, 1998, J IMMUNOL, V160, P3096; Diggle P., 2002, ANAL LONGITUDINAL DA; DIOGO M, 2001, ANN HUM GENET, V65, P1; ELLIS SA, 1990, J IMMUNOL, V144, P731; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; FUJII T, 1994, J IMMUNOL, V153, P5516; Gu ZL, 2002, MOL BIOL EVOL, V19, P256, DOI 10.1093/oxfordjournals.molbev.a004079; HAUCK WW, 1991, GENET EPIDEMIOL, V8, P187, DOI 10.1002/gepi.1370080305; Hiby SE, 1999, TISSUE ANTIGENS, V53, P1, DOI 10.1034/j.1399-0039.1999.530101.x; Hostetler J, 1974, HUTTERITE SOC; HUMPHREY KE, 1995, BRIT J OBSTET GYNAEC, V102, P707, DOI 10.1111/j.1471-0528.1995.tb11427.x; HUNT JS, 1992, FASEB J, V6, P2344, DOI 10.1096/fasebj.6.6.1544544; Hunt JS, 2000, AM J OBSTET GYNECOL, V183, P682, DOI 10.1067/mob.2000.106762; Hviid TVF, 1999, HUM IMMUNOL, V60, P1237, DOI 10.1016/S0198-8859(99)00130-5; Hviid TVF, 2001, IMMUNOGENETICS, V53, P48, DOI 10.1007/s002510100296; ISHITANI A, 1992, P NATL ACAD SCI USA, V89, P3947, DOI 10.1073/pnas.89.9.3947; Kapasi K, 2000, IMMUNOLOGY, V101, P191, DOI 10.1046/j.1365-2567.2000.00109.x; King A, 1996, NAT IMMUN, V15, P41; KOSTYU DD, 1989, AM J HUM GENET, V45, P261; KOVATS S, 1990, SCIENCE, V248, P220, DOI 10.1126/science.2326636; Le Bouteiller P, 1999, HUM REPROD UPDATE, V5, P223, DOI 10.1093/humupd/5.3.223; Le Bouteiller P, 1999, IMMUNOL REV, V167, P233; Le Gal FA, 1999, INT IMMUNOL, V11, P1351, DOI 10.1093/intimm/11.8.1351; Lee N, 1998, J IMMUNOL, V160, P4951; LEE N, 1995, IMMUNITY, V3, P591, DOI 10.1016/1074-7613(95)90130-2; Lefebvre S, 1999, J REPROD IMMUNOL, V43, P213, DOI 10.1016/S0165-0378(99)00035-2; Lopez-Botet M, 1999, SEMIN CANCER BIOL, V9, P19, DOI 10.1006/scbi.1998.0107; Mallet V, 2000, HUM IMMUNOL, V61, P212, DOI 10.1016/S0198-8859(99)00166-4; MARTIN AO, 1970, AM J PHYS ANTHROPOL, V32, P351, DOI 10.1002/ajpa.1330320305; MEDAWAR PB, 1953, SYM SOC EXP BIOL, V7, P320; Moreau P, 2003, P NATL ACAD SCI USA, V100, P1191, DOI 10.1073/pnas.0337539100; Moreau P, 1999, INT IMMUNOL, V11, P803, DOI 10.1093/intimm/11.5.803; Ober C, 1998, HUM REPROD, V13, P33, DOI 10.1093/humrep/13.1.33; Ober C, 1997, AM J HUM GENET, V61, P497, DOI 10.1086/515511; Ober C, 1999, AM J HUM GENET, V64, P225, DOI 10.1086/302198; Ober C, 1997, J REPROD IMMUNOL, V33, P89; Ober C, 1998, PLACENTA, V19, P127, DOI 10.1016/S0143-4004(98)90000-5; Ober C, 1996, J REPROD IMMUNOL, V32, P111, DOI 10.1016/S0165-0378(96)01000-5; Ober C, 1997, J REPROD IMMUNOL, V36, P1, DOI 10.1016/S0165-0378(97)00062-4; OBER C, 1992, AM J HUM GENET, V50, P6; OBER C, 1998, PRINCIPLES PRACTICE, P500; Olek A, 1996, NUCLEIC ACIDS RES, V24, P5064, DOI 10.1093/nar/24.24.5064; Pfeiffer KA, 2001, MOL HUM REPROD, V7, P373, DOI 10.1093/molehr/7.4.373; Rebmann V, 1999, TISSUE ANTIGENS, V53, P14, DOI 10.1034/j.1399-0039.1999.530102.x; SCHMIDT CM, 1995, IMMUNOL REV, V147, P53, DOI 10.1111/j.1600-065X.1995.tb00087.x; SCHMIDT CM, 1993, CRIT REV IMMUNOL, V13, P207; SHEPS MC, 1965, POP STUD-J DEMOG, V19, P65, DOI 10.2307/2173165; Solier C, 2001, IMMUNOGENETICS, V53, P617, DOI 10.1007/s00251-001-0373-0; STEINBERG ARTHUR G., 1967, P267; Stephenson MD, 2002, HUM REPROD, V17, P446, DOI 10.1093/humrep/17.2.446; Suarez MB, 1997, IMMUNOGENETICS, V45, P464, DOI 10.1007/s002510050235; Vockley J, 2000, AM J HUM GENET, V66, P356, DOI 10.1086/302751; WARBURTON D, 1964, AM J HUM GENET, V16, P1; Warnecke PM, 2002, METHODS, V27, P101, DOI 10.1016/S1046-2023(02)00060-9; Weitkamp LR, 1999, IMMUNOGENETICS, V49, P491, DOI 10.1007/s002510050525; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401; ZANGENBERG G, 1995, NAT GENET, V10, P407, DOI 10.1038/ng0895-407	65	171	183	0	8	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2003	72	6					1425	1435		10.1086/375501	http://dx.doi.org/10.1086/375501			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	685QV	12721954	Green Published, Bronze			2022-12-18	WOS:000183275500006
J	Gilbert, MTP; Hansen, AJ; Willerslev, E; Rudbeck, L; Barnes, I; Lynnerup, N; Cooper, A				Gilbert, MTP; Hansen, AJ; Willerslev, E; Rudbeck, L; Barnes, I; Lynnerup, N; Cooper, A			Characterization of genetic miscoding lesions caused by postmortem damage	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA-SEQUENCES; ANCIENT DNA; MOLECULAR ANALYSIS; NEANDERTHAL DNA; IN-VITRO; PRESERVATION; 5-FORMYLURACIL; RETRIEVAL; REPLICATION; TEMPLATES	The spectrum of postmortem damage in mitochondrial DNA was analyzed in a large data set of cloned sequences from ancient human specimens. The most common forms of damage observed are two complementary groups of transitions, termed "type 1" (adenine guanine/thymine-->cytosine) and "type 2" (cytosine-->thymine/guanine adenine). Single-primer extension PCR and enzymatic digestion with uracil-N-glycosylase confirm that each of these groups of transitions result from a single event, the deamination of adenine to hypoxanthine, and cytosine to uracil, respectively. The predominant form of transition-manifested damage varies by sample, though a marked bias toward type 2 is observed with increasing amounts of damage. The two transition types can be used to identify the original strand, light (L) or heavy (H), on which the initial damage event occurred, and this can increase the number of detected jumping-PCR artifacts by up to 80%. No bias toward H-strand-specific damage events is noted within the hypervariable 1 region of human mitochondria, suggesting the rapid postmortem degradation of the secondary displacement (D-loop) H strand. The data also indicate that, as damage increases within a sample, fewer H strands retain the ability to act as templates for enzymatic amplification. Last, a significant correlation between archaeological site and sample-specific level of DNA damage was detected.	Univ Oxford, Dept Zool, Henry Wellcome Ancient Biomol Ctr, Oxford OX1 3PS, England; Univ Copenhagen, Inst Forens Med, Lab Biol Anthropol, Copenhagen, Denmark; Univ Copenhagen, Res Lab, Copenhagen, Denmark; Univ Copenhagen, Inst Zool, Dept Evolutionary Biol, Copenhagen, Denmark	University of Oxford; University of Copenhagen; University of Copenhagen; University of Copenhagen	Cooper, A (corresponding author), Univ Oxford, Dept Zool, Henry Wellcome Ancient Biomol Ctr, S Parks Rd, Oxford OX1 3PS, England.	alan.cooper@zoo.ox.ac.uk	Hansen, Anders Johannes/A-5608-2013; Gilbert, Marcus TP/A-8936-2013; Cooper, Alan/E-8171-2012; Willerslev, Eske/AAA-5686-2019; Barnes, Ian C/B-8081-2008; Willerslev, Eske/A-9619-2011	Hansen, Anders Johannes/0000-0002-1890-2702; Gilbert, Marcus TP/0000-0002-5805-7195; Cooper, Alan/0000-0002-7738-7851; Barnes, Ian C/0000-0001-8322-6918; Willerslev, Eske/0000-0002-7081-6748				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Anensen H, 2001, MUTAT RES-FUND MOL M, V476, P99, DOI 10.1016/S0027-5107(01)00086-0; Bada JL, 1999, PHILOS T ROY SOC B, V354, P77, DOI 10.1098/rstb.1999.0361; Barnes I, 2002, SCIENCE, V295, P2267, DOI 10.1126/science.1067814; Burger J, 1999, ELECTROPHORESIS, V20, P1722; Cooper A, 2001, NATURE, V409, P704, DOI 10.1038/35055536; Di Benedetto G, 2000, EUR J HUM GENET, V8, P669, DOI 10.1038/sj.ejhg.5200514; Drancourt M, 1998, P NATL ACAD SCI USA, V95, P12637, DOI 10.1073/pnas.95.21.12637; DUNNING AM, 1988, NUCLEIC ACIDS RES, V16, P10393, DOI 10.1093/nar/16.21.10393; ECKERT KA, 1990, PCR PRACTICAL APPROA, P225; Fattorini P, 1999, ELECTROPHORESIS, V20, P3349, DOI 10.1002/(SICI)1522-2683(19991101)20:17<3349::AID-ELPS3349>3.0.CO;2-7; Fujikawa K, 1998, NUCLEIC ACIDS RES, V26, P4582, DOI 10.1093/nar/26.20.4582; Gilbert MTP, 2003, AM J HUM GENET, V72, P32, DOI 10.1086/345378; Handt O, 1996, AM J HUM GENET, V59, P368; Hansen AJ, 2001, MOL BIOL EVOL, V18, P262, DOI 10.1093/oxfordjournals.molbev.a003800; Hillis David M., 1996, P321; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Hoss M, 1996, NUCLEIC ACIDS RES, V24, P1304, DOI 10.1093/nar/24.7.1304; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Lalueza-Fox C, 2001, ANN HUM GENET, V65, P137, DOI 10.1017/S0003480001008533; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Loreille O, 2001, CURR BIOL, V11, P200, DOI 10.1016/S0960-9822(01)00046-X; Nielsen-Marsh CM, 2000, J ARCHAEOL SCI, V27, P1139, DOI 10.1006/jasc.1999.0537; Ovchinnikov IV, 2000, NATURE, V404, P490, DOI 10.1038/35006625; PAABO S, 1989, P NATL ACAD SCI USA, V86, P1939, DOI 10.1073/pnas.86.6.1939; PAABO S, 1990, J BIOL CHEM, V265, P4718; PAABO S, 1991, Current Biology, V1, P45, DOI 10.1016/0960-9822(91)90125-G; Poinar HN, 1999, P NATL ACAD SCI USA, V96, P8426, DOI 10.1073/pnas.96.15.8426; Poinar HN, 2001, P NATL ACAD SCI USA, V98, P4317, DOI 10.1073/pnas.061014798; Poinar HN, 1996, SCIENCE, V272, P864, DOI 10.1126/science.272.5263.864; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sanson GFO, 2002, MOL BIOL EVOL, V19, P170, DOI 10.1093/oxfordjournals.molbev.a004069; Smith CI, 2001, NATURE, V410, P771, DOI 10.1038/35071177; TINDALL KR, 1988, BIOCHEMISTRY-US, V27, P6008, DOI 10.1021/bi00416a027; WALLACE DC, 1995, HUMAN GENE MAPPING 1, P910; Willerslev E, 1999, P NATL ACAD SCI USA, V96, P8017, DOI 10.1073/pnas.96.14.8017; Yoshida M, 1997, NUCLEIC ACIDS RES, V25, P1570, DOI 10.1093/nar/25.8.1570; Zhang QM, 1997, NUCLEIC ACIDS RES, V25, P3969, DOI 10.1093/nar/25.20.3969; Zhang QM, 1999, INT J RADIAT BIOL, V75, P59, DOI 10.1080/095530099140816	39	171	178	2	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2003	72	1					48	61		10.1086/345379	http://dx.doi.org/10.1086/345379			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	631VE	12489042	Bronze, Green Published			2022-12-18	WOS:000180186800005
J	Melchionda, S; Ahituv, N; Bisceglia, L; Sobe, T; Glaser, F; Rabionet, R; Arbones, ML; Notarangelo, A; Di Iorio, E; Carella, M; Zelante, L; Estivill, X; Avraham, KB; Gasparini, P				Melchionda, S; Ahituv, N; Bisceglia, L; Sobe, T; Glaser, F; Rabionet, R; Arbones, ML; Notarangelo, A; Di Iorio, E; Carella, M; Zelante, L; Estivill, X; Avraham, KB; Gasparini, P			MYO6, the human homologue of the gene responsible for deafness in Snell's waltzer mice, is mutated in autosomal dominant nonsyndromic hearing loss	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MYOSIN VIIA GENE; UNCONVENTIONAL MYOSIN; HAIR-CELLS; MUTATIONS; MOTOR; SPERMATOGENESIS; DROSOPHILA; KCNQ4	Mutations in the unconventional myosin VI gene, Myo6, are associated with deafness and vestibular dysfunction in the Snell's waltzer (sv) mouse. The corresponding human gene, MYO6, is located on chromosome 6q13. We describe the mapping of a new deafness locus, DFNA22, on chromosome 6q13 in a family affected by a nonsyndromic dominant form of deafness (NSAD), and the subsequent identification of a missense mutation in the MYO6 gene in all members of the family with hearing loss.	IRCCS Hosp CSS, Med Genet Serv, I-71013 San Giovanni Rotondo, Italy; Tel Aviv Univ, Sackler Sch Med, Dept Human Genet & Mol Med, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel; Hosp Duren & Reynals, Inst Recerca Oncol, Med & Mol Genet Ctr, Barcelona, Spain; Tigem, Naples, Italy	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM)	Gasparini, P (corresponding author), IRCCS Hosp CSS, Med Genet Serv, I-71013 San Giovanni Rotondo, Italy.	genetcss@fg.nettuno.it	Rabionet, Raquel/C-8379-2009; Estivill, Xavier/A-3125-2013; Carella, Massimo/A-2804-2014; Bisceglia, Luigi/B-8720-2017; rabionet, raquel/A-7407-2009; Estivill, Xavier/E-2957-2012; Gasparini, Paolo/B-6173-2014; Arbones, Maria/D-4668-2016	Rabionet, Raquel/0000-0001-5006-8140; Estivill, Xavier/0000-0002-0723-2256; Carella, Massimo/0000-0002-6830-6829; Bisceglia, Luigi/0000-0001-5367-8518; rabionet, raquel/0000-0001-5006-8140; Arbones, Maria/0000-0002-6035-0235; Ahituv, Nadav/0000-0002-7434-8144; Gasparini, Paolo/0000-0002-0859-0856; Notarangelo, Angelantonio/0000-0002-1540-8530; Avraham, Karen B/0000-0002-4913-251X	FIC NIH HHS [1 R03 TW01108-01] Funding Source: Medline; Telethon [TGM06S01] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [R03TW001108] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Telethon(Fondazione Telethon); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Ahituv N, 2000, GENE, V261, P269, DOI 10.1016/S0378-1119(00)00535-7; Armon A, 2001, J MOL BIOL, V307, P447, DOI 10.1006/jmbi.2000.4474; Avraham KB, 1997, HUM MOL GENET, V6, P1225, DOI 10.1093/hmg/6.8.1225; AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; Coucke PJ, 1999, HUM MOL GENET, V8, P1321, DOI 10.1093/hmg/8.7.1321; Cramer LP, 2000, J CELL BIOL, V150, pF121, DOI 10.1083/jcb.150.6.F121; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; Hicks JL, 1999, MOL BIOL CELL, V10, P4341, DOI 10.1091/mbc.10.12.4341; Kelleher JF, 2000, CURR BIOL, V10, P1489, DOI 10.1016/S0960-9822(00)00828-9; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Liu XZ, 1997, NAT GENET, V17, P268, DOI 10.1038/ng1197-268; MERMALL V, 1995, J CELL BIOL, V129, P1575, DOI 10.1083/jcb.129.6.1575; OTT J, 1992, ANAL HUMAN LINKAGE; Probst FJ, 1998, SCIENCE, V280, P1444, DOI 10.1126/science.280.5368.1444; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Self T, 1999, DEV BIOL, V214, P331, DOI 10.1006/dbio.1999.9424; Wang AH, 1998, SCIENCE, V280, P1447, DOI 10.1126/science.280.5368.1447; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835	21	171	182	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2001	69	3					635	640		10.1086/323156	http://dx.doi.org/10.1086/323156			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	459VD	11468689	Bronze, Green Published			2022-12-18	WOS:000170271400015
J	Rahman, S; Poulton, J; Marchington, D; Suomalainen, A				Rahman, S; Poulton, J; Marchington, D; Suomalainen, A			Decrease of 3243 A -> G mtDNA mutation from blood in MELAS syndrome: A longitudinal study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSFER RNALEU(UUR) GENE; STROKE-LIKE EPISODES; POINT MUTATION; MITOCHONDRIAL-DNA; LACTIC-ACIDOSIS; MUSCLE; DIAGNOSIS; A3243G	It is widely held that changes in the distribution of mutant mtDNAs underlie the progressive nature of mtDNA diseases, but there are few data documenting such changes. We compared the levels of 3243 A-->G mutant mtDNA in blood at birth from Guthrie cards and at the time of diagnosis in a blood DNA sample from patients with mitochondrial encephalopathy, lactic acidosis, and strokelike episodes (MELAS) syndrome. Paired blood DNA samples separated by 9-13 years were obtained from six patients with MELAS. Quantification of mutant load, by means of a solid-phase minisequencing technique, demonstrated a decline (range 12%-29%) in the proportion of mutant mtDNA in all cases (P = .0015, paired t-test). These results suggest that mutant mtDNA is slowly selected from rapidly dividing blood cells in MELAS.	Univ Oxford, John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England; Inst Child Hlth, Metab Unit, London, England; Natl Publ Hlth Inst, Dept Human Mol Genet, Helsinki, Finland	University of Oxford; University of London; University College London; Finland National Institute for Health & Welfare	Poulton, J (corresponding author), Univ Oxford, John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England.		Poulton, Joanna/AAB-4828-2021; Rahman, Shamima/M-7904-2019; Rahman, Shamima/C-5232-2008	Rahman, Shamima/0000-0003-2088-730X; Suomalainen-Wartiovaara, Anu/0000-0003-4833-5195; Poulton, Joanna/0000-0002-2460-5587				CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408; Ghosh SS, 1996, AM J HUM GENET, V58, P325; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; HAMMANS SR, 1991, LANCET, V337, P1311, DOI 10.1016/0140-6736(91)92981-7; HART LT, 1996, HUM MUTAT, V7, P193; KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5; KOGA Y, 1988, ANN NEUROL, V24, P749, DOI 10.1002/ana.410240609; LARSSON NG, 1992, AM J HUM GENET, V51, P1201; LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011; Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959; MAKOWSKI GS, 1995, NUCLEIC ACIDS RES, V23, P3788, DOI 10.1093/nar/23.18.3788; POULTON J, 1993, ANN NEUROL, V34, P116, DOI 10.1002/ana.410340124; Romani N, 1996, J IMMUNOL METHODS, V196, P137, DOI 10.1016/0022-1759(96)00078-6; Sue CM, 1998, J NEUROL SCI, V161, P36, DOI 10.1016/S0022-510X(98)00179-8; SUOMALAINEN A, 1993, HUM MOL GENET, V2, P525, DOI 10.1093/hmg/2.5.525; SYVANEN AC, 1990, GENOMICS, V8, P684, DOI 10.1016/0888-7543(90)90255-S; VANDENOUWELAND JMW, 1994, DIABETES, V43, P746, DOI 10.2337/diabetes.43.6.746; Weber K, 1997, AM J HUM GENET, V60, P373	18	171	179	0	7	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2001	68	1					238	240		10.1086/316930	http://dx.doi.org/10.1086/316930			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	392FG	11085913	Bronze, Green Published			2022-12-18	WOS:000166399900024
J	Lalwani, AK; Goldstein, JA; Kelley, MJ; Luxford, W; Castelein, CM; Mhatre, AN				Lalwani, AK; Goldstein, JA; Kelley, MJ; Luxford, W; Castelein, CM; Mhatre, AN			Human nonsyndromic hereditary deafness DFNA17 is due to a mutation in nonmuscle myosin MYH9	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COCHLEOSACCULAR DEGENERATION; UNCONVENTIONAL MYOSIN; HEARING IMPAIRMENT; SPIRAL LIGAMENT; MESSENGER-RNA; GENE; CELLS; LOCALIZATION; ISOFORMS; CLONING	The authors had previously mapped a new locus-DFNA17, for nonsyndromic hereditary hearing impairment-to chromosome 22q12.2-q13.3. DFNA17 spans a 17- to 23-cM region, and MYH9, a nonmuscle-myosin heavy-chain gene, is located within the linked region. Because of the importance of myosins in hearing, MYH9 was tested as a candidate gene for DFNA17. Expression of MYH9 in the rat cochlea was confirmed using reverse transcriptase-PCR and immunohistochemistry. MYH9 was immunolocalized in the organ of Corti, the subcentral region of the spiral ligament, and the Reissner membrane. Sequence analysis of MYH9 in a family with DFNA17 identified, at nucleotide 2114, a G-->A transposition that cosegregated with the inherited autosomal dominant hearing impairment. This missense mutation changes codon 705 from an invariant arginine (R) to histidine (H), R705H, within a highly conserved SH1 linker region. Previous studies have shown that modification of amino acid residues within the SH1 helix causes dysfunction of the ATPase activity of the motor domain in myosin II. Both the precise role of MYH9 in the cochlea and the mechanism by which the R705H mutation leads to the DFNA17 phenotype (progressive hearing impairment and cochleosaccular degeneration) remain to be elucidated.	Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, Mol Oncol Lab, Epstein Labs, San Francisco, CA 94143 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; House Ear Clin, Los Angeles, CA USA	University of California System; University of California San Francisco; Duke University; House Research Institute	Lalwani, AK (corresponding author), Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, Mol Oncol Lab, Epstein Labs, 533 Parnassus Ave,Room U490A, San Francisco, CA 94143 USA.		Kelley, Michael/AAC-8939-2019	Kelley, Michael/0000-0001-9523-6080	NIDCD NIH HHS [K23DC00112, F31 DC000112] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K23DC000112, F31DC000112] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Avraham KB, 1997, HUM MOL GENET, V6, P1225, DOI 10.1093/hmg/6.8.1225; AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; COLLINS FS, 1995, NAT GENET, V9, P347, DOI 10.1038/ng0495-347; DELOZANNE A, 1987, SCIENCE, V236, P1086, DOI 10.1126/science.3576222; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Edwards KA, 1996, DEVELOPMENT, V122, P1499; Friedman TB, 1999, AM J MED GENET, V89, P147, DOI 10.1002/(SICI)1096-8628(19990924)89:3<147::AID-AJMG5>3.0.CO;2-6; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; Gulick AM, 1997, BIOESSAYS, V19, P561, DOI 10.1002/bies.950190707; Guo S, 1996, NATURE, V382, P455, DOI 10.1038/382455a0; Hasson T, 1997, CELL MOTIL CYTOSKEL, V37, P127, DOI 10.1002/(SICI)1097-0169(1997)37:2<127::AID-CM5>3.0.CO;2-5; HENSON MM, 1985, HEARING RES, V20, P207, DOI 10.1016/0378-5955(85)90025-5; HENSON MM, 1984, HEARING RES, V16, P231, DOI 10.1016/0378-5955(84)90112-6; Houdusse A, 1999, CELL, V97, P459, DOI 10.1016/S0092-8674(00)80756-4; Kelley CA, 1997, J CELL BIOL, V138, P215; Kelley CA, 1996, J CELL BIOL, V134, P675, DOI 10.1083/jcb.134.3.675; Kolega J, 1998, J CELL BIOCHEM, V68, P389, DOI 10.1002/(SICI)1097-4644(19980301)68:3<389::AID-JCB9>3.0.CO;2-Q; Kolega J, 1998, J CELL SCI, V111, P2085; Lalwani AK, 1999, AM J HUM GENET, V64, P318, DOI 10.1086/302216; Lalwani AK, 1997, AUDIOL NEURO-OTOL, V2, P139, DOI 10.1159/000259237; MAUPIN P, 1994, J CELL SCI, V107, P3077; Mhatre AN, 1999, BIOCHEM BIOPH RES CO, V264, P157, DOI 10.1006/bbrc.1999.1323; Patterson B, 1997, J BIOL CHEM, V272, P27612, DOI 10.1074/jbc.272.44.27612; PHILLIPS CL, 1995, J MUSCLE RES CELL M, V16, P379, DOI 10.1007/BF00114503; Probst FJ, 1998, SCIENCE, V280, P1444, DOI 10.1126/science.280.5368.1444; Rayment I, 1996, J BIOL CHEM, V271, P15850, DOI 10.1074/jbc.271.27.15850; SAEZ CG, 1990, P NATL ACAD SCI USA, V87, P1164, DOI 10.1073/pnas.87.3.1164; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; SIMONS M, 1991, CIRC RES, V69, P530, DOI 10.1161/01.RES.69.2.530; Suzuki Y, 1997, BIOCHEM BIOPH RES CO, V234, P701, DOI 10.1006/bbrc.1997.6671; Tullio AN, 1997, P NATL ACAD SCI USA, V94, P12407, DOI 10.1073/pnas.94.23.12407; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0	32	171	185	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2000	67	5					1121	1128		10.1016/S0002-9297(07)62942-5	http://dx.doi.org/10.1016/S0002-9297(07)62942-5			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	369WW	11023810	Green Published, Bronze			2022-12-18	WOS:000165091600009
J	Levinson, DF; Holmans, P; Straub, RE; Owen, MJ; Wildenauer, DB; Gejman, PV; Pulver, AE; Laurent, C; Kendler, KS; Walsh, D; Norton, N; Williams, NM; Schwab, SG; Lerer, B; Mowry, BJ; Sanders, AR; Antonarakis, SE; Blouin, JL; DeLeuze, JF; Mallet, J				Levinson, DF; Holmans, P; Straub, RE; Owen, MJ; Wildenauer, DB; Gejman, PV; Pulver, AE; Laurent, C; Kendler, KS; Walsh, D; Norton, N; Williams, NM; Schwab, SG; Lerer, B; Mowry, BJ; Sanders, AR; Antonarakis, SE; Blouin, JL; DeLeuze, JF; Mallet, J			Multicenter linkage study of schizophrenia candidate regions on chromosomes 5q, 6q, 10p, and 13q: Schizophrenia linkage collaborative group III	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE SEARCH; GENETICALLY COMPLEX TRAITS; SIB-PAIR ANALYSIS; SUSCEPTIBILITY LOCUS; MILLENNIUM-CONSORTIUM; VULNERABILITY LOCUS; POTENTIAL LINKAGE; FOLLOW-UP; GENES; FAMILIES	Schizophrenia candidate regions 33-51 cM in length on chromosomes 5q, 6q, 10p, and 13q were investigated for genetic linkage with mapped markers with an average spacing of 5.64 cM. We studied 734 informative multiplex pedigrees (824 independent affected sibling pairs [ASPs], or 1,003 ASPs when all possible pairs are counted), which were collected in eight centers. Cases with diagnoses of schizophrenia or schizoaffective disorder (DSM-IIIR criteria) were considered affected (n = 1,937). Data were analyzed with multipoint methods, including nonparametric linkage (NPL), ASP analysis using the possible-triangle method, and logistic-regression analysis of identity-by-descent (IBD) sharing in ASPs with sample as a covariate, in a test for intersample heterogeneity and for linkage with allowance for intersample heterogeneity. The data most supportive for linkage to schizophrenia were from chromosome 6q; logistic-regression analysis of linkage allowing for intersample heterogeneity produced an empirical P value < .0002 with, or P = .0004 without, inclusion of the sample that produced the first positive report in this region; the maximum Nm,score in this region was 2.47 (P = .0046), the maximum LOD score (MLS) from ASP analysis was 3.10 (empirical P = .0036), and there was significant evidence for intersample heterogeneity (empirical P = .0038). More-modest support for linkage was observed for chromosome 10p, with logistic-regression analysis of linkage producing an empirical P = .045 and with significant evidence for intersample heterogeneity (empirical P = .0096).	Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; Washington Univ, Dept Psychiat, St Louis, MO USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Human Genet, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Psychiat, Richmond, VA 23298 USA; Univ Wales, Coll Med, Dept Med Psychol, Cardiff CF1 3NS, S Glam, Wales; Univ Wales, Coll Med, Dept Med Genet, Cardiff CF1 3NS, S Glam, Wales; Univ Bonn, Dept Psychiat, D-5300 Bonn, Germany; Univ Chicago, Dept Psychiat, Chicago, IL 60637 USA; Johns Hopkins Univ, Dept Psychiat & Behav Sci, Baltimore, MD USA; Hop La Pitie Salpetriere, CNRS, Lab Genet Mol Neurotransmiss & Proc Neurodegenera, Paris, France; Aventis SA, Paris, France; Hlth Res Board, Dublin, Ireland; Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Psychiat, IL-91010 Jerusalem, Israel; Univ Queensland, Dept Psychiat, Brisbane, Qld, Australia; Wolston Pk Hosp, Queensland Ctr Schizophrenia Res, Brisbane, Qld, Australia; Univ Geneva, Sch Med, Dept Genet, CH-1211 Geneva, Switzerland	University of Pennsylvania; Washington University (WUSTL); Virginia Commonwealth University; Virginia Commonwealth University; Cardiff University; Cardiff University; University of Bonn; University of Chicago; Johns Hopkins University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Sanofi-Aventis; Sanofi France; Health Research Board - Ireland; Hebrew University of Jerusalem; University of Queensland; University of Geneva	Levinson, DF (corresponding author), Univ Penn, Dept Psychiat, 3600 Market St,Room 701, Philadelphia, PA 19104 USA.		Holmans, Peter/F-4518-2015; Kendler, Kenneth/AAF-2876-2019; Antonarakis, Stylianos E/N-8866-2014; Mowry, Bryan/G-5046-2010	Holmans, Peter/0000-0003-0870-9412; Antonarakis, Stylianos E/0000-0001-8907-5823; Mowry, Bryan/0000-0002-4115-5645	NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH046289, R01MH041953, U01MH046276, U01MH046318] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH041953, UO1 MH46289, U01 MH046318, U01 MH046276, U01 MH046289, UO1 MH46276] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Blouin JL, 1998, NAT GENET, V20, P70, DOI 10.1038/1734; Brzustowicz LM, 1999, AM J HUM GENET, V65, pA244; Cao QH, 1997, GENOMICS, V43, P1, DOI 10.1006/geno.1997.4815; Cloninger CR, 1998, AM J MED GENET, V81, P275, DOI 10.1002/(SICI)1096-8628(19980710)81:4<275::AID-AJMG1>3.3.CO;2-U; Coon H, 1998, MOL PSYCHIATR, V3, P521, DOI 10.1038/sj.mp.4000453; COON H, 1994, AM J MED GENET, V54, P59, DOI 10.1002/ajmg.1320540111; Dorr DA, 1997, GENET EPIDEMIOL, V14, P617, DOI 10.1002/(SICI)1098-2272(1997)14:6<617::AID-GEPI11>3.0.CO;2-T; Faraone SV, 1996, PSYCHOL MED, V26, P401, DOI 10.1017/S0033291700034796; Faraone SV, 1998, AM J MED GENET, V81, P290, DOI 10.1002/(SICI)1096-8628(19980710)81:4<290::AID-AJMG3>3.0.CO;2-Y; Gill M, 1996, AM J MED GENET, V67, P40, DOI 10.1002/(SICI)1096-8628(19960216)67:1<40::AID-AJMG6>3.0.CO;2-W; Hauser ER, 1997, AM J HUM GENET, V61, pA278; HOLMANS P, 1993, AM J HUM GENET, V52, P362; Holmans P, 1998, HUM BIOL, V70, P1025; Kaufmann CA, 1998, AM J MED GENET, V81, P282, DOI 10.1002/(SICI)1096-8628(19980710)81:4<282::AID-AJMG2>3.3.CO;2-R; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Levinson D.F., 2000, GENETIC INFLUENCES N, P47; Levinson DF, 1996, AM J MED GENET, V67, P580; Levinson DF, 1999, AM J PSYCHIAT, V156, P1138; Levinson DF, 1998, AM J PSYCHIAT, V155, P741; Lin HK, 1997, ACTA PHYS-CHIM SIN, V13, P417, DOI 10.3866/PKU.WHXB19970507; Lin MW, 1995, PSYCHIATR GENET, V5, P117, DOI 10.1097/00041444-199505030-00004; Martinez M, 1999, AM J MED GENET, V88, P337, DOI 10.1002/(SICI)1096-8628(19990820)88:4<337::AID-AJMG9>3.3.CO;2-1; Meunier F, 1997, GENET EPIDEMIOL, V14, P1107, DOI 10.1002/(SICI)1098-2272(1997)14:6<1107::AID-GEPI91>3.0.CO;2-K; MOISES HW, 1995, NAT GENET, V11, P321, DOI 10.1038/ng1195-321; PULVER AE, 1994, AM J MED GENET, V54, P44, DOI 10.1002/ajmg.1320540109; PULVER AE, 1994, AM J MED GENET, V54, P36, DOI 10.1002/ajmg.1320540108; Rice JP, 1997, AM J MED GENET, V74, P112, DOI 10.1002/(SICI)1096-8628(19970221)74:1<112::AID-AJMG22>3.0.CO;2-T; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P222; Roberts SB, 1999, AM J HUM GENET, V65, P876, DOI 10.1086/302528; Rybicki BA, 2000, AM J HUM GENET, V66, P593, DOI 10.1086/302778; SCHWAB SG, 1995, NAT GENET, V11, P325, DOI 10.1038/ng1195-325; Schwab SG, 1997, MOL PSYCHIATR, V2, P156, DOI 10.1038/sj.mp.4000263; Schwab SG, 1998, AM J MED GENET, V81, P302, DOI 10.1002/(SICI)1096-8628(19980710)81:4<302::AID-AJMG5>3.3.CO;2-4; Sham PC, 1997, ANN HUM GENET, V61, P61; Shaw SH, 1998, AM J MED GENET, V81, P364, DOI 10.1002/(SICI)1096-8628(19980907)81:5<364::AID-AJMG4>3.0.CO;2-T; Straub RE, 1997, MOL PSYCHIATR, V2, P148, DOI 10.1038/sj.mp.4000258; STRAUB RE, 1995, NAT GENET, V11, P287, DOI 10.1038/ng1195-287; Straub RE, 1998, AM J MED GENET, V81, P296, DOI 10.1002/(SICI)1096-8628(19980710)81:4<296::AID-AJMG4>3.0.CO;2-S; STRAUB RE, 1997, AM J MED GENET, V74, P559; Wildenauer DB, 1997, AM J MED GENET, V74, P558; Williams NM, 1999, HUM MOL GENET, V8, P1729, DOI 10.1093/hmg/8.9.1729; Wise LH, 1999, ANN HUM GENET, V63, P263, DOI 10.1046/j.1469-1809.1999.6330263.x	43	171	174	0	8	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2000	67	3					652	663		10.1086/303041	http://dx.doi.org/10.1086/303041			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	348TJ	10924404	Green Published, Bronze			2022-12-18	WOS:000089002300012
J	Simoni, L; Calafell, F; Pettener, D; Bertranpetit, J; Barbujani, G				Simoni, L; Calafell, F; Pettener, D; Bertranpetit, J; Barbujani, G			Geographic patterns of mtDNA diversity in Europe	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; HUMAN-GENE-FREQUENCIES; D-LOOP REGION; SEQUENCE-ANALYSIS; SPATIAL AUTOCORRELATION; POPULATION EXPANSION; NEOLITHIC LINEAGES; DEMIC DIFFUSION; NUCLEAR-DNA; ORIGIN	Genetic diversity in Europe has been interpreted as a reflection of phenomena occurring during the Paleolithic (similar to 45,000 years before the present [BP]), Mesolithic (similar to 18,000 years BP), and Neolithic (similar to 10,000 years BP) periods. A crucial role of the Neolithic demographic transition is supported by the analysis of most nuclear loci, but the interpretation of mtDNA evidence is controversial. More than 2,600 sequences of the first hypervariable mitochondrial control region were analyzed for geographic patterns in samples from Europe, the Near East, and the Caucasus. Two autocorrelation statistics were used, one based on allele-frequency differences between samples and the other based on both sequence and frequency differences between alleles. In the global analysis, limited geographic patterning was observed, which could largely be attributed to a marked difference between the Saami and all other populations. The distribution of the zones of highest mitochondrial variation (genetic boundaries) confirmed that the Saami are sharply differentiated from an otherwise rather homogeneous set of European samples. However, an area of significant clinal variation was identified around the Mediterranean Sea (and not in the north), even though the differences between northern and southern populations were insignificant. Both a Paleolithic expansion and the Neolithic demic diffusion of farmers could have determined a longitudinal dine of mtDNA diversity. However, additional phenomena must be considered in both models, to account both for the north-south differences and for the greater geographic scope of clinal patterns at nuclear loci. Conversely, two predicted consequences of models of Mesolithic reexpansion from glacial refugia were not observed in the present study.	Univ Ferrara, Dipartimento Biol, I-44100 Ferrara, Italy; Univ Bologna, Dept Evolutionary & Expt Biol, Bologna, Italy; Univ Pompeu Fabra, Fac Ciencies Salut & Vida, Unitat Biol Evolut, Barcelona, Spain	University of Ferrara; University of Bologna; Pompeu Fabra University	Barbujani, G (corresponding author), Univ Ferrara, Dipartimento Biol, Via L Borsari 46, I-44100 Ferrara, Italy.		Pettener, Davide/E-1576-2017; Bertranpetit, Jaume/F-8550-2012; Barbujani, Guido/ABE-9998-2020; Calafell, Francesc/C-8595-2014	Bertranpetit, Jaume/0000-0003-0100-0590; Barbujani, Guido/0000-0001-7854-6669; Calafell, Francesc/0000-0002-1083-9438				Ammerman A.J., 1984, NEOLITHIC TRANSITION; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ArisBrosou S, 1996, MOL BIOL EVOL, V13, P494, DOI 10.1093/oxfordjournals.molbev.a025610; BARBUJANI G, 1987, GENETICS, V117, P777; Barbujani G, 1998, AM J HUM GENET, V62, P488, DOI 10.1086/301719; BARBUJANI G, 1993, P NATL ACAD SCI USA, V90, P4670, DOI 10.1073/pnas.90.10.4670; BARBUJANI G, 1995, AM J PHYS ANTHROPOL, V96, P109, DOI 10.1002/ajpa.1330960202; BELLEDI M, IN PRESS EUR J HUM G; BERTORELLE G, 1995, GENETICS, V140, P811; BERTRANPETIT J, 1995, ANN HUM GENET, V59, P63, DOI 10.1111/j.1469-1809.1995.tb01606.x; Bosch E, 1997, HUM BIOL, V69, P295; Calafell F, 1996, ANN HUM GENET, V60, P35, DOI 10.1111/j.1469-1809.1996.tb01170.x; Casalotti R, 1999, P ROY SOC B-BIOL SCI, V266, P1959, DOI 10.1098/rspb.1999.0873; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CAVALLIS.LL, 1966, PROC R SOC SER B-BIO, V164, P362, DOI 10.1098/rspb.1966.0038; CavalliSforza LL, 1997, AM J HUM GENET, V61, P247, DOI 10.1016/S0002-9297(07)64303-1; Chikhi L, 1998, HUM BIOL, V70, P643; Chikhi L, 1998, P NATL ACAD SCI USA, V95, P9053, DOI 10.1073/pnas.95.15.9053; Comas D, 1997, HUM GENET, V99, P443, DOI 10.1007/s004390050386; Comas D, 1996, MOL BIOL EVOL, V13, P1067, DOI 10.1093/oxfordjournals.molbev.a025669; CorteReal HBSM, 1996, ANN HUM GENET, V60, P331, DOI 10.1111/j.1469-1809.1996.tb01196.x; CRUMPACKER DW, 1976, GEOGR ANAL, V8, P215; Decorte R, 1996, ADV FOREN H, V6, P17; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P597; Dupuy BM, 1996, ADV FOREN H, V6, P23; EXCOFFIER L, 1990, J MOL EVOL, V30, P125, DOI 10.1007/BF02099939; EXCOFFIER L, 1992, GENETICS, V131, P479; Francalacci P, 1996, AM J PHYS ANTHROPOL, V100, P443, DOI 10.1002/(SICI)1096-8644(199608)100:4<443::AID-AJPA1>3.0.CO;2-S; HANDT O, 1994, SCIENCE, V264, P1775, DOI 10.1126/science.8209259; Izagirre N, 1999, AM J HUM GENET, V65, P199, DOI 10.1086/302442; Jazin E, 1998, NAT GENET, V18, P109, DOI 10.1038/ng0298-109; JORDE LB, 1995, AM J HUM GENET, V57, P523; LEWONTIN RC, 1973, GENETICS, V74, P175; Lutz S, 1998, INT J LEGAL MED, V111, P67, DOI 10.1007/s004140050117; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; MALYARCHUK BA, 1998, RUSSIAN J GENET, V7, P842; MELLARS P, 1994, OXFORD ILLUSTRATED P, P42; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; Meyer S, 1999, GENETICS, V152, P1103; Nei M., 1987, MOL EVOLUTIONARY GEN; Parson W, 1998, INT J LEGAL MED, V111, P124, DOI 10.1007/s004140050132; Parsons TJ, 1997, NAT GENET, V15, P363, DOI 10.1038/ng0497-363; Pennington RL, 1996, AM J PHYS ANTHROPOL, V99, P259, DOI 10.1002/(SICI)1096-8644(199602)99:2<259::AID-AJPA4>3.0.CO;2-U; PIERCY R, 1993, INT J LEGAL MED, V106, P85, DOI 10.1007/BF01225046; Pinto F, 1996, ANN HUM GENET, V60, P321, DOI 10.1111/j.1469-1809.1996.tb01195.x; PULT I, 1994, BIOL CHEM H-S, V375, P837; RENDINE S, 1986, AM NAT, V128, P681, DOI 10.1086/284597; Renfrew C., 1987, ARCHAEOLOGY LANGUAGE; Richards M, 1998, AM J HUM GENET, V62, P491, DOI 10.1086/301733; Richards M, 1996, AM J HUM GENET, V59, P185; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; RICHARDS MB, 1997, AM J HUM GENET, V61, P247; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAJANTILA A, 1995, GENOME RES, V5, P42, DOI 10.1101/gr.5.1.42; Sajantila A, 1996, P NATL ACAD SCI USA, V93, P12035, DOI 10.1073/pnas.93.21.12035; Salas A, 1998, EUR J HUM GENET, V6, P365, DOI 10.1038/sj.ejhg.5200202; Seielstad MT, 1998, NAT GENET, V20, P278, DOI 10.1038/3088; Semino O, 1996, AM J HUM GENET, V59, P964; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Sokal R. R., 1995, BIOMETRY; SOKAL RR, 1978, BIOL J LINN SOC, V10, P199, DOI 10.1111/j.1095-8312.1978.tb00013.x; SOKAL RR, 1982, AM NAT, V119, P1, DOI 10.1086/283886; SOKAL RR, 1989, AM J PHYS ANTHROPOL, V80, P267, DOI 10.1002/ajpa.1330800302; SOKAL RR, 1988, P NATL ACAD SCI USA, V85, P1722, DOI 10.1073/pnas.85.5.1722; Sokal RR, 1999, HUM BIOL, V71, P1; SOKAL RR, 1979, CONT QUANTITATIVE EC; Stenico M, 1998, P ROY SOC B-BIOL SCI, V265, P555, DOI 10.1098/rspb.1998.0330; Stenico M, 1996, AM J HUM GENET, V59, P1363; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; TORRONI A, 1994, AM J HUM GENET, V55, P760; Whittle A, 1994, OXFORD ILLUSTRATED P, P136; WIJSMAN EM, 1984, ANNU REV ECOL SYST, V15, P279; Wise CA, 1998, GENETICS, V148, P409	75	171	175	3	21	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2000	66	1					262	278		10.1086/302706	http://dx.doi.org/10.1086/302706			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279FK	10631156	Bronze, Green Published			2022-12-18	WOS:000085033600027
J	Almqvist, EW; Bloch, M; Brinkman, R; Craufurd, D; Hayden, MR				Almqvist, EW; Bloch, M; Brinkman, R; Craufurd, D; Hayden, MR		Int Huntington Dis Collaborative Grp	A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PSYCHOLOGICAL CONSEQUENCES; DECISION-MAKING; RISK; ATTITUDES; EXPERIENCE; CANCER; GENE; APPLICANTS; DIAGNOSIS; CANADA	Prior to the implementation of predictive-testing programs for Huntington disease (HD), significant concern was raised concerning the likelihood of catastrophic events (CEs), particularly in those persons receiving an increased-risk result. We have investigated the frequency of CEs-that is, suicide, suicide attempt, and psychiatric hospitalization-after an HD predictive-testing result, through questionnaires sent to predictive-testing centers worldwide. A total of 44 persons (0.97%) in a cohort of 4,527 test participants had a CE: 5 successful suicides, 21 suicide attempts, and 18 hospitalizations for psychiatric reasons. All persons committing suicide had signs of HD, whereas 11 (52.4%) of 21 persons attempting suicide and 8 (44.4%) of 18 who had a psychiatric hospitalization were symptomatic, A total of 11 (84.6%) of 13 asymptomatic persons who experienced a CE during the first year after HD predictive testing received an increased-risk result. Factors associated with an increased risk of a CE included (a) a psychiatric history less than or equal to 5 years prior to testing and (b) unemployed status. The frequency of CEs did not differ between those persons receiving results of predictive testing through linkage analysis in whom there was only changes in direction of risk and those persons receiving definitive results after analysis for the mutation underlying HD. These findings provide insights into the frequency, associated factors, and timing of CEs in a worldwide cohort of persons receiving predictive-testing results and, as such, highlight persons for whom ongoing support may be beneficial.	Univ British Columbia, Ctr Mol Med & Therapeut, Dept Med Genet, Vancouver, BC V5Z 4H4, Canada; Riverview Hosp, Div Geriatr, Port Coquitlam, BC, Canada; St Marys Hosp, Dept Clin Genet, Manchester M13 0JH, Lancs, England	University of British Columbia; University of Manchester	Hayden, MR (corresponding author), Univ British Columbia, Ctr Mol Med & Therapeut, Dept Med Genet, Room 3024,950 W 28th Ave, Vancouver, BC V5Z 4H4, Canada.	mrh@cmmt.ubc.ca	Craufurd, David/G-5277-2013; Hayden, Michael R/D-8581-2011; Brinkman, Ryan/B-1108-2008	Hayden, Michael R/0000-0001-5159-1419; Brinkman, Ryan/0000-0002-9765-2990				Almqvist E, 1997, AM J HUM GENET, V61, P945, DOI 10.1086/514873; [Anonymous], 1989, J NEUROL SCI, V94, P327; BABUL R, 1993, JAMA-J AM MED ASSOC, V270, P2321, DOI 10.1001/jama.270.19.2321; BLOCH M, 1993, AM J MED GENET, V47, P368, DOI 10.1002/ajmg.1320470314; BLOCH M, 1992, AM J MED GENET, V42, P499, DOI 10.1002/ajmg.1320420416; BRANDT J, 1989, JAMA-J AM MED ASSOC, V261, P3108, DOI 10.1001/jama.261.21.3108; Bundey S, 1997, LANCET, V349, P4, DOI 10.1016/S0140-6736(05)62155-1; CODORI AM, 1994, AM J MED GENET, V54, P174, DOI 10.1002/ajmg.1320540304; CODORI AM, 1994, AM J MED GENET, V54, P167, DOI 10.1002/ajmg.1320540303; Codori AM, 1997, HEALTH PSYCHOL, V16, P36, DOI 10.1037/0278-6133.16.1.36; Decruyenaere M, 1996, J MED GENET, V33, P737, DOI 10.1136/jmg.33.9.737; Decruyenaere M, 1997, EUR J HUM GENET, V5, P351, DOI 10.1159/000484792; Decruyenaere M., 1995, Genetic Counseling, V6, P1; DIMAIO L, 1993, J MED GENET, V30, P293, DOI 10.1136/jmg.30.4.293; FARRER LA, 1986, AM J MED GENET, V24, P305, DOI 10.1002/ajmg.1320240211; FOX S, 1989, AM J MED GENET, V32, P211, DOI 10.1002/ajmg.1320320214; HAYDEN MR, 1993, J MED GENET, V30, P1020; HAYDEN MR, 1980, S AFR MED J, V58, P201; HOLLOWAY S, 1994, CLIN GENET, V46, P175; HUGGINS M, 1992, AM J MED GENET, V42, P508, DOI 10.1002/ajmg.1320420417; KENEN RH, 1978, AM J PUBLIC HEALTH, V68, P1116, DOI 10.2105/AJPH.68.11.1116; KESSLER S, 1987, AM J MED GENET, V26, P259, DOI 10.1002/ajmg.1320260204; KESSLER S, 1987, AM J ORTHOPSYCHIAT, V57, P212, DOI 10.1111/j.1939-0025.1987.tb03531.x; Lawson K, 1996, J MED GENET, V33, P856, DOI 10.1136/jmg.33.10.856; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MARSDEN CD, 1981, ANN NEUROL, V10, P202; MASTROMAURO C, 1987, AM J MED GENET, V26, P271, DOI 10.1002/ajmg.1320260205; MATTSSON B, 1991, FAM PRACT, V8, P23, DOI 10.1093/fampra/8.1.23; MEISSEN GJ, 1988, NEW ENGL J MED, V318, P535, DOI 10.1056/NEJM198803033180903; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; NANCE MA, 1991, AM J MED GENET, V40, P518, DOI 10.1002/ajmg.1320400431; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; *NIH, 1977, REP WORK GROUP GEN 1, V3, P63; OLIVER JE, 1970, BRIT J PSYCHIAT, V116, P241, DOI 10.1192/bjp.116.532.241; PLATT S, 1984, SOC SCI MED, V19, P93, DOI 10.1016/0277-9536(84)90276-4; QUAID KA, 1993, AM J HUM GENET, V53, P785; Reddy PS, 1997, CURR OPIN CELL BIOL, V9, P364, DOI 10.1016/S0955-0674(97)80009-9; ROSENFELD A, 1984, HASTINGS CENT REP, V14, P5, DOI 10.2307/3561179; SCHOENFELD M, 1984, J NEUROL NEUROSUR PS, V47, P1283, DOI 10.1136/jnnp.47.12.1283; SIMPSON SA, 1992, CLIN GENET, V41, P326; SORENSEN SA, 1992, J MED GENET, V29, P911, DOI 10.1136/jmg.29.12.911; Taylor CA, 1997, AM J MED GENET, V70, P365, DOI 10.1002/(SICI)1096-8628(19970627)70:4<365::AID-AJMG7>3.0.CO;2-S; Tibben A, 1997, HEALTH PSYCHOL, V16, P20, DOI 10.1037/0278-6133.16.1.20; TYLER A, 1992, BRIT J PSYCHIAT, V161, P481, DOI 10.1192/bjp.161.4.481; Wahlin TBR, 1997, AM J MED GENET, V73, P356, DOI 10.1002/(SICI)1096-8628(19971219)73:3<356::AID-AJMG24>3.0.CO;2-H; WEXLER NS, 1985, PROGR MED GENETICS, P278; WIGGINS S, 1992, NEW ENGL J MED, V327, P1401, DOI 10.1056/NEJM199211123272001; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; [No title captured]	49	171	173	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1999	64	5					1293	1304		10.1086/302374	http://dx.doi.org/10.1086/302374			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	192RP	10205260	Green Published, Bronze			2022-12-18	WOS:000080093000007
J	Kruse, R; Rutten, A; Lamberti, C; Hosseiny-Malayeri, HR; Wang, YP; Ruelfs, C; Jungck, M; Mathiak, M; Ruzicka, T; Hartschuh, W; Bisceglia, M; Friedl, W; Propping, P				Kruse, R; Rutten, A; Lamberti, C; Hosseiny-Malayeri, HR; Wang, YP; Ruelfs, C; Jungck, M; Mathiak, M; Ruzicka, T; Hartschuh, W; Bisceglia, M; Friedl, W; Propping, P			Muir-Torre phenotype has a frequency of DNA mismatch-repair gene mutations similar to that in hereditary nonpolyposis colorectal cancer families defined by the Amsterdam criteria	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HMSH2 MUTATIONS; LOCUS; POLYPOSIS; KINDREDS; HMLH1; HNPCC	Muir-Torre syndrome (MTS) is an autosomal dominant disease defined by the coincidence of at least one sebaceous skin tumor and one internal malignancy About half of MTS patients are affected by colorectal cancer. In a subgroup of MTS patients the disease has an underlying DNA mismatch-repair (MMR) defect and thus is allelic to hereditary nonpolyposis colorectal cancer (HNPCC). The purpose of this study was to examine to what extent germ-line mutations in DNA MMR genes are the underlying cause of the MTS phenotype. We ascertained 16 MTS patients with sebaceous skin tumors and colorectal cancer, and we examined their skin and visceral tumors for microsatellite instability. All the patients exhibited high genomic instability in at least one tumor. The search for germ-line mutations in the hMSH2 and hMLH1 genes in 13 of the MTS patients revealed truncating mutations in 9 (69%): eight mutations in the hMSH2 gene and one in the hMLH1 gene. This is the first systematic search for germ-line mutations in patients ascertained on the basis of sebaceous skin tumors. Our results indicate that (1) MTS patients exhibit significantly more mutations in the hMSH2 gene than in the hMLH1 gene; and (2) the subpopulation of MTS patients who are also affected by colorectal cancer, irrespective of family history and age at onset of tumors, may have a likelihood for an underlying DNA MMR defect similar to that for patients with a family history fulfilling the strict clinical criteria for HNPCC.	Univ Bonn, Inst Human Genet, D-53111 Bonn, Germany; Univ Bonn, Dept Gen Internal Med, D-53111 Bonn, Germany; Univ Bonn, Inst Pathol, D-53111 Bonn, Germany; Lab Dermatohistopathol, Friedrichshafen, Germany; Univ Dusseldorf, Dept Dermatol, D-4000 Dusseldorf, Germany; Univ Heidelberg, Dept Dermatol, D-6900 Heidelberg, Germany; Casa Sollievo della Sofferenza Hosp, Dept Anat Pathol, Foggia, Italy	University of Bonn; University of Bonn; University of Bonn; Heinrich Heine University Dusseldorf; Ruprecht Karls University Heidelberg; IRCCS Casa Sollievo Della Sofferenza	Kruse, R (corresponding author), Univ Bonn, Inst Human Genet, Wilhelmstr 31, D-53111 Bonn, Germany.							Bapat B, 1996, AM J HUM GENET, V59, P736; BISCEGLIA M, 1991, TUMORI, V77, P277, DOI 10.1177/030089169107700320; Bocker T, 1997, CANCER RES, V57, P4739; BURGDORF WHC, 1986, AM J DERMATOPATH, V8, P202, DOI 10.1097/00000372-198606000-00004; COHEN PR, 1991, AM J MED, V90, P606; Esche C, 1997, BRIT J DERMATOL, V136, P913, DOI 10.1046/j.1365-2133.1997.01805.x; FRIEDL W, 1993, HUM MOL GENET, V2, P1481, DOI 10.1093/hmg/2.9.1481; HALL NR, 1994, J MED GENET, V31, P627, DOI 10.1136/jmg.31.8.627; HARTIG C, 1995, HAUTARZT, V46, P107, DOI 10.1007/s001050050218; HONCHEL R, 1994, CANCER RES, V54, P1159; Jager AC, 1997, AM J HUM GENET, V61, P129, DOI 10.1086/513896; KOLODNER RD, 1994, GENOMICS, V24, P516, DOI 10.1006/geno.1994.1661; KOLODNER RD, 1995, CANCER RES, V55, P242; Kruse R, 1996, HUM GENET, V98, P747, DOI 10.1007/s004390050298; Liu B, 1996, NAT MED, V2, P169, DOI 10.1038/nm0296-169; LIU B, 1994, CANCER RES, V54, P4590; LUCE MC, 1995, GASTROENTEROLOGY, V109, P1368, DOI 10.1016/0016-5085(95)90600-2; LYNCH HT, 1981, ARCH INTERN MED, V141, P607, DOI 10.1001/archinte.141.5.607; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Miyaki M, 1997, NAT GENET, V17, P271, DOI 10.1038/ng1197-271; PANDAY SCN, 1993, NETH J MED, V43, P116; Papadopoulos N, 1997, HUM MUTAT, V10, P89, DOI 10.1002/(SICI)1098-1004(1997)10:2<89::AID-HUMU1>3.3.CO;2-K; Peltomaki P, 1997, GASTROENTEROLOGY, V113, P1146, DOI 10.1053/gast.1997.v113.pm9322509; SCHWARTZ RA, 1995, J AM ACAD DERMATOL, V33, P90, DOI 10.1016/0190-9622(95)90017-9; Vasen HFA, 1996, GASTROENTEROLOGY, V110, P1020, DOI 10.1053/gast.1996.v110.pm8612988; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Wehner M, 1997, HUM MUTAT, V10, P241; WIJNEN J, 1995, AM J HUM GENET, V56, P1060; Wijnen J, 1997, AM J HUM GENET, V61, P329, DOI 10.1086/514847	29	171	172	0	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1998	63	1					63	70		10.1086/301926	http://dx.doi.org/10.1086/301926			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZZ726	9634524	Green Published, Bronze			2022-12-18	WOS:000074761000011
J	Young, TL; Ronan, SM; Drahozal, LA; Wildenberg, SC; Alvear, AB; Oetting, WS; Atwood, LD; Wilkin, DJ; King, RA				Young, TL; Ronan, SM; Drahozal, LA; Wildenberg, SC; Alvear, AB; Oetting, WS; Atwood, LD; Wilkin, DJ; King, RA			Evidence that a locus for familial high myopia maps to chromosome 18p	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TANDEM REPEAT POLYMORPHISMS; MULTILOCUS LINKAGE ANALYSIS; DOMINANT JUVENILE GLAUCOMA; GENETIC-LINKAGE; MARFAN-SYNDROME; HUMAN GENOME; CONSTRUCTION; REFRACTION; INFANTS; SYSTEM	Myopia, or nearsightedness, is the most common human eye disorder. A genomewide screen was conducted to map the gene(s) associated with high, early-onset, autosomal dominant myopia. Eight families that each included two or more individuals with greater than or equal to-6.00 diopters (D) myopia, in two or more successive generations, were identified. Myopic individuals had no clinical evidence of connective-tissue abnormalities, and the average age at diagnosis of myopia was 6.8 years. The average spherical component refractive error for the affected individuals was -9.48 D. The families contained 82 individuals; of these, DNA was available for 71 (37 affected). Markers nanking or intragenic to the genes for Stickler syndrome types 1 and 2 (chromosomes 12q13.1-q13.3 and 6p21.3, respectively), Marfan syndrome (chromosome 15q21.1), and juvenile glaucoma (chromosome 1q21-q31) were also analyzed. No evidence of linkage was found for markers for the Stickler syndrome types 1 and 2, the Marfan syndrome, or the juvenile glaucoma loci. After a genomewide search, evidence of significant linkage was found on chromosome 18p. The maximum LOD score was 9.59, with marker D18S481, at a recombination fraction of .0010. Haplotype analysis further refined this myopia locus to a 7.6-cM interval between markers D18S59 and D18S1138 on 18p11.31.	Univ Minnesota, Dept Ophthalmol, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA; Univ Minnesota, Div Epidemiol, Minneapolis, MN 55455 USA; NIH, Med Genet Branch, Natl Human Genome Res Inst, Bethesda, MD USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Young, TL (corresponding author), Univ Minnesota, Dept Ophthalmol, Box 493,420 Delaware St, Minneapolis, MN 55455 USA.	young061@gold.tc.umn.edu						ASHTON GC, 1985, HUM HERED, V35, P232, DOI 10.1159/000153551; AYAD S, 1994, EXTRACELLULAR MATRIX, P111; BERG ES, 1993, GENOMICS, V16, P350, DOI 10.1006/geno.1993.1196; BRUNNER HG, 1994, HUM MOL GENET, V3, P1561, DOI 10.1093/hmg/3.9.1561; CLEARY EG, 1983, INT REV CONNECT TISS, V10, P97; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Curtin BJ, 1985, THE MYOPIAS, V1; Delbono E. A., 1995, American Journal of Human Genetics, V57, pA87; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; DUBOVSKY J, 1995, HUM MOL GENET, V4, P449, DOI 10.1093/hmg/4.3.449; EDWARDS M, 1991, OPHTHAL PHYSL OPT, V11, P227, DOI 10.1016/0275-5408(91)90094-Y; Flach Florence, 1942, JOUR HEREDITY, V33, P456; FRANCESCHETTI A, 1953, J GENET HUM, V2, P283; Francois J., 1961, HEREDITY OPHTHALMOLO; FRANCOMANO C A, 1987, Genomics, V1, P293, DOI 10.1016/0888-7543(87)90027-9; GOLDSCHMIDT E, 1981, ACTA OPHTHALMOL, V59, P759, DOI 10.1111/j.1755-3768.1981.tb08743.x; GWIAZDA J, 1993, CLIN VISION SCI, V8, P337; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HOYT CS, 1981, AM J OPHTHALMOL, V91, P197, DOI 10.1016/0002-9394(81)90173-2; JOHNSON AT, 1993, OPHTHALMOLOGY, V100, P524; KARLSSON JL, 1975, CLIN GENET, V7, P197; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1986, GENET EPIDEMIOL, V3, P39, DOI 10.1002/gepi.1370030105; LEE B, 1991, NATURE, V352, P330, DOI 10.1038/352330a0; Lin L L, 1988, Acta Ophthalmol Suppl, V185, P29; Macklin MT, 1927, CAN MED ASSOC J, V17, P1493; MARSHALL GE, 1992, EXP EYE RES, V54, P393, DOI 10.1016/0014-4835(92)90051-S; MARSHALL GE, 1995, BRIT J OPHTHALMOL, V79, P57, DOI 10.1136/bjo.79.1.57; MARSHALL GE, 1990, EXP EYE RES, V51, P691, DOI 10.1016/0014-4835(90)90054-X; MILLERMEEKS MJ, 1990, AM J OPHTHALMOL, V109, P199, DOI 10.1016/S0002-9394(14)75987-2; MINKOVITZ JB, 1993, INVEST OPHTH VIS SCI, V34, P1218; MORRISON J, 1995, EXP EYE RES, V60, P127, DOI 10.1016/S0014-4835(95)80002-6; *NAT ADV COUNC STR, 1993, VIS RES NAT PLAN 199; Oetting WS, 1995, GENOMICS, V30, P450, DOI 10.1006/geno.1995.1264; OTT J, 1983, ANN HUM GENET, V47, P311, DOI 10.1111/j.1469-1809.1983.tb01001.x; RAJAN U, 1995, P 5 INT C MYOP TOR O, P41; ROSS R, 1971, SCI AM, V224, P44; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SHEFFIELD VC, 1993, NAT GENET, V4, P47, DOI 10.1038/ng0593-47; SORSBY A, 1962, VISION RES, V2, P309, DOI 10.1016/0042-6989(62)90039-1; Sorsby A., 1962, REFRACTION ITS COMPO; SPERDUTO RD, 1983, ARCH OPHTHALMOL-CHIC, V101, P405, DOI 10.1001/archopht.1983.01040010405011; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; TEIKARI JM, 1991, HUM HERED, V41, P151, DOI 10.1159/000153994; WEBER JL, 1989, AM J HUM GENET, V44, P388; WIGGS JL, 1994, GENOMICS, V21, P299, DOI 10.1006/geno.1994.1269; WILKIN DJ, 1993, GENOMICS, V15, P372, DOI 10.1006/geno.1993.1070	50	171	193	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1998	63	1					109	119		10.1086/301907	http://dx.doi.org/10.1086/301907			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZZ726	9634508	Green Published, Bronze			2022-12-18	WOS:000074761000017
J	VANLIEBURG, AF; VERDIJK, MAJ; KNOERS, VVAM; VANESSEN, AJ; PROESMANS, W; MALLMANN, R; MONNENS, LAH; VANOOST, BA; VANOS, CH; DEEN, PMT				VANLIEBURG, AF; VERDIJK, MAJ; KNOERS, VVAM; VANESSEN, AJ; PROESMANS, W; MALLMANN, R; MONNENS, LAH; VANOOST, BA; VANOS, CH; DEEN, PMT			PATIENTS WITH AUTOSOMAL NEPHROGENIC DIABETES-INSIPIDUS HOMOZYGOUS FOR MUTATIONS IN THE AQUAPORIN-2 WATER-CHANNEL GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VASOPRESSIN V2-RECEPTOR GENE; MAJOR INTRINSIC PROTEIN; RECEPTOR GENE; RAT-KIDNEY; IDENTIFICATION; DEFECT; EXPRESSION; TUBULE; RNA	Mutations in the X-chromosomal V2 receptor gene are known to cause nephrogenic diabetes insipidus (NDI). Besides the X-linked form, an autosomal mode of inheritance has been described. Recently, mutations in the autosomal gene coding for water-channel aquaporin 2 (AQP2) of the renal collecting duct were reported in an NDI patient. In the present study, missense mutations and a single nucleotide deletion in the aquaporin 2 gene of three NDI patients from consanguineous matings are described. Expression studies in Xenopus oocytes showed that the missense AQP2 proteins are nonfunctional. These results prove that mutations in the AQP2 gene cause autosomal recessive NDI.	UNIV NIJMEGEN,DEPT PEDIAT,NIJMEGEN,NETHERLANDS; UNIV NIJMEGEN,DEPT HUMAN GENET,NIJMEGEN,NETHERLANDS; UNIV GRONINGEN,DEPT MED GENET,GRONINGEN,NETHERLANDS; CATHOLIC UNIV LEUVEN,DEPT PEDIAT,B-3000 LOUVAIN,BELGIUM; UNIV BONN,DEPT PEDIAT,W-5300 BONN,GERMANY	Radboud University Nijmegen; Radboud University Nijmegen; University of Groningen; KU Leuven; University of Bonn	VANLIEBURG, AF (corresponding author), UNIV NIJMEGEN,DEPT CELL PHYSIOL,POB 9101,6500 HB NIJMEGEN,NETHERLANDS.		Monnens, L.A.H./L-4526-2015; Deen, Peter MT/B-9854-2013; Deen, P.M.T./H-8023-2014	Deen, Peter MT/0000-0002-7868-4655; Deen, P.M.T./0000-0002-7868-4655				AERTS T, 1990, J BIOL CHEM, V265, P8675; BAKER ME, 1990, CELL, V60, P185, DOI 10.1016/0092-8674(90)90731-S; BIA MJ, 1979, AM J PHYSIOL, V277, pF218; BICHET DG, 1993, J CLIN INVEST, V92, P1262, DOI 10.1172/JCI116698; BRENNER B, 1988, J CLIN ENDOCR METAB, V67, P191, DOI 10.1210/jcem-67-1-191; DEEN PMT, 1994, CYTOGENET CELL GENET, V66, P260, DOI 10.1159/000133707; DEEN PMT, 1994, SCIENCE, V264, P92, DOI 10.1126/science.8140421; FUSHIMI K, 1993, NATURE, V361, P549, DOI 10.1038/361549a0; GELEHRTER TD, 1990, PRINCIPLES MED GENET; HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3; HOLTZMAN EJ, 1993, NEW ENGL J MED, V328, P1534, DOI 10.1056/NEJM199305273282105; KNOERS N, 1991, EUR J PEDIATR, V150, P370, DOI 10.1007/BF01955943; KNOERS N, 1993, PEDIATR NEPHROL, V7, P685, DOI 10.1007/BF00852579; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGLEY JM, 1991, AM J MED GENET, V38, P90, DOI 10.1002/ajmg.1320380120; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; MERENDINO JJ, 1993, NEW ENGL J MED, V328, P1538, DOI 10.1056/NEJM199305273282106; MOSES AM, 1988, J CLIN ENDOCR METAB, V66, P1259, DOI 10.1210/jcem-66-6-1259; NIELSEN S, 1993, P NATL ACAD SCI USA, V90, P11663, DOI 10.1073/pnas.90.24.11663; OHZEKI T, 1984, J PEDIATR-US, V104, P593, DOI 10.1016/S0022-3476(84)80556-9; PAN Y, 1992, NAT GENET, V2, P103, DOI 10.1038/ng1092-103; PRESTON GM, 1993, J BIOL CHEM, V268, P17; PRESTON GM, 1994, J BIOL CHEM, V269, P1; REIZER J, 1993, CRIT REV BIOCHEM MOL, V28, P235, DOI 10.3109/10409239309086796; ROSENTHAL W, 1992, NATURE, V359, P233, DOI 10.1038/359233a0; SASAKI S, 1994, J CLIN INVEST, V93, P1250, DOI 10.1172/JCI117079; SCHERLY D, 1989, EMBO J, V8, P4163, DOI 10.1002/j.1460-2075.1989.tb08601.x; SMITH BL, 1991, J BIOL CHEM, V266, P6407; VANDENOUWELAND AMW, 1992, NAT GENET, V2, P99, DOI 10.1038/ng1092-99; VANHOEK AN, 1991, J BIOL CHEM, V266, P16633; ZHANG R, 1991, AM J PHYSIOL, V260, pC26, DOI 10.1152/ajpcell.1991.260.1.C26; ZIMMERMAN D, 1975, PEDIATR RES, V9, P381	32	171	173	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1994	55	4					648	652						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PJ027	7524315				2022-12-18	WOS:A1994PJ02700006
J	BENN, PA				BENN, PA			SPECIFIC CHROMOSOME-ABERRATIONS IN SENESCENT FIBROBLAST CELL LINES DERIVED FROM HUMAN EMBRYOS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV BIRMINGHAM,DEPT CANC STUDIES,BIRMINGHAM B15 2TJ,ENGLAND	University of Birmingham								BRADLEY MO, 1975, EXP CELL RES, V96, P103, DOI 10.1016/S0014-4827(75)80042-5; BUCKTON KE, 1964, INT J RADIAT BIOL RE, V8, P439, DOI 10.1080/09553006414550551; CASPERSS.T, 1970, EXP CELL RES, V60, P315, DOI 10.1016/0014-4827(70)90523-9; CHEN TR, 1974, CHROMOSOMA, V47, P147, DOI 10.1007/BF00331802; FULDER SJ, 1975, CELL, V6, P67, DOI 10.1016/0092-8674(75)90075-6; HARNDEN DG, 1976, SOMAT CELL GENET, V2, P55, DOI 10.1007/BF01539242; HARNDEN DG, 1974, HUMAN CHROMOSOME MET, P167; HAYASHI K, 1975, HUMANGENETIK, V30, P135, DOI 10.1007/BF00291946; HAYATA I, 1975, LANCET, V1, P1300; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; HOLLIDAY R, 1972, NATURE, V238, P26, DOI 10.1038/238026a0; HSU TC, 1975, CYTOGENET CELL GENET, V15, P41, DOI 10.1159/000130497; LITTLEFIELD LG, 1975, AM J HUM GENET, V27, P190; MARTIN GM, 1970, LAB INVEST, V23, P86; MCCAW BK, 1975, P NATL ACAD SCI USA, V72, P2071, DOI 10.1073/pnas.72.6.2071; MOORHEAD PS, 1963, J CELL COMPAR PHYSL, V62, P57, DOI 10.1002/jcp.1030620109; MOORHEAD PS, 1964, MAMMALIAN CYTOGENETI, P17; ORGEL LE, 1963, P NATL ACAD SCI USA, V49, P517, DOI 10.1073/pnas.49.4.517; ORGEL LE, 1973, NATURE, V243, P441; REYE C, 1960, AMA J DIS CHILD, V99, P238, DOI 10.1001/archpedi.1960.02070030240016; RUSSELL WC, 1975, NATURE, V253, P461, DOI 10.1038/253461a0; SAKSELA E, 1963, P NATL ACAD SCI USA, V50, P390, DOI 10.1073/pnas.50.2.390; SWANSON CP, 1968, CYTOLOGY CYTOGENETIC; THOMPSON KVA, 1975, EXP CELL RES, V96, P1, DOI 10.1016/S0014-4827(75)80029-2; WELCH J P, 1975, Nature (London), V255, P241, DOI 10.1038/255241a0; WOLMAN S. R., 1964, CYTOGENETICS [BASEL], V3, P45, DOI 10.1159/000129797; ZECH C, 1976, INT J CANCER, V17, P47; 1971, BIRTH DEFECTS OAS, V8	29	171	175	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1976	28	5					465	473						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CH661	984042				2022-12-18	WOS:A1976CH66100004
J	CHEN, SH; MALCOLM, LA; YOSHIDA, A; GIBLETT, ER				CHEN, SH; MALCOLM, LA; YOSHIDA, A; GIBLETT, ER			PHOSPHOGLYCERATE KINASE - X-LINKED POLYMORPHISM IN MAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BEUTLER E, 1969, BIOCHEM GENET, V3, P189, DOI 10.1007/BF00520353; DAVIDSON RG, 1963, P NATL ACAD SCI USA, V50, P481, DOI 10.1073/pnas.50.3.481; KRAUS AP, 1968, BIOCHEM BIOPH RES CO, V30, P173, DOI 10.1016/0006-291X(68)90466-X; Motulsky A.G., 1969, BIOCH METHODS RED CE, P51; SCOPES RK, 1969, BIOCHEM J, V113, P551, DOI 10.1042/bj1130551; VALENTINE WN, 1969, NEW ENGL J MED, V280, P528, DOI 10.1056/NEJM196903062801003; 1967, WHO366 TECHN REP SER, P15	7	171	171	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1971	23	1					87	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	I6190	5581984				2022-12-18	WOS:A1971I619000010
J	Beaulieu, CL; Majewski, J; Schwartzentruber, J; Samuels, ME; Femandez, BA; Bernier, FP; Brudno, M; Knoppers, B; Marcadier, J; Dyment, D; Adam, S; Bulman, DE; Jones, SJM; Avard, D; Nguyen, MT; Rousseau, F; Marshall, C; Wintle, RF; Shen, YQ; Scherer, SW; Friedman, JM; Michaud, JL; Boycott, KM				Beaulieu, Chandree L.; Majewski, Jacek; Schwartzentruber, Jeremy; Samuels, Mark E.; Femandez, Bridget A.; Bernier, Francois P.; Brudno, Michael; Knoppers, Bartha; Marcadier, Janet; Dyment, David; Adam, Shelin; Bulman, Dennis E.; Jones, Steve J. M.; Avard, Denise; Minh Thu Nguyen; Rousseau, Francois; Marshall, Christian; Wintle, Richard F.; Shen, Yaoqing; Scherer, Stephen W.; Friedman, Jan M.; Michaud, Jacques L.; Boycott, Kym M.		FORGE Canada Consortium	FORGE Canada Consortium: Outcomes of a 2-Year National Rare-Disease Gene-Discovery Project	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CAUSE JOUBERT SYNDROME; SEQUENCING DATA; INTELLECTUAL DISABILITY; MUTATIONS; HAPLOINSUFFICIENCY; DEFICIENCY; PHENOTYPE; COMPONENT; SOFTWARE; COMPLEX	Inherited monogenic disease has an enormous impact on the well-being of children and their families. Over half of the children living with one of these conditions are without a molecular diagnosis because of the rarity of the disease, the marked clinical heterogeneity, and the reality that there are thousands of rare diseases for which causative mutations have yet to be identified. It is in this context that in 2010 a Canadian consortium was formed to rapidly identify mutations causing a wide spectrum of pediatric-onset rare diseases by using whole-exome sequencing. The FORGE (Finding of Rare Disease Genes) Canada Consortium brought together clinicians and scientists from 21 genetics centers and three science and technology innovation centers from across Canada. From nation-wide requests for proposals, 264 disorders were selected for study from the 371 submitted; disease-causing variants (including in 67 genes not previously associated with human disease; 41 of these have been genetically or functionally validated, and 26 are currently under study) were identified for 146 disorders over a 2-year period. Here, we present our experience with four strategies employed for gene discovery and discuss FORGE's impact in a number of realms, from clinical diagnostics to the broadening of the phenotypic spectrum of many diseases to the biological insight gained into both disease states and normal human development. Lastly, on the basis of this experience, we discuss the way forward for rare-disease genetic discovery both in Canada and internationally.	[Beaulieu, Chandree L.; Marcadier, Janet; Dyment, David; Bulman, Dennis E.; Boycott, Kym M.; FORGE Canada Consortium] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada; [Majewski, Jacek] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; [Schwartzentruber, Jeremy; Knoppers, Bartha; Avard, Denise; Minh Thu Nguyen] McGill Univ, Montreal, PQ H3A 1A4, Canada; [Schwartzentruber, Jeremy] Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; [Samuels, Mark E.; Michaud, Jacques L.] Univ Montreal, Dept Med, Ctr Hosp Univ St Justine, Ctr Rech, Montreal, PQ H3T 1C5, Canada; [Femandez, Bridget A.] Mem Univ Newfoundland, Fac Med, Discipline Genet, St John, NF A1B 3V6, Canada; [Femandez, Bridget A.] Mem Univ Newfoundland, Fac Med, Discipline Med, St John, NF A1B 3V6, Canada; [Bernier, Francois P.] Univ Calgary, Dept Med Genet, Calgary, AB T2N 4N1, Canada; [Brudno, Michael] Univ Toronto, Dept Comp Sci, Donnelly Ctr, Toronto, ON M5S 3G4, Canada; [Brudno, Michael] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3G4, Canada; [Brudno, Michael] Hosp Sick Children, Ctr Computat Med, Toronto, ON M5S 3G4, Canada; [Knoppers, Bartha; Avard, Denise; Minh Thu Nguyen] Ctr Genom & Policy, Montreal, PQ H3A 1A4, Canada; [Adam, Shelin; Friedman, Jan M.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada; [Jones, Steve J. M.; Shen, Yaoqing] British Columbia Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z4S6, Canada; [Rousseau, Francois] Univ Laval, Dept Mol Biol Med Biochem & Pathol, Ctr Hosp Univ Quebec, Ctr Rech, Quebec City, PQ G1L 3L5, Canada; [Brudno, Michael; Marshall, Christian; Wintle, Richard F.; Scherer, Stephen W.] Hosp Sick Children, Ctr Appl Genom & Genet & Genome Biol, Toronto, ON M5G 0A4, Canada; [Scherer, Stephen W.] Univ Toronto, McLaughlin Ctr, Toronto, ON M5G 0A4, Canada; [Scherer, Stephen W.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 0A4, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; McGill University; McGill University; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Memorial University Newfoundland; Memorial University Newfoundland; University of Calgary; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of British Columbia; British Columbia Cancer Agency; Laval University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Boycott, KM (corresponding author), Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada.	kboycott@cheo.on.ca	Bernier, Francois/AAP-2174-2020; Jones, Steven J/C-3621-2009; Scherer, Stephen W./B-3785-2013; Bernier, Francois/V-7150-2018	Jones, Steven J/0000-0003-3394-2208; Scherer, Stephen W./0000-0002-8326-1999; Bernier, Francois/0000-0001-7063-4269; Wintle, Richard/0000-0003-1987-1095; Schwartzentruber, Jeremy/0000-0002-6183-2092; Adam, Shelin/0000-0002-4401-6157; Friedman, Jan/0000-0002-7482-9570	Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Beaulieu CL, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-62; Bernier FP, 2012, AM J HUM GENET, V90, P925, DOI 10.1016/j.ajhg.2012.04.004; Berryer MH, 2013, HUM MUTAT, V34, P385, DOI 10.1002/humu.22248; Boycott KM, 2013, NAT REV GENET, V14, P681, DOI 10.1038/nrg3555; Cheung YH, 2013, AM J HUM GENET, V92, P996, DOI 10.1016/j.ajhg.2013.04.026; Demos MK, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-15; Dodge JA, 2011, ARCH DIS CHILD, V96, P791, DOI 10.1136/adc.2010.193664; Doherty D, 2012, AM J HUM GENET, V90, P1088, DOI 10.1016/j.ajhg.2012.04.008; Khuong-Quang DA, 2013, PEDIATRICS, V131, pE620, DOI 10.1542/peds.2012-1303; Dyment D, 2013, CLIN GENET; Dyment DA, 2013, AM J HUM GENET, V93, P158, DOI 10.1016/j.ajhg.2013.06.005; Farhan SMK, 2014, MOL GENET GENOM MED, V2, P73, DOI 10.1002/mgg3.46; Fernandez BA, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-111; Fernandez CV, 2013, GENET MED, V15, P558, DOI 10.1038/gim.2012.183; Fromer M, 2012, AM J HUM GENET, V91, P597, DOI 10.1016/j.ajhg.2012.08.005; Gibson WT, 2012, AM J HUM GENET, V90, P110, DOI 10.1016/j.ajhg.2011.11.018; Girdea M, 2013, HUM MUTAT, V34, P1057, DOI 10.1002/humu.22347; Greenway SC, 2014, CAN J CARDIOL, V30, P181, DOI 10.1016/j.cjca.2013.12.003; Halbritter J, 2013, AM J HUM GENET, V93, P915, DOI 10.1016/j.ajhg.2013.09.012; Hasselmann C, 2013, J GENOMES EXOMES, V2, P19, DOI DOI 10.4137/JGE.S11378; Hood RL, 2012, AM J HUM GENET, V90, P308, DOI 10.1016/j.ajhg.2011.12.001; Johnson JO, 2012, BRAIN, V135, P2875, DOI 10.1093/brain/aws161; Kleiderman E, 2013, J MED ETHICS; Kohler S, 2014, NUCLEIC ACIDS RES, V42, pD966, DOI 10.1093/nar/gkt1026; Koenekoop RK, 2012, NAT GENET, V44, P1035, DOI 10.1038/ng.2356; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lines MA, 2012, AM J HUM GENET, V90, P369, DOI 10.1016/j.ajhg.2011.12.023; Majewski J, 2011, HUM MUTAT, V32, P1114, DOI 10.1002/humu.21546; Marcadier JL, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-98; McDonell LM, 2013, NAT GENET, V45, P556, DOI 10.1038/ng.2602; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; McMillan HJ, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-90; Moffatt P, 2013, AM J HUM GENET, V92, P252, DOI 10.1016/j.ajhg.2012.12.001; Nikkei S.M., 2013, CLIN GENET; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Samuels ME, 2013, J MED GENET, V50, P324, DOI 10.1136/jmedgenet-2012-101483; Samuels ME, 2013, J CLIN ENDOCR METAB, V98, P736, DOI 10.1210/jc.2012-3199; Samuels ME, 2010, CURR GENOMICS, V11, P482, DOI 10.2174/138920210793175886; Schuurs-Hoeijmakers JHM, 2012, AM J HUM GENET, V91, P1073, DOI 10.1016/j.ajhg.2012.10.017; Senecal K., 2013, STATEMENT PRINCIPLES; Shi YH, 2013, BIOINFORMATICS, V29, P1461, DOI 10.1093/bioinformatics/btt151; Srour M, 2012, J MED GENET, V49, P636, DOI 10.1136/jmedgenet-2012-101132; Srour M, 2012, AM J HUM GENET, V90, P693, DOI 10.1016/j.ajhg.2012.02.011; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	46	170	174	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 5	2014	94	6					809	817		10.1016/j.ajhg.2014.05.003	http://dx.doi.org/10.1016/j.ajhg.2014.05.003			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AJ0HK	24906018	Green Published, hybrid			2022-12-18	WOS:000337331200002
J	Audo, I; Kohl, S; Leroy, BP; Munier, FL; Guillonneau, X; Mohand-Said, S; Bujakowska, K; Nandrot, EF; Lorenz, B; Preising, M; Kellner, U; Renner, AB; Bernd, A; Antonio, A; Moskova-Doumanova, V; Lancelot, ME; Poloschek, CM; Drumare, I; Defoort-Dhellemmes, S; Wissinger, B; Leveillard, T; Hamel, CP; Schorderet, DF; De Baere, E; Berger, W; Jacobson, SG; Zrenner, E; Sahel, JA; Bhattacharya, SS; Zeitz, C				Audo, Isabelle; Kohl, Susanne; Leroy, Bart P.; Munier, Francis L.; Guillonneau, Xavier; Mohand-Said, Saddek; Bujakowska, Kinga; Nandrot, Emeline F.; Lorenz, Birgit; Preising, Markus; Kellner, Ulrich; Renner, Agnes B.; Bernd, Antje; Antonio, Aline; Moskova-Doumanova, Veselina; Lancelot, Marie-Elise; Poloschek, Charlotte M.; Drumare, Isabelle; Defoort-Dhellemmes, Sabine; Wissinger, Bernd; Leveillard, Thierry; Hamel, Christian P.; Schorderet, Daniel F.; De Baere, Elfride; Berger, Wolfgang; Jacobson, Samuel G.; Zrenner, Eberhart; Sahel, Jose-Alain; Bhattacharya, Shomi S.; Zeitz, Christina			TRPM1 Is Mutated in Patients with Autosomal-Recessive Complete Congenital Stationary Night Blindness	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							METABOTROPIC RECEPTOR MGLUR6; ROD BIPOLAR CELLS; LIGHT RESPONSE; MUTATIONS; GENE; ELECTRORETINOGRAM; LOCALIZATION; PROTEIN; RICH; G-ALPHA(O)	Night vision requires signaling from rod photoreceptors to adjacent bipolar cells in the retina. Mutations in the genes NYX and GRM6, expressed in ON bipolar cells, lead to a disruption of the ON bipolar cell response. This dysfunction is present in patients with complete X-linked and autosomal-recessive congenital stationary night blindness (CSNB) and can be assessed by standard full-field electroretinography (ERG), showing severely reduced rod b-wave amplitude and slightly altered cone responses. Although many cases of complete CSNB (cCSNB) are caused by mutations in NYX and GRM6, in similar to 60% of the patients the gene defect remains unknown. Animal models of human diseases are a good source for candidate genes, and we noted that a cCSNB phenotype present in homozygous Appaloosa horses is associated with downregulation of TRPM1. TRPM 1, belonging to the family of transient receptor potential channels, is expressed in ON bipolar cells and therefore qualifies as an excellent candidate. Indeed, mutation analysis of 38 patients with CSNB identified ten unrelated cCSNB patients with 14 different mutations in this gene. The mutation spectrum comprises missense, splice-site, deletion, and nonsense mutations. We propose that the cCSNB phenotype in these patients is due to the absence of functional TRPM1 in retinal ON bipolar cells.	[Audo, Isabelle; Guillonneau, Xavier; Mohand-Said, Saddek; Bujakowska, Kinga; Nandrot, Emeline F.; Antonio, Aline; Moskova-Doumanova, Veselina; Lancelot, Marie-Elise; Leveillard, Thierry; Sahel, Jose-Alain; Bhattacharya, Shomi S.; Zeitz, Christina] INSERM, UMR S968, F-75012 Paris, France; [Audo, Isabelle; Guillonneau, Xavier; Mohand-Said, Saddek; Bujakowska, Kinga; Nandrot, Emeline F.; Antonio, Aline; Moskova-Doumanova, Veselina; Lancelot, Marie-Elise; Leveillard, Thierry; Sahel, Jose-Alain; Bhattacharya, Shomi S.; Zeitz, Christina] CNRS, UMR 7210, F-75012 Paris, France; [Audo, Isabelle; Guillonneau, Xavier; Mohand-Said, Saddek; Bujakowska, Kinga; Nandrot, Emeline F.; Antonio, Aline; Moskova-Doumanova, Veselina; Lancelot, Marie-Elise; Leveillard, Thierry; Sahel, Jose-Alain; Bhattacharya, Shomi S.; Zeitz, Christina] Univ Paris 06, Inst Vis, UMR S968, F-75012 Paris, France; [Audo, Isabelle; Mohand-Said, Saddek; Antonio, Aline; Sahel, Jose-Alain] INSERM, CHNO Quinze Vingts, CMR CIC 503, F-75012 Paris, France; [Audo, Isabelle; Bhattacharya, Shomi S.] Inst Ophthalmol, Dept Mol Genet, London EC1V 9EL, England; [Kohl, Susanne; Wissinger, Bernd] Inst Ophthalm Res, Mol Genet Lab, D-72076 Tubingen, Germany; [Leroy, Bart P.; De Baere, Elfride] Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium; [Leroy, Bart P.] Univ Ghent, Dept Ophthalmol, B-9000 Ghent, Belgium; [Munier, Francis L.] Jules Gonin Eye Hosp, Unit Oculogenet, CH-1004 Lausanne, Switzerland; [Lorenz, Birgit; Preising, Markus] Univ Giessen, Dept Ophthalmol, Univ Giessen Klinikum, D-35392 Giessen, Germany; [Lorenz, Birgit; Preising, Markus] Marburg GmbH, D-35392 Giessen, Germany; [Kellner, Ulrich] Augen Zentrum Siegburg, D-53721 Siegburg, Germany; [Renner, Agnes B.] Univ Med Ctr Regensburg, Dept Ophthalmol, D-93042 Regensburg, Germany; [Bernd, Antje; Zrenner, Eberhart] Univ Clin Tuebingen, Univ Eye Clin, Ctr Ophthalmol, D-72076 Tubingen, Germany; [Poloschek, Charlotte M.] Univ Freiburg, Dept Ophthalmol, D-79106 Freiburg, Germany; [Drumare, Isabelle; Defoort-Dhellemmes, Sabine] Hop Roger Salengro, CNRS, Lab Neurosci Fonct & Pathol, FRE 2726, F-59037 Lille, France; [Hamel, Christian P.] Hop St Eloi, INSERM, Inst Neurosci, U583, F-34091 Montpellier, France; [Munier, Francis L.; Schorderet, Daniel F.] Univ Lausanne, Inst Rech Ophtalmol, Ecole Polytech Fed Lausanne, CH-1950 Sion, Switzerland; [Berger, Wolfgang] Univ Zurich, Inst Med Genet, Div Med Mol Genet & Gene Diagnost, CH-8603 Schwerzenbach, Switzerland; [Jacobson, Samuel G.] Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; CHNO des Quinze-Vingts; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of London; University College London; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Ghent University; Ghent University; Justus Liebig University Giessen; University Hospital of Giessen & Marburg; University Hospital of Giessen & Marburg; University of Regensburg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Freiburg; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; CHU Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; University of Zurich; University of Pennsylvania; Pennsylvania Medicine	Zeitz, C (corresponding author), INSERM, UMR S968, F-75012 Paris, France.	christina.zeitz@inserm.fr	guillonneau, xavier/AAF-9495-2021; De Baere, Elfride/E-7405-2017; Preising, Markus/GQA-9591-2022; Zeitz, Christina/F-2757-2017; Bhattacharya, Shom/N-2926-2016; Léveillard, Thierry/AAR-1804-2020; Guillonneau, xavier/E-3995-2017; Moskova-Doumanova, Veselina/S-5757-2019; Bujakowska, Kinga Maria/AGL-1293-2022; Poloschek, Charlotte M/B-3097-2010; Sahel, Jose-Alain/F-3172-2017; Nandrot, Emeline F./AAN-3925-2020	guillonneau, xavier/0000-0001-7379-3935; De Baere, Elfride/0000-0002-5609-6895; Zeitz, Christina/0000-0002-3510-1712; Bhattacharya, Shom/0000-0002-1601-6344; Léveillard, Thierry/0000-0001-5692-8770; Guillonneau, xavier/0000-0001-7379-3935; Moskova-Doumanova, Veselina/0000-0001-5316-5835; Sahel, Jose-Alain/0000-0002-4831-1153; Kohl, Susanne/0000-0002-6438-6331; Bujakowska, Kinga/0000-0001-6809-9818; Jacobson, Samuel/0000-0003-2122-169X; Audo, Isabelle/0000-0003-0698-5309	Agence Nationale de la Recherche; Foundation Voir et Entendre and BQR; Universite Pierre et Marie Curie6; Foundation Fighting Blindness (FFB) [CD-CL-0808-0466-CHNO]; CIC503 recognized as an FFB center [C-CMM-0907-0428-INSERM04]; EU FP7; Integrated Project "EVI-GENORET" [LSHG-CT-2005-512036]; Swiss National Science Foundation [320030127558]; Research Foundation Flanders [G.0043.06N]; Deutsche Forschungsgemeinschaft [KFO134-KO2176/2-1, KFO134-ZR1/17-2]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Foundation Voir et Entendre and BQR; Universite Pierre et Marie Curie6; Foundation Fighting Blindness (FFB); CIC503 recognized as an FFB center; EU FP7(European Commission); Integrated Project "EVI-GENORET"(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Research Foundation Flanders(FWO); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors are grateful to the families described in this study, to Dominique Santiard-Baron and Christine Chaumeil for their help in DNA collection, and to the clinical staff. They thank Anne Friedrich, as well, for investigation of possibilities for the modeling of TRPM1 on a three-dimensional basis. The project was financially supported by Agence Nationale de la Recherche (to S.S.B), Foundation Voir et Entendre and BQR (Bonus Qualite Recherche), Universite Pierre et Marie Curie6 (to C.Z.), Foundation Fighting Blindness (FFB) (to I.A., grant no. CD-CL-0808-0466-CHNO; and the CIC503 recognized as an FFB center, grant no. C-CMM-0907-0428-INSERM04), EU FP7, Integrated Project "EVI-GENORET" (LSHG-CT-2005-512036), the Swiss National Science Foundation (to F.L.M. and D.F.S., grant no. 320030127558), Research Foundation Flanders (FWO) (to B.P.L., grant no. G.0043.06N), and the Deutsche Forschungsgemeinschaft (to S.K., BW., and E.Z.; grant no. KFO134-KO2176/2-1 and KFO134-ZR1/17-2).	Audo I, 2008, SURV OPHTHALMOL, V53, P16, DOI 10.1016/j.survophthal.2007.10.010; Bech-Hansen NT, 2000, NAT GENET, V26, P319, DOI 10.1038/81619; Bech-Hansen NT, 1998, NAT GENET, V19, P264, DOI 10.1038/947; Bellone RR, 2008, GENETICS, V179, P1861, DOI 10.1534/genetics.108.088807; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Dhingra A, 2002, J NEUROSCI, V22, P4878, DOI 10.1523/JNEUROSCI.22-12-04878.2002; Dhingra A, 2000, J NEUROSCI, V20, P9053; Dryja TP, 2005, P NATL ACAD SCI USA, V102, P4884, DOI 10.1073/pnas.0501233102; Fang D, 2000, BIOCHEM BIOPH RES CO, V279, P53, DOI 10.1006/bbrc.2000.3894; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; MIYAKE Y, 1986, ARCH OPHTHALMOL-CHIC, V104, P1013, DOI 10.1001/archopht.1986.01050190071042; MIYAKE Y, 1994, INVEST OPHTH VIS SCI, V35, P3770; Morgans CW, 2006, EUR J NEUROSCI, V23, P1163, DOI 10.1111/j.1460-9568.2006.04647.x; Nawy S, 1999, J NEUROSCI, V19, P2938; NOMURA A, 1994, CELL, V77, P361, DOI 10.1016/0092-8674(94)90151-1; Oancea E, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000146; Pusch CM, 2000, NAT GENET, V26, P324, DOI 10.1038/81627; Sandmeyer LS, 2007, VET OPHTHALMOL, V10, P368, DOI 10.1111/j.1463-5224.2007.00572.x; Sandmeyer LS, 2006, CAN VET J, V47, P1131; SCHUBERT G, 1952, OPHTHALMOLOGICA, V123, P396, DOI 10.1159/000301211; Shen Y, 2009, J NEUROSCI, V29, P6088, DOI 10.1523/JNEUROSCI.0132-09.2009; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Vardi N, 1997, VISUAL NEUROSCI, V14, P789, DOI 10.1017/S0952523800012736; Vardi N, 2000, J COMP NEUROL, V423, P402, DOI 10.1002/1096-9861(20000731)423:3<402::AID-CNE4>3.0.CO;2-E; WITZEL DA, 1978, INVEST OPHTH VIS SCI, V17, P788; Wycisk KA, 2006, AM J HUM GENET, V79, P973, DOI 10.1086/508944; Xu XZS, 2001, P NATL ACAD SCI USA, V98, P10692, DOI 10.1073/pnas.191360198; Zeitz C, 2005, INVEST OPHTH VIS SCI, V46, P4328, DOI 10.1167/iovs.05-0526; ZEITZ C, 2007, INVEST OPHTHALMOL VI, V49; ZEITZ C, 2009, INVEST OPHTHALMOL VI; Zeitz C, 2007, EXPERT REV OPHTHALMO, V2, P467, DOI 10.1586/17469899.2.3.467; Zeitz C, 2007, HUM MUTAT, V28, P771, DOI 10.1002/humu.20499	32	170	173	4	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 13	2009	85	5					720	729		10.1016/j.ajhg.2009.10.013	http://dx.doi.org/10.1016/j.ajhg.2009.10.013			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	521JH	19896113	Green Accepted, Green Published, Bronze			2022-12-18	WOS:000271916500019
J	Ruel, J; Emery, S; Nouvian, R; Bersot, T; Amilhon, B; Van Rybroek, JM; Rebillard, G; Lenoir, M; Eybalin, M; Delprat, B; Sivakumaran, TA; Giros, B; El Mestikawy, S; Moser, T; Smith, RJH; Lesperance, MM; Puel, JL				Ruel, Jerome; Emery, Sarah; Nouvian, Regis; Bersot, Tiphaine; Amilhon, Benedicte; Van Rybroek, Jana M.; Rebillard, Guy; Lenoir, Marc; Eybalin, Michel; Delprat, Benjamin; Sivakumaran, Theru A.; Giros, Bruno; El Mestikawy, Salah; Moser, Tobias; Smith, Richard J. H.; Lesperance, Marci M.; Puel, Jean-Luc			Impairment of SLC17A8 encoding vesicular glutamate transporter-3, VGLUT3, underlies nonsyndromic deafness DFNA25 and inner hair cell dysfunction in null mice	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY HEARING IMPAIRMENT; AUDITORY NEUROPATHY; SYNAPTIC-TRANSMISSION; RECEPTOR SUBUNITS; AFFERENT SYNAPSE; EXPRESSION; OTOFERLIN; COCHLEAR; AMPA; MOUSE	Autosomal-dominant sensorineural hearing loss is genetically heterogeneous, with a phenotype closely resembling presbycusis, the most common sensory defect associated with aging in humans. We have identified SLC17A8, which encodes the vesicular glutamate transporter-3 (VGLUT3), as the gene responsible for DFNA25, an autosomal-dominant form of progressive, high-frequency nonsyndromic deafness. In two unrelated families, a heterozygous missense mutation, c.632C -> T (p.A211V), was found to segregate with DFNA25 deafness and was not present in 267 controls. Linkage-disequilibrium analysis suggested that the families have a distant common ancestor. The A211 residue is conserved in VGLUT3 across species and in all human VGLUT subtypes (VGLUT1-3), suggesting an important functional role. In the cochlea, VGLUT3 accumulates glutamate in the synaptic vesicles of the sensory inner hair cells (IHCs) before releasing it onto receptors of auditory-nerve terminals. Null mice with a targeted deletion of Slc17a8 exon 2 lacked auditory-nerve responses to acoustic stimuli, although auditory brainstem responses could be elicited by electrical stimuli, and robust otoacoustic emissions were recorded. Ca2+-triggered synaptic-vesicle turnover was normal in IHCs of Slc17a8 null mice when probed by membrane capacitance measurements at 2 weeks of age. Later, the number of afferent synapses, spiral ganglion neurons, and lateral efferent endings below sensory IHCs declined. Ribbon synapses remaining by 3 months of age had a normal ultrastructural appearance. We conclude that deafness in Slc17a8-deficient mice is due to a specific defect of vesicular glutamate uptake and release and that VGLUT3 is essential for auditory coding at the IHC synapse.	[Emery, Sarah; Sivakumaran, Theru A.; Lesperance, Marci M.] Univ Michigan Hlth Syst, Dept Otolaryngol Head & Neck Surg, Div Pediat Otolaryngol, Ann Arbor, MI 48109 USA; [Ruel, Jerome; Bersot, Tiphaine; Rebillard, Guy; Lenoir, Marc; Eybalin, Michel; Delprat, Benjamin; Puel, Jean-Luc] Hop St Eloi, Inst Neurosci, INSERM, U 583, F-34091 Montpellier, France; [Ruel, Jerome; Bersot, Tiphaine; Rebillard, Guy; Lenoir, Marc; Eybalin, Michel; Delprat, Benjamin; Puel, Jean-Luc] Univ Montpellier I, F-34091 Montpellier, France; [Nouvian, Regis; Moser, Tobias] Univ Gottingen, Sch Med, Dept Otolaryngol, InnerEarLab, D-37075 Gottingen, Germany; [Nouvian, Regis; Moser, Tobias] Univ Gottingen, Sch Med, Ctr Mol Physiol Brain, D-37075 Gottingen, Germany; [Amilhon, Benedicte; Giros, Bruno; El Mestikawy, Salah] INSERM, U 513, F-75252 Paris, France; [Van Rybroek, Jana M.; Smith, Richard J. H.] Univ Iowa, Dept Otolaryngol & Head & Neck Surg, Iowa City, IA 52242 USA; [Moser, Tobias] Univ Gottingen, Bernstein Ctr Computat Neurosci, D-37075 Gottingen, Germany	University of Michigan System; University of Michigan; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; University of Gottingen; University of Gottingen; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Iowa; University of Gottingen	Lesperance, MM (corresponding author), Univ Michigan Hlth Syst, Dept Otolaryngol Head & Neck Surg, Div Pediat Otolaryngol, Ann Arbor, MI 48109 USA.	lesperan@med.umich.edu	Nouvian, Regis/AAW-4207-2021; Nouvian, Regis/AFQ-8065-2022; GIROS, Bruno/ABD-5790-2021; Delprat, Benjamin/O-3791-2018; Moser, Tobias/L-5068-2014; Amilhon, Bénédicte/AAZ-3182-2021; EYBALIN, Michel/A-9895-2011	Nouvian, Regis/0000-0002-0901-4666; Nouvian, Regis/0000-0002-0901-4666; GIROS, Bruno/0000-0001-5876-9822; Moser, Tobias/0000-0001-7145-0533; EYBALIN, Michel/0000-0001-9086-1856; Puel, jean-luc/0000-0002-3772-5190; Ruel, Jerome/0000-0003-2871-7321; Delprat, Benjamin/0000-0002-2457-6923; Smith, Richard/0000-0003-1201-6731	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K23DC000161, R01DC003544] Funding Source: NIH RePORTER; NIDCD NIH HHS [K23 DC000161, R01 DC003544, R01-DC003544, K23 DC00161] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Almqvist J, 2007, PROTEIN SCI, V16, P1819, DOI 10.1110/ps.072944707; Blaesse P, 2005, CELL TISSUE RES, V320, P33, DOI 10.1007/s00441-004-1054-8; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Boulland JL, 2004, J COMP NEUROL, V480, P264, DOI 10.1002/cne.20354; Brandt A, 2003, J NEUROSCI, V23, P10832; Brown J, 1997, ARCH OPHTHALMOL-CHIC, V115, P95, DOI 10.1001/archopht.1997.01100150097016; Brown SDM, 2008, NAT REV GENET, V9, P277, DOI 10.1038/nrg2309; Cruickshanks KJ, 1998, JAMA-J AM MED ASSOC, V279, P1715, DOI 10.1001/jama.279.21.1715; Eybalin M, 2002, EUR J NEUROSCI, V15, P1409, DOI 10.1046/j.1460-9568.2002.01978.x; Eybalin M, 2004, EUR J NEUROSCI, V20, P2981, DOI 10.1111/j.1460-9568.2004.03772.x; Fremeau RT, 2002, P NATL ACAD SCI USA, V99, P14488, DOI 10.1073/pnas.222546799; Fuchs PA, 2003, CURR OPIN NEUROBIOL, V13, P452, DOI 10.1016/S0959-4388(03)00098-9; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gates GA, 1999, ARCH OTOLARYNGOL, V125, P654, DOI 10.1001/archotol.125.6.654; Gillespie DC, 2005, NAT NEUROSCI, V8, P332, DOI 10.1038/nn1397; Gras C, 2002, J NEUROSCI, V22, P5442; Gras C, 2008, NAT NEUROSCI, V11, P292, DOI 10.1038/nn2052; Greene CC, 2001, AM J HUM GENET, V68, P254, DOI 10.1086/316925; HENRY KR, 1980, AUDIOLOGY, V19, P369; Herzog E, 2004, NEUROSCIENCE, V123, P983, DOI 10.1016/j.neuroscience.2003.10.039; Khimich D, 2005, NATURE, V434, P889, DOI 10.1038/nature03418; Kim TB, 2004, J MED GENET, V41, P872, DOI 10.1136/jmg.2004.020628; Knirsch M, 2007, J NEUROSCI, V27, P6442, DOI 10.1523/JNEUROSCI.5364-06.2007; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Matsubara A, 1996, J NEUROSCI, V16, P4457; Moser T, 2000, P NATL ACAD SCI USA, V97, P883, DOI 10.1073/pnas.97.2.883; Nemzou RM, 2006, NEUROSCIENCE, V141, P1849, DOI 10.1016/j.neuroscience.2006.05.057; NIEDZIELSKI AS, 1995, J NEUROSCI, V15, P2338, DOI 10.1523/JNEUROSCI.15-03-02338.1995; Nouvian R, 2006, J MEMBRANE BIOL, V209, P153, DOI 10.1007/s00232-005-0854-4; Nouvian R, 2007, J PHYSIOL-LONDON, V584, P535, DOI 10.1113/jphysiol.2007.139675; Obholzer N, 2008, J NEUROSCI, V28, P2110, DOI 10.1523/JNEUROSCI.5230-07.2008; Oestreicher E, 2000, EUR J NEUROSCI, V12, P1584, DOI 10.1046/j.1460-9568.2000.00049.x; PLEIS JR, 2006, VITAL HLTH STAT, V10, P1; Puel JL, 1995, PROG NEUROBIOL, V47, P449, DOI 10.1016/0301-0082(95)00028-3; Rajan I, 1998, J NEUROSCI, V18, P7836; Reimer RJ, 2004, PFLUG ARCH EUR J PHY, V447, P629, DOI 10.1007/s00424-003-1087-y; Rodriguez-Ballesteros M, 2003, HUM MUTAT, V22, P451, DOI 10.1002/humu.10274; Roehm Pamela C, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P294, DOI 10.1097/01.moo.0000180919.68812.b9; Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; Schafer MKH, 2002, J BIOL CHEM, V277, P50734, DOI 10.1074/jbc.M206738200; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Schug N, 2006, EUR J NEUROSCI, V24, P3372, DOI 10.1111/j.1460-9568.2006.05225.x; Seal RP, 2008, NEURON, V57, P263, DOI 10.1016/j.neuron.2007.11.032; Starr A, 2004, JARO-J ASSOC RES OTO, V5, P411, DOI 10.1007/s10162-004-5014-5; Thirlwall AS, 2003, ARCH OTOLARYNGOL, V129, P830, DOI 10.1001/archotol.129.8.830; Trigueiros-Cunha N, 2003, EUR J NEUROSCI, V18, P2653, DOI 10.1046/j.1460-9568.2003.02989.x; VandenLangenberg GM, 1998, AM J EPIDEMIOL, V148, P204, DOI 10.1093/oxfordjournals.aje.a009625; Varga R, 2003, J MED GENET, V40, P45, DOI 10.1136/jmg.40.1.45; Vissavajjhala P, 1996, EXP NEUROL, V142, P296, DOI 10.1006/exnr.1996.0199; WENTHOLD RJ, 1992, J BIOL CHEM, V267, P501; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; Yasunaga S, 1999, NAT GENET, V21, P363, DOI 10.1038/7693	53	170	186	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 8	2008	83	2					278	292		10.1016/j.ajhg.2008.07.008	http://dx.doi.org/10.1016/j.ajhg.2008.07.008			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337EL	18674745	Green Published, Bronze			2022-12-18	WOS:000258418200013
J	Qin, YY; Choi, Y; Zhao, H; Simpson, JL; Chen, ZJ; Rajkovic, A				Qin, Yingying; Choi, Youngsok; Zhao, Han; Simpson, Joe Leigh; Chen, Zi-Jiang; Rajkovic, Aleksandar			NOBOX homeobox mutation causes premature ovarian failure	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							STIMULATING-HORMONE RECEPTOR; DNA-BINDING SPECIFICITY; GENE; HOMEOPROTEIN; HOMEODOMAIN; EXPRESSION	NOBOX (newborn ovary homeobox gene) is an oocyte-specific homeobox gene that plays a critical role in early folliculogenesis and represents a candidate gene for nonsyndromic ovarian failure. We investigated whether mutations in the NOBOX gene cause premature ovarian failure (POF). We sequenced the NOBOX gene in 96 white women with POF and discovered seven known single-nucleotide polymorphisms and four novel variations, two of which, p.Arg355His and p.Arg360Gln, cause missense mutations in the homeobox domain. Electrophoretic mobility shift assay (EMSA) confirmed that the missense mutation, p.Arg355His, disrupted NOBOX homeodomain binding to NOBOX DNA-binding element (NBE) and had a dominant negative effect on the binding of wild-type NOBOX to DNA. Our findings demonstrate that NOBOX mutations can cause POF.	Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; Shandong Univ, Shandong Provincial Hosp, Ctr Reprod Med, Jinan 250100, Peoples R China; Florida Int Univ, Coll Med, Dept Human & Mol Genet, Miami, FL USA; Florida Int Univ, Coll Med, Dept Obstet, Miami, FL USA; Florida Int Univ, Coll Med, Dept Gynecol, Miami, FL USA	Baylor College of Medicine; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; State University System of Florida; Florida International University; State University System of Florida; Florida International University; State University System of Florida; Florida International University	Rajkovic, A (corresponding author), Baylor Coll Med, Dept Obstet & Gynecol, 1709 Dryden Rd,Suite 1100, Houston, TX 77030 USA.	rajkovic@bcm.edu	Yan, Junhao/AAH-8310-2019; Li, Yuan/GXV-1310-2022; Chen, Zi-Jiang/GOE-6119-2022	Chen, Zi-Jiang/0000-0001-6637-6631; Choi, Youngsok/0000-0002-3862-4105	NICHD NIH HHS [R01 HD044858, HD44858] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044858] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AITTOMAKI K, 1995, CELL, V82, P959, DOI 10.1016/0092-8674(95)90275-9; Banerjee-Basu S, 2001, NUCLEIC ACIDS RES, V29, P3258, DOI 10.1093/nar/29.15.3258; Bodin L, 2007, ENDOCRINOLOGY, V148, P393, DOI 10.1210/en.2006-0764; Bruun JA, 2005, NUCLEIC ACIDS RES, V33, P2661, DOI 10.1093/nar/gki562; Choi Y, 2006, CELL MOL LIFE SCI, V63, P579, DOI 10.1007/s00018-005-5394-7; Choi Y, 2006, J BIOL CHEM, V281, P35747, DOI 10.1074/jbc.M604008200; COULAM CB, 1986, OBSTET GYNECOL, V67, P604; Di Pasquale E, 2004, AM J HUM GENET, V75, P106, DOI 10.1086/422103; Huntriss J, 2006, MOL HUM REPROD, V12, P283, DOI 10.1093/molehr/gal035; Ju JH, 2006, J MOL BIOL, V360, P989, DOI 10.1016/j.jmb.2006.05.064; Kim DW, 2003, J BIOL CHEM, V278, P27532, DOI 10.1074/jbc.M301461200; Koizumi K, 2003, P NATL ACAD SCI USA, V100, P3119, DOI 10.1073/pnas.0438043100; Lacombe A, 2006, AM J HUM GENET, V79, P113, DOI 10.1086/505406; Nallathambi J, 2007, HUM GENET, V121, P107, DOI 10.1007/s00439-006-0276-0; Pangas SA, 2006, HUM REPROD UPDATE, V12, P65, DOI 10.1093/humupd/dmi033; Pangas SA, 2006, MOL ENDOCRINOL, V20, P1406, DOI 10.1210/me.2005-0462; Prueitt RL, 2001, NAT GENET, V27, P132, DOI 10.1038/84735; Racki WJ, 2006, DEVELOPMENT, V133, P4527, DOI 10.1242/dev.02651; Rajkovic A, 2004, SCIENCE, V305, P1157, DOI 10.1126/science.1099755; Rannikko A, 2002, MOL HUM REPROD, V8, P311, DOI 10.1093/molehr/8.4.311; Shiina H, 2006, P NATL ACAD SCI USA, V103, P224, DOI 10.1073/pnas.0506736102; Simpson JL, 1999, AM J MED GENET, V89, P186, DOI 10.1002/(SICI)1096-8628(19991229)89:4<186::AID-AJMG3>3.0.CO;2-5; SIMPSON JL, 2004, OVARY, P541; Sullivan AK, 2005, HUM REPROD, V20, P402, DOI 10.1093/humrep/deh635; Suzumori N, 2002, MECH DEVELOP, V111, P137, DOI 10.1016/S0925-4773(01)00620-7; Suzumori N, 2007, CURR MED CHEM, V14, P353, DOI 10.2174/092986707779941087; Touraine P, 1999, MOL ENDOCRINOL, V13, P1844, DOI 10.1210/me.13.11.1844; Vegetti W, 1998, HUM REPROD, V13, P1796, DOI 10.1093/humrep/13.7.1796; Wittenberger MD, 2007, FERTIL STERIL, V87, P456, DOI 10.1016/j.fertnstert.2006.09.004; Woad KJ, 2006, AUST NZ J OBSTET GYN, V46, P242, DOI 10.1111/j.1479-828X.2006.00585.x; Zhao XX, 2005, FERTIL STERIL, V83, P1843, DOI 10.1016/j.fertnstert.2004.12.031	31	170	186	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2007	81	3					576	581		10.1086/519496	http://dx.doi.org/10.1086/519496			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205PX	17701902	Green Published, Bronze			2022-12-18	WOS:000249128200013
J	Corut, A; Senyigit, A; Ugur, SA; Altin, S; Ozcelik, U; Calisir, H; Yildirim, Z; Gocmen, A; Tolun, A				Corut, Ayse; Senyigit, Abdurrahman; Ugur, Sibel Aylin; Altin, Sedat; Ozcelik, Ugur; Calisir, Haluk; Yildirim, Zeki; Gocmen, Ayhan; Tolun, Aslihan			Mutations in SLC34A2 cause pulmonary alveolar microlithiasis and are possibly associated with testicular microlithiasis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SODIUM-PHOSPHATE COTRANSPORTER; FUNCTIONAL-CHARACTERIZATION; GENES; LUNG; NEPHROLITHIASIS; HYDROXYAPATITE; IDENTIFICATION; LOCALIZATION; PREVALENCE; EXPRESSION	Pulmonary alveolar microlithiasis (PAM) is a rare disease characterized by the deposition of calcium phosphate microliths throughout the lungs. We first identified a PAM locus by homozygosity mapping to 4p15, then identified, by a candidate-gene approach, the gene responsible for the disease as SLC34A2 (the type IIb sodium-phosphate cotransporter gene), which is involved in phosphate homeostasis in several organs. We identified six homozygous exonic mutations in the seven unrelated patients with PAM we studied. Three of the mutations were frameshifts, one was a chain termination, one was an amino acid substitution, and one was a deletion spanning the minimal promoter and the first exon. Absence of functional protein product of the gene is compatible with calcium phosphate deposition in alveolar airspaces. We show that impaired activity of the phosphate transporter is presumably responsible for the microliths and that PAM is a recessive monogenic disease with full penetrance. Testicular microlithiasis (TM) is a disease that is more common than PAM. It is often associated with cancer and infertility. Since the gene we identified is also expressed in testis, we searched for mutations in subjects with TM. In 2 of the 15 subjects with TM we studied, we identified two rare variants, one synonymous and the other noncoding, that are possibly associated with the condition.	Bogazici Univ, Dept Mol Biol & Genet, TR-34342 Istanbul, Turkey; Yedikule Hosp Pulm Dis, Istanbul, Turkey; Dicle Univ, Fac Med, Dept Chest Dis, Diyarbakir, Turkey; Hacettepe Univ, Div Pediat Pulm Dis, Sch Med, Ankara, Turkey; Inonu Univ, Sch Med, Div Pulm Dis, Malatya, Turkey; Sureyyapasa Training & Res Hosp Pulm & Cardiovasc, Ankara, Turkey	Bogazici University; Istanbul Yedikule Chest Diseases & Thoracic Surgery Training & Research Hospital; Dicle University; Hacettepe University; Inonu University; Istanbul Sureyyapasa Chest Diseases & Thoracic Surgery Training & Research Hospital	Tolun, A (corresponding author), Bogazici Univ, Dept Mol Biol & Genet, TR-34342 Istanbul, Turkey.	tolun@boun.edu.tr	Tolun, Aslihan/AAS-2250-2020; Iseri, Sibel Aylin Ugur/AAD-6099-2020; OZCELIK, HAYRIYE UGUR/I-9320-2013	Tolun, Aslihan/0000-0002-0328-6046; OZCELIK, HAYRIYE UGUR/0000-0003-1587-5216; Ugur Iseri, Sibel Aylin/0000-0002-5790-6853				Arslan A, 1996, J Belge Radiol, V79, P118; Castellana G, 2002, AM J MED GENET, V111, P220, DOI 10.1002/ajmg.10530; Collins JS, 2002, AM J HUM GENET, V71, P1251, DOI 10.1086/344344; de Jong BWD, 2004, J UROLOGY, V171, P92, DOI 10.1097/01.ju.0000101948.98175.94; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Feild JA, 1999, BIOCHEM BIOPH RES CO, V258, P578, DOI 10.1006/bbrc.1999.0666; FRAPPART L, 1984, HUM PATHOL, V15, P880, DOI 10.1016/S0046-8177(84)80150-1; Hashimoto M, 2000, AM J PATHOL, V157, P21, DOI 10.1016/S0002-9440(10)64512-9; Kavaslar GN, 2000, AM J HUM GENET, V66, P1705, DOI 10.1086/302898; Kim B, 2003, EUR RADIOL, V13, P2567, DOI 10.1007/s00330-003-2014-5; Lorenz-Depiereux B, 2006, AM J HUM GENET, V78, P193, DOI 10.1086/499410; Mariotta S, 2004, SARCOIDOSIS VASC DIF, V21, P173; Middleton WD, 2002, RADIOLOGY, V224, P425, DOI 10.1148/radiol.2242011137; Miller FNAC, 2002, CLIN RADIOL, V57, P883, DOI 10.1053/crad.2002.1005; Morgan MP, 2001, MOL CARCINOGEN, V32, P111, DOI 10.1002/mc.1070; Murer H, 2004, PFLUG ARCH EUR J PHY, V447, P763, DOI 10.1007/s00424-003-1072-5; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Ozcelik U, 2002, PEDIATR RADIOL, V32, P380, DOI 10.1007/s00247-001-0651-X; PANT K, 1990, CHEST, V98, P245, DOI 10.1378/chest.98.1.245; Piesiak P, 2001, Pneumonol Alergol Pol, V69, P285; Pracyk JB, 1996, RESPIRATION, V63, P254; Prie D, 2002, NEW ENGL J MED, V347, P983, DOI 10.1056/NEJMoa020028; Senyigit A, 2001, RESPIRATION, V68, P204, DOI 10.1159/000050494; Serter S, 2006, SCAND J UROL NEPHROL, V40, P212, DOI 10.1080/00365590600589641; Sobel E, 1996, AM J HUM GENET, V58, P1323; Sumikawa H, 2005, Monaldi Arch Chest Dis, V63, P59; Traebert M, 1999, AM J PHYSIOL-LUNG C, V277, pL868, DOI 10.1152/ajplung.1999.277.5.L868; UCAN ES, 1993, THORAX, V48, P171, DOI 10.1136/thx.48.2.171; Xu H, 2005, AM J PHYSIOL-GASTR L, V288, pG175, DOI 10.1152/ajpgi.00396.2004; Xu H, 1999, GENOMICS, V62, P281, DOI 10.1006/geno.1999.6009; Yeo G, 2004, P NATL ACAD SCI USA, V101, P15700, DOI 10.1073/pnas.0404901101	31	170	197	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2006	79	4					650	656		10.1086/508263	http://dx.doi.org/10.1086/508263			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	089BV	16960801	Bronze, Green Published			2022-12-18	WOS:000240855900006
J	Carlton, VEH; Hu, XL; Chokkalingam, AP; Schrodi, SJ; Brandon, R; Alexander, HC; Chang, M; Catanese, JJ; Leong, DU; Ardlie, KG; Kastner, DL; Seldin, MF; Criswell, LA; Gregersen, PK; Beasley, E; Thomson, G; Amos, CI; Begovich, AB				Carlton, VEH; Hu, XL; Chokkalingam, AP; Schrodi, SJ; Brandon, R; Alexander, HC; Chang, M; Catanese, JJ; Leong, DU; Ardlie, KG; Kastner, DL; Seldin, MF; Criswell, LA; Gregersen, PK; Beasley, E; Thomson, G; Amos, CI; Begovich, AB			PTPN22 genetic variation: Evidence for multiple variants associated with rheumatoid arthritis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; SINGLE-NUCLEOTIDE POLYMORPHISM; SYSTEMIC-LUPUS-ERYTHEMATOSUS; DISEASE-PREDISPOSING VARIANTS; JUVENILE IDIOPATHIC ARTHRITIS; AUTOIMMUNE-DISEASES; R620W POLYMORPHISM; REGULATORY POLYMORPHISM; PSORIATIC-ARTHRITIS; FUNCTIONAL VARIANT	The minor allele of the R620W missense single-nucleotide polymorphism (SNP) (rs2476601) in the hematopoietic-specific protein tyrosine phosphatase gene, PTPN22, has been associated with multiple autoimmune diseases, including rheumatoid arthritis (RA). These genetic data, combined with biochemical evidence that this SNP affects PTPN22 function, suggest that this phosphatase is a key regulator of autoimmunity. To determine whether other genetic variants in PTPN22 contribute to the development of RA, we sequenced the coding regions of this gene in 48 white North American patients with RA and identified 15 previously unreported SNPs, including 2 coding SNPs in the catalytic domain. We then genotyped 37 SNPs in or near PTPN22 in 475 patients with RA and 475 individually matched controls (sample set 1) and selected a subset of markers for replication in an additional 661 patients with RA and 1,322 individually matched controls (sample set 2). Analyses of these results predict 10 common (frequency >1%) PTPN22 haplotypes in white North Americans. The sole haplotype found to carry the previously identified W620 risk allele was strongly associated with disease in both sample sets, whereas another haplotype, identical at all other SNPs but carrying the R620 allele, showed no association. R620W, however, does not fully explain the association between PTPN22 and RA, since significant differences between cases and controls persisted in both sample sets after the haplotype data were stratified by R620W. Additional analyses identified two SNPs on a single common haplotype that are associated with RA independent of R620W, suggesting that R620W and at least one additional variant in the PTPN22 gene region influence RA susceptibility.	Celera Diagnost, Alameda, CA 94502 USA; Celera Gen, Rockville, MD USA; Gen Collaborat Div SeraCare Life Sci, Cambridge, MA USA; NIAMSD, Genet & Gen Branch, NIH, Bethesda, MD 20892 USA; Univ Calif Davis, Dept Med, Rowe Program Human Genet, Davis, CA 95616 USA; Univ Calif San Francisco, Dept Med, Rosalind Russell Med Res Ctr Arthritis, San Francisco, CA 94143 USA; N Shore Long Isl Jewish Inst Med Res, Robert S Boas Ctr Gen & Human Genet, Manhasset, NY USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Texas, MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of California System; University of California Davis; University of California System; University of California San Francisco; Northwell Health; University of California System; University of California Berkeley; University of Texas System; UTMD Anderson Cancer Center	Begovich, AB (corresponding author), Celera Diagnost, 1401 Harbor Bay Pkway, Alameda, CA 94502 USA.	ann.begovich@celeradiagnostics.com	Schrodi, Steven J./O-4288-2019	Schrodi, Steven J./0000-0003-2304-8528	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000079] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041139, N01AR072232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035326] Funding Source: NIH RePORTER; NCRR NIH HHS [5 M01 RR-00079, M01 RR000079] Funding Source: Medline; NHGRI NIH HHS [R01 HG002275, HG02275] Funding Source: Medline; NIAMS NIH HHS [R01-AR44222, N01-AR-7-2232] Funding Source: Medline; NIGMS NIH HHS [GM35326, R01 GM035326] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Alarcon-Segovia D, 2005, ARTHRITIS RHEUM-US, V52, P1138, DOI 10.1002/art.20999; Alkhateeb A, 2003, PIGM CELL RES, V16, P208, DOI 10.1034/j.1600-0749.2003.00032.x; Becker KG, 1998, P NATL ACAD SCI USA, V95, P9979, DOI 10.1073/pnas.95.17.9979; Begovich AB, 2005, AM J HUM GENET, V76, P184, DOI 10.1086/427244; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; BRESLOW NE, 1980, STATISTICAL METHODS, V1, P32; Cloutier JF, 1996, EMBO J, V15, P4909, DOI 10.1002/j.1460-2075.1996.tb00871.x; Cohen S, 1999, BLOOD, V93, P2013, DOI 10.1182/blood.V93.6.2013.406k25_2013_2024; Cooper K. P., 1989, Journal of Laser Applications, V1, P21, DOI 10.2351/1.4745241; Criswell LA, 2005, AM J HUM GENET, V76, P561, DOI 10.1086/429096; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Germer S, 2000, GENOME RES, V10, P258, DOI 10.1101/gr.10.2.258; Gjorloff-Wingren A, 1999, EUR J IMMUNOL, V29, P3845, DOI 10.1002/(SICI)1521-4141(199912)29:12<3845::AID-IMMU3845>3.0.CO;2-U; Gregersen PK, 2005, IMMUNOL REV, V204, P74, DOI 10.1111/j.0105-2896.2005.00243.x; Gregorieff A, 1998, J BIOL CHEM, V273, P13217, DOI 10.1074/jbc.273.21.13217; Hasegawa K, 2004, SCIENCE, V303, P685, DOI 10.1126/science.1092138; Hinks A, 2005, ARTHRITIS RHEUM-US, V52, P1694, DOI 10.1002/art.21049; Ho P, 2004, ARTHRITIS RHEUM, V50, pS258; Hu XL, 2004, HUM HERED, V57, P156, DOI 10.1159/000079246; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Jawaheer D, 2004, ARTHRITIS RHEUM-US, V50, P736, DOI 10.1002/art.20066; Jawaheer D, 2001, AM J HUM GENET, V68, P927, DOI 10.1086/319518; Kochi Y, 2005, NAT GENET, V37, P478, DOI 10.1038/ng1540; Kyogoku C, 2004, AM J HUM GENET, V75, P504, DOI 10.1086/423790; Ladner MB, 2005, HUM IMMUNOL, V66, P60, DOI 10.1016/j.humimm.2004.09.016; Lake SL, 2003, HUM HERED, V55, P56, DOI 10.1159/000071811; Lee AT, 2005, GENES IMMUN, V6, P129, DOI 10.1038/sj.gene.6364159; Li H, 2001, ANN HUM GENET, V65, P189, DOI 10.1017/S0003480001008491; Lin JP, 1998, HUM GENET, V103, P475, DOI 10.1007/s004390050853; Lin SC, 2004, ARTHRITIS RHEUM-US, V50, P770, DOI 10.1002/art.20040; Marrack P, 2001, NAT MED, V7, P899, DOI 10.1038/90935; MATESANZ F, 2005, J NEUROL; Newton JL, 2004, GENES IMMUN, V5, P151, DOI 10.1038/sj.gene.6364045; Nielsen C, 2003, TISSUE ANTIGENS, V62, P492, DOI 10.1046/j.1399-0039.2003.00136.x; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Onengut-Gumuscu S, 2004, GENES IMMUN, V5, P678, DOI 10.1038/sj.gene.6364138; Orozco G, 2005, ARTHRITIS RHEUM-US, V52, P219, DOI 10.1002/art.20771; PAYAMI H, 1989, AM J HUM GENET, V45, P541; Peltekova VD, 2004, NAT GENET, V36, P471, DOI 10.1038/ng1339; Prahalad S, 2002, ARTHRITIS RHEUM, V46, P1851, DOI 10.1002/art.10370; Prokunina L, 2004, ARTHRITIS RHEUM-US, V50, P1770, DOI 10.1002/art.20280; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; Qu H, 2005, J MED GENET, V42, P266, DOI 10.1136/jmg.2004.026971; Rahman P, 2003, AM J HUM GENET, V73, P677, DOI 10.1086/378076; Rothman KJ, 2002, EPIDEMIOLOGY INTRO; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Seldin MF, 1999, ARTHRITIS RHEUM, V42, P1071, DOI 10.1002/1529-0131(199906)42:6<1071::AID-ANR1>3.0.CO;2-8; SELDIN MF, IN PRESS GENES IMMUN; Siminovitch KA, 2004, NAT GENET, V36, P1248, DOI 10.1038/ng1204-1248; Simkins HMA, 2005, ARTHRITIS RHEUM, V52, P2222, DOI 10.1002/art.21126; Smyth D, 2004, DIABETES, V53, P3020, DOI 10.2337/diabetes.53.11.3020; Steer S, 2005, ARTHRITIS RHEUM, V52, P358, DOI 10.1002/art.20737; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tait KF, 2004, DIABETIC MED, V21, P358, DOI 10.1111/j.1464-5491.2004.01162.x; THOMSON G, 1988, AM J HUM GENET, V43, P799; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Valdes AM, 1997, AM J HUM GENET, V60, P703; van Aken J, 2003, CLIN EXP RHEUMATOL, V21, pS100; van Oene M, 2005, ARTHRITIS RHEUM-US, V52, P1993, DOI 10.1002/art.21123; Velaga MR, 2004, J CLIN ENDOCR METAB, V89, P5862, DOI 10.1210/jc.2004-1108; Viken MK, 2005, GENES IMMUN, V6, P271, DOI 10.1038/sj.gene.6364178; Wandstrat A, 2001, NAT IMMUNOL, V2, P802, DOI 10.1038/ni0901-802; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Yoo JH, 2005, NUCLEIC ACIDS RES, V33, pW483, DOI 10.1093/nar/gki428; Zheng WP, 2005, DIABETES, V54, P906, DOI 10.2337/diabetes.54.3.906; ZHERNAKOVA A, 2005, GENES IMMUN	68	170	180	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2005	77	4					567	581		10.1086/468189	http://dx.doi.org/10.1086/468189			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	967QS	16175503	Green Published, Bronze			2022-12-18	WOS:000232106900005
J	John, S; Shephard, N; Liu, GY; Zeggini, E; Cao, MQ; Chen, WW; Vasavda, N; Mills, T; Barton, A; Hinks, A; Eyre, S; Jones, KW; Ollier, W; Silman, A; Gibson, N; Worthington, J; Kennedy, GC				John, S; Shephard, N; Liu, GY; Zeggini, E; Cao, MQ; Chen, WW; Vasavda, N; Mills, T; Barton, A; Hinks, A; Eyre, S; Jones, KW; Ollier, W; Silman, A; Gibson, N; Worthington, J; Kennedy, GC			Whole-genome scan, in a complex disease, using 11,245 single-nucleotide polymorphisms: Comparison with microsatellites	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RHEUMATOID-ARTHRITIS FAMILIES; AFFECTED SIBLING PAIRS; LINKAGE ANALYSIS; SUSCEPTIBILITY LOCUS; MULTIPLE-SCLEROSIS; UNITED-KINGDOM; MAP; IDENTIFICATION; POPULATION; TRAITS	Despite the theoretical evidence of the utility of single-nucleotide polymorphisms ( SNPs) for linkage analysis, no whole-genome scans of a complex disease have yet been published to directly compare SNPs with microsatellites. Here, we describe a whole-genome screen of 157 families with multiple cases of rheumatoid arthritis ( RA), performed using 11,245 genomewide SNPs. The results were compared with those from a 10-cM microsatellite scan in the same cohort. The SNP analysis detected HLA*DRB1, the major RA susceptibility locus (P = .00004), with a linkage interval of 31 cM, compared with a 50-cM linkage interval detected by the microsatellite scan. In addition, four loci were detected at a nominal significance level (P<.05) in the SNP linkage analysis; these were not observed in the microsatellite scan. We demonstrate that variation in information content was the main factor contributing to observed differences in the two scans, with the SNPs providing significantly higher information content than the microsatellites. Reducing the number of SNPs in the marker set to 3,300 (1-cM spacing) caused several loci to drop below nominal significance levels, suggesting that decreases in information content can have significant effects on linkage results. In contrast, differences in maps employed in the analysis, the low detectable rate of genotyping error, and the presence of moderate linkage disequilibrium between markers did not significantly affect the results. We have demonstrated the utility of a dense SNP map for performing linkage analysis in a late-age-at-onset disease, where DNA from parents is not always available. The high SNP density allows loci to be defined more precisely and provides a partial scaffold for association studies, substantially reducing the resource requirement for gene-mapping studies.	Affymetrix, Genom Collaborat, Santa Clara, CA 95051 USA; Univ Manchester, Manchester, Lancs, England; AstraZeneca, Macclesfield, Cheshire, England	Affymetrix; University of Manchester; AstraZeneca	Kennedy, GC (corresponding author), Affymetrix, Genom Collaborat, 3380 Cent Expressway, Santa Clara, CA 95051 USA.	giulia_kennedy@affymetrix.com	Hinks, Anne/E-1853-2015; eyre, stephen/K-3776-2017; Barton, Anne/N-2053-2014; Worthington, Jane/M-9770-2014	Hinks, Anne/0000-0001-8843-3967; eyre, stephen/0000-0002-1251-6974; Barton, Anne/0000-0003-3316-2527; Worthington, Jane/0000-0003-0544-042X; Zeggini, Eleftheria/0000-0003-4238-659X; Shephard, Neil/0000-0001-8301-6857				Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Ban M, 2002, GENES IMMUN, V3, P464, DOI 10.1038/sj.gene.6363910; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; CORDELL HJ, 1995, AM J HUM GENET, V57, P920; Cornelis F, 1998, P NATL ACAD SCI USA, V95, P10746, DOI 10.1073/pnas.95.18.10746; Daw EW, 2000, GENET EPIDEMIOL, V19, P366, DOI 10.1002/1098-2272(200012)19:4<366::AID-GEPI8>3.0.CO;2-F; Doran MF, 2002, ARTHRITIS RHEUM-US, V46, P625, DOI 10.1002/art.509; Ebers GC, 1996, NAT GENET, V13, P472, DOI 10.1038/ng0896-472; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Imrie H, 2001, J CLIN ENDOCR METAB, V86, P626, DOI 10.1210/jc.86.2.626; Jawaheer D, 2003, ARTHRITIS RHEUM-US, V48, P906, DOI 10.1002/art.10989; Jawaheer D, 2001, AM J HUM GENET, V68, P927, DOI 10.1086/319518; Kennedy GC, 2003, NAT BIOTECHNOL, V21, P1233, DOI 10.1038/nbt869; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kruglyak L, 1997, NAT GENET, V17, P21, DOI 10.1038/ng0997-21; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; MacKay K, 2002, ARTHRITIS RHEUM, V46, P632, DOI 10.1002/art.10147; Matise TC, 2003, AM J HUM GENET, V73, P271, DOI 10.1086/377137; Matsuzaki H, 2004, GENOME RES, V14, P414, DOI 10.1101/gr.2014904; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Rijsdijk FV, 2002, BEHAV GENET, V32, P211, DOI 10.1023/A:1016073113019; Schaid DJ, 2002, AM J HUM GENET, V71, P992, DOI 10.1086/342666; Seldin MF, 1999, ARTHRITIS RHEUM, V42, P1071, DOI 10.1002/1529-0131(199906)42:6<1071::AID-ANR1>3.0.CO;2-8; Shiozawa S, 1998, INT IMMUNOL, V10, P1891, DOI 10.1093/intimm/10.12.1891; *STATACORP, 2003, STAT SOFTW REL 8 0; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; WORDSWORTH P, 1991, ANN RHEUM DIS, V50, P343, DOI 10.1136/ard.50.6.343; WORTHINGTON J, 1994, BRIT J RHEUMATOL, V33, P970; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986	29	170	183	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2004	75	1					54	64		10.1086/422195	http://dx.doi.org/10.1086/422195			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	829FG	15154113	Bronze, Green Published			2022-12-18	WOS:000222031300007
J	Torroni, A; Rengo, C; Guida, V; Cruciani, F; Sellitto, D; Coppa, A; Calderon, FL; Simionati, B; Valle, G; Richards, M; Macaulay, V; Scozzari, R				Torroni, A; Rengo, C; Guida, V; Cruciani, F; Sellitto, D; Coppa, A; Calderon, FL; Simionati, B; Valle, G; Richards, M; Macaulay, V; Scozzari, R			Do the four clades of the mtDNA haplogroup L2 evolve at different rates?	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA POLYMORPHISMS; AFRICAN POPULATIONS REVEALS; NEAR-EASTERN; SEQUENCE; LINEAGES; GENOME; RADIATION; EVOLUTION; ANCESTRY; ORIGINS	Forty-seven mtDNAs collected in the Dominican Republic and belonging to the African-specific haplogroup L2 were studied by high-resolution RFLP and control-region sequence analyses. Four sets of diagnostic markers that subdivide L2 into four clades (L2a-L2d) were identified, and a survey of published African data sets appears to indicate that these clades encompass all L2 mtDNAs and harbor very different geographic/ethnic distributions. One mtDNA from each of the four clades was completely sequenced by means of a new sequencing protocol that minimizes time and expense. The phylogeny of the L2 complete sequences showed that the two mtDNAs from L2b and L2d seem disproportionately derived, compared with those from L2a and L2c. This result is not consistent with a simple model of neutral evolution with a uniform molecular clock. The pattern of nonsynonymous versus synonymous substitutions hints at a role for selection in the evolution of human mtDNA. Regardless of whether selection is shaping the evolution of modern human mtDNAs, the population screening of L2 mtDNAs for the mutations identified by our complete sequence study should allow the identification of marker motifs of younger age with more restricted geographic distributions, thus providing new clues about African prehistory and the origin and relationships of African ethnic groups.	Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy; Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, Rome, Italy; Univ Roma La Sapienza, Dipartimento Biol Anim & Uomo, Rome, Italy; Univ Cattolica Sacro Cuore, Ist Med Legale, Rome, Italy; CNR, Ctr Genet Evoluzionist, Rome, Italy; Museo Natl Hist Nat Santo Domingo, Santo Domingo, Dominican Rep; Univ Padua, Ctr Ric Interdipartimentale Biotecnol Innovat, Padua, Italy; Univ Huddersfield, Dept Chem & Biol Sci, Huddersfield HD1 3DH, W Yorkshire, England; Univ Oxford, Dept Stat, Oxford OX1 3TG, England	University of Pavia; Sapienza University Rome; Sapienza University Rome; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Consiglio Nazionale delle Ricerche (CNR); University of Padua; University of Huddersfield; University of Oxford	Torroni, A (corresponding author), Univ Pavia, Dipartimento Genet & Microbiol, Via Ferrata 1, I-27100 Pavia, Italy.		Cruciani, Fulvio/G-6105-2012; Guida, Valentina/K-4517-2015; Torroni, Antonio/E-1557-2011	Guida, Valentina/0000-0003-3946-645X; Torroni, Antonio/0000-0002-4163-4478; Cruciani, Fulvio/0000-0002-6900-024X; simionati, barbara/0000-0002-0522-0737; coppa, alfredo/0000-0002-7708-2484; VALLE, GIORGIO/0000-0003-4377-5685; RICHARDS, MARTIN/0000-0003-3118-0967	Telethon [E.0890] Funding Source: Medline	Telethon(Fondazione Telethon)		Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; BANDELT HJ, 1995, GENETICS, V141, P743; Chen YS, 2000, AM J HUM GENET, V66, P1362, DOI 10.1086/302848; CHEN YS, 1995, AM J HUM GENET, V57, P133; GRAVEN L, 1995, MOL BIOL EVOL, V12, P334; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; JOHNSON MJ, 1983, J MOL EVOL, V19, P255, DOI 10.1007/BF02099973; Kivisild T, 1999, CURR BIOL, V9, P1331, DOI 10.1016/S0960-9822(00)80057-3; Krings M, 1999, AM J HUM GENET, V64, P1166, DOI 10.1086/302314; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Mateu E, 1997, ANN HUM GENET, V61, P507, DOI 10.1017/S0003480097006544; Nachman MW, 1996, GENETICS, V142, P953; PEREIRA L, IN PRESS ANN HUM GEN; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Rando JC, 1998, ANN HUM GENET, V62, P531, DOI 10.1046/j.1469-1809.1998.6260531.x; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; SCOZZARI R, 1994, HUM BIOL, V66, P1; SCOZZARI R, 1988, AM J HUM GENET, V43, P534; SOODYALL H, 1992, ANN HUM GENET, V56, P315, DOI 10.1111/j.1469-1809.1992.tb01159.x; SOODYALL H, 1993, ANN HUM BIOL, V20, P477, DOI 10.1080/03014469300002872; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; SWOFFORD DL, 2000, PAUP STAR PHYLOGENET; Torroni A, 1999, AM J HUM GENET, V65, P1349, DOI 10.1086/302642; Torroni A, 1996, GENETICS, V144, P1835; Torroni A, 1997, AM J HUM GENET, V60, P1107; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; TORRONI A, 1993, AM J HUM GENET, V53, P563; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WALLACE DC, 1995, AM J HUM GENET, V57, P201; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503	32	170	173	1	8	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2001	69	6					1348	1356		10.1086/324511	http://dx.doi.org/10.1086/324511			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	491AY	11595973	Bronze, Green Published			2022-12-18	WOS:000172086900018
J	Ehm, MG; Karnoub, MC; Sakul, H; Gottschalk, K; Holt, DC; Weber, JL; Vaske, D; Briley, D; Briley, L; McMillen, P; Nguyen, Q; Reisman, M; Lai, EH; Joslyn, G; Shepherd, NS; Bell, C; Wagner, MJ; Burns, DK				Ehm, MG; Karnoub, MC; Sakul, H; Gottschalk, K; Holt, DC; Weber, JL; Vaske, D; Briley, D; Briley, L; McMillen, P; Nguyen, Q; Reisman, M; Lai, EH; Joslyn, G; Shepherd, NS; Bell, C; Wagner, MJ; Burns, DK		Amer Diabet Assoc GENNID Study Grp	Genomewide search for type 2 diabetes susceptibility genes in four American populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							P85-ALPHA REGULATORY SUBUNIT; MEXICAN-AMERICANS; PHOSPHATIDYLINOSITOL 3-KINASE; INSULIN SENSITIVITY; WIDE SEARCH; LINKAGE; NIDDM; MUTATIONS; MELLITUS; ONSET	Type 2 diabetes is a serious, genetically influenced disease for which no fully effective treatments are available. Identification of biochemical or regulatory pathways involved in the disease syndrome could lead to innovative therapeutic interventions, One way to identify such pathways is the genetic analysis of families with multiple affected members where disease predisposing genes are likely to be segregating. We undertook a genomewide screen (389-395 microsatellite markers) in samples of 835 white, 591 Mexican American, 229 black, and 128 Japanese American individuals collected as part of the American Diabetes Association's GENNID study. Multipoint nonparametric linkage analyses were performed with diabetes, and diabetes or impaired glucose homeostasis (IH). Linkage to diabetes or IH was detected near markers D5S1404 (map position 77 cM, LOD = 2.80), D12S853 (map position 82 cM, LOD = 2.81) and GATA172D05 (X-chromosome map position 130 cM, LOD = 2.99) in whites, near marker D3S2432 (map position 51 cM, LOD = 3.91) in Mexican Americans, and near marker D10S1412 (map position 14 cM, LOD = 2.39) in African Americans mainly collected in phase 1 of the study. Further analyses showed evidence for interactions between the chromosome 5 locus and region on chromosome 12 containing the MODY 3 gene (map position 132 cM) and between the X-chromosome locus and region near D12S853 (map position 82 cM) in whites. Although these results were not replicated in samples collected in phase 2 of the GENNID study, the region on chromosome 12 was replicated in samples from whites described by Bektas et al. (1999).	Glaxo Wellcome Inc, Res Triangle Pk, NC 27709 USA; Axys Pharmaceut, La Jolla, CA USA; Marshfield Med Res Fdn, Marshfield, WI 54449 USA	GlaxoSmithKline	Ehm, MG (corresponding author), Glaxo Wellcome Inc, POB 13398, Res Triangle Pk, NC 27709 USA.	mge37216@glaxowellcome.com		Gottschalk, William/0000-0001-6760-2338				Bektas A, 1999, DIABETES, V48, P2246, DOI 10.2337/diabetes.48.11.2246; Bell GI, 1997, DIABETES REV, V5, P277; Bowden DW, 1997, DIABETES, V46, P882, DOI 10.2337/diabetes.46.5.882; Chen JF, 1997, J MOL MED, V75, P283, DOI 10.1007/s001090050113; Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; Duggirala R, 1999, AM J HUM GENET, V64, P1127, DOI 10.1086/302316; Ehm MG, 1998, AM J HUM GENET, V62, P181, DOI 10.1086/301668; Elbein SC, 1999, DIABETES, V48, P1175, DOI 10.2337/diabetes.48.5.1175; FROGUEL P, 1993, NEW ENGL J MED, V328, P697, DOI 10.1056/NEJM199303113281005; Gavin JR, 1997, DIABETES CARE, V20, P1183; Ghosh S, 1999, P NATL ACAD SCI USA, V96, P2198, DOI 10.1073/pnas.96.5.2198; Hani E, 1997, DIABETES, V46, P688, DOI 10.2337/diabetes.46.4.688; Hanis CL, 1996, NAT GENET, V13, P161, DOI 10.1038/ng0696-161; Hansen T, 1997, DIABETES, V46, P494, DOI 10.2337/diabetes.46.3.494; Hanson RL, 1998, AM J HUM GENET, V63, P1130, DOI 10.1086/302061; HARRIS M, 1979, DIABETES, V28, P1039; Kawanishi M, 1997, DIABETES CARE, V20, P1043, DOI 10.2337/diacare.20.6.1043; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Mahtani MM, 1996, NAT GENET, V14, P90, DOI 10.1038/ng0996-90; Moxham CM, 1996, NATURE, V379, P840, DOI 10.1038/379840a0; Raffel LJ, 1996, DIABETES CARE, V19, P864, DOI 10.2337/diacare.19.8.864; RICH SS, 1990, DIABETES, V39, P1315, DOI 10.2337/diabetes.39.11.1315; RIGGS AC, 1995, DIABETES, V44, P689, DOI 10.2337/diabetes.44.6.689; SUAREZ BK, 1994, GENETIC APPROACHES M, P23; TANIZAWA Y, 1994, DIABETES, V43, P935, DOI 10.2337/diabetes.43.7.935; Terauchi Y, 1999, NAT GENET, V21, P230, DOI 10.1038/6023; TURNER RC, 1995, DIABETES, V44, P1, DOI 10.2337/diabetes.44.1.1; Urbanek M, 1999, P NATL ACAD SCI USA, V96, P8573, DOI 10.1073/pnas.96.15.8573; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0; Yuan B, 1997, AM J HUM GENET, V60, P459	34	170	178	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2000	66	6					1871	1881		10.1086/302950	http://dx.doi.org/10.1086/302950			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QU	10793009	Green Published, Bronze			2022-12-18	WOS:000088373800015
J	Weber, K; Wilson, JN; Taylor, L; Brierley, E; Johnson, MA; Turnbull, DM; Bindoff, LA				Weber, K; Wilson, JN; Taylor, L; Brierley, E; Johnson, MA; Turnbull, DM; Bindoff, LA			A new mtDNA mutation showing accumulation with time and restriction to skeletal muscle	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL PROTEIN-SYNTHESIS; GENE ORGANIZATION; POINT MUTATION; WILD-TYPE; DNA; SEQUENCE; MYOPATHY; GENOME; CARDIOMYOPATHY; FIBERS	We have identified a new mutation in mtDNA, involving tRNA(Leu(CUN)) in a patient manifesting an isolated skeletal myopathy. This heteroplasmic A-->G transition at position 12320 affects the T Psi C loop at a conserved site and was not found in 120 controls. Analysis of cultured fibroblasts, white blood cells/platelets, and skeletal muscle showed that only skeletal muscle contained the mutation and that only this tissue demonstrated a biochemical defect of respiratory-chain activity. In a series of four muscle-biopsy specimens taken over a 12-year period, there was a gradual increase, from 70% to 90%, in the overall level of mutation, as well as a marked clinical deterioration. Single-fiber PCR confirmed that the proportion of mutant mtDNA was highest in cytochrome c oxidase-negative fibers. This study, which reports a mutation involving tRNA(Leu(CUN)), demonstrates clearly that mtDNA point mutations can accumulate over time and may be restricted in their tissue distribution, Furthermore, clinical deterioration seemed to follow the increase in the level of mutation, although, interestingly, the appearance of fibers deficient in respiratory-chain activity showed a lag period.	MIDDLESBROUGH GEN HOSP,DEPT NEUROL,MIDDLESBROUGH TS5 5AZ,CLEVELAND,ENGLAND; UNIV NEWCASTLE UPON TYNE,SCH MED,DIV NEUROL,NEWCASTLE TYNE NE1 7RU,TYNE & WEAR,ENGLAND; UNIV NEWCASTLE UPON TYNE,SCH MED,DIV GERIATR,NEWCASTLE TYNE NE1 7RU,TYNE & WEAR,ENGLAND; UNIV NEWCASTLE UPON TYNE,SCH MED,DIV NEUROBIOL,NEWCASTLE TYNE NE1 7RU,TYNE & WEAR,ENGLAND	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK			Maniura, Katharina/N-2955-2016	Maniura, Katharina/0000-0001-7895-3563; Bindoff, Laurence/0000-0003-0988-276X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; ARNASON U, 1992, J MOL EVOL, V34, P493, DOI 10.1007/BF00160463; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; Birch-Machin MA, 1993, METHODS TOXICOL, V2, P51; CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236; DESJARDINS P, 1990, J MOL BIOL, V212, P599, DOI 10.1016/0022-2836(90)90225-B; DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; HAYASHI JI, 1994, J BIOL CHEM, V269, P19060; HOWELL N, 1991, AM J HUM GENET, V49, P939; JACKSON MJ, 1994, DIABETES CARE, V17, P728, DOI 10.2337/diacare.17.7.728; JOHNSON MA, 1993, ANN NEUROL, V33, P28, DOI 10.1002/ana.410330106; KAWAKAMI Y, 1994, ANN NEUROL, V35, P370, DOI 10.1002/ana.410350322; KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480; LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011; LOWERSON SA, 1992, ANAL BIOCHEM, V205, P372, DOI 10.1016/0003-2697(92)90453-E; MARIOTTI C, 1994, J CLIN INVEST, V93, P1102, DOI 10.1172/JCI117061; MERANTE F, 1994, AM J HUM GENET, V55, P437; MORAES CT, 1993, NAT GENET, V4, P284, DOI 10.1038/ng0793-284; MORAES CT, 1993, J CLIN INVEST, V92, P2906, DOI 10.1172/JCI116913; POULTON J, 1993, HUM MOL GENET, V2, P23, DOI 10.1093/hmg/2.1.23; REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311; ROE BA, 1985, J BIOL CHEM, V260, P9759; SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13; SEIBEL P, 1994, BIOCHEM BIOPH RES CO, V204, P482, DOI 10.1006/bbrc.1994.2485; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; TANAKA M, 1990, LANCET, V336, P1452, DOI 10.1016/0140-6736(90)93162-I; WALLACE DC, 1981, MOL CELL BIOL, V1, P697, DOI 10.1128/MCB.1.8.697; YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164; YOON KL, 1991, BIOCHEM BIOPH RES CO, V176, P1112, DOI 10.1016/0006-291X(91)90399-R; ZEVIANI M, 1991, AM J HUM GENET, V48, P203	32	170	172	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1997	60	2					373	380						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WE931	9012410				2022-12-18	WOS:A1997WE93100016
J	DeVries, DD; Went, LN; Bruyn, GW; Scholte, HR; Hofstra, RMW; Bolhuis, PA; vanOost, BA				DeVries, DD; Went, LN; Bruyn, GW; Scholte, HR; Hofstra, RMW; Bolhuis, PA; vanOost, BA			Genetic and biochemical impairment of mitochondrial complex I activity in a family with Leber hereditary optic neuropathy and hereditary spastic dystonia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; RED FIBERS MERRF; DNA HETEROPLASMY; ITALIAN FAMILIES; MTDNA MUTATION; ORGANIZATION; GENOME; CELLS; NEURORETINOPATHY; SEGREGATION	A rare form of Leber hereditary optic neuropathy (LHON) that is associated with hereditary spastic dystonia has been studied in a large Dutch family. Neuropathy and ophthalmological lesions were present together in some family members, whereas only one type of abnormality was found in others. mtDNA mutations previously reported in LHON were not present. Sequence analysis of the protein-coding mitochondrial genes revealed two previously unreported mtDNA mutations. A heteroplasmic A-->G transition at nucleotide position 11696 in the ND4 gene resulted in the substitution of an isoleucine for valine at amino acid position 312. A second mutation, a homoplasmic T-->A transition at nucleotide position 14596 in the ND6 gene, resulted in the substitution of a methionine for the isoleucine at amino acid residue 26. Biochemical analysis of a muscle biopsy revealed a severe complex I deficiency, providing a link between these unique mtDNA mutations and this rare, complex phenotype including Leber optic neuropathy.	UNIV NIJMEGEN HOSP, DEPT HUMAN GENET, 6500 HB NIJMEGEN, NETHERLANDS; UNIV NIJMEGEN HOSP, DEPT PEDIAT, 6500 HB NIJMEGEN, NETHERLANDS; LEIDEN UNIV, DEPT HUMAN GENET, 2300 RA LEIDEN, NETHERLANDS; LEIDEN UNIV, DEPT NEUROL, 2300 RA LEIDEN, NETHERLANDS; ERASMUS UNIV ROTTERDAM, CARDIOVASC RES INST, DEPT BIOCHEM, 3000 DR ROTTERDAM, NETHERLANDS; UNIV GRONINGEN, DEPT MED GENET, 9700 AB GRONINGEN, NETHERLANDS; UNIV AMSTERDAM, ACAD MED CTR, DEPT NEUROL, 1105 AZ AMSTERDAM, NETHERLANDS	Radboud University Nijmegen; Radboud University Nijmegen; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Erasmus University Rotterdam; University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam				Hofstra, Robert/0000-0001-7498-3829				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; ARNASON U, 1991, J MOL EVOL, V33, P556, DOI 10.1007/BF02102808; ARNASON U, 1992, J MOL EVOL, V34, P493, DOI 10.1007/BF00160463; BENECKE R, 1992, ANN NEUROL, V32, P683, DOI 10.1002/ana.410320512; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; BIRKY CW, 1989, GENETICS, V121, P613; BOLHUIS PA, 1990, BIOCHEM BIOPH RES CO, V170, P994, DOI 10.1016/0006-291X(90)90490-E; BROWN MD, 1992, AM J HUM GENET, V51, P378; BROWN MD, 1992, FASEB J, V6, P2791, DOI 10.1096/fasebj.6.10.1634041; BROWN MD, 1992, GENETICS, V130, P163; BRUYN GW, 1964, J NEUROL SCI, V1, P59, DOI 10.1016/0022-510X(64)90054-1; BRUYN GW, 1991, J NEUROL SCI, V103, P195, DOI 10.1016/0022-510X(91)90164-3; BRUYN GW, 1992, J NEUROL SCI, V113, P55, DOI 10.1016/0022-510X(92)90265-M; CLARY DO, 1985, J MOL EVOL, V22, P252, DOI 10.1007/BF02099755; CORNELISSEN JC, 1993, J INHERIT METAB DIS, V16, P531, DOI 10.1007/BF00711673; DESJARDINS P, 1990, J MOL BIOL, V212, P599, DOI 10.1016/0022-2836(90)90225-B; DESTORDEUR E, 1989, MOL GEN GENET, V220, P127, DOI 10.1007/BF00260866; DEVRIES D, 1994, J NEUROL SCI, V124, P77, DOI 10.1016/0022-510X(94)90014-0; DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319; DEVRIES DD, 1992, J INHERIT METAB DIS, V15, P307, DOI 10.1007/BF02435963; ESPOSTI MD, 1994, FEBS LETT, V352, P375, DOI 10.1016/0014-5793(94)00971-6; FEARNLEY IM, 1992, BIOCHIM BIOPHYS ACTA, V1140, P105, DOI 10.1016/0005-2728(92)90001-I; FUNAKAWA I, 1995, J NEUROL, V242, P75, DOI 10.1007/BF00887819; GADALETA G, 1989, J MOL EVOL, V28, P497, DOI 10.1007/BF02602930; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; Hauswirth W., 1985, ACHIEVEMENT PERSPECT, V2, P49; HOLT IJ, 1989, J MED GENET, V26, P739, DOI 10.1136/jmg.26.12.739; HOWELL N, 1994, CLIN NEUROSCI, V2, P130; HOWELL N, 1992, HUM GENET, V90, P117; HOWELL N, 1991, AM J HUM GENET, V48, P935; HOWELL N, 1991, AM J HUM GENET, V49, P939; HUOPONEN K, 1991, AM J HUM GENET, V48, P1147; JACOBS HT, 1988, J MOL BIOL, V202, P185, DOI 10.1016/0022-2836(88)90452-4; JOHNS DR, 1993, AM J HUM GENET, V53, P916; JOHNS DR, 1993, BIOCHEM BIOPH RES CO, V196, P810, DOI 10.1006/bbrc.1993.2321; JOHNS DR, 1992, BIOCHEM BIOPH RES CO, V187, P1551, DOI 10.1016/0006-291X(92)90479-5; JOHNS DR, 1991, BIOCHEM BIOPH RES CO, V174, P1324, DOI 10.1016/0006-291X(91)91567-V; JOHNS DR, 1993, ARCH OPHTHALMOL-CHIC, V111, P495, DOI 10.1001/archopht.1993.01090040087038; JOHNS DR, 1991, BIOCHEM BIOPH RES CO, V181, P1358, DOI 10.1016/0006-291X(91)92088-2; Jun A. S., 1994, American Journal of Human Genetics, V55, pA225; JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; KOEHLER CM, 1991, GENETICS, V129, P247; KOHCHI T, 1988, J MOL BIOL, V203, P353, DOI 10.1016/0022-2836(88)90004-6; KUPPUSWAMY MN, 1991, P NATL ACAD SCI USA, V88, P1143, DOI 10.1073/pnas.88.4.1143; LAMMINEN T, 1995, AM J HUM GENET, V56, P1238; LARSSON NG, 1991, ANN NEUROL, V30, P701, DOI 10.1002/ana.410300511; LEE WJ, 1995, GENETICS, V139, P873; LERTRIT P, 1994, HUM MOL GENET, V3, P1973, DOI 10.1093/hmg/3.11.1973; MACKEY D, 1992, AM J HUM GENET, V51, P1218; MAJANDER A, 1991, FEBS LETT, V292, P289, DOI 10.1016/0014-5793(91)80886-8; MARSDEN CD, 1986, J NEUROL NEUROSUR PS, V49, P500, DOI 10.1136/jnnp.49.5.500; MARZUKI S, 1991, HUM GENET, V88, P139; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NAKAMURA M, 1992, JPN J OPHTHALMOL, V36, P56; NEWMAN NJ, 1993, ARCH NEUROL-CHICAGO, V50, P540, DOI 10.1001/archneur.1993.00540050082021; NEWMAN NJ, 1991, AM J OPHTHALMOL, V111, P750, DOI 10.1016/S0002-9394(14)76784-4; NIKI Y, 1989, NATURE, V341, P551, DOI 10.1038/341551a0; NIKOSKELAINEN EK, 1994, CLIN NEUROSCI, V2, P115; NOVOTNY EJ, 1986, NEUROLOGY, V36, P1053, DOI 10.1212/WNL.36.8.1053; OKIMOTO R, 1992, GENETICS, V130, P471; PARKER WD, 1989, NEW ENGL J MED, V320, P1331, DOI 10.1056/NEJM198905183202007; PONTKINGDON GA, 1994, J MOL EVOL, V39, P387, DOI 10.1007/BF00160271; ROE BA, 1985, J BIOL CHEM, V260, P9759; SCHOLTE HR, 1987, J INHERIT METAB DIS, V10, P81, DOI 10.1007/BF01812849; SCHOLTE HR, 1995, BBA-MOL BASIS DIS, V1271, P75, DOI 10.1016/0925-4439(95)00013-T; SILVESTRI G, 1992, AM J HUM GENET, V51, P1213; SMITH PR, 1994, J NEUROL SCI, V122, P80, DOI 10.1016/0022-510X(94)90055-8; Srere P.A., 1969, METHODS ENZYM, V13, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; SWEENEY MG, 1992, AM J HUM GENET, V51, P741; TANAKA M, 1990, LANCET, V336, P1452, DOI 10.1016/0140-6736(90)93162-I; VILKKI J, 1990, AM J HUM GENET, V47, P95; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; WALLACE DC, 1991, CYTOGENET CELL GENET, V58, P2121; WALLACE DC, 1991, CYTOGENET CELL GENET, V58, P1103, DOI 10.1159/000133724; WENT LN, 1964, J NEUROL SCI, V1, P81, DOI 10.1016/0022-510X(64)90055-3; WENT LN, 1964, ACTA GENET STAT MED, V14, P220; ZEVIANI M, 1991, AM J HUM GENET, V48, P203	80	170	175	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1996	58	4					703	711						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UA380	8644732				2022-12-18	WOS:A1996UA38000006
J	BOCK, RD; KOLAKOWSKI, D				BOCK, RD; KOLAKOWSKI, D			FURTHER EVIDENCE OF SEX-LINKED MAJOR-GENE INFLUENCE ON HUMAN SPATIAL VISUALIZING ABILITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CHICAGO, DEPT EDUC, CHICAGO, IL 60637 USA; UNIV CONNECTICUT, DEPT BIOBEHAV SCI, STORRS, CT 06268 USA; UNIV CHICAGO, COMMITTEE HUMAN DEV, CHICAGO, IL 60637 USA	University of Chicago; University of Connecticut; University of Chicago								BENNETT GE, 1966, MANUAL DIFFERENTIAL; BOCK RD, 1972, PSYCHOMETRIKA, V37, P29; BOCK RD, 1967, AM PSYCHOL, V22, P571; BOCK RD, 1968, PROGR HUMAN BEHAVIOR, P233; BRIGHAM CC, 1932, STUDY ERROR; BROVERMA.DM, 1969, PSYCHOMETRIKA, V34, P5, DOI 10.1007/BF02290169; Buffery A. W. H., 1972, GENDER DIFFERENCES T; BURT C, 1956, BRIT J STAT PSYCHOL, V8, P95; COHEN J, 1957, J CONSULT PSYCHOL, V21, P283, DOI 10.1037/h0045077; DAY NE, 1969, BIOMETRIKA, V56, P463, DOI 10.1093/biomet/56.3.463; EDWARDS J. H., 1960, ACTA GENET ET STATIST MED, V10, P63; ELSTON RC, 1970, BEHAV GENET, V1, P3, DOI 10.1007/BF01067366; ERLENMEYER KIML.L, 1963, SCIENCE, V142, P1477; GARRON DC, 1970, PSYCHOL REV, V77, P147, DOI 10.1037/h0028714; Gazzaniga M., 1970, THE BISECTED BRAIN; GRUNDBACHER FJ, 1972, SCIENCE, V176, P311, DOI 10.1126/science.176.4032.311; GUILFORD JP, 1953, GUILFORD ZIMMERMAN A; HARTLAGE LC, 1970, PERCEPT MOTOR SKILL, V31, P610, DOI 10.2466/pms.1970.31.2.610; Kelley T. I., 1928, CROSSROADS MIND MAN; KOLAKOWSKI D, 1970, 12 U CHIC DEP ED MEM; KOUSSY E, 1935, BRIT J PSYCHOL MONOG, P20; Lord F. M., 1968, STAT THEORY MENTAL T; Maccoby Eleanor, 1966, DEV SEX DIFFERENCES, P25; MASICA DN, 1969, JOHNS HOPKINS MED J, V124, P34; MATHER K, 1963, NATURE, V198, P314, DOI 10.1038/198314a0; MCFARLANE M, 1925, BRIT J PSYCHOL MO S8; MICHAEL WB, 1957, EDUC PSYCHOL MEAS, V17, P185, DOI 10.1177/001316445701700202; MONEY J, 1965, AM J MENT DEF, V70, P69; OConnor J, 1943, STRUCTURAL VISUALIZA; OLKIN I, 1967, IMPROVING EXPERIMENT; Pearson K., 1903, BIOMETRIKA, V2, P357; RAVEN JC, 1962, PROGRESSIVE MATRICES; ROSENFIELD RL, 1971, J CLIN ENDOCR METAB, V32, P717, DOI 10.1210/jcem-32-6-717; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; SHERMAN JA, 1967, PSYCHOL REV, V74, P290, DOI 10.1037/h0024723; Sperry R.W., 1969, HDB CLINICAL NEUROLO, P273, DOI DOI 10.1023/B:HUMP.0000036333.34541.54; Stafford R. E., 1961, PERCEPT MOTOR SKILL, V13, P428, DOI DOI 10.2466/PMS.1961.13.3.428; STAFFORD RE, 1963, RBLOUU ED TEST SERV; STAFFORD RE, 1962, IDENTICAL BLOCKS FOR; STERN C, 1960, AM J HUM GENET; Thorndike EL, 1921, PSYCHOL REV, V28, P141, DOI 10.1037/h0070821; Thurstone L, 1938, PSYCHOMETRIC MONOGR, V1; Thurstone L. L., 1941, PRIMARY MENTAL ABILI; TREMBLY D, 1966, 7 P ANN CONV AM PSYC; VANDENBERG SG, 1967, GENETIC DIVERSITY HU, P99; Witkin H. A., 1964, COGNITION THEORY RES, P172	46	170	170	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1973	25	1					1	14						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	O5774	4684504				2022-12-18	WOS:A1973O577400001
J	GARDNER, EJ; PLENK, HP				GARDNER, EJ; PLENK, HP			HEREDITARY PATTERN FOR MULTIPLE OSTEOMAS IN A FAMILY GROUP	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		GARDNER EJ, 1950, AM J HUM GENET, V2, P41; GARDNER EJ, 1951, AM J HUM GENET, V3, P167	2	170	171	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1952	4	1					31	36						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XS396	14933371				2022-12-18	WOS:A1952XS39600003
J	Awadalla, P; Gauthier, J; Myers, RA; Casals, F; Hamdan, FF; Griffing, AR; Cote, M; Henrion, E; Spiegelman, D; Tarabeux, J; Piton, A; Yang, Y; Boyko, A; Bustamante, C; Xiong, L; Rapoport, JL; Addington, AM; DeLisi, JLE; Krebs, MO; Joober, R; Millet, B; Fombonne, E; Mottron, L; Zilversmit, M; Keebler, J; Daoud, H; Marineau, C; Roy-Gagnon, MH; Dube, MP; Eyre-Walker, A; Drapeau, P; Stone, EA; Lafreniere, RG; Rouleau, GA				Awadalla, Philip; Gauthier, Julie; Myers, Rachel A.; Casals, Ferran; Hamdan, Fadi F.; Griffing, Alexander R.; Cote, Melanie; Henrion, Edouard; Spiegelman, Dan; Tarabeux, Julien; Piton, Amelie; Yang, Yan; Boyko, Adam; Bustamante, Carlos; Xiong, Lan; Rapoport, Judith L.; Addington, Aniene M.; DeLisi, J. Lynn E.; Krebs, Marie-Odile; Joober, Ridha; Millet, Bruno; Fombonne, Eric; Mottron, Laurent; Zilversmit, Martine; Keebler, Jon; Daoud, Hussein; Marineau, Claude; Roy-Gagnon, Marie-Helene; Dube, Marie-Pierre; Eyre-Walker, Adam; Drapeau, Pierre; Stone, Eric A.; Lafreniere, Ronald G.; Rouleau, Guy A.			Direct Measure of the De Novo Mutation Rate in Autism and Schizophrenia Cohorts	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPECTRUM DISORDERS; PROTEIN FUNCTION; ASSOCIATION; DISEASES; DATABASE; HUMANS; NUCLEOTIDE; CHILDHOOD; FAMILY; SHANK3	The role of de novo mutations (DNMs) in common diseases remains largely unknown. Nonetheless, the rate of de novo deleterious mutations and the strength of selection against de novo mutations are critical to understanding the genetic architecture of a disease. Discovery of high-impact DNMs requires substantial high-resolution interrogation of partial or complete genomes of families via resequencing. We hypothesized that deleterious DNMs may play a role in cases of autism spectrum disorders (ASD) and schizophrenia (SCZ), two etiologically heterogeneous disorders with significantly reduced reproductive fitness. We present a direct measure of the de novo mutation rate (mu) and selective constraints from DNMs estimated from a deep resequencing data set generated from a large cohort of ASD and SCZ cases (n = 285) and population control individuals (n = 285) with available parental DNA. A survey of -430 Mb of DNA from 401 synapse-expressed genes across all cases and 25 Mb of DNA in controls found 28 candidate DNMs, 13 of which were cell line artifacts. Our calculated direct neutral mutation rate (1.36 x 10(-8)) is similar to previous indirect estimates, but we observed a significant excess of potentially deleterious DNMs in ASD and SCZ individuals. Our results emphasize the importance of DNMs as genetic mechanisms in ASD and SCZ and the limitations of using DNA from archived cell lines to identify functional variants.	[Awadalla, Philip; Myers, Rachel A.; Casals, Ferran; Zilversmit, Martine; Keebler, Jon; Rouleau, Guy A.] Univ Montreal, Dept Pediat, Montreal, PQ H3T 1C5, Canada; [Awadalla, Philip; Hamdan, Fadi F.; Roy-Gagnon, Marie-Helene; Rouleau, Guy A.] Univ Montreal, Ctr Hosp Univ St Justine Res Ctr, Montreal, PQ H3C 1G7, Canada; [Awadalla, Philip; Gauthier, Julie; Hamdan, Fadi F.; Cote, Melanie; Henrion, Edouard; Spiegelman, Dan; Tarabeux, Julien; Piton, Amelie; Yang, Yan; Xiong, Lan; Daoud, Hussein; Marineau, Claude; Lafreniere, Ronald G.; Rouleau, Guy A.] Univ Montreal, Ctr Excellence Neur, Ctr Hosp Univ Montreal, Montreal, PQ H2L 2W5, Canada; [Awadalla, Philip; Gauthier, Julie; Hamdan, Fadi F.; Cote, Melanie; Henrion, Edouard; Spiegelman, Dan; Tarabeux, Julien; Piton, Amelie; Yang, Yan; Xiong, Lan; Daoud, Hussein; Marineau, Claude; Lafreniere, Ronald G.; Rouleau, Guy A.] Univ Montreal, Dept Med, Montreal, PQ H2L 2W5, Canada; [Mottron, Laurent] Univ Montreal, Dept Psychiat, Hop Riviere Des Prairies, Montreal, PQ HIE 1A4, Canada; [Dube, Marie-Pierre] Univ Montreal, Dept Pharmacol, Ctr Rech Inst Cardiol Montreal, Montreal, PQ H1T 1C8, Canada; [Drapeau, Pierre] Univ Montreal, Grp Rech Syst Nerveux Cent, Dept Pathol & Cell Biol, Montreal, PQ H3C 3J7, Canada; [Myers, Rachel A.; Griffing, Alexander R.; Keebler, Jon; Stone, Eric A.] N Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC 27606 USA; [Boyko, Adam; Bustamante, Carlos] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Rapoport, Judith L.; Addington, Aniene M.] NIMH, Child Psychiat Branch, Bethesda, MD 20892 USA; [DeLisi, J. Lynn E.] Nathan S Kline Inst Psychiat Res, Ctr Adv Brain Imaging, Orangeburg, NY 10962 USA; [Krebs, Marie-Odile; Millet, Bruno] Univ Paris 05, INSERM, Lab Physiopathol Malad Psychiat, Ctr Psychiat & Neurosci,St Anne Hosp,U894, F-75014 Paris, France; [Joober, Ridha; Fombonne, Eric] McGill Univ, Dept Psychiat, Montreal, PQ H3A 1A1, Canada; [Joober, Ridha] Douglas Hosp, Montreal, PQ H3A 1A1, Canada; [Fombonne, Eric] Montreal Childrens Hosp, Montreal, PQ H3Z 1P2, Canada; [Eyre-Walker, Adam] Univ Sussex, Sch Life Sci, Ctr Study Evolut, Brighton BN1 9QG, E Sussex, England	Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; University of North Carolina; North Carolina State University; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Nathan Kline Institute for Psychiatric Research; GHU PARIS Psychiatrie Neurosciences; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; McGill University; McGill University; McGill University; University of Sussex	Awadalla, P (corresponding author), Univ Montreal, Dept Pediat, Montreal, PQ H3T 1C5, Canada.	philip.awadalla@umontreal.ca; guy.rouleau@umontreal.ca	Fombonne, Eric/M-4893-2018; Stone, Eric/Q-7840-2016; Dubé, Marie-Pierre/B-9364-2008; Krebs, Marie-Odile/O-2104-2017; Awadalla, Philip/AAC-4896-2021; Eyre-Walker, Adam/G-6216-2011; Casals, Ferran/H-4347-2015; Piton, Amelie/F-1201-2013	Fombonne, Eric/0000-0002-8605-3538; Dubé, Marie-Pierre/0000-0001-8442-4393; Krebs, Marie-Odile/0000-0002-4715-9890; Eyre-Walker, Adam/0000-0001-5527-8729; Casals, Ferran/0000-0002-8941-0369; Piton, Amelie/0000-0003-0408-7468; Addington, Anjene/0000-0001-7770-299X; Mottron, Laurent/0000-0001-5668-5422; Roy-Gagnon, Marie-Helene/0000-0001-8747-0846; spiegelman, dan/0000-0003-4971-8868; Stone, Eric/0000-0002-2725-4209	Genome Canada; Genome Quebec; Universite de Montreal; Canadian Foundation for Innovation; Ministre de Exploration, Innovation et Economique of Quebec; Fonds de Recherche Sante Quebec	Genome Canada(Genome Canada); Genome Quebec; Universite de Montreal; Canadian Foundation for Innovation(Canada Foundation for Innovation); Ministre de Exploration, Innovation et Economique of Quebec; Fonds de Recherche Sante Quebec	We would like to thank all the families and individuals who participated in this study. We are thankful for the efforts of the members of the Genome Quebec Innovation Centre Sequencing and Bioinformatic groups. This work was supported by Genome Canada and Genome Quebec and received cofunding from Universite de Montreal for the Synapse-to-Disease (S2D) Project, funding from the Canadian Foundation for Innovation to both G.A.R and RA., and cofunding from the Ministre de Exploration, Innovation et Economique of Quebec. G.A.R. holds the Canada Research Chair in Genetics of the Nervous System; P.A. holds career awards from the Fonds de Recherche Sante Quebec and Genome Quebec.	Bassett AS, 1996, SCHIZOPHR RES, V21, P151, DOI 10.1016/0920-9964(96)00018-7; Collins MO, 2005, J BIOL CHEM, V280, P5972, DOI 10.1074/jbc.M411220200; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Croen LA, 2007, ARCH PEDIAT ADOL MED, V161, P334, DOI 10.1001/archpedi.161.4.334; Croning MDR, 2009, NUCLEIC ACIDS RES, V37, pD846, DOI 10.1093/nar/gkn700; DeLisi LE, 2002, AM J PSYCHIAT, V159, P803, DOI 10.1176/appi.ajp.159.5.803; Eyre-Walker A, 1998, J MOL EVOL, V47, P686, DOI 10.1007/PL00006427; Eyre-Walker A, 1999, NATURE, V397, P344, DOI 10.1038/16915; Gauthier J, 2005, AM J MED GENET B, V132B, P74, DOI 10.1002/ajmg.b.30066; Gauthier J, 2010, P NATL ACAD SCI USA, V107, P7863, DOI 10.1073/pnas.0906232107; Gochman PA, 2004, SCHIZOPHR RES, V71, P43, DOI 10.1016/j.schres.2004.01.012; Gourion D, 2003, SCHIZOPHR RES, V63, P181, DOI 10.1016/S0920-9964(02)00333-X; Joober R, 2002, SCHIZOPHR RES, V53, P229, DOI 10.1016/S0920-9964(01)00279-1; Kondrashov AS, 2003, HUM MUTAT, V21, P12, DOI 10.1002/humu.10147; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Laumonnier F, 2007, AM J HUM GENET, V80, P205, DOI 10.1086/511441; Lemelin JP, 2007, CHILD DEV, V78, P1855, DOI 10.1111/j.1467-8624.2007.01103.x; Malaspina Dolores, 2002, CNS Spectr, V7, P26; Mechri A, 2009, EUR ARCH PSY CLIN N, V259, P218, DOI 10.1007/s00406-008-0859-y; Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522590; Nachman MW, 2000, GENETICS, V156, P297; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Piton A, 2008, HUM MOL GENET, V17, P3965, DOI 10.1093/hmg/ddn300; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Rutter M, 2005, ACTA PAEDIATR, V94, P2, DOI 10.1080/08035250410023124; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Skuse DH, 2000, PEDIATR RES, V47, P9, DOI 10.1203/00006450-200001000-00006; Smith NGC, 2001, MOL BIOL EVOL, V18, P982, DOI 10.1093/oxfordjournals.molbev.a003899; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone EA, 2005, GENOME RES, V15, P978, DOI 10.1101/gr.3804205; Stone EA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-222; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Trinidad JC, 2006, MOL CELL PROTEOMICS, V5, P914, DOI 10.1074/mcp.T500041-MCP200; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Zhang WX, 2007, NUCLEIC ACIDS RES, V35, pD737, DOI 10.1093/nar/gkl876	37	169	171	0	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP 10	2010	87	3					316	324		10.1016/j.ajhg.2010.07.019	http://dx.doi.org/10.1016/j.ajhg.2010.07.019			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	651JH	20797689	Green Published, Bronze			2022-12-18	WOS:000281923500001
J	Waltes, R; Kalb, R; Gatei, M; Kijas, AW; Stumm, M; Sobeck, A; Wieland, B; Varon, R; Lerenthal, Y; Lavin, MF; Schindler, D; Dork, T				Waltes, Regina; Kalb, Reinhard; Gatei, Magtouf; Kijas, Amanda W.; Stumm, Markus; Sobeck, Alexandra; Wieland, Britta; Varon, Raymonda; Lerenthal, Yaniv; Lavin, Martin F.; Schindler, Detlev; Doerk, Thilo			Human RAD50 Deficiency in a Nijmegen Breakage Syndrome-like Disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEPENDENT NUCLEAR-DYNAMICS; ATAXIA-TELANGIECTASIA; DNA-DAMAGE; PROTEIN COMPLEX; MRE11 COMPLEX; MRN COMPLEX; REPAIR; ATM; NBS1; RADIOSENSITIVITY	The MRE11/RAD50/NBN (MRN) complex plays a key role in recognizing and signaling DNA double-strand breaks (DSBs). Hypomorphic mutations in NBN (previously known as NBS1) and MRE11A give rise to the autosomal-recessive diseases Nijmegen breakage syndrome (NBS) and ataxia-telangiectasia-like disorder (ATLD), respectively. To date, no disease due to RAD50 deficiency has been described. Here, we report on a patient previously diagnosed as probably having NBS, with microcephaly, mental retardation, 'bird-like' face, and short stature. At variance with this diagnosis, she never had severe infections, had normal immunoglobulin levels, and did not develop lymphoid malignancy LIP to age 23 years. We found that she is Compound heterozygous for mutations in the RAD50 gene that give rise to low levels of unstable RAD50 protein. Cells from the patient were characterized by chromosomal instability; radiosensitivity; failure to form DNA damage-induced MRN foci; and impaired radiation-induced activation of and downstream signaling through the ATM protein, which is defective in the human genetic disorder ataxia-telangiectasia. These cells were also impaired in G1/S cell-cycle-checkpoint activation and displayed radioresistant DNA synthesis and G2-phase accumulation. The defective cellular phenotype was rescued by wild-type RAD50. In Conclusion, we have identified and characterized a patient with a RAD50 deficiency that results in a clinical phenotype that can be classified as an NBS-like disorder (NBSLD).	[Kalb, Reinhard; Sobeck, Alexandra; Schindler, Detlev] Univ Wurzburg, Dept Human Genet, D-97074 Wurzburg, Germany; [Waltes, Regina; Wieland, Britta; Doerk, Thilo] Hannover Med Sch, Clin Obstet, D-30625 Hannover, Germany; [Waltes, Regina; Wieland, Britta; Doerk, Thilo] Hannover Med Sch, Clin Gynaecol, D-30625 Hannover, Germany; [Waltes, Regina; Wieland, Britta] Hannover Med Sch, Inst Radiat Oncol, D-30625 Hannover, Germany; [Gatei, Magtouf; Kijas, Amanda W.; Lavin, Martin F.] Royal Brisbane Hosp, Queensland Inst Med Res, Herston, Qld 4029, Australia; [Stumm, Markus] Otto Von Guericke Univ, Inst Human Genet, D-39120 Magdeburg, Germany; [Varon, Raymonda] Alexander von Humboldt Univ, Inst Human Genet, D-13353 Berlin, Germany; [Lerenthal, Yaniv] Tel Aviv Univ, Dept Human Genet, Sackler Sch Med, IL-69978 Ramat Aviv, Israel; [Lerenthal, Yaniv] Tel Aviv Univ, Dept Human Mol Genet & Biochem, Sackler Sch Med, IL-69978 Ramat Aviv, Israel; [Lavin, Martin F.] Univ Queensland, Royal Brisbane Hosp, Clin Res Ctr, Brisbane, Qld 4029, Australia	University of Wurzburg; Hannover Medical School; Hannover Medical School; Hannover Medical School; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; Otto von Guericke University; Humboldt University of Berlin; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Royal Brisbane & Women's Hospital; University of Queensland	Schindler, D (corresponding author), Univ Wurzburg, Dept Human Genet, D-97074 Wurzburg, Germany.	schindler@biozentrum.uni-wuerzburg.de; doerk.thilo@mh-hannover.de	Dörk, Thilo/J-8620-2012; Kalb, Reinhard/AAR-3249-2021; Lavin, Martin F/F-5961-2014	Dörk, Thilo/0000-0002-9458-0282; Kalb, Reinhard/0000-0003-3906-6907; Lavin, Martin F/0000-0002-5940-4769; Kijas, Amanda/0000-0001-8538-7766				ATEN JA, 1992, HISTOCHEM J, V24, P251, DOI 10.1007/BF01046839; AURIAS A, 1980, MUTAT RES, V69, P369, DOI 10.1016/0027-5107(80)90101-3; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; BARBI G, 1991, AM J MED GENET, V40, P44, DOI 10.1002/ajmg.1320400109; BEAMISH H, 1994, INT J RADIAT BIOL, V65, P175, DOI 10.1080/09553009414550211; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Cerosaletti K, 2006, MOL CELL BIOL, V26, P1691, DOI 10.1128/MCB.26.5.1691-1699.2006; CHEN PC, 1978, NATURE, V274, P484, DOI 10.1038/274484a0; Ciapponi L, 2004, CURR BIOL, V14, P1360, DOI 10.1016/j.cub.2004.07.019; Collins JS, 2002, AM J HUM GENET, V71, P1251, DOI 10.1086/344344; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; Desai-Mehta A, 2001, MOL CELL BIOL, V21, P2184, DOI 10.1128/MCB.21.6.2184-2191.2001; Difilippantonio S, 2005, NAT CELL BIOL, V7, P675, DOI 10.1038/ncb1270; Digweed M, 2004, DNA REPAIR, V3, P1207, DOI 10.1016/j.dnarep.2004.03.004; FORD MD, 1981, NUCLEIC ACIDS RES, V9, P1395, DOI 10.1093/nar/9.6.1395; Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80; Hopfer U, 2002, J THEOR BIOL, V214, P539, DOI 10.1006/jtbi.2001.2479; HOULDSWORTH J, 1980, NUCLEIC ACIDS RES, V8, P3709, DOI 10.1093/nar/8.16.3709; Kastan MB, 2008, MOL CANCER RES, V6, P517, DOI 10.1158/1541-7786.MCR-08-0020; Kitagawa R, 2004, GENE DEV, V18, P1423, DOI 10.1101/gad.1200304; Kobayashi J, 2004, DNA REPAIR, V3, P855, DOI 10.1016/j.dnarep.2004.03.023; Kozlov SV, 2006, EMBO J, V25, P3504, DOI 10.1038/sj.emboj.7601231; Kulkarni A, 2008, AM J HUM GENET, V82, P539, DOI 10.1016/j.ajhg.2008.01.009; Lavin MF, 2007, ONCOGENE, V26, P7749, DOI 10.1038/sj.onc.1210880; Luo GB, 1999, P NATL ACAD SCI USA, V96, P7376, DOI 10.1073/pnas.96.13.7376; Maser RS, 2001, MOL CELL BIOL, V21, P6006, DOI 10.1128/MCB.21.17.6006-6016.2001; Maser RS, 1997, MOL CELL BIOL, V17, P6087, DOI 10.1128/MCB.17.10.6087; McKinnon PJ, 2007, ANNU REV GENOM HUM G, V8, P37, DOI 10.1146/annurev.genom.7.080505.115648; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Mirzoeva OK, 2003, MOL CANCER RES, V1, P207; Moreno-Herrero F, 2005, NATURE, V437, P440, DOI 10.1038/nature03927; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; O'Driscoll M, 2007, AM J HUM GENET, V81, P77, DOI 10.1086/518696; PAINTER RB, 1980, P NATL ACAD SCI-BIOL, V77, P7315, DOI 10.1073/pnas.77.12.7315; PARRA I, 1993, NAT GENET, V5, P17, DOI 10.1038/ng0993-17; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Paull TT, 2005, CELL CYCLE, V4, P737, DOI 10.4161/cc.4.6.1715; Petrini JHJ, 2004, CELL CYCLE, V3, P541; Petrini JHJ, 1999, AM J HUM GENET, V64, P1264, DOI 10.1086/302391; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SEYSCHAB H, 1992, EUR J PEDIATR, V151, P756, DOI 10.1007/BF01959085; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shull ERP, 2009, GENE DEV, V23, P171, DOI 10.1101/gad.1746609; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Stiff T, 2005, EMBO J, V24, P199, DOI 10.1038/sj.emboj.7600504; Stumm M, 2001, CYTOGENET CELL GENET, V92, P186, DOI 10.1159/000056900; TAYLOR AMR, 1981, INT J CANCER, V27, P311, DOI 10.1002/ijc.2910270309; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; van den Bosch M, 2003, EMBO REP, V4, P844, DOI 10.1038/sj.embor.embor925; van der Linden E, 2009, NUCLEIC ACIDS RES, V37, P1580, DOI 10.1093/nar/gkn1072; vanderBurgt I, 1996, J MED GENET, V33, P153, DOI 10.1136/jmg.33.2.153; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; Yang YG, 2006, EMBO J, V25, P5527, DOI 10.1038/sj.emboj.7601411; You ZS, 2007, NAT CELL BIOL, V9, P311, DOI 10.1038/ncb1651; Zhong H, 2005, HUM MOL GENET, V14, P2685, DOI 10.1093/hmg/ddi302; Zhu J, 2001, CURR BIOL, V11, P105, DOI 10.1016/S0960-9822(01)00019-7	60	169	171	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 15	2009	84	5					605	616		10.1016/j.ajhg.2009.04.010	http://dx.doi.org/10.1016/j.ajhg.2009.04.010			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	449OB	19409520	Green Published, Bronze			2022-12-18	WOS:000266338800005
J	Huang, L; Li, Y; Singleton, AB; Hardy, JA; Abecasis, G; Rosenberg, NA; Scheet, P				Huang, Lucy; Li, Yun; Singleton, Andrew B.; Hardy, John A.; Abecasis, Goncalo; Rosenberg, Noah A.; Scheet, Paul			Genotype-Imputation Accuracy across Worldwide Human Populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; LINKAGE DISEQUILIBRIUM; MISSING GENOTYPES; HAPLOTYPE; INFERENCE; LOCI; TRANSFERABILITY; PATTERNS; RISK	A Current approach to mapping complex-disease-susceptibility loci in genome-wide association (GWA) studies involves leveraging the information in a reference database of dense genotype data. By modeling the patterns of linkage disequilibrium in a reference panel, genotypes not directly measured In the study samples can be imputed and tested for disease association. This imputation strategy has been successful for GWA studies in populations well represented by existing reference panels. We used genotypes at 513,008 autosomal single-nucleotide polymorphism (SNP) loci in 443 unrelated individuals from 29 worldwide populations to evaluate the "portability" of the HapMap reference panels for imputation in studies of diverse populations. When a single HapMap panel was leveraged for imputation of randomly masked genotypes, European populations had the highest imputation accuracy, followed by populations from East Asia, Central and South Asia, the Americas, Oceania, the Middle East, and Africa. For each population, we identified "optimal" mixtures of reference panels that maximized imputation accuracy, and we found that in most populations, mixtures including individuals from at least two HapMap panels produced the highest imputation accuracy. From a separate survey of additional SNPs typed in the same samples, we evaluated imputation accuracy in the scenario in which all genotypes at a given SNP position were unobserved and were imputed on the basis of data from a commercial "SNP chip," again finding that most populations benefited from the use of combinations of two or more HapMap reference panels. Our results can serve as a guide for selecting appropriate reference panels for imputation-based GWA analysis in diverse populations.	[Huang, Lucy; Li, Yun; Abecasis, Goncalo; Rosenberg, Noah A.; Scheet, Paul] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Huang, Lucy; Rosenberg, Noah A.] Univ Michigan, Ctr Computat Med & Biol, Ann Arbor, MI 48109 USA; [Singleton, Andrew B.] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Hardy, John A.] UCL, Dept Mol Neurosci, London WC1N 3BG, England; [Hardy, John A.] UCL, Reta Lila Weston Inst Neurol Studies, Inst Neurol, London WC1N 3BG, England; [Rosenberg, Noah A.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Scheet, Paul] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of London; University College London; University of London; University College London; University of Michigan System; University of Michigan; University of Texas System; UTMD Anderson Cancer Center	Huang, L (corresponding author), Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA.	hlucy@umich.edu	Singleton, Andrew B/C-3010-2009; Hardy, John/C-2451-2009; Abecasis, Goncalo R/B-7840-2010	Hardy, John/0000-0002-3122-0423; Abecasis, Goncalo/0000-0003-1509-1825; Rosenberg, Noah/0000-0002-1829-8664	National Institutes of Health [R01 GM081441, R01 HL090564, U01 HL084729]; Burroughs Wellcome Fund; Alfred P. Sloan Foundation; National Institute on Aging, National Institutes of Health, Department of Health and Human Services [Z01AG000949-02]; MRC [G0701075] Funding Source: UKRI; Medical Research Council [G0701075] Funding Source: researchfish; Parkinson&quot;s UK [G-0907] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL008472, R01HL090564, U01HL084729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000932, Z01AG000949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); National Institute on Aging, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by grants from the National Institutes of Health (R01 GM081441, R01 HL090564, and U01 HL084729), the Burroughs Wellcome Fund, and the Alfred P. Sloan Foundation and by the Intramural Research Program of the National Institute on Aging, National Institutes of Health, Department of Health and Human Services (Z01AG000949-02).	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Browning SR, 2008, HUM GENET, V124, P439, DOI 10.1007/s00439-008-0568-7; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cann HM, 2002, SCIENCE, V296, P261; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gonzalez-Neira A, 2006, GENOME RES, V16, P323, DOI 10.1101/gr.4138406; Gu CC, 2008, GENET EPIDEMIOL, V32, P89, DOI 10.1002/gepi.20269; Gu S, 2007, EUR J HUM GENET, V15, P302, DOI 10.1038/sj.ejhg.5201751; Guan YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000279; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Li N, 2003, GENETICS, V165, P2213; Lin DY, 2008, AM J HUM GENET, V82, P444, DOI 10.1016/j.ajhg.2007.11.004; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Nicolae DL, 2006, GENET EPIDEMIOL, V30, P718, DOI 10.1002/gepi.20182; Pei YF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003551; Pemberton TJ, 2008, ANN HUM GENET, V72, P535, DOI 10.1111/j.1469-1809.2008.00457.x; Pezzolesi MG, 2006, AM J HUM GENET, V79, P923, DOI 10.1086/508943; Reiner AP, 2008, AM J HUM GENET, V82, P1193, DOI 10.1016/j.ajhg.2008.03.017; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Xing JC, 2008, GENOMICS, V92, P41, DOI 10.1016/j.ygeno.2008.03.011; Yu ZX, 2007, HUM GENET, V122, P495, DOI 10.1007/s00439-007-0427-y; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	32	169	174	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 13	2009	84	2					235	250		10.1016/j.ajhg.2009.01.013	http://dx.doi.org/10.1016/j.ajhg.2009.01.013			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	413NL	19215730	Green Published, Bronze			2022-12-18	WOS:000263799700013
J	Loges, NT; Olbrich, H; Fenske, L; Mussaffi, H; Horvath, J; Fliegauf, M; Kuhl, H; Baktai, G; Peterffy, E; Chodhari, R; Chung, EMK; Rutman, A; O'Callaghan, C; Blau, H; Tiszlavicz, L; Voelkel, K; Witt, M; Zietkiewicz, E; Neesen, J; Reinhardt, R; Mitchison, HM; Omran, H				Loges, Niki Tomas; Olbrich, Heike; Fenske, Lale; Mussaffi, Huda; Horvath, Judit; Fliegauf, Manfred; Kuhl, Heiner; Baktai, Gyorgy; Peterffy, Erzsebet; Chodhari, Rahul; Chung, Eddie M. K.; Rutman, Andrew; O'Callaghan, Christopher; Blau, Hannah; Tiszlavicz, Laszlo; Voelkel, Katarzyna; Witt, Michal; Zietkiewicz, Ewa; Neesen, Juergen; Reinhardt, Richard; Mitchison, Hannah M.; Omran, Heymut			DNAI2 Mutations Cause Primary Ciliary Dyskinesia with Defects in the Outer Dynein Arm	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNAH5 MUTATIONS; GENE; IDENTIFICATION; DISEASE; RANDOMIZATION; EXPRESSION; ASYMMETRY; CANDIDATE; PROTEIN; MUTANT	Primary ciliary dyskinesia (PCD) is a genetically heterogeneous disorder characterized by chronic destructive airway disease and randomization of left/right body asymmetry. Males often have reduced fertility due to impaired sperm tail function. The complex PCD phenotype results from dysfunction of cilia of the airways and the embryonic node and the structurally related motile sperm flagella. This is associated with underlying ultrastructural defects that frequently involve the Outer dynein arm (ODA) complexes that generate cilia and flagella movement. Applying a positional and functional candidate-gene approach, we identified homozygous loss-of-function DNAI2 mutations (IVS11 + 1G > A) in four individuals from a family with PCD and ODA defects. Further mutational screening of 105 unrelated PCD families detected two distinct homozygous mutations, including a nonsense (c.787C > T) and a splicing mutation (IVS3-31' > G) resulting in out-of-frame transcripts. Analysis of protein expression of the ODA intermediate chain DNAI2 showed sublocalization throughout respiratory cilia. Electron microscopy showed that mutant respiratory cells from these patients lacked DNAI2 protein expression and exhibited ODA defects. High-resolution immunofluorescence imaging demonstrated absence of the ODA heavy chains DNAH5 and DNAH9 from all DNAI2 mutant ciliary axonemes. In addition, we demonstrated complete or distal absence of DNAI2 from ciliary axonemes in respiratory cells of patients with mutations in genes encoding the ODA chains DNAH5 and DNAI1, respectively. Thus, DNAI2 and DNAH5 mutations affect assembly of proximal anddistal ODA complexes, whereas DNAI1 mutations mainly disrupt assembly of proximal ODA complexes.	[Loges, Niki Tomas; Olbrich, Heike; Fenske, Lale; Fliegauf, Manfred; Omran, Heymut] Univ Hosp Freiburg, Dept Pediat & Adolescent Med, Freiburg, Germany; [Loges, Niki Tomas] Univ Freiburg, Fac Biol, Freiburg, Germany; [Mussaffi, Huda; Blau, Hannah] Tel Aviv Univ, Sackler Sch Med, Schneider Childrens Med Ctr Israel, Pulm Unit, IL-69978 Tel Aviv, Israel; [Horvath, Judit] Natl Med Ctr, Budapest, Hungary; [Kuhl, Heiner; Reinhardt, Richard] Max Planck Inst Mol Genet, Berlin, Germany; [Baktai, Gyorgy; Peterffy, Erzsebet] Pediat Inst Svabhegy, Budapest, Hungary; [Chodhari, Rahul; Chung, Eddie M. K.; Mitchison, Hannah M.] UCL, Inst Child Hlth, Gen & Adolescent Paediat Unit, London, England; [Rutman, Andrew; O'Callaghan, Christopher] Univ Leicester, Leicester Royal Infirm, Dept Infect Immun & Inflammat, Div Child Hlth, Leicester, Leics, England; [Tiszlavicz, Laszlo] Univ Szeged, Dept Pathol, Szeged, Hungary; [Voelkel, Katarzyna; Witt, Michal; Zietkiewicz, Ewa] Polish Acad Sci, Inst Human Genet, Dept Mol & Clin Genet, PL-60479 Poznan, Poland; [Witt, Michal] Int Inst Mol & Cell Biol, Warsaw, Poland; [Neesen, Juergen] Univ Vienna, Dept Med Genet, Vienna, Austria	University of Freiburg; University of Freiburg; Tel Aviv University; Sackler Faculty of Medicine; Max Planck Society; University of London; University College London; University of Leicester; Szeged University; Polish Academy of Sciences; Institute of Human Genetics of the Polish Academy of Sciences; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; University of Vienna	Omran, H (corresponding author), Univ Hosp Freiburg, Dept Pediat & Adolescent Med, Freiburg, Germany.	heymut.omran@uniklinik-freiburg.de	Buzuk, Marijo/D-8199-2017; Vladislavic, Nives/N-9360-2013; Mitchison, Hannah M./C-1891-2008; Brinic, Slobodan/A-5131-2013; Grubač, Zoran/G-9661-2017; Zietkiewicz, Ewa/ABP-3539-2022; Kuhl, Heiner/L-2737-2019	Vladislavic, Nives/0000-0002-3185-6907; Grubač, Zoran/0000-0002-6173-1961; Neesen, Jurgen/0000-0002-3635-2097; Witt, Michal/0000-0003-1729-4159; Omran, Heymut/0000-0003-0282-6765; Zietkiewicz, Ewa/0000-0003-2437-5088; Mitchison, Hannah/0000-0002-3163-6293; Reinhardt, Richard/0000-0001-9376-2132	Deutsche Forschungsgemeinschaft grants DFG [Om 6/4, GRK1104, SFB592]; Polish State Committee for Scientific research [122/P05-1]; National Specialist Commissioning Advisory Group, UK; Milena Carvajal-Prokartagener Foundation	Deutsche Forschungsgemeinschaft grants DFG(German Research Foundation (DFG)); Polish State Committee for Scientific research(Polish State Committee for Scientific Research); National Specialist Commissioning Advisory Group, UK; Milena Carvajal-Prokartagener Foundation	We are grateful to the patients and their families for their participation in this study. We thank the German patient support group Kartagener Syndrom und Primaere Ciliaere Dyskinesie e.V. We thank R. Nitschke and S. Haxelmans at the life imaging center, Institute for Biology 1, University Freiburg, for their excellent support with confocal microscopy We thank C. Reinhard, A. Heer, A. Schwentek, E. Rutkiewicz, and K. Parker for excellent technical assistance. We would also like to thank Andrzej Pogorzelski from the Institute of Tuberculosis and Lung Diseases, Rabka for clinical diagnosis and recruitment of patients. This work was supported by Deutsche Forschungsgemeinschaft grants DFG Om 6/4, GRK1104, and SFB592 (to H.O.), and by grants from the Polish State Committee for Scientific research (PBZ KBN 122/P05-1, to E.Z.), the National Specialist Commissioning Advisory Group, UK (to C.O'C.), and the Milena Carvajal-Prokartagener Foundation (to H.M.M.). This work is dedicated to Bjorn A. Afzelius for his outstanding research in the field of ciliary structure and immotile-cilia syndrome.	AFZELIUS B A, 1976, Science (Washington D C), V193, P317; Bartoloni L, 2002, P NATL ACAD SCI USA, V99, P10282, DOI 10.1073/pnas.152337699; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Duriez B, 2007, P NATL ACAD SCI USA, V104, P3336, DOI 10.1073/pnas.0611405104; Failly M, 2008, RESPIRATION, V76, P198, DOI 10.1159/000128567; Fliegauf M, 2005, AM J RESP CRIT CARE, V171, P1343, DOI 10.1164/rccm.200411-1583OC; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Fowkes ME, 1998, MOL BIOL CELL, V9, P2337, DOI 10.1091/mbc.9.9.2337; Geremek Maciej, 2004, Journal of Applied Genetics, V45, P347; Hornef N, 2006, AM J RESP CRIT CARE, V174, P120, DOI 10.1164/rccm.200601-084OC; Ibanez-Tallon I, 2003, HUM MOL GENET, V12, pR27, DOI 10.1093/hmg/ddg061; Kennedy MP, 2007, CIRCULATION, V115, P2814, DOI 10.1161/CIRCULATIONAHA.106.649038; Kispert A, 2003, THORAX, V58, P552, DOI 10.1136/thorax.58.6.552-b; Lonergan KM, 2006, AM J RESP CELL MOL, V35, P651, DOI 10.1165/rcmb.2006-0056OC; Meeks M, 2000, PEDIATR PULM, V29, P307, DOI 10.1002/(SICI)1099-0496(200004)29:4<307::AID-PPUL11>3.0.CO;2-2; MITCHELL DR, 1985, J CELL BIOL, V100, P1228, DOI 10.1083/jcb.100.4.1228; MITCHELL DR, 1991, J CELL BIOL, V113, P835, DOI 10.1083/jcb.113.4.835; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Olbrich H, 2006, PEDIATR RES, V59, P418, DOI 10.1203/01.pdr.0000200809.21364.e2; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Omran H, 2000, AM J RESP CELL MOL, V23, P696, DOI 10.1165/ajrcmb.23.5.4257; Pazour GJ, 2006, J MED GENET, V43, P62, DOI 10.1136/jmg.2005.033001; Pennarun G, 1999, AM J HUM GENET, V65, P1508, DOI 10.1086/302683; Pennarun G, 2000, HUM GENET, V107, P642, DOI 10.1007/s004390000427; PFISTER KK, 1982, CELL MOTIL CYTOSKEL, V2, P525, DOI 10.1002/cm.970020604; Rashid S, 2006, MOL REPROD DEV, V73, P784, DOI 10.1002/mrd.20475; Schwabe GC, 2008, HUM MUTAT, V29, P289, DOI 10.1002/humu.20656; Zariwala MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/annurev.physiol.69.040705.141301; Zariwala MA, 2006, AM J RESP CRIT CARE, V174, P858, DOI 10.1164/rccm.200603-370OC	29	169	181	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 7	2008	83	5					547	558		10.1016/j.ajhg.2008.10.001	http://dx.doi.org/10.1016/j.ajhg.2008.10.001			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	373XN	18950741	Green Published, Bronze			2022-12-18	WOS:000261006900001
J	Ahituv, N; Kavaslar, N; Schackwitz, W; Ustaszewska, A; Martin, J; Hebert, S; Doelle, H; Ersoy, B; Kryukov, G; Schmidt, S; Yosef, N; Ruppin, E; Sharan, R; Vaisse, C; Sunyaev, S; Dent, R; Cohen, J; McPherson, R; Pennacchio, LA				Ahituv, Nadav; Kavaslar, Nihan; Schackwitz, Wendy; Ustaszewska, Anna; Martin, Joel; Hebert, Sybil; Doelle, Heather; Ersoy, Baran; Kryukov, Gregory; Schmidt, Steffen; Yosef, Nir; Ruppin, Eytan; Sharan, Roded; Vaisse, Christian; Sunyaev, Shamil; Dent, Robert; Cohen, Jonathan; McPherson, Ruth; Pennacchio, Len A.			Medical sequencing at the extremes of human body mass	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							ACTIVATED-RECEPTOR-GAMMA; UNCOUPLING PROTEIN-3 GENE; OBESITY-RELATED PHENOTYPES; HETERODIMER PARTNER GENE; EARLY-ONSET OBESITY; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; SINGLE-NUCLEOTIDE POLYMORPHISMS; GLY482SER MISSENSE MUTATION; AGOUTI-RELATED PROTEIN; HEALTHY NORMAL-WEIGHT	Body weight is a quantitative trait with significant heritability in humans. To identify potential genetic contributors to this phenotype, we resequenced the coding exons and splice junctions of 58 genes in 379 obese and 378 lean individuals. Our 96-Mb survey included 21 genes associated with monogenic forms of obesity in humans or mice, as well as 37 genes that function in body weight-related pathways. We found that the monogenic obesity-associated gene group was enriched for rare nonsynonymous variants unique to the obese population compared with the lean population. In addition, computational analysis predicted a greater fraction of deleterious variants within the obese cohort. Together, these data suggest that multiple rare alleles contribute to obesity in the population and provide a medical sequencing-based approach to detect them.	Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA; US Dept Energy Joint Genome Inst, Walnut Creek, CA USA; Univ Ottawa, Inst Heart, Div Cardiol, Ottawa, ON K1N 6N5, Canada; Univ Ottawa, Inst Heart, Atherosclerosis Res Grp, Ottawa, ON K1N 6N5, Canada; Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Tel Aviv Univ, Sch Comp Sci, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Sch Med, IL-69978 Tel Aviv, Israel; Univ Texas, Ctr Human Nutr, Dallas, TX 75230 USA; Univ Texas, McDermott Ctr Human Growth & Dev, Ctr Med, Dallas, TX 75230 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; University of Ottawa Heart Institute; University of California System; University of California San Francisco; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Tel Aviv University; Tel Aviv University; University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Dallas	Pennacchio, LA (corresponding author), Lawrence Berkeley Natl Lab, Genom Div, 1 Cyclotron Rd,MS 84-171, Berkeley, CA 94720 USA.	LAPennacchio@lbl.gov	Kryukov, Gregory V/A-9592-2008; Ersoy, Baran/F-8192-2012; Ruppin, Eytan/R-9698-2017; Schackwitz, Wendy/GXH-9536-2022; Vaisse, Christian/F-1067-2011	Ruppin, Eytan/0000-0002-7862-3940; Ahituv, Nadav/0000-0002-7434-8144; Kryukov, Gregory/0000-0002-6131-9483; Schmidt, Steffen/0000-0001-9077-6010; Martin, Joel/0000-0001-9511-6441; Schackwitz, Wendy/0000-0002-3013-9180; Pennacchio, Len/0000-0002-8748-3732	NIDDK NIH HHS [R01 DK068152, R01 DK060540] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060540, R01DK068152] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aberle J, 2005, CLIN GENET, V68, P152, DOI 10.1111/j.1399-0004.2005.00463.x; Ahituv N, 2006, HUM MOL GENET, V15, P387, DOI 10.1093/hmg/ddi455; Argyropoulos G, 2002, J CLIN ENDOCR METAB, V87, P4198, DOI 10.1210/jc.2002-011834; Argyropoulos G, 1998, J CLIN INVEST, V102, P1345, DOI 10.1172/JCI4115; Asnicar MA, 2001, ENDOCRINOLOGY, V142, P4394, DOI 10.1210/en.142.10.4394; Azuma K, 2004, HORM METAB RES, V36, P564, DOI 10.1055/s-2004-825762; Baessler A, 2005, DIABETES, V54, P259, DOI 10.2337/diabetes.54.1.259; Baker M, 2005, DIABETES, V54, P2492, DOI 10.2337/diabetes.54.8.2492; Banerjee RR, 2004, SCIENCE, V303, P1195, DOI 10.1126/science.1092341; Barnes BR, 2004, J BIOL CHEM, V279, P38441, DOI 10.1074/jbc.M405533200; Bell CG, 2005, NAT REV GENET, V6, P221, DOI 10.1038/nrg1556; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berthier MT, 2003, J HUM GENET, V48, P14, DOI 10.1007/s100380300002; Boey D, 2006, DIABETOLOGIA, V49, P1360, DOI 10.1007/s00125-006-0237-0; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Boucher N, 2002, MOL MED, V8, P158, DOI 10.1007/BF03402008; Bray MS, 2000, OBES RES, V8, P219, DOI 10.1038/oby.2000.25; Butler MG, 1998, CLIN GENET, V54, P385; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Cassell PG, 2000, DIABETOLOGIA, V43, P1558, DOI 10.1007/s001250051569; Chagnon YC, 1997, MOL MED, V3, P663, DOI 10.1007/BF03401705; Challis BG, 2000, DIABETES, V49, P872, DOI 10.2337/diabetes.49.5.872; Challis BG, 2002, HUM MOL GENET, V11, P1997, DOI 10.1093/hmg/11.17.1997; Chen AS, 2000, NAT GENET, V26, P97, DOI 10.1038/79254; Chen YN, 2005, EUR J HUM GENET, V13, P772, DOI 10.1038/sj.ejhg.5201407; Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082; Cohen JC, 2006, P NATL ACAD SCI USA, V103, P1810, DOI 10.1073/pnas.0508483103; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Comuzzie AG, 1998, SCIENCE, V280, P1374, DOI 10.1126/science.280.5368.1374; Conneely KN, 2004, DIABETOLOGIA, V47, P1782, DOI 10.1007/s00125-004-1537-x; Coudreau SK, 2003, OBES RES, V11, P1163, DOI 10.1038/oby.2003.160; Damcott CM, 2004, METABOLISM, V53, P303, DOI 10.1016/j.metabol.2003.10.010; Damcott CM, 2004, METABOLISM, V53, P458, DOI 10.1016/j.metabol.2003.11.019; del Giudice EM, 2001, DIABETES, V50, P2157, DOI 10.2337/diabetes.50.9.2157; del Giudice EM, 2001, INT J OBESITY, V25, P61, DOI 10.1038/sj.ijo.0801485; Dobner PR, 2001, P NATL ACAD SCI USA, V98, P8048, DOI 10.1073/pnas.141042198; DRANOFF G, 1994, SCIENCE, V264, P713, DOI 10.1126/science.8171324; Draper N, 2002, J CLIN ENDOCR METAB, V87, P4984, DOI 10.1210/jc.2001-011375; Echwald SM, 2004, HUM MUTAT, V24, P381, DOI 10.1002/humu.20090; Elosua R, 2006, J LIPID RES, V47, P990, DOI 10.1194/jlr.M500446-JLR200; Engert JC, 2002, DIABETES, V51, P1629, DOI 10.2337/diabetes.51.5.1629; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; Esterbauer H, 2002, DIABETES, V51, P1281, DOI 10.2337/diabetes.51.4.1281; Faivre L, 2002, J MED GENET, V39, P594, DOI 10.1136/jmg.39.8.594; Fanelli M, 2005, DIS MARKERS, V21, P175, DOI 10.1155/2005/576748; Filippi E, 2004, EUR J HUM GENET, V12, P199, DOI 10.1038/sj.ejhg.5201120; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; French SA, 2001, ANNU REV PUBL HEALTH, V22, P309, DOI 10.1146/annurev.publhealth.22.1.309; Friedman JM, 2003, SCIENCE, V299, P856, DOI 10.1126/science.1079856; Fumeron F, 2004, DIABETES, V53, P1150, DOI 10.2337/diabetes.53.4.1150; Gelernter-Yaniv L, 2003, INT J OBESITY, V27, P983, DOI 10.1038/sj.ijo.0802327; Geller F, 2004, AM J HUM GENET, V74, P572, DOI 10.1086/382490; Gollob MH, 2001, NEW ENGL J MED, V344, P1823, DOI 10.1056/NEJM200106143442403; Gong DW, 2000, J BIOL CHEM, V275, P16251, DOI 10.1074/jbc.M910177199; GOODMAN R, 1997, CHILD PSYCHOL PSYCHI, V2, P15; Gu HF, 2004, DIABETES, V53, pS31, DOI 10.2337/diabetes.53.2007.S31; Guerardel A, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-19; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Halsall DJ, 2001, INT J OBESITY, V25, P472, DOI 10.1038/sj.ijo.0801584; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Hamid YH, 2005, DIABETOLOGIA, V48, P251, DOI 10.1007/s00125-004-1623-0; Hanada R, 2004, NAT MED, V10, P1067, DOI 10.1038/nm1106; Harp JB, 2004, CURR OPIN LIPIDOL, V15, P303, DOI 10.1097/00041433-200406000-00010; Hedlund PB, 2003, P NATL ACAD SCI USA, V100, P1375, DOI 10.1073/pnas.0337340100; Heid IM, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.027011; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Hinney A, 2006, J CLIN ENDOCR METAB, V91, P1761, DOI 10.1210/jc.2005-2056; Hinney A, 2002, J CLIN ENDOCR METAB, V87, P2716, DOI 10.1210/jc.87.6.2716; Hinney A, 1999, J CLIN ENDOCR METAB, V84, P1483, DOI 10.1210/jc.84.4.1483; Hoffstedt J, 2002, HORM METAB RES, V34, P355, DOI 10.1055/s-2002-33466; Holder JL, 2000, HUM MOL GENET, V9, P101; HOMANICS GE, 1995, J BIOL CHEM, V270, P2974, DOI 10.1074/jbc.270.7.2974; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Hu FB, 2004, DIABETES, V53, P209, DOI 10.2337/diabetes.53.1.209; Huang QY, 2003, J HUM GENET, V48, P430, DOI 10.1007/s10038-003-0053-z; Humbles AA, 2000, NATURE, V406, P998, DOI 10.1038/35023175; Hung CCC, 2003, DIABETES, V52, P1288, DOI 10.2337/diabetes.52.5.1288; Hung CCC, 2004, DIABETES, V53, P2461, DOI 10.2337/diabetes.53.9.2461; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Ishii M, 2003, P NATL ACAD SCI USA, V100, P10540, DOI 10.1073/pnas.1334189100; Jenkinson CP, 2000, INT J OBESITY, V24, P580, DOI 10.1038/sj.ijo.0801200; Jiang Y, 2004, AM J HUM GENET, V75, P220, DOI 10.1086/422699; Karvonen MK, 1998, NAT MED, V4, P1434, DOI 10.1038/4027; Karvonen MK, 2000, J CLIN ENDOCR METAB, V85, P1455, DOI 10.1210/jc.85.4.1455; Keith B, 2001, P NATL ACAD SCI USA, V98, P6692, DOI 10.1073/pnas.121494298; Kelly MA, 2005, P NATL ACAD SCI USA, V102, P9942, DOI 10.1073/pnas.0503795102; Kerr TA, 2002, DEV CELL, V2, P713, DOI 10.1016/S1534-5807(02)00154-5; Kim KH, 2004, P NATL ACAD SCI USA, V101, P6780, DOI 10.1073/pnas.0305905101; Kimm SYS, 2002, AM J CLIN NUTR, V75, P714, DOI 10.1093/ajcn/75.4.714; KLEBIG ML, 1995, P NATL ACAD SCI USA, V92, P4728, DOI 10.1073/pnas.92.11.4728; Korbonits M, 2002, J CLIN ENDOCR METAB, V87, P4005, DOI 10.1210/jc.87.8.4005; Kotelevtsev Y, 1997, P NATL ACAD SCI USA, V94, P14924, DOI 10.1073/pnas.94.26.14924; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Kubaszek A, 2003, DIABETES, V52, P558, DOI 10.2337/diabetes.52.2.558; Kublaoui BM, 2006, ENDOCRINOLOGY, V147, P4542, DOI 10.1210/en.2006-0453; Kuczmarski R. J, 2002, VITAL HLTH STAT, DOI DOI 10.1016/J.BBRC.2015.06.114; Kushi A, 1998, P NATL ACAD SCI USA, V95, P15659, DOI 10.1073/pnas.95.26.15659; Lacourse KA, 1999, AM J PHYSIOL-GASTR L, V276, pG1302, DOI 10.1152/ajpgi.1999.276.5.G1302; Lanouette CM, 2002, J APPL PHYSIOL, V92, P1111, DOI 10.1152/japplphysiol.00726.2001; Lanouette CM, 2001, MOL MED, V7, P433, DOI 10.1007/BF03401848; LAVEBRATT C, 2005, INT J OBES LOND, V30, P453; Le Stunff C, 2000, DIABETES, V49, P2196, DOI 10.2337/diabetes.49.12.2196; Leabman MK, 2003, P NATL ACAD SCI USA, V100, P5896, DOI 10.1073/pnas.0730857100; Lee M, 2002, BMC MUSCULOSKEL DIS, V3, DOI 10.1186/1471-2474-3-3; Lee YS, 2006, CELL METAB, V3, P135, DOI 10.1016/j.cmet.2006.01.006; Li WD, 1999, ANN HUM GENET, V63, P227, DOI 10.1046/j.1469-1809.1999.6330227.x; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lindholm E, 2004, J DIABETES COMPLICAT, V18, P103, DOI 10.1016/S1056-8727(03)00019-9; Liu YJ, 2005, PHYSIOL GENOMICS, V22, P197, DOI 10.1152/physiolgenomics.00031.2005; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Lubrano-Berthelier C, 2006, J CLIN ENDOCR METAB, V91, P1811, DOI 10.1210/jc.2005-1411; Lubrano-Berthelier C, 2003, ANN NY ACAD SCI, V994, P49, DOI 10.1111/j.1749-6632.2003.tb03161.x; Lubrano-Berthelier C, 2003, HUM MOL GENET, V12, P145, DOI 10.1093/hmg/ddg016; Ludwig EH, 2002, CLIN GENET, V62, P68, DOI 10.1034/j.1399-0004.2002.620109.x; Ma LJ, 2005, DIABETES, V54, P1598, DOI 10.2337/diabetes.54.5.1598; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Mammes O, 2000, ANN HUM GENET, V64, P391, DOI 10.1017/S0003480000008277; Marks DL, 2004, AM J MED GENET A, V126A, P267, DOI 10.1002/ajmg.a.20600; Marsh DJ, 1998, NAT MED, V4, P718, DOI 10.1038/nm0698-718; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Mattevi VS, 2004, HUM GENET, V115, P208, DOI 10.1007/s00439-004-1128-4; McCarthy S, 2005, HUM GENET, V117, P545, DOI 10.1007/s00439-005-1328-6; Menzaghi C, 2002, DIABETES, V51, P2306, DOI 10.2337/diabetes.51.7.2306; Michaud JL, 2001, HUM MOL GENET, V10, P1465, DOI 10.1093/hmg/10.14.1465; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mitchell SMS, 2003, DIABETES, V52, P1276, DOI 10.2337/diabetes.52.5.1276; Miyasaka K, 2006, J NEURAL TRANSM, V113, P1279, DOI 10.1007/s00702-005-0393-2; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Muller YL, 2003, DIABETES, V52, P895, DOI 10.2337/diabetes.52.3.895; Naveilhan P, 1999, NAT MED, V5, P1188, DOI 10.1038/13514; Nishigori H, 2001, P NATL ACAD SCI USA, V98, P575, DOI 10.1073/pnas.98.2.575; Ogawa Y, 1999, DIABETES, V48, P1822, DOI 10.2337/diabetes.48.9.1822; OhkiHamazaki H, 1997, NATURE, V390, P165, DOI 10.1038/36568; Oksanen L, 1997, HUM GENET, V99, P559, DOI 10.1007/s004390050406; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Oshima M, 1996, DEV BIOL, V179, P297, DOI 10.1006/dbio.1996.0259; Otabe S, 2000, DIABETOLOGIA, V43, P245, DOI 10.1007/s001250050037; Otabe S, 1999, DIABETES, V48, P206; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Perusse L, 2005, OBES RES, V13, P381, DOI 10.1038/oby.2005.50; Pooley EC, 2004, AM J MED GENET B, V126B, P124, DOI 10.1002/ajmg.b.20143; Qian S, 2002, MOL CELL BIOL, V22, P5027, DOI 10.1128/MCB.22.14.5027-5035.2002; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Ridderstrale M, 2006, DIABETOLOGIA, V49, P496, DOI 10.1007/s00125-005-0129-8; Rosmond R, 2002, METABOLISM, V51, P642, DOI 10.1053/meta.2002.31333; Rosmond R, 2001, DIABETOLOGIA, V44, P1335, DOI 10.1007/s001250100649; Roth SM, 2003, J GERONTOL A-BIOL, V58, P1085; Rutanen J, 2004, OBES RES, V12, P1060, DOI 10.1038/oby.2004.133; Santoro N, 2004, J CLIN ENDOCR METAB, V89, P4846, DOI 10.1210/jc.2004-0333; Schalin-Jantti C, 2003, INT J OBESITY, V27, P70, DOI 10.1038/sj.ijo.0802184; Sentinelli F, 2002, DIABETES, V51, P860, DOI 10.2337/diabetes.51.3.860; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Sookoian S, 2005, J MOL ENDOCRINOL, V35, P373, DOI 10.1677/jme.1.01837; St-Pierre J, 2003, MOL GENET METAB, V78, P31, DOI 10.1016/S1096-7192(02)00223-8; Stephens JW, 2004, MOL GENET METAB, V82, P180, DOI 10.1016/j.ymgme.2004.04.001; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Stumvoll M, 2002, DIABETES, V51, P37, DOI 10.2337/diabetes.51.1.37; Sun MW, 2006, DIABETES, V55, P849, DOI 10.2337/diabetes.55.03.06.db05-1418; Sun YX, 2003, MOL CELL BIOL, V23, P7973, DOI 10.1128/MCB.23.22.7973-7981.2003; Sun YX, 2004, P NATL ACAD SCI USA, V101, P4679, DOI 10.1073/pnas.0305930101; Sutton BS, 2005, OBES RES, V13, P1491, DOI 10.1038/oby.2005.180; Suviolahti E, 2003, INT J OBESITY, V27, P1204, DOI 10.1038/sj.ijo.0802392; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Torekov SS, 2005, DIABETES, V54, P2261, DOI 10.2337/diabetes.54.7.2261; Ueno N, 1999, GASTROENTEROLOGY, V117, P1427, DOI 10.1016/S0016-5085(99)70293-3; Ukkola O, 2004, EUR J CLIN NUTR, V58, P654, DOI 10.1038/sj.ejcn.1601861; Ukkola O, 2002, OBES RES, V10, P782, DOI 10.1038/oby.2002.106; Ukkola O, 2001, J CLIN ENDOCR METAB, V86, P3996, DOI 10.1210/jc.86.8.3996; Ukkola O, 2001, EUR J CLIN NUTR, V55, P1008, DOI 10.1038/sj.ejcn.1601261; Uusitupa MIJ, 1998, ANN MED, V30, P508, DOI 10.3109/07853899809002597; Vaisse C, 2000, J CLIN INVEST, V106, P253, DOI 10.1172/JCI9238; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; Van der Lende T, 2005, VITAM HORM, V71, P373, DOI 10.1016/S0083-6729(05)71013-X; Vimaleswaran KS, 2006, INT J OBESITY, V30, P884, DOI 10.1038/sj.ijo.0803228; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Voisey J, 2002, PIGM CELL RES, V15, P10, DOI 10.1034/j.1600-0749.2002.00039.x; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Wang HJ, 2004, J CLIN ENDOCR METAB, V89, P157, DOI 10.1210/jc.2003-031395; Wernstedt I, 2004, INT J OBESITY, V28, P1272, DOI 10.1038/sj.ijo.0802763; Yamada K, 2002, INT J OBESITY, V26, P132, DOI 10.1038/sj.ijo.0801848; Yanagisawa Y, 2001, BIOCHEM BIOPH RES CO, V281, P772, DOI 10.1006/bbrc.2001.4417; Yang WS, 2003, J MOL MED-JMM, V81, P428, DOI 10.1007/s00109-002-0409-4; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	185	169	171	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2007	80	4					779	791		10.1086/513471	http://dx.doi.org/10.1086/513471			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	153VV	17357083	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000245465200018
J	Awad, MM; Dalal, D; Cho, E; Amat-Alarcon, N; James, C; Tichnell, C; Tucker, A; Russell, SD; Bluemke, DA; Dietz, HC; Calkins, H; Judge, DP				Awad, Mark M.; Dalal, Darshan; Cho, Eunpi; Amat-Alarcon, Nuria; James, Cynthia; Tichnell, Crystal; Tucker, April; Russell, Stuart D.; Bluemke, David A.; Dietz, Harry C.; Calkins, Hugh; Judge, Daniel P.			DSG2 mutations contribute to arrhythmogenic right ventricular dysplasia/cardiomyopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							E-CADHERIN; PALMOPLANTAR KERATODERMA; PEMPHIGUS-VULGARIS; NAXOS-DISEASE; WOOLLY HAIR; CARDIOMYOPATHY; PLAKOPHILIN-2; PLAKOGLOBIN; AUTOANTIBODIES; IDENTIFICATION	Arrhythmogenic right ventricular dysplasia/cardiomyopathy ( ARVD/C) is a disorder characterized by fibrofatty replacement of cardiac myocytes that typically manifests in the right ventricle. It is inherited as an autosomal dominant disease with reduced penetrance, although autosomal recessive forms of the disease also occur. We identified four probands with ARVD/C caused by mutations in DSG2, which encodes desmoglein-2, a component of the cardiac desmosome. No association between mutations in this gene and human disease has been reported elsewhere. One of these probands has compound-heterozygous mutations in DSG2, and the remaining three have isolated heterozygous missense mutations, each disrupting known functional components of desmoglein-2. We report that mutations in DSG2 contribute to the development of ARVD/C.	Johns Hopkins Univ, Sch Med, Div Cardiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; Howard Hughes Med Inst, Bethesda, MD 20817 USA; Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Judge, DP (corresponding author), Johns Hopkins Univ, Sch Med, Div Cardiol, Ross 1049,720 Rutland Ave, Baltimore, MD 21205 USA.	Djudge@jhmi.edu	; Bluemke, David/GYU-8169-2022	Judge, Daniel/0000-0002-3407-0248; Bluemke, David/0000-0002-8323-8086; James, Cynthia/0000-0001-8040-4600				AMAGAI M, 1991, CELL, V67, P869, DOI 10.1016/0092-8674(91)90360-B; ANDERSON ED, 1993, J BIOL CHEM, V268, P24887; Bauce B, 2005, EUR HEART J, V26, P1666, DOI 10.1093/eurheartj/ehi341; Bauce B, 2002, J AM COLL CARDIOL, V40, P341, DOI 10.1016/S0735-1097(02)01946-0; Beffagna G, 2005, CARDIOVASC RES, V65, P366, DOI 10.1016/j.cardiores.2004.10.005; Bowles NE, 2002, J AM COLL CARDIOL, V39, P892, DOI 10.1016/S0735-1097(02)01688-1; Calabrese F, 2006, CARDIOVASC PATHOL, V15, P11, DOI 10.1016/j.carpath.2005.10.004; Chitaev NA, 1998, J CELL SCI, V111, P1941; Dalal D, 2006, CIRCULATION, V113, P1641, DOI 10.1161/CIRCULATIONAHA.105.568642; Djabali K, 2002, J INVEST DERMATOL, V118, P557, DOI 10.1046/j.0022-202x.2001.01627.x; Eshkind L, 2002, EUR J CELL BIOL, V81, P592, DOI 10.1078/0171-9335-00278; Gerull B, 2004, NAT GENET, V36, P1162, DOI 10.1038/ng1461; Getsios S, 2004, NAT REV MOL CELL BIO, V5, P271, DOI 10.1038/nrm1356; Grossmann KS, 2004, J CELL BIOL, V167, P149, DOI 10.1083/jcb.200402096; Hanakawa Y, 2002, J CLIN INVEST, V110, P53, DOI 10.1172/JCI200215766; Huber O, 1999, J CELL SCI, V112, P4415; Kljuic A, 2003, CELL, V113, P249, DOI 10.1016/S0092-8674(03)00273-3; MCKENNA WJ, 1994, BRIT HEART J, V71, P215; McKoy G, 2000, LANCET, V355, P2119, DOI 10.1016/S0140-6736(00)02379-5; Mendell JT, 2001, CELL, V107, P411, DOI 10.1016/S0092-8674(01)00583-9; Norgett EE, 2000, HUM MOL GENET, V9, P2761, DOI 10.1093/hmg/9.18.2761; Norman M, 2005, CIRCULATION, V112, P636, DOI 10.1161/CIRCULATIONAHA.104.532234; OZAWA M, 1990, J CELL BIOL, V111, P1645, DOI 10.1083/jcb.111.4.1645; Pai LM, 1996, J BIOL CHEM, V271, P32411, DOI 10.1074/jbc.271.50.32411; Posthaus H, 2003, FEBS LETT, V536, P203, DOI 10.1016/S0014-5793(02)03897-8; Priori SG, 2001, CIRCULATION, V103, P196; PROTONOTARIOS N, 1986, BRIT HEART J, V56, P321; Rampazzo A, 2002, AM J HUM GENET, V71, P1200, DOI 10.1086/344208; RAMPAZZO A, 1995, HUM MOL GENET, V4, P2151, DOI 10.1093/hmg/4.11.2151; Rickman L, 1999, HUM MOL GENET, V8, P971, DOI 10.1093/hmg/8.6.971; SCHAFER S, 1994, EXP CELL RES, V211, P391, DOI 10.1006/excr.1994.1103; SCHWARZ MA, 1990, ANNU REV CELL BIOL, V6, P461, DOI 10.1146/annurev.cb.06.110190.002333; Sen-Chowdhry S, 2005, J CARDIOVASC ELECTR, V16, P927, DOI 10.1111/j.1540-8167.2005.40842.x; STANLEY JR, 1986, J IMMUNOL, V136, P1227; STAPPERT J, 1994, CELL ADHES COMMUN, V2, P319, DOI 10.3109/15419069409014207; Syrris P, 2006, CIRCULATION, V113, P356, DOI 10.1161/CIRCULATIONAHA.105.561654	36	169	177	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2006	79	1					136	142		10.1086/504393	http://dx.doi.org/10.1086/504393			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	053YD	16773573	Green Published, Bronze			2022-12-18	WOS:000238341200014
J	Cullen, M; Perfetto, SP; Klitz, W; Nelson, G; Carrington, M				Cullen, M; Perfetto, SP; Klitz, W; Nelson, G; Carrington, M			High-resolution patterns of meiotic recombination across the human major histocompatibility complex	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CLASS-II REGION; HUMAN PSEUDOAUTOSOMAL REGION; GLOBIN GENE-CLUSTER; LINKAGE DISEQUILIBRIUM; DNA-SEQUENCE; HOT-SPOTS; HOMOLOGOUS RECOMBINATION; HUMAN INSULIN; HUMAN GENOME; HUMAN-CELLS	Definitive characteristics of meiotic recombination events over large (i.e., >1 Mb) segments of the human genome remain obscure, yet they are essential for establishing the haplotypic structure of the genome and for efficient mapping of complex traits. We present a high-resolution map of recombination at the kilobase level across a 3.3-Mb interval encompassing the major histocompatibility complex (MHC). Genotyping of 20,031 single sperm from 12 individuals resulted in the identification and fine mapping of 325 recombinant chromosomes within genomic intervals as small as 7 kb. Several principal characteristics of recombination in this region were observed: (1) rates of recombination can differ significantly between individuals; (2) intense hot spots of recombination occur at least every 0.8 Mb but are not necessarily evenly spaced; (3) distribution in the location of recombination events can differ significantly among individuals; (4) between hot spots, low levels of recombination occur fairly evenly across 100-kb segments, suggesting the presence of warm spots of recombination; and (5) specific sequence motifs associate significantly with recombination distribution. These data provide a plausible model for recombination patterns of the human genome overall.	NCI, Lab Genom Divers, Basin Res Program, SAIC Frederick, Ft Detrick, MD 21702 USA; George Washington Univ, Grad Program Genet, Inst Biomed Sci, Washington, DC USA; NIH, USA Program, Vaccine Res Ctr, Bethesda, MD 20892 USA; Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA; Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; George Washington University; National Institutes of Health (NIH) - USA; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; University of California System; University of California Berkeley	Carrington, M (corresponding author), NCI, Lab Genom Divers, Basin Res Program, SAIC Frederick, POB B, Ft Detrick, MD 21702 USA.				PHS HHS [N01-C0-12400] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AOKI K, 1995, NAT GENET, V10, P167, DOI 10.1038/ng0695-167; Badge RM, 2000, HUM MOL GENET, V9, P1239, DOI 10.1093/hmg/9.8.1239; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Beck S, 2000, ANNU REV GENOM HUM G, V1, P117, DOI 10.1146/annurev.genom.1.1.117; BEGOVICH AB, 1992, J IMMUNOL, V148, P249; BENGER JC, 1991, GENOMICS, V9, P614, DOI 10.1016/0888-7543(91)90354-H; BERGEMANN AD, 1992, MOL CELL BIOL, V12, P1257, DOI 10.1128/MCB.12.3.1257; BOWCOCK AM, 1988, P NATL ACAD SCI USA, V85, P2701, DOI 10.1073/pnas.85.8.2701; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Brown GM, 1998, AM J HUM GENET, V62, P1484, DOI 10.1086/301863; Bugawan TL, 2000, TISSUE ANTIGENS, V56, P392, DOI 10.1034/j.1399-0039.2000.560502.x; CHAKRAVARTI A, 1986, P NATL ACAD SCI USA, V83, P1045, DOI 10.1073/pnas.83.4.1045; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; CHARMLEY P, 1990, P NATL ACAD SCI USA, V87, P4823, DOI 10.1073/pnas.87.12.4823; CORNISHBOWDEN A, 1986, J BIOL CHEM, V261, P13; CUI XF, 1989, P NATL ACAD SCI USA, V86, P9389, DOI 10.1073/pnas.86.23.9389; CULLEN M, 1995, AM J HUM GENET, V56, P1350; Cullen M, 1997, AM J HUM GENET, V60, P397; CULLEN M, 2001, MOL EPIDEMIOLOGY PRA, P145; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; DOBBS DL, 1994, NUCLEIC ACIDS RES, V22, P2479, DOI 10.1093/nar/22.13.2479; Dutreix M, 1997, J MOL BIOL, V273, P105, DOI 10.1006/jmbi.1997.1293; EDELMANN W, 1989, CELL, V57, P937, DOI 10.1016/0092-8674(89)90332-2; Fox ME, 2000, GENETICS, V156, P59; GALE JM, 1992, J MOL BIOL, V224, P343, DOI 10.1016/0022-2836(92)90999-Z; Gaudieri S, 1997, J MOL EVOL, V45, P17, DOI 10.1007/PL00006194; Goldstein DB, 2001, NAT GENET, V29, P109, DOI 10.1038/ng1001-109; GORADIA TM, 1991, GENOMICS, V10, P748, DOI 10.1016/0888-7543(91)90459-R; GRIMM T, 1989, AM J HUM GENET, V45, P368; HAMMOND HA, 1994, AM J HUM GENET, V55, P175; HEINE D, 1994, GENOMICS, V23, P168, DOI 10.1006/geno.1994.1474; HUBERT R, 1994, NAT GENET, V7, P420, DOI 10.1038/ng0794-420; HUGHES AL, 1995, IMMUNOGENETICS, V42, P233, DOI 10.1007/BF00176440; Jeffreys AJ, 2000, HUM MOL GENET, V9, P725, DOI 10.1093/hmg/9.5.725; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Jeffreys AJ, 1998, MOL CELL, V2, P267, DOI 10.1016/S1097-2765(00)80138-0; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; KLITZ W, 1995, AM J HUM GENET, V57, P1436; KWOK WW, 1993, J IMMUNOL, V150, P2263; LAZZERONI LC, 1994, AM J HUM GENET, V55, P431; LEBO RV, 1983, P NATL ACAD SCI-BIOL, V80, P4808, DOI 10.1073/pnas.80.15.4808; LEEFLANG EP, 1994, CURRENT PROTOCOLS S3, V1; LI H, 1991, Methods (Orlando), V2, P49, DOI 10.1016/S1046-2023(05)80125-2; LI HH, 1988, NATURE, V335, P414, DOI 10.1038/335414a0; Lien S, 2000, AM J HUM GENET, V66, P557, DOI 10.1086/302754; Lopes J, 1998, HUM MOL GENET, V7, P141, DOI 10.1093/hmg/7.1.141; Majewski J, 2000, GENOME RES, V10, P1108, DOI 10.1101/gr.10.8.1108; MARTIN M, 1995, HUM MOL GENET, V4, P423, DOI 10.1093/hmg/4.3.423; OUDET C, 1992, HUM MOL GENET, V1, P599, DOI 10.1093/hmg/1.8.599; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Reiter LT, 1996, NAT GENET, V12, P288, DOI 10.1038/ng0396-288; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; ROONEY SM, 1995, P NATL ACAD SCI USA, V92, P2141, DOI 10.1073/pnas.92.6.2141; ROUYER F, 1986, NATURE, V319, P291, DOI 10.1038/319291a0; Sanchez-Mazas A, 2000, EUR J HUM GENET, V8, P33, DOI 10.1038/sj.ejhg.5200391; SANDER M, 1985, NUCLEIC ACIDS RES, V13, P1057, DOI 10.1093/nar/13.4.1057; SCHMITT K, 1994, AM J HUM GENET, V55, P423; Schneider JA, 2002, HUM MOL GENET, V11, P207, DOI 10.1093/hmg/11.3.207; SCHULZ KH, 1999, TRANSPLANT LINK S, V1, P10; SHAH R, 1994, CELL, V79, P853, DOI 10.1016/0092-8674(94)90074-4; SMITH GR, 1981, CELL, V24, P429, DOI 10.1016/0092-8674(81)90333-0; Smith RA, 1998, BLOOD, V92, P4415, DOI 10.1182/blood.V92.11.4415.423a07_4415_4421; Snoek M, 1998, J IMMUNOL, V160, P266; Sokal R. R., 1995, BIOMETRY PRINCIPLES; Tracy RB, 1997, GENE DEV, V11, P3423, DOI 10.1101/gad.11.24.3423; WAHLS WP, 1990, MOL CELL BIOL, V10, P785, DOI 10.1128/MCB.10.2.785; Wahls WP, 1998, CURR TOP DEV BIOL, V37, P37; YANG SY, 1989, IMMUNOBIOLOGY HLA, V1; Yip SP, 1999, HUM MOL GENET, V8, P1699, DOI 10.1093/hmg/8.9.1699; YOSHINO M, 1994, IMMUNOGENETICS, V40, P280, DOI 10.1007/BF00189973; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185; Yu CY, 2000, IMMUNOL TODAY, V21, P320, DOI 10.1016/S0167-5699(00)01664-9; Yu J, 1996, AM J HUM GENET, V59, P1186; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847; ZIMMERER EJ, 1991, IMMUNOGENETICS, V33, P132, DOI 10.1007/BF00210827	76	169	180	0	7	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2002	71	4					759	776		10.1086/342973	http://dx.doi.org/10.1086/342973			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	604HT	12297984	Green Published, Bronze			2022-12-18	WOS:000178613800006
J	Ardlie, KG; Lunetta, KL; Seielstad, M				Ardlie, KG; Lunetta, KL; Seielstad, M			Testing for population subdivision and association in four case-control studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC ASSOCIATION; STRATIFICATION; POLYMORPHISMS; ADMIXTURE; DISEASES	Population structure has been presumed to cause many of the unreplicated disease-marker associations reported in the literature, yet few actual case-control studies have been evaluated for the presence of structure. Here, we examine four moderate case-control samples, comprising 3,472 individuals, to determine if detectable population subdivision is present. The four population samples include: 500 U. S. whites and 236 African Americans with hypertension; and 500 U. S. whites and 500 Polish whites with type 2 diabetes, all with matched control subjects. Both diabetes populations were typed for the PPARg Pro12Ala polymorphism, to replicate this well-supported association (Altshuler et al. 2000). In each of the four samples, we tested for structure, using the sum of the case-control allele frequency chi(2) statistics for 9 STR and 35 SNP markers (Pritchard and Rosenberg 1999). We found weak evidence for population structure in the African American sample only, but further refinement of the sample, to include only individuals with U.S.-born parents and grandparents, eliminated the stratification. Our examples provide insight into the factors affecting the replication of association studies and suggest that carefully matched, moderate-sized case-control samples in cosmopolitan U. S. and European populations are unlikely to contain levels of structure that would result in significantly inflated numbers of false-positive associations. We explore the role that extreme differences in power among studies, due to sample size and risk-allele frequency differences, may play in the replication problem.	Genom Collaborat, Cambridge, MA 02139 USA; Harvard Univ, Sch Publ Hlth, Program Populat Genet, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Ardlie, KG (corresponding author), Genom Collaborat, 99 Erie St, Cambridge, MA 02139 USA.	kardlie@genomicsinc.com	Seielstad, Mark/T-7841-2019	Seielstad, Mark/0000-0001-5783-1401; Lunetta, Kathryn/0000-0002-9268-810X				Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; [Anonymous], 1999, NAT GENET, V22, P1; BRESLOW NE, 1994, IARC SCI PUBLICATION, V82; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; CHAKRABORTY R, 1992, AM J HUM GENET, V50, P145; Destro-Bisol G, 1999, HUM GENET, V104, P149, DOI 10.1007/s004390050928; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Gambaro G, 2000, LANCET, V355, P308, DOI 10.1016/S0140-6736(99)07202-5; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Kokoris M, 2000, MOL DIAGN, V5, P329; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; MANTEL N, 1959, J NATL CANCER I, V22, P719; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Peltonen L, 2000, NAT REV GENET, V1, P182, DOI 10.1038/35042049; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543; Pritchard JK, 2000, GENETICS, V155, P945; Reich DE, 2001, GENET EPIDEMIOL, V20, P4, DOI 10.1002/1098-2272(200101)20:1<4::AID-GEPI2>3.0.CO;2-T; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Rosenberg NA, 2001, P NATL ACAD SCI USA, V98, P858, DOI 10.1073/pnas.98.3.858; Ross P, 1998, NAT BIOTECHNOL, V16, P1347, DOI 10.1038/4328; Satten GA, 2001, AM J HUM GENET, V68, P466, DOI 10.1086/318195; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; van den Hoogen PCW, 2000, NEW ENGL J MED, V342, P1, DOI 10.1056/NEJM200001063420101; Vieland VJ, 2001, NAT GENET, V29, P244, DOI 10.1038/ng1101-244; Wacholder S, 2000, J NATL CANCER I, V92, P1151, DOI 10.1093/jnci/92.14.1151; WALTERS DE, 1979, STATISTICIAN, V28, P219, DOI 10.2307/2987871; Weiss S. T., 2001, Pharmacogenomics Journal, V1, P157; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761	32	169	172	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2002	71	2					304	311		10.1086/341719	http://dx.doi.org/10.1086/341719			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	575ZE	12096349	Green Published, Bronze			2022-12-18	WOS:000176977700009
J	Greenwood, CMT; Fujiwara, TM; Boothroyd, LJ; Miller, MA; Frappier, D; Fanning, EA; Schurr, E; Morgan, K				Greenwood, CMT; Fujiwara, TM; Boothroyd, LJ; Miller, MA; Frappier, D; Fanning, EA; Schurr, E; Morgan, K			Linkage of tuberculosis to chromosome 2q35 loci, including NRAMP1, in a large aboriginal Canadian family	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NATURAL-RESISTANCE; MYCOBACTERIUM-TUBERCULOSIS; LOD SCORES; INTRACELLULAR PARASITES; MACROPHAGE PROTEIN; PROMOTER REGION; MODEL-FREE; GENE; SUSCEPTIBILITY; INFECTION	An epidemic of tuberculosis occurred in a community of Aboriginal Canadians during the period 1987-89. Genetic and epidemiologic data were collected on an extended family from this community, and the evidence for linkage to NRAMP1, a candidate gene for susceptibility to mycobacterial diseases, was assessed. Individuals were grouped into risk (liability) classes leased on vaccination, age, previous disease, and tuberculin skin-test results. Under the assumption of a dominant mode of inheritance and a relative risk of 10, which is associated with the high-risk genotypes, a maximum LOD score of 3.81 was observed for linkage between a tuberculosis-susceptibility locus and D2S424, which is located just distal to NRAMP1, in chromosome region 2q35. Significant linkage was also observed between a tuberculosis-susceptibility locus and a haplotype of 10 NRAMP1 intragenic variants. No linkage to the major histocompatibility-complex region on chromosome 6p was observed, despite distortion of transmission from one member of the oldest couple to their affected offspring. The ability to assign individuals to risk classes was crucial to the success of this study.	McGill Univ, Dept Human Genet, Montreal, PQ H3G 1A4, Canada; McGill Univ, Dept Med, Montreal, PQ H3G 1A4, Canada; McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ H3G 1A4, Canada; McGill Univ, McGill Ctr Study Host Resistance, Montreal, PQ H3G 1A4, Canada; McGill Univ, Dept Biochem, Montreal, PQ H3G 1A4, Canada; McGill Univ, Montreal Gen Hosp, Res Inst, Montreal, PQ H3G 1A4, Canada; Univ Alberta, Dept Med, Edmonton, AB, Canada	McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; University of Alberta	Greenwood, CMT (corresponding author), McGill Univ, Montreal Gen Hosp, Div Med Genet, L10-109,1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	celia@bagel.epi.mcgiIl.ca		Greenwood, Celia/0000-0002-2427-5696				Abel L, 1998, J INFECT DIS, V177, P133, DOI 10.1086/513830; Abreu PC, 1999, AM J HUM GENET, V65, P847, DOI 10.1086/302536; Bellamy R, 1998, NEW ENGL J MED, V338, P640, DOI 10.1056/NEJM199803053381002; Blackwell JM, 1997, PHILOS T R SOC B, V352, P1331, DOI 10.1098/rstb.1997.0118; BOOTHROYD LJ, 1994, THESIS MCGILL U MONT; BUU NT, 1995, IMMUNOGENETICS, V42, P428; CELLIER M, 1994, J EXP MED, V180, P1741, DOI 10.1084/jem.180.5.1741; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CURTIS D, 1995, AM J HUM GENET, V57, P703; DALFONSO S, 1994, IMMUNOGENETICS, V39, P150; Durner M, 1999, AM J HUM GENET, V64, P281, DOI 10.1086/302181; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Fanning A, 1999, CAN MED ASSOC J, V160, P837; Ferguson Robert George, 1955, STUDIES TUBERCULOSIS; Greenberg DA, 1998, AM J HUM GENET, V63, P870, DOI 10.1086/301997; GROS P, 1981, J IMMUNOL, V127, P2417; Halpern J, 1999, HUM HERED, V49, P194, DOI 10.1159/000022874; HODGE SE, 1994, GENET EPIDEMIOL, V11, P329, DOI 10.1002/gepi.1370110403; HODGE SE, 1980, AM J MED GENET, V5, P247, DOI 10.1002/ajmg.1320050305; Hodge SE, 1997, AM J HUM GENET, V60, P217; HOLDEN M, 1971, NEW ENGL J MED, V285, P1506, DOI 10.1056/NEJM197112302852704; HOUSTON S, 1990, AM J EPIDEMIOL, V131, P340, DOI 10.1093/oxfordjournals.aje.a115503; HUDSON TJ, 1997, CURRENT PROTOCOLS HU; KALLMANN F. J., 1943, American Review of Tuberculosis and Pulmonary Diseases, V47, P549; Kruglyak L, 1997, AM J HUM GENET, V61, P254; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1986, GENET EPIDEMIOL, V3, P39, DOI 10.1002/gepi.1370030105; Lewis LA, 1996, IMMUNOGENETICS, V44, P309, DOI 10.1007/s002510050129; Liebana E, 1996, J CLIN MICROBIOL, V34, P933; LIU J, 1995, GENOMICS, V26, P178, DOI 10.1016/0888-7543(95)80199-V; LIU J, 1995, AM J HUM GENET, V56, P845; LIU J, 1996, THESIS MCGILL U MONT; Mah M W, 1991, Can J Infect Dis, V2, P133; MCGUIRE W, 1994, NATURE, V371, P508, DOI 10.1038/371508a0; Medina E, 1996, J EXP MED, V183, P1045, DOI 10.1084/jem.183.3.1045; Meyer CG, 1998, TRENDS MICROBIOL, V6, P148, DOI 10.1016/S0966-842X(98)01240-2; MILLER MA, 1991, THESIS MCGILL U MONT; Morton NE, 1998, AM J HUM GENET, V62, P690, DOI 10.1086/301741; North RJ, 1999, INFECT IMMUN, V67, P5811, DOI 10.1128/IAI.67.11.5811-5814.1999; Ott J., 1991, ANAL HUMAN GENETIC L; RISCH N, 1992, HUM HERED, V42, P77, DOI 10.1159/000154047; ROTH MP, 1994, J NEUROIMMUNOL, V51, P93, DOI 10.1016/0165-5728(94)90133-3; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SCHURR E, 1995, TUBERCULOSIS, P247; Searle S, 1999, J MED GENET, V36, P295; Shaw MA, 1997, TUBERCLE LUNG DIS, V78, P35, DOI 10.1016/S0962-8479(97)90014-9; Skamene E, 1998, ANNU REV MED, V49, P275, DOI 10.1146/annurev.med.49.1.275; SMITH MHD, 1987, TXB PEDIATRIC INFECT, P1342; Stead WW, 1997, CLIN CHEST MED, V18, P65, DOI 10.1016/S0272-5231(05)70356-7; Terwilliger J., 1994, HDB HUMAN GENETIC LI; UDALOVA IA, 1993, GENOMICS, V16, P180, DOI 10.1006/geno.1993.1156; VIDAL S, 1995, J EXP MED, V182, P655, DOI 10.1084/jem.182.3.655; VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D; Wilson A. G., 1992, Human Molecular Genetics, V1, P353, DOI 10.1093/hmg/1.5.353	56	169	175	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2000	67	2					405	416		10.1086/303012	http://dx.doi.org/10.1086/303012			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354YA	10882571	Green Published, Bronze			2022-12-18	WOS:000089357800016
J	Giraud, S; Zhang, CX; Serova-Sinilnikova, O; Wautot, V; Salandre, J; Buisson, N; Waterlot, C; Bauters, C; Porchet, N; Aubert, JP; Emy, P; Cadiot, G; Delemer, B; Chabre, O; Niccoli, P; Leprat, F; Duron, F; Emperauger, B; Cougard, P; Goudet, P; Sarfati, E; Riou, JP; Guichard, S; Rodier, M; Meyrier, A; Caron, P; Vantyghem, MC; Assayag, M; Peix, JL; Pugeat, M; Rohmer, V; Vallotton, M; Lenoir, G; Gaudray, P; Proye, C; Conte-Devolx, B; Chanson, P; Shugart, YY; Goldgar, D; Murat, A; Calender, A				Giraud, S; Zhang, CX; Serova-Sinilnikova, O; Wautot, V; Salandre, J; Buisson, N; Waterlot, C; Bauters, C; Porchet, N; Aubert, JP; Emy, P; Cadiot, G; Delemer, B; Chabre, O; Niccoli, P; Leprat, F; Duron, F; Emperauger, B; Cougard, P; Goudet, P; Sarfati, E; Riou, JP; Guichard, S; Rodier, M; Meyrier, A; Caron, P; Vantyghem, MC; Assayag, M; Peix, JL; Pugeat, M; Rohmer, V; Vallotton, M; Lenoir, G; Gaudray, P; Proye, C; Conte-Devolx, B; Chanson, P; Shugart, YY; Goldgar, D; Murat, A; Calender, A			Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HYPERPARATHYROIDISM; GENE; TUMORS; MEN1; CHROMOSOME-11; CANCER; 11Q13	Multiple endocrine neoplasia type 1 (MEN1) is autosomal dominant syndrome predisposing to tumors of the parathyroid, endocrine pancreas, anterior pituitary, adrenal glands, and diffuse neuroendocrine tissues. The MEN1 gene has been assigned, by linkage analysis and loss of heterozygosity, to chromosome 11q13 and recently has been identified by positional cloning. In this study, a total of 84 families and/or isolated patients with either MEN1 or MEN1-related inherited endocrine tumors were screened for MEN1 germ-line mutations, by heteroduplex and sequence analysis of the MEN1 gene-coding region and untranslated exon 1. Germ-line MEN1 alterations were identified in 47/54 (87%) MEN1 families, in 9/11 (82%) isolated MEN1 patients, and in only 6/19 (31.5%) atypical MEN1-related inherited cases. We characterized 52 distinct mutations in a total of 62 MEN1 germ-line alterations. Thirty-five of the 52 mutations were frameshifts and nonsense mutations predicted to encode for a truncated MEN1 protein. We identified eight missense mutations and five in-frame deletions over the entire coding sequence. Six mutations were observed more than once in familial MEN1. Haplotype analysis in families with identical mutations indicate that these occurrences reflected mainly independent mutational events. No MEN1 germline mutations were found in 7/54 (13%) MEN1 families, in 2/11 (18%) isolated MEN1 cases, in 13/19 (68.5%) MEN1-related cases, and in a kindred with familial isolated hyperparathyroidism. Two hundred twenty gene carriers (167 affected and 53 unaffected) were identified. No evidence of genotype-phenotype correlation was found. Age-related penetrance was estimated to be >95% at age >30 years. Our results add to the diversity of MEN1 germ-line mutations and provide new tools in genetic screening of MEN1 and clinically related cases.	Fac Med Rockefeller, Lab Genet & Canc, CNRS, UMR 5641, Lyon, France; Hop Edouard Herriot, Serv Genet, Lyon, France; Hop Edouard Herriot, Serv Endocrinol, Lyon, France; Hop Antiquaille, Serv Endocrinol, Lyon, France; Hop Antiquaille, Serv Chirurg, Lyon, France; Ctr Int Rech Canc, Unite Genet & Epidemiol, Lyon, France; Hop Claude Huriez, Serv Endocrinol, Lille, France; Hop Claude Huriez, Serv Biochim, INSERM, U377, Lille, France; Hop Claude Huriez, Serv Endocrinol, Lille, France; Hop Claude Huriez, Serv Chirurg Endocrine, Lille, France; Ctr Hosp Germon & Gauthier, Serv Med & Endocrinol, Bethune, France; Ctr Hosp, Serv Endocrinol, Orleans, France; Ctr Hosp Univ Reims, Serv Hepatogastroenterol, Reims, France; Ctr Hosp Univ Reims, Serv Endocrinol, Reims, France; Hop Nord, Serv Endocrinol, Grenoble, France; Hop Enfants La Timone, Serv Endocrinol, Marseille, France; Hop Enfants La Timone, Serv Chirurg Endocrine, Marseille, France; Hop Haut Leveque, Serv Endocrinol, Bordeaux, France; Hop St Antoine, Serv Endocrinol, F-75571 Paris, France; Hop St Louis, Serv Chirurg Endocrine, Paris, France; Hop Lariboisiere, Dept Med Interne & Endocrinol, F-75475 Paris, France; Hop Gen, Dept Chirurg Gen Urgences & Endocrinienne, Dijon, France; Ctr Hosp, Serv Endocrinol & Med Interne, Nimes, France; Hop Avicenne, Serv Nephrol, F-93009 Bobigny, France; Hop Purpan, Ctr Hosp Univ, Serv Endocrinol, Toulouse, France; Hop Cantonal Univ Geneva, Dept Endocrinol & Diabetol, CH-1211 Geneva, Switzerland; UNSA, CNRS, UMR 6549, Lab Instabil & Alterat Genomes, Nice, France; Hop Bicetre, Serv Endocrinol, Le Kremlin Bicetre, France; Univ Pittsburgh, Sch Med, Dept Clin Epidemiol, Pittsburgh, PA USA; Ctr Hosp Univ, Hotel Dieu, Clin Endocrinol, Nantes, France	Centre National de la Recherche Scientifique (CNRS); CHU Lyon; CHU Lyon; CHU Lyon; CHU Lyon; World Health Organization; International Agency for Research on Cancer (IARC); Universite de Lille - ISITE; CHU Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Centre Hospitalier Regional d'Orleans; CHU de Reims; Universite de Reims Champagne-Ardenne; CHU de Reims; Universite de Reims Champagne-Ardenne; CHU Grenoble Alpes; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; CHU de Toulouse; University of Geneva; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Nantes Universite; CHU de Nantes	Calender, A (corresponding author), Fac Med Rockefeller, Lab Genet & Canc, CNRS, UMR 5641, Lyon, France.	calender@cismsun.univ-lyon1.fr	Meyrier, Alain/GWQ-3527-2022; Vantyghem, Marie-Christine/P-2939-2017; Chanson, Philippe/F-8511-2013; VANTYGHEM, Marie Christine/T-8613-2019; ZHANG, Chang Xian/G-2905-2013	Vantyghem, Marie-Christine/0000-0002-9369-0463; Chanson, Philippe/0000-0001-5096-5722; VANTYGHEM, Marie Christine/0000-0002-9369-0463; CHABRE, Olivier/0000-0001-8756-7218; Zhang, Chang Xian/0000-0002-5443-8951				ARGAWAL SK, 1997, HUM MOL GENET, V6, P1169; Bassett JHD, 1998, AM J HUM GENET, V62, P232, DOI 10.1086/301729; Bassett JHD, 1997, HUM GENET, V100, P657, DOI 10.1007/s004390050569; BYSTROM C, 1990, P NATL ACAD SCI USA, V87, P1968, DOI 10.1073/pnas.87.5.1968; CALENDER A, 1995, J INTERN MED, V238, P263, DOI 10.1111/j.1365-2796.1995.tb00933.x; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Chanson P, 1997, HORM RES, V47, P211, DOI 10.1159/000185466; Courseaux A, 1996, GENOMICS, V37, P354, DOI 10.1006/geno.1996.0570; Darling TN, 1997, ARCH DERMATOL, V133, P853, DOI 10.1001/archderm.133.7.853; Debelenko LV, 1997, HUM MOL GENET, V6, P2285, DOI 10.1093/hmg/6.13.2285; FRIEDMAN E, 1989, NEW ENGL J MED, V321, P213, DOI 10.1056/NEJM198907273210402; Giraud S, 1997, J CLIN ENDOCR METAB, V82, P3487, DOI 10.1210/jc.82.10.3487; Guru SC, 1998, P NATL ACAD SCI USA, V95, P1630, DOI 10.1073/pnas.95.4.1630; Heppner C, 1997, NAT GENET, V16, P375, DOI 10.1038/ng0897-375; Hessman O, 1998, CANCER RES, V58, P377; Kato H, 1996, INTERNAL MED, V35, P285, DOI 10.2169/internalmedicine.35.285; Kishi M, 1998, JPN J CANCER RES, V89, P1; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; LARSSON C, 1988, NATURE, V332, P85, DOI 10.1038/332085a0; LARSSON C, 1995, J INTERN MED, V238, P239, DOI 10.1111/j.1365-2796.1995.tb00929.x; Lemmens I, 1997, HUM MOL GENET, V6, P1177, DOI 10.1093/hmg/6.7.1177; Maquat LE, 1996, AM J HUM GENET, V59, P279; Mayr B, 1997, EUR J ENDOCRINOL, V137, P684, DOI 10.1530/eje.0.1370684; Metz David C., 1994, P591; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Olufemi SE, 1998, HUM MUTAT, V11, P264, DOI 10.1002/(SICI)1098-1004(1998)11:4<264::AID-HUMU2>3.3.CO;2-M; PETTY EM, 1994, AM J HUM GENET, V54, P1060; POLLAK MR, 1993, CELL, V75, P1297, DOI 10.1016/0092-8674(93)90617-Y; Prezant TR, 1998, J CLIN ENDOCR METAB, V83, P1388, DOI 10.1210/jc.83.4.1388; RADFORD DM, 1990, CANCER RES, V50, P6529; Sakurai A, 1996, JPN J CANCER RES, V87, P985, DOI 10.1111/j.1349-7006.1996.tb02130.x; Sambrook J., 1989, MOL CLONING LAB MANU, P6; Serova OM, 1997, AM J HUM GENET, V60, P486; SHEPHERD JJ, 1991, ARCH SURG-CHICAGO, V126, P935; Shimizu S, 1997, JPN J CANCER RES, V88, P1029, DOI 10.1111/j.1349-7006.1997.tb00325.x; SKOGSEID B, 1995, J INTERN MED, V238, P255, DOI 10.1111/j.1365-2796.1995.tb00932.x; SKOGSEID B, 1995, SURGERY, V118, P1077, DOI 10.1016/S0039-6060(05)80117-5; Stock JL, 1997, J CLIN ENDOCR METAB, V82, P486, DOI 10.1210/jc.82.2.486; Teh BT, 1996, ARCH SURG-CHICAGO, V131, P1230; Trump D, 1996, QJM-INT J MED, V89, P653; WASSIF WS, 1993, J CLIN ENDOCR METAB, V77, P1485, DOI 10.1210/jc.77.6.1485; Weitzmann MN, 1997, J BIOL CHEM, V272, P9517; WERMER P, 1954, AM J MED, V16, P363, DOI 10.1016/0002-9343(54)90353-8; Zhuang ZP, 1997, CANCER RES, V57, P4682; Zhuang ZP, 1997, CANCER RES, V57, P5446	45	169	173	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1998	63	2					455	467		10.1086/301953	http://dx.doi.org/10.1086/301953			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110CB	9683585	Green Published, Bronze			2022-12-18	WOS:000075360800021
J	Paznekas, WA; Cunningham, ML; Howard, TD; Korf, BR; Lipson, MH; Grix, AW; Feingold, M; Goldberg, R; Borochowitz, Z; Aleck, K; Mulliken, J; Yin, MF; Jabs, EW				Paznekas, WA; Cunningham, ML; Howard, TD; Korf, BR; Lipson, MH; Grix, AW; Feingold, M; Goldberg, R; Borochowitz, Z; Aleck, K; Mulliken, J; Yin, MF; Jabs, EW			Genetic heterogeneity of Saethre-Chotzen syndrome, due to TWIST and FGFR mutations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GROWTH-FACTOR RECEPTOR-2; JACKSON-WEISS-SYNDROME; CROUZON-SYNDROME; PFEIFFER-SYNDROME; BALANCED TRANSLOCATIONS; IDENTICAL MUTATIONS; SYNDROME LOCUS; APERT SYNDROME; CRANIOSYNOSTOSIS; 7P	Thirty-two unrelated patients with features of Saethre-Chotzen syndrome, a common autosomal dominant condition of craniosynostosis and limb anomalies, were screened for mutations in TWIST, FGFR2, and FGFR3. Nine novel and three recurrent TWIST mutations were found in 12 families. Seven families were found to have the FGFR3 P250R mutation, and one individual was found to have an FGFR2 VV269-270 deletion. To date, our detection rate for TWIST or FGFR mutations is 68% in our Saethre-Chotzen syndrome patients, including our five patients elsewhere reported with TWIST mutations. More than 35 different TWIST mutations are now known in the literature, The most common phenotypic features, present in more than a third of our patients with TWIST mutations, are coronal synostosis, brachycephaly, low frontal hairline, facial asymmetry, ptosis, hypertelorism, broad great toes, and clinodactyly. Significant intra-and interfamilial phenotypic variability is present for either TWIST mutations or FGFR mutations. The overlap in clinical features and the presence, in the same genes, of mutations for more than one craniosynostotic condition-such as Saethre-Chotzen, Crouzon, and Pfeiffer syndromes-support the hypothesis that TWIST and FGFRs are components of the same molecular pathway involved in the modulation of craniofacial and limb development in humans.	Johns Hopkins Sch Med, Inst Med Genet, Dept Pediat, Baltimore, MD 21287 USA; Johns Hopkins Sch Med, Inst Med Genet, Dept Med, Baltimore, MD 21287 USA; Johns Hopkins Sch Med, Inst Med Genet, Dept Surg, Baltimore, MD 21287 USA; Univ Washington, Div Congenital Defects Craniofacial Program, Seattle, WA 98195 USA; Childrens Hosp, Div Genet, Boston, MA 02115 USA; Childrens Hosp, Dept Surg, Boston, MA 02115 USA; So Calif Permanente Med Grp, Sacramento, CA USA; Natl Birth Defects Ctr, Waltham, MA USA; Albert Einstein Coll Med, Human Genet Program, Bronx, NY 10467 USA; Bnai Zion Med Ctr, Simon Winter Inst Human Genet, Haifa, Israel; Univ Arizona, Phoenix Childrens Hosp, Phoenix Genet Program, Phoenix, AZ USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University of Washington; University of Washington Seattle; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Kaiser Permanente; Southern California Permanente Medical Group (SCPMG); Permanente Medical Groups; Yeshiva University; Albert Einstein College of Medicine; Bnai Zion Medical Center; Phoenix Children's Hospital; University of Arizona	Jabs, EW (corresponding author), Johns Hopkins Sch Med, Inst Med Genet, Dept Pediat, 600 N Wolfe St, Baltimore, MD 21287 USA.		Korf, Bruce R/H-4882-2012	Jabs, Ethylin/0000-0001-8983-5466	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011441, P50DE011131] Funding Source: NIH RePORTER; NICHD NIH HHS [HD24061] Funding Source: Medline; NIDCR NIH HHS [DE11441, DE11131] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		AUGHTON DJ, 1991, AM J MED GENET, V40, P440, DOI 10.1002/ajmg.1320400412; Bellus GA, 1996, NAT GENET, V14, P174, DOI 10.1038/ng1096-174; Bourgeois P, 1996, MAMM GENOME, V7, P915, DOI 10.1007/s003359900269; BRUETON LA, 1992, J MED GENET, V29, P681, DOI 10.1136/jmg.29.10.681; Chotzen F., 1932, MSCHR KINDERHEILK, V55, P97; El Ghouzzi V, 1997, AM J HUM GENET, V61, pA332; ElGhouzzi V, 1997, NAT GENET, V15, P42; Galvin BD, 1996, P NATL ACAD SCI USA, V93, P7894, DOI 10.1073/pnas.93.15.7894; Golla A, 1997, J MED GENET, V34, P683, DOI 10.1136/jmg.34.8.683; Howard TD, 1997, NAT GENET, V15, P36, DOI 10.1038/ng0197-36; JABS EW, 1994, NAT GENET, V8, P275, DOI 10.1038/ng1194-275; JACKSON CE, 1976, J PEDIATR-US, V88, P963, DOI 10.1016/S0022-3476(76)81050-5; Jones K. L., 1997, SMITHS RECOGNIZABLE; KIKKAWA K, 1993, AM J MED GENET, V45, P108, DOI 10.1002/ajmg.1320450127; Krebs I, 1997, HUM MOL GENET, V6, P1079, DOI 10.1093/hmg/6.7.1079; LAJEUNIE E, 1995, NAT GENET, V9, P108, DOI 10.1038/ng0295-108; LEWANDA AF, 1994, AM J HUM GENET, V55, P1195; Ma HW, 1996, HUM GENET, V98, P228, DOI 10.1007/s004390050197; Meyers GA, 1996, AM J HUM GENET, V58, P491; Muenke M, 1997, AM J HUM GENET, V60, P555; MUENKE M, 1994, NAT GENET, V8, P269, DOI 10.1038/ng1194-269; NEILSON KM, 1995, J BIOL CHEM, V270, P26037, DOI 10.1074/jbc.270.44.26037; PARK WJ, 1995, AM J HUM GENET, V57, P321; PARK WJ, 1995, AM J HUM GENET, V57, P748; Ray PN, 1997, AM J HUM GENET, V61, pA344; REARDON W, 1993, AM J MED GENET, V47, P633, DOI 10.1002/ajmg.1320470510; REARDON W, 1994, NAT GENET, V8, P98, DOI 10.1038/ng0994-98; REID CS, 1993, AM J MED GENET, V47, P637, DOI 10.1002/ajmg.1320470511; Rose CSP, 1997, HUM MOL GENET, V6, P1369, DOI 10.1093/hmg/6.8.1369; ROSE CSP, 1994, HUM MOL GENET, V3, P1405; RUTLAND P, 1995, NAT GENET, V9, P173, DOI 10.1038/ng0295-173; Saethre H., 1931, DTSCH Z NERVENHEILK, V117, P533, DOI [10.1007/BF01673869, 10.1007/bf01673869]; SCHELL U, 1995, HUM MOL GENET, V4, P323, DOI 10.1093/hmg/4.3.323; SHISHIDO E, 1993, DEVELOPMENT, V117, P751; TSUJI K, 1994, AM J MED GENET, V49, P98, DOI 10.1002/ajmg.1320490119; VANHERWERDEN L, 1994, AM J HUM GENET, V54, P669; vonGernet S, 1996, AM J MED GENET, V63, P177; Wang SM, 1997, GENE, V187, P83, DOI 10.1016/S0378-1119(96)00727-5; WILKIE AOM, 1995, J MED GENET, V32, P174, DOI 10.1136/jmg.32.3.174; WILKIE AOM, 1995, NAT GENET, V9, P165, DOI 10.1038/ng0295-165	40	169	171	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1998	62	6					1370	1380		10.1086/301855	http://dx.doi.org/10.1086/301855			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZU224	9585583	Green Published, hybrid			2022-12-18	WOS:000074174700013
J	DAdamo, P; Fassone, L; Gedeon, A; Janssen, EAM; Bione, S; Bolhuis, PA; Barth, PG; Wilson, M; Haan, E; Orstavik, KH; Patton, MA; Green, AJ; Zammarchi, E; Donati, MA; Toniolo, D				DAdamo, P; Fassone, L; Gedeon, A; Janssen, EAM; Bione, S; Bolhuis, PA; Barth, PG; Wilson, M; Haan, E; Orstavik, KH; Patton, MA; Green, AJ; Zammarchi, E; Donati, MA; Toniolo, D			The X-linked gene G4.5 is responsible for different infantile dilated cardiomyopathies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BARTH SYNDROME; NEUTROPENIA; XQ28; DISEASE	Earth syndrome (BTHS) is an X-linked disorder characterized clinically by the associated features of cardiac and skeletal myopathy, short stature, and neutropenia. The clinical manifestations of the disease are, in general, quite variable, but cardiac failure as a consequence of cardiac dilatation and hypertrophy is a constant finding and is the most common cause of death in the first months of life; X-linked cardiomyopathies with clinical manifestations similar to BTHS have been reported, and it has been proposed that they may be allelic. We have recently identified the gene responsible for BTHS, in one of the Xq28 genes, G4.5. In this paper we report the sequence analysis of 11 additional familial cases: 8 were diagnosed as possibly affected with BTHS, and 3 were affected with X-linked dilated cardiomyopathies. Mutations in the G4.5 gene were found in nine of the patients analyzed. The molecular studies have linked together what were formerly considered different conditions and have shown that the G4.5 gene is responsible for BTHS (OMIM 302060), X-linked endocardial fibroelastosis (OMIM 305300), and severe X-linked cardiomyopathy (OMIM 300069). Our results also suggest that very severe phenotypes may be associated with null mutations in the gene, whereas mutations in alternative portions or missense mutations may give a ''less severe'' phenotype.	CNR,IGBE,I-27100 PAVIA,ITALY; WOMENS & CHILDRENS HOSP,DEPT CYTOGENET & MOL GENET,ADELAIDE,SA,AUSTRALIA; WOMENS & CHILDRENS HOSP,DEPT MED GENET & EPIDEMIOL,ADELAIDE,SA,AUSTRALIA; ACAD MED CTR,DEPT NEUROL,AMSTERDAM,NETHERLANDS; NEW CHILDRENS HOSP,DEPT CLIN GENET,WESTMEAD,NSW,AUSTRALIA; ULLEVAL HOSP,DEPT MED GENET,OSLO 1,NORWAY; ST GEORGE HOSP,SCH MED,DEPT MED GENET,LONDON,ENGLAND; UNIV CAMBRIDGE,DEPT MED GENET,CAMBRIDGE,ENGLAND; UNIV FLORENCE,DEPT PEDIAT,FLORENCE,ITALY	Consiglio Nazionale delle Ricerche (CNR); Womens & Childrens Hospital Australia; Womens & Childrens Hospital Australia; University of Amsterdam; Academic Medical Center Amsterdam; University of Sydney; University of Oslo; St Georges University London; University of Cambridge; University of Florence			Janssen, Emiel A.M./AAM-2357-2020; D'Adamo, Patrizia/AAN-3919-2020; Green, Andrew/AAJ-7592-2020; Toniolo, Daniela/AAE-2969-2019; Gedeon, Agi/G-7890-2011	D'Adamo, Patrizia/0000-0002-0312-5541; Toniolo, Daniela/0000-0001-9545-6032; Bione, Silvia/0000-0002-3924-4606; Green, Andrew/0000-0002-1077-7417; MARIA ALICE, DONATI/0000-0003-4769-5025	Telethon [E.0297] Funding Source: Medline	Telethon(Fondazione Telethon)		ADES LC, 1993, AM J MED GENET, V45, P327, DOI 10.1002/ajmg.1320450309; BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; BOLHUIS PA, 1991, AM J HUM GENET, V48, P481; CHRISTODOULOU J, 1994, AM J MED GENET, V50, P225; GEDEON AK, 1995, J MED GENET, V32, P383, DOI 10.1136/jmg.32.5.383; Keating MT, 1996, SCIENCE, V272, P681, DOI 10.1126/science.272.5262.681; KELLEY RI, 1991, J PEDIATR-US, V119, P738, DOI 10.1016/S0022-3476(05)80289-6; LINDENBAUM RH, 1973, BRIT HEART J, V35, P38; MAQUAT LE, 1995, RNA, V1, P453; ORSTAVIK KH, 1993, J MED GENET, V30, P269, DOI 10.1136/jmg.30.4.269; PATTON MA, 1994, J MED GENET, V31, P169	12	169	176	1	8	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1997	61	4					862	867		10.1086/514886	http://dx.doi.org/10.1086/514886			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YA591	9382096	Bronze, Green Published			2022-12-18	WOS:A1997YA59100012
J	Belmont, JW				Belmont, JW			Genetic control of X inactivation and processes leading to X-inactivation skewing	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							SEVERE COMBINED IMMUNODEFICIENCY; CHROMOSOME INACTIVATION; CARRIER DETECTION; MUSCULAR-DYSTROPHY; XIST GENE; METHYLATION; PATTERNS; EXPRESSION; DISEASE; FAMILY				Belmont, JW (corresponding author), BAYLOR COLL MED,DEPT MOL & HUMAN GENET,1 BAYLOR PLAZA,HOUSTON,TX 77030, USA.		Belmont, John/AAH-6084-2021; Belmont, John W/AAI-2494-2019	Belmont, John W/0000-0001-7409-3578				ALLEN RC, 1994, AM J HUM GENET, V54, P25; ALLEN RC, 1992, AM J HUM GENET, V51, P1229; ARIEL M, 1995, NAT GENET, V9, P312, DOI 10.1038/ng0395-312; AZOFEIFA J, 1995, HUM GENET, V96, P167, DOI 10.1007/BF00207374; Bamforth F, 1996, AM J MED GENET, V61, P209; BELMONT JW, 1995, TRENDS GENET, V11, P112, DOI 10.1016/S0168-9525(00)89012-5; BOGGS BA, 1994, P NATL ACAD SCI USA, V91, P6083, DOI 10.1073/pnas.91.13.6083; BORSANI G, 1991, NATURE, V351, P325, DOI 10.1038/351325a0; BOYD Y, 1990, GENOMICS, V7, P182, DOI 10.1016/0888-7543(90)90539-7; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1991, NATURE, V349, P82, DOI 10.1038/349082a0; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN CJ, 1994, NATURE, V368, P154, DOI 10.1038/368154a0; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; CACHIA PG, 1992, GENOMICS, V14, P70, DOI 10.1016/S0888-7543(05)80285-X; CONLEY ME, 1986, NEW ENGL J MED, V315, P564, DOI 10.1056/NEJM198608283150907; COURTIER B, 1995, P NATL ACAD SCI USA, V92, P3531, DOI 10.1073/pnas.92.8.3531; FEY MF, 1994, BLOOD, V83, P931; FIALKOW PJ, 1973, ANN HUM GENET, V37, P39, DOI 10.1111/j.1469-1809.1973.tb01813.x; GARTLER SM, 1969, ANN HUM GENET, V33, P171, DOI 10.1111/j.1469-1809.1969.tb01642.x; GIBBONS RJ, 1992, AM J HUM GENET, V51, P1136; GOODSHIP J, 1991, BLOOD, V77, P2677; Goodship J, 1996, AM J MED GENET, V61, P205, DOI 10.1002/(SICI)1096-8628(19960122)61:3<205::AID-AJMG3>3.0.CO;2-T; GORSKI JL, 1991, AM J MED GENET, V40, P332, DOI 10.1002/ajmg.1320400317; HARRIS A, 1992, J MED GENET, V29, P608, DOI 10.1136/jmg.29.9.608; Hatchwell E, 1996, J MED GENET, V33, P177, DOI 10.1136/jmg.33.3.177; Hatchwell E, 1996, J MED GENET, V33, P216, DOI 10.1136/jmg.33.3.216; HEARD E, 1994, HUM MOL GENET, V3, P1481, DOI 10.1093/hmg/3.suppl_1.1481; INGERSLEV J, 1989, CLIN GENET, V35, P41; JORGENSEN AL, 1992, AM J HUM GENET, V51, P291; JOSTEN KM, 1991, BLOOD, V78, P3162; KAY GF, 1993, CELL, V72, P171, DOI 10.1016/0092-8674(93)90658-D; KAY GF, 1994, CELL, V77, P639, DOI 10.1016/0092-8674(94)90049-3; KULHARYA AS, 1995, AM J MED GENET, V56, P16, DOI 10.1002/ajmg.1320560106; LANGLOIS S, 1993, AM J HUM GENET S, V51, P1188; LEPPIG KA, 1993, HUM MOL GENET, V2, P883, DOI 10.1093/hmg/2.7.883; LOCK LF, 1987, CELL, V48, P39, DOI 10.1016/0092-8674(87)90353-9; LOCK LF, 1986, MOL CELL BIOL, V6, P914, DOI 10.1128/MCB.6.3.914; LUPSKI JR, 1991, AM J MED GENET, V40, P354, DOI 10.1002/ajmg.1320400323; Lyon MF, 1996, NATURE, V379, P116, DOI 10.1038/379116a0; MARCUS S, 1992, HUM GENET, V89, P395; MIGEON BR, 1981, P NATL ACAD SCI-BIOL, V78, P5066, DOI 10.1073/pnas.78.8.5066; MIGEON BR, 1993, P NATL ACAD SCI USA, V90, P12025, DOI 10.1073/pnas.90.24.12025; MUTTER GL, 1995, AM J PATHOL, V146, P501; Naumova AK, 1996, AM J HUM GENET, V58, P1111; NORRIS DP, 1994, CELL, V77, P41, DOI 10.1016/0092-8674(94)90233-X; PEGORARO E, 1994, AM J HUM GENET, V54, P989; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; PUCK JM, 1992, AM J HUM GENET, V50, P742; PUCK JM, 1987, J CLIN INVEST, V79, P1395, DOI 10.1172/JCI112967; RASTAN S, 1982, GENET RES, V40, P139, DOI 10.1017/S0016672300019017; RASTAN S, 1990, GENET RES, V56, P99, DOI 10.1017/S0016672300035163; REDDY BK, 1984, HUM GENET, V67, P460, DOI 10.1007/BF00291412; RICHARDS CS, 1990, AM J HUM GENET, V46, P672; ROPERS HH, 1977, AM J HUM GENET, V29, P361; ROSSE WF, 1995, BLOOD, V86, P3277, DOI 10.1182/blood.V86.9.3277.bloodjournal8693277; SCHUBERT J, 1993, MAMM GENOME, V4, P523; SINGERSAM J, 1990, MOL CELL BIOL, V10, P4987, DOI 10.1128/MCB.10.9.4987; TSUKAMOTO N, 1993, BRIT J HAEMATOL, V83, P589, DOI 10.1111/j.1365-2141.1993.tb04695.x; TURHAN AG, 1989, NEW ENGL J MED, V321, P1758; WILLARD HF, 1995, METABOLIC MOL BASES, P717; WILLMAN CL, 1994, NEW ENGL J MED, V331, P154, DOI 10.1056/NEJM199407213310303; WINCHESTER B, 1992, AM J MED GENET, V44, P834, DOI 10.1002/ajmg.1320440625; WOLFF DJ, 1994, AM J HUM GENET, V55, P87; ZABEL BU, 1978, AM J MED GENET, V1, P309, DOI 10.1002/ajmg.1320010307; ZUCCOTTI M, 1995, NAT GENET, V9, P316, DOI 10.1038/ng0395-316	67	169	173	3	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1996	58	6					1101	1108						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UM271	8651285				2022-12-18	WOS:A1996UM27100001
J	Slaney, SF; Oldridge, M; Hurst, JA; MorrissKay, GM; Hall, CM; Poole, MD; Wilkie, AOM				Slaney, SF; Oldridge, M; Hurst, JA; MorrissKay, GM; Hall, CM; Poole, MD; Wilkie, AOM			Differential effects of FGFR2 mutations on syndactyly and cleft palate in Apert syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PARENTAL AGE; ANOMALIES	Apert syndrome is a distinctive human malformation characterized by craniosynostosis and severe syndactyly of the hands and feet. It is caused by specific missense substitutions involving adjacent amino acids (Ser252Trp or Pro253Arg) in the linker between the second and third extracellular immunoglobulin domains of fibroblast growth factor receptor 2 (FGFR2). We have developed a simple PCR assay for these mutations in genomic DNA, based on the creation of novel Sm and BstUI restriction sites. Analysis of DNA from 70 unrelated patients with Apert syndrome showed that 45 had the Ser252Trp mutation and 25 had the Pro253Arg mutation. Phenotypic differences between these two groups of patients were investigated. Significant differences were found for severity of syndactyly and presence of cleft palate. The syndactyly was more severe with the Pro253Arg mutation, for both the hands and the feet. In contrast, cleft palate was significantly more common in the Ser252Trp patients. No convincing differences were found in the prevalence of other malformations associated with Apert syndrome. We conclude that, although the phenotype attributable to the two mutations is very similar, there are subtle differences. The opposite trends for severity of syndactyly and cleft palate in relation to the two mutations may relate to the varying patterns of temporal and tissue-specific expression of different fibroblast growth factors, the ligands for FGFR2.	JOHN RADCLIFFE HOSP,INST MOLEC MED,OXFORD OX3 9DU,ENGLAND; RADCLIFFE INFIRM,OXFORD CRANIOFACIAL UNIT,OXFORD,ENGLAND; CHURCHILL HOSP,DEPT MED GENET,OXFORD OX3 7LJ,ENGLAND; UNIV OXFORD,DEPT HUMAN ANAT,OXFORD OX1 3QX,ENGLAND; GREAT ORMOND STREET HOSP CHILDREN,DEPT RADIOL,LONDON,ENGLAND	University of Oxford; Radcliffe Infirmary; University of Oxford; University of Oxford; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust			Wilkie, Andrew/AAC-3820-2020	Wilkie, Andrew/0000-0002-2972-5481	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Apert E., 1906, B SOC MED PARIS, V23, P1310; BLANK CE, 1960, ANN HUM GENET, V24, P151; BLAUTH W, 1978, Z ORTHOP GRENZGEB, V116, P1; CARTER CO, 1969, BRIT MED BULL, V25, P52, DOI 10.1093/oxfordjournals.bmb.a070671; CINALLI G, 1995, J NEUROSURG, V83, P575, DOI 10.3171/jns.1995.83.4.0575; COHEN MM, 1992, AM J MED GENET, V42, P655, DOI 10.1002/ajmg.1320420505; COHEN MM, 1993, AM J MED GENET, V47, P617, DOI 10.1002/ajmg.1320470508; COHEN MM, 1995, AM J MED GENET, V57, P82, DOI 10.1002/ajmg.1320570119; COHEN MM, 1990, AM J MED GENET, V35, P36, DOI 10.1002/ajmg.1320350108; COHEN MM, 1993, AM J MED GENET, V45, P758, DOI 10.1002/ajmg.1320450618; David D., 1982, CRANIOSYNOSTOSES CAU, V1st ed; DIONNE CA, 1990, EMBO J, V9, P2685, DOI 10.1002/j.1460-2075.1990.tb07454.x; ERICKSON JD, 1974, ANN HUM GENET, V38, P89, DOI 10.1111/j.1469-1809.1974.tb01996.x; FERGUSON MWJ, 1994, NAT GENET, V6, P329, DOI 10.1038/ng0494-329; GORRY MC, 1995, HUM MOL GENET, V4, P1387, DOI 10.1093/hmg/4.8.1387; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HENDERSON CA, 1995, BRIT J DERMATOL, V132, P139, DOI 10.1111/j.1365-2133.1995.tb08640.x; ISEKI S, IN PRESS J ANAT; JABS EW, 1994, NAT GENET, V8, P275, DOI 10.1038/ng1194-275; Johnson Daniel E., 1993, V60, P1; KREIBORG S, 1992, AM J MED GENET, V43, P704, DOI 10.1002/ajmg.1320430411; KREIBORG S, 1992, J CRAN GENET DEV BIO, V12, P41; LAJEUNIE E, 1995, NAT GENET, V9, P108, DOI 10.1038/ng0295-108; LEE SH, 1987, CRANIAL COMPUTED TOM; LEWANDA AF, 1993, AM J DIS CHILD, V147, P1306, DOI 10.1001/archpedi.1993.02160360048016; MA HW, 1995, HUM GENET, V96, P731, DOI 10.1007/BF00210308; MARGOLIS S, 1977, AM J OPHTHALMOL, V84, P830, DOI 10.1016/0002-9394(77)90506-2; MASON IJ, 1994, CELL, V78, P547, DOI 10.1016/0092-8674(94)90520-7; MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246; MOLONEY DM, IN PRESS NAT GENET; MUENKE M, 1995, TRENDS GENET, V11, P308, DOI 10.1016/S0168-9525(00)89088-5; MUENKE M, 1994, NAT GENET, V8, P269, DOI 10.1038/ng1194-269; NAGER F. R., 1948, PRACT OTO RHINO LARYNGOL, V10, P1; NARAYAN H, 1991, PRENAT DIAGN, V10, P187; OLDRIDGE M, 1995, HUM MOL GENET, V4, P1077; ORRURTREGER A, 1993, DEV BIOL, V158, P475, DOI 10.1006/dbio.1993.1205; PARK WJ, 1995, AM J HUM GENET, V57, P321; PARK WJ, 1995, HUM MOL GENET, V4, P1229, DOI 10.1093/hmg/4.7.1229; PATTON MA, 1988, J MED GENET, V25, P164, DOI 10.1136/jmg.25.3.164; PETERS KG, 1992, DEVELOPMENT, V114, P233; REARDON W, 1994, NAT GENET, V8, P98, DOI 10.1038/ng0994-98; RISCH N, 1987, AM J HUM GENET, V41, P218; ROLLNICK BR, 1988, CLIN GENET, V33, P87; RUTLAND P, 1995, NAT GENET, V9, P173, DOI 10.1038/ng0295-173; SCHELL U, 1995, HUM MOL GENET, V4, P323, DOI 10.1093/hmg/4.3.323; Sokal R.R., 1981, BIOMETRY PRINCIPLES; STEINBERGER D, 1995, HUM GENET, V96, P113, DOI 10.1007/BF00214198; TEMTAMY S, 1969, Birth Defects Original Article Series, V5, P125; THOMPSON DNP, 1995, CHILD NERV SYST, V11, P269, DOI 10.1007/BF00301758; TRIGLIA T, 1988, NUCLEIC ACIDS RES, V16, P8186, DOI 10.1093/nar/16.16.8186; UPTON J, 1991, CLIN PLAST SURG, V18, P321; VOGT ALFRED, 1933, KLIN MONATSBL AUGENHEILK, V90, P441; WILKIE AOM, 1995, NAT GENET, V9, P165, DOI 10.1038/ng0295-165; WILKIE AOM, 1995, CURR BIOL, V5, P500	54	169	180	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1996	58	5					923	932						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UH192	8651276				2022-12-18	WOS:A1996UH19200004
J	KWOK, C; WELLER, PA; GUIOLI, S; FOSTER, JW; MANSOUR, S; ZUFFARDI, O; PUNNETT, HH; DOMINGUEZSTEGLICH, MA; BROOK, JD; YOUNG, ID; GOODFELLOW, PN; SCHAFER, AJ				KWOK, C; WELLER, PA; GUIOLI, S; FOSTER, JW; MANSOUR, S; ZUFFARDI, O; PUNNETT, HH; DOMINGUEZSTEGLICH, MA; BROOK, JD; YOUNG, ID; GOODFELLOW, PN; SCHAFER, AJ			MUTATIONS IN SOX9, THE GENE RESPONSIBLE FOR CAMPOMELIC DYSPLASIA AND AUTOSOMAL SEX REVERSAL	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CAMPTOMELIC DWARFISM; DISORDER; SSCP	Campomelic dysplasia (CD) is a skeletal malformation syndrome frequently accompanied by 46,XY sex reversal. A mutation-screening strategy using SSCP was employed to identify mutations in SOX9, the chromosome 17q24 gene responsible for CD and autosomal sex reversal in man. We have screened seven CD patients with no cytologically detectable chromosomal aberrations and two CD patients with chromosome 17 rearrangements for mutations in the entire open reading frame of SOX9. Five different mutations have been identified in six CD patients: two missense mutations in the SOX9 putative DNA binding domain (high mobility group, or HMG, box); three frameshift mutations and a splice-acceptor mutation. An identical frameshift mutation is found in two unrelated 46,XY patients, one exhibiting a male phenotype and the other displaying a female phenotype (XY sex reversal). All mutations found affect a single allele, which is consistent with a dominant mode of inheritance. No mutations were found in the SOX9 open reading frame of two patients with chromosome 17q rearrangements, suggesting that the translocations affect SOX9 expression. These findings are consistent with the hypothesis that CD results from haploinsufficiency of SOX9.	UNIV CAMBRIDGE,DEPT GENET,CAMBRIDGE CB2 3EH,ENGLAND; ST GEORGE HOSP,SCH MED,DEPT CLIN GENET,LONDON,ENGLAND; DIPARTIMENTO PATOL UMANA EREDITARIA BIOL GEN & GE,PAVIA,ITALY; ST CHRISTOPHERS HOSP CHILDREN,GENET LAB,PHILADELPHIA,PA 19133; CITY HOSP NOTTINGHAM,CTR MED GENET,NOTTINGHAM,ENGLAND; UNIV NOTTINGHAM,QUEENS MED CTR,DEPT GENET,NOTTINGHAM NG7 2UH,ENGLAND	University of Cambridge; St Georges University London; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham				Guioli, Silvana/0000-0002-4920-7745; Brook, John David/0000-0002-5946-6740; zuffardi, orsetta/0000-0002-1466-4559	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bardossy G., 1982, KARST BAUXITES, P441; CONNOR JM, 1985, AM J MED GENET, V22, P243, DOI 10.1002/ajmg.1320220205; COOKE CT, 1985, PATHOLOGY, V17, P526, DOI 10.3109/00313028509105515; DIANZANI I, 1993, TRENDS GENET, V9, P403, DOI 10.1016/0168-9525(93)90100-V; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; GLAVAC D, 1993, HUM MUTAT, V2, P404, DOI 10.1002/humu.1380020513; GOODFELLOW PN, 1993, ANNU REV GENET, V27, P71, DOI 10.1146/annurev.ge.27.120193.000443; HARLEY VR, 1994, MOL REPROD DEV, V39, P184, DOI 10.1002/mrd.1080390211; HAWKINS JR, 1994, HUM MOL GENET, V3, P1463, DOI 10.1093/hmg/3.suppl_1.1463; HAYASHI K, 1993, HUM MUTAT, V2, P338, DOI 10.1002/humu.1380020503; HOEFNAGEL D, 1978, CLIN GENET, V13, P489; HOUSTON CS, 1983, AM J MED GENET, V15, P3, DOI 10.1002/ajmg.1320150103; HOVMOLLER ML, 1977, HEREDITAS, V86, P51; JAGER RJ, 1993, HUM GENET, V90, P350; LAUDET V, 1993, NUCLEIC ACIDS RES, V21, P2493, DOI 10.1093/nar/21.10.2493; LEREN TP, 1993, PCR METH APPL, V3, P159; MARAIA R, 1991, CLIN GENET, V39, P401; MENSOUR S, 1995, J MED GENET, V32, P415; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; NASRIN N, 1991, NATURE, V354, P317, DOI 10.1038/354317a0; NORMANN EK, 1993, EUR J PEDIATR, V152, P331, DOI 10.1007/BF01956747; POULAT F, 1995, J CELL BIOL, V128, P737, DOI 10.1083/jcb.128.5.737; SHEFFIELD VC, 1993, GENOMICS, V16, P325, DOI 10.1006/geno.1993.1193; TOMMERUP N, 1993, NAT GENET, V4, P170, DOI 10.1038/ng0693-170; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; YOUNG ID, 1992, J MED GENET, V29, P251, DOI 10.1136/jmg.29.4.251	27	169	174	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1995	57	5					1028	1036						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TA449	7485151				2022-12-18	WOS:A1995TA44900007
J	HASSOLD, T; MERRILL, M; ADKINS, K; FREEMAN, S; SHERMAN, S				HASSOLD, T; MERRILL, M; ADKINS, K; FREEMAN, S; SHERMAN, S			RECOMBINATION AND MATERNAL AGE-DEPENDENT NONDISJUNCTION - MOLECULAR STUDIES OF TRISOMY-16	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ISODISOMY	Trisomy 16 is the most common human trisomy, occurring in greater than or equal to 1% of all clinically recognized pregnancies. It is thought to be completely dependent on maternal age and thus provides a useful model for studying the association of increasing maternal age and nondisjunction. We have been conducting a study to determine the parent and meiotic stage of origin of trisomy 16 and the possible association of nondisjunction and aberrant recombination. In the present report, we summarize our observations on 62 spontaneous abortions with trisomy 16. All trisomies were maternally derived, and in virtually all the error occurred at meiosis I. In studies of genetic recombination, we observed a highly significant reduction in recombination in the trisomy-generating meioses by comparison with normal female meioses. However, most cases of trisomy 16 had at least one detectable crossover between the nondisjoined chromosomes, indicating that it is reduced-and not absent-recombination that is the important predisposing factor. Additionally, our data indicate an altered distribution of crossing-over in trisomy 16, as we rarely observed crossovers in the proximal long and short arms. Thus, it may be that, at least for trisomy 16, the association between maternal age and trisomy is due to diminished recombination, particularly in the proximal regions of the chromosome.	CASE WESTERN RESERVE UNIV,CTR HUMAN GENET,CLEVELAND,OH 44106; UNIV HOSP CLEVELAND,CLEVELAND,OH; EMORY UNIV,DEPT MOLEC & MED GENET,ATLANTA,GA 30322	Case Western Reserve University; University Hospitals of Cleveland; Emory University	HASSOLD, T (corresponding author), CASE WESTERN RESERVE UNIV,DEPT GENET,BRB 724,10900 EUCLID AVE,CLEVELAND,OH 44106, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021341] Funding Source: NIH RePORTER; NICHD NIH HHS [HD21341] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANGELL RR, 1994, CYTOGENET CELL GENET, V65, P194, DOI 10.1159/000133631; ANGELL RR, 1994, HUM REPROD, V9, P199; CHAKRAVARTI A, 1989, MOL CYTOGENETIC STUD, P45; CHENG EY, 1994, HUM GENET, V94, P389; CROWLEY PH, 1979, NATURE, V280, P417, DOI 10.1038/280417a0; EICHENLAUBRITTER U, 1989, CYTOGENET CELL GENET, V52, P170, DOI 10.1159/000132871; FISHER JM, 1995, AM J HUM GENET, V56, P669; GERMAN J, 1968, NATURE, V217, P516, DOI 10.1038/217516a0; HASSOLD T, 1980, ANN HUM GENET, V44, P151, DOI 10.1111/j.1469-1809.1980.tb00955.x; HASSOLD TJ, 1991, J MED GENET, V28, P159, DOI 10.1136/jmg.28.3.159; HASSOLD TJ, 1984, ANNU REV GENET, V18, P69, DOI 10.1146/annurev.genet.18.1.69; HAWLEY RS, 1994, HUM MOL GENET, V3, P1521, DOI 10.1093/hmg/3.9.1521; HENDERSON SA, 1968, NATURE, V218, P22, DOI 10.1038/218022a0; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LORDASANCHEZ I, 1992, HUM GENET, V89, P534; MACDONALD M, 1994, HUM MOL GENET, V3, P1365, DOI 10.1093/hmg/3.8.1365; MARTIN RH, 1991, AM J MED GENET, V38, P321; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; MORTON NE, 1989, ANN HUM GENET, V53, P263, DOI 10.1111/j.1469-1809.1989.tb01793.x; MORTON NE, 1984, GENET RES, V44, P99, DOI 10.1017/S0016672300026276; MORTON NE, 1988, ANN HUM GENET, V52, P227, DOI 10.1111/j.1469-1809.1988.tb01100.x; NGO KY, 1993, AM J HUM GENET, V53, P1207; Penrose L.S., 1966, DOWNS ANOMALY; Penrose LS, 1933, J GENET, V27, P219, DOI 10.1007/BF02984413; RAO DC, 1977, HUM HERED, V27, P99, DOI 10.1159/000152856; RISCH N, 1986, AM J HUM GENET, V39, P68; ROBINSON WP, 1993, AM J HUM GENET, V53, P740; SHEN Y, 1994, GENOMICS, V22, P68, DOI 10.1006/geno.1994.1346; SHERMAN SL, 1994, HUM MOL GENET, V3, P1529, DOI 10.1093/hmg/3.9.1529; SUTCLIFFE MJ, 1993, AM J HUM GENET, V53, P1464; WILLIAMS BJ, 1993, HUM MOL GENET, V2, P1929, DOI 10.1093/hmg/2.11.1929; ZARAGOZA RV, 1994, HUM GENET, V94, P411; ZHENG CJ, 1992, HUM GENET, V90, P1; [No title captured]	34	169	173	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1995	57	4					867	874						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RV793	7573048				2022-12-18	WOS:A1995RV79300018
J	WAGSTAFF, J; KNOLL, JHM; FLEMING, J; KIRKNESS, EF; MARTINGALLARDO, A; GREENBERG, F; GRAHAM, JM; MENNINGER, J; WARD, D; VENTER, JC; LALANDE, M				WAGSTAFF, J; KNOLL, JHM; FLEMING, J; KIRKNESS, EF; MARTINGALLARDO, A; GREENBERG, F; GRAHAM, JM; MENNINGER, J; WARD, D; VENTER, JC; LALANDE, M			LOCALIZATION OF THE GENE ENCODING THE GABA(A) RECEPTOR-BETA-3 SUBUNIT TO THE ANGELMAN PRADER-WILLI REGION OF HUMAN CHROMOSOME-15	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PARENTAL ORIGIN; FUNCTIONAL EXPRESSION; ALPHA-SUBUNIT; 15Q DELETIONS; HETEROGENEITY; 15Q11-13; SEQUENCE; PROBES; BRAIN	Deletions of the proximal long arm of chromosome 15 (bands 15q11q13) are found in the majority of patients with two distinct genetic disorders, Angelman syndrome (AS) and Prader-Willi syndrome (PWS). The deleted regions in the two syndromes, defined cytogenetically and by using cloned DNA probes, are similar. However, deletions in AS occur on the maternally inherited chromosome 15, and deletions in PWS occur on the paternally derived chromosome 15. This observation has led to the suggestion that one or more genes in this region show differential expression dependent on parental origin (genetic imprinting). No genes of known function have previously been mapped to this region. We show here that the gene encoding the GABA(A) (gamma-aminobutyric acid) receptor beta-3 subunit maps to the AS/PWS region. Deletion of this gene (GABRB3) was found in AS and PWS patients with interstitial cytogenetic deletions. Evidence of beta-3 gene deletion was also found in an AS patient with an unbalanced 13;15 translocation but not in a PWS patient with an unbalanced 9;15 translocation. The localization of this receptor gene to the AS/PWS region suggests a possible role of the inhibitory neurotransmitter GABA in the pathogenesis of one or both of these syndromes.	CHILDRENS HOSP MED CTR,DIV GENET,300 LONGWOOD AVE,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT PEDIAT,BOSTON,MA 02115; HOWARD HUGHES MED INST,BOSTON,MA; NINCDS,MOLEC & CELLULAR BIOL LAB,BETHESDA,MD 20892; BAYLOR COLL MED,INST MOLEC GENET,HOUSTON,TX 77030; UNIV CALIF LOS ANGELES,CEDARS SINAI MED CTR,SCH MED,CTR MED GENET BIRTH DEFECTS,LOS ANGELES,CA 90048; YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Baylor College of Medicine; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Yale University			Graham, John M./J-1429-2019	Knoll, Joan/0000-0001-6691-1710	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD018658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007748] Funding Source: NIH RePORTER; NICHD NIH HHS [HD18658] Funding Source: Medline; NIGMS NIH HHS [T32GM07748] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; ANGELMAN H, 1965, DEV MED CHILD NEUROL, V7, P681; BALDINI A, 1991, GENOMICS, V9, P770, DOI 10.1016/0888-7543(91)90374-N; BUCKLE VJ, 1989, NEURON, V3, P647, DOI 10.1016/0896-6273(89)90275-4; BUTLER MG, 1983, LANCET, V1, P1285; BUTLER MG, 1990, AM J MED GENET, V35, P319, DOI 10.1002/ajmg.1320350306; CUTTING GR, 1991, P NATL ACAD SCI USA, V88, P2673, DOI 10.1073/pnas.88.7.2673; DONLON TA, 1986, P NATL ACAD SCI USA, V83, P4408, DOI 10.1073/pnas.83.12.4408; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GREENBERG F, 1987, AM J MED GENET, V28, P813, DOI 10.1002/ajmg.1320280405; GUSSOW D, 1987, J IMMUNOL, V139, P3132; KAPLAN LC, 1987, AM J MED GENET, V28, P45, DOI 10.1002/ajmg.1320280107; KHRESTCHATISKY M, 1989, NEURON, V3, P745, DOI 10.1016/0896-6273(89)90243-2; KIRKNESS EF, IN PRESS GENOMICS; KNOLL JHM, 1991, AM J HUM GENET, V48, P16; KNOLL JHM, 1990, AM J HUM GENET, V47, P149; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; LALANDE M, 1985, CYTOMETRY, V6, P1, DOI 10.1002/cyto.990060102; LALANDE M, 1984, CANCER GENET CYTOGEN, V13, P283, DOI 10.1016/0165-4608(84)90073-6; LEDBETTER DH, 1981, NEW ENGL J MED, V304, P325, DOI 10.1056/NEJM198102053040604; LEVITAN ES, 1988, NATURE, V335, P76, DOI 10.1038/335076a0; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; LOLAIT SJ, 1989, FEBS LETT, V246, P145, DOI 10.1016/0014-5793(89)80271-6; LOLAIT SJ, 1989, FEBS LETT, V258, P17, DOI 10.1016/0014-5793(89)81605-9; LUDDENS H, 1990, NATURE, V346, P648, DOI 10.1038/346648a0; MAGENIS RE, 1990, AM J MED GENET, V35, P333, DOI 10.1002/ajmg.1320350307; MELDRUM BS, 1989, BRIT J CLIN PHARMACO, V27, pS3, DOI 10.1111/j.1365-2125.1989.tb03454.x; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; Olsen RW, 1986, BENZODIAZEPINE GABA; PEMBREY M, 1989, J MED GENET, V26, P73, DOI 10.1136/jmg.26.2.73; SHIVERS BD, 1989, NEURON, V3, P327, DOI 10.1016/0896-6273(89)90257-2; TANTRAVAHI U, 1989, AM J MED GENET, V33, P78, DOI 10.1002/ajmg.1320330110; TAYLOR CP, 1988, TRENDS NEUROSCI, V11, P375, DOI 10.1016/0166-2236(88)90070-7; WILLIAMS CA, 1990, AM J MED GENET, V35, P350, DOI 10.1002/ajmg.1320350308; WILLIAMS CA, 1989, AM J MED GENET, V32, P339, DOI 10.1002/ajmg.1320320313; YMER S, 1990, EMBO J, V9, P3261, DOI 10.1002/j.1460-2075.1990.tb07525.x; YMER S, 1989, EMBO J, V8, P1665, DOI 10.1002/j.1460-2075.1989.tb03557.x; YMER S, 1989, FEBS LETT, V258, P119, DOI 10.1016/0014-5793(89)81630-8	39	169	174	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1991	49	2					330	337						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GA866	1714232				2022-12-18	WOS:A1991GA86600009
J	NEEL, JV; SCHULL, WJ; AWA, AA; SATOH, C; KATO, H; OTAKE, M; YOSHIMOTO, Y				NEEL, JV; SCHULL, WJ; AWA, AA; SATOH, C; KATO, H; OTAKE, M; YOSHIMOTO, Y			THE CHILDREN OF PARENTS EXPOSED TO ATOMIC BOMBS - ESTIMATES OF THE GENETIC DOUBLING DOSE OF RADIATION FOR HUMANS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TEXAS, CTR DEMOG & POPULAT GENET, HOUSTON, TX 77025 USA; RADIAT EFFECTS RES FDN, HIROSHIMA 730, JAPAN	University of Texas System; Radiation Effects Research Foundation - Japan	NEEL, JV (corresponding author), UNIV MICHIGAN, SCH MED, DEPT HUMAN GENET, M4708 MED SCI 2, ANN ARBOR, MI 48109 USA.							ABRAHAMSON S, 1976, NATURE, V264, P715, DOI 10.1038/264715a0; ALBERMAN ED, 1977, J MED GENET, V14, P313, DOI 10.1136/jmg.14.5.313; AWA AA, 1968, NATURE, V218, P367, DOI 10.1038/218367a0; AWA AA, 1975, J RADIAT RES, V16, P78; AWA AA, 1987, CYTOGENETICS BASIC A, P166; AWA AA, 1973, EXCERPTA MED INT C S, V297, P92; BAIRD PA, 1988, AM J HUM GENET, V42, P677; BROWN WMC, 1969, ANN HUM GENET, V33, P1, DOI 10.1111/j.1469-1809.1969.tb01623.x; CHAKRABORTY R, 1989, P NATL ACAD SCI USA, V86, P9407, DOI 10.1073/pnas.86.23.9407; Cohen BH, 1977, POPULATION CYTOGENET, P301; CZEIZEL A, 1987, MUTAT RES, V186, P73, DOI 10.1016/0165-1110(87)90015-7; CZEIZEL A, 1988, GENET EPIDEMIOL, V5, P183, DOI 10.1002/gepi.1370050305; DALLAPICCOLA B, 1987, Acta Medica Auxologica (Milan), V19, P5; DEGROUCHY J, 1983, PRINCIPLES PRACTICE, V1, P170; DELEHANTY J, 1986, MUTAT RES, V167, P215, DOI 10.1016/0165-1110(86)90031-X; EVANS HJ, 1977, J MED GENET, V14, P309, DOI 10.1136/jmg.14.5.309; FAVOR J, 1989, GENOME, V31, P844, DOI 10.1139/g89-149; FURUSHO T, 1978, RERF478 RAD EFF RES; FURUSHO T, 1985, RERF985 RAD EFF RES; FURUSHO T, 1978, RERF578 RAD EFF RES; FURUSHO T, 1979, RERF1479 RAD EFF RES; FURUSHO T, 1980, RERF180 RAD EFF RES; GOLDSTEIN H, 1988, CLIN GENET, V34, P366; GRAHN D, 1983, RADIAT RES, V95, P566, DOI 10.2307/3576101; GRAHN D, 1972, MUTAT RES, V15, P331, DOI 10.1016/0027-5107(72)90079-6; GRAHN D, 1984, MUTAT RES, V129, P215, DOI 10.1016/0027-5107(84)90154-4; HIRAIZUMI Y, 1960, GENETICS, V45, P1071; HOOK EB, 1989, ANN HUM GENET, V53, P237, DOI 10.1111/j.1469-1809.1989.tb01790.x; JACOBS PA, 1981, AM J HUM GENET, V33, P44; Kato H., 1966, AM J HUM GENET, V16, P214; KUROKI Y, 1983, J YONAGAO MED ASS, V34, P1; LUNING KG, 1971, MUTAT RES, V12, P291, DOI 10.1016/0027-5107(71)90017-0; MACHIN GA, 1974, LANCET, V1, P549; MAEDA T, 1979, SHUSANKI IGAKU, V9, P1455; MATSUNOBU A, 1989, JPN J HUM GENET, V34, P52; MUKAI T, 1972, GENETICS, V72, P335; Muller H J, 1927, Science, V66, P84, DOI 10.1126/science.66.1699.84; MULVIHILL JJ, 1983, MUTAT RES, V123, P345, DOI 10.1016/0165-1110(83)90028-3; NEEL JV, 1986, P NATL ACAD SCI USA, V83, P389, DOI 10.1073/pnas.83.2.389; NEEL JV, 1974, GENETICS, V76, P311; NEEL JV, 1988, AM J HUM GENET, V42, P663; NEEL JV, 1980, P NATL ACAD SCI-BIOL, V77, P4221, DOI 10.1073/pnas.77.7.4221; NEEL JV, 1988, AM J HUM GENET, V43, P981; NEEL JV, 1989, GENOME, V31, P853, DOI 10.1139/g89-150; NEEL JV, 1958, AM J HUM GENET, V10, P398; NEEL JV, 1984, 2 DIMENSIONAL GEL EL, P259; NEEL JV, 1989, LOW DOSE RAD BIOL BA, P42; NEEL JV, IN PRESS ANN REV GEN; NEEL JV, 1989, 2 DIMENSIONAL ELECTR, P79; NEEL JV, 1956, PUB NATIONAL ACADEMY, V461; OTAKE M, 1990, RADIAT RES, V122, P1, DOI 10.2307/3577576; Roesch WC, 1987, US JAPAN JOINT REASS, V1; RUSSELL WL, 1965, P NATL ACAD SCI USA, V54, P1552, DOI 10.1073/pnas.54.6.1552; RUSSELL WL, 1958, SCIENCE, V128, P1546, DOI 10.1126/science.128.3338.1546; RUSSELL WL, 1951, COLD SPRING HARB SYM, V16, P327, DOI 10.1101/SQB.1951.016.01.024; SANKARANARAYANAN K, 1988, AM J HUM GENET, V42, P651; SATOH C, 1983, AM J HUM GENET, V35, P656; SCHULL WJ, 1981, SCIENCE, V213, P1220, DOI 10.1126/science.7268429; SCHULL WJ, 1966, AM J HUM GENET, V18, P328; SCHULL WJ, 1962, LANCET, V1, P537; Schull WJ, 1965, EFFECTS INBREEDING J; SEARLE AG, 1989, LOW DOSE RAD BIOL BA, P123; SEARLE AG, 1986, GENETIC TOXICOLOGY B, P511; STERN C, 1952, GENETICS, V37, P413; UCHIDA IA, 1977, POPULATION CYTOGENET, P285; WETTKESCHAFER R, 1983, HUM GENET, V64, P1, DOI 10.1007/BF00289472; YOSHIMOTO Y, 1990, AM J HUM GENET, V46, P1041; YOSHIMOTO Y, UNPUB MORTALITY OFFS; [No title captured]; 1947, SCIENCE, V106, P331; 1980, INFLUENCE DOSE ITS D; 1986, ICRUM40 INT COMM RAD, P1; [No title captured]	73	169	176	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1990	46	6					1053	1072						20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DF202	2339701				2022-12-18	WOS:A1990DF20200006
J	RAO, DC; MORTON, NE; YEE, S				RAO, DC; MORTON, NE; YEE, S			ANALYSIS OF FAMILY RESEMBLANCE .2. LINEAR-MODEL FOR FAMILIAL CORRELATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV HAWAII, POPULATION GENET LAB, HONOLULU, HI 96822 USA	University of Hawaii System								BURKS BS, 1928, 27 YB NATIONAL SOC 1; CATTELL RB, 1964, AM J HUM GENET, V16, P397; CATTELL RB, 1955, AM J HUM GENET, V7, P122; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; EAVES LJ, 1972, NATURE, V240, P84, DOI 10.1038/240084a0; Fisher R.A., 1921, METRON, V1, P3, DOI DOI 10.1093/BIOMET/9.1-2.22; HIGGINS JV, 1962, EUGEN QUART, V9, P84, DOI 10.1080/19485565.1962.9987508; Jencks C., 1972, INEQUALITY; KENDALL MG, 1961, ADV THEORY STATISTIC, V2; Morton N., 1967, MONOGRAPHS HUMAN GEN, V3; MORTON NE, 1955, ANN HUM GENET, V20, P125; MORTON NE, 1974, AM J HUM GENET, V26, P318; MORTON NE, IN PRESS; NORTON HW, 1971, AM J HUM GENET, V23, P225; ROBSON EB, 1955, ANN HUM GENET, V19, P262, DOI 10.1111/j.1469-1809.1955.tb01352.x; SCARRSALAPATEK S, 1971, SCIENCE, V174, P1285, DOI 10.1126/science.174.4016.1285; SKODAK M, 1950, PEDAGOGICAL SEMINARY, V77, P3; Wright S, 1934, ANN MATH STAT, V5, P161, DOI 10.1214/aoms/1177732676; Wright S, 1931, J AM STAT ASSOC, V26, P155; Wright S, 1920, J AGRIC RES, V20, P0557; Wright S, 1968, GENETICS BIOMETRIC F, V1	21	169	170	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1974	26	3					331	359						29	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	T0991	4857114				2022-12-18	WOS:A1974T099100004
J	Charlesworth, G; Plagnol, V; Holmstrom, KM; Bras, J; Sheerin, UM; Preza, E; Rubio-Agusti, I; Ryten, M; Schneider, SA; Stamelou, M; Trabzuni, D; Abramov, AY; Bhatia, KP; Wood, NW				Charlesworth, Gavin; Plagnol, Vincent; Holmstroem, Kira M.; Bras, Jose; Sheerin, Una-Marie; Preza, Elisavet; Rubio-Agusti, Ignacio; Ryten, Mina; Schneider, Susanne A.; Stamelou, Maria; Trabzuni, Daniah; Abramov, Andrey Y.; Bhatia, Kailash P.; Wood, Nicholas W.		UK Human Brain Expression Consorti	Mutations in ANO3 Cause Dominant Craniocervical Dystonia: Ion Channel Implicated in Pathogenesis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACTIVATED CHLORIDE CHANNELS; PRIMARY TORSION DYSTONIA; CERVICAL DYSTONIA; HUMAN BRAIN; PROTEINS; FAMILY; TRANSCRIPTOME; EXPRESSION; DONATION; TMEM16A	In this study, we combined linkage analysis with whole-exome sequencing of two individuals to identify candidate causal variants in a moderately-sized UK kindred exhibiting autosomal-dominant inheritance of craniocervical dystonia. Subsequent screening of these candidate causal variants in a large number of familial and sporadic cases of cervical dystonia led to the identification of a total of six putatively pathogenic mutations in ANO3, a gene encoding a predicted Ca2+-gated chloride channel that we show to be highly expressed in the striatum. Functional studies using Ca2+ imaging in case and control fibroblasts demonstrated clear abnormalities in endoplasmic-reticulum-dependent Ca2+ signaling. We conclude that mutations in ANO3 are a cause of autosomal-dominant craniocervical dystonia. The locus DYT23 has been reserved as a synonym for this gene. The implication of an ion channel in the pathogenesis of dystonia provides insights into an alternative mechanism that opens fresh avenues for further research.	[Rubio-Agusti, Ignacio; Stamelou, Maria; Bhatia, Kailash P.] UCL, Inst Neurol, Sobell Dept Movement Disorders, London WC1N 3BG, England; [Plagnol, Vincent; Wood, Nicholas W.] UCL, Genet Inst, London WC1E 6BT, England; [Charlesworth, Gavin; Holmstroem, Kira M.; Bras, Jose; Sheerin, Una-Marie; Preza, Elisavet; Ryten, Mina; Trabzuni, Daniah; Abramov, Andrey Y.; Wood, Nicholas W.] UCL, Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Rubio-Agusti, Ignacio] Hosp Univ La Fe, Movement Disorders Unit, Valencia 46009, Spain; [Schneider, Susanne A.] Univ Kiel, Dept Neurol, D-24105 Kiel, Germany; [Trabzuni, Daniah] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia	University of London; University College London; University of London; University College London; University of London; University College London; Hospital Universitari i Politecnic La Fe; University of Kiel; King Faisal Specialist Hospital & Research Center	Bhatia, KP (corresponding author), UCL, Inst Neurol, Sobell Dept Movement Disorders, London WC1N 3BG, England.	k.bhatia@ucl.ac.uk; n.wood@ucl.ac.uk	Ryten, Mina/Q-8419-2016; Holmstrom, Kira/G-1158-2010; Wood, Nicholas W/C-2505-2009; Charlesworth, Gavin/B-5895-2011; Preza, Elisavet/C-1829-2013; Trabzuni, Daniah M/C-4034-2012; Abramov, Andrey Y/H-9053-2012; Bras, Jose MT/A-1428-2011; Trabzuni, Daniah/AAI-2037-2021; Abramov, Andrey/AAC-6712-2019	Wood, Nicholas W/0000-0002-9500-3348; Trabzuni, Daniah M/0000-0003-4826-9570; Abramov, Andrey Y/0000-0002-7646-7235; Trabzuni, Daniah/0000-0003-4826-9570; Abramov, Andrey/0000-0002-7646-7235; Holmstrom, Kira/0000-0001-6434-7909; Bras, Jose/0000-0001-8186-0333; Plagnol, Vincent/0000-0002-5597-9215; PREZA, ELISAVET/0000-0003-4082-4621; Bhatia, Kailash/0000-0001-8185-286X	Medical Research Council [WT089698/Z/09/Z]; Wellcome Trust; Department of Health's National Institute for Health Research Biomedical Research Centres; GlaxoSmithKline; Boehringer-Ingelheim; Ipsen; Merz; Orion Pharma; Dystonia Society UK; Halley Stewart Trust; Medical Research Council [G1100479, G0802462, MC_G0901330, MC_PC_09003, MC_G1000735] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10376] Funding Source: researchfish; Parkinson&quot;s UK [G-1107] Funding Source: researchfish; MRC [G1100479, MC_PC_09003, MC_G0901330, MC_G1000735, G0802462] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Department of Health's National Institute for Health Research Biomedical Research Centres(National Institute for Health Research (NIHR)); GlaxoSmithKline(GlaxoSmithKline); Boehringer-Ingelheim(Boehringer Ingelheim); Ipsen(Ipsen); Merz; Orion Pharma; Dystonia Society UK; Halley Stewart Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Parkinson&quot;s UK(Parkinson&apos;s UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to extend our thanks to the individuals whose participation made this research possible. This work was supported financially by a strategic award (WT089698/Z/09/Z) from the Medical Research Council and Wellcome Trust. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was undertaken at University College London Hospitals and University College London (UCL), which receive support from the funding streams of the Department of Health's National Institute for Health Research Biomedical Research Centres. Expression data were provided by the UK Human Brain Expression Consortium (UKBEC), which comprises John A. Hardy, Mina Ryten, Daniah Trabzuni, Michael Weale, Adaikalavan Ramasamy, Colin Smith, and Robert Walker. UKBEC members are affiliated with the UCL Institute of Neurology (J.A.H., M.R., and D.T.), King's College London (M.W. and A.R.), and the University of Edinburgh (C.S. and R.W). Kailash P. Bhatia received advisor, honorarial, and financial support to attend and speak at meetings from GlaxoSmithKline, Boehringer-Ingelheim, Ipsen, Merz, and Orion Pharma. He holds research grants from the Dystonia Society UK and the Halley Stewart Trust.	Beach TG, 2008, CELL TISSUE BANK, V9, P229, DOI 10.1007/s10561-008-9067-2; Bolduc V, 2010, AM J HUM GENET, V86, P213, DOI 10.1016/j.ajhg.2009.12.013; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Cenedese V, 2012, J GEN PHYSIOL, V139, P285, DOI 10.1085/jgp.201110764; CHAN J, 1991, MOVEMENT DISORD, V6, P119, DOI 10.1002/mds.870060206; Defazio G, 2003, NEUROL SCI, V24, P168, DOI 10.1007/s10072-003-0113-3; Duffey P O, 1998, Adv Neurol, V78, P121; Duran C, 2012, AM J PHYSIOL-CELL PH, V302, pC482, DOI 10.1152/ajpcell.00140.2011; Duran C, 2011, ACTA PHARMACOL SIN, V32, P685, DOI 10.1038/aps.2011.48; Duvvuri U, 2012, CANCER RES, V72, P3270, DOI 10.1158/0008-5472.CAN-12-0475-T; Fuchs T, 2009, NAT GENET, V41, P286, DOI 10.1038/ng.304; Gritli-Linde A, 2009, GENE EXPR PATTERNS, V9, P178, DOI 10.1016/j.gep.2008.11.002; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Huang WC, 2012, NEURON, V74, P179, DOI 10.1016/j.neuron.2012.01.033; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Milenkovic VM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-319; Millar T, 2007, J PATHOL, V213, P369, DOI 10.1002/path.2247; Munchau A, 2000, MOVEMENT DISORD, V15, P954, DOI 10.1002/1531-8257(200009)15:5<954::AID-MDS1028>3.0.CO;2-I; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Penttila S, 2012, NEUROLOGY, V78, P897, DOI 10.1212/WNL.0b013e31824c4682; Quinn NP, 2011, MOVEMENT DISORD, V26, P18, DOI 10.1002/mds.23289; Skogseid IM, 2007, EUR J NEUROL, V14, P1129, DOI 10.1111/j.1468-1331.2007.01922.x; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Trabzuni D, 2012, HUM MOL GENET, V21, P4094, DOI 10.1093/hmg/dds238; Trabzuni D, 2011, J NEUROCHEM, V119, P275, DOI 10.1111/j.1471-4159.2011.07432.x; Vaarmann A, 2010, CELL CALCIUM, V48, P176, DOI 10.1016/j.ceca.2010.08.008; Velickovic M, 2001, DRUGS, V61, P1921, DOI 10.2165/00003495-200161130-00004; Vermeer S, 2010, AM J HUM GENET, V87, P813, DOI 10.1016/j.ajhg.2010.10.015; Warner T, 2000, J NEUROL, V247, P787; Xiao JF, 2012, ANN NEUROL, V71, P458, DOI 10.1002/ana.23547; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yu K, 2012, CIRC RES, V110, P990, DOI 10.1161/CIRCRESAHA.112.264440	34	168	175	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC 7	2012	91	6					1041	1050		10.1016/j.ajhg.2012.10.024	http://dx.doi.org/10.1016/j.ajhg.2012.10.024			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	055LI	23200863	Green Published, hybrid			2022-12-18	WOS:000312417400007
J	Cho, TJ; Lee, KE; Lee, SK; Song, SJ; Kim, KJ; Jeon, D; Lee, G; Kim, HN; Lee, HR; Eom, HH; Lee, ZH; Kim, OH; Park, WY; Park, SS; Ikegawa, S; Yoo, WJ; Choi, IH; Kim, JW				Cho, Tae-Joon; Lee, Kyung-Eun; Lee, Sook-Kyung; Song, Su Jeong; Kim, Kyung Jin; Jeon, Daehyun; Lee, Gene; Kim, Ha-Neui; Lee, Hye Ran; Eom, Hye-Hyun; Lee, Zang Hee; Kim, Ok-Hwa; Park, Woong-Yang; Park, Sung Sup; Ikegawa, Shiro; Yoo, Won Joon; Choi, In Ho; Kim, Jung-Wook			A Single Recurrent Mutation in the 5 '-UTR of IFITM5 Causes Osteogenesis Imperfecta Type V	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CLASSIFICATION	Osteogenesis imperfecta (OI) is a heterogenous group of genetic disorders of bone fragility. OI type V is an autosomal-dominant disease characterized by calcification of the forearm interosseous membrane, radial head dislocation, a subphyseal metaphyseal radiodense line, and hyperplastic callus formation; the causative mutation involved in this disease has not been discovered yet. Using linkage analysis in a four-generation family and whole-exome sequencing, we identified a heterozygous mutation of c.-14C>T in the 5'-untranslated region of a gene encoding interferon-induced transmembrane protein 5 (IFITM5). It completely cosegregated with the disease in three families and occurred de novo in five simplex individuals. Transfection of wild-type and mutant IFITM5 constructs revealed that the mutation added five amino acids (Met-Ala-Leu-Glu-Pro) to the N terminus of IFITM5. Given that IFITM5 expression and protein localization is restricted to the skeletal tissue and IFITM5 involvement in bone formation, we conclude that this recurrent mutation would have a specific effect on IFITM5 function and thus cause OI type V.	[Lee, Kyung-Eun; Lee, Sook-Kyung; Song, Su Jeong; Kim, Jung-Wook] Seoul Natl Univ, Sch Dent, Dept Pediat Dent, Seoul 110749, South Korea; [Cho, Tae-Joon; Lee, Zang Hee; Yoo, Won Joon; Choi, In Ho] Seoul Natl Univ, Childrens Hosp, Div Pediatr Orthopaed, Seoul 110744, South Korea; [Jeon, Daehyun; Lee, Gene; Kim, Jung-Wook] Seoul Natl Univ, Sch Dent, Dept Mol Genet, Seoul 110749, South Korea; [Kim, Ha-Neui; Lee, Zang Hee] Seoul Natl Univ, Sch Dent, Dept Cell & Dev Biol, Seoul 110749, South Korea; [Lee, Kyung-Eun; Lee, Sook-Kyung; Song, Su Jeong; Kim, Kyung Jin; Jeon, Daehyun; Lee, Gene; Kim, Ha-Neui; Lee, Zang Hee; Kim, Jung-Wook] Seoul Natl Univ, Sch Dent, Dent Res Inst, Seoul 110749, South Korea; [Eom, Hye-Hyun; Park, Woong-Yang] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul 110799, South Korea; [Kim, Ok-Hwa] Ajou Univ Hosp, Dept Radiol, Suwon 443721, South Korea; [Park, Woong-Yang] Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul 110799, South Korea; [Ikegawa, Shiro] RIKEN, Ctr Genom Med, Lab Bone & Joint Dis, Tokyo 1088639, Japan	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Ajou University; Ajou University Hospital; Seoul National University (SNU); RIKEN	Kim, JW (corresponding author), Seoul Natl Univ, Sch Dent, Dept Pediat Dent, Seoul 110749, South Korea.	tjcho@snu.ac.kr; pedoman@snu.ac.kr	Choi, In-Ho/U-2836-2019; Ikegawa, Shiro/N-6895-2015; Park, Sung Sup/J-2756-2012; Yoo, Wonjoon/J-5552-2012; Cho, Tae-Joon/I-9355-2012	Ikegawa, Shiro/0000-0003-0316-2147; Cho, Tae-Joon/0000-0001-8514-377X; Park, Sung Sup/0000-0003-3754-4848; Park, Woong-Yang/0000-0003-4234-0380; Eum, Hye Hyeon/0000-0002-8081-4121	Bio & Medical Technology Development Program [2011-0027790]; Science Research Center grant of the National Research Foundation (NRF) [2012-0000487]; Korean government (MEST); Korea Healthcare Technology Research and Development Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea [A080588]	Bio & Medical Technology Development Program; Science Research Center grant of the National Research Foundation (NRF); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Korea Healthcare Technology Research and Development Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea	The authors sincerely thank all the family members for their participation in this study. This work was supported by a grant from the Bio & Medical Technology Development Program (2011-0027790) and by a Science Research Center grant to the Bone Metabolism Research Center (2012-0000487) of the National Research Foundation (NRF) funded by the Korean government (MEST) and by a grant from the Korea Healthcare Technology Research and Development Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (A080588).	Alanay Y, 2010, AM J HUM GENET, V86, P551, DOI 10.1016/j.ajhg.2010.02.022; Becker J, 2011, AM J HUM GENET, V88, P362, DOI 10.1016/j.ajhg.2011.01.015; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Christiansen HE, 2010, AM J HUM GENET, V86, P389, DOI 10.1016/j.ajhg.2010.01.034; Cundy T, 2012, CALCIFIED TISSUE INT, V90, P439, DOI 10.1007/s00223-012-9588-3; Forlino A, 2011, NAT REV ENDOCRINOL, V7, P540, DOI 10.1038/nrendo.2011.81; Glorieux FH, 2000, J BONE MINER RES, V15, P1650, DOI 10.1359/jbmr.2000.15.9.1650; Hanagata N, 2011, J BONE MINER METAB, V29, P279, DOI 10.1007/s00774-010-0221-0; Lee DY, 2006, J KOREAN MED SCI, V21, P709, DOI 10.3346/jkms.2006.21.4.709; Moffatt P, 2008, J BONE MINER RES, V23, P1497, DOI 10.1359/JBMR.080412; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Rauch F, 2004, LANCET, V363, P1377, DOI 10.1016/S0140-6736(04)16051-0; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; Van Dijk FS, 2010, EUR J MED GENET, V53, P1, DOI 10.1016/j.ejmg.2009.10.007; van Dijk FS, 2009, AM J HUM GENET, V85, P521, DOI 10.1016/j.ajhg.2009.09.001; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909	16	168	179	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG 10	2012	91	2					343	348		10.1016/j.ajhg.2012.06.005	http://dx.doi.org/10.1016/j.ajhg.2012.06.005			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	990CN	22863190	Green Published, Bronze			2022-12-18	WOS:000307608700013
J	Pierce, SB; Walsh, T; Chisholm, KM; Lee, MK; Thornton, AM; Fiumara, A; Opitz, JM; Levy-Lahad, E; Klevit, RE; King, MC				Pierce, Sarah B.; Walsh, Tom; Chisholm, Karen M.; Lee, Ming K.; Thornton, Anne M.; Fiumara, Agata; Opitz, John M.; Levy-Lahad, Ephrat; Klevit, Rachel E.; King, Mary-Claire			Mutations in the DBP-Deficiency Protein HSD17B4 Cause Ovarian Dysgenesis, Hearing Loss, and Ataxia of Perrault Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ENOYL-COA HYDRATASE; BIFUNCTIONAL PROTEIN; BETA-OXIDATION; DEHYDROGENASE; D-3-HYDROXYACYL-COA; RESOLUTION; SPECTRUM; SEQUENCE	Perrault syndrome is a recessive disorder characterized by ovarian dysgenesis in females, sensorineural deafness in both males and females, and in some patients, neurological manifestations. No genes for Perrault syndrome have heretofore been identified. A small family of mixed European ancestry includes two sisters with well-characterized Perrault syndrome. Whole-exome sequencing of genomic DNA from one of these sisters revealed exactly one gene with two rare functional variants: HSD17B4, which encodes 17 beta-hydroxysteroid dehydrogenase type 4 (HSD17B4), also known as D-bifunctional protein (DBP). HSD17B4/DBP is a multifunctional peroxisomal enzyme involved in fatty acid beta-oxidation and steroid metabolism. Both sisters are compound heterozygotes for HSD17B4 c.650A>G (p.Y217C) (maternal allele) and HSB17B4c.1704T>A (p.Y568X) (paternal allele). The missense mutation is predicted by structural analysis to destabilize the HSD17B4 dehydrogenase domain. The nonsense mutation leads to very low levels of HSD17B4 transcript. Expression of mutant HSD17B4 protein in a compound heterozygote was severely reduced. Mutations in HSD17B4 are known to cause DBP deficiency, an autosomal-recessive disorder of peroxisomal fatty acid beta-oxidation that is generally fatal within the first two years of life. No females with DBP deficiency surviving past puberty have been reported, and ovarian dysgenesis has not previously been associated with this illness. Six other families with Perrault syndrome have wild-type sequences of HSD17B4. These results indicate that Perrault syndrome and DBP deficiency overlap clinically; that Perrault syndrome is genetically heterogeneous; that DBP deficiency may be underdiagnosed; and that whole-exome sequencing can reveal critical genes in small, nonconsanguineous families.	[Pierce, Sarah B.; Walsh, Tom; Chisholm, Karen M.; Lee, Ming K.; Thornton, Anne M.; King, Mary-Claire] Univ Washington, Dept Med Med Genet, Seattle, WA 98195 USA; [Pierce, Sarah B.; Walsh, Tom; Chisholm, Karen M.; Lee, Ming K.; Thornton, Anne M.; King, Mary-Claire] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Fiumara, Agata] Univ Catania, Reg Referral Ctr Inborn Errors Metab, I-95123 Catania, Italy; [Opitz, John M.] Univ Utah Sch Med, Dept Pediat Med Genet, Salt Lake City, UT 84117 USA; [Opitz, John M.] Univ Utah Sch Med, Dept Pathol, Salt Lake City, UT 84117 USA; [Opitz, John M.] Univ Utah Sch Med, Dept Human Genet, Salt Lake City, UT 84117 USA; [Opitz, John M.] Univ Utah Sch Med, Dept Obstet & Gynecol, Salt Lake City, UT 84117 USA; [Levy-Lahad, Ephrat] Shaare Zedek Med Ctr, Inst Med Genet, IL-91031 Jerusalem, Israel; [Levy-Lahad, Ephrat] Hebrew Univ Jerusalem, Sch Med, IL-91120 Jerusalem, Israel; [Klevit, Rachel E.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Catania; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; University of Washington; University of Washington Seattle	King, MC (corresponding author), Univ Washington, Dept Med Med Genet, Seattle, WA 98195 USA.	mcking@uw.edu	Klevit, Rachel/AAI-7038-2021; Fiumara, Agata/F-7200-2012; Levy-Lahad, Ephrat/F-2186-2018	Klevit, Rachel/0000-0002-3476-969X; Levy-Lahad, Ephrat/0000-0002-2637-1921; King, Mary-Claire/0000-0001-9426-1743; Chisholm, Karen/0000-0002-1898-1252; Walsh, Tom/0000-0002-8875-0310; Pierce, Sarah/0000-0001-6739-7135	National Institute of Deafness and other Communication Disorders of the NIH [R01DC005641]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005641] Funding Source: NIH RePORTER	National Institute of Deafness and other Communication Disorders of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institute of Deafness and other Communication Disorders of the NIH (R01DC005641) with a supplement from the American Recovery and Reinvestment Act.	Breitling R, 2001, MOL CELL ENDOCRINOL, V171, P205, DOI 10.1016/S0303-7207(00)00415-9; de Launoit Y, 1999, J MOL ENDOCRINOL, V22, P227, DOI 10.1677/jme.0.0220227; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Ferdinandusse S, 2006, ANN NEUROL, V59, P92, DOI 10.1002/ana.20702; Ferdinandusse S, 2006, AM J HUM GENET, V78, P112, DOI 10.1086/498880; Fiumara A, 2004, AM J MED GENET A, V128A, P246, DOI 10.1002/ajmg.a.20616; Gottschalk ME, 1996, AM J MED GENET, V65, P274, DOI 10.1002/(SICI)1096-8628(19961111)65:4<274::AID-AJMG5>3.0.CO;2-P; Haapalainen AM, 2003, STRUCTURE, V11, P87, DOI 10.1016/S0969-2126(02)00931-0; Jiang LL, 1997, J BIOCHEM-TOKYO, V121, P364; Jiang LL, 1996, J BIOCHEM-TOKYO, V120, P624; LEENDERS F, 1994, MOL CELL ENDOCRINOL, V104, P127, DOI 10.1016/0303-7207(94)90114-7; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; MALILA LH, 1993, J BIOL CHEM, V268, P21578; MCCARTHY DJ, 1985, AM J MED GENET, V22, P629, DOI 10.1002/ajmg.1320220324; NISHI Y, 1988, AM J MED GENET, V31, P623, DOI 10.1002/ajmg.1320310317; Paton BC, 2000, CELL BIOCHEM BIOPHYS, V32, P247, DOI 10.1385/CBB:32:1-3:247; Paton BC, 1996, J CLIN INVEST, V97, P681, DOI 10.1172/JCI118465; PERRAULT M, 1951, Bull Mem Soc Med Hop Paris, V67, P79; Soorani-Lunsing RJ, 2005, J INHERIT METAB DIS, V28, P1172, DOI 10.1007/s10545-005-0149-z; van Grunsven EG, 1999, HUM MOL GENET, V8, P1509, DOI 10.1093/hmg/8.8.1509; van Grunsven EG, 1999, AM J HUM GENET, V64, P99, DOI 10.1086/302180; Walsh T, 2010, P NATL ACAD SCI USA, V107, P12629, DOI 10.1073/pnas.1007983107; Walsh T, 2010, AM J HUM GENET, V87, P90, DOI 10.1016/j.ajhg.2010.05.010; Wanders R.J., 2001, METABOLIC MOL BASES, P3219	24	168	188	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 13	2010	87	2					282	288		10.1016/j.ajhg.2010.07.007	http://dx.doi.org/10.1016/j.ajhg.2010.07.007			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641EG	20673864	Green Published, Bronze			2022-12-18	WOS:000281107000013
J	Kayser, M; Liu, F; Janssens, ACJW; Rivadeneira, F; Lao, O; van Duijn, K; Vermeulen, M; Arp, P; Jhamai, MM; van IJcken, WFJ; den Dunnen, JT; Heath, S; Zelenika, D; Despriet, DDG; Klaver, CCW; Vingerling, JR; De Jong, PTVM; Hofman, A; Aulchenko, YS; Uitterlinden, AG; Oostra, BA; van Duijn, CM				Kayser, Manfred; Liu, Fan; Janssens, A. Cecile J. W.; Rivadeneira, Fernando; Lao, Oscar; van Duijn, Kate; Vermeulen, Mark; Arp, Pascal; Jhamai, Mila M.; van IJcken, Wilfred F. J.; den Dunnen, Johan T.; Heath, Simon; Zelenika, Diana; Despriet, Dominiek D. G.; Klaver, Caroline C. W.; Vingerling, Johannes R.; De Jong, Paulus T. V. M.; Hofman, Albert; Aulchenko, Yurii S.; Uitterlinden, Andre G.; Oostra, Ben A.; van Duijn, Cornelia M.			Three genome-wide association studies and a linkage analysis identify HERC2 as a human iris color gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PINK-EYED-DILUTION; II OCULOCUTANEOUS ALBINISM; HUMAN PIGMENTATION; DUTCH POPULATION; WILLI SYNDROME; P-GENE; OCA2; HYPOPIGMENTATION; DELETION; REGION	Human iris color was one of the first traits for which Mendelian segregation was established. To date, the genetics of iris color is still not fully understood and is of interest, particularly in view of forensic applications. In three independent genome-wide association (GWA) studies of a total of 1406 persons and a genome-wide linkage study of 1292 relatives, all from the Netherlands, we found that the 15q13.1 region is the predominant region involved in human iris color. There were no other regions showing consistent genome-wide evidence for association and linkage to iris color. Single nucleotide polymorphisms (SNPs) in the HERC2 gene and, to a lesser extent, in the neighboring OCA2 gene were independently associated to iris color variation. OCA2 has been implicated in iris color previously. A replication study within two populations confirmed that the HERC2 gene is a new and significant determinant of human iris color variation, in addition to OCA2. Furthermore, HERC2 rs916977 showed a clinal allele distribution across 23 European populations, which was significantly correlated to iris color variation. We suggest that genetic variants regulating expression of the OCA2 gene exist in the HERC2 gene or, alternatively, within the 11.7 kb of sequence between OCA2 and HERC2, and that most iris color variation in Europeans is explained by those two genes. Testing markers in the HERC2-OCA2 region may be useful in forensic applications to predict eye color phenotypes of unknown persons of European genetic origin.	[Kayser, Manfred; Lao, Oscar; van Duijn, Kate; Vermeulen, Mark] Erasmus Univ, Med Ctr, Dept Forens Mol Biol, NL-3000 CA Rotterdam, Netherlands; [Liu, Fan; Aulchenko, Yurii S.; Oostra, Ben A.; van Duijn, Cornelia M.] Erasmus Univ, Med Ctr, Genet Epidemiol Unit, Dept Epidemiol & Biostat, NL-3000 CA Rotterdam, Netherlands; [Liu, Fan; Aulchenko, Yurii S.; Oostra, Ben A.; van Duijn, Cornelia M.] Erasmus Univ, Med Ctr, Genet Epidemiol Unit, Dept Clin Genet, NL-3000 CA Rotterdam, Netherlands; [Rivadeneira, Fernando; Arp, Pascal; Jhamai, Mila M.; Uitterlinden, Andre G.] Erasmus Univ, Med Ctr, Genet Lab, Dept Internal Med, NL-3000 CA Rotterdam, Netherlands; [Janssens, A. Cecile J. W.] Erasmus Univ, Med Ctr, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; [Rivadeneira, Fernando; Despriet, Dominiek D. G.; Klaver, Caroline C. W.; Vingerling, Johannes R.; De Jong, Paulus T. V. M.; Hofman, Albert; Uitterlinden, Andre G.] Erasmus Univ, Med Ctr, Dept Epidemiol & Biostat, NL-3000 CA Rotterdam, Netherlands; [van IJcken, Wilfred F. J.] Erasmus Univ, Med Ctr, Erasmus Ctr Biom, NL-3000 CA Rotterdam, Netherlands; [Despriet, Dominiek D. G.; Klaver, Caroline C. W.; Vingerling, Johannes R.] Erasmus Univ, Med Ctr, Dept Ophthalmol, NL-3000 CA Rotterdam, Netherlands; [Vermeulen, Mark] Netherlands Forens Inst, Dept Biol, NL-2490 AA The Hague, Netherlands; [den Dunnen, Johan T.] Leiden Genome Technol Ctr, Dept Human & Clin Genet, NL-2300 RC Leiden, Netherlands; [Heath, Simon; Zelenika, Diana] Ctr Natl Ctr Genotypage, F-91057 Evry, France; [De Jong, Paulus T. V. M.] Royal Netherlands Acad Arts & Sci, Netherlands Inst Med Ctr, NL-1105 BA Amsterdam, Netherlands; [De Jong, Paulus T. V. M.] Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, NL-1100 DD Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam	Kayser, M (corresponding author), Erasmus Univ, Med Ctr, Dept Forens Mol Biol, NL-3000 CA Rotterdam, Netherlands.	m.kayser@erasinusmc.nl	Aulchenko, Yurii/M-8270-2013; van ijcken, willem/N-9805-2018; Rivadeneira, Fernando/O-5385-2015; dunnen, johan den/ABH-4228-2020; Liu, Fan/B-8833-2013; Klaver, Caroline C.W./A-2013-2016; Heath, Simon C/J-4138-2012; Lao, Oscar/N-9930-2017	Aulchenko, Yurii/0000-0002-7899-1575; van ijcken, willem/0000-0002-0421-8301; Rivadeneira, Fernando/0000-0001-9435-9441; dunnen, johan den/0000-0002-6304-1710; Liu, Fan/0000-0001-9241-8161; Heath, Simon C/0000-0002-9550-0897; Lao, Oscar/0000-0002-8525-9649; Van Duijn, Cornelia/0000-0002-2374-9204; Janssens, A Cecile/0000-0002-6153-4976; Klaver, Caroline/0000-0002-2355-5258				Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Aulchenko YS, 2004, EUR J HUM GENET, V12, P527, DOI 10.1038/sj.ejhg.5201188; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Beals R. L., 1965, INTRO ANTHR; Bito LZ, 1997, ARCH OPHTHALMOL-CHIC, V115, P659, DOI 10.1001/archopht.1997.01100150661017; Brilliant MH, 2001, PIGM CELL RES, V14, P86, DOI 10.1034/j.1600-0749.2001.140203.x; BUTLER MG, 1989, AM J HUM GENET, V45, P140; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Chai JH, 2003, AM J HUM GENET, V73, P898, DOI 10.1086/378816; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Duffy DL, 2007, AM J HUM GENET, V80, P241, DOI 10.1086/510885; Duffy DL, 2004, HUM MOL GENET, V13, P447, DOI 10.1093/hmg/ddh043; Frost P, 2006, EVOL HUM BEHAV, V27, P85, DOI 10.1016/j.evolhumbehav.2005.07.002; Frudakis T, 2003, GENETICS, V165, P2071; Frudakis T, 2007, HUM GENET, V122, P311, DOI 10.1007/s00439-007-0401-8; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Graf J, 2005, HUM MUTAT, V25, P278, DOI 10.1002/humu.20143; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Imesch PD, 1997, SURV OPHTHALMOL, V41, pS117, DOI 10.1016/S0039-6257(97)80018-5; Imesch PD, 1996, ARCH OPHTHALMOL-CHIC, V114, P443, DOI 10.1001/archopht.1996.01100130439015; Jannot AS, 2005, EUR J HUM GENET, V13, P913, DOI 10.1038/sj.ejhg.5201415; Ji YG, 1999, HUM MOL GENET, V8, P533, DOI 10.1093/hmg/8.3.533; Ji YG, 2000, GENOME RES, V10, P319, DOI 10.1101/gr.10.3.319; Kanetsky PA, 2002, AM J HUM GENET, V70, P770, DOI 10.1086/339076; KING RA, 1993, AM J MED GENET, V46, P40, DOI 10.1002/ajmg.1320460109; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Pardo LM, 2005, ANN HUM GENET, V69, P288, DOI 10.1046/j.1529-8817.2005.00162.x; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Posthuma D, 2006, BEHAV GENET, V36, P12, DOI 10.1007/s10519-005-9007-x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RAMSAY M, 1992, AM J HUM GENET, V51, P879; Rebbeck TR, 2002, CANCER EPIDEM BIOMAR, V11, P782; RINCHIK EM, 1993, NATURE, V361, P72, DOI 10.1038/361072a0; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Service S, 2006, NAT GENET, V38, P556, DOI 10.1038/ng1770; SOKAL RR, 1978, BIOL J LINN SOC, V10, P199, DOI 10.1111/j.1095-8312.1978.tb00013.x; SPRITZ RA, 1995, AM J HUM GENET, V56, P1320; Staehling-Hampton K, 2002, AM J MED GENET, V110, P144, DOI 10.1002/ajmg.10401; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Sturm RA, 2004, TRENDS GENET, V20, P327, DOI 10.1016/j.tig.2004.06.010; Wielgus AR, 2005, PIGM CELL RES, V18, P454, DOI 10.1111/j.1600-0749.2005.00268.x; WIESNER GL, 1987, AM J HUM GENET, V40, P431; Zhu G, 2004, TWIN RES, V7, P197, DOI 10.1375/136905204323016186	45	168	176	2	70	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2008	82	2					411	423		10.1016/j.ajhg.2007.10.003	http://dx.doi.org/10.1016/j.ajhg.2007.10.003			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NN	18252221	Green Published, Bronze			2022-12-18	WOS:000253223900013
J	Betz, RC; Planko, L; Eigelshoven, S; Hanneken, S; Pasternack, SM; Bussow, H; Van den Bogaert, K; Wenzel, J; Braun-Falco, M; Rutten, A; Rogers, MA; Ruzicka, T; Nothen, MM; Magin, TM; Kruse, R				Betz, RC; Planko, L; Eigelshoven, S; Hanneken, S; Pasternack, SM; Bussow, H; Van den Bogaert, K; Wenzel, J; Braun-Falco, M; Rutten, A; Rogers, MA; Ruzicka, T; Nothen, MM; Magin, TM; Kruse, R			Loss-of-function mutations in the keratin 5 gene lead to Dowling-Degos disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EPIDERMOLYSIS-BULLOSA SIMPLEX; INTERMEDIATE-FILAMENT PROTEINS; CYTOSKELETON; DESMOSOMES; STABILITY; SCAFFOLDS; TRANSPORT; DYNAMICS; HUMANS	Dowling-Degos disease (DDD) is an autosomal dominant genodermatosis characterized by progressive and disfiguring reticulate hyperpigmentation of the flexures. We performed a genomewide linkage analysis of two German families and mapped DDD to chromosome 12q, with a total LOD score of 4.42 (theta = 0.0) for marker D12S368. This region includes the keratin gene cluster, which we screened for mutations. We identified loss-of-function mutations in the keratin 5 gene (KRT5) in all affected family members and in six unrelated patients with DDD. These represent the first identified mutations that lead to haploinsufficiency in a keratin gene. The identification of loss-of-function mutations, along with the results from additional functional studies, suggest a crucial role for keratins in the organization of cell adhesion, melanosome uptake, organelle transport, and nuclear anchorage.	Univ Bonn, Inst Human Genet, D-53111 Bonn, Germany; Univ Bonn, Inst Phys Chem, D-53111 Bonn, Germany; Univ Bonn, Inst Anat, D-53111 Bonn, Germany; Univ Bonn, Dept Gen, Life & Brain Ctr, D-53111 Bonn, Germany; Univ Bonn, Dept Dermatol, D-53111 Bonn, Germany; Univ Dusseldorf, Dept Dermatol, D-4000 Dusseldorf, Germany; Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium; Univ Freiburg, Dept Dermatol, Freiburg, Germany; Lab Dermatohistopathol, Friedrichshafen, Germany; German Canc Res Ctr, Sect Normal & Neoplast Epidermal Differentiat, D-6900 Heidelberg, Germany	University of Bonn; University of Bonn; University of Bonn; University of Bonn; University of Bonn; Heinrich Heine University Dusseldorf; University of Antwerp; University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ)	Betz, RC (corresponding author), Univ Bonn, Inst Human Genet, Wilhelmstr 31, D-53111 Bonn, Germany.	regina.betz@uni-bonn.de	Wenzel, Jörg/AAX-2644-2020; Betz, Regina C/E-8591-2011; Nöthen, Markus/B-2027-2009; Rogers, Michael A./J-9803-2012	Wenzel, Jörg/0000-0002-4744-5993; Betz, Regina C/0000-0001-5024-3623; Nöthen, Markus/0000-0002-8770-2464; Rogers, Michael A./0000-0002-3728-2107				BILTZ H, 1988, Z HAUTKRANKHEITEN, V63, P642; Braun-Falco M, 2003, BRIT J DERMATOL, V149, P1293, DOI 10.1111/j.1365-2133.2003.05645.x; Braun-Falco M, 2001, J AM ACAD DERMATOL, V45, P760, DOI 10.1067/mjd.2001.116340; Byers HR, 2003, J INVEST DERMATOL, V121, P813; Chang L, 2004, NAT REV MOL CELL BIO, V5, P601, DOI 10.1038/nrm1438; Coulombe PA, 2004, NAT CELL BIOL, V6, P699, DOI 10.1038/ncb0804-699; CROVATO F, 1983, BRIT J DERMATOL, V108, P473, DOI 10.1111/j.1365-2133.1983.tb04602.x; DEGOS R, 1954, Ann Dermatol Syphiligr (Paris), V81, P147; Dowling G, 1938, BRIT J DERMATOL, V50, P467; Fontao L, 2003, MOL BIOL CELL, V14, P1978, DOI 10.1091/mbc.e02-08-0548; Getsios S, 2004, NAT REV MOL CELL BIO, V5, P271, DOI 10.1038/nrm1356; GRIFFITHS WAD, 1984, CLIN EXP DERMATOL, V9, P439, DOI 10.1111/j.1365-2230.1984.tb00838.x; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Gu LH, 2003, J INVEST DERMATOL, V121, P482, DOI 10.1046/j.1523-1747.2003.12424.x; Hardman MJ, 2005, MOL CELL BIOL, V25, P969, DOI 10.1128/MCB.25.3.969-978.2005; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Hesse M, 2001, J CELL SCI, V114, P2569; Hesse M, 2004, EUR J CELL BIOL, V83, P19, DOI 10.1078/0171-9335-00354; JAFARI R, 2003, AKTUEL DERMATOL, V29, P240; Jamora C, 2003, NATURE, V422, P317, DOI 10.1038/nature01458; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Magin TM, 2004, EXP CELL RES, V301, P91, DOI 10.1016/j.yexcr.2004.08.018; Maquat LE, 2005, J CELL SCI, V118, P1773, DOI 10.1242/jcs.01701; Marks MS, 2001, NAT REV MOL CELL BIO, V2, P738, DOI 10.1038/35096009; MILDE P, 1992, HAUTARZT, V43, P369; Milde P., 1994, Z HAUTKRANKHEITEN, V69, P282; O'Goshi KI, 2001, ACTA DERM-VENEREOL, V81, P148; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Rao MV, 2002, J CELL BIOL, V159, P279, DOI 10.1083/JCB.200205062; Reichelt J, 1999, J INVEST DERMATOL, V113, P329, DOI 10.1046/j.1523-1747.1999.00702.x; Reichelt J, 2001, MOL BIOL CELL, V12, P1557, DOI 10.1091/mbc.12.6.1557; Relchelt J, 2002, J CELL SCI, V115, P2639; RUGG EL, 1994, GENE DEV, V8, P2563, DOI 10.1101/gad.8.21.2563; Rutten A, 1995, AKTUEL DERMATOL, V21, P255; Smith EA, 1998, J CELL BIOL, V141, P1229, DOI 10.1083/jcb.141.5.1229; Styers ML, 2004, MOL BIOL CELL, V15, P5369, DOI 10.1091/mbc.E04-03-0272; Uttam J, 1996, P NATL ACAD SCI USA, V93, P9079, DOI 10.1073/pnas.93.17.9079; Wenzel J, 2002, DERMATOL SURG, V28, P748, DOI 10.1046/j.1524-4725.2002.02014.x; Werner NS, 2004, MOL BIOL CELL, V15, P990, DOI 10.1091/mbc.E03-09-0687; WILSONJONES E, 1978, ARCH DERMATOL, V114, P1150	41	168	176	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2006	78	3					510	519		10.1086/500850	http://dx.doi.org/10.1086/500850			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032AY	16465624	Bronze, Green Published			2022-12-18	WOS:000236747500018
J	Kayser, M; Kittler, R; Erler, A; Hedman, M; Lee, AC; Mohyuddin, A; Mehdi, SQ; Rosser, Z; Stoneking, M; Jobling, MA; Sajantila, A; Tyler-Smith, C				Kayser, M; Kittler, R; Erler, A; Hedman, M; Lee, AC; Mohyuddin, A; Mehdi, SQ; Rosser, Z; Stoneking, M; Jobling, MA; Sajantila, A; Tyler-Smith, C			A comprehensive survey of human Y-chromosomal microsatellites	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							STR HAPLOTYPES; REFERENCE DATABASE; FORENSIC ANALYSIS; POLYMORPHISMS; POPULATIONS; MUTATIONS; PATERNITY; LOCI; INSTABILITY; MULTIPLEX	We have screened the nearly complete DNA sequence of the human Y chromosome for microsatellites (short tandem repeats) that meet the criteria of having a repeat-unit size of greater than or equal to3 and a repeat count of greater than or equal to8 and thus are likely to be easy to genotype accurately and to be polymorphic. Candidate loci were tested in silico for novelty and for probable Y specificity, and then they were tested experimentally to identify Y-specific loci and to assess their polymorphism. This yielded 166 useful new Y-chromosomal microsatellites, 139 of which were polymorphic, in a sample of eight diverse Y chromosomes representing eight Y-SNP haplogroups. This large sample of microsatellites, together with 28 previously known markers analyzed here-all sharing a common evolutionary history-allowed us to investigate the factors influencing their variation. For simple microsatellites, the average repeat count accounted for the highest proportion of repeat variance (similar to34%). For complex microsatellites, the largest proportion of the variance (again, similar to34%) was explained by the average repeat count of the longest homogeneous array, which normally is variable. In these complex microsatellites, the additional repeats outside the longest homogeneous array significantly increased the variance, but this was lower than the variance of a simple microsatellite with the same total repeat count. As a result of this work, a large number of new, highly polymorphic Y-chromosomal microsatellites are now available for population-genetic, evolutionary, genealogical, and forensic investigations.	Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany; Univ Helsinki, Dept Forens Med, Helsinki, Finland; Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; Biomed & Genet Engn Labs, Islamabad, Pakistan; Wellcome Trust Sanger Inst, Cambridge, England	Max Planck Society; University of Helsinki; University of Leicester; University of Oxford; Wellcome Trust Sanger Institute	Kayser, M (corresponding author), Erasmus MC Univ Med Ctr Rotterdam, Dept Forens Mol Biol, Med Genet Cluster,POB 1738, NL-3000 DR Rotterdam, Netherlands.	m.kayser@erasmusmc.nl	Kittler, Ralf/I-4662-2013; Schneider, Peter M./A-6661-2011; Sajantila, Antti/AAY-9084-2021; Kittler, Ralf/AAD-4258-2020; Mehdi, Syed Qasim/L-2385-2015	Kittler, Ralf/0000-0002-0098-6792; Kittler, Ralf/0000-0002-0098-6792; Jobling, Mark/0000-0002-8061-1308; Sajantila, Antti/0000-0003-4117-5248	Wellcome Trust [057559] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Amos W, 1996, NAT GENET, V13, P390, DOI 10.1038/ng0896-390; Ayub Q, 2000, Nucleic Acids Res, V28, pe8, DOI 10.1093/nar/28.2.e8; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bosch E, 2002, FORENSIC SCI INT, V125, P42, DOI 10.1016/S0379-0738(01)00627-2; Bosch E, 2003, HUM MOL GENET, V12, P341, DOI 10.1093/hmg/ddg031; Butler JM, 2002, FORENSIC SCI INT, V129, P10, DOI 10.1016/S0379-0738(02)00195-0; Callinan PA, 2003, GENE, V317, P103, DOI 10.1016/S0378-1119(03)00662-0; CHEN HM, 1994, HUM MUTAT, V4, P208, DOI 10.1002/humu.1380040306; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Ellis N, 2002, GENOME RES, V12, P339; Forster P, 2000, AM J HUM GENET, V67, P182, DOI 10.1086/302953; Hedman A, 2004, FORENSIC SCI INT, V142, P37, DOI 10.1016/j.forsciint.2003.07.003; Iida R, 2001, INT J LEGAL MED, V115, P54, DOI 10.1007/s004140100207; Iida R, 2002, INT J LEGAL MED, V116, P191, DOI 10.1007/s00414-001-0266-7; Jin L, 1996, P NATL ACAD SCI USA, V93, P15285, DOI 10.1073/pnas.93.26.15285; Jobling MA, 1996, HUM MOL GENET, V5, P1767, DOI 10.1093/hmg/5.11.1767; Jobling MA, 2001, TRENDS GENET, V17, P353, DOI 10.1016/S0168-9525(01)02284-3; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Jobling MA, 1997, INT J LEGAL MED, V110, P118, DOI 10.1007/s004140050050; Kayser M, 2002, J FORENSIC SCI, V47, P513; Kayser M, 1997, INT J LEGAL MED, V110, P125, DOI 10.1007/s004140050051; Kayser M, 2000, AM J HUM GENET, V66, P1580, DOI 10.1086/302905; Kayser M, 2001, FORENSIC SCI INT, V118, P116, DOI 10.1016/S0379-0738(00)00480-1; Kayser M, 2001, AM J HUM GENET, V68, P990, DOI 10.1086/319510; Kittler R, 2003, EUR J HUM GENET, V11, P304, DOI 10.1038/sj.ejhg.5200960; Maddison W. P., 1992, MACCLADE ANAL PHYLOG; MATHIAS N, 1994, HUM MOL GENET, V3, P115, DOI 10.1093/hmg/3.1.115; Mohyuddin A, 2004, BBA-GEN SUBJECTS, V1670, P81, DOI 10.1016/j.bbagen.2003.10.014; Mohyuddin A, 2001, FORENSIC SCI INT, V118, P141, DOI 10.1016/S0379-0738(01)00382-6; Nadir E, 1996, P NATL ACAD SCI USA, V93, P6470, DOI 10.1073/pnas.93.13.6470; Nei M., 1987, MOL EVOLUTIONARY GEN; Redd AJ, 2002, FORENSIC SCI INT, V130, P97, DOI 10.1016/S0379-0738(02)00347-X; Roewer L, 2001, FORENSIC SCI INT, V118, P106, DOI 10.1016/S0379-0738(00)00478-3; Rolf B, 2001, INT J LEGAL MED, V115, P12, DOI 10.1007/s004140000201; Rozen S, 2000, Methods Mol Biol, V132, P365; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; Santos FR, 1996, AM J HUM GENET, V58, P1369; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Stumpf MPH, 2001, SCIENCE, V291, P1738, DOI 10.1126/science.291.5509.1738; Subramanian S, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r13; Thomas MG, 1999, HUM GENET, V105, P577, DOI 10.1007/s004390051148; Walsh B, 2001, GENETICS, V158, P897; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; White PS, 1999, GENOMICS, V57, P433, DOI 10.1006/geno.1999.5782; Zerjal T, 2003, AM J HUM GENET, V72, P717, DOI 10.1086/367774	45	168	190	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2004	74	6					1183	1197		10.1086/421531	http://dx.doi.org/10.1086/421531			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	823ZB	15195656	Bronze, Green Published			2022-12-18	WOS:000221651900011
J	Badano, JL; Ansley, SJ; Leitch, CC; Lewis, RA; Lupski, JR; Katsanis, N				Badano, JL; Ansley, SJ; Leitch, CC; Lewis, RA; Lupski, JR; Katsanis, N			Identification of a novel Bardet-Biedl syndrome protein, BBS7, that shares structural features with BBS1 and BBS2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMOSOME 16Q; SYNDROME LOCUS; LINKAGE; OBESITY; GENE; MUTATIONS; 11Q13	Bardet-Biedl syndrome (BBS) is a genetically heterogeneous disorder, the primary features of which include obesity, retinal dystrophy, polydactyly, hypogenitalism, learning difficulties, and renal malformations. Conventional linkage and positional cloning have led to the mapping of six BBS loci in the human genome, four of which (BBS1, BBS2, BBS4, and BBS6) have been cloned. Despite these advances, the protein sequences of the known BBS genes have provided little or no insight into their function. To delineate functionally important regions in BBS2, we performed phylogenetic and genomic studies in which we used the human and zebrafish BBS2 peptide sequences to search dbEST and the translation of the draft human genome. We identified two novel genes that we initially named "BBS2L1" and "BBS2L2" and that exhibit modest similarity with two discrete, overlapping regions of BBS2. In the present study, we demonstrate that BBS2L1 mutations cause BBS, thereby defining a novel locus for this syndrome, BBS7, whereas BBS2L2 has been shown independently to be BBS1. The motif-based identification of a novel BBS locus has enabled us to define a potential functional domain that is present in three of the five known BBS proteins and, therefore, is likely to be important in the pathogenesis of this complex syndrome.	Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21287 USA; Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21287 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Texas Childrens Hosp, Baylor Coll Med, Houston, TX 77030 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Katsanis, N (corresponding author), Johns Hopkins Univ, McKusick Nathans Inst Genet Med, 600 N Wolfe St,2-127 Jefferson St Bldg, Baltimore, MD 21287 USA.		Katsanis, Nicholas/E-1837-2012	Katsanis, Nicholas/0000-0002-2480-0171; Badano, Jose/0000-0002-0706-8652				Badano JL, 2002, NAT REV GENET, V3, P779, DOI 10.1038/nrg910; Beales PL, 1999, J MED GENET, V36, P437; Beales PL, 2001, AM J HUM GENET, V68, P606, DOI 10.1086/318794; Bruford EA, 1997, GENOMICS, V41, P93, DOI 10.1006/geno.1997.4613; CARMI R, 1995, HUM MOL GENET, V4, P9, DOI 10.1093/hmg/4.1.9; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Katsanis N, 1999, AM J HUM GENET, V65, P1672, DOI 10.1086/302684; Katsanis N, 2002, AM J HUM GENET, V71, P22, DOI 10.1086/341031; Katsanis N, 2001, HUM MOL GENET, V10, P2293, DOI 10.1093/hmg/10.20.2293; Katsanis N, 2000, NAT GENET, V26, P67, DOI 10.1038/79201; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; KWITEKBLACK AE, 1993, NAT GENET, V5, P392, DOI 10.1038/ng1293-392; LEPPERT M, 1994, NAT GENET, V7, P108, DOI 10.1038/ng0594-108; Lo Conte L, 2002, NUCLEIC ACIDS RES, V30, P264; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Mykytyn K, 2002, NAT GENET, V31, P435, DOI 10.1038/ng935; Mykytyn K, 2001, NAT GENET, V28, P188, DOI 10.1038/88925; Nishimura DY, 2001, HUM MOL GENET, V10, P865, DOI 10.1093/hmg/10.8.865; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; SHEFFIELD VC, 1994, HUM MOL GENET, V3, P1331, DOI 10.1093/hmg/3.8.1331; Slavotinek AM, 2000, NAT GENET, V26, P15, DOI 10.1038/79116; Stone DL, 2000, NAT GENET, V25, P79, DOI 10.1038/75637; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Young TL, 1999, AM J HUM GENET, V64, P900, DOI 10.1086/302301	24	168	175	0	5	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2003	72	3					650	658		10.1086/368204	http://dx.doi.org/10.1086/368204			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	648LJ	12567324	Green Published, Bronze			2022-12-18	WOS:000181152600014
J	Eymard-Pierre, E; Lesca, G; Dollet, S; Santorelli, FM; di Capua, M; Bertini, E; Boespflug-Tanguy, O				Eymard-Pierre, E; Lesca, G; Dollet, S; Santorelli, FM; di Capua, M; Bertini, E; Boespflug-Tanguy, O			Infantile-onset ascending hereditary spastic paralysis is associated with mutations in the alsin gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CHROMOSOME 2Q33-Q34; CRITICAL REGION; PARAPLEGIA; LINKAGE; LOCUS; FORM; PROTEIN; PARAPARESIS; DISEASE	We studied 15 patients, from 10 families, who presented with severe spastic paralysis with an infantile onset and an ascending progression. Spastic paraplegia began during the first 2 years of life and extended to upper limbs within the next few years. During the first decade of life, the disease progressed to tetraplegia, anarthria, dysphagia, and slow eye movements. Overall, the disease was compatible with long survival. Signs of lower motor-neuron involvement were never observed, whereas motor-evoked potentials and magnetic resonance imaging demonstrated a primitive, pure degeneration of the upper motor neurons. Genotyping and linkage analyses demonstrated that this infantile-onset ascending hereditary spastic paralysis (IAHSP) is allelic to the condition previously reported as juvenile amyotrophic lateral sclerosis at the ALS2 locus on chromosome 2q33-35 (LOD score 6.66 at recombination fraction 0). We analyzed ALS2, recently found mutated in consanguineous Arabic families presenting either an ALS2 phenotype or juvenile-onset primary lateral sclerosis (JPLS), as a candidate gene. In 4 of the 10 families, we found abnormalities: three deletions and one splice-site mutation. All the mutations lead to a truncated alsin protein. In one case, the mutation affected both the short and the long alsin transcript. In the six remaining families, absence of cDNA ALS2 mutations suggests either mutations in regulatory ALS2 regions or genetic heterogeneity, as already reported in JPLS. Alsin mutations are responsible for a primitive, retrograde degeneration of the upper motor neurons of the pyramidal tracts, leading to a clinical continuum from infantile (IAHSP) to juvenile forms with (ALS2) or without (JPLS) lower motor-neuron involvement. Further analyses will determine whether other hereditary disorders with primitive involvement of the central motor pathways, as pure forms of spastic paraplegia, could be due to alsin dysfunction.	Fac Med, INSERM, UMR384, F-63001 Clermont Ferrand, France; Fac Med, Federat Genet Humaine Auvergne, F-63001 Clermont Ferrand, France; Univ Lyon, Serv Genet, Lyon, France; Bambino Gesu Pediat Hosp, Mol Med Unit, Rome, Italy; Bambino Gesu Pediat Hosp, Div Pediat Neurol, Rome, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); IRCCS Bambino Gesu; IRCCS Bambino Gesu	Boespflug-Tanguy, O (corresponding author), Fac Med, INSERM, UMR384, 28 Pl Henri Dunant,BP 38, F-63001 Clermont Ferrand, France.		Carlet-Dollet, Sandra/X-8945-2019; EYMARD-PIERRE, ELEONORE/Y-4187-2019; Bertini, Enrico/A-2284-2014; Santorelli, Filippo M/ABE-5124-2020; Bertini, Enrico/ABG-1278-2020	Carlet-Dollet, Sandra/0000-0003-3908-6051; EYMARD-PIERRE, ELEONORE/0000-0003-0460-8112; Bertini, Enrico/0000-0001-9276-4590; Santorelli, Filippo M/0000-0002-1359-9062; Lesca, Gaetan/0000-0001-7691-9492; Marteil, Gaelle/0000-0002-0064-571X				BENHAMIDA M, 1990, BRAIN, V113, P347; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Chance PF, 1998, AM J HUM GENET, V62, P633, DOI 10.1086/301769; Figlewicz DA, 1999, NEUROLOGY, V53, P5, DOI 10.1212/WNL.53.1.5; Hadano S, 1999, GENOMICS, V55, P106, DOI 10.1006/geno.1998.5637; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; Hadano S, 2001, GENOMICS, V71, P200, DOI 10.1006/geno.2000.6392; Hand CK, 2002, AM J HUM GENET, V70, P251, DOI 10.1086/337945; Hansen JJ, 2002, AM J HUM GENET, V70, P1328, DOI 10.1086/339935; HARDING AE, 1981, J NEUROL NEUROSUR PS, V44, P871, DOI 10.1136/jnnp.44.10.871; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Hentati A, 1998, NEUROGENETICS, V2, P55, DOI 10.1007/s100480050052; HENTATI A, 1994, NAT GENET, V7, P425, DOI 10.1038/ng0794-425; JOUET M, 1994, NAT GENET, V7, P402, DOI 10.1038/ng0794-402; LATHROP GM, 1985, AM J HUM GENET, V37, P482; McDermott CJ, 2000, J NEUROL NEUROSUR PS, V69, P150, DOI 10.1136/jnnp.69.2.150; MULDER DW, 1986, NEUROLOGY, V36, P511, DOI 10.1212/WNL.36.4.511; PRINGLE CE, 1992, BRAIN, V115, P495, DOI 10.1093/brain/115.2.495; Reid E, 2000, AM J HUM GENET, V66, P728, DOI 10.1086/302783; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SAUGIERVEBER P, 1994, NAT GENET, V6, P257, DOI 10.1038/ng0394-257; Seri M, 1999, AM J HUM GENET, V64, P586, DOI 10.1086/302241; SIDDIQUE T, 1991, NEW ENGL J MED, V324, P1381, DOI 10.1056/NEJM199105163242001; Vazza G, 2000, AM J HUM GENET, V67, P504, DOI 10.1086/303017; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160; Zhao XP, 2001, NAT GENET, V29, P326, DOI 10.1038/ng758	26	168	171	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2002	71	3					518	527		10.1086/342359	http://dx.doi.org/10.1086/342359			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	584VN	12145748	Bronze, Green Published			2022-12-18	WOS:000177489600006
J	Gresham, D; Morar, B; Underhill, PA; Passarino, G; Lin, AA; Wise, C; Angelicheva, D; Calafell, F; Oefner, PJ; Shen, PD; Tournev, I; de Pablo, R; Kucinskas, V; Perez-Lezaun, A; Marushiakova, E; Popov, V; Kalaydjieva, L				Gresham, D; Morar, B; Underhill, PA; Passarino, G; Lin, AA; Wise, C; Angelicheva, D; Calafell, F; Oefner, PJ; Shen, PD; Tournev, I; de Pablo, R; Kucinskas, V; Perez-Lezaun, A; Marushiakova, E; Popov, V; Kalaydjieva, L			Origins and divergence of the Roma (Gypsies)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEUROPATHY CCFDN SYNDROME; HOMO-SAPIENS SAPIENS; Y-CHROMOSOME; MITOCHONDRIAL-DNA; SEQUENCE VARIATION; HUMAN-POPULATIONS; FOUNDER MUTATION; CONTROL-REGION; MTDNA; EUROPE	The identification of a growing number of novel Mendelian disorders and private mutations in the Roma (Gypsies) points to their unique genetic heritage. Linguistic evidence suggests that they are of diverse Indian origins. Their social structure within Europe resembles that of the jatis of India, where the endogamous group, often defined by profession, is the primary unit. Genetic studies have reported dramatic differences in the frequencies of mutations and neutral polymorphisms in different Romani populations. However, these studies have not resolved ambiguities regarding the origins and relatedness of Romani populations. In this study, we examine the genetic structure of 14 well-defined Romani populations. Y-chromosome and mtDNA markers of different mutability were analyzed in a total of 275 individuals. Asian Y-chromosome haplogroup VI-68, defined by a mutation at the M82 locus, was present in all 14 populations and accounted for 44.8% of Romani Y chromosomes. Asian mtDNA-haplogroup M was also identified in all Romani populations and accounted for 26.5% of female lineages in the sample. Limited diversity within these two haplogroups, measured by the variation at eight short-tandem- repeat loci for the Y chromosome, and sequencing of the HVS1 for the mtDNA are consistent with a small group of founders splitting from a single ethnic population in the Indian subcontinent. Principal-components analysis and analysis of molecular variance indicate that genetic structure in extant endogamous Romani populations has been shaped by genetic drift and differential admixture and correlates with the migrational history of the Roma in Europe. By contrast, social organization and professional group divisions appear to be the product of a more recent restitution of the caste system of India.	Edith Cowan Univ, Ctr Human Genet, Perth, WA 6027, Australia; Western Australian Inst Med Res, Perth, WA, Australia; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Univ Calabria, Dipartimento Biol Cellulare, Arcavacata Di Rende, Italy; Univ Pompeu Fabra, Fac Ciencies & Vida, Unitat Biol Evolut, Barcelona, Spain; Stanford Genome Technol Ctr, Palo Alto, CA USA; Med Univ Sofia, Dept Neurol, Sofia, Bulgaria; Fdn Hlth Problems Ethn Minor, Sofia, Bulgaria; Bulgarian Acad Sci, Inst Ethnol, Sofia, Bulgaria; Clin Puerta Hierro, Unidad Immunol, Madrid, Spain; Univ Vilnius, Fac Med, Ctr Human Genet, Vilnius, Lithuania	Edith Cowan University; University of Western Australia; Stanford University; University of Calabria; Pompeu Fabra University; Stanford University; Medical University Sofia; Bulgarian Academy of Sciences; Clinica Veterinaria Puerta de Hierro; Hospital Puerta de Hierro-Majadahonda; Vilnius University	Kalaydjieva, L (corresponding author), Edith Cowan Univ, Ctr Human Genet, Joondalup Campus, Perth, WA 6027, Australia.		Morar, Bharti/O-8697-2014; de Pablo, Rosario/L-1853-2014; Popov, Veselin/AAR-4356-2020; Marushiakova, Elena/AAR-2927-2020; KUČINSKAS, Vaidutis/A-4798-2013; Calafell, Francesc/C-8595-2014	Morar, Bharti/0000-0003-3897-1403; Popov, Veselin/0000-0002-6565-8730; Marushiakova, Elena/0000-0001-5333-2330; Calafell, Francesc/0000-0002-1083-9438				Abicht A, 1999, NEUROLOGY, V53, P1564, DOI 10.1212/WNL.53.7.1564; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Angelicheva D, 1999, EUR J HUM GENET, V7, P560, DOI 10.1038/sj.ejhg.5200319; Bamshad M, 2001, GENOME RES, V11, P994, DOI 10.1101/gr.GR-1733RR; BANDELT HJ, 1995, GENETICS, V141, P743; Bray MS, 2001, HUM MUTAT, V17, P296, DOI 10.1002/humu.27; Calafell F, 1996, ANN HUM GENET, V60, P35, DOI 10.1111/j.1469-1809.1996.tb01170.x; COLOCCI A, 1889, ZINGARA STORIA POPOL; de Knijff P, 2000, AM J HUM GENET, V67, P1055; EXCOFFIER L, 1992, GENETICS, V131, P479; FINGS K, 1997, RACE SCI CAMPS GYPSI; Fraser A., 1992, GYPSIES; HAMMER MF, 1995, AM J HUM GENET, V56, P951; HANCOCK I, 1987, PARIAH SYNDROME; Hancock Ian, 2000, SCHOLARSHIP GYPSY ST, P1; Heyer E, 1997, HUM MOL GENET, V6, P799, DOI 10.1093/hmg/6.5.799; Kalaydjieva L, 2000, AM J HUM GENET, V67, P47, DOI 10.1086/302978; Kalaydjieva L, 1999, AM J HUM GENET, V65, P1299, DOI 10.1086/302611; Kalaydjieva L, 1996, NAT GENET, V14, P214, DOI 10.1038/ng1096-214; Kalaydjieva L, 2001, BMC Med Genet, V2, P5, DOI 10.1186/1471-2350-2-5; Kalaydjieva L, 2001, EUR J HUM GENET, V9, P97, DOI 10.1038/sj.ejhg.5200597; KALMAN B, 1991, ACTA NEUROL SCAND, V84, P181, DOI 10.1111/j.1600-0404.1991.tb04934.x; Kaneva R, 1998, PSYCHIATR GENET, V8, P245, DOI 10.1097/00041444-199808040-00008; Kayser M, 1997, INT J LEGAL MED, V110, P125, DOI 10.1007/s004140050051; Kittles RA, 1998, AM J HUM GENET, V62, P1171, DOI 10.1086/301831; Kivisild T, 1999, CURR BIOL, V9, P1331, DOI 10.1016/S0960-9822(00)80057-3; Liegeois Jean Pierre, 1994, ROMA GYPSIES TRAVELL; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Marushiakova E., 2001, GYPSIES OTTOMAN EMPI; MARUSHIAKOVA E, 2001, PAST FUTURE ROMA CEN, P370; Meyer S, 1999, GENETICS, V152, P1103; Milanov I, 2000, NEUROEPIDEMIOLOGY, V19, P206, DOI 10.1159/000026257; Nei M., 1987, MOL EVOLUTIONARY GEN; Okely J., 1983, TRAVELLER GYPSIES; Passarino G, 1996, AM J HUM GENET, V59, P927; Piccolo F, 1996, HUM MOL GENET, V5, P2019, DOI 10.1093/hmg/5.12.2019; Plasilova M, 1999, J MED GENET, V36, P290; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Reyniers A., 1995, INT MIGRATION LABOUR, V1, P8; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; ROCHOW I, 1998, JB OSTERREICHISCHEN, V41, P241; Rogers T, 2000, AM J HUM GENET, V67, P664, DOI 10.1086/303053; Rolf B, 1998, EUR J HUM GENET, V6, P583, DOI 10.1038/sj.ejhg.5200223; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Shen PD, 2000, P NATL ACAD SCI USA, V97, P7354, DOI 10.1073/pnas.97.13.7354; Simoni L, 2000, AM J HUM GENET, V66, P262, DOI 10.1086/302706; Stoneking M, 2000, AM J HUM GENET, V67, P1029, DOI 10.1086/303092; Thomas MG, 1998, NATURE, V394, P138, DOI 10.1038/28083; THOMAS PK, ANN NEUROL, V50, P452; Tournev I, 1999, ACTA NEUROPATHOL, V98, P165, DOI 10.1007/s004010051065; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; WEXLER P, 1997, 3 INT C ROM LING PRA; 1915, J GYPSY LORE SOC, V9, P1	59	168	171	0	27	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2001	69	6					1314	1331		10.1086/324681	http://dx.doi.org/10.1086/324681			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	491AY	11704928	Green Published, Bronze			2022-12-18	WOS:000172086900016
J	Williams, JT; Van Eerdewegh, P; Almasy, L; Blangero, J				Williams, JT; Van Eerdewegh, P; Almasy, L; Blangero, J			Joint multipoint linkage analysis of multivariate qualitative and quantitative traits. I. Likelihood formulation and simulation results	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VARIANCE-COMPONENTS MODELS; ASSESSING GENETIC-LINKAGE; PEDIGREE ANALYSIS; EXTENDED PEDIGREES; ROBUST INFERENCE; PIMA-INDIANS; SERUM IRON; LOCI; ALCOHOLISM; FAMILIES	We describe a variance-components method for multipoint linkage analysis that allows joint consideration of a discrete trait and a correlated continuous biological marker (e.g., a disease precursor or associated risk factor) in pedigrees of arbitrary size and complexity. The continuous trait is assumed to be multivariate normally distributed within pedigrees, and the discrete trait is modeled by a threshold process acting on an underlying multivariate normal liability distribution. The liability is allowed to be correlated with the quantitative trait, and the liability and quantitative phenotype may each include covariate effects. Bivariate discrete-continuous observations will be common, but the method easily accommodates qualitative and quantitative phenotypes that are themselves multivariate. Formal likelihood-based tests are described for coincident linkage (i.e., linkage of the traits to distinct quantitative-trait loci [QTLs] that happen to be linked) and pleiotropy (i.e., the same QTL influences both discrete-trait status and the correlated continuous phenotype). The properties of the method are demonstrated by use of simulated data from Genetic Analysis Workshop 10. In a companion paper, the method is applied to data from the Collaborative Study on the Genetics of Alcoholism, in a bivariate linkage analysis of alcoholism diagnoses and P300 amplitude of event-related brain potentials.	SW Fdn Biomed Res, Dept Genet, San Antonio, TX 78245 USA; Genome Therapeut Corp, Waltham, MA USA	Texas Biomedical Research Institute	Williams, JT (corresponding author), SW Fdn Biomed Res, Dept Genet, 7620 NW Loop 410,POB 760549, San Antonio, TX 78245 USA.		Almasy, Laura/V-3156-2019; Blangero, John/ABA-7175-2021		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL045522, P01HL028972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK044297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM018897, R01GM031575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059490, R37MH059490] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL028972, HL45522, P01 HL045522] Funding Source: Medline; NIDDK NIH HHS [DK44297] Funding Source: Medline; NIGMS NIH HHS [R01 GM031575, F32 GM018897] Funding Source: Medline; NIMH NIH HHS [R01 MH059490, MH59490, R37 MH059490] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aitken, 1934, P EDINBURGH MATH SOC, V4, P106, DOI [DOI 10.1017/S0013091500008063, 10.1017/S0013091500008063]; Almasy L, 1997, GENET EPIDEMIOL, V14, P953, DOI 10.1002/(SICI)1098-2272(1997)14:6<953::AID-GEPI65>3.0.CO;2-K; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; AMOS CI, 1990, AM J HUM GENET, V47, P247; AMOS CI, 1994, AM J HUM GENET, V54, P535; Amos CI, 1996, ANN HUM GENET, V60, P143, DOI 10.1111/j.1469-1809.1996.tb01184.x; AMOS CI, 1993, GENET EPIDEMIOL, V10, P671, DOI 10.1002/gepi.1370100657; ANDREWS DF, 1971, BIOMETRICS, V27, P825, DOI 10.2307/2528821; BEATY TH, 1985, ANN HUM GENET, V49, P315, DOI 10.1111/j.1469-1809.1985.tb01707.x; BEATY TH, 1987, GENET EPIDEMIOL, V4, P203, DOI 10.1002/gepi.1370040305; BEATY TH, 1987, GENET EPIDEMIOL, V4, P211, DOI 10.1002/gepi.1370040306; Begleiter H, 1995, ALCOHOL HEALTH RES W, V19, P228; BEGLEITER H, 1984, SCIENCE, V225, P1493, DOI 10.1126/science.6474187; BLACKWOOD DHR, 1991, ARCH GEN PSYCHIAT, V48, P899; BLANGERO J, 1993, HUM BIOL, V65, P941; Blangero J, 1995, GENET EPIDEMIOL, V12, P689, DOI 10.1002/gepi.1370120628; Blangero J, 1997, AM J MED GENET, V74, P602; BLANGERO J, 1992, CYTOGENET CELL GENET, V59, P179, DOI 10.1159/000133238; Boehnke M, 1984, Prog Clin Biol Res, V147, P173; BOEHNKE M, 1986, AM J MED GENET, V23, P775, DOI 10.1002/ajmg.1320230306; BONNEY GE, 1988, AM J HUM GENET, V43, P29; BORECKI IB, 1990, AM J HUM GENET, V47, P542; CLIFFORD C A, 1984, Genetic Epidemiology, V1, P63, DOI 10.1002/gepi.1370010109; Comuzzie AG, 1997, NAT GENET, V15, P273, DOI 10.1038/ng0397-273; CRITTENDEN L, 1961, ANN NY ACAD SCI, V91, P769, DOI 10.1111/j.1749-6632.1961.tb31106.x; CZERWINSKI SA, IN PRESS GENET EPIDE; de Andrade M, 1997, GENET EPIDEMIOL, V14, P773, DOI 10.1002/(SICI)1098-2272(1997)14:6<773::AID-GEPI35>3.0.CO;2-L; DUCROCQ V, 1993, J ANIM BREED GENET, V110, P81, DOI 10.1111/j.1439-0388.1993.tb00719.x; Duggirala R, 1997, GENET EPIDEMIOL, V14, P987, DOI 10.1002/(SICI)1098-2272(1997)14:6<987::AID-GEPI71>3.0.CO;2-G; ELSTON RC, 1975, ANN HUM GENET, V39, P67, DOI 10.1111/j.1469-1809.1975.tb00109.x; Falconer D. S., 1989, Introduction to quantitative genetics.; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; Freedman R, 1997, P NATL ACAD SCI USA, V94, P587, DOI 10.1073/pnas.94.2.587; FULKER DW, 1995, AM J HUM GENET, V56, P1224; Ghosh S, 1996, DIABETES, V45, P1, DOI 10.2337/diabetes.45.1.1; GNANADESIKAN R, 1977, METHODS STAT DATA AN; GOLDGAR DE, 1990, AM J HUM GENET, V47, P957; GOLDIN LR, 1997, GENET EPIDEMIOL, V14, P549; HASSTEDT SJ, 1993, GENET EPIDEMIOL, V10, P145, DOI 10.1002/gepi.1370100302; HOPPER JL, 1982, ANN HUM GENET, V46, P373, DOI 10.1111/j.1469-1809.1982.tb01588.x; ITURRIA SJ, IN PRESS GENET EPIDE; JIANG CJ, 1995, GENETICS, V140, P1111; KOROL AB, 1995, GENETICS, V140, P1137; LALOUEL JM, 1985, AM J HUM GENET, V37, P700; LANDER ES, 1988, NATURE, V336, P105, DOI 10.1038/336105a0; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LANGE K, 1983, AM J MED GENET, V14, P513, DOI 10.1002/ajmg.1320140315; LANGE K, 1978, J MATH BIOL, V6, P59, DOI 10.1007/BF02478517; LANGE K, 1976, ANN HUM GENET, V39, P485, DOI 10.1111/j.1469-1809.1976.tb00156.x; Lange K., 1997, MATH STAT METHODS GE; LANGE KL, 1989, J AM STAT ASSOC, V84, P881, DOI 10.2307/2290063; LILLIOJA S, 1993, NEW ENGL J MED, V329, P1988, DOI 10.1056/NEJM199312303292703; LILLIOJA S, 1987, DIABETES, V36, P1329, DOI 10.2337/diabetes.36.11.1329; MacCluer JW, 1997, GENET EPIDEMIOL, V14, P737, DOI 10.1002/(SICI)1098-2272(1997)14:6<737::AID-GEPI29>3.0.CO;2-Q; Mangin B, 1998, BIOMETRICS, V54, P88, DOI 10.2307/2533998; MENDELL NR, 1974, BIOMETRICS, V30, P41, DOI 10.2307/2529616; MOLDIN SO, 1990, GENET EPIDEMIOL, V7, P371, DOI 10.1002/gepi.1370070507; MOLDIN SO, 1994, SCHIZOPHRENIA BULL, V20, P169, DOI 10.1093/schbul/20.1.169; MORTON N E, 1970, Clinical Genetics, V1, P81; MORTON NE, 1974, AM J HUM GENET, V26, P489; OTT J, 1995, HUM HERED, V45, P169, DOI 10.1159/000154280; Pearson K, 1903, PHILOS T R SOC LOND, V200, P1, DOI 10.1098/rsta.1903.0001; POLICH J, 1994, PSYCHOL BULL, V115, P55, DOI 10.1037/0033-2909.115.1.55; Porjesz B, 1998, ALCOHOL CLIN EXP RES, V22, P1317; RICE J, 1979, BIOMETRICS, V35, P451, DOI 10.2307/2530347; RONIN YI, 1995, THEOR APPL GENET, V90, P776, DOI 10.1007/BF00222012; SCHORK NJ, 1993, AM J HUM GENET, V53, P1306; Searle SR, 1971, LINEAR MODELS; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Tiwari HK, 1997, ANN HUM GENET, V61, P253, DOI 10.1017/S0003480097006167; Tong YL., 2012, MULTIVARIATE NORMAL; van Eerdewegh, 1982, THESIS WASHINGTON U; Weller JI, 1996, THEOR APPL GENET, V92, P998, DOI 10.1007/BF00224040; Wijsman EM, 1997, GENET EPIDEMIOL, V14, P719, DOI 10.1002/(SICI)1098-2272(1997)14:6<719::AID-GEPI28>3.0.CO;2-S; Williams JT, 1999, AM J HUM GENET, V65, P1148, DOI 10.1086/302571; Williams JT, 1997, GENET EPIDEMIOL, V14, P1065, DOI 10.1002/(SICI)1098-2272(1997)14:6<1065::AID-GEPI84>3.0.CO;2-F; Williams JT, 1999, GENET EPIDEMIOL, V16, P113, DOI 10.1002/(SICI)1098-2272(1999)16:2<113::AID-GEPI1>3.0.CO;2-6; Wright S, 1934, GENETICS, V19, P0537; Wright S, 1934, GENETICS, V19, P0506; Xu SZ, 1996, GENETICS, V143, P1417	80	168	172	0	9	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1999	65	4					1134	1147		10.1086/302570	http://dx.doi.org/10.1086/302570			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	241XW	10486333	Green Published, Bronze			2022-12-18	WOS:000082910000023
J	Weinberg, CR				Weinberg, CR			Allowing for missing parents in genetic studies of case-parent triads	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSMISSION DISEQUILIBRIUM TEST; LINKAGE DISEQUILIBRIUM; RELATIVE RISKS; ASSOCIATION; DESIGN	In earlier work, my colleagues and I described a loglinear model for genetic data from triads composed of affected probands and their parents. This model allows detection of and discrimination between effects of an inherited haplotype versus effects of the maternal,haplotype, which presumably would be mediated by prenatal factors. Like the transmission disequilibrium test (TDT), the likelihood-ratio test (LRT) based on this model is not sensitive to associations that are due to genetic admixture. When used as a method for testing for linkage disequilibrium, the LRT can-be regarded as an alternative:to the TDT. When one or both parents are missing, the resulting incomplete triad must be discarded to ensure validity of the TDT, thereby sacrificing information. By contrast, when the problem is set in a likelihood framework, the :expectation-maximization algorithm allows the incomplete triads to contribute their information to the LRT without invalidation of the analysis. Simulations demonstrate that much of the lost statistical power can be recaptured by means of this missing-data technique. In fact, power is reasonably good even when no triad is complete-for example; when a study is designed to include only mothers of cases. Information from siblings also can be incorporated to further improve the statistical power when genetic data from parents or probands are missing.	NIEHS, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Weinberg, CR (corresponding author), NIEHS, POB 12233, Res Triangle Pk, NC 27709 USA.			Weinberg, Clarice/0000-0002-7713-8556	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES040007, ZIAES040007] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Baker R, 1978, GLIM SYSTEM RELEASE; CURTIS D, 1995, AM J HUM GENET, V56, P811; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; EWENS WJ, 1995, AM J HUM GENET, V57, P455; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; SCHAID DJ, 1993, AM J HUM GENET, V53, P1114; SCHAID DJ, 1994, AM J HUM GENET, V55, P402; SELF SG, 1991, BIOMETRICS, V47, P53, DOI 10.2307/2532495; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Sun FZ, 1998, AM J EPIDEMIOL, V148, P902; Weinberg CR, 1998, AM J HUM GENET, V62, P969, DOI 10.1086/301802; Wilcox AJ, 1998, AM J EPIDEMIOL, V148, P893	13	168	171	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1999	64	4					1186	1193		10.1086/302337	http://dx.doi.org/10.1086/302337			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184UV	10090904	Green Published, Bronze			2022-12-18	WOS:000079632900030
J	Tassabehji, M; Metcalfe, K; Karmiloff-Smith, A; Carette, MJ; Grant, J; Dennis, N; Reardon, W; Splitt, M; Read, AP; Donnai, D				Tassabehji, M; Metcalfe, K; Karmiloff-Smith, A; Carette, MJ; Grant, J; Dennis, N; Reardon, W; Splitt, M; Read, AP; Donnai, D			Williams syndrome: Use of chromosomal microdeletions as a tool to dissect cognitive and physical phenotypes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUPRAVALVULAR AORTIC-STENOSIS; HEMIZYGOTIC DELETION; POINT MUTATIONS; ELASTIN LOCUS; GENE; 7Q11.23; IDENTIFICATION; INDIVIDUALS; DISORDER; LANGUAGE	In Williams syndrome (WS), a deletion of similar to 1.5 Mb on one copy of chromosome 7 causes specific physical, cognitive, and behavioral abnormalities. Molecular dissection of the phenotype may be a route to identification of genes important in human cognition and behavior. Among the genes known to be deleted in WS are ELN (which encodes elastin), LIMK1 (which encodes a protein tyrosine kinase expressed in the developing brain), STX1A (which encodes a component of the synaptic apparatus), and FZD3. Study of patients with deletions or mutations confined to ELN showed that hemizygosity for elastin is responsible for the cardiological features of LIMK1 and STX1A are good candidates for cognitive or behavioral aspects of WS. Here we describe genetic and psychometric testing of patients who have small deletions within the WS critical region. Our results suggest that neither LIMK1 hemizygosity (contrary to a previous report) nor STX1A hemizygosity is likely to contribute to any part of the WS phenotype, and they emphasize the importance of such patients for dissecting subtle but highly penetrant phenotypes.	Univ Manchester, Dept Med Genet, St Marys Hosp, Manchester M13 0JH, Lancs, England; Univ Manchester, Reg Genet Serv, St Marys Hosp, Manchester M13 0JH, Lancs, England; MRC, Cognit Dev Unit, London WC1H 0AH, England; Inst Child Hlth, London, England; St Annes Hosp, Wessex Reg Genet Serv, Southampton, Hants, England; No Reg Genet Serv, Newcastle Upon Tyne, Tyne & Wear, England	University of Manchester; University of Manchester; University of London; University College London; Newcastle University - UK	Tassabehji, M (corresponding author), Univ Manchester, Dept Med Genet, St Marys Hosp, Manchester M13 0JH, Lancs, England.	m.tassabehji@man.ac.uk	Karmiloff-Smith, Annette/N-4535-2014	Karmiloff-Smith, Annette/0000-0002-2470-5609; Reardon, Willie/0000-0001-7329-9179	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Baumer A, 1998, HUM MOL GENET, V7, P887, DOI 10.1093/hmg/7.5.887; Bellugi U., 1994, ATYPICAL COGNITIVE D, P23; Einfeld SL, 1997, AM J MENT RETARD, V102, P45, DOI 10.1352/0895-8017(1997)102<0045:BAEDII>2.0.CO;2; Elliott C., 1997, BRIT ABILITIES SCALE; Elliott C.D., 1990, DIFFERENTIAL ABILITY; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; EWART AK, 1993, P NATL ACAD SCI USA, V90, P3226, DOI 10.1073/pnas.90.8.3226; FOSTER K, 1993, ANN HUM GENET, V57, P87, DOI 10.1111/j.1469-1809.1993.tb00890.x; Frangiskakis JM, 1996, CELL, V86, P59, DOI 10.1016/S0092-8674(00)80077-X; Fryssira H, 1997, J MED GENET, V34, P306, DOI 10.1136/jmg.34.4.306; Greenberg F, 1996, AM J MED GENET, V62, P247, DOI 10.1002/(SICI)1096-8628(19960329)62:3<247::AID-AJMG9>3.3.CO;2-9; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; Jarrold C, 1998, J CHILD PSYCHOL PSYC, V39, P511; KARMILOFFSMITH A, 1995, J COGNITIVE NEUROSCI, V7, P196, DOI 10.1162/jocn.1995.7.2.196; KarmiloffSmith A, 1997, DEV NEUROPSYCHOL, V13, P513, DOI 10.1080/87565649709540693; KarmiloffSmith A, 1997, CHILD DEV, V68, P246, DOI 10.1111/j.1467-8624.1997.tb01938.x; Li DY, 1997, HUM MOL GENET, V6, P1021, DOI 10.1093/hmg/6.7.1021; LOWERY MC, 1995, AM J HUM GENET, V57, P49; Mari A, 1998, CLIN GENET, V53, P226; MERVIS CB, IN PRESS NEURODEVELO; MORRIS CA, 1988, J PEDIATR-US, V113, P318, DOI 10.1016/S0022-3476(88)80272-5; NICKERSON E, 1995, AM J HUM GENET, V56, P1156; Okano I, 1995, J BIOL CHEM, V270, P31321, DOI 10.1074/jbc.270.52.31321; Osborne LR, 1996, GENOMICS, V36, P328, DOI 10.1006/geno.1996.0469; Osborne LR, 1997, AM J HUM GENET, V61, P449, DOI 10.1086/514850; Peoples R, 1996, AM J HUM GENET, V58, P1370; Read AP, 1997, J MED GENET, V34, P656, DOI 10.1136/jmg.34.8.656; Ryan AK, 1997, J MED GENET, V34, P798, DOI 10.1136/jmg.34.10.798; Sarimski K, 1996, CHILD CARE HLTH DEV, V22, P143, DOI 10.1046/j.1365-2214.1996.779779.x; Tassabehji M, 1996, NAT GENET, V13, P272, DOI 10.1038/ng0796-272; Tassabehji M, 1997, HUM MOL GENET, V6, P1029, DOI 10.1093/hmg/6.7.1029; UDWIN O, 1991, J CLIN EXP NEUROPSYC, V13, P232, DOI 10.1080/01688639108401040; UDWIN O, 1987, J CHILD PSYCHOL PSYC, V28, P297, DOI 10.1111/j.1469-7610.1987.tb00212.x; Wang YK, 1997, HUM MOL GENET, V6, P465, DOI 10.1093/hmg/6.3.465; Wechsler D., 1997, WAIS 3 WECHSLER ADUL; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735	37	168	171	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1999	64	1					118	125		10.1086/302214	http://dx.doi.org/10.1086/302214			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	164RM	9915950	Green Published, Bronze			2022-12-18	WOS:000078477400016
J	Phillips, HA; Scheffer, IE; Crossland, KM; Bhatia, KP; Fish, DR; Marsden, CD; Howell, SJL; Stephenson, JBP; Tolmie, J; Plazzi, G; Eeg-Olofsson, O; Singh, R; Lopes-Cendes, I; Andermann, E; Andermann, F; Berkovic, SF; Mulley, JC				Phillips, HA; Scheffer, IE; Crossland, KM; Bhatia, KP; Fish, DR; Marsden, CD; Howell, SJL; Stephenson, JBP; Tolmie, J; Plazzi, G; Eeg-Olofsson, O; Singh, R; Lopes-Cendes, I; Andermann, E; Andermann, F; Berkovic, SF; Mulley, JC			Autosomal dominant nocturnal frontal-lobe epilepsy: Genetic heterogeneity and evidence for a second locus at 15q24	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; FAMILIAL INFANTILE CONVULSIONS; ALPHA-4 SUBUNIT; NEONATAL CONVULSIONS; HUMAN GENOME; CHRNA4; MUTATION; MOUSE; IDENTIFICATION; LOCALIZATION	Autosomal dominant nocturnal frontal-lobe epilepsy (ADNFLE) is a recently identified partial epilepsy in which two different mutations have been described in the alpha 4 subunit of the neuronal nicotinic acetylcholine receptor (CHRNA4). An additional seven families are presented in which ADNFLE is unlinked to the CHRNA4 region on chromosome 20q13.2. Seven additional sporadic cases showed no evidence of defective CHRNA4. One of the families showed evidence of linkage to 15q24, close to the CHRNA3/CHRNA5/CHRNB4 cluster (maximum LOD score of 3.01 with D15S152). Recombination between ADNFLE and CHRNA4, linkage to 15q24 in one family, and exclusion from 15q24 and 20q13.2 in others demonstrate genetic heterogeneity with at least three different genes for ADNFLE. The CHRNA4 gene and the two known CHRNA4 mutations are responsible for only a minority of ADNFLE. Although the ADNFLE phenotype is clinically homogeneous, there appear to be a variety of molecular defects responsible for this disorder, which will provide a challenge to the understanding of the basic mechanism of epileptogenesis.	Womens & Childrens Hosp, Dept Cytogenet & Mol Genet, Ctr Med Genet, Adelaide, SA 5006, Australia; Univ Melbourne, Austin & Repatriat Med Ctr, Dept Med Neurol, Heidelberg, Vic, Australia; Neurol Inst, London, England; Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England; Royal Hosp Sick Children, Glasgow G3 8SJ, Lanark, Scotland; Univ Bologna, Inst Clin Neurol, Bologna, Italy; Univ Uppsala, Childrens Hosp, Child Neurol Unit, Uppsala, Sweden; Montreal Neurol Hosp & Inst, Montreal, PQ H3A 2B4, Canada; Univ Adelaide, Dept Genet, Adelaide, SA, Australia	Womens & Childrens Hospital Australia; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of London; University College London; University of Sheffield; University of Glasgow; University of Bologna; Uppsala University; McGill University; University of Adelaide	Mulley, JC (corresponding author), Womens & Childrens Hosp, Dept Cytogenet & Mol Genet, Ctr Med Genet, 72 King William Rd, Adelaide, SA 5006, Australia.		Scheffer, Ingrid E/G-1668-2013; jiang, yu/HGU-0029-2022; Lopes-Cendes, Iscia/B-9416-2013; Plazzi, Giuseppe/AAB-9627-2020	Scheffer, Ingrid E/0000-0002-2311-2174; Lopes-Cendes, Iscia/0000-0002-6221-6822; Berkovic, Samuel/0000-0003-4580-841X; Plazzi, Giuseppe/0000-0002-1051-0472				Berkovic Samuel F., 1995, Epilepsia, V36, P147; Berkovic SF, 1997, BRAIN DEV-JPN, V19, P13, DOI 10.1016/S0387-7604(96)00060-5; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; BOULTER J, 1990, J BIOL CHEM, V265, P4472; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Elmslie FV, 1997, HUM MOL GENET, V6, P1329, DOI 10.1093/hmg/6.8.1329; ENG CM, 1991, GENOMICS, V9, P278, DOI 10.1016/0888-7543(91)90253-B; Engel AG, 1996, HUM MOL GENET, V5, P1217, DOI 10.1093/hmg/5.9.1217; Guipponi M, 1997, HUM MOL GENET, V6, P473, DOI 10.1093/hmg/6.3.473; HAYASHI K, 1993, HUM MUTAT, V2, P338, DOI 10.1002/humu.1380020503; Hayman M, 1997, NEUROLOGY, V49, P969, DOI 10.1212/WNL.49.4.969; Johnson EW, 1998, HUM MOL GENET, V7, P63, DOI 10.1093/hmg/7.1.63; Kuryatov A, 1997, J NEUROSCI, V17, P9035; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LEPPERT M, 1989, NATURE, V337, P647, DOI 10.1038/337647a0; LEWIS TB, 1993, AM J HUM GENET, V53, P670; LopesCendes I, 1995, EPILEPSY RES, V22, P227, DOI 10.1016/0920-1211(95)00049-6; Ohno K, 1997, HUM MOL GENET, V6, P753, DOI 10.1093/hmg/6.5.753; Oldani A, 1998, BRAIN, V121, P205, DOI 10.1093/brain/121.2.205; OTTMAN R, 1995, NAT GENET, V10, P56, DOI 10.1038/ng0595-56; PEARSON P, 1994, NUCLEIC ACIDS RES, V22, P3470, DOI 10.1093/nar/22.17.3470; Phillips HA, 1997, CLIN GENET, V51, P135; PHILLIPS HA, 1995, NAT GENET, V10, P117, DOI 10.1038/ng0595-117; RISE ML, 1991, SCIENCE, V253, P669, DOI 10.1126/science.1871601; SARGENT PB, 1993, ANNU REV NEUROSCI, V16, P403, DOI 10.1146/annurev.ne.16.030193.002155; SCHEFFER IE, 1995, BRAIN, V118, P61, DOI 10.1093/brain/118.1.61; SCHEFFER IE, 1994, LANCET, V343, P515, DOI 10.1016/S0140-6736(94)91463-X; SCHOEPFER R, 1988, NEURON, V1, P241, DOI 10.1016/0896-6273(88)90145-6; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; STEINLEIN O, 1995, HUM GENET, V96, P130, DOI 10.1007/BF00214201; Steinlein O, 1996, GENOMICS, V32, P289, DOI 10.1006/geno.1996.0119; STEINLEIN OK, 1995, NAT GENET, V11, P201, DOI 10.1038/ng1095-201; Steinlein OK, 1997, HUM MOL GENET, V6, P943, DOI 10.1093/hmg/6.6.943; Stewart EA, 1997, GENOME RES, V7, P422, DOI 10.1101/gr.7.5.422; Szepetowski P, 1997, AM J HUM GENET, V61, P889, DOI 10.1086/514877; Wallace RH, 1996, J MED GENET, V33, P308, DOI 10.1136/jmg.33.4.308; Weiland S, 1996, CLIN GENET, V50, P433; Weiland S, 1996, FEBS LETT, V398, P91, DOI 10.1016/S0014-5793(96)01215-X; WHITING PJ, 1991, MOL BRAIN RES, V10, P61, DOI 10.1016/0169-328X(91)90057-5	40	168	176	0	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1998	63	4					1108	1116		10.1086/302047	http://dx.doi.org/10.1086/302047			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	131LP	9758605	Green Published, Bronze			2022-12-18	WOS:000076577800025
J	Schaid, DJ; McDonnell, SK; Blute, ML; Thibodeau, SN				Schaid, DJ; McDonnell, SK; Blute, ML; Thibodeau, SN			Evidence for autosomal dominant inheritance of prostate cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILY HISTORY; SEGREGATION ANALYSIS; LINKAGE ANALYSIS; RISK; RELATIVES; ACCURACY; BREAST; MODEL	A family-history cancer survey was conducted on 5,486 men who underwent a radical prostatectomy, for clinically localized prostate cancer, in the Department of Urology at the Mayo Clinic during 1966-95; 4,288 men responded to the survey. Complex segregation analysis was performed to assess the genetic basis of age at diagnosis and the familial clustering of prostate cancer. For the total group, no single-gene model of inheritance clearly explained familial clustering of disease, which could be partly explained by lack of Hardy-Weinberg equilibrium, with an excess of homozygotes. After accounting for deviations from Hardy-Weinberg equilibrium, the best-fitting model that explained the familial aggregation and age at diagnosis was a rare autosomal dominant susceptibility gene, and this model fitted best when probands were diagnosed at <60 years of age. The model predicts that the frequency of the susceptibility gene in the population is .006 and that the risk of prostate cancer by age 85 years is 89% among carriers of the gene and 3% among noncarriers. A strength of our study is its large size, such that genetic models could be fitted within strata defined by the age of the proband. Although the autosomal dominant model was consistently the best model, the parameter estimates differed somewhat (P = .03) across the different age groups, suggesting genetic heterogeneity. Additional evidence that the hereditary basis of prostate cancer is likely to be genetically complex was provided by the following: (1) there was a significantly elevated age-adjusted risk of prostate cancer among brothers of probands, compared with their fathers (relative risk 1.5 [95% confidence interval 1.4-1.7]); (2) the autosomal dominant model predicted an excess of homozygotes, over that predicted by Hardy-Weinberg equilibrium; and (3) the model-predicted risk of prostate cancer among relatives was inadequate when probands were diagnosed at age greater than or equal to 70 years.	Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Med Genet, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Urol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Lab Med, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Schaid, DJ (corresponding author), Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Harwick 7,200 1st St SW, Rochester, MN 55905 USA.			McDonnell, Shannon/0000-0001-6201-369X	NCI NIH HHS [R01 CA 72818] Funding Source: Medline; NCRR NIH HHS [1 P41 RR03655] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA072818] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Ahlbom A, 1997, J NATL CANCER I, V89, P287, DOI 10.1093/jnci/89.4.287; BONDY ML, 1994, J CLIN EPIDEMIOL, V47, P89, DOI 10.1016/0895-4356(94)90037-X; BONNEY GE, 1986, BIOMETRICS, V42, P611, DOI 10.2307/2531211; Cannon L., 1982, CANCER SURV, V1, P47; CARTER BS, 1990, PROSTATE, V16, P187, DOI 10.1002/pros.2990160302; CARTER BS, 1992, P NATL ACAD SCI USA, V89, P3367, DOI 10.1073/pnas.89.8.3367; CARTER BS, 1993, J UROLOGY, V150, P797, DOI 10.1016/S0022-5347(17)35617-3; Cooney KA, 1997, J NATL CANCER I, V89, P955, DOI 10.1093/jnci/89.13.955; EASTON DF, 1993, AM J HUM GENET, V52, P678; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; Feuer EJ, 1997, J NATL CANCER I, V89, P279, DOI 10.1093/jnci/89.4.279; GO RCP, 1983, J NATL CANCER I, V71, P455; GOLDGAR DE, 1994, J NATL CANCER I, V86, P1600, DOI 10.1093/jnci/86.21.1600; Gronberg H, 1997, AM J EPIDEMIOL, V146, P552, DOI 10.1093/oxfordjournals.aje.a009313; Gronberg H, 1997, JAMA-J AM MED ASSOC, V278, P1251, DOI 10.1001/jama.278.15.1251; JACOBSEN SJ, 1995, JAMA-J AM MED ASSOC, V274, P1445, DOI 10.1001/jama.274.18.1445; KOSARY CL, 1995, NIH PUBL; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; LOVE RR, 1985, J CHRON DIS, V38, P289, DOI 10.1016/0021-9681(85)90074-8; McIndoe RA, 1997, AM J HUM GENET, V61, P347, DOI 10.1086/514853; MEIKLE AW, 1982, J CLIN ENDOCR METAB, V54, P1104, DOI 10.1210/jcem-54-6-1104; MONROE KR, 1995, NAT MED, V1, P827, DOI 10.1038/nm0895-827; MUIR CS, 1987, IARC SCI PUBL, V88; Parker SL, 1997, CA-CANCER J CLIN, V47, P5, DOI 10.3322/canjclin.47.1.5; *SAGE, 1994, STAT AN GEN EP REL 2; Smigel K, 1997, J NATL CANCER I, V89, P195, DOI 10.1093/jnci/89.3.195; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; SPITZ MR, 1991, J UROLOGY, V146, P1305, DOI 10.1016/S0022-5347(17)38074-6; STEINBERG GD, 1990, PROSTATE, V17, P337, DOI 10.1002/pros.2990170409; WHITTEMORE AS, 1995, AM J EPIDEMIOL, V141, P732, DOI 10.1093/oxfordjournals.aje.a117495; WOOLF CM, 1960, CANCER, V13, P739, DOI 10.1002/1097-0142(196007/08)13:4<739::AID-CNCR2820130414>3.0.CO;2-E	32	168	172	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1998	62	6					1425	1438		10.1086/301862	http://dx.doi.org/10.1086/301862			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZU224	9585590	Green Published, Bronze			2022-12-18	WOS:000074174700019
J	SYKES, B; LEIBOFF, A; LOWBEER, J; TETZNER, S; RICHARDS, M				SYKES, B; LEIBOFF, A; LOWBEER, J; TETZNER, S; RICHARDS, M			THE ORIGINS OF THE POLYNESIANS - AN INTERPRETATION FROM MITOCHONDRIAL LINEAGE ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PACIFIC ISLANDERS; DNA; POPULATION; SEQUENCES; AFFINITIES; REGION	Using mitochondrial lineage analysis of 1,178 individuals from Polynesia, the western Pacific, and Taiwan, we show that the major prehistoric settlement of Polynesia was from the west and involved two or possibly three genetically distinct populations. The predominant lineage group, accounting for 94% of Polynesian mtDNA, shares a 9-bp COIL/tRNA(Lys) intergenic deletion and characteristic control region transition variants, compared to the Cambridge reference sequence. In Polynesia, the diversity of this group is extremely restricted, while related lineages in Indonesia, the Philippines, and Taiwan are increasingly diverse. This suggests a relatively recent major eastward expansion into Polynesia, perhaps originating from Taiwan, in agreement with archaeological and linguistic evidence, but which experienced one or more severe population bottlenecks. The second mitochondrial lineage group, accounting for 3.5% of Polynesian mtDNA haplotypes, does not have the 9-bp deletion and is characterized by an A-C transversional variant at nt position 16265. Specific oligonucleotides for this variant were used to select individuals from the population sample who, with other sequences, show that the Polynesian lineages were part of a diverse group in Vanuatu and Papua New Guinea. The very low overall diversity of both lineage groups in Polynesia suggests there was severe population restriction during the colonization of remote Oceania. A third group, represented by only four individuals (0.6%) in Polynesia but also present in the Philippines, shares variants at nt positions 16172 and 16304. Two Polynesians had unrelated haplotypes matching published sequences from native South Americans, which may be the first genetic evidence of prehistoric human contact between Polynesia and South America.			SYKES, B (corresponding author), UNIV OXFORD, INST MOLEC MED, OXFORD OX3 9DU, ENGLAND.			RICHARDS, MARTIN/0000-0003-3118-0967				ALLEN J, 1989, J POLYNESIAN SOC, V98, P129; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; [Anonymous], 1993, MEGA MOL EVOLUTIONAR; AVISE JC, 1991, ANNU REV GENET, V25, P45, DOI 10.1146/annurev.ge.25.120191.000401; BANDELT HJ, 1995, GENETICS, V141, P743; Bellwood P, 1987, POLYNESIANS, V2nd; BENDALL KE, 1995, AM J HUM GENET, V57, P248; BERTRANPETIT J, 1995, ANN HUM GENET, V59, P63, DOI 10.1111/j.1469-1809.1995.tb01606.x; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; GINTHER C, 1993, EXS, V67, P211; HAGELBERG E, 1993, P ROY SOC B-BIOL SCI, V252, P163, DOI 10.1098/rspb.1993.0061; HERTZBERG M, 1989, AM J HUM GENET, V44, P504; HEWETT DR, 1994, J MED GENET, V31, P338, DOI 10.1136/jmg.31.4.338; HEYERDAHL T, 1950, KONTIKI PACIFIC RAFT; HILL AVS, 1987, AM J HUM GENET, V40, P453; HORAI S, 1990, AM J HUM GENET, V46, P828; IRWIN G, 1989, J POLYNESIAN SOC, V98, P167; Irwin G., 1992, PREHISTORIC EXPLORAT; KIRCH PV, 1988, RADIOCARBON, V30, P161, DOI 10.1017/S0033822200044106; KIRK RL, 1989, COLONIZATION PACIFIC; Langdon Robert, 1975, LOST CARAVEL; LUM JK, 1994, HUM BIOL, V66, P567; MICKLEM K, 1994, MACPAIRWISE 4 3 COMM; MORIN PA, 1994, SCIENCE, V265, P1193, DOI 10.1126/science.7915048; Nei M., 1987, MOL EVOLUTIONARY GEN; PIERCY R, 1993, INT J LEGAL MED, V106, P85, DOI 10.1007/BF01225046; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; STONEKING M, 1990, GENETICS, V124, P717; STONEKING M, 1991, AM J HUM GENET, V48, P370; SWOFFORD DL, 1993, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; Terrell J., 1986, PREHISTORY PACIFIC I; TORRONI A, 1993, AM J HUM GENET, V53, P563; TRENT RJ, 1988, AM J HUM GENET, V42, P601; VIGILANT L, 1989, P NATL ACAD SCI USA, V86, P9350, DOI 10.1073/pnas.86.23.9350; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; WRISCHNIK LA, 1987, NUCLEIC ACIDS RES, V15, P529, DOI 10.1093/nar/15.2.529	37	168	170	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1995	57	6					1463	1475						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TE655	8533777				2022-12-18	WOS:A1995TE65500025
J	BASSETT, AS; HONER, WG				BASSETT, AS; HONER, WG			EVIDENCE FOR ANTICIPATION IN SCHIZOPHRENIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MYOTONIC-DYSTROPHY; TRIPLET REPEAT; DISORDERS; RELATIVES; ILLNESS; FAMILY	Anticipation, or increasing severity of a disorder across successive generations, is a genetic phenomenon with an identified molecular mechanism: expansion of unstable trinucleotide repeat sequences. This study examined anticipation in familial schizophrenia. Three generations of siblines from the affected side of families selected for unilineal, autosomal dominant-like inheritance of schizophrenia were studied (n = 186). Across generations more subjects were hospitalized with psychotic illness (P<.0001), at progressively earlier ages (P<.0001), and with increasing severity of illness (P<.0003). The results indicate that anticipation is present in familial schizophrenia. These findings support both an active search for unstable trinucleotide repeat sequences in schizophrenia and reconsideration of the genetic model used for linkage studies in this disorder.	UNIV TORONTO, DEPT PSYCHIAT, TORONTO, ON, CANADA; UNIV BRITISH COLUMBIA, DEPT PSYCHIAT, VANCOUVER, BC, CANADA	University of Toronto; University of British Columbia	BASSETT, AS (corresponding author), QUEEN ST MENTAL HLTH CTR, SCHIZOPHRENIA RES PROGRAM, GENET SECT, 1001 QUEEN ST W, TORONTO M6J 1H4, ON, CANADA.							ANDREASEN NC, 1977, ARCH GEN PSYCHIAT, V34, P1229; BASSETT AS, 1993, SCHIZOPHR RES, V11, P9, DOI 10.1016/0920-9964(93)90033-F; BASSETT AS, 1991, SOC BIOL, V38, P189; Bleuler M., 1978, SCHIZOPHRENIC DISORD; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; CASKEY CT, 1992, SCIENCE, V256, P784, DOI 10.1126/science.1589758; DECINA P, 1991, PSYCHIAT RES, V39, P81, DOI 10.1016/0165-1781(91)90010-M; FLINT J, 1992, PSYCHOL MED, V22, P5, DOI 10.1017/S0033291700032669; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; GERSHON ES, 1987, ARCH GEN PSYCHIAT, V44, P314; HARPER PS, 1992, AM J HUM GENET, V51, P10; KARLSSON JL, 1966, BIOL BASIS SCHIZOPHR; KAY DWK, 1963, ACTA PSYCHIAT SCAND, V39, P159, DOI 10.1111/j.1600-0447.1963.tb07464.x; KENDLER KS, 1985, ARCH GEN PSYCHIAT, V42, P770; LAVEDAN C, 1993, AM J HUM GENET, V52, P875; LOWING PA, 1983, AM J PSYCHIAT, V140, P1167; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MCINNIS MG, 1993, AM J HUM GENET, V53, P385; Mott FW, 1911, LANCET, V1, P1251; Mott FW, 1910, BRIT MED J, V1910, P1013, DOI 10.1136/bmj.2.2597.1013; ODEGAARD O, 1972, GENETIC FACTORS SCHI, P256; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PENROSE LS, 1948, ANN EUGENIC, V14, P125; PENROSE LS, 1971, MODERN PERSPECTIVES, P3; RISCH N, 1990, AM J HUM GENET, V46, P222; SCHALLING M, 1993, NAT GENET, V4, P135, DOI 10.1038/ng0693-135; SHARMA T, 1993, SCHIZOPHR RES, V9, P124; Shields J, 1982, SCHIZOPHRENIA EPIGEN; Slater E, 1971, GENETICS MENTAL DISO; SUTHERLAND GR, 1992, AM J HUM GENET, V51, P7; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WETTERBERG L, 1991, EUR ARCH PSY CLIN N, V240, P188, DOI 10.1007/BF02190762	32	168	168	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1994	54	5					864	870						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NH394	8178826				2022-12-18	WOS:A1994NH39400016
J	NAVIDI, W; ARNHEIM, N; WATERMAN, MS				NAVIDI, W; ARNHEIM, N; WATERMAN, MS			A MULTIPLE-TUBES APPROACH FOR ACCURATE GENOTYPING OF VERY SMALL DNA SAMPLES BY USING PCR - STATISTICAL CONSIDERATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMERASE CHAIN-REACTION; ENZYMATIC AMPLIFICATION; SINGLE-SPERM; BETA-GLOBIN; SEQUENCES; DIAGNOSIS; HAPLOTYPE	A multiple-tubes procedure is described for using PCR to determine the genotype of a very small DNA sample. The procedure involves dividing the sample among several tubes, then amplifying and typing the contents of each tube separately. The results are analyzed by a statistical procedure which determines whether a genotype can be conclusively assigned to the DNA sample. Simulation studies show that this procedure usually gives correct results even when the number of double-stranded fragments in the sample is as small as 30. The procedure remains effective even in the presence of small amounts of laboratory contamination. We find that the multiple-tubes procedure is superior to the standard one-tube procedure, either when the sample is small or when laboratory contamination is a potential problem; and we recommend its use in these situations. Because the procedure is statistical, it allows the degree of certainty in the result to be quantified and may be useful in other PCR applications as well.	UNIV SO CALIF,DEPT MOLEC BIOL,LOS ANGELES,CA 90089	University of Southern California	NAVIDI, W (corresponding author), UNIV SO CALIF,DEPT MATH,LOS ANGELES,CA 90089, USA.			Arnheim, Norman/0000-0003-1247-1347	NHGRI NIH HHS [HG00328] Funding Source: Medline; NIGMS NIH HHS [GM36745, GM3620] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036745, R37GM036745] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARNHEIM N, 1990, BIOSCIENCE, V40, P174, DOI 10.2307/1311362; ARNHEIM N, 1990, GENOMICS, V8, P415, DOI 10.1016/0888-7543(90)90026-Q; BOEHNKE M, 1989, AM J HUM GENET, V45, P21; CUI XF, 1989, P NATL ACAD SCI USA, V86, P9389, DOI 10.1073/pnas.86.23.9389; ERLICH HA, 1991, SCIENCE, V252, P1643, DOI 10.1126/science.2047872; Erlich HA., 1989, PCR TECHNOLOGY PRINC, DOI 10.1007/978-1-349-20235-5; GORADIA TM, 1991, GENOMICS, V10, P748, DOI 10.1016/0888-7543(91)90459-R; HIGUCHI R, 1989, BANBURY REPORT, V32; KOGAN SC, 1987, NEW ENGL J MED, V317, P985, DOI 10.1056/NEJM198710153171603; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; LANDEGREN U, 1988, SCIENCE, V241, P1077, DOI 10.1126/science.3413476; LI H, 1991, Methods (Orlando), V2, P49, DOI 10.1016/S1046-2023(05)80125-2; LI HH, 1988, NATURE, V335, P414, DOI 10.1038/335414a0; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NAVIDI W, 1991, HUM REPROD, V6, P836, DOI 10.1093/oxfordjournals.humrep.a137438; RUANO G, 1990, P NATL ACAD SCI USA, V87, P6296, DOI 10.1073/pnas.87.16.6296; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; STEPHENS JC, 1990, AM J HUM GENET, V46, P1149; UGOZZOLI L, 1991, Methods (Orlando), V2, P42, DOI 10.1016/S1046-2023(05)80124-0; VONBEROLDINGEN CH, 1989, PCR TECHNOLOGY PRINC, P209; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI [10.1016/0307-4412(91), DOI 10.1016/0307-4412(91)]; WHITE TJ, 1989, TRENDS GENET, V5, P185, DOI 10.1016/0168-9525(89)90073-5	24	168	180	0	16	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1992	50	2					347	359						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HD001	1734715				2022-12-18	WOS:A1992HD00100010
J	BLUMBERG, BS; MELARTIN, L; GUINTO, RA; WERNER, B				BLUMBERG, BS; MELARTIN, L; GUINTO, RA; WERNER, B			FAMILY STUDIES OF A HUMAN SERUM ISOANTIGEN SYSTEM (AUSTRALIA ANTIGEN)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALTER HJ, 1966, BLOOD-J HEMATOL, V27, P297, DOI 10.1182/blood.V27.3.297.297; Blumberg B S, 1966, Int J Lepr Other Mycobact Dis, V34, P60; BLUMBERG BARUCH S., 1964, BULL N Y ACAD MED, V40, P377; BLUMBERG BS, 1962, NATURE, V194, P656, DOI 10.1038/194656a0; BLUMBERG BS, 1963, J CLIN INVEST, V42, P867, DOI 10.1172/JCI104779; BLUMBERG BS, 1965, J AMER MED ASSOC, V191, P541, DOI 10.1001/jama.1965.03080070025007; BLUMBERG BS, 1964, VOX SANG, V9, P128, DOI 10.1111/j.1423-0410.1964.tb03672.x; BLUMBERG BS, 1965, J CLIN INVEST, V44, P1029; BLUMBERG BS, 1966, J CLIN INVEST, V45, P988; BLUMBERG BS, IN PREPARATION; CONARD RA, 1965, MEDICAL SURVEY PEOPL; Kensinger Kenneth M., 1965, EXPEDITION, V7, P5; LILIENFELD AM, 1959, AM J PUBLIC HEALTH N, V49, P199, DOI 10.2105/AJPH.49.2.199; MELARTIN L, 1966, NATURE, V210, P1340, DOI 10.1038/2101340a0; SMITH CAB, 1956, ANN HUM GENET, V20, P257; SMITH SM, 1965, MATHEMATICAL TABLES	16	168	168	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1966	18	6					594	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	86655	4959134				2022-12-18	WOS:A19668665500009
J	Stark, Z; Dolman, L; Manolio, TA; Ozenberger, B; Hill, SL; Caulfied, MJ; Levy, Y; Glazer, D; Wilson, J; Lawler, M; Boughtwood, T; Braithwaite, J; Goodhand, P; Birney, E; North, KN				Stark, Zornitza; Dolman, Lena; Manolio, Teri A.; Ozenberger, Brad; Hill, Sue L.; Caulfied, Mark J.; Levy, Yves; Glazer, David; Wilson, Julia; Lawler, Mark; Boughtwood, Tiffany; Braithwaite, Jeffrey; Goodhand, Peter; Birney, Ewan; North, Kathryn N.			Integrating Genomics into Healthcare: A Global Responsibility	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COST-EFFECTIVENESS; CLINICAL UTILITY; MEDICINE; CLINVAR; LABORATORIES; FRAMEWORK; SERVICES	Genomic sequencing is rapidly transitioning into clinical practice, and implementation into healthcare systems has been supported by substantial government investment, totaling over US$4 billion, in at least 14 countries. These national genomic-medicine initiatives are driving transformative change under real-life conditions while simultaneously addressing barriers to implementation and gathering evidence for wider adoption. We review the diversity of approaches and current progress made by national genomic-medicine initiatives in the UK, France, Australia, and US and provide a roadmap for sharing strategies, standards, and data internationally to accelerate implementation.	[Stark, Zornitza; Boughtwood, Tiffany; Braithwaite, Jeffrey; North, Kathryn N.] Australian Genom Hlth Alliance, Melbourne, Vic 3052, Australia; [Stark, Zornitza; Boughtwood, Tiffany; North, Kathryn N.] Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia; [Stark, Zornitza; North, Kathryn N.] Univ Melbourne, Dept Paediat, Melbourne, Vic 3052, Australia; [Dolman, Lena; Goodhand, Peter; Birney, Ewan; North, Kathryn N.] Global Alliance Genom & Hlth, 661 Univ Ave,Suite 510, Toronto, ON M5G 0A3, Canada; [Dolman, Lena; Goodhand, Peter] Ontario Inst Canc Res, 661 Univ Ave,Suite 510, Toronto, ON M5G 0A3, Canada; [Manolio, Teri A.] NHGRI, NIH, Bethesda, MD 20892 USA; [Ozenberger, Brad] NIH, Us Res Program, Bldg 10, Bethesda, MD 20892 USA; [Hill, Sue L.] Natl Hlth Serv England, Skipton House,80 London Rd, London SE1 6LH, England; [Caulfied, Mark J.] Queen Mary Univ London, Genom England, Dawson Hall, London EC1M 6BQ, England; [Levy, Yves] INSERM French Natl Inst Hlth & Med Res, F-75654 Paris 13, France; [Glazer, David] Verily Life Sci, 269 East Grand Ave, San Francisco, CA 94080 USA; [Wilson, Julia] Wellcome Sanger Inst, Wellcome Genome Campus, Cambridge CB10 1SA, England; [Lawler, Mark] Queens Univ Belfast, Ctr Canc Res & Cell Biol, 97 Lisburn Rd, Belfast BT9 7AE, Antrim, North Ireland; [Braithwaite, Jeffrey] Macquarie Univ, Australian Inst Hlth Innovat, 75 Talavera Rd, Sydney, NSW 2113, Australia; [Birney, Ewan] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England	Murdoch Children's Research Institute; University of Melbourne; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; University of London; Queen Mary University London; Institut National de la Sante et de la Recherche Medicale (Inserm); Wellcome Trust Sanger Institute; Queens University Belfast; Macquarie University; European Molecular Biology Laboratory (EMBL)	North, KN (corresponding author), Australian Genom Hlth Alliance, Melbourne, Vic 3052, Australia.; North, KN (corresponding author), Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia.; North, KN (corresponding author), Univ Melbourne, Dept Paediat, Melbourne, Vic 3052, Australia.; North, KN (corresponding author), Global Alliance Genom & Hlth, 661 Univ Ave,Suite 510, Toronto, ON M5G 0A3, Canada.	kathryn.north@mcri.edu.au	Braithwaite, Jeffrey/AAN-1467-2020; North, Kathryn N/K-6476-2012	Braithwaite, Jeffrey/0000-0003-0296-4957; North, Kathryn N/0000-0003-0841-8009; Boughtwood, Tiffany/0000-0002-9634-3731; Dolman, Lena/0000-0002-3938-588X; Birney, Ewan/0000-0001-8314-8497; Glazer, David/0000-0002-6407-8646	Australian National Health and Medical Research Council [GNT1113531]; National Institute for Health Research; NHS England; Wellcome Trust; Cancer Research UK; Medical Research Council; Health Data Research UK	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Institute for Health Research(National Institute for Health Research (NIHR)); NHS England; Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Health Data Research UK	The Australian Genomics Health Alliance is supported by the Australian National Health and Medical Research Council (GNT1113531). The 100,000 Genomes Project is managed by Genomics England (a wholly owned company of the Department of Health). It is funded by the National Institute for Health Research and NHS England. The Wellcome Trust, Cancer Research UK, and Medical Research Council have also funded research infrastructure. The 100,000 Genomes Project uses data provided by patients and collected by the National Health Service as part of their care and support. M.L. is funded by Health Data Research UK.	Al-Adawi S., 2018, HLTH SYSTEMS IMPROVE; Amendola LM, 2016, AM J HUM GENET, V98, P1067, DOI 10.1016/j.ajhg.2016.03.024; Australian Government Department of Health,, 2017, NAT HLTH GEN POL FRA; Berg JS, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2252; Berg JS, 2013, GENET MED, V15, P860, DOI 10.1038/gim.2013.133; Birney E., 2017, GENOMICS HEALTHCARE, DOI [10.1101/203554, DOI 10.1101/203554]; Carey DJ, 2016, GENET MED, V18, P906, DOI 10.1038/gim.2015.187; Ceyhan-Birsoy O, 2017, GENET MED, V19, P809, DOI 10.1038/gim.2016.193; Christensen KD, 2018, VALUE HEALTH, V21, P1054, DOI 10.1016/j.jval.2018.06.013; Christensen KD, 2018, GENET MED, V20, P1544, DOI 10.1038/gim.2018.35; Davies S.C., 2016, ANN REPORT CHIEF MED; Dolman L, 2018, HUM MUTAT, V39, P1686, DOI 10.1002/humu.23625; Dotson WD, 2016, GENET MED, V18, P672, DOI 10.1038/gim.2015.153; Friedman JM, 2019, GENET MED, V21, P498, DOI 10.1038/s41436-018-0055-z; GAFF CL, 2017, NPJ GENOM MED, V2, DOI DOI 10.1038/S41525-017-0017-4; Genetti CA, 2019, GENET MED, V21, P622, DOI 10.1038/s41436-018-0105-6; Ginsburg G, 2014, NATURE, V508, P451, DOI 10.1038/508451a; Global Alliance Genomics Hlth, 2016, SCIENCE, V352, P1278, DOI 10.1126/science.aaf6162; Green ED, 2011, NATURE, V470, P204, DOI 10.1038/nature09764; Green RC, 2016, AM J HUM GENET, V98, P1051, DOI 10.1016/j.ajhg.2016.04.011; Harrison SM, 2018, HUM MUTAT, V39, P1641, DOI 10.1002/humu.23643; Hart MR, 2019, GENET MED, V21, P1100, DOI 10.1038/s41436-018-0308-x; Holm IA, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1200-1; Horton S, 2018, LANCET, V391, P1953, DOI 10.1016/S0140-6736(18)30460-4; Joyner MJ, 2016, JAMA-J AM MED ASSOC, V316, P1355, DOI 10.1001/jama.2016.11076; Landrum MJ, 2018, HUM MUTAT, V39, P1623, DOI 10.1002/humu.23641; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Landry LG, 2018, HEALTH AFFAIR, V37, P780, DOI 10.1377/hlthaff.2017.1595; Lawler M, 2018, LANCET ONCOL, V19, P1014, DOI 10.1016/S1470-2045(18)30425-X; Lawler M, 2017, NEW ENGL J MED, V376, P2006, DOI 10.1056/NEJMp1612254; Levenson D, 2016, AM J MED GENET A, V170, P293, DOI 10.1002/ajmg.a.37305; Maddirevula S, 2019, GENET MED, V21, P736, DOI 10.1038/s41436-018-0138-x; Manolio TA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab0194; Manolio TA, 2013, GENET MED, V15, P258, DOI 10.1038/gim.2012.157; Morris ZS, 2011, J ROY SOC MED, V104, P510, DOI 10.1258/jrsm.2011.110180; Mulder N, 2018, PHARMACOGEN PERS MED, V11, P59, DOI 10.2147/PGPM.S141546; National Academy of Sciences Engineering and Medicine, 2016, APPL IMPL SCI APPR G; O'Daniel JM, 2017, GENET MED, V19, P575, DOI 10.1038/gim.2016.152; Orlando LA, 2018, GENET MED, V20, P655, DOI 10.1038/gim.2017.144; Petrikin JE, 2018, NPJ GENOM MED, V3, DOI 10.1038/s41525-018-0045-8; Philippakis AA, 2015, HUM MUTAT, V36, P915, DOI 10.1002/humu.22858; Porter KM, 2018, MOL GENET GENOM MED, V6, P898, DOI 10.1002/mgg3.453; Rasmussen LV, 2016, APPL CLIN INFORM, V7, P870, DOI 10.4338/ACI-2016-04-RA-0060; Roberts JS, 2018, GENET MED, V20, P1069, DOI 10.1038/gim.2017.223; Roberts JS, 2017, PUBLIC HEALTH GENOM, V20, P36, DOI 10.1159/000455006; Shashi V, 2019, GENET MED, V21, P161, DOI 10.1038/s41436-018-0044-2; Sperber NR, 2017, BMC MED GENOMICS, V10, DOI 10.1186/s12920-017-0273-2; Splinter K, 2018, NEW ENGL J MED, V379, P2131, DOI 10.1056/NEJMoa1714458; Stark Z, 2019, GENET MED, V21, P173, DOI 10.1038/s41436-018-0006-8; Stark Z, 2018, GENET MED, V20, P1554, DOI 10.1038/gim.2018.37; Stark Z, 2017, GENET MED, V19, P867, DOI 10.1038/gim.2016.221; Stark Z, 2016, GENET MED, V18, P1090, DOI 10.1038/gim.2016.1; Strande NT, 2017, AM J HUM GENET, V100, P895, DOI 10.1016/j.ajhg.2017.04.015; Sukasem C, 2018, ANNU REV GENOM HUM G, V19, P329, DOI 10.1146/annurev-genom-083115-022324; Tan TY, 2017, JAMA PEDIATR, V171, P855, DOI 10.1001/jamapediatrics.2017.1755; Tandy-Connor S, 2018, GENET MED, V20, P1515, DOI 10.1038/gim.2018.38; Turnbull C, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1687; Watson M, 2015, GENET MED, V17, P505, DOI 10.1038/gim.2015.41; Wilson BJ, 2017, J CLIN EPIDEMIOL, V92, P4, DOI 10.1016/j.jclinepi.2017.08.018; Wolf SM, 2018, GENET MED, V20, P545, DOI 10.1038/gim.2017.137	60	167	167	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 3	2019	104	1					13	20		10.1016/j.ajhg.2018.11.014	http://dx.doi.org/10.1016/j.ajhg.2018.11.014			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HG2EH	30609404	hybrid, Green Published			2022-12-18	WOS:000454775500004
J	Semler, O; Garbes, L; Keupp, K; Swan, D; Zimmermann, K; Becker, J; Iden, S; Wirth, B; Eysel, P; Koerber, F; Schoenau, E; Bohlander, SK; Wollnik, B; Netzer, C				Semler, Oliver; Garbes, Lutz; Keupp, Katharina; Swan, Daniel; Zimmermann, Katharina; Becker, Jutta; Iden, Sandra; Wirth, Brunhilde; Eysel, Peer; Koerber, Friederike; Schoenau, Eckhard; Bohlander, Stefan K.; Wollnik, Bernd; Netzer, Christian			A Mutation in the 5 '-UTR of IFITM5 Creates an In-Frame Start Codon and Causes Autosomal-Dominant Osteogenesis Imperfecta Type V with Hyperplastic Callus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AMINO-ACID-SEQUENCE; PREDICTION; COLLAGEN; HUMANS; EXPRESSION; UPSTREAM; GENE; FORM; IDENTIFICATION; GLYCOSYLATION	Osteogenesis imperfecta (OI) is a clinically and genetically heterogeneous disorder associated with bone fragility and susceptibility to fractures after minimal trauma. OI type V has an autosomal-dominant pattern of inheritance and is not caused by mutations in the type I collagen genes COL1A1 and COL1A2. The most remarkable and pathognomonic feature, observed in similar to 65% of affected individuals, is a predisposition to develop hyperplastic callus after fractures or surgical interventions. To identify the molecular cause of OI type V, we performed whole-exome sequencing in a female with OI type V and her unaffected parents and searched for de novo mutations. We found a heterozygous de novo mutation in the 5'-untranslated region of IFITM5 (the gene encoding Interferon induced transmembrane protein 5), 14 bp upstream of the annotated translation initiation codon (c.-14C>T). Subsequently, we identified an identical heterozygous de novo mutation in a second individual with OI type V by Sanger sequencing, thereby confirming that this is the causal mutation for the phenotype. IFITM5 is a protein that is highly enriched in osteoblasts and has a putative function in bone formation and osteoblast maturation. The mutation c.-14C>T introduces an upstream start codon that is in frame with the reference open-reading frame of IFITM5 and is embedded into a stronger Kozak consensus sequence for translation initiation than the annotated start codon. In vitro, eukaryotic cells were able to recognize this start codon, and they used it instead of the reference translation initiation signal. This suggests that five amino acids (Met-Ala-Leu-Glu-Pro) are added to the N terminus and alter IFITM5 function in individuals with the mutation.	[Garbes, Lutz; Keupp, Katharina; Zimmermann, Katharina; Becker, Jutta; Wirth, Brunhilde; Wollnik, Bernd; Netzer, Christian] Univ Cologne, Inst Human Genet, Cologne, Germany; [Semler, Oliver; Schoenau, Eckhard] Univ Cologne, Childrens Hosp, D-50924 Cologne, Germany; [Swan, Daniel] Oxford Gene Technol, Computat Biol Grp, Oxford OX5 1PF, England; [Garbes, Lutz; Keupp, Katharina; Wirth, Brunhilde; Wollnik, Bernd] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Eysel, Peer] Univ Cologne, Dept Orthopaed & Trauma Surg, D-50937 Cologne, Germany; [Wirth, Brunhilde] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Koerber, Friederike] Univ Cologne, Dept Radiol, D-50937 Cologne, Germany; [Keupp, Katharina; Iden, Sandra; Wollnik, Bernd] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Bohlander, Stefan K.] Univ Munich Hosp, Dept Internal Med 3, D-81377 Munich, Germany; [Bohlander, Stefan K.] Philipps Univ Marburg, Ctr Human Genet, D-35033 Marburg, Germany	University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Munich; Philipps University Marburg	Netzer, C (corresponding author), Univ Cologne, Inst Human Genet, Cologne, Germany.	christian.netzer@uk-koeln.de	Iden, Sandra/I-1585-2012; Wollnik, Bernd/GRY-6062-2022; Wirth, Brunhilde/H-3192-2019; Iden, Sandra/ABB-2698-2021	Wollnik, Bernd/0000-0003-2589-0364; Iden, Sandra/0000-0003-2333-9827; Semler, Oliver/0000-0003-0029-7556; Bohlander, Stefan/0000-0002-2202-9088; Wirth, Brunhilde/0000-0003-4051-5191; Swan, Daniel/0000-0001-8978-8129	German Federal Ministry of Education and Research (BMBF) [01GM0880]; Wellcome Trust; Collaborative Research Centers [SFB829, SFB832]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UC2HL102926, UC2HL102923, RC2HL102926, UC2HL102925, RC2HL102923, RC2HL103010, RC2HL102925, RC2HL102924, UC2HL103010, UC2HL102924] Funding Source: NIH RePORTER	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Wellcome Trust(Wellcome TrustEuropean Commission); Collaborative Research Centers; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful to our patients and their parents for participating in this study. We would like to thank Angelika Stabrey for preparing Figure 1, Barbel Tutlewski for performing the dual-energy X-ray absorptiometry scans, and Monika Kron for administrative support. Whole-exome sequencing was financed by the Jurgen Bierich Award of the Arbeitsgemeinschaft Padiatrische Endokrinologie to O.S. This work was partially supported by the German Federal Ministry of Education and Research (BMBF) by grant number 01GM0880 (SKELNET) to B.Wo. This study makes use of data generated by the DECIPHER Consortium. A full list of centers that contributed to the generation of the data is available from http://decipher.sanger.ac.uk and via email from decipher@sanger.ac.uk. Funding for the project was provided by the Wellcome Trust. The authors would also like to thank the NHLBI GO Exome Sequencing Project and its ongoing studies, which produced and provided exome variant calls for comparison: the Lung GO Sequencing Project (HL-102923), the WHI Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926), and the Heart GO Sequencing Project (HL-103010). is supported by Collaborative Research Centers SFB829 and SFB832.	Alanay Y, 2010, AM J HUM GENET, V86, P551, DOI 10.1016/j.ajhg.2010.02.022; Asharani PV, 2012, AM J HUM GENET, V90, P661, DOI 10.1016/j.ajhg.2012.02.026; Barnes AM, 2010, NEW ENGL J MED, V362, P521, DOI 10.1056/NEJMoa0907705; BARSH GS, 1981, P NATL ACAD SCI-BIOL, V78, P5142, DOI 10.1073/pnas.78.8.5142; Becker J, 2011, AM J HUM GENET, V88, P362, DOI 10.1016/j.ajhg.2011.01.015; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; BYERS PH, 1988, AM J HUM GENET, V42, P237; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Cheung MS, 2007, J BONE MINER RES, V22, P1181, DOI 10.1359/jbmr.070418; Christiansen HE, 2010, AM J HUM GENET, V86, P389, DOI 10.1016/j.ajhg.2010.01.034; CHU ML, 1983, NATURE, V304, P78, DOI 10.1038/304078a0; Cintas HL, 2003, AM J PHYS MED REHAB, V82, P33, DOI 10.1097/00002060-200301000-00006; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dogan RI, 2007, NUCLEIC ACIDS RES, V35, pW285, DOI 10.1093/nar/gkm407; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Frottin F, 2006, MOL CELL PROTEOMICS, V5, P2336, DOI 10.1074/mcp.M600225-MCP200; Glorieux FH, 2000, J BONE MINER RES, V15, P1650, DOI 10.1359/jbmr.2000.15.9.1650; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Hanagata N, 2007, J BIOMED MATER RES A, V83A, P362, DOI 10.1002/jbm.a.31240; Hanagata N, 2011, BIOCHEM BIOPH RES CO, V409, P378, DOI 10.1016/j.bbrc.2011.04.136; Hanagata N, 2011, J BONE MINER METAB, V29, P279, DOI 10.1007/s00774-010-0221-0; Homan EP, 2011, J BONE MINER RES, V26, P2798, DOI 10.1002/jbmr.487; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; JONES DT, 1994, BIOCHEMISTRY-US, V33, P3038, DOI 10.1021/bi00176a037; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Keightley PD, 2012, GENETICS, V190, P295, DOI 10.1534/genetics.111.134668; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; Lapunzina P, 2010, AM J HUM GENET, V87, P110, DOI 10.1016/j.ajhg.2010.05.016; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Marsden RL, 2002, PROTEIN SCI, V11, P2814, DOI 10.1110/ps.0209902; Martinez A, 2008, PROTEOMICS, V8, P2809, DOI 10.1002/pmic.200701191; Martinez-Glez V, 2012, HUM MUTAT, V33, P343, DOI 10.1002/humu.21647; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Moffatt P, 2008, J BONE MINER RES, V23, P1497, DOI 10.1359/JBMR.080412; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Nishikawa T, 2000, BIOINFORMATICS, V16, P960, DOI 10.1093/bioinformatics/16.11.960; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pickering BM, 2005, SEMIN CELL DEV BIOL, V16, P39, DOI 10.1016/j.semcdb.2004.11.006; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Rogozin IB, 1997, J MOL EVOL, V45, P50, DOI 10.1007/PL00006200; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; Stenson Peter D, 2009, Hum Genomics, V4, P69; van Dijk FS, 2012, EUR J HUM GENET, V20, P11, DOI 10.1038/ejhg.2011.141; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Wethmar K, 2010, BIOESSAYS, V32, P885, DOI 10.1002/bies.201000037; WILLIAMS CJ, 1983, J BIOL CHEM, V258, P5915; Zhang J, 2006, CYTOGENET GENOME RES, V115, P205, DOI 10.1159/000095916	50	167	176	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG 10	2012	91	2					349	357		10.1016/j.ajhg.2012.06.011	http://dx.doi.org/10.1016/j.ajhg.2012.06.011			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	990CN	22863195	Bronze, Green Published			2022-12-18	WOS:000307608700014
J	Riley, LG; Cooper, S; Hickey, P; Rudinger-Thirion, J; McKenzie, M; Compton, A; Lim, SC; Thorburn, D; Ryan, MT; Giege, R; Bahlo, M; Christodoulou, J				Riley, Lisa G.; Cooper, Sandra; Hickey, Peter; Rudinger-Thirion, Joelle; McKenzie, Matthew; Compton, Alison; Lim, Sze Chern; Thorburn, David; Ryan, Michael T.; Giege, Richard; Bahlo, Melanie; Christodoulou, John			Mutation of the Mitochondrial Tyrosyl-tRNA Synthetase Gene, YARS2, Causes Myopathy, Lactic Acidosis, and Sideroblastic Anemia-MLASA Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TISSUE-SPECIFICITY; PUS1 GENE; DISEASE; DEFICIENCIES; MECHANISMS; DISORDERS; CHILDREN; FEATURES; MAPS	Mitochondrial respiratory chain disorders are a heterogeneous group of disorders in which the underlying genetic defect is often unknown. We have identified a pathogenic mutation (c.156C>G [p.F52L]) in YARS2, located at chromosome 12p11.21, by using genome-wide SNP-based homozygosity analysis of a family with affected members displaying myopathy, lactic acidosis, and sideroblastic anemia (MLASA). We subsequently identified the same mutation in another unrelated MLASA patient. The YARS2 gene product, mitochondrial tyrosyl-tRNA synthetase (YARS2), was present at lower levels in skeletal muscle whereas fibroblasts were relatively normal. Complex I, Ill, and IV were dysfunctional as indicated by enzyme analysis, immunoblotting, and immunohistochemistry. A mitochondrial protein-synthesis assay showed reduced levels of respiratory chain subunits in myotubes generated from patient cell lines. A tRNA aminoacylation assay revealed that mutant YARS2 was still active; however, enzyme kinetics were abnormal compared to the wild-type protein. We propose that the reduced aminoacylation activity of mutant YARS2 enzyme leads to decreased mitochondrial protein synthesis, resulting in mitochondrial respiratory chain dysfunction. MLASA has previously been associated with PUS1 mutations; hence, the YARS2 mutation reported here is an alternative cause of MLASA.	[Riley, Lisa G.; Christodoulou, John] Childrens Hosp Westmead, Genet Metab Disorders Res Unit, Sydney, NSW 2145, Australia; [Cooper, Sandra] Childrens Hosp Westmead, Inst Neurosci & Muscle Res, Sydney, NSW 2145, Australia; [Cooper, Sandra; Christodoulou, John] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia; [Hickey, Peter; Bahlo, Melanie] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Melbourne, Vic 3050, Australia; [Rudinger-Thirion, Joelle; Giege, Richard] Univ Strasbourg, Architecture & React ARN, CNRS, IBMC, F-67000 Strasbourg, France; [McKenzie, Matthew; Ryan, Michael T.] La Trobe Univ, Dept Biochem, Melbourne, Vic 3086, Australia; [Compton, Alison; Lim, Sze Chern; Thorburn, David] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia; [Compton, Alison; Lim, Sze Chern; Thorburn, David] Royal Childrens Hosp, Genet Hlth Serv Victoria, Melbourne, Vic 3052, Australia; [Lim, Sze Chern; Thorburn, David] Univ Melbourne, Dept Paediat, Melbourne, Vic 3010, Australia; [Christodoulou, John] Univ Sydney, Discipline Genet Med, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney; Walter & Eliza Hall Institute; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; La Trobe University; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; University of Sydney	Christodoulou, J (corresponding author), Childrens Hosp Westmead, Genet Metab Disorders Res Unit, Sydney, NSW 2145, Australia.	johnc@chw.edu.au	Ryan, Michael/X-2152-2019; Hickey, Peter/ABB-7174-2020; Lim, Sze Chern/I-6763-2013; Ryan, Michael T/C-6673-2011; Christodoulou, John/E-5866-2015; Christodoulou, John/M-3628-2019; Thorburn, David R/G-6266-2013; McKenzie, Matthew/H-4926-2019	Ryan, Michael/0000-0003-2586-8829; Hickey, Peter/0000-0002-8153-6258; Lim, Sze Chern/0000-0003-0312-9937; Ryan, Michael T/0000-0003-2586-8829; Christodoulou, John/0000-0002-8431-0641; McKenzie, Matthew/0000-0001-7508-1800; Bahlo, Melanie/0000-0001-5132-0774; Cooper, Sandra/0000-0002-7314-5097; Compton, Alison/0000-0002-2725-7055; thorburn, david/0000-0002-7725-9470	March of Dimes Foundation; Australian National Health and Medical Research Council	March of Dimes Foundation(March of Dimes); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Thanks to N. Fischel-Ghodsian for PUS1 mutation screening, L. Bonnefond for preparation of Figure 4, S. Taplin for assistance in the generation of Figure Si, L. Waddell for cutting muscle sections, and M. Menezes for preliminary haplotype analysis. This work was supported by a grant from the March of Dimes Foundation. D.T. is supported by an Australian National Health and Medical Research Council Principal Research Fellowship. M.B. is supported by an Australian National Health and Medical Research Council Career Development Award.	Abecasis GR, 2005, AM J HUM GENET, V77, P754, DOI 10.1086/497345; Antonellis A, 2008, ANNU REV GENOM HUM G, V9, P87, DOI 10.1146/annurev.genom.9.081307.164204; Antonicka H, 2006, HUM MOL GENET, V15, P1835, DOI 10.1093/hmg/ddl106; Bahlo M, 2009, BIOINFORMATICS, V25, P1961, DOI 10.1093/bioinformatics/btp313; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bonnefond L, 2005, BIOCHEMISTRY-US, V44, P4805, DOI 10.1021/bi047527z; Bonnefond L, 2007, STRUCTURE, V15, P1505, DOI 10.1016/j.str.2007.09.018; Bykhovskaya Y, 2007, MOL GENET METAB, V91, P148, DOI 10.1016/j.ymgme.2007.02.006; Casas K, 2004, AM J MED GENET A, V127A, P44, DOI 10.1002/ajmg.a.20652; Cooper ST, 2007, NEUROMUSCULAR DISORD, V17, P276, DOI 10.1016/j.nmd.2006.12.010; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; DIMAURO S, 2006, MITOCHONDRIAL MED; Fechter P, 2000, BIOCHEMISTRY-US, V39, P1725, DOI 10.1021/bi992276t; Fernandez-Vizarra E, 2007, J MED GENET, V44, P173, DOI 10.1136/jmg.2006.045252; Fernandez-Vizarra E, 2009, BBA-MOL CELL RES, V1793, P200, DOI 10.1016/j.bbamcr.2008.05.028; Giege R, 2009, DNA RNA MODIFICATION, P475; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255; Koenig MK, 2008, PEDIATR NEUROL, V38, P305, DOI 10.1016/j.pediatrneurol.2007.12.001; McKenzie M, 2009, METHOD ENZYMOL, V456, P321, DOI 10.1016/S0076-6879(08)04418-2; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Patton JR, 2005, J BIOL CHEM, V280, P19823, DOI 10.1074/jbc.M500216200; Remels AHV, 2010, MOL CELL ENDOCRINOL, V315, P113, DOI 10.1016/j.mce.2009.09.029; Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170; Tanji K, 2008, METHODS, V46, P274, DOI 10.1016/j.ymeth.2008.09.027; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; Thorburn D R, 2000, Hum Reprod, V15 Suppl 2, P57; Yaremchuk A, 2002, EMBO J, V21, P3829, DOI 10.1093/emboj/cdf373; Zeharia A, 2005, J CHILD NEUROL, V20, P449, DOI 10.1177/08830738050200051301	31	167	177	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 9	2010	87	1					52	59		10.1016/j.ajhg.2010.06.001	http://dx.doi.org/10.1016/j.ajhg.2010.06.001			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	627HD	20598274	Green Published, Bronze			2022-12-18	WOS:000280029200005
J	Armanios, M; Alder, JK; Parry, EM; Karim, B; Strong, MA; Greider, CW				Armanios, Mary; Alder, Jonathan K.; Parry, Erin M.; Karim, Baktiar; Strong, Margaret A.; Greider, Carol W.			Short Telomeres are Sufficient to Cause the Degenerative Defects Associated with Aging	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOMINANT DYSKERATOSIS-CONGENITA; IDIOPATHIC PULMONARY-FIBROSIS; CELLS LACKING TELOMERASE; DNA-DAMAGE RESPONSE; SACCHAROMYCES-CEREVISIAE; STEM-CELLS; SUPPRESS TUMORIGENESIS; HEMATOPOIETIC STEM; BONE-MARROW; MICE	Telomerase function is critical for telomere maintenance. Mutations in telomerase components lead to telomere shortening and progressive bone marrow failure in the premature aging syndrome dyskeratosis congenita. Short telomeres are also acquired with aging, yet the role that they play in mediating age-related disease is not fully known. We generated wild-type mice that have short telomeres. In these mice, we identified hematopoietic and immune defects that resembled those present in dyskeratosis congenita patients. When mice with short telomeres were interbred, telomere length was only incrementally restored, and even several generations later, wild-type mice with short telomeres still displayed degenerative defects. Our findings implicate telomere length as a unique heritable trait that, when short, is sufficient to mediate the degenerative defects of aging, even when telomerase is wild-type.	[Armanios, Mary; Alder, Jonathan K.; Parry, Erin M.; Greider, Carol W.] Johns Hopkins Univ, Dept Oncol, Sch Med, Baltimore, MD 21287 USA; [Karim, Baktiar] Johns Hopkins Univ, Dept Mol & Comparat Pathobiol, Sch Med, Baltimore, MD 21287 USA; [Strong, Margaret A.; Greider, Carol W.] Johns Hopkins Univ, Dept Mol Biol & Genet, Sch Med, Baltimore, MD 21287 USA; [Parry, Erin M.] Johns Hopkins Univ, Grad Program Human Genet, Sch Med, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Armanios, M (corresponding author), Johns Hopkins Univ, Dept Oncol, Sch Med, Baltimore, MD 21287 USA.	marmani1@jhmi.edu	Alder, Jonathan/AAF-3540-2020	Parry, Erin/0000-0002-3382-9769; Alder, Jonathan/0000-0003-3741-6512; Greider, Carol/0000-0002-5494-8126; Strong, Margaret/0000-0002-0055-6573	National Institutes of Health [K08CA118416, R01AG27406]; Kimmel Foundation (M.A.); Maryland Stem Cell Research Fellowship; Medical Scientist Training Program [T32GM007309]; NATIONAL CANCER INSTITUTE [K08CA118416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027406] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kimmel Foundation (M.A.); Maryland Stem Cell Research Fellowship; Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to Curt Civin, Steve Desidefio, and Katie Whartenby, as well as lab members, for helpfl discussions. We thank Ling-Yang Hao for setting up the wt* crosses and Brendan Cormack for critical comments on the manuscript. This work was supported by National Institutes of Health grants K08CA118416 (M.A.) and R01AG27406 (C.W.G.), the Kimmel Foundation (M.A.), and a Maryland Stem Cell Research Fellowship (J.K.A.). E.M.P. received support from a Medical Scientist Training Program grant (T32GM007309).	Alder JK, 2008, P NATL ACAD SCI USA, V105, P13051, DOI 10.1073/pnas.0804280105; Alter BP, 2009, BLOOD, V113, P6549, DOI 10.1182/blood-2008-12-192880; Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; Armanios M, 2009, ANNU REV GENOM HUM G, V10, P45, DOI 10.1146/annurev-genom-082908-150046; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Buchkovich KJ, 1996, MOL BIOL CELL, V7, P1443, DOI 10.1091/mbc.7.9.1443; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Chiu CP, 1996, STEM CELLS, V14, P239, DOI 10.1002/stem.140239; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [10.1038/nature02118, DOI 10.1038/NATURE02118]; Davila Marta L, 2006, Curr Treat Options Gastroenterol, V9, P249, DOI 10.1007/s11938-006-0043-2; Dokal I, 2003, BLOOD REV, V17, P217, DOI 10.1016/S0268-960X(03)00020-1; Enomoto S, 2002, MOL BIOL CELL, V13, P2626, DOI 10.1091/mbc.02-02-0012; Feldser DM, 2007, CANCER CELL, V11, P461, DOI 10.1016/j.ccr.2007.02.026; Goldman F, 2005, P NATL ACAD SCI USA, V102, P17119, DOI 10.1073/pnas.0505318102; Greenberg RA, 1999, CELL, V97, P515, DOI 10.1016/S0092-8674(00)80761-8; Guo X, 2007, EMBO J, V26, P4709, DOI 10.1038/sj.emboj.7601893; Hao LY, 2005, CELL, V123, P1121, DOI 10.1016/j.cell.2005.11.020; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HARTSOCK RJ, 1965, AM J CLIN PATHOL, V43, P326; Hathcock KS, 2002, P NATL ACAD SCI USA, V99, P3591, DOI 10.1073/pnas.012549799; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Hemann MT, 2000, NUCLEIC ACIDS RES, V28, P4474, DOI 10.1093/nar/28.22.4474; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Ijpma AS, 2003, MOL BIOL CELL, V14, P987, DOI 10.1091/mbc.02-04-0057; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0; Knudson M, 2005, BLOOD, V105, P682, DOI 10.1182/blood-2004-04-1673; LEE BW, 1992, ARCH DIS CHILD, V67, P524, DOI 10.1136/adc.67.4.524; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Makovets S, 2008, GENETICS, V178, P245, DOI 10.1534/genetics.107.083030; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Morra M, 2005, P NATL ACAD SCI USA, V102, P4819, DOI 10.1073/pnas.0408681102; Morrison SJ, 1996, IMMUNITY, V5, P207, DOI 10.1016/S1074-7613(00)80316-7; Njajou OT, 2007, P NATL ACAD SCI USA, V104, P12135, DOI 10.1073/pnas.0702703104; Qi L, 2003, CANCER RES, V63, P8188; ROSE C, 1992, CLIN INFECT DIS, V15, P1056, DOI 10.1093/clind/15.6.1056; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871; Schlessinger D, 2001, MECH AGEING DEV, V122, P1537, DOI 10.1016/S0047-6374(01)00299-8; Segal JB, 2006, ANN EPIDEMIOL, V16, P123, DOI 10.1016/j.annepidem.2005.06.052; Smith TJ, 2006, J CLIN ONCOL, V24, P3187, DOI 10.1200/JCO.2006.06.4451; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Vulliamy T, 2004, NAT GENET, V36, P447, DOI 10.1038/ng1346; Weng NP, 2006, IMMUNITY, V24, P495, DOI 10.1016/j.immuni.2006.05.001; Weng NP, 1996, J EXP MED, V183, P2471, DOI 10.1084/jem.183.6.2471; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; Yilmaz OH, 2006, BLOOD, V107, P924, DOI 10.1182/blood-2005-05-2140	50	167	172	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 11	2009	85	6					823	832		10.1016/j.ajhg.2009.10.028	http://dx.doi.org/10.1016/j.ajhg.2009.10.028			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	533BN	19944403	Green Published, hybrid			2022-12-18	WOS:000272797100006
J	Gorden, NT; Arts, HH; Parisi, MA; Coene, KLM; Letteboer, SJF; van Beersum, SEC; Mans, DA; Hikida, A; Eckert, M; Knutzen, D; Alswaid, AF; Ozyurek, H; Dibooglu, S; Otto, EA; Liu, YF; Davis, EE; Hutter, CM; Bammler, TK; Farin, FM; Dorschner, M; Topcu, M; Zackai, EH; Rosenthal, P; Owens, KN; Katsanis, N; Vincent, JB; Hildebrandt, F; Rubel, EW; Raible, DW; Knoers, NVAM; Chance, PF; Roepman, R; Moens, CB; Glass, IA; Doherty, D				Gorden, Nicholas T.; Arts, Heleen H.; Parisi, Melissa A.; Coene, Karlien L. M.; Letteboer, Stef J. F.; van Beersum, Sylvia E. C.; Mans, Dorus A.; Hikida, Abigail; Eckert, Melissa; Knutzen, Dana; Alswaid, Abdulrahman F.; Ozyurek, Hamit; Dibooglu, Sel; Otto, Edgar A.; Liu, Yangfan; Davis, Erica E.; Hutter, Carolyn M.; Bammler, Theo K.; Farin, Frederico M.; Dorschner, Michael; Topcu, Meral; Zackai, Elaine H.; Rosenthal, Phillip; Owens, Kelly N.; Katsanis, Nicholas; Vincent, John B.; Hildebrandt, Friedhelm; Rubel, Edwin W.; Raible, David W.; Knoers, Nine V. A. M.; Chance, Phillip F.; Roepman, Ronald; Moens, Cecilia B.; Glass, Ian A.; Doherty, Dan			CC2D2A Is Mutated in Joubert Syndrome and Interacts with the Ciliopathy-Associated Basal Body Protein CEP290	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BARDET-BIEDL-SYNDROME; LEBER CONGENITAL AMAUROSIS; PRIMARY CILIUM FORMATION; RENAL CYSTIC-DISEASE; MECKEL-SYNDROME; JUVENILE NEPHRONOPHTHISIS; MOLECULAR PATHOLOGY; CENTROSOMAL PROTEIN; DOMAIN PROTEIN; SYNDROME GENE	Joubert syndrome and related disorders (JSRD) are primarily autosomal-recessive conditions characterized by hypotonia, ataxia, abnormal eye movements, and intellectual disability with a distinctive mid-hindbrain malformation. Variable features include retinal dystrophy, cystic kidney disease, and liver fibrosis. JSRD) are included in the rapidly expanding group of disorders called ciliopathies, because all six gene products implicated in JSRD (NPHP1, AHI1, CEP290, RPGRIP1L, TMEM67, and ARL13B) function in the primary cilium/basal body organelle. By using homozygosity mapping in consanguineous families, we identify loss-of-function Mutations in CC2D2A in JSRD patients with and without retinal, kidney, and liver disease. CC2D2A is expressed in all fetal and adult tissues tested. In ciliated cells, we observe localization of recombinant CC2D2A at the basal body and colocalization with CEP290, whose cognate gene is mutated in multiple hereditary ciliopathies. In addition, the proteins can physically interact in vitro, as shown by yeast two-hybrid and GSTpulldown experiments. A nonsense mutation in the zebrafish CC2D2A ortholog (sentinel) results in pronephric cysts, a hallmark of ciliary dysfunction analogous to human cystic kidney disease. Knockdown of cep290 function in sentinel fish results in a synergistic pronephric cyst phenotype, revealing a genetic interaction between CC2D2A and CEP290 and implicating CC2D2A in cilium/basal body function. These observations extend the genetic spectrum of JSRD and provide a model system for Studying extragenic modifiers in JSRD and other ciliopathies.	[Gorden, Nicholas T.; Parisi, Melissa A.; Hikida, Abigail; Knutzen, Dana; Chance, Phillip F.; Glass, Ian A.; Doherty, Dan] Univ Washington, Sch Med, Dept Pediat, Div Genet & Dev Med, Seattle, WA 98195 USA; [Hutter, Carolyn M.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Bammler, Theo K.; Farin, Frederico M.] Univ Washington, Sch Publ Hlth, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Dorschner, Michael] Univ Washington, Sch Med, Dept Med, Div Med Oncol, Seattle, WA 98195 USA; [Owens, Kelly N.; Rubel, Edwin W.] Univ Washington, Sch Med, Dept Otolaryngol Head & Neck Surg, Seattle, WA 98195 USA; [Owens, Kelly N.; Rubel, Edwin W.; Raible, David W.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Owens, Kelly N.; Raible, David W.] Univ Washington, Virginia Merrill Bloedel Hearing Res Ctr, Seattle, WA 98195 USA; [Arts, Heleen H.; Coene, Karlien L. M.; Letteboer, Stef J. F.; van Beersum, Sylvia E. C.; Mans, Dorus A.; Knoers, Nine V. A. M.; Roepman, Ronald] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Arts, Heleen H.; Coene, Karlien L. M.; Letteboer, Stef J. F.; van Beersum, Sylvia E. C.; Mans, Dorus A.; Knoers, Nine V. A. M.; Roepman, Ronald] Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Eckert, Melissa] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Alswaid, Abdulrahman F.] King Abdul Aziz Med City, Dept Pediat, Riyadh 111426, Saudi Arabia; [Ozyurek, Hamit] Ondokuz Mayis Univ, Dept Pediat, TR-55139 Kurupelit, Samsun, Turkey; [Dibooglu, Sel] Univ Missouri, Dept Econ, SSB 408, St Louis, MO 63121 USA; [Otto, Edgar A.; Hildebrandt, Friedhelm] Univ Michigan Hlth Syst, Dept Pediat, Ann Arbor, MI 48109 USA; [Liu, Yangfan; Davis, Erica E.; Katsanis, Nicholas] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Liu, Yangfan; Davis, Erica E.; Katsanis, Nicholas] Johns Hopkins Univ, Dept Ophthalmol, Baltimore, MD 21205 USA; [Liu, Yangfan; Davis, Erica E.; Katsanis, Nicholas] Johns Hopkins Univ, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Topcu, Meral] Hacettepe Childrens Hosp Med Ctr, Dept Child Neurol, TR-06100 Ankara, Turkey; [Zackai, Elaine H.] Univ Penn, Childrens Hosp Philadelphia, Sch Med Genet & Mol Biol, Clin Genet Ctr, Philadelphia, PA 19104 USA; [Rosenthal, Phillip] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Rosenthal, Phillip] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; [Vincent, John B.] Ctr Addict & Mental Hlth, Neurogenet Sect, Toronto, ON M57 1R8, Canada; [Moens, Cecilia B.] Howard Hughes Med Inst, Seattle, WA 98109 USA; [Moens, Cecilia B.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Radboud University Nijmegen; Radboud University Nijmegen; University of California System; University of California Davis; King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; Ondokuz Mayis University; University of Missouri System; University of Missouri Saint Louis; University of Michigan System; University of Michigan; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Hacettepe University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Howard Hughes Medical Institute; Fred Hutchinson Cancer Center	Doherty, D (corresponding author), Univ Washington, Sch Med, Dept Pediat, Div Genet & Dev Med, Seattle, WA 98195 USA.	ddoher@u.washington.edu	arts, heleen/ACL-6040-2022; Coene, Karlien/K-7583-2016; Chance, Phillip/AAX-5826-2020; Katsanis, Nicholas/E-1837-2012; Letteboer, Stef JF/P-8272-2015; Moens, Cecilia/AAN-1536-2020; Dibooglu, Sel/AAJ-4102-2020; van Beersum, Sylvia E.C./P-8653-2015; Roepman, Ronald/B-1339-2014	Coene, Karlien/0000-0001-9873-1458; Dibooglu, Sel/0000-0002-3865-5868; van Beersum, Sylvia E.C./0000-0002-4552-2908; Roepman, Ronald/0000-0002-5178-8163; Katsanis, Nicholas/0000-0002-2480-0171; Davis, Erica/0000-0002-2412-8397; Otto, Edgar/0000-0002-2387-9973; Moens, Cecilia/0000-0002-1099-0728; Arts, Heleen/0000-0002-9860-3744; Raible, David/0000-0002-5342-5841	US National Institutes of Health [K23NS45832]; NCRR [5KI.2RR025015]; University of Washington Center on Human Development and Disability [P30HD02274]; Howard Hughes Medical Institute; March of Dimes Endowment; Dutch Kidney Foundation [C04.2112]; EVIGENORET [LSHG-CT-2005 512036]; Netherlands Organisation for Scientific Research [Vidi-91786396];  [K24HD46712];  [P30ES07033];  [021.001.014]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD002274] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K24HD046712] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS045832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005987] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of Washington Center on Human Development and Disability(University of Washington); Howard Hughes Medical Institute(Howard Hughes Medical Institute); March of Dimes Endowment(March of Dimes); Dutch Kidney Foundation; EVIGENORET(European Commission); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank all the participating families with Joubert syndrome and M. Landsverk, R. Howard, J. Adkins, and members of the Moens laboratory for expert technical assistance and helpful discussions. This work was supported by the US National Institutes of Health (grants K23NS45832 to M.A.P, K24HD46712 to I.A.G., NCRR 5KI.2RR025015 to D.D., and P30ES07033 to F.M.F.), the University of Washington Center on Human Development and Disability (P30HD02274 to D.D., M.A.P, and I.A.G.), Howard Hughes Medical Institute (to C.B.M.), the University of Washington Center on Ecogenetics and Environmental Health and the March of Dimes Endowment for Healthier Babies at Children's Hospital in Seattle (to D.D., M.A.P., and I.A.G.), as well as grants from the Dutch Kidney Foundation (C04.2112 to N.V.A.M.K. and R.R.), EVIGENORET (LSHG-CT-2005 512036 to R.R.), and the Netherlands Organisation for Scientific Research (NWO Vidi-91786396 to R.R. and NWO Toptalent-021.001.014 to K.L.M.C.).	Adams M, 2008, J MED GENET, V45, P257, DOI 10.1136/jmg.2007.054999; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Arts HH, 2007, NAT GENET, V39, P882, DOI 10.1038/ng2069; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Baala L, 2007, AM J HUM GENET, V81, P170, DOI 10.1086/519494; Baala L, 2007, AM J HUM GENET, V80, P186, DOI 10.1086/510499; Badano JL, 2006, NATURE, V439, P326, DOI 10.1038/nature04370; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Beales PL, 1999, J MED GENET, V36, P437; Blacque OE, 2005, CURR BIOL, V15, P935, DOI 10.1016/j.cub.2005.04.059; Brent MR, 2008, NAT REV GENET, V9, P62, DOI 10.1038/nrg2220; Cantagrel V, 2008, AM J HUM GENET, V83, P170, DOI 10.1016/j.ajhg.2008.06.023; Dawe HR, 2007, HUM MOL GENET, V16, P173, DOI 10.1093/hmg/ddl459; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Dryja TP, 2001, AM J HUM GENET, V68, P1295, DOI 10.1086/320113; Efimenko E, 2005, DEVELOPMENT, V132, P1923, DOI 10.1242/dev.01775; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Graber D, 2001, ARCH PEDIATRIE, V8, P186, DOI 10.1016/S0929-693X(00)00183-4; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Hoefele J, 2007, J AM SOC NEPHROL, V18, P2789, DOI 10.1681/ASN.2007020243; Johnson CA, 2003, J MED GENET, V40, P311, DOI 10.1136/jmg.40.5.311; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Kulaga HM, 2004, NAT GENET, V36, P994, DOI 10.1038/ng1418; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Noor A, 2008, AM J HUM GENET, V82, P1011, DOI 10.1016/j.ajhg.2008.01.021; Otto EA, 2005, NAT GENET, V37, P282, DOI 10.1038/ng1520; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Owens KN, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000020; Owens KN, 2007, J COMP NEUROL, V502, P522, DOI 10.1002/cne.21345; Parisi MA, 2006, J MED GENET, V43, P334, DOI 10.1136/jmg.2005.036608; Parisi MA, 2004, AM J HUM GENET, V75, P82, DOI 10.1086/421846; Parisi MA, 2007, EUR J HUM GENET, V15, P511, DOI 10.1038/sj.ejhg.5201648; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Roepman Ronald, 2007, V43, P209, DOI 10.1007/978-1-4020-5943-8_10; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Shen XC, 2005, P NATL ACAD SCI USA, V102, P5969, DOI 10.1073/pnas.0407928102; Takano K, 2003, PEDIATR NEUROL, V28, P142, DOI 10.1016/S0887-8994(02)00619-7; Tallila J, 2008, AM J HUM GENET, V82, P1361, DOI 10.1016/j.ajhg.2008.05.004; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; VERLOES A, 1989, AM J MED GENET, V32, P227, DOI 10.1002/ajmg.1320320217	45	167	173	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 7	2008	83	5					559	571		10.1016/j.ajhg.2008.10.002	http://dx.doi.org/10.1016/j.ajhg.2008.10.002			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	373XN	18950740	Bronze, Green Published			2022-12-18	WOS:000261006900002
J	Adaimy, L; Chouery, E; Megarbane, H; Mroueh, S; Delague, V; Nicolas, E; Belguith, H; de Mazancourt, P; Megarbane, A				Adaimy, Lynn; Chouery, Eliane; Megarbane, Hala; Mroueh, Salman; Delague, Valerie; Nicolas, Elsa; Belguith, Hanen; de Mazancourt, Philippe; Megarbane, Andre			Mutation in WNT10A is associated with an autosomal recessive ectodermal dysplasia: The odonto-onycho-dermal dysplasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ODONTOONYCHODERMAL DYSPLASIA; LEBANESE FAMILY; TOOTH; GENE; CLASSIFICATION; EXPRESSION; TARGET; CANCER; MAP	Odonto-onycho-dermal dysplasia is a rare autosomal recessive syndrome in which the presenting phenotype is dry hair, severe hypodontia, smooth tongue with marked reduction of fungiform and filiform papillae, onychodysplasia, keratoderma and hyperhidrosis of palms and soles, and hyperkeratosis of the skin. We studied three consanguineous Lebanese Muslim Shiite families that included six individuals affected with odonto-onycho-dermal dysplasia. Using a homozygosity-mapping strategy, we assigned the disease locus to an similar to 9-cM region at chromosome 2q35-q36.2, located between markers rs16853834 and D2S353, with a maximum multipoint LOD score of 5.7. Screening of candidate genes in this region led us to identify the same c. 697GrT (p. Glu233X) homozygous nonsense mutation in exon 3 of the WNT10A gene in all patients. At the protein level, the mutation is predicted to result in a premature truncated protein of 232 aa instead of 417 aa. This is the first report to our knowledge of a human phenotype resulting from a mutation in WNT10A, and it is the first demonstration of an ectodermal dysplasia caused by an altered WNT signaling pathway, expanding the list of WNT-related diseases.	Univ St Joseph, Fac Med, Unite Genet Med, Beirut, Lebanon; Dermatol Serv, Beirut, Lebanon; Amer Univ Beirut, Dept Pediat, Beirut, Lebanon; Fac Med Timone, INSERM, U491, Marseille, France; Univ Versailles St Quentin Yvelines Ea 2493, Hop Raymond Poincare, Garches, France	Saint Joseph University Beirut; American University of Beirut; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Paris Saclay	Megarbane, A (corresponding author), Univ St Joseph Beyrouth, Fac Med, Unite Genet Med, 42 Rue Grenelle, F-75007 Paris, France.	megarbane@usj.edu.lb	Mroueh, Salman M/AAW-3755-2020; Megarbane, Andre/ABD-5574-2021; Chouery, Eliane/AAC-5957-2021; delague, valerie/K-5837-2013	Mroueh, Salman M/0000-0002-2869-0360; delague, valerie/0000-0003-2652-362X				Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; ARNOLD WP, 1995, AM J MED GENET, V59, P242, DOI 10.1002/ajmg.1320590224; Biason-Lauber A, 2004, NEW ENGL J MED, V351, P792, DOI 10.1056/NEJMoa040533; Blaydon DC, 2006, NAT GENET, V38, P1245, DOI 10.1038/ng1883; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Dassule HR, 1998, DEV BIOL, V202, P215, DOI 10.1006/dbio.1998.8992; Delague V, 2000, AM J HUM GENET, V67, P236, DOI 10.1086/302980; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FADHIL M, 1983, AM J MED GENET, V14, P335, DOI 10.1002/ajmg.1320140213; Freire-Maia N, 1988, Birth Defects Orig Artic Ser, V24, P109; Freire-Maia N, 1984, ECTODERMAL DYSPLASIA, P172; FRIED K, 1977, J MED GENET, V14, P137, DOI 10.1136/jmg.14.2.137; Itin PH, 2004, AM J MED GENET C, V131C, P45, DOI 10.1002/ajmg.c.30033; Jarvinen E, 2006, P NATL ACAD SCI USA, V103, P18627, DOI 10.1073/pnas.0607289103; Jordan BK, 2003, P NATL ACAD SCI USA, V100, P10866, DOI 10.1073/pnas.1834480100; Kirikoshi H, 2001, BIOCHEM BIOPH RES CO, V283, P798, DOI 10.1006/bbrc.2001.4855; Kratochwil K, 2002, GENE DEV, V16, P3173, DOI 10.1101/gad.1035602; Lamartine J, 2003, CLIN EXP DERMATOL, V28, P351, DOI 10.1046/j.1365-2230.2003.01319.x; Lammi L, 2004, AM J HUM GENET, V74, P1043, DOI 10.1086/386293; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Liu F, 2007, NAT GENET, V39, P106, DOI 10.1038/ng1932; Megarbane A, 1998, AM J MED GENET, V75, P196, DOI 10.1002/(SICI)1096-8628(19980113)75:2<196::AID-AJMG15>3.3.CO;2-X; Megarbane H, 2004, AM J MED GENET A, V129A, P193, DOI 10.1002/ajmg.a.30188; Millar SE, 1999, DEV BIOL, V207, P133, DOI 10.1006/dbio.1998.9140; Narita T, 2005, DEV DYNAM, V233, P282, DOI 10.1002/dvdy.20321; Niemann S, 2004, AM J HUM GENET, V74, P558, DOI 10.1086/382196; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; PINHEIRO M, 1981, BRIT J DERMATOL, V105, P371, DOI 10.1111/j.1365-2133.1981.tb00768.x; PINHEIRO M, 1994, AM J MED GENET, V53, P153, DOI 10.1002/ajmg.1320530207; Priolo M, 2001, J MED GENET, V38, P579, DOI 10.1136/jmg.38.9.579; Reddy S, 2001, MECH DEVELOP, V107, P69, DOI 10.1016/S0925-4773(01)00452-X; Robitaille J, 2002, NAT GENET, V32, P326, DOI 10.1038/ng957; SALAMON T, 1972, HAUTARZT, V23, P441; Sarkar L, 1999, MECH DEVELOP, V85, P197, DOI 10.1016/S0925-4773(99)00095-7; SCHOPF E, 1971, Birth Defects Original Article Series, V7, P219; Wang H.F., 1996, HUBEI GEOLOGY, V10, P10; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Woods CG, 2006, AM J HUM GENET, V79, P402, DOI 10.1086/506332; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; ZIRBEL GM, 1995, BRIT J DERMATOL, V133, P797	41	167	207	0	10	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2007	81	4					821	828		10.1086/520064	http://dx.doi.org/10.1086/520064			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	208GK	17847007	Green Published, Bronze			2022-12-18	WOS:000249307600023
J	Makino, S; Kaji, R; Ando, S; Tomizawa, M; Yasuno, K; Goto, S; Matsumoto, S; Tabuena, MD; Maranon, E; Dantes, M; Lee, LV; Ogasawara, K; Tooyama, I; Akatsu, H; Nishimura, M; Tamiya, G				Makino, Satoshi; Kaji, Ryuji; Ando, Satoshi; Tomizawa, Maiko; Yasuno, Katsuhito; Goto, Satoshi; Matsumoto, Shinnichi; Tabuena, Ma. Daisy; Maranon, Elma; Dantes, Marita; Lee, Lillian V.; Ogasawara, Kazumasa; Tooyama, Ikuo; Akatsu, Hiroyasu; Nishimura, Masataka; Tamiya, Gen			Reduced neuron-specific expression of the TAF1 gene is associated with X-linked dystonia-parkinsonism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EXPANDED POLYGLUTAMINE; REGION; ELEMENTS; ENHANCER; INTRON; PHOSPHATASE; TAF(II)250; CLONING; LOCUS; EXON	X-linked dystonia- parkinsonism (XDP) is a movement disorder endemic to the Philippines. The disease locus, DYT3, has been mapped to Xq13.1. In a search for the causative gene, we performed genomic sequencing analysis, followed by expression analysis of XDP brain tissues. We found a disease- specific SVA ((s) under bar hort interspersed nuclear element, (v) under bar ariable number of tandem repeats, and (A) under bar lu composite) retrotransposon insertion in an intron of the TATA- binding protein-associated factor 1 gene (TAF1), which encodes the largest component of the TFIID complex, and significantly decreased expression levels of TAF1 and the dopamine receptor D2 gene (DRD2) in the caudate nucleus. We also identified an abnormal pattern of DNA methylation in the retrotransposon in the genome from the patient's caudate, which could account for decreased expression of TAF1. Our findings suggest that the reduced neuron-specific expression of the TAF1 gene is associated with XDP.	Univ Tokushima, Grad Sch Med, Dept Neurol & Neurosci, Tokushima 7708503, Japan; Tokai Univ, Sch Med, Dept Mol Life Sci, Kanagawa 2591100, Japan; Kumamoto Univ, Grad Sch Med Sci, Dept Neurosurg, Kumamoto, Japan; W Visayas State Univ, Med Ctr, Neurol Sect, Dept Internal Med, Iloilo, Philippines; Philippine Childrens Med Ctr, Dept Hlth, Quezon City, Philippines; Shiga Univ Med Sci, Dept Pathol, Otsu, Shiga 52021, Japan; Shiga Univ Med Sci, Mol Neurosci Res Ctr, Otsu, Shiga 52021, Japan; Fukushimura Hosp, Choju Med Inst, Toyohashi, Aichi, Japan	Tokushima University; Tokai University; Kumamoto University; Shiga University of Medical Science; Shiga University of Medical Science	Tamiya, G (corresponding author), Univ Tokushima, Grad Sch Med, Dept Neurol & Neurosci, Tokushima 7708503, Japan.	gtamiya@genetix-h.com	Yasuno, Katsuhito/E-1960-2012	Yasuno, Katsuhito/0000-0002-3606-532X; Tooyama, Ikuo/0000-0001-8054-9666; Tamiya, Gen/0000-0002-0597-415X				ANNWEILER A, 1992, MOL CELL BIOL, V12, P3107, DOI 10.1128/MCB.12.7.3107; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Dirksen WP, 2003, J BIOL CHEM, V278, P9722, DOI 10.1074/jbc.M207969200; DONOGHUE M, 1988, GENE DEV, V2, P1779, DOI 10.1101/gad.2.12b.1779; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Fahn S, 1998, Adv Neurol, V78, P1; GILLIES SD, 1983, CELL, V33, P717, DOI 10.1016/0092-8674(83)90014-4; Goto S, 2005, ANN NEUROL, V58, P7, DOI 10.1002/ana.20513; HABERHAUSEN G, 1995, AM J HUM GENET, V57, P644; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; HISATAKE K, 1993, NATURE, V362, P179, DOI 10.1038/362179a0; Igarashi S, 1998, NAT GENET, V18, P111, DOI 10.1038/ng0298-111; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Lee L V, 1976, Adv Neurol, V14, P137; Lee LV, 2001, J CLIN PATHOL-MOL PA, V54, P362; MARUYAMA K, 1994, GENE, V138, P171; Nakamura K, 2001, HUM MOL GENET, V10, P1441, DOI 10.1093/hmg/10.14.1441; Nemeth AH, 1999, GENOMICS, V60, P320, DOI 10.1006/geno.1999.5929; Nolte D, 2003, P NATL ACAD SCI USA, V100, P10347, DOI 10.1073/pnas.1831949100; Ostertag EM, 2003, AM J HUM GENET, V73, P1444, DOI 10.1086/380207; RIPPE RA, 1989, MOL CELL BIOL, V9, P2224, DOI 10.1128/MCB.9.5.2224; RUPPERT S, 1993, NATURE, V362, P175, DOI 10.1038/362175a0; SHEN LM, 1994, J BIOL CHEM, V269, P8466; Varon R, 2003, NAT GENET, V35, P185, DOI 10.1038/ng1243; VERMEULEN W, 1994, COLD SPRING HARB SYM, V59, P317, DOI 10.1101/SQB.1994.059.01.036; Wassarman DA, 2001, J CELL SCI, V114, P2895; WATERS CH, 1993, MOVEMENT DISORD, V8, P387, DOI 10.1002/mds.870080328; WILHELMSEN KC, 1991, ANN NEUROL, V29, P124, DOI 10.1002/ana.410290203; Wilund KR, 2002, HUM MOL GENET, V11, P3019, DOI 10.1093/hmg/11.24.3019	30	167	175	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2007	80	3					393	406		10.1086/512129	http://dx.doi.org/10.1086/512129			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	139AB	17273961	Bronze, Green Published			2022-12-18	WOS:000244403300001
J	Agrawal, PB; Greenleaf, RS; Tomczak, KK; Lehtokari, VL; Wallgren-Pettersson, C; Wallefeld, W; Laing, NG; Darras, BT; Maciver, SK; Dormitzer, PR; Beggs, AH				Agrawal, Pankaj B.; Greenleaf, Rebecca S.; Tomczak, Kinga K.; Lehtokari, Vilma-Lotta; Wallgren-Pettersson, Carina; Wallefeld, William; Laing, Nigel G.; Darras, Basil T.; Maciver, Sutherland K.; Dormitzer, Philip R.; Beggs, Alan H.			Nemaline myopathy with minicores caused by mutation of the CFL2 gene encoding the skeletal muscle actin-binding protein, cofilin-2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALPHA-TROPOMYOSIN GENE; RARE CAUSE; NEBULIN; TPM3	Nemaline myopathy (NM) is a congenital myopathy characterized by muscle weakness and nemaline bodies in affected myofibers. Five NM genes, all encoding components of the sarcomeric thin filament, are known. We report identification of a sixth gene, CFL2, encoding the actin-binding protein muscle cofilin-2, which is mutated in two siblings with congenital myopathy. The proband's muscle contained characteristic nemaline bodies, as well as occasional fibers with minicores, concentric laminated bodies, and areas of F-actin accumulation. Her affected sister's muscle was reported to exhibit nonspecific myopathic changes. Cofilin-2 levels were significantly lower in the proband's muscle, and the mutant protein was less soluble when expressed in Escherichia coli, suggesting that deficiency of cofilin-2 may result in reduced depolymerization of actin filaments, causing their accumulation in nemaline bodies, minicores, and, possibly, concentric laminated bodies.	Childrens Hosp, Div Genet, Dept Med, Boston, MA 02115 USA; Childrens Hosp, Genom Program, Dept Med, Boston, MA 02115 USA; Childrens Hosp, Div Neonatol, Dept Med, Boston, MA 02115 USA; Childrens Hosp, Mol Med Lab, Dept Med, Boston, MA 02115 USA; Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Univ Helsinki, Biomed Helsinki, Folkhalsan Inst Genet, Helsinki, Finland; Univ Helsinki, Biomed Helsinki, Dept Med Genet, Helsinki, Finland; Univ Western Australia, Queen Elizabeth II Med Ctr, Western Australian Inst Med Res, Mol Neurogenet Lab,Ctr Med Res, Nedlands, WA 6009, Australia; Univ Edinburgh, Coll Med, Ctr Integrat Physiol, Edinburgh EH8 9YL, Midlothian, Scotland	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Helsinki; University of Helsinki; University of Western Australia; University of Edinburgh	Beggs, AH (corresponding author), Childrens Hosp, Div Genet, Dept Med, 300 Longwood Ave, Boston, MA 02115 USA.	beggs@enders.tch.harvard.edu	Agrawal, Pankaj/ABG-8957-2021; Maciver, Sutherland Kester/H-6284-2019	Maciver, Sutherland Kester/0000-0001-8234-6061; Lehtokari, Vilma-Lotta/0000-0002-8276-0972; Laing, Nigel/0000-0001-5111-3732; Darras, Basil/0000-0002-1536-8145; Beggs, Alan/0000-0001-8818-0568	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044345] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR044345, AR44345] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Bonnemann CG, 2003, J NEUROL SCI, V206, P71, DOI 10.1016/S0022-510X(02)00341-6; Bowman GD, 2000, PROTEINS, V41, P374, DOI 10.1002/1097-0134(20001115)41:3<374::AID-PROT90>3.0.CO;2-F; Chan YM, 1998, BIOCHEM BIOPH RES CO, V248, P134, DOI 10.1006/bbrc.1998.8920; Donner K, 2002, NEUROMUSCULAR DISORD, V12, P151, DOI 10.1016/S0960-8966(01)00252-8; Gommans IMP, 2003, BRAIN, V126, P1545, DOI 10.1093/brain/awg162; IIDA K, 1992, CELL STRUCT FUNCT, V17, P39, DOI 10.1247/csf.17.39; Johnston JJ, 2000, AM J HUM GENET, V67, P814, DOI 10.1086/303089; LAING NG, 1995, NAT GENET, V9, P75, DOI 10.1038/ng0195-75; Lee YJ, 2005, MOL BIOTECHNOL, V31, P1, DOI 10.1385/MB:31:1:001; Maciver SK, 2002, GENOME BIOL, V3; North KN, 1997, J MED GENET, V34, P705, DOI 10.1136/jmg.34.9.705; Nowak KJ, 1999, NAT GENET, V23, P208, DOI 10.1038/13837; Ono S, 1999, J CELL BIOL, V145, P491, DOI 10.1083/jcb.145.3.491; Ono S, 2002, J CELL BIOL, V156, P1065, DOI 10.1083/jcb.200110013; PAYNE CM, 1976, J NEUROL SCI, V29, P311, DOI 10.1016/0022-510X(76)90180-5; Pelin K, 1999, P NATL ACAD SCI USA, V96, P2305, DOI 10.1073/pnas.96.5.2305; Ryan MM, 2003, NEUROLOGY, V60, P665, DOI 10.1212/01.WNL.0000046585.81304.BC; Ryan MM, 2001, ANN NEUROL, V50, P312, DOI 10.1002/ana.1080; Sanoudou D, 2001, TRENDS MOL MED, V7, P362, DOI 10.1016/S1471-4914(01)02089-5; Thirion C, 2001, EUR J BIOCHEM, V268, P3473, DOI 10.1046/j.1432-1327.2001.02247.x; Vartiainen MK, 2002, MOL BIOL CELL, V13, P183, DOI 10.1091/mbc.01-07-0331; Wallgren-Pettersson C, 2004, NEUROMUSCULAR DISORD, V14, P461, DOI 10.1016/j.nmd.2004.03.006; Wattanasirichaigoon D, 2002, NEUROLOGY, V59, P613, DOI 10.1212/WNL.59.4.613	24	167	175	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2007	80	1					162	167		10.1086/510402	http://dx.doi.org/10.1086/510402			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	120RG	17160903	Green Published, Bronze			2022-12-18	WOS:000243102500015
J	Carta, C; Pantaleoni, F; Bocchinfuso, G; Stella, L; Vasta, I; Sarkozy, A; Digilio, C; Palleschi, A; Pizzuti, A; Grammatico, P; Zampino, G; Dallapiccola, B; Gelb, BD; Tartaglia, M				Carta, Claudio; Pantaleoni, Francesca; Bocchinfuso, Gianfranco; Stella, Lorenzo; Vasta, Isabella; Sarkozy, Anna; Digilio, Cristina; Palleschi, Antonio; Pizzuti, Antonio; Grammatico, Paola; Zampino, Giuseppe; Dallapiccola, Bruno; Gelb, Bruce D.; Tartaglia, Marco			Germline missense mutations affecting KRAS isoform B are associated with a severe Noonan syndrome phenotype	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SOMATIC PTPN11 MUTATIONS; FACIO-CUTANEOUS SYNDROME; K-RAS; LEOPARD-SYNDROME; CANCER-THERAPY; GTP-BINDING; MOUSE MODEL; NF1 GENE; LEUKEMIA; MUTANTS	Noonan syndrome ( NS) is a developmental disorder characterized by short stature, facial dysmorphia, congenital heart disease, and multiple skeletal and hematologic defects. NS is an autosomal dominant trait and is genetically heterogeneous. Gain of function of SHP-2, a protein tyrosine phosphatase that positively modulates RAS signaling, is observed in nearly 50% of affected individuals. Here, we report the identification of heterozygous KRAS gene mutations in two subjects exhibiting a severe NS phenotype with features overlapping those of cardiofaciocutaneous and Costello syndromes. Both mutations were de novo and affected exon 6, which encodes the C-terminal portion of KRAS isoform B but does not contribute to KRAS isoform A. Structural analysis indicated that both substitutions ( Va1152Gly and Asp153Val) perturb the conformation of the guanine ring-binding pocket of the protein, predicting an increase in the guanine diphosphate/guanine triphosphate ( GTP) dissociation rate that would favor GTP binding to the KRASB isoform and bypass the requirement for a guanine nucleotide exchange factor.	Ist Super Sanita, Dipartimento Biol Cellulare & Neurosci, I-00161 Rome, Italy; Univ Roma Tor Vergata, Dipartimento Sci & Tecnol Chim, I-00161 Rome, Italy; Univ Cattolica Sacro Cuore, Ist Clin Pediat, Rome, Italy; Univ Roma La Sapienza, Dipartimento Med Sperimentale & Patol, Rome, Italy; Bambino Gesu Pediat Hosp, Ist CSS Mendel, Rome, Italy; Univ Roma La Sapienza, Dipartimento Med Sperimentale & Patol, Azienda Osped S Camillo Forlanini, Rome, Italy; IRCCS, CCS, San Giovanni Rotondo, Italy; CUNY Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA	Istituto Superiore di Sanita (ISS); University of Rome Tor Vergata; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Sapienza University Rome; IRCCS Bambino Gesu; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; Azienda Ospedaliera San Camillo-Forlanini; Sapienza University Rome; IRCCS Casa Sollievo Della Sofferenza; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Tartaglia, M (corresponding author), Ist Super Sanita, Dipartimento Biol Cellulare & Neurosci, Viale Regina Elena 299, I-00161 Rome, Italy.	mtartaglia@iss.it	palleschi, antonio/G-5464-2012; Carta, Claudio/A-7305-2013; Tartaglia, Marco/K-2955-2018; Zampino, Giuseppe/AAC-2152-2019; Stella, Lorenzo/A-7996-2010; Bocchinfuso, Gianfranco/E-9014-2011; Dallapiccola, Bruno/K-8692-2016	Carta, Claudio/0000-0003-3545-198X; Tartaglia, Marco/0000-0001-7736-9672; Stella, Lorenzo/0000-0002-5489-7381; Bocchinfuso, Gianfranco/0000-0002-5556-7691; PIZZUTI, Antonio/0000-0003-3245-1925; Dallapiccola, Bruno/0000-0002-5031-1013	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K24HD001294] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071207, P50HL074728] Funding Source: NIH RePORTER; NHLBI NIH HHS [P50 HL074728, R01 HL071207] Funding Source: Medline; NICHD NIH HHS [K24 HD001294] Funding Source: Medline; Telethon [GGP04172] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Telethon(Fondazione Telethon)		Adjei AA, 2001, JNCI-J NATL CANCER I, V93, P1062, DOI 10.1093/jnci/93.14.1062; ALLANSON JE, 1987, J MED GENET, V24, P9, DOI 10.1136/jmg.24.1.9; Aoki Y, 2005, NAT GENET, V37, P1038, DOI 10.1038/ng1641; Araki T, 2004, NAT MED, V10, P849, DOI 10.1038/nm1084; Baralle D, 2003, AM J MED GENET A, V119A, P1, DOI 10.1002/ajmg.a.20023; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BOS JL, 1989, CANCER RES, V49, P4682; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chan RJ, 2005, BLOOD, V105, P3737, DOI 10.1182/blood-2004-10-4002; CLANTON DJ, 1986, P NATL ACAD SCI USA, V83, P5076, DOI 10.1073/pnas.83.14.5076; De Luca A, 2005, AM J HUM GENET, V77, P1092, DOI 10.1086/498454; DER CJ, 1986, MOL CELL BIOL, V6, P3291, DOI 10.1128/MCB.6.9.3291; Digilio MC, 2002, AM J HUM GENET, V71, P389, DOI 10.1086/341528; FEIG LA, 1986, P NATL ACAD SCI USA, V83, P4607, DOI 10.1073/pnas.83.13.4607; Fragale A, 2004, HUM MUTAT, V23, P267, DOI 10.1002/humu.20005; Friday BB, 2005, BBA-REV CANCER, V1756, P127, DOI 10.1016/j.bbcan.2005.08.001; Herrmann C, 2003, CURR OPIN STRUC BIOL, V13, P122, DOI 10.1016/S0959-440X(02)00007-6; JAMIESON CR, 1994, NAT GENET, V8, P357, DOI 10.1038/ng1294-357; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; Kavamura MI, 2002, AM J MED GENET, V112, P12, DOI 10.1002/ajmg.10681; Keilhack H, 2005, J BIOL CHEM, V280, P30984, DOI 10.1074/jbc.M504699200; Koera K, 1997, ONCOGENE, V15, P1151, DOI 10.1038/sj.onc.1201284; Kontaridis MI, 2006, J BIOL CHEM, V281, P6785, DOI 10.1074/jbc.M513068200; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Legius E, 2002, J MED GENET, V39, P571, DOI 10.1136/jmg.39.8.571; Loh ML, 2004, BLOOD, V103, P2325, DOI 10.1182/blood-2003-09-3287; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Marino B, 1999, J PEDIATR-US, V135, P703, DOI 10.1016/S0022-3476(99)70088-0; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Mitin N, 2005, CURR BIOL, V15, pR563, DOI 10.1016/j.cub.2005.07.010; Mohi MG, 2005, CANCER CELL, V7, P179, DOI 10.1016/j.ccr.2005.01.010; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Niihori T, 2006, NAT GENET, V38, P294, DOI 10.1038/ng1749; NOONAN JA, 1994, CLIN PEDIATR, V33, P548, DOI 10.1177/000992289403300907; NOONAN JA, 1968, AM J DIS CHILD, V116, P373, DOI 10.1001/archpedi.1968.02100020377005; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Plowman SJ, 2003, MOL CELL BIOL, V23, P9245, DOI 10.1128/MCB.23.24.9245-9250.2003; PROUD CG, 1986, TRENDS BIOCHEM SCI, V11, P73, DOI 10.1016/0968-0004(86)90269-0; Rodriguez-Viciana P, 2006, SCIENCE, V311, P1287, DOI 10.1126/science.1124642; Schubbert S, 2006, NAT GENET, V38, P331, DOI 10.1038/ng1748; Schubbert S, 2005, BLOOD, V106, P311, DOI 10.1182/blood-2004-11-4207; SIGAL IS, 1986, P NATL ACAD SCI USA, V83, P4725, DOI 10.1073/pnas.83.13.4725; Silvius JR, 2002, J MEMBRANE BIOL, V190, P83, DOI 10.1007/s00232-002-1026-4; Tartaglia M, 2006, AM J HUM GENET, V78, P279, DOI 10.1086/499925; Tartaglia M, 2005, ANNU REV GENOM HUM G, V6, P45, DOI 10.1146/annurev.genom.6.080604.162305; Tartaglia M, 2004, BLOOD, V104, P307, DOI 10.1182/blood-2003-11-3876; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tartaglia M, 2002, AM J HUM GENET, V70, P1555, DOI 10.1086/340847; VANDERBURGT I, 1994, AM J MED GENET, V53, P187, DOI 10.1002/ajmg.1320530213; Venanzi M, 2006, CHEMBIOCHEM, V7, P43, DOI 10.1002/cbic.200500271; WALTER M, 1986, SCIENCE, V233, P649, DOI 10.1126/science.3487832; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wittinghofer A, 2000, ANGEW CHEM INT EDIT, V39, P4193, DOI 10.1002/1521-3773(20001201)39:23<4192::AID-ANIE4192>3.0.CO;2-Y	55	167	179	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2006	79	1					129	135		10.1086/504394	http://dx.doi.org/10.1086/504394			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	053YD	16773572	Green Published, Bronze			2022-12-18	WOS:000238341200013
J	Quack, I; Vonderstrass, B; Stock, M; Aylsworth, AS; Becker, A; Brueton, L; Lee, PJ; Majewski, F; Mulliken, JB; Suri, M; Zenker, M; Mundlos, S; Otto, F				Quack, I; Vonderstrass, B; Stock, M; Aylsworth, AS; Becker, A; Brueton, L; Lee, PJ; Majewski, F; Mulliken, JB; Suri, M; Zenker, M; Mundlos, S; Otto, F			Mutation analysis of cove binding factor A1 in patients with cleidocranial dysplasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSCRIPTION FACTOR OSF2/CBFA1; OSTEOBLAST DIFFERENTIATION; ALPHA-SUBUNIT; BETA-SUBUNIT; DNA-BINDING; GENE; CBFA1; EXPRESSION; FAMILY; HEMATOPOIESIS	Cleidocranial dysplasia (CCD) is a dominantly inherited disorder characterized by patent fontanelles, wide cranial sutures, hypoplasia of clavicles, short stature, supernumerary teeth, and other skeletal anomalies. We recently demonstrated that mutations in the transcription factor CBFA1, on chromosome 6p21, are associated with CCD. We have now analyzed the CBFA1 gene in 42 unrelated patients with CCD. In 18 patients, mutations were detected in the coding region of the CBFA1 gene, including 8 frameshift, 2 nonsense, and 9 missense mutations, as well as 2 novel polymorphisms. A cluster of missense mutations at arginine 225 (R225) identifies this residue as crucial for CBFA1 function. In vitro green fluorescent protein fusion studies show that R225 mutations interfere with nuclear accumulation of CBFA1 protein. There is no phenotypic difference between patients with deletions or frameshifts and those with other intragenic mutations, suggesting that CCD is generally caused by haploinsufficiency. However, we were able to extend the CCD phenotypic spectrum. A missense mutation identified in one family with supernumerary teeth and a radiologically normal skeleton indicates that mutations in CBFA1 can be associated exclusively with a dental phenotype. In addition, one patient with severe CCD and a frameshift mutation in codon 402 had osteoporosis leading to recurrent bone fractures and scoliosis, providing first evidence that CBFA1 may help maintain adult bone, in addition to its function in bone development.	Univ Mainz Klinikum, Kinderklin, Mainz, Germany; Univ Freiburg, Med Ctr, Dept Hematol Oncol, D-7800 Freiburg, Germany; Univ N Carolina, Dept Pediat, Div Genet & Metab, Chapel Hill, NC USA; Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Fac Med Dent, Dept Orthodont, Jerusalem, Israel; NW Thames Reg Genet Serv, Kennedy Galton Ctr, Harrow, Middx, England; UCL Hosp, Middlesex Hosp, Metab Unit, London, England; Univ Dusseldorf, Inst Humangenet & Anthropol, D-4000 Dusseldorf, Germany; Harvard Univ, Childrens Hosp, Sch Med, Div Plast Surg, Boston, MA 02115 USA; City Hosp, Dept Clin Genet, Nottingham NG5 1PB, England; Univ Erlangen Nurnberg, Inst Humangenet, D-8520 Erlangen, Germany	Johannes Gutenberg University of Mainz; University of Freiburg; University of North Carolina; University of North Carolina Chapel Hill; Hebrew University of Jerusalem; University College London Hospitals NHS Foundation Trust; University of London; University College London; Heinrich Heine University Dusseldorf; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Nottingham; University of Erlangen Nuremberg	Mundlos, S (corresponding author), Johannes Gutenberg Univ Mainz, Kinderklin, Langenbeckstr 1, D-55101 Mainz, Germany.	mundlos@kinder.klinik.uni-mainz.de; otto@mm11.ukl.uni-freiburg.de	Mundlos, Stefan/ABH-9585-2020; Stock, Michael/B-9829-2009	Mundlos, Stefan/0000-0002-9788-3166; Stock, Michael/0000-0002-3322-0961				AKESON AL, 1989, J CELL BIOCHEM, V39, P217, DOI 10.1002/jcb.240390302; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Geoffroy V, 1998, MAMM GENOME, V9, P54, DOI 10.1007/s003359900679; Hashimoto S, 1996, BLOOD, V88, P561, DOI 10.1182/blood.V88.2.561.bloodjournal882561; Huang LF, 1997, DEV DYNAM, V210, P33, DOI 10.1002/(SICI)1097-0177(199709)210:1<33::AID-AJA4>3.0.CO;2-2; Kagoshima H, 1996, J BIOL CHEM, V271, P33074, DOI 10.1074/jbc.271.51.33074; Kanno T, 1998, MOL CELL BIOL, V18, P2444, DOI 10.1128/MCB.18.5.2444; Kim IS, 1999, MECH DEVELOP, V80, P159, DOI 10.1016/S0925-4773(98)00210-X; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lee B, 1997, NAT GENET, V16, P307, DOI 10.1038/ng0797-307; LEVANON D, 1994, GENOMICS, V23, P425, DOI 10.1006/geno.1994.1519; Lindenmuth DM, 1997, J CELL BIOCHEM, V66, P123; Mundlos S, 1999, J MED GENET, V36, P177; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; MUNDLOS S, 1995, HUM MOL GENET, V4, P71, DOI 10.1093/hmg/4.1.71; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; RedfordBadwal DA, 1996, J CLIN INVEST, V97, P1035, DOI 10.1172/JCI118495; STIFANI S, 1992, NAT GENET, V2, P119, DOI 10.1038/ng1092-119; Thirunavukkarasu K, 1998, MOL CELL BIOL, V18, P4197, DOI 10.1128/MCB.18.7.4197; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Xiao ZS, 1998, GENE, V214, P187, DOI 10.1016/S0378-1119(98)00227-3	24	167	180	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1999	65	5					1268	1278		10.1086/302622	http://dx.doi.org/10.1086/302622			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252YZ	10521292	Bronze, Green Published			2022-12-18	WOS:000083531000008
J	vanBeijsterveldt, CEM; Molenaar, PCM; deGeus, EJC; Boomsma, DI				vanBeijsterveldt, CEM; Molenaar, PCM; deGeus, EJC; Boomsma, DI			Heritability of human brain functioning as assessed by electroencephalography	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TEST-RETEST RELIABILITY; EEG; AMPLITUDE; LISREL; TWINS	To study the genetic and environmental contributions to individual differences in CNS functioning, the electroencephalogram (EEG) was measured in 213 twin pairs age 16 years. EEG was measured in 91 MZ and 122 DZ twins. To quantify sex differences in the genetic architecture, EEG was measured in female and male same-sex twins and in opposite-sex twins. EEG was recorded on 14 scalp positions during quiet resting with eyes closed. Spectral powers were calculated for four frequency bands: delta, theta, alpha, and beta, Twin correlations pointed toward high genetic influences for all these powers and scalp locations. Model fitting confirmed these findings; the largest part of the variance of the EEG is explained by additive genetic factors. The averaged heritabilities for the delta, theta, alpha, and beta frequencies was 76%, 89%, 83%, and 86%, respectively. Multivariate analyses suggested that the same genes for EEG alpha rhythm were expressed in different brain areas in the left and right hemisphere. This study shows that brain functioning, as indexed by rhythmic brain-electrical activity, is one of the most heritable characteristics in humans.	UNIV AMSTERDAM,DEPT PSYCHOL,AMSTERDAM,NETHERLANDS	University of Amsterdam	vanBeijsterveldt, CEM (corresponding author), FREE UNIV AMSTERDAM,DEPT PSYCHOPHYSIOL,BOELELAAN 1111,1081 HV AMSTERDAM,NETHERLANDS.		Boomsma, Dorret I/AAX-4470-2020; de Geus, Eco J.C./M-9318-2015	de Geus, Eco J.C./0000-0001-6022-2666; van Beijsterveldt, Toos/0000-0002-6617-4201				ANOKHIN A, 1992, HUM GENET, V90, P99; ANOKHIN AP, 1987, PSIKHOL ZH, V8, P146; [Anonymous], 1975, TIME SERIES DATA ANA; BOOMSMA D, 1994, PSYCHOPHYSIOLOGY, V89, P219; BOOMSMA DI, 1994, ADDICTION, V89, P219, DOI 10.1111/j.1360-0443.1994.tb00881.x; BOOMSMA DI, 1985, PSYCHOPHYSIOLOGY, V22, P249, DOI 10.1111/j.1469-8986.1985.tb01596.x; BOOMSMA DI, 1986, BEHAV GENET, V16, P237, DOI 10.1007/BF01070799; BURGESS A, 1993, ELECTROEN CLIN NEURO, V86, P219, DOI 10.1016/0013-4694(93)90101-Z; CHRISTIAN JC, 1988, GENET EPIDEMIOL, V5, P217, DOI 10.1002/gepi.1370050403; Davis H, 1936, ARCH NEURO PSYCHIATR, V36, P1214, DOI 10.1001/archneurpsyc.1936.02260120061004; EAVES LJ, 1978, HEREDITY, V41, P249, DOI 10.1038/hdy.1978.101; Fisher K., 1994, HUMAN BEHAV DEV BRAI, P3; GASSER T, 1988, ELECTROEN CLIN NEURO, V69, P91, DOI 10.1016/0013-4694(88)90204-0; GASSER T, 1985, ELECTROEN CLIN NEURO, V60, P312, DOI 10.1016/0013-4694(85)90005-7; GEVINS A, 1991, ANN NY ACAD SCI, V260, P22; HEATH AC, 1989, BEHAV GENET, V19, P9, DOI 10.1007/BF01065881; HUDSPETH WJ, 1990, J EDUC PSYCHOL, V82, P881, DOI 10.1037/0022-0663.82.4.881; JASPER HH, 1958, ELECTROENCEPHALOGRAP, V10, P370, DOI DOI 10.1016/0013-4694(58)90053-1; Joreskog KG, 1986, PRELIS PREPROCESSOR; LENNOX WG, 1945, J HERED, V36, P233; Lykken D T, 1974, Biol Psychol, V1, P245, DOI 10.1016/0301-0511(74)90001-5; MARTIN NG, 1977, HEREDITY, V38, P79, DOI 10.1038/hdy.1977.9; Matousek M., 1973, AUTOMATION CLIN ELEC, P75; MATSUURA M, 1985, ELECTROENCEPHALOGR C, V60, P393; Meshkova T, 1982, EVOLUTION DETERMINAT, P92; Neale M.C.C.L., 2013, METHODOLOGY GENETIC, V67, DOI DOI 10.1007/978-94-015-8018-2; NEALE MC, 1994, MX STATISTICAL MODEL; NUNEZ PL, 1981, ELECTRIC FIELDS BRAI; PIVIK RT, 1993, PSYCHOPHYSIOLOGY, V30, P547, DOI 10.1111/j.1469-8986.1993.tb02081.x; POLLOCK VE, 1991, ELECTROEN CLIN NEURO, V79, P20, DOI 10.1016/0013-4694(91)90152-T; Raney ET, 1939, J EXP PSYCHOL, V24, P21, DOI 10.1037/h0054799; RIJSDIJK FV, 1995, BEHAV GENET, V25, P341, DOI 10.1007/BF02197283; SALINSKY MC, 1991, ELECTROEN CLIN NEURO, V79, P382, DOI 10.1016/0013-4694(91)90203-G; SIMONOVA O, 1967, ACTA U CAROL MED, V13, P543; STASSEN HH, 1987, ELECTROEN CLIN NEURO, V66, P489, DOI 10.1016/0013-4694(87)90095-2; STEINLEIN O, 1992, GENOMICS, V12, P69, DOI 10.1016/0888-7543(92)90408-K; STEINMETZ H, 1994, NEW ENGL J MED, V331, P952, DOI 10.1056/NEJM199410063311419; STERIADE M, 1990, ELECTROEN CLIN NEURO, V76, P481, DOI 10.1016/0013-4694(90)90001-Z; THATCHER RW, 1992, BRAIN COGNITION, V20, P24, DOI 10.1016/0278-2626(92)90060-Y; THATCHER RW, 1987, SCIENCE, V236, P1110, DOI 10.1126/science.3576224; TRUBNIKOV V, 1993, BEHAV GENET, V23, P455, DOI 10.1007/BF01067980; Van Baal G. C. M., 1994, Behavior Genetics, V24, P534; VANBEIJSTERVELDT CEM, 1994, HUM GENET, V94, P319, DOI 10.1007/BF00201587; VOGEL F, 1970, HUMANGENETIK, V10, P91, DOI 10.1007/BF00295509; Vogel F., 1958, ERBLICHKEIT NORMALEN	45	167	169	0	10	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1996	58	3					562	573						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	TV564	8644716				2022-12-18	WOS:A1996TV56400015
J	GREENBERG, F; ELDER, FFB; HAFFNER, P; NORTHRUP, H; LEDBETTER, DH				GREENBERG, F; ELDER, FFB; HAFFNER, P; NORTHRUP, H; LEDBETTER, DH			CYTOGENETIC FINDINGS IN A PROSPECTIVE SERIES OF PATIENTS WITH DIGEORGE ANOMALY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											GREENBERG, F (corresponding author), BAYLOR COLL MED, INST MOLEC GENET, ONE BAYLOR PLAZA, HOUSTON, TX 77030 USA.				NCRR NIH HHS [RR05-425-23] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		AUGUSSEAU S, 1986, HUM GENET, V74, P206, DOI 10.1007/BF00282098; BACK E, 1980, ANN GENET-PARIS, V23, P244; BOWEN P, 1986, CLIN GENET, V29, P174; BRIDGMAN G, 1980, ARCH DIS CHILD, V55, P474, DOI 10.1136/adc.55.6.474; CONLEY ME, 1979, J PEDIATR-US, V94, P883, DOI 10.1016/S0022-3476(79)80207-3; DEBEVEC M, 1986, 7TH INT C HUM GEN BE, V1, P74; DECICCO F, 1973, J PEDIATR-US, V83, P836, DOI 10.1016/S0022-3476(73)80382-8; DELACHAPELLE A, 1981, HUM GENET, V57, P253, DOI 10.1007/BF00278938; FAED MJW, 1987, J MED GENET, V24, P225, DOI 10.1136/jmg.24.4.225; FIBISON W J, 1987, American Journal of Human Genetics, V41, pA119; FIREMAN P, 1965, J PEDIATR-US, V67, P907; GENCIK A, 1983, J MED GENET, V20, P107, DOI 10.1136/jmg.20.2.107; GREENBERG F, 1986, J PEDIATR-US, V109, P489, DOI 10.1016/S0022-3476(86)80124-X; GREENBERG F, 1984, HUM GENET, V65, P317, DOI 10.1007/BF00291554; GREENBERG F, IN PRESS AM J MED GE; HARNDEN DG, 1985, CELL GENE; HERVE J, 1984, ANN PEDIATR-PARIS, V31, P77; KELLEY RI, 1982, J PEDIATR-US, V101, P197, DOI 10.1016/S0022-3476(82)80116-9; KOENIG R, 1985, ANN GENET-PARIS, V28, P173; Lammer E J, 1986, Am J Med Genet Suppl, V2, P113, DOI 10.1002/ajmg.1320250615; LEDBETTER DH, 1982, AM J HUM GENET, V34, P278; MALLETTE LE, 1982, J CLIN ENDOCR METAB, V54, P1017, DOI 10.1210/jcem-54-5-1017; ROSENTHA.IM, 1972, PEDIATR RES, V6, P358; Schinzel A, 1984, CATALOGUE UNBALANCED; SCHWANITZ G, 1987, ANN GENET-PARIS, V30, P80; TAYLOR MJ, 1981, AM J MED GENET, V9, P5, DOI 10.1002/ajmg.1320090103; TOWNES PL, 1978, AM J DIS CHILD, V132, P498, DOI 10.1001/archpedi.1978.02120300058012; VANDENBE.H, 1973, HUMANGENETIK, V18, P225; YUNIS JJ, 1976, SCIENCE, V191, P1268, DOI 10.1126/science.1257746	29	167	170	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1988	43	5					605	611						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q9336	3189331				2022-12-18	WOS:A1988Q933600006
J	Zhu, HJ; Patrick, KS; Yuan, HJ; Wang, JS; Donovan, JL; DeVane, CL; Malcolm, R; Johnson, JA; Youngblood, GL; Sweet, DH; Langaee, TY; Markowitz, JS				Zhu, Hao-Jie; Patrick, Kennerly S.; Yuan, Hong-Jie; Wang, Jun-Sheng; Donovan, Jennifer L.; DeVane, C. Lindsay; Malcolm, Robert; Johnson, Julie A.; Youngblood, Geri L.; Sweet, Douglas H.; Langaee, Tairnour Y.; Markowitz, John S.			Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: Clinical significance and molecular basis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; METHYLPHENIDATE; PHARMACODYNAMICS; PHARMACOKINETICS; PHARMACOLOGY; ENANTIOMERS; METABOLISM; DISCOVERY; ETHANOL; DESIGN	The human carboxylesterase 1 (CES1) gene encodes for the enzyme carboxylesterase 1, a serine esterase governing both metabolic deactivation and activation of numerous therapeutic agents. During the course of a study of the pharmacokinetics of the methyl ester racemic psychostimulant methylphenidate, profoundly elevated methylphenidate plasma concentrations, unprecedented distortions in isomer disposition, and increases in hemodynamic measures were observed in a subject of European descent. These observations led to a focused study of the subject's CES1 gene. DNA sequencing detected two coding region single-nucleotide mutations located in exons 4 and 6. The mutation in exon 4 is located in codon 143 and leads to a nonconservative substitution, p.Gly143Glu. A deletion in exon 6 at codon 260 results in a frameshift mutation, p.Asp260fs, altering residues 260-299 before truncating at a premature stop codon. The minor allele frequency of p.Gly143Glu was determined to be 3.7%, 4.3%, 2.0%, and 0% in white, black, Hispanic, and Asian populations, respectively. Of 925 individual DNA samples examined, none carried the p.Asp260fs, indicating it is an extremely rare mutation. In vitro functional studies demonstrated the catalytic functions of both p.Gly143Glu and p.Asp260fs are substantially impaired, resulting in a complete loss of hydrolytic activity toward methylphenidate. When a more sensitive esterase substrate, p-nitrophenyl acetate was utilized, only 21.4% and 0.6% catalytic efficiency (V-max/K-m) were determined in p.Gly143Glu and p.Asp260fs, respectively, compared to the wild-type enzyme. These findings indicate that specific CES1 gene variants can lead to clinically significant alterations in pharmacokinetics and drug response of carboxylesterase 1 substrates.	[Zhu, Hao-Jie; Patrick, Kennerly S.; Youngblood, Geri L.; Sweet, Douglas H.; Markowitz, John S.] Med Univ S Carolina, Dept Pharmaceut & Biomed Sci, Charleston, SC 29425 USA; [Zhu, Hao-Jie; Yuan, Hong-Jie; Wang, Jun-Sheng; Donovan, Jennifer L.; DeVane, C. Lindsay; Markowitz, John S.] Med Univ S Carolina, Charles P Darby Childrens Res Inst, Lab Drug Disposit & Pharmacogenet, Charleston, SC 29425 USA; [Yuan, Hong-Jie; Wang, Jun-Sheng; Donovan, Jennifer L.; DeVane, C. Lindsay; Malcolm, Robert; Markowitz, John S.] Med Univ S Carolina, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA; [Johnson, Julie A.; Langaee, Tairnour Y.] Univ Florida, Dept Pharm Practice, Gainesville, FL 32610 USA; [Johnson, Julie A.; Langaee, Tairnour Y.] Univ Florida, Ctr Pharmacogenom, Gainesville, FL 32610 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Markowitz, JS (corresponding author), Med Univ S Carolina, Dept Pharmaceut & Biomed Sci, Charleston, SC 29425 USA.	markowij@musc.edu	Sweet, Douglas H/H-7914-2013; DeVane, Lindsay/B-6645-2012; Zhu, Hao-Jie/F-4794-2012	Sweet, Douglas H/0000-0002-8911-9184; Zhu, Hao-Jie/0000-0002-2248-4419	NCRR NIH HHS [M01 RR001070, M01 RR01070-18] Funding Source: Medline; NHLBI NIH HHS [R01 HL074730, R01 HL74730] Funding Source: Medline; NIAAA NIH HHS [R01 AA-016707, R01 AA016707] Funding Source: Medline; NIDA NIH HHS [R01 DA-15797, R01 DA015797] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001070] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015797] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Beaumont K, 2003, CURR DRUG METAB, V4, P461, DOI 10.2174/1389200033489253; Biederman J, 2005, BIOL PSYCHIAT, V57, P1215, DOI 10.1016/j.biopsych.2004.10.020; Brunner M, 2007, AM J CARDIOL, V99, P1549, DOI 10.1016/j.amjcard.2007.01.029; Faraone Stephen V, 2003, World Psychiatry, V2, P104; Findling RL, 2001, J AM ACAD CHILD PSY, V40, P525, DOI 10.1097/00004583-200105000-00011; Fleming CD, 2005, J MOL BIOL, V352, P165, DOI 10.1016/j.jmb.2005.07.016; Geshi E, 2005, HYPERTENS RES, V28, P719, DOI 10.1291/hypres.28.719; Imai T, 2006, DRUG METAB PHARMACOK, V21, P173, DOI 10.2133/dmpk.21.173; Kelly RP, 2005, J CLIN PHARMACOL, V45, P851, DOI 10.1177/0091270005276737; Laizure SC, 2003, DRUG METAB DISPOS, V31, P16, DOI 10.1124/dmd.31.1.16; Markowitz JS, 2008, J CLIN PSYCHOPHARM, V28, pS54, DOI 10.1097/JCP.0b013e3181733560; Markowitz JS, 2003, PHARMACOTHERAPY, V23, P1281, DOI 10.1592/phco.23.12.1281.32697; Masson P, 2007, BBA-PROTEINS PROTEOM, V1774, P16, DOI 10.1016/j.bbapap.2006.10.012; McGough JJ, 2005, BIOL PSYCHIAT, V57, P1367, DOI 10.1016/j.biopsych.2004.10.021; Patrick KS, 2007, CLIN PHARMACOL THER, V81, P346, DOI 10.1038/sj.clpt.6100082; Patrick Kennerly S, 2005, Expert Opin Drug Deliv, V2, P121; PATRICK KS, 1987, J PHARMACOL EXP THER, V241, P152; PATRICK KS, 1981, J MED CHEM, V24, P1237, DOI 10.1021/jm00142a021; Penny KI, 1996, APPL STAT-J ROY ST C, V45, P73, DOI 10.2307/2986224; Redinbo MR, 2003, BIOCHEM SOC T, V31, P620, DOI 10.1042/BST0310620; Rosner B., 2000, FUNDAMENTALS BIOSTAT; Satoh T, 2002, DRUG METAB DISPOS, V30, P488, DOI 10.1124/dmd.30.5.488; Shi DS, 2006, J PHARMACOL EXP THER, V319, P1477, DOI 10.1124/jpet.106.111807; SOLDIN SJ, 1979, CLIN CHEM, V25, P401; Sun ZJ, 2004, J PHARMACOL EXP THER, V310, P469, DOI 10.1124/jpet.104.067116; Volkow ND, 2003, PSYCHOPHARMACOLOGY, V166, P264, DOI 10.1007/s00213-002-1340-7; Zhang JH, 2003, PHARM RES, V20, P1881, DOI 10.1023/B:PHAM.0000003389.77585.be	27	166	180	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2008	82	6					1241	1248		10.1016/j.ajhg.2008.04.015	http://dx.doi.org/10.1016/j.ajhg.2008.04.015			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	312CP	18485328	Bronze, Green Published			2022-12-18	WOS:000256647000002
J	Zuchner, S; Wang, GF; Tran-Viet, KN; Nance, MA; Gaskell, PC; Vance, JM; Ashley-Koch, AE; Pericak-Vance, MA				Zuchner, Stephan; Wang, Gaofeng; Tran-Viet, Khanh-Nhat; Nance, Martha A.; Gaskell, Perry C.; Vance, Jeffery M.; Ashley-Koch, Allison E.; Pericak-Vance, Margaret A.			Mutations in the novel mitochondrial protein REEP1 cause hereditary spastic paraplegia type 31	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							REPRESSION; EXPRESSION; MICRORNAS	Hereditary spastic paraplegia (HSP) comprises a group of clinically and genetically heterogeneous diseases that affect the upper motor neurons and their axonal projections. For the novel SPG31 locus on chromosome 2p12, we identified six different mutations in the receptor expression-enhancing protein 1 gene (REEP1). REEP1 mutations occurred in 6.5% of the patients with HSP in our sample, making it the third-most common HSP gene. We show that REEP1 is widely expressed and localizes to mitochondria, which underlines the importance of mitochondrial function in neurodegenerative disease.	Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; Pk Nicollet Clin, Minneapolis, MN USA	Duke University; Duke University	Zuchner, S (corresponding author), Duke Univ, Med Ctr, Ctr Human Genet, 595 LaSalle St,Box 3445, Durham, NC 27710 USA.	szuchner@chg.duhs.duke.edu		Vance, Jeffery/0000-0003-3815-8199; Ashley-Koch, Allison/0000-0001-5409-9155				Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Chen GC, 2002, ANTICANCER RES, V22, P633; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Fink JK, 2003, EXP NEUROL, V184, pS106, DOI 10.1016/j.expneurol.2003.08.005; Hansen JJ, 2002, AM J HUM GENET, V70, P1328, DOI 10.1086/339935; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Reid E, 2002, AM J HUM GENET, V71, P1189, DOI 10.1086/344210; Reid E, 1999, J NEUROL, V246, P995, DOI 10.1007/s004150050503; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Saxena S, 2005, J NEUROSCI, V25, P10930, DOI 10.1523/JNEUROSCI.2029-05.2005; Verhoeven K, 2003, AM J HUM GENET, V72, P722, DOI 10.1086/367847; Zuchner S, 2006, NEUROGENETICS, V7, P127, DOI 10.1007/s10048-006-0029-1; Zuchner S, 2005, J MOL MED-JMM, V83, P935, DOI 10.1007/s00109-005-0694-9	15	166	172	0	14	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2006	79	2					365	369		10.1086/505361	http://dx.doi.org/10.1086/505361			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	063SR	16826527	Bronze, Green Published			2022-12-18	WOS:000239040400018
J	Schaeffer, AJ; Chung, J; Heretis, K; Wong, A; Ledbetter, DH; Martin, CL				Schaeffer, AJ; Chung, J; Heretis, K; Wong, A; Ledbetter, DH; Martin, CL			Comparative genomic hybridization-array analysis enhances the detection of aneuploidies and submicroscopic imbalances in spontaneous miscarriages	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HIGH-RESOLUTION ANALYSIS; CYTOGENETIC ANALYSIS; CHROMOSOME; ABERRATION; PATIENT; CGH	Miscarriage is a condition that affects 10%-15% of all clinically recognized pregnancies, most of which occur in the first trimester. Approximately 50% of first-trimester miscarriages result from fetal chromosome abnormalities. Currently, G-banded chromosome analysis is used to determine if large-scale genetic imbalances are the cause of these pregnancy losses. This technique relies on the culture of cells derived from the fetus, a technique that has many limitations, including a high rate of culture failure, maternal overgrowth of fetal cells, and poor chromosome morphology. Comparative genomic hybridization (CGH)-array analysis is a powerful new molecular cytogenetic technique that allows genomewide analysis of DNA copy number. By hybridizing patient DNA and normal reference DNA to arrays of genomic clones, unbalanced gains or losses of genetic material across the genome can be detected. In this study, 41 product-of-conception (POC) samples, which were previously analyzed by G-banding, were tested using CGH arrays to determine not only if the array could identify all reported abnormalities, but also whether any previously undetected genomic imbalances would be discovered. The array methodology detected all abnormalities as reported by G-banding analysis and revealed new abnormalities in 4/41 (9.8%) cases. Of those, one trisomy 21 POC was also mosaic for trisomy 20, one had a duplication of the 10q telomere region, one had an interstitial deletion of chromosome 9p, and the fourth had an interstitial duplication of the Prader-Willi/Angelman syndrome region on chromosome 15q, which, if maternally inherited, has been implicated in autism. This retrospective study demonstrates that the DNA-based CGH-array technology overcomes many of the limitations of routine cytogenetic analysis of POC samples while enhancing the detection of fetal chromosome aberrations.	Emory Univ, Dept Human Genet, Sch Med, Atlanta, GA 30322 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	Emory University; University of Chicago	Martin, CL (corresponding author), Emory Univ, Dept Human Genet, Sch Med, 615 Michael St,Room 315, Atlanta, GA 30322 USA.	clmartin@genetics.emory.edu						Albertson DG, 2003, HUM MOL GENET, V12, pR145, DOI 10.1093/hmg/ddg261; Bell GJ, 1999, NAV RES LOG, V46, P341, DOI 10.1002/(SICI)1520-6750(199906)46:4<341::AID-NAV1>3.0.CO;2-A; Bell KA, 2001, FERTIL STERIL, V75, P374, DOI 10.1016/S0015-0282(00)01703-9; Cai WW, 2002, NAT BIOTECHNOL, V20, P393, DOI 10.1038/nbt0402-393; Cook EH, 1997, AM J HUM GENET, V60, P928; Daniely M, 1998, HUM REPROD, V13, P805, DOI 10.1093/humrep/13.4.805; Fritz B, 2001, EUR J HUM GENET, V9, P539, DOI 10.1038/sj.ejhg.5200669; Goddijn M, 2000, BEST PRACT RES CL OB, V14, P855, DOI 10.1053/beog.2000.0124; Gunn SR, 2003, AM J MED GENET A, V120A, P127, DOI 10.1002/ajmg.a.20026; HASSOLD T, 1980, ANN HUM GENET, V44, P151, DOI 10.1111/j.1469-1809.1980.tb00955.x; Hodgson G, 2001, NAT GENET, V29, P459, DOI 10.1038/ng771; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; Ki A, 2003, AM J MED GENET A, V120A, P365, DOI 10.1002/ajmg.a.20236; Kirchhoff M, 2001, J MED GENET, V38, P740, DOI 10.1136/jmg.38.11.740; Lomax B, 2000, AM J HUM GENET, V66, P1516, DOI 10.1086/302878; Paris PL, 2003, AM J PATHOL, V162, P763, DOI 10.1016/S0002-9440(10)63873-4; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Schwaenen C, 2003, ANN HEMATOL, V82, P323, DOI 10.1007/s00277-003-0649-6; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754; Tabet AC, 2001, PRENATAL DIAG, V21, P613, DOI 10.1002/pd.115; Veltman JA, 2002, AM J HUM GENET, V70, P1269, DOI 10.1086/340426; Vissers LELM, 2003, AM J HUM GENET, V73, P1261, DOI 10.1086/379977	22	166	186	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2004	74	6					1168	1174		10.1086/421250	http://dx.doi.org/10.1086/421250			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	823ZB	15127362	Green Published, Bronze			2022-12-18	WOS:000221651900009
J	Wang, Q; Rao, SQ; Shen, GQ; Li, L; Moliterno, DJ; Newby, LK; Rogers, WJ; Cannata, R; Zirzow, E; Elston, RC; Topol, EJ				Wang, Q; Rao, SQ; Shen, GQ; Li, L; Moliterno, DJ; Newby, LK; Rogers, WJ; Cannata, R; Zirzow, E; Elston, RC; Topol, EJ			Premature myocardial infarction novel susceptibility locus on chromosome 1P34-36 identified by genomewide linkage analysis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CORONARY HEART-DISEASE; COMPLEX TRAITS; QUANTITATIVE TRAIT; MULTIPLE; GENE; ATHEROSCLEROSIS; POLYMORPHISMS; SIBSHIPS; SUGGESTS; HASEMAN	The most frequent causes of death and disability in the Western world are atherosclerotic coronary artery disease <LF>(CAD) and acute myocardial infarction (MI). This common disease is thought to have a polygenic basis with a complex interaction with environmental factors. Here, we report results of a genomewide search for susceptibility genes for MI in a well-characterized U. S. cohort consisting of 1,613 individuals in 428 multiplex families with familial premature CAD and MI: 712 with MI, 974 with CAD, and average age of onset of 44.4+/-9.7 years. Genotyping was performed at the National Heart, Lung, and Blood Institute Mammalian Genotyping Facility through use of 408 markers that span the entire human genome every 10 cM. Linkage analysis was performed with the modified Haseman-Elston regression model through use of the SIBPAL program. Three genomewide scans were conducted: single-point, multipoint, and multipoint performed on of white pedigrees only (92% of the cohort). One novel significant susceptibility locus was detected for MI on chromosomal region 1p34-36, with a multipoint allele-sharing P value of less than or equal to10(-12) (LOD=11.68). Validation by use of a permutation test yielded a pointwise empirical P value of .00011 at this locus, which corresponds to a genomewide significance of P<.05. For the less restrictive phenotype of CAD, no genetic locus was detected, suggesting that CAD and MI may not share all susceptibility genes. The present study thus identifies a novel genetic-susceptibility locus for MI and provides a framework for the ultimate cloning of a gene for the complex disease MI.	Cleveland Clin Fdn, Lerner Res Inst, Dept Cardiovasc Med F25, Ctr Cardiovasc Genet, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Cardiol, Ctr Cardiovasc Genet, Cleveland, OH 44195 USA; Case Western Reserve Univ, Cleveland Clin Lerner Coll Med, Dept Mol Med, Cleveland, OH 44106 USA; Case Western Reserve Univ, Cleveland Clin, Coll Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; Case Western Reserve Univ, Cleveland Clin, Coll Med, Dept Med, Cleveland, OH 44106 USA; Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; Univ Alabama, Med Ctr, Dept Med, Birmingham, AL 35294 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Duke University; University of Alabama System; University of Alabama Birmingham	Topol, EJ (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Cardiovasc Med F25, Ctr Cardiovasc Genet, 9500 Euclid Ave, Cleveland, OH 44195 USA.	topole@ccf.org		Rao, Shaoqi/0000-0001-7809-3700; Topol, Eric/0000-0002-1478-4729	NCRR NIH HHS [P41 RR003655, RR03655] Funding Source: Medline; NHLBI NIH HHS [R01 HL65630, R01 HL065630, R01 HL066251, R01 HL66251] Funding Source: Medline; NIGMS NIH HHS [R01 GM028356, R37 GM028356, GM28356] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066251, R01HL065630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028356, R01GM028356] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		*AM HEART ASS, 2002, HEART DIS STROK STAT; Bertomeu A, 2003, BRIT MED J, V327, P591, DOI 10.1136/bmj.327.7415.591; Boerma M, 1999, J INTERN MED, V246, P211, DOI 10.1046/j.1365-2796.1999.00564.x; Broeckel U, 2002, NAT GENET, V30, P210, DOI 10.1038/ng827; Elston RC, 2000, GENET EPIDEMIOL, V19, P1, DOI 10.1002/1098-2272(200007)19:1<1::AID-GEPI1>3.0.CO;2-E; Francke S, 2001, HUM MOL GENET, V10, P2751, DOI 10.1093/hmg/10.24.2751; Harrap SB, 2002, ARTERIOSCL THROM VAS, V22, P874, DOI 10.1161/01.ATV.0000016258.40568.F1; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LEWIS D, 2002, ENCY LIFE SCI, V10, P508; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; NORA JJ, 1980, CIRCULATION, V61, P503, DOI 10.1161/01.CIR.61.3.503; Olson JM, 1999, AM J HUM GENET, V64, P1464, DOI 10.1086/302360; Olson JM, 1999, STAT MED, V18, P2961, DOI 10.1002/(SICI)1097-0258(19991115)18:21<2961::AID-SIM206>3.0.CO;2-U; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Pajukanta P, 2000, AM J HUM GENET, V67, P1481, DOI 10.1086/316902; *SAGE, 2003, STAT AN GEN EP; Schick JH, 2003, AM J HUM GENET, V72, P1412, DOI 10.1086/375500; Shete S, 2003, HUM HERED, V55, P79, DOI 10.1159/000072312; SLACK J., 1966, J MED GENET, V3, P239, DOI 10.1136/jmg.3.4.239; Slager SL, 2003, AM J HUM GENET, V72, P759, DOI 10.1086/368230; Topol EJ, 2001, CIRCULATION, V104, P2641, DOI 10.1161/hc4701.100910; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; WANG Q, 2003, NATURE ENCY HUMAN GE, V1, P396; Wang Q, 2000, TXB CARDIOVASCULAR M, P1; WANG Q, 2001, TXB CARDIOVASCULAR M; Weber JL, 2001, ADV GENET, V42, P77, DOI 10.1016/S0065-2660(01)42016-5; Wessman M, 2002, AM J HUM GENET, V70, P652, DOI 10.1086/339078; Willett WC, 2002, SCIENCE, V296, P695, DOI 10.1126/science.1071055; Wiltshire S, 2002, AM J HUM GENET, V71, P1175, DOI 10.1086/342976; Yamada Y, 2002, NEW ENGL J MED, V347, P1916, DOI 10.1056/NEJMoa021445; Yeh HI, 2000, ARTERIOSCL THROM VAS, V20, P1753, DOI 10.1161/01.ATV.20.7.1753; Yeh HI, 2001, INT J CARDIOL, V81, P251, DOI 10.1016/S0167-5273(01)00574-5; Yeh HI, 1998, CIRC RES, V83, P1248, DOI 10.1161/01.RES.83.12.1248	35	166	172	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2004	74	2					262	271		10.1086/381560	http://dx.doi.org/10.1086/381560			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	772UM	14732905	Green Published, Bronze			2022-12-18	WOS:000188860000007
J	Onda, H; Kasuya, H; Yoneyama, T; Takakura, K; Hori, T; Takeda, J; Nakajima, T; Inoue, I				Onda, H; Kasuya, H; Yoneyama, T; Takakura, K; Hori, T; Takeda, J; Nakajima, T; Inoue, I			Genomewide-linkage and haplotype-association studies map intracranial aneurysm to chromosome 7q11	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUPRAVALVULAR AORTIC-STENOSIS; HUMAN ELASTIN GENE; SUBARACHNOID HEMORRHAGE; REPEAT POLYMORPHISM; CEREBRAL ANEURYSMS; POINT MUTATIONS; IZUMO CITY; COMMUNITY; REGION; PROGNOSIS	Rupture of intracranial aneurysms (IAs) causes subarachnoid hemorrhage, a devastating condition with high morbidity and mortality. Angiographic and autopsy studies show that IA is a common disorder, with a prevalence of 3%-6%. Although IA has a substantial genetic component, little attention has been given to the genetic determinants. We report here a genomewide linkage study of IA in 104 Japanese affected sib pairs in which positive evidence of linkage on chromosomes 5q22-31 (maximum LOD score [MLS] 2.24), 7q11 (MLS 3.22), and 14q22 (MLS 2.31) were found. The best evidence of linkage is detected at D7S2472, in the vicinity of the elastin gene (ELN), a candidate gene for IA. Fourteen distinct single-nucleotide polymorphisms (SNPs) were identified in ELN, and no obvious allelic association between IA and each SNP was observed. The haplotype between the intron-20/intron-23 polymorphism of ELN is strongly associated with IA (3.81 x 10(-6)), and homozygous patients are at high risk (P=.002), with an odds ratio of 4.39. These findings suggest that a genetic locus for IA lies within or close to the ELN locus on chromosome 7.	Univ Tokyo, Inst Med Sci, Div Genet Diag, Minato Ku, Tokyo 1088639, Japan; Tokyo Womens Med Univ, Inst Neurol, Dept Neurosurg, Tokyo, Japan; Gunma Univ, Inst Mol & Cellular Regulat, Mol Genet Lab, Maebashi, Gumma 371, Japan	University of Tokyo; Tokyo Women's Medical University; Gunma University	Inoue, I (corresponding author), Univ Tokyo, Inst Med Sci, Div Genet Diag, Minato Ku, Shirokanedai 4-6-1, Tokyo 1088639, Japan.			Hori, Tomokatsu/0000-0001-7611-896X				ANIDJAR S, 1990, CIRCULATION, V82, P973, DOI 10.1161/01.CIR.82.3.973; CALABRETTA B, 1982, NATURE, V296, P219, DOI 10.1038/296219a0; CARMICHAEL R, 1945, J PATHOL BACTERIOL, V57, P345, DOI 10.1002/path.1700570308; CARMICHAEL R, 1950, J PATHOL BACTERIOL, V62, P1, DOI 10.1002/path.1700620102; CURRAN ME, 1993, CELL, V73, P159, DOI 10.1016/0092-8674(93)90168-P; ELSTON RC, 1997, STAT ANAL GENETIC EP; FOSTER K, 1993, ANN HUM GENET, V57, P87, DOI 10.1111/j.1469-1809.1993.tb00890.x; Glynn LE, 1940, J PATHOL BACTERIOL, V51, P213, DOI 10.1002/path.1700510206; HASHIMOTO N, 1978, SURG NEUROL, V10, P3; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; INAGAWA T, 1988, STROKE, V19, P170, DOI 10.1161/01.STR.19.2.170; INAGAWA T, 1995, STROKE, V26, P761, DOI 10.1161/01.STR.26.5.761; Iwamoto H, 1999, STROKE, V30, P1390, DOI 10.1161/01.STR.30.7.1390; KAHARI VM, 1990, J BIOL CHEM, V265, P9485; Kasuya H, 2000, NEUROSURGERY, V46, P1301, DOI 10.1097/00006123-200006000-00004; KIYOHARA Y, 1989, STROKE, V20, P1150, DOI 10.1161/01.STR.20.9.1150; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LEWONTIN RC, 1964, GENETICS, V49, P49; Li DY, 1997, HUM MOL GENET, V6, P1021, DOI 10.1093/hmg/6.7.1021; LONGSTRETH WT, 1993, NEUROLOGY, V43, P712, DOI 10.1212/WNL.43.4.712; Miskolczi L, 1998, NEUROSURGERY, V43, P595, DOI 10.1097/00006123-199809000-00110; NAKAGAWA T, 1994, J NEUROSURG, V80, P217, DOI 10.3171/jns.1994.80.2.0217; Peoples R, 2000, AM J HUM GENET, V66, P47, DOI 10.1086/302722; PHILLIPS LH, 1980, NEUROLOGY, V30, P1034, DOI 10.1212/WNL.30.10.1034; Ronkainen A, 1997, LANCET, V349, P380, DOI 10.1016/S0140-6736(97)80009-8; SACCO RL, 1984, NEUROLOGY, V34, P847, DOI 10.1212/WNL.34.7.847; SCHIEVINK WI, 1994, STROKE, V25, P2028, DOI 10.1161/01.STR.25.10.2028; SCHIEVINK WI, 1995, NEUROLOGY, V45, P871, DOI 10.1212/WNL.45.5.871; SCHIEVINK WI, 1995, J NEUROSURG, V83, P426, DOI 10.3171/jns.1995.83.3.0426; Schievink WI, 1997, NEUROSURGERY, V40, P651, DOI 10.1097/00006123-199704000-00001; STEBHENS WE, 1963, ARCH NEUROL-CHICAGO, V8, P272; Szabo Z, 1999, J MOL EVOL, V49, P664, DOI 10.1007/PL00006587; Tassabehji M, 1997, HUM MOL GENET, V6, P1029, DOI 10.1093/hmg/6.7.1029; TROMP G, 1991, NUCLEIC ACIDS RES, V19, P4314, DOI 10.1093/nar/19.15.4314-a; UJIIE H, 1993, STROKE, V24, P1850, DOI 10.1161/01.STR.24.12.1850; Urban Z, 1999, HUM GENET, V104, P135, DOI 10.1007/s004390050926; Urban Z, 1997, CLIN GENET, V51, P133	38	166	179	0	5	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2001	69	4					804	819		10.1086/323614	http://dx.doi.org/10.1086/323614			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	472WP	11536080	Green Published, Bronze			2022-12-18	WOS:000171008200013
J	Leavitt, BR; Guttman, JA; Hodgson, JG; Kimel, GH; Singaraja, R; Vogl, AW; Hayden, MR				Leavitt, BR; Guttman, JA; Hodgson, JG; Kimel, GH; Singaraja, R; Vogl, AW; Hayden, MR			Wild-type huntingtin reduces the cellular toxicity of mutant huntingtin in vivo	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; DISEASE GENE; NUCLEAR-LOCALIZATION; TARGETED DISRUPTION; EMBRYONIC LETHALITY; TERMINAL FRAGMENTS; STRIATAL NEURONS; CAG REPEAT; MICE; LENGTH	We have developed yeast artificial chromosome (YAC) transgenic mice expressing normal (YAC18) and mutant (YAC46 or YAC72) human huntingtin (htt), in a developmental- and tissue-specific manner, that is identical to endogenous htt. YAC72 mice develop selective degeneration of medium spiny projection neurons in the lateral striatum, similar to what is observed in Huntington disease. Mutant human htt expressed by YAC transgenes can compensate for the absence of endogenous htt and can rescue the embryonic lethality that characterizes mice homozygous for targeted disruption of the endogenous Hdh gene (-/-). YAC72 mice lacking endogenous htt (YAC72 -/-) manifest a novel phenotype characterized by infertility, testicular atrophy, aspermia, and massive apoptotic cell death in the testes. The testicular cell death in YAC72 -/- mice can be markedly reduced by increasing endogenous htt levels. YAC72 mice with equivalent levels of both wild-type and mutant htt (YAC72 +/+) breed normally and have no evidence of increased testicular cell death. Similar findings are seen in YAC46 -/- mice compared with YAC46 +/+ mice, in which wild-type htt can completely counteract the proapoptotic effects of mutant htt. YAC18 -/- mice display no evidence of increased cellular apoptosis, even in the complete absence of endogenous htt, demonstrating that the massive cellular apoptosis observed in YAC46 -/- mice and YAC72 -/- mice is polyglutamine-mediated toxicity from the mutant transgene. These data provide the first direct in vivo evidence of a role for wild-type htt in decreasing the cellular toxicity of mutant htt.	Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada; Univ British Columbia, Dept Anat, Vancouver, BC V6T 1W5, Canada	University of British Columbia	Hayden, MR (corresponding author), Ctr Mol Med & Therapeut, 950 W 28th Ave, Vancouver, BC V5Z 4H4, Canada.	mrh@cmmt.ubc.ca	Hayden, Michael R/D-8581-2011; Leavitt, Blair R/G-1934-2012	Hayden, Michael R/0000-0001-5159-1419; Singaraja, Roshni/0000-0002-3418-3867				ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Bao J, 1996, P NATL ACAD SCI USA, V93, P5037, DOI 10.1073/pnas.93.10.5037; Becher MW, 1998, NEUROBIOL DIS, V4, P387, DOI 10.1006/nbdi.1998.0168; Burke JR, 1996, NAT MED, V2, P347, DOI 10.1038/nm0396-347; Cooper JK, 1998, HUM MOL GENET, V7, P783, DOI 10.1093/hmg/7.5.783; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dragatsis I, 2000, NAT GENET, V26, P300, DOI 10.1038/81593; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hackam AS, 1998, J CELL BIOL, V141, P1097, DOI 10.1083/jcb.141.5.1097; Hodgson JG, 1996, HUM MOL GENET, V5, P1875, DOI 10.1093/hmg/5.12.1875; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Kalchman MA, 1996, J BIOL CHEM, V271, P19385, DOI 10.1074/jbc.271.32.19385; Kalchman MA, 1997, NAT GENET, V16, P44, DOI 10.1038/ng0597-44; Li H, 2000, NAT GENET, V25, P385, DOI 10.1038/78054; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; LIN BY, 1994, HUM MOL GENET, V3, P85, DOI 10.1093/hmg/3.1.85; MacDonald ME, 1996, CURR OPIN NEUROBIOL, V6, P638, DOI 10.1016/S0959-4388(96)80097-3; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Martindale D, 1998, NAT GENET, V18, P150, DOI 10.1038/ng0298-150; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; O'Kusky JR, 1999, BRAIN RES, V818, P468, DOI 10.1016/S0006-8993(98)01312-2; Rigamonti D, 2000, J NEUROSCI, V20, P3705, DOI 10.1523/JNEUROSCI.20-10-03705.2000; SANDOU F, 1998, CELL, V95, P55; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Sharp AH, 1996, NEUROBIOL DIS, V3, P3, DOI 10.1006/nbdi.1996.0002; Sisodia SS, 1998, CELL, V95, P1, DOI 10.1016/S0092-8674(00)81743-2; Wanker EE, 1997, HUM MOL GENET, V6, P487, DOI 10.1093/hmg/6.3.487; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155	35	166	167	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2001	68	2					313	324		10.1086/318207	http://dx.doi.org/10.1086/318207			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	394LD	11133364	Bronze, Green Published			2022-12-18	WOS:000166524800002
J	Engelman, JA; Zhang, XL; Galbiati, F; Volonte, D; Sotgia, F; Pestell, RG; Minetti, C; Scherer, PE; Okamoto, T; Lisanti, MP				Engelman, JA; Zhang, XL; Galbiati, F; Volonte, D; Sotgia, F; Pestell, RG; Minetti, C; Scherer, PE; Okamoto, T; Lisanti, MP			Molecular genetics of the caveolin gene family: Implications for human cancers, diabetes, Alzheimer disease, and muscular dystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ONCOGENICALLY TRANSFORMED-CELLS; RICH MEMBRANE DOMAINS; TYROSINE KINASE; IN-VIVO; EXPRESSION; PROTEIN; IDENTIFICATION; SEQUENCE; MICRODOMAINS; ASSOCIATION		Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; Univ Genoa, Serv Malattie Neuromuscolari, Gaslini Inst, Genoa, Italy; Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44195 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Genoa; IRCCS Istituto Giannina Gaslini; Cleveland Clinic Foundation	Lisanti, MP (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	lisanti@aecom.yu.edu	Scherer, Philipp E/K-7819-2012; Lisanti, Michael/B-6131-2018; Lisanti, Michael P/C-6866-2013; Galbiati, Ferruccio/AAF-3527-2020; Minetti, Carlo/K-4666-2018	Scherer, Philipp E/0000-0003-0680-3392; Lisanti, Michael/0000-0003-2034-1382; Minetti, Carlo/0000-0002-0640-1804; Sotgia, Federica/0000-0003-2826-4529	NIGMS NIH HHS [T32-GM-07288, GM-50443] Funding Source: Medline; NIMH NIH HHS [MH-56036] Funding Source: Medline; Telethon [1111] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288, R29GM050443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH056036] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Telethon(Fondazione Telethon); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Couet J, 1997, J BIOL CHEM, V272, P30429, DOI 10.1074/jbc.272.48.30429; Couet J, 1997, TRENDS CARDIOVAS MED, V7, P103, DOI 10.1016/S1050-1738(97)00001-7; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Engelman JA, 1998, FEBS LETT, V428, P205, DOI 10.1016/S0014-5793(98)00470-0; Engelman JA, 1998, FEBS LETT, V429, P330, DOI 10.1016/S0014-5793(98)00619-X; Engelman JA, 1998, FEBS LETT, V436, P403, DOI 10.1016/S0014-5793(98)01134-X; Engelman JA, 1998, J BIOL CHEM, V273, P20448, DOI 10.1074/jbc.273.32.20448; Engelman JA, 1997, J BIOL CHEM, V272, P16374, DOI 10.1074/jbc.272.26.16374; Faux MC, 1996, CELL, V85, P9, DOI 10.1016/S0092-8674(00)81075-2; Galbiati F, 1998, P NATL ACAD SCI USA, V95, P10257, DOI 10.1073/pnas.95.17.10257; Galbiati F, 1998, EMBO J, V17, P6633, DOI 10.1093/emboj/17.22.6633; GarciaCardena G, 1997, J BIOL CHEM, V272, P25437, DOI 10.1074/jbc.272.41.25437; GIORDANO S, 1989, NATURE, V339, P155, DOI 10.1038/339155a0; GLENNEY JR, 1992, FEBS LETT, V314, P45, DOI 10.1016/0014-5793(92)81458-X; Ikezu T, 1998, BRAIN RES, V804, P177, DOI 10.1016/S0006-8993(98)00498-3; Ikezu T, 1998, J BIOL CHEM, V273, P10485, DOI 10.1074/jbc.273.17.10485; KOLESKE AJ, 1995, P NATL ACAD SCI USA, V92, P1381, DOI 10.1073/pnas.92.5.1381; Lee SJ, 1998, NAT MED, V4, P730, DOI 10.1038/nm0698-730; Lee SW, 1998, ONCOGENE, V16, P1391, DOI 10.1038/sj.onc.1201661; Li SW, 1998, FEBS LETT, V434, P127, DOI 10.1016/S0014-5793(98)00945-4; Li SW, 1996, J BIOL CHEM, V271, P28647, DOI 10.1074/jbc.271.45.28647; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Lisanti Michael P., 1994, Trends in Cell Biology, V4, P231, DOI 10.1016/0962-8924(94)90114-7; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; Liu J, 1997, J BIOL CHEM, V272, P7211, DOI 10.1074/jbc.272.11.7211; Liu PS, 1997, P NATL ACAD SCI USA, V94, P13666, DOI 10.1073/pnas.94.25.13666; McNally EM, 1998, HUM MOL GENET, V7, P871, DOI 10.1093/hmg/7.5.871; Minetti C, 1998, NAT GENET, V18, P365, DOI 10.1038/ng0498-365; Oka N, 1997, J BIOL CHEM, V272, P33416, DOI 10.1074/jbc.272.52.33416; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Parton RG, 1996, CURR OPIN CELL BIOL, V8, P542, DOI 10.1016/S0955-0674(96)80033-0; PISTERS LL, 1995, J UROLOGY, V154, P293, DOI 10.1016/S0022-5347(01)67297-5; RUBIN CS, 1994, BBA-MOL CELL RES, V1224, P467; SAGER R, 1994, COLD SPRING HARB SYM, V59, P537, DOI 10.1101/SQB.1994.059.01.060; SARGIACOMO M, 1995, P NATL ACAD SCI USA, V92, P9407, DOI 10.1073/pnas.92.20.9407; SARGIACOMO M, 1993, J CELL BIOL, V122, P789, DOI 10.1083/jcb.122.4.789; Scherer PE, 1997, J BIOL CHEM, V272, P29337, DOI 10.1074/jbc.272.46.29337; Scherer PE, 1996, P NATL ACAD SCI USA, V93, P131, DOI 10.1073/pnas.93.1.131; Scherer PE, 1997, J BIOL CHEM, V272, P20698, DOI 10.1074/jbc.272.33.20698; SCHERER PE, 1994, J CELL BIOL, V127, P1233, DOI 10.1083/jcb.127.5.1233; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Song KS, 1996, J BIOL CHEM, V271, P15160, DOI 10.1074/jbc.271.25.15160; Tang ZL, 1996, J BIOL CHEM, V271, P2255, DOI 10.1074/jbc.271.4.2255; Tang ZL, 1997, J BIOL CHEM, V272, P2437, DOI 10.1074/jbc.272.4.2437; Yamamoto M, 1998, J BIOL CHEM, V273, P26962, DOI 10.1074/jbc.273.41.26962; Yang CPH, 1998, FEBS LETT, V439, P368, DOI 10.1016/S0014-5793(98)01354-4; Yang G, 1998, CLIN CANCER RES, V4, P1873	49	166	168	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1998	63	6					1578	1587		10.1086/302172	http://dx.doi.org/10.1086/302172			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EL	9837809	Green Published, Bronze			2022-12-18	WOS:000077707700002
J	Horvath, S; Laird, NM				Horvath, S; Laird, NM			A discordant-sibship test for disequilibrium and linkage: No need for parental data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASSOCIATION; MARKERS; DISEASE	The sibship disequilibrium test (SDT) is designed to detect both linkage in the presence of association and association in the presence of linkage (linkage disequilibrium). The test does not require parental data but requires discordant sibships with at least one affected and one unaffected sibling. The SDT has many desirable properties: it uses all the siblings in the sibship; it remains valid if there are misclassifications of the affectation status; it does not detect spurious associations due to population stratification; asymptotically it has a chi(2) distribution under the null hypothesis; and exact P values can be easily computed for a biallelic marker. We show how to extend the SDT to markers with multiple alleles and how to combine families with parents and data from discordant sibships. We discuss the power of the test by presenting sample-size calculations involving a complex disease model, and we present formulas for the asymptotic relative efficiency (which is approximately the ratio of sample sizes) between SDT and the transmission/disequilibrium test (TDT) for special family structures. For sib pairs, we compare the SDT to a test proposed both by Curtis and, independently, by Spielman and Ewens. We show that, for discordant sib pairs, the SDT has good power for testing linkage disequilibrium relative both to Curtis's tests and to the TDT using trios comprising an affected sib and its parents. With additional sibs, we show that the SDT can be more powerful than the TDT for testing linkage disequilibrium, especially for disease prevalence >.3.	Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Laird, NM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Biostat, 667 Huntington Ave, Boston, MA 02115 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029745] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM29745] Funding Source: Medline; NIMH NIH HHS [MH59536] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BICKEL PJ, 1965, ANN MATH STAT, V36, P160, DOI 10.1214/aoms/1177700280; Boehnke M, 1998, AM J HUM GENET, V62, P950, DOI 10.1086/301787; Cleves MA, 1997, GENET EPIDEMIOL, V14, P337, DOI 10.1002/(SICI)1098-2272(1997)14:4<337::AID-GEPI1>3.3.CO;2-S; Curtis D, 1997, ANN HUM GENET, V61, P319, DOI 10.1017/S000348009700626X; CURTIS D, 1995, AM J HUM GENET, V56, P811; Laird NM, 1998, AM J HUM GENET, V63, P1915, DOI 10.1086/302151; MANTEL N, 1959, J NATL CANCER I, V22, P719; Martin ER, 1997, AM J HUM GENET, V61, P439, DOI 10.1086/514860; OTT J, 1989, GENET EPIDEMIOL, V6, P127, DOI 10.1002/gepi.1370060124; RANDLES RH, 1989, J AM STAT ASSOC, V84, P1045, DOI 10.2307/2290081; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rosner B., 2011, FUNDAMENTALS BIOSTAT, P352; Schaid DJ, 1996, GENET EPIDEMIOL, V13, P423, DOI 10.1002/(SICI)1098-2272(1996)13:5<423::AID-GEPI1>3.0.CO;2-3; SELF SG, 1991, BIOMETRICS, V47, P53, DOI 10.2307/2532495; SERFLING RJ, 1981, APPROXIMATION THEORE, P317; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; SPIELMAN RS, 1993, AM J HUM GENET, V53, P863; SUAREZ BK, 1976, ANN HUM GENET, V40, P231, DOI 10.1111/j.1469-1809.1976.tb00186.x; THOMSON G, 1995, AM J HUM GENET, V57, P474	19	166	179	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1998	63	6					1886	1897		10.1086/302137	http://dx.doi.org/10.1086/302137			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EL	9837840	Bronze, Green Published			2022-12-18	WOS:000077707700033
J	Wiggs, JL; Allingham, RR; Vollrath, D; Jones, KH; De La Paz, M; Kern, J; Patterson, K; Rabb, VL; Del Bono, A; Broomer, BW; Pericak-Vance, MA; Haines, JL				Wiggs, JL; Allingham, RR; Vollrath, D; Jones, KH; De La Paz, M; Kern, J; Patterson, K; Rabb, VL; Del Bono, A; Broomer, BW; Pericak-Vance, MA; Haines, JL			Prevalence of mutations in TIGR/myocilin in patients with adult and juvenile primary open-angle glaucoma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							GENETIC-HETEROGENEITY; CHROMOSOME 1Q21-Q31; LINKAGE; LOCUS; EXCLUSION; PEDIGREES; FAMILY; GLC1A; TIGR		Tufts Univ, Sch Med, Boston, MA 02111 USA; Tufts Univ, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA; New England Med Ctr, Dept Ophthalmol, Boston, MA 02111 USA; Duke Univ, Ctr Eye, Durham, NC USA; Duke Univ, Ctr Human Genet, Durham, NC USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Vanderbilt Univ, Nashville, TN USA	Tufts University; Tufts University; Tufts Medical Center; Duke University; Duke University; Stanford University; Vanderbilt University	Wiggs, JL (corresponding author), Tufts Univ, Sch Med, 750 Washington St,Box 450, Boston, MA 02111 USA.		Haines, Jonathan/C-3374-2012	Haines, Jonathan/0000-0002-4351-4728	NATIONAL EYE INSTITUTE [R01EY011405, R01EY009847, R29EY009847, R01EY010886] Funding Source: NIH RePORTER; NEI NIH HHS [EY11405, EY09847, EY10886, R01 EY009847] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adam MF, 1997, HUM MOL GENET, V6, P2091, DOI 10.1093/hmg/6.12.2091; Alward WLM, 1998, NEW ENGL J MED, V338, P1022, DOI 10.1056/NEJM199804093381503; Avramopoulos D, 1996, J MED GENET, V33, P1043, DOI 10.1136/jmg.33.12.1043; Belmouden A, 1997, GENOMICS, V39, P348, DOI 10.1006/geno.1996.4491; GRAFF C, 1995, HUM GENET, V96, P285; Kubota R, 1997, GENOMICS, V41, P360, DOI 10.1006/geno.1997.4682; LESKE MC, 1983, AM J EPIDEMIOL, V118, P166, DOI 10.1093/oxfordjournals.aje.a113626; Morissette J, 1998, NAT GENET, V19, P319, DOI 10.1038/1203; NGUYEN TD, 1993, BASIC ASPECTS GLAUCO, V3, P331; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; RICHARDS JE, 1994, AM J HUM GENET, V54, P62; Richards JE, 1996, OPHTHALMOLOGY, V103, P1035, DOI 10.1016/S0161-6420(96)30570-8; Sarfarazi M, 1998, AM J HUM GENET, V62, P641, DOI 10.1086/301767; SHEFFIELD VC, 1993, NAT GENET, V4, P47, DOI 10.1038/ng0593-47; Stoilova D, 1996, GENOMICS, V36, P142, DOI 10.1006/geno.1996.0434; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Suzuki Y, 1997, AM J HUM GENET, V61, P1202, DOI 10.1086/301612; Trifan OC, 1998, AM J OPHTHALMOL, V126, P17, DOI 10.1016/S0002-9394(98)00073-7; Wiggs JL, 1995, OPHTHALMOLOGY, V102, P1782, DOI 10.1016/S0161-6420(95)30793-2; WIGGS JL, 1994, GENOMICS, V21, P299, DOI 10.1006/geno.1994.1269; Wirtz M. K., 1998, IOVS, V39, pS512; Wirtz MK, 1997, AM J HUM GENET, V60, P296; WuDunn D, 1996, OPHTHALMIC GENET, V17, P87, DOI 10.3109/13816819609057110	23	166	174	1	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1998	63	5					1549	1552		10.1086/302098	http://dx.doi.org/10.1086/302098			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	138QZ	9792882	Green Published, Bronze			2022-12-18	WOS:000076985200032
J	Fodor, FH; Weston, A; Bleiweiss, IJ; McCurdy, LD; Walsh, MM; Tartter, PI; Brower, ST; Eng, CM				Fodor, FH; Weston, A; Bleiweiss, IJ; McCurdy, LD; Walsh, MM; Tartter, PI; Brower, ST; Eng, CM			Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OVARIAN-CANCER; HISTOPROGNOSTIC GRADE; FAMILIES; WOMEN; GENE; SUSCEPTIBILITY; 185DELAG	Based on breast cancer families with multiple and/or early-onset cases, estimates of the lifetime risk of breast cancer in carriers of BRCA1 or BRCA2 mutations may be as high as 85%. The risk for individuals not selected for family history or other risk factors is uncertain.We determined the frequency of the common BRCA1 (185delAG and 5382insC) and BRCA2 (6174delT) mutations in a series of 268 anonymous Ashkenazi Jewish women with breast cancer, regardless of family history or age at onset. DNA was analyzed for the three mutations by allele-specific oligonucleotide hybridization. Eight patients (3.0%, 95% confidence interval [CI] 1.5%-5.8%) were heterozygous far the 185delAG mutation, two (0.75%, 95% CI 0.20-2.7) for the 5382insC mutation, and eight (3.0%, 95% CI 1.5-5.8) for the 6174delT mutation. The lifetime risk for breast cancer in Ashkenazi Jewish carriers of the BRCA1 185delAG or BRCA2, 6174delT mutations was calculated to be 36%, approximately three times the overall risk for the general population (relative risk 2.9, 95% CI 1.5-5.8). For the 5382insC mutation, because of the low number of carriers found, further studies are necessary. The results differ markedly from previous estimates based on high-risk breast cancer families and are consistent with lower estimates derived from a recent population-based study in the Baltimore area. Thus, presymptomatic screening and counseling for these common mutations in Ashkenazi Jewish women not selected for family history of breast cancer should be reconsidered until the risk associated with these mutations is firmly established, especially since early diagnostic and preventive-treatment modalities are limited.	CUNY Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Community Med, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Pathol, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Surg, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Eng, CM (corresponding author), CUNY Mt Sinai Sch Med, Dept Human Genet, Box 1497,1 Gustave Levy Pl, New York, NY 10029 USA.				NCRR NIH HHS [5 MO1 RR00071] Funding Source: Medline; PHS HHS [U01 69398] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000071] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Abeliovich D, 1997, AM J HUM GENET, V60, P505; BIGNON YJ, 1995, LANCET, V346, P258, DOI 10.1016/S0140-6736(95)91310-6; CLAUS EB, 1991, AM J HUM GENET, V48, P232; EASTON DF, 1995, AM J HUM GENET, V56, P265; Egan KM, 1996, LANCET, V347, P1645, DOI 10.1016/S0140-6736(96)91485-3; Eisinger F, 1996, CANCER RES, V56, P471; FitzGerald MG, 1996, NEW ENGL J MED, V334, P143, DOI 10.1056/NEJM199601183340302; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; FRIEDMAN LS, 1995, AM J HUM GENET, V57, P1284; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; Gayther SA, 1996, AM J HUM GENET, V58, P451; HOSKINS KF, 1995, JAMA-J AM MED ASSOC, V273, P577, DOI 10.1001/jama.273.7.577; Marcus JN, 1996, CANCER-AM CANCER SOC, V77, P697, DOI 10.1002/(SICI)1097-0142(19960215)77:4<697::AID-CNCR16>3.0.CO;2-W; Neuhausen S, 1996, NAT GENET, V13, P126, DOI 10.1038/ng0596-126; Oddoux C, 1996, NAT GENET, V14, P188, DOI 10.1038/ng1096-188; Offit K, 1996, LANCET, V347, P1643, DOI 10.1016/S0140-6736(96)91484-1; Parker SL, 1997, CA-CANCER J CLIN, V47, P5, DOI 10.3322/canjclin.47.1.5; Roa BB, 1996, NAT GENET, V14, P185, DOI 10.1038/ng1096-185; SEPP R, 1994, J CLIN PATHOL, V47, P318, DOI 10.1136/jcp.47.4.318; ShattuckEidens D, 1997, JAMA-J AM MED ASSOC, V278, P1242, DOI 10.1001/jama.278.15.1242; Shuber AP, 1995, GENOME RES, V5, P488, DOI 10.1101/gr.5.5.488; SIMARD J, 1994, NAT GENET, V8, P392, DOI 10.1038/ng1294-392; Stratton MR, 1996, HUM MOL GENET, V5, P1515, DOI 10.1093/hmg/5.Supplement_1.1515; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Struewing JP, 1996, NAT GENET, V12, P110, DOI 10.1038/ng0196-110c; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; TONIN P, 1995, AM J HUM GENET, V57, P189; Tonin P, 1996, NAT MED, V2, P1179, DOI 10.1038/nm1196-1179; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231	29	166	171	0	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1998	63	1					45	51		10.1086/301903	http://dx.doi.org/10.1086/301903			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZZ726	9634504	Green Published, Bronze			2022-12-18	WOS:000074761000008
J	Norman, RA; Tataranni, PA; Pratley, R; Thompson, DB; Hanson, RL; Prochazka, M; Baier, L; Ehm, MG; Sakul, H; Foroud, T; Garvey, WT; Burns, D; Knowler, WC; Bennett, PH; Bogardus, C; Ravussin, E				Norman, RA; Tataranni, PA; Pratley, R; Thompson, DB; Hanson, RL; Prochazka, M; Baier, L; Ehm, MG; Sakul, H; Foroud, T; Garvey, WT; Burns, D; Knowler, WC; Bennett, PH; Bogardus, C; Ravussin, E			Autosomal genomic scan for loci linked to obesity and energy metabolism in Pima Indians	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BODY-MASS INDEX; DEPENDENT DIABETES-MELLITUS; NECROSIS-FACTOR-ALPHA; OB GENE REGION; FAT MASS; INSULIN-RESISTANCE; GLUCOSE-TRANSPORT; MARKERS FLANKING; EXTREME OBESITY; COMPLEX TRAITS	An autosomal genomic scan to search for linkage to obesity and energy metabolism was completed in Pima Indians, a population prone to obesity. Obesity was assessed by percent body fat (by hydrodensitometry) and fat distribution (the ratio of waist circumference to thigh circumference). Energy metabolism was measured in;a respiratory chamber as 24-h metabolic rate, sleeping metabolic rate, and 24-h respiratory quotient (24RQ), an indicator of the ratio of carbohydrate oxidation to fat oxidation. Five hundred sixteen microsatellite markers with a median spacing of 6.4 cM were analyzed, in 362 siblings who had measurements of body composition and in 220 siblings who had measurements of energy metabolism. These comprised 451 sib pairs in 127 nuclear families, for linkage analysis to obesity, and 236 sib pairs in 82 nuclear families, for linkage analysis to energy metabolism. Pointwise and multipoint met:hods for regression of sib-pair differences in identity by descent, as well as a sibling-based variance-components method, were used to detect linkage. LOD scores greater than or equal to 2 were found at 11q21-q22, for percent body fat (LOD = 2.1; P = .001), at 11q23-q24, for 24-h energy expenditure (LOD = 2.0; P = .001), and at 1p31-p21 (LOD = 2.0) and 20q11.2 (LOD = 3.0; P = .0001), for 24RQ, by pointwise and multipoint analysts. With the variance-components method, the highest LOD score (LOD = 2.3 P = .0006) was found at 18q21, for percent body fat, and at 1p31-p21 (LOD = 2.8; P = .0003), for 24RQ. Possible candidate genes include LEPR (leptin receptor), at 1p31, and ASIP (agouti-signaling protein), at 20q11.2.	NIDDKD, Phoenix Epidemiol & Clin Res Branch, NIH, Phoenix, AZ 85016 USA; Glaxo Wellcome Inc, Res Triangle Pk, NC 27709 USA; Sequana Therapeut Inc, Dept Stat Genet, La Jolla, CA USA; Indiana Univ, Sch Med, Dept Med Genet, Indianapolis, IN 46202 USA; Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); GlaxoSmithKline; Indiana University System; Indiana University-Purdue University Indianapolis; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Ravussin, E (corresponding author), NIDDKD, Phoenix Epidemiol & Clin Res Branch, NIH, Room 541,4212 N 16th St, Phoenix, AZ 85016 USA.	eric_ravussin@nih.gov	Ravussin, Eric/N-1985-2017; Hanson, Robert L/O-3238-2015; Steib, Lori/B-6628-2014	Ravussin, Eric/0000-0003-2129-547X; Hanson, Robert L/0000-0002-4252-7068; Steib, Lori/0000-0001-8274-318X	NCRR NIH HHS [1 P41 RR03655] Funding Source: Medline; NIDDK NIH HHS [DK-47461] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047461] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allison DB, 1996, INT J OBESITY, V20, P501; AMOS CI, 1994, AM J HUM GENET, V54, P535; AMOS CI, 1989, GENET EPIDEMIOL, V6, P435, DOI 10.1002/gepi.1370060306; BOGARDUS C, 1986, NEW ENGL J MED, V315, P96, DOI 10.1056/NEJM198607103150205; BOUCHARD C, 1989, METABOLISM, V38, P364, DOI 10.1016/0026-0495(89)90126-1; BOUCHARD C, 1988, INT J OBESITY, V12, P205; CHURCHILL GA, 1994, GENETICS, V138, P963; Clement K, 1996, DIABETES, V45, P687, DOI 10.2337/diabetes.45.5.687; COMUZZIE AG, 1995, GENET EPIDEMIOL, V12, P475, DOI 10.1002/gepi.1370120505; Comuzzie AG, 1997, NAT GENET, V15, P273, DOI 10.1038/ng0397-273; Curtis D, 1996, NAT GENET, V12, P356, DOI 10.1038/ng0496-356; Daly MJ, 1996, NAT GENET, V14, P131, DOI 10.1038/ng1096-131; DUBOVSKY J, 1995, HUM MOL GENET, V4, P449, DOI 10.1093/hmg/4.3.449; Duggirala R, 1996, AM J HUM GENET, V59, P694; Edwards DR, 1996, INT J OBESITY, V20, pS9; Ehm M. G., 1996, American Journal of Human Genetics, V59, pA217; Elbein SC, 1996, J CLIN ENDOCR METAB, V81, P4422, DOI 10.1210/jc.81.12.4422; EVANS JL, 1995, CELL SIGNAL, V7, P365, DOI 10.1016/0898-6568(95)00007-C; Fisher R. A., 1935, DESIGN EXPT; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; FONTAINE E, 1985, ACTA GENET MED GEMEL, V34, P41, DOI 10.1017/S0001566000004906; GARN SM, 1986, AM J CLIN NUTR, V44, P996, DOI 10.1093/ajcn/44.6.996; Hanson RL, 1997, DIABETES S1, V46, pA51; HESELTINE L, 1995, MOL CELL BIOCHEM, V144, P147, DOI 10.1007/BF00944394; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; KNOWLER WC, 1990, DIABETES METAB REV, V6, P1, DOI 10.1002/dmr.5610060101; KNOWLER WC, 1991, AM J CLIN NUTR, V53, pS1543, DOI 10.1093/ajcn/53.6.1543S; KUCZMARSKI RJ, 1994, JAMA-J AM MED ASSOC, V272, P205, DOI 10.1001/jama.272.3.205; KWON HY, 1994, P NATL ACAD SCI USA, V91, P9760, DOI 10.1073/pnas.91.21.9760; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LILLIOJA S, 1993, NEW ENGL J MED, V329, P1988, DOI 10.1056/NEJM199312303292703; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Norman RA, 1996, DIABETES, V45, P1229, DOI 10.2337/diabetes.45.9.1229; NORMAN RA, 1995, J CLIN INVEST, V96, P158, DOI 10.1172/JCI118016; Norman RA, 1997, AM J HUM GENET, V60, P166; PISUNYER FX, 1991, AM J CLIN NUTR, V53, pS1595; PRICE RA, 1994, HUM BIOL, V66, P251; RAVUSSIN E, 1986, J CLIN INVEST, V78, P1568, DOI 10.1172/JCI112749; RAVUSSIN E, 1988, NEW ENGL J MED, V318, P467, DOI 10.1056/NEJM198802253180802; RAVUSSIN E, 1993, INT J OBESITY, V17, pS28; Reed DR, 1996, DIABETES, V45, P691, DOI 10.2337/diabetes.45.5.691; RICE T, 1993, AM J HUM GENET, V52, P967; Rice T, 1996, OBES RES, V4, P125, DOI 10.1002/j.1550-8528.1996.tb00524.x; Rice T, 1996, OBES RES, V4, P441, DOI 10.1002/j.1550-8528.1996.tb00252.x; ROTHSCHILD CB, 1993, AM J HUM GENET, V52, P110; Sakul H, 1997, AM J HUM GENET, V60, P651; SCHWENGEL DA, 1994, GENOMICS, V22, P46, DOI 10.1006/geno.1994.1344; Shimabukuro M, 1997, P NATL ACAD SCI USA, V94, P4637, DOI 10.1073/pnas.94.9.4637; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; Tebar F, 1996, ENDOCRINOLOGY, V137, P4181, DOI 10.1210/en.137.10.4181; Thompson DB, 1997, GENOMICS, V39, P227, DOI 10.1006/geno.1996.4504; WALSTON J, 1995, NEW ENGL J MED, V333, P343, DOI 10.1056/NEJM199508103330603; WILSON BD, 1995, HUM MOL GENET, V4, P223, DOI 10.1093/hmg/4.2.223; Witte JS, 1996, NAT GENET, V12, P355, DOI 10.1038/ng0496-355; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; ZURLO F, 1992, AM J PHYSIOL, V263, pE296, DOI 10.1152/ajpendo.1992.263.2.E296; ZURLO F, 1990, AM J PHYSIOL, V259, pE650	59	166	166	1	5	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1998	62	3					659	668		10.1086/301758	http://dx.doi.org/10.1086/301758			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZF407	9497255	Green Published, Bronze			2022-12-18	WOS:000072894400020
J	ROBERTS, RG; BARBY, TFM; MANNERS, E; BOBROW, M; BENTLEY, DR				ROBERTS, RG; BARBY, TFM; MANNERS, E; BOBROW, M; BENTLEY, DR			DIRECT DETECTION OF DYSTROPHIN GENE REARRANGEMENTS BY ANALYSIS OF DYSTROPHIN MESSENGER-RNA IN PERIPHERAL-BLOOD LYMPHOCYTES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BECKER MUSCULAR-DYSTROPHY; POLYMERASE CHAIN-REACTION; POINT MUTATIONS; HAEMOPHILIA-B; DMD GENE; DELETION; DUCHENNE; DNA; SEQUENCE; TRANSCRIPTION	Using 10 overlapping nested sets of primers and using peripheral blood lymphocyte (PBL) total RNA as template, we have developed a system, based on PCR, which allows the rapid production of double-stranded cDNA corresponding to the entire coding sequence of the dystrophin gene. The product can be visualized on native minigels by ethidium staining and directly sequenced after gel purification. We have used this system to analyze the structures of PBL dystrophin mRNA in 26 Duchenne, Becker, or intermediate muscular dystrophy patients who have gross rearrangements of the dystrophin gene. In each case, the effect that the genomic rearrangement has on the structure of the transcript - and, by inference, on the dystrophin protein-has been determined, and the results confirm the frameshift hypothesis. The study also identifies a series of alternatively spliced transcripts which are specific to the rearranged genotypes and which seem therefore to arise following the alteration in the context of the splice signal. The system has been used for unambiguous identification of carrier females. Furthermore, the rapid production of microgram quantities of dystrophin cDNA from a readily accessible tissue makes point-mutation screening a practical proposition.			ROBERTS, RG (corresponding author), UNITED MED & DENT SCH GUYS & ST THOMAS HOSP, GUYS HOSP, DIV MED & MOLEC GENET, LONDON SE1 9RT, ENGLAND.		Roberts, Roland G/C-3596-2009	Roberts, Roland/0000-0001-6636-1579				BERG LP, 1990, HUM GENET, V85, P655; CHELLY J, 1988, NATURE, V333, P858, DOI 10.1038/333858a0; CHELLY J, 1989, P NATL ACAD SCI USA, V86, P2617, DOI 10.1073/pnas.86.8.2617; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COTTON RGH, 1988, P NATL ACAD SCI USA, V85, P4397, DOI 10.1073/pnas.85.12.4397; DUBOWITZ V, 1989, J CHILD NEUROL, V4, P240, DOI 10.1177/088307388900400402; DUNNEN J, 1989, AM J HUM GENET, V45, P835; FEENER CA, 1989, NATURE, V338, P509, DOI 10.1038/338509a0; GILLARD EF, 1989, AM J HUM GENET, V45, P507; GREEN PM, 1989, EMBO J, V8, P1067, DOI 10.1002/j.1460-2075.1989.tb03474.x; HODGSON S, 1989, J MED GENET, V26, P682, DOI 10.1136/jmg.26.11.682; HOLDING C, 1989, LANCET, V2, P532; KOENIG M, 1989, AM J HUM GENET, V45, P498; KOENIG M, 1990, J BIOL CHEM, V265, P4560; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; MEERY AEH, 1987, OXFORD MONOGRAPHS ME, V15; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; MONTANDON AJ, 1989, NUCLEIC ACIDS RES, V17, P3347, DOI 10.1093/nar/17.9.3347; NAYLOR JA, 1991, LANCET, V337, P635, DOI 10.1016/0140-6736(91)92450-G; NORMAN AM, 1990, J MED GENET, V27, P236, DOI 10.1136/jmg.27.4.236; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; ROBERTS RG, 1990, LANCET, V336, P1523, DOI 10.1016/0140-6736(90)93305-9; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SARKAR G, 1989, SCIENCE, V244, P331, DOI 10.1126/science.2565599; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; WINNARD A, 1990, AM J HUM GENET S, V47, pA242; WINSHIP PR, 1989, NUCLEIC ACIDS RES, V17, P1266, DOI 10.1093/nar/17.3.1266	28	166	183	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1991	49	2					298	310						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GA866	1867192				2022-12-18	WOS:A1991GA86600006
J	Park, E; Pan, ZC; Zhang, ZJ; Lin, L; Xing, Y				Park, Eddie; Pan, Zhicheng; Zhang, Zijun; Lin, Lan; Xing, Yi			The Expanding Landscape of Alternative Splicing Variation in Human Populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							GENE-EXPRESSION VARIATION; RNA-SEQ; SUSCEPTIBILITY LOCI; TRANSCRIPTOME; IDENTIFICATION; QUANTIFICATION; ASSOCIATION; ELEMENTS; VARIANTS; REVEALS	Alternative splicing is a tightly regulated biological process by which the number of gene products for any given gene can be greatly expanded. Genomic variants in splicing regulatory sequences can disrupt splicing and cause disease. Recent developments in sequencing technologies and computational biology have allowed researchers to investigate alternative splicing at an unprecedented scale and resolution. Population-scale transcriptome studies have revealed many naturally occurring genetic variants that modulate alternative splicing and consequently influence phenotypic variability and disease susceptibility in human populations. Innovations in experimental and computational tools such as massively parallel reporter assays and deep learning have enabled the rapid screening of genomic variants for their causal impacts on splicing. In this review, we describe technological advances that have greatly increased the speed and scale at which discoveries are made about the genetic variation of alternative splicing. We summarize major findings from population transcriptomic studies of alternative splicing and discuss the implications of these findings for human genetics and medicine.	[Park, Eddie; Lin, Lan; Xing, Yi] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Pan, Zhicheng; Zhang, Zijun; Xing, Yi] Univ Calif Los Angeles, Bioinformat Interdept Grad Program, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Xing, Y (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.; Xing, Y (corresponding author), Univ Calif Los Angeles, Bioinformat Interdept Grad Program, Los Angeles, CA 90095 USA.	yxing@ucla.edu		park, eddie/0000-0001-5651-1481	National Institutes of Health [R01GM088342, R01GM117624]; Alfred Sloan Research Fellowship [BR2013-117]; National Institutes of Health postdoctoral training grant [T32AR059033]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR059033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088342, R01GM117624] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred Sloan Research Fellowship; National Institutes of Health postdoctoral training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Maggie Lam, John Phillips, Douglas Black, Andrey Damianov, Yang Pan, Levon Demirdjian, and Rocky Cheung for their helpful comments and Shihao Shen for technical assistance. This work was supported by National Institutes of Health grants R01GM088342 and R01GM117624 to Y.X. Y.X. is supported by an Alfred Sloan Research Fellowship (BR2013-117). E.P. is supported by National Institutes of Health postdoctoral training grant T32AR059033. Y.X. is a scientific cofounder of Trimontia Genomics Inc. and IsoTex Biotechnology Inc.	1000 Genomes Project Consortium, 2015, Nature, V526, P68, DOI 10.1038/nature15393; Alamancos GP, 2015, RNA, V21, P1521, DOI 10.1261/rna.051557.115; Alamancos GP, 2014, METHODS MOL BIOL, V1126, P357, DOI 10.1007/978-1-62703-980-2_26; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Andres AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001157; Angermueller C, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156651; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Au KF, 2013, P NATL ACAD SCI USA, V110, pE4821, DOI 10.1073/pnas.1320101110; Barash Y, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r114; Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Battle A, 2014, GENOME RES, V24, P14, DOI 10.1101/gr.155192.113; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Bloch DB, 1996, J BIOL CHEM, V271, P29198, DOI 10.1074/jbc.271.46.29198; Bolisetty MT, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0777-z; Braunschweig U, 2013, CELL, V152, P1252, DOI 10.1016/j.cell.2013.02.034; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Brown SJ, 2012, HUM MOL GENET, V21, pR90, DOI 10.1093/hmg/dds353; Byrne A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16027; Byron SA, 2016, NAT REV GENET, V17, P257, DOI 10.1038/nrg.2016.10; Chaisson MJP, 2015, NAT REV GENET, V16, P627, DOI 10.1038/nrg3933; Chen KH, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6090; Chen L, 2016, CELL, V167, P1398, DOI 10.1016/j.cell.2016.10.026; Collado-Torres L, 2017, NAT BIOTECHNOL, V35, P319, DOI 10.1038/nbt.3838; Conesa A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0881-8; Corey DR, 2017, NAT NEUROSCI, V20, P497, DOI 10.1038/nn.4508; Coulombe-Huntington J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000766; Cummings BB, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal5209; Di Bernardo MC, 2008, NAT GENET, V40, P1204, DOI 10.1038/ng.219; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dror G, 2005, BIOINFORMATICS, V21, P897, DOI 10.1093/bioinformatics/bti132; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eilbeck K, 2017, NAT REV GENET, V18, P599, DOI 10.1038/nrg.2017.52; Fadista J, 2014, P NATL ACAD SCI USA, V111, P13924, DOI 10.1073/pnas.1402665111; Feng YX, 2015, GENOM PROTEOM BIOINF, V13, P4, DOI 10.1016/j.gpb.2015.01.009; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Freese P, 2017, BIORXIV; Fu XD, 2014, NAT REV GENET, V15, P689, DOI 10.1038/nrg3778; Goodwin S, 2016, NAT REV GENET, V17, P333, DOI 10.1038/nrg.2016.49; Gymrek M, 2016, NAT GENET, V48, P22, DOI 10.1038/ng.3461; Hsiao YHE, 2016, GENOME RES, V26, P440, DOI 10.1101/gr.193359.115; Huang YH, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1248-5; Jha A, 2017, BIOINFORMATICS, V33, pI274, DOI 10.1093/bioinformatics/btx268; Jia C, 2015, CANCER INFORM, V14, P45, DOI 10.4137/CIN.S24832; Johnson N. T, 2017, BIORXIV; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kelemen O, 2013, GENE, V514, P1, DOI 10.1016/j.gene.2012.07.083; Lalonde E, 2011, GENOME RES, V21, P545, DOI 10.1101/gr.111211.110; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lee C, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-231; Leung MKK, 2014, BIOINFORMATICS, V30, P121, DOI 10.1093/bioinformatics/btu277; Li G, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks280; Li M, 2017, HUM MUTAT, V38, P16, DOI 10.1002/humu.23111; Li X, 2014, AM J HUM GENET, V95, P245, DOI 10.1016/j.ajhg.2014.08.004; Li YI, 2016, SCIENCE, V352, P600, DOI 10.1126/science.aad9417; Libbrecht MW, 2015, NAT REV GENET, V16, P321, DOI 10.1038/nrg3920; Lim KH, 2011, P NATL ACAD SCI USA, V108, P11093, DOI 10.1073/pnas.1101135108; Linares AJ, 2015, ELIFE, V4, DOI 10.7554/eLife.09268; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Lu ZX, 2012, WIRES RNA, V3, P581, DOI 10.1002/wrna.120; Lubeck E, 2014, NAT METHODS, V11, P360, DOI 10.1038/nmeth.2892; Matesanz F, 2015, HUM MOL GENET, V24, P5619, DOI 10.1093/hmg/ddv256; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Monlong J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5698; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Mort M, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r19; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Ongen H, 2015, AM J HUM GENET, V97, P567, DOI 10.1016/j.ajhg.2015.09.004; Osborne RJ, 2006, HUM MOL GENET, V15, pR162, DOI 10.1093/hmg/ddl181; Pagani F, 2004, NAT REV GENET, V5, P389, DOI 10.1038/nrg1327; Pala M, 2017, NAT GENET, V49, P700, DOI 10.1038/ng.3840; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Park E, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1270-7; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Percifield R, 2014, METHODS MOL BIOL, V1126, P299, DOI 10.1007/978-1-62703-980-2_22; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Ratsch G, 2005, BIOINFORMATICS, V21, pI369, DOI 10.1093/bioinformatics/bti1053; Rhoads A, 2015, GENOM PROTEOM BIOINF, V13, P278, DOI 10.1016/j.gpb.2015.08.002; Rosenberg AB, 2015, CELL, V163, P698, DOI 10.1016/j.cell.2015.09.054; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; Sandberg R, 2014, NAT METHODS, V11, P22, DOI 10.1038/nmeth.2764; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Scotti MM, 2016, NAT REV GENET, V17, P19, DOI 10.1038/nrg.2015.3; Sharon D, 2013, NAT BIOTECHNOL, V31, P1009, DOI 10.1038/nbt.2705; SHARP PA, 1994, CELL, V77, P805, DOI 10.1016/0092-8674(94)90130-9; Shen SH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11548; Shen SH, 2014, P NATL ACAD SCI USA, V111, pE5593, DOI 10.1073/pnas.1419161111; Singh G, 2006, BIOTECHNIQUES, V41, P177, DOI 10.2144/000112208; Soemedi R, 2017, NAT GENET, V49, P848, DOI 10.1038/ng.3837; Song Y, 2017, MOL CELL, V67, P148, DOI 10.1016/j.molcel.2017.06.003; Sorek R, 2004, GENOME RES, V14, P1617, DOI 10.1101/gr.2572604; Starita LM, 2017, AM J HUM GENET, V101, P315, DOI 10.1016/j.ajhg.2017.07.014; Stein Shayna, 2015, Nucleic Acids Res, V43, P10612, DOI 10.1093/nar/gkv1099; Takata A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14519; Tanioka T, 2003, J BIOL CHEM, V278, P32275, DOI 10.1074/jbc.M305076200; Tilgner H, 2015, NAT BIOTECHNOL, V33, P736, DOI 10.1038/nbt.3242; Tilgner H, 2014, P NATL ACAD SCI USA, V111, P9869, DOI 10.1073/pnas.1400447111; Tilgner H, 2012, GENOME RES, V22, P1616, DOI 10.1101/gr.134445.111; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trincado JL, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0339-3; Vaquero-Garcia J, 2016, ELIFE, V5, DOI 10.7554/eLife.11752; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang ET, 2012, CELL, V150, P710, DOI 10.1016/j.cell.2012.06.041; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Ward MC, 2017, NATURE, V550, P190, DOI 10.1038/550190a; Warren CR, 2017, CELL STEM CELL, V20, P431, DOI 10.1016/j.stem.2017.03.021; Woolfe A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r20; Wu J, 2011, BIOINFORMATICS, V27, P3010, DOI 10.1093/bioinformatics/btr508; Xing Y, 2006, NUCLEIC ACIDS RES, V34, P3150, DOI 10.1093/nar/gkl396; Xiong HY, 2015, SCIENCE, V347, DOI 10.1126/science.1254806; Xiong HY, 2011, BIOINFORMATICS, V27, P2554, DOI 10.1093/bioinformatics/btr444; Yang L, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r16; Yang Qian, 2017, BMC Genomics, V18, P963, DOI 10.1186/s12864-016-3258-1; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102; Zhang XL, 2015, NAT GENET, V47, P345, DOI 10.1038/ng.3220; Zhang XJ, 2014, HUM MOL GENET, V23, P3024, DOI 10.1093/hmg/ddu019; Zhao KY, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r74; Zucchelli C, 2014, FEBS J, V281, P216, DOI 10.1111/febs.12588	126	165	174	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 4	2018	102	1					11	26		10.1016/j.ajhg.2017.11.002	http://dx.doi.org/10.1016/j.ajhg.2017.11.002			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FR8DU	29304370	Green Published, hybrid			2022-12-18	WOS:000419305500002
J	Conomos, MP; Reiner, AP; Weir, BS; Thornton, TA				Conomos, Matthew P.; Reiner, Alexander P.; Weir, Bruce S.; Thornton, Timothy A.			Model-free Estimation of Recent Genetic Relatedness	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POPULATION STRATIFICATION; ASSOCIATION; ANCESTRY; INFERENCE; HERITABILITY; COEFFICIENT; SELECTION; IDENTITY; COMMON; TOOL	Genealogical inference from genetic data is essential for a variety of applications in human genetics. In genome-wide and sequencing association studies, for example, accurate inference on both recent genetic relatedness, such as family structure, and more distant genetic relatedness, such as population structure, is necessary for protection against spurious associations. Distinguishing familial relatedness from population structure with genotype data, however, is difficult because both manifest as genetic similarity through the sharing of alleles. Existing approaches for inference on recent genetic relatedness have limitations in the presence of population structure, where they either (1) make strong and simplifying assumptions about population structure, which are often untenable, or (2) require correct specification of and appropriate reference population panels for the ancestries in the sample, which might be unknown or not well defined. Here, we propose PC-Relate, a model-free approach for estimating commonly used measures of recent genetic relatedness, such as kinship coefficients and IBD sharing probabilities, in the presence of unspecified structure. PC-Relate uses principal components calculated from genome-screen data to partition genetic correlations among sampled individuals due to the sharing of recent ancestors and more distant common ancestry into two separate components, without requiring specification of the ancestral populations or reference population panels. In simulation studies with population structure, including admixture, we demonstrate that PC-Relate provides accurate estimates of genetic relatedness and improved relationship classification over widely used approaches. We further demonstrate the utility of PC-Relate in applications to three ancestrally diverse samples that vary in both size and genealogical complexity.	[Conomos, Matthew P.; Weir, Bruce S.; Thornton, Timothy A.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Reiner, Alexander P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Reiner, Alexander P.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Conomos, MP (corresponding author), Univ Washington, Dept Biostat, Seattle, WA 98195 USA.	mconomos@uw.edu; tathornt@uw.edu	Weir, Bruce S/A-2894-2013; Conomos, Matthew P./A-8136-2019	Conomos, Matthew P./0000-0001-9744-0851	NIH [R01 GM 075091, P01 GM 099568, T32 GM 81062, GM 075091, GM 099568, K01 CA148958, U01 DK085524, U01 DK085584, U01 DK085501, U01 DK085526, U01 DK085545, R01 GM031575]; NHLBI [HHSN268201300005C, N02-HL-64278]; NHLBI, U.S. Department of Health and Human Services [HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, HHSN271201100004C]; NATIONAL CANCER INSTITUTE [K01CA148958] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085545, U01DK085524, U01DK085501, U01DK085584, U01DK085526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031575, P01GM099568, T32GM081062, R01GM075091] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI, U.S. Department of Health and Human Services; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the NIH grants R01 GM 075091, P01 GM 099568, T32 GM 81062, GM 075091, GM 099568, and K01 CA148958 and NHLBI contract HHSN268201300005C. The WHI program is funded by the NHLBI, U.S. Department of Health and Human Services through contracts HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, and HHSN271201100004C. Funding for WHI SNP Health Association Resource (WHI-SHARe) genotyping was provided by NHLBI contract N02-HL-64278. The T2D-GENES Consortium is supported by NIH grants U01 DK085524, U01 DK085584, U01 DK085501, U01 DK085526, and U01 DK085545. The Genetic Analysis Workshop 18 was supported by NIH grant R01 GM031575.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Almasy Laura, 2014, BMC Proc, V8, pS2, DOI 10.1186/1753-6561-8-S1-S2; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; BALDING DJ, 1995, GENETICA, V96, P3, DOI 10.1007/BF01441146; Bhatia G, 2013, GENOME RES, V23, P1514, DOI 10.1101/gr.154831.113; Browning SR, 2011, AM J HUM GENET, V89, P191, DOI 10.1016/j.ajhg.2011.05.025; Choi Y, 2009, GENET EPIDEMIOL, V33, P668, DOI 10.1002/gepi.20418; Conomos MP, 2015, GENET EPIDEMIOL, V39, P276, DOI 10.1002/gepi.21896; Garcia-Cortes LA, 2014, J ANIM BREED GENET, V131, P97, DOI 10.1111/jbg.12076; Hayes BJ, 2009, GENET RES, V91, P47, DOI 10.1017/S0016672308009981; Hays J, 2003, ANN EPIDEMIOL, V13, pS18, DOI 10.1016/S1047-2797(03)00042-5; Hill WG, 2011, GENET RES, V93, P47, DOI 10.1017/S0016672310000480; Jacquard A, 1970, STRUCTURES GENETIQUE; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Manichaikul A, 2012, PLOS GENET, V8, P285, DOI 10.1371/journal.pgen.1002640; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Milligan BG, 2003, GENETICS, V163, P1153; Moltke I, 2014, BIOINFORMATICS, V30, P1027, DOI 10.1093/bioinformatics/btt652; Morrison J, 2013, GENET EPIDEMIOL, V37, P635, DOI 10.1002/gepi.21737; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reiner AP, 2012, AM J HUM GENET, V91, P502, DOI 10.1016/j.ajhg.2012.07.023; REYNOLDS J, 1983, GENETICS, V105, P767; Seldin MF, 2011, NAT REV GENET, V12, P523, DOI 10.1038/nrg3002; Speed D, 2015, NAT REV GENET, V16, P33, DOI 10.1038/nrg3821; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; THOMPSON EA, 1975, ANN HUM GENET, V39, P173, DOI 10.1111/j.1469-1809.1975.tb00120.x; Thompson EA, 2013, GENETICS, V194, P301, DOI 10.1534/genetics.112.148825; Thornton Timothy, 2014, BMC Proc, V8, pS5, DOI 10.1186/1753-6561-8-S1-S5; Thornton T, 2012, AM J HUM GENET, V91, P122, DOI 10.1016/j.ajhg.2012.05.024; Thornton T, 2010, AM J HUM GENET, V86, P172, DOI 10.1016/j.ajhg.2010.01.001; Thornton TA, 2014, GENET EPIDEMIOL, V38, pS5, DOI 10.1002/gepi.21819; Vitezica ZG, 2013, GENETICS, V195, P1223, DOI 10.1534/genetics.113.155176; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Wu CQ, 2011, ANN HUM GENET, V75, P418, DOI 10.1111/j.1469-1809.2010.00639.x; Yang J, 2014, NAT GENET, V46, P100, DOI 10.1038/ng.2876; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zheng X., 2015, THEOR POPUL BIOL; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	47	165	165	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 7	2016	98	1					127	148		10.1016/j.ajhg.2015.11.022	http://dx.doi.org/10.1016/j.ajhg.2015.11.022			22	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DA8JL	26748516	Bronze, Green Published			2022-12-18	WOS:000368050800010
J	Conomos, MP; Laurie, CA; Stilp, AM; Gogarten, SM; McHugh, CP; Nelson, SC; Sofer, T; Fernandez-Rhodes, L; Justice, AE; Graff, M; Young, KL; Seyerle, AA; Avery, CL; Taylor, KD; Rotter, JI; Talavera, GA; Daviglus, ML; Wassertheil-Smoller, S; Schneiderman, N; Heiss, G; Kaplan, RC; Franceschini, N; Reiner, AP; Shaffer, JR; Barr, RG; Kerr, KF; Browning, SR; Browning, BL; Weir, BS; Aviles-Santa, ML; Papanicolaou, GJ; Lumley, T; Szpiro, AA; North, KE; Rice, K; Thornton, TA; Laurie, CC				Conomos, Matthew P.; Laurie, Cecelia A.; Stilp, Adrienne M.; Gogarten, Stephanie M.; McHugh, Caitlin P.; Nelson, Sarah C.; Sofer, Tamar; Fernandez-Rhodes, Lindsay; Justice, Anne E.; Graff, Mariaelisa; Young, Kristin L.; Seyerle, Amanda A.; Avery, Christy L.; Taylor, Kent D.; Rotter, Jerome I.; Talavera, Gregory A.; Daviglus, Martha L.; Wassertheil-Smoller, Sylvia; Schneiderman, Neil; Heiss, Gerardo; Kaplan, Robert C.; Franceschini, Nora; Reiner, Alex P.; Shaffer, John R.; Barr, R. Graham; Kerr, Kathleen F.; Browning, Sharon R.; Browning, Brian L.; Weir, Bruce S.; Aviles-Santa, M. Larissa; Papanicolaou, George J.; Lumley, Thomas; Szpiro, Adam A.; North, Kari E.; Rice, Ken; Thornton, Timothy A.; Laurie, Cathy C.			Genetic Diversity and Association Studies in US Hispanic/Latino Populations: Applications in the Hispanic Community Health Study/Study of Latinos	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; LINEAR MIXED MODELS; ADMIXED POPULATIONS; UNITED-STATES; MEXICAN-AMERICANS; ENVIRONMENT DATA; QUALITY-CONTROL; STRATIFICATION; ANCESTRY; TRAITS	US Hispanic/Latino individuals are diverse in genetic ancestry, culture, and environmental exposures. Here, we characterized and controlled for this diversity in genome-wide association studies (GWASs) for the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). We simultaneously estimated population-structure principal components (PCs) robust to familial relatedness and pairwise kinship coefficients (KCs) robust to population structure, admixture, and Hardy-Weinberg departures. The PCs revealed substantial genetic differentiation within and among six self-identified background groups (Cuban, Dominican, Puerto Rican, Mexican, and Central and South American). To control for variation among groups, we developed a multi-dimensional clustering method to define a "genetic-analysis group" variable that retains many properties of self-identified background while achieving substantially greater genetic homogeneity within groups and including participants with non-specific self-identification. In GWASs of 22 biomedical traits, we used a linear mixed model (LMM) including pairwise empirical KCs to account for familial relatedness, PCs for ancestry, and genetic-analysis groups for additional group-associated effects. Including the genetic-analysis group as a covariate accounted for significant trait variation in 8 of 22 traits, even after we fit 20 PCs. Additionally, genetic-analysis groups had significant heterogeneity of residual variance for 20 of 22 traits, and modeling this heteroscedasticity within the LMM reduced genomic inflation for 19 traits. Furthermore, fitting an LMM that utilized a genetic-analysis group rather than a self-identified background group achieved higher power to detect previously reported associations. We expect that the methods applied here will be useful in other studies with multiple ethnic groups, admixture, and relatedness.	[Conomos, Matthew P.; Laurie, Cecelia A.; Stilp, Adrienne M.; Gogarten, Stephanie M.; McHugh, Caitlin P.; Nelson, Sarah C.; Sofer, Tamar; Kerr, Kathleen F.; Browning, Sharon R.; Weir, Bruce S.; Szpiro, Adam A.; Rice, Ken; Thornton, Timothy A.; Laurie, Cathy C.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Fernandez-Rhodes, Lindsay; Justice, Anne E.; Graff, Mariaelisa; Young, Kristin L.; Seyerle, Amanda A.; Avery, Christy L.; Heiss, Gerardo; Franceschini, Nora; North, Kari E.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27514 USA; [Taylor, Kent D.; Rotter, Jerome I.] Harbor UCLA Med Ctr, Inst Translat Genom & Populat Sci, Los Angeles Biomed Res Inst, Torrance, CA 90502 USA; [Taylor, Kent D.; Rotter, Jerome I.] Harbor UCLA Med Ctr, Dept Pediat, Torrance, CA 90502 USA; [Talavera, Gregory A.] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA; [Daviglus, Martha L.] Univ Illinois, Inst Minor Hlth, Chicago, IL 60612 USA; [Wassertheil-Smoller, Sylvia; Kaplan, Robert C.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA; [Schneiderman, Neil] Univ Miami, Dept Psychol & Behav Med, Miami, FL 33124 USA; [Reiner, Alex P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Shaffer, John R.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Barr, R. Graham] Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA; [Barr, R. Graham] Columbia Univ, Med Ctr, Dept Epidemiol, New York, NY 10032 USA; [Browning, Brian L.] Univ Washington, Dept Med, Seattle, WA 98077 USA; [Aviles-Santa, M. Larissa; Papanicolaou, George J.] NHLBI, Div Cardiovasc Sci, NIH, Bethesda, MD 20892 USA; [Lumley, Thomas] Univ Auckland, Dept Stat, Auckland 1010, New Zealand	University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; California State University System; San Diego State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Yeshiva University; Albert Einstein College of Medicine; University of Miami; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Columbia University; Columbia University; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Auckland	Conomos, MP (corresponding author), Univ Washington, Dept Biostat, Seattle, WA 98195 USA.	mconomos@uw.edu; cclaurie@uw.edu	Conomos, Matthew P./A-8136-2019; Weir, Bruce S/A-2894-2013; Kerr, Kathleen F./A-2893-2013; Nelson, Sarah Catherine/AAN-9814-2020; Young, Kristin/Q-6908-2019; Rotter, Jerome/AAY-6598-2021; Browning, Brian L/A-1178-2010; Browning, Sharon/B-1530-2008	Conomos, Matthew P./0000-0001-9744-0851; Kerr, Kathleen F./0000-0002-6438-9583; Nelson, Sarah Catherine/0000-0002-2109-6465; Browning, Brian L/0000-0001-6454-6633; Browning, Sharon/0000-0001-7251-9715; Sofer, Tamar/0000-0001-8520-8860; Gogarten, Stephanie/0000-0002-7231-9745; Fernandez-Rhodes, Lindsay/0000-0001-6985-423X; Justice, Anne/0000-0002-8903-8712; Aviles-Santa, M Larissa/0000-0002-8130-0026; Seyerle, Amanda/0000-0001-5660-3837; Shaffer, John/0000-0003-1897-1131	NHLBI [N01-HC65233]; University of Miami [N01-HC65234]; Albert Einstein College of Medicine [N01-HC65235]; Northwestern University [N01-HC65236]; San Diego State University [N01-HC65237]; NHLBI; NIDCR [HHSN268201300005C AM03, MOD03]; NIH Department of Health and Human Services [HSN26220/20054C]; National Center for Advancing Translational Science Clinical Translational Science Institute [UL1TR000124]; NIDDK Diabetes Research Center [DK063491];  [1R01DK101855-01];  [13GRNT16490017]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC065233] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K01CA148958] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124, KL2TR001109] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007055, R01HL065234, U01HL065233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, P30DK020541, R01DK101855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099568, T32GM081062] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Miami; Albert Einstein College of Medicine; Northwestern University; San Diego State University; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Science Clinical Translational Science Institute; NIDDK Diabetes Research Center; ; ; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the participants and staff of the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) for their contributions to this study. The baseline examination of HCHS/SOL was carried out as a collaborative study supported by contracts from the NHLBI to the University of North Carolina (N01-HC65233), University of Miami (N01-HC65234), Albert Einstein College of Medicine (N01-HC65235), Northwestern University (N01-HC65236), and San Diego State University (N01-HC65237). The following institutes, centers, and offices contributed to the first phase of HCHS/SOL through a transfer of funds to the NHLBI: National Institute on Minority Health and Health Disparities, National Institute on Deafness and Other Communication Disorders, National Institute of Dental and Craniofacial Research (NIDCR), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Neurological Disorders and Stroke, and NIH Office of Dietary Supplements. The Genetic Analysis Center at the University of Washington was supported by NHLBI and NIDCR contracts (HHSN268201300005C AM03 and MOD03). Additional analysis support was provided by 1R01DK101855-01 and 13GRNT16490017. Genotyping efforts were supported by the NIH Department of Health and Human Services (HSN26220/20054C), National Center for Advancing Translational Science Clinical Translational Science Institute (UL1TR000124), and NIDDK Diabetes Research Center (DK063491). This manuscript has been reviewed by the HCHS/SOL Publications Committee for scientific content and consistency of data interpretation with previous HCHS/SOL publications.	Adler D, 2014, RGL 3D VISUALIZATION; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Barr R. G., 2015, AM J RESP CRIT CARE; Bivand, 2015, PACKAGE RGDAL BINDIN; Bivand R., 2015, MAPTOOLS TOOLS READI; Bryc K, 2015, AM J HUM GENET, V96, P37, DOI 10.1016/j.ajhg.2014.11.010; Bryc K, 2010, P NATL ACAD SCI USA, V107, P8954, DOI 10.1073/pnas.0914618107; Burnham KP, 2002, MODEL SELECTION MULT; Bustamante CD, 2011, NATURE, V475, P163, DOI 10.1038/475163a; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Cavalli-Sforza LL, 2005, NAT REV GENET, V6, P333, DOI 10.1038/nrg1579; Cheng I, 2012, CANCER EPIDEM BIOMAR, V21, P2048, DOI 10.1158/1055-9965.EPI-12-0598; COCHRAN WG, 1950, BIOMETRIKA, V37, P256, DOI 10.1093/biomet/37.3-4.256; Comuzzie AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051954; Conomos MP, 2016, AM J HUM GENET, V98, P127, DOI 10.1016/j.ajhg.2015.11.022; Conomos MP, 2015, GENET EPIDEMIOL, V39, P276, DOI 10.1002/gepi.21896; Conomos MP, 2014, THESIS; Daviglus ML, 2012, JAMA-J AM MED ASSOC, V308, P1775, DOI 10.1001/jama.2012.14517; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Denis JB, 1997, HEREDITY, V79, P162, DOI 10.1038/hdy.1997.139; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Drake KA, 2014, J ALLERGY CLIN IMMUN, V133, P370, DOI 10.1016/j.jaci.2013.06.043; Fejerman L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6260; Gao XY, 2013, INVEST OPHTH VIS SCI, V54, P2435, DOI 10.1167/iovs.13-11692; Gilmour AR, 1995, BIOMETRICS, V51, P1440, DOI 10.2307/2533274; Gogarten SM, 2012, BIOINFORMATICS, V28, P3329, DOI 10.1093/bioinformatics/bts610; Gravel S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004023; Hill WG, 2011, GENET RES, V93, P47, DOI 10.1017/S0016672310000480; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Joliffe I., 2004, PRINCIPAL COMPONENT; Kahle D, 2013, R J, V5, P144; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kaplan RC, 2014, AM J PREV MED, V46, P496, DOI 10.1016/j.amepre.2014.01.014; Laurie CC, 2012, NAT GENET, V44, P642, DOI 10.1038/ng.2271; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Lavange LM, 2010, ANN EPIDEMIOL, V20, P642, DOI 10.1016/j.annepidem.2010.05.006; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lin DY, 2010, GENET EPIDEMIOL, V34, P60, DOI 10.1002/gepi.20435; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/NMETH.1681, 10.1038/nmeth.1681]; Listgarten J, 2012, NAT METHODS, V9, P525, DOI 10.1038/nmeth.2037; Liu JH, 2013, AM J EPIDEMIOL, V177, P351, DOI 10.1093/aje/kws234; Manichaikul A, 2014, AM J RESP CRIT CARE, V189, P408, DOI 10.1164/rccm.201306-1061OC; Manichaikul A, 2012, PLOS GENET, V8, P285, DOI 10.1371/journal.pgen.1002640; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Melton PE, 2013, CIRC-CARDIOVASC GENE, V6, P211, DOI 10.1161/CIRCGENETICS.113.000079; Moreno-Estrada A, 2014, SCIENCE, V344, P1280, DOI 10.1126/science.1251688; Moreno-Estrada A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003925; Norris JM, 2009, OBESITY, V17, P1932, DOI 10.1038/oby.2009.143; Palmer ND, 2010, DIABETOLOGIA, V53, P281, DOI 10.1007/s00125-009-1586-2; Palmer ND, 2015, DIABETES, V64, P1853, DOI 10.2337/db14-0732; Pfeffermann D, 2011, SURV METHODOL, V37, P115; Piepho HP, 2000, GENETICS, V156, P2043; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Rich SS, 2009, DIABETOLOGIA, V52, P1326, DOI 10.1007/s00125-009-1373-0; Rodriguez CJ, 2014, CIRCULATION, V130, P593, DOI 10.1161/CIR.0000000000000071; Rousseeuw P., 2015, ROBUSTBASE BASIC ROB; Rousseeuw PJ, 1999, TECHNOMETRICS, V41, P212, DOI 10.2307/1270566; Schloerke B., 2014, GGALLY EXTENSION GGP; Siega-Riz AM, 2014, AM J CLIN NUTR, V99, P1487, DOI 10.3945/ajcn.113.082685; Sorlie PD, 2010, ANN EPIDEMIOL, V20, P629, DOI 10.1016/j.annepidem.2010.03.015; Speed D, 2015, NAT REV GENET, V16, P33, DOI 10.1038/nrg3821; Taylor P., 2012, LABELS DONT FIT HISP; Thornton T, 2012, AM J HUM GENET, V91, P122, DOI 10.1016/j.ajhg.2012.05.024; Torgerson DG, 2012, J ALLERGY CLIN IMMUN, V130, P76, DOI 10.1016/j.jaci.2012.02.040; Wang XX, 2011, BIOINFORMATICS, V27, P670, DOI 10.1093/bioinformatics/btq709; WEGMAN EJ, 1990, J AM STAT ASSOC, V85, P664, DOI 10.2307/2290001; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williams AL, 2014, NATURE, V506, P97, DOI 10.1038/nature12828; Wise AL, 2013, AM J HUM GENET, V92, P643, DOI 10.1016/j.ajhg.2013.03.017; Wu CQ, 2011, ANN HUM GENET, V75, P418, DOI 10.1111/j.1469-1809.2010.00639.x; Yang J, 2014, NAT GENET, V46, P100, DOI 10.1038/ng.2876; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	79	165	165	1	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 7	2016	98	1					165	184		10.1016/j.ajhg.2015.12.001	http://dx.doi.org/10.1016/j.ajhg.2015.12.001			20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DA8JL	26748518	Bronze, Green Published			2022-12-18	WOS:000368050800012
J	Ferrucci, L; Perry, JRB; Matteini, A; Perola, M; Tanaka, T; Silander, K; Rice, N; Melzer, D; Murray, A; Cluett, C; Fried, LR; Albanes, D; Corsi, AM; Cherubini, A; Guralnik, J; Bandinelli, S; Singleton, A; Virtamo, J; Walston, J; Semba, RD; Frayling, TM				Ferrucci, Luigi; Perry, John R. B.; Matteini, Amy; Perola, Markus; Tanaka, Tosbiko; Silander, Kaisa; Rice, Neil; Melzer, David; Murray, Anna; Cluett, Christie; Fried, Linda R.; Albanes, Demetrius; Corsi, Anna-Maria; Cherubini, Antonio; Guralnik, Jack; Bandinelli, Stefania; Singleton, Andrew; Virtamo, Jarmo; Walston, Jeremy; Semba, Richard D.; Frayling, Timothy M.			Common Variation in the beta-Carotene 15,15 '-Monooxygenase 1 Gene Affects Circulating Levels of Carotenoids: A Genome-wide Association Study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MEDITERRANEAN-STYLE DIET; VITAMIN-E LEVELS; ALPHA-TOCOPHEROL; CARDIOVASCULAR-DISEASE; PLASMA-CONCENTRATIONS; METABOLIC SYNDROME; VEGETABLE INTAKE; RISK; INFLAMMATION; RETINOL	Low plasma levels of carotenoids and tocopherols are associated with increased risk of chronic disease and disability. Because dietary intake of these lipid-soluble antioxidant vitamins is only poorly correlated with plasma levels, we hypothesized that circulating carotenoids (vitamin A-related compounds) and tocopherols (vitamin E-related compounds) are affected by common genetic variation. By conducting a genome-wide association Study in a sample of Italians (n = 1190), we identified novel common variants associated with circulating carotenoid levels anti known lipid variants associated with alpha-tocopherol levels. Effects were replicated in the Women's Health and Aging Study (n = 615) and in the alpha-Tocopherol, beta-Carotene Cancer Prevention (ATBC) study (n 2136). In meta-analyses including all three Studies, the G allele at rs6564851, near the beta-carotene 15,15'-monooxygenase 1 (BCMO1) gene, was associated with higher beta-carotene (p = 1.6 x 10(-24)) and alpha-carotene (p = 0.0001) levels and lower lycopene (0.003), zeaxanthin (p = 1.3 x 10(-5)), and lutein (p = 7.3 x 10(-15)) levels, with effect sizes ranging from 0.10-0.28 SDs per allele. Interestingly, this genetic variant had no significant effect on plasma retinol (p > 0.05). The SNP rs12272004, in linkage disequilibrium with the S19W variant in the APOA5 gene, was associated with alpha-tocopherol (meta-analysis p = 7.8 x 10(-10)) levels, and this association was substantially weaker when we adjusted for triglyceride levels (p = 0.002). Our findings might shed light on the controversial relationship between lipid-soluble anti-oxidant nutrients and human health.	[Ferrucci, Luigi; Tanaka, Tosbiko] NIA, Longitudinal Studies Sect, Clin Res Branch, NIH, Bethesda, MD 20892 USA; [Guralnik, Jack] NIA, Lab Epidemiol Demog & Biometry, NIH, Bethesda, MD 20892 USA; [Singleton, Andrew] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Perry, John R. B.; Rice, Neil; Melzer, David; Murray, Anna; Cluett, Christie; Frayling, Timothy M.] Univ Exeter, Peninsula Coll Med & Dent, Inst Biomed & Clin Sci, Exeter EX1 2LU, Devon, England; [Matteini, Amy; Walston, Jeremy] Johns Hopkins Med Inst, Dept Med, Div Geriatr, Baltimore, MD 21224 USA; [Virtamo, Jarmo] Natl Publ Hlth Inst, Dept Hlth Promot & Chron Dis Prevent, FI-00271 Helsinki, Finland; [Perola, Markus; Silander, Kaisa] Inst Mol Med, Dept Mol Med, FIMM, FI-00271 Helsinki, Finland; [Tanaka, Tosbiko] MedStar Res Inst, Baltimore, MD 21225 USA; [Fried, Linda R.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10032 USA; [Albanes, Demetrius] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Corsi, Anna-Maria] Tuscany Reg Hlth Agcy, I-50100 Florence, Italy; [Cherubini, Antonio] Univ Perugia, Sch Med, Dept Clin & Expt Med, Inst Gerontol & Geriatr, I-06122 Perugia, Italy; [Bandinelli, Stefania] Azienda Sanit Firenze, Geriatr Unit, I-50125 Florence, Italy; [Semba, Richard D.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Exeter; University of Plymouth; Johns Hopkins University; Johns Hopkins Medicine; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; Columbia University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Perugia; Azienda Sanitaria di Firenze; Johns Hopkins University	Ferrucci, L (corresponding author), NIA, Longitudinal Studies Sect, Clin Res Branch, NIH, Bethesda, MD 20892 USA.	ferruccilu@grc.nia.nih.gov	Albanes, Demetrius/B-9749-2015; Cherubini, Antonio/AAL-4632-2020; bandinelli, stefania/AAL-4570-2020; Singleton, Andrew B/C-3010-2009; Stefanadis, Christodoulos/ABH-2232-2020	Frayling, Timothy/0000-0001-8362-2603; Melzer, David/0000-0002-0170-3838; Stefanadis, Christodoulos/0000-0001-5974-6454; Murray, Anna/0000-0002-2351-2522; Cherubini, Antonio/0000-0003-0261-9897	Italian Ministry of Health [ICS110.1\RS97.71]; National Institute on Aging [N01-AG-916413, N01-AG-821336]; US Public Health Service [N01-CN-45165, N01-RC-45035, N01-RC-37004]; National Cancer Institute, Department of Health and Human Service; National Institute on Aging, National Institutes of Health; National Institute on Aging, Pathogenesis of Physical Disability in Aging Women [R37 AG 19905, R01 AG027012]; Johns Hopkins Claude D. Pepper Older Americans Independence Center [P30 AG021334]; DIVISION OF CANCER PREVENTION AND CONTROL [N01CN045165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000015, R01AG027012, R37AG019905, ZIAAG001050, ZIAAG000965, P30AG021334] Funding Source: NIH RePORTER	Italian Ministry of Health(Ministry of Health, Italy); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Cancer Institute, Department of Health and Human Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Aging, Pathogenesis of Physical Disability in Aging Women(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Johns Hopkins Claude D. Pepper Older Americans Independence Center; DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The InCHIANTI study was supported as a "targeted project" (ICS110.1\RS97.71) by the Italian Ministry of Health and in part by the National Institute on Aging (contracts N01-AG-916413, N01-AG-821336). The ATBC study was Supported by the US Public Health Service contracts N01-CN-45165, N01-RC-45035, and N01-RC-37004 from the National Cancer Institute, Department of Health and Human Service. This research was supported in part by the Intramural Research Program of the National Institute on Aging, National Institutes of Health. A portion of that support was through an R&D contract with the MedStar Research Institute. We would like to thank Dr. Arun Barua (Iowa State University) for precious help in interpreting our findings in the context of carotenoid metabolism in humans. We acknowledge the important contribution of Leena Peltonen Palotie of the Finnish Public Health Institute, who made genotyping the ATBC study possible. The WHAS was supported by a MERIT AWARD from the National Institute on Aging, Pathogenesis of Physical Disability in Aging Women (R37 AG 19905 and R01 AG027012) and the Johns Hopkins Claude D. Pepper Older Americans Independence Center (P30 AG021334).	Akbaraly NT, 2007, J GERONTOL A-BIOL, V62, P308, DOI 10.1093/gerona/62.3.308; Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; Bartali B, 2008, JAMA-J AM MED ASSOC, V299, P308, DOI 10.1001/jama.299.3.308; Bartali B, 2006, J GERONTOL A-BIOL, V61, P589, DOI 10.1093/gerona/61.6.589; Bazzano LA, 2002, AM J CLIN NUTR, V76, P93; Ble A, 2006, J GERONTOL A-BIOL, V61, P278, DOI 10.1093/gerona/61.3.278; BLOMHOFF R, 1991, PHYSIOL REV, V71, P951, DOI 10.1152/physrev.1991.71.4.951; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Castenmiller JJM, 1998, ANNU REV NUTR, V18, P19, DOI 10.1146/annurev.nutr.18.1.19; Cherubini A, 2005, NEUROBIOL AGING, V26, P987, DOI 10.1016/j.neurobiolaging.2004.09.002; Chrysohoou C, 2004, J AM COLL CARDIOL, V44, P152, DOI 10.1016/j.jacc.2004.03.039; COSTANTINO JP, 1988, AM J CLIN NUTR, V48, P1277, DOI 10.1093/ajcn/48.5.1277; Di Iorio A, 2006, NEUROBIOL AGING, V27, P1280, DOI 10.1016/j.neurobiolaging.2005.07.004; Dorgan JF, 2004, CANCER EPIDEM BIOMAR, V13, P1276; During A, 2002, J LIPID RES, V43, P1086, DOI 10.1194/jlr.M200068-JLR200; Esposito K, 2004, JAMA-J AM MED ASSOC, V292, P1440, DOI 10.1001/jama.292.12.1440; Estruch R, 2006, ANN INTERN MED, V145, P1, DOI 10.7326/0003-4819-145-1-200607040-00004; Ferrucci L, 2000, J AM GERIATR SOC, V48, P1618, DOI 10.1111/j.1532-5415.2000.tb03873.x; Food and Nutrition Board & Institute of Medicine, 2000, DIET REF INT VIT C V; Girona J, 2008, CLIN CHEM LAB MED, V46, P453, DOI 10.1515/CCLM.2008.110; GOODMAN DS, 1965, SCIENCE, V149, P879, DOI 10.1126/science.149.3686.879; GOODMAN DS, 1966, J BIOL CHEM, V241, P1929; Greenwald Peter, 2003, J Natl Cancer Inst, V95, pE1; Harrison EH, 2001, J NUTR, V131, P1405, DOI 10.1093/jn/131.5.1405; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Houston DK, 2005, AM J CLIN NUTR, V81, P515; Kasper JD, 1999, ANN EPIDEMIOL, V9, P498, DOI 10.1016/S1047-2797(99)00026-5; KRINSKY N, 2004, H S; LAKSHMAN MR, 1993, METHOD ENZYMOL, V214, P256; Lauretani F, 2008, REJUV RES, V11, P557, DOI 10.1089/rej.2007.0581; Lauretani F, 2008, J GERONTOL A-BIOL, V63, P376, DOI 10.1093/gerona/63.4.376; Lindqvist A, 2007, J NUTR, V137, P2346, DOI 10.1093/jn/137.11.2346; Liu S, 2000, AM J CLIN NUTR, V72, P922; Lopez-Garcia E, 2004, AM J CLIN NUTR, V80, P1029, DOI 10.1093/ajcn/80.4.1029; Mahaney MC, 2000, ARTERIOSCL THROM VAS, V20, P683, DOI 10.1161/01.ATV.20.3.683; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; MILNE DB, 1986, CLIN CHEM, V32, P874; Monge-Rojas R, 2003, ARCH LATINOAM NUTR, V53, P165; NIKI E, 1984, J BIOL CHEM, V259, P4177; Njalsson R, 2005, HUM GENET, V116, P384, DOI 10.1007/s00439-005-1255-6; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Ribaya-Mercado JD, 2003, AM J CLIN NUTR, V77, P694, DOI 10.1093/ajcn/77.3.694; SEMBA R, 2007, HDB NUTR OFTALMOLOGY; Siluk D, 2007, J PHARMACEUT BIOMED, V44, P1001, DOI 10.1016/j.jpba.2007.03.033; SOWELL AL, 1994, CLIN CHEM, V40, P411; Talegawkar SA, 2008, PUBLIC HEALTH NUTR, V11, P989, DOI 10.1017/S1368980007001310; Talmud PJ, 2002, HUM MOL GENET, V11, P3039, DOI 10.1093/hmg/11.24.3039; The Alpha-Tocopherol Beta-Carotene Lung Cancer Prevention Study, 1994, ANN EPIDEMIOL, V4, P1; Timpson NJ, 2005, LANCET, V366, P1954, DOI 10.1016/S0140-6736(05)67786-0; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Tucker KL, 1999, J NUTR, V129, P438, DOI 10.1093/jn/129.2.438; Virtamo J, 2003, JAMA-J AM MED ASSOC, V290, P476, DOI 10.1001/jama.290.4.476; Voutilainen S, 2006, AM J CLIN NUTR, V83, P1265; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287	56	165	175	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 13	2009	84	2					123	133		10.1016/j.ajhg.2008.12.019	http://dx.doi.org/10.1016/j.ajhg.2008.12.019			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	413NL	19185284	Bronze, Green Published			2022-12-18	WOS:000263799700004
J	Lange, K; Cantor, R; Horvath, S; Perola, M; Sabatti, C; Sinsheimer, J; Sobel, E				Lange, K; Cantor, R; Horvath, S; Perola, M; Sabatti, C; Sinsheimer, J; Sobel, E			Mendel version 4.0: a complete package for the exact genetic analysis of discrete traits in pedigree and population data sets.	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract									Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; Univ Calif Los Angeles, Dept Biomath, Los Angeles, CA USA; Univ Calif Los Angeles, Dept Stat, Los Angeles, CA USA; Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles									0	165	167	0	8	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2001	69	4		1		1886	504	504						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	483RD					2022-12-18	WOS:000171648901888
J	Goodman, FR; Bacchelli, C; Brady, AF; Brueton, LA; Fryns, JP; Mortlock, DP; Innis, JW; Holmes, LB; Donnenfeld, AE; Feingold, M; Beemer, FA; Hennekam, RCM; Scambler, PJ				Goodman, FR; Bacchelli, C; Brady, AF; Brueton, LA; Fryns, JP; Mortlock, DP; Innis, JW; Holmes, LB; Donnenfeld, AE; Feingold, M; Beemer, FA; Hennekam, RCM; Scambler, PJ			Novel HOXA13 mutations and the phenotypic spectrum of hand-foot-genital syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							URINARY-TRACT ABNORMALITIES; 2 UNRELATED FAMILIES; HOXD13; GENE; COMPLEX; UPDATE	Hand-foot-genital syndrome (HFGS) is a rare, dominantly inherited condition affecting the distal limbs and genitourinary tract. A nonsense mutation in the homeobox of HOXA13 has been identified in one affected family, making HFGS the second human syndrome shown to be caused by a HOX gene mutation. We have therefore examined HOXA13 in two new and four previously reported families with features of HFGS. In families 1, 2, and 3, nonsense mutations truncating the encoded protein N-terminal to or within the homeodomain produce typical limb and genitourinary abnormalities; in family 4, an expansion of an N-terminal polyalanine tract produces a similar phenotype; in family 5, a missense mutation, which alters an invariant domain, produces an exceptionally severe limb phenotype; and in family 6, in which limb abnormalities were atypical, no HOXA13 mutation could be detected. Mutations in HOXA13 can therefore cause more-severe limb abnormalities than previously suspected and may act by more than one mechanism.	Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; Northwick Pk Hosp, Kennedy Galton Ctr, London, England; Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium; Stanford Univ, Beckman Ctr, Dept Dev Biol, Stanford, CA 94305 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; Harvard Univ, Massachusetts Gen Hosp, Dept Genet & Teratol, Boston, MA USA; Penn Hosp, Genet Sect, Philadelphia, PA USA; Natl Birth Defects Ctr, Waltham, MA USA; Univ Med Ctr, Dept Med Genet, Utrecht, Netherlands; Univ Amsterdam, Dept Pediat, Amsterdam, Netherlands; Univ Amsterdam, Inst Human Genet, Amsterdam, Netherlands	University of London; University College London; KU Leuven; Stanford University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Massachusetts General Hospital; University of Pennsylvania; Pennsylvania Medicine; Utrecht University; Utrecht University Medical Center; University of Amsterdam; University of Amsterdam	Goodman, FR (corresponding author), Inst Child Hlth, Mol Med Unit, 30 Guilford St, London WC1N 1EH, England.		Scambler, Peter J/C-4998-2008; Morlock, Doug/C-3482-2012; Mortlock, Douglas P/C-9981-2010; Scambler, Peter/AAZ-6026-2020	Scambler, Peter J/0000-0002-1487-4628; Scambler, Peter/0000-0002-1487-4628	NIAMS NIH HHS [P60 AR20557] Funding Source: Medline; NICHD NIH HHS [HD34059] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD034059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR020557] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Akarsu AN, 1996, HUM MOL GENET, V5, P945, DOI 10.1093/hmg/5.7.945; Brown SA, 1998, NAT GENET, V20, P180, DOI 10.1038/2484; CLEVELAND RH, 1990, PEDIATR RADIOL, V20, P339, DOI 10.1007/BF02013170; Devriendt K, 1999, AM J HUM GENET, V65, P249, DOI 10.1086/302452; DONNENFELD AE, 1992, AM J MED GENET, V44, P482, DOI 10.1002/ajmg.1320440419; ELIAS S, 1978, FERTIL STERIL, V29, P239; FromentalRamain C, 1996, DEVELOPMENT, V122, P2997; FRYNS JP, 1993, CLIN GENET, V43, P232; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; Giedion A, 1976, Pediatr Radiol, V4, P96, DOI 10.1007/BF00973951; GOEMINNE L, 1981, TIJDSCHR GENEESKD, V37, P1461; Goodman F, 1998, AM J HUM GENET, V63, P992, DOI 10.1086/302070; Goodman FR, 1997, P NATL ACAD SCI USA, V94, P7458, DOI 10.1073/pnas.94.14.7458; HALAL F, 1988, AM J MED GENET, V30, P793, DOI 10.1002/ajmg.1320300312; HENNEKAM RCM, 1989, AM J MED GENET, V34, P454, DOI 10.1002/ajmg.1320340325; Mortlock DP, 1997, NAT GENET, V15, P179, DOI 10.1038/ng0297-179; Mortlock DP, 1996, NAT GENET, V13, P284, DOI 10.1038/ng0796-284; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Muragaki Y, 1996, SCIENCE, V272, P548, DOI 10.1126/science.272.5261.548; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; Post LC, 2000, DEV BIOL, V217, P290, DOI 10.1006/dbio.1999.9550; POZNANSKI A K, 1975, Birth Defects Original Article Series, V11, P127; STERN AM, 1970, J PEDIATR-US, V77, P109, DOI 10.1016/S0022-3476(70)80052-X; VERP MS, 1983, FERTIL STERIL, V40, P80; VERP MS, 1989, AM J MED GENET, V32, P555, DOI 10.1002/ajmg.1320320429; Warren ST, 1997, SCIENCE, V275, P408, DOI 10.1126/science.275.5298.408; WOLBERGER C, 1991, CELL, V67, P517, DOI 10.1016/0092-8674(91)90526-5; Zakany J, 1996, NATURE, V384, P69, DOI 10.1038/384069a0	28	165	176	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2000	67	1					197	202		10.1086/302961	http://dx.doi.org/10.1086/302961			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	347JY	10839976	Green Published, Bronze			2022-12-18	WOS:000088926900021
J	Knight, SW; Heiss, NS; Vulliamy, TJ; Greschner, S; Stavrides, G; Pai, GS; Lestringant, G; Varma, N; Mason, PJ; Dokal, I; Poustka, A				Knight, SW; Heiss, NS; Vulliamy, TJ; Greschner, S; Stavrides, G; Pai, GS; Lestringant, G; Varma, N; Mason, PJ; Dokal, I; Poustka, A			X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMOSOME INACTIVATION; NUCLEOLAR PROTEIN; PSEUDOURIDINE SYNTHASE; INCONTINENTIA PIGMENTI; ENDOGENOUS RETROVIRUS; YEAST; THALASSEMIA; CARRIERS; CBF5P; LYMPHOCYTES	Dyskeratosis congenita is a rare inherited bone marrow-failure syndrome characterized by abnormal skin pigmentation, nail dystrophy, and mucosal leukoplakia. More than 80% of patients develop bone-marrow failure, and this is the major cause of premature death. The X-linked form of the disease (MIM 305000) has been shown to be caused by mutations in the DKC1 gene. The gene encodes a 514-amino-acid protein, dyskerin, that is homologous to Saccharomyces cerevisiae Cbf5p and rat Nap57 proteins. By analogy to the homologues in other species, dyskerin is predicted to be a nucleolar protein with a role in both the biogenesis of ribosomes and, in particular, the pseudouridylation of rRNA precursors. We have determined the genomic structure of the DKC1 gene; it consists of 15 exons spanning a region of 15 kb. This has enabled us to screen for mutations in the genomic DNA, by using SSCP analysis. Mutations were detected in 21 of 37 additional families with dyskeratosis congenita that were analyzed. These mutations consisted of 11 different single-nucleotide substitutions, which resulted in 10 missense mutations and 1 putative splicing mutation within an intron. The missense change A353V was observed in 10 different families and was shown to be a recurring de novo event. Two polymorphisms were also detected, one of which resulted in the insertion of an additional lysine in the carboxy-terminal polylysine domain. It is apparent that X-linked dyskeratosis congenita is predominantly caused by missense mutations; the precise effect on the function of dyskerin remains to be determined.	Med Univ S Carolina, Dept Pediat, Div Genet & Child Dev, Charleston, SC USA; Tawam Hosp, Al Ain Med Dist, Abu Dhabi, U Arab Emirates; Postgrad Inst Med Educ & Res, Dept Haematol, Chandigarh 160012, India	Medical University of South Carolina; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Poustka, A (corresponding author), Deutsch Krebsforschungszentrum, Dept Mol Genome Anal, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.		Mason, Philip J/B-1087-2008	Dokal, Inderjeet/0000-0003-4462-4782				Becker HF, 1997, NUCLEIC ACIDS RES, V25, P4493, DOI 10.1093/nar/25.22.4493; BELDJORD C, 1988, NUCLEIC ACIDS RES, V16, P4927, DOI 10.1093/nar/16.11.4927; Cadwell C, 1997, MOL CELL BIOL, V17, P6175, DOI 10.1128/MCB.17.10.6175; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; CONNOR JM, 1986, HUM GENET, V72, P348, DOI 10.1007/BF00290963; Coulthard S, 1998, BRIT J HAEMATOL, V102, P1162, DOI 10.1046/j.1365-2141.1998.00893.x; Demiroglu H, 1997, BRIT J HAEMATOL, V97, P243; Devriendt K, 1997, AM J HUM GENET, V60, P581; Dokal I, 1996, BRIT J HAEMATOL, V92, P775, DOI 10.1046/j.1365-2141.1996.355881.x; DOKAL I, 1994, LEUKEMIA LYMPHOMA, V15, P1, DOI 10.3109/10428199409051671; DRACHTMAN RA, 1992, AM J PEDIAT HEMATOL, V14, P297; Ferraris AM, 1997, AM J HUM GENET, V61, P458; Gasparini G, 1985, G Ital Dermatol Venereol, V120, P429; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; JIANG WD, 1995, MOL GEN GENET, V246, P360, DOI 10.1007/BF00288609; JIANG WD, 1993, MOL CELL BIOL, V13, P4884, DOI 10.1128/MCB.13.8.4884; Jouet M, 1997, EUR J HUM GENET, V5, P168, DOI 10.1159/000484753; KEHRER H, 1992, CLIN GENET, V41, P129; Knight S, 1998, BRIT J HAEMATOL, V103, P990, DOI 10.1046/j.1365-2141.1998.01103.x; Knight SW, 1998, J MED GENET, V35, P993, DOI 10.1136/jmg.35.12.993; Koonin EV, 1996, NUCLEIC ACIDS RES, V24, P2411, DOI 10.1093/nar/24.12.2411; Lafontaine DLJ, 1998, GENE DEV, V12, P527, DOI 10.1101/gad.12.4.527; Luzzatto L, 1998, NAT GENET, V19, P6, DOI 10.1038/ng0598-6; MEIER UT, 1994, J CELL BIOL, V127, P1505, DOI 10.1083/jcb.127.6.1505; MEIER UT, 1992, CELL, V70, P127; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; MURRU S, 1991, BLOOD, V77, P1342; NURSE K, 1995, RNA, V1, P102; ONO M, 1987, NUCLEIC ACIDS RES, V15, P8725, DOI 10.1093/nar/15.21.8725; PAI GS, 1989, CYTOGENET CELL GENET, V52, P186, DOI 10.1159/000132874; Phillips B, 1998, MOL GEN GENET, V260, P20, DOI 10.1007/s004380050866; RICHARDS B, 1991, NUCLEIC ACIDS RES, V19, P1944, DOI 10.1093/nar/19.8.1944; SMAHI A, 1994, HUM MOL GENET, V3, P273, DOI 10.1093/hmg/3.2.273; TEE MK, 1995, HUM MOL GENET, V4, P2299, DOI 10.1093/hmg/4.12.2299; Villard L, 1996, AM J HUM GENET, V58, P499; Vulliamy TJ, 1997, BLOOD, V90, P2213; VULLIAMY TJ, IN PRESS BLOOD; Winkler AA, 1998, YEAST, V14, P37, DOI 10.1002/(SICI)1097-0061(19980115)14:1<37::AID-YEA198>3.3.CO;2-U; ZHU ZB, 1992, J EXP MED, V175, P1783, DOI 10.1084/jem.175.6.1783	39	165	177	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1999	65	1					50	58		10.1086/302446	http://dx.doi.org/10.1086/302446			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	212NZ	10364516	Bronze, Green Published			2022-12-18	WOS:000081224300008
J	Hakansson, S; Johannsson, O; Johansson, U; Sellberg, G; Loman, N; Gerdes, AM; Holmberg, E; Dahl, N; Pandis, N; Kristoffersson, U; Olsson, H; Borg, A				Hakansson, S; Johannsson, O; Johansson, U; Sellberg, G; Loman, N; Gerdes, AM; Holmberg, E; Dahl, N; Pandis, N; Kristoffersson, U; Olsson, H; Borg, A			Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OVARIAN-CANCER; SUSCEPTIBILITY GENE; IDENTIFICATION	Previous studies of high-risk breast cancer families have proposed that two major breast cancer-susceptibility genes, BRCA1 and BRCA2, may account for at least two-thirds of all hereditary breast cancer. We have screened index cases from 106 Scandinavian (mainly southern Swedish) breast cancer and breast-ovarian cancer families for germ-line mutations in all coding exons of the BRCA1, and BRCA2 genes, using the protein-truncation test, SSCP analysis, or direct sequencing. A total of 24 families exhibited 11 different BRCA1 mutations, whereas 11 different BRCA2 mutations were detected in 12 families, of which 3 contained cases of male breast cancer. One BRCA2 mutation, 4486delG, was found in two families of the present study and, in a separate study, also in breast tumors from three unrelated males with unknown family history, suggesting that at least one BRCA2 founder mutation exists in the Scandinavian population. We report 1 novel BRCA1 mutation, eight additional cases of 4 BRCA1 mutations described elsewhere, and 11 novel BRCA2 mutations (3 frameshift deletions and 2 nonsense mutations), of which all are predicted to cause premature truncation of the translated products. The relatively low frequency of BRCA1 and BRCA2 mutations in the present study could be explained by insufficient screening sensitivity to the location of mutations in uncharacterized regulatory regions, the analysis of phenocopies, or, most likely, within predisposed families, additional uncharacterized BRCA genes.	UNIV LUND HOSP,DEPT ONCOL,S-22185 LUND,SWEDEN; UNIV LUND HOSP,DEPT CLIN GENET,S-22185 LUND,SWEDEN; ODENSE UNIV HOSP,DEPT CLIN GENET,DK-5000 ODENSE,DENMARK; UMEA UNIV HOSP,DEPT CLIN GENET,S-90185 UMEA,SWEDEN; UNIV UPPSALA HOSP,DEPT CLIN GENET,S-75185 UPPSALA,SWEDEN	Lund University; Skane University Hospital; Lund University; Skane University Hospital; University of Southern Denmark; Odense University Hospital; Umea University; Uppsala University; Uppsala University Hospital				Olsson, Hakan/0000-0002-8794-9635; Gerdes, Anne-Marie/0000-0002-0328-3320				Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; CLETONJANSEN AM, 1995, BRIT J CANCER, V72, P1241, DOI 10.1038/bjc.1995.493; Couch FJ, 1996, NAT GENET, V13, P123, DOI 10.1038/ng0596-123; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; Gudmundsson J, 1996, AM J HUM GENET, V58, P749; Jensen RA, 1996, NAT GENET, V12, P303, DOI 10.1038/ng0396-303; Johannsson O, 1996, AM J HUM GENET, V58, P441; Kainu T, 1996, CANCER RES, V56, P2912; Lancaster JM, 1996, NAT GENET, V13, P238, DOI 10.1038/ng0696-238; Mazoyer S, 1996, NAT GENET, V14, P253, DOI 10.1038/ng1196-253; Miki Y, 1996, NAT GENET, V13, P245, DOI 10.1038/ng0696-245; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Moore MP, 1996, DIS BREAST, P859; Neuhausen S, 1996, NAT GENET, V13, P126, DOI 10.1038/ng0596-126; OLSSON H, 1984, CANCER, V53, P1974, DOI 10.1002/1097-0142(19840501)53:9<1974::AID-CNCR2820530928>3.0.CO;2-G; Phelan CM, 1996, NAT GENET, V13, P120, DOI 10.1038/ng0596-120; Rebbeck TR, 1996, AM J HUM GENET, V59, P547; SCHUTTE M, 1995, P NATL ACAD SCI USA, V92, P5950, DOI 10.1073/pnas.92.13.5950; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; SZABO CI, 1995, HUM MOL GENET, V4, P1811, DOI 10.1093/hmg/4.suppl_1.1811; Takahashi H, 1996, CANCER RES, V56, P2738; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Teng DHF, 1996, NAT GENET, V13, P241, DOI 10.1038/ng0696-241; Thorlacius S, 1996, NAT GENET, V13, P117, DOI 10.1038/ng0596-117; vandenBerg J, 1996, BRIT J CANCER, V74, P1615, DOI 10.1038/bjc.1996.597; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	28	165	172	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1997	60	5					1068	1078						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX760	9150154				2022-12-18	WOS:A1997WX76000007
J	Stockler, S; Isbrandt, D; Hanefeld, F; Schmidt, B; vonFigura, K				Stockler, S; Isbrandt, D; Hanefeld, F; Schmidt, B; vonFigura, K			Guanidinoacetate methyltransferase deficiency: The first inborn error of creatine metabolism in man	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GLYCINE AMIDINOTRANSFERASE; U1 SNRNA; ARGININE; SITE	In two children with an accumulation of guanidinoacetate in brain and a deficiency of creatine in blood, a severe deficiency of guanidinoacetate methyltransferase (GAMT) activity was detected in the liver. Two mutant GAMT alleles were identified that carried a single base substitution within a 5' splice site or a 13-nt insertion and gave rise to four mutant transcripts. Three of the transcripts encode truncated polypeptides that lack a residue known to be critical for catalytic activity of GAMT. Deficiency of GAMT is the first inborn error of creatine metabolism. It causes a severe developmental delay and extrapyramidal symptoms in early infancy and is treatable by oral substitution with creatine.	UNIV GOTTINGEN,BIOCHEM ABT 2,D-37073 GOTTINGEN,GERMANY; UNIV GOTTINGEN,CHILDRENS HOSP,GOTTINGEN,GERMANY	University of Gottingen; University of Gottingen				Isbrandt, Dirk/0000-0002-4720-1016				CANTONI GL, 1954, J BIOL CHEM, V209, P647; CARROLL M, 1978, BIOCHEM J, V173, P191, DOI 10.1042/bj1730191; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Cooper DN, 1995, METABOLIC MOL BASES, P259; FILIPE MI, 1990, HISTOCHEMISTRY PATHO; HOBERMAN HD, 1948, J BIOL CHEM, V172, P45; IM YS, 1979, ANAL BIOCHEM, V95, P87, DOI 10.1016/0003-2697(79)90189-1; Isbrandt D, 1995, BBA-GENE STRUCT EXPR, V1264, P265, DOI 10.1016/0167-4781(95)00184-0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCGUIRE DM, 1984, J BIOL CHEM, V259, P2034; MUDD SH, 1975, METABOLISM, V24, P721, DOI 10.1016/0026-0495(75)90040-2; OGAWA H, 1988, NUCLEIC ACIDS RES, V16, P8715, DOI 10.1093/nar/16.17.8715; OGAWA H, 1983, ARCH BIOCHEM BIOPHYS, V226, P265, DOI 10.1016/0003-9861(83)90293-X; RICHTERICH R, 1971, KLIN CHEM THEORIE PR; Sambrook J., 1989, MOL CLONING; SIPILA I, 1980, BIOCHIM BIOPHYS ACTA, V613, P79, DOI 10.1016/0005-2744(80)90194-1; STOCKLER S, 1994, PEDIATR RES, V36, P409; TAKATA Y, 1994, J BIOL CHEM, V269, P5537; Walker J B, 1979, Adv Enzymol Relat Areas Mol Biol, V50, P177; WEBER S, 1988, NUCLEIC ACIDS RES, V16, P471, DOI 10.1093/nar/16.2.471; ZHUANG Y, 1986, CELL, V46, P827, DOI 10.1016/0092-8674(86)90064-4	21	165	169	0	10	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1996	58	5					914	922						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UH192	8651275				2022-12-18	WOS:A1996UH19200003
J	HERTZBERG, M; MICKLESON, KNP; SERJEANTSON, SW; PRIOR, JF; TRENT, RJ				HERTZBERG, M; MICKLESON, KNP; SERJEANTSON, SW; PRIOR, JF; TRENT, RJ			AN ASIAN-SPECIFIC 9-BP DELETION OF MITOCHONDRIAL-DNA IS FREQUENTLY FOUND IN POLYNESIANS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LENGTH MUTATIONS; GLOBIN GENES; POLYMORPHISM; SEQUENCE; PACIFIC		SIR CHARLES GAIRDNER HOSP, DEPT HAEMATOL, NEDLANDS, WA 6009, AUSTRALIA; MIDDLEMORE HOSP, DEPT PAEDIAT, Auckland, NEW ZEALAND; AUSTRALIAN NATL UNIV, JOHN CURTIN SCH MED RES,HUMAN GENET GRP, CANBERRA, ACT 2601, AUSTRALIA	University of Western Australia; Australian National University; John Curtin School of Medical Research	HERTZBERG, M (corresponding author), UNIV SYDNEY, CLIN IMMUNOL RES CTR, MOLEC BIOL LAB, SYDNEY, NSW 2006, AUSTRALIA.							ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BECK CE, UNPUB ASIAN TAG AMER; Bellwood P.S., 1987, POLYNESIANS PREHISTO; BELLWOOD PS, IN PRESS COLONIZATIO; BELLWOOD PS, 1978, ASIAN PERSPECT, V19, P240; BROWN WM, 1980, P NATL ACAD SCI-BIOL, V77, P3605, DOI 10.1073/pnas.77.6.3605; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; CANN RL, 1983, GENETICS, V104, P699; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; Green R.C., 1979, PREHISTORY POLYNESIA, P27; GREEN RC, 1985, J PAC HIST, V20, P220, DOI 10.1080/00223348508572523; HERTZBERG MS, 1988, AM J HUM GENET, V43, P971; HILL AVS, 1985, AM J HUM GENET, V37, P571; HORAI S, 1986, HUM GENET, V72, P105; JOHNSON MJ, 1983, J MOL EVOL, V19, P255, DOI 10.1007/BF02099973; KICH PV, 1984, EVOLUTION POLYNESIAN; Maniatis T., 1982, MOL CLONING; Old JM., 1983, METHODS HEMATOLOGY T, V6, P74; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SERJEANTSON SW, 1987, HUM IMMUNOL, V20, P145, DOI 10.1016/0198-8859(87)90028-0; SERJEANTSON SW, 1982, AM J HUM GENET, V34, P904; SINGH G, 1987, NATURE, V329, P270, DOI 10.1038/329270a0; SPRIGGS M, 1984, OUT ASIA, P185; STONEKING M, 1986, COLD SPRING HARB SYM, V51, P433, DOI 10.1101/SQB.1986.051.01.052; STONEKING M, IN PRESS COLONIZATIO; TRENT RJ, 1986, AM J HUM GENET, V39, P350; TRENT RJ, 1988, AM J HUM GENET, V42, P601; TRYON DT, 1984, OUT ASIA, P147; WILSON AC, 1985, BIOL J LINN SOC, V26, P375, DOI 10.1111/j.1095-8312.1985.tb02048.x; WRISCHNIK LA, 1987, NUCLEIC ACIDS RES, V15, P529, DOI 10.1093/nar/15.2.529; WURM SA, 1967, J PAC HIST, V2, P25, DOI 10.1080/00223346708572100	33	165	170	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1989	44	4					504	510						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	T8109	2929595				2022-12-18	WOS:A1989T810900009
J	BALAZS, I; BAIRD, M; CLYNE, M; MEADE, E				BALAZS, I; BAIRD, M; CLYNE, M; MEADE, E			HUMAN-POPULATION GENETIC-STUDIES OF 5 HYPERVARIABLE DNA LOCI	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											BALAZS, I (corresponding author), LIFECODES CORP,SAW MILL RIVER RD,VALHALLA,NY 10595, USA.			Clyne, Mindy/0000-0001-9884-7856				BAIRD M, 1986, AM J HUM GENET, V39, P489; BELL GI, 1982, NATURE, V295, P31, DOI 10.1038/295031a0; CAPON DJ, 1983, NATURE, V302, P33, DOI 10.1038/302033a0; COOKE HJ, 1985, NATURE, V317, P687, DOI 10.1038/317687a0; COOKE HJ, 1986, COLD SPRING HARB SYM, V51, P213, DOI 10.1101/SQB.1986.051.01.026; DYKES D, 1986, ELECTROPHORESIS, V7, P278, DOI 10.1002/elps.1150070607; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FISHER RA, 1960, HEREDITY, V5, P95; GINSBURG D, 1985, J CLIN INVEST, V75, P596, DOI 10.1172/JCI111736; GIUSTI A, 1986, J FORENSIC SCI, V31, P409; HARUMOTO TK, 1988, ADV FORENSIC HAEMOGE, V2, P373; ITO H, 1985, JPN J HUM GENET, V30, P261, DOI 10.1007/BF01907963; JARMAN AP, 1986, EMBO J, V5, P1857, DOI 10.1002/j.1460-2075.1986.tb04437.x; JEFFREYS AJ, 1988, NATURE, V332, P278, DOI 10.1038/332278a0; KANTER E, 1986, J FORENSIC SCI, V31, P403; KNOWLTON R, 1985, CYTOGENET CELL GENET, V40, P669; LATHROP GM, 1987, CYTOGENET CELL GENET, V46, P644; Maniatis T., 1982, MOL CLONING; MCCLAIN J, 1987, American Journal of Human Genetics, V41, pA259; NAKAMURA Y, 1987, CYTOGENET CELL GENET, V46, P668; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; WAINSCOAT JS, 1987, HUM GENET, V75, P384, DOI 10.1007/BF00284114; WYMAN A R, 1986, American Journal of Human Genetics, V39, pA226	24	165	165	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1989	44	2					182	190						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	R9705	2563192				2022-12-18	WOS:A1989R970500002
J	HIGASHI, Y; TANAE, A; INOUE, H; FUJIIKURIYAMA, Y				HIGASHI, Y; TANAE, A; INOUE, H; FUJIIKURIYAMA, Y			EVIDENCE FOR FREQUENT GENE CONVERSION IN THE STEROID 21-HYDROXYLASE P-450(C21) GENE - IMPLICATIONS FOR STEROID 21-HYDROXYLASE DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JAPANESE FDN CANC RES,INST CANC,DEPT BIOCHEM,1-37-1 KAMI IKEBUKURO,TOSHIMA KU,TOKYO 170,JAPAN; NATL CHILDRENS HOSP,TOKYO 154,JAPAN	Japanese Foundation for Cancer Research; National Center for Child Health & Development - Japan								AMOS DB, 1969, TRANSPLANTATION, V7, P220, DOI 10.1097/00007890-196903000-00023; CARROLL MC, 1985, P NATL ACAD SCI USA, V82, P521, DOI 10.1073/pnas.82.2.521; DONOHOUE PA, 1986, J CLIN ENDOCR METAB, V62, P995, DOI 10.1210/jcem-62-5-995; DUPONT B, 1977, LANCET, V2, P1309; DUPONT B, 1984, HISTOCOMPATIBILITY T, P660; GUTAI JP, 1977, J PEDIATR-US, V90, P924, DOI 10.1016/S0022-3476(77)80560-X; HANSEN JA, 1979, IMMUNOGENETICS, V8, P51, DOI 10.1007/BF01561413; HIGASHI Y, 1986, P NATL ACAD SCI USA, V83, P2841, DOI 10.1073/pnas.83.9.2841; MIYADA CG, 1985, P NATL ACAD SCI USA, V82, P2890, DOI 10.1073/pnas.82.9.2890; NEW MI, 1984, ANNU REV MED, V35, P649, DOI 10.1146/annurev.me.35.020184.003245; SHIROISHI T, 1987, P NATL ACAD SCI USA, V84, P2819, DOI 10.1073/pnas.84.9.2819; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPEISER PW, 1985, TRENDS GENET, V1, P275, DOI 10.1016/0168-9525(85)90104-0; SPEISER PW, 1985, AM J HUM GENET, V37, P650; STEINMETZ M, 1986, CELL, V44, P395; WERKMEISTER JW, 1986, AM J HUM GENET, V39, P461; WHITE PC, 1984, P NATL ACAD SCI-BIOL, V81, P7505, DOI 10.1073/pnas.81.23.7505; WHITE PC, 1985, P NATL ACAD SCI USA, V82, P1089, DOI 10.1073/pnas.82.4.1089; WHITE PC, 1986, P NATL ACAD SCI USA, V83, P5111, DOI 10.1073/pnas.83.14.5111	19	165	169	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1988	42	1					17	25						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	L8697	2827462				2022-12-18	WOS:A1988L869700003
J	Myers, CT; McMahon, JM; Schneider, AL; Petrovski, S; Allen, AS; Carvill, GL; Zemel, M; Say-Kally, JE; LaCroix, AJ; Heinzen, EL; Hollingsworth, G; Nikanorova, M; Corbett, M; Gecz, J; Coman, D; Freeman, J; Calvert, S; Gill, D; Carney, P; Lerman-Sagie, T; Sampaio, H; Cossette, P; Delanty, N; Dlugos, D; Eichler, EE; Epstein, MP; Glauser, T; Johnson, MR; Kuzniecky, R; Marson, AG; O'Brien, TJ; Petrou, ROS; Poduri, A; Pickrell, WO; Chung, SK; Rees, MI; Sherr, E; Sadleir, LG; Goldstein, DB; Lowenstein, DH; Moller, RS; Berkovic, SF; Scheffer, IE; Mefford, HC				Myers, Candace T.; McMahon, Jacinta M.; Schneider, Amy L.; Petrovski, Slave; Allen, Andrew S.; Carvill, Gemma L.; Zemel, Matthew; Say-Kally, Julia E.; LaCroix, Amy J.; Heinzen, Erin L.; Hollingsworth, Georgina; Nikanorova, Marina; Corbett, Mark; Gecz, Jozef; Coman, David; Freeman, Jeremy; Calvert, Sophie; Gill, Deepak; Carney, Patrick; Lerman-Sagie, Tally; Sampaio, Hugo; Cossette, Patrick; Delanty, Norman; Dlugos, Dennis; Eichler, Evan E.; Epstein, Michael P.; Glauser, Tracy; Johnson, Michael R.; Kuzniecky, Ruben; Marson, Anthony G.; O'Brien, Terence J.; Petrou, Ruth Ottman Stephen; Poduri, Annapurna; Pickrell, William O.; Chung, Seo-Kyung; Rees, Mark I.; Sherr, Elliott; Sadleir, Lynette G.; Goldstein, David B.; Lowenstein, Daniel H.; Moller, Rikke S.; Berkovic, Samuel F.; Scheffer, Ingrid E.; Mefford, Heather C.		Epi4K Consortium	De Novo Mutations in SLC1A2 and CACNA1A Are Important Causes of Epileptic Encephalopathies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GLUTAMATE TRANSPORTER EAAT2; INTELLECTUAL DISABILITY; SEIZURES; DIAGNOSIS; VARIANTS; DISEASE; GENES	Epileptic encephalopathies (EEs) are the most clinically important group of severe early-onset epilepsies. Next-generation sequencing has highlighted the crucial contribution of de novo mutations to the genetic architecture of EEs as well as to their underlying genetic heterogeneity. Our previous whole-exome sequencing study of 264 parent-child trios revealed more than 290 candidate genes in which only a single individual had a de novo variant. We sought to identify additional pathogenic variants in a subset ( n = 27) of these genes via targeted sequencing in an unsolved cohort of 531 individuals with a diverse range of EEs. We report 17 individuals with pathogenic variants in seven of the 27 genes, defining a genetic etiology in 3.2% of this unsolved cohort. Our results provide definitive evidence that de novo mutations in SLC1A2 and CACNA1A cause specific EEs and expand the compendium of clinically relevant genotypes for GABRB3. We also identified EEs caused by genetic variants in ALG13, DNM1, and GNAO1 and report a mutation in IQSEC2. Notably, recurrent mutations accounted for 7/17 of the pathogenic variants identified. As a result of high-depth coverage, parental mosaicism was identified in two out of 14 cases tested with mutant allelic fractions of 5%-6% in the unaffected parents, carrying significant reproductive counseling implications. These results confirm that dysregulation in diverse cellular neuronal pathways causes EEs, and they will inform the diagnosis and management of individuals with these devastating disorders.					Scheffer, Ingrid E/G-1668-2013; Sander-Effron, Samuel/AAX-2231-2020; Ottman, Ruth/O-2371-2013; Chung, Seo-Kyung/I-3329-2017; Marson, Anthony/AAW-9776-2020; jiang, yu/HGU-0029-2022; Goldstein, David/AAY-8125-2020; Rees, Mark I/J-3129-2012; Corbett, Mark/A-8063-2010; Gecz, Jozef/X-3469-2019; Chung, Seo-Kyung/AAT-4693-2021; Resource Center, NINDS Human Genetics/AGF-2474-2022; Pickrell, William Owen/F-7110-2014; O'Brien, Terence/AAU-5525-2021; O'Brien, Terence/L-8102-2013; Lerman-Sagie, Tally/AAY-7598-2021; Coman, David/F-5145-2013	Scheffer, Ingrid E/0000-0002-2311-2174; Ottman, Ruth/0000-0001-7074-242X; Chung, Seo-Kyung/0000-0002-5008-8384; Marson, Anthony/0000-0002-6861-8806; Rees, Mark I/0000-0003-3570-5986; Corbett, Mark/0000-0001-9298-3072; Gecz, Jozef/0000-0002-7884-6861; Chung, Seo-Kyung/0000-0002-5008-8384; Pickrell, William Owen/0000-0003-4396-5657; O'Brien, Terence/0000-0002-7198-8621; Lerman-Sagie, Tally/0000-0001-6641-6875; Gill, Deepak/0000-0002-6219-9479; Berkovic, Samuel/0000-0003-4580-841X; Sadleir, Lynette/0000-0002-5355-7115; Coman, David/0000-0001-6303-6471; Freeman, Jeremy/0000-0002-4184-3683; Allen, Andrew/0000-0002-7232-2143; Moller, Rikke S./0000-0002-9664-1448	NIH National Institute of Neurological Disorders and Stroke Center without Walls [U01NS077274, U01NS077276, U01NS077303, U01NS077364, U01NS077275, 2R01NS069605]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS077275, U01NS077274, U01NS077303, U01NS077364, U01NS077276, R01NS069605] Funding Source: NIH RePORTER	NIH National Institute of Neurological Disorders and Stroke Center without Walls; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding for this study comes from the NIH National Institute of Neurological Disorders and Stroke Center without Walls (U01NS077274, U01NS077276, U01NS077303, U01NS077364, and U01NS077275 to the Epi4K administrative core and 2R01NS069605 to H.C.M.). David Goldstein, Steve Petrou, and Slave Petrovski have interests in companies related to epilepsy precision medicine.	Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Appenzeller S, 2014, AM J HUM GENET, V95, P360, DOI 10.1016/j.ajhg.2014.08.013; Auvin S, 2009, EPILEPSIA, V50, P2501, DOI 10.1111/j.1528-1167.2009.02189.x; Bagnall RD, 2016, ANN NEUROL, V79, P522, DOI 10.1002/ana.24596; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Carvill GL, 2015, AM J HUM GENET, V96, P808, DOI 10.1016/j.ajhg.2015.02.016; Carvill GL, 2013, NAT GENET, V45, P1073, DOI 10.1038/ng.2727; Carvill GL, 2013, NAT GENET, V45, P825, DOI 10.1038/ng.2646; Colton CK, 2010, J BIOMOL SCREEN, V15, P653, DOI 10.1177/1087057110370998; Damaj L, 2015, EUR J HUM GENET, V23, P1505, DOI 10.1038/ejhg.2015.21; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Dimassi S, 2016, CLIN GENET, V89, P198, DOI 10.1111/cge.12636; Hamdan FF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004772; Hino-Fukuyo N, 2015, HUM GENET, V134, P649, DOI 10.1007/s00439-015-1553-6; Kim K, 2011, J CELL PHYSIOL, V226, P2484, DOI 10.1002/jcp.22609; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Kong QM, 2014, J CLIN INVEST, V124, P1255, DOI 10.1172/JCI66163; McTague A, 2016, LANCET NEUROL, V15, P304, DOI 10.1016/S1474-4422(15)00250-1; Mefford HC, 2011, ANN NEUROL, V70, P974, DOI 10.1002/ana.22645; Nakamura K, 2013, AM J HUM GENET, V93, P496, DOI 10.1016/j.ajhg.2013.07.014; Papandreou A, 2016, DEV MED CHILD NEUROL, V58, P416, DOI 10.1111/dmcn.12976; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; REUTENS DC, 1992, EPILEPSIA, V33, P1065, DOI 10.1111/j.1528-1157.1992.tb01760.x; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Shoubridge C, 2010, NAT GENET, V42, P486, DOI 10.1038/ng.588; Smith-Packard B, 2015, JIMD REP, V22, P95, DOI 10.1007/8904_2015_416; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Xu XX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124925	29	164	172	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 4	2016	99	2					287	298		10.1016/j.ajhg.2016.06.003	http://dx.doi.org/10.1016/j.ajhg.2016.06.003			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT6TO	27476654	Green Published, Green Accepted, Bronze			2022-12-18	WOS:000381617200003
J	Bashamboo, A; Ferraz-de-Souza, B; Lourenco, D; Lin, L; Sebire, NJ; Montjean, D; Bignon-Topalovic, J; Mandelbaum, J; Siffroi, JP; Christin-Maitre, S; Radhakrishna, U; Rouba, H; Ravel, C; Seeler, J; Achermann, JC; McElreavey, K				Bashamboo, Anu; Ferraz-de-Souza, Bruno; Lourenco, Diana; Lin, Lin; Sebire, Neil J.; Montjean, Debbie; Bignon-Topalovic, Joelle; Mandelbaum, Jacqueline; Siffroi, Jean-Pierre; Christin-Maitre, Sophie; Radhakrishna, Uppala; Rouba, Hassan; Ravel, Celia; Seeler, Jacob; Achermann, John C.; McElreavey, Ken			Human Male Infertility Associated with Mutations in NR5A1 Encoding Steroidogenic Factor 1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NUCLEAR RECEPTOR; FACTOR-I; GONADAL DEVELOPMENT; SEX DETERMINATION; SF-1; EXPRESSION; MEN; SPERMATOGENESIS; TRANSCRIPTION; INHERITANCE	One in seven couples worldwide are infertile, and male factor Infertility accounts for approximately 30%-50% of these cases Although many genes are known to be essential for gametogenesis, there are surprisingly few monogenic mutations that have been conclusively demonstrated to cause human spermatogenic failure. A nuclear receptor, NR5A1 (also called steroidogenic factor 1), is a key transcriptional regulator of genes involved in the hypothalamic-pituitary-steroidogenic axis, and it is expressed in the steroidogenic tissue of the developing and adult human gonad Mutations of NR5A1 have been reported in 46,XY disorders of sex development and in 46,XX primary ovarian insufficiency To test the hypothesis that mutations in NR5A1 cause male infertility, we sequenced NR5A1 in 315 men with idiopathic spermatogenic failure We identified seven men with severe spermatogenic failure who carried missense mutations in NR5A1. Functional studies indicated that these mutations impaired NR5A1 transactivational activity We did not observe these mutations in more than 4000 control alleles, including the entire coding sequence of 359 normospermic men and 370 fertile male controls. NR5A1 mutations are found in approximately 4% of men with otherwise unexplained severe spermatogenic failure	[Bashamboo, Anu; Lourenco, Diana; Montjean, Debbie; Bignon-Topalovic, Joelle; Ravel, Celia; McElreavey, Ken] Inst Pasteur, F-75724 Paris, France; [Ferraz-de-Souza, Bruno; Lin, Lin; Achermann, John C.] UCL Inst Child Hlth, Dev Endocrinol Res Grp, Clin & Mol Genet Unit, London WC1N 1EH, England; [Sebire, Neil J.] Great Ormond St Hosp Sick Children, Dept Paediat Histopathol, London WC1N 3JH, England; [Mandelbaum, Jacqueline; Ravel, Celia] UPMC, AP HP, Hop Tenon, Serv Histol & Biol Reprod, F-75020 Paris, France; [Siffroi, Jean-Pierre] UPMC, Hop Armand Trousseau, AP HP ER9, Serv Genet & Embryol Med, F-75012 Paris, France; [Christin-Maitre, Sophie] Hop St Antoine, Serv Endocrinol, F-75012 Paris, France; [Radhakrishna, Uppala] Creighton Univ, Ctr Canc, Omaha, NE 68178 USA; [Rouba, Hassan] Inst Pasteur Morocco, Human Genet Unit, Casablanca 20100, Morocco; [Seeler, Jacob] Inst Pasteur, Nucl Org & Oncogenesis Unit, INSERM, U579, F-75724 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Creighton University; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Bashamboo, A (corresponding author), Inst Pasteur, F-75724 Paris, France.		RAVEL, Celia/F-2702-2015; Ferraz-de-Souza, Bruno/G-1069-2010; Achermann, John/C-5476-2008; Achermann, John/N-2906-2019	RAVEL, Celia/0000-0001-5013-6932; Ferraz-de-Souza, Bruno/0000-0003-4863-2544; Achermann, John/0000-0001-8787-6272; Achermann, John/0000-0001-8787-6272; Sebire, Neil/0000-0001-5348-9063; Seeler, Jacob-Sebastian/0000-0001-8209-8555	Agence Nationale de la Recherche-GIS Institut des Maladies Rues; March of Dimes Foundation [1-FY07-490]; EuroDSD in the European Community [201444]; Portuguese Foundation for Science and Technology; Agence de la Biomedecine; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes, Brazil) [4798066]; Wellcome Trust [079666]; Great Ormond Street Hospital Childrens Charity [V0907] Funding Source: researchfish	Agence Nationale de la Recherche-GIS Institut des Maladies Rues(French National Research Agency (ANR)); March of Dimes Foundation(March of Dimes); EuroDSD in the European Community; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Agence de la Biomedecine; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Wellcome Trust(Wellcome TrustEuropean Commission); Great Ormond Street Hospital Childrens Charity	This work is supported by grants from the Agence Nationale de la Recherche-GIS Institut des Maladies Rues (to K M.), by a research grant (1-FY07-490) from the March of Dimes Foundation (to K M), by a research grant from the EuroDSD in the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 201444 (to J C A, KM, and A B), by a research grant from the Portuguese Foundation for Science and Technology (to D.L.), by a research grant from the Agence de la Biomedecine (to A.B), by a studentship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes, Brazil) (4798066, to B F-de-S), and by a Wellcome Trust Senior Research Fellowship in Clinical Science (079666; to I C A.) The authors wish to thank the Biobank for Research on Human Reproduction GERMETHEQUE for contributing biomaterial for this study.	Andersen AN, 2006, INT J ANDROL, V29, P12, DOI 10.1111/j.1365-2605.2005.00577.x; Andersson AM, 2004, J CLIN ENDOCR METAB, V89, P3161, DOI 10.1210/jc.2003-031786; CANTU JM, 1981, HUM GENET, V59, P380, DOI 10.1007/BF00295476; Gianotten J, 2004, HUM REPROD, V19, P71, DOI 10.1093/humrep/deh008; Hammer GD, 1999, MOL CELL, V3, P521, DOI 10.1016/S1097-2765(00)80480-3; Hanley NA, 1999, MECH DEVELOP, V87, P175, DOI 10.1016/S0925-4773(99)00123-9; Hoivik EA, 2010, MOL CELL ENDOCRINOL, V315, P27, DOI 10.1016/j.mce.2009.07.003; IKEDA Y, 1994, MOL ENDOCRINOL, V8, P654, DOI 10.1210/me.8.5.654; Ito M, 2000, J BIOL CHEM, V275, P31708, DOI 10.1074/jbc.M002892200; Jeyasuria P, 2004, MOL ENDOCRINOL, V18, P1610, DOI 10.1210/me.2003-0404; Jorgensen N, 2006, INT J ANDROL, V29, P54, DOI 10.1111/j.1365-2605.2005.00635.x; Kirsh O, 2002, EMBO J, V21, P2682, DOI 10.1093/emboj/21.11.2682; Kojima Y, 2006, INT J UROL, V13, P785, DOI 10.1111/j.1442-2042.2006.01403.x; Krylova IN, 2005, CELL, V120, P343, DOI 10.1016/j.cell.2005.01.024; Lee MB, 2005, MOL CELL BIOL, V25, P1879, DOI 10.1128/MCB.25.5.1879-1890.2005; Lin L, 2008, SEX DEV, V2, P200, DOI 10.1159/000152036; Lin L, 2007, J CLIN ENDOCR METAB, V92, P991, DOI 10.1210/jc.2006-1672; Lourenco D, 2009, NEW ENGL J MED, V360, P1200, DOI 10.1056/NEJMoa0806228; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; McLachlan RI, 2010, J CLIN ENDOCR METAB, V95, P1013, DOI 10.1210/jc.2009-1925; Mellon SH, 2007, MOL ENDOCRINOL, V21, P89, DOI 10.1210/me.2005-0355; MOROHASHI K, 1994, MOL ENDOCRINOL, V8, P643, DOI 10.1210/me.8.5.643; MOROHASHI K, 1992, J BIOL CHEM, V267, P17913; O'Brien KLO, 2010, FERTIL STERIL, V93, P1, DOI 10.1016/j.fertnstert.2009.10.045; Sablin EP, 2009, MOL ENDOCRINOL, V23, P25, DOI 10.1210/me.2007-0508; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Skakkebaek NE, 2006, INT J ANDROL, V29, P2, DOI 10.1111/j.1365-2605.2005.00573.x; Suzawa M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002117; Tuerlings JHAM, 2002, FERTIL STERIL, V77, P415, DOI 10.1016/S0015-0282(01)02996-X; Wohlfahrt-Veje C, 2009, CLIN ENDOCRINOL, V71, P459, DOI 10.1111/j.1365-2265.2009.03545.x; Zhao LP, 2001, DEVELOPMENT, V128, P147	31	164	170	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 8	2010	87	4					505	512		10.1016/j.ajhg.2010.09.009	http://dx.doi.org/10.1016/j.ajhg.2010.09.009			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	665LU	20887963	Green Submitted, Green Published, hybrid			2022-12-18	WOS:000283037600006
J	Doherty, L; Sheen, MR; Vlachos, A; Choesmel, V; O'Donohue, MF; Clinton, C; Schneider, HE; Sieff, CA; Newburger, PE; Ball, SE; Niewiadomska, E; Matysiak, M; Glader, B; Arceci, RJ; Farrar, JE; Atsidaftos, E; Lipton, JM; Gleizes, PE; Gazda, HT				Doherty, Leana; Sheen, Mee Rie; Vlachos, Adrianna; Choesmel, Valerie; O'Donohue, Marie-Francoise; Clinton, Catherine; Schneider, Hal E.; Sieff, Colin A.; Newburger, Peter E.; Ball, Sarah E.; Niewiadomska, Edyta; Matysiak, Michal; Glader, Bertil; Arceci, Robert J.; Farrar, Jason E.; Atsidaftos, Eva; Lipton, Jeffrey M.; Gleizes, Pierre-Emmanuel; Gazda, Hanna T.			Ribosomal Protein Genes RPS10 and RPS26 Are Commonly Mutated in Diamond-Blackfan Anemia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							S19 DEFICIENCY; MUTATIONS; REGISTRY; ERYTHROPOIESIS; ABNORMALITIES; BIOGENESIS; APOPTOSIS; LEADS; RNA; UK	Diamond-Blackfan anemia (DBA), an inherited bone marrow failure syndrome characterized by anemia that usually presents before the first birthday or in early childhood, is associated with birth defects and an increased risk of cancer. Although anemia is the most prominent feature of DBA, the disease is also characterized by growth retardation and congenital malformations, in particular craniofacial, upper limb, heart, and urinary system defects that are present in similar to 30%-50% of patients. DBA has been associated with mutations in seven ribosomal protein (RP) genes, RPS19, RPS24, RPS17, RPL35A, RPL5, RPL11, and RPS7, in about 43% of patients. To continue our large-scale screen of RP genes in a DBA population, we sequenced 35 ribosomal protein genes, RPL15, RPL24, RPL29, RPL32, RPL34, RPL9, RPL37, RPS14, RPS23, RPL10A, RPS10, RPS12, RPS18, RPL30, RPS20, RPL12, RPL7A, RPS6, RPL27A, RPLP2, RPS25, RPS3, RPL41, RPL6, RPLP0, RPS26, RPL21, RPL36AL, RPS29, RPL4, RPLP1, RPL13, RPS15A, RPS2, and RPL38, in our DBA patient cohort of 117 probands. We identified three distinct Mutations of RPS10 in five probands and nine distinct mutations of RPS26 in 12 probands. Pre-rRNA analysis in lymphoblastoid cells from patients bearing mutations in RPS10 and RPS26 showed elevated levels of 18S-E prerRNA. This accumulation is consistent with the phenotype observed in HeLa cells after knockdown of RPS10 or RIIS26 expression with siRNAs, which indicates that mutations in the RPS10 and RPS26 genes in DBA patients affect the function of the proteins in rRNA processing.	[Doherty, Leana; Sheen, Mee Rie; Clinton, Catherine; Schneider, Hal E.; Gazda, Hanna T.] Childrens Hosp Boston, Manton Ctr Orphan Dis Res, Div Genet, Boston, MA 02115 USA; [Doherty, Leana; Sheen, Mee Rie; Clinton, Catherine; Schneider, Hal E.; Gazda, Hanna T.] Childrens Hosp Boston, Manton Ctr Orphan Dis Res, Program Genom, Boston, MA 02115 USA; [Vlachos, Adrianna; Atsidaftos, Eva; Lipton, Jeffrey M.] Feinstein Inst Med Res, Manhasset, NY 11030 USA; [Vlachos, Adrianna; Atsidaftos, Eva; Lipton, Jeffrey M.] Schneider Childrens Hosp, Albert Einstein Coll Med, New Hyde Pk, NY 11040 USA; [Choesmel, Valerie; O'Donohue, Marie-Francoise; Gleizes, Pierre-Emmanuel] Univ Toulouse, UPS, Lab Biol Mol Eucaryote, F-31000 Toulouse, France; [Choesmel, Valerie; O'Donohue, Marie-Francoise; Gleizes, Pierre-Emmanuel] CNRS, UMR 5099, F-31000 Toulouse, France; [Sieff, Colin A.] Childrens Hosp Boston, Div Pediat Hematol, Boston, MA 02115 USA; [Sieff, Colin A.; Gazda, Hanna T.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Newburger, Peter E.] Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA 01655 USA; [Ball, Sarah E.] St Georges Univ London, Dept Cellular & Mol Med, London SW17 0RE, England; [Niewiadomska, Edyta; Matysiak, Michal] Med Univ Warsaw, Dept Paediat Haematol & Oncol, PL-00576 Warsaw, Poland; [Glader, Bertil] Stanford Univ, Sch Med, Div Pediat Hematol Oncol, Palo Alto, CA 94304 USA; [Arceci, Robert J.; Farrar, Jason E.] Johns Hopkins Univ, Sch Med, Kimmel Comprehens Canc Ctr, Dept Oncol,Div Pediat Oncol, Baltimore, MD 21231 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Northwell Health; Northwell Health; North Shore University Hospital; Steven & Alexandra Cohen Children's Medical Center of New York; Yeshiva University; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; St Georges University London; Medical University of Warsaw; Stanford University; Johns Hopkins University	Gazda, HT (corresponding author), Childrens Hosp Boston, Manton Ctr Orphan Dis Res, Div Genet, Boston, MA 02115 USA.	hanna.gazda@childrens.harvard.edu	Farrar, Jason/G-8451-2017; Gleizes, Pierre-Emmanuel/H-3821-2014; Gleizes, Pierre-Emmanuel/ABB-9653-2021; Matysiak, Michal J/V-6942-2018	Farrar, Jason/0000-0003-2148-5839; Gleizes, Pierre-Emmanuel/0000-0003-0830-7341; Gleizes, Pierre-Emmanuel/0000-0003-0830-7341; Matysiak, Michal J/0000-0001-8748-7883; Newburger, Peter/0000-0002-8615-673X; O'Donohue, Marie-Francoise/0000-0002-1204-8285; Niewiadomska, Edyta/0000-0003-2045-6278	The Manton Foundation; French National Research Agency (Agence Nationale de la Recherche); Daniella Maria Arturi Foundation; Diamond Blackfan Anemia Foundation; Pediatric Cancer Foundation; National Institutes of Health (NIH) [R01 HL 079571]; Feinstein Institute for Medical Research at the North Shore Long Island Jewish General Clinical Research Center [M01 RR018535]; Developmental Disabilities Research Center (NIH) [HD18655, P50 NS040828]; Children's Hospital Boston SNP; National Heart, Lung, and Blood Institute Resequencing & Genotyping Service [R109 MOHLKE]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR018535] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL092224, R01HL079571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS040828] Funding Source: NIH RePORTER	The Manton Foundation; French National Research Agency (Agence Nationale de la Recherche)(French National Research Agency (ANR)); Daniella Maria Arturi Foundation; Diamond Blackfan Anemia Foundation; Pediatric Cancer Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Feinstein Institute for Medical Research at the North Shore Long Island Jewish General Clinical Research Center; Developmental Disabilities Research Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital Boston SNP; National Heart, Lung, and Blood Institute Resequencing & Genotyping Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was Supported by a generous gift from The Manton Foundation and a grant from the French National Research Agency (Agence Nationale de la Recherche, RIBODBA project), as welt as grants from the Daniella Maria Arturi Foundation, the Diamond Blackfan Anemia Foundation, the Pediatric Cancer Foundation (J.M.L.), the National Institutes of Health (NIH) (R01 HL 079571) (J.M.L., A.V., E.A.), and the Feinstein Institute for Medical Research at the North Shore Long Island Jewish General Clinical Research Center (M01 RR018535) U.M.L., A.V., L.A.). DNA sequencing was performed by he Children's Hospital Boston Program in Genomics and the Molecular Genetics Core Facility Supported by the Developmental Disabilities Research Center (NIH P30 HD18655) and the Harvard Neuromuscular Disease Project (NIH P50 NS040828), by the Children's Hospital Boston SNP Genotyping Facilities, and by the Diamond Blackfan Anernia Gene Discovery and ReseqUencing Project (National Heart, Lung, and Blood Institute Resequencing & Genotyping Service) (R109 MOHLKE). We thank Alan Beggs for many helpful discussions, advice, and Support; Marie Arturi for stimulating DBA research collaboration; and all of the physicians and DBA patients for participating in the study.	Alter BP, 1998, NATHAN OSKIS HEMATOL, P237; Ball SE, 1996, BRIT J HAEMATOL, V94, P645, DOI 10.1046/j.1365-2141.1996.d01-1839.x; Campagnoli MF, 2004, HAEMATOLOGICA, V89, P480; Choesmel V, 2008, HUM MOL GENET, V17, P1253, DOI 10.1093/hmg/ddn015; Choesmel V, 2007, BLOOD, V109, P1275, DOI 10.1182/blood-2006-07-038372; Cmejla R, 2007, HUM MUTAT, V28, P1178, DOI 10.1002/humu.20608; Danilova N, 2008, BLOOD, V112, P5228, DOI 10.1182/blood-2008-01-132290; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; Farrar JE, 2008, BLOOD, V112, P1582, DOI 10.1182/blood-2008-02-140012; Flygare J, 2007, BLOOD, V109, P980, DOI 10.1182/blood-2006-07-038232; Gazda HT, 2006, AM J HUM GENET, V79, P1110, DOI 10.1086/510020; Gazda HT, 2008, AM J HUM GENET, V83, P769, DOI 10.1016/j.ajhg.2008.11.004; Gazda HT, 2004, BRIT J HAEMATOL, V127, P105, DOI 10.1111/j.1365-2141.2004.05152.x; GLADER BE, 1988, BRIT J HAEMATOL, V68, P165, DOI 10.1111/j.1365-2141.1988.tb06184.x; Idol RA, 2007, BLOOD CELL MOL DIS, V39, P35, DOI 10.1016/j.bcmd.2007.02.001; Janov AJ, 1996, MEDICINE, V75, P77, DOI 10.1097/00005792-199603000-00004; Leger-Silvestre I, 2005, J BIOL CHEM, V280, P38177, DOI 10.1074/jbc.M506916200; Lipton JM, 2006, PEDIATR BLOOD CANCER, V46, P558, DOI 10.1002/pbc.20642; McGowan KA, 2008, NAT GENET, V40, P963, DOI 10.1038/ng.188; Miyake K, 2008, STEM CELLS, V26, P323, DOI 10.1634/stemcells.2007-0569; Orfali KA, 2004, BRIT J HAEMATOL, V125, P243, DOI 10.1111/j.1365-2141.2004.04890.x; PERDAHL EB, 1994, BLOOD, V83, P645; QUARELLO P, 2009, DIAMOND BLACKFAN ANE; Vlachos A, 2001, J PEDIAT HEMATOL ONC, V23, P377, DOI 10.1097/00043426-200108000-00015; Vlachos A, 2008, BRIT J HAEMATOL, V142, P859, DOI 10.1111/j.1365-2141.2008.07269.x; Willig TN, 1999, BLOOD, V94, P4294; Willig TN, 1999, PEDIATR RES, V46, P553, DOI 10.1203/00006450-199911000-00011	27	164	174	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 12	2010	86	2					222	228		10.1016/j.ajhg.2009.12.015	http://dx.doi.org/10.1016/j.ajhg.2009.12.015			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	556ZS	20116044	Green Published, Bronze			2022-12-18	WOS:000274637200011
J	Denier, C; Goutagny, S; Labauge, P; Krivosic, V; Arnoult, M; Cousin, A; Benabid, AL; Comoy, J; Frerebeau, P; Gilbert, B; Houtteville, JP; Jan, M; Lapierre, F; Loiseau, H; Menei, P; Mercier, P; Moreau, JJ; Nivelon-Chevallier, A; Parker, F; Redondo, AM; Scarabin, JM; Tremoulet, M; Zerah, M; Maciazek, J; Tournier-Lasserve, E				Denier, C; Goutagny, S; Labauge, P; Krivosic, V; Arnoult, M; Cousin, A; Benabid, AL; Comoy, J; Frerebeau, P; Gilbert, B; Houtteville, JP; Jan, M; Lapierre, F; Loiseau, H; Menei, P; Mercier, P; Moreau, JJ; Nivelon-Chevallier, A; Parker, F; Redondo, AM; Scarabin, JM; Tremoulet, M; Zerah, M; Maciazek, J; Tournier-Lasserve, E		Societe Francaise de Neurochirurgi	Mutations within the MGC4607 gene cause cerebral cavernous malformations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ENCODING KRIT1; BINDING-PROTEIN; CCM1 GENE; HETEROGENEITY; ASSOCIATION; ANGIOMAS; FAMILIES; LINKAGE	Cerebral cavernous malformations (CCM) are hamartomatous vascular malformations characterized by abnormally enlarged capillary cavities without intervening brain parenchyma. They cause seizures and focal neurological deficits due to cerebral hemorrhages. CCM loci have already been assigned to chromosomes 7q (CCM1), 7p (CCM2), and 3q (CCM3) and have been identified in 40%, 20%, and 40%, respectively, of families with CCM. Loss-of-function mutations have been identified in CCM1/KRIT1, the sole CCM gene identified to date. We report here the identification of MGC4607 as the CCM2 gene. We first reduced the size of the CCM2 interval from 22 cM to 7.5 cM by genetic linkage analysis. We then hypothesized that large deletions might be involved in the disorder, as already reported in other hamartomatous conditions, such as tuberous sclerosis or neurofibromatosis. We performed a high-density microsatellite genotyping of this 7.5-cM interval to search for putative null alleles in 30 unrelated families, and we identified, in 2 unrelated families, null alleles that were the result of deletions within a 350-kb interval flanked by markers D7S478 and D7S621. Additional microsatellite and single-nucleotide polymorphism genotyping showed that these two distinct deletions overlapped and that both of the two deleted the first exon of MGC4607, a known gene of unknown function. In both families, one of the two MGC4607 transcripts was not detected. We then identified eight additional point mutations within MGC4607 in eight of the remaining families. One of them led to the alteration of the initiation codon and five of them to a premature termination codon, including one nonsense, one frameshift, and three splice-site mutations. All these mutations cosegregated with the disease in the families and were not observed in 192 control chromosomes. MGC4607 is so far unrelated to any known gene family. Its implication in CCMs strongly suggests that it is a new player in vascular morphogenesis.	CHU Necker Enfants Malad, Fac Med Lariboisiere, INSERM, E365, F-75010 Paris, France; CHU Necker Enfants Malad, Assistance Publ Hop Paris, Hop Lariboisiere, Lab Cytogenet, Paris, France; CHU Necker Enfants Malad, Serv Neurochirurg, Paris, France; CHU Montpellier, Serv Neurol, Nimes, France; CHU Grenoble, Serv Neurochirurg, F-38043 Grenoble, France; CHU Kremlin Bicetre, Serv Neurochirurg, Le Kremlin Bicetre, France; CHU Montpellier, Serv Neurochirurg, Montpellier, France; CHU Limoges, Serv Neurochirurg, Limoges, France; CHU Caen, Serv Neurochirurg, F-14000 Caen, France; CHU Tours, Serv Neurochirurg, Tours, France; CHU Poitiers, Serv Neurochirurg, Poitiers, France; CHU Toulouse, Serv Neurochirurg, Toulouse, France; CHU Angers, Serv Neurochirurg, Angers, France; CHU Dijon, Dijon, France; Hop Beaujon, Serv Neurochirurg, Clichy, France; CHU Rennes, Serv Neurochirurg, Rennes, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Montpellier; CHU de Montpellier; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Universite de Montpellier; CHU de Montpellier; CHU Limoges; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU Tours; CHU Poitiers; Universite de Poitiers; CHU de Toulouse; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU Dijon Bourgogne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Rennes	Tournier-Lasserve, E (corresponding author), CHU Necker Enfants Malad, Fac Med Lariboisiere, INSERM, E365, 10 Ave Verdun, F-75010 Paris, France.	tournier-lasserve@paris7.jussieu.fr	Benabid, Alim L/Q-3506-2017; Tournier-Lasserve, Elisabeth/N-7134-2017; ZERAH, Michel/E-6473-2012; MENEI, Philippe/L-6860-2015	Tournier-Lasserve, Elisabeth/0000-0002-3039-1677; menei, philippe/0000-0002-2794-1316; Goutagny, Stephane/0000-0001-6975-9945				Cave-Riant F, 2002, EUR J HUM GENET, V10, P733, DOI 10.1038/sj.ejhg.5200870; Chen DH, 2002, J NEUROL SCI, V196, P91, DOI 10.1016/S0022-510X(02)00031-X; Craig HD, 1998, HUM MOL GENET, V7, P1851, DOI 10.1093/hmg/7.12.1851; Davenport WJ, 2001, NEUROLOGY, V56, P540, DOI 10.1212/WNL.56.4.540; DUBOVSKY J, 1995, HUM MOL GENET, V4, P453, DOI 10.1093/hmg/4.3.453; Dupre N, 2003, CAN J NEUROL SCI, V30, P122, DOI 10.1017/S0317167100053385; Eerola I, 2000, HUM MOL GENET, V9, P1351, DOI 10.1093/hmg/9.9.1351; Labauge P, 1998, LANCET, V352, P1892, DOI 10.1016/S0140-6736(98)03011-6; Laberge S, 1999, EUR J HUM GENET, V7, P499, DOI 10.1038/sj.ejhg.5200324; Laberge-le Couteulx S, 1999, NAT GENET, V23, P189, DOI 10.1038/13815; Laberge-Le Couteulx S, 2002, ARCH OPHTHALMOL-CHIC, V120, P217; Laurans MSH, 2003, J NEUROSURG, V99, P38, DOI 10.3171/jns.2003.99.1.0038; Lucas M, 2001, ANN NEUROL, V49, P529, DOI 10.1002/ana.105; Lucas Miguel, 2003, BMC Neurol, V3, P5, DOI 10.1186/1471-2377-3-5; Marini V, 2003, J NEUROL SCI, V212, P75, DOI 10.1016/S0022-510X(03)00108-4; Musunuru K, 2003, J NEUROSURG, V99, P412, DOI 10.3171/jns.2003.99.2.0412; NELLIST M, 1993, CELL, V75, P1305; OTTEN P, 1989, NEUROCHIRURGIE, V35, P82; RIGAMONTI D, 1988, NEW ENGL J MED, V319, P343, DOI 10.1056/NEJM198808113190605; ROBINSON JR, 1991, J NEUROSURG, V75, P709, DOI 10.3171/jns.1991.75.5.0709; Russell DS, 1989, PATHOLOGY TUMOURS NE, P730; Sahoo T, 2001, GENOMICS, V71, P123, DOI 10.1006/geno.2000.6426; Sahoo T, 1999, HUM MOL GENET, V8, P2325, DOI 10.1093/hmg/8.12.2325; Serebriiskii I, 1997, ONCOGENE, V15, P1043, DOI 10.1038/sj.onc.1201268; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; Verlaan DJ, 2002, AM J HUM GENET, V70, P1564, DOI 10.1086/340604; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; Xu Yu-lun, 2003, Zhonghua Bing Li Xue Za Zhi, V32, P220; Zawistowski JS, 2002, HUM MOL GENET, V11, P389, DOI 10.1093/hmg/11.4.389; Zhang J, 2000, NEUROSURGERY, V46, P1272, DOI 10.1097/00006123-200005000-00064; Zhang J, 2001, HUM MOL GENET, V10, P2953, DOI 10.1093/hmg/10.25.2953	31	164	171	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2004	74	2					326	337		10.1086/381718	http://dx.doi.org/10.1086/381718			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	772UM	14740320	Bronze, Green Published			2022-12-18	WOS:000188860000013
J	Ogdie, MN; Macphie, IL; Minassian, SL; Yang, M; Fisher, SE; Francks, C; Cantor, RM; McCracken, JT; McGough, JJ; Nelson, SF; Monaco, AP; Smalley, SL				Ogdie, MN; Macphie, IL; Minassian, SL; Yang, M; Fisher, SE; Francks, C; Cantor, RM; McCracken, JT; McGough, JJ; Nelson, SF; Monaco, AP; Smalley, SL			A genomewide scan for attention-deficit/hyperactivity disorder in an extended sample: Suggestive linkage on 17p11	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEFICIT HYPERACTIVITY DISORDER; DOPAMINE-D4 RECEPTOR GENE; QUANTITATIVE-TRAIT LOCUS; CHROMOSOME 6P INFLUENCES; READING-DISABILITY; SUSCEPTIBILITY GENE; DIAGNOSTIC-CRITERIA; TRANSPORTER GENE; TEACHER RATINGS; ASSOCIATION	Attention-deficit/hyperactivity disorder (ADHD [MIM 143465]) is a common, highly heritable neurobehavioral disorder of childhood onset, characterized by hyperactivity, impulsivity, and/or inattention. As part of an ongoing study of the genetic etiology of ADHD, we have performed a genomewide linkage scan in 204 nuclear families comprising 853 individuals and 270 affected sibling pairs (ASPs). Previously, we reported genomewide linkage analysis of a "first wave" of these families composed of 126 ASPs. A follow-up investigation of one region on 16p yielded significant linkage in an extended sample. The current study extends the original sample of 126 ASPs to 270 ASPs and provides linkage analyses of the entire sample, using polymorphic microsatellite markers that define an similar to10-cM map across the genome. Maximum LOD score (MLS) analysis identified suggestive linkage for 17p11 () and four nominal regions with MLS values >1.0, including 5p13, 6q14, 11q25, and 20q13. These MLS = 2.98 data, taken together with the fine mapping on 16p13, suggest two regions as highly likely to harbor risk genes for ADHD: 16p13 and 17p11. Interestingly, both regions, as well as 5p13, have been highlighted in genomewide scans for autism.	Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA 90024 USA; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Oxford; Wellcome Centre for Human Genetics	Smalley, SL (corresponding author), Univ Calif Los Angeles, Ctr Neurobehav Genet, 760 Westwood Plaza, Los Angeles, CA 90024 USA.	ssmalley@mednet.ucla.edu	Fisher, Simon E./E-9130-2012; Francks, Clyde/AGU-8875-2022; Francks, Clyde/E-1384-2012; Nelson, Stanley F/D-4771-2009; Monaco, Anthony P/A-4495-2010	Fisher, Simon E./0000-0002-3132-1996; Francks, Clyde/0000-0002-9098-890X; Nelson, Stanley F/0000-0002-2082-3114; Monaco, Anthony P/0000-0001-7480-3197	NIGMS NIH HHS [T32 GM007104, GM07104] Funding Source: Medline; NIMH NIH HHS [MH01805, R01 MH058277, MH58277, MH01969, K24 MH001805] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058277, K24MH001805] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Achenbach T., 2007, CBCL PROFILE SCORING; American Psychiatric Association DSM-IV, 1994, DSM 4 DIAGN STAT MAN; ANDERSON JC, 1987, ARCH GEN PSYCHIAT, V44, P69; AUGUST GJ, 1989, J AM ACAD CHILD PSY, V28, P739, DOI 10.1097/00004583-198909000-00016; Bakker SC, 2003, AM J HUM GENET, V72, P1251, DOI 10.1086/375143; Barkley RA, 1997, J DEV BEHAV PEDIATR, V18, P271; Barr CL, 2001, MOL PSYCHIATR, V6, P334, DOI 10.1038/sj.mp.4000863; BAUMGAERTEL A, 1995, J AM ACAD CHILD PSY, V34, P629, DOI 10.1097/00004583-199505000-00015; BECK KD, 1995, NATURE, V373, P339, DOI 10.1038/373339a0; Biederman J, 1996, ARCH GEN PSYCHIAT, V53, P437; BIEDERMAN J, 1992, ARCH GEN PSYCHIAT, V49, P728; Brown RT, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.3.e43; Buxbaum JD, 2001, AM J HUM GENET, V68, P1514, DOI 10.1086/320588; CANTWELL DP, 1975, J CHILD PSYCHOL PSYC, V16, P261, DOI 10.1111/j.1469-7610.1975.tb01275.x; Cantwell DP, 1996, J AM ACAD CHILD PSY, V35, P978, DOI 10.1097/00004583-199608000-00008; CARDON LR, 1994, SCIENCE, V266, P276, DOI 10.1126/science.7939663; Comings DE, 2000, CLIN GENET, V58, P31, DOI 10.1034/j.1399-0004.2000.580106.x; COMINGS DE, 1995, BIOL PSYCHIAT, V37, P484, DOI 10.1016/0006-3223(94)00311-P; COOK EH, 1995, AM J HUM GENET, V56, P993; Curran S, 2001, MOL PSYCHIATR, V6, P425, DOI 10.1038/sj.mp.4000914; Daly G, 1999, MOL PSYCHIATR, V4, P192, DOI 10.1038/sj.mp.4000510; DEUTSCH CK, 1990, J AM ACAD CHILD PSY, V29, P189, DOI 10.1097/00004583-199003000-00006; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Faraone SV, 2001, AM J PSYCHIAT, V158, P1052, DOI 10.1176/appi.ajp.158.7.1052; FARAONE SV, 1994, HARVARD REV PSYCHIAT, V1, P271, DOI 10.3109/10673229409017090; Faraone SV, 2001, CHILD ADOL PSYCH CL, V10, P299; Faraone SV, 1998, BIOL PSYCHIAT, V44, P951, DOI 10.1016/S0006-3223(98)00240-6; Faraone SV, 2000, GENET EPIDEMIOL, V18, P1; FARAONE SV, 1992, PSYCHIATR GENET, V2, P257, DOI 10.1097/00041444-199210000-00004; Fisher SE, 1999, AM J HUM GENET, V64, P146, DOI 10.1086/302190; Fisher SE, 2002, AM J HUM GENET, V70, P1183, DOI 10.1086/340112; FYER AJ, 1995, ARCH GEN PSYCHIAT, V52, P564; Gayan J, 1999, AM J HUM GENET, V64, P157, DOI 10.1086/302191; Geschwind DH, 2001, AM J MED GENET, V101, P370; GILGER JW, 1992, J AM ACAD CHILD PSY, V31, P343, DOI 10.1097/00004583-199203000-00024; Gill M, 1997, MOL PSYCHIATR, V2, P311, DOI 10.1038/sj.mp.4000290; Goldman LS, 1998, JAMA-J AM MED ASSOC, V279, P1100, DOI 10.1001/jama.279.14.1100; Gomez R, 1999, J CHILD PSYCHOL PSYC, V40, P265, DOI 10.1111/1469-7610.00440; Grigorenko EL, 2000, AM J HUM GENET, V66, P715, DOI 10.1086/302755; HOLMANS P, 1993, AM J HUM GENET, V52, P362; Holmes J, 2000, MOL PSYCHIATR, V5, P523, DOI 10.1038/sj.mp.4000751; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kent L, 2002, MOL PSYCHIATR, V7, P908, DOI 10.1038/sj.mp.4001100; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LaHoste GJ, 1996, MOL PSYCHIATR, V1, P121; Levy F, 1997, J AM ACAD CHILD PSY, V36, P737, DOI 10.1097/00004583-199706000-00009; Liu JJ, 2001, AM J HUM GENET, V69, P327, DOI 10.1086/321980; Manor I, 2001, AM J MED GENET, V105, P91; MARKWARDT FC, 1989, EXAMINERS MANUAL PEA; McCracken JT, 2000, MOL PSYCHIATR, V5, P531, DOI 10.1038/sj.mp.4000770; Mill J, 2001, MOL PSYCHIATR, V6, P440, DOI 10.1038/sj.mp.4000881; MORRISON JR, 1973, ARCH GEN PSYCHIAT, V28, P888; Nyholt DR, 2000, AM J HUM GENET, V67, P282, DOI 10.1086/303029; Odell JD, 1997, NEUROPSYCHOBIOLOGY, V35, P181; Palferman S, 2001, AM J HUM GENET, V69, P570; Palmer K J, 1999, Drugs R D, V1, P9, DOI 10.2165/00126839-199901010-00002; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Payton A, 2001, AM J MED GENET, V105, P464, DOI 10.1002/ajmg.1407; PELHAM WE, 1992, J AM ACAD CHILD PSY, V31, P210, DOI 10.1097/00004583-199203000-00006; Petryshen TL, 2001, AM J MED GENET, V105, P507, DOI 10.1002/ajmg.1475; Philippe A, 1999, HUM MOL GENET, V8, P805, DOI 10.1093/hmg/8.5.805; Rinehart NJ, 2002, J AUTISM DEV DISORD, V32, P321, DOI 10.1023/A:1016387020095; RISCH N, 1990, AM J HUM GENET, V46, P229; Rohde LA, 1999, J AM ACAD CHILD PSY, V38, P716, DOI 10.1097/00004583-199906000-00019; Scahill L, 2000, CHILD ADOL PSYCH CL, V9, P541; SCHAAR DG, 1993, EXP NEUROL, V124, P368, DOI 10.1006/exnr.1993.1207; Seeger G, 2001, NEUROSCI LETT, V313, P45, DOI 10.1016/S0304-3940(01)02253-4; SEMRUDCLIKEMAN M, 1992, J AM ACAD CHILD PSY, V31, P439, DOI 10.1097/00004583-199205000-00009; Smalley SL, 1997, AM J HUM GENET, V60, P1276, DOI 10.1086/515485; Smalley SL, 2000, J AM ACAD CHILD PSY, V39, P1135, DOI 10.1097/00004583-200009000-00013; Smalley SL, 2002, AM J HUM GENET, V71, P959, DOI 10.1086/342732; Smalley SL, 1998, MOL PSYCHIATR, V3, P427, DOI 10.1038/sj.mp.4000457; SUAREZ BK, 1994, PROBLEMS REPLICATING; Swanson JM, 1998, LANCET, V351, P429, DOI 10.1016/S0140-6736(97)11450-7; Swanson JM., 1995, SNAP 4 SCALE; Tahir E, 2000, MOL PSYCHIATR, V5, P396, DOI 10.1038/sj.mp.4000744; TERWILLIGER JD, 1993, GENET EPIDEMIOL, V10, P217, DOI 10.1002/gepi.1370100402; VANDENOORD EJCG, 1994, BEHAV GENET, V24, P193, DOI 10.1007/BF01067187; WARREN RP, 1995, SCIENCE, V268, P786, DOI 10.1126/science.7605493; Wechsler D., 1991, EXAMINERS MANUAL WEC; WEEKS DE, 1995, TRENDS GENET, V11, P513, DOI 10.1016/S0168-9525(00)89163-5; Wilens TE, 2002, ANNU REV MED, V53, P113, DOI 10.1146/annurev.med.53.082901.103945; Willcutt EG, 2002, AM J MED GENET, V114, P260, DOI 10.1002/ajmg.10205; Willcutt EG, 2000, J CHILD PSYCHOL PSYC, V41, P1039, DOI 10.1017/S0021963099006368; Wolraich ML, 1996, J AM ACAD CHILD PSY, V35, P319, DOI 10.1097/00004583-199603000-00013; Wolraich ML, 1998, J DEV BEHAV PEDIATR, V19, P162, DOI 10.1097/00004703-199806000-00003; Yamasaki H, 2002, P NATL ACAD SCI USA, V99, P11447, DOI 10.1073/pnas.182176499; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	89	164	167	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2003	72	5					1268	1279		10.1086/375139	http://dx.doi.org/10.1086/375139			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	671PZ	12687500	Green Published, Bronze			2022-12-18	WOS:000182474400018
J	Cardoso, C; Leventer, RJ; Ward, HL; Toyo-oka, K; Chung, J; Gross, A; Martin, CL; Allanson, J; Pilz, DT; Olney, AH; Mutchinick, OM; Hirotsune, S; Wynshaw-Boris, A; Dobyns, WB; Ledbetter, DH				Cardoso, C; Leventer, RJ; Ward, HL; Toyo-oka, K; Chung, J; Gross, A; Martin, CL; Allanson, J; Pilz, DT; Olney, AH; Mutchinick, OM; Hirotsune, S; Wynshaw-Boris, A; Dobyns, WB; Ledbetter, DH			Refinement of a 400-kb critical region allows genotypic differentiation between isolated lissencephaly, Miller- Dieker syndrome, and other phenotypes secondary to deletions of 17p13.3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYNDROME CHROMOSOME REGION; SUPPRESSOR LOCUS; MUTATIONS CAUSE; LIS1 GENE; MALFORMATION; MAP; EXPRESSION; PROTEIN-2; SEQUENCE; PRODUCT	Deletions of 17p13.3, including the LIS1 gene, result in the brain malformation lissencephaly, which is characterized by reduced gyration and cortical thickening; however, the phenotype can vary from isolated lissencephaly sequence (ILS) to Miller-Dieker syndrome (MDS). At the clinical level, these two phenotypes can be differentiated by the presence of significant dysmorphic facial features and a more severe grade of lissencephaly in MDS. Previous work has suggested that children with MDS have a larger deletion than those with ILS, but the precise boundaries of the MDS critical region and causative genes other than LIS1 have never been fully determined. We have completed a physical and transcriptional map of the 17p13.3 region from LIS1 to the telomere. Using fluorescence in situ hybridization, we have mapped the deletion size in 19 children with ILS, 11 children with MDS, and 4 children with 17p13.3 deletions not involving LIS1. We show that the critical region that differentiates ILS from MDS at the molecular level can be reduced to 400 kb. Using somatic cell hybrids from selected patients, we have identified eight genes that are consistently deleted in patients classified as having MDS. In addition, deletion of the genes CRK and 14-3-3epsilon delineates patients with the most severe lissencephaly grade. On the basis of recent functional data and the creation of a mouse model suggesting a role for 14-3-3epsilon in cortical development, we suggest that deletion of one or both of these genes in combination with deletion of LIS1 may contribute to the more severe form of lissencephaly seen only in patients with MDS.	Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Fac Med La Timone, INSERM, U491, Marseille, France; Royal Childrens Hosp, Dept Neurol, Melbourne, Vic, Australia; Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; Childrens Hosp Eastern Ontario, Div Genet, Ottawa, ON K1H 8L1, Canada; Univ Ottawa, Ottawa, ON, Canada; Univ Wales Hosp, Inst Med Genet, Cardiff CF4 4XN, S Glam, Wales; Univ Nebraska, Med Ctr, Ctr Human Genet, Omaha, NE USA; Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Genet, Tlalpan, Mexico; Saitama Med Sch, Res Inst Genom Med, Hidaka, Japan	University of Chicago; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Cardiff University; University of Nebraska System; University of Nebraska Medical Center; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Saitama Medical University	Ledbetter, DH (corresponding author), Univ Chicago, Dept Human Genet, 920 E 58th St, Chicago, IL 60637 USA.		Toyooka, Kazuhito/AAQ-6928-2020; Dobyns, William/AAI-2768-2020; Toyooka, Kazuhito/AAH-7175-2019; Cardoso, Carlos/H-4520-2016; Dobyns, William Brian/ABC-6525-2021; Cardoso, Carlos/M-2767-2019	Toyooka, Kazuhito/0000-0002-0173-0430; Dobyns, William/0000-0002-7681-2844; Toyooka, Kazuhito/0000-0002-0173-0430; Cardoso, Carlos/0000-0003-1914-9553; Cardoso, Carlos/0000-0003-1914-9553	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS039404] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD36715-03] Funding Source: Medline; NINDS NIH HHS [P01 NS039404, P01 NS39404] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adachi H, 2002, J BIOL CHEM, V277, P24014, DOI 10.1074/jbc.M201854200; Cardoso C, 2000, HUM MOL GENET, V9, P3019, DOI 10.1093/hmg/9.20.3019; Chong SS, 1997, HUM MOL GENET, V6, P147, DOI 10.1093/hmg/6.2.147; Chong SS, 1996, GENOME RES, V6, P735, DOI 10.1101/gr.6.8.735; Christian SL, 1999, HUM MOL GENET, V8, P1025, DOI 10.1093/hmg/8.6.1025; DOBYNS WB, 1991, AM J HUM GENET, V48, P584; Dobyns WB, 1999, NEUROLOGY, V53, P270, DOI 10.1212/WNL.53.2.270; DOBYNS WB, 1993, JAMA-J AM MED ASSOC, V270, P2838, DOI 10.1001/jama.270.23.2838; Feller SM, 1998, J CELL PHYSIOL, V177, P535, DOI 10.1002/(SICI)1097-4652(199812)177:4<535::AID-JCP5>3.3.CO;2-5; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Hoff C, 2000, GENOMICS, V70, P26, DOI 10.1006/geno.2000.6353; Holt JR, 2002, CELL, V108, P371, DOI 10.1016/S0092-8674(02)00629-3; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Kim YJ, 2001, HUM MOL GENET, V10, P1129, DOI 10.1093/hmg/10.11.1129; Knight SJL, 2000, AM J HUM GENET, V67, P320, DOI 10.1086/302998; Kuhn AN, 1999, MOL CELL, V3, P65, DOI 10.1016/S1097-2765(00)80175-6; LEDBETTER DH, 1989, P NATL ACAD SCI USA, V86, P5136, DOI 10.1073/pnas.86.13.5136; LEDBETTER SA, 1992, AM J HUM GENET, V50, P182; Leventer RJ, 2001, NEUROLOGY, V57, P416, DOI 10.1212/WNL.57.3.416; LISCOVITCH M, 1995, CELL, V81, P659, DOI 10.1016/0092-8674(95)90525-1; LoNigro C, 1997, HUM MOL GENET, V6, P157, DOI 10.1093/hmg/6.2.157; Martin CL, 2002, J MED GENET, V39, P734, DOI 10.1136/jmg.39.10.734; McHale JC, 2000, CYTOGENET CELL GENET, V88, P225, DOI 10.1159/000015556; MORROW B, 1995, AM J HUM GENET, V56, P1391; Mutchinick OM, 1999, AM J MED GENET, V85, P99, DOI 10.1002/(SICI)1096-8628(19990716)85:2<99::AID-AJMG1>3.0.CO;2-W; Osborne LR, 1997, GENOMICS, V45, P402, DOI 10.1006/geno.1997.4923; Pilz DT, 1998, HUM MOL GENET, V7, P2029, DOI 10.1093/hmg/7.13.2029; Pilz DT, 1998, GENET MED, V1, P29; Plummer SJ, 1997, GENOMICS, V45, P140, DOI 10.1006/geno.1997.4906; REICHMAN CT, 1992, CELL GROWTH DIFFER, V3, P451; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; STACK M, 1995, HUM MOL GENET, V4, P2047, DOI 10.1093/hmg/4.11.2047; Tsuda M, 2002, CELL GROWTH DIFFER, V13, P131; van Tuinen P, 1987, Genomics, V1, P374, DOI 10.1016/0888-7543(87)90042-5; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4	35	164	175	0	6	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2003	72	4					918	930		10.1086/374320	http://dx.doi.org/10.1086/374320			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662WT	12621583	Green Published, Bronze			2022-12-18	WOS:000181972600012
J	Veltman, JA; Schoenmakers, EFPM; Eussen, BH; Janssen, I; Merkx, G; van Cleef, B; van Ravenswaaij, CM; Brunner, HG; Smeets, D; van Kessel, AG				Veltman, JA; Schoenmakers, EFPM; Eussen, BH; Janssen, I; Merkx, G; van Cleef, B; van Ravenswaaij, CM; Brunner, HG; Smeets, D; van Kessel, AG			High-throughput analysis of subtelomeric chromosome rearrangements by use of array-based comparative genomic hybridization	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IDIOPATHIC MENTAL-RETARDATION; IN-SITU HYBRIDIZATION; CLINICAL-APPLICATION; COPY NUMBER; PROBES; DUPLICATION; TELOMERES; CHILDREN; SET; DNA	Telomeric chromosome rearrangements may cause mental retardation, congenital anomalies, and miscarriages. Automated detection of subtle deletions or duplications involving telomeres is essential for high-throughput diagnosis, but impossible when conventional cytogenetic methods are used. Array-based comparative genomic hybridization (CGH) allows high-resolution screening of copy number abnormalities by hybridizing differentially labeled test and reference genomes to arrays of robotically spotted clones. To assess the applicability of this technique in the diagnosis of (sub) telomeric imbalances, we here describe a blinded study, in which DNA from 20 patients with known cytogenetic abnormalities involving one or more telomeres was hybridized to an array containing a validated set of human-chromosome-specific (sub) telomere probes. Single-copy-number gains and losses were accurately detected on these arrays, and an excellent concordance between the original cytogenetic diagnosis and the array-based CGH diagnosis was obtained by use of a single hybridization. In addition to the previously identified cytogenetic changes, array-based CGH revealed additional telomere rearrangements in 3 of the 20 patients studied. The robustness and simplicity of this array-based telomere copy-number screening make it highly suited for introduction into the clinic as a rapid and sensitive automated diagnostic procedure.	Univ Med Ctr Nijmegen, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Acad Hosp Rotterdam, Dept Clin Genet, Rotterdam, Netherlands	Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC	Veltman, JA (corresponding author), Univ Med Ctr Nijmegen, Dept Human Genet, POB 9101, NL-6500 HB Nijmegen, Netherlands.		van Kessel, Ad Geurts/A-2810-2010; Brunner, Han/C-9928-2013; Janssen, Irene M/V-3667-2018; Veltman, Joris A/F-5128-2010; Smeets, D.F.C.M./L-4653-2015	Veltman, Joris A/0000-0002-3218-8250; 				Albertson DG, 2000, NAT GENET, V25, P144, DOI 10.1038/75985; Antonarakis SE, 2001, NAT GENET, V27, P230, DOI 10.1038/85769; Armour JAL, 2000, NUCLEIC ACIDS RES, V28, P605, DOI 10.1093/nar/28.2.605; Battaglia A, 1998, AM J MED GENET, V75, P541, DOI 10.1002/(SICI)1096-8628(19980217)75:5<541::AID-AJMG18>3.3.CO;2-I; Bonifacio S, 2001, CYTOGENET CELL GENET, V93, P16, DOI 10.1159/000056939; Brown J, 2001, NAT MED, V7, P497, DOI 10.1038/86581; Bruder CEG, 2001, HUM MOL GENET, V10, P271, DOI 10.1093/hmg/10.3.271; Cassidy SB, 2000, AM J MED GENET, V97, P136, DOI 10.1002/1096-8628(200022)97:2<136::AID-AJMG5>3.0.CO;2-V; Cheung VG, 2001, NATURE, V409, P953, DOI 10.1038/35057192; de Bruijn DRH, 2001, CYTOGENET CELL GENET, V92, P310, DOI 10.1159/000056920; de Vries BBA, 2001, J MED GENET, V38, P145, DOI 10.1136/jmg.38.3.145; DEDIESMULDERS CEM, 1995, AM J MED GENET, V59, P369, DOI 10.1002/ajmg.1320590318; Donnai D, 2000, AM J MED GENET, V97, P164, DOI 10.1002/1096-8628(200022)97:2<164::AID-AJMG8>3.0.CO;2-F; FLINT J, 1995, NAT GENET, V9, P132, DOI 10.1038/ng0295-132; GUO WJ, 1995, AM J MED GENET, V58, P230, DOI 10.1002/ajmg.1320580307; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; Knight SJL, 2000, AM J HUM GENET, V67, P320, DOI 10.1086/302998; Knight SJL, 2000, J MED GENET, V37, P401, DOI 10.1136/jmg.37.6.401; Knight SJL, 1999, LANCET, V354, P1676, DOI 10.1016/S0140-6736(99)03070-6; Knight SJL, 1997, EUR J HUM GENET, V5, P1; Lichter P, 2000, SEMIN HEMATOL, V37, P348, DOI 10.1053/shem.2000.16594; Ning Y, 1996, NAT GENET, V14, P86, DOI 10.1038/ng0996-86; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Scambler PJ, 2000, HUM MOL GENET, V9, P2421, DOI 10.1093/hmg/9.16.2421; Simons A, 1999, GENE CHROMOSOME CANC, V26, P115, DOI 10.1002/(SICI)1098-2264(199910)26:2<115::AID-GCC3>3.0.CO;2-E; Sismani C, 2001, EUR J HUM GENET, V9, P527, DOI 10.1038/sj.ejhg.5200670; Slavotinek A, 1999, J MED GENET, V36, P405; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754; SolinasToldo S, 1997, GENE CHROMOSOME CANC, V20, P399, DOI 10.1002/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; Weiss MM, 1999, J CLIN PATHOL-MOL PA, V52, P243; Wilhelm M, 2002, CANCER RES, V62, P957	32	164	198	0	8	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2002	70	5					1269	1276		10.1086/340426	http://dx.doi.org/10.1086/340426			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	541XT	11951177	Green Published, Bronze			2022-12-18	WOS:000175012400016
J	Van Duijn, CM; Vaessen, N; Pullen, J; Houwing-Duistermaat, JJ; Snijders, P; Sandkuijl, LA; Edwards, M; Heutink, P; Oostra, BA				Van Duijn, CM; Vaessen, N; Pullen, J; Houwing-Duistermaat, JJ; Snijders, P; Sandkuijl, LA; Edwards, M; Heutink, P; Oostra, BA			Localizing genes involved type 1 and type 2 diabetes in a genetically isolated population.	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract									Erasmus Univ, Dept Epidemiol & Biostat, Genet Epidemiol Unit, NL-3000 DR Rotterdam, Netherlands; Erasmus Univ, Dept Clin Genet, Genet Epidemiol Unit, NL-3000 DR Rotterdam, Netherlands; Oxagen, Abingdon, Oxon, England	Erasmus University Rotterdam; Erasmus University Rotterdam; Oxagen Limited			Houwing-Duistermaat, Jeanne/V-9048-2018; PULLEN, JEFFREY/Q-7144-2019						0	164	167	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2001	69	4		1		1895	505	505						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	483RD					2022-12-18	WOS:000171648901893
J	Bonafe, L; Thony, B; Penzien, JM; Czarnecki, B; Blau, N				Bonafe, L; Thony, B; Penzien, JM; Czarnecki, B; Blau, N			Mutations in the sepiapterin reductase gene cause a novel tetrahydrobiopterin-dependent monoamine-neurotransmitter deficiency without hyperphenylalaninemia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DROSOPHILA-MELANOGASTER; ALDOSE REDUCTASE; CHROMOSOMAL LOCALIZATION; CARBONYL REDUCTASE; RAT ERYTHROCYTES; HUMAN-BRAIN; BIOSYNTHESIS; PURIFICATION; ENZYME; TETRAHYDROPTERIN	Classic tetrahydrobiopterin (BH4) deficiencies are characterized by hyperphenylalaninemia and deficiency of monoamine neurotransmitters. In this article, we report two patients with progressive psychomotor retardation, dystonia, severe dopamine and serotonin deficiencies (low levels of 5-hydroxyindoleacetic and homovanillic acids), and abnormal pterin pattern (high levels of biopterin and dihydrobiopterin) in cerebrospinal fluid. Furthermore, they presented with normal urinary pterins and without hyperphenylalaninemia. Investigation of skin fibroblasts revealed inactive sepiapterin reductase (SR), the enzyme catalyzing the final two-step reaction in the biosynthesis of BH4. Mutations in the SPR gene were detected in both patients and their family members. One patient was homozygous for a TC-->CT dinucleotide exchange, predicting a truncated SR (Q119X). The other patient was a compound heterozygote for a genomic 5-bp deletion (1397-1401delAGAAC) resulting in abolished SPR-gene expression and an A-->G transition leading to an R150G amino acid substitution and to inactive SR as confirmed by recombinant expression. The absence of hyperphenylalaninemia and the presence of normal urinary pterin metabolites and of normal SR-like activity in red blood cells may be explained by alternative pathways for the final two-step reaction of BH4 biosynthesis in peripheral and neuronal tissues. We propose that, for the biosynthesis of BH4 in peripheral tissues, SR activity may be substituted by aldose reductase (AR), carbonyl reductase (CR), and dihydrofolate reductase, whereas, in the brain, only AR and CR are fully present. Thus, autosomal recessive SR deficiency leads to BH4 and to neurotransmitter deficiencies without hyperphenylalaninemia and may not be detected by neonatal screening for phenylketonuria.	Univ Zurich, Childrens Hosp, Div Clin Chem & Biochem, CH-8032 Zurich, Switzerland; Childrens Hosp, Augsburg, Germany; Childrens Hosp Konigsborn, Unna, Germany	University Children's Hospital Zurich; University of Zurich	Blau, N (corresponding author), Univ Zurich, Childrens Hosp, Div Clin Chem & Biochem, Steinwiesstr 75, CH-8032 Zurich, Switzerland.			Blau, Nenad/0000-0003-4347-3230				Auerbach G, 1997, EMBO J, V16, P7219, DOI 10.1093/emboj/16.24.7219; Blau N, 1996, J INHERIT METAB DIS, V19, P8, DOI 10.1007/BF01799342; Blau N, 1998, J INHERIT METAB DIS, V21, P433, DOI 10.1023/A:1005327313348; Blau N, 1999, J INHERIT METAB DIS, V22, P216, DOI 10.1023/A:1005584627797; Blau N., 2001, METABOLIC MOL BASIS, P1725; Bonafe L, 2001, CLIN CHEM, V47, P477; Cho SH, 1999, BIOCHEM J, V340, P497, DOI 10.1042/0264-6021:3400497; CITRON BA, 1990, P NATL ACAD SCI USA, V87, P6436, DOI 10.1073/pnas.87.16.6436; CURTIUS HC, 1991, TECHNIQUES DIAGNOSTI, P377; FERRE J, 1988, CLIN CHIM ACTA, V174, P271, DOI 10.1016/0009-8981(88)90053-8; Forrest GL, 2000, CHEM-BIOL INTERACT, V129, P21, DOI 10.1016/S0009-2797(00)00196-4; ICHINOSE H, 1991, BIOCHEM BIOPH RES CO, V179, P183, DOI 10.1016/0006-291X(91)91352-D; Iino T, 2000, ARCH BIOCHEM BIOPHYS, V373, P442, DOI 10.1006/abbi.1999.1561; IINO T, 1992, ZOOL SCI, V9, P119; KATOH S, 1971, ARCH BIOCHEM BIOPHYS, V146, P202, DOI 10.1016/S0003-9861(71)80057-7; KATOH S, 1984, BIOCHEM BIOPH RES CO, V118, P859, DOI 10.1016/0006-291X(84)91474-8; Katoh S, 1989, Prog Clin Biol Res, V290, P381; KATOH S, 1988, J BIOCHEM-TOKYO, V103, P286, DOI 10.1093/oxfordjournals.jbchem.a122262; KATOH S, 1987, J BIOCHEM-TOKYO, V101, P275, DOI 10.1093/oxfordjournals.jbchem.a121901; KAUFMAN S, 1991, NEUROCHEM RES, V16, P1031, DOI 10.1007/BF00965847; Kim YA, 2000, MOL CELLS, V10, P405; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee SW, 1999, BBA-GENE STRUCT EXPR, V1445, P165, DOI 10.1016/S0167-4781(99)00030-5; LEVINE RA, 1990, J NEUROCHEM, V54, P1218, DOI 10.1111/j.1471-4159.1990.tb01951.x; LUDWIG R, 1987, BLUT, V55, P483, DOI 10.1007/BF00320216; MILSTIEN S, 1989, BIOCHEM BIOPH RES CO, V165, P845, DOI 10.1016/S0006-291X(89)80043-9; MILSTIEN S, 1986, P169; Nygaard TG, 1998, NEUROLOGY, V50, P853, DOI 10.1212/WNL.50.4.853; Ohye T, 1998, BIOCHEM BIOPH RES CO, V251, P597, DOI 10.1006/bbrc.1998.9503; OTA A, 1995, BBA-GENE STRUCT EXPR, V1260, P320, DOI 10.1016/0167-4781(94)00225-R; OYAMA R, 1990, BIOCHEM BIOPH RES CO, V173, P627, DOI 10.1016/S0006-291X(05)80081-6; PARK YS, 1991, BIOCHEM BIOPH RES CO, V175, P738, DOI 10.1016/0006-291X(91)91628-P; PRIMUS JP, 1994, INSECT BIOCHEM MOLEC, V24, P907, DOI 10.1016/0965-1748(94)90019-1; RuizVazquez P, 1996, COMP BIOCHEM PHYS B, V113, P131, DOI 10.1016/0305-0491(96)02005-6; Seong C, 2000, GENE, V255, P357, DOI 10.1016/S0378-1119(00)00314-0; SMITH GK, 1992, J BIOL CHEM, V267, P5599; SMITH GK, 1987, ARCH BIOCHEM BIOPHYS, V255, P254, DOI 10.1016/0003-9861(87)90392-4; STEINERSTAUCH P, 1989, BIOCHEM BIOPH RES CO, V164, P1130, DOI 10.1016/0006-291X(89)91786-5; SUEOKA T, 1985, BIOCHIM BIOPHYS ACTA, V843, P193, DOI 10.1016/0304-4165(85)90139-4; SUEOKA T, 1982, BIOCHIM BIOPHYS ACTA, V717, P265, DOI 10.1016/0304-4165(82)90178-7; Thony B, 2000, BIOCHEM J, V347, P1, DOI 10.1042/0264-6021:3470001; THONY B, 1994, AM J HUM GENET, V54, P782; WERMUTH B, 1982, EUR J BIOCHEM, V127, P279, DOI 10.1111/j.1432-1033.1982.tb06867.x; WERMUTH B, 1981, J BIOL CHEM, V256, P1206; Wermuth B, 1982, Prog Clin Biol Res, V114, P261; Wermuth B, 1985, Prog Clin Biol Res, V174, P209; Wirth H P, 1985, Prog Clin Biol Res, V174, P231	47	164	178	0	7	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2001	69	2					269	277		10.1086/321970	http://dx.doi.org/10.1086/321970			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XN	11443547	Bronze, Green Published			2022-12-18	WOS:000170108200003
J	Biason-Lauber, A; Schoenle, EJ				Biason-Lauber, A; Schoenle, EJ			Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NR5A1/SF-1) and adrenocortical insufficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GONADAL DEVELOPMENT; FACTOR-I; EXPRESSION; GENE	Steroidogenic factor 1 (NR5A1/SF-1) plays an essential role in the development of the hypothalamic-pituitary-adrenal and hypothalamic-pituitary-gonadal axes, controlling expression of their many important genes. The recent description of a 46,XY patient bearing a mutation in the NR5A1 gene, causing male pseudohermaphroditism and adrenal failure, demonstrated the crucial role of SF-1 in male gonadal differentiation. The role of SF-1 in human ovarian development was, until now, unknown. We describe a phenotypically and genotypically normal girl, with signs and symptoms of adrenal insufficiency and no apparent defect in ovarian maturation, bearing a heterozygote G-->T transversion in exon 4 of the NR5A1 gene that leads to the missense R255L in the SF-1 protein. The exchange does not interfere with protein translation and stability. Consistent with the clinical picture, R255L is transcriptionally inactive and has no dominant-negative activity. The inability of the mutant (MUT) NR5A1/SF-1 to bind canonical DNA sequences might offer a possible explanation for the failure of the mutant protein to transactivate target genes. This is the first report of a mutation in the NR5A1 gene in a genotypically female patient, and it suggests that NR5A1/SF-1 is not necessary for female gonadal development, confirming the crucial role of NR5A1/SF-1 in adrenal gland formation in both sexes.	Univ Zurich, Childrens Hosp, Dept Endocrinol & Diabetol, Zurich, Switzerland; Univ Zurich, Childrens Hosp, Dept Clin Chem & Biochem, Zurich, Switzerland	University Children's Hospital Zurich; University of Zurich; University Children's Hospital Zurich; University of Zurich	Biason-Lauber, A (corresponding author), Univ Zurich, Dept Pediat, Div Pediat Endocrinol Diabetol, Steinwiesstr 75, CH-8032 Zurich, Switzerland.	alauber@kispi.unizh.ch						Achermann JC, 1999, NAT GENET, V22, P125, DOI 10.1038/9629; Biason-Lauber A, 2000, ENDOCRINOLOGY, V141, P1446, DOI 10.1210/en.141.4.1446; CLEMENS JW, 1994, ENDOCRINOLOGY, V134, P1499, DOI 10.1210/en.134.3.1499; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DRACOPOLI NC, 2000, CURRENT PROTOCOLS HU, V3; Hanley NA, 1999, MECH DEVELOP, V87, P175, DOI 10.1016/S0925-4773(99)00123-9; LALA DS, 1992, MOL ENDOCRINOL, V6, P1249, DOI 10.1210/me.6.8.1249; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; Monte D, 1998, J BIOL CHEM, V273, P4585, DOI 10.1074/jbc.273.8.4585; Parker KL, 1999, CELL MOL LIFE SCI, V55, P831, DOI 10.1007/s000180050337; Sehested A, 2000, J CLIN ENDOCR METAB, V85, P1634, DOI 10.1210/jc.85.4.1634	11	164	178	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2000	67	6					1563	1568		10.1086/316893	http://dx.doi.org/10.1086/316893			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	378WE	11038323	Green Published, Bronze			2022-12-18	WOS:000165607600020
J	Annunen, S; Korkko, J; Czarny, M; Warman, ML; Brunner, HG; Kaariainen, H; Mulliken, JB; Tranebjaerg, L; Brooks, DG; Cox, GF; Cruysberg, JR; Curtis, MA; Davenport, SLH; Friedrich, CA; Kaitila, I; Krawczynski, MR; Latos-Bielenska, A; Mukai, S; Olsen, BR; Shinno, N; Somer, M; Vikkula, M; Zlotogora, J; Prockop, DJ; Ala-Kokko, L				Annunen, S; Korkko, J; Czarny, M; Warman, ML; Brunner, HG; Kaariainen, H; Mulliken, JB; Tranebjaerg, L; Brooks, DG; Cox, GF; Cruysberg, JR; Curtis, MA; Davenport, SLH; Friedrich, CA; Kaitila, I; Krawczynski, MR; Latos-Bielenska, A; Mukai, S; Olsen, BR; Shinno, N; Somer, M; Vikkula, M; Zlotogora, J; Prockop, DJ; Ala-Kokko, L			Splicing mutations of 54-bp exons in the COL11A1 gene cause Marshall syndrome, but other mutations cause overlapping Marshall/Stickler phenotypes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SENSITIVE GEL-ELECTROPHORESIS; STICKLER-SYNDROME; XI COLLAGEN; WEISSENBACHER-ZWEYMULLER; PCR PRODUCTS; DISEASES; COL2A1; SUBSTITUTION; CARTILAGE; SPECTRUM	Stickler and Marshall syndromes are dominantly inherited chondrodysplasias characterized by midfacial hypoplasia, high myopia, and sensorineural-hearing deficit. Since the characteristics of these syndromes overlap, it has been argued whether they are distinct entities of different manifestations of a single syndrome. Several mutations causing Stickler syndrome have been found in the COL2A1 gene, and one mutation causing Stickler syndrome and one causing Marshall syndrome have been detected in the COL11A1 gene. We characterize here the genomic structure of the COL11A1 gene. Screening of patients with Stickler, Stickler-like, or Marshall syndrome pointed to 23 novel mutations. Genotypic-phenotypic comparison revealed an association between the Marshall syndrome phenotype and splicing mutations of 54-bp exons in the C-terminal region of the COL11A1 gene. Null-allele mutations in the COL2A1. gene led to a typical phenotype of Stickler syndrome. Some patients, however, presented with phenotypes of both Marshall and Stickler syndromes.	Univ Oulu, Dept Med Biochem, SF-90220 Oulu, Finland; Univ Oulu, Bioctr, Collagen Res Unit, Oulu, Finland; Univ Helsinki, Cent Hosp, Dept Med Genet, Helsinki, Finland; Med Coll Penn & Hahnemann Univ, Ctr Gene Therapy, Philadelphia, PA USA; Univ Penn, Sch Med, Dept Med, Div Med Genet, Philadelphia, PA 19104 USA; Karol Marcinkowski Univ Med Sci, Dept Med Genet, Poznan, Poland; Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; Univ Nijmegen Hosp, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Univ Nijmegen Hosp, Dept Ophthalmol, NL-6500 HB Nijmegen, Netherlands; Massachusetts Eye & Ear Infirm, Boston, MA USA; Harvard Univ, Sch Med, Dept Cell Biol, Cambridge, MA 02138 USA; Harvard Univ, Sch Dent Med, Harvard Forsyth Dept Oral Biol, Boston, MA 02115 USA; Univ Tromso Hosp, Dept Med Genet, N-9012 Tromso, Norway; Univ Arkansas Med Sci, Dept Pediat, Div Clin Genet, Little Rock, AR 72205 USA; Sensory Genet Neuro Dev, Bloomington, MN USA; Kaiser Permanente W, Dept Clin Genet, Los Angeles, CA USA; Christian de Duve Inst, Lab Human Mol Genet, Brussels, Belgium; Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Human Genet, Jerusalem, Israel	University of Oulu; University of Oulu; University of Helsinki; Helsinki University Central Hospital; Drexel University; University of Pennsylvania; Poznan University of Medical Sciences; Case Western Reserve University; Radboud University Nijmegen; Radboud University Nijmegen; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard University; Harvard School of Dental Medicine; UiT The Arctic University of Tromso; University Hospital of North Norway; University of Arkansas System; University of Arkansas Medical Sciences; Kaiser Permanente; Hebrew University of Jerusalem; Hadassah University Medical Center	Ala-Kokko, L (corresponding author), Univ Oulu, Dept Med Biochem, Kajaanintie 52A, SF-90220 Oulu, Finland.		Brunner, Han/C-9928-2013; Cruysberg, Johannes R. M./D-4313-2009; Vikkula, Miikka/Q-1038-2018	Cruysberg, Johannes R. M./0000-0002-5330-0774; Vikkula, Miikka/0000-0002-6236-338X; Krawczynski, Maciej Robert/0000-0002-4268-7707				ALAKOKKO L, 1995, BIOCHEM J, V308, P923, DOI 10.1042/bj3080923; AYME S, 1984, J MED GENET, V21, P34, DOI 10.1136/jmg.21.1.34; BERNARD M, 1988, J BIOL CHEM, V263, P17159; BONAVENTURE J, 1992, HUM GENET, V90, P164; BROWN DM, 1993, AM J HUM GENET, V53, P1133; COHEN MM, 1974, J PEDIATR-US, V85, P878; Eyre D, 1987, STRUCTURE FUNCTION C, P261; FRANCOMANO C A, 1987, Genomics, V1, P293, DOI 10.1016/0888-7543(87)90027-9; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; Griffith AJ, 1998, AM J HUM GENET, V62, P816, DOI 10.1086/301789; Helleday T, 1998, J MOL BIOL, V279, P687, DOI 10.1006/jmbi.1998.1809; HENTHORN PS, 1990, GENOMICS, V6, P226, DOI 10.1016/0888-7543(90)90561-8; Herrmann J, 1975, Birth Defects Orig Artic Ser, V11, P76; Kielty Cay M., 1993, P103; KNOWLTON RG, 1989, AM J HUM GENET, V45, P681; Korkko J, 1998, P NATL ACAD SCI USA, V95, P1681, DOI 10.1073/pnas.95.4.1681; Kuivaniemi H, 1997, HUM MUTAT, V9, P300, DOI 10.1002/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9; MARSHALL D, 1958, AM J OPHTHALMOL, V45, P143, DOI 10.1016/0002-9394(58)90236-8; MAYNE R, 1993, J BIOL CHEM, V268, P9381; O'Donnell J J, 1976, Birth Defects Orig Artic Ser, V12, P299; Pihlajamaa T, 1998, AM J MED GENET, V80, P115, DOI 10.1002/(SICI)1096-8628(19981102)80:2<115::AID-AJMG5>3.0.CO;2-O; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Richards AJ, 1996, HUM MOL GENET, V5, P1339, DOI 10.1093/hmg/5.9.1339; Shanske AL, 1997, AM J MED GENET, V70, P52, DOI 10.1002/(SICI)1096-8628(19970502)70:1<52::AID-AJMG11>3.0.CO;2-W; Sirko-Osadsa D, 1998, J PEDIATR-US, V132, P368, DOI 10.1016/S0022-3476(98)70466-4; SLEPECKY NB, 1992, ACTA OTO-LARYNGOL, V112, P611, DOI 10.3109/00016489209137449; SPRANGER J, 1994, EUR J PEDIATR, V153, P56, DOI 10.1007/BF01959208; STICKLER GB, 1967, MAYO CLIN PROC, V42, P495; STICKLER GB, 1965, MAYO CLIN PROC, V40, P433; STRATTON RF, 1991, AM J MED GENET, V41, P35, DOI 10.1002/ajmg.1320410111; TEMPLE IK, 1989, J MED GENET, V26, P119, DOI 10.1136/jmg.26.2.119; vanSteensel MAM, 1997, AM J MED GENET, V70, P315; VIKKULA M, 1994, ANN MED, V26, P107; VIKKULA M, 1995, CELL, V80, P431, DOI 10.1016/0092-8674(95)90493-X; VINTINER GM, 1991, AM J MED GENET, V41, P44, DOI 10.1002/ajmg.1320410113; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; Williams CJ, 1996, AM J MED GENET, V63, P461, DOI 10.1002/(SICI)1096-8628(19960614)63:3<461::AID-AJMG9>3.0.CO;2-U; WINTER RM, 1983, AM J MED GENET, V16, P189, DOI 10.1002/ajmg.1320160209; ZHIDKOVA NI, 1995, J BIOL CHEM, V270, P9486, DOI 10.1074/jbc.270.16.9486; ZLOTOGORA J, 1992, AM J MED GENET, V42, P337, DOI 10.1002/ajmg.1320420316	40	164	174	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1999	65	4					974	983		10.1086/302585	http://dx.doi.org/10.1086/302585			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	241XW	10486316	Green Published, Bronze			2022-12-18	WOS:000082910000006
J	Boehnke, M; Langefeld, CD				Boehnke, M; Langefeld, CD			Genetic association mapping based on discordant sib pairs: The discordant-alleles test	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HAPLOTYPE-RELATIVE-RISK; LINKAGE DISEQUILIBRIUM; ALZHEIMERS-DISEASE; FAMILIES; LOCI	Family-based tests of association provide the opportunity to test for an association between a disease and a genetic marker. Such tests avoid false-positive results produced by population stratification, so that evidence for association may be interpreted as evidence for linkage or causation. Several methods that use family-based controls have been proposed, including the haplotype relative risk, the transmission-disequilibrium test, and affected family-based controls. However, because these methods require genotypes on affected individuals and their parents, they are not ideally suited to the study of late-onset diseases. In this paper, we develop several family-based tests of association that use discordant sib pairs (DSPs) in which one sib is affected with a disease and the other sib is not. These tests are based on statistics that compare counts of alleles or genotypes or that test for symmetry in tables of alleles or genotypes. We describe the use of a permutation framework to assess the significance of these statistics. These DSP-based tests provide the same general advantages as parent-offspring trio-based tests, while being applicable to essentially any disease; they may also be tailored to particular hypotheses regarding the genetic model. We compare the statistical properties of our DSP-based tests by computer simulation and illustrate their use with an application to Alzheimer disease and the apolipoprotein E polymorphism. Our results suggest that the discordant-alleles test, which compares the numbers of nonmatching alleles in DSPs, is the most powerful of the tests we considered, for a wide class of disease models and marker types. Finally, we discuss advantages and disadvantages of the DSP design for genetic association mapping.	Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Boehnke, M (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Biostat, 1420 Washington Hts, Ann Arbor, MI 48109 USA.	boehnke@umich.edu			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000376, R29HG000376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031153] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00376, HG00040] Funding Source: Medline; NINDS NIH HHS [NS31153] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agresti A., 1990, CATEGORICAL DATA ANA, pXV; BESAG J, 1991, BIOMETRIKA, V78, P301; BOWKER AH, 1948, J AM STAT ASSOC, V43, P572, DOI 10.2307/2280710; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; CLARKE CA, 1956, BRIT MED J, V2, P725, DOI 10.1136/bmj.2.4995.725; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Curtis D, 1997, ANN HUM GENET, V61, P319, DOI 10.1017/S000348009700626X; CURTIS D, 1995, AM J HUM GENET, V56, P811; Efron B, 1993, INTRO BOOTSTRAP, P202; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; KNAPP M, 1993, AM J HUM GENET, V52, P1085; OTT J, 1989, GENET EPIDEMIOL, V6, P127, DOI 10.1002/gepi.1370060124; RISCH N, 1995, SCIENCE, V268, P1584, DOI 10.1126/science.7777857; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; RISCH N, 1987, AM J HUM GENET, V40, P1; Rogus JJ, 1996, AM J HUM GENET, V59, P1376; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Schaid DJ, 1996, GENET EPIDEMIOL, V13, P423, DOI 10.1002/(SICI)1098-2272(1996)13:5<423::AID-GEPI1>3.0.CO;2-3; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; THOMSON G, 1995, AM J HUM GENET, V57, P487; UTERMANN G, 1980, AM J HUM GENET, V32, P339	23	164	178	0	3	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1998	62	4					950	961		10.1086/301787	http://dx.doi.org/10.1086/301787			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZM197	9529345	Green Published, Bronze			2022-12-18	WOS:000073514400027
J	MURRAY, JC				MURRAY, JC			FACE FACTS - GENES, ENVIRONMENT, AND CLEFTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							GROWTH-FACTOR-ALPHA; MATERNAL CIGARETTE-SMOKING; HOMEOBOX GENE; NO EVIDENCE; DEVELOPMENTAL DEFECTS; VANDERWOUDE SYNDROME; SEGREGATION ANALYSIS; TARGETED DISRUPTION; TREACHER-COLLINS; MAJOR LOCUS		UNIV IOWA,COLL MED,IOWA CITY,IA	University of Iowa					NIDCR NIH HHS [DE09170, DE08559] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE008559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE008559, P50DE009170] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ABBOTT BD, 1990, TERATOLOGY, V42, P597, DOI 10.1002/tera.1420420604; ARDINGER HH, 1989, AM J HUM GENET, V45, P348; BEIRAGHI S, 1994, CLIN GENET, V46, P255; BURDICK AB, 1985, J CRAN GENET DEV BIO, V5, P181; CARINCI F, 1995, AM J HUM GENET, V56, P337; CHENEVIXTRENCH G, 1991, AM J HUM GENET, V48, P1012; CHENEVIXTRENCH G, 1992, AM J HUM GENET, V51, P1377; CHISAKA O, 1992, NATURE, V355, P516, DOI 10.1038/355516a0; CHISAKA O, 1991, NATURE, V350, P473, DOI 10.1038/350473a0; CHRISTENSEN K, 1992, AM J HUM GENET, V51, P654; CHUNG CS, 1986, AM J HUM GENET, V39, P603; COLLINS FS, 1995, NAT GENET, V9, P347, DOI 10.1038/ng0495-347; CONDIE BG, 1994, NATURE, V370, P304, DOI 10.1038/370304a0; DAMM K, 1993, P NATL ACAD SCI USA, V909, P2989; DAVIES AF, 1995, HUM MOL GENET, V4, P121; Dixon Michael J., 1992, Human Molecular Genetics, V1, P249, DOI 10.1093/hmg/1.4.249; DIXON MJ, 1991, ANAT EMBRYOL, V184, P83, DOI 10.1007/BF01744264; DOLLE P, 1992, DIFFERENTIATION, V49, P93, DOI 10.1111/j.1432-0436.1992.tb00773.x; DRISCOLL DA, 1992, AM J MED GENET, V44, P261, DOI 10.1002/ajmg.1320440237; EIBERG H, 1987, CLIN GENET, V32, P129; FARRALL M, 1992, AM J HUM GENET, V50, P270; FARRALL M, 1993, AM J HUM GENET, V52, P434; FENG HS, 1994, AM J HUM GENET, V55, P932; FERGUSON MWJ, 1988, DEVELOPMENT, V103, P41; Field L. Leigh, 1994, European Journal of Human Genetics, V2, P159; Fogh-Andersen, 1942, INHERITANCE HARELIP; FRANCOMANO C A, 1987, Genomics, V1, P293, DOI 10.1016/0888-7543(87)90027-9; FRASER FC, 1970, AM J HUM GENET, V22, P336; GASSER DL, 1991, J CRAN GENET DEV BIO, V11, P366; Gorlin RJ, 1990, PLAST RECONSTR SURG; HANSON JW, 1989, J PEDIATR, V4, P662; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; Healey S. C., 1994, American Journal of Human Genetics, V55, pA47; HECHT JT, 1993, AM J HUM GENET, V52, P1230; HECHT JT, 1991, AM J HUM GENET, V49, P674; HECHT JT, 1991, AM J HUM GENET, V49, P682; HECHT JT, 1992, AM J HUM GENET, V51, P442; HODGE SE, 1993, AM J HUM GENET, V53, P367; HOLDER SE, 1992, J MED GENET, V29, P390, DOI 10.1136/jmg.29.6.390; HOLLISTER DW, 1990, NEW ENGL J MED, V323, P152, DOI 10.1056/NEJM199007193230303; HWANG SJ, 1995, AM J EPIDEMIOL, V141, P629, DOI 10.1093/oxfordjournals.aje.a117478; JARA L, 1995, AM J HUM GENET, V56, P339; JONES KL, 1973, LANCET, V1, P1267; JONES MC, 1988, CLEFT PALATE J, V25, P16; JURILOFF DM, 1995, MAMM GENOME, V6, P63, DOI 10.1007/BF00303246; KAROLYI J, 1993, J CRAN GENET DEV BIO, V13, P1; KHOURY MJ, 1989, AM J DIS CHILD, V143, P333, DOI 10.1001/archpedi.1989.02150150091023; KOTCH LE, 1992, AM J MED GENET, V44, P168, DOI 10.1002/ajmg.1320440210; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; KURIHARA Y, 1994, NATURE, V368, P703, DOI 10.1038/368703a0; LALLIER T, 1993, SCIENCE, V259, P692, DOI 10.1126/science.8430321; LAMMER EJ, 1985, NEW ENGL J MED, V313, P837, DOI 10.1056/NEJM198510033131401; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LETTERIO JJ, 1994, SCIENCE, V264, P1936, DOI 10.1126/science.8009224; LUETTEKE NC, 1993, CELL, V73, P263, DOI 10.1016/0092-8674(93)90228-I; LUFKIN T, 1993, P NATL ACAD SCI USA, V90, P7225, DOI 10.1073/pnas.90.15.7225; MARAZITA ML, 1992, AM J HUM GENET, V51, P648; MELNICK M, 1992, AM J MED GENET, V42, P10, DOI 10.1002/ajmg.1320420104; MITCHELL LE, 1992, AM J HUM GENET, V51, P323; MOORE GE, 1987, NATURE, V326, P91, DOI 10.1038/326091a0; MUENKE M, 1994, P NATL ACAD SCI USA, V91, P8102, DOI 10.1073/pnas.91.17.8102; MURRAY JC, 1990, AM J HUM GENET, V46, P486; NAKATSU Y, 1993, NATURE, V364, P448, DOI 10.1038/364448a0; SASSANI R, 1993, AM J MED GENET, V45, P565, DOI 10.1002/ajmg.1320450508; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; SHAW D, 1993, AM J HUM GENET, V53, P1156; SHIANG R, 1993, AM J HUM GENET, V53, P836; STEIN J, 1995, AM J HUM GENET, V57, P257; STEIN JD, 1995, J MED GENET, V32, P78, DOI 10.1136/jmg.32.1.78; STOLL C, 1992, AM J HUM GENET, V50, P870; STUDER M, 1994, SCIENCE, V265, P1728, DOI 10.1126/science.7916164; SULIK KK, 1989, CLEFT PALATE J, V26, P209; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; TOLAROVA M, 1982, LANCET, V2, P217; TYAN ML, 1993, P SOC EXP BIOL MED, V202, P482, DOI 10.3181/00379727-202-43563; VINTINER GM, 1992, J MED GENET, V29, P393, DOI 10.1136/jmg.29.6.393; VINTINER GM, 1993, J MED GENET, V30, P773, DOI 10.1136/jmg.30.9.773; WAKASUGI S, 1988, DEV GENET, V9, P203, DOI 10.1002/dvg.1020090306; Warkany J, 1943, AM J DIS CHILD, V65, P882, DOI 10.1001/archpedi.1943.02010180058007; WERLER MM, 1990, AM J EPIDEMIOL, V132, P926, DOI 10.1093/oxfordjournals.aje.a115735	80	164	173	0	8	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1995	57	2					227	232		10.2134/agronj1965.00021962005700020028x	http://dx.doi.org/10.2134/agronj1965.00021962005700020028x			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RL771	7668246				2022-12-18	WOS:A1995RL77100003
J	CARMELLI, D; CARDON, LR; FABSITZ, R				CARMELLI, D; CARDON, LR; FABSITZ, R			CLUSTERING OF HYPERTENSION, DIABETES, AND OBESITY IN ADULT MALE TWINS - SAME GENES OR SAME ENVIRONMENTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL DYSLIPIDEMIC HYPERTENSION; CORONARY HEART-DISEASE; INSULIN RESISTANCE; RISK-FACTORS; CARDIOVASCULAR RISK; GLUCOSE-INTOLERANCE; ADIPOSE-TISSUE; BODY-FAT; CONCORDANCE; METABOLISM	We investigated the mediating role of genetic factors in the clustering of hypertension, diabetes, and obesity, using the twin registry maintained by the National Academy of Sciences-National Research Council. The study sample included 2,508 male twin pairs born between 1917 and 1927 who responded to a mailed questionnaire that covered demographic variables, cardiovascular risk factors, and health behaviors. The incidence of hypertension and diabetes in this cohort was ascertained from subjects' self-report of a physician diagnosis and/or the use of prescription medications. The body-mass index calculated from self-reports of height and weight was used as a measure of obesity. Descriptive analyses indicated probandwise concordance rates of 34.0%, 31.2%, and 32.7%, respectively, for the joint occurrences of hypertension and diabetes, hypertension and obesity, and diabetes and obesity in MZ twin pairs. Corresponding concordance rates in DZ twin pairs were 8.1%, 14.9%, and 2.8%. The probandwise concordance for the clustering of all three conditions in the same individuals was 31.6% in MZ pairs and 6.3% in DZ pairs (relative risk 5.0; chi(2)(1)=2.6; P<.15). Multivariate genetic modeling of the correlation in liabilities to develop these conditions suggested the presence of a common latent factor mediating the clustering of hypertension, diabetes, and obesity in this twin sample. This common factor was influenced by both genetic and environmental effects (59% genetic, 41% environmental). The genetic influences on the common latent factor were due to dominant rather than additive sources; the environmental influences appeared to be specific rather than shared by co-twins.	NHLBI,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	CARMELLI, D (corresponding author), SRI INT,HLTH SCI PROGRAM,333 RAVENSWOOD AVE,MENLO PK,CA 94025, USA.				NHLBI NIH HHS [HL 46115] Funding Source: Medline; NIAAA NIH HHS [ADAMHA AA08925] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R03HL046115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA008925] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; BJORNTORP P, 1990, ARTERIOSCLEROSIS, V10, P493, DOI 10.1161/01.ATV.10.4.493; BOUCHARD C, 1988, INT J OBESITY, V12, P205; BRINDLEY DN, 1989, CLIN SCI, V77, P453, DOI 10.1042/cs0770453; CARMELLI D, 1994, J HYPERTENS, V12, P323; CEDERLOEF R, 1961, ACTA GENET STAT MED, V11, P338; CEDERLOF R, 1978, TWIN RES C, P189; FABSITZ RR, 1992, INT J OBESITY, V16, P657; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; FERRANNINI E, 1991, AM HEART J, V121, P1274, DOI 10.1016/0002-8703(91)90433-I; FERRANNINI E, 1990, J HYPERTENS, V8, pS169; FRAYN KN, 1992, CLIN SCI, V82, P1, DOI 10.1042/cs0820001; GILLUM RF, 1987, J CHRON DIS, V40, P421, DOI 10.1016/0021-9681(87)90175-5; HRUBEC Z, 1978, TWIN RES B, P153; HUNT SC, 1989, ARTERIOSCLEROSIS, V9, P335, DOI 10.1161/01.ATV.9.3.335; HVARFNER A, 1988, J HYPERTENS, V6, P71; JABLON S, 1967, AM J HUM GENET, V19, P133; JORESKOG K, 1988, PRELIS PREPROCESSOR; Joreskog K.G., 1989, LISREL 7 GUIDE PROGR; KAPLAN NM, 1989, ARCH INTERN MED, V149, P1514, DOI 10.1001/archinte.149.7.1514; KAPRIO J, 1978, TWIN RES BIOL EPIDEM, P179; KENDLER KS, 1992, JAMA-J AM MED ASSOC, V268, P1877, DOI 10.1001/jama.268.14.1877; LAASKO M, 1989, EUR J CLIN INVEST, V19, P518; LAWS A, 1991, Annals of Behavioral Medicine, V13, P125; LILLIOJA S, 1987, DIABETES, V36, P1329, DOI 10.2337/diabetes.36.11.1329; MARTIN NG, 1978, HEREDITY, V40, P97, DOI 10.1038/hdy.1978.10; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; MITCHELL BD, 1990, AM J EPIDEMIOL, V131, P423, DOI 10.1093/oxfordjournals.aje.a115517; MODAN M, 1985, J CLIN INVEST, V75, P809, DOI 10.1172/JCI111776; NATALI A, 1991, HYPERTENSION, V17, P170, DOI 10.1161/01.HYP.17.2.170; Neale M.C.C.L., 2013, METHODOLOGY GENETIC, V67, DOI DOI 10.1007/978-94-015-8018-2; NEWMAN B, 1987, DIABETOLOGIA, V30, P763; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; SELBY JV, 1991, JAMA-J AM MED ASSOC, V265, P2079, DOI 10.1001/jama.265.16.2079; SMITH C, 1974, AM J HUM GENET, V26, P454; WILLIAMS RR, 1988, JAMA-J AM MED ASSOC, V259, P3579, DOI 10.1001/jama.259.24.3579; WILLIAMS RR, 1989, J HYPERTENS, V7, pS8, DOI 10.1097/00004872-198900076-00003	37	164	172	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1994	55	3					566	573						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PF509	8079995				2022-12-18	WOS:A1994PF50900018
J	LAMY, M; DEGROUCHY, J; SCHWEISGUTH, O				LAMY, M; DEGROUCHY, J; SCHWEISGUTH, O			GENETIC AND NON-GENETIC FACTORS IN THE ETIOLOGY OF CONGENITAL HEART DISEASE - STUDY OF 1188 CASES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ABBOUD M A, 1953, Arch Pediatr, V70, P294; ALBAUGH CH, 1945, JAMA-J AM MED ASSOC, V129, P719, DOI 10.1001/jama.1945.02860450005002; ALZAMORA V, 1953, PEDIATRICS, V12, P259; ANDERSON RC, 1954, PEDIATRICS, V14, P143; ANDERSON RC, 1956, COMMUNICATION; ARAKI B, 1935, NAGASAKI IGAKKAI ZAS, V13, P1700; BENESOVA D, 1954, J PATHOL BACTERIOL, V67, P367, DOI 10.1002/path.1700670210; BERTOYE P, 1952, J Med Lyon, V33, P391; BOLAND S J, 1952, J Ir Med Assoc, V30, P7; NIKOLOWSKI W, 1954, Z Haut Geschlechtskr, V17, P129; BRUYNE JID, 1952, MAANDSCHRIFT KINDERG, V20, P308; BUCK C, 1955, Can Med Assoc J, V72, P744; BUSH JA, 1955, PEDIATRICS, V15, P93; CARRUTHERS D. G., 1945, Medical Journal of Australia, V1, P315; COBLENTZ B, 1952, Arch Mal Coeur Vaiss, V45, P490; Cockayne EA, 1938, Q J MED, V7, P479; CONTE WR, 1945, AM J DIS CHILD, V70, P301; CORTESE L, 1955, Minerva Nipiol, V5, P21; DEMIRAG B, 1951, Ann Paediatr, V177, P187; DOOLITTLE WF, 1940, CITED INDIRECTLY; EVANS PR, 1950, BRIT HEART J, V12, P258; FALLOT A, 1888, MARSEILLE MED, V25, P341; FALLOT A, 1888, MARSEILLE MED, V25, P403; FALLOT A, 1888, MARSEILLE MED, V25, P138; FALLOT A, 1888, MARSEILLE MED, V25, P270; FALLOT A, 1888, MARSEILLE MED, V25, P207; Fallot ELA., 1888, MARSEILLE MEDICAL, V25, P403; GANSSLEN M, 1940, HDB ERBBIOLOGIE MENS, V4, P198; GOLDMAN IR, 1952, AM HEART J, V44, P159, DOI 10.1016/0002-8703(52)90185-3; GRANATA G, 1952, Pediatria (Napoli), V60, P281; GREAVES JL, 1954, ARCH DIS CHILD, V29, P447, DOI 10.1136/adc.29.147.447; Gregg NM, 1941, T OPHTHALMOL SOC AUS, V3, P35; HELWEGLARSEN HF, 1947, ANN EUGENIC, V14, P1; HELWEGLARSEN HF, 1948, OPERA DOMO BIOL HERE, V18; JEUNE M, 1948, ARCH FRANC PEDIAT, V5, P252; Kean BH, 1942, J HERED, V33, P217, DOI 10.1093/oxfordjournals.jhered.a105172; KJAERGAARD H, 1946, ACTA MED SCAND, V125, P339; KRUGMAN S, 1954, J PEDIATR-US, V44, P489, DOI 10.1016/S0022-3476(54)80334-9; KUYJER PJ, 1954, PRESSE MED, V62, P199; LAMY M., 1948, ANN PAEDIATR, V171, P245; LAMY M, 1951, 13E C PED LANG FR AL; LAMY M, 1947, ACTA PEDIATRICI, V36, P689; LANDAUER W, 1952, ANN NY ACAD SCI, V55, P172, DOI 10.1111/j.1749-6632.1952.tb26532.x; LANDTMAN B, 1948, ARCH DIS CHILD, V23, P237, DOI 10.1136/adc.23.116.237; LELORIER G, 1955, MATERNITE PARIS  FEV, P47; Lerner IM, 1954, GENETIC HOMEOSTASIS; LOGAN WPD, 1951, BMJ-BRIT MED J, V2, P641, DOI 10.1136/bmj.2.4732.641; LOWE CR, 1954, ANN EUGENIC, V18, P267; LOWYS P, 1955, J Fr Med Chir Thorac, V9, P34; MacMahon B, 1952, BR J SOC MED, V6, P178; MCCLINTOCK K, 1945, ARCH DIS CHILD, V20, P47, DOI 10.1136/adc.20.101.47; MCKEOWN T, 1953, BRIT HEART J, V15, P273; MORISON JE, 1949, ARCH DIS CHILD, V24, P214, DOI 10.1136/adc.24.119.214; MURPHY DP, 1947, CONGENITAL MALFORMAT; OWEN RH, 1951, BRIT J RADIOL, V24, P398, DOI 10.1259/0007-1285-24-283-398; PEZZI C, 1924, CUORE CIRC, V8, P361; POLANI P. E., 1955, ANN HUMAN GENETICS, V19, P209, DOI 10.1111/j.1469-1809.1955.tb01345.x; Reese AB, 1944, AM J OPHTHALMOL, V27, P483; REINHARDT C, 1912, DEUT MIL ARZTL Z, V41, P932; RICHARDS MR, 1955, PEDIATRICS, V15, P12; RONES B, 1944, AM J OPHTHALMOL, V27, P483; RUTSTEIN DD, 1952, AMA AM J DIS CHILD, V84, P199, DOI 10.1001/archpedi.1952.02050020063007; SAWIN PB, 1949, ANAT REC, V105, P377, DOI 10.1002/ar.1091050302; SAWIN PB, 1947, J EXP ZOOL, V105, P173; SCHWEISGUTH O, 1952, RECUEIL TRAVAUX I NA, V2; STEIN I, 1945, AM HEART J, V30, P118, DOI 10.1016/0002-8703(45)90002-0; SWAN C., 1943, Medical Journal of Australia, V2, P201; Swan CT, 1944, MED J AUSTRALIA, V1, P409; TORGERSEN J, 1948, J HERED, V39, P293, DOI 10.1093/oxfordjournals.jhered.a105772; TUCKER AW, 1945, AM HEART J, V30, P54, DOI 10.1016/0002-8703(45)90078-0; TUMAY S B, 1952, Arch Fr Pediatr, V9, P1027; TYLER FH, 1953, AM J MED, V15, P421, DOI 10.1016/0002-9343(53)90127-2; VULLIAMY D G, 1953, Proc R Soc Med, V46, P279; WADE G, 1952, BRIT HEART J, V14, P475; WALLACE HM, 1956, AMA J DIS CHILD, V91, P529, DOI 10.1001/archpedi.1956.02060020531002; WOLF J, 1955, BMJ-BRIT MED J, V4908, P269	76	164	164	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1957	9	1					17	41						25	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA214	13410899				2022-12-18	WOS:A1957WA21400003
J	Limaye, N; Kangas, J; Mendola, A; Godfraind, C; Schlogel, MJ; Helaers, R; Eklund, L; Boon, LM; Vikkula, M				Limaye, Nisha; Kangas, Jaakko; Mendola, Antonella; Godfraind, Catherine; Schlogel, Matthieu J.; Helaers, Raphael; Eklund, Lauri; Boon, Laurence M.; Vikkula, Miikka			Somatic Activating PIK3CA Mutations Cause Venous Malformation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LYMPHATIC ENDOTHELIAL-CELLS; GENE; OVERGROWTH; DIAGNOSIS; PI3K	Somatic mutations in TEK, the gene encoding endothelial cell tyrosine kinase receptor TIE2, cause more than half of sporadically occurring unifocal venous malformations (VMs). Here, we report that somatic mutations in PIK3CA, the gene encoding the catalytic p110 alpha subunit of PI3K, cause 54% (27 out of 50) of VMs with no detected TEK mutation. The hotspot mutations c.1624G>A, c.1633G>A, and c.3140A>G (p.Glu542Lys, p.Glu545Lys, and p.His1047Arg), frequent in PIK3CA-associated cancers, overgrowth syndromes, and lymphatic malformation (LM), account for >92% of individuals who carry mutations. Like VM-causative mutations in TEK, the PIK3CA mutations cause chronic activation of AKT, dysregulation of certain important angiogenic factors, and abnormal endothelial cell morphology when expressed in human umbilical vein endothelial cells (HUVECs). The p110 alpha-specific inhibitor BYL719 restores all abnormal phenotypes tested, in PIK3CA- as well as TEK-mutant HUVECs, demonstrating that they operate via the same pathogenic pathways. Nevertheless, significant genotype-phenotype correlations in lesion localization and histology are observed between individuals with mutations in PIK3CA versus TEK, pointing to gene-specific effects.	[Limaye, Nisha; Mendola, Antonella; Schlogel, Matthieu J.; Helaers, Raphael; Boon, Laurence M.; Vikkula, Miikka] Catholic Univ Louvain, Duve Inst, Human Mol Genet, B-1200 Brussels, Belgium; [Kangas, Jaakko; Eklund, Lauri] Univ Oulu, Bioctr Oulu, Fac Biochem & Mol Med, Oulu Ctr Cell Matrix Res, Oulu 90014, Finland; [Godfraind, Catherine] Univ Auvergne, Clermont Univ, F-63000 Clermont Ferrand, France; [Godfraind, Catherine] CHU Clermont Ferrand, Serv Anatomopathol, Hop Gabriel Montpied, F-63000 Clermont Ferrand, France; [Boon, Laurence M.] Clin Univ St Luc, Ctr Vasc Anomalies, Div Plast Surg, B-1200 Brussels, Belgium; [Boon, Laurence M.] Catholic Univ Louvain, B-1200 Brussels, Belgium	Universite Catholique Louvain; University of Oulu; Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain	Vikkula, M (corresponding author), Catholic Univ Louvain, Duve Inst, Human Mol Genet, B-1200 Brussels, Belgium.	miikka.vikkula@uclouvain.be	Vikkula, Miikka/Q-1038-2018; Boon, Laurence/HCI-3629-2022	Vikkula, Miikka/0000-0002-6236-338X; Helaers, Raphael/0000-0002-7046-7867; Kangas, Jaakko/0000-0001-5474-0985	Belgian Science Policy Office Interuniversity Attraction Poles (BELSPO-IAP) program [IAP P7/43-BeMGI]; National Institutes of Health [P01 AR048564]; Fonds de la Recherche Scientifique (FRS-FNRS) [T.0026.14]; Academy of Finland [136880]; Academy of Finland (Centre of Excellence Program); la Communaute Francaise de Wallonie-Bruxelles; la Lotterie Nationale, Belgium; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR048564] Funding Source: NIH RePORTER	Belgian Science Policy Office Interuniversity Attraction Poles (BELSPO-IAP) program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds de la Recherche Scientifique (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); Academy of Finland(Academy of Finland); Academy of Finland (Centre of Excellence Program)(Academy of Finland); la Communaute Francaise de Wallonie-Bruxelles; la Lotterie Nationale, Belgium; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are grateful to all the participants and their family members. These studies were partially supported by funding from the Belgian Science Policy Office Interuniversity Attraction Poles (BELSPO-IAP) program through the project IAP P7/43-BeMGI; the National Institutes of Health, Program Project P01 AR048564 (both to M.V.); the Fonds de la Recherche Scientifique (FRS-FNRS) under Grant T.0026.14 (to M.V.); and the Academy of Finland (136880 and Centre of Excellence Program 2012-2017 to L.E.). We also thank la Communaute Francaise de Wallonie-Bruxelles and la Lotterie Nationale, Belgium for their support. N.L. is a "Chercheur Qualifie du FRS-FNRS." We thank the genetics platform of Universite Catholique de Louvain for access to the IonTorrent Next Generation Sequencer. The authors thank Ms. Liliana Niculescu for secretarial help.	Boscolo E, 2015, J CLIN INVEST, V125, P3491, DOI 10.1172/JCI76004; Boscolo E, 2015, ANGIOGENESIS, V18, P151, DOI 10.1007/s10456-014-9453-2; Dompmartin A, 2010, PHLEBOLOGY, V25, P224, DOI 10.1258/phleb.2009.009041; Dompmartin A, 2008, ARCH DERMATOL, V144, P873, DOI 10.1001/archderm.144.7.873; Dompmartin A, 2009, ARCH DERMATOL, V145, P1239, DOI 10.1001/archdermatol.2009.296; Furet P, 2013, BIOORG MED CHEM LETT, V23, P3741, DOI 10.1016/j.bmcl.2013.05.007; Graupera M, 2008, NATURE, V453, P662, DOI 10.1038/nature06892; Keppler-Noreuil KM, 2014, AM J MED GENET A, V164, P1713, DOI 10.1002/ajmg.a.36552; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kurek KC, 2012, AM J HUM GENET, V90, P1108, DOI 10.1016/j.ajhg.2012.05.006; Lee JH, 2012, NAT GENET, V44, P941, DOI 10.1038/ng.2329; Limaye N, 2009, NAT GENET, V41, P118, DOI 10.1038/ng.272; Lindhurst MJ, 2012, NAT GENET, V44, P928, DOI 10.1038/ng.2332; Luks VL, 2015, J PEDIATR-US, V166, P1048, DOI 10.1016/j.jpeds.2014.12.069; Maclellan RA, 2014, PLAST RECONSTR SURG, V133, p12E, DOI 10.1097/01.prs.0000436822.26709.7c; Natynki M, 2015, HUM MOL GENET, V24, P6374, DOI 10.1093/hmg/ddv349; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Osborn AJ, 2015, HUM MOL GENET, V24, P926, DOI 10.1093/hmg/ddu505; Rios JJ, 2013, HUM MOL GENET, V22, P444, DOI 10.1093/hmg/dds440; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Samuels Y, 2011, CURR TOP MICROBIOL, V347, P21, DOI 10.1007/82_2010_68; Soblet J, 2013, MOL SYNDROMOL, V4, P179, DOI 10.1159/000348327; Thorpe LM, 2015, NAT REV CANCER, V15, P7, DOI 10.1038/nrc3860; Uebelhoer M, 2013, HUM MOL GENET, V22, P3438, DOI 10.1093/hmg/ddt198; Vikkula M, 1996, CELL, V87, P1181, DOI 10.1016/S0092-8674(00)81814-0; Wouters V, 2010, EUR J HUM GENET, V18, P414, DOI 10.1038/ejhg.2009.193; Wu XY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5961	28	163	173	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2015	97	6					914	921		10.1016/j.ajhg.2015.11.011	http://dx.doi.org/10.1016/j.ajhg.2015.11.011			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DB3UM	26637981	Bronze, Green Published			2022-12-18	WOS:000368437900014
J	Kleefstra, T; Kramer, JM; Neveling, K; Willemsen, MH; Koemans, TS; Vissers, LELM; Wissink-Lindhout, W; Fenckova, M; van den Akker, WMR; Kasri, NN; Nillesen, WM; Prescott, T; Clark, RD; Devriendt, K; van Reeuwijk, J; de Brouwer, APM; Gilissen, C; Zhou, HQ; Brunner, HG; Veltman, JA; Schenck, A; van Bokhoven, H				Kleefstra, Tjitske; Kramer, Jamie M.; Neveling, Kornelia; Willemsen, Marjolein H.; Koemans, Tom S.; Vissers, Lisenka E. L. M.; Wissink-Lindhout, Willemijn; Fenckova, Michaela; van den Akker, Willem M. R.; Kasri, Nael Nadif; Nillesen, Willy M.; Prescott, Trine; Clark, Robin D.; Devriendt, Koenraad; van Reeuwijk, Jeroen; de Brouwer, Arjan P. M.; Gilissen, Christian; Zhou, Huiqing; Brunner, Han G.; Veltman, Joris A.; Schenck, Annette; van Bokhoven, Hans			Disruption of an EHMT1-Associated Chromatin-Modification Module Causes Intellectual Disability	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACTIVATING SIGNAL COINTEGRATOR-2; NUCLEAR RECEPTOR; TRANSCRIPTIONAL COACTIVATOR; HISTONE METHYLTRANSFERASES; SWI/SNF COMPLEX; GENE-EXPRESSION; MUTATIONS; BINDING; IDENTIFICATION; METHYLATION	Intellectual disability (ID) disorders are genetically and phenotypically highly heterogeneous and present a major challenge in clinical genetics and medicine. Although many genes involved in ID have been identified, the etiology is unknown in most affected individuals. Moreover, the function of most genes associated with ID remains poorly characterized. Evidence is accumulating that the control of gene transcription through epigenetic modification of chromatin structure in neurons has an important role in cognitive processes and in the etiology of ID. However, our understanding of the key molecular players and mechanisms in this process is highly fragmentary. Here, we identify a chromatin-modification module that underlies a recognizable form of ID, the Kleefstra syndrome phenotypic spectrum (KSS). In a cohort of KSS individuals without mutations in EHMT1 (the only gene known to be disrupted in KSS until now), we identified de novo mutations in four genes, MBD5, MLL3, SMARCB1, and NR1I3, all of which encode epigenetic regulators. Using Drosophila, we demonstrate that MBD5, MLL3, and NR1I3 cooperate with EHMT1, whereas SMARCB1 is known to directly interact with MLL3. We propose a highly conserved epigenetic network that underlies cognition in health and disease. This network should allow the design of strategies to treat the growing group of ID pathologies that are caused by epigenetic defects.	[Kleefstra, Tjitske; Kramer, Jamie M.; Neveling, Kornelia; Willemsen, Marjolein H.; Koemans, Tom S.; Vissers, Lisenka E. L. M.; Wissink-Lindhout, Willemijn; Fenckova, Michaela; van den Akker, Willem M. R.; Nillesen, Willy M.; van Reeuwijk, Jeroen; de Brouwer, Arjan P. M.; Gilissen, Christian; Zhou, Huiqing; Brunner, Han G.; Veltman, Joris A.; Schenck, Annette; van Bokhoven, Hans] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Kleefstra, Tjitske; Neveling, Kornelia; Willemsen, Marjolein H.; Vissers, Lisenka E. L. M.; Gilissen, Christian; Brunner, Han G.; Veltman, Joris A.] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis, NL-6500 HB Nijmegen, Netherlands; [Kleefstra, Tjitske; Kramer, Jamie M.; Neveling, Kornelia; Willemsen, Marjolein H.; Koemans, Tom S.; Vissers, Lisenka E. L. M.; Fenckova, Michaela; van den Akker, Willem M. R.; Kasri, Nael Nadif; van Reeuwijk, Jeroen; de Brouwer, Arjan P. M.; Gilissen, Christian; Zhou, Huiqing; Brunner, Han G.; Veltman, Joris A.; Schenck, Annette; van Bokhoven, Hans] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Kramer, Jamie M.; Koemans, Tom S.; Fenckova, Michaela; van den Akker, Willem M. R.; Kasri, Nael Nadif; de Brouwer, Arjan P. M.; Schenck, Annette; van Bokhoven, Hans] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, NL-6500 HE Nijmegen, Netherlands; [Kasri, Nael Nadif] Radboud Univ Nijmegen, Med Ctr, Dept Cognit Neurosci, NL-6500 HB Nijmegen, Netherlands; [Prescott, Trine] Oslo Univ Hosp, Dept Med Genet, N-0424 Oslo, Norway; [Clark, Robin D.] Loma Linda Univ, Div Med Genet, Dept Pediat, Sch Med, Loma Linda, CA 92354 USA; [Devriendt, Koenraad] Univ Louvain, Ctr Human Genet, B-3000 Louvain, Belgium; [Zhou, Huiqing] Radboud Univ Nijmegen, Fac Sci, Dept Mol Dev Biol, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Oslo; Loma Linda University; Radboud University Nijmegen	Kleefstra, T (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, POB 9101, NL-6500 HB Nijmegen, Netherlands.	t.kleefstra@gen.umcn.nl; a.schenck@gen.umcn.nl	Veltman, Joris A/F-5128-2010; Schenck, Annette/E-4514-2012; Willemsen, Marjolein/G-9491-2013; Gilissen, Christian/E-5246-2012; van Reeuwijk, Jeroen/P-8665-2015; Nadif Kasri, Nael/E-2270-2012; Willemsen, Marjolein/R-5958-2019; Bokhoven, J.H.L.M. van van/H-8015-2014; Vissers, Lisenka ELM/A-2598-2015; Kleefstra, Tjitske/G-2619-2012; Neveling, K./L-4544-2015; Brunner, Han/C-9928-2013; Zhou, Huiqing/B-1721-2013; Fenckova, Michaela/AGY-9276-2022; van Bokhoven, Hans/D-8764-2012; de Brouwer, Arjan PM/P-5949-2015; Fenckova, Michaela/H-8622-2017	Veltman, Joris A/0000-0002-3218-8250; Schenck, Annette/0000-0002-6918-3314; Gilissen, Christian/0000-0003-1693-9699; van Reeuwijk, Jeroen/0000-0002-0658-4399; Nadif Kasri, Nael/0000-0002-7448-9289; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Vissers, Lisenka ELM/0000-0001-6470-5497; Zhou, Huiqing/0000-0002-2434-3986; Fenckova, Michaela/0000-0002-5716-1652; Fenckova, Michaela/0000-0002-5716-1652; Kramer, Jamie/0000-0002-0924-1279; van den Akker, Willem M.R./0000-0001-9492-4359	EU FP7 Large-Scale Integrating Project Genetic and Epigenetic Networks in Cognitive Dysfunction [241995]; EU FP7 project TECHGENE [223143]; Hersenstichting Nederland [2009 [1]-122]; ZonMw (Zorg Onderzoek Nederland) [990700365]; Netherlands Organization for Scientific Research Vidi grant [917-96-346]; Department of Human Genetics, Nijmegen	EU FP7 Large-Scale Integrating Project Genetic and Epigenetic Networks in Cognitive Dysfunction; EU FP7 project TECHGENE; Hersenstichting Nederland; ZonMw (Zorg Onderzoek Nederland)(Netherlands Organization for Health Research and Development); Netherlands Organization for Scientific Research Vidi grant; Department of Human Genetics, Nijmegen	We thank all family members who participated in this study. We would also like to thank the Bloomington Drosophila Stock Center and the Vienna Drosophila RNAi Center for providing fly stocks. We are grateful to Martijn Huynen for bioinformatics analyses and discussions. This project was supported by the EU FP7 Large-Scale Integrating Project Genetic and Epigenetic Networks in Cognitive Dysfunction (241995 to A.S. and H.v.B.), the EU FP7 project TECHGENE (grant agreement 223143 to J.A.V.), the grant from Hersenstichting Nederland (2009 [1]-122 to T. Kleefstra), the ZonMw (Zorg Onderzoek Nederland) Clinical Fellowship (990700365 to T. Kleefstra), and a Netherlands Organization for Scientific Research Vidi grant (917-96-346) to A.S. Next-generation-sequencing experiments were financially supported by the Department of Human Genetics, Nijmegen.	Bi WM, 2004, HUM GENET, V115, P515, DOI 10.1007/s00439-004-1187-6; Bier E, 2005, NAT REV GENET, V6, P9, DOI 10.1038/nrg1503; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bredrup C, 2011, AM J HUM GENET, V89, P634, DOI 10.1016/j.ajhg.2011.10.001; Choi E, 2005, MOL ENDOCRINOL, V19, P1711, DOI 10.1210/me.2005-0066; Christiaans I, 2011, J MED GENET, V48, P93, DOI 10.1136/jmg.2010.082420; Cobb S, 2010, BIOCHEM SOC T, V38, P498, DOI 10.1042/BST0380498; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; Darvekar S, 2012, BIOCHEM J, V442, P65, DOI 10.1042/BJ20111230; Day JJ, 2011, NEURON, V70, P813, DOI 10.1016/j.neuron.2011.05.019; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Ding N, 2008, MOL CELL, V31, P347, DOI 10.1016/j.molcel.2008.05.023; Dutheil F, 2009, DRUG METAB DISPOS, V37, P1528, DOI 10.1124/dmd.109.027011; Eaton KW, 2011, PEDIATR BLOOD CANCER, V56, P7, DOI 10.1002/pbc.22831; Goo YH, 2003, MOL CELL BIOL, V23, P140, DOI 10.1128/MCB.23.1.140-149.2003; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Hadfield KD, 2008, J MED GENET, V45, P332, DOI 10.1136/jmg.2007.056499; Hoischen A, 2010, HUM MUTAT, V31, P492, DOI 10.1002/humu.21221; Huang HS, 2012, NATURE, V481, P185, DOI 10.1038/nature10726; Inlow JK, 2004, GENETICS, V166, P835, DOI 10.1534/genetics.166.2.835; Jaillard S, 2009, J MED GENET, V46, P847, DOI 10.1136/jmg.2008.058156; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Jyrkkarinne J, 2003, J MED CHEM, V46, P4687, DOI 10.1021/jm030861t; Kleefstra T, 2009, J MED GENET, V46, P598, DOI 10.1136/jmg.2008.062950; Kleefstra T, 2006, AM J HUM GENET, V79, P370, DOI 10.1086/505693; Kramer JM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000569; Lacombe A, 2006, AM J HUM GENET, V79, P113, DOI 10.1086/505406; Laget S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011982; Laporte J, 2003, HUM MOL GENET, V12, pR285, DOI 10.1093/hmg/ddg273; Lee S, 2009, MOL ENDOCRINOL, V23, P610, DOI 10.1210/me.2008-0455; Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118; McBride SMJ, 2005, NEURON, V45, P753, DOI 10.1016/j.neuron.2005.01.038; Nishimura Masuhiro, 2004, Drug Metab Pharmacokinet, V19, P135, DOI 10.2133/dmpk.19.135; Risheg H, 2007, NAT GENET, V39, P451, DOI 10.1038/ng1992; Ropers HH, 2010, ANNU REV GENOM HUM G, V11, P161, DOI 10.1146/annurev-genom-082509-141640; Rousseau G, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-9; Santen GWE, 2012, NAT GENET, V44, P379, DOI 10.1038/ng.2217; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sedkov Y, 2003, NATURE, V426, P78, DOI 10.1038/nature02080; Stewart DR, 2007, AM J MED GENET C, V145C, P383, DOI 10.1002/ajmg.c.30148; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; Talkowski ME, 2011, AM J HUM GENET, V89, P551, DOI 10.1016/j.ajhg.2011.09.011; Tsurusaki Y, 2012, NAT GENET, V44, P376, DOI 10.1038/ng.2219; Underhill C, 2000, J BIOL CHEM, V275, P40463, DOI 10.1074/jbc.M007864200; van Bokhoven H, 2011, ANNU REV GENET, V45, P81, DOI 10.1146/annurev-genet-110410-132512; van Bokhoven H, 2010, NEUROBIOL DIS, V39, P3, DOI 10.1016/j.nbd.2010.03.010; van Bon BWM, 2010, EUR J HUM GENET, V18, P163, DOI 10.1038/ejhg.2009.152; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Willemsen MH, 2011, MOL SYNDROMOL, V2, P202, DOI 10.1159/000335648; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Yan QJ, 2005, NEUROPHARMACOLOGY, V49, P1053, DOI 10.1016/j.neuropharm.2005.06.004; Yanagiya T, 2007, HUM MOL GENET, V16, P3017, DOI 10.1093/hmg/ddm260	53	163	170	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 13	2012	91	1					73	82		10.1016/j.ajhg.2012.05.003	http://dx.doi.org/10.1016/j.ajhg.2012.05.003			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	974OE	22726846	Green Published, Bronze			2022-12-18	WOS:000306445000006
J	Parry, DA; Logan, CV; Hayward, BE; Shires, M; Landolsi, H; Diggle, C; Carr, I; Rittore, C; Touitou, I; Philibert, L; Fisher, RA; Fallahian, M; Huntriss, JD; Picton, HM; Malik, S; Taylor, GR; Johnson, CA; Bonthron, DT; Sheridan, EG				Parry, David A.; Logan, Clare V.; Hayward, Bruce E.; Shires, Michael; Landolsi, Hanene; Diggle, Christine; Carr, Ian; Rittore, Cecile; Touitou, Isabelle; Philibert, Laurent; Fisher, Rosemary A.; Fallahian, Masoumeh; Huntriss, John D.; Picton, Helen M.; Malik, Saghira; Taylor, Graham R.; Johnson, Colin A.; Bonthron, David T.; Sheridan, Eamonn G.			Mutations Causing Familial Biparental Hydatidiform Mole Implicate C6orf221 as a Possible Regulator of Genomic Imprinting in the Human Oocyte	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MATERNAL-EFFECT GENE; DNA-SEQUENCING DATA; FEMALE GERM-LINE; NLRP7 MUTATIONS; EMBRYONIC-DEVELOPMENT; REPRODUCTIVE WASTAGE; EVOLUTION; EXPRESSION; METHYLTRANSFERASES; IDENTIFICATION	Familial biparental hydatidiform mole (FBHM) is the only known pure maternal-effect recessive inherited disorder in humans. Affected women, although developmentally normal themselves, suffer repeated pregnancy loss because of the development of the conceptus into a complete hydatidiform mole in which extraembryonic trophohlastic tissue develops but the embryo itself suffers early demise. This developmental phenotype results from a genome-wide failure to correctly specify or maintain a maternal epigenotype at imprinted loci. Most cases of FBHM result from mutations of NLRP7, but genetic heterogeneity has been demonstrated. Here, we report biallelic mutations of C6orf221 in three families with FBHM. The previously described biological properties of their respective gene families suggest that NLRP7 and C6orf221 may interact as components of an oocyte complex that is directly or indirectly required for determination of epigenetic status on the oocyte genome.	[Parry, David A.; Logan, Clare V.; Hayward, Bruce E.; Shires, Michael; Diggle, Christine; Carr, Ian; Malik, Saghira; Taylor, Graham R.; Johnson, Colin A.; Bonthron, David T.; Sheridan, Eamonn G.] St James Hosp, Leeds Inst Mol Med, Genet Sect, Leeds LS9 7TF, W Yorkshire, England; [Landolsi, Hanene] CHU, Lab Anat & Cytol Pathol, Sousse 4000, Tunisia; [Rittore, Cecile; Touitou, Isabelle; Philibert, Laurent] Univ Montpellier I, INSERM, U844, Unite Med Malad Autoinflammatoires,Ctr Hosp Univ, F-34006 Montpellier, France; [Fisher, Rosemary A.] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London SW7 2AZ, England; [Fallahian, Masoumeh] Shaheed Beheshti Univ Med Sci, Tehran, Iran; [Huntriss, John D.; Picton, Helen M.] Univ Leeds, Leeds Inst Genet Hlth & Therapeut, Leeds LS2 9JT, W Yorkshire, England	Saint James's University Hospital; University of Leeds; Imperial College London; Shahid Beheshti University Medical Sciences; University of Leeds	Sheridan, EG (corresponding author), St James Hosp, Leeds Inst Mol Med, Genet Sect, Wellcome Trust Brenner Bldg, Leeds LS9 7TF, W Yorkshire, England.	e.sheridan@leeds.ac.uk		Fisher, Rosemary/0000-0002-2721-8726; Parry, David/0000-0003-0376-7736; Logan, Clare/0000-0003-4323-1602; Bonthron, David/0000-0001-8132-8179; Johnson, Colin/0000-0002-2979-8234	Wellbeing of Women; Sir Jules Thorn Award for Biomedical Research; Medical Research Council [G0701388]; MRC [G0701388] Funding Source: UKRI; The Sir Jules Thorn Charitable Trust [09JTA] Funding Source: researchfish	Wellbeing of Women(Wellbeing of Women (WoW)); Sir Jules Thorn Award for Biomedical Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Sir Jules Thorn Charitable Trust	The authors thank the families for participating in this study. This work was supported by grants from Wellbeing of Women (to E.S), the Sir Jules Thorn Award for Biomedical Research (to C.A.J., E.S., G.R.T., and D.T.B.). J.D. and H.M.P. are supported by funding from the Medical Research Council (grant number G0701388).	Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; [Anonymous], EXONPRIMER; BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; Carr IM, 2006, HUM MUTAT, V27, P1041, DOI 10.1002/humu.20383; Carr IM, 2009, HUM MUTAT, V30, P960, DOI 10.1002/humu.20974; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; El-Maarri O, 2003, HUM MOL GENET, V12, P1405, DOI 10.1093/hmg/ddg152; Fisher RA, 2002, HUM MOL GENET, V11, P3267, DOI 10.1093/hmg/11.26.3267; Grishin NV, 2001, NUCLEIC ACIDS RES, V29, P638, DOI 10.1093/nar/29.3.638; Hayward BE, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-2; Hayward BE, 2009, HUM MUTAT, V30, pE629, DOI 10.1002/humu.20993; Horsthemke B, 2010, AM J MED GENET C, V154C, P321, DOI 10.1002/ajmg.c.30269; Huntriss J, 2006, MOL HUM REPROD, V12, P283, DOI 10.1093/molehr/gal035; Huntriss J, 2004, MOL REPROD DEV, V67, P323, DOI 10.1002/mrd.20030; Huntriss J, 2011, FERTIL STERIL, V95, P2564, DOI 10.1016/j.fertnstert.2011.04.035; Judson H, 2002, NATURE, V416, P539, DOI 10.1038/416539a; KAJII T, 1977, NATURE, V268, P633, DOI 10.1038/268633a0; Kou YC, 2008, MOL HUM REPROD, V14, P33, DOI 10.1093/molehr/gam079; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Landolsi H, 2011, INT J GYNECOL PATHOL, V30, P348, DOI 10.1097/PGP.0b013e31820dc3b0; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Muhlstein J, 2011, EUR J OBSTET GYN R B, V157, P197, DOI 10.1016/j.ejogrb.2011.02.019; Murdoch S, 2006, NAT GENET, V38, P300, DOI 10.1038/ng1740; Newton H, 1999, J REPROD FERTIL, V115, P141, DOI 10.1530/jrf.0.1150141; Newton H, 1996, HUM REPROD, V11, P1487; Obata Y, 2002, J BIOL CHEM, V277, P5285, DOI 10.1074/jbc.M108586200; Ohsugi M, 2008, DEVELOPMENT, V135, P259, DOI 10.1242/dev.011445; Pierre A, 2007, GENOMICS, V90, P583, DOI 10.1016/j.ygeno.2007.06.003; Qian JH, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9498; Reik W, 2001, NAT GENET, V27, P255, DOI 10.1038/85804; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; Tashiro F, 2010, GENES CELLS, V15, P813, DOI 10.1111/j.1365-2443.2010.01420.x; Thorvaldsen JL, 2007, CELL, V130, DOI 10.1016/j.cell.2007.08.033; Tian X, 2009, BIOL REPROD, V80, P616, DOI 10.1095/biolreprod.108.073684; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Vallender EJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-51; Van den Veyver IB, 2006, HUM REPROD UPDATE, V12, P233, DOI 10.1093/humupd/dmk005; Wang CM, 2009, J MED GENET, V46, P569, DOI 10.1136/jmg.2008.064196; Wang E, 2000, NAT BIOTECHNOL, V18, P457, DOI 10.1038/74546; Wang QT, 2004, DEV CELL, V6, P133, DOI 10.1016/S1534-5807(03)00404-0; Zhang P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002755; Zheng P, 2007, SEMIN REPROD MED, V25, P243, DOI 10.1055/s-2007-980218; Zheng P, 2009, P NATL ACAD SCI USA, V106, P7473, DOI 10.1073/pnas.0900519106; AUTOSNPA; IBDFINDER; DBSNP131	49	163	176	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 9	2011	89	3					451	458		10.1016/j.ajhg.2011.08.002	http://dx.doi.org/10.1016/j.ajhg.2011.08.002			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	820XQ	21885028	Green Published, Bronze			2022-12-18	WOS:000294939800011
J	Tarpey, PS; Raymond, FL; O'Meara, S; Edkins, S; Teague, J; Butler, A; Dicks, E; Stevens, C; Tofts, C; Avis, T; Barthorpe, S; Buck, G; Cole, J; Gray, K; Halliday, K; Harrison, R; Hills, K; Jenkinson, A; Jones, D; Menzies, A; Mironenko, T; Perry, J; Raine, K; Richardson, D; Shepherd, R; Small, A; Varian, J; West, S; Widaa, S; Mallya, U; Moon, J; Luo, Y; Holder, S; Smithson, SF; Hurst, JA; Clayton-Smith, J; Kerr, B; Boyle, J; Shaw, M; Vandeleur, L; Rodriguez, J; Slaugh, R; Easton, DF; Wooster, R; Bobrow, M; Srivastava, AK; Stevenson, RE; Schwartz, CE; Turner, G; Gecz, J; Futreal, PA; Stratton, MR; Partington, M				Tarpey, Patrick S.; Raymond, F. Lucy; O'Meara, Sarah; Edkins, Sarah; Teague, Jon; Butler, Adam; Dicks, Ed; Stevens, Claire; Tofts, Calli; Avis, Tim; Barthorpe, Syd; Buck, Gemma; Cole, Jennifer; Gray, Kristian; Halliday, Kelly; Harrison, Rachel; Hills, Katy; Jenkinson, Andrew; Jones, David; Menzies, Andrew; Mironenko, Tatiana; Perry, Janet; Raine, Keiran; Richardson, David; Shepherd, Rebecca; Small, Alexandra; Varian, Jennifer; West, Sofie; Widaa, Sara; Mallya, Uma; Moon, Jenny; Luo, Ying; Holder, Susan; Smithson, Sarah F.; Hurst, Jane A.; Clayton-Smith, Jill; Kerr, Bronwyn; Boyle, Jackie; Shaw, Marie; Vandeleur, Lucianne; Rodriguez, Jayson; Slaugh, Rachel; Easton, Douglas F.; Wooster, Richard; Bobrow, Martin; Srivastava, Anand K.; Stevenson, Roger E.; Schwartz, Charles E.; Turner, Gillian; Gecz, Jozef; Futreal, P. Andrew; Stratton, Michael R.; Partington, Michael			Mutations in CUL4B, which encodes a ubiquitin E3 ligase subunit, cause an X-linked mental retardation syndrome associated with aggressive outbursts, seizures, relative macrocephaly, central obesity, hypogonadism, pes cavus, and tremor	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ANGELMAN SYNDROME; PROTEIN; GENE; COMPLEX; DEGRADATION; INSIGHTS; ENZYME; XLMR; ARX	We have identified three truncating, two splice-site, and three missense variants at conserved amino acids in the CUL4B gene on Xq24 in 8 of 250 families with X-linked mental retardation (XLMR). During affected subjects' adolescence, a syndrome emerged with delayed puberty, hypogonadism, relative macrocephaly, moderate short stature, central obesity, unprovoked aggressive outbursts, fine intention tremor, pes cavus, and abnormalities of the toes. This syndrome was first described by Cazebas et al., in a family that was included in our study and that carried a CUL4B missense variant. CUL4B is a ubiquitin E3 ligase subunit implicated in the regulation of several biological processes, and CUL4B is the first XLMR gene that encodes an E3 ubiquitin ligase. The relatively high frequency of CUL4B mutations in this series indicates that it is one of the most commonly mutated genes underlying XLMR and suggests that its introduction into clinical diagnostics should be a high priority.	Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge CB10 1SA, England; Cambridge Inst Med Res, Cambridge, England; Canc Res UK Genet Epidemiol Unit, Cambridge, England; Univ Newcastle, Newcastle, NSW 2308, Australia; Univ Adelaide, Dept Med Genet, Womens & Childrens Hosp, Adelaide, SA, Australia; Univ Adelaide, Dept Paediat, Adelaide, SA, Australia; Univ Adelaide, Dept Mol Biosci, Adelaide, SA, Australia; Greenwood Genet Ctr, JC Self Res Inst Human Genet, Greenwood, SC 29646 USA; Washington Univ, Sch Med, Dept Pediat, Div Genet, St Louis, MO 63110 USA; Northwick Pk Hosp & Clin Res Ctr, N W Thames Reg Genet Serv, Harrow HA1 3UJ, Middx, England; St Michaels Hosp, Bristol, Avon, England; John Radcliffe Hosp, Oxford OX3 9DU, England; St Marys Hosp, Manchester M13 0JH, Lancs, England	University of Cambridge; Wellcome Trust Sanger Institute; University of Cambridge; Cancer Research UK; University of Cambridge; University of Newcastle; University of Adelaide; Womens & Childrens Hospital Australia; University of Adelaide; University of Adelaide; Greenwood Genetic Center; Washington University (WUSTL); Imperial College London; University of Oxford; University of Manchester	Stratton, MR (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	mrs@sanger.ac.uk	Gecz, Jozef/X-3469-2019	Gecz, Jozef/0000-0002-7884-6861; Avis, Tim/0000-0001-6120-5729; Buck, Gemma/0000-0001-5289-1050; Gray, Kristian/0000-0002-7035-7107; Raine, Keiran/0000-0002-5634-1539; Richardson, David/0000-0003-0247-9118; Slaugh, Rachel/0000-0002-5742-9153; Jenkinson, Andrew/0000-0002-0703-6984	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD026202] Funding Source: NIH RePORTER; NICHD NIH HHS [HD26202, R01 HD026202] Funding Source: Medline; Wellcome Trust Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust(Wellcome TrustEuropean Commission)		Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Cabezas DA, 2000, J MED GENET, V37, P663, DOI 10.1136/jmg.37.9.663; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chelly J, 2006, EUR J HUM GENET, V14, P701, DOI 10.1038/sj.ejhg.5201595; Conaway RC, 2002, SCIENCE, V296, P1254, DOI 10.1126/science.1067466; Gecz J, 2006, CURR OPIN GENET DEV, V16, P308, DOI 10.1016/j.gde.2006.04.003; Guardavaccaro D, 2004, ONCOGENE, V23, P2037, DOI 10.1038/sj.onc.1207413; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; Higa LA, 2006, CELL CYCLE, V5, P71, DOI 10.4161/cc.5.1.2266; Higa LA, 2006, CELL CYCLE, V5, P1675, DOI 10.4161/cc.5.15.3149; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Merienne K, 1999, NAT GENET, V22, P13, DOI 10.1038/8719; Nascimento RMP, 2006, AM J HUM GENET, V79, P549, DOI 10.1086/507047; Pagano M, 2003, CANCER CELL, V4, P251, DOI 10.1016/S1535-6108(03)00243-5; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Poirier K, 2006, NEUROGENETICS, V7, P39, DOI 10.1007/s10048-005-0014-0; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Ropers HH, 2005, NAT REV GENET, V6, P46, DOI 10.1038/nrg1501; Stevenson RE, 2000, AM J MED GENET, V97, P174, DOI 10.1002/1096-8628(200023)97:3<174::AID-AJMG1034>3.0.CO;2-4; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	26	163	167	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2007	80	2					345	352		10.1086/511134	http://dx.doi.org/10.1086/511134			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	129KX	17236139	Green Published, Bronze			2022-12-18	WOS:000243729500014
J	Seddon, JM; Santangelo, SL; Book, K; Chong, S; Cote, J				Seddon, JM; Santangelo, SL; Book, K; Chong, S; Cote, J			A genomewide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DIETARY-FAT; FAMILIAL AGGREGATION; GENETIC ASSOCIATION; PEDIGREE ANALYSIS; APOLIPOPROTEIN-E; 5-YEAR INCIDENCE; DISEASE GENE; LOD SCORES; MACULOPATHY; RISK	We report the results of a genomewide scan for age-related macular degeneration (AMD) in 158 multiplex families. AMD classification was based on fundus photography and was assigned a grade ranging from 1 ( no disease) to 5 (exudative disease). Genotyping was performed by the National Heart, Lung, and Blood Institute Mammalian Genotyping Service at Marshfield (404 short tandem repeat markers). The sample included 158 families with two or more siblings with AMD, 490 affected individuals, 101 unaffected individuals, and 38 whose affection status was unknown. Relative pairs included 511 affected sibling, 28 avuncular, 53 cousin, 7 grandparent-grandchild, and 9 grand-avuncular pairs. Two-point parametric and multipoint parametric and nonparametric analyses were performed. Maximum two-point LOD scores of 1.0-2.0 were found for markers on chromosomes 1, 2, 8, 10, 14, 15, and 22. Multipoint analyses were consistent with the two-point results for chromosomes 1, 2, 8, 10, and 22 and provided evidence for additional linkage regions on chromosomes 3, 6, 8, 12, 16, and X. Our signals on chromosomes 1q, 6p, and 10q are consistent with some other previously published results. Significant linkage to AMD was found for one marker on chromosome 2, two adjacent markers on chromosome 3, two adjacent markers on chromosome 6, and seven contiguous markers on chromosome 8, with empirical P values of .00001. The consistency of many of the other signals across both two-point and multipoint, as well as parametric and nonparametric, analyses indicate several other regions worthy of follow-up.	Massachusetts Eye & Ear Infirm, Ophthalmol Epidemiol Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Psychiat, Psychiat & Neurodev Genet Unit, Charlestown, MA USA	Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital	Seddon, JM (corresponding author), Massachusetts Eye & Ear Infirm, Epidemiol Unit, 243 Charles St, Boston, MA 02114 USA.	Johanna_Seddon@meei.harvard.edu			NEI NIH HHS [U10 EY011309, R01 EY011309, EY11309] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Age-Related Eye Dis Study Res Grp, 2001, AM J OPHTHALMOL, V132, P668; Allikmets R, 2000, AM J HUM GENET, V67, P487, DOI 10.1086/303018; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Ayyagari R, 2001, Ophthalmic Genet, V22, P233, DOI 10.1076/opge.22.4.233.2219; Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; Cho E, 2001, AM J CLIN NUTR, V73, P209; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Danciger M, 2001, INVEST OPHTH VIS SCI, V42, P2458; DeJong PTVM, 1997, AM J OPHTHALMOL, V124, P862, DOI 10.1016/S0002-9394(14)71715-5; DelaPaz MA, 1997, INVEST OPHTH VIS SCI, V38, P1060; Delcourt C, 1998, ARCH OPHTHALMOL-CHIC, V116, P1031, DOI 10.1001/archopht.116.8.1031; Duren WL, 1997, AM J HUM GENET, V61, pA273; Durner M, 1999, AM J HUM GENET, V64, P281, DOI 10.1086/302181; Epstein MP, 2000, AM J HUM GENET, V67, P1219, DOI 10.1016/S0002-9297(07)62952-8; Friedman E, 1997, AM J OPHTHALMOL, V124, P677, DOI 10.1016/S0002-9394(14)70906-7; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Hamdi HK, 2002, BIOCHEM BIOPH RES CO, V295, P668, DOI 10.1016/S0006-291X(02)00728-3; Hammond CJ, 2002, OPHTHALMOLOGY, V109, P730, DOI 10.1016/S0161-6420(01)01049-1; HEIBA IM, 1994, GENET EPIDEMIOL, V11, P51, DOI 10.1002/gepi.1370110106; Hyman L, 2000, ARCH OPHTHALMOL-CHIC, V118, P351, DOI 10.1001/archopht.118.3.351; Ikeda T, 2001, AM J OPHTHALMOL, V132, P191, DOI 10.1016/S0002-9394(01)00975-8; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Kimura K, 2000, AM J OPHTHALMOL, V130, P769, DOI 10.1016/S0002-9394(00)00552-3; Klaver CCW, 1998, AM J HUM GENET, V63, P200, DOI 10.1086/301901; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1646, DOI 10.1001/archopht.116.12.1646; Klein BEK, 2001, AM J EPIDEMIOL, V154, P207, DOI 10.1093/aje/154.3.207; Klein ML, 1998, ARCH OPHTHALMOL-CHIC, V116, P1082, DOI 10.1001/archopht.116.8.1082; Klein R, 1997, OPHTHALMOLOGY, V104, P7, DOI 10.1016/S0161-6420(97)30368-6; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lagali PS, 2002, BIOCHEM BIOPH RES CO, V293, P356, DOI 10.1016/S0006-291X(02)00228-0; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; Liu Q, 2002, INVEST OPHTH VIS SCI, V43, P22; MARESPERLMAN JA, 1995, ARCH OPHTHALMOL-CHIC, V113, P743, DOI 10.1001/archopht.1995.01100060069034; *NAT ADV EY COUNC, 2001, NIH PUBL; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Schick JH, 2003, AM J HUM GENET, V72, P1412, DOI 10.1086/375500; Seddon J, 2001, RETINA-J RET VIT DIS, P1039; SEDDON JM, 1990, INVEST OPHTH VIS SCI, V31, P1592; Seddon JM, 2001, OPHTHALMOLOGY, V108, P2060, DOI 10.1016/S0161-6420(01)00777-1; Seddon JM, 1996, JAMA-J AM MED ASSOC, V276, P1141, DOI 10.1001/jama.276.14.1141; Seddon JM, 1997, AM J OPHTHALMOL, V123, P199, DOI 10.1016/S0002-9394(14)71036-0; SEDDON JM, 1994, JAMA-J AM MED ASSOC, V272, P1413, DOI 10.1001/jama.272.18.1413; Seddon JM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1191, DOI 10.1001/archopht.119.8.1191; Shastry BS, 1999, OPHTHALMOLOGICA, V213, P165, DOI 10.1159/000027413; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; Smith W, 1996, ARCH OPHTHALMOL-CHIC, V114, P1518, DOI 10.1001/archopht.1996.01100140716016; Sobel E, 1996, AM J HUM GENET, V58, P1323; Souied EH, 1998, AM J OPHTHALMOL, V125, P353, DOI 10.1016/S0002-9394(99)80146-9; SPERDUTO RD, 1986, ARCH OPHTHALMOL-CHIC, V104, P216; Stone EM, 1999, NAT GENET, V22, P199, DOI 10.1038/9722; VandenLangenberg GM, 1998, AM J EPIDEMIOL, V148, P204, DOI 10.1093/oxfordjournals.aje.a009625; VIELAND VJ, 1992, GENET EPIDEMIOL, V9, P45, DOI 10.1002/gepi.1370090106; Vingerling JR, 1996, ARCH OPHTHALMOL-CHIC, V114, P1193, DOI 10.1001/archopht.1996.01100140393005; Weeks DE, 2000, HUM MOL GENET, V9, P1329, DOI 10.1093/hmg/9.9.1329; WEEKS DE, 1995, AM J HUM GENET, V56, P1506; Weeks DE, 2001, AM J OPHTHALMOL, V132, P682, DOI 10.1016/S0002-9394(01)01214-4; White K, 2000, HUM MUTAT, V15, P301, DOI 10.1002/(SICI)1098-1004(200004)15:4<301::AID-HUMU1>3.0.CO;2-N; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; YANNUZZI LA, 1992, ARCH OPHTHALMOL-CHIC, V110, P1701; Yokota T, 1996, NEW ENGL J MED, V335, P1770, DOI 10.1056/NEJM199612053352315; Zurdel J, 2002, BRIT J OPHTHALMOL, V86, P214, DOI 10.1136/bjo.86.2.214	66	163	171	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2003	73	4					780	790		10.1086/378505	http://dx.doi.org/10.1086/378505			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	727TL	12945014	Bronze, Green Published			2022-12-18	WOS:000185676100006
J	Hull, J; Ackerman, H; Isles, K; Usen, S; Pinder, M; Thomson, A; Kwiatkowski, D				Hull, J; Ackerman, H; Isles, K; Usen, S; Pinder, M; Thomson, A; Kwiatkowski, D			Unusual haplotypic structure of IL8, a susceptibility locus for a common respiratory virus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE REGION; BRONCHIOLITIS	Interleukin-8 (IL8) is believed to play a role in the pathogenesis of bronchiolitis, a common viral disease of infancy, and a recent U.K. family study identified an association between this disease and the IL8-251A allele. In the present study we report data, from a different set of families, which replicate this finding; combined analysis of 194 nuclear families through use of the transmission/disequilibrium test gives. To explore the underlying genetic cause, we identified nine single-nucleotide polymorphisms (SNPs) in a 7.6-kb segment spanning the IL8 gene and its promoter region and used six of these SNPs to define the haplotypic structure of the IL8 locus. The IL8-251A allele resides on two haplotypes, only one of which is associated with disease, suggesting that this may not be the functional allele. Europeans show an unusual haplotype genealogy that is dominated by two common haplotypes differing at multiple sites, whereas Africans have much greater haplotypic diversity. These marked haplotype-frequency differences give an F-ST of .25, and, in the European sample, both Tajima's D statistic (D = 2.58, P = .007) and the Hudson/Kreitman/Aguade test (chi (2) = 4.9, P = .03) reject neutral equilibrium, suggesting that selective pressure may have acted on this locus.	Univ Oxford, Dept Paediat, Oxford OX3 9DU, England; Wellcome Trust Ctr Human Genet, Oxford, England; MRC Labs, Fajara, Gambia	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; MRC Laboratory Molecular Biology	Hull, J (corresponding author), Univ Oxford, Dept Paediat, Oxford OX3 9DU, England.		Garza-González, Elvira/B-7569-2009; Ackerman, Hans/U-9621-2019	Ackerman, Hans/0000-0003-4940-3305; Kwiatkowski, Dominic/0000-0002-5023-0176				Abu-Harb M, 1999, EUR RESPIR J, V14, P139, DOI 10.1034/j.1399-3003.1999.14a23.x; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Fiedler MA, 1996, AM J PHYSIOL-LUNG C, V271, pL963, DOI 10.1152/ajplung.1996.271.6.L963; GRIFFITHS RC, 1994, STAT SCI, V9, P307, DOI 10.1214/ss/1177010378; Hamblin MT, 2000, AM J HUM GENET, V66, P1669, DOI 10.1086/302879; HUDSON RR, 1987, GENETICS, V116, P153; Hull J, 2000, THORAX, V55, P1023, DOI 10.1136/thorax.55.12.1023; Modi WS, 1998, GENOMICS, V47, P136, DOI 10.1006/geno.1997.5100; Nei M., 1987, MOL EVOLUTIONARY GEN; NOAH TL, 1995, J INFECT DIS, V171, P584, DOI 10.1093/infdis/171.3.584; Smyth RL, 2000, ARCH DIS CHILD S, V82, pA4; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAJIMA F, 1989, GENETICS, V123, P585; Wright S, 1931, GENETICS, V16, P0097	16	163	172	0	5	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2001	69	2					413	419		10.1086/321291	http://dx.doi.org/10.1086/321291			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XN	11431705	Green Published, Bronze			2022-12-18	WOS:000170108200015
J	Cavanaugh, J				Cavanaugh, J		IBD Int Genetics Consortium	International collaboration provides convincing linkage replication in complex disease through analysis of a large pooled data set: Crohn disease and chromosome 16	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; DEPENDENT DIABETES-MELLITUS; LARGE EUROPEAN COHORT; SUSCEPTIBILITY LOCUS; ULCERATIVE-COLITIS; SUPPORTS LINKAGE; GENETIC-ANALYSIS; HETEROGENEITY; FAMILIES; GENOME	Numerous familial, non-Mendelian (i.e., complex) diseases have been screened by linkage analysis for regions harboring susceptibility genes. Except for rare, high-penetrance syndromes showing Mendelian inheritance, such as BRCA1 and BRCA2, most attempts have failed to produce replicable linkage findings. For example, in multiple sclerosis and other complex diseases, there have been many reports of significant linkage, followed by numerous failures to replicate. In inflammatory bowel disease (IBD), linkage to two regions has elsewhere been reported at genomewide significance levels: the pericentromeric region on chromosome 16 (IBD1) and chromosome 12q (IBD2). As with other complex diseases, the subsequent support for these localizations has been variable. In this article, we report the results of an international collaborative effort to investigate these putative localization by pooling of data sets that do not individually provide convincing evidence for linkage to these regions. Our results, generated by the genotyping and analysis of 12 microsatellite markers in 613 families, provide unequivocal replication of linkage for a common human disease: a Crohn disease susceptibility locus on chromosome 16 (maximum LOD score 5.79). Despite failure to replicate the previous evidence for linkage on chromosome 12, the results described herein indicate the need to further investigate the potential role of this locus in susceptibility to ulcerative colitis. This report provides a convincing example of the collaborative approach necessary to obtain the sample numbers required to achieve statistical power in studies of complex human traits.	Canberra Hosp, Gastroenterol Unit, Canberra, ACT, Australia; UZ Gasthuisberg, Gastroenterol Unit, Louvain, Belgium; UZ Gasthuisberg, Ctr Human Genet, Louvain, Belgium; MIT, Whitehead Inst, Ctr Genome Res, Cambridge, MA 02139 USA; Univ Toronto, Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; Fdn Jean Dausset, CEPH, Paris, France; Univ Helsinki, Cent Hosp, Dept Med, Helsinki, Finland; CNR Mol Genet, S Maria La Palma, Italy; Univ Penn, Childrens Hosp, Philadelphia, PA 19104 USA; CSS IRCCS Hosp, S Giovanni Rotondo, Italy; Radcliffe Infirm, Gastroenterol Unit, Oxford OX2 6HE, England; Wellcome Trust Ctr Human Genet, Oxford, England; Oxagen Ltd, Oxford, England; Johns Hopkins Univ, Sch Med, Baltimore, MD USA; NHGRI, NIH, Baltimore, MD USA; Boston Univ, Sch Med, Boston, MA 02118 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA; Univ Chicago Hosp, Dept Med, Gastroenterol Sect, Martin Boyer Genet Res Labs, Chicago, IL 60637 USA; Univ Chicago Hosp, Dept Pediat, Gastroenterol Sect, Martin Boyer Genet Res Labs, Chicago, IL 60637 USA; Univ Chicago Hosp, Dept Med, Gastroenterol Sect, Martin Boyer Genet Res Labs, Chicago, IL 60637 USA; Cedars Sinai Med Ctr, Div Med Genet, Los Angeles, CA 90048 USA; Cedars Sinai Med Ctr, IBD Ctr, Los Angeles, CA 90048 USA; NYU, Sch Med, N Shore Univ Hosp, Dept Med,Div Mol Med, Manhasset, NY USA; Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA USA; Univ Pittsburgh, Sch Med, Ctr Genom Sci, Pittsburgh, PA USA; Cleveland Clin Fdn, Dept Gastroenterol, Cleveland, OH 44195 USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA	Australian National University; Canberra Hospital; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Foundation Jean Dausset-CEPH; University of Helsinki; Helsinki University Central Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Radcliffe Infirmary; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Oxagen Limited; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); NIH National Institute on Aging (NIA); Boston University; Johns Hopkins University; University of Chicago; University of Illinois System; University of Chicago; University of Illinois System; University of Chicago; University of Illinois System; Cedars Sinai Medical Center; Cedars Sinai Medical Center; New York University; Northwell Health; North Shore University Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cleveland Clinic Foundation; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Stanford University	Cavanaugh, J (corresponding author), Canberra Hosp, Gastroenterol Res Unit, Woden, ACT 2606, Australia.		Cavanaugh, Juleen/C-9413-2009; Pavli, Paul/GZL-0607-2022; Siminovitch, Katherine/K-1475-2013; Rioux, John D./A-9599-2015; Latiano, Anna/R-1965-2016; Duerr, Richard/B-4188-2009	Rioux, John D./0000-0001-7560-8326; Lench, Nicholas/0000-0002-6108-0759; Bailey-Wilson, Joan/0000-0002-9153-2920; Parkes, Miles/0000-0002-6467-0631; Latiano, Anna/0000-0003-3719-2061; Vermeire, Severine/0000-0001-9942-3019; Kirschner, Barbara/0000-0003-4640-2438; Duerr, Richard/0000-0001-6586-3905; FORABOSCO, PAOLA/0000-0002-2006-2693; Fortina, Paolo/0000-0002-5898-2081				Annese V, 1999, EUR J HUM GENET, V7, P567, DOI 10.1038/sj.ejhg.5200328; Bell JI, 1996, NAT GENET, V13, P377, DOI 10.1038/ng0896-377; Binder V, 1998, DIGEST DIS, V16, P351, DOI 10.1159/000016891; Brant SR, 1998, GASTROENTEROLOGY, V115, P1056, DOI 10.1016/S0016-5085(98)70073-3; Cavanaugh JA, 1998, ANN HUM GENET, V62, P291, DOI 10.1046/j.1469-1809.1998.6240291.x; Concannon P, 1998, NAT GENET, V19, P292, DOI 10.1038/985; Curran ME, 1998, GASTROENTEROLOGY, V115, P1066, DOI 10.1016/S0016-5085(98)70075-7; Duerr RH, 1998, AM J HUM GENET, V63, P95, DOI 10.1086/301929; Hampe J, 1999, AM J HUM GENET, V64, P808, DOI 10.1086/302294; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Mirza MM, 1998, J MED GENET, V35, P218, DOI 10.1136/jmg.35.3.218; Ohmen JD, 1996, HUM MOL GENET, V5, P1679, DOI 10.1093/hmg/5.10.1679; Parkes M, 2000, AM J HUM GENET, V67, P1605, DOI 10.1086/316905; Parkes M, 1996, LANCET, V348, P1588, DOI 10.1016/S0140-6736(05)66204-6; Rioux JD, 1998, GASTROENTEROLOGY, V115, P1062, DOI 10.1016/S0016-5085(98)70074-5; ROTTER JI, 1981, AM J HUM GENET, V33, P835; Satsangi J, 1996, NAT GENET, V14, P199, DOI 10.1038/ng1096-199; Vermeire S, 2000, INFLAMM BOWEL DIS, V6, P165, DOI 10.1097/00054725-200008000-00002; YANG H, 1999, INFLAMMATORY BOWEL D; Yang HY, 1999, GENET MED, V1, P194	21	163	168	0	8	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2001	68	5					1165	1171		10.1086/320119	http://dx.doi.org/10.1086/320119			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	423HZ	11309682	Bronze, Green Published			2022-12-18	WOS:000168171200010
J	Williams, JT; Begleiter, H; Porjesz, B; Edenberg, HJ; Foroud, T; Reich, T; Goate, A; Van Eerdewegh, P; Almasy, L; Blangero, J				Williams, JT; Begleiter, H; Porjesz, B; Edenberg, HJ; Foroud, T; Reich, T; Goate, A; Van Eerdewegh, P; Almasy, L; Blangero, J			Joint multipoint linkage analysis of multivariate qualitative and quantitative traits. II. Alcoholism and event-related potentials	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							ALDEHYDE DEHYDROGENASE GENOTYPES; VARIANCE-COMPONENTS MODELS; GENOME-WIDE SEARCH; GENETIC-LINKAGE; CHROMOSOMAL ASSIGNMENT; METABOLIZING ENZYMES; BIOLOGICAL MARKERS; DRINKING BEHAVIOR; ROBUST INFERENCE; BRAIN POTENTIALS	The availability of robust quantitative biological markers that are correlated with qualitative psychiatric phenotypes can potentially improve the power of linkage methods to detect quantitative-trait loci influencing psychiatric disorders. We apply a variance-component method for joint multipoint linkage analysis of multivariate discrete and continuous traits to the extended pedigree data from the Collaborative Study on the Genetics of Alcoholism, in a bivariate analysis of qualitative alcoholism phenotypes and quantitative event-related potentials. Joint consideration of the DSM-IV diagnosis of alcoholism and the amplitude of the P300 component of the Ct event-related potential significantly increases the evidence for linkage of these traits to a chromosome 4 region near the class I alcohol dehydrogenase locus ADH3. A likelihood-ratio test for complete pleiotropy is significant, suggesting that the same quantitative-trait locus influences both risk of alcoholism and the amplitude of the P300 component.	SW Fdn Biomed Res, Dept Genet, San Antonio, TX 78245 USA; SUNY Hlth Sci Ctr, Dept Psychiat, Neurodynam Lab, Brooklyn, NY 11203 USA; Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA; Indiana Univ, Sch Med, Dept Med Genet, Indianapolis, IN 46202 USA; Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Genome Therapeut Corp, Waltham, MA USA	Texas Biomedical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Washington University (WUSTL)	Williams, JT (corresponding author), SW Fdn Biomed Res, Dept Genet, 7620 NW Loop 410,POB 760549, San Antonio, TX 78245 USA.	jeffw@darwin.sfbr.org	Almasy, Laura/V-3156-2019; Blangero, John/ABA-7175-2021	Edenberg, Howard/0000-0003-0344-9690; Goate, Alison/0000-0002-0576-2472	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL028972, P01HL045522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK044297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031575, F32GM018897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059490, R37MH059490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U10AA008401] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL045522, P01 HL028972, HL45522] Funding Source: Medline; NIAAA NIH HHS [U10 AA008401] Funding Source: Medline; NIDDK NIH HHS [DK44297] Funding Source: Medline; NIGMS NIH HHS [F32 GM018897, R01 GM031575] Funding Source: Medline; NIMH NIH HHS [MH59490, R37 MH059490, R01 MH059490] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALEXANDER JE, 1994, INT J PSYCHOPHYSIOL, V17, P35, DOI 10.1016/0167-8760(94)90053-1; Almasy L, 1997, GENET EPIDEMIOL, V14, P953, DOI 10.1002/(SICI)1098-2272(1997)14:6<953::AID-GEPI65>3.0.CO;2-K; Almasy L, 1999, AM J MED GENET, V88, P383; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; American Psychiatric Association, 1980, DIAGN STAT MAN MENT; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; Amos CI, 1996, ANN HUM GENET, V60, P143, DOI 10.1111/j.1469-1809.1996.tb01184.x; BEATY TH, 1987, GENET EPIDEMIOL, V4, P203, DOI 10.1002/gepi.1370040305; BEATY TH, 1987, GENET EPIDEMIOL, V4, P211, DOI 10.1002/gepi.1370040306; Begleiter H, 1995, ALCOHOL HEALTH RES W, V19, P228; BEGLEITER H, 1984, SCIENCE, V225, P1493, DOI 10.1126/science.6474187; Begleiter H, 1998, EVOKED POTENTIAL, V108, P244, DOI 10.1016/S0168-5597(98)00002-1; BLACKWOOD DHR, 1991, ARCH GEN PSYCHIAT, V48, P899; Blangero J, 1997, GENET EPIDEMIOL, V14, P959, DOI 10.1002/(SICI)1098-2272(1997)14:6<959::AID-GEPI66>3.0.CO;2-K; Blangero J, 1997, AM J MED GENET, V74, P602; BLUM K, 1990, JAMA-J AM MED ASSOC, V263, P2055, DOI 10.1001/jama.263.15.2055; BLUM K, 1996, HDB PSYCHIAT GENETIC; BOEHNKE M, 1984, AM J HUM GENET, V36, P1298; BOEHNKE M, 1986, AM J MED GENET, V23, P775, DOI 10.1002/ajmg.1320230306; BOSRON WF, 1986, HEPATOLOGY, V6, P502, DOI 10.1002/hep.1840060330; BUCHOLZ KK, 1994, J STUD ALCOHOL, V55, P149, DOI 10.15288/jsa.1994.55.149; Chen WJ, 1996, BRIT J PSYCHIAT, V168, P762, DOI 10.1192/bjp.168.6.762; COHEN HL, 1994, ALCOHOL, V11, P583, DOI 10.1016/0741-8329(94)90087-6; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; Comuzzie AG, 1997, GENET EPIDEMIOL, V14, P975, DOI 10.1002/(SICI)1098-2272(1997)14:6<975::AID-GEPI69>3.0.CO;2-I; COMUZZIE AG, IN PRESS GENET EPIDE; CRABB DW, 1989, J CLIN INVEST, V83, P314, DOI 10.1172/JCI113875; CUTTING GR, 1992, GENOMICS, V12, P801, DOI 10.1016/0888-7543(92)90312-G; CZERWINSKI SA, IN PRESS GENET EPIDE; DEAN M, 1991, AM J HUM GENET, V49, P621; Duggirala R, 1997, GENET EPIDEMIOL, V14, P987, DOI 10.1002/(SICI)1098-2272(1997)14:6<987::AID-GEPI71>3.0.CO;2-G; Edenberg HJ, 1998, ALCOHOL CLIN EXP RES, V22, P505, DOI 10.1097/00000374-199804000-00030; EDENBERG HJ, 1997, COMPREHENSIVE TOXICO, V3, P119; EWING JA, 1974, AM J PSYCHIAT, V131, P206, DOI 10.1176/ajp.131.2.206; FEIGHNER JP, 1972, ARCH GEN PSYCHIAT, V26, P57, DOI 10.1001/archpsyc.1972.01750190059011; FENNA D, 1971, CAN MED ASSOC J, V105, P472; Freedman R, 1997, P NATL ACAD SCI USA, V94, P587, DOI 10.1073/pnas.94.2.587; GOEDDE HW, 1992, HUM GENET, V88, P344; GOEDDE HW, 1979, HUM GENET, V51, P331; GOEDDE HW, 1986, AM J HUM GENET, V38, P395; HARADA S, 1982, LANCET, V2, P827, DOI 10.1016/s0140-6736(82)92722-2; HARADA S, 1985, ALCOHOL, V2, P391, DOI 10.1016/0741-8329(85)90100-4; Higuchi S, 1996, ALCOHOL CLIN EXP RES, V20, P493, DOI 10.1111/j.1530-0277.1996.tb01080.x; Hill SY, 1998, ALCOHOL, V16, P53, DOI 10.1016/S0741-8329(97)00177-8; HOLZMAN PS, 1973, SCIENCE, V181, P179, DOI 10.1126/science.181.4095.179; HOPPER JL, 1982, ANN HUM GENET, V46, P373, DOI 10.1111/j.1469-1809.1982.tb01588.x; HSU LC, 1986, AM J HUM GENET, V38, P641; Hsu LC, 1988, GENOMICS, V2, P57, DOI 10.1016/0888-7543(88)90109-7; IMPRAIM C, 1982, AM J HUM GENET, V34, P837; JIANG CJ, 1995, GENETICS, V140, P1111; Katsanis J, 1997, PSYCHOPHYSIOLOGY, V34, P47, DOI 10.1111/j.1469-8986.1997.tb02415.x; LANDER ES, 1988, NATURE, V336, P105, DOI 10.1038/336105a0; Liang KY, 1996, GENET EPIDEMIOL, V13, P575; Long JC, 1998, AM J MED GENET, V81, P216, DOI 10.1002/(SICI)1096-8628(19980508)81:3<216::AID-AJMG2>3.0.CO;2-U; LONG JC, 1996, PSYCHIAT GENET, V6, P162; Mangin B, 1998, BIOMETRICS, V54, P88, DOI 10.2307/2533998; MCGUFFIN P, 1984, PSYCHOL MED, V14, P255, DOI 10.1017/S0033291700003524; MOLDIN SO, 1994, SCHIZOPHRENIA BULL, V20, P169, DOI 10.1093/schbul/20.1.169; MURAMATSU T, 1995, HUM GENET, V96, P151, DOI 10.1007/BF00207371; NIELSEN DA, 1992, AM J HUM GENET, V51, P1366; OCONNOR S, 1994, ELECTROEN CLIN NEURO, V92, P115, DOI 10.1016/0168-5597(94)90052-3; OCONNOR S, 1987, ALCOHOL, V4, P323; Osier M, 1999, AM J HUM GENET, V64, P1147, DOI 10.1086/302317; OTT J, 1995, HUM HERED, V45, P169, DOI 10.1159/000154280; Ott J., 1991, ANAL HUMAN GENETIC L; PFEFFERBAUM A, 1991, ALCOHOL CLIN EXP RES, V15, P839, DOI 10.1111/j.1530-0277.1991.tb00611.x; Phillips TJ, 1998, NAT NEUROSCI, V1, P610, DOI 10.1038/2843; POLICH J, 1987, NEUROPSYCHOLOGIA, V25, P299, DOI 10.1016/0028-3932(87)90143-6; POLICH J, 1994, PSYCHOL BULL, V115, P55, DOI 10.1037/0033-2909.115.1.55; Porjesz B, 1998, ALCOHOL CLIN EXP RES, V22, P1317; Porjesz B., 1985, ALCOHOL BRAIN CHRONI, P139; PORJESZ B, 1996, ALCOH ALCOHOLISM, V2, P207; PRITCHARD WS, 1981, PSYCHOL BULL, V89, P506, DOI 10.1037/0033-2909.89.3.506; Regan D., 1989, HUMAN BRAIN ELECTROP; Reich T, 1998, AM J MED GENET, V81, P207, DOI 10.1002/(SICI)1096-8628(19980508)81:3<207::AID-AJMG1>3.3.CO;2-X; Reich T, 1997, AM J MED GENET, V74, P573; Reich T, 1996, ALCOHOL CLIN EXP RES, V20, pA133, DOI 10.1111/j.1530-0277.1996.tb01763.x; RISCH N, 1990, AM J HUM GENET, V46, P229; ROGERS TD, 1991, ACTA PSYCHIAT SCAND, V83, P412, DOI 10.1111/j.1600-0447.1991.tb05566.x; RUSSEK SJ, 1994, GENOMICS, V23, P528, DOI 10.1006/geno.1994.1539; SCHUCKIT MA, 1994, ADDICTION, V89, P1629, DOI 10.1111/j.1360-0443.1994.tb03764.x; SCHWITTERS SY, 1982, BEHAV GENET, V12, P349, DOI 10.1007/BF01067854; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Shen YC, 1997, ALCOHOL CLIN EXP RES, V21, P1272, DOI 10.1111/j.1530-0277.1997.tb04448.x; SHIBUYA A, 1988, AM J HUM GENET, V43, P744; SHIBUYA A, 1989, HUM GENET, V82, P14, DOI 10.1007/BF00288263; SHIBUYA A, 1988, AM J HUM GENET, V43, P741; Shriver MD, 1997, ANN INTERN MED, V127, P401, DOI 10.7326/0003-4819-127-5-199709010-00011; SINNETT D, 1993, AM J HUM GENET, V52, P1216; SMITH M, 1986, ADV HUM GENET, V15, P249; STAMATOYANNOPOULOS G, 1975, AM J HUM GENET, V27, P789; TAKESHITA T, 1994, HUM GENET, V94, P217; TENG YS, 1979, HUM GENET, V53, P87, DOI 10.1007/BF00289455; TENG YS, 1981, BIOCHEM GENET, V19, P107, DOI 10.1007/BF00486141; Thomasson HR, 1995, ALCOHOL CLIN EXP RES, V19, P1494, DOI 10.1111/j.1530-0277.1995.tb01013.x; THOMASSON HR, 1991, AM J HUM GENET, V48, P677; THOMPSON EA, 1993, 243 U WASH DEP STAT; TSUKAHARA M, 1989, GENOMICS, V4, P218, DOI 10.1016/0888-7543(89)90304-2; VALLEJO RL, 1998, AM J HUM GENET S, V63, pA45; vanBeijsterveldt CEM, 1996, AM J HUM GENET, V58, P562; VANEERDEWEGH P, 1998, GEN AN WORKSH 11 ARC; Wall TL, 1997, ANN INTERN MED, V127, P376, DOI 10.7326/0003-4819-127-5-199709010-00007; *WHO, 1992, ICD10 ICD10 CLASSIFI; Wijsman EM, 1997, GENET EPIDEMIOL, V14, P719, DOI 10.1002/(SICI)1098-2272(1997)14:6<719::AID-GEPI28>3.0.CO;2-S; WILKIN JK, 1981, ANN INTERN MED, V95, P468, DOI 10.7326/0003-4819-95-4-468; Williams JT, 1999, AM J HUM GENET, V65, P1134, DOI 10.1086/302570; Williams JT, 1999, GENET EPIDEMIOL, V16, P113, DOI 10.1002/(SICI)1098-2272(1999)16:2<113::AID-GEPI1>3.0.CO;2-6; WOLFF PH, 1972, SCIENCE, V175, P449, DOI 10.1126/science.175.4020.449; WOLFF PH, 1973, AM J HUM GENET, V25, P193; Xu SZ, 1996, GENETICS, V143, P1417; YASUNAMI M, 1990, GENOMICS, V7, P152, DOI 10.1016/0888-7543(90)90535-3; YOSHIDA A, 1991, PROG NUCLEIC ACID RE, V40, P255; YOSHIDA A, 1984, P NATL ACAD SCI-BIOL, V81, P258, DOI 10.1073/pnas.81.1.258; YOSHIDA A, 1983, AM J HUM GENET, V35, P1107; ZEINER AR, 1981, DRUG DEPENDENCE ALCO, V1, P573	116	163	164	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1999	65	4					1148	1160		10.1086/302571	http://dx.doi.org/10.1086/302571			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	241XW	10486334	Green Published, Bronze			2022-12-18	WOS:000082910000024
J	Monreal, AW; Zonana, J; Ferguson, B				Monreal, AW; Zonana, J; Ferguson, B			Identification of a new splice form of the EDA1 gene permits detection of nearly all X-linked hypohidrotic ectodermal dysplasia mutations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; PROTEIN; DOMAINS; MEDIATE; BINDING	X-linked hypohidrotic ectodermal dysplasia (XLHED), the most common of the ectodermal dysplasias, results in the abnormal development of teeth, hair, and eccrine sweat glands. The gene responsible for this disorder, EDA1, was identified by isolation of a single cDNA that was predicted to encode a 135-amino-acid protein. Mutations in this splice form were detected ire <10% of families with XLHED. The subsequent cloning of the murine homologue of the EDA1 gene (Tabby [Ta]) allowed us to identify a second putative isoform of the EDA1 protein (isoform II) in humans. This EDA1 cDNA is predicted to encode a 391-residue protein, of which 256 amino acids are encoded by the new exons. The putative protein is 94% identical to the Ta protein and includes a collagen-like domain with 19 repeats of a Gly-X-Y motif in the presumptive extracellular domain. The genomic structure of the EDA1 gene was established, and the complete sequence of the seven new exons was determined in 18 XLHED-affected males. putative mutations, including 12 missense, one nonsense, and four deletion mutations, were identified in similar to 95% of the families. The results suggest that EDA1 isoform II plays a critical role in tooth, hair, and sweat gland morphogenesis, whereas the biological significance of isoform I remains unclear. Identification of mutations in nearly all of the XLHED families studied suggests that direct molecular diagnosis of the disorder is feasible. Direct diagnosis will allow carrier detection in families with a single affected male and will assist in distinguishing XLHED from the rarer, clinically indistinguishable, autosomal recessive form of the disorder.	Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA	Oregon Health & Science University	Zonana, J (corresponding author), Oregon Hlth & Sci Univ, Dept Mol & Med Genet, L-103,3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	zonanaj@OHSU.edu			NIDCR NIH HHS [DE11311] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011311] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ACTON S, 1993, J BIOL CHEM, V268, P3530; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arnold C, 1991, PCR Methods Appl, V1, P39; Arte S, 1996, J DENT RES, V75, P1346, DOI 10.1177/00220345960750060401; Brodsky B, 1995, FASEB J, V9, P1537, DOI 10.1096/fasebj.9.15.8529832; CLARKE A, 1987, J MED GENET, V24, P659, DOI 10.1136/jmg.24.11.659; CLARKE A, 1987, ARCH DIS CHILD, V62, P989, DOI 10.1136/adc.62.10.989; Ezer S, 1997, HUM MOL GENET, V6, P1581, DOI 10.1093/hmg/6.9.1581; Ferguson BM, 1998, J MED GENET, V35, P112, DOI 10.1136/jmg.35.2.112; Ferguson BM, 1997, HUM MOL GENET, V6, P1589, DOI 10.1093/hmg/6.9.1589; Gatalica B, 1997, AM J HUM GENET, V60, P352; GROMPE M, 1993, NAT GENET, V5, P111, DOI 10.1038/ng1093-111; Holbrook K A, 1988, Birth Defects Orig Artic Ser, V24, P15; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Liu Q, 1996, HUM MOL GENET, V5, P107, DOI 10.1093/hmg/5.1.107; Munoz F, 1997, AM J HUM GENET, V61, P94; Pearson W R, 1994, Methods Mol Biol, V24, P307; Peltonen S, 1997, DNA CELL BIOL, V16, P227, DOI 10.1089/dna.1997.16.227; PINHEIRO M, 1979, AM J MED GENET, V4, P113, DOI 10.1002/ajmg.1320040202; ROHRER L, 1990, NATURE, V343, P570, DOI 10.1038/343570a0; SHEFFIELD VC, 1993, GENOMICS, V16, P325, DOI 10.1006/geno.1993.1193; Srivastava AK, 1997, P NATL ACAD SCI USA, V94, P13069, DOI 10.1073/pnas.94.24.13069; Srivastava AK, 1996, AM J HUM GENET, V58, P126; ZONANA J, 1989, J PEDIATR-US, V114, P392, DOI 10.1016/S0022-3476(89)80556-6; ZONANA J, 1992, AM J HUM GENET, V51, P1036; ZONANA J, 1988, AM J HUM GENET, V43, P75; ZONANA J, 1994, J MED GENET, V31, P287, DOI 10.1136/jmg.31.4.287; ZONANA J, 1993, SEMIN DERMATOL, V12, P241	28	163	178	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1998	63	2					380	389		10.1086/301984	http://dx.doi.org/10.1086/301984			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110CB	9683615	Green Published, Bronze			2022-12-18	WOS:000075360800013
J	Byrne, J; Rasmussen, SA; Steinhorn, SC; Connelly, RR; Myers, MH; Lynch, CF; Flannery, J; Austin, DF; Holmes, FF; Holmes, GE; Strong, LC; Mulvihill, JJ				Byrne, J; Rasmussen, SA; Steinhorn, SC; Connelly, RR; Myers, MH; Lynch, CF; Flannery, J; Austin, DF; Holmes, FF; Holmes, GE; Strong, LC; Mulvihill, JJ			Genetic disease in offspring of long-term survivors of childhood and adolescent cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BIRTH-DEFECTS; WILMS-TUMOR; CONGENITAL-ANOMALIES; PREGNANCY; CHILDREN; LEUKEMIA; MALFORMATIONS; RADIATION; EXPOSURE; PREVALENCE	Numerous case series have addressed the concern that cancer therapy may damage germ cells, leading to clinical disease in offspring of survivors. None has documented an increased risk. However, the methodological problems of small series make it difficult to draw firm conclusions regarding the potential of cancer treatments to damage the health of future offspring. We conducted a large interview study of adult survivors of childhood cancer treated before 1976. Genetic disease occurred in 3.4% of 2,198 offspring of survivors, compared with 3.1% of 4,544 offspring of controls (P = .33; not significant); there were no statistically significant differences in the proportion of offspring with cytogenetic syndromes, single-gene defects, or simple malformations. A comparison of survivors treated with potentially mutagenic therapy with survivors not so treated showed no association with sporadic genetic disease (P = .43). The present study provides reassurance that cancer treatment using older protocols does not carry a large risk for genetic disease in offspring conceived many years after treatment. With 80% power to detect an increase as small as 40% in the rate of genetic disease in offspring, this study did not do so. However, we cannot rule out the possibility that new therapeutic agents or specific combinations of agents at high doses may damage germ cells.	Childrens Natl Med Ctr, Dept Hematol Oncol, Washington, DC 20010 USA; NCI, Clin Epidemiol Branch, NIH, Bethesda, MD 20892 USA; NCI, Biometry Branch, NIH, Bethesda, MD 20892 USA; Boyne Res Inst, Drogheda, Ireland; Univ Florida, Dept Pediat, Div Genet, Gainesville, FL USA; Dept Hlth Serv, Calif Tumor Registry, Emeryville, CA USA; Dept Publ Hlth, Connecticut Tumor Registry, Hartford, CT USA; State Hlth Registry Iowa, Iowa City, IA USA; Univ Texas, MD Anderson Hosp & Tumor Inst, Dept Expt Pediat Genet, Houston, TX USA; Oregon Hlth Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97201 USA; Univ Kansas, Med Ctr, Dept Pediat, Kansas City, KS 66103 USA; Univ Kansas, Med Ctr, Dept Internal Med, Kansas City, KS 66103 USA; Univ Kansas, Med Ctr, Dept Prevent Med, Kansas City, KS 66103 USA; Univ Pittsburgh, Dept Genet, Pittsburgh, PA USA	Children's National Health System; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); State University System of Florida; University of Florida; University of Texas System; UTMD Anderson Cancer Center; Oregon Health & Science University; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Byrne, J (corresponding author), Childrens Natl Med Ctr, Dept Hematol Oncol, 111 Michigan Ave NW, Washington, DC 20010 USA.	jbyrne@cnmc.org						AISNER J, 1993, J CLIN ONCOL, V11, P507, DOI 10.1200/JCO.1993.11.3.507; BOUND JP, 1995, J EPIDEMIOL COMMUN H, V49, P164, DOI 10.1136/jech.49.2.164; BYRNE J, 1987, NEW ENGL J MED, V317, P1315, DOI 10.1056/NEJM198711193172104; BYRNE J, 1988, MED PEDIATR ONCOL, V16, P233, DOI 10.1002/mpo.2950160403; BYRNE J, 1992, NEW ENGL J MED, V326, P137; CORREAVILLASENOR A, 1991, AM J EPIDEMIOL, V134, P393, DOI 10.1093/oxfordjournals.aje.a116101; CROW JF, 1985, ADV HUM GENET, V14, P59; DEMARINI DM, 1989, MUTAT RES, V220, P11, DOI 10.1016/0165-1110(89)90006-7; DODDS L, 1993, BRIT MED J, V307, P164, DOI 10.1136/bmj.307.6897.164; Ellegren H, 1997, NATURE, V389, P593, DOI 10.1038/39303; EPSTEIN RJ, 1990, J CLIN ONCOL, V8, P2062, DOI 10.1200/JCO.1990.8.12.2062; FERENCZ C, 1985, AM J EPIDEMIOL, V121, P31, DOI 10.1093/oxfordjournals.aje.a113979; GARDNER MJ, 1990, BRIT MED J, V300, P423, DOI 10.1136/bmj.300.6722.423; GREEN DM, 1989, CANCER-AM CANCER SOC, V64, P2335, DOI 10.1002/1097-0142(19891201)64:11<2335::AID-CNCR2820641124>3.0.CO;2-7; GREEN DM, 1991, NEW ENGL J MED, V325, P141, DOI 10.1056/NEJM199107183250301; Green DM, 1997, ARCH PEDIAT ADOL MED, V151, P379, DOI 10.1001/archpedi.1997.02170410053007; Gurney JG, 1996, CANCER, V78, P532; HALES BF, 1992, TERATOLOGY, V45, P671, DOI 10.1002/tera.1420450612; HAWKINS MM, 1995, BRIT J CANCER, V71, P1335, DOI 10.1038/bjc.1995.259; HAWKINS MM, 1991, J NATL CANCER I, V83, P1643, DOI 10.1093/jnci/83.22.1643; HAWKINS MM, 1989, INT J CANCER, V43, P399, DOI 10.1002/ijc.2910430309; HAWKINS MM, 1994, BRIT MED J, V309, P1034, DOI 10.1136/bmj.309.6961.1034; JAMES LM, 1993, TERATOLOGY, V48, P551, DOI 10.1002/tera.1420480605; Kenney LB, 1996, CANCER, V78, P169, DOI 10.1002/(SICI)1097-0142(19960701)78:1<169::AID-CNCR23>3.3.CO;2-S; LI FP, 1987, JAMA-J AM MED ASSOC, V257, P216, DOI 10.1001/jama.257.2.216; MITTENDORF R, 1995, TERATOLOGY, V51, P435, DOI 10.1002/tera.1420510609; MOHRENWEISER HW, 1989, MUTAT RES, V212, P241, DOI 10.1016/0027-5107(89)90075-4; MULVIHILL JJ, 1985, CLINICS ONCOL, V4, P333; MULVIHILL JJ, 1987, CANCER, V60, P1143, DOI 10.1002/1097-0142(19870901)60:5<1143::AID-CNCR2820600537>3.0.CO;2-E; MULVIHILL JJ, 1987, LANCET, V2, P813; Neel J V, 1991, CHILDREN ATOMIC BOMB; NEEL JV, 1990, AM J HUM GENET, V46, P1053; NELSON K, 1989, NEW ENGL J MED, V320, P19, DOI 10.1056/NEJM198901053200104; NICHOLSON HS, 1994, CANCER, V73, P3094; Nicholson HS, 1996, CANCER, V78, P887; NOMURA T, 1982, NATURE, V296, P575, DOI 10.1038/296575a0; RASMUSSEN SA, 1990, AM J HUM GENET, V46, P478; Ries LAG, 1994, NIH PUBL; RUSSELL LB, 1981, MUTAT RES, V86, P329, DOI 10.1016/0165-1110(81)90010-5; SCHOLTE PJL, 1964, HUM GENET, V16, P26; SHU XO, 1994, CANCER EPIDEM BIOMAR, V3, P645	41	163	169	0	4	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1998	62	1					45	52		10.1086/301677	http://dx.doi.org/10.1086/301677			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YY246	9443870	Bronze, Green Published			2022-12-18	WOS:000072127900009
J	VERMA, RS; LUBS, HA				VERMA, RS; LUBS, HA			SIMPLE R-BANDING TECHNIQUE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV COLORADO,MED CTR,JOHN F KENNEDY CTR,DEPT PEDIAT,4200 E 9TH AVE,DENVER,CO 80220	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver								BOBROW M, 1973, CYTOGENET CELL GENET, V12, P145, DOI 10.1159/000130450; CARPENTIER S, 1972, ANN GENET-PARIS, V15, P203; COMINGS DE, 1973, EXP CELL RES, V77, P469, DOI 10.1016/0014-4827(73)90601-0; COMINGS DE, 1973, 23 P NOB S STOCKH, P293; DUTRILLAUX B, 1971, CR ACAD SCI D NAT, V272, P2638; DUTRILLAUX B, 1973, 23 P NOB S STOCKH, P38; EIBERG H, 1973, CLIN GENET, V4, P556; LAURENT C, 1972, ANN GENET-PARIS, V15, P201; Lubs H A, 1973, Methods Cell Biol, V6, P345, DOI 10.1016/S0091-679X(08)60057-6; LUBS HA, 1973, 23 P NOB S STOCKH, P315; SCHRECK RR, 1973, P NATL ACAD SCI USA, V70, P804, DOI 10.1073/pnas.70.3.804; WYANDT HE, 1974, 12 ANN SOM CELL GEN	12	163	163	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1975	27	1					110	117						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	V5202	50737				2022-12-18	WOS:A1975V520200010
J	KIDD, KK; SGARAMEL.LA				KIDD, KK; SGARAMEL.LA			PHYLOGENETIC ANALYSIS - CONCEPTS AND METHODS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BALAKRISHNAN V, 1968, BIOMETRICS, V24, P859, DOI 10.2307/2528876; Bhattacharyya A, 1946, SANKHYA, V7, P401; BOYCE AJ, 1969, NUMERICAL TAXONOMY; CAVALLI-SFORZA L. L., 1960, ATTI ASS GENET ITAL, V5, P333; CAVALLISFORZA LL, 1969, AM J HUM GENET, V21, P252; CAVALLISFORZA LL, 1967, EVOLUTION, V21, P550, DOI 10.1111/j.1558-5646.1967.tb03411.x; CAVALLISFORZA LL, 1964, 11 P INT C GEN HAG, V3, P923; CAVALLISFORZA LL, 1966, P ROY SOC          B, V194, P362; CAVALLISFORZA LL, 1969, 12 P INT C GEN TOK, V3, P405; CAVALLISFORZA LL, 1967, AM J HUM GENET, V9, P234; COTTERMAN CW, UNPUBLISHED NOTES; EDWARDS AW, TO BE PUBLISHED; EDWARDS AWF, 1965, BIOMETRICS, V21, P362, DOI 10.2307/2528096; EDWARDS AWF, 1970, J ROY STAT SOC B, V32, P155; EDWARDS AWF, 1971, ASSESSMENT AFFINITY; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; FITCH WM, 1969, AM J HUM GENET, V21, P384; FITCH WM, 1968, BROOKHAVEN SYM BIOL, P217; FRIEDLAENDER JS, 1971, AM J HUM GENET, V23, P253; GOWER JC, 1967, BIOMETRICS, V23, P623, DOI 10.2307/2528417; HAIGH J, 1970, J APPL PROBAB, V7, P79, DOI 10.2307/3212150; KIDD KK, 1969, GENETICS, V61, pS31; KIDD KK, 1971, 12 P INT C AN BLOOD; KIDD KK, 1971, P ANGLOROMANIAN C MA; KIDD KK, 1969, THESIS U WISCONSIN; Ore O., 1963, GRAPHS THEIR USES; PRIM RC, 1957, AT&T TECH J, V36, P1389, DOI 10.1002/j.1538-7305.1957.tb01515.x; Sokal R, 1963, PRINCIPLES NUMERICAL; WARD RH, 1970, AM J HUM GENET, V22, P538; ZONTA LA, 1966, ATTI ASSOC GENET IT, V11, P326; [No title captured]	31	163	166	0	10	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1971	23	3					235	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	J3602	5089842				2022-12-18	WOS:A1971J360200001
J	Mulle, JG; Dodd, AF; McGrath, JA; Wolyniec, PS; Mitchell, AA; Shetty, AC; Sobreira, NL; Valle, D; Rudd, MK; Satten, G; Cutler, DJ; Pulver, AE; Warren, ST				Mulle, Jennifer Gladys; Dodd, Anne F.; McGrath, John A.; Wolyniec, Paula S.; Mitchell, Adele A.; Shetty, Amol C.; Sobreira, Nara L.; Valle, David; Rudd, M. Katharine; Satten, Glen; Cutler, David J.; Pulver, Ann E.; Warren, Stephen T.			Microdeletions of 3q29 Confer High Risk for Schizophrenia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MENTAL-RETARDATION; RECURRENT REARRANGEMENTS; SUSCEPTIBILITY LOCI; BIPOLAR DISORDER; COMMON VARIANTS; CHROMOSOME 3Q29; LINKAGE; AUTISM; SAP97; ASSOCIATION	Schizophrenia (SZ) is a severe psychiatric illness that affects similar to 1% of the population and has a strong genetic underpinning. Recently, genome-wide analysis of copy-number variation (CNV) has implicated rare and de novo events as important in SZ. Here, we report a genome-wide analysis of 245 SZ cases and 490 controls, all of Ashkenazi Jewish descent. Because many studies have found an excess burden of large, rare deletions in cases, we limited our analysis to deletions over 500 kb in size. We observed seven large, rare deletions in cases, with 57% of these being de novo. We focused on one 836 kb de novo deletion at chromosome 3q29 that falls within a 1.3-1.6 Mb deletion previously identified in children with intellectual disability (ID) and autism, because increasing evidence suggests an overlap of specific rare copy-number variants (CNVs) between autism and SZ. By combining our data with prior CNV studies of SZ and analysis of the data of the Genetic Association Information Network (GAIN), we identified six 3q29 deletions among 7545 schizophrenic subjects and one among 39,748 controls, resulting in a statistically significant association with SZ (p = 0.02) and an odds ratio estimate of 17 (95% confidence interval: 1.36-1198.4). Moreover, this 3q29 deletion region contains two linkage peaks from prior SZ family studies, and the minimal deletion interval implicates 20 annotated genes, including PAK2 and DLG1, both paralogous to X-linked ID genes and now strong candidates for SZ susceptibility.	[Mulle, Jennifer Gladys; Dodd, Anne F.; Shetty, Amol C.; Rudd, M. Katharine; Satten, Glen; Cutler, David J.; Warren, Stephen T.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [McGrath, John A.; Wolyniec, Paula S.; Pulver, Ann E.] Johns Hopkins Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21231 USA; [Mitchell, Adele A.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Sobreira, Nara L.; Valle, David] Johns Hopkins Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21231 USA; [Satten, Glen] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA; [Pulver, Ann E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21231 USA; [Warren, Stephen T.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Warren, Stephen T.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA	Emory University; Johns Hopkins University; Johns Hopkins Medicine; Icahn School of Medicine at Mount Sinai; Johns Hopkins University; Johns Hopkins Medicine; Centers for Disease Control & Prevention - USA; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Emory University; Emory University	Mulle, JG (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.	jmulle@emory.edu; swarren@emory.edu	Shetty, Amol Carl/W-7121-2019; Mitchell, Adele/AAZ-1994-2020; Warren, Stephen T/A-2498-2012	McGrath, John A./0000-0002-9756-7892; Satten, Glen/0000-0001-7275-5371; Shetty, Amol/0000-0001-8790-7649	National Institute of Mental Health (NIMH); Genetic Association Information Network (GAIN); NIH, NIMH [MH080129, MH083722]; Ruth Kirschstein NRSA [5F32MH080583]; NARSAD; New York Crohn's Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F31HD068133] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Genetic Association Information Network (GAIN); NIH, NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Ruth Kirschstein NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD(NARSAD); New York Crohn's Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding support for the genome-wide association of schizophrenia study was provided by the National Institute of Mental Health (NIMH), and the genotyping of samples was provided through the Genetic Association Information Network (GAIN). The data used for the analyses described in this manuscript were obtained from the database of Genotype and Phenotype (dbGaP; accession number phs000021.v). Samples and associated phenotype data for the genome-wide association of schizophrenia study were provided by the Molecular Genetics of Schizophrenia Collaboration (PI: P.V. Gejman, Evanston Northwestern Healthcare [ENH] and Northwestern University, Evanston, IL, USA). Funding for this study was provided by NIH grants NIMH MH080129 and MH083722 to S.T.W., a Ruth Kirschstein NRSA (5F32MH080583) to J.G.M., and a NARSAD Young Investigator Award to J.G.M. This work was also supported by a grant from the New York Crohn's Foundation to A.A.M. We wish to thank L. Ozelius (Mt. Sinai University) and M. Abreu (University of Miami) for contribution of Ashkenazi Jewish control samples; K. Keith, K.E. Hermetz, and I.S. Goldlust (Emory University) for help with CNV validation; and M.E. Zwick (Emory University) for helpful discussion. The authors wish to thank the individuals diagnosed with schizophrenia and their family members who participated in this research.	Agresti A., 2003, CATEGORICAL DATA ANA; AGRESTI A, 1990, CATEGORICAL DATA ANA, P230; Akil H, 2010, SCIENCE, V327, P1580, DOI 10.1126/science.1188654; Atzmon G, 2010, AM J HUM GENET, V86, P850, DOI 10.1016/j.ajhg.2010.04.015; Bailer U, 2002, BIOL PSYCHIAT, V52, P40, DOI 10.1016/S0006-3223(02)01320-3; Ballif BC, 2008, MOL CYTOGENET, V1, DOI 10.1186/1755-8166-1-8; Baynam G, 2006, CLIN DYSMORPHOL, V15, P145, DOI 10.1097/01.mcd.0000198934.55071.ee; Ben-Shachar S, 2009, J MED GENET, V46, P382, DOI 10.1136/jmg.2008.064378; Crespi B, 2010, P NATL ACAD SCI USA, V107, P1736, DOI 10.1073/pnas.0906080106; Devlin B, 2002, MOL PSYCHIATR, V7, P689, DOI 10.1038/sj.mp.4001056; Fallin MD, 2005, AM J HUM GENET, V77, P918, DOI 10.1086/497703; Fallin MD, 2003, AM J HUM GENET, V73, P601, DOI 10.1086/378158; Gaspar PA, 2009, J NEUROCHEM, V111, P891, DOI 10.1111/j.1471-4159.2009.06325.x; Guilmatre A, 2009, ARCH GEN PSYCHIAT, V66, P947, DOI 10.1001/archgenpsychiatry.2009.80; Hayashi-Takagi A, 2010, NAT NEUROSCI, V13, P327, DOI 10.1038/nn.2487; Howard MA, 2010, P NATL ACAD SCI USA, V107, P3805, DOI 10.1073/pnas.0914422107; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Kirov G, 2009, SCHIZOPHRENIA BULL, V35, P851, DOI 10.1093/schbul/sbp079; Lin S, 2004, NAT GENET, V36, P1181, DOI 10.1038/ng1457; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Miller DT, 2009, J MED GENET, V46, P242, DOI 10.1136/jmg.2008.059907; Nash JE, 2010, J NEUROCHEM, V112, P677, DOI 10.1111/j.1471-4159.2009.06480.x; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Pagnamenta AT, 2009, EUR J HUM GENET, V17, P687, DOI 10.1038/ejhg.2008.228; Pique-Regi R, 2008, BIOINFORMATICS, V24, P309, DOI 10.1093/bioinformatics/btm601; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; R Foundation for Statistical Computing R Development Core Team, 2010, R LANG ENV STAT COMP; Rujescu D, 2009, EPIDEMIOL PSICHIAT S, V18, P91, DOI 10.1017/S1121189X00000944; Sato J, 2008, J NEURAL TRANSM, V115, P1355, DOI 10.1007/s00702-008-0085-9; Schosser A, 2004, J PSYCHIATR RES, V38, P357, DOI 10.1016/j.jpsychires.2003.11.004; Schosser A, 2007, EUR NEUROPSYCHOPHARM, V17, P501, DOI 10.1016/j.euroneuro.2007.01.004; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Shields J, 1982, SCHIZOPHRENIA EPIGEN; Shin EY, 2009, BIOCHEM BIOPH RES CO, V379, P384, DOI 10.1016/j.bbrc.2008.12.066; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Tian C, 2009, MOL MED, V15, P371, DOI 10.2119/molmed.2009.00094; Toyooka K, 2002, J NEUROCHEM, V83, P797, DOI 10.1046/j.1471-4159.2002.01181.x; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Willatt L, 2005, AM J HUM GENET, V77, P154, DOI 10.1086/431653; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Zhou WG, 2008, J NEUROSCI, V28, P10220, DOI 10.1523/JNEUROSCI.3434-08.2008; NATURE, V455, P237	46	162	165	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG 13	2010	87	2					229	236		10.1016/j.ajhg.2010.07.013	http://dx.doi.org/10.1016/j.ajhg.2010.07.013			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641EG	20691406	Green Published, Bronze			2022-12-18	WOS:000281107000007
J	Froyen, G; Corbett, M; Vandewalle, J; Jarvela, I; Lawrence, O; Meldrum, C; Bauters, M; Govaerts, K; Vandeleur, L; van Esch, H; Chelly, J; Sanlaville, D; van Bokhoven, H; Ropers, HH; Laumonnier, F; Ranieri, E; Schwartz, CE; Abidi, F; Tarpey, PS; Futreal, PA; Whibley, A; Raymond, FL; Stratton, MR; Fryns, JP; Scott, R; Peippo, M; Sipponen, M; Partington, M; Mowat, D; Field, M; Hackett, A; Marynen, P; Turner, G; Gecz, J				Froyen, Guy; Corbett, Mark; Vandewalle, Joke; Jarvela, Irma; Lawrence, Owen; Meldrum, Cliff; Bauters, Marijke; Govaerts, Karen; Vandeleur, Lucianne; van Esch, Hilde; Chelly, Jamel; Sanlaville, Damien; van Bokhoven, Hans; Ropers, Hans-Hilger; Laumonnier, Frederic; Ranieri, Enzo; Schwartz, Charles E.; Abidi, Fatima; Tarpey, Patrick S.; Futreal, P. Andrew; Whibley, Annabel; Raymond, F. Lucy; Stratton, Michael R.; Fryns, Jean-Pierre; Scott, Rodney; Peippo, Maarit; Sipponen, Marjatta; Partington, Michael; Mowat, David; Field, Michael; Hackett, Anna; Marynen, Peter; Turner, Gillian; Gecz, Jozef			Submicroscopic duplications of the hydroxysteroid dehydrogenase HSD17B10 and the E3 ubiquitin ligase HUWE1 are associated with mental retardation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; ARRAY-CGH; ANGELMAN SYNDROME; GENE-EXPRESSION; BRAIN DISEASES; MUTATIONS; PROTEIN; ABNORMALITIES; DEFICIENCY; ISOLEUCINE	Submicroscopic copy-number imbalances contribute significantly to the genetic etiology of human disease. Here, we report a novel microduplication hot spot at Xp11.22 identified in six unrelated families with predominantly nonsyndromic XLMR. All duplications segregate with the disease, including the large families MRX17 and MRX31. The minimal, commonly duplicated region contains three genes: R1BC1, HSD17B10, and HUWE1. RIBC1 could be excluded on the basis of its absence of expression in the brain and because it escapes X inactivation in females. For the other genes, expression array and quantitative PCR analysis in patient cell lines compared to controls showed a significant upregulation of HSD17B10 and HUWE1 as well as several important genes in their molecular pathways. Loss-of-function mutations of HSD17B10 have previously been associated with progressive neurological disease and XLMR. The E3 ubiquitin ligase HUWE1 has been implicated in TP53-associated regulation of the neuronal cell cycle. Here, we also report segregating sequence changes of highly conserved residues in HUWE1 in three XLMR families; these changes are possibly associated with the phenotype. Our findings demonstrate that an increased gene dosage of HSD17B10, HUWE1, or both contribute to the etiology of XLMR and suggest that point mutations in HUWE1 are associated with this disease too.	[Froyen, Guy; Vandewalle, Joke; Bauters, Marijke; Govaerts, Karen; Marynen, Peter] VIB, Human Genome Lab, Dept Mol & Dev Genet, B-3000 Louvain, Belgium; [Vandewalle, Joke; Bauters, Marijke; Govaerts, Karen; Marynen, Peter] Katholieke Univ Leuven, Dept Human Genet, Human Genet Lab, B-3000 Louvain, Belgium; [Corbett, Mark; Vandeleur, Lucianne; Gecz, Jozef] Womens & Childrens Hosp, Dept Med Genet, Adelaide, SA 5005, Australia; [Jarvela, Irma] Univ Helsinki, Cent Hosp, Lab Serv, Genet Mol Lab, FIN-00290 Helsinki, Finland; [Jarvela, Irma] Univ Helsinki, Dept Med Genet, FIN-00290 Helsinki, Finland; [Lawrence, Owen; Meldrum, Cliff; Scott, Rodney] John Hunter Hosp, Mol Genet Lab HAPS, Newcastle, NSW 2305, Australia; [van Esch, Hilde; Fryns, Jean-Pierre] Univ Leuven, Univ Hosp Leuven, Dept Human Genet, B-3000 Louvain, Belgium; [Chelly, Jamel] Univ Paris 05, CNRS, Inst Cochin, UMR 8104, F-75014 Paris, France; [Chelly, Jamel] INSERM, U567, F-75014 Paris, France; [Sanlaville, Damien] Necker Enfants Malad Hosp, Dept Genet, F-75935 Paris, France; [van Bokhoven, Hans] Univ Med Ctr, Dept Human Genet, NL-6500 Nijmegen, Netherlands; [Ropers, Hans-Hilger] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Laumonnier, Frederic] Ctr Hosp Univ Tours, Univ Bretonneau, INSERM, U619, F-37044 Tours, France; [Schwartz, Charles E.; Abidi, Fatima] Greenwood Genet Ctr, JC Self Res Inst Human Genet, Greenwood, SC 29646 USA; [Tarpey, Patrick S.; Futreal, P. Andrew; Stratton, Michael R.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Whibley, Annabel; Raymond, F. Lucy] Cambridge Inst Med Res, Cambridge CB2 2XY, England; [Peippo, Maarit; Sipponen, Marjatta] Family Fed Finland, Helsinki, Finland; [Partington, Michael; Field, Michael; Hackett, Anna; Turner, Gillian] Univ Newcastle, GOLD Serv Hunter Genet, Newcastle, NSW 2308, Australia; [Mowat, David] Sydney Childrens Hosp, Dept Genet, Newcastle, NSW 2308, Australia; [Gecz, Jozef] Univ Adelaide, Dept Pediat, Adelaide, SA 5005, Australia; [Gecz, Jozef] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia	Flanders Institute for Biotechnology (VIB); KU Leuven; Womens & Childrens Hospital Australia; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; John Hunter Hospital; KU Leuven; University Hospital Leuven; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Max Planck Society; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Greenwood Genetic Center; Wellcome Trust Sanger Institute; University of Cambridge; Family Federation of Finland; University of Newcastle; University of Adelaide; University of Adelaide	Froyen, G (corresponding author), VIB, Human Genome Lab, Dept Mol & Dev Genet, B-3000 Louvain, Belgium.	guy.froyen@med.kuleuven.be	Jarvela, Irma E/L-5836-2013; Chelly, Jamel/J-7528-2015; Van+Esch, Hilde/AAU-5688-2020; Bokhoven, J.H.L.M. van van/H-8015-2014; Whibley, Annabel/G-2836-2011; Whibley, Annabel/P-2509-2017; Corbett, Mark/A-8063-2010; van Bokhoven, Hans/D-8764-2012; Gecz, Jozef/X-3469-2019; Sanlaville, Damien/M-4716-2014; Laumonnier, Frederic/N-1165-2016; Scott, Rodney/B-2827-2013	Jarvela, Irma E/0000-0002-1770-6187; Chelly, Jamel/0000-0002-0939-8719; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Whibley, Annabel/0000-0003-1878-7705; Corbett, Mark/0000-0001-9298-3072; Gecz, Jozef/0000-0002-7884-6861; Sanlaville, Damien/0000-0001-9939-2849; Laumonnier, Frederic/0000-0003-2567-0708; Meldrum, Cliff/0000-0002-5685-1918; Scott, Rodney/0000-0001-7724-3404; Van Esch, Hilde/0000-0002-9604-5726	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD026202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031564] Funding Source: NIH RePORTER; NICHD NIH HHS [HD26202, R01 HD026202] Funding Source: Medline; NINDS NIH HHS [R01 NS031564, NS31564] Funding Source: Medline; Wellcome Trust Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Albertson DG, 2003, HUM MOL GENET, V12, pR145, DOI 10.1093/hmg/ddg261; ARMSTRONG JF, 1995, CURR BIOL, V5, P931, DOI 10.1016/S0960-9822(95)00183-7; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Donnelly AJ, 1996, AM J MED GENET, V64, P113, DOI 10.1002/(SICI)1096-8628(19960712)64:1<113::AID-AJMG19>3.0.CO;2-Q; Froyen G, 2007, HUM MUTAT, V28, P1034, DOI 10.1002/humu.20564; Gecz J, 2004, FRONT BIOSCI, V9, P1, DOI 10.2741/1199; GEDEON A, 1994, AM J MED GENET, V51, P553, DOI 10.1002/ajmg.1320510453; Inoue T, 2005, ADV INFORM TECHNOL, V2, P1; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Korman SH, 2006, MOL GENET METAB, V89, P289, DOI 10.1016/j.ymgme.2006.07.010; Laumonnier F, 2007, AM J HUM GENET, V80, P205, DOI 10.1086/511441; Lenski C, 2007, AM J HUM GENET, V80, P372, DOI 10.1086/511527; Leonard H, 2002, MENT RETARD DEV D R, V8, P117, DOI 10.1002/mrdd.10031; Lugtenberg D, 2007, GENET MED, V9, P560, DOI 10.1097/GIM.0b013e318149e647; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Medrano S, 2005, BIOCHEM BIOPH RES CO, V331, P828, DOI 10.1016/j.bbrc.2005.03.194; Menten B, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039453; Musio A, 2006, NAT GENET, V38, P528, DOI 10.1038/ng1779; Nascimento RMP, 2006, AM J HUM GENET, V79, P549, DOI 10.1086/507047; Ofman R, 2003, AM J HUM GENET, V72, P1300, DOI 10.1086/375116; Poll-The BT, 2004, MOL GENET METAB, V81, P295, DOI 10.1016/j.ymgme.2003.11.013; Ropers HH, 2006, CURR OPIN GENET DEV, V16, P260, DOI 10.1016/j.gde.2006.04.017; Ross CA, 2004, TRENDS CELL BIOL, V14, P703, DOI 10.1016/j.tcb.2004.10.006; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Saifi GM, 2003, J INVEST MED, V51, P261, DOI 10.1136/jim-51-05-14; Shaffer UG, 2006, J PEDIATR-US, V149, P98, DOI 10.1016/j.jpeds.2006.02.006; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731; Stankiewicz P, 2007, CURR OPIN GENET DEV, V17, P182, DOI 10.1016/j.gde.2007.04.009; Tarpey PS, 2007, AM J HUM GENET, V80, P345, DOI 10.1086/511134; Tien K, 2004, ANN NEUROL, V56, P51, DOI 10.1002/ana.20133; TURNER G, 1994, AM J MED GENET, V51, P575, DOI 10.1002/ajmg.1320510456; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; Vissers LELM, 2003, AM J HUM GENET, V73, P1261, DOI 10.1086/379977; Yang SY, 2007, MOL GENET METAB, V92, P36, DOI 10.1016/j.ymgme.2007.06.001; Yang SY, 2005, FEBS J, V272, P4874, DOI 10.1111/j.1742-4658.2005.04911.x; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4; Yoon SY, 2005, BIOCHEM BIOPH RES CO, V326, P7, DOI 10.1016/j.bbrc.2004.11.004; Zenker M, 2005, NAT GENET, V37, P1345, DOI 10.1038/ng1681	42	162	169	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2008	82	2					432	443		10.1016/j.ajhg.2007.11.002	http://dx.doi.org/10.1016/j.ajhg.2007.11.002			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NN	18252223	Bronze, Green Published			2022-12-18	WOS:000253223900015
J	Zhernakova, A; Alizadeh, BZ; Bevova, M; van Leeuwen, MA; Coenen, MJH; Franke, B; Franke, L; Posthumus, MD; van Heel, DA; van der Steege, G; Radstake, TRDJ; Barrera, P; Roep, BO; Koeleman, BPC; Wijmenga, C				Zhernakova, Alexandra; Alizadeh, Behrooz Z.; Bevova, Marianna; van Leeuwen, Miek A.; Coenen, Marieke J. H.; Franke, Barbara; Franke, Lude; Posthumus, Marcel D.; van Heel, David A.; van der Steege, Gerrit; Radstake, Timothy R. D. J.; Barrera, Pilar; Roep, Bart O.; Koeleman, Bobby P. C.; Wijmenga, Cisca			Novel association in chromosome 4q27 region with rheumatoid arthritis and confirmation of type 1 diabetes point to a general risk locus for autoimmune diseases	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CELIAC-DISEASE; DIFFERENTIATION; INTERLEUKIN-21; SUSCEPTIBILITY; MODULATOR; PTPN22; IL-21	Recently, association of celiac disease with common single-nucleotide polymorphism (SNP) variants in an extensive linkage-disequilibrium block of 480 kb containing the KIAA1109, Tenr, IL2, and IL21 genes has been demonstrated in three independent populations (rs6822844P(combined) = 1.3 x 10(-14)). The KIA1109/Tenr/IL2/IL21 block corresponds to the Idd3 locus in the nonobese diabetic mouse model of type 1 diabetes (T1D). This block was recently found to be associated with T1D in a genomewide association study, although this finding lacks unequivocal confirmation. We therefore aimed to investigate whether the KIAA1109/Tenr/IL2/IL21 region is involved in susceptibility to multiple autoimmune diseases. We tested SNP rs6822844 for association with disease in 350 T1D-affected and 1,047 rheumatoid arthritis (RA)-affected Dutch patients and in 929 controls. We replicated the association with T1D (P=.0006; OR 0.64 [95% Cl 0.50-0.83]), and revealed a similar novel association with RA (P=.0002; OR 0.72 [95% Cl 0.61-0.86]). Our results replicate and extend the association found in the KIAA1109/Tenr/IL2/IL21 gene region with autoimmune diseases, implying that this locus is a general risk factor for multiple autoimmune diseases.	Univ Med Ctr Utrecht, Dept Med Genet, Complex Genet Sect, NL-3508 AB Utrecht, Netherlands; Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol, Groningen, Netherlands; Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; Radford Univ, Nijmegen Med Ctr, Dept Human Genet, Nijmegen, Netherlands; Radford Univ, Nijmegen Med Ctr, Dept Rheumatol, Nijmegen, Netherlands; Barts & London Queen Marys Sch Med & Dent, Inst Cell & Mol Sci, London, England	Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; University of Groningen; Radboud University Nijmegen; Radboud University Nijmegen; University of London; Queen Mary University London	Koeleman, BPC (corresponding author), Univ Med Ctr Utrecht, Dept Med Genet, Complex Genet Sect, PO Box 85060, NL-3508 AB Utrecht, Netherlands.	b.p.c.koeleman@umcutrecht.nl	van der Steege, Gerrit/AET-2661-2022; Alizadeh, Behrooz Z Ziad/J-2921-2017; Franke, Barbara/D-4836-2009; Franke, Lude/P-7036-2016; Roep, Bart/AAD-7609-2021; Wijmenga, Cisca/D-2173-2009; Zhernakova, Alexandra/ABA-9372-2020; Wijmenga, Cisca/AAE-7719-2019; Coenen, Marieke/A-2159-2010	Alizadeh, Behrooz Z Ziad/0000-0002-1415-8007; Franke, Barbara/0000-0003-4375-6572; Franke, Lude/0000-0002-5159-8802; Wijmenga, Cisca/0000-0002-5635-1614; Coenen, Marieke/0000-0001-8796-2031; van Heel, David/0000-0002-0637-2265; Zhernakova, Alexandra/0000-0002-4574-0841	Wellcome Trust [GR068094MA] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Barera G, 2002, PEDIATRICS, V109, P833, DOI 10.1542/peds.109.5.833; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Brand Oliver, 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009981; Brandt K, 2007, CYTOKINE GROWTH F R, V18, P223, DOI 10.1016/j.cytogfr.2007.04.003; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; HALDANE JBS, 1956, ANN HUM GENET, V20, P309; Herber D, 2007, J IMMUNOL, V178, P3822, DOI 10.4049/jimmunol.178.6.3822; King C, 2004, CELL, V117, P265, DOI 10.1016/S0092-8674(04)00335-6; Lee AT, 2005, GENES IMMUN, V6, P129, DOI 10.1038/sj.gene.6364159; Leonard WJ, 2005, NAT REV IMMUNOL, V5, P688, DOI 10.1038/nri1688; Levin L, 2003, AUTOIMMUN REV, V2, P377, DOI 10.1016/S1568-9972(03)00080-6; Lin JP, 1998, HUM GENET, V103, P475, DOI 10.1007/s004390050853; Michou L, 2007, P NATL ACAD SCI USA, V104, P1649, DOI 10.1073/pnas.0610250104; Ozaki K, 2004, J IMMUNOL, V173, P5361, DOI 10.4049/jimmunol.173.9.5361; Tait KF, 2004, DIABETIC MED, V21, P358, DOI 10.1111/j.1464-5491.2004.01162.x; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Vella A, 2005, AM J HUM GENET, V76, P773, DOI 10.1086/429843; Welsing PMJ, 2004, J RHEUMATOL, V31, P14; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958	22	162	165	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2007	81	6					1284	1288		10.1086/522037	http://dx.doi.org/10.1086/522037			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233NY	17999365	Bronze, Green Published			2022-12-18	WOS:000251098800014
J	Asimaki, A; Syrris, P; Wichter, T; Matthias, P; Saffitz, JE; McKenna, WJ				Asimaki, Angeliki; Syrris, Petros; Wichter, Thomas; Matthias, Paul; Saffitz, Jeffrey E.; McKenna, William J.			A novel dominant mutation in plakoglobin causes Arrhythmogenic right ventricular cardiomyopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BETA-CATENIN; BINDING-SITES; NAXOS-DISEASE; PROTEIN; CADHERIN; IDENTIFICATION; GENE; DYSPLASIA/CARDIOMYOPATHY; DESMOCOLLIN-2; PLAKOPHILIN-2	Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited disorder associated with arrhythmias and sudden death. A recessive mutation in the gene encoding plakoglobin has been shown to cause Naxos disease, a cardiocutaneous syndrome characterized by ARVC and abnormalities of hair and skin. Here, we report, for the first time, a dominant mutation in the gene encoding plakoglobin in a German family with ARVC but no cutaneous abnormalities. The mutation (S39_K40insS) is predicted to insert an extra serine residue at position 39 in the N-terminus of plakoglobin. Analysis of a biopsy sample of the right ventricle from the proband showed markedly decreased localization of plakoglobin, desmoplakin, and connexin43 at intercalated discs in cardiac myocytes. A yeast-two-hybrid screen revealed that the mutant protein established novel interactions with histidine-rich calcium-binding protein and TGF beta induced apoptosis protein 2. Immunoblotting and confocal microscopy in human embryonic kidney 293 (HEK293) cell lines transfected to stably express either wild-type or mutant plakoglobin protein showed that the mutant protein was apparently ubiquitylated and was preferentially located in the cytoplasm, suggesting that the S39_K40insS mutation may increase plakoglobin turnover via proteasomal degradation. HEK293 cells expressing mutant plakoglobin also showed higher rates of proliferation and lower rates of apoptosis than did cells expressing the wild-type protein. Electron microscopy showed smaller and fewer desmosomes in cells expressing mutant plakoglobin. Taken together, these observations suggest that the S39_K40insS mutation affects the structure and distribution of mechanical and electrical cell junctions and could interfere with regulatory mechanisms mediated by Wnt-signaling pathways. These results implicate novel molecular mechanisms in the pathogenesis of ARVC.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; Natl Hlth Serv Trust, Univ Coll London Hosp, Heart Hosp, Dept Med, London, England; Univ Hosp Munster, Dept Cardiol & Angiol, Munster, Germany	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Munster	Saffitz, JE (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA.	jsaffitz@bidmc.harvard.edu	SYRRIS, PETROS/C-1703-2008; McKenna, William J/C-3243-2008; ASIMAKI, ANGELIKI/J-7140-2016	SYRRIS, PETROS/0000-0002-2363-8758; McKenna, William J/0000-0001-7994-2460; ASIMAKI, ANGELIKI/0000-0001-9886-6870				Charpentier E, 2000, J CELL BIOL, V149, P503, DOI 10.1083/jcb.149.2.503; Chen XY, 2002, J BIOL CHEM, V277, P10512, DOI 10.1074/jbc.M108765200; Chitaev NA, 1996, J CELL BIOL, V133, P359, DOI 10.1083/jcb.133.2.359; Garcia-Gras E, 2006, J CLIN INVEST, V116, P2012, DOI 10.1172/JCI27751; Gerull B, 2004, NAT GENET, V36, P1162, DOI 10.1038/ng1461; Green KJ, 2000, NAT REV MOL CELL BIO, V1, P208, DOI 10.1038/35043032; Hakimelahi S, 2000, J BIOL CHEM, V275, P10905, DOI 10.1074/jbc.275.15.10905; Hatsell S, 2003, J BIOL CHEM, V278, P37745, DOI 10.1074/jbc.M301346200; Heuser A, 2006, AM J HUM GENET, V79, P1081, DOI 10.1086/509044; Kaplan SR, 2004, HEART RHYTHM, V1, P3, DOI 10.1016/j.hrthm.2004.01.001; Kaplan SR, 2004, CARDIOVASC PATHOL, V13, P26, DOI 10.1016/S1054-8807(03)00107-8; Kim E, 2003, BIOCHEM BIOPH RES CO, V300, P192, DOI 10.1016/S0006-291X(02)02829-2; Kowalczyk AP, 1997, J CELL BIOL, V139, P773, DOI 10.1083/jcb.139.3.773; MCKENNA WJ, 1994, BRIT HEART J, V71, P215; McKoy G, 2000, LANCET, V355, P2119, DOI 10.1016/S0140-6736(00)02379-5; Pilichou K, 2006, CIRCULATION, V113, P1171, DOI 10.1161/CIRCULATIONAHA.105.583674; Rampazzo A, 2002, AM J HUM GENET, V71, P1200, DOI 10.1086/344208; Rubenstein A, 1997, DEV GENET, V20, P91, DOI 10.1002/(SICI)1520-6408(1997)20:2<91::AID-DVG2>3.0.CO;2-3; SACCO PA, 1995, J BIOL CHEM, V270, P20201, DOI 10.1074/jbc.270.34.20201; Sadot E, 2000, ONCOGENE, V19, P1992, DOI 10.1038/sj.onc.1203519; Saffitz JE, 2000, AM J PHYSIOL-HEART C, V278, pH1662, DOI 10.1152/ajpheart.2000.278.5.H1662; Syrris P, 2006, AM J HUM GENET, V79, P978, DOI 10.1086/509122; THIENE G, 1988, NEW ENGL J MED, V318, P129, DOI 10.1056/NEJM198801213180301; Tiso N, 2001, HUM MOL GENET, V10, P189, DOI 10.1093/hmg/10.3.189; Troyanovsky RB, 1996, J CELL SCI, V109, P3069; Uzumcu A, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.032904; Witcher LL, 1996, J BIOL CHEM, V271, P10904, DOI 10.1074/jbc.271.18.10904; Yamaji K, 2005, ACTA CARDIOL, V60, P465, DOI 10.2143/AC.60.5.2004965; Zhurinsky J, 2000, J CELL SCI, V113, P3127	29	162	167	0	9	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2007	81	5					964	973		10.1086/521633	http://dx.doi.org/10.1086/521633			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	224XE	17924338	Green Published, Bronze			2022-12-18	WOS:000250480900008
J	Wagner, A; Barrows, A; Wijnen, JT; van der Klift, H; Franken, PF; Verkuijlen, P; Nakagawa, H; Geugien, M; Jaghmohan-Changur, S; Breukel, C; Meijers-Heijboer, H; Morreau, H; van Puijenbroek, M; Burn, J; Coronel, S; Kinarski, Y; Okimoto, R; Watson, P; Lynch, JF; de la Chapelle, A; Lynch, HT; Fodde, R				Wagner, A; Barrows, A; Wijnen, JT; van der Klift, H; Franken, PF; Verkuijlen, P; Nakagawa, H; Geugien, M; Jaghmohan-Changur, S; Breukel, C; Meijers-Heijboer, H; Morreau, H; van Puijenbroek, M; Burn, J; Coronel, S; Kinarski, Y; Okimoto, R; Watson, P; Lynch, JF; de la Chapelle, A; Lynch, HT; Fodde, R			Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: High mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MISMATCH-REPAIR GENES; MICROSATELLITE INSTABILITY; GERMLINE MUTATIONS; COLON-CANCER; FUNCTIONAL-ANALYSIS; HUMAN MLH1; HNPCC; TUMORS; HMLH1; REARRANGEMENTS	The identification of germline mutations in families with HNPCC is hampered by genetic heterogeneity and clinical variability. In previous studies, MSH2 and MLH1 mutations were found in approximately two-thirds of the Amsterdam-criteria-positive families and in much lower percentages of the Amsterdam-criteria-negative families. Therefore, a considerable proportion of HNPCC seems not to be accounted for by the major mismatch repair (MMR) genes. Does the latter result from a lack of sensitivity of mutation detection techniques, or do additional genes underlie the remaining cases? In this study we address these questions by thoroughly investigating a cohort of clinically selected North American families with HNPCC. We analyzed 59 clinically well-defined U. S. families with HNPCC for MSH2, MLH1, and MSH6 mutations. To maximize mutation detection, different techniques were employed, including denaturing gradient gel electrophoresis, Southern analysis, microsatellite instability, immunohistochemistry, and monoallelic expression analysis. In 45 (92%) of the 49 Amsterdam-criteria-positive families and in 7 (70%) of the 10 Amsterdam-criteria-negative families, a mutation was detected in one of the three analyzed MMR genes. Forty-nine mutations were in MSH2 or MLH1, and only three were in MSH6. A considerable proportion (27%) of the mutations were genomic rearrangements ( 12 in MSH2 and 2 in MLH1). Notably, a deletion encompassing exons 1-6 of MSH2 was detected in seven apparently unrelated families (12% of the total cohort) and was subsequently proven to be a founder. Screening of a second U. S. cohort with HNPCC from Ohio allowed the identification of two additional kindreds with the identical founder deletion. In the present study, we show that optimal mutation detection in HNPCC is achieved by combining accurate and expert clinical selection with an extensive mutation detection strategy. Notably, we identified a common North American deletion in MSH2, accounting for similar to10% of our cohort. Genealogical, molecular, and haplotype studies showed that this deletion represents a North American founder mutation that could be traced back to the 19th century.	Leiden Univ, Ctr Human & Clin Genet, Med Ctr, NL-2333 AL Leiden, Netherlands; Leiden Univ, Dept Pathol, Med Ctr, NL-2333 AL Leiden, Netherlands; Erasmus Univ, Dept Clin Genet, Med Ctr, NL-3000 DR Rotterdam, Netherlands; Creighton Univ, Dept Prevent Med & Publ Hlth, Omaha, NE 68178 USA; Ohio State Univ, Ctr Comprehens Canc, Human Canc Genet Program, Columbus, OH 43210 USA; Univ Newcastle Upon Tyne, Dept Clin Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Creighton University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Newcastle University - UK	Fodde, R (corresponding author), Leiden Univ, Ctr Human & Clin Genet, Med Ctr, Wassenaarseweg 72, NL-2333 AL Leiden, Netherlands.		Fodde, Riccardo/AAW-9394-2021	Fodde, Riccardo/0000-0001-9839-4324; Burn, John/0000-0002-9823-2322	NATIONAL CANCER INSTITUTE [U01CA067941, R01CA067941] Funding Source: NIH RePORTER; NCI NIH HHS [U01 CA067941, R01 CA067941, CA67941, CA169058] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AALTONEN LA, 1994, CANCER RES, V54, P1645; Aarnio M, 1999, INT J CANCER, V81, P214, DOI 10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO;2-L; Akiyama Y, 1997, CANCER RES, V57, P3920; Boland CR, 1998, CANCER RES, V58, P5248; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; Charbonnier F, 2002, CANCER RES, V62, P848; de Leeuw WJF, 2000, J PATHOL, V192, P328, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH701>3.0.CO;2-2; Ellison AR, 2001, HUM MOL GENET, V10, P1889, DOI 10.1093/hmg/10.18.1889; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Foulkes WD, 2002, AM J HUM GENET, V71, P1395, DOI 10.1086/345075; Fujiwara T, 1998, AM J PATHOL, V153, P1063, DOI 10.1016/S0002-9440(10)65651-9; Giardiello FM, 2001, GASTROENTEROLOGY, V121, P198, DOI 10.1053/gast.2001.25581; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; Halford S, 2002, CANCER RES, V62, P53; HAMILTON SR, 1995, NEW ENGL J MED, V332, P839, DOI 10.1056/NEJM199503303321302; Hendriks Y, 2003, AM J PATHOL, V162, P469, DOI 10.1016/S0002-9440(10)63841-2; Hutter P, 2000, J MED GENET, V37, P776, DOI 10.1136/jmg.37.10.776; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Jagmohan-Changur S, 2003, CANCER RES, V63, P154; Jarvinen HJ, 2000, GASTROENTEROLOGY, V118, P829, DOI 10.1016/S0016-5085(00)70168-5; Kolodner RD, 1999, CANCER RES, V59, P5068; Lindor NM, 2002, J CLIN ONCOL, V20, P1043, DOI 10.1200/JCO.20.4.1043; Liu T, 2001, CANCER RES, V61, P7798; Lynch HT, 1999, CANCER, V86, P1637; Lynch HT, 1999, CYTOGENET CELL GENET, V86, P130, DOI 10.1159/000015365; Miyaki M, 1997, NAT GENET, V17, P271, DOI 10.1038/ng1197-271; Nakagawa H, 2002, CANCER RES, V62, P4579; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; PAPADOPOULOS N, 1995, NAT GENET, V11, P99, DOI 10.1038/ng0995-99; Peltomaki P, 1997, GASTROENTEROLOGY, V113, P1146, DOI 10.1053/gast.1997.v113.pm9322509; RodriguezBigas MA, 1997, J NATL CANCER I, V89, P1758, DOI 10.1093/jnci/89.23.1758; Shimodaira H, 1998, NAT GENET, V19, P384, DOI 10.1038/1277; Shin KH, 2002, CANCER RES, V62, P38; Smits R, 2000, GENE CHROMOSOME CANC, V29, P229, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1033>3.0.CO;2-R; Stella A, 2001, CANCER RES, V61, P7020; Syngal S, 2000, J MED GENET, V37, P641, DOI 10.1136/jmg.37.9.641; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Trojan J, 2002, GASTROENTEROLOGY, V122, P211, DOI 10.1053/gast.2002.30296; Vasen HFA, 1996, GASTROENTEROLOGY, V110, P1020, DOI 10.1053/gast.1996.v110.pm8612988; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Wagner A, 2002, GENE CHROMOSOME CANC, V35, P49, DOI 10.1002/gcc.10094; Wagner A, 2001, J MED GENET, V38, P318, DOI 10.1136/jmg.38.5.318; Wahlberg SS, 2002, CANCER RES, V62, P3485; WIJNEN J, 1994, HUM MOL GENET, V3, P2268, DOI 10.1093/hmg/3.12.2268-a; Wijnen J, 1998, NAT GENET, V20, P326, DOI 10.1038/3795; Wijnen J, 1997, AM J HUM GENET, V61, P329, DOI 10.1086/514847; Wijnen J, 1999, NAT GENET, V23, P142, DOI 10.1038/13773; Wijnen JT, 1998, NEW ENGL J MED, V339, P511, DOI 10.1056/NEJM199808203390804; Wu Y, 2001, NAT GENET, V29, P137, DOI 10.1038/ng1001-137; Wu Y, 2001, GASTROENTEROLOGY, V120, P1580, DOI 10.1053/gast.2001.25117; Wu Y, 1999, AM J HUM GENET, V65, P1291, DOI 10.1086/302612; Yan H, 2000, NATURE, V403, P723, DOI 10.1038/35001659; Yuan ZQ, 1999, J MED GENET, V36, P790	54	162	171	0	6	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2003	72	5					1088	1100		10.1086/373963	http://dx.doi.org/10.1086/373963			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671PZ	12658575	Bronze, Green Published			2022-12-18	WOS:000182474400003
J	Gilbert, MTP; Willerslev, E; Hansen, AJ; Barnes, I; Rudbeck, L; Lynnerup, N; Cooper, A				Gilbert, MTP; Willerslev, E; Hansen, AJ; Barnes, I; Rudbeck, L; Lynnerup, N; Cooper, A			Distribution patterns of postmortem damage in human mitochondrial DNA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUBSTITUTION RATE VARIATION; ANCIENT DNA; POPULATION EXPANSION; RATE HETEROGENEITY; MISCODING LESIONS; ANALYSIS REVEALS; NEANDERTHAL DNA; CONTROL REGION; MTDNA ANALYSIS; HUMAN REMAINS	The distribution of postmortem damage in mitochondrial DNA retrieved from 37 ancient human DNA samples was analyzed by cloning and was compared with a selection of published animal data. A relative rate of damage (rho(v)) was calculated for nucleotide positions within the human hypervariable region 1 (HVR1) and cytochrome oxidase subunit III genes. A comparison of damaged sites within and between the regions reveals that damage hotspots exist and that, in the HVR1, these correlate with sites known to have high in vivo mutation rates. Conversely, HVR1 subregions with known structural function, such as MT5, have lower in vivo mutation rates and lower postmortem-damage rates. The postmortem data also identify a possible functional subregion of the HVR1, termed "low-diversity 1," through the lack of sequence damage. The amount of postmortem damage observed in mitochondrial coding regions was significantly lower than in the HVR1, and, although hotspots were noted, these did not correlate with codon position. Finally, a simple method for the identification of incorrect archaeological haplogroup designations is introduced, on the basis of the observed spectrum of postmortem damage.	Univ Oxford, Dept Zool, Henry Wellcome Ancient Biomol Ctr, Oxford OX1 3PS, England; Univ Copenhagen, Inst Zool, Dept Evolutionary Biol, Copenhagen, Denmark; Univ Copenhagen, Res Lab, Copenhagen, Denmark; Univ Copenhagen, Inst Forens Med, Lab Biol Anthropol, Copenhagen, Denmark	University of Oxford; University of Copenhagen; University of Copenhagen; University of Copenhagen	Cooper, A (corresponding author), Univ Oxford, Dept Zool, Henry Wellcome Ancient Biomol Ctr, S Parks Rd, Oxford OX1 3PS, England.	alan.cooper@zoo.ox.ac.uk	Barnes, Ian C/B-8081-2008; Cooper, Alan/E-8171-2012; Willerslev, Eske/AAA-5686-2019; Hansen, Anders Johannes/A-5608-2013; Willerslev, Eske/A-9619-2011; Gilbert, Marcus TP/A-8936-2013	Barnes, Ian C/0000-0001-8322-6918; Cooper, Alan/0000-0002-7738-7851; Hansen, Anders Johannes/0000-0002-1890-2702; Willerslev, Eske/0000-0002-7081-6748; Gilbert, Marcus TP/0000-0002-5805-7195				Adcock GJ, 2001, P NATL ACAD SCI USA, V98, P537, DOI 10.1073/pnas.98.2.537; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ArisBrosou S, 1996, MOL BIOL EVOL, V13, P494, DOI 10.1093/oxfordjournals.molbev.a025610; Arneborg J, 1999, RADIOCARBON, V41, P157, DOI 10.1017/S0033822200019512; Bada JL, 1999, PHILOS T ROY SOC B, V354, P77, DOI 10.1098/rstb.1999.0361; Barnes I, 2002, SCIENCE, V295, P2267, DOI 10.1126/science.1067814; Burger J, 1999, ELECTROPHORESIS, V20, P1722; CHANG DD, 1985, P NATL ACAD SCI USA, V82, P351, DOI 10.1073/pnas.82.2.351; Cooper A, 1997, AM J HUM GENET, V60, P1001; Cooper A, 2000, SCIENCE, V289, P1139; Cooper A, 2001, SCIENCE, V292, P1655, DOI 10.1126/science.292.5522.1655; Cooper A, 2001, NATURE, V409, P704, DOI 10.1038/35055536; Di Bernardo G, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e16; Dinner AR, 2001, NATURE, V413, P752, DOI 10.1038/35099587; DODA ND, 1981, P NATL ACAD SCI USA, V10, P6116; Excoffier L, 1999, MOL BIOL EVOL, V16, P1357, DOI 10.1093/oxfordjournals.molbev.a026046; Faerman M, 1995, GENE, V167, P327, DOI 10.1016/0378-1119(95)00697-4; Fily ML, 1998, CR ACAD SCI III-VIE, V321, P79, DOI 10.1016/S0764-4469(97)89629-1; Finnila S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591; Gilbert MTP, 2003, AM J HUM GENET, V72, P48, DOI 10.1086/345379; Gocke CD, 1998, HUM GENET, V102, P182, DOI 10.1007/s004390050674; Greenwood AD, 1999, MOL BIOL EVOL, V16, P1466, DOI 10.1093/oxfordjournals.molbev.a026058; Handt O, 1996, AM J HUM GENET, V59, P368; HANNI C, 1994, GENOMICS, V22, P487, DOI 10.1006/geno.1994.1417; Hansen AJ, 2001, MOL BIOL EVOL, V18, P262, DOI 10.1093/oxfordjournals.molbev.a003800; HASEGAWA M, 1991, J MOL EVOL, V32, P37, DOI 10.1007/BF02099927; HASEGAWA M, 1993, J MOL EVOL, V37, P347, DOI 10.1007/BF00178865; Heyer E, 2001, AM J HUM GENET, V69, P1113, DOI 10.1086/324024; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Hoss M, 1996, NUCLEIC ACIDS RES, V24, P1304, DOI 10.1093/nar/24.7.1304; Kaestle FA, 2001, AM J PHYS ANTHROPOL, V115, P1, DOI 10.1002/ajpa.1051; Kolman CJ, 2000, AM J PHYS ANTHROPOL, V111, P5; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Krings M, 1999, P NATL ACAD SCI USA, V96, P5581, DOI 10.1073/pnas.96.10.5581; KUROSAKI K, 1993, AM J HUM GENET, V53, P638; Lalueza-Fox C, 2001, ANN HUM GENET, V65, P137, DOI 10.1017/S0003480001008533; Lau AY, 2000, P NATL ACAD SCI USA, V97, P13573, DOI 10.1073/pnas.97.25.13573; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Loreille O, 2001, CURR BIOL, V11, P200, DOI 10.1016/S0960-9822(01)00046-X; LUNDSTROM R, 1992, P NATL ACAD SCI USA, V89, P5961, DOI 10.1073/pnas.89.13.5961; LYNNERUP N, 1998, MEDDELELSER GRONLAND, V0024; Macaulay VA, 1997, AM J HUM GENET, V61, P983; MERRIWETHER DA, 1994, EXPERIENTIA, V50, P592, DOI 10.1007/BF01921730; Meyer S, 1999, GENETICS, V152, P1103; Mourier T, 2001, MOL BIOL EVOL, V18, P1833, DOI 10.1093/oxfordjournals.molbev.a003971; Nielsen-Marsh CM, 2000, J ARCHAEOL SCI, V27, P1139, DOI 10.1006/jasc.1999.0537; OHNO K, 1991, BIOCHEM INT, V24, P263; OOTA H, 1995, AM J PHYS ANTHROPOL, V98, P133, DOI 10.1002/ajpa.1330980204; Oota H, 1999, AM J HUM GENET, V64, P250, DOI 10.1086/302197; Ovchinnikov IV, 2000, NATURE, V404, P490, DOI 10.1038/35006625; PAABO S, 1989, P NATL ACAD SCI USA, V86, P1939, DOI 10.1073/pnas.86.6.1939; PAABO S, 1990, J BIOL CHEM, V265, P4718; Poinar HN, 1999, P NATL ACAD SCI USA, V96, P8426, DOI 10.1073/pnas.96.15.8426; Poinar HN, 1998, SCIENCE, V281, P402, DOI 10.1126/science.281.5375.402; Poinar HN, 1996, SCIENCE, V272, P864, DOI 10.1126/science.272.5263.864; Pusch CM, 1998, NUCLEIC ACIDS RES, V26, P857, DOI 10.1093/nar/26.3.857; RibeirodosSantos AKC, 1996, AM J PHYS ANTHROPOL, V101, P29, DOI 10.1002/(SICI)1096-8644(199609)101:1<29::AID-AJPA3>3.0.CO;2-8; RICHARDS M, 2000, ARCHAEOGENETICS DNA, P139; RICHARDS MB, 1995, J ARCHAEOL SCI, V22, P291, DOI 10.1006/jasc.1995.0031; Stone AC, 1998, AM J HUM GENET, V62, P1153, DOI 10.1086/301838; Stoneking M, 2000, AM J HUM GENET, V67, P1029, DOI 10.1086/303092; STONEKING M, 1995, AM J HUM GENET, V57, P1259; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Vasan S, 1996, NATURE, V382, P275, DOI 10.1038/382275a0; VERNESI C, 1999, ANCIENT BIOMOL, V2, P295; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WAKELEY J, 1993, J MOL EVOL, V37, P613; WALLACE DC, 1995, HUMAN GENE MAPPING 1, P910; Willerslev E, 1999, P NATL ACAD SCI USA, V96, P8017, DOI 10.1073/pnas.96.14.8017	69	162	175	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2003	72	1					32	47		10.1086/345378	http://dx.doi.org/10.1086/345378			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	631VE	12489041	Bronze, Green Published			2022-12-18	WOS:000180186800004
J	Gao, HL; Boustany, RMN; Espinola, JA; Cotman, SL; Srinidhi, L; Antonellis, KA; Gillis, T; Qin, XB; Liu, SM; Donahue, LR; Bronson, RT; Faust, JR; Stout, D; Haines, JL; Lerner, TJ; MacDonald, ME				Gao, HL; Boustany, RMN; Espinola, JA; Cotman, SL; Srinidhi, L; Antonellis, KA; Gillis, T; Qin, XB; Liu, SM; Donahue, LR; Bronson, RT; Faust, JR; Stout, D; Haines, JL; Lerner, TJ; MacDonald, ME			Mutations in a novel CLN6-encoded transmembrane protein cause variant neuronal ceroid lipofuscinosis in man and mouse	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LYSOSOMAL STORAGE DISEASES; BATTEN-DISEASE; MODEL; GENE; CLN6; LOCALIZATION; PATHOGENESIS; DEGENERATION; THIOESTERASE; 15Q21-23	The CLN6 gene that causes variant late-infantile neuronal ceroid lipofuscinosis (vLINCL), a recessively inherited neurodegenerative disease that features blindness, seizures, and cognitive decline, maps to 15q21-23. We have used multiallele markers spanning this similar to4-Mb candidate interval to reveal a core haplotype, shared in Costa Rican families with vLINCL but not in a Venezuelan kindred, that highlighted a region likely to contain the CLN6 defect. Systematic comparison of genes from the minimal region uncovered a novel candidate, FLJ20561, that exhibited DNA sequence changes specific to the different disease chromosomes: a G T transversion in exon 3, introducing a stop codon on the Costa Rican haplotype, and a codon deletion in exon 5, eliminating a conserved tyrosine residue on the Venezuelan chromosome. Furthermore, sequencing of the murine homologue in the nclf mouse, which manifests recessive NCL-like disease, disclosed a third lesion-an extra base pair in exon 4, producing a frameshift truncation on the nclf chromosome. Thus, the novel similar to36-kD CLN6-gene product augments an intriguing set of unrelated membrane-spanning proteins, whose deficiency causes NCL in mouse and man.	Massachusetts Gen Hosp, Mol Neurogenet Unit, Charlestown, MA 02129 USA; Duke Univ, Med Ctr, Div Pediat Neurol, Durham, NC USA; Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA; Jackson Lab, Bar Harbor, ME 04609 USA; Vanderbilt Univ, Med Ctr, Program Human Genet, Nashville, TN USA	Harvard University; Massachusetts General Hospital; Duke University; Tufts University; Jackson Laboratory; Vanderbilt University	MacDonald, ME (corresponding author), Massachusetts Gen Hosp, Mol Neurogenet Unit, Bldg 149,13th St, Charlestown, MA 02129 USA.	macdonam@helix.mgh.harvard.edu	Haines, Jonathan/C-3374-2012	Haines, Jonathan/0000-0002-4351-4728	NINDS NIH HHS [NS30170, NS33648, R01 NS033648] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033648, R01NS030170] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; Auger KJ, 1999, MOL GENET METAB, V66, P332, DOI 10.1006/mgme.1999.2805; Bennett MJ, 1999, J INHERIT METAB DIS, V22, P535, DOI 10.1023/A:1005564509027; Boustany R., 1996, HDB CLIN NEUROLOGY, V66, P671; Bronson RT, 1998, AM J MED GENET, V77, P289, DOI 10.1002/(SICI)1096-8628(19980526)77:4<289::AID-AJMG8>3.0.CO;2-I; BRONSON RT, 1993, ANN NEUROL, V33, P381, DOI 10.1002/ana.410330408; Broom MF, 1999, MOL GENET METAB, V66, P373, DOI 10.1006/mgme.1999.2823; Broom MF, 1998, J MED GENET, V35, P717, DOI 10.1136/jmg.35.9.717; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; DYKEN PR, 1989, J CHILD NEUROL, V4, P165, DOI 10.1177/088307388900400302; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Gardiner RM, 2000, NEUROL SCI, V21, pS15, DOI 10.1007/s100720070035; Haines JL, 1998, NEUROGENETICS, V1, P217, DOI 10.1007/s100480050032; Janes RW, 1996, FEBS LETT, V399, P75, DOI 10.1016/S0014-5793(96)01290-2; JOLLY RD, 1992, AM J MED GENET, V42, P609, DOI 10.1002/ajmg.1320420436; Jolly RD, 1997, NEUROPEDIATRICS, V28, P60, DOI 10.1055/s-2007-973670; KOHLSCHUTTER A, 1993, J INHERIT METAB DIS, V16, P241, DOI 10.1007/BF00710254; LERNER TJ, 1995, CELL, V82, P949, DOI 10.1016/0092-8674(95)90274-0; MESSER A, 1992, GENOMICS, V13, P797, DOI 10.1016/0888-7543(92)90155-L; Mitchell W A, 2001, Eur J Paediatr Neurol, V5 Suppl A, P21, DOI 10.1053/ejpn.2000.0429; Nielsen H, 1997, Int J Neural Syst, V8, P581, DOI 10.1142/S0129065797000537; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Pearce DA, 2000, J NEUROSCI RES, V59, P19, DOI 10.1002/(SICI)1097-4547(20000101)59:1<19::AID-JNR3>3.0.CO;2-Y; Pena JA, 2001, PEDIATR NEUROL, V25, P78, DOI 10.1016/S0887-8994(01)00284-3; Prasad A, 1996, J CHILD NEUROL, V11, P301, DOI 10.1177/088307389601100408; Ranta S, 1999, NAT GENET, V23, P233, DOI 10.1038/13868; Rider J A, 1988, Am J Med Genet Suppl, V5, P21; Rider JA, 1999, MOL GENET METAB, V66, P231, DOI 10.1006/mgme.1999.2827; Savukoski M, 1998, NAT GENET, V19, P286, DOI 10.1038/975; SAVUKOSKI M, 1994, AM J HUM GENET, V55, P695; Sharp JD, 1999, MOL GENET METAB, V66, P329, DOI 10.1006/mgme.1999.2806; Sharp JD, 1997, HUM MOL GENET, V6, P591, DOI 10.1093/hmg/6.4.591; Sleat DE, 1997, SCIENCE, V277, P1802, DOI 10.1126/science.277.5333.1802; Suopanki J, 1999, MOL GENET METAB, V66, P290, DOI 10.1006/mgme.1999.2839; VESA J, 1995, NATURE, V376, P584, DOI 10.1038/376584a0; WHEELER JE, 1999, MOL GENET METAB, V66; Wheeler RB, 1999, MOL GENET METAB, V66, P337, DOI 10.1006/mgme.1999.2804; Wisniewski K E, 1988, Am J Med Genet Suppl, V5, P27	38	162	171	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2002	70	2					324	335		10.1086/338190	http://dx.doi.org/10.1086/338190			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	511FQ	11791207	Green Published, Bronze			2022-12-18	WOS:000173254300006
J	Jumlongras, D; Bei, M; Stimson, JM; Wang, WF; DePalma, SR; Seidman, CE; Felbor, U; Maas, R; Seidman, JG; Olsen, BR				Jumlongras, D; Bei, M; Stimson, JM; Wang, WF; DePalma, SR; Seidman, CE; Felbor, U; Maas, R; Seidman, JG; Olsen, BR			A nonsense mutation in MSX1 causes Witkop syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HIDROTIC ECTODERMAL DYSPLASIA; SELECTIVE TOOTH AGENESIS; HOMEODOMAIN; EXPRESSION; PROTEIN; NAIL; MICE	Witkop syndrome, also known as tooth and nail syndrome (TNS), is a rare autosomal dominant disorder. Affected individuals have nail dysplasia and several congenitally missing teeth. To identify the gene responsible for TNS, we used candidate-gene linkage analysis in a three-generation family affected by the disorder. We found linkage between TNS and polymorphic markers surrounding the MSX1 locus. Direct sequencing and restriction-enzyme analysis revealed that a heterozygous stop mutation in the homeodomain of MSX1 cosegregated with the phenotype. In addition, histological analysis of Msx1-knockout mice, combined with a finding of Msx1 expression in mesenchyme of developing nail beds, revealed that not only was tooth development disrupted in these mice, but nail development was affected as well. Nail plates in Msx1-null mice were defective and were thinner than those of their wild-type littermates. The resemblance between the tooth and nail phenotype in the human family and that of Msx1-knockout mice strongly supports the conclusions that a nonsense mutation in MSX1 causes TNS and that Msx1 is critical for both tooth and nail development.	Brigham & Womens Hosp, Dept Cell Biol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; Harvard Univ, Sch Dent Med, Harvard Forsyth Dept Oral Biol, Boston, MA USA; Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard School of Dental Medicine; Howard Hughes Medical Institute	Olsen, BR (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.			DePalma, Steven/0000-0002-0381-5016	NIAMS NIH HHS [R37 AR036819, R01 AR036819, AR36819] Funding Source: Medline; NIDCR NIH HHS [DE11697, R37 DE011697, F32 DE005737, R01 DE011697, DE05737] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR036819, R01AR036819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE011697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE011697, F32DE005737] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Bei M, 1998, DEVELOPMENT, V125, P4325; Chitty LS, 1996, J MED GENET, V33, P707, DOI 10.1136/jmg.33.8.707; GIANSANTI JS, 1974, ORAL SURG ORAL MED O, V37, P576, DOI 10.1016/0030-4220(74)90289-8; Hartmann C, 2000, DEVELOPMENT, V127, P3141; HEWITT JE, 1991, GENOMICS, V11, P670, DOI 10.1016/0888-7543(91)90074-O; Hodges S J, 1999, Int J Paediatr Dent, V9, P207, DOI 10.1046/j.1365-263x.1999.00128.x; Hu GZ, 1998, MOL CELL BIOL, V18, P6044, DOI 10.1128/MCB.18.10.6044; HUDSON CD, 1975, ORAL SURG ORAL MED O, V39, P409, DOI 10.1016/0030-4220(75)90085-7; ISAAC VE, 1995, BIOCHEMISTRY-US, V34, P7127, DOI 10.1021/bi00021a026; JOHNSON M, 1991, BRIT J DERMATOL, V125, P27, DOI 10.1111/j.1365-2133.1991.tb06034.x; Keranen SVE, 1998, DEV GENES EVOL, V208, P477, DOI 10.1007/s004270050206; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Lamartine J, 2000, NAT GENET, V26, P142, DOI 10.1038/79851; MACKENZIE A, 1991, DEVELOPMENT, V111, P269; MURDOCHKINCH CA, 1993, ORAL SURG ORAL MED O, V75, P403, DOI 10.1016/0030-4220(93)90159-2; REGINELLI AD, 1995, DEVELOPMENT, V121, P1065; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; SLAVKIN HC, 1998, MOL BASIS EPITHELIAL, P15; Stimson J M, 1997, J Clin Pediatr Dent, V21, P269; Stock DW, 1997, BIOESSAYS, V19, P481, DOI 10.1002/bies.950190607; van den Boogaard MJH, 2000, NAT GENET, V25, P125; van den Boogaard MJH, 2000, NAT GENET, V24, P342, DOI 10.1038/74155; Vastardis H, 1996, NAT GENET, V13, P417, DOI 10.1038/ng0896-417; Witkop CJ., 1965, ORAL PATHOLOGY, P810; WITKOP CJ, 1990, BIRTH DEFECTS ENCY C, P920; Zhang HL, 1996, P NATL ACAD SCI USA, V93, P1764, DOI 10.1073/pnas.93.5.1764; Zhang HL, 1997, MOL CELL BIOL, V17, P2920, DOI 10.1128/MCB.17.5.2920	27	162	171	0	9	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2001	69	1					67	74		10.1086/321271	http://dx.doi.org/10.1086/321271			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XM	11369996	Green Published, Bronze			2022-12-18	WOS:000170108100007
J	Kayser, M; Krawczak, M; Excoffier, L; Dieltjes, P; Corach, D; Pascali, V; Gehrig, C; Bernini, LF; Jespersen, J; Bakker, E; Roewer, L; de Knijff, P				Kayser, M; Krawczak, M; Excoffier, L; Dieltjes, P; Corach, D; Pascali, V; Gehrig, C; Bernini, LF; Jespersen, J; Bakker, E; Roewer, L; de Knijff, P			An extensive analysis of Y-chromosomal microsatellite haplotypes in globally dispersed human populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN EVOLUTIONARY HISTORY; HUMAN MITOCHONDRIAL-DNA; ALLELE FREQUENCIES; GENETIC AFFINITIES; SEQUENCE VARIATION; X-CHROMOSOME; POLYMORPHISMS; LOCI; DIVERSITY; ORIGIN	The genetic variance at seven Y-chromosomal microsatellite loci (or short tandem repeats [STRs]) was studied among 986 male individuals from 20 globally dispersed human populations. A total of 598 different haplotypes were observed, of which 437 (73.1%) were each found in a single male only. Population-specific haplotype-diversity values were .86-.99. Analyses of haplotype diversity and population-specific haplotypes revealed marked population-structure differences between more-isolated indigenous populations (e.g., Central African Pygmies or Greenland Inuit) and more-admixed populations (e.g., Europeans or Surinamese). Furthermore, male individuals from isolated indigenous populations shared haplotypes mainly with male individuals from their own population. By analysis of molecular variance, we found that 76.8% of the total genetic variance present among these male individuals could be attributed to genetic differences between male individuals who were members of the same population. Haplotype sharing between populations, Phi (ST) statistics, and phylogenetic analysis identified close genetic affinities among European populations and among New Guinean populations. Our data illustrate that Y-chromosomal STR haplotypes are an ideal tool for the study of the genetic affinities between groups of male subjects and for detection of population structure.	Leiden Univ, Med Ctr, MGC Dept Human & Clin Genet, NL-2300 RA Leiden, Netherlands; Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany; Univ Wales Coll Med, Inst Med Genet, Cardiff CF4 4XN, S Glam, Wales; Univ Geneva, Dept Anthropol & Ecol, Genet & Biometry Lab, CH-1211 Geneva, Switzerland; Inst Legal Med, Geneva, Switzerland; Leiden Univ, Med Ctr, MGC Dept Human & Clin Genet, Leiden, Netherlands; Univ Cattolica Sacro Cuore, Ist Med Legale, Rome, Italy; Univ Buenos Aires, Serv Huellas Digitales Genet, Buenos Aires, DF, Argentina; Univ S Denmark, Dept Thrombosis Res, Esbjerg, Denmark; Humboldt Univ, Inst Rechts Med, Charite, Berlin, Germany	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Max Planck Society; Cardiff University; University of Geneva; University of Geneva; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Buenos Aires; University of Southern Denmark; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	de Knijff, P (corresponding author), Leiden Univ, Med Ctr, MGC Dept Human & Clin Genet, POB 9503, NL-2300 RA Leiden, Netherlands.		Krawczak, Michael/A-8964-2010; Bakker, Egbert/D-3525-2009; de Knijff, Peter/Y-2519-2018; pascali, vincenzo lorenzo/AAC-8436-2022; Excoffier, Laurent/D-3498-2013	Krawczak, Michael/0000-0003-2603-1502; Bakker, Egbert/0000-0002-2843-7357; de Knijff, Peter/0000-0002-0899-771X; Excoffier, Laurent/0000-0002-7507-6494; Roewer, Lutz/0000-0001-9383-4941; Corach, Daniel/0000-0002-0662-7424				Armour JAL, 1996, NAT GENET, V13, P154, DOI 10.1038/ng0696-154; Ayub Q, 2000, Nucleic Acids Res, V28, pe8, DOI 10.1093/nar/28.2.e8; BANDELT HJ, 1995, GENETICS, V141, P743; BAR W, 1995, VOX SANG, V69, P70; Bianchi NO, 1998, AM J HUM GENET, V63, P1862, DOI 10.1086/302141; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; BRUFORD MW, 1993, CURR OPIN GENET DEV, V3, P939, DOI 10.1016/0959-437X(93)90017-J; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Carvalho-Silva DR, 2001, AM J HUM GENET, V68, P281, DOI 10.1086/316931; CHEN HM, 1994, HUM MUTAT, V4, P208, DOI 10.1002/humu.1380040306; de Knijff P, 2000, AM J HUM GENET, V67, P1055; de Knijff P., 2000, ARCHAEOGENETICS DNA, P301; Deka R, 1996, GENOME RES, V6, P1177, DOI 10.1101/gr.6.12.1177; deKnijff P, 1997, INT J LEGAL MED, V110, P134, DOI 10.1007/s004140050052; EXCOFFIER L, 1994, GENETICS, V136, P343; EXCOFFIER L, 1992, GENETICS, V131, P479; Flint J, 1999, HUM GENET, V105, P567, DOI 10.1007/s004390051147; Forster P, 2000, AM J HUM GENET, V67, P182, DOI 10.1086/302953; GOLDSTEIN DB, 1995, P NATL ACAD SCI USA, V92, P6723, DOI 10.1073/pnas.92.15.6723; GOLDSTEIN DB, 1995, GENETICS, V139, P463; HAMMER MF, 1994, MOL BIOL EVOL, V11, P749; HAMMER MF, 1995, NATURE, V378, P376, DOI 10.1038/378376a0; HAMMOND HA, 1994, AM J HUM GENET, V55, P175; Helgason A, 2000, AM J HUM GENET, V67, P697, DOI 10.1086/303046; Heyer E, 1997, HUM MOL GENET, V6, P799, DOI 10.1093/hmg/6.5.799; Honda K, 1999, J FORENSIC SCI, V44, P868; Hurles ME, 1998, AM J HUM GENET, V63, P1793, DOI 10.1086/302147; JOBLING MA, 1994, HUM MOL GENET, V3, P107, DOI 10.1093/hmg/3.1.107; JOBLING MA, 1995, TRENDS GENET, V11, P449, DOI 10.1016/S0168-9525(00)89144-1; Jorde LB, 2000, AM J HUM GENET, V66, P979, DOI 10.1086/302825; Kayser M, 2000, CURR BIOL, V10, P1237, DOI 10.1016/S0960-9822(00)00734-X; Kayser M, 1997, INT J LEGAL MED, V110, P125, DOI 10.1007/s004140050051; Kayser M, 2000, AM J HUM GENET, V66, P1580, DOI 10.1086/302905; Kayser M, 2001, AM J HUM GENET, V68, P173, DOI 10.1086/316949; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P115, DOI 10.1007/BF02289694; Lahermo P, 1999, EUR J HUM GENET, V7, P447, DOI 10.1038/sj.ejhg.5200316; MATHIAS N, 1994, HUM MOL GENET, V3, P115, DOI 10.1093/hmg/3.1.115; MELTON T, 1995, AM J HUM GENET, V57, P403; Mountain JL, 1997, AM J HUM GENET, V61, P705, DOI 10.1086/515510; NAKAHORI Y, 1989, NUCLEIC ACIDS RES, V17, P2152, DOI 10.1093/nar/17.5.2152; Nei M., 1987, MOL EVOLUTIONARY GEN; PerezLezaun A, 1997, J MOL EVOL, V45, P265, DOI 10.1007/PL00006229; Poloni ES, 1997, AM J HUM GENET, V61, P1015, DOI 10.1086/301602; Prinz M, 1997, FORENSIC SCI INT, V85, P209, DOI 10.1016/S0379-0738(96)02096-8; PULT I, 1994, BIOL CHEM H-S, V375, P837; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; ROEWER L, 1992, HUM GENET, V89, P389; Roewer L, 1996, HUM MOL GENET, V5, P1029, DOI 10.1093/hmg/5.7.1029; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Ruhlen M., 1994, ORIGIN LANGUAGE TRAC; Sala A, 1997, HUM BIOL, V69, P777; Seielstad M, 1999, GENOME RES, V9, P558; SEIELSTAD MT, 1994, HUM MOL GENET, V3, P2159; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; SLATKIN M, 1995, GENETICS, V139, P457; Stoneking M, 1997, GENOME RES, V7, P1061, DOI 10.1101/gr.7.11.1061; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Underhill PA, 1996, P NATL ACAD SCI USA, V93, P196, DOI 10.1073/pnas.93.1.196; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; White PS, 1999, GENOMICS, V57, P433, DOI 10.1006/geno.1999.5782; WHITFIELD LS, 1995, NATURE, V378, P379, DOI 10.1038/378379a0; Zerjal T, 1997, AM J HUM GENET, V60, P1174	64	162	169	0	7	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2001	68	4					990	1018		10.1086/319510	http://dx.doi.org/10.1086/319510			29	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	414KQ	11254455	Green Published, Bronze			2022-12-18	WOS:000167666000020
J	Isotalo, PA; Wells, GA; Donnelly, JG				Isotalo, PA; Wells, GA; Donnelly, JG			Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms: An examination of C677T and A1298C mutations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEURAL-TUBE DEFECTS; RISK FACTOR; COMMON MUTATION; MTHFR; POPULATION; GENOTYPES	Methylenetetrahydrofolate reductase (MTHFR) mutations are commonly associated with hyperhomocysteinemia, and, through their defects in homocysteine metabolism, they have been implicated as risk factors for neural tube defects and unexplained, recurrent embryo losses in early pregnancy. Folate sufficiency is thought to play an integral role in the phenotypic expression of MTHFR mutations. Samples of neonatal cord blood (n = 119) and fetal tissue (n = 161) were analyzed for MTHFR C677T and A1298C mutations to determine whether certain MTHFR genotype combinations mere associated with decreased in utero viability. Mutation analysis revealed that all possible MTHFR genotype combinations were represented in the fetal group, demonstrating that 677T and 1298C alleles could occur in both cis and trans configurations. Combined 677CT/1298CC and 677TT/1298CC genotypes, which contain three and four mutant alleles, respectively, were not observed in the neonatal group (P = .0402). This suggests decreased viability among fetuses carrying these mutations and a possible selection disadvantage among fetuses with increased numbers of mutant MTHFR alleles. This is the first report that describes the existence of human MTHFR 677CT/1298CC and 677TT/1298CC genotypes and demonstrates their potential role in compromised fetal viability.	Ottawa Hosp, Dept Pathol & Lab Med, Ottawa, ON K1Y 4E9, Canada; Univ Ottawa, Dept Pathol & Lab Med, Ottawa, ON, Canada; Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; Loeb Med Res Inst, Clin Epidemiol Unit, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Donnelly, JG (corresponding author), Ottawa Hosp, Dept Pathol & Lab Med, Civic Campus,1053 Carling Ave, Ottawa, ON K1Y 4E9, Canada.		Wells, George A/M-4549-2017	Wells, George A/0000-0002-2289-9139				Christensen B, 1999, AM J MED GENET, V84, P151, DOI 10.1002/(SICI)1096-8628(19990521)84:2<151::AID-AJMG12>3.0.CO;2-T; Donnelly JG, 1999, CLIN BIOCHEM, V32, P223, DOI 10.1016/S0009-9120(99)00015-6; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Isotalo PA, 2000, MOL DIAGN, V5, P59, DOI 10.1016/S1084-8592(00)00012-6; Jacques PF, 1996, CIRCULATION, V93, P7, DOI 10.1161/01.CIR.93.1.7; MILLS JL, 1995, LANCET, V345, P149, DOI 10.1016/S0140-6736(95)90165-5; Nelen WLDM, 1997, LANCET, V350, P861, DOI 10.1016/S0140-6736(97)24038-9; Rady PL, 1999, AM J MED GENET, V86, P380, DOI 10.1002/(SICI)1096-8628(19991008)86:4<380::AID-AJMG13>3.0.CO;2-9; Rozen R, 1997, THROMB HAEMOSTASIS, V78, P523; Shields DC, 1999, AM J HUM GENET, V64, P1045, DOI 10.1086/302310; Stegmann K, 1999, AM J MED GENET, V87, P23, DOI 10.1002/(SICI)1096-8628(19991105)87:1<23::AID-AJMG5>3.0.CO;2-E; van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086/301825; VANDERPUT NMJ, 1995, LANCET, V346, P1070, DOI 10.1016/S0140-6736(95)91743-8; Weisberg I, 1998, MOL GENET METAB, V64, P169, DOI 10.1006/mgme.1998.2714; WHITEHEAD AS, 1995, QJM-MON J ASSOC PHYS, V88, P763; WOUTERS MGAJ, 1993, FERTIL STERIL, V60, P820	16	162	179	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4					986	990		10.1086/303082	http://dx.doi.org/10.1086/303082			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	360DL	10958762	Green Published, Bronze			2022-12-18	WOS:000089651100021
J	Finckh, U; Muller-Thomsen, T; Mann, U; Eggers, C; Marksteiner, J; Meins, W; Binetti, G; Alberici, A; Hock, C; Nitsch, RM; Gal, A				Finckh, U; Muller-Thomsen, T; Mann, U; Eggers, C; Marksteiner, J; Meins, W; Binetti, G; Alberici, A; Hock, C; Nitsch, RM; Gal, A			High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL ALZHEIMERS-DISEASE; CREUTZFELDT-JAKOB-DISEASE; PRION PROTEIN GENE; STRAUSSLER-SCHEINKER-DISEASE; PRESENILIN-1 GENE; MISSENSE MUTATION; PRNP; POLYMORPHISM; DIAGNOSIS; HETEROGENEITY	Clinical differential diagnosis of early-onset dementia (EOD) includes familial Alzheimer disease (FAD) and hereditary prion disease. In both disease entities, postmortem brain histopathological examination is essential for unambiguous diagnosis. Mutations in the genes encoding the presenilins (PS1 and PS2) and amyloid precursor protein (APP) are associated with FAD, whereas mutations in the prion protein (PrP) gene are associated with prion disease. To investigate the proportion of EOD attributable to known genes, we prospectively (i.e., antemortem) screened these four genes for mutations by sequencing genomic PCR products from patients with EOD before age 60 years. Family history for dementia was positive (PFH) in 16 patients, negative (NFH) in 17 patients, and unknown (UFH) in 3 patients. In 12 patients, we found five novel mutations (in PS1, F105L; in PS2, T122P and M239I; and in PrP, Q160X and T188K) and five previously reported mutations (in APP, in three patients who were most likely unrelated, V7171; in PS1, A79V and M139V; and in PrP, P102L and T183A) that are all considered to be disease causing. Of these 12 patients, 3 had PFH. This indicates a detection rate of 56% (3/16) in patients with PFH. We found two mutations (APP V717I) in two of the three UFH patients, and only one mutation (PrP T188K) in 1 of the 17 patients with NFH. We conclude that because of the lack of specific antemortem diagnostic markers for FAD and hereditary prion disease, all four genes should be included in a molecular diagnostic program in patients with EOD who had PFH.	Univ Hamburg, Hosp Eppendorf, Dept Human Genet, D-20246 Hamburg, Germany; Univ Hamburg, Hosp Eppendorf, Dept Psychiat, D-20246 Hamburg, Germany; Univ Hamburg, Hosp Eppendorf, Dept Neurol, D-20246 Hamburg, Germany; Albertinen Haus, Geriatr Ctr, Hamburg, Germany; Univ Innsbruck, Psychiat Clin, A-6020 Innsbruck, Austria; IRCCS Ctr S Giovanni di Dio, Alzheimer Dis Unit, Brescia, Italy; Univ Basel, Dept Psychiat, Basel, Switzerland; Univ Zurich, Dept Psychiat Res, Zurich, Switzerland	University of Hamburg; University of Hamburg; University of Hamburg; University of Innsbruck; IRCCS Fatebenefratelli; University of Basel; University of Zurich	Finckh, U (corresponding author), Univ Klinikum Hamburg Eppendorf, Inst Human Genet, Butenfeld 42, D-22529 Hamburg, Germany.	finckh@uke.uni-hamburg.de	Alberici, Antonella/K-2038-2018; Binetti, Giuliano/K-4519-2016	Binetti, Giuliano/0000-0003-2759-5844				Aldudo J, 1998, ANN NEUROL, V44, P985, DOI 10.1002/ana.410440624; Barbanti P, 1996, NEUROLOGY, V47, P734, DOI 10.1212/WNL.47.3.734; Bird TD, 1996, ANN NEUROL, V40, P932, DOI 10.1002/ana.410400619; Cruts M, 1998, HUM MOL GENET, V7, P43, DOI 10.1093/hmg/7.1.43; Dermaut B, 1999, AM J HUM GENET, V64, P290, DOI 10.1086/302200; ElHachimi KH, 1996, AMYLOID, V3, P223, DOI 10.3109/13506129609014369; Finckh U, 1998, HUM MUTAT, V12, P206, DOI 10.1002/(SICI)1098-1004(1998)12:3<206::AID-HUMU8>3.3.CO;2-K; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox NC, 1997, BRAIN, V120, P491, DOI 10.1093/brain/120.3.491; Geldmacher DS, 1997, NEUROLOGY, V48, pS2, DOI 10.1212/WNL.48.5_Suppl_6.2S; Ghetti B, 1996, P NATL ACAD SCI USA, V93, P744, DOI 10.1073/pnas.93.2.744; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOLDFARB LG, 1992, SCIENCE, V258, P806, DOI 10.1126/science.1439789; Hainfellner JA, 1998, ACTA NEUROPATHOL, V96, P116, DOI 10.1007/s004010050870; HAINFELLNER JA, 1995, BRAIN PATHOL, V5, P201, DOI 10.1111/j.1750-3639.1995.tb00596.x; HALTIA M, 1994, ANN NEUROL, V36, P362, DOI 10.1002/ana.410360307; Hamasaki S, 1998, LANCET, V352, P1358, DOI 10.1016/S0140-6736(05)60749-0; Hardy J, 1998, SCIENCE, V282, P1075, DOI 10.1126/science.282.5391.1075; HSIAO K, 1989, NATURE, V338, P342, DOI 10.1038/338342a0; Hull M, 1998, EUR ARCH PSY CLIN N, V248, P123, DOI 10.1007/s004060050028; Kamimura K, 1998, J NEUROL SCI, V160, P76, DOI 10.1016/S0022-510X(98)00219-6; KITAMOTO T, 1993, BIOCHEM BIOPH RES CO, V192, P525, DOI 10.1006/bbrc.1993.1447; KRETZSCHMAR HA, 1986, DNA-J MOLEC CELL BIO, V5, P315, DOI 10.1089/dna.1986.5.315; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Mattila KM, 1998, ANN NEUROL, V44, P965, DOI 10.1002/ana.410440617; MAYEUX R, 1985, NEUROLOGY, V35, P453, DOI 10.1212/WNL.35.4.453; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Nishimura M, 1999, NAT MED, V5, P164, DOI 10.1038/5526; Nitrini R, 1997, ANN NEUROL, V42, P138, DOI 10.1002/ana.410420203; OWEN F, 1989, LANCET, V1, P51; PALMER MS, 1993, HUM MOL GENET, V2, P541, DOI 10.1093/hmg/2.5.541; PERRY RT, 1995, AM J MED GENET, V60, P12, DOI 10.1002/ajmg.1320600104; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Sherrington R, 1996, HUM MOL GENET, V5, P985, DOI 10.1093/hmg/5.7.985; Young K, 1997, MOL BRAIN RES, V44, P147, DOI 10.1016/S0169-328X(96)00251-3	37	162	173	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2000	66	1					110	117		10.1086/302702	http://dx.doi.org/10.1086/302702			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279FK	10631141	Green Published, Bronze			2022-12-18	WOS:000085033600012
J	Kayaalp, E; Treacy, E; Waters, PJ; Byck, S; Nowacki, P; Scriver, CR				Kayaalp, E; Treacy, E; Waters, PJ; Byck, S; Nowacki, P; Scriver, CR			Human phenylalanine hydroxylase mutations and hyperphenylalaninemia phenotypes: A metanalysis of genotype-phenotype correlations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MISSENSE MUTATIONS; MILD HYPERPHENYLALANINEMIA; PHENYLKETONURIA GENOTYPES; PRENATAL-DIAGNOSIS; MOLECULAR-BASIS; GENE; LOCUS; DEFICIENCY; PKU; HETEROGENEITY	We analyzed correlations between mutant genotypes at the human phenylalanine hydroxylase locus (gene symbol PAH) and the corresponding hyperphenylalaninemia (HPA) phenotypes (notably, phenylketonuria [OMIM 261600]). We used reports, both published and in the PAH Mutation Analysis Consortium Database, on 365 patients harboring 73 different PAH mutations in 161 different genotypes. KPA phenotypes were classified as phenylketonuria (PKU), variant PKU, and non-PKU HPA. By analysis both of homoallelic mutant genotypes and of "functionally hemizygous" heteroallelic genotypes, we characterized the phenotypic effect of 48 of the 73 different, largely missense mutations. Among those with consistent in vivo expression, 24 caused PKU, 3 caused variant PKU, and 10 caused non-PKU HPA. However, 11 mutations were inconsistent in their effect: 9 appeared in two different phenotype classes, and 2 (I65T and Y414C) appeared in all three classes. Seven mutations were inconsistent in phenotypic effect when in vitro (unit-protein) expression was compared with the corresponding in vivo phenotype (an emergent property). We conclude that the majority of PAH mutations confer a consistent phenotype and that this is concordant with their effects, when known, predicted from in vitro expression analysis. However, significant inconsistencies, both between in vitro and in vivo phenotypes and between different individuals with similar PAH genotypes, reveal that the HPA-phenotype is more complex than that predicted by Mendelian inheritance of alleles at the PAH locus.	McGill Univ, Montreal Childrens Hosp, Res Inst, DeBelle Lab, Montreal, PQ H3H 1P3, Canada; McGill Univ, Dept Human Genet, Montreal, PQ, Canada; McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada; McGill Univ, Dept Biol, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University	Scriver, CR (corresponding author), McGill Univ, Montreal Childrens Hosp, Res Inst, DeBelle Lab, Room A-717,2300 Tupper St, Montreal, PQ H3H 1P3, Canada.	mc77@musica.mcgill.ca		Kayaalp, Emre/0000-0002-6520-0236; Treacy, Eileen/0000-0002-6226-1615				Apold Jaran, 1993, Developmental Brain Dysfunction, V6, P109; ARMSTRONG MD, 1955, J CLIN INVEST, V34, P565, DOI 10.1172/JCI103105; Beaudet AL, 1996, HUM MUTAT, V8, P197; BENIT P, 1994, HUM MUTAT, V4, P229, DOI 10.1002/humu.1380040311; Beutler E, 1996, HUM MUTAT, V8, P203, DOI 10.1002/(SICI)1098-1004(1996)8:3<203::AID-HUMU1>3.3.CO;2-C; BICKEL H, 1954, Acta Paediatr, V43, P64, DOI 10.1111/j.1651-2227.1954.tb04000.x; Burgard P, 1996, EUR J PEDIATR, V155, pS11, DOI 10.1007/PL00014222; DESVIAT LR, 1995, AM J HUM GENET, V57, P337; DIANZANI I, 1995, HUM MUTAT, V6, P247, DOI 10.1002/humu.1380060308; DIANZANI I, 1995, EUR J HUM GENET, V3, P294; DICKSON PW, 1994, J BIOL CHEM, V269, P20369; DILELLA AG, 1986, BIOCHEMISTRY-US, V25, P743, DOI 10.1021/bi00352a001; DISILVESTRE D, 1991, AM J HUM GENET, V48, P1014; DWORNICZAK B, 1991, HUM GENET, V87, P731; Eiken HG, 1996, EUR J PEDIATR, V155, P554; Eiken HG, 1996, HUM MUTAT, V7, P228, DOI 10.1002/(SICI)1098-1004(1996)7:3<228::AID-HUMU7>3.0.CO;2-6; GIBBS BS, 1993, J BIOL CHEM, V268, P8046; GULDBERG P, 1994, J INHERIT METAB DIS, V17, P645, DOI 10.1007/BF00712004; Guldberg P, 1996, J MED GENET, V33, P161, DOI 10.1136/jmg.33.2.161; GULDBERG P, 1994, GENOMICS, V21, P453, DOI 10.1006/geno.1994.1296; GULDBERG P, 1995, EUR J PEDIATR, V154, P551, DOI 10.1007/BF02074833; GUTTLER F, 1987, J PEDIATR-US, V110, P68, DOI 10.1016/S0022-3476(87)80290-1; Guttler Flemming, 1993, Developmental Brain Dysfunction, V6, P92; John Simon W. M., 1992, Human Mutation, V1, P147, DOI 10.1002/humu.1380010210; KACSER H, 1981, GENETICS, V97, P639; KALAYDJIEVA L, 1992, CLIN GENET, V41, P123; Kayaalp E., 1996, American Journal of Human Genetics, V59, pA201; KLEIMAN S, 1993, J MED GENET, V30, P284, DOI 10.1136/jmg.30.4.284; KONECKI DS, 1992, BIOCHEMISTRY-US, V31, P8363, DOI 10.1021/bi00150a033; KOWLESSUR D, 1995, P NATL ACAD SCI USA, V92, P4743, DOI 10.1073/pnas.92.11.4743; Kunert Erich, 1993, Developmental Brain Dysfunction, V6, P114; KWOK SCM, 1985, BIOCHEMISTRY-US, V24, P556, DOI 10.1021/bi00324a002; LANGENBECK U, 1988, BRAIN DYSFUNCT, V1, P103; LEDLEY FD, 1986, NEW ENGL J MED, V314, P1276, DOI 10.1056/NEJM198605153142002; LIDSKY AS, 1985, AM J HUM GENET, V37, P619; LYONNET S, 1989, AM J HUM GENET, V44, P511; MARTINEZPARDO M, 1994, J INHERIT METAB DIS, V17, P366, DOI 10.1007/BF00711832; Mayr E., 1982, GROWTH BIOL THOUGHT; Nowacki P, 1997, NUCLEIC ACIDS RES, V25, P139, DOI 10.1093/nar/25.1.139; OKANO Y, 1991, GENOMICS, V9, P96, DOI 10.1016/0888-7543(91)90225-4; OKANO Y, 1990, AM J HUM GENET, V46, P18; OKANO Y, 1991, NEW ENGL J MED, V324, P1232, DOI 10.1056/NEJM199105023241802; PENROSE LS, 1946, LANCET, V250, P949; PEREZ B, 1995, HUM MUTAT, V5, P188, DOI 10.1002/humu.1380050217; PEREZ B, 1994, J INHERIT METAB DIS, V17, P377, DOI 10.1007/BF00711839; Quinsey NS, 1996, J NEUROCHEM, V66, P908; RAMUS SJ, 1993, J MED GENET, V30, P401, DOI 10.1136/jmg.30.5.401; Romano V, 1996, J INHERIT METAB DIS, V19, P15, DOI 10.1007/BF01799343; Rosenberg, 1973, AMINO ACID METABOLIS; SALTER M, 1986, BIOCHEM J, V234, P635, DOI 10.1042/bj2340635; Scriver C.R., 1995, METABOLIC MOL BASIS, V7th ed, P1015; SCRIVER CR, 1985, METABOLISM, V34, P868, DOI 10.1016/0026-0495(85)90112-X; SCRIVER CR, 1991, NEW ENGL J MED, V324, P1280, DOI 10.1056/NEJM199105023241810; SVENSSON E, 1993, EUR J PEDIATR, V152, P132, DOI 10.1007/BF02072490; Svensson Elisabeth, 1992, Human Mutation, V1, P129; Treacy E, 1996, J INHERIT METAB DIS, V19, P595, DOI 10.1007/BF01799832; Treacy EP, 1997, PEDIATR RES, V42, P430, DOI 10.1203/00006450-199710000-00002; TREFZ FK, 1993, CLIN CHIM ACTA, V217, P15, DOI 10.1016/0009-8981(93)90233-T; TYFIELD LA, 1995, J MED GENET, V32, P867, DOI 10.1136/jmg.32.11.867; Waters PJ, 1998, HUM MUTAT, V11, P4; WEINSTEIN M, 1993, HUM GENET, V90, P645; Weiss KM, 1996, MOL PHYLOGENET EVOL, V5, P259, DOI 10.1006/mpev.1996.0019; WOO SLC, 1983, NATURE, V306, P151, DOI 10.1038/306151a0; WOOLF LI, 1955, BRIT MED J, V1, P57, DOI 10.1136/bmj.1.4905.57; ZSCHOCKE J, 1994, HUM MUTAT, V4, P114, DOI 10.1002/humu.1380040204; ZYGULSKA M, 1994, HUM MUTAT, V4, P297, DOI 10.1002/humu.1380040412; ZYGULSKA M, 1991, HUM GENET, V88, P91, DOI 10.1007/BF00204935	67	162	175	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1997	61	6					1309	1317		10.1086/301638	http://dx.doi.org/10.1086/301638			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YT019	9399896	Green Published, Bronze			2022-12-18	WOS:000071555900014
J	Parry, DM; MacCollin, MM; KaiserKupfer, MI; Pulaski, K; Nicholson, HS; Bolesta, M; Eldridge, R; Gusella, JF				Parry, DM; MacCollin, MM; KaiserKupfer, MI; Pulaski, K; Nicholson, HS; Bolesta, M; Eldridge, R; Gusella, JF			Germ-line mutations in the neurofibromatosis 2 gene: Correlations with disease severity and retinal abnormalities	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BILATERAL ACOUSTIC NEUROFIBROMATOSIS; TUMOR-SUPPRESSOR GENE; NF2 GENE; TYPE-2 NEUROFIBROMATOSIS; PIGMENT EPITHELIUM; ADENOMATOUS POLYPOSIS; COMBINED HAMARTOMA; OCULAR FUNDUS; SCHWANNOMAS; DELETION	Neurofibromatosis 2 (NF2) features bilateral vestibular schwannomas, other benign neural tumors, and cataracts. Patients in some families develop many tumors at an early age and have rapid clinical progression, whereas in other families, patients may not have symptoms until much later and vestibular schwannomas may be the only tumors. The NF2 gene has been cloned from chromosome 22q; most identified germ-line mutations result in a truncated protein and severe NF2. To look for additional mutations and clinical correlations, we used SSCP analysis to screen DNA from 32 unrelated patients. We identified 20 different mutations in 21 patients (66%): 10 nonsense mutations, 2 frameshifts, 7 splice site mutations, and 1 large in-frame deletion. Clinical information on 47 patients from the 21 families included ages at onset and at diagnosis, numbers of meningiomas, spinal and skin tumors, and presence of cataracts and retinal abnormalities. We compared clinical findings in patients with nonsense or frameshift mutations to those with splice-site mutations. When each patient was considered as an independent random event, the two groups differed (P less than or equal to .05) for nearly every variable. Patients with nonsense or frameshift mutations were)lounger at onset and at diagnosis and had a higher frequency and mean number of tumors, supporting the correlation between nonsense and frameshift mutations and severe NF2. When each family was considered as an independent random event, statistically significant differences between the two groups were observed only for mean ages at onset and at diagnosis. A larger data set is needed to resolve these discrepancies. We observed retinal hamartomas and/or epiretinal membranes in nine patients from five families with four different nonsense mutations. This finding, which may represent a new genotype-phenotype correlation, merits further study.	NEI, OPHTHALM GENET & CLIN SERV BRANCH, NIH, BETHESDA, MD 20892 USA; US PHS, BETHESDA, MD USA; MASSACHUSETTS GEN HOSP, DEPT NEUROL, BOSTON, MA 02114 USA; MASSACHUSETTS GEN HOSP, NEUROGENET UNIT, BOSTON, MA 02114 USA; CHILDRENS NATL MED CTR, DEPT HEMATOL ONCOL, WASHINGTON, DC 20010 USA; UNIV MARYLAND, DEPT MEASUREMENT STAT & EVALUAT, COLLEGE PK, MD 20742 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); United States Public Health Service; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Children's National Health System; University System of Maryland; University of Maryland College Park	Parry, DM (corresponding author), NCI, GENET EPIDEMIOL BRANCH, EXECUT PLAZA N, ROOM 400, 6130 EXECUT BLVD MSC7360, BETHESDA, MD 20892 USA.				DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS [N01CP015602] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CP-15602, N01-CP-33060, N01-CP-40500] Funding Source: Medline	DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALLEN J C, 1974, Birth Defects Original Article Series, V10, P171; ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; ARAI E, 1994, HUM MOL GENET, V3, P937, DOI 10.1093/hmg/3.6.937; BASER ME, IN PRESS NEUROLOGY; BIJLSMA EK, 1995, HUM GENET, V96, P1, DOI 10.1007/BF00214177; BOURN D, 1994, HUM MOL GENET, V3, P813, DOI 10.1093/hmg/3.5.813; BOURN D, 1994, AM J HUM GENET, V55, P69; BOUZAS EA, 1992, RETINA-J RET VIT DIS, V12, P103, DOI 10.1097/00006982-199212020-00005; BOUZAS EA, 1993, NEUROLOGY, V43, P622, DOI 10.1212/WNL.43.3_Part_1.622; CASPARI R, 1994, LANCET, V343, P629, DOI 10.1016/S0140-6736(94)92634-4; CHEN F, 1995, HUM MUTAT, V5, P66, DOI 10.1002/humu.1380050109; COTLIER E, 1977, ARCH OPHTHALMOL-CHIC, V95, P1990; DAVIES DR, 1995, AM J HUM GENET, V57, P1151; DEPREZ RHL, 1994, AM J HUM GENET, V54, P1022; Eldridge R, 1991, AM J HUM GENET S, V49, pA676; EVANS DGR, 1995, J MED GENET, V32, P470, DOI 10.1136/jmg.32.6.470; EVANS DGR, 1992, J MED GENET, V29, P841, DOI 10.1136/jmg.29.12.841; EVANS DGR, 1992, Q J MED, V84, P603; FONT RL, 1989, RETINA-J RET VIT DIS, V9, P302, DOI 10.1097/00006982-198909040-00011; Gardner WJ, 1930, ARCH NEURO PSYCHIATR, V23, P266, DOI 10.1001/archneurpsyc.1930.02220080050005; GOOD WV, 1991, BRIT J OPHTHALMOL, V75, P190, DOI 10.1136/bjo.75.3.190; JACOBY LB, 1994, HUM MOL GENET, V3, P413, DOI 10.1093/hmg/3.3.413; KAISERKUPFER MI, 1989, ARCH OPHTHALMOL-CHIC, V107, P541, DOI 10.1001/archopht.1989.01070010555030; KANTER WR, 1980, NEUROLOGY, V30, P851, DOI 10.1212/WNL.30.8.851; KAYE LD, 1992, OPHTHALMOLOGY, V99, P1424; KILPATRICK TJ, 1992, J NEUROL NEUROSUR PS, V55, P391, DOI 10.1136/jnnp.55.5.391; KLUWE L, 1995, HUM GENET, V95, P443; Kluwe L, 1996, HUM GENET, V97, P224, DOI 10.1007/BF02265270; LANDAU K, 1993, BRIT J OPHTHALMOL, V77, P646, DOI 10.1136/bjo.77.10.646; LANDAU K, 1990, ARCH OPHTHALMOL-CHIC, V108, P328, DOI 10.1001/archopht.1990.01070050026011; LEE DK, 1969, ARCH NEUROL-CHICAGO, V20, P154, DOI 10.1001/archneur.1969.00480080054006; MACCOLLIN M, 1993, JAMA-J AM MED ASSOC, V270, P2316, DOI 10.1001/jama.270.19.2316; MACCOLLIN M, 1994, AM J HUM GENET, V55, P314; MARTUZA RL, 1988, NEW ENGL J MED, V318, P684, DOI 10.1056/NEJM198803173181106; MEREL P, 1995, GENE CHROMOSOME CANC, V12, P117, DOI 10.1002/gcc.2870120206; MEREL P, 1995, GENE CHROMOSOME CANC, V13, P211, DOI 10.1002/gcc.2870130311; Mori M, 1985, No To Shinkei, V37, P403; NAROD SA, 1992, AM J HUM GENET, V51, P486; OLSCHWANG S, 1993, CELL, V75, P959, DOI 10.1016/0092-8674(93)90539-3; PARRY DM, 1991, ANN NY ACAD SCI, V630, P305, DOI 10.1111/j.1749-6632.1991.tb19615.x; PARRY DM, 1994, AM J MED GENET, V52, P450, DOI 10.1002/ajmg.1320520411; RAGGE NK, 1995, AM J OPHTHALMOL, V120, P634, DOI 10.1016/S0002-9394(14)72210-X; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; ROULEAU GA, 1987, NATURE, V329, P246, DOI 10.1038/329246a0; RUTTLEDGE MH, 1993, NEUROLOGY, V43, P1753, DOI 10.1212/WNL.43.9.1753; SAINZ J, 1995, HUM MOL GENET, V4, P137, DOI 10.1093/hmg/4.1.137; SANSON M, 1993, HUM MOL GENET, V2, P1215, DOI 10.1093/hmg/2.8.1215; SATO N, 1992, J CELL SCI, V103, P131; SCHACHAT AP, 1984, OPHTHALMOLOGY, V91, P1609; SIVALINGAM A, 1991, J PEDIATR OPHTHALMOL, V28, P320; THOMAS PK, 1990, MUSCLE NERVE, V13, P93, DOI 10.1002/mus.880130202; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; TWIST EC, 1994, HUM MOL GENET, V3, P147, DOI 10.1093/hmg/3.1.147; VANHEYNINGEN V, 1994, NATURE, V367, P319, DOI 10.1038/367319a0; WATSON CJ, 1993, HUM MOL GENET, V2, P701, DOI 10.1093/hmg/2.6.701; Wishart J H, 1822, Edinb Med Surg J, V18, P393; YOUNG DF, 1970, J AMER MED ASSOC, V214, P347, DOI 10.1001/jama.214.2.347; 1994, ARCH NEUROL-CHICAGO, V51, P210	58	162	168	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1996	59	3					529	539						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN625	8751853				2022-12-18	WOS:A1996VN62500006
J	RANUM, LPW; CHUNG, MY; BANFI, S; BRYER, A; SCHUT, LJ; RAMESAR, R; DUVICK, LA; MCCALL, A; SUBRAMONY, SH; GOLDFARB, L; GOMEZ, C; SANDKUIJL, LA; ORR, HT; ZOGHBI, HY				RANUM, LPW; CHUNG, MY; BANFI, S; BRYER, A; SCHUT, LJ; RAMESAR, R; DUVICK, LA; MCCALL, A; SUBRAMONY, SH; GOLDFARB, L; GOMEZ, C; SANDKUIJL, LA; ORR, HT; ZOGHBI, HY			MOLECULAR AND CLINICAL CORRELATIONS IN SPINOCEREBELLAR ATAXIA TYPE-I - EVIDENCE FOR FAMILIAL EFFECTS ON THE AGE AT ONSET	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOMINANT CEREBELLAR-ATAXIA; HUNTINGTONS-DISEASE; TRINUCLEOTIDE REPEAT; MYOTONIC-DYSTROPHY; JOSEPH DISEASE; PHENOTYPIC VARIATION; HEREDITARY ATAXIA; GENETIC-LINKAGE; LARGE KINDREDS; CTG REPEAT	The spinocerebellar ataxias are a group of debilitating neurodegenerative diseases for which a clinical classification system has proved unreliable. We have recently isolated the gene for spinocerebellar ataxia type 1 (SCA1) and have shown that the disease is caused by an expanded, unstable, CAG trinucleotide repeat within an expressed gene. Normal alleles have a size range of 19-36 repeats, while SCA1 alleles have 42-81 repeats. In this study, we examined the frequency and variability of the SCA1 repeat expansion in 87 kindreds with diverse ethnic backgrounds and dominantly inherited ataxia. All nine families for which linkage to the SCA1 region of 6p had previously been established showed repeat expansion, while 3 of the remaining 78 showed a similar abnormality. For 113 patients from the families with repeat expansion, inverse correlations between CAG repeat size and both age at onset and disease duration were observed. Repeat size accounted for 66% of the variation in age at onset in these patients. After correction for repeat size, interfamilial differences in age at onset remained significant, suggesting that additional genetic factors affect the expression of the SCA1 gene product.	UNIV MINNESOTA,DEPT LAB MED & PATHOL,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,DEPT NEUROL,MINNEAPOLIS,MN 55455; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT MOLEC & HUMAN GENET,HOUSTON,TX 77030; GROOTE SCHUUR HOSP,DEPT NEUROL,CAPE TOWN,SOUTH AFRICA; UNIV CAPE TOWN,DEPT HUMAN GENET,MRC,MED GENET RES UNIT,CAPE TOWN,SOUTH AFRICA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Baylor College of Medicine; Baylor College of Medicine; University of Cape Town; University of Cape Town	RANUM, LPW (corresponding author), UNIV MINNESOTA,SCH MED,INST HUMAN GENET,420 DELAWARE ST SE,BOX 206,UMHC,MINNEAPOLIS,MN 55455, USA.		Banfi, Sandro/K-3963-2018; Ramesar, Raj S/I-6941-2015	Banfi, Sandro/0000-0002-6541-8833; Ramesar, Raj S/0000-0001-5688-1634; Chung, Ming-yi/0000-0003-2198-6860; Zoghbi, Huda/0000-0002-0700-3349; Orr, Harry/0000-0001-6118-741X				ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; AUBURGER G, 1990, AM J HUM GENET, V46, P1163; BANFI S, 1993, GENOMICS, V18, P627, DOI 10.1016/S0888-7543(05)80365-9; BANFI S, 1994, IN PRESS NATURE GENE; Biancalana V., 1992, Human Molecular Genetics, V1, P255, DOI 10.1093/hmg/1.4.255; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BRYER A, 1992, TISSUE ANTIGENS, V40, P111, DOI 10.1111/j.1399-0039.1992.tb02101.x; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; CARSON WJ, 1992, GENOMICS, V13, P852, DOI 10.1016/0888-7543(92)90168-R; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; COUTINHO P, 1978, NEUROLOGY, V28, P703, DOI 10.1212/WNL.28.7.703; CURRIER RD, 1972, NEUROLOGY, V22, P1040, DOI 10.1212/WNL.22.9.1040; DIAZ GO, 1990, NEUROLOGY, V40, P1369, DOI 10.1212/WNL.40.9.1369; DUAYO M, 1993, NAT GENET, V4, P387; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GISPERT S, 1993, NAT GENET, V4, P295, DOI 10.1038/ng0793-295; GOLDBERG YP, 1993, NAT GENET, V5, P174, DOI 10.1038/ng1093-174; GOLDFARB LG, 1989, NEUROLOGY, V39, P1527, DOI 10.1212/WNL.39.11.1527; Greenfield JG., 1954, SPINO CEREBELLAR DEG; HAINES JL, 1984, NEUROLOGY, V34, P1542, DOI 10.1212/WNL.34.12.1542; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; JACKSON JF, 1977, NEW ENGL J MED, V296, P1138, DOI 10.1056/NEJM197705192962003; KEATS BJB, 1991, AM J HUM GENET, V49, P972; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; KUMAR D, 1986, HUM GENET, V72, P327, DOI 10.1007/BF00290959; KWIATKOWSKI TJ, 1993, AM J HUM GENET, V53, P391; LI SH, 1993, GENOMICS, V16, P572, DOI 10.1006/geno.1993.1232; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; McKusick V.A., 1978, MENDELIAN INHERITANC; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; NINO HE, 1980, NEUROLOGY, V30, P12, DOI 10.1212/WNL.30.1.12; NORREMOLLE A, 1993, HUM MOL GENET, V2, P1475, DOI 10.1093/hmg/2.9.1475; ORR HT, 1993, NAT GENET, V4, P211; RANUM LPW, 1991, AM J HUM GENET, V49, P31; RANUM LPW, 1992, NEUROLOGY, V42, P344, DOI 10.1212/WNL.42.2.344; SAKAI T, 1983, NEUROLOGY, V33, P74, DOI 10.1212/WNL.33.1.74; SCHUT JW, 1950, ARCH NEURO PSYCHIATR, V63, P535, DOI 10.1001/archneurpsyc.1950.02310220002001; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; STRONG TV, 1993, NAT GENET, V5, P259, DOI 10.1038/ng1193-259; TAKIYAMA Y, 1993, NAT GENET, V4, P300, DOI 10.1038/ng0793-300; TELENIUS H, 1993, HUM MOL GENET, V2, P1535, DOI 10.1093/hmg/2.10.1535; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; YAKURA H, 1974, NEW ENGL J MED, V291, P154; ZOGHBI HY, 1988, ANN NEUROL, V23, P580, DOI 10.1002/ana.410230609; ZOGHBI HY, 1991, AM J HUM GENET, V49, P23; ZUHLKE C, 1993, HUM MOL GENET, V2, P1467; 1993, CELL, V72, P971	48	162	167	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1994	55	2					244	252						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NZ336	8037204				2022-12-18	WOS:A1994NZ33600004
J	WORDSWORTH, P; PILE, KD; BUCKELY, JD; LANCHBURY, JSS; OLLIER, B; LATHROP, M; BELL, JI				WORDSWORTH, P; PILE, KD; BUCKELY, JD; LANCHBURY, JSS; OLLIER, B; LATHROP, M; BELL, JI			HLA HETEROZYGOSITY CONTRIBUTES TO SUSCEPTIBILITY TO RHEUMATOID-ARTHRITIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SHARED EPITOPE HYPOTHESIS; CLASS-II REGION; HISTOCOMPATIBILITY MOLECULES; ASSOCIATION; DR4; HYBRIDIZATION; HETEROGENEITY; INHERITANCE; SELECTION; GENETICS	We have investigated the role of HLA-DR genotypes in 184 patients with severe rheumatoid arthritis (RA) and in 46 patients with Felty syndrome, to establish the relative contribution of the RA-associated subtypes of DR4 (Dw4, Dw14, and Dw15). There was an excess of DR4 homozygotes, particularly Dw4/Dw14 compound heterozygotes (relative risk [RR] 49). The risk associated with Dw4 depended on the other allele present-Dw4/DR1 (RR 21), Dw4/Dw4 (RR 15), and Dw4/DRX (RR 6). There was a significant risk from Dw4/Dw14 compared with Dw4/Dw4, both in those with severe RA (RR 2.9; P < .02) and in those with Felty syndrome (RR 4.2; P < .02). In contrast, in a further 63 known DR4 homozygotes with RA, not selected for severe disease, the excess of Dw4/Dw14 was much less striking (RR 1.4; not significant), suggesting that this genotype may be particularly associated with more severe disease. We also found four cases with the rare Dw4/Dw15 genotype (expected less-than-or-equal-to 0.5; P less-than-or-equal-to .02). Since the Dw4, Dw14, Dw15, and DR1 molecules have similar antigen-binding sites and since combinations of these alleles particularly predispose to severe RA, we suggest that synergistic mechanisms are involved. These could include an effect on T-cell repertoire selection.	UNIV SO CALIF,DEPT PREVENT MED,LOS ANGELES,CA 90089; INST MOLEC MED,OXFORD,ENGLAND; GUYS HOSP,MOLEC IMMUNOGENET LAB,LONDON SE1 9RT,ENGLAND; UNIV MANCHESTER,ARTHRITIS & RHEUMATISM COUNCIL EPIDEMIOL UNIT,MANCHESTER M13 9PL,LANCS,ENGLAND; CTR ETUD POLYMORPHISME HUMAIN,PARIS,FRANCE	University of Southern California; University of Oxford; Guy's & St Thomas' NHS Foundation Trust; University of Manchester					Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BELL JI, UNPUB MULTIPLE MHC D; BROWN JH, 1988, NATURE, V332, P845, DOI 10.1038/332845a0; BROWN MG, 1991, NATURE, V353, P355, DOI 10.1038/353355a0; CAMPION G, 1990, MEDICINE, V69, P69, DOI 10.1097/00005792-199069020-00001; DAVIS MM, 1990, ANNU REV BIOCHEM, V59, P475, DOI 10.1146/annurev.biochem.59.1.475; GAO XJ, 1990, ARTHRITIS RHEUM, V33, P939, DOI 10.1002/art.1780330704; GLYNNE R, 1991, NATURE, V353, P357, DOI 10.1038/353357a0; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; GREGERSEN PK, 1986, P NATL ACAD SCI USA, V83, P2462; JARAQUEMADA D, 1986, ANN RHEUM DIS, V45, P627, DOI 10.1136/ard.45.8.627; KHAN MA, 1988, TISSUE ANTIGENS, V31, P254, DOI 10.1111/j.1399-0039.1988.tb02092.x; LANCHBURY JSS, 1990, HUM IMMUNOL, V27, P136, DOI 10.1016/0198-8859(90)90110-B; LANCHBURY JSS, 1991, HUM IMMUNOL, V32, P56, DOI 10.1016/0198-8859(91)90117-R; LATHROP GM, 1983, TISSUE ANTIGENS, V22, P160, DOI 10.1111/j.1399-0039.1983.tb01183.x; MAEDA H, 1981, ANN RHEUM DIS, V40, P299, DOI 10.1136/ard.40.3.299; MCDERMOTT M, 1986, DIS MARKERS, V4, P103; NEPOM BS, 1984, J CLIN INVEST, V74, P287, DOI 10.1172/JCI111413; NEPOM GT, 1986, LANCET, V2, P1002; NICKLAS JA, 1985, HUM IMMUNOL, V13, P95, DOI 10.1016/0198-8859(85)90016-3; OLLIER W, 1986, DIS MARKERS, V4, P85; PAYAMI H, 1986, TISSUE ANTIGENS, V27, P57; PILE KD, 1992, TISSUE ANTIGENS, V39, P138, DOI 10.1111/j.1399-0039.1992.tb01924.x; RIGBY AS, 1991, GENET EPIDEMIOL, V8, P153, DOI 10.1002/gepi.1370080303; ROPES M W, 1958, Bull Rheum Dis, V9, P175; SHEEHY MJ, 1989, J CLIN INVEST, V83, P830, DOI 10.1172/JCI113965; SOLLID LM, 1989, J EXP MED, V169, P345, DOI 10.1084/jem.169.1.345; THOMSON G, 1988, AM J HUM GENET, V43, P799; WILLKENS RF, 1991, ARTHRITIS RHEUM, V34, P43, DOI 10.1002/art.1780340107; WORDSWORTH BP, 1989, P NATL ACAD SCI USA, V86, P10049, DOI 10.1073/pnas.86.24.10049; WORDSWORTH BP, 1991, BRIT J RHEUMATOL, V30, P178; WORDSWORTH BP, 1991, BRIT J RHEUMATOL, V30, P151; WORDSWORTH BP, 1990, IMMUNOGENETICS, V32, P413	32	162	165	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1992	51	3					585	591						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JJ828	1496989				2022-12-18	WOS:A1992JJ82800016
J	GLOVER, TW; STEIN, CK				GLOVER, TW; STEIN, CK			CHROMOSOME BREAKAGE AND RECOMBINATION AT FRAGILE SITES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MICHIGAN,DEPT PEDIAT & COMMUNICABLE DIS,ANN ARBOR,MI 48109; UNIV MICHIGAN,FACHBEREICH HUMAN GENET,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan					NATIONAL CANCER INSTITUTE [R01CA043222] Funding Source: NIH RePORTER; NCI NIH HHS [CA 43222] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; DEAGAU KV, 1978, AM J HUM GENET, V30, pA78; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GERBER MJ, 1986, CYTOGENET CELL GENET, V42, P72, DOI 10.1159/000132254; GLOVER TW, 1981, AM J HUM GENET, V33, P234; GLOVER TW, 1987, AM J HUM GENET, V41, P882; GLOVER TW, 1984, HUM GENET, V67, P136, DOI 10.1007/BF00272988; HARRIS P, 1986, CYTOMETRY, V7, P589, DOI 10.1002/cyto.990070614; HECHT F, 1984, CANCER GENET CYTOGEN, V13, P185, DOI 10.1016/0165-4608(84)90060-8; HECHT F, 1984, CANCER GENET CYTOGEN, V12, P189; LEBEAU MM, 1984, NATURE, V308, P607, DOI 10.1038/308607a0; LEDBETTER DH, 1986, NATURE, V324, P161, DOI 10.1038/324161a0; NAYLOR SL, 1984, P NATL ACAD SCI-BIOL, V81, P2447, DOI 10.1073/pnas.81.8.2447; NAYLOR SL, 1987, NATURE, V329, P451, DOI 10.1038/329451a0; NAYLOR SL, 1985, P NATL ACAD SCI USA, V82, P8274; NUSSBAUM RL, 1986, AM J MED GENET, V23, P715, DOI 10.1002/ajmg.1320230162; PATTERSON D, 1983, SOMAT CELL GENET, V9, P359, DOI 10.1007/BF01539144; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Sutherland G, 1985, FRAGILE SITES HUMAN; SUTHERLAND GR, 1985, AM J MED GENET, V22, P433, DOI 10.1002/ajmg.1320220234; TOMMERUP N, 1981, J MED GENET, V18, P374, DOI 10.1136/jmg.18.5.374; TOMMERUP N, 1986, 7TH INT C HUM GEN W; WARREN ST, 1987, SCIENCE, V237, P420, DOI 10.1126/science.3603029; WYANDT HE, 1976, EXP CELL RES, V102, P85, DOI 10.1016/0014-4827(76)90302-5; YUNIS JJ, 1984, SCIENCE, V226, P1199, DOI 10.1126/science.6239375	25	162	163	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1988	43	3					265	273						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	P8841	3137811				2022-12-18	WOS:A1988P884100006
J	Germain, M; Chasman, DI; de Haan, H; Tang, W; Lindstrom, S; Weng, LC; de Andrade, M; de Visser, MCH; Wiggins, KL; Suchon, P; Saut, N; Smadja, DM; Le Gal, G; Vlieg, AV; Di Narzo, A; Hao, K; Nelson, CP; Rocanin-Arjo, A; Folkersen, L; Monajemi, R; Rose, LM; Brody, JA; Slagboom, E; Aissi, D; Gagnon, F; Deleuze, JF; Deloukas, P; Tzourio, C; Dartigues, JF; Berr, C; Taylor, KD; Civelek, M; Eriksson, P; Psaty, BM; Houwing-Duitermaat, J; Goodall, AH; Cambien, F; Kraft, P; Amouyel, P; Samani, NJ; Basu, S; Ridker, PM; Rosendaal, FR; Kabrhel, C; Folsom, AR; Heit, J; Reitsma, PH; Tregouet, DA; Smith, NL; Morange, PE				Germain, Marine; Chasman, Daniel I.; de Haan, Hugoline; Tang, Weihong; Lindstroem, Sara; Weng, Lu-Chen; de Andrade, Mariza; de Visser, Marieke C. H.; Wiggins, Kerri L.; Suchon, Pierre; Saut, Noemie; Smadja, David M.; Le Gal, Gregoire; Vlieg, Astrid van Hylckama; Di Narzo, Antonio; Hao, Ke; Nelson, Christopher P.; Rocanin-Arjo, Ares; Folkersen, Lasse; Monajemi, Ramin; Rose, Lynda M.; Brody, Jennifer A.; Slagboom, Eline; Aissi, Dylan; Gagnon, France; Deleuze, Jean-Francois; Deloukas, Panos; Tzourio, Christophe; Dartigues, Jean-Francois; Berr, Claudine; Taylor, Kent D.; Civelek, Mete; Eriksson, Per; Psaty, Bruce M.; Houwing-Duitermaat, Jeanine; Goodall, Alison H.; Cambien, Francois; Kraft, Peter; Amouyel, Philippe; Samani, Nilesh J.; Basu, Saonli; Ridker, Paul M.; Rosendaal, Frits R.; Kabrhel, Christopher; Folsom, Aaron R.; Heit, John; Reitsma, Pieter H.; Tregouet, David-Alexandre; Smith, Nicholas L.; Morange, Pierre-Emmanuel		Cardiogenics Consortium	Meta-analysis of 65,734 Individuals Identifies TSPAN15 and SLC44A2 as Two Susceptibility Loci for Venous Thromboembolism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; ENDOTHELIAL-CELLS; GENE-EXPRESSION; PLASMA-LEVELS; CARDIOVASCULAR-DISEASE; GENOTYPING ARRAYS; AGING RESEARCH; BREAST-CANCER; RISK VARIANTS; PROTEIN-C	Venous thromboembolism (VTE), the third leading cause of cardiovascular mortality, is a complex thrombotic disorder with environmental and genetic determinants. Although several genetic variants have been found associated with VTE, they explain a minor proportion of VTE risk in cases. We undertook a meta-analysis of genome-wide association studies (GWASs) to identify additional VTE susceptibility genes. Twelve GWASs totaling 7,507 VTE case subjects and 52,632 control subjects formed our discovery stage where 6,751,884 SNPs were tested for association with VTE. Nine loci reached the genome-wide significance level of 5 x 10(-8) including six already known to associate with VTE (ABO, F2, F5, F11, FGG, and PROCR) and three unsuspected loci. SNPs mapping to these latter were selected for replication in three independent case-control studies totaling 3,009 VTE-affected individuals and 2,586 control subjects. This strategy led to the identification and replication of two VTE-associated loci, TSPAN15 and SLC44A2, with lead risk alleles associated with odds ratio for disease of 1.31 (p = 1.67 x 10(-16)) and 1.21 (p = 2.75 x 10(-15)), respectively. The lead SNP at the TSPAN15 locus is the intronic rs78707713 and the lead SLC44A2 SNP is the non-synonymous rs2288904 previously shown to associate with transfusion-related acute lung injury. We further showed that these two variants did not associate with known hemostatic plasma markers. TSPAN15 and SLC44A2 do not belong to conventional pathways for thrombosis and have not been associated to other cardiovascular diseases nor related quantitative biomarkers. Our findings uncovered unexpected actors of VTE etiology and pave the way for novel mechanistic concepts of VTE pathophysiology.	[Germain, Marine; Rocanin-Arjo, Ares; Aissi, Dylan; Cambien, Francois; Tregouet, David-Alexandre] INSERM, UMR S 1166, F-75013 Paris, France; [Germain, Marine; Rocanin-Arjo, Ares; Aissi, Dylan; Cambien, Francois; Tregouet, David-Alexandre] Univ Paris 06, Univ Sorbonne, UMR S 1166, Team Genom & Pathophysiol Cardiovasc Dis, F-75013 Paris, France; [Germain, Marine; Rocanin-Arjo, Ares; Aissi, Dylan; Cambien, Francois; Tregouet, David-Alexandre] ICAN, F-75013 Paris, France; [Chasman, Daniel I.; Ridker, Paul M.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; [Chasman, Daniel I.; Ridker, Paul M.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [de Haan, Hugoline; Vlieg, Astrid van Hylckama; Rosendaal, Frits R.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Dept Thrombosis & Hemostasis, NL-2333 ZA Leiden, Netherlands; [Tang, Weihong; Weng, Lu-Chen; Folsom, Aaron R.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA; [Lindstroem, Sara; Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Program Genet Epidemiol & Stat Genet, Boston, MA 02115 USA; [de Andrade, Mariza] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [de Visser, Marieke C. H.; Reitsma, Pieter H.] Leiden Univ, Med Ctr, Dept Thrombosis & Hemostasis, Einthoven Lab Expt Vasc Med, NL-2300 RC Leiden, Netherlands; [Wiggins, Kerri L.; Smith, Nicholas L.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Suchon, Pierre; Saut, Noemie; Morange, Pierre-Emmanuel] Hop Enfants La Timone, Haematol Lab, F-13385 Marseille, France; [Suchon, Pierre; Saut, Noemie; Morange, Pierre-Emmanuel] INSERM, UMR S 1062, Nutr Obes & Risk Thrombosis, F-13385 Marseille, France; [Suchon, Pierre; Saut, Noemie; Morange, Pierre-Emmanuel] Aix Marseille Univ, UMR S 1062, Nutr Obes & Risk Thrombosis, F-13385 Marseille, France; [Smadja, David M.] Univ Paris 05, Sorbonne Paris Cite, F-75006 Paris, France; [Smadja, David M.] Hop Europeen Georges Pompidou, AP HP, Serv Hematol Biol, F-75015 Paris, France; [Smadja, David M.] Fac Pharm, INSERM, UMR S 1140, F-75006 Paris, France; [Le Gal, Gregoire] Univ Brest, EA3878, F-29238 Brest, France; [Le Gal, Gregoire] Univ Brest, CIC1412, F-29238 Brest, France; [Le Gal, Gregoire] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON K1Y 4E9, Canada; [Di Narzo, Antonio; Hao, Ke] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Nelson, Christopher P.; Goodall, Alison H.; Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester LE1 7RH, Leics, England; [Nelson, Christopher P.; Goodall, Alison H.; Samani, Nilesh J.] Natl Inst Hlth Res, Leicester Cardiovasc Biomed Res Unit, Leicester LE3 9QP, Leics, England; [Folkersen, Lasse] Dept PharmacoGenet, DK-2400 Copenhagen, Denmark; [Monajemi, Ramin; Houwing-Duitermaat, Jeanine] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, NL-2300 RC Leiden, Netherlands; [Rose, Lynda M.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; [Brody, Jennifer A.; Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Brody, Jennifer A.; Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Brody, Jennifer A.; Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Slagboom, Eline] Leiden Univ, Med Ctr, Dept Mol Epidemiol, NL-2300 RC Leiden, Netherlands; [Gagnon, France] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON M5T 3M7, Canada; [Deleuze, Jean-Francois] Commissariat Energie Atom, Direct Sci Vivant, Inst Genom, Ctr Natl Genotypage, F-91057 Evry, France; [Deloukas, Panos] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London E1 4NS, England; [Deloukas, Panos] King Abdulaziz Univ, Princess Al Jawhara Al Brahim Ctr Excellence Res, Jeddah 21589, Saudi Arabia; [Tzourio, Christophe; Dartigues, Jean-Francois] Univ Bordeaux, INSERM, Res Ctr, U897, F-33000 Bordeaux, France; [Berr, Claudine] Univ Montpellier I, INSERM, Res Unit, U1061, F-34000 Montpellier, France; [Taylor, Kent D.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90502 USA; [Taylor, Kent D.] Harbor UCLA Med Ctr, Dept Pediat, Torrance, CA 90502 USA; [Civelek, Mete] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; [Eriksson, Per] Karolinska Inst, Dept Med, Ctr Mol Med, Atherosclerosis Res Unit, S-17177 Stockholm, Sweden; [Psaty, Bruce M.; Smith, Nicholas L.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA 98101 USA; [Amouyel, Philippe] Univ Lille Nord France, INSERM, UMR S 744, Inst Pasteur Lille, F-59000 Lille, France; [Amouyel, Philippe] Ctr Hosp Reg Univ Lille, F-59000 Lille, France; [Basu, Saonli] Univ Minnesota, Div Biostat, Minneapolis, MN 55455 USA; [Kabrhel, Christopher] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Emergency Med,Channing Network Med, Boston, MA USA; [Heit, John] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA; [Smith, Nicholas L.] VA Off Res & Dev, Seattle Epidemiol Res & Informat Ctr, Seattle, WA 98108 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Harvard T.H. Chan School of Public Health; Mayo Clinic; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Washington; University of Washington Seattle; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Bretagne Occidentale; Universite de Bretagne Occidentale; University of Ottawa; Ottawa Hospital Research Institute; Icahn School of Medicine at Mount Sinai; University of Leicester; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Harvard University; Brigham & Women's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Toronto; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; University of London; Queen Mary University London; King Abdulaziz University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; Karolinska Institutet; Group Health Cooperative; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Harvard Medical School; Massachusetts General Hospital; Mayo Clinic	Smith, NL (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.	nlsmith@u.washington.edu; pierre.morange@ap-hm.fr	Kraft, Peter/GQH-8448-2022; DARTIGUES, Jean François/T-4513-2019; berr, Claudine/D-5238-2014; de Visser, Marieke/AAC-5167-2020; Tzourio, christophe/B-4015-2009; Cambien, Francois/AAP-9751-2020; van Hylckama Vlieg, Astrid/A-3323-2017; Tregouet, David-Alexandre/E-3961-2016; Trégouët, David-Alexandre/P-9210-2019; Rosendaal, Frits/Q-3842-2017; Deloukas, Panos/B-2922-2013; Morange, Pierre/T-9070-2019; Aïssi, Dylan/AAH-1499-2019; Slagboom, P. Eline/R-4790-2016; Tzourio, christophe/L-6344-2019; Smadja, David/M-3872-2017	berr, Claudine/0000-0001-5254-7655; Tzourio, christophe/0000-0002-6517-2984; Trégouët, David-Alexandre/0000-0001-9084-7800; Rosendaal, Frits/0000-0003-2558-7496; Deloukas, Panos/0000-0001-9251-070X; Morange, Pierre/0000-0002-9065-722X; Aïssi, Dylan/0000-0002-5858-6468; Slagboom, P. Eline/0000-0002-2875-4723; Tzourio, christophe/0000-0002-6517-2984; Germain, Marine/0000-0002-8489-8916; Basu, Saonli/0000-0003-1200-4546; de Haan, Hugoline/0000-0003-1126-4776; Goodall, Alison/0000-0002-7883-9645; Kabrhel, Christopher/0000-0002-8699-7176; Amouyel, Philippe/0000-0001-9088-234X; Monajemi, Ramin/0000-0002-4277-6523; Smadja, David/0000-0001-7731-9202; Nelson, Christopher/0000-0001-8025-2897; Civelek, Mete/0000-0002-8141-0284; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Wiggins, Kerri L/0000-0003-2749-1279; Suchon, Pierre/0000-0001-8845-9163; Eriksson, Per/0000-0002-5635-2692; Folkersen, Lasse/0000-0003-0708-9530	French National Institute for Health and Medical Research; French Ministry of Health; French Medical Research Foundation; French Agency for Research; National Heart, Lung, and Blood Institute (USA); National Institute for Health Research (USA); National Human Genome Research Institute (USA); National Cancer Institute (USA); Donald W. Reynolds Foundation; Fondation Leducq; European Commission; Netherlands Organisation for Scientific Research; Netherlands Heart Foundation; Dutch Cancer Foundation; Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada; British Heart Foundation; ICAN Institute for Cardiometabolism and Nutrition; NATIONAL CANCER INSTITUTE [UM1CA182913] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043201, R01HL116854, R01HL059367, R01HL095080, R01HL085251, R01HL074745, R01HL073410, R01HL068639, R01HL068986, R01HL060739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; National Institute for Health Research [NF-SI-0611-10170] Funding Source: researchfish	French National Institute for Health and Medical Research(Institut National de la Sante et de la Recherche Medicale (Inserm)); French Ministry of Health; French Medical Research Foundation(Fondation pour la Recherche Medicale); French Agency for Research(French National Research Agency (ANR)); National Heart, Lung, and Blood Institute (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute for Health Research (USA); National Human Genome Research Institute (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Donald W. Reynolds Foundation; Fondation Leducq(Leducq Foundation); European Commission(European CommissionEuropean Commission Joint Research Centre); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Heart Foundation(Netherlands Heart Foundation); Dutch Cancer Foundation(KWF Kankerbestrijding); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); British Heart Foundation(British Heart Foundation); ICAN Institute for Cardiometabolism and Nutrition; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute for Health Research(National Institute for Health Research (NIHR))	This work is the product of the International Network against Thrombosis (INVENT) collaboration. This work was financially supported by the French National Institute for Health and Medical Research; French Ministry of Health; French Medical Research Foundation; French Agency for Research; National Heart, Lung, and Blood Institute (USA); National Institute for Health Research (USA); National Human Genome Research Institute (USA); National Cancer Institute (USA); the Donald W. Reynolds Foundation; Fondation Leducq; The European Commission; Netherlands Organisation for Scientific Research; Netherlands Heart Foundation; Dutch Cancer Foundation; Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada; British Heart Foundation; and ICAN Institute for Cardiometabolism and Nutrition. The lists of grants supporting this research can be found in the Supplemental Data.	[Anonymous], 1856, GESAMMELTE ABH; Bailey RL, 2011, BIOCHEM SOC T, V39, P1667, DOI 10.1042/BST20110745; Barenboim M, 2013, BIOINFORMATICS, V29, P2197, DOI 10.1093/bioinformatics/btt356; Bayat B, 2013, ARTERIOSCL THROM VAS, V33, P2538, DOI 10.1161/ATVBAHA.113.301206; Berditchevski F, 2001, J CELL SCI, V114, P4143; Blom JW, 2005, JAMA-J AM MED ASSOC, V293, P715, DOI 10.1001/jama.293.6.715; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Curtis BR, 2010, BLOOD, V115, P2073, DOI 10.1182/blood-2009-11-248336; de Visser MCH, 2013, J THROMB HAEMOST, V11, P1474, DOI 10.1111/jth.12313; Dick KJ, 2014, LANCET, V383, P1990, DOI 10.1016/S0140-6736(13)62674-4; Erbilgin A, 2013, J LIPID RES, V54, P1894, DOI 10.1194/jlr.M037085; Fairfax BP, 2014, SCIENCE, V343, P1118, DOI 10.1126/science.1246949; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Folkersen L, 2010, CIRC-CARDIOVASC GENE, V3, P365, DOI 10.1161/CIRCGENETICS.110.948935; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Garnier S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003240; Gauderman WJ, 2002, STAT MED, V21, P35, DOI 10.1002/sim.973; Germain M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038538; Germain M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025581; Goschnick MW, 2006, BLOOD, V108, P1911, DOI 10.1182/blood-2006-02-004267; Greinacher A, 2010, NAT MED, V16, P45, DOI 10.1038/nm.2070; HANKINSON SE, 1995, CANCER CAUSE CONTROL, V6, P217, DOI 10.1007/BF00051793; Heit JA, 2012, J THROMB HAEMOST, V10, P1521, DOI 10.1111/j.1538-7836.2012.04810.x; Heit JA, 2004, J THROMB HAEMOST, V2, P731, DOI 10.1111/j.1538-7933.2004.00660.x; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Johnson EO, 2013, HUM GENET, V132, P509, DOI 10.1007/s00439-013-1266-7; Kabakchiev B, 2013, GASTROENTEROLOGY, V144, P1488, DOI 10.1053/j.gastro.2013.03.001; Lau LM, 2004, BLOOD, V104, P2368, DOI 10.1182/blood-2003-12-4430; Li MX, 2012, HUM GENET, V131, P747, DOI 10.1007/s00439-011-1118-2; Li Y, 2009, J THROMB HAEMOST, V7, P1802, DOI 10.1111/j.1538-7836.2009.03544.x; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Morange PE, 2013, J THROMB HAEMOST, V11, P111, DOI 10.1111/jth.12233; Naess IA, 2007, J THROMB HAEMOST, V5, P692, DOI 10.1111/j.1538-7836.2007.02450.x; Oger E, 2006, J THROMB HAEMOST, V4, P793, DOI 10.1111/j.1538-7836.2006.01856.x; Oudot-Mellakh T, 2012, BRIT J HAEMATOL, V157, P230, DOI 10.1111/j.1365-2141.2011.09025.x; Panagiotou OA, 2012, INT J EPIDEMIOL, V41, P273, DOI 10.1093/ije/dyr178; Poeter M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4738; PSATY BM, 1995, JAMA-J AM MED ASSOC, V274, P620, DOI 10.1001/jama.274.8.620; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; Rocanin-Arjo A, 2014, BLOOD, V123, P777, DOI 10.1182/blood-2013-10-529628; Sabater-Lleal M, 2013, CIRCULATION, V128, P1310, DOI 10.1161/CIRCULATIONAHA.113.002251; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Smith NL, 2011, CIRCULATION, V123, P1864, DOI 10.1161/CIRCULATIONAHA.110.009480; Smith NL, 2010, CIRCULATION, V121, P1382, DOI 10.1161/CIRCULATIONAHA.109.869156; Tang WH, 2013, GENET EPIDEMIOL, V37, P512, DOI 10.1002/gepi.21731; Tang WH, 2012, AM J HUM GENET, V91, P152, DOI 10.1016/j.ajhg.2012.05.009; Tang WH, 2010, BLOOD, V116, P5032, DOI 10.1182/blood-2010-05-283739; Tell G S, 1993, Ann Epidemiol, V3, P358, DOI 10.1016/1047-2797(93)90062-9; Traiffort E, 2013, MOL ASPECTS MED, V34, P646, DOI 10.1016/j.mam.2012.10.011; Tregouet DA, 2009, BLOOD, V113, P5298, DOI 10.1182/blood-2008-11-190389; Tworoger SS, 2006, CANCER RES, V66, P2476, DOI 10.1158/0008-5472.CAN-05-3369; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Zoller B, 2011, CIRCULATION, V124, P1012, DOI 10.1161/CIRCULATIONAHA.110.965020	57	161	165	0	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 2	2015	96	4					532	542		10.1016/j.ajhg.2015.01.019	http://dx.doi.org/10.1016/j.ajhg.2015.01.019			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CF0DJ	25772935	Green Published, Bronze			2022-12-18	WOS:000352212600002
J	Moorjani, P; Thangaraj, K; Patterson, N; Lipson, M; Loh, PR; Govindaraj, P; Berger, B; Reich, D; Singh, L				Moorjani, Priya; Thangaraj, Kumarasamy; Patterson, Nick; Lipson, Mark; Loh, Po-Ru; Govindaraj, Periyasamy; Berger, Bonnie; Reich, David; Singh, Lalji			Genetic Evidence for Recent Population Mixture in India	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA; HUNTER-GATHERERS; ADMIXTURE; SETTLEMENT; FARMERS; COMMON; SOUTH; ASIA	Most Indian groups descend from a mixture of two genetically divergent populations: Ancestral North Indians (AND related to Central Asians, Middle Easterners, Caucasians, and Europeans; and Ancestral South Indians (ASI) not closely related to groups outside the subcontinent. The date of mixture is unknown but has implications for understanding Indian history. We report genome-wide data from 73 groups from the Indian subcontinent and analyze linkage disequilibrium to estimate ANI-ASI mixture dates ranging from about 1,900 to 4,200 years ago. In a subset of groups, 100% of the mixture is consistent with having occurred during this period. These results show that India experienced a demographic transformation several thousand years ago, from a region in which major population mixture was common to one in which mixture even between closely related groups became rare because of a shift to endogamy.	[Moorjani, Priya; Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Moorjani, Priya; Patterson, Nick; Berger, Bonnie; Reich, David] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Thangaraj, Kumarasamy; Govindaraj, Periyasamy; Singh, Lalji] CSIR, Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; [Lipson, Mark; Loh, Po-Ru; Berger, Bonnie] MIT, Dept Math & Comp Sci, Cambridge, MA 02139 USA; [Lipson, Mark; Loh, Po-Ru; Berger, Bonnie] MIT, Artificial Intelligence Lab, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Moorjani, P (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	moorjani@genetics.med.harvard.edu; thangs@ccmb.res.in		Thangaraj, Kumarasamy/0000-0002-0075-0106	National Institutes of Health grant [GM100233]; National Science Foundation HOMINID grant [1032255]; NSF Graduate Research Fellowships; UKIERI Major Award [RG-4772]; Network Project fund from the Council of Scientific and Industrial Research, Government of India [GENESIS: BSC0121]; Bhatnagar Fellowship grant from the Council of Scientific and Industrial Research of the Government of India; J.C. Bose Fellowship from the Department of Science and Technology, Government of India; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100233] Funding Source: NIH RePORTER; Division Of Behavioral and Cognitive Sci [1032255] Funding Source: National Science Foundation	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation HOMINID grant; NSF Graduate Research Fellowships(National Science Foundation (NSF)); UKIERI Major Award; Network Project fund from the Council of Scientific and Industrial Research, Government of India; Bhatnagar Fellowship grant from the Council of Scientific and Industrial Research of the Government of India; J.C. Bose Fellowship from the Department of Science and Technology, Government of India; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	We thank the volunteers who donated DNA samples. We acknowledge the help of Rakesh Tamang, Justin Carlus, and A. Govardhana Reddy in sample collection and handling. We thank Richard Meadow and Michael Witzel for discussions and critical readings of the manuscript. P.M., N.P., and D.R. were supported by National Institutes of Health grant GM100233 and National Science Foundation HOMINID grant 1032255. M.L. and P.-R.L. were supported by NSF Graduate Research Fellowships. K.T. was supported by a UKIERI Major Award (RG-4772) and the Network Project (GENESIS: BSC0121) fund from the Council of Scientific and Industrial Research, Government of India. L.S. was supported by a Bhatnagar Fellowship grant from the Council of Scientific and Industrial Research of the Government of India and by a J.C. Bose Fellowship from the Department of Science and Technology, Government of India. Genotyping data for the samples collected for this study will be made available upon request from the corresponding authors.	Abbi A, 2009, LANG SCI, V31, P791, DOI 10.1016/j.langsci.2008.02.002; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Auton A, 2009, GENOME RES, V19, P795, DOI 10.1101/gr.088898.108; Barik SS, 2008, AM J PHYS ANTHROPOL, V136, P19, DOI 10.1002/ajpa.20773; Behar DM, 2010, NATURE, V466, P238, DOI 10.1038/nature09103; Brahmachari SK, 2008, J GENET, V87, P3; Bramanti B, 2009, SCIENCE, V326, P137, DOI 10.1126/science.1176869; Bryant Edwin, 2005, INDO ARYAN CONTROVER; Busing FMTA, 1999, STAT COMPUT, V9, P3, DOI 10.1023/A:1008800423698; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; Costantini L., 1984, S ASIAN ARCHAEOLOGY, P29; Fenner JN, 2005, AM J PHYS ANTHROPOL, V128, P415, DOI 10.1002/ajpa.20188; Fuller DQ, 2011, CURR ANTHROPOL, V52, pS347, DOI 10.1086/658900; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; Herraez DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007888; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Kenoyer J, 1998, ANCIENT CITIES INDUS; Kivisild T, 1999, CURR BIOL, V9, P1331, DOI 10.1016/S0960-9822(00)80057-3; Kivisild T, 2003, EXAMINING FARMING LA, P215; Lawler A, 2008, SCIENCE, V320, P1281, DOI 10.1126/science.320.5881.1281; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Loh PR, 2013, GENETICS, V193, P1233, DOI 10.1534/genetics.112.147330; Mallory Joseph P., 1997, ENCY INDOEUROPEAN CU; MALMER MP, 2002, NEOLITHIC S SWEDEN T; Meadow R. H., 1991, HARAPPA EXCAVATIONS; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Metspalu M, 2011, AM J HUM GENET, V89, P731, DOI 10.1016/j.ajhg.2011.11.010; Moorjani P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058633; Moorjani P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001373; Naegele Charles J., 2008, THESIS GOLDEN GATE U; Osborne MR., 2016, J APPL PROBAB, V23, P419, DOI [10.2307/3214370, DOI 10.2307/3214370]; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Pickrell JK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2140; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Reich D, 2011, AM J HUM GENET, V89, P516, DOI 10.1016/j.ajhg.2011.09.005; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Renfrew C., 1990, ARCHAEOLOGY LANGUAGE; Sahoo S, 2006, AM J PHYS ANTHROPOL, V131, P84, DOI 10.1002/ajpa.20399; Sarkar S.S., 1964, ANCIENT RACES BALUCH; Shah AM, 2011, AM J HUM GENET, V89, P154, DOI 10.1016/j.ajhg.2011.05.030; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Thangaraj K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-151; Trautmann Thomas Roger, 2005, ARYAN DEBATE; Witzel E.J. Michael, 1999, ELECT J VEDIC STUDIE, V5, P1; Witzel Michael, 1995, INDOARYANS ANCIENT S, P85; Yunusbayev B, 2012, MOL BIOL EVOL, V29, P359, DOI 10.1093/molbev/msr221	46	161	161	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 5	2013	93	3					422	438		10.1016/j.ajhg.2013.07.006	http://dx.doi.org/10.1016/j.ajhg.2013.07.006			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	297QB	23932107	Green Published, Bronze			2022-12-18	WOS:000330268900002
J	Miraoui, H; Dwyer, AA; Sykiotis, GP; Plummer, L; Chung, W; Feng, BH; Beenken, A; Clarke, J; Pers, TH; Dworzynski, P; Keefe, K; Niedziela, M; Raivio, T; Crowley, WF; Seminara, SB; Quinton, R; Hughes, VA; Kumanov, P; Young, J; Yialamas, MA; Hall, JE; Van Vliet, G; Chanoine, JP; Rubenstein, J; Mohammadi, M; Tsai, PS; Sidis, Y; Lage, K; Pitteloud, N				Miraoui, Hichem; Dwyer, Andrew A.; Sykiotis, Gerasimos P.; Plummer, Lacey; Chung, Wilson; Feng, Bihua; Beenken, Andrew; Clarke, Jeff; Pers, Tune H.; Dworzynski, Piotr; Keefe, Kimberley; Niedziela, Marek; Raivio, Taneli; Crowley, William F., Jr.; Seminara, Stephanie B.; Quinton, Richard; Hughes, Virginia A.; Kumanov, Philip; Young, Jacques; Yialamas, Maria A.; Hall, Janet E.; Van Vliet, Guy; Chanoine, Jean-Pierre; Rubenstein, John; Mohammadi, Moosa; Tsai, Pei-San; Sidis, Yisrael; Lage, Kasper; Pitteloud, Nelly			Mutations in FGF17, IL17RD, DUSP6, SPRY4, and FLRT3 Are Identified in Individuals with Congenital Hypogonadotropic Hypogonadism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GONADOTROPIN-RELEASING-HORMONE; DIGENIC MUTATIONS; MOUSE EMBRYOS; EXPRESSION; GROWTH; SEF; GENE; DIFFERENTIATION; DEFICIENCY; SPROUTY2	Congenital hypogonadotropic hypogonadism (CHH) and its anosmia-associated form (Kallmann syndrome [KS]) are genetically heterogeneous. Among the >15 genes implicated in these conditions, mutations in FGF8 and FGFR1 account for similar to 12% of cases; notably, KAL1 and HS6ST1 are also involved in FGFR1 signaling and can be mutated in CHH. We therefore hypothesized that mutations in genes encoding a broader range of modulators of the FGFR1 pathway might contribute to the genetics of CHH as causal or modifier mutations. Thus, we aimed to (1) investigate whether CHH individuals harbor mutations in members of the so-called "FGF8 synexpression" group and (2) validate the ability of a bioinformatics algorithm on the basis of protein-protein interactome data (interactome-based affiliation scoring [IBAS]) to identify high-quality candidate genes. On the basis of sequence homology, expression, and structural and functional data, seven genes were selected and sequenced in 386 unrelated CHH individuals and 155 controls. Except for FGF18 and SPRY2, all other genes were found to be mutated in CHH individuals: FGF17 (n = 3 individuals), IL17RD (n = 8), DUSP6 (n = 5), SPRY4 (n = 14), and FLRT3 (n = 3). Independently, IBAS predicted FGF17 and IL17RD as the two top candidates in the entire proteome on the basis of a statistical test of their protein-protein interaction patterns to proteins known to be altered in CHH. Most of the FGF17 and IL17RD mutations altered protein function in vitro. IL17RD mutations were found only in KS individuals and were strongly linked to hearing loss (6/8 individuals). Mutations in genes encoding components of the FGF pathway are associated with complex modes of CHH inheritance and act primarily as contributors to an oligogenic genetic architecture underlying CHH.	[Miraoui, Hichem; Dwyer, Andrew A.; Hughes, Virginia A.; Sidis, Yisrael; Pitteloud, Nelly] Univ Lausanne, Serv Endocrinol Diabetol & Metab, CHU Vaudois, Fac Biol & Med, CH-1005 Lausanne, Switzerland; [Miraoui, Hichem; Dwyer, Andrew A.; Sykiotis, Gerasimos P.; Plummer, Lacey; Feng, Bihua; Keefe, Kimberley; Crowley, William F., Jr.; Seminara, Stephanie B.; Hughes, Virginia A.; Hall, Janet E.; Sidis, Yisrael; Pitteloud, Nelly] Harvard Univ, Sch Med, Ctr Excellence Reprod Endocrinol, Reprod Endocrine Unit,Massachusetts Gen Hosp, Boston, MA 02114 USA; [Sykiotis, Gerasimos P.] Univ Patras, Sch Med, Dept Internal Med, Div Endocrinol & Metab, Patras 26500, Greece; [Chung, Wilson; Tsai, Pei-San] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA; [Chung, Wilson; Tsai, Pei-San] Univ Colorado, Ctr Neurosci, Boulder, CO 80309 USA; [Beenken, Andrew; Mohammadi, Moosa] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA; [Clarke, Jeff] Univ Calif San Francisco, Dept Psychiat, Ctr Neurobiol & Psychiat, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94158 USA; [Pers, Tune H.; Dworzynski, Piotr; Lage, Kasper] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Pers, Tune H.; Lage, Kasper] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Pers, Tune H.] Boston Childrens Hosp, Div Endocrinol, Boston, MA 02114 USA; [Pers, Tune H.] Boston Childrens Hosp, Ctr Basic & Translat Obes Res, Boston, MA 02114 USA; [Niedziela, Marek] Poznan Univ Med Sci, Dept Pediat Endocrinol & Rheumatol, PL-60572 Poznan, Poland; [Raivio, Taneli] Helsinki Univ Cent Hosp, Univ Helsinki Childrens Hosp, Inst Biomed Physiol, Helsinki 00029, Finland; [Quinton, Richard] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Kumanov, Philip] Med Univ Sofia, Clin Ctr Endocrinol, Sofia 1431, Bulgaria; [Young, Jacques] Hop Bicetre, Serv Endocrinol & Malad Reprod, F-94275 Le Kremlin Bicetre, France; [Yialamas, Maria A.] Brigham & Womens Hosp, Dept Med, Div Endocrine, Boston, MA 02114 USA; [Van Vliet, Guy] Univ Montreal, Ctr Hosp St Justine, Fac Med, Serv Endocrinol, Montreal, PQ H3T 1C5, Canada; [Van Vliet, Guy] Univ Montreal, Ctr Hosp St Justine, Fac Med, Res Ctr, Montreal, PQ H3T 1C5, Canada; [Chanoine, Jean-Pierre] Univ British Columbia, British Columbia Childrens Hosp, Endocrinol & Diabet Unit, Vancouver, BC V6H 3V4, Canada; [Lage, Kasper] Massachusetts Gen Hosp, Pediat Surg Res Labs, Dept Mol Biol, Boston, MA 02114 USA; [Lage, Kasper] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Dept Med, Boston, MA 02114 USA; [Lage, Kasper] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen, Denmark	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Patras; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; New York University; University of California System; University of California San Francisco; Technical University of Denmark; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Poznan University of Medical Sciences; University of Helsinki; Helsinki University Central Hospital; Newcastle University - UK; Medical University Sofia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Harvard University; Brigham & Women's Hospital; Universite de Montreal; Universite de Montreal; BC Childrens Hospital; University of British Columbia; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Copenhagen	Pitteloud, N (corresponding author), Univ Lausanne, Serv Endocrinol Diabetol & Metab, CHU Vaudois, Fac Biol & Med, Rue Bugnon 7, CH-1005 Lausanne, Switzerland.	nelly.pitteloud@chuv.ch	Young, Jacques/T-2976-2018; Dwyer, Andrew A./D-8099-2012; Niedziela, Marek/A-1155-2011; Chanoine, Jean-Pierre/K-5026-2019; Hall, Janet E/F-3516-2019; Young, Jacques/N-5251-2019; Mohammadi, Moosa/ABA-6745-2020; PITTELOUD, Nelly/K-2709-2014; kasaei, fahime/T-7197-2018; Sykiotis, Gerasimos P/E-7407-2017	Young, Jacques/0000-0001-9286-5631; Dwyer, Andrew A./0000-0002-7023-6794; Niedziela, Marek/0000-0001-8862-6937; Chanoine, Jean-Pierre/0000-0002-5167-2064; Hall, Janet E/0000-0003-4644-3061; Young, Jacques/0000-0001-9286-5631; Mohammadi, Moosa/0000-0003-2434-9437; Sykiotis, Gerasimos/0000-0002-9565-4941; Raivio, Taneli/0000-0001-5385-434X; Chung, Wilson/0000-0003-0550-7567; Tsai, Pei-San/0000-0002-8650-647X; Dworzynski, Piotr/0000-0002-6717-8052; Pers, Tune/0000-0003-0207-4831	Eunice Kennedy Shriver National Institute of Child Health and Human Development/National Institutes of Health [R01HD056264, R01HD15788, U54HD028138, 2R01DE013686-11]; NINDS [R01 NS34661]; Swiss National Science Foundation; COST Action [BM1105]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD015788, U54HD028138, R01HD056264, R01HD042634, K24HD067388, T32HD007396, R01HD043341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034661] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); COST Action(European Cooperation in Science and Technology (COST)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the individuals and their families for their invaluable and enthusiastic participation. This work was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development/National Institutes of Health R01HD056264 (N.P.), R01HD15788 (W.C.), through Cooperative Agreement U54HD028138 as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research, 2R01DE013686-11 (MM), NINDS R01 NS34661 (J.R.), the Swiss National Science Foundation (N.P.), and COST Action BM1105.	Abraira VE, 2007, J NEUROSCI, V27, P4273, DOI 10.1523/JNEUROSCI.3477-06.2007; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alsina FC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032087; Bachler M, 2001, MECH DEVELOP, V100, P313, DOI 10.1016/S0925-4773(00)00518-9; Bianco SDC, 2009, NAT REV ENDOCRINOL, V5, P569, DOI 10.1038/nrendo.2009.177; Bottcher RT, 2004, NAT CELL BIOL, V6, P38, DOI 10.1038/ncb1082; Chan YM, 2011, J CLIN ENDOCR METAB, V96, pE1771, DOI 10.1210/jc.2011-0518; Chan YM, 2009, P NATL ACAD SCI USA, V106, P11703, DOI 10.1073/pnas.0903449106; Cholfin JA, 2007, P NATL ACAD SCI USA, V104, P7652, DOI 10.1073/pnas.0702225104; Chung WCJ, 2008, ENDOCRINOLOGY, V149, P4997, DOI 10.1210/en.2007-1634; Correia KM, 2001, METHODS, V23, P335, DOI 10.1006/meth.2000.1145; de Maximy AA, 1999, MECH DEVELOP, V81, P213, DOI 10.1016/S0925-4773(98)00241-X; Dickinson RJ, 2002, MECH DEVELOP, V113, P193, DOI 10.1016/S0925-4773(02)00024-2; Dode C, 2003, NAT GENET, V33, P463, DOI 10.1038/ng1122; Falardeau J, 2008, J CLIN INVEST, V118, P2822, DOI 10.1172/JCI34538; Ferrer-Costa C, 2004, PROTEINS, V57, P811, DOI 10.1002/prot.20252; FRANCO B, 1991, NATURE, V353, P529, DOI 10.1038/353529a0; Francou B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025614; Furthauer M, 2002, NAT CELL BIOL, V4, P170, DOI 10.1038/ncb750; Gianetti E, 2010, J CLIN ENDOCR METAB, V95, P2857, DOI 10.1210/jc.2009-2320; Gonzalez-Martinez D, 2004, J NEUROSCI, V24, P10384, DOI 10.1523/JNEUROSCI.3400-04.2004; Hausott B, 2012, HIPPOCAMPUS, V22, P434, DOI 10.1002/hipo.20910; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kawauchi S, 2005, DEVELOPMENT, V132, P5211, DOI 10.1242/dev.02143; Kovalenko D, 2003, J BIOL CHEM, V278, P14087, DOI 10.1074/jbc.C200606200; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Ladher RK, 2005, GENE DEV, V19, P603, DOI 10.1101/gad.1273605; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lage K, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.36; Lage K, 2008, P NATL ACAD SCI USA, V105, P20870, DOI 10.1073/pnas.0810772105; Leeksma OC, 2002, EUR J BIOCHEM, V269, P2546, DOI 10.1046/j.1432-1033.2002.02921.x; LEGOUIS R, 1991, CELL, V67, P423, DOI 10.1016/0092-8674(91)90193-3; Lewandoski M, 2000, NAT GENET, V26, P460, DOI 10.1038/82609; Li CY, 2007, DEVELOPMENT, V134, P167, DOI 10.1242/dev.02701; Lin W, 2005, GENESIS, V41, P110, DOI 10.1002/gene.20103; Lin W, 2002, MECH DEVELOP, V113, P163, DOI 10.1016/S0925-4773(02)00018-7; Liu ZH, 2002, GENE DEV, V16, P859, DOI 10.1101/gad.965602; Mailleux AA, 2001, MECH DEVELOP, V102, P81, DOI 10.1016/S0925-4773(01)00286-6; Maretto S, 2008, DEV BIOL, V318, P184, DOI 10.1016/j.ydbio.2008.03.021; Martinez-Morales JR, 2005, DEV CELL, V8, P565, DOI 10.1016/j.devcel.2005.01.022; Mason I, 2000, BIOCHEM CELL BIOL, V78, P577, DOI 10.1139/bcb-78-5-577; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Miraoui H, 2011, MOL CELL ENDOCRINOL, V346, P37, DOI 10.1016/j.mce.2011.05.042; Mortensen OV, 2013, CELL CALCIUM, V53, P224, DOI 10.1016/j.ceca.2012.12.004; Niehrs C, 2002, NATURE, V417, P35, DOI 10.1038/417035a; Ohbayashi N, 2002, GENE DEV, V16, P870, DOI 10.1101/gad.965702; Olsen SK, 2006, GENE DEV, V20, P185, DOI 10.1101/gad.1365406; Perantoni AO, 2005, DEVELOPMENT, V132, P3859, DOI 10.1242/dev.01945; Pirvola U, 2002, NEURON, V35, P671, DOI 10.1016/S0896-6273(02)00824-3; Pitteloud N, 2002, J CLIN ENDOCR METAB, V87, P4128, DOI 10.1210/jc.2002-020518; Pitteloud N, 2007, J CLIN INVEST, V117, P457, DOI 10.1172/JCI29884; Quaynor SD, 2011, FERTIL STERIL, V96, P1424, DOI 10.1016/j.fertnstert.2011.09.046; Quinton R, 2001, CLIN ENDOCRINOL, V55, P163, DOI 10.1046/j.1365-2265.2001.01277.x; Raivio T, 2009, J CLIN ENDOCR METAB, V94, P4380, DOI 10.1210/jc.2009-0179; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Robinson M, 2004, MOL CELL NEUROSCI, V27, P202, DOI 10.1016/j.mcn.2004.06.008; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shaw ND, 2011, J CLIN ENDOCR METAB, V96, pE566, DOI 10.1210/jc.2010-2292; Shim K, 2005, DEV CELL, V8, P553, DOI 10.1016/j.devcel.2005.02.009; Storm EE, 2003, P NATL ACAD SCI USA, V100, P1757, DOI 10.1073/pnas.0337736100; Sykiotis GP, 2010, P NATL ACAD SCI USA, V107, P15140, DOI 10.1073/pnas.1009622107; Sykiotis GP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000288; Taniguchi K, 2007, BIOCHEM BIOPH RES CO, V352, P896, DOI 10.1016/j.bbrc.2006.11.107; Tata BK, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095992; Thisse B, 2005, DEV BIOL, V287, P390, DOI 10.1016/j.ydbio.2005.09.011; Topaloglu AK, 2009, NAT GENET, V41, P354, DOI 10.1038/ng.306; Topp S, 2008, J COMP NEUROL, V510, P422, DOI 10.1002/cne.21802; Torii S, 2004, DEV CELL, V7, P33, DOI 10.1016/j.devcel.2004.05.019; Tornberg J, 2011, P NATL ACAD SCI USA, V108, P11524, DOI 10.1073/pnas.1102284108; Tsai PS, 2005, MOL ENDOCRINOL, V19, P225, DOI 10.1210/me.2004-0330; Tsang M, 2002, NAT CELL BIOL, V4, P165, DOI 10.1038/ncb749; Tucker ES, 2010, DEVELOPMENT, V137, P2471, DOI 10.1242/dev.049718; Vieira C, 2005, BRAIN RES REV, V49, P158, DOI 10.1016/j.brainresrev.2004.12.038; Waldstreicher J, 1996, J CLIN ENDOCR METAB, V81, P4388, DOI 10.1210/jc.81.12.4388; WHITE BJ, 1983, AM J MED GENET, V15, P417, DOI 10.1002/ajmg.1320150307; Xu JS, 2000, DEVELOPMENT, V127, P1833; Yamagishi S, 2011, EMBO J, V30, P2920, DOI 10.1038/emboj.2011.189	77	161	187	4	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 2	2013	92	5					725	743		10.1016/j.ajhg.2013.04.008	http://dx.doi.org/10.1016/j.ajhg.2013.04.008			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	139KY	23643382	Green Published, Bronze			2022-12-18	WOS:000318582800008
J	Koren, A; Polak, P; Nemesh, J; Michaelson, JJ; Sebat, J; Sunyaev, SR; McCarroll, SA				Koren, Amnon; Polak, Paz; Nemesh, James; Michaelson, Jacob J.; Sebat, Jonathan; Sunyaev, Shamil R.; McCarroll, Steven A.			Differential Relationship of DNA Replication Timing to Different Forms of Human Mutation and Variation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DE-NOVO MUTATIONS; SUBSTITUTION RATES; GENOME; RECOMBINATION; INSTABILITY; LANDSCAPES; MECHANISMS; EVOLUTION; ALIGNMENT; SHAPE	Human genetic variation is distributed nonrandomly across the genome, though the principles governing its distribution are only partially known. DNA replication creates opportunities for mutation, and the timing of DNA replication correlates with the density of SNPs across the human genome. To enable deeper investigation of how DNA replication timing relates to human mutation and variation, we generated a high-resolution map of the human genome's replication timing program and analyzed its relationship to point mutations, copy number variations, and the meiotic recombination hotspots utilized by males and females. DNA replication timing associated with point mutations far more strongly than predicted from earlier analyses and showed a stronger relationship to transversion than transition mutations. Structural mutations arising from recombination-based mechanisms and recombination hotspots used more extensively by females were enriched in early-replicating parts of the genome, though these relationships appeared to relate more strongly to the genomic distribution of causative sequence features. These results indicate differential and sex-specific relationship of DNA replication timing to different forms of mutation and recombination.	[Koren, Amnon; McCarroll, Steven A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Koren, Amnon; Polak, Paz; Nemesh, James; Sunyaev, Shamil R.; McCarroll, Steven A.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Polak, Paz; Sunyaev, Shamil R.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Genet, Boston, MA 02115 USA; [Michaelson, Jacob J.; Sebat, Jonathan] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [McCarroll, Steven A.] Broad Inst Harvard & MIT, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of California System; University of California San Diego; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	McCarroll, SA (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	mccarroll@genetics.med.harvard.edu	Polak, Paz/AAH-9380-2020	McCarroll, Steven/0000-0002-6954-8184; Michaelson, Jacob/0000-0001-9713-0992; Sebat, Jonathan/0000-0002-9087-526X	Harvard-Armenise Junior Faculty Award; Stanley Center for Psychiatric Research at the Broad Institute of Harvard; MIT; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH076431] Funding Source: NIH RePORTER	Harvard-Armenise Junior Faculty Award; Stanley Center for Psychiatric Research at the Broad Institute of Harvard; MIT; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank David Reich for helpful comments. This work was supported by startup resources from the Harvard Medical School Department of Genetics, by a Harvard-Armenise Junior Faculty Award to S.A.M., and by the Stanley Center for Psychiatric Research at the Broad Institute of Harvard and MIT.	Agier N, 2012, MOL BIOL EVOL, V29, P905, DOI 10.1093/molbev/msr280; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ashida H, 2012, NUCLEIC ACIDS RES, V40, P6435, DOI 10.1093/nar/gks354; Berg IL, 2010, NAT GENET, V42, P859, DOI 10.1038/ng.658; Borde V, 2000, SCIENCE, V290, P806, DOI 10.1126/science.290.5492.806; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Burkhalter MD, 2009, DNA REPAIR, V8, P1258, DOI 10.1016/j.dnarep.2009.07.009; Cardoso-Moreira M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002340; Chen CL, 2010, GENOME RES, V20, P447, DOI 10.1101/gr.098947.109; Chowdhury R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000648; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; De Raedt T, 2006, NAT GENET, V38, P1419, DOI 10.1038/ng1920; De S, 2011, NAT BIOTECHNOL, V29, P1103, DOI 10.1038/nbt.2030; De S, 2011, NAT STRUCT MOL BIOL, V18, P950, DOI 10.1038/nsmb.2089; Diamant N, 2012, NUCLEIC ACIDS RES, V40, P170, DOI 10.1093/nar/gkr596; Flynn KM, 2010, GENOME BIOL EVOL, V2, P859, DOI 10.1093/gbe/evq068; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hiratani L, 2009, CURR OPIN GENET DEV, V19, P142, DOI 10.1016/j.gde.2009.02.002; Hodgkinson A, 2012, HUM MUTAT, V33, P136, DOI 10.1002/humu.21616; Hombauer H, 2011, SCIENCE, V334, P1713, DOI 10.1126/science.1210770; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Koren A, 2010, GENOME RES, V20, P781, DOI 10.1101/gr.102764.109; Kugou K, 2009, MOL BIOL CELL, V20, P3064, DOI 10.1091/mbc.E08-12-1223; Kumar D, 2011, NUCLEIC ACIDS RES, V39, P1360, DOI 10.1093/nar/gkq829; Lang GI, 2011, GENOME BIOL EVOL, V3, P799, DOI 10.1093/gbe/evr054; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindsay SJ, 2006, AM J HUM GENET, V79, P890, DOI 10.1086/508709; McLean CY, 2011, NATURE, V471, P216, DOI 10.1038/nature09774; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Pink CJ, 2010, MOL BIOL EVOL, V27, P1077, DOI 10.1093/molbev/msp314; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sasaki M, 2010, NAT REV MOL CELL BIO, V11, P182, DOI 10.1038/nrm2849; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Segurel L, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001211; SHARP PM, 1989, SCIENCE, V246, P808, DOI 10.1126/science.2683084; Stamatoyannopoulos JA, 2009, NAT GENET, V41, P393, DOI 10.1038/ng.363; Weber CC, 2012, MOL BIOL EVOL, V29, P873, DOI 10.1093/molbev/msr265; WOLFE KH, 1989, NATURE, V337, P283, DOI 10.1038/337283a0; Woo YH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1982; Zhao JH, 2010, CELL MOL LIFE SCI, V67, P43, DOI 10.1007/s00018-009-0131-2	45	161	165	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 7	2012	91	6					1033	1040		10.1016/j.ajhg.2012.10.018	http://dx.doi.org/10.1016/j.ajhg.2012.10.018			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	055LI	23176822	Green Published, Bronze			2022-12-18	WOS:000312417400006
J	Johnston, JJ; Rubinstein, WS; Facio, FM; Ng, D; Singh, LN; Teer, JK; Mullikin, JC; Biesecker, LG				Johnston, Jennifer J.; Rubinstein, Wendy S.; Facio, Flavia M.; Ng, David; Singh, Larry N.; Teer, Jamie K.; Mullikin, James C.; Biesecker, Leslie G.			Secondary Variants in Individuals Undergoing Exome Sequencing: Screening of 572 Individuals Identifies High-Penetrance Mutations in Cancer-Susceptibility Genes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MANAGING INCIDENTAL FINDINGS; DIFFUSE GASTRIC-CANCER; E-CADHERIN MUTATIONS; GERMLINE MUTATIONS; BREAST; DATABASE; RECOMMENDATIONS; BRCA1; CLASSIFICATION; PREVALENCE	Genome- and exome-sequencing costs are continuing to fall, and many individuals are undergoing these assessments as research participants and patients. The issue of secondary (so-called incidental) findings in exome analysis is controversial, and data are needed on methods of detection and their frequency. We piloted secondary variant detection by analyzing exomes for mutations in cancer-susceptibility syndromes in subjects ascertained for atherosclerosis phenotypes. We performed exome sequencing on 572 ClinSeq participants, and in 37 genes, we interpreted variants that cause high-penetrance cancer syndromes by using an algorithm that filtered results on the basis of mutation type, quality, and frequency and that filtered mutation-database entries on the basis of defined categories of causation. We identified 454 sequence variants that differed from the human reference. Exclusions were made on the basis of sequence quality (26 variants) and high frequency in the cohort (77 variants) or dbSNP (17 variants), leaving 334 variants of potential clinical importance. These were further filtered on the basis of curation of literature reports. Seven participants, four of whom were of Ashkenazi Jewish descent and three of whom did not meet family-history-based referral criteria, had deleterious BRCA1 or BRCA2 mutations. One participant had a deleterious SDHC mutation, which causes paragangliomas. Exome sequencing, coupled with multidisciplinary interpretation, detected clinically important mutations in cancer-susceptibility genes; four of such mutations were in individuals without a significant family history of disease. We conclude that secondary variants of high clinical importance will be detected at an appreciable frequency in exomes, and we suggest that priority be given to the development of more efficient modes of interpretation with trials in larger patient groups.	[Johnston, Jennifer J.; Rubinstein, Wendy S.; Facio, Flavia M.; Ng, David; Singh, Larry N.; Teer, Jamie K.; Mullikin, James C.; Biesecker, Leslie G.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; [Rubinstein, Wendy S.] NorthShore Univ HealthSyst, Dept Med, Div Genet, Evanston, IL 60201 USA; [Rubinstein, Wendy S.] Univ Chicago, Pritzker Sch Med, Dept Med, Chicago, IL 60637 USA; [Teer, Jamie K.; Mullikin, James C.; Biesecker, Leslie G.] NHGRI, NIH, Intramural Sequencing Ctr, Bethesda, MD 20852 USA; [Mullikin, James C.] NHGRI, Genome Technol Branch, NIH, Rockville, MD 20852 USA; [Mullikin, James C.] NIH, Intramural Sequencing Ctr, Comparat Sequencing Program, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); NorthShore University Health System; University of Chicago; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Biesecker, LG (corresponding author), NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA.	leslieb@helix.nih.gov	Biesecker, Leslie/AAG-2526-2021; Singh, Larry N./AAG-6880-2021	Singh, Larry N./0000-0002-2478-5864	NIH National Human Genome Research Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200330, ZIBHG000196, ZIAHG200359, ZIAHG200387] Funding Source: NIH RePORTER	NIH National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors are grateful for the contributions of the staff of the National Institutes of Health (NIH) Intramural Sequencing Center and the NIH Clinical Center; specifically, we thank the clinical support and nursing staff for their help with the clinical aspects of this study. Donna Maglott facilitated the inclusion of ClinVar accession numbers. This study was funded by the Intramural Research Program of the NIH National Human Genome Research Institute.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; Bardella C, 2011, BBA-BIOENERGETICS, V1807, P1432, DOI 10.1016/j.bbabio.2011.07.003; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Berg AO, 2005, ANN INTERN MED, V143, P355, DOI 10.7326/0003-4819-143-5-200509060-00011; Berry DA, 2002, J CLIN ONCOL, V20, P2701, DOI 10.1200/JCO.2002.05.121; Biesecker LG, 2009, GENOME RES, V19, P1665, DOI 10.1101/gr.092841.109; Bredenoord AL, 2011, TRENDS GENET, V27, P41, DOI 10.1016/j.tig.2010.11.004; Brooks-Wilson AR, 2004, J MED GENET, V41, P508, DOI 10.1136/jmg.2004.018275; Burnichon N, 2009, J CLIN ENDOCR METAB, V94, P2817, DOI 10.1210/jc.2008-2504; Caulfield T, 2008, PLOS BIOL, V6, P430, DOI 10.1371/journal.pbio.0060073; Cotton RGH, 2008, HUM MUTAT, V29, P2, DOI 10.1002/humu.20650; Domchek SM, 2010, JAMA-J AM MED ASSOC, V304, P967, DOI 10.1001/jama.2010.1237; Edwards SM, 2003, AM J HUM GENET, V72, P1, DOI 10.1086/345310; Facio FM, 2011, EUR J HUM GENET, V19, P1213, DOI 10.1038/ejhg.2011.123; Fitzgerald RC, 2010, J MED GENET, V47, P436, DOI 10.1136/jmg.2009.074237; Fokkema IFAC, 2005, HUM MUTAT, V26, P63, DOI 10.1002/humu.20201; Greenblatt MS, 2008, HUM MUTAT, V29, P1273, DOI 10.1002/humu.20889; Klein R.D., 2009, GENEREVIEWS; Kohane IS, 2012, GENET MED, V14, P399, DOI 10.1038/gim.2011.68; Lebo RV, 2007, GENET TEST, V11, P11, DOI 10.1089/gte.2006.9996; Lindor Noralane M, 2008, J Natl Cancer Inst Monogr, P1, DOI 10.1093/jncimonographs/lgn001; Mateus AR, 2009, EXP CELL RES, V315, P1393, DOI 10.1016/j.yexcr.2009.02.020; Mitra AV, 2011, BJU INT, V107, P28, DOI 10.1111/j.1464-410X.2010.09648.x; Neuhausen S, 1996, NAT GENET, V13, P126, DOI 10.1038/ng0596-126; Neumann HPH, 2009, CANCER RES, V69, P3650, DOI 10.1158/0008-5472.CAN-08-4057; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Parmigiani G, 1998, AM J HUM GENET, V62, P145, DOI 10.1086/301670; Pasini B, 2008, EUR J HUM GENET, V16, P79, DOI 10.1038/sj.ejhg.5201904; Plon SE, 2008, HUM MUTAT, V29, P1282, DOI 10.1002/humu.20880; Rubinstein WS, 2009, GENET MED, V11, P629, DOI 10.1097/GIM.0b013e3181afd322; Schiavi F, 2005, JAMA-J AM MED ASSOC, V294, P2057, DOI 10.1001/jama.294.16.2057; Schwartz PJ, 2010, CIRCULATION, V122, P1272, DOI 10.1161/CIRCULATIONAHA.110.950147; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Szabo C, 2000, HUM MUTAT, V16, P123, DOI 10.1002/1098-1004(200008)16:2<123::AID-HUMU4>3.0.CO;2-Y; Teer JK, 2012, BIOINFORMATICS, V28, P599, DOI 10.1093/bioinformatics/btr711; Teer JK, 2010, GENOME RES, V20, P1420, DOI 10.1101/gr.106716.110; Walsh T, 2010, P NATL ACAD SCI USA, V107, P12629, DOI 10.1073/pnas.1007983107; Weitzel JN, 2007, JAMA-J AM MED ASSOC, V297, P2587, DOI 10.1001/jama.297.23.2587; Wolf SM, 2008, J LAW MED ETHICS, V36, P219, DOI 10.1111/j.1748-720X.2008.00266.x; Wolf SM, 2012, GENET MED, V14, P361, DOI 10.1038/gim.2012.23	43	161	161	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 13	2012	91	1					97	108		10.1016/j.ajhg.2012.05.021	http://dx.doi.org/10.1016/j.ajhg.2012.05.021			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	974OE	22703879	Bronze, Green Published			2022-12-18	WOS:000306445000008
J	Latour, P; Thauvin-Robinet, C; Baudelet-Mery, C; Soichot, P; Cusin, V; Faivre, L; Locatelli, MC; Mayencon, M; Sarcey, A; Broussolle, E; Camu, W; David, A; Rousson, R				Latour, Philippe; Thauvin-Robinet, Christel; Baudelet-Mery, Chantal; Soichot, Pierre; Cusin, Veronica; Faivre, Laurence; Locatelli, Marie-Claire; Mayencon, Martine; Sarcey, Annie; Broussolle, Emmanuel; Camu, William; David, Albert; Rousson, Robert			A Major Determinant for Binding and Aminoacylation of tRNA(Ala) in Cytoplasmic Alanyl-tRNA Synthetase Is Mutated in Dominant Axonal Charcot-Marie-Tooth Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MUTATIONS; FEATURES; DESIGN	Charcot-Marie-Tooth disease (CMT) is the most Common cause of inherited peripheral neuropathy, with an estimated frequency Of 1/2500. We Studied a large family with 17 patients affected by the axonal form of CMT (CMT2). Analysis of the 15 genes or loci known to date was negative. Genome-wide genotyping identified a CMT2 locus in 16q21-q23 between D16S3050 and D16S3106. The maximum two-point LOD score was 4.77 at theta = 0 for marker D16S3050. Sequencing of candidate genes identified a unique mutation, c.986G>A (p.Arg329His), affecting a totally conserved amino acid ill the helical domain of cytoplasmic alanyl-tRNA synthetase (AlaRS). A second family with the same Mutation and a different founder was then identified in a cohort of 91 CMT2 families. Although mislocation Of Mutant Arg329His-AlaRS in axons remains to be evaluated, experimental data point mostly to a quantitative,e reduction ill tRZN(Ala) aminoacylation. Aminoacylation and editing functions closely cooperate in AlaRS, and Arg329His Mutation could also lead to qualitative errors participating in neurodegeneration. Our report documents in 18 patients the deleterious impact of a mutation in human cytoplasmic AlaRS and broadens the spectrum of defects found in tRNA synthetases. Patients present with sensory-motor distal degeneration secondary to predominant axonal neuropathy, slight demyelination, and no atypical or additional CNS features.	[Latour, Philippe; Locatelli, Marie-Claire; Mayencon, Martine; Sarcey, Annie; Rousson, Robert] Hosp Civils Lyon, Ctr Biol Est, Dept Biochim, F-69500 Bron, France; [Broussolle, Emmanuel] Hosp Civils Lyon, Hop Neurol, Serv Neurol C, F-69500 Bron, France; [Thauvin-Robinet, Christel; Cusin, Veronica; Faivre, Laurence] Hop Enfants, Ctr Genet, F-21000 Dijon, France; [Soichot, Pierre] Ctr Hosp Univ, Hop Gen, Lab Explorat Syst Nerveux, F-21000 Dijon, France; [Baudelet-Mery, Chantal] Cabinet Neurol, F-71100 Chalon Sur Saone, France; [Broussolle, Emmanuel] Univ Lyon 1, F-69000 Lyon, France; [Broussolle, Emmanuel] CNRS, UMR 52 29, F-69000 Lyon, France; [Camu, William] CHU Montpellier, Hop Gui Chauliac, Serv Neurol, F-34000 Montpellier, France; [David, Albert] CHU Nantes, Hop Mere & Enfant, Serv Genet Med, F-44000 Nantes, France	CHU Lyon; CHU Lyon; CHU Dijon Bourgogne; CHU Dijon Bourgogne; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; CHU de Montpellier; Nantes Universite; CHU de Nantes	Latour, P (corresponding author), Hosp Civils Lyon, Ctr Biol Est, Dept Biochim, F-69500 Bron, France.	philippe.latour@chu-lyon.fr	Broussolle, Emmanuel/H-1592-2017; camu, william/AAB-4727-2020	Broussolle, Emmanuel/0000-0002-0410-9519; Faivre, Laurence/0000-0001-9770-444X				Ahel I, 2003, P NATL ACAD SCI USA, V100, P15422, DOI 10.1073/pnas.2136934100; Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Antonellis A, 2008, ANNU REV GENOM HUM G, V9, P87, DOI 10.1146/annurev.genom.9.081307.164204; Antonellis A, 2006, J NEUROSCI, V26, P10397, DOI 10.1523/JNEUROSCI.1671-06.2006; Beebe K, 2003, EMBO J, V22, P668, DOI 10.1093/emboj/cdg065; Beebe K, 2008, NATURE, V451, P90, DOI 10.1038/nature06454; Bienfait HME, 2007, NEUROLOGY, V68, P1658, DOI 10.1212/01.wnl.0000263479.97552.94; Chihade JW, 2000, P NATL ACAD SCI USA, V97, P12153, DOI 10.1073/pnas.220388797; DAVIS CJF, 1978, J GENET HUM, V26, P311; de Pouplana LR, 1998, EMBO J, V17, P5449, DOI 10.1093/emboj/17.18.5449; Dyck P, 1993, PERIPHERAL NEUROPATH; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Guo M, 2009, SCIENCE, V325, P744, DOI 10.1126/science.1174343; HARDING AE, 1980, BRAIN, V103, P259, DOI 10.1093/brain/103.2.259; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; Koch Kerstin, 2002, In Silico Biology, V2, P351; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; SCHIMMEL P, 1995, TRENDS BIOCHEM SCI, V20, P333, DOI 10.1016/S0968-0004(00)89067-2; Sokabe M, 2009, P NATL ACAD SCI USA, V106, P11028, DOI 10.1073/pnas.0904645106; Stapley BJ, 1997, J MOL BIOL, V272, P456, DOI 10.1006/jmbi.1997.1250; Swairjo MA, 2004, MOL CELL, V13, P829, DOI 10.1016/S1097-2765(04)00126-1	21	161	166	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 8	2010	86	1					77	82		10.1016/j.ajhg.2009.12.005	http://dx.doi.org/10.1016/j.ajhg.2009.12.005			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	554XZ	20045102	Green Published, Bronze			2022-12-18	WOS:000274471200008
J	Shojaee, S; Sina, F; Banihosseini, SS; Kazemi, MH; Kalhor, R; Shahidi, GA; Fakhrai-Rad, H; Ronaghi, M; Elahi, E				Shojaee, Seyedmehdi; Sina, Farzad; Banihosseini, Setareh Sadat; Kazemi, Mohammad Hossein; Kalhor, Reza; Shahidi, Gholam-Ali; Fakhrai-Rad, Hossein; Ronaghi, Mostafa; Elahi, Elahe			Genome-wide linkage analysis of a Parkinsonian-pyramidal syndrome pedigree by 500 KSNP arrays	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MARKERS; SINGLE; FAMILY; FBXO7; MAPS; DISEQUILIBRIUM; PROTEOLYSIS; GUIDELINES; INHIBITOR; SYNAPSIN	Robust SNP genotyping technologies and data analysis programs have encouraged researchers in recent years to use SNPs for linkage studies. Platforms used to date have been 10 K chip arrays, but the possible value of interrogating SNPs at higher densities has been considered. Here, we present a genome-wide linkage analysis by means of a 500 K SNP platform. The analysis was done on a large pedigree affected with Parkinsonian-pyramidal syndrome (PPS), and the results showed linkage to chromosome 22. Sequencing of candidate genes revealed a disease-associated homozygous variation (R378G) in FBXO7. FBXO7 codes for a member of the F-box family of proteins, all of which may have a role in the ubiquitin-proteosome protein-degradation pathway. This pathway has been implicated in various neurodegenerative diseases, and identification of FBXO7 as the causative gene of PPS is expected to shed new light on its role. The performance of the array was assessed and systematic analysis of effects of SNP density reduction was performed with the real experimental data. Our results suggest that linkage in our pedigree may have been missed had we used chips containing less than 100,000 SNPs across the genome.	[Shojaee, Seyedmehdi] Univ Tehran, Coll Sci, Sch Biol, Tehran, Iran; [Elahi, Elahe] Univ Tehran, Coll Sci, Sch Math Stat & Comp Sci, Ctr Excellence Biomath, Tehran, Iran; [Elahi, Elahe] Univ Tehran, Coll Sci, Dept Biotechnol, Tehran, Iran; [Sina, Farzad; Shahidi, Gholam-Ali] Iran Univ Med Sci, Hazrat Rasool Hosp, Tehran, Iran; [Banihosseini, Setareh Sadat; Kazemi, Mohammad Hossein] Univ Tehran Med Sci, Tehran, Iran; [Kalhor, Reza] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Fakhrai-Rad, Hossein; Ronaghi, Mostafa] Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA	University of Tehran; University of Tehran; University of Tehran; Iran University of Medical Sciences; Tehran University of Medical Sciences; University of Southern California; Stanford University	Elahi, E (corresponding author), Univ Tehran, Coll Sci, Sch Biol, Tehran, Iran.	elaheelahi@ut.act.ir	sina, farzad/N-7103-2018	sina, farzad/0000-0002-6934-2442; Shahidi, Gholam Ali/0000-0002-3889-4973				ABDELAZIZ MM, 2006, ANN HUM GENET, V71, P281; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; APTE SS, 1995, J BIOL CHEM, V270, P14313, DOI 10.1074/jbc.270.24.14313; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Chang YF, 2006, BIOCHEM BIOPH RES CO, V342, P1022, DOI 10.1016/j.bbrc.2006.02.061; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Evans DM, 2004, AM J HUM GENET, V75, P687, DOI 10.1086/424696; Goddard KAB, 2002, GENET EPIDEMIOL, V22, P205, DOI 10.1002/gepi.0177; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Hosaka M, 1998, J BIOL CHEM, V273, P13371, DOI 10.1074/jbc.273.22.13371; Hsu JM, 2004, J BIOL CHEM, V279, P32592, DOI 10.1074/jbc.M404950200; Huang QQ, 2004, AM J HUM GENET, V75, P1106, DOI 10.1086/426000; Jankovic J, 2007, PARKINSONS DIS MOVEM; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kalita J, 2003, NEUROL INDIA, V51, P383; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kao HT, 1998, P NATL ACAD SCI USA, V95, P4667, DOI 10.1073/pnas.95.8.4667; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1997, NAT GENET, V17, P21, DOI 10.1038/ng0997-21; Laman H, 2006, CELL CYCLE, V5, P279, DOI 10.4161/cc.5.3.2403; Laman H, 2005, EMBO J, V24, P3104, DOI 10.1038/sj.emboj.7600775; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Levinson DF, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S6; Matise TC, 2003, AM J HUM GENET, V73, P271, DOI 10.1086/377137; Middleton FA, 2004, AM J HUM GENET, V74, P886, DOI 10.1086/420775; NISIPEANU P, 1999, MOVEMENT DISORDER NE, P247; Panagariya A, 2007, Indian J Med Sci, V61, P156; Paterson AD, 2007, J AM SOC NEPHROL, V18, P2408, DOI 10.1681/ASN.2007020241; Schaid DJ, 2002, AM J HUM GENET, V71, P992, DOI 10.1086/342666; Sellick GS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh163; Shcherbik N, 2004, J CELL BIOCHEM, V93, P11, DOI 10.1002/jcb.20130; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; Srivastava T, 2005, J NEUROL, V252, P1537, DOI 10.1007/s00415-005-0852-6; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; TRANCHANT C, 1991, REV NEUROL, V147, P308; Vance C, 2006, BRAIN, V129, P868, DOI 10.1093/brain/awl030; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; Wilson AF, 2000, AM J HUM GENET, V66, P1610, DOI 10.1086/302889; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Woods CG, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.016873	41	161	164	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2008	82	6					1375	1384		10.1016/j.ajhg.2008.05.005	http://dx.doi.org/10.1016/j.ajhg.2008.05.005			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	312CP	18513678	Bronze, Green Published			2022-12-18	WOS:000256647000016
J	Cruciani, F; La Fratta, R; Santolamazza, P; Sellitto, D; Pascone, R; Moral, P; Watson, E; Guida, V; Colomb, EB; Zaharova, B; Lavinha, J; Vona, G; Aman, R; Cali, F; Akar, N; Richards, M; Torroni, A; Novelletto, A; Scozzari, R				Cruciani, F; La Fratta, R; Santolamazza, P; Sellitto, D; Pascone, R; Moral, P; Watson, E; Guida, V; Colomb, EB; Zaharova, B; Lavinha, J; Vona, G; Aman, R; Cali, F; Akar, N; Richards, M; Torroni, A; Novelletto, A; Scozzari, R			Phylogeographic analysis of haplogroup E3b (E-M215) Y chromosomes reveals multiple migratory events within and out of Africa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HIGH-RESOLUTION ANALYSIS; HUMAN-POPULATIONS; MICROSATELLITE LOCI; SEQUENCE VARIATION; MITOCHONDRIAL-DNA; HAPLOTYPES; DIVERSITY; PATTERNS; DIVERGENCE; NETWORKS	We explored the phylogeography of human Y-chromosomal haplogroup E3b by analyzing 3,401 individuals from five continents. Our data refine the phylogeny of the entire haplogroup, which appears as a collection of lineages with very different evolutionary histories, and reveal signatures of several distinct processes of migrations and/or recurrent gene flow that occurred in Africa and western Eurasia over the past 25,000 years. In Europe, the overall frequency pattern of haplogroup E-M78 does not support the hypothesis of a uniform spread of people from a single parental Near Eastern population. The distribution of E-M81 chromosomes in Africa closely matches the present area of distribution of Berber-speaking populations on the continent, suggesting a close haplogroup-ethnic group parallelism. E-M34 chromosomes were more likely introduced in Ethiopia from the Near East. In conclusion, the present study shows that earlier work based on fewer Y-chromosome markers led to rather simple historical interpretations and highlights the fact that many population-genetic analyses are not robust to a poorly resolved phylogeny.	Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, I-00185 Rome, Italy; Univ Roma La Sapienza, Dipartimento Sci Ginecol Perinatol & Puericultura, Rome, Italy; CNR, Ist Biol & Patol Mol, Rome, Italy; Ist Casa Sollievo Sofferenza Mendel, Rome, Italy; Univ Barcelona, Dept Anim Biol, Barcelona, Spain; Swedish Museum Nat Hist, S-10405 Stockholm, Sweden; Hop St Marguerite, Immunol Lab, Marseille, France; Univ Hosp Obstet & Gynecol, Lab Mol Pathol, Sofia, Bulgaria; Inst Nacl Saude Dr Ricardo Jorge, Ctr Genet Humana, Lisbon, Portugal; Univ Cagliari, Dipartimento Biol Sperimentale, Cagliari, Italy; Natl Museums Kenya, Dept Mol Genet, Nairobi, Kenya; African Ctr Clin Trials, Nairobi, Kenya; Assoc Oasi Maria SS, Ist Ric Ritardo Mentale & Involuz Cerebrale, Troina, Italy; Ankara Univ, Dept Pediat, TR-06100 Ankara, Turkey; Univ Leeds, Sch Biol, Leeds, W Yorkshire, England; Univ Leeds, Sch Comp, Leeds, W Yorkshire, England; Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy; Univ Calabria, Dipartimento Biol Cellulare, Arcavacata Di Rende, Italy	Sapienza University Rome; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; University of Barcelona; Swedish Museum of Natural History; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Medical University Sofia; Instituto Nacional de Saude Dr. Ricardo Jorge; University of Cagliari; IRCCS Oasi Maria SS; Ankara University; University of Leeds; University of Leeds; University of Pavia; University of Calabria	Scozzari, R (corresponding author), Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, Piazzale A Moro 5, I-00185 Rome, Italy.	rosaria.scozzari@uniroma1.it	Torroni, Antonio/E-1557-2011; Akar, Nejat/H-2949-2019; Guida, Valentina/K-4517-2015; Cruciani, Fulvio/G-6105-2012; Moral, Pedro/K-9587-2014; Calì, Francesco/D-9178-2017	Torroni, Antonio/0000-0002-4163-4478; Guida, Valentina/0000-0003-3946-645X; Moral, Pedro/0000-0001-5072-5892; Calì, Francesco/0000-0001-8667-8223; RICHARDS, MARTIN/0000-0003-3118-0967; Lavinha, Joao/0000-0002-7474-6871; Novelletto, Andrea/0000-0002-1146-7680; Cruciani, Fulvio/0000-0002-6900-024X	Telethon [E.0890] Funding Source: Medline	Telethon(Fondazione Telethon)		Ayub Q, 2000, Nucleic Acids Res, V28, pe8, DOI 10.1093/nar/28.2.e8; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bosch E, 2001, AM J HUM GENET, V68, P1019, DOI 10.1086/319521; Cann HM, 2002, SCIENCE, V296, P261; Cinnioglu C, 2004, HUM GENET, V114, P127, DOI 10.1007/s00439-003-1031-4; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; Ellis N, 2002, GENOME RES, V12, P339; GOLDSTEIN DB, 1995, GENETICS, V139, P463; Hammer MF, 2000, P NATL ACAD SCI USA, V97, P6769, DOI 10.1073/pnas.100115997; HAMMER MF, 1995, AM J HUM GENET, V56, P951; Hammer MF, 1998, MOL BIOL EVOL, V15, P427, DOI 10.1093/oxfordjournals.molbev.a025939; Hammer MF, 2001, MOL BIOL EVOL, V18, P1189, DOI 10.1093/oxfordjournals.molbev.a003906; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Kayser M, 2000, AM J HUM GENET, V66, P1580, DOI 10.1086/302905; Maca-Meyer N, 2003, ANN HUM GENET, V67, P329, DOI 10.1046/j.1469-1809.2003.00045.x; Malaspina P, 2000, ANN HUM GENET, V64, P395, DOI 10.1046/j.1469-1809.2000.6450395.x; Malaspina P, 2001, ANN HUM GENET, V65, P339, DOI 10.1017/S0003480001008727; Malaspina P, 1997, J MOL EVOL, V44, P652; MATHIAS N, 1994, HUM MOL GENET, V3, P115, DOI 10.1093/hmg/3.1.115; Richards M, 2002, AM J HUM GENET, V71, P1168, DOI 10.1086/342930; ROEWER L, 1992, HUM GENET, V89, P389; Roewer L, 1996, HUM MOL GENET, V5, P1029, DOI 10.1093/hmg/5.7.1029; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Scozzari R, 2001, HUM IMMUNOL, V62, P871, DOI 10.1016/S0198-8859(01)00286-5; Scozzari R, 1999, AM J HUM GENET, V65, P829, DOI 10.1086/302538; Scozzari R, 1997, AM J HUM GENET, V61, P719, DOI 10.1086/515500; SCOZZARI R, 1999, AM J HUM GENET, V66, P346; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295; Semino O, 2002, AM J HUM GENET, V70, P265, DOI 10.1086/338306; SLATKIN M, 1995, GENETICS, V139, P457; Thomas MG, 1998, NATURE, V394, P138, DOI 10.1038/28083; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; VANSINA J, 1984, J AFR HIST, V25, P129, DOI 10.1017/S0021853700022829; Weale ME, 2003, GENETICS, V165, P229; White PS, 1999, GENOMICS, V57, P433, DOI 10.1006/geno.1999.5782; WHITFIELD LS, 1995, NATURE, V378, P379, DOI 10.1038/378379a0; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911	41	161	167	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2004	74	5					1014	1022		10.1086/386294	http://dx.doi.org/10.1086/386294			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	813SF	15042509	Bronze, Green Published			2022-12-18	WOS:000220926100019
J	Tambets, K; Rootsi, S; Kivisild, T; Help, H; Serk, P; Loogvali, EL; Tolk, HV; Reidla, M; Metspalu, E; Pliss, L; Balanovsky, O; Pshenichnov, A; Balanovska, E; Gubina, M; Zhadanov, S; Osipova, L; Damba, L; Voevoda, M; Kutuev, I; Bermisheva, M; Khusnutdinova, E; Gusar, V; Grechanina, E; Parik, J; Pennarun, E; Richard, C; Chaventre, A; Moisan, JP; Barac, L; Pericic, M; Rudan, P; Terzic, R; Mikerezi, I; Krumina, A; Baumanis, V; Koziel, S; Rickards, O; De Stefano, GF; Anagnou, N; Pappa, KI; Michalodimitrakis, E; Ferak, V; Furedi, S; Komel, R; Beckman, L; Villems, R				Tambets, K; Rootsi, S; Kivisild, T; Help, H; Serk, P; Loogvali, EL; Tolk, HV; Reidla, M; Metspalu, E; Pliss, L; Balanovsky, O; Pshenichnov, A; Balanovska, E; Gubina, M; Zhadanov, S; Osipova, L; Damba, L; Voevoda, M; Kutuev, I; Bermisheva, M; Khusnutdinova, E; Gusar, V; Grechanina, E; Parik, J; Pennarun, E; Richard, C; Chaventre, A; Moisan, JP; Barac, L; Pericic, M; Rudan, P; Terzic, R; Mikerezi, I; Krumina, A; Baumanis, V; Koziel, S; Rickards, O; De Stefano, GF; Anagnou, N; Pappa, KI; Michalodimitrakis, E; Ferak, V; Furedi, S; Komel, R; Beckman, L; Villems, R			The western and eastern roots of the Saami - The story of genetic "outliers" told by mitochondrial DNA and Y chromosomes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MTDNA CONTROL REGION; SEQUENCE DIVERSITY; D-LOOP; PHYLOGENETIC NETWORK; POPULATION-DATA; CODING-REGION; LINEAGES; ORIGIN; INDIVIDUALS; VARIABILITY	The Saami are regarded as extreme genetic outliers among European populations. In this study, a high-resolution phylogenetic analysis of Saami genetic heritage was undertaken in a comprehensive context, through use of maternally inherited mitochondrial DNA ( mtDNA) and paternally inherited Y-chromosomal variation. DNA variants present in the Saami were compared with those found in Europe and Siberia, through use of both new and previously published data from 445 Saami and 17,096 western Eurasian and Siberian mtDNA samples, as well as 127 Saami and 2,840 western Eurasian and Siberian Y-chromosome samples. It was shown that the "Saami motif" variant of mtDNA haplogroup U5b is present in a large area outside Scandinavia. A detailed phylogeographic analysis of one of the predominant Saami mtDNA haplogroups, U5b1b, which also includes the lineages of the "Saami motif," was undertaken in 31 populations. The results indicate that the origin of U5b1b, as for the other predominant Saami haplogroup, V, is most likely in western, rather than eastern, Europe. Furthermore, an additional haplogroup (H1) spread among the Saami was virtually absent in 781 Samoyed and Ob-Ugric Siberians but was present in western and central European populations. The Y-chromosomal variety in the Saami is also consistent with their European ancestry. It suggests that the large genetic separation of the Saami from other Europeans is best explained by assuming that the Saami are descendants of a narrow, distinctive subset of Europeans. In particular, no evidence of a significant directional gene flow from extant aboriginal Siberian populations into the haploid gene pools of the Saami was found.	Univ Tartu, Dept Evolutionary Biol, Estonian Bioctr, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia; Biomed Res & Study Ctr, Riga, Latvia; P Stradins Univ, Riga, Latvia; Russian Acad Med Sci, Med Genet Res Ctr, Moscow, Russia; Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia; Russian Acad Sci, Ufa Res Ctr, Inst Biochem & Genet, Ufa 450001, Russia; Kharkov Clin Genet & Prenatal Diagnost Ctr, Kharkov, Ukraine; ADN, Fac Med, Lab Etud Polymorphisme, Nantes, France; Inst Anthropol Res, Zagreb, Croatia; Med Sch Tuzla, Dept Biol & Genet, Tuzla, Bosnia & Herceg; Tirana Univ, Fac Nat Sci, Dept Biol, Tirana, Albania; Inst Anthropol, Wroclaw, Poland; Univ Tor Vergata, Dipartimento Biol, Rome, Italy; Inst Mol Biol & Biotechnol, Iraklion, Greece; Univ Crete, Sch Med, Dept Forens Sci & Toxicol, Iraklion, Greece; Univ Athens, Sch Med, Dept Basic Sci, GR-11527 Athens, Greece; Comenius Univ, Fac Nat Sci, Dept Mol Genet, Bratislava, Slovakia; Inst Forens Sci, Budapest, Hungary; Univ Ljubljana, Med Ctr Mol Biol, Ljubljana, Slovenia; Gotland Univ, Visby, Sweden	Estonian Biocentre; University of Tartu; Latvian Biomedical Research & Study Centre; Riga Stradins University; Research Centre for Medical Genetics; Russian Academy of Medical Sciences; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; Institute for Anthropological Research Zagreb; University of Tuzla; University of Tirana (UT); University of Rome Tor Vergata; University of Crete; Athens Medical School; National & Kapodistrian University of Athens; Comenius University Bratislava; University of Ljubljana	Tambets, K (corresponding author), Univ Tartu, Dept Evolutionary Biol, Estonian Bioctr, Inst Mol & Cell Biol, Riia 23, EE-51010 Tartu, Estonia.	ktambets@ebc.ee	Terzić, Rifet/AHC-7996-2022; Osipova, Ludmila P/O-6480-2014; Gubina, Marina/AAD-9163-2019; Kivisild, Toomas/P-5889-2017; Balanovsky, Oleg/G-1549-2014; Rickards, Olga/L-7878-2015; Tambets, Kristiina/M-2568-2019; Anagnou, Nicholas/GLR-3609-2022; Pennarun, Erwan/AAW-7041-2020; Gusar, Vladyslava/ABB-9155-2021; Khusnutdinova, Elza Kamilevna/A-4810-2013; Voevoda, Mikhail/N-6713-2015; Kozieł, Sławomir/AAE-1003-2022; PAPPA, KALLIOPI/K-9345-2018; Grecanina, Elena/H-6931-2018	Osipova, Ludmila P/0000-0001-7602-1156; Kivisild, Toomas/0000-0002-6297-7808; Rickards, Olga/0000-0003-2880-7466; Tambets, Kristiina/0000-0002-8173-6380; Pennarun, Erwan/0000-0002-8267-883X; Khusnutdinova, Elza Kamilevna/0000-0003-2987-3334; Voevoda, Mikhail/0000-0001-9425-413X; Kozieł, Sławomir/0000-0002-0584-4427; PAPPA, KALLIOPI/0000-0002-1061-7405; Grecanina, Elena/0000-0002-8196-1617; Gusar, Vladyslava/0000-0003-3990-6224				Akey JM, 2001, BIOTECHNIQUES, V30, P358, DOI 10.2144/01302tt05; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Baasner A, 1998, FORENSIC SCI INT, V98, P169, DOI 10.1016/S0379-0738(98)00163-7; Bandelt HJ, 2001, INT J LEGAL MED, V115, P64, DOI 10.1007/s004140100228; Barac L, 2003, EUR J HUM GENET, V11, P535, DOI 10.1038/sj.ejhg.5200992; BECKMAN G, 1993, HUM HERED, V43, P362, DOI 10.1159/000154160; BECKMAN L, 1988, HUM HERED, V38, P18, DOI 10.1159/000153748; Bermisheva MA, 2002, MOL BIOL+, V36, P802, DOI 10.1023/A:1021677708482; BERTRANPETIT J, 1995, ANN HUM GENET, V59, P63, DOI 10.1111/j.1469-1809.1995.tb01606.x; Cali F, 2001, INT J LEGAL MED, V114, P229, DOI 10.1007/s004140000169; Capelli C, 2003, CURR BIOL, V13, P979, DOI 10.1016/S0960-9822(03)00373-7; CASANOVA M, 1985, SCIENCE, V230, P1403, DOI 10.1126/science.2999986; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CAVALLISFORZA LL, 1993, EUR J HUM GENET, V1, P3; Comas D, 1998, AM J HUM GENET, V63, P1824, DOI 10.1086/302133; CorteReal HBSM, 1996, ANN HUM GENET, V60, P331, DOI 10.1111/j.1469-1809.1996.tb01196.x; Crespillo M, 2000, INT J LEGAL MED, V114, P130, DOI 10.1007/s004140000158; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; Danan C, 1999, AM J HUM GENET, V65, P463, DOI 10.1086/302484; De La Chapelle A, 1998, P NATL ACAD SCI USA, V95, P12416, DOI 10.1073/pnas.95.21.12416; Delghandi M, 1998, HUM HERED, V48, P108, DOI 10.1159/000022789; Derbeneva O. A., 2002, Genetika, V38, P1554; Derbeneva OA, 2002, AM J HUM GENET, V70, P1009, DOI 10.1086/339524; Derenko MV, 2003, ANN HUM GENET, V67, P391, DOI 10.1046/j.1469-1809.2003.00035.x; Dimo-Simonin N, 2000, INT J LEGAL MED, V113, P89, DOI 10.1007/PL00007715; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; Donner J., 1995, QUATERNARY HIST SCAN; Dupuy BM, 1996, ADV FOREN H, V6, P23; Ellis N, 2002, GENOME RES, V12, P339; Fedorova S. A., 2003, Molekulyarnaya Biologiya (Moscow), V37, P643; Finnila S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591; Finnila S, 2000, AM J HUM GENET, V66, P1017, DOI 10.1086/302802; Forster P, 2002, INT J LEGAL MED, V116, P99, DOI 10.1007/s00414-001-0261-z; Forster P, 1996, AM J HUM GENET, V59, P935; Francalacci P, 1996, AM J PHYS ANTHROPOL, V100, P443, DOI 10.1002/(SICI)1096-8644(199608)100:4<443::AID-AJPA1>3.0.CO;2-S; GUGLIELMINO CR, 1990, AM J PHYS ANTHROPOL, V83, P57, DOI 10.1002/ajpa.1330830107; Haetta O. M., 1996, SAMI INDIGENOUS PEOP; HAMMER MF, 1995, AM J HUM GENET, V56, P951; Helgason A, 2000, AM J HUM GENET, V67, P697, DOI 10.1086/303046; Helgason A, 2001, AM J HUM GENET, V68, P723, DOI 10.1086/318785; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Hofmann S, 1997, HUM MOL GENET, V6, P1835, DOI 10.1093/hmg/6.11.1835; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Kaessmann H, 1999, NAT GENET, V22, P78, DOI 10.1038/8785; Karafet TM, 2002, HUM BIOL, V74, P761, DOI 10.1353/hub.2003.0006; Kittles RA, 1999, AM J PHYS ANTHROPOL, V108, P381, DOI 10.1002/(SICI)1096-8644(199904)108:4<381::AID-AJPA1>3.0.CO;2-5; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996; Kolman CJ, 1996, GENETICS, V142, P1321; Kong QP, 2003, AM J HUM GENET, V73, P671, DOI 10.1086/377718; Kong QP, 2003, HUM GENET, V113, P391, DOI 10.1007/s00439-003-1004-7; KOZLOWSKI J, 1984, ARCTIC, V37, P359; Lahermo P, 1996, AM J HUM GENET, V58, P1309; Laitinen V, 2002, HUM HERED, V53, P68, DOI 10.1159/000057985; Lutz S, 1998, INT J LEGAL MED, V111, P67, DOI 10.1007/s004140050117; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Malyarchuk BA, 2003, ANN HUM GENET, V67, P412, DOI 10.1046/j.1469-1809.2003.00042.x; Malyarchuk BA, 2002, ANN HUM GENET, V66, P261, DOI 10.1017/S0003480002001161; Malyarchuk BA, 2001, ANN HUM GENET, V65, P63, DOI 10.1046/j.1469-1809.2001.6510063.x; MATHIAS N, 1994, HUM MOL GENET, V3, P115, DOI 10.1093/hmg/3.1.115; Meinila M, 2001, HUM HERED, V52, P160, DOI 10.1159/000053372; Metspalu E, 1999, GENOMIC DIVERSITY, P121; Mogentale-Profizi N, 2001, ANN HUM GENET, V65, P153, DOI 10.1017/S0003480001008545; NEI M, 1987, MOL EVOLUTIONARY GEN, P145; NEVANLINNA HR, 1972, HEREDITAS-GENETISK A, V71, P195; NYGAARD SE, 1989, J WORLD PREHIST, V3, P71, DOI 10.1007/BF00996246; Opdal SH, 1998, ACTA PAEDIATR, V87, P1039, DOI 10.1080/080352598750031347; Orekhov V, 1999, FEBS LETT, V445, P197, DOI 10.1016/S0014-5793(99)00115-5; Pakendorf B, 2003, AM J PHYS ANTHROPOL, V120, P211, DOI 10.1002/ajpa.10145; Parson W, 1998, INT J LEGAL MED, V111, P124, DOI 10.1007/s004140050132; Passarino G, 2002, EUR J HUM GENET, V10, P521, DOI 10.1038/sj.ejhg.5200834; Peltonen L, 2000, NAT REV GENET, V1, P182, DOI 10.1038/35042049; Pereira L, 2000, ANN HUM GENET, V64, P491, DOI 10.1046/j.1469-1809.2000.6460491.x; Pfeiffer H, 1999, INT J LEGAL MED, V112, P291, DOI 10.1007/s004140050252; Pfeiffer H, 2001, INT J LEGAL MED, V114, P169, DOI 10.1007/s004140000165; PIERCY R, 1993, INT J LEGAL MED, V106, P85, DOI 10.1007/BF01225046; PULT I, 1994, BIOL CHEM H-S, V375, P837; Puzyrev V. P., 2003, Genetika, V39, P975; Raitio M, 2001, GENOME RES, V11, P471, DOI 10.1101/gr.156301; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 2002, AM J HUM GENET, V71, P1168, DOI 10.1086/342930; Richards M, 1996, AM J HUM GENET, V59, P185; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; ROOTSI S, 2000, ROOTS PEOPLES LANGUA, P148; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Rousselet F, 1998, INT J LEGAL MED, V111, P292, DOI 10.1007/s004140050174; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; SAILLARD J, 2000, MCDONALD I ARCHAEOLO, P255; SAJANTILA A, 1995, GENOME RES, V5, P42, DOI 10.1101/gr.5.1.42; Sajantila A, 1996, P NATL ACAD SCI USA, V93, P12035, DOI 10.1073/pnas.93.21.12035; SAJANTILA A, 1995, NAT GENET, V11, P359, DOI 10.1038/ng1295-359; Salas A, 1998, EUR J HUM GENET, V6, P365, DOI 10.1038/sj.ejhg.5200202; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; Sammallahti P., 1998, SAAMI LANGUAGES INTR; Sanchez JJ, 2003, FORENSIC SCI INT, V137, P74, DOI 10.1016/S0379-0738(03)00299-8; Schurr TG, 1999, AM J PHYS ANTHROPOL, V108, P1, DOI 10.1002/(SICI)1096-8644(199901)108:1<1::AID-AJPA1>3.0.CO;2-1; Seielstad M, 2003, AM J HUM GENET, V73, P700, DOI 10.1086/377589; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Sumkin VJ, 1990, ACTA BOREAL, V7, P3; Tagliabracci A, 2001, INT J LEGAL MED, V114, P224, DOI 10.1007/s004140000168; Tambets K, 2003, MCDONALD I ARCHAEOLO, P449; TAMBETS K, 2000, MCDONALD I ARCHAEOLO, P219; Tolk HV, 2000, COLLEGIUM ANTROPOL, V24, P267; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 1996, GENETICS, V144, P1835; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; TORRONI A, 1992, GENETICS, V130, P153; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; VILLEMS R, 1998, ROOTS PEOPLES LANGUA, V1, P180; Weale ME, 2002, MOL BIOL EVOL, V19, P1008, DOI 10.1093/oxfordjournals.molbev.a004160; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; WHITFIELD LS, 1995, NATURE, V378, P379, DOI 10.1038/378379a0; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; Zerjal T, 1997, AM J HUM GENET, V60, P1174; Zerjal T, 2001, MOL BIOL EVOL, V18, P1077, DOI 10.1093/oxfordjournals.molbev.a003879	117	161	170	0	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2004	74	4					661	682		10.1086/383203	http://dx.doi.org/10.1086/383203			22	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	804EA	15024688	Bronze, Green Published			2022-12-18	WOS:000220280800006
J	Smalley, SL; Kustanovich, V; Minassian, SL; Stone, JL; Ogdie, MN; McGough, JJ; McCracken, JT; MacPhie, IL; Francks, C; Fisher, SE; Cantor, RM; Monaco, AP; Nelson, SF				Smalley, SL; Kustanovich, V; Minassian, SL; Stone, JL; Ogdie, MN; McGough, JJ; McCracken, JT; MacPhie, IL; Francks, C; Fisher, SE; Cantor, RM; Monaco, AP; Nelson, SF			Genetic linkage of attention-deficit/hyperactivity disorder on chromosome 16p13, in a region implicated in autism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEX TRAITS; DEFICIT; STRATEGIES; SYMPTOMS; FAMILIES; CHILDREN; SCAN	Attention-deficit/hyperactivity disorder (ADHD) is the most commonly diagnosed behavioral disorder in childhood and likely represents an extreme of normal behavior. ADHD significantly impacts learning in school-age children and leads to impaired functioning throughout the life span. There is strong evidence for a genetic etiology of the disorder, although putative alleles, principally in dopamine-related pathways suggested by candidate-gene studies, have very small effect sizes. We use affected-sib-pair analysis in 203 families to localize the first major susceptibility locus for ADHD to a 12-cM region on chromosome 16p13 (maximum LOD score 4.2; P =.000005), building upon an earlier genomewide scan of this disorder. The region overlaps that highlighted in three genome scans for autism, a disorder in which inattention and hyperactivity are common, and physically maps to a 7-Mb region on 16p13. These findings suggest that variations in a gene on 16p13 may contribute to common deficits found in both ADHD and autism.	Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA 90024 USA; Wellcome Trust Ctr Human Genet, Oxford, England	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Oxford; Wellcome Centre for Human Genetics	Smalley, SL (corresponding author), Univ Calif Los Angeles, Ctr Neurobehav Genet, 760 Westwood Plaza, Los Angeles, CA 90024 USA.	ssmalley@mednet.ucla.edu	Francks, Clyde/AGU-8875-2022; Fisher, Simon E./E-9130-2012; Monaco, Anthony P/A-4495-2010; Francks, Clyde/E-1384-2012; Nelson, Stanley F/D-4771-2009	Fisher, Simon E./0000-0002-3132-1996; Monaco, Anthony P/0000-0001-7480-3197; Francks, Clyde/0000-0002-9098-890X; Nelson, Stanley F/0000-0002-2082-3114	NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH001805, R01MH058277] Funding Source: NIH RePORTER; NIMH NIH HHS [K24 MH001805, MH01805, MH01969, R01 MH058277, MH58277] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		American Psychiatric Association DSM-IV, 1994, DSM 4 DIAGN STAT MAN; Bailey A, 1998, HUM MOL GENET, V7, P571; Brown RT, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.3.e43; Cantwell DP, 1996, J AM ACAD CHILD PSY, V35, P978, DOI 10.1097/00004583-199608000-00008; Faraone SV, 2001, AM J PSYCHIAT, V158, P1052, DOI 10.1176/appi.ajp.158.7.1052; Fisher SE, 2002, AM J HUM GENET, V70, P1183, DOI 10.1086/340112; Greene RW, 1996, J AM ACAD CHILD PSY, V35, P571, DOI 10.1097/00004583-199605000-00011; Handen BL, 2000, J AUTISM DEV DISORD, V30, P245, DOI 10.1023/A:1005548619694; Hirschhorn JN, 2000, P NATL ACAD SCI USA, V97, P12164, DOI 10.1073/pnas.210394597; Khare L, 2001, J MED GENET, V38, P347, DOI 10.1136/jmg.38.5.347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levy F, 1997, J AM ACAD CHILD PSY, V36, P737, DOI 10.1097/00004583-199706000-00009; Liu JJ, 2001, AM J HUM GENET, V69, P327, DOI 10.1086/321980; Nyholt DR, 2000, AM J HUM GENET, V67, P282, DOI 10.1086/303029; Ozonoff S, 1999, J AUTISM DEV DISORD, V29, P171, DOI 10.1023/A:1023052913110; Palferman S, 2001, AM J HUM GENET, V69, P570; Philippe A, 1999, HUM MOL GENET, V8, P805, DOI 10.1093/hmg/8.5.805; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P222; Sergeant JA, 2002, BEHAV BRAIN RES, V130, P3, DOI 10.1016/S0166-4328(01)00430-2; Smalley SL, 1997, AM J HUM GENET, V60, P1276, DOI 10.1086/515485; Smalley SL, 2000, J AM ACAD CHILD PSY, V39, P1135, DOI 10.1097/00004583-200009000-00013; Smalley SL, 1998, J AUTISM DEV DISORD, V28, P407, DOI 10.1023/A:1026052421693; Swanson J, 2001, Curr Psychiatry Rep, V3, P92, DOI 10.1007/s11920-001-0005-2; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	27	161	174	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2002	71	4					959	963		10.1086/342732	http://dx.doi.org/10.1086/342732			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	604HT	12187510	Bronze, Green Submitted, Green Published			2022-12-18	WOS:000178613800023
J	Nishimura, DY; Searby, CC; Alward, WL; Walton, D; Craig, JE; Mackey, DA; Kawase, K; Kanis, AB; Patil, SR; Stone, EM; Sheffield, VC				Nishimura, DY; Searby, CC; Alward, WL; Walton, D; Craig, JE; Mackey, DA; Kawase, K; Kanis, AB; Patil, SR; Stone, EM; Sheffield, VC			A spectrum of FOXC1 mutations suggests gene dosage as a mechanism for developmental defects of the anterior chamber of the eye	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRIMARY CONGENITAL GLAUCOMA; TRANSCRIPTION FACTOR GENE; RIEGER SYNDROME; ANOMALY MAPS; 6P25; IRIDOGONIODYSGENESIS; IDENTIFICATION; ABNORMALITIES; FKHL7; LOCUS	Mutations in the forkhead transcription-factor gene (FOXC1), have been shown to cause defects of the anterior chamber of the eye that are associated with developmental forms of glaucoma. Discovery of these mutations was greatly facilitated by the cloning and characterization of the 6p25 breakpoint in a patient with both congenital glaucoma and a balanced-translocation event involving chromosomes 6 and 13. Here we describe the identification of novel mutations in the FOXC1 gene in patients with anterior-chamber defects of the eye. We have detected nine new mutations (eight of which are novel) in the FOXC1 gene in patients with anterior-chamber eye defects. Of these mutations, five frameshift mutations predict loss of the forkhead domain, as a result of premature termination of translation. Of particular interest is the fact that two families have a duplication of 6p25, involving the FOXC1 gene. These data suggest that both FOXC1 haploinsufficiency and increased gene dosage can cause anterior-chamber defects of the eye.	Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; Univ Iowa, Dept Ophthalmol, Iowa City, IA 52242 USA; Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA; Univ Tasmania, Menzies Ctr Populat Hlth Res, Hobart, Tas, Australia; Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic, Australia; Gifu Univ, Dept Ophthalmol, Gifu, Japan	University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa; Harvard University; Harvard Medical School; University of Tasmania; Centre for Eye Research Australia; University of Melbourne; Gifu University	Sheffield, VC (corresponding author), Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA.	val-sheffield@uiowa.edu	Alward, Wallace/AAY-4149-2020; Mackey, David A/H-5340-2014	Mackey, David A/0000-0001-7914-4709; Sheffield, Val/0000-0002-6282-0835; Stone, Edwin M./0000-0003-3343-4414; Craig, Jamie/0000-0001-9955-9696; Searby, Charles/0000-0002-8108-8782; Alward, Wallace/0000-0001-6368-9018	NEI NIH HHS [R01-EY-10564, R01 EY010564] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010564] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aalfs CM, 1997, AM J MED GENET, V73, P267, DOI 10.1002/(SICI)1096-8628(19971219)73:3<267::AID-AJMG7>3.0.CO;2-P; Alward WLM, 2000, EYE, V14, P429, DOI 10.1038/eye.2000.127; Blixt A, 1998, GENOMICS, V53, P387, DOI 10.1006/geno.1998.5451; Fingert JH, 1999, HUM MOL GENET, V8, P899, DOI 10.1093/hmg/8.5.899; GLASER T, 1994, NAT GENET, V7, P463, DOI 10.1038/ng0894-463; Gould DB, 1997, AM J HUM GENET, V61, P765; Graff C, 1997, HUM GENET, V101, P130, DOI 10.1007/s004390050601; Jordan T, 1997, AM J HUM GENET, V61, P882, DOI 10.1086/514874; Lehmann OJ, 2000, AM J HUM GENET, V67, P1129; Mears AJ, 1996, AM J HUM GENET, V59, P1321; Mears AJ, 1998, AM J HUM GENET, V63, P1316, DOI 10.1086/302109; Mirzayans F, 2000, EUR J HUM GENET, V8, P71, DOI 10.1038/sj.ejhg.5200354; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; Phillips JC, 1996, AM J HUM GENET, V59, P613; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Schedl A, 1996, CELL, V86, P71, DOI 10.1016/S0092-8674(00)80078-1; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Smith RS, 2000, HUM MOL GENET, V9, P1021, DOI 10.1093/hmg/9.7.1021; Stoilov I, 1997, HUM MOL GENET, V6, P641, DOI 10.1093/hmg/6.4.641; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Swiderski RE, 1999, DEV DYNAM, V216, P16, DOI 10.1002/(SICI)1097-0177(199909)216:1<16::AID-DVDY4>3.0.CO;2-1	21	161	167	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2001	68	2					364	372		10.1086/318183	http://dx.doi.org/10.1086/318183			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	394LD	11170889	Green Published, Bronze			2022-12-18	WOS:000166524800007
J	Cazeneuve, C; Ajrapetyan, H; Papin, S; Roudot-Thoraval, F; Genevieve, D; Mndjoyan, E; Papazian, M; Sarkisian, A; Babloyan, A; Boissier, B; Duquesnoy, P; Kouyoumdjian, JC; Girodon-Boulandet, E; Grateau, G; Sarkisian, T; Amselem, S				Cazeneuve, C; Ajrapetyan, H; Papin, S; Roudot-Thoraval, F; Genevieve, D; Mndjoyan, E; Papazian, M; Sarkisian, A; Babloyan, A; Boissier, B; Duquesnoy, P; Kouyoumdjian, JC; Girodon-Boulandet, E; Grateau, G; Sarkisian, T; Amselem, S			Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SERUM AMYLOID-A; PHENOTYPE-GENOTYPE CORRELATION; APOLIPOPROTEIN-E; DISEASE; AMYLOIDOGENESIS; FREQUENCY; MUTATIONS; ALLELES; PROTEIN; SAA1	Familial Mediterranean fever (FMF) is a recessively inherited disorder predisposing to renal amyloidosis and associated with mutations in MEFV, a gene encoding a protein of unknown function. Differences in clinical expression have been attributed to MEFV-allelic heterogeneity, with the M694V/M694V genotype associated with a high prevalence of renal amyloidosis. However, the variable risk for patients with identical MEFV mutations to develop this severe complication, prevented by lifelong administration of colchicine, strongly suggests a role for other genetic and/or environmental factors. To overcome the well-known difficulties in the identification of modifying genetic factors, we investigated a relatively homogeneous population sample consisting of 137 Armenian patients with FMF from 127 independent families living in Armenia. We selected the SAA1, SAA2, and APOE genes-encoding serum amyloid proteins and apolipoprotein E, respectively-as well as the patients' sex, as candidate modifiers for renal amyloidosis. A stepwise logistic-regression analysis showed that the SAA1 alpha/alpha genotype was associated with a sevenfold increased risk for renal amyloidosis, compared with other SAA1 genotypes (odds ratio [OR] 6.9; 95% confidence interval [CI] 2.5-19.0). This association, which was present whatever the MEFV genotype, was extremely marked in patients homozygous for M694V (11/11). The risk for male patients of developing renal amyloidosis was fourfold higher than that for female patients (OR = 4.0; 95% CI = 1.5-10.8). This association, particularly marked in patients who were not homozygous for M694V (34.0% vs. 11.6%), was independent of SAA1-allelic variations. Polymorphisms in the SAA2 or APOE gene did nor: appear to influence susceptibility to renal amyloidosis. Overall, these data, which provide new insights into the pathophysiology of FMF, demonstrate that susceptibility to renal amyloidosis in this Mendelian disorder is influenced by at least two MEFV-independent factors of genetic origin-SAA1 and sex-that act independently of each other.	Hop Henri Mondor, INSERM U468, Serv Biochim & Genet Mol, F-94010 Creteil, France; Hop Henri Mondor, Serv Sante Publ, F-94010 Creteil, France; Hop Hotel Dieu, Serv Med Interne, F-75181 Paris, France; Natl Acad Sci, Ctr Genet Med, Yerevan, Armenia; Arabkir Med Ctr, Yerevan, Armenia	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; National Academy of Sciences of Armenia	Amselem, S (corresponding author), Hop Henri Mondor, INSERM U468, Serv Biochim & Genet Mol, 51 Ave Marechal de Lattre de Tassigny, F-94010 Creteil, France.			Sarkisian, Tamara/0000-0002-4767-7567; Papin, Stephanie/0000-0003-1358-9988				Aksentijevich I, 1997, CELL, V90, P797; BABA S, 1995, HUM MOL GENET, V4, P1083, DOI 10.1093/hmg/4.6.1083; Bernot A, 1998, HUM MOL GENET, V7, P1317, DOI 10.1093/hmg/7.8.1317; Bernot A, 1997, NAT GENET, V17, P25; Booth DR, 1998, QJM-INT J MED, V91, P603, DOI 10.1093/qjmed/91.9.603; Booth DR, 1998, AMYLOID, V5, P262, DOI 10.3109/13506129809007299; CASTANO EM, 1995, J BIOL CHEM, V270, P17610, DOI 10.1074/jbc.270.29.17610; Cazeneuve C, 1999, AM J HUM GENET, V65, P88, DOI 10.1086/302459; Dewalle M, 1998, EUR J HUM GENET, V6, P95, DOI 10.1038/sj.ejhg.5200170; Dipple KM, 2000, AM J HUM GENET, V66, P1729, DOI 10.1086/302938; FEINGOLD J, 2000, MED SCI, V16, P1; GOLDFARB LG, 1992, SCIENCE, V258, P806, DOI 10.1126/science.1439789; Kisilevsky R, 2000, NAT MED, V6, P633, DOI 10.1038/76203; Kluve-Beckerman B, 1999, AM J PATHOL, V155, P123, DOI 10.1016/S0002-9440(10)65107-3; KluveBeckerman B, 1997, BIOCHEM J, V322, P663, DOI 10.1042/bj3220663; LIEPNIEKS JJ, 1995, BBA-MOL BASIS DIS, V1270, P81, DOI 10.1016/0925-4439(94)00076-3; Livneh A, 1997, ARTHRITIS RHEUM-US, V40, P1879, DOI 10.1002/art.1780401023; MEEK RL, 1986, J EXP MED, V163, P499, DOI 10.1084/jem.163.3.499; MEYERHOFF J, 1980, MEDICINE, V59, P66, DOI 10.1097/00005792-198001000-00004; Moriguchi M, 1999, HUM GENET, V105, P360, DOI 10.1007/s004390051115; ROMEO G, 1994, NAT GENET, V7, P451, DOI 10.1038/ng0894-451; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Scharf JM, 1998, NAT GENET, V20, P83, DOI 10.1038/1753; Shohat M, 1999, EUR J HUM GENET, V7, P287, DOI 10.1038/sj.ejhg.5200303; SOHAR E, 1967, AM J MED, V43, P227, DOI 10.1016/0002-9343(67)90167-2; Tesson F, 1997, J MOL CELL CARDIOL, V29, P831, DOI 10.1006/jmcc.1996.0332; WHICHER JT, 1983, BIOCH CLIN PRACTICE, P221; WISNIEWSKI T, 1994, AM J PATHOL, V145, P1030; WISNIEWSKI T, 1992, NEUROSCI LETT, V135, P235, DOI 10.1016/0304-3940(92)90444-C; WOLFF SM, 1994, HARRISONS PRINCIPLES, P1684; Yalcinkaya F, 1998, NEW ENGL J MED, V338, P993, DOI 10.1056/NEJM199804023381414; Yamada T, 1999, AMYLOID, V6, P199, DOI 10.3109/13506129909007327; Yan SD, 2000, NAT MED, V6, P643, DOI 10.1038/76216; ZEMER D, 1986, NEW ENGL J MED, V314, P1001, DOI 10.1056/NEJM198604173141601	34	161	166	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2000	67	5					1136	1143		10.1016/S0002-9297(07)62944-9	http://dx.doi.org/10.1016/S0002-9297(07)62944-9			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	369WW	11017802	Green Published, Bronze			2022-12-18	WOS:000165091600011
J	Krantz, ID; Colliton, RP; Genin, A; Rand, EB; Li, LH; Piccoli, DA; Spinner, NB				Krantz, ID; Colliton, RP; Genin, A; Rand, EB; Li, LH; Piccoli, DA; Spinner, NB			Spectrum and frequency of Jagged1 (JAG1) mutations in Alagille syndrome patients and their families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ARTERIOHEPATIC DYSPLASIA; RAPID DETECTION; NOTCH; DELETION; DELTA; GENE; 20P	Alagille syndrome (AGS) is a dominantly inherited disorder characterized by liver disease in combination with heart, skeletal, ocular, facial, renal, and pancreatic abnormalities. We have recently demonstrated that Jagged1 (JAG1) is the AGS gene. JAG1 encodes a ligand in the Notch intercellular signaling pathway. AGS is the first developmental disorder to be associated with this pathway and the first human disorder caused by a Notch ligand. We have screened 54 AGS probands and family members to determine the frequency of mutations in JAG1. Three patients (6%) had deletions of the entire gene. Of the remaining 51 patients, 35 (63%) had mutations within JAG1, identified by SSCP analysis. Of the 35 identified intragenic mutations, all were unique, with the exceptions of a 5-bp deletion in exon 16, seen in two unrelated patients, and a C insertion at base 1618 in exon 3, also seen in two unrelated patients. The 35 intragenic mutations included 3 nonsense mutations (26%); 2 missense mutations (6%); 11 small deletions (31%), 8 small insertions (23%), and 1 complex rearrangement (3%), all leading to frameshifts; and 4 splice-site mutations (11%). The mutations are spread across the coding sequence of the gene within the evolutionarily conserved motifs of the JAG1 protein. There is no phenotypic difference between patients with deletions of the entire JAG1 gene and those with intragenic mutations, which suggests that one mechanism involved in AGS is haploinsufficiency. The two missense mutations occur at the same amino acid residue. The mechanism by which these missense mutations lead to the disease is not yet understood; however, they suggest that mechanisms other than haploinsufficiency may result in the AGS phenotype.	Childrens Hosp, Div Human Genet, Philadelphia, PA 19104 USA; Childrens Hosp, Div Gastroenterol & Nutr, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Univ Washington, Stowers Inst Med Res, Seattle, WA 98195 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Stowers Institute for Medical Research; University of Washington; University of Washington Seattle	Spinner, NB (corresponding author), Childrens Hosp, Div Human Genet, 1007 ARC,34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA.			Li, Linheng/0000-0001-9963-430X	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053104, K08DK002338] Funding Source: NIH RePORTER; NCRR NIH HHS [3M01RR00240-32S7CRC] Funding Source: Medline; NIDDK NIH HHS [DK02338, 1R01DK53104-01] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALAGILLE D, 1987, J PEDIATR-US, V110, P195, DOI 10.1016/S0022-3476(87)80153-1; ALAGILLE D, 1975, J PEDIATR-US, V86, P63, DOI 10.1016/S0022-3476(75)80706-2; ANAD F, 1990, J MED GENET, V27, P729, DOI 10.1136/jmg.27.12.729; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; BEAUDET AL, 1993, HUM MUTAT, V2, P245, DOI 10.1002/humu.1380020402; Becker KF, 1996, TRENDS GENET, V12, P250, DOI 10.1016/S0168-9525(96)90032-3; BYRNE JLB, 1986, AM J MED GENET, V24, P673, DOI 10.1002/ajmg.1320240411; DANKS DM, 1977, ARCH DIS CHILD, V52, P360, DOI 10.1136/adc.52.5.360; DHORNEPOLLET S, 1994, J MED GENET, V31, P453, DOI 10.1136/jmg.31.6.453; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; ELMSLIE FV, 1995, J MED GENET, V32, P264, DOI 10.1136/jmg.32.4.264; HOL FA, 1995, HUM GENET, V95, P687; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; KOPAN R, 1993, J CELL BIOL, V121, P631, DOI 10.1083/jcb.121.3.631; Krantz ID, 1997, J MED GENET, V34, P152, DOI 10.1136/jmg.34.2.152; Krantz ID, 1997, AM J MED GENET, V70, P80, DOI 10.1002/(SICI)1096-8628(19970502)70:1<80::AID-AJMG15>3.0.CO;2-T; LEGIUS E, 1990, AM J MED GENET, V35, P532, DOI 10.1002/ajmg.1320350419; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; MUSKAVITCH MAT, 1994, DEV BIOL, V166, P415, DOI 10.1006/dbio.1994.1326; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; RAND EB, 1995, AM J HUM GENET, V57, P1068; ROBEY E, 1996, CELL, V87, P486; ROEST PAM, 1993, HUM MOL GENET, V2, P1719, DOI 10.1093/hmg/2.10.1719; SCHNITTGER S, 1989, HUM GENET, V83, P239, DOI 10.1007/BF00285164; SHULMAN SA, 1984, AM J MED GENET, V19, P325, DOI 10.1002/ajmg.1320190215; SPINNER NB, 1994, AM J HUM GENET, V55, P238; Sun X, 1996, DEVELOPMENT, V122, P2465; TEEBI AS, 1992, AM J MED GENET, V42, P35, DOI 10.1002/ajmg.1320420109; ZHANG FR, 1990, J PEDIATR-US, V116, P73, DOI 10.1016/S0022-3476(05)81648-8	31	161	165	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1998	62	6					1361	1369		10.1086/301875	http://dx.doi.org/10.1086/301875			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZU224	9585603	Green Published, Bronze			2022-12-18	WOS:000074174700012
J	Wijnen, J; Khan, PM; Vasen, H; vanderKlift, H; Mulder, A; vanLeeuwenCornelisse, I; Bakker, B; Losekoot, M; Moller, P; Fodde, R				Wijnen, J; Khan, PM; Vasen, H; vanderKlift, H; Mulder, A; vanLeeuwenCornelisse, I; Bakker, B; Losekoot, M; Moller, P; Fodde, R			Hereditary nonpolyposis colorectal cancer families not complying with the Amsterdam criteria show extremely low frequency of mismatch-repair-gene mutations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GRADIENT-GEL-ELECTROPHORESIS; MICROSATELLITE INSTABILITY; COLON-CANCER; HOMOLOG; HNPCC; CARCINOMA; RECEPTOR; HMSH2; HMLH1	Hereditary nonpolyposis colorectal cancer (HNPCC) is a common autosomal dominant cancer-susceptibility condition characterized by early onset colorectal cancer. Germline mutations in one of four DNA mismatch repair (MMR) genes, hMSH2, hMLH1, hPMS1, or hPMS2, are known to cause HNPCC. Although many mutations in these genes have been found in HNPCC kindreds complying with the so-called Amsterdam criteria, little is known about the involvement of these genes in families not satisfying these criteria but showing clear-cut familial clustering of colorectal cancer and other cancers. Here, we applied denaturing gradient-gel electrophoresis to screen for hMSH2 and hMLH1 mutations in two sets of HNPCC families, one set comprising families strictly complying with the Amsterdam criteria and another set in which at least one of the criteria was not satisfied. Interestingly, hMSH2 and hMLH1 mutations were found in 49% of the kindreds fully complying with the Amsterdam criteria, whereas a disease-causing mutation could be identified in only 8% of the families in which the criteria were not satisfied fully. In correspondence with these findings, 4 of 6 colorectal tumors from patients belonging to kindreds meeting the criteria showed microsatellite instability, whereas only 3 of 11 tumors from the other set of families demonstrated this instability. Although the number of tumors included in the study admittedly is small, the frequencies of mutations in the MMR genes show obvious differences between the two clinical sets of families. These results also emphasize the practical importance of the Amsterdam criteria, which provide a valid clinical subdivision between families, on the basis of their chance of carrying an hMSH2 or an hMLH1 mutation, and which bear important consequences for genetic testing and counseling and for the management of colorectal cancer families.	LEIDEN UNIV, MGC, DEPT HUMAN GENET, SYLVIUS LABS, NL-2300 RA LEIDEN, NETHERLANDS; LEIDEN UNIV, FDN DETECT HEREDIT TUMORS, MED CTR, LEIDEN, NETHERLANDS; NORWEGIAN RADIUM HOSP, OSLO, NORWAY	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Oslo			Losekoot, Monique/AAC-2182-2022; Bakker, Egbert/D-3525-2009; Fodde, Riccardo/AAW-9394-2021	Bakker, Egbert/0000-0002-2843-7357; Fodde, Riccardo/0000-0001-9839-4324; Vasen, Hans/0000-0003-2682-2603				AALTONEN LA, 1994, CANCER RES, V54, P1645; AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; BURKS RT, 1994, ONCOGENE, V9, P1163; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; FODDE R, 1992, GENOMICS, V13, P1162, DOI 10.1016/0888-7543(92)90032-N; FODDE R, 1994, HUM MUTAT, V3, P83, DOI 10.1002/humu.1380030202; HAN HJ, 1993, CANCER RES, V53, P5087; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; KOLODNER RD, 1995, CANCER RES, V55, P242; LAZAR V, 1994, HUM MOL GENET, V3, P2257, DOI 10.1093/hmg/3.12.2257; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; LERMAN LS, 1987, METHOD ENZYMOL, V155, P482; Liu B, 1996, NAT MED, V2, P169, DOI 10.1038/nm0296-169; LYNCH HT, 1993, GASTROENTEROLOGY, V104, P1535, DOI 10.1016/0016-5085(93)90368-M; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Moslein G, 1996, HUM MOL GENET, V5, P1245, DOI 10.1093/hmg/5.9.1245; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; NAN HJ, 1995, HUM MOL GENET, V4, P237, DOI 10.1093/hmg/4.2.237; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; NystromLahti M, 1996, HUM MOL GENET, V5, P763, DOI 10.1093/hmg/5.6.763; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; PARSONS R, 1995, CANCER RES, V55, P5548; RISINGER JI, 1993, CANCER RES, V53, P5100; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; WATSON P, 1993, CANCER, V71, P677, DOI 10.1002/1097-0142(19930201)71:3<677::AID-CNCR2820710305>3.0.CO;2-#; WIJNEN J, 1995, AM J HUM GENET, V56, P1060; Wijnen J, 1996, AM J HUM GENET, V58, P300; WOOSTER R, 1994, NAT GENET, V6, P152, DOI 10.1038/ng0294-152	30	161	164	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1997	61	2					329	335		10.1086/514847	http://dx.doi.org/10.1086/514847			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XX701	9311737	Green Published, Bronze			2022-12-18	WOS:A1997XX70100010
J	FRIEDMAN, LS; SZABO, CI; OSTERMEYER, EA; DOWD, P; BUTLER, L; PARK, T; LEE, MK; GOODE, EL; ROWELL, SE; KING, MC				FRIEDMAN, LS; SZABO, CI; OSTERMEYER, EA; DOWD, P; BUTLER, L; PARK, T; LEE, MK; GOODE, EL; ROWELL, SE; KING, MC			NOVEL INHERITED MUTATIONS AND VARIABLE EXPRESSIVITY OF BRCA1 ALLELES, INCLUDING THE FOUNDER MUTATION 185DELAG IN ASHKENAZI-JEWISH FAMILIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OVARIAN CANCER GENE; BREAST-CANCER; MESSENGER-RNA; DNA; CHROMOSOME-17Q21; IDENTIFICATION; STABILITY; SEQUENCES; LINKAGE; REGION	Thirty-seven families with four or more cases of breast cancer or breast and ovarian cancer were analyzed for mutations in BRCA1. Twelve different germ-line mutations, four novel and eight previously observed, were detected in 16 families. Five families of Ashkenazi Jewish descent carried the 185delAG mutation and shared the same haplotype at eight polymorphic markers spanning similar to 850 kb at BRCA1. Expressivity of 185delAG in these families varied, from early-onset bilateral breast cancer and ovarian cancer to late-onset breast cancer without ovarian cancer. Mutation 4184delTCAA occurred independently in two families. In one family, penetrance was complete, with females developing early-onset breast cancer or ovarian cancer and the male carrier developing prostatic cancer, whereas, in the other family, penetrance was incomplete and only breast cancer occurred, diagnosed at ages 38-81 years. Two novel nonsense mutations led to the loss of mutant BRCA1 transcript in families with 10 and 6 cases of early-onset breast cancer and ovarian cancer. A 665-nt segment of the BRCA1 3'-UTR and 1.3 kb of genomic sequence including the putative promoter region were invariant by single-strand conformation analysis in 13 families without coding-sequence mutations. Overall in our series, BRCA1 mutations have been detected in 26 families: 16 with positive BRCA1 lod scores, 7 with negative lod scores (reflecting multiple sporadic breast cancers), and 3 not tested for linkage. Three other families have positive led scores for linkage to BRCA2, but 13 families without detected BRCA1 mutations have negative lod scores for both BRCA1 and BRCA2.	UNIV CALIF BERKELEY, DEPT MOLEC & CELL BIOL, BERKELEY, CA USA; UNIV CALIF BERKELEY, SCH PUBL HLTH, BERKELEY, CA USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley				King, Mary-Claire/0000-0001-9426-1743	NATIONAL CANCER INSTITUTE [R01CA027632] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA27632, F32 CA66293] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AMARA FM, 1993, NUCLEIC ACIDS RES, V21, P4803, DOI 10.1093/nar/21.20.4803; ANDERSON LA, 1993, GENOMICS, V17, P618, DOI 10.1006/geno.1993.1381; BLANCHETBARDON C, 1987, BRIT J DERMATOL, V117, P363, DOI 10.1111/j.1365-2133.1987.tb04144.x; BOWCOCK AM, 1993, AM J HUM GENET, V52, P718; BOYD M, 1995, NATURE, V375, P541, DOI 10.1038/375541b0; BROWN MA, 1994, NATURE, V372, P733, DOI 10.1038/372733a0; CASTILLA LH, 1994, NAT GENET, V8, P387, DOI 10.1038/ng1294-387; CLAUS EB, 1991, AM J HUM GENET, V48, P232; CUI Y, 1995, GENE DEV, V9, P423, DOI 10.1101/gad.9.4.423; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; DUNN JM, 1989, MOL CELL BIOL, V9, P4596, DOI 10.1128/MCB.9.11.4596; EASTON D, 1993, CANCER SURV, V18, P95; EASTON DF, 1993, AM J HUM GENET, V52, P678; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; FRIEDMAN LS, 1995, GENOMICS, V25, P256, DOI 10.1016/0888-7543(95)80133-7; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; GAYTHER SA, IN PRESS NAT GENET; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HARTMANN A, 1995, ONCOGENE, V10, P681; HELMRICH SP, 1983, AM J EPIDEMIOL, V117, P35, DOI 10.1093/oxfordjournals.aje.a113513; HENICS T, 1994, J BIOL CHEM, V269, P5377; HOGERVORST FBL, 1995, NAT GENET, V10, P208, DOI 10.1038/ng0695-208; HOSKING L, 1995, NAT GENET, V9, P343, DOI 10.1038/ng0495-343; KELSEY JL, 1991, CA-CANCER J CLIN, V41, P146, DOI 10.3322/canjclin.41.3.146; KING MC, 1993, JAMA-J AM MED ASSOC, V269, P1975, DOI 10.1001/jama.269.15.1975; KUNKEL TA, 1986, J BIOL CHEM, V261, P3581; LEEDS P, 1991, GENE DEV, V5, P2303, DOI 10.1101/gad.5.12a.2303; LIM SK, 1992, MOL CELL BIOL, V12, P1149, DOI 10.1128/MCB.12.3.1149; LOSSON R, 1979, P NATL ACAD SCI USA, V76, P5134, DOI 10.1073/pnas.76.10.5134; LOVERING R, 1993, P NATL ACAD SCI USA, V90, P2112, DOI 10.1073/pnas.90.6.2112; MENON KP, 1994, CELL MOL BIOL, V40, P999; MERAJVER SD, 1995, NAT GENET, V9, P439, DOI 10.1038/ng0495-439; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; NAROD SA, 1991, LANCET, V338, P82; NEWMAN B, 1988, P NATL ACAD SCI USA, V85, P3044, DOI 10.1073/pnas.85.9.3044; PETRAKIS NL, 1982, CANCER EPIDEMIOLOGY; PULAK R, 1993, GENE DEV, V7, P1885, DOI 10.1101/gad.7.10.1885; ROEST PAM, 1993, NEUROMUSCULAR DISORD, V3, P391, DOI 10.1016/0960-8966(93)90083-V; ROY N, 1992, NUCLEIC ACIDS RES, V20, P5753, DOI 10.1093/nar/20.21.5753; SCHLOTTERER C, 1992, NUCLEIC ACIDS RES, V20, P211, DOI 10.1093/nar/20.2.211; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; SIMARD J, 1994, NAT GENET, V8, P392, DOI 10.1038/ng1294-392; SMITH SA, 1993, AM J HUM GENET, V52, P767; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; STRUEWING JP, 1995, AM J HUM GENET, V57, P1; TAKAHASHI H, 1995, CANCER RES, V55, P2998; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; THOMPSON ME, 1995, NAT GENET, V9, P444, DOI 10.1038/ng0495-444; TONIN P, 1995, AM J HUM GENET, V57, P189; TORCHARD D, 1994, NAT GENET, V6, P106, DOI 10.1038/ng0194-106; VANDERLUIJT R, 1994, GENOMICS, V20, P1, DOI 10.1006/geno.1994.1119; VIDALPUIG A, 1994, BIOTECHNIQUES, V17, P490; WANG XM, 1995, MOL CELL BIOL, V15, P1769; WOOD WI, 1985, P NATL ACAD SCI USA, V82, P1585, DOI 10.1073/pnas.82.6.1585; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; 1994, CANCER FACTS FIGURES	57	161	167	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1995	57	6					1284	1297						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TE655	8533757				2022-12-18	WOS:A1995TE65500005
J	SAIJO, T; ITO, M; TAKEDA, E; HUQ, AHMM; NAITO, E; YOKOTA, I; SONE, T; PIKE, JW; KURODA, Y				SAIJO, T; ITO, M; TAKEDA, E; HUQ, AHMM; NAITO, E; YOKOTA, I; SONE, T; PIKE, JW; KURODA, Y			A UNIQUE MUTATION IN THE VITAMIN-D RECEPTOR GENE IN 3 JAPANESE PATIENTS WITH VITAMIN-D DEPENDENT RICKETS TYPE-II - UTILITY OF SINGLE-STRAND CONFORMATION POLYMORPHISM ANALYSIS FOR HETEROZYGOUS CARRIER DETECTION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PHYTOHEMAGGLUTININ-STIMULATED LYMPHOCYTES; POINT MUTATIONS; 1,25-DIHYDROXYVITAMIN-D3; RESISTANCE; BINDING; ACID	Vitamin D-dependent rickets type II is a hereditary disease resulting from a defective vitamin D receptor. In three Japanese patients with vitamin D-dependent rickets type II whose fibroblasts displayed normal cytosol binding and impaired nuclear uptake of 1,25-dihydroxyvitamin D3, western, Southern, and northern analyses failed to disclose any abnormalities in vitamin D3 receptor protein and its gene. Exons 2 and 3 of the vitamin D receptor cDNA, which encode the DNA-binding domain consisting of two zinc fingers, were amplified by PCR and sequenced to identify the specific mutations in the vitamin D receptor gene. In the three patients and one normal control a T-to-C transition was found in the putative initiation codon, while this transition was not observed in another normal control. This finding suggested that an original initiation codon was located at positions 10-12 in the human vitamin D receptor cDNA sequence reported previously. In contrast, a unique G-to-A transition at position 140 in exon 3, resulting in substitution of arginine by glutamine at residue 47, was revealed only in these three patients. The arginine at 47 is located between two zinc fingers and is conserved within all steroid hormone receptors. Therefore, it is highly conceivable that this amino acid substitution is responsible for the defect of the vitamin D receptor in the patients. Single-strand conformation polymorphism analysis of amplified DNA confirmed that all patients were homozygous and that parents from one family were heterozygous carriers for this mutation.	BAYLOR COLL MED,DEPT CELL BIOL & PEDIAT,HOUSTON,TX 77030	Baylor College of Medicine	SAIJO, T (corresponding author), UNIV TOKUSHIMA,SCH MED,DEPT PEDIAT,KURAMOTO CHO 2,TOKUSHIMA 770,JAPAN.							BAKER AR, 1988, P NATL ACAD SCI USA, V85, P3294, DOI 10.1073/pnas.85.10.3294; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; HATA A, 1990, NUCLEIC ACIDS RES, V18, P5407, DOI 10.1093/nar/18.18.5407; HUGHES MR, 1988, SCIENCE, V242, P1702, DOI 10.1126/science.2849209; KERNER SA, 1989, P NATL ACAD SCI USA, V86, P4455, DOI 10.1073/pnas.86.12.4455; LIBERMAN UA, 1983, J CLIN INVEST, V71, P192, DOI 10.1172/JCI110759; MALLOY PJ, 1989, J CLIN ENDOCR METAB, V68, P263, DOI 10.1210/jcem-68-2-263; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PIKE J W, 1987, Steroids, V49, P3, DOI 10.1016/0039-128X(87)90077-8; PIKE JW, 1984, J BIOL CHEM, V259, P1167; SONE T, 1990, MOL ENDOCRINOL, V4, P623, DOI 10.1210/mend-4-4-623; TAKEDA E, 1989, EUR J PEDIATR, V149, P54, DOI 10.1007/BF02024336; TAKEDA E, 1986, CLIN CHIM ACTA, V155, P245, DOI 10.1016/0009-8981(86)90244-5; TAKEDA E, 1990, J CLIN ENDOCR METAB, V70, P1068, DOI 10.1210/jcem-70-4-1068; YOKOTA I, IN PRESS J INHERITED	16	161	166	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1991	49	3					668	673						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GE367	1652893				2022-12-18	WOS:A1991GE36700021
J	KAMIGUCHI, Y; MIKAMO, K				KAMIGUCHI, Y; MIKAMO, K			AN IMPROVED, EFFICIENT METHOD FOR ANALYZING HUMAN-SPERM CHROMOSOMES USING ZONA-FREE HAMSTER OVA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											KAMIGUCHI, Y (corresponding author), ASAHIKAWA MED COLL,DEPT BIOL SCI,4-5 NISHIKAGURA,ASAHIKAWA 07811,JAPAN.							BALKAN W, 1983, HUM GENET, V63, P345, DOI 10.1007/BF00274760; BALKAN W, 1983, CYTOGENET CELL GENET, V35, P295, DOI 10.1159/000131882; BALKAN W, 1983, AM J MED GENET, V16, P169, DOI 10.1002/ajmg.1320160206; Boue J., 1975, AGING GAMETES THEIR, P330; BRANDRIFF B, 1985, HUM GENET, V70, P18, DOI 10.1007/BF00389451; BRANDRIFF B, 1984, HUM GENET, V66, P193, DOI 10.1007/BF00286600; CHAUDHURI JP, 1984, GAMETE RES, V10, P233, DOI 10.1002/mrd.1120100303; EDMONDS DK, 1982, FERTIL STERIL, V38, P447; FRASER LR, 1979, ENVIRON HEALTH PERSP, V31, P141, DOI 10.2307/3429152; GREEN DPL, 1978, J CELL SCI, V32, P137; HIRAO Y, 1978, J EXP ZOOL, V206, P365, DOI 10.1002/jez.1402060308; INOUE M, 1980, JPN J FERTIL STERIL, V25, P153; KAMIGUCHI Y, 1985, J FERTIL STERIL, V30, P57; MARTIN RH, 1984, CLIN GENET, V25, P357; MARTIN RH, 1983, CYTOGENET CELL GENET, V35, P252, DOI 10.1159/000131876; MARTIN RH, 1983, HUM GENET, V63, P305, DOI 10.1007/BF00274750; MARTIN RH, 1982, AM J HUM GENET, V34, P459; MATSUDA Y, 1985, MUTAT RES, V148, P113, DOI 10.1016/0027-5107(85)90214-3; ORSINI MW, 1952, SCIENCE, V115, P88, DOI 10.1126/science.115.2978.88; OVERSTREET JW, 1980, FERTIL STERIL, V33, P534; PERREAULT SD, 1982, FERTIL STERIL, V38, P258; RUDAK E, 1978, NATURE, V274, P911, DOI 10.1038/274911a0; RUSSELL L, 1979, J EXP ZOOL, V208, P41, DOI 10.1002/jez.1402080106; SAITO A, 1984, JPN J FERTIL STERIL, V29, P90; Sasaki, 1983, RAD INDUCED CHROMOSO, P411; SMITH M, 1983, J EXP ZOOL, V225, P157, DOI 10.1002/jez.1402250120; SUGAWARA S, 1986, CHROMOSOMA; TARKOWSKI AK, 1966, CYTOGENETICS, V5, P394, DOI 10.1159/000129914; TOHDA H, 1980, CANCER RES, V40, P4775; YANAGIMACHI R, 1984, GAMETE RES, V10, P187, DOI 10.1002/mrd.1120100210; YANAGIMACHI R, 1976, BIOL REPROD, V15, P471, DOI 10.1095/biolreprod15.4.471	31	161	171	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1986	38	5					724	740						17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	C9730	3717161				2022-12-18	WOS:A1986C973000011
J	Campbell, IM; Yuan, B; Robberecht, C; Pfundt, R; Szafranski, P; McEntagart, ME; Nagamani, SCS; Erez, A; Bartnik, M; Wisniowiecka-Kowanik, B; Plunkett, KS; Pursley, AN; Kang, SHL; Bi, WM; Lalani, SR; Bacino, CA; Vast, M; Marks, K; Patton, M; Olofsson, P; Patel, A; Veltman, JA; Cheung, SW; Shaw, CA; Vissers, LELM; Vermeesch, JR; Lupski, JR; Stankiewicz, P				Campbell, Ian M.; Yuan, Bo; Robberecht, Caroline; Pfundt, Rolph; Szafranski, Przemyslaw; McEntagart, Meriel E.; Nagamani, Sandesh C. S.; Erez, Ayelet; Bartnik, Magdalena; Wisniowiecka-Kowanik, Barbara; Plunkett, Katie S.; Pursley, Amber N.; Kang, Sung-Hae L.; Bi, Weimin; Lalani, Seema R.; Bacino, Carlos A.; Vast, Mala; Marks, Karen; Patton, Michael; Olofsson, Peter; Patel, Ankita; Veltman, Joris A.; Cheung, Sau Wai; Shaw, Chad A.; Vissers, Lisenka E. L. M.; Vermeesch, Joris R.; Lupski, James R.; Stankiewicz, Pawel			Parental Somatic Mosaicism Is Underrecognized and Influences Recurrence Risk of Genomic Disorders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DETECTABLE CLONAL MOSAICISM; AGE; MUTATION; DELETION; ORIGIN; ACGH	New human mutations are thought to originate in germ cells, thus making a recurrence of the same mutation in a sibling exceedingly rare. However, increasing sensitivity of genomic technologies has anecdotally revealed mosaicism for mutations in somatic tissues of apparently healthy parents. Such somatically mosaic parents might also have germline mosaicism that can potentially cause unexpected intergenerational recurrences. Here, we show that somatic mosaicism for transmitted mutations among parents of children with simplex genetic disease is more common than currently appreciated. Using the sensitivity of individual-specific breakpoint PCR, we prospectively screened 100 families with children affected by genomic disorders due to rare deletion copy-number variants (CNVs) determined to be de novo by clinical analysis of parental DNA. Surprisingly, we identified four cases of low-level somatic mosaicism for the transmitted CNV in DNA isolated from parental blood. Integrated probabilistic modeling of gametogenesis developed in response to our observations predicts that mutations in parental blood increase recurrence risk substantially more than parental mutations confined to the germline. Moreover, despite the fact that maternally transmitted mutations are the minority of alleles, our model suggests that sexual dimorphisms in gametogenesis result in a greater proportion of somatically mosaic transmitting mothers who are thus at increased risk of recurrence. Therefore, somatic mosaicism together with sexual differences in gametogenesis might explain a considerable fraction of unexpected recurrences of X-linked recessive disease. Overall, our results underscore an important role for somatic mosaicism and mitotic replicative mutational mechanisms in transmission genetics.	[Campbell, Ian M.; Yuan, Bo; Szafranski, Przemyslaw; Nagamani, Sandesh C. S.; Erez, Ayelet; Plunkett, Katie S.; Pursley, Amber N.; Kang, Sung-Hae L.; Bi, Weimin; Lalani, Seema R.; Bacino, Carlos A.; Patel, Ankita; Cheung, Sau Wai; Shaw, Chad A.; Lupski, James R.; Stankiewicz, Pawel] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Robberecht, Caroline; Vermeesch, Joris R.] Katholieke Univ Leuven, Ctr Human Genet, Univ Hosp, B-3000 Leuven, Belgium; [Pfundt, Rolph; Veltman, Joris A.; Vissers, Lisenka E. L. M.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Pfundt, Rolph; Veltman, Joris A.; Vissers, Lisenka E. L. M.] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Disorders, NL-6500 HB Nijmegen, Netherlands; [McEntagart, Meriel E.; Vast, Mala; Marks, Karen; Patton, Michael] St Georges Univ London, Dept Med Genet, London SW17 0RE, England; [Nagamani, Sandesh C. S.; Erez, Ayelet; Lalani, Seema R.; Bacino, Carlos A.; Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA; [Bartnik, Magdalena; Wisniowiecka-Kowanik, Barbara] Inst Mother & Child Hlth, Dept Med Genet, PL-01211 Warsaw, Poland; [Olofsson, Peter] Trinity Univ, Dept Math, San Antonio, TX 78212 USA; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lupski, James R.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Stankiewicz, Pawel] Inst Mother & Child Hlth, PL-01211 Warsaw, Poland	Baylor College of Medicine; KU Leuven; Radboud University Nijmegen; Radboud University Nijmegen; St Georges University London; Baylor College of Medicine; Trinity University; Baylor College of Medicine; Baylor College of Medicine	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	jlupski@bcm.edu; pawels@bcm.edu	Veltman, Joris A/F-5128-2010; Lalani, Seema/AAI-5090-2020; Stankiewicz, Paweł/AAP-7906-2021; Vissers, Lisenka ELM/A-2598-2015; Pfundt, Rolph/L-4576-2015	Veltman, Joris A/0000-0002-3218-8250; Stankiewicz, Paweł/0000-0002-6456-7490; Vissers, Lisenka ELM/0000-0001-6470-5497; Bartnik-Glaska, Magdalena/0000-0002-9533-3494; Campbell, Ian/0000-0002-3749-2884; Vermeesch, Joris/0000-0002-3071-1191; Wisniowiecka-Kowalnik, Barbara/0000-0001-6533-3090; Nagamani, Sandesh/0000-0001-6818-7367	Baylor College of Medicine (BCM) Medical Scientist Training Program [T32 GM007330-34]; National Institute of Neurological Disorders and Stroke [F31 NS083159, R01 NS058529]; Doris Duke Charitable Foundation; Intellectual and Developmental Disabilities Research Center [P30 HD024064]; Baylor-Hopkins Center for Mendelian Genomics [U54HG006542]; National Heart, Blood, and Lung Institute [R01 HL101975]; Polish Ministry of Science and Higher Education [R13-0005-04/2008]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083092, P30HD024064] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101975] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM093957, T32GM007330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS083159, R01NS058529] Funding Source: NIH RePORTER	Baylor College of Medicine (BCM) Medical Scientist Training Program; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Intellectual and Developmental Disabilities Research Center; Baylor-Hopkins Center for Mendelian Genomics; National Heart, Blood, and Lung Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the families for their participation in this project. We thank Greet Peeters for laboratory support, John D. Belmont for insightful suggestions concerning X-linked disease, and La Donna Immken for assistance in subject recruitment. I.M.C. is a fellow of the Baylor College of Medicine (BCM) Medical Scientist Training Program (T32 GM007330-34) and was supported by a fellowship from the National Institute of Neurological Disorders and Stroke (F31 NS083159). S.C.S.N. is a recipient of the Clinical Scientist Development Award from the Doris Duke Charitable Foundation. This study was supported in part by grants from the Intellectual and Developmental Disabilities Research Center (P30 HD024064), the Baylor-Hopkins Center for Mendelian Genomics (U54HG006542), and the National Institute of Neurological Disorders and Stroke (R01 NS058529) to J.R.L. and by grants from the National Heart, Blood, and Lung Institute (R01 HL101975) and Polish Ministry of Science and Higher Education (R13-0005-04/2008) to P.S. J.R.L. holds stock ownership in 23andMe Inc. and Ion Torrent Systems Inc. and is a coinventor on multiple United States and European patents related to molecular diagnostics. The Department of Molecular and Human Genetics at BCM derives revenue from molecular genetic testing offered in the Medical Genetics Laboratories (http://www.bcm.edu/geneticlabs/).	BAKKER E, 1987, NATURE, V329, P554, DOI 10.1038/329554a0; BAKKER E, 1989, J MED GENET, V26, P553, DOI 10.1136/jmg.26.9.553; Biesecker LG, 2013, NAT REV GENET, V14, P307, DOI 10.1038/nrg3424; Campbell IM, 2011, AM J MED GENET A, V155A, P1442, DOI 10.1002/ajmg.a.34015; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; DROST JB, 1995, ENVIRON MOL MUTAGEN, V25, P48, DOI 10.1002/em.2850250609; Erickson RP, 2010, MUTAT RES-REV MUTAT, V705, P96, DOI 10.1016/j.mrrev.2010.04.002; Forsberg LA, 2012, AM J HUM GENET, V90, P217, DOI 10.1016/j.ajhg.2011.12.009; Forsberg LA, 2013, J MED GENET, V50, P1, DOI 10.1136/jmedgenet-2012-101322; FUJIMOTO T, 1977, ANAT REC, V188, P315, DOI 10.1002/ar.1091880305; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hehir-Kwa JY, 2011, J MED GENET, V48, P776, DOI 10.1136/jmedgenet-2011-100147; Helderman-van den Enden ATJM, 2009, CLIN GENET, V75, P465, DOI 10.1111/j.1399-0004.2009.01173.x; HIGUCHI M, 1988, MOL BIOL MED, V5, P23; Iourov IY, 2010, CURR GENOMICS, V11, P387, DOI 10.2174/138920210793176065; Jacobs KB, 2012, NAT GENET, V44, P651, DOI 10.1038/ng.2270; JOFFE A, 1982, J APPL PROBAB, V19, P767, DOI 10.2307/3213829; Kang SHL, 2010, AM J MED GENET A, V152A, P1111, DOI 10.1002/ajmg.a.33278; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Laurie CC, 2012, NAT GENET, V44, P642, DOI 10.1038/ng.2271; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Lupski JR, 2013, SCIENCE, V341, P358, DOI 10.1126/science.1239503; Marques-Mari AI, 2009, HUM REPROD UPDATE, V15, P379, DOI 10.1093/humupd/dmp001; Milewicz DM, 2008, ANNU REV GENOM HUM G, V9, P283, DOI 10.1146/annurev.genom.8.080706.092303; Olofsson P, 2002, J MATH BIOL, V45, P279, DOI 10.1007/s002850200148; Pham J, 2014, EUR J HUM GENET, V22, DOI 10.1038/ejhg.2013.285; Qin J, 2007, PLOS BIOL, V5, P1912, DOI 10.1371/journal.pbio.0050224; Rothlisberger B, 2007, AM J MED GENET A, V143A, P1708, DOI 10.1002/ajmg.a.31826; SESHADRI R, 1987, CANCER RES, V47, P407; Smyk M, 2007, AM J MED GENET A, V143A, P866, DOI 10.1002/ajmg.a.31631; Sundberg K, 1997, LANCET, V350, P697, DOI 10.1016/S0140-6736(97)02449-5; Zhang F, 2009, NAT GENET, V41, P849, DOI 10.1038/ng.399	33	160	163	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 7	2014	95	2					173	182		10.1016/j.ajhg.2014.07.003	http://dx.doi.org/10.1016/j.ajhg.2014.07.003			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM7VE	25087610	Bronze, Green Published			2022-12-18	WOS:000340076000004
J	Rope, AF; Wang, K; Evjenth, R; Xing, JC; Johnston, JJ; Swensen, JJ; Johnson, WE; Moore, B; Huff, CD; Bird, LM; Carey, JC; Opitz, JM; Stevens, CA; Jiang, T; Schank, C; Fain, HD; Robison, R; Dalley, B; Chin, S; South, ST; Pysher, TJ; Jorde, LB; Hakonarson, H; Lillehaug, JR; Biesecker, LG; Yandell, M; Arnesen, T; Lyon, GJ				Rope, Alan F.; Wang, Kai; Evjenth, Rune; Xing, Jinchuan; Johnston, Jennifer J.; Swensen, Jeffrey J.; Johnson, W. Evan; Moore, Barry; Huff, Chad D.; Bird, Lynne M.; Carey, John C.; Opitz, John M.; Stevens, Cathy A.; Jiang, Tao; Schank, Christa; Fain, Heidi Deborah; Robison, Reid; Dalley, Brian; Chin, Steven; South, Sarah T.; Pysher, Theodore J.; Jorde, Lynn B.; Hakonarson, Hakon; Lillehaug, Johan R.; Biesecker, Leslie G.; Yandell, Mark; Arnesen, Thomas; Lyon, Gholson J.			Using VAAST to Identify an X-Linked Disorder Resulting in Lethality in Male Infants Due to N-Terminal Acetyltransferase Deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALPHA-ACETYLTRANSFERASE; MUTATIONS; CANCER; ARD1	We have identified two families with a previously undescribed lethal X-linked disorder of infancy; the disorder comprises a distinct combination of an aged appearance, craniofacial anomalies, hypotonia, global developmental delays, cryptorchidism, and cardiac arrhythmias. Using X chromosome exon sequencing and a recently developed probabilistic algorithm aimed at discovering disease-causing variants, we identified in one family a c.109T>C (p.Ser37Pro) variant in NAA 10, a gene encoding the catalytic subunit of the major human N-terminal acetyltransferase (NAT). A parallel effort on a second unrelated family converged on the same variant. The absence of this variant in controls, the amino acid conservation of this region of the protein, the predicted disruptive change, and the co-occurrence in two unrelated families with the same rare disorder suggest that this is the pathogenic mutation. We confirmed this by demonstrating a significantly impaired biochemical activity of the mutant hNaa10p, and from this we conclude that a reduction in acetylation by hNaa10p causes this disease. Here we provide evidence of a human genetic disorder resulting from direct impairment of N-terminal acetylation, one of the most common protein modifications in humans.	[Rope, Alan F.; Carey, John C.; South, Sarah T.] Univ Utah, Sch Med, Dept Pediat Med Genet, Salt Lake City, UT 84112 USA; [Wang, Kai; Hakonarson, Hakon] Univ Utah, Sch Med, Ctr Appl Genom, Salt Lake City, UT 84112 USA; [Evjenth, Rune; Lillehaug, Johan R.; Arnesen, Thomas] Univ Bergen, Dept Mol Biol, N-5020 Bergen, Norway; [Xing, Jinchuan; Moore, Barry; Huff, Chad D.; Opitz, John M.; Jorde, Lynn B.; Yandell, Mark] Univ Utah, Eccles Inst Human Genet, Salt Lake City, UT 84112 USA; [Johnston, Jennifer J.; Biesecker, Leslie G.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; [Swensen, Jeffrey J.; Opitz, John M.; Chin, Steven; Pysher, Theodore J.] Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA; [Swensen, Jeffrey J.; South, Sarah T.] ARUP Labs, Salt Lake City, UT 84112 USA; [Johnson, W. Evan; Schank, Christa] Brigham Young Univ, Dept Stat, Provo, UT 84602 USA; [Bird, Lynne M.] Rady Childrens Hosp, San Diego, CA 92123 USA; [Bird, Lynne M.] Univ Calif San Diego, Dept Pediat, San Diego, CA 92123 USA; [Opitz, John M.] Univ Utah, Dept Obstet & Gynecol, Salt Lake City, UT 84112 USA; [Opitz, John M.] Univ Utah, Dept Neurol, Salt Lake City, UT 84112 USA; [Stevens, Cathy A.] Univ Tennessee, Coll Med, Dept Pediat, Chattanooga, TN 38163 USA; [Jiang, Tao] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Jiang, Tao] Shenzhen Univ, Sch Med, Genome Res Inst, Shenzhen 510860, Peoples R China; [Fain, Heidi Deborah; Robison, Reid] Univ Utah, Dept Psychiat, Salt Lake City, UT 84112 USA; [Dalley, Brian] Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Arnesen, Thomas] Haukeland Hosp, Dept Surg, N-5021 Bergen, Norway; [Lyon, Gholson J.] New York Univ Child Study Ctr, New York, NY 10016 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Bergen; Utah System of Higher Education; University of Utah; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; ARUP Laboratories; Brigham Young University; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Tennessee System; University of Tennessee Health Science Center; Beijing Genomics Institute (BGI); Shenzhen University; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; University of Bergen; Haukeland University Hospital; New York University	Lyon, GJ (corresponding author), Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA.	lyong1@email.chop.edu	Bird, Lynne/AAG-9533-2021; Xing, Jinchuan/A-2489-2012; Arnesen, Thomas/Q-8117-2019; Lyon, Gholson/D-2765-2014; Biesecker, Leslie/AAG-2526-2021; Arnesen, Thomas/J-7139-2017	Arnesen, Thomas/0000-0002-3005-147X; Lyon, Gholson/0000-0002-5869-0716; Arnesen, Thomas/0000-0002-3005-147X; Bird, Lynne/0000-0003-4833-3747; Johnson, W. Evan/0000-0002-6247-6595	CCTS at the University of Utah [UL1RR025764]; National Cancer Institute [P30CA042014]; Research Council of Norway [197136]; Norwegian Cancer Society; National Human Genome Research Institute (NHGRI) [1RC2HG005619]; NIH/National Center for Research Resources [UL1 RR025774]; NIH/NHGRI [K99HG005846]; NHGRI [5R01HG5692]; NHGRI, NIH; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025774, UL1RR025764] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005619, R01HG005692, ZIAHG200328, R44HG006579, K99HG005846] Funding Source: NIH RePORTER	CCTS at the University of Utah; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH/NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We express our gratitude to the families for their extraordinary cooperation and assistance. We also thank David Nix, Nina Glomnes, and Whitney Fitts for advice and/or technical assistance with family 1. Exon capture and sequencing for family 1 was paid for by the Department of Psychiatry, University of Utah (to G.J.L.). Collection of DNA and phenotyping for family 1 was supported by the Clinical Genetics Research Program: Phenotyping Core, under CCTS grant UL1RR025764 at the University of Utah. The University of Utah Microarray and Genomic Analysis core facility was supported by award number P30CA042014 from the National Cancer Institute. Functional analyses were supported by the Research Council of Norway (grant 197136 to T.A.) and the Norwegian Cancer Society (to J.R.L. and T.A.). B.M. and M.Y. were supported by National Human Genome Research Institute (NHGRI) 1RC2HG005619, K.W. by a pilot/methodological study award from NIH/National Center for Research Resources grant UL1 RR025774, J.X. by NIH/NHGRI K99HG005846, and W.E.J. by NHGRI 5R01HG5692. The research on family 2 was supported by Intramural Funds of the NHGRI, NIH (L.G.B.). These authors thank Danielle Brinkman for the initial consenting and records gathering for family 2 and Caitlin Krause and Jamie Teer for technical support.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; [Anonymous], ANNOVAR SOFTWARE; [Anonymous], PICARD; [Anonymous], GNUMAP; [Anonymous], GATK SOFTWARE; Arnesen T, 2005, BIOCHEM J, V386, P433, DOI 10.1042/BJ20041071; Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Biesecker LG, 2009, GENOME RES, V19, P1665, DOI 10.1101/gr.092841.109; Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327; Bonnefond A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013630; Capell BC, 2009, J INVEST DERMATOL, V129, P2340, DOI 10.1038/jid.2009.103; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Clement NL, 2010, BIOINFORMATICS, V26, P38, DOI 10.1093/bioinformatics/btp614; Evjenth Rune, 2009, BMC Proc, V3 Suppl 6, pS5, DOI 10.1186/1753-6561-3-S6-S5; Evjenth R, 2009, J BIOL CHEM, V284, P31122, DOI 10.1074/jbc.M109.001347; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gromyko D, 2010, INT J CANCER, V127, P2777, DOI 10.1002/ijc.25275; Hedges D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008232; Hua KT, 2011, CANCER CELL, V19, P218, DOI 10.1016/j.ccr.2010.11.010; Huff CD, 2011, GENOME RES, V21, P768, DOI 10.1101/gr.115972.110; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Ingram AK, 2000, MOL BIOCHEM PARASIT, V111, P309, DOI 10.1016/S0166-6851(00)00322-4; Johnston JJ, 2010, AM J HUM GENET, V86, P743, DOI 10.1016/j.ajhg.2010.04.007; Johnston JJ, 2005, AM J HUM GENET, V76, P609, DOI 10.1086/429346; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kurpinski KT, 2003, AM J MED GENET A, V120A, P1, DOI 10.1002/ajmg.a.10201; Lee CF, 2010, J CLIN INVEST, V120, P2920, DOI 10.1172/JCI42275; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Lim JH, 2006, CANCER RES, V66, P10677, DOI 10.1158/0008-5472.CAN-06-3171; Liu GH, 2011, NATURE, V472, P221, DOI 10.1038/nature09879; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MULLEN JR, 1989, EMBO J, V8, P2067, DOI 10.1002/j.1460-2075.1989.tb03615.x; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Pierce SB, 2010, AM J HUM GENET, V87, P282, DOI 10.1016/j.ajhg.2010.07.007; Plasman K, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003301; Polevoda Bogdan, 2009, BMC Proc, V3 Suppl 6, pS2, DOI 10.1186/1753-6561-3-S6-S2; Reese MG, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r88; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Sanchez-Puig N, 2006, PROTEIN SCI, V15, P1968, DOI 10.1110/ps.062264006; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Teer JK, 2010, GENOME RES, V20, P1420, DOI 10.1101/gr.106716.110; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang Y, 2010, DEV DYNAM, V239, P2813, DOI 10.1002/dvdy.22418; Yandell M, 2011, GENOME RES, V21, P1529, DOI 10.1101/gr.123158.111	48	160	169	3	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 15	2011	89	1					28	43		10.1016/j.ajhg.2011.05.017	http://dx.doi.org/10.1016/j.ajhg.2011.05.017			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	796HF	21700266	Green Published, Bronze			2022-12-18	WOS:000293041700003
J	Nikopoulos, K; Gilissen, C; Hoischen, A; van Nouhuys, CE; Boonstra, FN; Blokland, EAW; Arts, P; Wieskamp, N; Strom, TM; Ayuso, C; Tilanus, MAD; Bouwhuis, S; Mukhopadhyay, A; Scheffer, H; Hoefsloot, LH; Veltman, JA; Cremers, FPM; Collin, RWJ				Nikopoulos, Konstantinos; Gilissen, Christian; Hoischen, Alexander; van Nouhuys, C. Erik; Boonstra, F. Nienke; Blokland, Ellen A. W.; Arts, Peer; Wieskamp, Nienke; Strom, Tim M.; Ayuso, Carmen; Tilanus, Mauk A. D.; Bouwhuis, Sanne; Mukhopadhyay, Arijit; Scheffer, Hans; Hoefsloot, Lies H.; Veltman, Joris A.; Cremers, Frans P. M.; Collin, Rob W. J.			Next-Generation Sequencing of a 40 Mb Linkage Interval Reveals TSPAN12 Mutations in Patients with Familial Exudative Vitreoretinopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TETRASPANIN FUNCTIONS; FZD4 MUTATIONS; GENE; VASCULATURE; VERTEBRATE; GENOME; NORRIN	Familial exudative vitreoretinopathy (FEVR) is a genetically heterogeneous retinal disorder characterized by abnormal vascularisation of the peripheral retina, often accompanied by retinal detachment. To date, mutations in three genes (FZD4, LRP5, and NDP) have been shown to be causative for FEVR. In two large Dutch pedigrees segregating autosomal-dominant FEVR, genome-wide SNP analysis identified an FEVR locus of similar to 40 Mb on chromosome 7. Microsatellite marker analysis suggested similar at risk haplotypes in patients of both families. To identify the causative gene, we applied next-generation sequencing in the proband of one of the families, by analyzing all exons and intron-exon boundaries of 338 genes, in addition to microRNAs, noncoding RNAs, and other highly conserved genomic regions in the 40 Mb linkage interval. After detailed bioinformatic analysis of the sequence data, prioritization of all detected sequence variants led to three candidates to be considered as the causative genetic defect in this family. One of these variants was an alanine-to-proline substitution in the transmembrane 4 superfamily member 12 protein, encoded by TSPAN12. This protein has very recently been implicated in regulating the development of retinal vasculature, together with the proteins encoded by FZD4, LRP5, and NDP. Sequence analysis of TSPAN12 revealed two mutations segregating in five of 11 FEVR families, indicating that mutations in TSPAN12 are a relatively frequent cause of FEVR. Furthermore, we demonstrate the power of targeted next-generation sequencing technology to identify disease genes in linkage intervals.	[Nikopoulos, Konstantinos; Gilissen, Christian; Hoischen, Alexander; Blokland, Ellen A. W.; Arts, Peer; Wieskamp, Nienke; Bouwhuis, Sanne; Mukhopadhyay, Arijit; Scheffer, Hans; Hoefsloot, Lies H.; Veltman, Joris A.; Cremers, Frans P. M.; Collin, Rob W. J.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Nikopoulos, Konstantinos; Gilissen, Christian; Hoischen, Alexander; Arts, Peer; Wieskamp, Nienke; Mukhopadhyay, Arijit; Scheffer, Hans; Veltman, Joris A.; Cremers, Frans P. M.; Collin, Rob W. J.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6525 GA Nijmegen, Netherlands; [Tilanus, Mauk A. D.; Collin, Rob W. J.] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6525 GA Nijmegen, Netherlands; [van Nouhuys, C. Erik] Canisius Wilhelmina Hosp, Dept Ophthalmol, NL-6532 SZ Nijmegen, Netherlands; [Boonstra, F. Nienke] Bartimeus Inst Visually Impaired, NL-3702 AD Zeist, Netherlands; [Strom, Tim M.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Ayuso, Carmen] Fdn Jimenez Diaz, Dept Genet, E-28040 Madrid, Spain; [Ayuso, Carmen] CIBERER, Madrid 28040, Spain; [Mukhopadhyay, Arijit] CSIR, Inst Genom & Integrat Biol, Dept Genom & Mol Med, Delhi 110007, India	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Canisius-Wilhelmina Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Cremers, FPM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands.	f.cremers@antrg.umcn.nl	Arts, Peer/Q-4139-2019; Cremers, Frans/A-5625-2014; Hoischen, Alexander/D-1282-2013; Gilissen, Christian/E-5246-2012; Hoischen, Alexander/AGF-7293-2022; Tilanus, M.A.D./L-4691-2015; Collin, Rob/N-3575-2014; Veltman, Joris A/F-5128-2010; Scheffer, Hans/E-4644-2012	Arts, Peer/0000-0002-6742-6239; Cremers, Frans/0000-0002-4954-5592; Hoischen, Alexander/0000-0002-8072-4476; Gilissen, Christian/0000-0003-1693-9699; Hoischen, Alexander/0000-0002-8072-4476; Veltman, Joris A/0000-0002-3218-8250; Scheffer, Hans/0000-0002-2986-0915; Ayuso, Carmen/0000-0002-9242-7065; Nikopoulos, Konstantinos/0000-0002-1856-2752	European Union [CT2003-5040032, Health-FS-2009-223143]; Netherlands Organization for Health Research and Development [917-66-36, 911-08-025]; AnEUploidy [LSHG-CT-2006-37627]; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; F.P. Fischer Stichting; Gelderse Blinden Sticliting; Landelijke Stichting voor Blinden en Slechtzienden; Rotterdamse Vereniging Blindenbelangen; Stichting Blindenhulp; Stichting Blinden-Penning; Stichting Nederlands Oogheelkundig Onderzoek; Stichting OOG; Stichting voor Oogliiders; Stichting tot Verbetering van bet Lot der Blinden; Vereniging Bartimeus	European Union(European Commission); Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); AnEUploidy; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; F.P. Fischer Stichting; Gelderse Blinden Sticliting; Landelijke Stichting voor Blinden en Slechtzienden; Rotterdamse Vereniging Blindenbelangen; Stichting Blindenhulp; Stichting Blinden-Penning; Stichting Nederlands Oogheelkundig Onderzoek; Stichting OOG; Stichting voor Oogliiders; Stichting tot Verbetering van bet Lot der Blinden; Vereniging Bartimeus	The authors thank Christel Beumer, Diana T. Cremers, Michael Kwint, Kornelia Neveling, Saskia D. van der Velde-Visser, and Ilse de Wijs for excellent technical assistance. We also thank all of the participating FEVR patients and their relatives. This study was financially supported by (I) the European Union Research Training Network grant RETNET (MRTN-CT2003-5040032 to F.P.M.C.); (2) the Netherlands Organization for Health Research and Development (ZonMW grants 917-66-36 and 911-08-025 to J.A.V.); (3) the EU-funded TECHGENE project (Health-FS-2009-223143 to P.A., H.S., and J.A.V.); (4) the AnEUploidy project (LSHG-CT-2006-37627 to A.H. and J.A.V.); (5) the following Dutch blindness foundations: the Algemene Nederlandse Vereniging ter Voorkoming van Blindheid, the F.P. Fischer Stichting, the Gelderse Blinden Sticliting, the Landelijke Stichting voor Blinden en Slechtzienden, the Rotterdamse Vereniging Blindenbelangen, the Stichting Blindenhulp, the Stichting Blinden-Penning, the Stichting Nederlands Oogheelkundig Onderzoek, the Stichting OOG, the Stichting voor Oogliiders, the Stichting tot Verbetering van bet Lot der Blinden (to F.P.M.C., F.N.B., M.A.D.T., and C.E.v.N.); and (6) the Vereniging Bartimeus (to F.N.B.).	Bi M, 2003, BIOCHEM J, V375, P477, DOI 10.1042/BJ20030753; Boonstra FN, 2009, INVEST OPHTH VIS SCI, V50, P4379, DOI 10.1167/iovs.08-3320; Boucheix C, 2001, CELL MOL LIFE SCI, V58, P1189, DOI 10.1007/PL00000933; Brkanac Z, 2009, AM J HUM GENET, V84, P692, DOI 10.1016/j.ajhg.2009.04.008; CANNY CLB, 1976, ARCH OPHTHALMOL-CHIC, V94, P1114; CHEN ZY, 1993, NAT GENET, V5, P180, DOI 10.1038/ng1093-180; CHEN ZY, 1993, HUM MOL GENET, V2, P1727, DOI 10.1093/hmg/2.10.1727; Crew VK, 2004, BLOOD, V104, P2217, DOI 10.1182/blood-2004-04-1512; CRISWICK VG, 1969, AM J OPHTHALMOL, V68, P578, DOI 10.1016/0002-9394(69)91237-9; FELDMAN EL, 1983, ARCH OPHTHALMOL-CHIC, V101, P1532; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Garcia-Espana A, 2008, GENOMICS, V91, P326, DOI 10.1016/j.ygeno.2007.12.005; GOW J, 1971, ARCH OPHTHALMOL-CHIC, V86, P150, DOI 10.1001/archopht.1971.01000010152007; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hemler ME, 2001, J CELL BIOL, V155, P1103, DOI 10.1083/jcb.200108061; Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571; Jiao XD, 2004, AM J HUM GENET, V75, P878, DOI 10.1086/425080; Junge HJ, 2009, CELL, V139, P299, DOI 10.1016/j.cell.2009.07.048; Keen TJ, 1996, HUM MUTAT, V8, P297; Kohl S, 1997, J MED GENET, V34, P620, DOI 10.1136/jmg.34.8.620; Luhmann UFO, 2008, EUR J NEUROSCI, V27, P2619, DOI 10.1111/j.1460-9568.2008.06237.x; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Pushkarev D, 2009, NAT BIOTECHNOL, V27, P847, DOI 10.1038/nbt.1561; Rackham O, 2009, NUCLEIC ACIDS RES, V37, P5859, DOI 10.1093/nar/gkp627; Robitaille JM, 2009, OPHTHALMIC GENET, V30, P23, DOI 10.1080/13816810802464312; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Siepel A, 2006, LECT NOTES COMPUT SC, V3909, P190; Toomes C, 2004, INVEST OPHTH VIS SCI, V45, P2083, DOI 10.1167/iovs.03-1044; VANNOUHUYS CE, 1982, DOC OPHTHALMOL, V54, P1; VANNOUHUYS CE, 1985, OPHTHALMIC PAED GEN, V5, P31, DOI 10.3109/13816818509007853; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Xia CH, 2008, HUM MOL GENET, V17, P1605, DOI 10.1093/hmg/ddn047; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Zemni R, 2000, NAT GENET, V24, P167, DOI 10.1038/72829	37	160	180	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 12	2010	86	2					240	247		10.1016/j.ajhg.2009.12.016	http://dx.doi.org/10.1016/j.ajhg.2009.12.016			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	556ZS	20159111	Green Published, Bronze			2022-12-18	WOS:000274637200013
J	Steinfeld, R; Grapp, M; Kraetzner, R; Dreha-Kulaczewski, S; Hems, G; Dechent, P; Wevers, R; Grosso, S; Gartner, J				Steinfeld, Robert; Grapp, Marcel; Kraetzner, Ralph; Dreha-Kulaczewski, Steffi; Hems, Gunther; Dechent, Peter; Wevers, Ron; Grosso, Salvatore; Gaertner, Jutta			Folate Receptor Alpha Defect Causes Cerebral Folate Transport Deficiency: A Treatable Neurodegenerative Disorder Associated with Disturbed Myelin Metabolism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MOLECULAR-BASIS; MICE LACKING; DNA; METHIONINE; IDENTIFICATION; SPECTROSCOPY; HOMOCYSTEINE; REDUCTASE; KINETICS; CLONING	Sufficient folate supplementation is essential for a multitude of biological processes and diverse organ systems. At least five distinct inherited disorders of folate transport and metabolism are presently known, all of which cause systemic folate deficiency. We identified an inherited brain-specific folate transport defect that is caused by mutations in the folate receptor 1 (FOLR1) gene coding for folate receptor alpha (FR alpha). Three patients carrying FOLR1 mutations developed progressive movement disturbance, psychomotor decline, and epilepsy and showed severely reduced folate concentrations in the cerebrospinal fluid (CSF). Brain magnetic resonance imaging (MRI) demonstrated profound hypomyelination, and MR-based in vivo metabolite analysis indicated a combined depletion of white-matter choline and inositol. Retroviral transfection of patient cells with either FR alpha or FR beta could rescue folate binding. Furthermore, CSF folate concentrations, as well as glial choline and inositol depletion, were restored by folinic acid therapy and preceded clinical improvements. Our studies not only characterize a previously unknown and treatable disorder of early childhood, but also provide new insights into the folate metabolic pathways involved in postnatal myelination and brain development.	[Steinfeld, Robert; Grapp, Marcel; Kraetzner, Ralph; Dreha-Kulaczewski, Steffi; Gaertner, Jutta] Univ Gottingen, Dept Pediat & Pediat Neurol, D-37075 Gottingen, Germany; [Hems, Gunther; Dechent, Peter] Univ Gottingen, MR Res Neurol & Psychiat, D-37075 Gottingen, Germany; [Wevers, Ron] Radboud Univ Nijmegen, Med Ctr, Lab Pediat & Neurol, NL-6525 GA Nijmegen, Netherlands; [Grosso, Salvatore] Univ Siena, Dept Pediat, I-53100 Siena, Italy	University of Gottingen; University of Gottingen; Radboud University Nijmegen; University of Siena	Steinfeld, R (corresponding author), Univ Gottingen, Dept Pediat & Pediat Neurol, Robert Koch Str 40, D-37075 Gottingen, Germany.	rsteinfeld@med.uni-goettingen.de	Wevers, Ron A./H-8116-2014; Helms, Gunther/A-9114-2010	Wevers, Ron A./0000-0003-2278-9746; Helms, Gunther/0000-0002-1371-5123; Steinfeld, Robert/0000-0003-0956-6601				Beckman D R, 1987, Birth Defects Orig Artic Ser, V23, P47; BERSUDSKY Y, 1994, EUR NEUROPSYCHOPHARM, V4, P463, DOI 10.1016/0924-977X(94)90294-1; Bersudsky Y, 2008, BIPOLAR DISORD, V10, P453, DOI 10.1111/j.1399-5618.2007.00546.x; Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290, DOI 10.1073/pnas.94.7.3290; DEBER CM, 1991, CLIN BIOCHEM, V24, P113, DOI 10.1016/0009-9120(91)90421-A; Fournier I, 2002, J NUTR, V132, P2781, DOI 10.1093/jn/132.9.2781; Fowler B, 1998, EUR J PEDIATR, V157, pS60, DOI 10.1007/PL00014306; Frahm J, 1996, NEUROPEDIATRICS, V27, P64, DOI 10.1055/s-2007-973751; FRAHM J, 1989, MAGNET RESON MED, V9, P79, DOI 10.1002/mrm.1910090110; Ghoshal K, 2006, J NUTR, V136, P1522, DOI 10.1093/jn/136.6.1522; GOYETTE P, 1994, NAT GENET, V7, P551, DOI 10.1038/ng0894-551a; Hilton JE, 2003, HUM MUTAT, V22, P67, DOI 10.1002/humu.10236; HIRONO H, 1978, J NUTR, V108, P766, DOI 10.1093/jn/108.5.766; JANSEN G, 1986, CLIN CHIM ACTA, V157, P277, DOI 10.1016/0009-8981(86)90303-7; Kronenberg G, 2008, J NEUROSCI, V28, P7219, DOI 10.1523/JNEUROSCI.0940-08.2008; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Leclerc D, 1998, P NATL ACAD SCI USA, V95, P3059, DOI 10.1073/pnas.95.6.3059; Leclerc D, 1996, HUM MOL GENET, V5, P1867, DOI 10.1093/hmg/5.12.1867; Li ZY, 2007, J BIOL CHEM, V282, P10283, DOI 10.1074/jbc.M611726200; Ling MM, 1997, ANAL BIOCHEM, V254, P157, DOI 10.1006/abio.1997.2428; Linhart HG, 2009, GASTROENTEROLOGY, V136, P227, DOI 10.1053/j.gastro.2008.10.016; Matherly LH, 2003, VITAM HORM, V66, P403, DOI 10.1016/S0083-6729(03)01012-4; McLean E, 2008, FOOD NUTR BULL, V29, pS38, DOI 10.1177/15648265080292S107; Moore CM, 1999, BIOL PSYCHIAT, V45, P1197, DOI 10.1016/S0006-3223(98)00249-2; Piedrahita JA, 1999, NAT GENET, V23, P228, DOI 10.1038/13861; Pogribny IP, 2008, BRAIN RES, V1237, P25, DOI 10.1016/j.brainres.2008.07.077; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Ramaekers VT, 2005, NEW ENGL J MED, V352, P1985, DOI 10.1056/NEJMoa043160; Rosenblatt DS, 2001, METABOLIC MOL BASES, P3897; Schwahn BC, 2003, FASEB J, V17, P512, DOI 10.1096/fj.02-0456fje; Shinohara Y, 2006, METABOLISM, V55, P899, DOI 10.1016/j.metabol.2006.02.017; Verbeek MM, 2008, MOL GENET METAB, V95, P127, DOI 10.1016/j.ymgme.2008.07.004; WEITMAN SD, 1992, CANCER RES, V52, P3396; Wolfson M, 2000, NEUROCHEM RES, V25, P977, DOI 10.1023/A:1007556509371; Wollack JB, 2008, J NEUROCHEM, V104, P1494, DOI 10.1111/j.1471-4159.2007.05095.x; Zhao RB, 2009, J BIOL CHEM, V284, P4267, DOI 10.1074/jbc.M807665200	37	160	165	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 11	2009	85	3					354	363		10.1016/j.ajhg.2009.08.005	http://dx.doi.org/10.1016/j.ajhg.2009.08.005			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	497ZN	19732866	Green Published, Bronze			2022-12-18	WOS:000270104500005
J	Duncan, AJ; Bitner-Glindzicz, M; Meunier, B; Costello, H; Hargreaves, IP; Lopez, LC; Hirano, M; Quinzii, CM; Sadowski, MI; Hardy, J; Singleton, A; Clayton, PT; Rahman, S				Duncan, Andrew J.; Bitner-Glindzicz, Maria; Meunier, Brigitte; Costello, Harry; Hargreaves, Iain P.; Lopez, Luis C.; Hirano, Michio; Quinzii, Catarina M.; Sadowski, Michael I.; Hardy, John; Singleton, Andrew; Clayton, Peter T.; Rahman, Shamima			A Nonsense Mutation in COQ9 Causes Autosomal-Recessive Neonatal-Onset Primary Coenzyme Q(10) Deficiency: A Potentially Treatable Form of Mitochondrial Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CEREBELLAR-ATAXIA; UBIQUINONE DEFICIENCY; MUSCLE; ENCEPHALOMYOPATHY; HOMOZYGOSITY; NEPHROPATHY; SYNTHASE	Coenzyme Q(10) is a mobile lipophilic electron carrier located in the inner mitochondrial membrane. Defects of coenzyme Q(10) biosynthesis represent one of the few treatable mitochondrial diseases. We genotyped a patient with primary coenzyme Q(10) deficiency who presented with neonatal lactic acidosis and later developed multisytem disease including intractable seizures, global developmental delay, hypertrophic cardiomyopathy, and renal tubular dysfunction. Cultured skin fibroblasts from the patient had a coenzyme Q(10) biosynthetic rate of 11% of normal controls and accumulated an abnormal metabolite that we believe to be a biosynthetic intermediate. In view of the rarity of coenzyme Q(10) deficiency, we hypothesized that the disease-causing gene might lie in a region of ancestral homozygosity by descent. Data from an Illumina HumanHap550 array were analyzed with BeadStudio software. Sixteen regions of homozygosity > 1.5 Mb were identified in the affected infant. Two of these regions included the loci of two of 16 candidate genes implicated in human coenzyme Q(10) biosynthesis. Sequence analysis demonstrated a homozygous stop mutation affecting a highly conserved residue of COQ9, leading to the truncation of 75 amino acids. Site-directed mutagenesis targeting the equivalent residue in the yeast Saccharomyces cerevisiae abolished respiratory growth.	[Duncan, Andrew J.; Bitner-Glindzicz, Maria; Costello, Harry; Clayton, Peter T.; Rahman, Shamima] UCL, Inst Child Hlth, Mitochondrial Res Grp, Clin & Mol Genet Unit, London WC1N 1EH, England; [Meunier, Brigitte] CNRS, Ctr Genet Mol, FRC3115, F-91198 Gif Sur Yvette, France; [Hargreaves, Iain P.] Natl Hosp Neurol, Neurometab Unit, London WC1N 3BG, England; [Lopez, Luis C.; Hirano, Michio; Quinzii, Catarina M.] Columbia Univ, Med Ctr, New York, NY 10032 USA; [Sadowski, Michael I.] Natl Inst Med Res, Div Math Biol, London NW7 1AA, England; [Hardy, John] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Hardy, John] Inst Neurol, Reta Lila Western Labs, London WC1N 3BG, England; [Singleton, Andrew] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Clayton, Peter T.; Rahman, Shamima] Great Ormond St Hosp Sick Children, Metab Unit, London WC1N 3JH, England; [Rahman, Shamima] MRC Ctr Neuromuscular Dis, London WC1N 3BG, England	University of London; University College London; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Columbia University; MRC National Institute for Medical Research; University of London; University College London; University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London	Rahman, S (corresponding author), UCL, Inst Child Hlth, Mitochondrial Res Grp, Clin & Mol Genet Unit, London WC1N 1EH, England.	s.rahman@ich.ucl.ac.uk	Sadowski, Michael/F-4475-2010; Singleton, Andrew B/C-3010-2009; Rahman, Shamima/M-7904-2019; Bitner-Glindzicz, Maria/A-4231-2009; Rahman, Shamima/C-5232-2008; Hargreaves, Iain/AAJ-6757-2020; Lopez, Luis Carlos/L-5129-2014; Lopez, Luis Carlos/AAP-9411-2020; Hardy, John/C-2451-2009; Clayton, Peter T/C-1523-2008	Sadowski, Michael/0000-0002-4546-2159; Rahman, Shamima/0000-0003-2088-730X; Lopez, Luis Carlos/0000-0003-3355-0298; Lopez, Luis Carlos/0000-0003-3355-0298; Hardy, John/0000-0002-3122-0423; Clayton, Peter/0000-0001-7592-4302; Meunier, Brigitte/0000-0002-6988-4663; Costello, Harry/0000-0003-4490-9219	Department of Health's NIHR Biomedical Research Centres; UK Medical Research Council [G0200335]; European Commission [LSHG-CT-2003-503265]; National Institutes of Health, Department of Health and Human Services [AG000932-01]; MRC [G0701075, G0200335] Funding Source: UKRI; Medical Research Council [G0200335, G0701075] Funding Source: researchfish; Parkinson&quot;s UK [G-0907] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1220] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000932, ZIAAG000958, K23AG000932] Funding Source: NIH RePORTER	Department of Health's NIHR Biomedical Research Centres(National Institute for Health Research (NIHR)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK); Great Ormond Street Hospital Childrens Charity; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was undertaken at GOSH/UCL Institute of Child Health, which received a proportion of funding from the Department of Health's NIHR Biomedical Research Centres funding scheme. We gratefully acknowledge funding from the UK Medical Research Council (grant number G0200335); the Biosapiens Network of Excellence (funded by the European Commission within its FP6 Programme, under the thematic area Life sciences, Genomics and Biotechnology for Health, contract number LSHG-CT-2003-503265); and the Intramural Research Program of the National Institute on Aging, National Institutes of Health, Department of Health and Human Services, project AG000932-01. We also thank Tabitha Owen for her excellent technical assistance.	Boitier E, 1998, J NEUROL SCI, V156, P41, DOI 10.1016/S0022-510X(98)00006-9; Brooksbank C, 2003, NUCLEIC ACIDS RES, V31, P43, DOI 10.1093/nar/gkg066; Camargos S, 2008, LANCET NEUROL, V7, P207, DOI 10.1016/S1474-4422(08)70022-X; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; DeLano W. L, 2002, PYMOL MOL GENETICS G; Diomedi-Camassei F, 2007, J AM SOC NEPHROL, V18, P2773, DOI 10.1681/ASN.2006080833; Duncan AJ, 2005, CLIN CHEM, V51, P2380, DOI 10.1373/clinchem.2005.054643; Gempel K, 2007, BRAIN, V130, P2037, DOI 10.1093/brain/awm054; Gibbs JR, 2006, PLOS GENET, V2, P1511, DOI 10.1371/journal.pgen.0020150; Gibson J, 2006, HUM MOL GENET, V15, P789, DOI 10.1093/hmg/ddi493; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; HOLM L, 1992, J MOL BIOL, V225, P93, DOI 10.1016/0022-2836(92)91028-N; Hsieh EJ, 2007, ARCH BIOCHEM BIOPHYS, V463, P19, DOI 10.1016/j.abb.2007.02.016; Johnson A, 2005, J BIOL CHEM, V280, P31397, DOI 10.1074/jbc.M503277200; Jones DT, 2003, PROTEINS, V53, P573, DOI 10.1002/prot.10528; Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024; Lalani SR, 2005, ARCH NEUROL-CHICAGO, V62, P317, DOI 10.1001/archneur.62.2.317; Lamperti C, 2005, ARCH NEUROL-CHICAGO, V62, P1709, DOI 10.1001/archneur.62.11.1709; Lamperti C, 2003, NEUROLOGY, V60, P1206, DOI 10.1212/01.WNL.0000055089.39373.FC; Le Ber I, 2007, NEUROLOGY, V68, P295, DOI 10.1212/01.wnl.0000252366.10731.43; Lopez LC, 2006, AM J HUM GENET, V79, P1125, DOI 10.1086/510023; Lopez-Martin JM, 2007, HUM MOL GENET, V16, P1091, DOI 10.1093/hmg/ddm058; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022; Mollet J, 2007, J CLIN INVEST, V117, P765, DOI 10.1172/JCI29089; Molyneux Sarah, 2004, N Z Med J, V117, pU1108; Molyneux Sarah L, 2008, Clin Biochem Rev, V29, P71; Montini G, 2008, NEW ENGL J MED, V358, P2849, DOI 10.1056/NEJMc0800582; Musumeci O, 2001, NEUROLOGY, V56, P849, DOI 10.1212/WNL.56.7.849; OGASAHARA S, 1989, P NATL ACAD SCI USA, V86, P2379, DOI 10.1073/pnas.86.7.2379; Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092; Quinzii CM, 2008, BIOFACTORS, V32, P113, DOI 10.1002/biof.5520320113; Quinzii CM, 2007, NEUROCHEM RES, V32, P723, DOI 10.1007/s11064-006-9190-z; Quinzii CM, 2005, NEUROLOGY, V64, P539, DOI 10.1212/01.WNL.0000150588.75281.58; Rahman S, 2001, J PEDIATR-US, V139, P456, DOI 10.1067/mpd.2001.117575; Rotig A, 2000, LANCET, V356, P391, DOI 10.1016/S0140-6736(00)02531-9; Rotig A, 2007, MITOCHONDRION, V7, pS112, DOI 10.1016/j.mito.2007.02.008; Sadowski MI, 2007, PROTEINS, V69, P476, DOI 10.1002/prot.21531; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sobreira C, 1997, NEUROLOGY, V48, P1238, DOI 10.1212/WNL.48.5.1238; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; Van Maldergem L, 2002, ANN NEUROL, V52, P750, DOI 10.1002/ana.10371	42	160	166	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 15	2009	84	5					558	566		10.1016/j.ajhg.2009.03.018	http://dx.doi.org/10.1016/j.ajhg.2009.03.018			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	449OB	19375058	Bronze, Green Published			2022-12-18	WOS:000266338800001
J	Aridon, P; Marini, C; Di Resta, C; Brilli, E; De Fusco, M; Politi, F; Parrini, E; Manfredi, I; Pisano, T; Pruna, D; Curia, G; Cianchetti, C; Pasqualetti, M; Becchetti, A; Guerrini, R; Casari, G				Aridon, Paolo; Marini, Carla; Di Resta, Chiara; Brilli, Elisa; De Fusco, Maurizio; Politi, Fausta; Parrini, Elena; Manfredi, Irene; Pisano, Tiziana; Pruna, Dario; Curia, Giulia; Cianchetti, Carlo; Pasqualetti, Massimo; Becchetti, Andrea; Guerrini, Renzo; Casari, Giorgio			Increased sensitivity of the neuronal nicotinic receptor alpha 2 subunit causes familial epilepsy with nocturnal wandering and ictal fear	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUBUNIT MESSENGER-RNAS; FRONTAL-LOBE EPILEPSY; ACETYLCHOLINE-RECEPTOR; IDIOPATHIC EPILEPSIES; NACHR SUBUNIT; BRAIN; HYPERPERFUSION; LOCALIZATION; ACTIVATION; MUTATIONS	Sleep has traditionally been recognized as a precipitating factor for some forms of epilepsy, although differential diagnosis between some seizure types and parasomnias may be difficult. Autosomal dominant frontal lobe epilepsy is characterized by nocturnal seizures with hyperkinetic automatisms and poorly organized stereotyped movements and has been associated with mutations of the alpha 4 and beta 2 subunits of the neuronal nicotinic acetylcholine receptor. We performed a clinical and molecular genetic study of a large pedigree segregating sleep-related epilepsy in which seizures are associated with fear sensation, tongue movements, and nocturnal wandering, closely resembling nightmares and sleep walking. We identified a new genetic locus for familial sleep-related focal epilepsy on chromosome 8p12.3-8q12.3. By sequencing the positional candidate neuronal cholinergic receptor alpha 2 subunit gene (CHRNA2), we detected a heterozygous missense mutation, I279N, in the first transmembrane domain that is crucial for receptor function. Whole-cell recordings of transiently transfected HEK293 cells expressing either the mutant or the wild-type receptor showed that the new CHRNA2 mutation markedly increases the receptor sensitivity to acetylcholine, therefore indicating that the nicotinic a2 subunit alteration is the underlying cause. CHRNA2 is the third neuronal cholinergic receptor gene to be associated with familial sleep-related epilepsies. Compared with the CHRNA4 and CHRNB2 mutations reported elsewhere, CHRNA2 mutations cause a more complex and finalized ictal behavior.	Vita Salute San Raffaele Univ, I-20132 Milan, Italy; Univ Milan, Human Mol Genet Unit, Dibit San Raffaele Sci Inst, Milan, Italy; Univ Milan, Dipartimento Biotecnol & Biosci, Milan, Italy; Univ Pisa, Div Child Neurol & Psychiat, Pisa, Italy; Fdn Stella Maris, Pisa, Italy; Univ Pisa, Dipartimento Biol, Unita Biol Cellulare & Sviluppo, Ghezzano Pisa, Italy; Univ Cagliari, Child & Adolescent Neuropsychiat Clin, Cagliari, Italy	Vita-Salute San Raffaele University; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan; University of Pisa; IRCCS Fondazione Stella Maris; University of Pisa; University of Cagliari	Casari, G (corresponding author), Vita Salute San Raffaele Univ, Via Olgettina 58, I-20132 Milan, Italy.	casari.giorgio@hsr.it	Marini, Carla/AAC-2413-2022; Casari, Giorgio/J-3070-2018; De Fusco, Maurizio/AAN-7358-2020; Becchetti, Andrea/AAF-7821-2020; Cianchetti, Carlo/ABD-9536-2021; Pasqualetti, Massimo/F-8682-2012; Curia, Giulia/A-8863-2008; Di Resta, Chiara/J-3627-2018; Parrini, Elena/K-5283-2016; Pisano, Tiziana/K-4975-2016	Marini, Carla/0000-0002-9212-2691; Casari, Giorgio/0000-0002-0115-8980; Becchetti, Andrea/0000-0002-9297-0527; Curia, Giulia/0000-0002-8472-350X; Parrini, Elena/0000-0001-8933-7694; Pisano, Tiziana/0000-0001-8920-9078; DI RESTA, Chiara/0000-0003-2880-6631; Pasqualetti, Massimo/0000-0002-0844-8139; Guerrini, Renzo/0000-0002-7272-7079; Aridon, Paolo/0000-0002-7424-9533	Telethon [GP0023Y01] Funding Source: Medline	Telethon(Fondazione Telethon)		Alkondon M, 2000, J NEUROSCI, V20, P66, DOI 10.1523/JNEUROSCI.20-01-00066.2000; Becchetti A, 2002, EUR J NEUROSCI, V16, P415, DOI 10.1046/j.1460-9568.2002.02079.x; Bertrand D, 2005, NEUROBIOL DIS, V20, P799, DOI 10.1016/j.nbd.2005.05.013; Bertrand D, 2002, EPILEPSIA, V43, P112, DOI 10.1046/j.1528-1157.43.s.5.16.x; Bonanni P, 2004, EPILEPSIA, V45, P149, DOI 10.1111/j.0013-9580.2004.04303.x; Callenbach PMC, 2005, EUR J PAEDIATR NEURO, V9, P91, DOI 10.1016/j.ejpn.2004.12.005; CLARKE PBS, 1985, BRAIN RES, V348, P355, DOI 10.1016/0006-8993(85)90456-1; De Fusco M, 2000, NAT GENET, V26, P275; Forsgren L, 2005, EUR J NEUROL, V12, P245, DOI 10.1111/j.1468-1331.2004.00992.x; Gotti C, 2004, PROG NEUROBIOL, V74, P363, DOI 10.1016/j.pneurobio.2004.09.006; Gourfinkel-An I, 2004, LANCET NEUROL, V3, P209, DOI 10.1016/S1474-4422(04)00706-9; Han ZY, 2000, EUR J NEUROSCI, V12, P3664, DOI 10.1046/j.1460-9568.2000.00262.x; Hayman M, 1997, NEUROLOGY, V49, P969, DOI 10.1212/WNL.49.4.969; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; LATHROP GM, 1985, AM J HUM GENET, V37, P482; Lubin M, 1999, ANN NY ACAD SCI, V868, P628, DOI 10.1111/j.1749-6632.1999.tb11337.x; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Nobili L, 2004, NEUROLOGY, V62, P482, DOI 10.1212/01.WNL.0000106945.68292.DC; Quik M, 2000, J COMP NEUROL, V425, P58, DOI 10.1002/1096-9861(20000911)425:1<58::AID-CNE6>3.0.CO;2-X; Radcliffe KA, 1998, J NEUROSCI, V18, P7075; REUTENS DC, 1992, EPILEPSIA, V33, P1065, DOI 10.1111/j.1528-1157.1992.tb01760.x; Rocca WA, 2001, NEUROEPIDEMIOLOGY, V20, P237, DOI 10.1159/000054796; Sambrook J, 1989, MOL CLONING LAB MANU; Schindler K, 2001, NEUROLOGY, V57, P917, DOI 10.1212/WNL.57.5.917; Schonherr R, 1999, EUR J NEUROSCI, V11, P753, DOI 10.1046/j.1460-9568.1999.00493.x; Steinlein O, 1997, AM J MED GENET, V74, P445, DOI 10.1002/(SICI)1096-8628(19970725)74:4<445::AID-AJMG18>3.0.CO;2-I; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Vetrugno R, 2005, NEUROLOGY, V64, P356, DOI 10.1212/01.WNL.0000149530.07703.FA; Wilson GG, 2001, P NATL ACAD SCI USA, V98, P1241, DOI 10.1073/pnas.031567798	30	160	168	0	8	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2006	79	2					342	350		10.1086/506459	http://dx.doi.org/10.1086/506459			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	063SR	16826524	Green Published, Bronze			2022-12-18	WOS:000239040400015
J	Boycott, KM; Flavelle, S; Bureau, A; Glass, HC; Fujiwara, TM; Wirrell, E; Davey, K; Chudley, AE; Scott, JN; McLeod, DR; Parboosingh, JS				Boycott, KM; Flavelle, S; Bureau, A; Glass, HC; Fujiwara, TM; Wirrell, E; Davey, K; Chudley, AE; Scott, JN; McLeod, DR; Parboosingh, JS			Homozygous deletion of the very low density lipoprotein receptor gene causes autosomal recessive cerebellar hypoplasia with cerebral gyral simplification	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VLDL RECEPTOR; KNOCKOUT MICE; HUTTERITES; DISRUPTION; LACKING; REELIN; BRAIN	An autosomal recessive syndrome of nonprogressive cerebellar ataxia and mental retardation is associated with inferior cerebellar hypoplasia and mild cerebral gyral simplification in the Hutterite population. An identity-by-descent mapping approach using eight patients from three interrelated Hutterite families localized the gene for this syndrome to chromosome region 9p24. Haplotype analysis identified familial and ancestral recombination events and refined the minimal region to a 2-Mb interval between markers D9S129 and D9S1871. A 199-kb homozygous deletion encompassing the entire very low density lipoprotein receptor (VLDLR) gene was present in all affected individuals. VLDLR is part of the reelin signaling pathway, which guides neuroblast migration in the cerebral cortex and cerebellum. To our knowledge, this syndrome represents the first human lipoprotein receptor malformation syndrome and the second human disease associated with a reelin pathway defect.	Alberta Childrens Prov Gen Hosp, Dept Med Genet, Mol Diagnost Hosp, Calgary, AB T2T 5C7, Canada; Alberta Childrens Prov Gen Hosp, Div Pediat Neurol, Calgary, AB, Canada; Univ Calgary, Calgary, AB, Canada; Foothills Prov Gen Hosp, Dept Radiol, Calgary, AB T2N 2T9, Canada; Univ Lethbridge, Sch Hlth Sci, Lethbridge, AB T1K 3M4, Canada; McGill Univ, Dept Human Genet, Montreal, PQ, Canada; McGill Univ, Dept Med, Montreal, PQ, Canada; Univ Manitoba, Sect Genet & Metabol, Childrens Hosp, Winnipeg, MB, Canada; Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB, Canada	Alberta Childrens Hospital; University of Calgary; Alberta Childrens Hospital; University of Calgary; University of Calgary; University of Calgary; University of Lethbridge; McGill University; McGill University; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba	Parboosingh, JS (corresponding author), Alberta Childrens Prov Gen Hosp, Dept Med Genet, Mol Diagnost Hosp, 1820 Richmond Rd SW, Calgary, AB T2T 5C7, Canada.	Jillian.Parboosingh@calgaryhealthregion.ca		Bureau, Alexandre/0000-0001-8220-9999	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS066137] Funding Source: NIH RePORTER; NINDS NIH HHS [K23 NS066137] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Antonarakis S. E., 2001, METABOLIC MOL BASES, P343; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; FRYKMAN PK, 1995, P NATL ACAD SCI USA, V92, P8453, DOI 10.1073/pnas.92.18.8453; GLASS HC, IN PRESS DEV MED CHI; Goudriaan JR, 2001, ARTERIOSCL THROM VAS, V21, P1488, DOI 10.1161/hq0901.095147; HAGBERG B, 1972, ACTA PAEDIATR SC   S, V61, P1; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; HOSTETLER JA, 1985, AM J MED GENET, V22, P453, DOI 10.1002/ajmg.1320220303; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Innes AM, 1999, AM J HUM GENET, V65, pA216; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lambert de Rouvroit C, 1998, Adv Anat Embryol Cell Biol, V150, P1; Nimgaonkar VL, 2000, AM J PSYCHIAT, V157, P1065, DOI 10.1176/appi.ajp.157.7.1065; PALLISTER P, 1986, AM J MED GENET, V22, P567; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Ross ME, 2001, NEUROPEDIATRICS, V32, P256, DOI 10.1055/s-2001-19120; SAKAI J, 1994, J BIOL CHEM, V269, P2173; SCHURIG V, 1981, AM J MED GENET, V9, P43, DOI 10.1002/ajmg.1320090109; Tacken PJ, 2000, J LIPID RES, V41, P2055; Takahashi Sadao, 2004, J Atheroscler Thromb, V11, P200; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5	22	160	168	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2005	77	3					477	483		10.1086/444400	http://dx.doi.org/10.1086/444400			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	956QE	16080122	Green Published, Bronze			2022-12-18	WOS:000231314100013
J	Rybicki, BA; Walewski, JL; Maliarik, MJ; Kian, H; Iannuzzi, MC				Rybicki, BA; Walewski, JL; Maliarik, MJ; Kian, H; Iannuzzi, MC		Access Research Grp	The BTNL2 gene and sarcoidosis susceptibility in African Americans and whites	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISEQUILIBRIUM; HAPLOTYPES; PATTERNS; ALLELES; LINKAGE; REGION; HLA	The BTNL2 gene is a member of the B7 receptor family that probably functions as a T-cell costimulatory molecule. It resides in the class II major histocompatibility complex (MHC) region of chromosome 6p and has recently been associated with sarcoidosis susceptibility in a white German population. We sought to replicate the BTNL2 association in an African American family-based study population (n=219 nuclear families) and two case-control populations-one African American (n=295 pairs) and one white (n=366 pairs). Ten SNPs were detected within a 490- bp region spanning exon/ intron 5 of BTNL2. Haplotype variation within this region was significantly associated with sarcoidosis in all three study populations but more so in whites (P=.0006) than in the African American case-control (P=.02 ) or family-based (P=.03) samples. The previously reported BTNL2 SNP with the strongest sarcoidosis association, rs2076530, was also the SNP with the strongest association in our white population (P=.0001). The A allele of rs2076530 results in a premature exon-splice site and increases risk for sarcoidosis (odds ratio = 2.03; 95% confidence interval 1.32-3.12). Although rs2076530 was not associated with sarcoidosis in either African American sample, a three-locus haplotype that included rs2076530 was associated with sarcoidosis across all three study samples. Multivariable logistic regression analyses showed that BTNL2 effects are independent of human leukocyte antigen class II genes in whites but may interact antagonistically in African Americans. Our results underscore the complexity of genetic risk for sarcoidosis emanating from the MHC region.	Mt Sinai Med Ctr, Div Pulm Crit Care & Sleep Med, New York, NY 10029 USA; Henry Ford Hlth Syst, Dept Biostat & Res Epidemiol, Detroit, MI USA	Icahn School of Medicine at Mount Sinai; Henry Ford Health System; Henry Ford Hospital	Iannuzzi, MC (corresponding author), Mt Sinai Med Ctr, Div Pulm Crit Care & Sleep Med, 1 Gustave Levy Pl,Box 1232, New York, NY 10029 USA.	Michael.Iannuzzi@mssm.edu	Rybicki, Benjamin/L-4614-2019	Rybicki, Benjamin/0000-0003-3190-3467	DIVISION OF LUNG DISEASES [N01HR056066, N01HR056071, N01HR056070, N01HR056075, N01HR056073, N01HR056068, N01HR056072, N01HR056065, N01HR056074, N01HR056067, N01HR056069] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000051] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054306, U01HL060263] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR000051, MO1 RR00051] Funding Source: Medline; NHLBI NIH HHS [N01-HR-56068, N01-HR-56074, U01 HL060263, N01-HR-56071, N01-HR-56067, N01-HR-56073, U01-HL060263, N01-HR-56066, R01-HL54306, N01-HR-56075, N01-HR-56070, N01-HR-56069, N01-HR-56072, N01-HR-56065] Funding Source: Medline	DIVISION OF LUNG DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1999, Am J Respir Crit Care Med, V160, P736; Baughman RP, 2001, AM J RESP CRIT CARE, V164, P1885, DOI 10.1164/ajrccm.164.10.2104046; Baughman RP, 1999, J CLIN EPIDEMIOL, V52, P1173; Cao K, 2004, TISSUE ANTIGENS, V63, P293, DOI 10.1111/j.0001-2815.2004.00192.x; Cullen M, 2002, AM J HUM GENET, V71, P759, DOI 10.1086/342973; Epstein MP, 2003, AM J HUM GENET, V73, P1316, DOI 10.1086/380204; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Garcia-Closas M, 1999, AM J EPIDEMIOL, V149, P689; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; HEDRICK PW, 1987, GENETICS, V117, P331; Horvath S, 2004, GENET EPIDEMIOL, V26, P61, DOI 10.1002/gepi.10295; Iannuzzi MC, 2003, AM J RESP CRIT CARE, V167, P1225, DOI 10.1164/rccm.200209-1097OC; Just JJ, 1997, TISSUE ANTIGENS, V49, P546, DOI 10.1111/j.1399-0039.1997.tb02801.x; Krinzman SJ, 1996, J CLIN INVEST, V98, P2693, DOI 10.1172/JCI119093; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Lazarus R, 2002, IMMUNOL REV, V190, P9, DOI 10.1034/j.1600-065X.2002.19002.x; LEWONTIN RC, 1964, GENETICS, V49, P49; Martinetti M, 2002, SARCOIDOSIS VASC DIF, V19, P83; Rhodes DA, 2001, GENOMICS, V71, P351, DOI 10.1006/geno.2000.6406; Rossman MD, 2003, AM J HUM GENET, V73, P720, DOI 10.1086/378097; Rybicki BA, 2004, EUR RESPIR J, V24, P251, DOI 10.1183/09031936.04.00005904; Rybicki BA, 2003, AM J RESP CRIT CARE, V167, P444, DOI 10.1164/rccm.2112060; Sato H, 2002, AM J RESP CELL MOL, V27, P406, DOI 10.1165/rcmb.4782; Schurmann M, 2001, AM J RESP CRIT CARE, V164, P840, DOI 10.1164/ajrccm.164.5.2007056; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Stenzel A, 2004, HUM GENET, V114, P377, DOI 10.1007/s00439-003-1075-5; Valentonyte R, 2005, NAT GENET, V37, P357, DOI 10.1038/ng1519; Walsh EC, 2003, AM J HUM GENET, V73, P580, DOI 10.1086/378101	29	160	166	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2005	77	3					491	499		10.1086/444435	http://dx.doi.org/10.1086/444435			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	956QE	16080124	Bronze, Green Published			2022-12-18	WOS:000231314100015
J	Tomer, Y; Ban, Y; Concepcion, E; Barbesino, G; Villanueva, R; Greenberg, DA; Davies, TF				Tomer, Y; Ban, Y; Concepcion, E; Barbesino, G; Villanueva, R; Greenberg, DA; Davies, TF			Common and unique susceptibility loci in Graves and Hashimoto diseases: Results of whole-genome screening in a data set of 102 multiplex families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTOIMMUNE THYROID-DISEASE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; DEPENDENT DIABETES-MELLITUS; LINKAGE ANALYSIS; DOMINANT TRANSMISSION; GENETIC-HETEROGENEITY; DEGREE RELATIVES; WHICKHAM SURVEY; COMPLEX TRAITS; DETECT LINKAGE	The autoimmune thyroid diseases (AITDs), comprising Graves disease (GD) and Hashimoto thyroiditis (HT), develop as a result of a complex interaction between predisposing genes and environmental triggers. Previously, we identified six loci that showed evidence for linkage with AITD in a data set of 56 multiplex families. The goals of the present study were to replicate/reject the previously identified loci before fine mapping and sequencing the candidate genes in these regions. We performed a whole-genome linkage study in an expanded data set of 102 multiplex families with AITD (540 individuals), through use of 400 microsatellite markers. Seven loci showed evidence for linkage to AITD. Three loci, on chromosomes 6p, 8q, and 10q, showed evidence for linkage with both GD and HT (maximum multipoint heterogeneity LOD scores [HLOD] 2.0, 3.5, and 4.1, respectively). Three loci showed evidence for linkage with GD: on 7q (HLOD 2.3), 14q (HLOD 2.1), and 20q (LOD 3.3, in a subset of the families). One locus on 12q showed evidence of linkage with HT, giving an HLOD of 3.4. Comparison with the results obtained in the original data set showed that the 20q (GD-2) and 12q (HT-2) loci continued to show evidence for linkage in the expanded data set; the 6p and 14q loci were located within the same region as the previously identified 6p and 14q loci (AITD-1 and GD-1, respectively), but the Xq (GD-3) and 13q (HT-1) loci were not replicated in the expanded data set. These results demonstrated that multiple genes may predispose to GD and HT and that some may be common to both diseases and some are unique. The loci that continue to show evidence for linkage in the expanded data set represent serious candidate regions for gene identification.	CUNY Mt Sinai Sch Med, Dept Med, Div Endocrinol Diabet & Bone Dis, New York, NY 10029 USA; Columbia Univ, Div Stat Genet, New York, NY USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Columbia University	Tomer, Y (corresponding author), Mt Sinai Med Ctr, Div Endocrinol & Metab, Box 1055,1 Gustave L Levy Pl, New York, NY 10029 USA.	Yaron.Tomer@mssm.edu	Tomer, Yaron/GWU-8933-2022		NIDDK NIH HHS [DK35764, DK31775, DK61659, R01 DK073681, DK52464, R01 DK052464, R01 DK061659, DK45011, DK58072, R01 DK031775] Funding Source: Medline; NIMH NIH HHS [R01 MH048858, MH48858] Funding Source: Medline; NINDS NIH HHS [NS27941, R01 NS027941] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031775, R01DK061659, R01DK035764, R01DK045011, R01DK052464, R01DK073681, R03DK058072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH048858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027941] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHO K, 1983, ACTA ENDOCRINOL-COP, V102, P11; Alkhateeb A, 2002, HUM MOL GENET, V11, P661, DOI 10.1093/hmg/11.6.661; Ban Y, 2002, CLIN ENDOCRINOL, V57, P81, DOI 10.1046/j.1365-2265.2002.01566.x; Barbesino G, 1998, J CLIN ENDOCR METAB, V83, P1580, DOI 10.1210/jc.83.5.1580; BODE HH, 1973, J CLIN ENDOCR METAB, V37, P692, DOI 10.1210/jcem-37-5-692; Brix TH, 2000, J CLIN ENDOCR METAB, V85, P536, DOI 10.1210/jc.85.2.536; Brix TH, 2001, J CLIN ENDOCR METAB, V86, P930, DOI 10.1210/jc.86.2.930; BUREK CL, 1982, CLIN IMMUNOL IMMUNOP, V25, P395, DOI 10.1016/0090-1229(82)90204-5; Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; Davies T.F., 2000, WERNER INGBARS THYRO, P518; Delepine M, 1997, AM J HUM GENET, V60, P174; Durner M, 1996, HUM HERED, V46, P265, DOI 10.1159/000154363; Durner M, 2001, ANN NEUROL, V49, P328, DOI 10.1002/ana.69.abs; FARID NR, 1980, CLIN ENDOCRINOL, V13, P535, DOI 10.1111/j.1365-2265.1980.tb03421.x; Gaffney PM, 1998, P NATL ACAD SCI USA, V95, P14875, DOI 10.1073/pnas.95.25.14875; GRAY RS, 1983, Q J MED, V52, P244; GREENBERG DA, 1989, AM J MED GENET, V34, P480, DOI 10.1002/ajmg.1320340406; Greenberg DA, 1998, AM J HUM GENET, V63, P870, DOI 10.1086/301997; HALL R, 1972, CLIN GENET, V3, P319; HASHIMOTO L, 1994, NATURE, V371, P161, DOI 10.1038/371161a0; HAWKINS BR, 1985, ACTA ENDOCRINOL-COP, V110, P66, DOI 10.1530/acta.0.1100066; Hodge SE, 1997, AM J HUM GENET, V60, P217; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Imrie H, 2001, J CLIN ENDOCR METAB, V86, P626, DOI 10.1210/jc.86.2.626; Jacobson DL, 1997, CLIN IMMUNOL IMMUNOP, V84, P223, DOI 10.1006/clin.1997.4412; Kordonouri O, 2002, DIABETES CARE, V25, P1346, DOI 10.2337/diacare.25.8.1346; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LUO DF, 1995, AM J HUM GENET, V57, P911; Luo DF, 1996, HUM MOL GENET, V5, P693, DOI 10.1093/hmg/5.5.693; MATHER BA, 1980, CLIN ENDOCRINOL, V12, P155, DOI 10.1111/j.1365-2265.1980.tb02130.x; MILLER FW, 1987, ARTHRITIS RHEUM-US, V30, P1124, DOI 10.1002/art.1780301006; MORTON NE, 1956, AM J HUM GENET, V8, P80; Ott J, 1996, NATURE, V379, P772, DOI 10.1038/379772a0; OTT J, 1976, AM J HUM GENET, V28, P528; Ott J, 1999, ANAL HUMAN GENETIC L; Pal DK, 2002, HUM HERED, V53, P216, DOI 10.1159/000066195; Pearce SHS, 1999, AM J HUM GENET, V65, P1462, DOI 10.1086/302610; PHILLIPS D, 1990, J CLIN ENDOCR METAB, V70, P742, DOI 10.1210/jcem-70-3-742; Sakai K, 2001, HUM MOL GENET, V10, P1379, DOI 10.1093/hmg/10.13.1379; Schilham MW, 1997, EUR J IMMUNOL, V27, P1292, DOI 10.1002/eji.1830270534; SHIELDS DC, 1994, AM J HUM GENET, V55, P540; STENSZKY V, 1985, J CLIN ENDOCR METAB, V61, P735, DOI 10.1210/jcem-61-4-735; Tomer Y, 1999, J CLIN ENDOCR METAB, V84, P4656, DOI 10.1210/jc.84.12.4656; Tomer Y, 1997, TRENDS ENDOCRIN MET, V8, P63, DOI 10.1016/S1043-2760(96)00266-4; TOMER Y, 1993, ENDOCR REV, V14, P107, DOI 10.1210/er.14.1.107; Tomer Y, 2002, THYROID, V12, P1129, DOI 10.1089/105072502321085234; Tomer Y, 1998, AM J HUM GENET, V63, P1749, DOI 10.1086/302146; Tomer Y, 2002, J CLIN ENDOCR METAB, V87, P404, DOI 10.1210/jc.87.1.404; Tomer Y, 2001, J CLIN ENDOCR METAB, V86, P1687, DOI 10.1210/jc.86.4.1687; TOMER Y, 2002, GENETICS ENDOCRINOLO, P137; TUNBRIDGE WMG, 1977, CLIN ENDOCRINOL, V7, P481, DOI 10.1111/j.1365-2265.1977.tb01340.x; Vaidya B, 2000, AM J HUM GENET, V66, P1710, DOI 10.1086/302908; Vaidya B, 1999, HUM MOL GENET, V8, P1195, DOI 10.1093/hmg/8.7.1195; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; Vieland VJ, 2001, HUM HERED, V51, P199, DOI 10.1159/000053343; Villanueva R, 2000, THYROID, V10, P791, DOI 10.1089/thy.2000.10.791; VOLPE R, 1985, AUTOIMMUNITY ENDOCRI, P109; Vyse TJ, 1997, J IMMUNOL, V158, P5566; Vyse TJ, 1996, CELL, V85, P311, DOI 10.1016/S0092-8674(00)81110-1; Weetman Anthony P., 1996, P738; WEETMAN AP, 1987, BRIT J RHEUMATOL, V26, P359; YANAGAWA T, 1995, J CLIN ENDOCR METAB, V80, P41, DOI 10.1210/jcem.80.1.7829637; Zamani M, 2000, AM J MED GENET, V95, P432, DOI 10.1002/1096-8628(20001218)95:5<432::AID-AJMG5>3.0.CO;2-7	65	160	167	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2003	73	4					736	747		10.1086/378588	http://dx.doi.org/10.1086/378588			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	727TL	12973666	Green Published, Bronze			2022-12-18	WOS:000185676100003
J	Zollino, M; Lecce, R; Fischetto, R; Murdolo, M; Faravelli, F; Selicorni, A; Butte, C; Memo, L; Capovilla, G; Neri, G				Zollino, M; Lecce, R; Fischetto, R; Murdolo, M; Faravelli, F; Selicorni, A; Butte, C; Memo, L; Capovilla, G; Neri, G			Mapping the Wolf-Hirschhorn syndrome phenotype outside the currently accepted WHS critical region and defining a new critical region, WHSCR-2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ROGERS-DANKS-SYNDROME; DELETION; GENE; MAP; MICRODELETION; DUPLICATION; 4P16.3	In an attempt to define the distinctive Wolf-Hirschhorn syndrome (WHS) phenotype, and to map its specific clinical manifestations, a total of eight patients carrying a 4p16.3 microdeletion were analyzed for their clinical phenotype and their respective genotypes. The extent of each individual deletion was established by fluorescence in situ hybridization, with a cosmid contig spanning the genomic region from MSX1 (distal half of 4p16.1) to the subtelomeric locus D4S3359. The deletions were 1.9-3.5 Mb, and all were terminal. All the patients presented with a mild phenotype, in which major malformations were usually absent. It is worth noting that head circumference was normal for height in two patients (those with the smallest deletions [1.9 and 2.2 Mb]). The currently accepted WHS critical region (WHSCR) was fully preserved in the patient with the 1.9-Mb deletion, in spite of a typical WHS phenotype. The deletion in this patient spanned the chromosome region from D4S3327 (190 b4 cosmid clone included) to the telomere. From a clinical point of view, the distinctive WHS phenotype is defined by the presence of typical facial appearance, mental retardation, growth delay, congenital hypotonia, and seizures. These signs represent the minimal diagnostic criteria for WHS. This basic phenotype maps distal to the currently accepted WHSCR. Here, we propose a new critical region for WHS, and we refer to this region as "WHSCR-2." It falls within a 300-600-kb interval in 4p16.3, between the loci D4S3327 and D4S98-D4S168. Among the candidate genes already described for WHS, LETM1 (leucine zipper/EF-hand-containing transmembrane) is likely to be pathogenetically involved in seizures. On the basis of genotype-phenotype correlation analysis, dividing the WHS phenotype into two distinct clinical entities, a "classical" and a "mild" form, is recommended for the purpose of proper genetic counseling.	Univ Cattolica Sacro Cuore, Ist Genet Med, Fac Med A Gemelli, I-00168 Rome, Italy; Azienda Osped Venere Giovanni XXIII, Div Malattie Metab & Genet, Bari, Italy; Osped Galliera, Genoa, Italy; Univ Milan, Clin Pediat G&D De Marchi, Milan, Italy; Osped Ca Foncello, Unita Osped Patol Neonatale, Treviso, Italy; Azienda Osped Carlo Poma, Serv Osped Neuropsichiatria Infantile, Mantova, Italy; E Medea Assoc Nostra Famiglia, Ist Ricovero & Cura Carattere Sci, Bosisio Parini, Lecco, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Ente Ospedaliero Ospedali Galliera; University of Milan; ULSS 2 Marca TV; Ospedale Ca' Foncello Treviso; Hospital Carlo Poma; IRCCS Eugenio Medea	Zollino, M (corresponding author), Univ Cattolica Sacro Cuore, Ist Genet Med, Fac Med A Gemelli, Lgo F Vito 1, I-00168 Rome, Italy.		Zollino, Marcella/AAC-3891-2022	Zollino, Marcella/0000-0003-4871-9519				BAXENDALE S, 1993, NAT GENET, V4, P181, DOI 10.1038/ng0693-181; Burgess DL, 1997, CELL, V88, P385, DOI 10.1016/S0092-8674(00)81877-2; Clemens M, 1996, AM J MED GENET, V66, P95, DOI 10.1002/(SICI)1096-8628(19961202)66:1<95::AID-AJMG26>3.3.CO;2-5; Endele S, 1999, GENOMICS, V60, P218, DOI 10.1006/geno.1999.5881; ESTABROOKS LL, 1995, AM J MED GENET, V57, P581, DOI 10.1002/ajmg.1320570413; Fang YY, 1997, AM J MED GENET, V71, P453, DOI 10.1002/(SICI)1096-8628(19970905)71:4<453::AID-AJMG15>3.3.CO;2-0; GANDELMAN KY, 1992, AM J HUM GENET, V51, P571; JOHNSON VP, 1994, AM J MED GENET, V52, P70, DOI 10.1002/ajmg.1320520114; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; LindemanKusse MC, 1996, AM J MED GENET, V66, P104, DOI 10.1002/(SICI)1096-8628(19961202)66:1<104::AID-AJMG28>3.0.CO;2-V; Partington MW, 1997, J MED GENET, V34, P719, DOI 10.1136/jmg.34.9.719; Rauch A, 2001, AM J MED GENET, V99, P338, DOI 10.1002/ajmg.1203; SGRO V, 1995, EPILEPSIA, V36, P1206, DOI 10.1111/j.1528-1157.1995.tb01064.x; Somer M., 1995, American Journal of Human Genetics, V57, pA127; Stec I, 1998, HUM MOL GENET, V7, P1071, DOI 10.1093/hmg/7.7.1071; Wieczorek D, 2000, EUR J HUM GENET, V8, P519, DOI 10.1038/sj.ejhg.5200498; WILSON MG, 1981, HUM GENET, V59, P297, DOI 10.1007/BF00295461; Wright TJ, 1997, HUM MOL GENET, V6, P317, DOI 10.1093/hmg/6.2.317; Wright TJ, 1999, GENOMICS, V59, P203, DOI 10.1006/geno.1999.5871; WRIGHT TJ, 1996, P 4 INT WORKSH HUM C; Zollino M, 1999, AM J MED GENET, V82, P371; Zollino M, 2000, AM J MED GENET, V94, P254, DOI 10.1002/1096-8628(20000918)94:3<254::AID-AJMG13>3.0.CO;2-7	22	160	173	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2003	72	3					590	597		10.1086/367925	http://dx.doi.org/10.1086/367925			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	648LJ	12563561	Green Published, Bronze			2022-12-18	WOS:000181152600009
J	Siguroardottir, S; Helgason, A; Gulcher, JR; Stefansson, K; Donnelly, P				Siguroardottir, S; Helgason, A; Gulcher, JR; Stefansson, K; Donnelly, P			The mutation rate in the human mtDNA control region	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; POINT MUTATIONS; LINEAGES; HETEROGENEITY; SUBSTITUTION; PATTERN	The mutation rate of the mitochondrial control region has been widely used to calibrate human population history. However, estimates of the mutation rate in this region have spanned two orders of magnitude. To readdress this rate, we sequenced the mtDNA control region in 272 individuals, who were related by a total of 705 mtDNA transmission events, from 26 large Icelandic pedigrees. Three base substitutions were observed, and the mutation rate across the two hypervariable regions was estimated to be 3/705 = .0043 per generation (95% confidence interval [CI] .00088-.013), or .32/site/1 million years (95% CI.065-.97). This study is substantially larger than others published, which have directly assessed mtDNA mutation rates on the basis of pedigrees, and the estimated mutation rate is intermediate among those derived from pedigree-based studies. Our estimated rate remains higher than those based on phylogenetic comparisons. We discuss possible reasons for-and consequences of-this discrepancy. The present study also provides information on rates of insertion/deletion mutations, rates of heteroplasmy, and the reliability of maternal links in the Icelandic genealogy database.	deCode Genet Inc, IS-110 Reykjavik, Iceland; Univ Oxford, Dept Stat, Oxford OX1 3TG, England	University of Oxford	Stefansson, K (corresponding author), deCode Genet Inc, Lynghals 1, IS-110 Reykjavik, Iceland.		Stefansson, Kari/AAE-7187-2019; Helgason, Agnar/K-1522-2015	Helgason, Agnar/0000-0002-8545-3767; Donnelly, Peter/0000-0001-9495-3408				[Anonymous], 1984, AM NAT; Awadalla P, 1999, SCIENCE, V286, P2524, DOI 10.1126/science.286.5449.2524; Bendall KE, 1996, AM J HUM GENET, V59, P1276; Bendall KE, 1997, AM J HUM GENET, V61, P1303, DOI 10.1086/301636; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; DONNELLY P, 1991, STAT SCI, V6, P277; FORSTER P, 1996, THESIS U HAMBURG HAM; Gulcher J, 1998, CLIN CHEM LAB MED, V36, P523, DOI 10.1515/CCLM.1998.089; HAUSWIRTH WW, 1985, NUCLEIC ACIDS RES, V13, P8093, DOI 10.1093/nar/13.22.8093; Helgason A, 2000, AM J HUM GENET, V66, P999, DOI 10.1086/302816; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; Howell N, 1996, AM J HUM GENET, V59, P501; Jazin E, 1998, NAT GENET, V18, P109, DOI 10.1038/ng0298-109; Loewe L, 1997, TRENDS ECOL EVOL, V12, P422, DOI 10.1016/S0169-5347(97)01204-4; Macaulay VA, 1997, AM J HUM GENET, V61, P983; Meyer S, 1999, GENETICS, V152, P1103; Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Parsons TJ, 1997, NAT GENET, V15, P363, DOI 10.1038/ng0497-363; Richards M, 1996, AM J HUM GENET, V59, P185; SAJANTILA A, 1995, GENOME RES, V5, P42, DOI 10.1101/gr.5.1.42; Soodyall H, 1997, AM J PHYS ANTHROPOL, V104, P157, DOI 10.1002/(SICI)1096-8644(199710)104:2<157::AID-AJPA2>3.0.CO;2-W; STONEKING M, 1992, PHILOS T ROY SOC B, V337, P167, DOI 10.1098/rstb.1992.0094; Tremblay M, 2000, AM J HUM GENET, V66, P651, DOI 10.1086/302770; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720	26	160	164	0	35	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2000	66	5					1599	1609		10.1086/302902	http://dx.doi.org/10.1086/302902			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QT	10756141	Green Published, Bronze			2022-12-18	WOS:000088373700014
J	Greenberg, DA; Abreu, P; Hodge, SE				Greenberg, DA; Abreu, P; Hodge, SE			The power to detect linkage in complex disease by means of simple LOD-score analyses	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECOMBINATION FRACTION; 2-LOCUS MODELS; INFERRING MODE; LOCUS; INHERITANCE; TRAITS; LIKELIHOOD; PENETRANCE	Maximum-likelihood analysis (via LOD score) provides the most powerful method for finding linkage when the mode of inheritance (MOI) is known. However, because one must assume an MOI, the application of LOD-score analysis to complex disease has been questioned. Although it is known that one can legitimately maximize the maximum LOD score with respect to genetic parameters, this approach raises three concerns: (1) multiple testing, (2) effect on power to detect linkage, and (3) adequacy of the approximate MOI for the true MOI. We evaluated the power of LOD scores to detect linkage when the true MOI was complex but a LOD score analysis assumed simple models. We simulated data from 14 different genetic models, including dominant and recessive at high (80%) and low (20%) penetrances, intermediate models, and several additive two-locus models. We calculated LOD scores by assuming two simple models, dominant and recessive, each with 50% penetrance, then took the higher of the two LOD scores as the raw test statistic and corrected for multiple tests. We call this test statistic "MMLS-C." We found that the ELODs for MMLS-C are greater than or equal to 80% of the ELOD under the true model when the ELOD for the true model is greater than or equal to 3. Similarly, the power to reach a given LOD score was usually greater than or equal to 80% that of the true model, when the power under the true model was greater than or equal to 60%. These results underscore that a critical factor in LOD-score analysis is the MOI at the linked locus, not that of the disease or trait per se. Thus, a limited set of simple genetic models in LOD-score analysis can work well in testing for linkage.	Mt Sinai Med Ctr, Dept Psychiat, New York, NY 10029 USA; Mt Sinai Med Ctr, Dept Biomath, New York, NY 10029 USA; Columbia Univ, Sch Publ Hlth, Div Biostat, New York, NY 10032 USA; New York State Psychiat Inst, Div Clin Genet Epidemiol, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Columbia University; New York State Psychiatry Institute; Columbia University	Greenberg, DA (corresponding author), Mt Sinai Med Ctr, Dept Psychiat, Box 1229,1 Gustave Levy Pl, New York, NY 10029 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH048858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027941] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK31775] Funding Source: Medline; NIMH NIH HHS [MH48858] Funding Source: Medline; NINDS NIH HHS [NS27941] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; CLERGETDARPOUX F, 1992, ANN HUM GENET, V56, P145, DOI 10.1111/j.1469-1809.1992.tb01140.x; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; Dizier MH, 1996, AM J HUM GENET, V58, P1338; Durner M, 1997, AM J HUM GENET, V61, pA274; ELSTON RC, 1989, AM J MED GENET, V34, P487, DOI 10.1002/ajmg.1320340407; GOLDIN LR, 1993, AM J HUM GENET, V53, P908; Greenberg DA, 1996, AM J HUM GENET, V58, P892; GREENBERG DA, 1989, GENET EPIDEMIOL, V6, P259, DOI 10.1002/gepi.1370060145; GREENBERG DA, 1989, AM J MED GENET, V34, P480, DOI 10.1002/ajmg.1320340406; GREENBERG DA, 1990, GENET EPIDEMIOL, V7, P467, DOI 10.1002/gepi.1370070608; Greenberg DA, 1996, GENET EPIDEMIOL, V13, P243; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HODGE SE, 1994, GENET EPIDEMIOL, V11, P329, DOI 10.1002/gepi.1370110403; Hodge SE, 1997, AM J HUM GENET, V60, P217; Hodge SE, 1998, AM J MED GENET, V81, P66, DOI 10.1002/(SICI)1096-8628(19980207)81:1<66::AID-AJMG13>3.3.CO;2-V; KNAPP M, 1994, HUM HERED, V44, P44, DOI 10.1159/000154188; KRUGLYAK L, 1995, AM J HUM GENET, V56, P1212; Lathrop G. M., 1990, AM J HUM GENET S, V47, pA188; Leder RO, 1998, HUM HERED, V48, P198, DOI 10.1159/000022802; OTT J, 1974, AM J HUM GENET, V26, P588; SUAREZ BK, 1984, AM J MED GENET, V18, P135, DOI 10.1002/ajmg.1320180117; VIELAND VJ, 1992, GENET EPIDEMIOL, V9, P45, DOI 10.1002/gepi.1370090106; WEEKS DE, 1988, AM J HUM GENET, V42, P315; Whittemore AS, 1996, AM J HUM GENET, V59, P704; WILLIAMSON JA, 1990, GENET EPIDEMIOL, V7, P309, DOI 10.1002/gepi.1370070502	26	160	161	0	3	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1998	63	3					870	879		10.1086/301997	http://dx.doi.org/10.1086/301997			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	119VN	9718328	Green Submitted, hybrid, Green Published			2022-12-18	WOS:000075919000026
J	Bignell, GR; Canzian, F; Shayeghi, M; Stark, M; Shugart, YY; Biggs, P; Mangion, J; Hamoudi, R; Rosenblatt, J; Buu, P; Sun, S; Stoffer, SS; Goldgar, DE; Romeo, G; Houlston, RS; Narod, SA; Stratton, MR; Foulkes, WD				Bignell, GR; Canzian, F; Shayeghi, M; Stark, M; Shugart, YY; Biggs, P; Mangion, J; Hamoudi, R; Rosenblatt, J; Buu, P; Sun, S; Stoffer, SS; Goldgar, DE; Romeo, G; Houlston, RS; Narod, SA; Stratton, MR; Foulkes, WD			Familial nontoxic multinodular thyroid goiter locus maps to chromosome 149 but does not account for familial nonmedullary thyroid cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; CONGENITAL GOITER; CARCINOMA; MUTATIONS	Thyroid goiter is a common condition that is often associated with iodine deficiency. Familial forms of goiter in areas not known to feature iodine deficiency are much less common. We have performed a genomic search on a single large Canadian family with 18 cases of nontoxic multinodular goiter in which 2 individuals also had papillary lesions highly suggestive of papillary carcinoma. A locus on chromosome 14q (MNG1 [multinodular goiter 1]) has been identified, with a maximal two-point LOD score of 3.8 at D14S1030 and a multipoint LOD score of 4.88 at the same marker, defined by D14S1062 (upper boundary) and D14S267 (lower boundary). The gene encoding thyroid-stimulating hormone receptor (TSHR), which is located on chromosome 14q, is outside the linked region. To determine the role of this gene in familial nonmedullary thyroid cancer (NMTC), we studied 37 smaller pedigrees each containing at least two cases of NMTC. Analysis by both parametric and nonparametric methods indicates that only a very small proportion of familial NMTC (point estimate 0.001, support intervals 0 - .6 under a dominant model) is attributable to MNG1.	MCGILL UNIV,MONTREAL GEN HOSP,DEPT MED,MONTREAL,PQ H3G 1A4,CANADA; MCGILL UNIV,MONTREAL GEN HOSP,DEPT HUMAN GENET,MONTREAL,PQ H3G 1A4,CANADA; SIR MORTIMER B DAVIS JEWISH HOSP,CANC PREVENT RES UNIT,MONTREAL,PQ H3T 1E2,CANADA; OAKLAND INTERNISTS & ASSOCIATES,SOUTHFIELD,MI; UNIV TORONTO,WOMENS COLL HOSP,DEPT MED,TORONTO,ON,CANADA; INT AGCY RES CANC,F-69372 LYON,FRANCE; INST CANC RES,SECT MOL CARCINOGENESIS,SUTTON,SURREY,ENGLAND; INST CANC RES,EPIDEMIOL SECT,SUTTON,SURREY,ENGLAND	McGill University; McGill University; McGill University; University of Toronto; University Toronto Affiliates; Womens College Hospital; World Health Organization; International Agency for Research on Cancer (IARC); University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK			Canzian, Federico/I-2804-2014; Foulkes, William D./AAR-9586-2021; Biggs, Patrick Jon/H-3355-2014; Narod, Steven A/AAA-6112-2022	Foulkes, William D./0000-0001-7427-4651; Biggs, Patrick Jon/0000-0002-0285-4101; Houlston, Richard/0000-0002-5268-0242; Hamoudi, Rifat/0000-0002-1402-0868; Canzian, Federico/0000-0002-4261-4583				AUSTONI M, 1988, LANCET, V1, P1115; Burgess JR, 1997, J CLIN ENDOCR METAB, V82, P345, DOI 10.1210/jc.82.2.345; COOPER DS, 1981, J CLIN ENDOCR METAB, V52, P294, DOI 10.1210/jcem-52-2-294; CORRAL J, 1993, LANCET, V341, P462, DOI 10.1016/0140-6736(93)90209-Y; COUCH RM, 1986, AM J HUM GENET, V39, P811; DEGROOT LJ, 1984, THYROID ITS DISEASES; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Druker HA, 1997, AM J MED GENET, V72, P30, DOI 10.1002/(SICI)1096-8628(19971003)72:1<30::AID-AJMG6>3.0.CO;2-Z; DUPREZ L, 1994, NAT GENET, V7, P396, DOI 10.1038/ng0794-396; GOLDGAR DE, 1994, J NATL CANCER I, V86, P1600, DOI 10.1093/jnci/86.21.1600; GREIG WR, 1967, Q J MED, V36, P175; GROSSMAN RF, 1995, ARCH SURG-CHICAGO, V130, P892; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HOULSTON RS, 1995, QJM-MON J ASSOC PHYS, V88, P685; IEIRI T, 1991, J CLIN INVEST, V88, P1901, DOI 10.1172/JCI115513; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LIAW D, 1997, NAT GENET, V16, P68; Loh KC, 1997, THYROID, V7, P107, DOI 10.1089/thy.1997.7.107; LOTE K, 1980, CANCER, V46, P1291, DOI 10.1002/1097-0142(19800901)46:5<1291::AID-CNCR2820460534>3.0.CO;2-Q; MEDEIROS.GA, 1966, J CLIN ENDOCR METAB, V26, P23, DOI 10.1210/jcem-26-1-23; MORTENSEN JD, 1955, J CLIN ENDOCR METAB, V15, P1270, DOI 10.1210/jcem-15-10-1270; MULLIGAN LM, 1993, NATURE, V363, P458, DOI 10.1038/363458a0; MURRAY IPC, 1966, J CLIN ENDOCR METAB, V26, P1039, DOI 10.1210/jcem-26-10-1039; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; OZAKI O, 1988, WORLD J SURG, V12, P565, DOI 10.1007/BF01655453; PARKIM DM, 1992, CANC INCIDENCE 5 CON; PARMA J, 1993, NATURE, V365, P649, DOI 10.1038/365649a0; PENDRED V, 1896, LANCET, V2, P523; PRESTONMARTIN S, 1987, BRIT J CANCER, V55, P191, DOI 10.1038/bjc.1987.36; RAPOPORT B, 1972, J CLIN ENDOCR METAB, V34, P822, DOI 10.1210/jcem-34-5-822; RON E, 1987, JNCI-J NATL CANCER I, V79, P1; STOFFER SS, 1986, AM J MED GENET, V25, P775, DOI 10.1002/ajmg.1320250415; TUNBRIDGE WMG, 1977, CLIN ENDOCRINOL, V7, P481, DOI 10.1111/j.1365-2265.1977.tb01340.x; VANDER JB, 1954, NEW ENGL J MED, V251, P970, DOI 10.1056/NEJM195412092512403	35	160	160	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1997	61	5					1123	1130		10.1086/301610	http://dx.doi.org/10.1086/301610			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YH017	9345104	Green Published, Bronze			2022-12-18	WOS:A1997YH01700018
J	deVries, BBA; vandenOuweland, AMW; Mohkamsing, S; Duivenvoorden, HJ; Mol, E; Gelsema, K; vanRijn, M; Halley, DJJ; Sandkuijl, LA; Oostra, BA; Tibben, A; Niermeijer, MF				deVries, BBA; vandenOuweland, AMW; Mohkamsing, S; Duivenvoorden, HJ; Mol, E; Gelsema, K; vanRijn, M; Halley, DJJ; Sandkuijl, LA; Oostra, BA; Tibben, A; Niermeijer, MF			Screening and diagnosis for the fragile X syndrome among the mentally retarded: An epidemiological and psychological survey	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MARTIN-BELL SYNDROME; FMR-1 GENE; LEARNING-DIFFICULTIES; CGG REPEAT; POPULATION; DNA; INSTABILITY; METHYLATION; PREVALENCE; REGION	The fragile X syndrome is an X-linked mental retardation disorder caused by an expanded CGG repeat in the first exon of the fragile X mental retardation (FMR1) gene. Its frequency, X-linked inheritance, and consequences for relatives all prompt for diagnosis of this disorder on a large scale in all affected individuals. A screening for the fragile X syndrome has been conducted in a representative sample of 3,352 individuals in schools and institutes for the mentally retarded in the southwestern Netherlands, by use of a brief physical examination and the DNA test. The attitudes and reactions of (non)consenting parents/guardians were studied by (pre-and posttest) questionnaires. A total of 2,189 individuals (65%) were eligible for testing, since they had no valid diagnosis, cerebral palsy, or a previous test for the FMR1 gene mutation. Seventy percent (1,531/2,189) of the: parents/guardians consented to testing. Besides 32 previously diagnosed fragile)( patients, 11 new patients (9 males and 2 females) were diagnosed. Scoring of physical features was effective in preselection, especially for males (sensitivity .91 and specificity .92). Major motives to participate in the screening were the wish to obtain a diagnosis (82%), the hereditary implications (80%), and the support of research into mental retardation (81%). Thirty-four percent of the parents/guardians will seek additional diagnostic workup after exclusion of the fragile X syndrome. The prevalence of the fragile X syndrome was estimated at 1/6,045 for males (95% confidence interval 1/9,981-1/3,851). On the basis of the actual number of diagnosed cases in the Netherlands, it is estimated that >50% of the fragile X cases are undiagnosed at present.	UNIV HOSP DIJKZIGT,DEPT CLIN GENET,NL-3015 GD ROTTERDAM,NETHERLANDS; UNIV HOSP DIJKZIGT,DEPT MED PSYCHOL & PSYCHOTHERAPY,NL-3015 GD ROTTERDAM,NETHERLANDS	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	deVries, BBA (corresponding author), ERASMUS UNIV ROTTERDAM,DEPT CLIN GENET,POB 1738,NL-3000 DR ROTTERDAM,NETHERLANDS.		Tibben, Aad/A-9540-2008	Tibben, Aad/0000-0002-4560-1710				*AM COLL MED GEN, 1994, AM J MED GENET, V53, P380; BONTHRON D, 1993, LANCET, V341, P769, DOI 10.1016/0140-6736(93)90552-R; BUNDEY S, 1993, LANCET, V3451, P770; CRAFT N, 1995, BRIT MED J, V310, P148, DOI 10.1136/bmj.310.6973.148a; FRYNS JP, 1989, FRAGILE X SYNDROME, P1; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; HAGERMAN RJ, 1994, AM J MED GENET, V51, P474, DOI 10.1002/ajmg.1320510436; HAGERMAN RJ, 1996, FRAGILE X SYNDROME D, P3; HOWARDPEEBLES PN, 1993, LANCET, V341, P770; JACOBS PA, 1993, J MED GENET, V30, P454, DOI 10.1136/jmg.30.6.454; LAING S, 1991, AM J MED GENET, V38, P256, DOI 10.1002/ajmg.1320380219; LAXOVA R, 1995, AM J MED GENET, V57, P508, DOI 10.1002/ajmg.1320570335; MAAS JMA, 1988, FREQUENTIE ONDERZOEK; MCKUSICK VA, 1995, MENDELIAN INHERITANC; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Murray A, 1996, HUM MOL GENET, V5, P727, DOI 10.1093/hmg/5.6.727; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; OOSTRA BA, 1993, J MED GENET, V30, P410, DOI 10.1136/jmg.30.5.410; PALOMAKI GE, 1993, LANCET, V341, P373, DOI 10.1016/0140-6736(93)90176-H; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; ROUSSEAU F, 1995, AM J HUM GENET, V57, P1006; SLANEY SF, 1995, ARCH DIS CHILD, V72, P33, DOI 10.1136/adc.72.1.33; *STAT NETH, 1995, STAT YB NETH 1995; STEELE J, 1995, AM J MENT RETARD, V99, P664; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; Sutherland G, 1985, FRAGILE SITES HUMAN; TURNER G, 1986, NEW ENGL J MED, V315, P607, DOI 10.1056/NEJM198609043151002; TURNER G, 1992, LANCET, V339, P1210, DOI 10.1016/0140-6736(92)91142-U; Turner G, 1996, AM J MED GENET, V64, P196, DOI 10.1002/(SICI)1096-8628(19960712)64:1<196::AID-AJMG35>3.0.CO;2-G; VANDENOUWELAND AMW, 1994, AM J MED GENET, V51, P482, DOI 10.1002/ajmg.1320510437; VERHEIJ C, 1993, NATURE, V363, P722, DOI 10.1038/363722a0; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WEBB TP, 1986, AM J MED GENET, V23, P573, DOI 10.1002/ajmg.1320230151; WILLEMSEN R, 1995, LANCET, V345, P1147, DOI 10.1016/S0140-6736(95)90979-6; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179	35	160	164	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1997	61	3					660	667		10.1086/515496	http://dx.doi.org/10.1086/515496			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XY523	9326332	Green Published, Bronze			2022-12-18	WOS:A1997XY52300024
J	FULKER, DW; CHERNY, SS; CARDON, LR				FULKER, DW; CHERNY, SS; CARDON, LR			MULTIPOINT INTERVAL MAPPING OF QUANTITATIVE TRAIT LOCI, USING SIB PAIRS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE	The sib-pair interval-mapping procedure of Fulker and Cardon is extended to take account of all available marker information on a chromosome simultaneously. The method provides a computationally fast multipoint analysis of sib-pair data, using a modified Haseman-Elston approach. It gives results very similar to those of the earlier interval-mapping procedure when marker information is relatively uniform and a coarse map is used. However, there is a substantial improvement over the original method when markers differ in information content and/or when a dense map is employed. The method is illustrated by using simulated sib-pair data.	STANFORD UNIV,DEPT MATH,STANFORD,CA 94305; SRI INT,HLTH SCI SECT,MENLO PK,CA 94025	Stanford University; SRI International	FULKER, DW (corresponding author), UNIV COLORADO,INST BEHAV GENET,BOX 447,BOULDER,CO 80309, USA.		Cherny, Stacey S/B-3315-2008	Cherny, Stacey S/0000-0002-0269-3352	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD027802] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD011681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH043899] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-11681, HD-27802] Funding Source: Medline; NIMH NIH HHS [MH-43899] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		CARDON LR, 1994, AM J HUM GENET, V55, P825; CARDON LR, 1994, SCIENCE, V265, P276; COHEN J., 1983, APPL MULTIPLE REGRES, V2; ELSTON R C, 1985, Genetic Epidemiology, V2, P211, DOI 10.1002/gepi.1370020217; FULKER DW, 1994, AM J HUM GENET, V54, P1092; FULKER DW, 1994, ALCOHOL CLIN EXP RES, V18, P452; GOLDGAR DE, 1990, AM J HUM GENET, V47, P957; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; LANDER ES, 1989, GENETICS, V121, P185; SCHORK NJ, 1993, AM J HUM GENET, V53, P1127; TANKSLEY SD, 1993, ANNU REV GENET, V27, P205, DOI 10.1146/annurev.ge.27.120193.001225; TRAN LD, 1989, SAGE STATISTICAL ANA	14	160	161	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1995	56	5					1224	1233						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QU586	7726180				2022-12-18	WOS:A1995QU58600027
J	FREBOURG, T; BARBIER, N; YAN, YX; GARBER, JE; DREYFUS, M; FRAUMENI, J; LI, FP; FRIEND, SH				FREBOURG, T; BARBIER, N; YAN, YX; GARBER, JE; DREYFUS, M; FRAUMENI, J; LI, FP; FRIEND, SH			GERM-LINE P53 MUTATIONS IN 15 FAMILIES WITH LI-FRAUMENI SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CANCER-PRONE FAMILY; BREAST-CANCER; SPLICING MUTATION; GENE; PROTEIN; PATIENT; PEDIGREE; TUMORS; SITE	Germ-line mutations of the tumor-suppressor gene p53 have been observed in some families with the Li-Fraumeni syndrome (LFS), a familial cancer syndrome in which affected relatives develop a diverse set of early-onset malignancies including breast carcinoma, sarcomas, and brain tumors. The analysis of the p53 gene in LFS families has been limited, in most studies to date, to the region between exon 5 and exon 9. In order to determine the frequency and distribution of germ-line p53 mutations in LFS, we sequenced the 10 coding exons of the p53 gene in lymphocytes and fibroblast cell lines derived from 15 families with the syndrome. Germ-line mutations were observed in eight families. Six mutations were missense mutations located between exons 5 and 8. One mutation was a nonsense mutation in exon 6, and one mutation was a splicing mutation in intron 4, generating aberrant shorter p53 RNA(s). In three families, a mutation of the p53 gene was observed in the fibroblast cell line derived from the proband. However, the mutation was not found in affected relatives in two families and in the blood from the one individual, indicating that the mutation probably occurred during cell culture in vitro. In four families, no mutation was observed. This study indicates that germ-line p53 mutations in LFS are mostly located between exons 5 and 8 and that similar to 50% of patients with LFS have no germ-line mutations in the coding region of the p53 gene. The observation of p53 mutations occurring during primary cultures of human fibroblasts shows that analysis for germ-line p53 mutations must be performed on cells that have not been grown in vitro.	MASSACHUSETTS GEN HOSP E,DIV MOLEC GENET,BOSTON,MA; CHILDRENS HOSP,DEPT PEDIAT,DIV HEMATOL ONCOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV CANC EPIDEMIOL & CANC CONTROL,BOSTON,MA 02115; NCI,DIV CANC ETIOL,EPIDEMIOL & BIOSTAT PROGRAM,BETHESDA,MD 20892	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)			Frebourg, Thierry/AAK-8390-2020					BIRCH JM, 1994, CANCER RES, V54, P1298; BORRESEN AL, 1992, CANCER RES, V52, P3234; BRUGIERES L, 1993, CANCER RES, V53, P452; DEFROMENTEL CC, 1992, GENE CHROMOSOME CANC, V4, P1; DILLER L, 1990, MOL CELL BIOL, V10, P5772, DOI 10.1128/MCB.10.11.5772; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; EELES RA, 1993, ONCOGENE, V8, P1269; EELES RA, 1993, EUR J CANCER, V29A, P1361, DOI 10.1016/0959-8049(93)90001-V; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FELIX CA, 1993, ONCOGENE, V8, P1203; FELIX CA, 1992, J CLIN INVEST, V89, P640, DOI 10.1172/JCI115630; FREBOURG T, 1992, CANCER RES, V52, P6976; FREBOURG T, 1992, J CLIN INVEST, V90, P1637, DOI 10.1172/JCI116034; FREBOURG T, 1992, P NATL ACAD SCI USA, V89, P6413, DOI 10.1073/pnas.89.14.6413; FUTREAL PA, 1991, NUCLEIC ACIDS RES, V19, P6977, DOI 10.1093/nar/19.24.6977; HARPER JW, 1993, CELL, V75, P805; HARRIS CC, 1993, NEW ENGL J MED, V329, P1318, DOI 10.1056/NEJM199310283291807; HARVEY DM, 1991, GENE DEV, V5, P2375, DOI 10.1101/gad.5.12b.2375; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; IAVARONE A, 1992, P NATL ACAD SCI USA, V8, P4207; ISHIOKA C, 1993, NAT GENET, V5, P124, DOI 10.1038/ng1093-124; KOVAR H, 1992, ONCOGENE, V7, P2169; KUIVANIEMI H, 1988, J BIOL CHEM, V15, P11407; LAW JC, 1991, CANCER RES, V51, P6385; LEVINE AJ, 1991, NATURE, V35, P453; LI FP, 1988, CANCER RES, V48, P5358; LI FP, 1992, J NATL CANCER I, V84, P1156, DOI 10.1093/jnci/84.15.1156; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MALKIN D, 1992, NEW ENGL J MED, V326, P1309, DOI 10.1056/NEJM199205143262002; MARX J, 1993, SCIENCE, V26, P1385; MCINTYRE JF, 1994, J CLIN ONCOL, V12, P925, DOI 10.1200/JCO.1994.12.5.925; METZGER AK, 1991, P NATL ACAD SCI USA, V88, P7825, DOI 10.1073/pnas.88.17.7825; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P1068, DOI 10.1093/nar/18.4.1068; PRIVES C, 1993, GENE DEV, V7, P529, DOI 10.1101/gad.7.4.529; SAKURABA H, 1992, GENOMICS, V12, P643, DOI 10.1016/0888-7543(92)90288-4; Sambrook J., 1989, MOL CLONING LAB MANU; SAMESHIMA Y, 1992, J NATL CANCER I, V84, P703, DOI 10.1093/jnci/84.9.703; SANTIBANEZKOREF MF, 1991, LANCET, V338, P1490, DOI 10.1016/0140-6736(91)92303-J; SCOTT RJ, 1993, SCHWEIZ MED WOCHENSC, V25, P1287; SHERRAT TG, 1993, AM J HUM GENET, V53, P1007; SIDRANSKY D, 1992, CANCER RES, V52, P2984; SRIVASTAVA S, 1990, NATURE, V348, P747, DOI 10.1038/348747a0; SUN F, 1993, J CLIN INVEST, V92, P1174, DOI 10.1172/JCI116687; TOGUCHIDA J, 1992, NEW ENGL J MED, V326, P1301, DOI 10.1056/NEJM199205143262001; VOGELSTEIN B, 1992, CELL, V70, P523, DOI 10.1016/0092-8674(92)90421-8; WARNEFORD SG, 1992, CELL GROWTH DIFFER, V3, P839; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WEIL D, 1988, J BIOL CHEM, V18, P8561	49	160	170	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1995	56	3					608	615						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QK918	7887414				2022-12-18	WOS:A1995QK91800008
J	ROTIG, A; BESSIS, JL; ROMERO, N; CORMIER, V; SAUDUBRAY, JM; NARCY, P; LENOIR, G; RUSTIN, P; MUNNICH, A				ROTIG, A; BESSIS, JL; ROMERO, N; CORMIER, V; SAUDUBRAY, JM; NARCY, P; LENOIR, G; RUSTIN, P; MUNNICH, A			MATERNALLY INHERITED DUPLICATION OF THE MITOCHONDRIAL GENOME IN A SYNDROME OF PROXIMAL TUBULOPATHY, DIABETES-MELLITUS, AND CEREBELLAR-ATAXIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							KEARNS-SAYRE SYNDROME; C OXIDASE DEFICIENCY; SKELETAL-MUSCLE; DNA; DELETIONS; MUTATION; MYOPATHIES; DISORDER	Two sisters in the first year of life presented with a proximal tubulopathy of unknown etiology. They subsequently developed a pluritissular disorder including diabetes mellitus, skin abnormalities, mitochondrial myopathy with ragged-red fibers, and cerebellar ataxia. Their mother had ptosis, ophthalmoplegia, and muscle weakness. Analysis of the mitochondrial respiratory chain showed a complex III deficiency in both skeletal muscle and lymphocytes of the second girl. Southern blot analysis provided evidence for a heteroplasmic partial duplication of the mtDNA (26 kb), involving one full-length and one partly deleted mitochondrial genome and with one single abnormal junction between the genes for ATPase 6 and cytochrome b. Using PCR amplification of lymphocyte DNA, we were able to detect minute amounts of duplicated molecules in the mother, which provided evidence for maternal inheritance of the partial duplication. While maternal transmission of point mutations have been reported in Leber disease, retinitis pigmentosa, and MERRF disease, this observation is, to our knowledge, the first example of a maternally inherited duplication of the mitochondrial genome in man.	HOP NECKER ENFANTS MALAD,INSERM,U12,UNITE RECH HANDICAPS GENET ENFANT,149 RUE SEVRES,F-75743 PARIS 15,FRANCE; HOP NECKER ENFANTS MALAD,DEPT PEDIAT,F-75743 PARIS 15,FRANCE; INSERM,U153,CTR RECH BIOL & PATHOL NEUROMUSCULAIRES,F-75005 PARIS,FRANCE; HOP LOUIS PASTEUR,CHERBOURG,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)			cormier-daire, valerie/H-6520-2017; ROTIG, AGNES/G-9592-2017	cormier-daire, valerie/0000-0002-2839-9856; ROTIG, AGNES/0000-0003-0589-0703				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; CHRETIEN D, 1990, BIOCHEM BIOPH RES CO, V173, P26, DOI 10.1016/S0006-291X(05)81016-2; CLAYTON DA, 1967, NATURE, V216, P652, DOI 10.1038/216652a0; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; CORMIER V, 1991, AM J HUM GENET, V48, P643; Dujon B., 1989, MOBILE DNA, P861; ERLICH HA, 1988, NATURE, V331, P461, DOI 10.1038/331461a0; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; HOLT IJ, 1990, AM J HUM GENET, V46, P428; HUDSON B, 1967, NATURE, V216, P647, DOI 10.1038/216647a0; LESTIENNE P, 1988, LANCET, V1, P885; MORITZ C, 1987, P NATL ACAD SCI USA, V84, P7183, DOI 10.1073/pnas.84.20.7183; OGIER H, 1988, J PEDIATR-US, V112, P734, DOI 10.1016/S0022-3476(88)80690-5; POULTON J, 1991, AM J HUM GENET, V48, P649; POULTON J, 1989, LANCET, V1, P236; POULTON J, 1989, NUCLEIC ACIDS RES, V17, P10223, DOI 10.1093/nar/17.24.10223; Robinson B.H., 1989, METABOLIC BASIS INHE, P869; ROMERO NB, 1989, J NEUROL SCI, V93, P297, DOI 10.1016/0022-510X(89)90199-8; ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881; ROTIG A, 1991, GENOMICS, V10, P502, DOI 10.1016/0888-7543(91)90342-C; RUSTIN P, 1991, LANCET, V338, P60, DOI 10.1016/0140-6736(91)90057-V; SENGERS RCA, 1984, EUR J PEDIATR, V141, P192, DOI 10.1007/BF00572761; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; ZEVIANI M, 1988, NEUROLOGY, V38, P1339; ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0	27	160	161	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1992	50	2					364	370						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HD001	1531167				2022-12-18	WOS:A1992HD00100012
J	PAULI, RM; LIAN, JB; MOSHER, DF; SUTTIE, JW				PAULI, RM; LIAN, JB; MOSHER, DF; SUTTIE, JW			ASSOCIATION OF CONGENITAL DEFICIENCY OF MULTIPLE VITAMIN-K-DEPENDENT COAGULATION-FACTORS AND THE PHENOTYPE OF THE WARFARIN EMBRYOPATHY - CLUES TO THE MECHANISM OF TERATOGENICITY OF COUMARIN DERIVATIVES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WISCONSIN,DEPT PEDIAT,MADISON,WI 53705; UNIV WISCONSIN,DEPT MED GENET,MADISON,WI 53705; UNIV WISCONSIN,DEPT BIOCHEM,MADISON,WI 53705; UNIV WISCONSIN,DEPT MED,MADISON,WI 53705; UNIV WISCONSIN,DEPT PHYSIOL CHEM,MADISON,WI 53705; HARVARD UNIV,SCH MED,DEPT BIOL CHEM,CAMBRIDGE,MA 02138	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Harvard University					NHLBI NIH HHS [HL-29586] Funding Source: Medline; NIADDK NIH HHS [AM-33920] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM033920] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029586] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BECHTOLD H, 1983, LANCET, V1, P596; BECKER MH, 1975, AM J DIS CHILD, V129, P356, DOI 10.1001/archpedi.1975.02120400056013; BLANCHARD RA, 1981, NEW ENGL J MED, V305, P242, DOI 10.1056/NEJM198107303050502; BLANCHARD RA, 1983, J LAB CLIN MED, V101, P242; BLEYER WA, 1971, J PEDIATR-US, V79, P838, DOI 10.1016/S0022-3476(71)80405-5; CHONG MB, 1984, BRIT J OBSTET GYNAEC, V91, P1070, DOI 10.1111/j.1471-0528.1984.tb15077.x; CHUNG KS, 1979, BLOOD, V53, P776; DAVIE EW, 1975, ANNU REV BIOCHEM, V44, P799; DELMAS PD, 1984, CALCIFIED TISSUE INT, V36, P308, DOI 10.1007/BF02405335; FASCO MJ, 1982, J BIOL CHEM, V257, P1210; FISCHER M, 1966, Z KINDERHEILKD, V95, P309, DOI 10.1007/BF01886321; GALLOP PM, 1980, NEW ENGL J MED, V302, P1460, DOI 10.1056/NEJM198006263022608; GANROT PO, 1968, SCAND J CLIN LAB INV, V22, P23; GOLDSMITH GH, 1982, J CLIN INVEST, V69, P1253, DOI 10.1172/JCI110564; GREER FR, IN PRESS PEDIATRICS; GUNDBERG CM, 1983, CLIN CHIM ACTA, V128, P1, DOI 10.1016/0009-8981(83)90049-9; GUNDBERG CM, 1983, J CLIN ENDOCR METAB, V57, P1221, DOI 10.1210/jcem-57-6-1221; GUNDBERG CM, 1984, METHOD ENZYMOL, V107, P517; HALL JG, 1980, AM J MED, V68, P122, DOI 10.1016/0002-9343(80)90181-3; HAUSCHKA PV, 1978, DEV BIOL, V65, P426, DOI 10.1016/0012-1606(78)90038-6; HAUSCHKA PV, 1975, P NATL ACAD SCI USA, V72, P3925, DOI 10.1073/pnas.72.10.3925; HAUSCHKA PV, 1978, TRENDS BIOCHEM SCI, V3, P75, DOI 10.1016/S0968-0004(78)80002-4; JOHNSON CA, 1980, BRIT J HAEMATOL, V44, P461, DOI 10.1111/j.1365-2141.1980.tb05916.x; Juchau M, 1981, BIOCH BASIS CHEM TER; KORT HI, 1981, S AFR MED J, V60, P578; LAURELL CB, 1972, SCAND J CLIN LAB INV, V29, P21, DOI 10.3109/00365517209102748; LEVY RJ, 1979, CLIN PHARMACOL THER, V25, P562; LIAN JB, 1982, CALCIFIED TISSUE INT, V34, pS82; MCMILLAN CW, 1966, NEW ENGL J MED, V274, P1313, DOI 10.1056/NEJM196606092742309; MELICK RA, 1985, AUST NZ J MED, V15, P410, DOI 10.1111/j.1445-5994.1985.tb02761.x; NEWCOMB T, 1956, AM J MED, V20, P798, DOI 10.1016/0002-9343(56)90163-2; NISHIMOTO SK, 1980, J BIOL CHEM, V255, P6579; OAKLEY C, 1983, BRIT MED J, V286, P1680, DOI 10.1136/bmj.286.6379.1680; ONEILL H, 1982, BRIT J OBSTET GYNAEC, V89, P940, DOI 10.1111/j.1471-0528.1982.tb05062.x; PAULI RM, 1976, J PEDIATR-US, V88, P506, DOI 10.1016/S0022-3476(76)80281-8; PETTIFOR JM, 1975, J PEDIATR-US, V86, P459; PRICE PA, 1980, P NATL ACAD SCI-BIOL, V77, P2234, DOI 10.1073/pnas.77.4.2234; PRICE PA, 1976, P NATL ACAD SCI USA, V73, P1447, DOI 10.1073/pnas.73.5.1447; PRICE PA, 1981, J BIOL CHEM, V256, P2754; PRICE PA, 1983, BIOCHEM BIOPH RES CO, V117, P765, DOI 10.1016/0006-291X(83)91663-7; Riggs B L, 1986, J Bone Miner Res, V1, P539; SHAH DV, 1984, THROMB RES, V35, P451, DOI 10.1016/0049-3848(84)90236-6; SHAH DV, 1978, BIOCHIM BIOPHYS ACTA, V539, P209, DOI 10.1016/0304-4165(78)90007-7; SHAUL WL, 1975, AM J DIS CHILD, V129, P360, DOI 10.1001/archpedi.1975.02120400060014; SHEARER MJ, 1982, LANCET, V2, P460; SHEFFIELD LJ, 1976, J PEDIATR-US, V89, P916, DOI 10.1016/S0022-3476(76)80596-3; SOFF GA, 1981, SEMIN THROMB HEMOST, V7, P112, DOI 10.1055/s-2007-1005073; SUTTIE JW, 1985, ANNU REV BIOCHEM, V54, P459, DOI 10.1146/annurev.bi.54.070185.002331; SUTTIE JW, 1980, ENZYMOLOGY POST TRAN, P213; SUTTIE JW, 1983, NUTRITION HEMATOLOGY, P245; UENO T, 1983, ANAL BIOCHEM, V133, P62, DOI 10.1016/0003-2697(83)90222-1	51	160	167	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1987	41	4					566	583						18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	K4621	3499071				2022-12-18	WOS:A1987K462100006
J	Lange, LA; Hu, YN; Zhang, H; Xue, CY; Schmidt, EM; Tang, ZZ; Bizon, C; Lange, EM; Smith, JD; Turner, EH; Jun, G; Kang, HM; Peloso, G; Auer, P; Li, KP; Flannick, J; Zhang, J; Fuchsberger, C; Gaulton, K; Lindgren, C; Locke, A; Manning, A; Sim, XL; Rivas, MA; Holmen, OL; Gottesman, O; Lu, YC; Ruderfer, D; Stah, EA; Duan, Q; Li, Y; Durda, P; Jiao, S; Isaacs, A; Hofman, A; Bis, JC; Correa, A; Griswold, ME; Jakobsdottir, J; Smith, AV; Schreiner, PJ; Feitosa, ME; Zhang, QY; Huffman, JE; Crosby, J; Wasse, CL; Do, R; Franceschini, N; Martin, LW; Robinson, JG; Assimes, TL; Crosslin, DR; Rosenthal, EA; Tsai, M; Rieder, MJ; Farlow, DN; Folsom, AR; Lumley, T; Fox, ER; Carlson, CS; Peters, U; Jackson, RD; Van Duijn, CM; Uitterlinden, AG; Levy, D; Rotter, JI; Taylor, HA; Gudnason, V; Siscovick, DS; Fornage, M; Borecki, IB; Hayward, C; Rudan, I; Chen, YE; Bottinger, EP; Loos, RJF; Strom, P; Hveem, K; Boehnke, M; Groop, L; McCarthy, M; Meitinger, T; Ballantyne, CM; Gabriel, SB; O'Donne, CJ; Post, WS; North, KE; Reiner, AP; Boerwinkle, E; Psaty, BM; Altshuler, D; Kathiresan, S; Lin, DY; Jarvik, GP; Cupples, LA; Kooperberg, C; Wilson, JG; Nickerson, DA; Abecasis, GR; Rich, SS; Tracy, RP; Willer, CJ				Lange, Leslie A.; Hu, Youna; Zhang, He; Xue, Chenyi; Schmidt, Ellen M.; Tang, Zheng-Zheng; Bizon, Chris; Lange, Ethan M.; Smith, Joshua D.; Turner, Emily H.; Jun, Goo; Kang, Hyun Min; Peloso, Gina; Auer, Paul; Li, Kuo-Ping; Flannick, Jason; Zhang, Ji; Fuchsberger, Christian; Gaulton, Kyle; Lindgren, Cecilia; Locke, Adam; Manning, Alisa; Sim, Xueling; Rivas, Manuel A.; Holmen, Oddgeir L.; Gottesman, Omri; Lu, Yingchang; Ruderfer, Douglas; Stah, Eli A.; Duan, Qing; Li, Yun; Durda, Peter; Jiao, Shuo; Isaacs, Aaron; Hofman, Albert; Bis, Joshua C.; Correa, Adolfo; Griswold, Michael E.; Jakobsdottir, Johanna; Smith, Albert V.; Schreiner, Pamela J.; Feitosa, Mary E.; Zhang, Qunyuan; Huffman, Jennifer E.; Crosby, Jacy; Wasse, Christina L.; Do, Ron; Franceschini, Nora; Martin, Lisa W.; Robinson, Jennifer G.; Assimes, Themistocles L.; Crosslin, David R.; Rosenthal, Elisabeth A.; Tsai, Michael; Rieder, Mark J.; Farlow, Deborah N.; Folsom, Aaron R.; Lumley, Thomas; Fox, Ervin R.; Carlson, Christopher S.; Peters, Ulrike; Jackson, Rebecca D.; Van Duijn, Cornelia M.; Uitterlinden, Andre G.; Levy, Daniel; Rotter, Jerome I.; Taylor, Herman A.; Gudnason, Vilmundur, Jr.; Siscovick, David S.; Fornage, Myriam; Borecki, Ingrid B.; Hayward, Caroline; Rudan, Igor; Chen, Y. Eugene; Bottinger, Erwin P.; Loos, Ruth J. F.; Strom, Pal; Hveem, Kristian; Boehnke, Michael; Groop, Leif; McCarthy, Mark; Meitinger, Thomas; Ballantyne, Christie M.; Gabriel, Stacey B.; O'Donne, Christopher J.; Post, Wendy S.; North, Kari E.; Reiner, Alexander P.; Boerwinkle, Eric; Psaty, Bruce M.; Altshuler, David; Kathiresan, Sekar; Lin, Dan-Yu; Jarvik, Gail P.; Cupples, L. Adrienne; Kooperberg, Charles; Wilson, James G.; Nickerson, Deborah A.; Abecasis, Goncalo R.; Rich, Stephen S.; Tracy, Russell P.; Willer, Cristen J.		NHLBI Grand Opportunity Exome Sequ	Whole-Exome Sequencing Identifies Rare and Low-Frequency Coding Variants Associated with LDL Cholesterol	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DENSITY-LIPOPROTEIN-CHOLESTEROL; HEART-DISEASE; PLASMA; SUSCEPTIBILITY; OBJECTIVES; GENE	Elevated low-density lipoprotein cholesterol (LDL-C) is a treatable, heritable risk factor for cardiovascular disease. Genome-wide association studies (GWASs) have identified 157 variants associated with lipid levels but are not well suited to assess the impact of rare and low-frequency variants. To determine whether rare or low-frequency coding variants are associated with LDL-C, we exome sequenced 2,005 individuals, including 554 individuals selected for extreme LDL-C (>98th or <2nd percentile). Follow-up analyses included sequencing of 1,302 additional individuals and genotype-based analysis of 52,221 individuals. We observed significant evidence of association between LDL-C and the burden of rare or low-frequency variants in PNPLA5, encoding a phospholipase-domain-containing protein, and both known and previously unidentified variants in PCSK9, LDLR and APOB, three known lipid-related genes. The effect sizes for the burden of rare variants for each associated gene were substantially higher than those observed for individual SNPs identified from GWASs. We replicated the PNPLA5 signal in an independent large-scale sequencing study of 2,084 individuals. In conclusion, this large whole-exome-sequencing study for LDL-C identified a gene not known to be implicated in LDL-C and provides unique insight into the design and analysis of similar experiments.	[Lange, Leslie A.; Lange, Ethan M.; Duan, Qing; Li, Yun] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Hu, Youna; Jun, Goo; Kang, Hyun Min; Li, Kuo-Ping; Fuchsberger, Christian; Locke, Adam; Sim, Xueling; Boehnke, Michael; Abecasis, Goncalo R.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Zhang, He; Zhang, Ji; Chen, Y. Eugene; Willer, Cristen J.] Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; [Xue, Chenyi; Schmidt, Ellen M.; Willer, Cristen J.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Tang, Zheng-Zheng; Lange, Ethan M.; Li, Yun; Lin, Dan-Yu] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA; [Bizon, Chris] Renaissance Comp Inst, Chapel Hill, NC 27517 USA; [Smith, Joshua D.; Turner, Emily H.; Rieder, Mark J.; Jarvik, Gail P.; Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Peloso, Gina; Do, Ron; Altshuler, David; Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Peloso, Gina; Manning, Alisa; Do, Ron; Gabriel, Stacey B.; Altshuler, David; Kathiresan, Sekar] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02141 USA; [Auer, Paul; Jiao, Shuo; Carlson, Christopher S.; Peters, Ulrike; Kooperberg, Charles] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; [Auer, Paul; Manning, Alisa] Univ Wisconsin, Sch Publ Hlth, Milwaukee, WI 53201 USA; [Flannick, Jason; Manning, Alisa; Farlow, Deborah N.] Broad Inst Harvard & MIT, Cambridge, MA 02141 USA; [Flannick, Jason; Altshuler, David] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Gaulton, Kyle; Lindgren, Cecilia; Rivas, Manuel A.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX1 2JD, England; [Manning, Alisa; Altshuler, David] Harvard Univ, Dept Genet, Sch Med, Boston, MA 02138 USA; [Holmen, Oddgeir L.; Hveem, Kristian] Norwegian Univ Sci & Technol, Dept Publ Hlth, HUNT Res Ctr, N-7600 Levanger, Norway; [Gottesman, Omri; Bottinger, Erwin P.] Charles Bronfman Inst Personalized Med, Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Lu, Yingchang; Loos, Ruth J. F.] Charles Bronfman Inst Personalized Med, Icahn Sch Med Mt Sinai, Genet Obes & Related Metab Traits Program, New York, NY 10029 USA; [Ruderfer, Douglas; Stah, Eli A.] Icahn Sch Med Mt Sinai, Dept Psychiat, Div Psychiat Genom, New York, NY 10029 USA; [Li, Yun] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC 27599 USA; [Durda, Peter; Tracy, Russell P.] Univ Vermont, Dept Pathol, Colchester, VT 05446 USA; [Isaacs, Aaron; Van Duijn, Cornelia M.] Erasmus MC, Dept Epidemiol, Genet Epidemiol Unit, NL-3015 DR Rotterdam, Netherlands; [Hofman, Albert] Erasmus MC, Dept Epidemiol, NL-3000 DR Rotterdam, Netherlands; [Bis, Joshua C.; Siscovick, David S.; Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Correa, Adolfo; Griswold, Michael E.; Fox, Ervin R.; Taylor, Herman A.] Univ Mississippi Med Ctr, Dept Med, Jackson, MS 39216 USA; [Jakobsdottir, Johanna; Smith, Albert V.; Gudnason, Vilmundur, Jr.] Iceland Heart Assoc, IS-201 Kopavogur, Iceland; [Smith, Albert V.; Gudnason, Vilmundur, Jr.] Univ Iceland, IS-101 Reykjavik, Iceland; [Schreiner, Pamela J.; Tsai, Michael; Folsom, Aaron R.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA; [Feitosa, Mary E.; Zhang, Qunyuan; Borecki, Ingrid B.] Washington Univ, Div Stat Genom, Dept Genet, Sch Med, St Louis, MO 63110 USA; [Huffman, Jennifer E.; Hayward, Caroline] Univ Edinburgh, Med Res Ctr Human Genet, Med Res Ctr Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Crosby, Jacy; Fornage, Myriam; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Wasse, Christina L.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Franceschini, Nora; North, Kari E.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Martin, Lisa W.] George Washington Sch Med & Hlth Sci, Div Cardiol, Washington, DC 20037 USA; [Robinson, Jennifer G.] Univ Iowa, Dept Epidemiol, Iowa City, IA 52242 USA; [Robinson, Jennifer G.] Univ Iowa, Dept Med, Iowa City, IA 52242 USA; [Assimes, Themistocles L.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Crosslin, David R.; Rosenthal, Elisabeth A.; Jarvik, Gail P.] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Crosslin, David R.; Lumley, Thomas] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Lumley, Thomas] Univ Auckland, Dept Stat, Auckland 1142, New Zealand; [Jackson, Rebecca D.] Ohio State Univ, Div Endocrinol, Columbus, OH 43210 USA; [Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, NL-3000 DR Rotterdam, Netherlands; [Levy, Daniel; O'Donne, Christopher J.; Cupples, L. Adrienne] NHLBI, Ctr Populat Studies, Framingham, MA 01702 USA; [Levy, Daniel] NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; [Rotter, Jerome I.] Harbor UCLA Med Ctr, Inst Translat Genom & Populat Sci, Los Angeles BioMed Res Inst, Torrance, CA 90502 USA; [Rotter, Jerome I.] Harbor UCLA Med Ctr, Dept Pediat, Torrance, CA 90502 USA; [Taylor, Herman A.] Tougaloo Coll, Jackson, MS 39174 USA; [Taylor, Herman A.] Jackson State Univ, Jackson, MS 39217 USA; [Siscovick, David S.; Reiner, Alexander P.; Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Siscovick, David S.; Psaty, Bruce M.] Univ Washington, Dept Med, Med Ctr, Seattle, WA 98195 USA; [Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, Houston, TX 77030 USA; [Rudan, Igor] Univ Edinburgh, Ctr Populat Hlth Sci, Sch Med, Edinburgh EH8 9YL, Midlothian, Scotland; [Strom, Pal] Norwegian Univ Sci & Technol, Dept Comp & Informat Sci, N-7491 Trondheim, Norway; [Strom, Pal] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7489 Trondheim, Norway; [Groop, Leif] Lund Univ, Dept Clin Sci Diabet & Endocrinol, Skane Univ Hosp, S-22100 Malmo, Sweden; [Groop, Leif] Glostrup Univ Hosp, Glostrup Res Inst, DK-2600 Glostrup, Denmark; [McCarthy, Mark] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX1 2JD, England; [McCarthy, Mark] Univ Oxford, Churchill Hosp, Oxford Natl Inst Hlth Res Biomed Res Ctr, Oxford OX1 2JD, England; [Meitinger, Thomas] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Human Genet, D-85764 Neuherberg, Germany; [Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, D-85764 Neuherberg, Germany; [Ballantyne, Christie M.] Baylor Coll Med, Houston, TX 77030 USA; [Ballantyne, Christie M.] Houston Methodist DeBakey Heart & Vasc Ctr, Houston, TX 77030 USA; [O'Donne, Christopher J.; Kathiresan, Sekar] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Post, Wendy S.] Johns Hopkins Univ, Dept Med, Sch Med, Baltimore, MD 21205 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA 98195 USA; [Cupples, L. Adrienne] Boston Univ, Dept Biostat, Sch Publ Hlth, Boston, MA 02215 USA; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA; [Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA; [Tracy, Russell P.] Univ Vermont, Dept Biochem, Burlington, VT 05405 USA; [Willer, Cristen J.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Fred Hutchinson Cancer Center; University of Wisconsin System; University of Wisconsin Milwaukee; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; University of Oxford; Wellcome Centre for Human Genetics; Harvard University; Harvard Medical School; Norwegian University of Science & Technology (NTNU); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of North Carolina; University of North Carolina Chapel Hill; University of Vermont; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Washington; University of Washington Seattle; University of Mississippi; University of Mississippi Medical Center; Icelandic Heart Association; University of Iceland; University of Minnesota System; University of Minnesota Twin Cities; Washington University (WUSTL); University of Edinburgh; University of Texas System; University of Texas Health Science Center Houston; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; University of North Carolina Chapel Hill; George Washington University; University of Iowa; University of Iowa; Stanford University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Auckland; University System of Ohio; Ohio State University; Erasmus University Rotterdam; Erasmus MC; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Tougaloo College; Jackson State University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Health Science Center Houston; University of Edinburgh; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Lund University; Skane University Hospital; University of Copenhagen; University of Oxford; University of Oxford; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; Harvard University; Massachusetts General Hospital; Johns Hopkins University; Group Health Cooperative; Boston University; University of Mississippi; University of Mississippi Medical Center; University of Virginia; University of Vermont; University of Michigan System; University of Michigan	Willer, CJ (corresponding author), Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA.	cristen@umich.edu	Manning, Alisa Knodle/ABC-7711-2021; Ruderfer, Douglas M/M-5795-2016; Locke, Adam/K-2000-2019; Loos, Ruth J F/Q-2862-2016; Johnson, Andrew D/G-6520-2013; Jarvik, Gail P/N-6476-2014; , Jennifer/AAD-8336-2019; Tang, Zheng-Zheng/F-6642-2014; Rotter, Jerome/AAY-6598-2021; Hardy, John/C-2451-2009; Altshuler, David M/A-4476-2009; Gudnason, Vilmundur/K-6885-2015; Auer, Paul/AAC-5060-2019; de Bakker, Paul IW/B-8730-2009; Gudnason, Vilmundur/AAE-7126-2019; Assimes, Themistocles Leonard/D-9696-2015; Rivas, Manuel/ABE-8173-2020; Levy, Daniel/ABB-2752-2021; Singleton, Andrew B/C-3010-2009; Smith, Albert Vernon/K-5150-2015; Feitosa, Mary F/K-8044-2012; Levy, Daniel/ABF-6873-2021; Sim, Xueling/AAZ-6652-2020; Ballantyne, Christie/A-6599-2008; Hayward, Caroline/M-8818-2016; Loos, Ruth/GON-5877-2022; Rudan, Igor/I-1467-2012; Jun, Goo/F-1941-2017; Meitinger, Thomas/O-1318-2015; Fuchsberger, Christian/ABD-7127-2021; Hveem, Kristian/AFV-4683-2022; Zhang, Ji/J-4009-2014; Barbalić, Maja/E-2161-2017; McCarthy, Mark/M-3763-2015; Carr, John/A-1938-2012	Ruderfer, Douglas M/0000-0002-2365-386X; Locke, Adam/0000-0001-6227-198X; Loos, Ruth J F/0000-0002-8532-5087; Johnson, Andrew D/0000-0001-6369-5178; Jarvik, Gail P/0000-0002-6710-8708; Tang, Zheng-Zheng/0000-0003-3802-8087; Hardy, John/0000-0002-3122-0423; Altshuler, David M/0000-0002-7250-4107; Gudnason, Vilmundur/0000-0001-5696-0084; de Bakker, Paul IW/0000-0001-7735-7858; Gudnason, Vilmundur/0000-0001-5696-0084; Assimes, Themistocles Leonard/0000-0003-2349-0009; Rivas, Manuel/0000-0003-1457-9925; Smith, Albert Vernon/0000-0003-1942-5845; Feitosa, Mary F/0000-0002-0933-2410; Levy, Daniel/0000-0003-1843-8724; Sim, Xueling/0000-0002-1233-7642; Hayward, Caroline/0000-0002-9405-9550; Rudan, Igor/0000-0001-6993-6884; Jun, Goo/0000-0003-0891-0204; Fuchsberger, Christian/0000-0002-5918-8947; Barbalić, Maja/0000-0001-8914-1691; Bustamante, Carlos D./0000-0002-4187-7920; Lindgren, Cecilia/0000-0002-4903-9374; Van Duijn, Cornelia/0000-0002-2374-9204; Akey, Joshua/0000-0002-4411-1330; Lunetta, Kathryn/0000-0002-9268-810X; Schmidt, Ellen/0000-0003-1198-7536; Willer, Cristen/0000-0001-5645-4966; McCarthy, Mark/0000-0002-4393-0510; Seshadri, Sudha/0000-0001-6135-2622; O'Connor, Timothy/0000-0002-0276-1896; Ballantyne, Christie/0000-0002-6432-1730; Thomas, Fridtjof/0000-0003-1325-4870; Quinlan, Aaron/0000-0003-1756-0859; Carr, John/0000-0002-4398-8237; Jakobsdottir, Johanna/0000-0002-8019-9683; Martin, Lisa Warsinger/0000-0003-4352-0914; Zhang, He/0000-0001-9198-6503; Konstan, Michael/0000-0002-0557-7277; Saetrom, Pal/0000-0001-8142-7441; Voight, Benjamin/0000-0002-6205-9994; Tsai, Michael/0000-0001-7553-3408; Gordon, Adam/0000-0002-2058-7289; Rich, Stephen/0000-0003-3872-7793; Cupples, L. Adrienne/0000-0003-0273-7965; Schreiner, Pamela/0000-0002-9920-6257; Meitinger, Thomas/0000-0002-8838-8403; Pulit, Sara/0000-0002-2502-3669; Rosenfeld, Margaret/0000-0002-8105-614X; Shendure, Jay/0000-0002-1516-1865; Caan, Bette/0000-0002-5803-310X; Turner, Emily/0000-0001-9040-9229	NHLBI [RC2 HL-103010, RC2 HL-102923, RC2 HL-102924, RC2 HL-102925, RC2 HL-102926]; Northwest Institute of Genomic Medicine; Washington State Life Sciences Discovery Fund; National Institutes of Health [R01HL107816]; Amarin; Amgen; Astra-Zeneca; Daiichi-Sankyo; Esperion; F. Hoffman-La Roche; Glaxo-Smith Kline; Merck; Regeneron; Sanofi; Takeda; Zinfandel;  [R01 HL67406];  [R00 HL94535];  [R01 HL109946]; NATIONAL CANCER INSTITUTE [R01CA082659] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UC2HL102924, UC2HL102925, R01HL107816, RC2HL102924, RC2HL102926, RC2HL102923, R01HL067406, T32HL007208, R01HL109946, R00HL094535, RC2HL102925, RC2HL103010] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062370, P30DK063491, P30DK079637, P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG008122, U01AG049505, R01AG033193] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006899] Funding Source: NIH RePORTER; Medical Research Council [MC_PC_U127561128] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10099] Funding Source: researchfish; MRC [MC_PC_U127561128] Funding Source: UKRI	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Northwest Institute of Genomic Medicine; Washington State Life Sciences Discovery Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amarin; Amgen(Amgen); Astra-Zeneca(AstraZeneca); Daiichi-Sankyo(Daiichi Sankyo Company Limited); Esperion; F. Hoffman-La Roche; Glaxo-Smith Kline(GlaxoSmithKline); Merck(Merck & Company); Regeneron(Regeneron); Sanofi; Takeda(Takeda Pharmaceutical Company Ltd); Zinfandel; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors wish to acknowledge the support of the NHLBI and the contributions of the research institutions, study investigators, field staff, and study participants in creating this resource for biomedical research. Funding for the NHLBI Grand Opportunity (GO) Exome Sequencing Project was provided by NHLBI grants RC2 HL-103010 (HeartGO), RC2 HL-102923 (LungGO), and RC2 HL-102924 (Women's Health Initiative Sequencing Project). Exome sequencing was performed through NHLBI grants RC2 HL-102925 (BroadGO) and RC2 HL-102926 (SeattleGO). G.J. is supported by R01 HL67406 and the Northwest Institute of Genomic Medicine, funded by the Washington State Life Sciences Discovery Fund. S.K.'s effort is funded through National Institutes of Health grant R01HL107816. C.J.W. is supported by R00 HL94535 and R01 HL109946. The University of Iowa receives financial support from Amarin, Amgen, Astra-Zeneca, Daiichi-Sankyo, Esperion, F. Hoffman-La Roche, Glaxo-Smith Kline, Merck, Regeneron and Sanofi, and Takeda and Zinfandel for J.G.R's research. B.M.P serves on the data and safety monitoring board of a clinical trial for Zoll LifeCor. Additional acknowledgements are provided in the Supplemental Data.	Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Cohen JC, 2006, P NATL ACAD SCI USA, V103, P1810, DOI 10.1073/pnas.0508483103; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Chagas SVD, 2011, PUBLIC HEALTH, V125, P329, DOI 10.1016/j.puhe.2011.02.009; Epstein MP, 2000, AM J HUM GENET, V67, P1219, DOI 10.1016/S0002-9297(07)62952-8; Fokkema IFAC, 2005, HUM MUTAT, V26, P63, DOI 10.1002/humu.20201; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Harris TB, 2007, AM J EPIDEMIOL, V165, P1076, DOI 10.1093/aje/kwk115; Higgins M, 1996, AM J EPIDEMIOL, V143, P1219, DOI 10.1093/oxfordjournals.aje.a008709; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Joachims T, 1999, ADVANCES IN KERNEL METHODS, P169; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Krokstad S, 2013, INT J EPIDEMIOL, V42, P968, DOI 10.1093/ije/dys095; Lee MH, 2001, NAT GENET, V27, P79, DOI 10.1038/83799; Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Musunuru K, 2010, NEW ENGL J MED, V363, P2220, DOI 10.1056/NEJMoa1002926; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rahalkar AR, 2008, MOL GENET METAB, V93, P282, DOI 10.1016/j.ymgme.2007.10.007; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Taylor HA, 2005, ETHNIC DIS, V15, pS4; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; YOUNG SG, 1987, J CLIN INVEST, V79, P1842, DOI 10.1172/JCI113026; Zemunik T, 2009, CROAT MED J, V50, P23, DOI 10.3325/cmj.2009.50.23	40	159	166	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 6	2014	94	2					233	245		10.1016/j.ajhg.2014.01.010	http://dx.doi.org/10.1016/j.ajhg.2014.01.010			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AA9NF	24507775	Green Published, Bronze			2022-12-18	WOS:000331419500007
J	French, JD; Ghoussaini, M; Edwards, SL; Meyer, KB; Michailidou, K; Ahmed, S; Khan, S; Maranian, MJ; O'Reilly, M; Hillman, KM; Betts, JA; Carro, T; Bailey, PJ; Dicks, E; Beesley, J; Tyrer, J; Maia, AT; Beck, A; Knoblauch, NW; Chen, C; Kraft, P; Barnes, D; Gonzalez-Neira, A; Alonso, MR; Herrero, D; Tessier, DC; Vincent, D; Bacot, F; Luccarini, C; Baynes, C; Conroy, D; Dennis, J; Bolla, MK; Wang, Q; Hopper, JL; Southey, MC; Schmidt, MK; Broeks, A; Verhoef, S; Cornelissen, S; Muir, K; Lophatananon, A; Stewart-Brown, S; Siriwanarangsan, P; Fasching, PA; Loehberg, CR; Ekici, AB; Beckmann, MW; Peto, J; Silva, IDS; Johnson, N; Aitken, Z; Sawyer, EJ; Tomlinson, I; Kerin, MJ; Miller, N; Marme, F; Schneeweiss, A; Sohn, C; Burwinkel, B; Guenel, P; Truong, T; Laurent-Puig, P; Menegaux, F; Bojesen, SE; Nordestgaard, NG; Nielsen, SF; Flyger, H; Milne, RL; Zamora, MP; Perez, JIA; Benitez, J; Anton-Culver, H; Brenner, H; Muller, H; Arndt, V; Stegmaier, C; Meind, A; Lichtner, P; Schmutzler, RK; Engel, C; Brauch, H; Hamann, U; Justenhoven, C; Aaltonen, K; Heikkila, P; Aittomaki, K; Blomqvist, C; Matsuo, K; Ito, H; Iwata, H; Sueta, A; Bogdanova, NV; Antonenkova, NN; Dork, T; Lindblom, A; Margolin, S; Mannermaa, A; Kataja, V; Kosma, VM; Hartikainen, JM; Wu, AH; Tseng, CC; Van Den Berg, D; Stram, DO; Lambrechts, D; Peeters, S; Smeets, A; Floris, G; Chang-Claude, J; Rudolph, A; Nickels, S; Flesch-Janys, D; Radice, P; Peterlongo, P; Bonanni, B; Sardella, D; Couch, FJ; Wang, XS; Pankratz, VS; Lee, A; Giles, GG; Severi, G; Baglietto, L; Haiman, CA; Henderson, BE; Schumacher, F; Le Marchand, L; Simard, J; Goldberg, MS; Labreche, F; Dumont, M; Teo, SH; Yip, CH; Ng, CH; Vithana, EN; Kristensen, V; Zheng, W; Deming-Halverson, S; Shrubsole, M; Long, JR; Winqvist, R; Pylkas, K; Jukkola-Vuorinen, A; Grip, M; Andrulis, IL; Knight, JA; Glendon, G; Mulligan, AM; Devilee, P; Seynaeve, C; Garcia-Closas, M; Figueroa, J; Chanock, SJ; Lissowska, J; Czene, K; Klevebring, D; Schoof, N; Hooning, MJ; Martens, JWM; Collee, JM; Tilanus-Linthorst, M; Hall, P; Li, JM; Liu, JJ; Humphreys, K; Shu, XO; Lu, W; Gao, YT; Cai, H; Cox, A; Balasubramanian, SP; Blot, W; Signorello, LB; Cai, QY; Pharoah, PDP; Healey, CS; Shah, M; Pooley, KA; Kang, D; Yoo, KY; Noh, DY; Hartman, M; Miao, H; Sng, JH; Sim, X; Jakubowska, A; Lubinski, J; Jaworska-Bieniek, K; Durda, K; Sangrajrang, S; Gaborieau, V; McKay, J; Toland, AE; Ambrosone, CB; Yannoukakos, D; Godwin, AK; Shen, CY; Hsiung, CN; Wu, PE; Chen, ST; Swerdlow, A; Ashworth, A; Orr, N; Schoemaker, MJ; Ponder, BAJ; Nevanlinna, H; Brown, MA; Chenevix-Trench, G; Easton, DF; Dunning, AM				French, Juliet D.; Ghoussaini, Maya; Edwards, Stacey L.; Meyer, Kerstin B.; Michailidou, Kyriaki; Ahmed, Shahana; Khan, Sofia; Maranian, Mel J.; O'Reilly, Martin; Hillman, Kristine M.; Betts, Joshua A.; Carro, Thomas; Bailey, Peter J.; Dicks, Ed; Beesley, Jonathan; Tyrer, Jonathan; Maia, Ana-Teresa; Beck, Andrew; Knoblauch, Nicholas W.; Chen, Constance; Kraft, Peter; Barnes, Daniel; Gonzalez-Neira, Anna; Rosario Alonso, M.; Herrero, Daniel; Tessier, Daniel C.; Vincent, Daniel; Bacot, Francois; Luccarini, Craig; Baynes, Caroline; Conroy, Don; Dennis, Joe; Bolla, Manjeet K.; Wang, Qin; Hopper, John L.; Southey, Melissa C.; Schmidt, Marjanka K.; Broeks, Annegien; Verhoef, Senno; Cornelissen, Sten; Muir, Kenneth; Lophatananon, Artitaya; Stewart-Brown, Sarah; Siriwanarangsan, Pomthep; Fasching, Peter A.; Loehberg, Christian R.; Ekici, Arif B.; Beckmann, Matthias W.; Peto, Julian; Silva, Isabel dos Santos; Johnson, Nichola; Aitken, Zoe; Sawyer, Elinor J.; Tomlinson, Ian; Kerin, Michael J.; Miller, Nicola; Marme, Frederik; Schneeweiss, Andreas; Sohn, Christof; Burwinkel, Barbara; Guenel, Pascal; Therese Truong; Laurent-Puig, Pierre; Menegaux, Florence; Bojesen, Stig E.; Nordestgaard, Norge G.; Nielsen, Sune F.; Flyger, Henrik; Milne, Roger L.; Pilar Zamora, M.; Arias Perez, Jose Ignacio; Benitez, Javier; Anton-Culver, Hoda; Brenner, Hermann; Mueller, Heiko; Arndt, Volker; Stegmaier, Christa; Meind, Alfons; Lichtner, Peter; Schmutzler, Rita K.; Engel, Christoph; Brauch, Hiltrud; Hamann, Ute; Justenhoven, Christina; Aaltonen, Kirsimari; Heikkila, Paivi; Aittomaki, Kristiina; Blomqvist, Carl; Matsuo, Keitaro; Ito, Hidemi; Iwata, Hiroji; Sueta, Aiko; Bogdanova, Natalia V.; Antonenkova, Natalia N.; Dork, Thilo; Lindblom, Annika; Margolin, Sara; Mannermaa, Arto; Kataja, Vesa; Kosma, Veli-Matti; Hartikainen, Jaana M.; Wu, Anna H.; Tseng, Chiu-chen; Van Den Berg, David; Stram, Daniel O.; Lambrechts, Diether; Peeters, Stephanie; Smeets, Ann; Floris, Giuseppe; Chang-Claude, Jenny; Rudolph, Anja; Nickels, Stefan; Flesch-Janys, Dieter; Radice, Paolo; Peterlongo, Paolo; Bonanni, Bernardo; Sardella, Domenico; Couch, Fergus J.; Wang, Xianshu; Pankratz, Vernon S.; Lee, Adam; Giles, Graham G.; Severi, Gianluca; Baglietto, Laura; Haiman, Christopher A.; Henderson, Brian E.; Schumacher, Fredrick; Le Marchand, Loic; Simard, Jacques; Goldberg, Mark S.; Labreche, France; Dumont, Martine; Teo, Soo Hwang; Yip, Cheng Har; Ng, Char-Hong; Vithana, Eranga Nishanthie; Kristensen, Vessela; Zheng, Wei; Deming-Halverson, Sandra; Shrubsole, Martha; Long, Jirong; Winqvist, Robert; Pylkas, Katri; Jukkola-Vuorinen, Arja; Grip, Mervi; Andrulis, Irene L.; Knight, Julia A.; Glendon, Gord; Mulligan, Anna Marie; Devilee, Peter; Seynaeve, Caroline; Garcia-Closas, Montserrat; Figueroa, Jonine; Chanock, Stephen J.; Lissowska, Jolanta; Czene, Kamila; Klevebring, Daniel; Schoof, Nils; Hooning, Maartje J.; Martens, John W. M.; Collee, J. Margriet; Tilanus-Linthorst, Madeleine; Hall, Per; Li, Jingmei; Liu, Jianjun; Humphreys, Keith; Shu, Xiao-Ou; Lu, Wei; Gao, Yu-Tang; Cai, Hui; Cox, Angela; Balasubramanian, Sabapathy P.; Blot, William; Signorello, Lisa B.; Cai, Qiuyin; Pharoah, Paul D. P.; Healey, Catherine S.; Shah, Mitul; Pooley, Karen A.; Kang, Daehee; Yoo, Keun-Young; Noh, Dong-Young; Hartman, Mikael; Miao, Hui; Sng, Jen-Hwei; Sim, Xueling; Jakubowska, Anna; Lubinski, Jan; Jaworska-Bieniek, Katarzyna; Durda, Katarzyna; Sangrajrang, Suleeporn; Gaborieau, Valerie; McKay, James; Toland, Amanda E.; Ambrosone, Christine B.; Yannoukakos, Drakoulis; Godwin, Andrew K.; Shen, Chen-Yang; Hsiung, Chia-Ni; Wu, Pei-Ei; Chen, Shou-Tung; Swerdlow, Anthony; Ashworth, Alan; Orr, Nick; Schoemaker, Minouk J.; Ponder, Bruce A. J.; Nevanlinna, Heli; Brown, Melissa A.; Chenevix-Trench, Georgia; Easton, Douglas F.; Dunning, Alison M.		GENICA Network; KConFab Investigators	Functional Variants at the 11q13 Risk Locus for Breast Cancer Regulate Cyclin D1 Expression through Long-Range Enhancers	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GROWTH-FACTOR RECEPTOR-2; ESTROGEN-RECEPTOR; DOWN-REGULATION; MULTIPLE LOCI; CELL-CYCLE; GATA-3; GENE; ALPHA; DIFFERENTIATION	Analysis of 4,405 variants in 89,050 European subjects from 41 case-control studies identified three independent association signals for estrogen-receptor-positive tumors at 11q13. The strongest signal maps to a transcriptional enhancer element in which the G allele of the best candidate causative variant rs554219 increases risk of breast cancer, reduces both binding of ELK4 transcription factor and luciferase activity in reporter assays, and may be associated with low cyclin D1 protein levels in tumors. Another candidate variant, rs78540526, lies in the same enhancer element. Risk association signal 2, rs75915166, creates a GATA3 binding site within a silencer element. Chromatin conformation studies demonstrate that these enhancer and silencer elements interact with each other and with their likely target gene, CCND1.	[French, Juliet D.; Edwards, Stacey L.; Hillman, Kristine M.; Betts, Joshua A.; Bailey, Peter J.; Lee, Adam; Brown, Melissa A.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Ghoussaini, Maya; Ahmed, Shahana; Maranian, Mel J.; Dicks, Ed; Tyrer, Jonathan; Luccarini, Craig; Baynes, Caroline; Conroy, Don; Pharoah, Paul D. P.; Healey, Catherine S.; Shah, Mitul; Easton, Douglas F.; Dunning, Alison M.] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Oncol, Cambridge CB1 8RN, England; [Meyer, Kerstin B.; O'Reilly, Martin; Carro, Thomas; Maia, Ana-Teresa; Ponder, Bruce A. J.] Li Ka Shing Ctr, Canc Res UK Cambridge Res Inst, Cambridge CB2 ORE, England; [Michailidou, Kyriaki; Barnes, Daniel; Dennis, Joe; Bolla, Manjeet K.; Wang, Qin; Pharoah, Paul D. P.; Pooley, Karen A.; Easton, Douglas F.] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England; [Khan, Sofia; Aaltonen, Kirsimari; Nevanlinna, Heli] Univ Helsinki, Dept Obstet & Gynecol, Helsinki 00029, Finland; [Khan, Sofia; Aaltonen, Kirsimari; Heikkila, Paivi; Aittomaki, Kristiina; Blomqvist, Carl; Nevanlinna, Heli] Univ Helsinki, Cent Hosp, Helsinki 00029, Finland; [Beesley, Jonathan; Chenevix-Trench, Georgia] Queensland Inst Med Res, Dept Genet, Brisbane, Qld 4029, Australia; [Beck, Andrew; Knoblauch, Nicholas W.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Beck, Andrew; Knoblauch, Nicholas W.] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Chen, Constance; Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02215 USA; [Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA; [Gonzalez-Neira, Anna; Rosario Alonso, M.; Herrero, Daniel; Benitez, Javier] Spanish Natl Canc Res Ctr CNIO, Human Canc Genet Program, Human Genotyping CEGEN Unit, Madrid 28029, Spain; [Tessier, Daniel C.; Vincent, Daniel; Bacot, Francois] Ctr Innovat Genome Quebec, Montreal, PQ H3A 0G1, Canada; [Tessier, Daniel C.; Vincent, Daniel; Bacot, Francois] McGill Univ, Montreal, PQ H3A 0G1, Canada; [Hopper, John L.; Giles, Graham G.; Severi, Gianluca; Baglietto, Laura] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic 3010, Australia; [Southey, Melissa C.] Univ Melbourne, Dept Pathol, Genet Epidemiol Lab, Melbourne, Vic 3010, Australia; [Schmidt, Marjanka K.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Div Psychosocial Res & Epidemiol, NL-1066 CX Amsterdam, Netherlands; [Schmidt, Marjanka K.; Broeks, Annegien; Cornelissen, Sten] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Div Mol Pathol, NL-1066 CX Amsterdam, Netherlands; [Verhoef, Senno] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Family Canc Clin, NL-1066 CX Amsterdam, Netherlands; [Muir, Kenneth; Lophatananon, Artitaya; Stewart-Brown, Sarah] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Siriwanarangsan, Pomthep] Minist Publ Hlth, Bangkok 10400, Thailand; [Fasching, Peter A.] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol & Oncol, Dept Med, Los Angeles, CA 90095 USA; [Fasching, Peter A.; Loehberg, Christian R.; Beckmann, Matthias W.] Univ Hosp Erlangen, Dept Obstet & Gynecol, Univ Breast Ctr Franconia, D-91054 Erlangen, Germany; [Ekici, Arif B.] Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany; [Peto, Julian; Silva, Isabel dos Santos; Aitken, Zoe] Univ London London Sch Hyg & Trop Med, Noncommunicable Dis Epidemiol Dept, London WC1E 7HT, England; [Johnson, Nichola; Garcia-Closas, Montserrat; Ashworth, Alan; Orr, Nick] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Sawyer, Elinor J.] Guys & St Thomas NHS Fdn Trust Partnership Kings, NIHR Comprehens Biomed Res Ctr, Div Canc Studies, London SE1 9RT, England; [Tomlinson, Ian] Univ Oxford, Welcome Trust Ctr Human Genet, Oxford 0X3 7BN, England; [Tomlinson, Ian] Univ Oxford, Oxford Biomed Res Ctr, Oxford 0X3 7BN, England; [Kerin, Michael J.; Miller, Nicola] Galway Univ Hosp, Inst Clin Sci, Galway, Ireland; [Kerin, Michael J.; Miller, Nicola] Natl Univ Ireland, Galway, Ireland; [Marme, Frederik; Schneeweiss, Andreas; Sohn, Christof; Burwinkel, Barbara] Heidelberg Univ, Dept Obstet & Gynecol, D-69115 Heidelberg, Germany; [Marme, Frederik; Schneeweiss, Andreas] Heidelberg Univ, Natl Ctr Tumor Dis, D-69120 Heidelberg, Germany; [Burwinkel, Barbara] German Canc Res Ctr, Mol Epidemiol Grp, D-69120 Heidelberg, Germany; [Guenel, Pascal; Therese Truong; Menegaux, Florence] INSERM, Natl Inst Hlth & Med Res, CESP Ctr Res Epidemiol & Populat Hlth, Environm Epidemiol Canc Team,U1018, F-94807 Villejuif, France; [Guenel, Pascal; Therese Truong; Menegaux, Florence] Univ Paris 11, UMRS 1018, F-94807 Villejuif, France; [Laurent-Puig, Pierre] Univ Paris Sorbonne Cite, UMR S775, INSERM, F-75270 Paris 06, France; [Bojesen, Stig E.; Nordestgaard, Norge G.; Nielsen, Sune F.] Univ Copenhagen, Copenhagen Univ Hosp, Herlev Hosp, Copenhagen Gen Populat Study, DK-2730 Herlev, Denmark; [Bojesen, Stig E.; Nordestgaard, Norge G.; Nielsen, Sune F.] Univ Copenhagen, Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark; [Flyger, Henrik] Copenhagen Univ Hosp, Dept Breast Surg, Herlev Hosp, DK-2730 Herlev, Denmark; [Milne, Roger L.] Spanish Natl Canc Res Ctr CNIO, Human Canc Genet Program, Genet & Mol Epidemiol Grp, Madrid 28029, Spain; [Pilar Zamora, M.] Hosp Univ La Paz, Med Oncol Serv, Madrid 28046, Spain; [Arias Perez, Jose Ignacio] Hosp Monte Naranco, Serv Cirugia Gen & Especialidades, Oviedo 33012, Spain; [Benitez, Javier] Ctr Invest Red Enfermedades Raras CIBERER, Madrid 28029, Spain; [Anton-Culver, Hoda] Univ Calif Irvine, Dept Epidemiol, Irvine, CA 92697 USA; [Brenner, Hermann; Mueller, Heiko; Arndt, Volker] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-69120 Heidelberg, Germany; [Stegmaier, Christa] Saarland Canc Registry, D-66024 Saarbrucken, Germany; [Meind, Alfons] Tech Univ Munich, Div Gynaecol & Obstet, D-81675 Munich, Germany; [Lichtner, Peter] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Schmutzler, Rita K.] Univ Cologne, Dept Obstet & Gynaecol, Div Mol Gynecooncol, D-50931 Cologne, Germany; [Engel, Christoph] Univ Leipzig, Inst Med Informat Stat & Epidemiol, D-04107 Leipzig, Germany; [Brauch, Hiltrud; Justenhoven, Christina] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany; [Brauch, Hiltrud; Justenhoven, Christina] Univ Tubingen, D-72074 Tubingen, Germany; [Hamann, Ute] German Canc Res Ctr, D-69120 Heidelberg, Germany; Johanniter Krankenhaus, Evangel Kliniken Bonn gGmbH, Dept Internal Med, D-53113 Bonn, Germany; Univ Saarland, Med Ctr, Inst & Outpatient Clin Occupat Med, D-66421 Homburg, Germany; Univ Saarland, Fac Med, D-66421 Homburg, Germany; German Social Accid Insurance IPA, Inst Prevent & Occupat Med, D-44789 Bochum, Germany; [GENICA Network] Univ Bonn, Fac Med, Inst Pathol, D-53123 Bonn, Germany; [Aaltonen, Kirsimari; Aittomaki, Kristiina] Univ Helsinki, Dept Clin Genet, Helsinki 00029, Finland; [Heikkila, Paivi] Univ Helsinki, Dept Pathol, Helsinki 00029, Finland; [Blomqvist, Carl] Univ Helsinki, Dept Oncol, Helsinki 00029, Finland; [Matsuo, Keitaro; Ito, Hidemi; Sueta, Aiko] Aichi Canc Ctr Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 4648681, Japan; [Iwata, Hiroji] Aichi Canc Ctr Hosp, Dept Breast Oncol, Nagoya, Aichi 4648681, Japan; [Bogdanova, Natalia V.; Dork, Thilo] Hannover Med Sch, Dept Obstet & Gynaecol, D-30625 Hannover, Germany; [Bogdanova, Natalia V.] Hannover Med Sch, Dept Radiat Oncol, D-30625 Hannover, Germany; [Antonenkova, Natalia N.] NN Alexandrov Res Inst Oncol & Med Radiol, Minsk 223040, BELARUS; [Lindblom, Annika] Karolinska Inst, Dept Mol Med & Surg, S-17177 Stockholm, Sweden; [Margolin, Sara] Karolinska Inst, Dept Oncol Pathol, S-17177 Stockholm, Sweden; [Mannermaa, Arto; Kosma, Veli-Matti; Hartikainen, Jaana M.] Kuopio Univ Hosp, Dept Clin Pathol, Imaging Ctr, Kuopio 70211, Finland; [Mannermaa, Arto; Kataja, Vesa; Kosma, Veli-Matti; Hartikainen, Jaana M.] Univ Eastern Finland, Canc Ctr Eastern Finland, Inst Clin Med Pathol & Forens Med, Bioctr Kuopio,Sch Med, Kuopio 70211, Finland; [Kataja, Vesa] Kuopio Univ Hosp, Ctr Canc, Kuopio 70211, Finland; [KConFab Investigators] Peter MacCallum Canc Ctr, Melbourne, Vic 3002, Australia; [Wu, Anna H.; Tseng, Chiu-chen; Van Den Berg, David; Stram, Daniel O.; Haiman, Christopher A.; Henderson, Brian E.; Schumacher, Fredrick] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA; [Lambrechts, Diether] Univ Leuven, Dept Oncol, Lab Translat Genet, B-3000 Louvain, Belgium; [Lambrechts, Diether] VIB, Vesalius Res Ctr, B-3000 Louvain, Belgium; [Peeters, Stephanie; Smeets, Ann; Floris, Giuseppe] Univ Hosp Leuven, Multidisciplinary Breast Ctr, B-3000 Louvain, Belgium; [Peeters, Stephanie; Smeets, Ann; Floris, Giuseppe] Katholieke Univ Leuven, B-3000 Louvain, Belgium; [Chang-Claude, Jenny; Rudolph, Anja; Nickels, Stefan; Flesch-Janys, Dieter] German Canc Res Ctr, Div Canc Epidemiol, D-69120 Heidelberg, Germany; [Flesch-Janys, Dieter] Univ Clin Hamburg Eppendorf, Clin Canc Registry, Dept Canc Epidemiol, D-20246 Hamburg, Germany; [Flesch-Janys, Dieter] Univ Clin Hamburg Eppendorf, Inst Med Biometr & Epidemiol, D-20246 Hamburg, Germany; [Radice, Paolo; Peterlongo, Paolo] Fdn IRCCS Ist Nazl Tumori INI, Dept Prevent & Predict Med, Unit Mol Bases Genet Risk & Genet Testing, I-20133 Milan, Italy; [Radice, Paolo; Peterlongo, Paolo; Sardella, Domenico] Fdn Ist FIRC Oncol Mol, IFOM, I-20139 Milan, Italy; [Bonanni, Bernardo] Ist Europeo Oncol, Div Canc Prevent & Genet, I-20141 Milan, Italy; [Couch, Fergus J.; Wang, Xianshu] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Pankratz, Vernon S.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Lee, Adam] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [Giles, Graham G.; Severi, Gianluca; Baglietto, Laura] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic 3053, Australia; [Le Marchand, Loic] Univ Hawaii, Canc Res Ctr, Program Epidemiol, Honolulu, HI 96813 USA; [Simard, Jacques; Dumont, Martine] CHU Quebec, Canc Genom Lab, Quebec City, PQ G1V 4G2, Canada; [Simard, Jacques; Dumont, Martine] Univ Laval, Quebec City, PQ G1V 4G2, Canada; [Goldberg, Mark S.] McGill Univ, Dept Med, Montreal, PQ H3A 1A1, Canada; [Goldberg, Mark S.] McGill Univ, Royal Victoria Hosp, Ctr Hlth, Div Clin Epidemiol, Montreal, PQ H3A 1A1, Canada; [Labreche, France] Univ Montreal, Dept Sante Environm & Sante Travail, Dept Social & Prevent Med, Montreal, PQ H3A 3C2, Canada; [Teo, Soo Hwang] Sime Darby Med Ctr, Canc Res Initiat Fdn, Subang Jaya 47500, Selangor, Malaysia; [Teo, Soo Hwang; Yip, Cheng Har; Ng, Char-Hong] Univ Malaya, Fac Med, Canc Res Inst, Breast Canc Res Unit, Kuala Lumpur 50603, Malaysia; [Vithana, Eranga Nishanthie] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore 168751, Singapore; [Kristensen, Vessela] Radiumhospitalet, Oslo Univ Hosp, Inst Canc Res, Dept Genet, N-0310 Oslo, Norway; [Kristensen, Vessela] Univ Oslo, Fac Div Ahus, Fac Med, N-0318 Oslo, Norway; [Zheng, Wei; Deming-Halverson, Sandra; Shrubsole, Martha; Long, Jirong; Shu, Xiao-Ou; Cai, Hui; Blot, William; Signorello, Lisa B.; Cai, Qiuyin] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Vanderbilt Epidemiol Ctr,Dept Med,Div Epidemiol, Nashville, TN 37203 USA; [Winqvist, Robert; Pylkas, Katri] Univ Oulu, Dept Clin Genet, Oulu Univ Hosp, Lab Canc Genet & Tumor Biol, Oulu 90014, Finland; [Jukkola-Vuorinen, Arja] Univ Oulu, Bioctr Oulu, Oulu Univ Hosp, Oulu 90014, Finland; [Jukkola-Vuorinen, Arja] Univ Oulu, Dept Oncol, Oulu Univ Hosp, Oulu 90014, Finland; [Grip, Mervi] Univ Oulu, Dept Surg, Oulu Univ Hosp, Oulu 90014, Finland; [Andrulis, Irene L.] Univ Toronto, Dept Mol Genet, Toronto, ON MSS 1A8, Canada; [Andrulis, Irene L.; Glendon, Gord] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ontario Canc Genet Network, Toronto, ON M5G 1X5, Canada; [Knight, Julia A.] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON M5T 3M7, Canada; [Knight, Julia A.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Prosserman Ctr Hlth Res, Toronto, ON M5T 3L9, Canada; [Mulligan, Anna Marie] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Mulligan, Anna Marie] Univ Hlth Network, Lab Med Program, Toronto, ON MSG 2C4, Canada; [Devilee, Peter] Leiden Univ, Med Ctr, Dept Human Genet, NL-2300 RC Leiden, Netherlands; [Devilee, Peter] Leiden Univ, Med Ctr, Dept Pathol, NL-2300 RC Leiden, Netherlands; [Seynaeve, Caroline] Erasmus MC Daniel den Hoed Canc Ctr, Dept Med Oncol, Family Canc Clin, NL-3075 EA Rotterdam, Netherlands; [Seynaeve, Caroline; Hooning, Maartje J.; Martens, John W. M.] Erasmus Univ, Med Ctr, Dept Med Oncol, NL-3075 EA Rotterdam, Netherlands; [Garcia-Closas, Montserrat; Swerdlow, Anthony; Schoemaker, Minouk J.] Inst Canc Res, Div Genet & Epidemiol, London SM2 5NG, England; [Garcia-Closas, Montserrat; Swerdlow, Anthony; Schoemaker, Minouk J.] Breakthrough Breast Canc Res Ctr, Div Genet & Epidemiol, London SM2 5NG, England; [Garcia-Closas, Montserrat; Swerdlow, Anthony; Orr, Nick] Inst Canc Res, Div Breast Canc Res, London SW3 6JB, England; [Figueroa, Jonine; Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Lissowska, Jolanta] M Sklodowska Curie Mem Canc, Dept Canc Epidemiol & Prevent, PL-02781 Warsaw, Poland; [Lissowska, Jolanta] Inst Oncol, PL-02781 Warsaw, Poland; [Czene, Kamila; Klevebring, Daniel; Schoof, Nils; Hall, Per; Humphreys, Keith] Karolinska Inst, S-17177 Stockholm, Sweden; [Collee, J. Margriet; Tilanus-Linthorst, Madeleine] Erasmus Univ, Med Ctr, Dept Clin Genet, NL-3008 AE Rotterdam, Netherlands; [Li, Jingmei; Liu, Jianjun] Genome Inst Singapore, Human Genet Div, Singapore 138672, Singapore; [Lu, Wei] Shanghai Ctr Dis Control & Prevent, Shanghai 200336, Peoples R China; [Gao, Yu-Tang] Shanghai Canc Inst, Dept Epidemiol, Shanghai 200032, Peoples R China; [Cox, Angela; Balasubramanian, Sabapathy P.] Univ Sheffield, Dept Oncol, CRUK YCR Sheffield Canc Res Ctr, Sheffield S10 2RX, S Yorkshire, England; [Blot, William; Signorello, Lisa B.] Int Epidemiol Inst, Rockville, MD 20850 USA; [Kang, Daehee; Yoo, Keun-Young; Noh, Dong-Young] Seoul Natl Univ, Coll Med, Seoul 110799, South Korea; [Hartman, Mikael; Sng, Jen-Hwei] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 119228, Singapore; [Hartman, Mikael; Miao, Hui] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117597, Singapore; [Sim, Xueling] Natl Univ Singapore, Ctr Mol Epidemiol, Singapore 117597, Singapore; [Jakubowska, Anna; Lubinski, Jan; Jaworska-Bieniek, Katarzyna; Durda, Katarzyna] Pomeranian Med Univ, Dept Genet & Pathol, PL-70115 Szczecin, Poland; [Jaworska-Bieniek, Katarzyna] Warsaw Med Univ, Postgrad Sch Mol Med, PL-02091 Warsaw, Poland; [Sangrajrang, Suleeporn] Natl Canc Inst, Bangkok 10400, Thailand; [Gaborieau, Valerie; McKay, James] Int Agcy Res Canc, F-69372 Lyon 08, France; [Toland, Amanda E.] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Ambrosone, Christine B.] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA; [Yannoukakos, Drakoulis] Natl Ctr Sci Res Demokritos, IRRP, Mol Diagnost Lab, Athens 15310, Greece; [Godwin, Andrew K.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA; [Shen, Chen-Yang] China Med Univ, Colleague Publ Hlth, Taichong 40402, Taiwan; [Shen, Chen-Yang; Hsiung, Chia-Ni] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Wu, Pei-Ei] Acad Sinica, Taiwan Biobank, Inst Biomed Sci, Taipei 115, Taiwan; [Chen, Shou-Tung] Changhua Christian Hosp, Dept Surg, Changhua 500, Taiwan	University of Queensland; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; QIMR Berghofer Medical Research Institute; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Centro Nacional de Investigaciones Oncologicas (CNIO); McGill University; University of Melbourne; University of Melbourne; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; University of Warwick; Ministry of Public Health - Thailand; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of London; London School of Hygiene & Tropical Medicine; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; King's College London; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; Centro Nacional de Investigaciones Oncologicas (CNIO); Hospital Universitario La Paz; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of California System; University of California Irvine; Helmholtz Association; German Cancer Research Center (DKFZ); Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Cologne; Leipzig University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Helmholtz Association; German Cancer Research Center (DKFZ); Saarland University; Saarland University; Ruhr University Bochum; University of Bonn; University of Helsinki; University of Helsinki; University of Helsinki; Aichi Cancer Center; Aichi Cancer Center; Hannover Medical School; Hannover Medical School; Karolinska Institutet; Karolinska Institutet; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Peter Maccallum Cancer Center; University of Southern California; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; KU Leuven; Helmholtz Association; German Cancer Research Center (DKFZ); University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Fondazione IRCCS Istituto Nazionale Tumori Milan; IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); Mayo Clinic; Mayo Clinic; Mayo Clinic; Cancer Council Victoria; Cancer Research Center of Hawaii; University of Hawaii System; Laval University; Laval University; McGill University; McGill University; Royal Victoria Hospital; Universite de Montreal; Universiti Malaya; National University of Singapore; Singapore National Eye Center; University of Oslo; University of Oslo; Vanderbilt University; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Maria Sklodowska-Curie National Research Institute of Oncology; Karolinska Institutet; Erasmus University Rotterdam; Erasmus MC; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Shanghai Center for Disease Control & Prevention; Shanghai Jiao Tong University; University of Sheffield; Seoul National University (SNU); National University of Singapore; National University of Singapore; National University of Singapore; Pomeranian Medical University; Medical University of Warsaw; National Cancer Institute - Thailand; World Health Organization; International Agency for Research on Cancer (IARC); James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Roswell Park Cancer Institute; National Centre of Scientific Research "Demokritos"; University of Kansas; University of Kansas Medical Center; China Medical University Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Changhua Christian Hospital	Dunning, AM (corresponding author), Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Oncol, Cambridge CB1 8RN, England.	amd24@medschl.cam.ac.uk	Maia, Ana-Teresa/F-4404-2012; Kerin, Michael J/D-6748-2013; Liu, Jianjun/AAK-4989-2020; Severi, Gianluca/H-3774-2018; Ng, Char Hong/M-9966-2019; truong, therese/A-2837-2013; Menegaux, Florence/H-4261-2018; laurent-puig, pierre/B-2226-2013; Figueroa, Jonine/AAG-1065-2022; Brenner, Hermann/B-4627-2017; Dörk, Thilo/J-8620-2012; Floris, Giuseppe/AFL-6620-2022; smeets, ann/AAP-9191-2020; Yip, Cheng-Har/B-1909-2010; Flyger, Henrik/AAM-6494-2021; Zheng, Wei/O-3351-2013; Jakubowska, Anna/O-8050-2014; Schumacher, Fredrick/R-6043-2019; gao, yi/HCI-8298-2022; Chenevix-Trench, Georgia/AAV-2014-2020; Ekici, Arif B/C-3971-2013; Floris, Giuseppe/AAG-6754-2022; Brown, Melissa A/F-1451-2010; Edwards, Stacey/A-4980-2011; balasubramanian, saba prakash/H-2830-2019; Radice, Paolo/O-3119-2013; Ng, Char Hong/F-8462-2010; Michailidou, Kyriaki/ABD-5122-2020; zhang, weihua/GXV-1334-2022; Margolin, Sara/AAX-9034-2020; Devilee, Peter/GXV-8005-2022; Severi, Gianluca/Q-1824-2019; Gonzalez-Neira, Anna/C-5791-2015; DEVILEE, PETER/ABR-2140-2022; Miller, Nicola/F-4009-2018; Sim, Xueling/AAZ-6652-2020; Knight, Julia/R-5617-2019; Guenel, Pascal/AAS-7688-2021; French, Juliet/AAV-4435-2020; Gao, Yu/HGE-1937-2022; Toland, Amanda Ewart/E-4202-2011; Hartikainen, Jaana M/E-6256-2015; French, Juliet D/A-4982-2011; Knight, Julia/A-6843-2012; Peterlongo, Paolo/Q-4717-2018; Andrulis, Irene L./E-7267-2013; Lissowska, Jolanta/AAH-3252-2020; Guenel, Pascal/H-3728-2018; Arndt, Volker/AAI-7282-2020; Teo, Soo-hwang/H-2353-2014; Figueroa, Jonine/GWD-1322-2022; Arndt, Volker/B-4999-2014; Lu, Wei/AAE-2921-2022; /AAM-5330-2020; Matsuo, Keitaro/H-6758-2019; Baglietto, Laura/AAB-9051-2019; Van Den Berg, David J/G-8598-2017; Schmidt, Marjanka K/G-9058-2011; Lambrechts, Diether/AAJ-3167-2020; Pharoah, Paul/V-6658-2019; Bogdanova, Natalia V./Y-2205-2019; Figueroa, Jonine/AFK-2752-2022; Li, Jingmei/I-2904-2012; Shrubsole, Martha J/K-5052-2015; Bonanni, Bernardo/AAM-7928-2020; Fasching, Peter A/ABH-9912-2020; Laurent-Puig, Pierre/K-3641-2019; Garcia-Closas, Montserrat/F-3871-2015; Garcia-Closas, Montserrat/AAZ-6930-2021; Gao, Y./GWZ-3665-2022; Noh, Dong-Young/G-5531-2011; Brenner, Hermann/ABE-6383-2020; Hartman, Mikael/B-4324-2011	Maia, Ana-Teresa/0000-0002-0454-9207; Liu, Jianjun/0000-0002-3255-3019; Severi, Gianluca/0000-0001-7157-419X; truong, therese/0000-0002-2943-6786; Menegaux, Florence/0000-0003-3363-6411; laurent-puig, pierre/0000-0001-8475-5459; Figueroa, Jonine/0000-0002-5100-623X; Brenner, Hermann/0000-0002-6129-1572; Dörk, Thilo/0000-0002-9458-0282; Floris, Giuseppe/0000-0003-2391-5425; Zheng, Wei/0000-0003-1226-070X; Jakubowska, Anna/0000-0002-5650-0501; Schumacher, Fredrick/0000-0002-3073-7463; Chenevix-Trench, Georgia/0000-0002-1878-2587; Ekici, Arif B/0000-0001-6099-7066; Floris, Giuseppe/0000-0003-2391-5425; balasubramanian, saba prakash/0000-0001-5953-2843; Radice, Paolo/0000-0001-6298-4111; Michailidou, Kyriaki/0000-0001-7065-1237; Severi, Gianluca/0000-0001-7157-419X; Gonzalez-Neira, Anna/0000-0002-5421-2020; Miller, Nicola/0000-0002-5416-7047; Sim, Xueling/0000-0002-1233-7642; Knight, Julia/0000-0002-7610-7635; Guenel, Pascal/0000-0002-8359-518X; French, Juliet/0000-0002-9770-0198; Hartikainen, Jaana M/0000-0001-8267-1905; Peterlongo, Paolo/0000-0001-6951-6855; Lissowska, Jolanta/0000-0003-2695-5799; Guenel, Pascal/0000-0002-8359-518X; Arndt, Volker/0000-0001-9320-8684; Figueroa, Jonine/0000-0002-5100-623X; Arndt, Volker/0000-0001-9320-8684; Lu, Wei/0000-0002-4150-8674; Matsuo, Keitaro/0000-0003-1761-6314; Van Den Berg, David J/0000-0002-5404-5218; Schmidt, Marjanka K/0000-0002-2228-429X; Lambrechts, Diether/0000-0002-3429-302X; Pharoah, Paul/0000-0001-8494-732X; Figueroa, Jonine/0000-0002-5100-623X; Li, Jingmei/0000-0001-8587-7511; Shrubsole, Martha J/0000-0002-5591-7575; Fasching, Peter A/0000-0003-4885-8471; Laurent-Puig, Pierre/0000-0001-8475-5459; Garcia-Closas, Montserrat/0000-0003-1033-2650; Garcia-Closas, Montserrat/0000-0003-1033-2650; Brenner, Hermann/0000-0002-6129-1572; Baglietto, Laura/0000-0002-8193-7529; Brown, Melissa/0000-0002-2830-9259; Khan, Sofia/0000-0003-4185-8882; Devilee, Peter/0000-0002-8023-2009; Schoemaker, Minouk/0000-0001-8403-2234; Barnes, Daniel/0000-0002-3781-7570; Kerin, Michael/0000-0003-4164-5561; Beesley, Jonathan/0000-0003-1942-325X; Winqvist, Robert/0000-0003-0932-9104; Klevebring, Daniel/0000-0002-9810-3838; Dunning, Alison Margaret/0000-0001-6651-7166; Rudolph, Anja/0000-0001-7520-2035; Simard, Jacques/0000-0001-6906-3390; Margolin, Sara/0000-0002-5526-5570; Long, Jirong/0000-0002-7433-9766; Schoof, Nils/0000-0003-0509-9217; Dennis, Joe/0000-0003-4591-1214; Mulligan, Anna Marie/0000-0002-7239-5297; Knoblauch, Nicholas/0000-0002-2890-6520; Nordestgaard, Borge/0000-0002-1954-7220; Lubinski, Jan/0000-0003-2931-3003; Giles, Graham/0000-0003-4946-9099; dos Santos Silva, Isabel/0000-0002-6596-8798; Engel, Christoph/0000-0002-7247-282X; Brauch, Hiltrud/0000-0001-7531-2736; Aitken, Zoe/0000-0002-5413-2450; Southey, Melissa/0000-0002-6313-9005; Swerdlow, Anthony/0000-0001-5550-4159; Durocher, Francine/0000-0001-8012-4641; Thorne, Heather/0000-0003-3610-2511; Arias Perez, Jose Ignacio/0000-0003-4500-397X; Hartman, Mikael/0000-0001-5726-9965; Blomqvist, Carl/0000-0003-3041-1938; Bojesen, Stig/0000-0002-4061-4133; Bailey, Peter/0000-0002-0857-2041; Kang, Daehee/0000-0003-4031-5878; Pylkas, Katri/0000-0002-2449-0521; Nevanlinna, Heli/0000-0002-0916-2976; Yannoukakos, Drakoulis/0000-0001-7509-3510; Czene, Kamila/0000-0002-3233-5695; Ito, Hidemi/0000-0002-8023-4581; Cox, Angela/0000-0002-5138-1099; Kataja, Vesa/0000-0003-4846-4843	Cancer Research UK [10119, 10124, 11022, 10118] Funding Source: Medline; NCI NIH HHS [R01 CA092447, R01 CA122340, R01 CA128978, P01 CA087969, P50 CA116201] Funding Source: Medline; Breast Cancer Now [BREAST CANCER NOW RESEARCH CENTRE] Funding Source: Medline; Cancer Research UK [16561, 19275, 16565] Funding Source: researchfish; National Institute for Health Research [03/DHCS/03/G121/51] Funding Source: researchfish; The Francis Crick Institute [10119, 10124] Funding Source: researchfish; National Breast Cancer Foundation [ECF-12-04, IF-12-06] Funding Source: researchfish; Cancer Foundation Finland sr [110135] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [ZIACP010201, ZIACP010126, R01CA122340, R01CA128978, P01CA087969, R01CA092447, P50CA116201] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Breast Cancer Now; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); The Francis Crick Institute; National Breast Cancer Foundation; Cancer Foundation Finland sr; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aaltonen K, 2009, BRIT J CANCER, V100, P1055, DOI 10.1038/sj.bjc.6604874; ADNANE J, 1991, ONCOGENE, V6, P659; Arnold JM, 2010, BREAST CANCER RES TR, V119, P491, DOI 10.1007/s10549-008-0269-x; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Bienvenu F, 2010, NATURE, V463, P374, DOI 10.1038/nature08684; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Day BW, 2011, NEURO-ONCOLOGY, V13, P1202, DOI 10.1093/neuonc/nor119; Eeckhoute J, 2007, CANCER RES, V67, P6477, DOI 10.1158/0008-5472.CAN-07-0746; Eeckhoute J, 2006, GENE DEV, V20, P2513, DOI 10.1101/gad.1446006; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Fu MF, 2005, J BIOL CHEM, V280, P16934, DOI 10.1074/jbc.M500403200; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; Gudmundsson J, 2009, NAT GENET, V41, P1122, DOI 10.1038/ng.448; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Jang JH, 2001, CANCER RES, V61, P3541; Janssen JWG, 2002, INT J CANCER, V102, P608, DOI 10.1002/ijc.10765; Jiang L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-20; Jirawatnotai S, 2011, NATURE, V474, P230, DOI 10.1038/nature10155; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kong SL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.59; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Lambrechts D, 2012, HUM MUTAT, V33, P1123, DOI 10.1002/humu.22089; Lehn S, 2010, AM J PATHOL, V177, P2886, DOI 10.2353/ajpath.2010.100303; Luo Y, 2012, ONCOGENE; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Meyer KB, 2008, PLOS BIOL, V6, P1098, DOI 10.1371/journal.pbio.0060108; Michailidou K., 2013, NAT GENET; Moffa AB, 2004, MOL CANCER RES, V2, P643; Ochsner SA, 2012, PHYSIOL GENOMICS, V44, P853, DOI 10.1152/physiolgenomics.00033.2012; Ormandy CJ, 2003, BREAST CANCER RES TR, V78, P323, DOI 10.1023/A:1023033708204; Purdue MP, 2011, NAT GENET, V43, P60, DOI 10.1038/ng.723; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Schodel J, 2012, NAT GENET, V44, P420, DOI 10.1038/ng.2204; Schumacher FR, 2011, HUM MOL GENET, V20, P3867, DOI 10.1093/hmg/ddr295; Stram DO, 2003, HUM HERED, V55, P27, DOI 10.1159/000071807; Sur IK, 2012, SCIENCE, V338, P1360, DOI 10.1126/science.1228606; Tan-Wong SM, 2008, P NATL ACAD SCI USA, V105, P5160, DOI 10.1073/pnas.0801048105; Theodorou V, 2013, GENOME RES, V23, P12, DOI 10.1101/gr.139469.112; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Tobin NP, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-417; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhong ZJ, 2010, CANCER RES, V70, P2105, DOI 10.1158/0008-5472.CAN-08-1108; Zwijsen RML, 1998, GENE DEV, V12, P3488, DOI 10.1101/gad.12.22.3488	48	159	161	1	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 4	2013	92	4					489	503		10.1016/j.ajhg.2013.01.002	http://dx.doi.org/10.1016/j.ajhg.2013.01.002			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	124FR	23540573	Green Published, Bronze			2022-12-18	WOS:000317449700002
J	Lubs, HA; Stevenson, RE; Schwartz, CE				Lubs, Herbert A.; Stevenson, Roger E.; Schwartz, Charles E.			Fragile X and X-Linked Intellectual Disability: Four Decades of Discovery	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							PELIZAEUS-MERZBACHER-DISEASE; SEVERE MENTAL-RETARDATION; FINEMAN-MYERS-SYNDROME; FG-SYNDROME; XLMR GENES; INTERNATIONAL WORKSHOP; HOMEOBOX GENE; ATR-X; CEREBELLAR HYPOPLASIA; OLIGOPHRENIN-1 GENE	X-Linked intellectual disability (XLID) accounts for 5%-10% of intellectual disability in males. Over 150 syndromes, the most common of which is the fragile X syndrome, have been described. A large number of families with nonsyndromal XLID, 95 of which have been regionally mapped, have been described as well. Mutations in 102 X-linked genes have been associated with 81 of these XLID syndromes and with 35 of the regionally mapped families with nonsyndromal XLID. Identification of these genes has enabled considerable reclassification and better understanding of the biological basis of XLID. At the same time, it has improved the clinical diagnosis of XLID and allowed for carrier detection and prevention strategies through gamete donation, prenatal diagnosis, and genetic counseling. Progress in delineating XLID has far outpaced the efforts to understand the genetic basis for autosomal intellectual disability. In large measure, this has been because of the relative ease of identifying families with XLID and finding the responsible mutations, as well as the determined and interactive efforts of a small group of researchers worldwide.	[Lubs, Herbert A.; Stevenson, Roger E.; Schwartz, Charles E.] Greenwood Genet Ctr, JC Self Res Inst Human Genet, Greenwood, SC 29646 USA	Greenwood Genetic Center	Stevenson, RE (corresponding author), Greenwood Genet Ctr, JC Self Res Inst Human Genet, 113 Gregor Mendel Circle, Greenwood, SC 29646 USA.	res@ggc.org						Abidi F, 1999, AM J MED GENET, V85, P249, DOI 10.1002/(SICI)1096-8628(19990730)85:3<249::AID-AJMG12>3.0.CO;2-U; Abidi FE, 2005, EUR J HUM GENET, V13, P176, DOI 10.1038/sj.ejhg.5201303; ADES LC, 1991, AM J MED GENET, V40, P467, DOI 10.1002/ajmg.1320400419; Allan W, 1944, AM J MENT DEF, V48, P325; Battaglia A, 2006, AM J MED GENET A, V140A, P2075, DOI 10.1002/ajmg.a.31302; Bedeschi MF, 2008, AM J MED GENET A, V146A, P1718, DOI 10.1002/ajmg.a.32365; BELL MV, 1991, CELL, V64, P861, DOI 10.1016/0092-8674(91)90514-Y; Bergmann C, 2003, BRAIN, V126, P1537, DOI 10.1093/brain/awg173; BICKERS DS, 1949, BRAIN, V72, P246, DOI 10.1093/brain/72.2.246; Bienvenu T, 2002, HUM MOL GENET, V11, P981, DOI 10.1093/hmg/11.8.981; Bittel DC, 2007, GENET MED, V9, P464, DOI 10.1097/GIM.0b013e3180ca9a9a; Briault S, 1997, AM J MED GENET, V73, P87; Briault S, 2000, AM J MED GENET, V95, P178, DOI 10.1002/1096-8628(20001113)95:2<178::AID-AJMG17>3.0.CO;2-V; BROWN WT, 1991, AM J MED GENET, V38, P158, DOI 10.1002/ajmg.1320380202; Chelly J, 2006, EUR J HUM GENET, V14, P701, DOI 10.1038/sj.ejhg.5201595; Chiurazzi P, 2001, EUR J HUM GENET, V9, P71, DOI 10.1038/sj.ejhg.5200603; Chiurazzi P, 2008, EUR J HUM GENET, V16, P422, DOI 10.1038/sj.ejhg.5201994; Clark RD, 2009, GENET MED, V11, P769, DOI 10.1097/GIM.0b013e3181bd3d90; Dessay S, 2002, AM J MED GENET, V112, P6, DOI 10.1002/ajmg.10546; DUNN HG, 1963, AM J MENT DEF, V67, P827; French CA, 2003, CANCER RES, V63, P304; Friez MJ, 2006, PEDIATRICS, V118, pE1687, DOI 10.1542/peds.2006-0395; Frints SGM, 2002, AM J MED GENET, V112, P427, DOI 10.1002/ajmg.10629; Froyen G, 2008, AM J HUM GENET, V82, P432, DOI 10.1016/j.ajhg.2007.11.002; Froyen G, 2007, HUM MUTAT, V28, P1034, DOI 10.1002/humu.20564; Gecz J, 2009, TRENDS GENET, V25, P308, DOI 10.1016/j.tig.2009.05.002; GIBBONS RJ, 1995, AM J MED GENET, V55, P288, DOI 10.1002/ajmg.1320550309; GIBBONS RJ, 1995, CELL, V80, P837, DOI 10.1016/0092-8674(95)90287-2; Gijsbers ACJ, 2011, CLIN GENET, V79, P71, DOI 10.1111/j.1399-0004.2010.01438.x; GIRAUD F, 1976, HUM GENET, V34, P125, DOI 10.1007/BF00278880; Graves JAM, 2002, CYTOGENET GENOME RES, V99, P141, DOI 10.1159/000071585; Guerrini R, 2000, ANN NEUROL, V47, P117; Hantash FM, 2010, GENET MED, V12, P162, DOI 10.1097/GIM.0b013e3181d0d40e; HARRISON CJ, 1983, J MED GENET, V20, P280, DOI 10.1136/jmg.20.4.280; HARVEY J, 1977, J MED GENET, V14, P46, DOI 10.1136/jmg.14.1.46; HEDGES LV, 1995, SCIENCE, V269, P41, DOI 10.1126/science.7604277; HERBST DS, 1980, AM J MED GENET, V7, P461, DOI 10.1002/ajmg.1320070407; Horn D, 2007, MED GENETIK, V19, P62; Jehee FS, 2005, AM J MED GENET A, V139A, P221, DOI 10.1002/ajmg.a.30991; JOLLY DJ, 1983, P NATL ACAD SCI-BIOL, V80, P477, DOI 10.1073/pnas.80.2.477; KAISERMCCAW B, 1980, AM J MED GENET, V7, P503, DOI 10.1002/ajmg.1320070411; Kalscheuer VM, 2003, NAT GENET, V35, P313, DOI 10.1038/ng1264; Kato M, 2004, HUM MUTAT, V23, P147, DOI 10.1002/humu.10310; Kitamura K, 2002, NAT GENET, V32, P359, DOI 10.1038/ng1009; Kleefstra T, 2005, CLIN GENET, V67, P451, DOI 10.1111/j.1399-0004.2005.00434.x; Koolen DA, 2009, HUM MUTAT, V30, P283, DOI 10.1002/humu.20883; LEHRKE R G, 1974, Birth Defects Original Article Series, V10, P1; Lenski C, 2004, AM J HUM GENET, V74, P777, DOI 10.1086/383205; LOSOWSKY MS, 1961, J MENT DEFIC RES, V5, P60, DOI 10.1111/jir.1961.5.1.60; Lossi AM, 1999, AM J HUM GENET, V65, P558, DOI 10.1086/302499; Lubs H, 1999, AM J MED GENET, V83, P237, DOI 10.1002/(SICI)1096-8628(19990402)83:4<237::AID-AJMG2>3.3.CO;2-#; Lubs H, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.037556; Lubs HA, 1996, AM J MED GENET, V64, P147, DOI 10.1002/(SICI)1096-8628(19960712)64:1<147::AID-AJMG25>3.0.CO;2-M; LUBS HA, 1969, AM J HUM GENET, V21, P231; Lubs HA, 1999, AM J MED GENET, V85, P206, DOI 10.1002/(SICI)1096-8628(19990730)85:3<206::AID-AJMG3>3.0.CO;2-8; LUBS HA, 1970, SCIENCE, V169, P495, DOI 10.1126/science.169.3944.495; Lyons MJ, 2009, J MED GENET, V46, P9, DOI 10.1136/jmg.2008.060509; Martin JP, 1943, J NEUROL PSYCHIATRY, V6, P154, DOI 10.1136/jnnp.6.3-4.154; MATTEI JF, 1983, CLIN GENET, V23, P70; McMaster Gerald, 2004, NATIVE UNIVERSE VOIC; Mimault C, 1999, AM J HUM GENET, V65, P360, DOI 10.1086/302483; Neri G, 2000, AM J MED GENET, V97, P228, DOI 10.1002/1096-8628(200023)97:3<228::AID-AJMG1041>3.0.CO;2-2; NERI G, 1991, AM J MED GENET, V38, P186, DOI 10.1002/ajmg.1320380204; NERI G, 1992, AM J MED GENET, V43, P373, DOI 10.1002/ajmg.1320430158; NERI G, 1988, AM J MED GENET, V30, P1, DOI 10.1002/ajmg.1320300102; NERI G, 1994, AM J MED GENET, V51, P542, DOI 10.1002/ajmg.1320510451; Nguyen DK, 2006, NAT GENET, V38, P47, DOI 10.1038/ng1705; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; OPITZ JM, 1988, AM J MED GENET, V30, P309, DOI 10.1002/ajmg.1320300132; OPITZ JM, 1974, Z KINDERHEILKD, V117, P1, DOI 10.1007/BF00439020; OPITZ JM, 1984, AM J MED GENET, V17, P5, DOI 10.1002/ajmg.1320170103; Ozonoff S, 2000, AM J MED GENET, V97, P112, DOI 10.1002/1096-8628(200022)97:2<112::AID-AJMG2>3.0.CO;2-D; Penrose L.S., 1938, CLIN GENETIC STUDY 1; Philip N, 2003, J MED GENET, V40, P441, DOI 10.1136/jmg.40.6.441; Piluso G, 2003, HUM GENET, V112, P124, DOI 10.1007/s00439-002-0863-7; Renieri A, 2005, J CELL PHYSIOL, V204, P8, DOI 10.1002/jcp.20296; RENPENNING H, 1962, CAN MED ASSOC J, V87, P954; Rio M, 2010, EUR J HUM GENET, V18, P285, DOI 10.1038/ejhg.2009.159; Risheg H, 2007, NAT GENET, V39, P451, DOI 10.1038/ng1992; Baraitser M, 1994, Clin Dysmorphol, V3, P40; Ropers HH, 2008, CURR OPIN GENET DEV, V18, P241, DOI 10.1016/j.gde.2008.07.008; Ropers HH, 2005, NAT REV GENET, V6, P46, DOI 10.1038/nrg1501; Salomons GS, 2001, AM J HUM GENET, V68, P1497, DOI 10.1086/320595; Skuse DH, 2005, HUM MOL GENET, V14, pR27, DOI 10.1093/hmg/ddi112; SMITH RD, 1980, AM J MED GENET, V7, P5, DOI 10.1002/ajmg.1320070103; Solomon NM, 2004, J MED GENET, V41, P669, DOI 10.1136/jmg.2003.016949; Stepp ML, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-16; Stevenson R. E., 2012, ATLAS X LINKED INTEL; Stevenson RE, 2005, AM J MED GENET A, V134A, P415, DOI 10.1002/ajmg.a.30664; Stevenson RE, 2002, CYTOGENET GENOME RES, V99, P265, DOI 10.1159/000071603; Stevenson RE, 2009, DEV DISABIL RES REV, V15, P361, DOI 10.1002/ddrr.81; Stromme P, 2002, NAT GENET, V30, P441, DOI 10.1038/ng862; Stromme P, 2002, BRAIN DEV-JPN, V24, P266, DOI 10.1016/S0387-7604(02)00079-7; SUTHERLAND GR, 1977, SCIENCE, V197, P265, DOI 10.1126/science.877551; Tarpey PS, 2007, NAT GENET, V39, P1127, DOI 10.1038/ng2100; Trivier E, 1996, NATURE, V384, P567, DOI 10.1038/384567a0; Turner G, 2008, CLIN GENET, V73, P188, DOI 10.1111/j.1399-0004.2007.00929.x; TURNER G, 1986, AM J MED GENET, V23, P11, DOI 10.1002/ajmg.1320230103; Turner G, 1996, AM J HUM GENET, V58, P1109; TURNER G, 1991, J MED GENET, V28, P429, DOI 10.1136/jmg.28.6.429; Turner G, 1996, LANCET, V347, P1814, DOI 10.1016/S0140-6736(96)91623-2; Unger S, 2007, AM J MED GENET A, V143A, P1876, DOI 10.1002/ajmg.a.31751; Uyanik G, 2003, NEUROLOGY, V61, P232, DOI 10.1212/01.WNL.0000079371.19562.BA; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Villard L, 2000, AM J MED GENET, V91, P83, DOI 10.1002/(SICI)1096-8628(20000306)91:1<83::AID-AJMG15>3.3.CO;2-E; Villard L, 1999, J MED GENET, V36, P183; Villard L, 1996, NAT GENET, V12, P359, DOI 10.1038/ng0496-359; Wagenstaller J, 2007, AM J HUM GENET, V81, P768, DOI 10.1086/521274; Whibley AC, 2010, AM J HUM GENET, V87, P173, DOI 10.1016/j.ajhg.2010.06.017; Woodward K, 1999, PRENATAL DIAG, V19, P266, DOI 10.1002/(SICI)1097-0223(199903)19:3<266::AID-PD515>3.0.CO;2-#; Yntema HG, 2002, AM J MED GENET, V110, P243, DOI 10.1002/ajmg.10446; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179; Zechner U, 2001, TRENDS GENET, V17, P697, DOI 10.1016/S0168-9525(01)02446-5	114	159	168	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR 6	2012	90	4					579	590		10.1016/j.ajhg.2012.02.018	http://dx.doi.org/10.1016/j.ajhg.2012.02.018			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	926LV	22482801	Green Published, Bronze			2022-12-18	WOS:000302833400001
J	Hamdan, FF; Daoud, H; Rochefort, D; Piton, A; Gauthier, J; Langlois, M; Foomani, G; Dobrzeniecka, S; Krebs, MO; Joober, R; Lafreniere, RG; Lacaille, JC; Mottron, L; Drapeau, P; Beauchamp, MH; Phillips, MS; Fombonne, E; Rouleau, GA; Michaud, JL				Hamdan, Fadi F.; Daoud, Hussein; Rochefort, Daniel; Piton, Amelie; Gauthier, Julie; Langlois, Mathieu; Foomani, Gila; Dobrzeniecka, Sylvia; Krebs, Marie-Odile; Joober, Ridha; Lafreniere, Ronald G.; Lacaille, Jean-Claude; Mottron, Laurent; Drapeau, Pierre; Beauchamp, Miriam H.; Phillips, Michael S.; Fombonne, Eric; Rouleau, Guy A.; Michaud, Jacques L.			De Novo Mutations in FOXP1 in Cases with Intellectual Disability, Autism, and Language Impairment	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FORKHEAD-DOMAIN; SEVERE SPEECH; GENE; EXPRESSION; PROTEIN; ENTEROPATHY; VARIANTS; CNTNAP2; LUNG	Heterozygous mutations in FOXP2, which encodes a forkhead transcription factor have been shown to cause developmental verbal dyspraxia and language impairment FOXP2 and its closest homolog FOXP1, are coexpressed in brain regions that are Important for language and cooperatively regulate developmental processes, raising the possibility that FOXP1 may also be involved in developmental conditions that are associated with language impairment In order to explore this possibility, we searched for mutations in FOXP1 in patients with intellectual disability (ID mental retardation) and/or autism spectrum disorders (ASD) We first performed array based genomic hybridization on sporadic nonsyndromic ID (NSID) (n = 30) or ASD (n = 80) cases We identified a de novo intragenic deletion encompassing exons 4-14 of FOXP1 in a patient with NSID and autistic features In addition sequencing of all coding exons of FOXP1 in sporadic NSID (n = 110) or MD (n = 135) cases, as well as in 570 controls, revealed the presence of a de novo nonsense mutation (c 1573C>T [p R525X]) in the conserved forkhead DNA binding domain in a patient with NSID and autism Luciferase reporter assays showed that the p R525X alteration disrupts the activity of the protein Formal assessments revealed that both patients with de novo mutations in FOXP1 also show severe language impairment mood lability with physical aggressiveness, and specific obsessions and compulsions In conclusion, both FOXP1 and FOXP2 are associated with language impairment, but decrease of the former has a more global impact on brain development than that of the latter	[Hamdan, Fadi F.; Beauchamp, Miriam H.; Rouleau, Guy A.; Michaud, Jacques L.] Univ Montreal, Ctr Excellence Neur, St Justine Hosp, Res Ctr, Montreal, PQ H3T 1C5, Canada; [Daoud, Hussein; Rochefort, Daniel; Piton, Amelie; Gauthier, Julie; Dobrzeniecka, Sylvia; Lafreniere, Ronald G.; Rouleau, Guy A.] Univ Montreal & Dept Med, Ctr Excellence Neur, Montreal, PQ H2L 2W5, Canada; [Langlois, Mathieu; Phillips, Michael S.] Univ Montreal, Beaulieu Saucier Univ Montreal, Pharmacogenom Ctr, Montreal, PQ H1T 1C8, Canada; [Foomani, Gila; Fombonne, Eric] McGill Univ, Dept Psychiat, Montreal Childrens Hosp, Montreal, PQ H3Z 1P2, Canada; [Krebs, Marie-Odile] Univ Paris 05, INSERM, U894, St Anne Hosp, F-75014 Paris, France; [Joober, Ridha] McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Montreal, PQ H3A 1A1, Canada; [Lacaille, Jean-Claude] Univ Montreal, Dept Physiol, Grp Rech Syst Nerveux Cent, Montreal, PQ H3C 3J7, Canada; [Mottron, Laurent] Hop Riviere Prairies, Ctr Rech Fernand Seguin, Montreal, PQ H1E 1A4, Canada; [Drapeau, Pierre] Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ H3C 3J7, Canada; [Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; McGill University; GHU PARIS Psychiatrie Neurosciences; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; McGill University; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Rouleau, GA (corresponding author), Univ Montreal, Ctr Excellence Neur, St Justine Hosp, Res Ctr, Montreal, PQ H3T 1C5, Canada.		Fombonne, Eric/M-4893-2018; piton, amelie/F-1201-2013; Krebs, Marie-Odile/O-2104-2017	Fombonne, Eric/0000-0002-8605-3538; piton, amelie/0000-0003-0408-7468; Krebs, Marie-Odile/0000-0002-4715-9890; spiegelman, dan/0000-0003-4971-8868; Mottron, Laurent/0000-0001-5668-5422	Canadian Institute of Health Research (CIHR); Reseau de Genetique Medicale Appliquee (RMGA); Genome Canada; Genome Quebec; Universite de Montreal; CIHR (Institute of Genetics); FRSQ	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Reseau de Genetique Medicale Appliquee (RMGA); Genome Canada(Genome Canada); Genome Quebec; Universite de Montreal; CIHR (Institute of Genetics)(Canadian Institutes of Health Research (CIHR)); FRSQ(Fonds de la Recherche en Sante du Quebec)	This work was supported by grants from the Canadian Institute of Health Research (CIHR) (JLM G A R, J C L), Reseau de Genetique Medicale Appliquee (RMGA) / Fonds de la Recherche en Sante du Quebec (FRSQ) U L M and MS P), Genome Canada and Genome Quebec, and cofunding by Universite de Montreal for the Synapse to Diseases (S2D) project (G A R and Pc D) JLM is the recipient of a Clinical Investigatorship Award of the CIHR (Institute of Genetics) and a Senior Scientist Award from FRSQ E F holds the CIHR funded Canada Research Chair in Child Psychiatry H D is a recipient of a CIHR postdoctoral fellowship award We thank the patients and their parents for participating in this study We are grateful for the dedicated work of members of the S2D team (CHUM Research Center, Montreal), including Management (Claude Marineau), Bioinformatics (Edouard Hen non, Ousmane Diallo, and Dan Spiegelman), and the Genetic Screening divisions (Annie Levert, Annie Raymond, Pascal Thibo deau, Sandra Laurent, and Kanne Lachapelle) We are thankful for the efforts of the members of McGill University and Genome Quebec Innovation Centre Sequencing (Pierre Lepage, Sebastien Brunet, and Hao Fan Yam) and Bioinformatics (Louis Letourneau and Louis Dumond Joseph) groups	Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Banham AH, 2001, CANCER RES, V61, P8820; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bodfish JW, 2000, J AUTISM DEV DISORD, V30, P237, DOI 10.1023/A:1005596502855; Brown EC, 2002, RES DEV DISABIL, V23, P45, DOI 10.1016/S0891-4222(01)00091-9; Carr CW, 2010, EUR J HUM GENET, V18, P1216, DOI 10.1038/ejhg.2010.96; Enard W, 2009, CELL, V137, P961, DOI 10.1016/j.cell.2009.03.041; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; Fisher SE, 2003, ANNU REV NEUROSCI, V26, P57, DOI 10.1146/annurev.neuro.26.041002.131144; Fisher SE, 2009, TRENDS GENET, V25, P166, DOI 10.1016/j.tig.2009.03.002; Gauthier J, 2010, P NATL ACAD SCI USA, V107, P7863, DOI 10.1073/pnas.0906232107; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; Hamdan FF, 2009, NEW ENGL J MED, V360, P599, DOI 10.1056/NEJMoa0805392; Hannenhalli S, 2009, NAT REV GENET, V10, P233, DOI 10.1038/nrg2523; Jin Y, 2010, NAT GENET, V42, P576, DOI 10.1038/ng.602; KAUFMAN L, 2010, J NEURODEV DISORD, DOI DOI 10.1007/S11689.010.9055.2; Konopka G, 2009, NATURE, V462, P213, DOI 10.1038/nature08549; Lai CSL, 2003, BRAIN, V126, P2455, DOI 10.1093/brain/awg247; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Li SR, 2004, MOL CELL BIOL, V24, P809, DOI 10.1128/MCB.24.2.809-822.2004; MacDermot KD, 2005, AM J HUM GENET, V76, P1074, DOI 10.1086/430841; Pantano L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-573; Pariani MJ, 2009, EUR J MED GENET, V52, P123, DOI 10.1016/j.ejmg.2009.03.012; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Shu WG, 2007, DEVELOPMENT, V134, P1991, DOI 10.1242/dev.02846; Shu WG, 2001, J BIOL CHEM, V276, P27488, DOI 10.1074/jbc.M100636200; Stroud JC, 2006, STRUCTURE, V14, P159, DOI 10.1016/j.str.2005.10.005; Teramitsu I, 2004, J NEUROSCI, V24, P3152, DOI 10.1523/JNEUROSCI.5589-03.2004; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828; Vernes SC, 2006, HUM MOL GENET, V15, P3154, DOI 10.1093/hmg/ddl392; Vernes SC, 2009, EUR J HUM GENET, V17, P1354, DOI 10.1038/ejhg.2009.43; Wang B, 2003, J BIOL CHEM, V278, P24259, DOI 10.1074/jbc.M207174200; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Zhang J, 2006, CYTOGENET GENOME RES, V115, P205, DOI 10.1159/000095916	36	159	166	2	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 12	2010	87	5					671	678		10.1016/j.ajhg.2010.09.017	http://dx.doi.org/10.1016/j.ajhg.2010.09.017			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	686AE	20950788	Green Published, Bronze			2022-12-18	WOS:000284668400013
J	Yang, TL; Chen, XD; Guo, Y; Lei, SF; Wang, JT; Zhou, Q; Pan, F; Chen, Y; Zhang, ZX; Dong, SS; Xu, XH; Yan, H; Liu, X; Qiu, C; Zhu, XZ; Chen, T; Li, M; Zhang, H; Zhang, L; Drees, BM; Hamilton, JJ; Papasian, CJ; Recker, RR; Song, XP; Cheng, J; Deng, HW				Yang, Tie-Lin; Chen, Xiang-Ding; Guo, Yan; Lei, Shu-Feng; Wang, Jin-Tang; Zhou, Qi; Pan, Feng; Chen, Yuan; Zhang, Zhi-Xin; Dong, Shan-Shan; Xu, Xiang-Hong; Yan, Han; Liu, Xiaogang; Qiu, Chuan; Zhu, Xue-Zhen; Chen, Teng; Li, Meng; Zhang, Hong; Zhang, Liang; Drees, Betty M.; Hamilton, James J.; Papasian, Christopher J.; Recker, Robert R.; Song, Xiao-Ping; Cheng, Jing; Deng, Hong-Wen			Genome-wide Copy-Number-Variation Study Identified a Susceptibility Gene, UGT2B17, for Osteoporosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CROSS-SECTIONAL GEOMETRY; BONE-MINERAL DENSITY; STRUCTURAL VARIATION; DELETION POLYMORPHISM; PROXIMAL FEMUR; ASSOCIATION; MASS; FRACTURES; ALGORITHMS; EXPRESSION	Osteoporosis, a highly heritable disease, is characterized mainly by low bone-mineral density (BMD), poor bone geometry, and/or osteoporotic fractures (OF). Copy-number variation (CNV) has been shown to be associated with complex human diseases. The contribution of CNV to osteoporosis has not been determined yet. We conducted case-control genome-wide CNV analyses, using the Affymetrix 500K Array Set, in 700 elderly Chinese individuals comprising 350 cases with homogeneous hip OF and 350 matched controls. We constructed a genomic map containing 727 CNV regions in Chinese individuals. We found that CNV 4q13.2 was strongly associated with OF (p=2.0 x 10(-4), Bonferroni-corrected p = 0.02, odds ratio=1.73). Validation experiments using PCR and electrophoresis, as well as real-time PCR, further identified a deletion variant of UGT2B17 in CNV 4q13.2. Importantly, the association between CNV of UGT2B17 and OF was successfully replicated in an independent Chinese sample containing 399 cases with hip OF and 400 controls. We further examined this CNV's relevance to major risk factors for OF (i.e., hip BMD and femoral-neck bone geometry) in both Chinese (689 subjects) and white (1000 subjects) samples and found consistently significant results (p = 5.0 x 10(-4) -0.021). Because UGT2B17 encodes an enzyme catabolizing steroid hormones, we measured the concentrations of serum testosterone and estradiol for 236 young Chinese males and assessed their UGT2B17 copy number. Subjects without UG'172B17 had significantly higher concentrations of testosterone and estradiol. Our findings suggest the important contribution of CNV of UGT2B.17 to the pathogenesis of osteoporosis.	[Yang, Tie-Lin; Guo, Yan; Zhou, Qi; Pan, Feng; Chen, Yuan; Zhang, Zhi-Xin; Dong, Shan-Shan; Xu, Xiang-Hong; Yan, Han; Liu, Xiaogang; Qiu, Chuan; Zhu, Xue-Zhen; Song, Xiao-Ping; Deng, Hong-Wen] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Inst Mol Genet, Minist Educ,Key Lab Biomed Informat Engn, Xian 710049, Peoples R China; [Chen, Xiang-Ding; Lei, Shu-Feng; Deng, Hong-Wen] Hunan Normal Univ, Coll Life Sci, Mol & Stat Genet Lab, Changsha 410081, Hunan, Peoples R China; [Drees, Betty M.; Hamilton, James J.; Papasian, Christopher J.; Deng, Hong-Wen] Univ Missouri Kansas City, Sch Med, Kansas City, MO 64108 USA; [Zhang, Liang; Cheng, Jing] Natl Engn Res Ctr Beijing Biochip Technol, Beijing 102206, Peoples R China; [Recker, Robert R.] Creighton Univ, Osteoporosis Res Ctr, Omaha, NE 68131 USA	Xi'an Jiaotong University; Hunan Normal University; University of Missouri System; University of Missouri Kansas City; Creighton University	Deng, HW (corresponding author), Xi An Jiao Tong Univ, Sch Life Sci & Technol, Inst Mol Genet, Minist Educ,Key Lab Biomed Informat Engn, Xian 710049, Peoples R China.	dengh@umkc.edu	Guo, Yan/G-8742-2014; Qiu, Chuan/AAN-3319-2021; Yang, Tie-Lin/G-8365-2014; Song, Xiaoping/E-7788-2010	Guo, Yan/0000-0002-7364-2392; Qiu, Chuan/0000-0001-6202-9229; Yang, Tie-Lin/0000-0001-7062-3025; Deng, Hong-Wen/0000-0002-0387-8818	National Natural Science Foundation of China [30570875]; Xi'an Jiaotong University; Ministry of Education of China; Huo Ying Dong Education Foundation; HuNan Province; Hunan Normal University; University of Missouri-Kansas City; NIH [R01 AR050496, R21 AG027110, R01 AG026564, P50 AR055081, R21 AA015973]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050496, P50AR055081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG027110, R01AG026564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA015973] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Xi'an Jiaotong University(Xi'an Jiaotong University); Ministry of Education of China(Ministry of Education, China); Huo Ying Dong Education Foundation; HuNan Province; Hunan Normal University; University of Missouri-Kansas City; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank all participants for taking part in this research. Investigators of this project were funded in part by grant 30570875 from the National Natural Science Foundation of China, as well as by Xi'an Jiaotong University, the Ministry of Education of China, Huo Ying Dong Education Foundation, HuNan Province, and Hunan Normal University. H.W.D. was supported by a Dickson and Missouri endowment from University of Missouri-Kansas City and by grants from the NIH (R01 AR050496, R21 AG027110, R01 AG026564, P50 AR055081, and R21 AA015973).	Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Baross A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-368; Beaulieu M, 1996, J BIOL CHEM, V271, P22855, DOI 10.1074/jbc.271.37.22855; Beck TJ, 2001, J BONE MINER RES, V16, P2103, DOI 10.1359/jbmr.2001.16.11.2103; Buckland PR, 2003, ANN MED, V35, P308, DOI 10.1080/07853890310001276; Chouinard S, 2004, ENDOCR RES, V30, P717, DOI 10.1081/ERC-200044014; Chouinard S, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703370200; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; de Smith AJ, 2007, HUM MOL GENET, V16, P2783, DOI 10.1093/hmg/ddm208; Deng HW, 2002, J CLIN ENDOCR METAB, V87, P5151, DOI 10.1210/jc.2002-020474; Deng HW, 2002, GENET EPIDEMIOL, V22, P12, DOI 10.1002/gepi.1040; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Di XJ, 2005, BIOINFORMATICS, V21, P1958, DOI 10.1093/bioinformatics/bti275; Duan YB, 2003, J BONE MINER RES, V18, P1766, DOI 10.1359/jbmr.2003.18.10.1766; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Friedman JM, 2006, AM J HUM GENET, V79, P500, DOI 10.1086/507471; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Kiel DP, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S14; Komura D, 2006, GENOME RES, V16, P1575, DOI 10.1101/gr.5629106; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Liu YZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003160; Liu YJ, 2008, HUM MOL GENET, V17, P1803, DOI 10.1093/hmg/ddn072; Liu YJ, 2006, J BONE MINER RES, V21, P1511, DOI 10.1359/JBMR.051002; Lupski JR, 2007, NEW ENGL J MED, V356, P1169, DOI 10.1056/NEJMcibr067658; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; Michaelsson K, 2005, ARCH INTERN MED, V165, P1825, DOI 10.1001/archinte.165.16.1825; Nelson DA, 2000, J BONE MINER RES, V15, P1992, DOI 10.1359/jbmr.2000.15.10.1992; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Pritchard JK, 2000, GENETICS, V155, P945; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Slemenda CW, 1996, OSTEOPOROSIS INT, V6, P178, DOI 10.1007/BF01623944; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Terakura S, 2005, BRIT J HAEMATOL, V129, P221, DOI 10.1111/j.1365-2141.2005.05427.x; Vanderschueren D, 2004, ENDOCR REV, V25, P389, DOI 10.1210/er.2003-0003; Wilson W, 2004, GENOMICS, V84, P707, DOI 10.1016/j.ygeno.2004.06.011; Xiong DH, 2006, J BONE MINER RES, V21, P424, DOI 10.1359/JBMR.051202	43	159	173	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 12	2008	83	6					663	674		10.1016/j.ajhg.2008.10.006	http://dx.doi.org/10.1016/j.ajhg.2008.10.006			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	385NY	18992858	Bronze, Green Published			2022-12-18	WOS:000261822100001
J	Fuku, N; Park, KS; Yamada, Y; Nishigaki, Y; Cho, YM; Matsuo, H; Segawa, T; Watanabe, S; Kato, K; Yokoi, K; Nozawa, Y; Lee, HK; Tanaka, M				Fuku, Noriyuki; Park, Kyong Soo; Yamada, Yoshiji; Nishigaki, Yutaka; Cho, Young Min; Matsuo, Hitoshi; Segawa, Tomonori; Watanabe, Sachiro; Kato, Kimihiko; Yokoi, Kiyoshi; Nozawa, Yoshinori; Lee, Hong Kyu; Tanaka, Masashi			Mitochondrial haplogroup N9a confers resistance against type 2 diabetes in Asians	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INSULIN-RESISTANCE; DNA; POLYMORPHISMS; ASSOCIATION; VARIANT; ADULTS; MTDNA; POPULATION; SECRETION; LONGEVITY	Because mitochondria play pivotal roles in both insulin secretion from the pancreatic beta cells and insulin resistance of skeletal muscles, we performed a large-scale association study to identify mitochondrial haplogroups that may confer resistance against or susceptibility to type 2 diabetes mellitus (T2DM). The study population comprised 2,906 unrelated Japanese individuals, including 1,289 patients with T2DM and 1,617 controls, and 1,365 unrelated Korean individuals, including 732 patients with T2DM and 633 controls. The genotypes for 25 polymorphisms in the coding region of the mitochondrial genome were determined, and the haplotypes were classified into 10 major haplogroups (i. e., F, B, A, N9a, M7a, M7b, G, D4a, D4b, and D5). Multivariate logistic- regression analysis with adjustment for age and sex revealed that the mitochondrial haplogroup N9a was significantly associated with resistance against T2DM (P = .0002) with an odds ratio of 0.55 (95% confidence interval 0.40-0.75). Even in the modern environment, which is often characterized by satiety and physical inactivity, this haplogroup might confer resistance against T2DM.	Tokyo Metropolitan Inst Gerontol, Dept Genom Longev & Hlth, Itabashi Ku, Tokyo 1730015, Japan; Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; Mie Univ, Life Sci Res Ctr, Dept Human Funct Genom, Tsu, Mie 514, Japan; Gifu Prefectural Gifu Hosp, Dept Cardiol, Gifu, Japan; Gifu Prefectural Tajimi Hosp, Dept Cardiovasc Med, Tajimi, Japan; Gifu Int Inst Biotechnol, Kakamigahara, Japan	Tokyo Metropolitan Institute of Gerontology; Seoul National University (SNU); Mie University	Tanaka, M (corresponding author), Tokyo Metropolitan Inst Gerontol, Dept Genom Longev & Hlth, Itabashi Ku, 35-2 Sakae Cho, Tokyo 1730015, Japan.	mtanaka@tmig.or.jp	Park, Kyong Soo/C-2265-2008; Cho, Young Min/J-5669-2012	Park, Kyong Soo/0000-0003-3597-342X; Fuku, Noriyuki/0000-0001-7792-5835				ALCOLADO JC, 1991, BRIT MED J, V302, P1178, DOI 10.1136/bmj.302.6786.1178; Chinnery PF, 2005, LANCET, V366, P1650, DOI 10.1016/S0140-6736(05)67492-2; Fuku N, 2002, BIOCHEM BIOPH RES CO, V290, P1199, DOI 10.1006/bbrc.2002.6330; Guo LJ, 2005, MITOCHONDRION, V5, P15, DOI 10.1016/j.mito.2004.09.001; IKEBE S, 1995, MOL BRAIN RES, V28, P281, DOI 10.1016/0169-328X(94)00209-W; Itoh Y, 2005, IMMUNOGENETICS, V57, P717, DOI 10.1007/s00251-005-0048-3; Kim JH, 2002, DIABETIC MED, V19, P681, DOI 10.1046/j.1464-5491.2002.00747.x; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Niemi AK, 2005, EUR J HUM GENET, V13, P166, DOI 10.1038/sj.ejhg.5201308; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Poulton J, 2002, HUM MOL GENET, V11, P1581, DOI 10.1093/hmg/11.13.1581; Poyton RO, 1996, ANNU REV BIOCHEM, V65, P563, DOI 10.1146/annurev.bi.65.070196.003023; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Saxena R, 2006, AM J HUM GENET, V79, P54, DOI 10.1086/504926; Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649; Soejima A, 1996, J BIOL CHEM, V271, P26194, DOI 10.1074/jbc.271.42.26194; Tanaka M, 1998, LANCET, V351, P185, DOI 10.1016/S0140-6736(05)78211-8; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; Tanaka Masashi, 2002, Journal of Neurology, V249, P11; THOMAS F, 1994, DIABETES, V43, P63, DOI 10.2337/diabetes.43.1.63; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Weng SW, 2005, J CLIN ENDOCR METAB, V90, P5037, DOI 10.1210/jc.2005-0227; Zhang J, 2003, P NATL ACAD SCI USA, V100, P1116, DOI 10.1073/pnas.242719399	27	159	164	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2007	80	3					407	415		10.1086/512202	http://dx.doi.org/10.1086/512202			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	139AB	17273962	Green Published, Bronze			2022-12-18	WOS:000244403300002
J	Duffy, DL; Montgomery, GW; Chen, W; Zhao, ZZ; Le, L; James, MR; Hayward, NK; Martin, NG; Sturm, RA				Duffy, David L.; Montgomery, Grant W.; Chen, Wei; Zhao, Zhen Zhen; Le, Lien; James, Michael R.; Hayward, Nicholas K.; Martin, Nicholas G.; Sturm, Richard A.			A three-single-nucleotide polymorphism haplotype in intron 1 of OCA2 explains most human eye-color variation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							P-GENE; OCULOCUTANEOUS ALBINISM; MELANOCORTIN-1 RECEPTOR; PRADER-WILLI; SKIN PIGMENTATION; MELANOCYTIC-NEVI; DILUTION LOCUS; HUMAN IRIDES; IRIS COLOR; MELANOMA	We have previously shown that a quantitative-trait locus linked to the OCA2 region of 15q accounts for 74% of variation in human eye color. We conducted additional genotyping to clarify the role of the OCA2 locus in the inheritance of eye color and other pigmentary traits associated with skin-cancer risk in white populations. Fifty-eight synonymous and nonsynonymous exonic single-nucleotide polymorphisms (SNPs) and tagging SNPs were typed in a collection of 3,839 adolescent twins, their siblings, and their parents. The highest association for blue/nonblue eye color was found with three OCA2 SNPs: rs7495174 T/C, rs6497268 G/T, and rs11855019 T/C (P values of 1.02 x 10(-61), 1.57 x 10(-96), and 4.45 x 10(-54), respectively) in intron 1. These three SNPs are in one major haplotype block, with TGT representing 78.4% of alleles. The TGT/TGT diplotype found in 62.2% of samples was the major genotype seen to modify eye color, with a frequency of 0.905 in blue or green compared with only 0.095 in brown eye color. This genotype was also at highest frequency in subjects with light brown hair and was more frequent in fair and medium skin types, consistent with the TGT haplotype acting as a recessive modifier of lighter pigmentary phenotypes. Homozygotes for rs11855019 C/C were predominantly without freckles and had lower mole counts. The minor population impact of the nonsynonymous coding-region polymorphisms Arg305Trp and Arg419Gln associated with nonblue eyes and the tight linkage of the major TGT haplotype within the intron 1 of OCA2 with blue eye color and lighter hair and skin tones suggest that differences within the 5' proximal regulatory control region of the OCA2 gene alter expression or messenger RNA-transcript levels and may be responsible for these associations.	Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; Univ Queensland, Queensland Inst Med Res, Brisbane, Qld 4072, Australia	University of Queensland; QIMR Berghofer Medical Research Institute; University of Queensland	Sturm, RA (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	R.Sturm@imb.uq.edu.au	Montgomery, Grant W/B-7148-2008; hayward, nicholas k/C-1367-2015; Duffy, David L/B-7392-2013; hayward, nick/AAV-8802-2020; Sturm, Richard A/C-9943-2009	Montgomery, Grant W/0000-0002-4140-8139; hayward, nicholas k/0000-0003-4760-1033; Duffy, David L/0000-0001-7227-632X; Sturm, Richard A/0000-0003-1301-0294; Martin, Nicholas/0000-0003-4069-8020	NCI NIH HHS [CA88363, R01 CA088363] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA088363] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akahoshi K, 2004, AM J MED GENET A, V126A, P290, DOI 10.1002/ajmg.a.20580; Akahoshi K, 2001, AM J MED GENET, V104, P299, DOI 10.1002/ajmg.10095; Akey JM, 2001, HUM GENET, V108, P516, DOI 10.1007/s004390100524; Albert Daniel M, 2003, Trans Am Ophthalmol Soc, V101, P217; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Ancans J, 2003, ANN NY ACAD SCI, V994, P373, DOI 10.1111/j.1749-6632.2003.tb03202.x; Armstrong BK, 2001, J PHOTOCH PHOTOBIO B, V63, P8, DOI 10.1016/S1011-1344(01)00198-1; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Biswas S, 2006, TRENDS GENET, V22, P437, DOI 10.1016/j.tig.2006.06.005; Bito LZ, 1997, ARCH OPHTHALMOL-CHIC, V115, P659, DOI 10.1001/archopht.1997.01100150661017; BLISS JM, 1995, INT J CANCER, V62, P367, DOI 10.1002/ijc.2910620402; Brilliant MH, 2001, PIGM CELL RES, V14, P86, DOI 10.1034/j.1600-0749.2001.140203.x; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Davenport GC, 1907, SCIENCE, V26, P589, DOI 10.1126/science.26.670.589-b; Dellavalle RP, 2005, ARCH DERMATOL, V141, P1042, DOI 10.1001/archderm.141.8.1042; Duffy DL, 2004, HUM MOL GENET, V13, P447, DOI 10.1093/hmg/ddh043; EIBERG H, 1987, CLIN GENET, V31, P186; Eiberg H, 1996, EUR J HUM GENET, V4, P237; Frudakis T, 2003, GENETICS, V165, P2071; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Garcia-Borron JC, 2005, PIGM CELL RES, V18, P393, DOI 10.1111/j.1600-0749.2005.00278.x; GARDNER JM, 1992, SCIENCE, V257, P1121, DOI 10.1126/science.257.5073.1121; HASSTEDT SJ, 1995, GENET EPIDEMIOL, V12, P109, DOI 10.1002/gepi.1370120202; Hothorn T, 2004, UNBIASED RECURSIVE P; Imesch PD, 1997, SURV OPHTHALMOL, V41, pS117, DOI 10.1016/S0039-6257(97)80018-5; Imesch PD, 1996, ARCH OPHTHALMOL-CHIC, V114, P443, DOI 10.1001/archopht.1996.01100130439015; Jannot AS, 2005, EUR J HUM GENET, V13, P913, DOI 10.1038/sj.ejhg.5201415; Kanetsky PA, 2002, AM J HUM GENET, V70, P770, DOI 10.1086/339076; Kerr R, 2000, HUM MUTAT, V15, P166, DOI 10.1002/(SICI)1098-1004(200002)15:2<166::AID-HUMU5>3.0.CO;2-Z; Lange K, 2001, AM J HUM GENET, V69, P504; LEE ST, 1994, NEW ENGL J MED, V330, P529, DOI 10.1056/NEJM199402243300803; LEE ST, 1995, GENOMICS, V26, P354, DOI 10.1016/0888-7543(95)80220-G; McGregor B, 1999, GENET EPIDEMIOL, V16, P40, DOI 10.1002/(SICI)1098-2272(1999)16:1<40::AID-GEPI4>3.3.CO;2-T; Oetting W S, 1998, Hum Mutat, V12, P434, DOI 10.1002/(SICI)1098-1004(1998)12:6<434::AID-HUMU15>3.0.CO;2-A; Palmer JS, 2000, AM J HUM GENET, V66, P176, DOI 10.1086/302711; Pastinen T, 2004, SCIENCE, V306, P647, DOI 10.1126/science.1101659; Posthuma D, 2006, BEHAV GENET, V36, P12, DOI 10.1007/s10519-005-9007-x; Prota G, 1998, EXP EYE RES, V67, P293, DOI 10.1006/exer.1998.0518; RAMSAY M, 1992, AM J HUM GENET, V51, P879; Rebbeck TR, 2002, CANCER EPIDEM BIOMAR, V11, P782; Rees JL, 2004, AM J HUM GENET, V75, P739, DOI 10.1086/425285; Rees JL, 2003, ANNU REV GENET, V37, P67, DOI 10.1146/annurev.genet.37.110801.143233; RINCHIK EM, 1993, NATURE, V361, P72, DOI 10.1038/361072a0; Rouzaud F, 2005, MUTAT RES-FUND MOL M, V571, P133, DOI 10.1016/j.mrfmmm.2004.09.014; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Spritz RA, 1997, AM J MED GENET, V71, P57, DOI 10.1002/(SICI)1096-8628(19970711)71:1<57::AID-AJMG11>3.0.CO;2-U; Sturm RA, 2004, TRENDS GENET, V20, P327, DOI 10.1016/j.tig.2004.06.010; Sturm RA, 2003, PIGM CELL RES, V16, P266, DOI 10.1034/j.1600-0749.2003.00041.x; Sturm RA, 2002, MELANOMA RES, V12, P405, DOI 10.1097/00008390-200209000-00001; Sturm RA, 2006, TRENDS GENET, V22, P464, DOI 10.1016/j.tig.2006.06.010; Suzuki I, 2002, J INVEST DERMATOL, V118, P73, DOI 10.1046/j.1523-1747.2002.01647.x; Suzuki T, 2003, AM J MED GENET A, V118A, P402, DOI 10.1002/ajmg.a.20044; Sviderskaya EV, 1997, J INVEST DERMATOL, V108, P30, DOI 10.1111/1523-1747.ep12285621; Tucker MA, 2003, ONCOGENE, V22, P3042, DOI 10.1038/sj.onc.1206444; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Voisey J, 2006, PIGM CELL RES, V19, P226, DOI 10.1111/j.1600-0749.2006.00301.x; Wielgus AR, 2005, PIGM CELL RES, V18, P454, DOI 10.1111/j.1600-0749.2005.00268.x; Wilkerson CL, 1996, ARCH OPHTHALMOL-CHIC, V114, P437, DOI 10.1001/archopht.1996.01100130433014; Zhao ZZ, 2006, MOL HUM REPROD, V12, P671, DOI 10.1093/molehr/gal078; Zhu G, 2004, TWIN RES, V7, P197, DOI 10.1375/136905204323016186; Zhu G, 1999, AM J HUM GENET, V65, P483, DOI 10.1086/302494	62	159	167	1	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2007	80	2					241	252		10.1086/510885	http://dx.doi.org/10.1086/510885			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	129KX	17236130	Green Published, Bronze			2022-12-18	WOS:000243729500004
J	Nishimura, DY; Swiderski, RE; Searby, CC; Berg, EM; Ferguson, AL; Hennekam, R; Merin, S; Weleber, RG; Biesecker, LG; Stone, EM; Sheffield, VC				Nishimura, DY; Swiderski, RE; Searby, CC; Berg, EM; Ferguson, AL; Hennekam, R; Merin, S; Weleber, RG; Biesecker, LG; Stone, EM; Sheffield, VC			Comparative genomics and gene expression analysis identifies BBS9, a new Bardet-Biedl syndrome gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN OBESITY SYNDROME; CHROMOSOME 16Q; SYNDROME LOCUS; MUTATIONS; DISEASE; PROTEIN	Bardet-Biedl syndrome (BBS) is an autosomal recessive, genetically heterogeneous, pleiotropic human disorder characterized by obesity, retinopathy, polydactyly, renal and cardiac malformations, learning disabilities, and hypogenitalism. Eight BBS genes representing all known mapped loci have been identified. Mutation analysis of the known BBS genes in BBS patients indicate that additional BBS genes exist and/or that unidentified mutations exist in the known genes. To identify new BBS genes, we performed homozygosity mapping of small, consanguineous BBS pedigrees, using moderately dense SNP arrays. A bioinformatics approach combining comparative genomic analysis and gene expression studies of a BBS-knockout mouse model was used to prioritize BBS candidate genes within the newly identified loci for mutation screening. By use of this strategy, parathyroid hormone-responsive gene B1 (B1) was found to be a novel BBS gene (BBS9), supported by the identification of homozygous mutations in BBS patients. The identification of BBS9 illustrates the power of using a combination of comparative genomic analysis, gene expression studies, and homozygosity mapping with SNP arrays in small, consanguineous families for the identification of rare autosomal recessive disorders. We also demonstrate that small, consanguineous families are useful in identifying intragenic deletions. This type of mutation is likely to be underreported because of the difficulty of deletion detection in the heterozygous state by the mutation screening methods that are used in many studies.	Univ Iowa, Dept Pediat, Div Med Genet, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Univ Iowa, Dept Ophthalmol, Iowa City, IA 52242 USA; Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA; UCL, Inst Child Hlth, London, England; Great Ormond St Hosp Sick Children, London WC1N 3JH, England; Hadassah Med Org, Dept Ophthalmol, Jerusalem, Israel; Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; NHGRI, NIH, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Hebrew University of Jerusalem; Hadassah University Medical Center; Oregon Health & Science University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Sheffield, VC (corresponding author), Univ Iowa, Dept Pediat, Div Med Genet, Howard Hughes Med Inst, Iowa City, IA 52242 USA.	val-sheffield@uiowa.edu	Biesecker, Leslie/AAG-2526-2021	Sheffield, Val/0000-0002-6282-0835; Stone, Edwin M./0000-0003-3343-4414; Searby, Charles/0000-0002-8108-8782	NEI NIH HHS [R01 EY011298, R01-EY-11298] Funding Source: Medline; NHLBI NIH HHS [P50-HL-55006, P50 HL055006] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011298] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL055006] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG200328, ZIAHG200328] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Adams AE, 1999, BONE, V24, P305, DOI 10.1016/S8756-3282(98)00188-4; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Badano JL, 2003, AM J HUM GENET, V72, P650, DOI 10.1086/368204; BARDET G, 1920, THESIS PARIS; Beales PL, 2003, AM J HUM GENET, V72, P1187, DOI 10.1086/375178; Biedl A., 1922, DEUT MED WOCHENSCHR, V48, P1630; Blacque OE, 2004, GENE DEV, V18, P1630, DOI 10.1101/gad.1194004; CARMI R, 1995, HUM MOL GENET, V4, P9, DOI 10.1093/hmg/4.1.9; Chiang AP, 2004, AM J HUM GENET, V75, P475, DOI 10.1086/423903; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; ELBEDOUR K, 1994, AM J MED GENET, V52, P164, DOI 10.1002/ajmg.1320520208; Fan YL, 2004, NAT GENET, V36, P989, DOI 10.1038/ng1414; Garrod AE, 1902, LANCET, V2, P1616; GREEN JS, 1989, NEW ENGL J MED, V321, P1002, DOI 10.1056/NEJM198910123211503; HARNETT JD, 1988, NEW ENGL J MED, V319, P615, DOI 10.1056/NEJM198809083191005; Hichri H, 2005, EUR J HUM GENET, V13, P607, DOI 10.1038/sj.ejhg.5201372; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Katsanis N, 2004, HUM MOL GENET, V13, pR65, DOI 10.1093/hmg/ddh092; Katsanis N, 2000, NAT GENET, V26, P67, DOI 10.1038/79201; Kolomietz E, 2002, GENE CHROMOSOME CANC, V35, P97, DOI 10.1002/gcc.10111; KWITEKBLACK AE, 1993, NAT GENET, V5, P392, DOI 10.1038/ng1293-392; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Mykytyn K, 2004, P NATL ACAD SCI USA, V101, P8664, DOI 10.1073/pnas.0402354101; Mykytyn K, 2002, NAT GENET, V31, P435, DOI 10.1038/ng935; Mykytyn K, 2001, NAT GENET, V28, P188, DOI 10.1038/88925; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; Nishimura DY, 2001, HUM MOL GENET, V10, P865, DOI 10.1093/hmg/10.8.865; RUDIGER NS, 1995, NUCLEIC ACIDS RES, V23, P256, DOI 10.1093/nar/23.2.256; SHEFFIELD VC, 1994, HUM MOL GENET, V3, P1331, DOI 10.1093/hmg/3.8.1331; Slavotinek AM, 2000, NAT GENET, V26, P15, DOI 10.1038/79116; Swiderski RE, 1999, MOL BRAIN RES, V68, P64, DOI 10.1016/S0169-328X(99)00085-6; Vernon EG, 2003, ONCOGENE, V22, P1371, DOI 10.1038/sj.onc.1206332; Young TL, 1999, AM J HUM GENET, V64, P900, DOI 10.1086/302301	35	159	164	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2005	77	6					1021	1033		10.1086/498323	http://dx.doi.org/10.1086/498323			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	983OE	16380913	Bronze, Green Published			2022-12-18	WOS:000233241200011
J	Van Den Bogaert, A; Schumacher, J; Schulze, TG; Otte, AC; Ohlraun, S; Kovalenko, S; Becker, T; Freudenberg, J; Jonsson, EG; Mattila-Evenden, M; Sedvall, GC; Czerski, PM; Kapelski, P; Hauser, J; Maier, W; Rietschel, M; Propping, P; Nothen, MM; Cichon, S				Van Den Bogaert, A; Schumacher, J; Schulze, TG; Otte, AC; Ohlraun, S; Kovalenko, S; Becker, T; Freudenberg, J; Jonsson, EG; Mattila-Evenden, M; Sedvall, GC; Czerski, PM; Kapelski, P; Hauser, J; Maier, W; Rietschel, M; Propping, P; Nothen, MM; Cichon, S			The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							6P22.3 GENE; SUSCEPTIBILITY; ASSOCIATION; LINKAGE; NEUREGULIN-1; HAPLOTYPE; SUPPORT; LOCUS; IRISH	We have investigated the gene for dystrobrevin-binding protein 1 (DTNBP1), or dysbindin, which has been strongly suggested as a positional candidate gene for schizophrenia, in three samples of subjects with schizophrenia and unaffected control subjects of German (418 cases, 285 controls), Polish (294 cases, 113 controls), and Swedish (142 cases, 272 controls) descent. We analyzed five single-nucleotide polymorphisms (P1635, P1325, P1320, P1757, and P1578) and identified significant evidence of association in the Swedish sample but not in those from Germany or Poland. The results in the Swedish sample became even more significant after a separate analysis of those cases with a positive family history of schizophrenia, in whom the five-marker haplotype A-C-A-T-T showed a P value of .00009 (3.1% in controls, 17.8% in cases; OR 6.75; P = .00153 after Bonferroni correction). Our results suggest that genetic variation in the dysbindin gene is particularly involved in the development of schizophrenia in cases with a familial loading of, the disease. This would also explain the difficulty of replicating this association in consecutively ascertained case-control samples, which usually comprise only a small proportion of subjects with a family history of disease.	Univ Antwerp, Dept Med Genet, B-2610 Antwerp, Belgium; Univ Bonn, Dept Psychiat, D-5300 Bonn, Germany; Univ Bonn, Inst Human Genet, D-5300 Bonn, Germany; Univ Bonn, Inst Med Biometry Informat & Epidemiol, D-5300 Bonn, Germany; Cent Inst Mental Hlth, Div Genet Epidemiol Psychiat, D-6800 Mannheim, Germany; Karolinska Hosp & Inst, Dept Clin Neurosci, Psychiat Sect, Human Brain Informat Project, Stockholm, Sweden; Univ Poznan, Dept Psychiat, Poznan, Poland	University of Antwerp; University of Bonn; University of Bonn; University of Bonn; Central Institute of Mental Health; Karolinska Institutet; Karolinska University Hospital; Adam Mickiewicz University	Cichon, S (corresponding author), Univ Antwerp, Dept Med Genet, Univ Pl 1, B-2610 Antwerp, Belgium.	svcichon@uia.ua.ac.be	Nöthen, Markus/B-2027-2009; Czerski, Piotr M./B-8446-2011; Schulze, Thomas G/H-2157-2013; Schumacher, Johannes/F-4970-2015; Cichon, Sven/B-9618-2014; Cichon, Sven/H-8803-2013	Nöthen, Markus/0000-0002-8770-2464; Czerski, Piotr M./0000-0003-0745-5916; Schumacher, Johannes/0000-0001-9217-6457; Cichon, Sven/0000-0002-9475-086X; Cichon, Sven/0000-0002-9475-086X; Becker, Tim/0000-0002-6573-1109; Jonsson, Erik/0000-0001-8368-6332				American Psychiatric Association, 1987, DIAGN STAT MAN MENT; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Dudbridge F, 2002, AM J HUM GENET, V71, P569; Fallin D, 2000, AM J HUM GENET, V67, P947, DOI 10.1086/303069; First M.B., 2015, SCID 2 PERSONALITY Q; Johnson MC, 2002, IEEE T VLSI SYST, V10, P1, DOI 10.1109/92.988724; Levinson DF, 1996, AM J MED GENET, V67, P580; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; MOISES HW, 1995, NAT GENET, V11, P321, DOI 10.1038/ng1195-321; Morris DW, 2003, SCHIZOPHR RES, V60, P167, DOI 10.1016/S0920-9964(02)00527-3; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; SCHWAB SG, 1995, NAT GENET, V11, P325, DOI 10.1038/ng1195-325; Schwab SG, 2003, AM J HUM GENET, V72, P185, DOI 10.1086/345463; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; STRAUB RE, 1995, NAT GENET, V11, P287, DOI 10.1038/ng1195-287; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; van den Oord EJCG, 2003, MOL PSYCHIATR, V8, P499, DOI 10.1038/sj.mp.4001263; WANG SB, 1995, NAT GENET, V10, P41, DOI 10.1038/ng0595-41; Williams NM, 2003, MOL PSYCHIATR, V8, P485, DOI 10.1038/sj.mp.4001348	20	159	164	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2003	73	6					1438	1443		10.1086/379928	http://dx.doi.org/10.1086/379928			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	756PW	14618545	Green Published, Bronze			2022-12-18	WOS:000187491100018
J	Schrijver, I; Liu, W; Brenn, T; Furthmayr, H; Francke, U				Schrijver, I; Liu, W; Brenn, T; Furthmayr, H; Francke, U			Cysteine substitutions in epidermal growth factor-like domains of fibrillin-1: Distinct effects on biochemical and clinical phenotypes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEONATAL MARFAN-SYNDROME; EGF-LIKE DOMAINS; MISSENSE MUTATION; CALCIUM-BINDING; POINT MUTATIONS; PATHOGENETIC MECHANISMS; FBN1 MUTATIONS; GENE; EXONS; DISORDERS	Fibrillin-1 (FBN1) contains 47 epidermal growth factor (EGF)-like domains characterized by six conserved cysteine residues. Cysteine substitutions that disrupt one of the three disulfide bonds are frequent causes of Marfan syndrome (MFS). We identified 19 new substitutions involving cysteine residues in each of the six positions of EGF-like domains. Allele-specific mRNA assays revealed equal abundance of mutant and normal FBN1 transcripts in all 10 individuals studied. Quantitative pulse-chase analysis of fibrillin protein was performed on 25 mutant fibroblast strains with substitutions of 22 different cysteine residues in 18 different EGF-like domains spanning the entire gene. Normal synthesis and stability of mutant fibrillin molecules was seen in 20/25 individuals, 11 of whom showed delayed intracellular processing and/or secretion. In the remaining five cases, the mutant protein was apparently unstable. In four of these five cases, the second or third disulfide bond of EGF-like domains immediately preceding an 8-cysteine or hybrid domain was affected. All but two mutations caused severe reduction of matrix deposition, which was attributed to a dominant-negative effect of mutant molecules. For genotype/phenotype comparisons, clinical data on 25 probands and 19 mutation-positive family members were analyzed. Ocular manifestations were among the most consistent features (ectopia lentis in 86%, myopia in 80%). Nine mutations encoded by exons 26-32 resulted in early-onset classic MFS and, in one case, neonatal-lethal MFS. Mutations outside this region were associated with variable clinical phenotypes, including individuals with fibrillinopathies not meeting diagnostic criteria for MFS.	Stanford Univ, Sch Med, Med Ctr, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Francke, U (corresponding author), Stanford Univ, Sch Med, Med Ctr, Howard Hughes Med Inst, Stanford, CA 94305 USA.		Furthmayr, Heinz -/A-6295-2010					Ades LC, 1996, J MED GENET, V33, P665, DOI 10.1136/jmg.33.8.665; AOYAMA T, 1995, AM J MED GENET, V58, P169, DOI 10.1002/ajmg.1320580216; AOYAMA T, 1993, HUM MOL GENET, V2, P2135, DOI 10.1093/hmg/2.12.2135; AOYAMA T, 1994, J CLIN INVEST, V94, P130, DOI 10.1172/JCI117298; Booms P, 1997, HUM GENET, V100, P195, DOI 10.1007/s004390050489; Brenn T, 1996, LAB INVEST, V75, P389; CAMPBELL ID, 1993, CURR OPIN STRUC BIOL, V3, P385, DOI 10.1016/S0959-440X(05)80111-3; Collod-Beroud G, 1998, NUCLEIC ACIDS RES, V26, P229, DOI 10.1093/nar/26.1.229; CORSON GM, 1993, GENOMICS, V17, P476, DOI 10.1006/geno.1993.1350; DePaepe A, 1996, AM J MED GENET, V62, P417, DOI 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.3.CO;2-S; Dietz Harry C., 1992, Human Mutation, V1, P366, DOI 10.1002/humu.1380010504; DIETZ HC, 1995, HUM MOL GENET, V4, P1799, DOI 10.1093/hmg/4.suppl_1.1799; DIETZ HC, 1992, J CLIN INVEST, V89, P1674, DOI 10.1172/JCI115766; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Downing AK, 1996, CELL, V85, P597, DOI 10.1016/S0092-8674(00)81259-3; Furthmayr H, 1997, Semin Thorac Cardiovasc Surg, V9, P191; Giannelli F, 1998, NUCLEIC ACIDS RES, V26, P265, DOI 10.1093/nar/26.1.265; HALIASSOS A, 1989, NUCLEIC ACIDS RES, V17, P8093, DOI 10.1093/nar/17.20.8093; HANDFORD PA, 1990, EMBO J, V9, P475, DOI 10.1002/j.1460-2075.1990.tb08133.x; HAYWARD C, 1994, HUM MOL GENET, V3, P373, DOI 10.1093/hmg/3.2.373; Hayward C, 1997, HUM MUTAT, V10, P280, DOI 10.1002/(SICI)1098-1004(1997)10:4<280::AID-HUMU3>3.3.CO;2-L; Hayward C, 1997, HUM MUTAT, V10, P415, DOI 10.1002/(SICI)1098-1004(1997)10:6<415::AID-HUMU1>3.3.CO;2-2; HEWETT D, 1994, AM J HUM GENET, V55, P447; HEWETT DR, 1994, J MED GENET, V31, P338, DOI 10.1136/jmg.31.4.338; KAINULAINEN K, 1994, NAT GENET, V6, P64, DOI 10.1038/ng0194-64; KIELTY CM, 1993, FEBS LETT, V336, P323, DOI 10.1016/0014-5793(93)80829-J; LAPPALAINEN J, 1995, GENOMICS, V27, P274, DOI 10.1006/geno.1995.1042; Liu WG, 1996, HUM MOL GENET, V5, P1581, DOI 10.1093/hmg/5.10.1581; Liu WG, 1997, NAT GENET, V16, P328, DOI 10.1038/ng0897-328; Liu WO, 1997, GENET TEST, V1, P237, DOI 10.1089/gte.1997.1.237; Lonnqvist L, 1996, GENOMICS, V36, P468, DOI 10.1006/geno.1996.0492; MASLEN CL, 1991, NATURE, V352, P334, DOI 10.1038/352334a0; Mathews K., 1995, American Journal of Human Genetics, V57, pA339; Maumenee I H, 1981, Trans Am Ophthalmol Soc, V79, P684; MILEWICZ DM, 1994, AM J HUM GENET, V54, P447; NIJBROEK G, 1995, AM J HUM GENET, V57, P8; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; Pepe G, 1997, J MOL CELL CARDIOL, V29, P1877, DOI 10.1006/jmcc.1997.0426; PEREIRA L, 1993, HUM MOL GENET, V2, P961, DOI 10.1093/hmg/2.7.961; PIERSALL LD, 1994, HUM MOL GENET, V3, P1013, DOI 10.1093/hmg/3.6.1013; Putnam EA, 1996, AM J MED GENET, V62, P233, DOI 10.1002/(SICI)1096-8628(19960329)62:3<233::AID-AJMG7>3.0.CO;2-U; PYERITZ RE, 1979, NEW ENGL J MED, V300, P772, DOI 10.1056/NEJM197904053001406; RAO Z, 1995, CELL, V82, P131, DOI 10.1016/0092-8674(95)90059-4; Reinhardt DP, 1997, J BIOL CHEM, V272, P1231, DOI 10.1074/jbc.272.2.1231; Reinhardt DP, 1997, J BIOL CHEM, V272, P7368, DOI 10.1074/jbc.272.11.7368; Richards CS, 1997, AM J HUM GENET, V60, P1085; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; TYNAN K, 1993, HUM MOL GENET, V2, P1813, DOI 10.1093/hmg/2.11.1813; Varret M, 1998, NUCLEIC ACIDS RES, V26, P248, DOI 10.1093/nar/26.1.248; Wang M, 1997, HUM MUTAT, V9, P359, DOI 10.1002/(SICI)1098-1004(1997)9:4<359::AID-HUMU10>3.0.CO;2-1	50	159	167	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1999	65	4					1007	1020		10.1086/302582	http://dx.doi.org/10.1086/302582			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	241XW	10486319	Green Published, Bronze			2022-12-18	WOS:000082910000009
J	Pfeifer, D; Kist, R; Dewar, K; Devon, K; Lander, ES; Birren, B; Korniszewski, L; Back, E; Scherer, G				Pfeifer, D; Kist, R; Dewar, K; Devon, K; Lander, ES; Birren, B; Korniszewski, L; Back, E; Scherer, G			Campomelic dysplasia translocation breakpoints are scattered over 1 Mb proximal to SOX9: Evidence for an extended control region	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTOSOMAL SEX REVERSAL; SRY-RELATED GENE; RECIPROCAL TRANSLOCATION; COLLAGEN GENE; II COLLAGEN; GENOMIC DNA; MOUSE; KB; EXPRESSION; MUTATIONS	Campomelic dysplasia (CD), a skeletal malformation syndrome with or without XY sex reversal, is usually caused by mutations within the SOX9 gene on distal 17q. Several CD translocation and inversion cases have been described with breakpoints outside the coding region, mapping to locations >130 kb proximal to SOX9. Such cases are generally less severely affected than cases with SOX9 coding-region mutations, as is borne out by three new translocation cases that we present. We have cloned the region extending 1.2 Mb upstream of the SOX9 gene in overlapping bacterial-artificial-chromosome and P1-artificial-chromosome clones and have established a restriction map with rare-cutter enzymes. With sequence-tagged-site-content mapping in somatic-cell hybrids, as well as with FISH, we have precisely mapped the breakpoints of the three new and of three previously described CD cases. The six CD breakpoints map to an interval that is 140-950 kb proximal to the SOX9 gene. With exon trapping, we could isolate five potential exons from the YAC 946B12 that spans the region, four of which could be placed in the contig in the vicinity of the breakpoints. They show the same transcriptional orientation, but only two have an open reading frame (ORF). We failed to detect expression of these fragments in several human and mouse cDNA libraries, as well as on northern blots. Genomic sequence totaling 1,063 kb from the SOX9 5'-flanking region was determined and was analyzed by the gene-prediction program GENSCAN and by a search of dbEST and other databases. No genes or transcripts could be identified. Together, these data suggest that the chromosomal rearrangements most likely remove one or more cis-regulatory elements from an extended SOX9 control region.	Univ Freiburg, Inst Human Genet & Anthropol, D-79106 Freiburg, Germany; Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; MIT, Ctr Genome Res, Whitehead Inst, Cambridge, MA 02139 USA; Med Acad Warsaw, Clin Infants & Metab Dis, Warsaw, Poland	University of Freiburg; University of Freiburg; Massachusetts Institute of Technology (MIT); Whitehead Institute	Scherer, G (corresponding author), Univ Freiburg, Inst Human Genet & Anthropol, Breisacherstr 33, D-79106 Freiburg, Germany.	scherer@humangenetik.ukl.uni-freiburg.de	Kist, Ralf/B-4982-2008	Kist, Ralf/0000-0003-3729-5693				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BEDELL MA, 1995, GENE DEV, V9, P455, DOI 10.1101/gad.9.4.455; Bedell MA, 1996, NAT GENET, V12, P229, DOI 10.1038/ng0396-229; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Bernardi G, 1995, ANNU REV GENET, V29, P445, DOI 10.1146/annurev.ge.29.120195.002305; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Cameron FJ, 1996, HUM MOL GENET, V5, P1625, DOI 10.1093/hmg/5.10.1625; daSilva SM, 1996, NAT GENET, V14, P62, DOI 10.1038/ng0996-62; De Santa Barbara P, 1998, MOL CELL BIOL, V18, P6653, DOI 10.1128/MCB.18.11.6653; deKok YJM, 1996, HUM MOL GENET, V5, P1229, DOI 10.1093/hmg/5.9.1229; FANTES J, 1995, HUM MOL GENET, V4, P415, DOI 10.1093/hmg/4.3.415; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Goji K, 1998, HUM MUTAT, pS114; GROSSCHEDL R, 1994, TRENDS GENET, V10, P94, DOI 10.1016/0168-9525(94)90232-1; Hageman RM, 1998, HUM MUTAT, pS112; HOUSTON CS, 1983, AM J MED GENET, V15, P3, DOI 10.1002/ajmg.1320150103; Kent J, 1996, DEVELOPMENT, V122, P2813; KWOK C, 1995, AM J HUM GENET, V57, P1028; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; LENGAUER C, 1992, GENOMICS, V13, P826, DOI 10.1016/0888-7543(92)90160-T; LENZ S, 1989, J BIOL CHEM, V264, P9009; MANSOUR S, 1995, J MED GENET, V32, P415, DOI 10.1136/jmg.32.6.415; MARAIA R, 1991, CLIN GENET, V39, P401; Marra MA, 1997, GENOME RES, V7, P1072, DOI 10.1101/gr.7.11.1072; Meyer J, 1997, HUM MOL GENET, V6, P91, DOI 10.1093/hmg/6.1.91; NEHLS M, 1995, MAMM GENOME, V6, P321, DOI 10.1007/BF00364794; NEHLS M, 1994, ONCOGENE, V9, P2169; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; Ninomiya S, 1996, HUM MOL GENET, V5, P69, DOI 10.1093/hmg/5.1.69; NINOMIYA S, 1995, AM J MED GENET, V56, P31, DOI 10.1002/ajmg.1320560109; Pevny LH, 1997, CURR OPIN GENET DEV, V7, P338, DOI 10.1016/S0959-437X(97)80147-5; PFEIFER D, 1998, 48 ANN M AM SOC HUM; Savarirayan R, 1998, J MED GENET, V35, P597, DOI 10.1136/jmg.35.7.597; SCHERER S, 1991, P33; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Sudbeck P, 1996, NAT GENET, V13, P230, DOI 10.1038/ng0696-230; Sutherland HF, 1996, AM J HUM GENET, V59, P23; TODER R, 1995, HUM GENET, V95, P22; TOMMERUP N, 1993, NAT GENET, V4, P170, DOI 10.1038/ng0693-170; Wagner T, 1997, CYTOGENET CELL GENET, V76, P172, DOI 10.1159/000134538; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Wirth J, 1996, HUM GENET, V97, P186, DOI 10.1007/BF02265263; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Wunderle VM, 1998, P NATL ACAD SCI USA, V95, P10649, DOI 10.1073/pnas.95.18.10649; YOUNG ID, 1992, J MED GENET, V29, P251, DOI 10.1136/jmg.29.4.251	46	159	161	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1999	65	1					111	124		10.1086/302455	http://dx.doi.org/10.1086/302455			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	212NZ	10364523	Green Published, Bronze			2022-12-18	WOS:000081224300015
J	Choo, KHA				Choo, KHA			Centromere DNA dynamics: Latent centromeres and neocentromere formation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUPERNUMERARY MARKER CHROMOSOMES; DETECTABLE ALPHA-SATELLITE; HUMAN Y-CHROMOSOME; CENP-C; SCHIZOSACCHAROMYCES-POMBE; INSITU HYBRIDIZATION; PARASCARIS-UNIVALENS; PROTEIN-BINDING; FISSION YEAST; DICENTRIC Y		Royal Childrens Hosp, Murdoch Inst Res Birth Defects, Parkville, Vic 3052, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Choo, KHA (corresponding author), Royal Childrens Hosp, Murdoch Inst Res Birth Defects, Flemington Rd, Parkville, Vic 3052, Australia.	choo@cryptic.rch.unimelb.edu.au						Abeliovich D, 1996, CANCER GENET CYTOGEN, V89, P1, DOI 10.1016/0165-4608(95)00300-2; Allshire RC, 1997, CURR OPIN GENET DEV, V7, P264, DOI 10.1016/S0959-437X(97)80137-2; BERNAT RL, 1990, J CELL BIOL, V111, P1519, DOI 10.1083/jcb.111.4.1519; BLENNOW E, 1994, AM J HUM GENET, V54, P877; BROWN KE, 1994, HUM MOL GENET, V3, P1227, DOI 10.1093/hmg/3.8.1227; Bukvic N, 1996, HUM GENET, V97, P453; CALLEN DF, 1992, AM J MED GENET, V43, P709, DOI 10.1002/ajmg.1320430412; Choo KHA., 1997, CENTROMERE; CLARKE L, 1985, ANNU REV GENET, V19, P29, DOI 10.1146/annurev.genet.19.1.29; CROLLA JA, 1992, J MED GENET, V29, P699, DOI 10.1136/jmg.29.10.699; Depinet TW, 1997, HUM MOL GENET, V6, P1195, DOI 10.1093/hmg/6.8.1195; DEWALD GW, 1979, CYTOGENET CELL GENET, V24, P15, DOI 10.1159/000131352; duSart D, 1997, NAT GENET, V16, P144; DUTRILLAUX B, 1979, HUM GENET, V48, P251, DOI 10.1007/BF00272830; EARNSHAW WC, 1989, CHROMOSOMA, V98, P1, DOI 10.1007/BF00293329; EARNSHAW WC, 1994, FASEB J, V8, P947, DOI 10.1096/fasebj.8.12.8088460; GODAY C, 1989, CHROMOSOMA, V98, P160, DOI 10.1007/BF00329679; GODAY C, 1992, J CELL BIOL, V118, P23, DOI 10.1083/jcb.118.1.23; HAAF T, 1992, CELL, V70, P681, DOI 10.1016/0092-8674(92)90436-G; HAHNENBERGER KM, 1991, MOL CELL BIOL, V11, P2206, DOI 10.1128/MCB.11.4.2206; HAHNENBERGER KM, 1989, P NATL ACAD SCI USA, V86, P577, DOI 10.1073/pnas.86.2.577; Harrington JJ, 1997, NAT GENET, V15, P345, DOI 10.1038/ng0497-345; HEARTLEIN MW, 1988, MOL CELL BIOL, V8, P3611, DOI 10.1128/MCB.8.9.3611; ING PS, 1983, CLIN GENET, V24, P194; JACKSON MS, 1993, NUCLEIC ACIDS RES, V21, P5865, DOI 10.1093/nar/21.25.5865; LARIN Z, 1994, HUM MOL GENET, V3, P689, DOI 10.1093/hmg/3.5.689; LOMBILLO VA, 1995, J CELL BIOL, V128, P107, DOI 10.1083/jcb.128.1.107; Maraschio P, 1996, HUM GENET, V97, P382; Mitchell AR, 1996, J CELL SCI, V109, P2199; MOROI Y, 1980, P NATL ACAD SCI-BIOL, V77, P1627, DOI 10.1073/pnas.77.3.1627; MURPHY TD, 1995, CELL, V82, P599, DOI 10.1016/0092-8674(95)90032-2; MURRAY AW, 1983, NATURE, V305, P189, DOI 10.1038/305189a0; Ngan VK, 1997, MOL CELL BIOL, V17, P3305, DOI 10.1128/MCB.17.6.3305; OHASHI H, 1994, AM J HUM GENET, V55, P1202; PAGE SL, 1995, HUM MOL GENET, V4, P289, DOI 10.1093/hmg/4.2.289; PETIT P, IN PRESS GENET COUNS; PLUTA AF, 1995, SCIENCE, V270, P1591, DOI 10.1126/science.270.5242.1591; RAUCH A, 1992, CLIN GENET, V42, P84; RIVERA H, 1989, J MED GENET, V26, P626, DOI 10.1136/jmg.26.10.626; Sacchi N, 1996, CYTOGENET CELL GENET, V73, P123, DOI 10.1159/000134322; SEARLE AG, 1989, ANN HUM GENET, V53, P89, DOI 10.1111/j.1469-1809.1989.tb01777.x; STEINER NC, 1994, CELL, V79, P865, DOI 10.1016/0092-8674(94)90075-2; SULLIVAN BA, 1995, HUM MOL GENET, V4, P2189, DOI 10.1093/hmg/4.12.2189; SULLIVAN KF, 1994, J CELL BIOL, V127, P581, DOI 10.1083/jcb.127.3.581; Therman E, 1993, HUMAN CHROMOSOMES ST; THROWER DA, 1995, EMBO J, V14, P918, DOI 10.1002/j.1460-2075.1995.tb07073.x; TOMKIEL J, 1994, J CELL BIOL, V125, P531, DOI 10.1083/jcb.125.3.531; TROWELL HE, 1993, HUM MOL GENET, V2, P1639, DOI 10.1093/hmg/2.10.1639; TYLERSMITH C, 1993, NAT GENET, V5, P368, DOI 10.1038/ng1293-368; TYLERSMITH C, 1987, J MOL BIOL, V195, P457, DOI 10.1016/0022-2836(87)90175-6; Vance GH, 1997, AM J MED GENET, V71, P436, DOI 10.1002/(SICI)1096-8628(19970905)71:4<436::AID-AJMG13>3.0.CO;2-H; VOULLAIRE LE, 1993, AM J HUM GENET, V52, P1153; WEVRICK R, 1991, NUCLEIC ACIDS RES, V19, P2295, DOI 10.1093/nar/19.9.2295	53	159	166	0	10	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1997	61	6					1225	1233		10.1086/301657	http://dx.doi.org/10.1086/301657			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YT019	9399915	Green Published, Bronze			2022-12-18	WOS:000071555900003
J	McConville, CM; Stankovic, T; Byrd, PJ; McGuire, GM; Yao, QY; Lennox, GG; Taylor, AMR				McConville, CM; Stankovic, T; Byrd, PJ; McGuire, GM; Yao, QY; Lennox, GG; Taylor, AMR			Mutations associated with variant phenotypes in ataxia-telangiectasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SCHIZOSACCHAROMYCES-POMBE; MAMMALIAN PROTEIN; GENE; RECEPTOR; SEQUENCE; DNA	We have identified 14 families with ataxia-telangiectasia (A-T) in which mutation of the ATM gene is associated with a less severe clinical and cellular phenotype (similar to 10%-15% of A-T families identified in the United Kingdom). In 10 of these families, all the homozygotes have a 137-bp insertion in their cDNA caused by a point mutation in a sequence resembling a splice-donor site. The second A-T allele has a different mutation in each patient. We show that the less severe phenotype in these patients is caused by some degree of normal splicing, which occurs as an alternative product from the insertion-containing allele. The level of the 137-bp PCR product containing the insertion was lowest in two patients who showed a later onset of cerebellar ataxia. A further four families who do not have this insertion have been identified. Mutations detected in two of four of these are missense mutations, normally rare in A-T patients. The demonstration of mutations giving rise to a slightly milder phenotype in A-T raises the interesting question of what range of phenotypes might occur in individuals in whom both mutations are milder. One possibility might be that individuals who are compound heterozygotes for ATM mutations are more common than we realize.	UNIV BIRMINGHAM,SCH MED,CRC,INST CANC STUDIES,BIRMINGHAM B15 2TJ,W MIDLANDS,ENGLAND; UNIV NOTTINGHAM HOSP,QUEENS MED CTR,DIV CLIN NEUROL,NOTTINGHAM NG7 2UH,ENGLAND	University of Birmingham; University of Nottingham				Stankovic, Tatjana/0000-0002-3780-274X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Byrd PJ, 1996, HUM MOL GENET, V5, P145, DOI 10.1093/hmg/5.1.145; Gilad S, 1996, HUM MOL GENET, V5, P433, DOI 10.1093/hmg/5.4.433; HARI KL, 1995, CELL, V82, P815, DOI 10.1016/0092-8674(95)90478-6; HOLLMANN M, 1993, NEURON, V10, P943, DOI 10.1016/0896-6273(93)90209-A; JIMENEZ G, 1992, P NATL ACAD SCI USA, V89, P4952, DOI 10.1073/pnas.89.11.4952; LELLI N, 1995, J LIPID RES, V36, P1315; LIU Q, 1995, BIOTECHNIQUES, V18, P470; MCCONVILLE CM, 1994, INT J RADIAT BIOL, V66, P545; MENON KP, 1994, CELL MOL BIOL, V12, P1149; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SAVITSKY K, 1995, HUM MOL GENET, V4, P2025, DOI 10.1093/hmg/4.11.2025; SEATON BL, 1992, GENE, V119, P83, DOI 10.1016/0378-1119(92)90069-2; Sedgwick R, 1991, HDB CLIN NEUROLOGY, P347; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Spector BD, 1982, ATAXIA TELANGIECTASI, P103; STAMM S, 1994, NUCLEIC ACIDS RES, V22, P1515, DOI 10.1093/nar/22.9.1515; SZABO CI, 1995, HUM MOL GENET, V4, P1811, DOI 10.1093/hmg/4.suppl_1.1811; Taylor A. M. R., 1996, P138; TAYLOR AMR, 1994, INT J RADIAT BIOL, V66, pS35, DOI 10.1080/09553009414551841; Taylor AMR, 1996, BLOOD, V87, P423, DOI 10.1182/blood.V87.2.423.bloodjournal872423; Uziel T, 1996, GENOMICS, V33, P317, DOI 10.1006/geno.1996.0201	23	159	165	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1996	59	2					320	330						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VM288	8755918				2022-12-18	WOS:A1996VM28800007
J	deVries, BBA; Wiegers, AM; Smits, APT; Mohkamsing, S; Duivenvoorden, HJ; Fryns, JP; Curfs, LMG; Halley, DJJ; Oostra, BA; vandenOuweland, AMW; Niermeijer, MF				deVries, BBA; Wiegers, AM; Smits, APT; Mohkamsing, S; Duivenvoorden, HJ; Fryns, JP; Curfs, LMG; Halley, DJJ; Oostra, BA; vandenOuweland, AMW; Niermeijer, MF			Mental status of females with an FMR1 gene full mutation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRAGILE-X-SYNDROME; CHROMOSOME INACTIVATION MOSAICISM; HETEROZYGOUS CARRIERS; CGG REPEAT; RETARDATION; FREQUENCY; DNA; INSTABILITY; EXPRESSION; PHENOTYPE	The cloning of the FMR1 gene enables molecular diagnosis in patients and in carriers (male and female) of this X-linked mental retardation disorder. Unlike most X-linked disorders, a considerable proportion of the female carriers of a full mutation in the FMR1 gene is affected. In this study, the intelligence quotients (IQs) were ascertained by the Wechsler Adult Intelligence Scale in 33 adult females with a full mutation, with 28 first-degree adult female relatives (mainly sisters) without a full mutation as controls. Seventy-one percent of the females with a full mutation had IQ scores below 85. In paired analysis, no significant correlation could be detected between the IQs of the females with a full mutation and those of their first-degree female relatives, reflecting a dominant effect of the FMR1 gene full mutation in the mental development of females. Considering females with a full mutation only, we observed a significant relation between the proportion of normal FMR1 alleles on the active X chromosome and IQ. We present a model to explain this relationship.	UNIV HOSP DIJKZIGT,DEPT MED PSYCHOL & PSYCHOTHERAPY,3000 DR ROTTERDAM,NETHERLANDS; ERASMUS UNIV ROTTERDAM,ROTTERDAM,NETHERLANDS; RES DEPT OBSERVAT CTR HONDSBERG,OISTERWIJK,NETHERLANDS; UNIV NIJMEGEN HOSP,DEPT HUMAN GENET,6500 HB NIJMEGEN,NETHERLANDS; UNIV HOSP GASTHUISBERG,DIV HUMAN GENET,B-3000 LOUVAIN,BELGIUM	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Radboud University Nijmegen; KU Leuven; University Hospital Leuven	deVries, BBA (corresponding author), UNIV HOSP DIJKZIGT,DEPT CLIN GENET,POB 1738,3000 DR ROTTERDAM,NETHERLANDS.							ABRAMS MT, 1994, AM J MED GENET, V51, P317, DOI 10.1002/ajmg.1320510407; CATTELL RB, 1963, J EDUC PSYCHOL, V54, P1, DOI 10.1037/h0046743; CHUDLEY AE, 1983, AM J MED GENET, V14, P699, DOI 10.1002/ajmg.1320140412; CRONISTER A, 1991, AM J MED GENET, V38, P269, DOI 10.1002/ajmg.1320380221; DEVRIES BBA, 1993, EUR J HUM GENET, V1, P72; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FIALKOW PJ, 1973, ANN HUM GENET, V37, P39, DOI 10.1111/j.1469-1809.1973.tb01813.x; FRYNS JP, 1984, HUM GENET, V65, P400, DOI 10.1007/BF00291567; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; HAGERMAN RJ, 1992, PEDIATRICS, V89, P395; HORN JL, 1968, PSYCHOL REV, V75, P242, DOI 10.1037/h0025662; KNOLL JH, 1984, AM J HUM GENET, V36, P640; KOLEHMAINEN K, 1994, AM J MED GENET, V51, P328, DOI 10.1002/ajmg.1320510408; LOESCH DZ, 1993, AM J HUM GENET, V53, P1064; LUBS HA, 1969, AM J HUM GENET, V21, P231; Lyon Mary F., 1994, European Journal of Human Genetics, V2, P255; MCMAHON A, 1983, J EMBRYOL EXP MORPH, V74, P207; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1214; NESBITT MN, 1971, DEV BIOL, V26, P252, DOI 10.1016/0012-1606(71)90125-4; NIELSEN KB, 1983, HUM GENET, V64, P240, DOI 10.1007/BF00279401; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; OOSTRA BA, 1993, J MED GENET, V30, P410, DOI 10.1136/jmg.30.5.410; PAUL J, 1984, HUM GENET, V66, P344, DOI 10.1007/BF00287638; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; REISS AL, 1995, NAT GENET, V11, P331, DOI 10.1038/ng1195-331; REISS AL, 1993, AM J HUM GENET, V52, P884; ROUSSEAU F, 1991, J MED GENET, V28, P830, DOI 10.1136/jmg.28.12.830; ROUSSEAU F, 1994, AM J HUM GENET, V55, P225; ROUSSEAU F, 1991, NEW ENGL J MED, V325, P1673, DOI 10.1056/NEJM199112123252401; Sambrook J, 1989, MOL CLONING LAB MANU; SHERMAN SL, 1985, HUM GENET, V69, P289, DOI 10.1007/BF00291644; SMITS A, 1994, AM J MED GENET, V51, P497, DOI 10.1002/ajmg.1320510440; Stinissen J., 1970, HANDLEIDING BIJ NEDE; SUTHERLAND GR, 1977, SCIENCE, V197, P265, DOI 10.1126/science.877551; TAYLOR AK, 1994, JAMA-J AM MED ASSOC, V271, P507, DOI 10.1001/jama.271.7.507; TURNER G, IN PRESS AM J MED GE; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WEBB TP, 1986, J MED GENET, V23, P396, DOI 10.1136/jmg.23.5.396; WILHELM D, 1988, AM J MED GENET, V30, P407, DOI 10.1002/ajmg.1320300141; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179	40	159	161	0	11	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1996	58	5					1025	1032						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UH192	8651263				2022-12-18	WOS:A1996UH19200015
J	CURTIS, D; SHAM, PC				CURTIS, D; SHAM, PC			A NOTE ON THE APPLICATION OF THE TRANSMISSION DISEQUILIBRIUM TEST WHEN A PARENT IS MISSING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									INST PSYCHIAT,DEPT BIOSTAT & COMP,LONDON SE5 8AF,ENGLAND	University of London; King's College London	CURTIS, D (corresponding author), INST PSYCHIAT,DEPT PSYCHOL MED,DE CRESPIGNY PK,LONDON SE5 8AF,ENGLAND.		Curtis, David/HGB-3921-2022	Curtis, David/0000-0002-4089-9183				SPIELMAN RS, 1993, AM J HUM GENET, V52, P506	1	159	162	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1995	56	3					811	812						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QK918	7887437				2022-12-18	WOS:A1995QK91800032
J	KALOUSEK, DK; LANGLOIS, S; BARRETT, I; YAM, I; WILSON, DR; HOWARDPEEBLES, PN; JOHNSON, MP; GIORGIUTTI, E				KALOUSEK, DK; LANGLOIS, S; BARRETT, I; YAM, I; WILSON, DR; HOWARDPEEBLES, PN; JOHNSON, MP; GIORGIUTTI, E			UNIPARENTAL DISOMY FOR CHROMOSOME-16 IN HUMANS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISMS; POLYMERASE CHAIN-REACTION; PLACENTAL MOSAICISM; CHORIONIC VILLI; FOLLOW-UP; TRISOMY-16; DNA; DIAGNOSIS; ISODISOMY; FRAGMENTS	The association between chromosomal mosaicism observed on chorionic villus sampling (CVS) and poor pregnancy outcome has been well documented. CVS mosaicism usually represents abnormal cell lines confined to the placenta and often involves chromosomal trisomy. Such confined placental mosaicism (CPM) may occur when there is complete dichotomy between a trisomic karyotype in the placenta and a normal diploid fetus or when both diploid and trisomic components are present within the placenta. Gestations involving pure or significant trisomy in placental lineages associated with a diploid fetal karyotype probably result from a trisomic zygote which has lost one copy of the trisomic chromosome in the embryonic progenitor cells during cleavage. Uniparental disomy would be expected to occur in one-third of such cases. Trisomy of chromosome 7, 9, 15, or 16 is most common among the gestations with these dichotomic CPMs. Nine pregnancies with trisomy 16 confined to the placenta were prenatally diagnosed. Pregnancy outcome, levels of trisomic cells in term placentas, and fetal uniparental disomy were studied. Intrauterine growth retardation (IUGR), low birthweight, or fetal death was observed in six of these pregnancies and correlated with high levels of trisomic cells in the term placentas. Four of the five cases of IUGR or fetal death showed fetal uniparental disomy for chromosome 16. One of the infants with maternal uniparental disomy 16 had a significant malformation (imperforate anus). All infants with normal intrauterine growth showed term placentas with low levels of trisomic cells. The collected data do not allow us to distinguish between the effects that uniparental disomy and high levels of trisomic cells in the term placenta have on fetal intrauterine growth.	UNIV BRITISH COLUMBIA, DEPT PATHOL, VANCOUVER V6T 1W5, BC, CANADA; UNIV BRITISH COLUMBIA, DEPT MED GENET, VANCOUVER V6T 1W5, BC, CANADA; GENET & IVF INST, FAIRFAX, VA USA; VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, RICHMOND, VA 23298 USA; WAYNE STATE UNIV, DEPT OBSTET & GYNECOL, DETROIT, MI 48202 USA; WAYNE STATE UNIV, DEPT GENET, DETROIT, MI 48202 USA; INST GENET & MED PRENATAL, BUENOS AIRES, ARGENTINA	University of British Columbia; University of British Columbia; Virginia Commonwealth University; Wayne State University; Wayne State University			Langlois, Sylvie/AAR-7978-2021					APPELMAN Z, 1991, AM J MED GENET, V40, P464, DOI 10.1002/ajmg.1320400418; BATANIAN JR, 1990, HUM GENET, V85, P555; BOERWINKLE E, 1989, P NATL ACAD SCI USA, V86, P212, DOI 10.1073/pnas.86.1.212; BREED ASPM, 1991, PRENATAL DIAG, V11, P577, DOI 10.1002/pd.1970110814; BUDOWLE B, 1991, AM J HUM GENET, V48, P137; CALLEN DF, 1988, PRENATAL DIAG, V8, P453, DOI 10.1002/pd.1970080610; CASSIDY SB, 1992, AM J HUM GENET, V51, P701; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; ENGEL E, 1991, AM J MED GENET, V40, P432, DOI 10.1002/ajmg.1320400411; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FRYBURG JS, 1992, PRENATAL DIAG, V12, P157, DOI 10.1002/pd.1970120303; GILBERTSON NJ, 1990, ARCH DIS CHILD-FETAL, V65, P388, DOI 10.1136/adc.65.4_Spec_No.388; GOELZ SE, 1985, BIOCHEM BIOPH RES CO, V130, P118, DOI 10.1016/0006-291X(85)90390-0; GREALLY JM, 1990, AM J HUM GENET S, V47, pA218; HALL JG, 1990, AM J HUM GENET, V46, P857; HASHISH AF, 1989, PRENATAL DIAG, V9, P427, DOI 10.1002/pd.1970090608; HASSOLD T, 1984, ANN HUM GENET, V48, P129, DOI 10.1111/j.1469-1809.1984.tb01008.x; HAYDEN MR, 1987, AM J HUM GENET, V40, P421; HENRY I, 1991, NATURE, V351, P665, DOI 10.1038/351665a0; Jacobs P.A., 1987, HUM GENET, P233; JOHNSON A, 1990, OBSTET GYNECOL, V75, P573; JOHNSON GD, 1981, J IMMUNOL METHODS, V43, P349, DOI 10.1016/0022-1759(81)90183-6; KALOUSEK D K, 1990, Pediatric Pathology, V10, P69; KALOUSEK DK, 1992, HUM GENET, V88, P642, DOI 10.1007/BF02265289; KALOUSEK DK, 1989, AM J HUM GENET, V44, P338; KALOUSEK DK, 1991, PRENATAL DIAG, V11, P743, DOI 10.1002/pd.1970111002; KENNERKNECHT I, 1990, PRENATAL DIAG, V10, P539, DOI 10.1002/pd.1970100810; LESCHOT NJ, 1987, BRIT MED J, V295, P407, DOI 10.1136/bmj.295.6595.407; LESCHOT NJ, 1991, PRENATAL DIAG, V11, P403, DOI 10.1002/pd.1970110611; MIKKELSEN M, 1987, HUM GENET, P597; NORRIS ML, 1990, OXFORD REV REPROD B, V12, P225; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; PURVISSMITH SG, 1992, AM J HUM GENET, V50, P1348; SACHS ES, 1990, AM J MED GENET, V37, P268, DOI 10.1002/ajmg.1320370222; SCHWINGER E, 1989, PRENATAL DIAG, V9, P639, DOI 10.1002/pd.1970090907; SEARLE AG, 1989, ANN HUM GENET, V53, P89, DOI 10.1111/j.1469-1809.1989.tb01777.x; Simoni G, 1985, 1ST TRIMESTER FETAL, P137; SMEETS DFCM, 1992, NEW ENGL J MED, V326, P807, DOI 10.1056/NEJM199203193261206; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPENCE JE, 1988, AM J HUM GENET, V42, P217; SURANI MA, 1988, TRENDS GENET, V4, P59, DOI 10.1016/0168-9525(88)90040-6; THARAPEL AT, 1989, PRENATAL DIAG, V9, P467, DOI 10.1002/pd.1970090703; VERP MS, 1989, LANCET, V2, P915; VOSS R, 1989, AM J HUM GENET, V45, P373; WARBURTON D, 1978, AM J HUM GENET, V30, P609; WATSON J D, 1988, American Journal of Human Genetics, V43, pA252; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4034, DOI 10.1093/nar/18.13.4034; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4640, DOI 10.1093/nar/18.15.4640-a; WILLIAMS J, 1992, PRENATAL DIAG, V12, P163, DOI 10.1002/pd.1970120304	50	159	160	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1993	52	1					8	16						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KK908	8434609				2022-12-18	WOS:A1993KK90800002
J	Sirmaci, A; Spiliopoulos, M; Brancati, F; Powell, E; Duman, D; Abrams, A; Bademci, G; Agolini, E; Guo, SR; Konuk, B; Kavaz, A; Blanton, S; Digilio, MC; Dallapiccola, B; Young, J; Zuchner, S; Tekin, M				Sirmaci, Asli; Spiliopoulos, Michail; Brancati, Francesco; Powell, Eric; Duman, Duygu; Abrams, Alex; Bademci, Guney; Agolini, Emanuele; Guo, Shengru; Konuk, Berrin; Kavaz, Asli; Blanton, Susan; Digilio, Maria Christina; Dallapiccola, Bruno; Young, Juan; Zuchner, Stephan; Tekin, Mustafa			Mutations in ANKRD11 Cause KBG Syndrome, Characterized by Intellectual Disability, Skeletal Malformations, and Macrodontia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DELINEATION	KBG syndrome is characterized by intellectual disability associated with macrodontia of the upper central incisors as well as distinct craniofacial findings, short stature, and skeletal anomalies. Although believed to be genetic in origin, the specific underlying defect is unknown. Through whole-exome sequencing, we identified deleterious heterozygous mutations in ANKRD11 encoding ankyrin repeat domain 11, also known as ankyrin repeat-containing cofactor 1. A splice-site mutation, c.7570-1G>C (p.Glu2524_Lys2525del), cosegregated with the disease in a family with three affected members, whereas in a simplex case a de novo truncating mutation, c.2305delT (p.Ser769GlnfsX8), was detected. Sanger sequencing revealed additional de novo truncating ANKRD11 mutations in three other simplex cases. ANKRD11 is known to interact with nuclear receptor complexes to modify transcriptional activation. We demonstrated that ANKRD11 localizes mainly to the nuclei of neurons and accumulates in discrete inclusions when neurons are depolarized, suggesting that it plays a role in neural plasticity. Our results demonstrate that mutations in ANKRD11 cause KBG syndrome and outline a fundamental role of ANKRD11 in craniofacial, dental, skeletal, and central nervous system development and function.	[Sirmaci, Asli; Powell, Eric; Abrams, Alex; Bademci, Guney; Guo, Shengru; Blanton, Susan; Young, Juan; Zuchner, Stephan; Tekin, Mustafa] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA; [Sirmaci, Asli; Spiliopoulos, Michail; Powell, Eric; Abrams, Alex; Bademci, Guney; Guo, Shengru; Blanton, Susan; Young, Juan; Zuchner, Stephan; Tekin, Mustafa] Univ Miami, Miller Sch Med, Dr John T Macdonald Dept Human Genet, Miami, FL 33136 USA; [Brancati, Francesco; Agolini, Emanuele] IRCCS Casa Sollievo Sofferenza, Mendel Lab, I-00198 Rome, Italy; [Brancati, Francesco] Univ Roma Tor Vergata, Dept Biopathol & Diagnost Imaging, I-00133 Rome, Italy; [Brancati, Francesco] DAnnunzio Univ, Dept Biomed Sci, I-66100 Chieti, Italy; [Duman, Duygu; Konuk, Berrin; Kavaz, Asli; Tekin, Mustafa] Ankara Univ, Sch Med, Div Pediat Genet, TR-06100 Ankara, Turkey; [Digilio, Maria Christina; Dallapiccola, Bruno] IRCCS Bambino Gesu Children Hosp, I-00198 Rome, Italy	University of Miami; University of Miami; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; University of Rome Tor Vergata; G d'Annunzio University of Chieti-Pescara; Ankara University; IRCCS Bambino Gesu	Tekin, M (corresponding author), Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA.	mtekin@med.miami.edu	Blanton, Susan Halloran/ABF-1323-2021; Spiliopoulos, Michail/AAK-7087-2020; Duman, Duygu/AAG-7765-2019; Tekin, Mustafa/ABG-7627-2020; duman, duygu/AAF-8093-2020; Agolini, Emanuele/AAC-1378-2019; tufan, aslı kavaz/ABI-3407-2020; yuksel, berrin/AAB-5080-2019; Brancati, Francesco/AAC-3778-2022; Agolini, Emanuele/A-2106-2015; Dallapiccola, Bruno/K-8692-2016	Spiliopoulos, Michail/0000-0003-1277-7477; duman, duygu/0000-0001-7583-0349; Agolini, Emanuele/0000-0001-6543-6225; tufan, aslı kavaz/0000-0003-1311-9468; yuksel, berrin/0000-0001-7107-1939; Brancati, Francesco/0000-0003-3624-2354; Agolini, Emanuele/0000-0002-8947-7344; Dallapiccola, Bruno/0000-0002-5031-1013; Tekin, Mustafa/0000-0002-3525-7960; Bademci, Guney/0000-0002-4052-8833	University of Miami; Ricerca Corrente; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072248] Funding Source: NIH RePORTER	University of Miami; Ricerca Corrente(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Corrente (MOH-RC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study is supported in part by funds from the University of Miami and a grant (Ricerca Corrente 2011) to F.B. and E.A.	Barbaric I, 2008, PHYSIOL GENOMICS, V32, P311, DOI 10.1152/physiolgenomics.00116.2007; Brancati F, 2004, AM J MED GENET A, V131A, P144, DOI 10.1002/ajmg.a.30292; Dowling P A, 2001, Int J Paediatr Dent, V11, P131, DOI 10.1046/j.1365-263x.2001.00231.x; Hah M, 2009, J AUTISM DEV DISORD, V39, P1744, DOI 10.1007/s10803-009-0811-7; Herrmann J, 1975, Birth Defects Orig Artic Ser, V11, P7; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Skjei KL, 2007, AM J MED GENET A, V143A, P292, DOI 10.1002/ajmg.a.31597; Smithson SF, 2000, CLIN DYSMORPHOL, V9, P87, DOI 10.1097/00019605-200009020-00002; Tekin M, 2004, AM J MED GENET A, V130A, P284, DOI 10.1002/ajmg.a.30291; Willemsen MH, 2010, EUR J HUM GENET, V18, P429, DOI 10.1038/ejhg.2009.192; Xia ZG, 1996, J NEUROSCI, V16, P5425; Young JI, 2004, AM J HUM GENET, V74, P511, DOI 10.1086/382228; Youngs EL, 2011, CLIN DYSMORPHOL, V20, P170, DOI 10.1097/MCD.0b013e328346f6ae; Zhang AH, 2004, J BIOL CHEM, V279, P33799, DOI 10.1074/jbc.M403997200; Zhang AH, 2007, BIOCHEM BIOPH RES CO, V358, P1034, DOI 10.1016/j.bbrc.2007.05.017; ZOLLINO M, 1994, AM J MED GENET, V52, P302, DOI 10.1002/ajmg.1320520310	16	158	165	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 12	2011	89	2					289	294		10.1016/j.ajhg.2011.06.007	http://dx.doi.org/10.1016/j.ajhg.2011.06.007			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	810TA	21782149	Green Published, Bronze			2022-12-18	WOS:000294148800008
J	Ellouze, S; Augustin, S; Bouaita, A; Bonnet, C; Simonutti, M; Forster, V; Picaud, S; Sahel, JA; Corral-Debrinski, M				Ellouze, Sami; Augustin, Sebastien; Bouaita, Aicha; Bonnet, Crystel; Simonutti, Manuel; Forster, Valerie; Picaud, Serge; Sahel, Jose-Alain; Corral-Debrinski, Marisol			Optimized allotopic expression of the human mitochondrial ND4 prevents blindness in a rat model of mitochondrial dysfunction	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RETINAL GANGLION-CELLS; HEREDITARY OPTIC NEUROPATHY; LEBERS CONGENITAL AMAUROSIS; MESSENGER-RNA LOCALIZATION; IN-VIVO ELECTROPORATION; GENE-THERAPY; VISUAL FUNCTION; COMPLEX-I; DISEASE; DEFICIENCY	Mitochondrial diseases due to mutations in mitochondrial DNA can no longer be ignored in most medical areas. With prevalence certainly higher than one in 6000, they probably represent the most common form of metabolic disorders. Despite progress in identification of their molecular mechanisms, little has been done with regard to therapy. We have recently optimized the allotopic expression for the mitochondrial genes ATP6, ND1, and ND4 and obtained a complete and long-lasting rescue of mitochondrial dysfunction in the human fibroblasts in which these genes were mutated. However, biosafety and benefit to mitochondrial function must be validated in animal models prior to clinical applications. To create an animal model of Leber Hereditary Optic Neuropathy (LHON), we introduced the human ND4 gene harboring the G11778A mutation, responsible of 60% of LHON cases, to rat eyes by in vivo electroporation. The treatment induced the degeneration of retinal ganglion cells (RGCs), which were 40% less abundant in treated eyes than in control eyes. This deleterious effect was also confirmed in primary cell culture, in which both RGC survival and neurite outgrowth were compromised. Importantly, RGC loss was clearly associated with a decline in visual performance. A subsequent electroporation with wild-type ND4 prevented both RGC loss and the impairment of visual function. Hence, these data provide the proof-of-principle that optimized allotopic expression can be an effective treatment for LHON, and they open the way to clinical studies on other devastating mitochondrial disorders.	[Ellouze, Sami; Augustin, Sebastien; Bouaita, Aicha; Bonnet, Crystel; Simonutti, Manuel; Forster, Valerie; Picaud, Serge; Sahel, Jose-Alain; Corral-Debrinski, Marisol] Univ Paris 06, Inst Vis, UMR S 592, F-75012 Paris, France	UDICE-French Research Universities; Sorbonne Universite	Corral-Debrinski, M (corresponding author), Univ Paris 06, Inst Vis, UMR S 592, 17 Rue Moreau, F-75012 Paris, France.	marisol.corral@inserm.fr	Picaud, Serge/H-4012-2014; Sahel, Jose-Alain/F-3172-2017; Bonnet, Crystel/AAN-5950-2021	Picaud, Serge/0000-0002-0548-5145; Sahel, Jose-Alain/0000-0002-4831-1153; Bonnet, Crystel/0000-0002-1916-9119	INSERM (U592); Agence National pour la Recherche (ANR)/Maladies Rares; Fondations des Gueules Cassees; INSERM; ANR; Retina France; the Carnot Institute; Methuselah Foundation	INSERM (U592)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence National pour la Recherche (ANR)/Maladies Rares(French National Research Agency (ANR)); Fondations des Gueules Cassees; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ANR(French National Research Agency (ANR)); Retina France; the Carnot Institute; Methuselah Foundation	We thank Mark Hamalainen for useful discussions. This work was supported by funds from the INSERM (U592) and Agence National pour la Recherche (ANR)/Maladies Rares and Fondations des Gueules Cassees. C.B. was the recipient of Ouvrir les Yeux Association awards and the ANR/Maladies Rares funding, S.E. is the recipient of an Ile de France fellowship, A.B. is supported by the INSERM and the ANR, and S.A. was supported by Retina France, the Carnot Institute, and Methuselah Foundation.	Abu-Amero KK, 2006, INVEST OPHTH VIS SCI, V47, P4211, DOI 10.1167/iovs.06-0295; Bainbridge JWB, 2006, GENE THER, V13, P1191, DOI 10.1038/sj.gt.3302812; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; Bokori-Brown M, 2006, REJUV RES, V9, P455, DOI 10.1089/rej.2006.9.455; BONNET C, BIOCH BIOPH IN PRESS; Bonnet C, 2007, REJUV RES, V10, P127, DOI 10.1089/rej.2006.0526; Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003; Carelli V, 2007, BIOSCIENCE REP, V27, P173, DOI 10.1007/s10540-007-9045-0; Chinnery P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub2; Coffey PJ, 2002, NAT NEUROSCI, V5, P53, DOI 10.1038/nn782; COWEY A, 1979, EXP BRAIN RES, V35, P443; Danias J, 2002, INVEST OPHTH VIS SCI, V43, P587; DiMauro S, 2007, BIOSCIENCE REP, V27, P125, DOI 10.1007/s10540-007-9041-4; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; Feher J, 2006, NEUROBIOL AGING, V27, P983, DOI 10.1016/j.neurobiolaging.2005.05.012; Fuchs C, 2005, INVEST OPHTH VIS SCI, V46, P2983, DOI 10.1167/iovs.04-1177; Goto T, 2004, MOL THER, V10, P929, DOI 10.1016/j.ymthe.2004.07.028; Guy J, 2002, ANN NEUROL, V52, P534, DOI 10.1002/ana.10354; Hanein S, 2006, ADV EXP MED BIOL, V572, P15; Huizing M, 2005, MOL GENET METAB, V86, P51, DOI 10.1016/j.ymgme.2005.07.034; Ishikawa H, 2005, GENE THER, V12, P289, DOI 10.1038/sj.gt.3302277; Jacobson SG, 2006, HUM GENE THER, V17, P845, DOI 10.1089/hum.2006.17.845; Kaltimbacher V, 2006, RNA, V12, P1408, DOI 10.1261/rna.18206; Kaneda T, 2007, ENDOCRINOLOGY, V148, P2335, DOI 10.1210/en.2006-1077; Lin B, 2004, NEURON, V43, P475, DOI 10.1016/j.neuron.2004.08.002; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015; Manfredi G, 2002, NAT GENET, V30, P394, DOI 10.1038/ng851; McFarland R, 2007, CURR TOP DEV BIOL, V77, P113, DOI 10.1016/S0070-2153(06)77005-3; Oca-Cossio J, 2003, GENETICS, V165, P707; Perkins GA, 2004, MITOCHONDRION, V4, P695, DOI 10.1016/j.mito.2004.07.020; Qi XP, 2007, INVEST OPHTH VIS SCI, V48, P1, DOI 10.1167/iovs.06-0789; Ruiz-Ederra J, 2004, MOL VIS, V10, P83; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Sadun Alfredo A, 2006, Trans Am Ophthalmol Soc, V104, P51; Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; Singh KK, 2006, ANN NY ACAD SCI, V1067, P182, DOI 10.1196/annals.1354.022; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; XIANG MQ, 1995, J NEUROSCI, V15, P4762; Yen MY, 2006, PROG RETIN EYE RES, V25, P381, DOI 10.1016/j.preteyeres.2006.05.002	42	158	166	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP 12	2008	83	3					373	387		10.1016/j.ajhg.2008.08.013	http://dx.doi.org/10.1016/j.ajhg.2008.08.013			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	349TW	18771762	Bronze, Green Published			2022-12-18	WOS:000259307200008
J	Magen, D; Georgopoulos, C; Bross, P; Ang, D; Segev, Y; Goldsher, D; Nemirovski, A; Shahar, E; Ravid, S; Luder, A; Heno, B; Gershoni-Baruch, R; Skorecki, K; Mandel, H				Magen, Daniella; Georgopoulos, Costa; Bross, Peter; Ang, Debbie; Segev, Yardena; Goldsher, Dorit; Nemirovski, Alexandra; Shahar, Eli; Ravid, Sarit; Luder, Anthony; Heno, Bayan; Gershoni-Baruch, Ruth; Skorecki, Karl; Mandel, Hanna			Mitochondrial Hsp60 chaperonopathy causes an autosomal-recessive neurodegenerative disorder linked to brain hypomyelination and leukodystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PELIZAEUS-MERZBACHER-DISEASE; SPASTIC PARAPLEGIA SPG13; MOLECULAR CHAPERONES; GJA12 MUTATIONS; PROTEIN HSP60; GENE; CHAIN; HEAT-SHOCK-PROTEIN-60; PATHOGENESIS; SYSTEM	Hypomyelinating leukodystrophies (HMLs) are disorders involving aberrant myelin formation. The prototype of primary HMLs is the X-linked Pelizaeus-Merzbacher disease (PMD) caused by mutations in PLP1. Recently, homozygous mutations in GJA12 encoding connexin 47 were found in patients with autosomal-recessive Pelizaeus-Merzbacher-like disease (PMLD). However, many patients of both genders with PMLD carry neither PLP1 nor GJA12 mutations. We report a consanguineous Israeli Bedouin kindred with clinical and radiological findings compatible with PMLD, in which linkage to PLP1 and GJA12 was excluded. Using homozygosity mapping and mutation analysis, we have identified a homozygous missense mutation (D29G) not previously described in HSPD1, encoding the mitochondrial heat-shock protein 60 (Hsp60) in all affected individuals. The D29G mutation completely segregates with the disease-associated phenotype. The pathogenic effect of D29G on Hsp60-chaperonin activity was verified by an in vivo E. coli complementation assay, which demonstrated compromised ability of the D29G-Hsp60 mutant protein to support E, coli survival, especially at high temperatures. The disorder, which we have termed MitCHAP-60 disease, can be distinguished from spastic paraplegia 13 (SPG13), another Hsp60-associated autosomal-dominant neurodegenerative disorder, by its autosomal-recessive inheritance pattern, as well as by its early-onset, profound cerebral involvement and lethality. Our findings suggest that Hsp60 defects can cause neurodegenerative pathologies of varying severity, not previously suspected on the basis of the SPG13 phenotype. These findings should help to clarify the important role of Hsp60 in myelinogenesis and neurodegeneration.	[Mandel, Hanna] Metab Dis Unit, IL-31096 Haifa, Israel; [Magen, Daniella] Pediat Nephrol Unit, IL-31096 Haifa, Israel; Pediat Nephrol Unit, IL-31096 Haifa, Israel; [Magen, Daniella; Segev, Yardena; Skorecki, Karl] Mol Med Lab, IL-31096 Haifa, Israel; [Magen, Daniella; Segev, Yardena; Goldsher, Dorit; Shahar, Eli; Ravid, Sarit; Luder, Anthony; Heno, Bayan; Gershoni-Baruch, Ruth; Skorecki, Karl; Mandel, Hanna] Technion Israel Inst Technol, Rappaport Fac Med, IL-35001 Haifa, Israel; [Magen, Daniella; Segev, Yardena; Goldsher, Dorit; Shahar, Eli; Ravid, Sarit; Luder, Anthony; Heno, Bayan; Gershoni-Baruch, Ruth; Skorecki, Karl; Mandel, Hanna] Technion Israel Inst Technol, Res Inst, IL-35001 Haifa, Israel; [Georgopoulos, Costa; Ang, Debbie] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA; [Bross, Peter] Arhus Univ Hosp, Res Unit Mol Med, Fac Hlth Sci, Aarhus 8200, Denmark; [Goldsher, Dorit; Nemirovski, Alexandra] MRI Inst, IL-31096 Haifa, Israel; [Shahar, Eli; Ravid, Sarit] Meyer Childrens Hosp, Child Neurol Unit, IL-31096 Haifa, Israel; [Shahar, Eli; Ravid, Sarit] Meyer Childrens Hosp, Epilepsy Serv, IL-31096 Haifa, Israel; [Luder, Anthony; Heno, Bayan] Ziv Med Ctr, Dept Pediat & Genet, IL-13100 Safed, Israel; [Gershoni-Baruch, Ruth] Meyer Childrens Hosp, Dept Human Genet, IL-31096 Haifa, Israel	Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Utah System of Higher Education; University of Utah; Aarhus University; Rambam Health Care Campus; Rambam Health Care Campus; Ziv Medical Center; Rambam Health Care Campus	Mandel, H (corresponding author), Metab Dis Unit, Rambam Hlth Care Campus, IL-31096 Haifa, Israel.	h_mandel@rambam.health.gov.il	Bross, Peter/B-7219-2013	Bross, Peter/0000-0001-9526-8525				Arya R, 2007, J BIOSCIENCES, V32, P595, DOI 10.1007/s12038-007-0059-3; Bross P, 2008, J BIOL CHEM, V283, P15694, DOI 10.1074/jbc.M800548200; Bross P, 2007, J HUM GENET, V52, P56, DOI 10.1007/s10038-006-0080-7; Bugiani M, 2006, NEUROLOGY, V67, P273, DOI 10.1212/01.wnl.0000223832.66286.e4; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Cailloux F, 2000, EUR J HUM GENET, V8, P837, DOI 10.1038/sj.ejhg.5200537; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Chan JYH, 2007, J BIOL CHEM, V282, P4585, DOI 10.1074/jbc.M603394200; Chandra D, 2007, J BIOL CHEM, V282, P31289, DOI 10.1074/jbc.M702777200; Chang AYW, 2006, J PHYSIOL-LONDON, V574, P547, DOI 10.1113/jphysiol.2006.110890; CHENG MY, 1989, NATURE, V337, P620, DOI 10.1038/337620a0; CHRETIEN D, 1994, CLIN CHIM ACTA, V228, P53, DOI 10.1016/0009-8981(94)90056-6; Corydon TJ, 2005, MOL GENET METAB, V85, P260, DOI 10.1016/j.ymgme.2005.04.003; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; Fink JK, 2003, ARCH NEUROL-CHICAGO, V60, P1045, DOI 10.1001/archneur.60.8.1045; Fink JK, 2006, CURR NEUROL NEUROSCI, V6, P65, DOI 10.1007/s11910-996-0011-1; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Garbern J, 1999, ARCH NEUROL-CHICAGO, V56, P1210, DOI 10.1001/archneur.56.10.1210; Garbern JY, 2007, CELL MOL LIFE SCI, V64, P50, DOI 10.1007/s00018-006-6182-8; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Haas RH, 2007, MITOCHONDRION, V7, pS136, DOI 10.1016/j.mito.2007.03.008; Hansen J, 2007, J NEUROL, V254, P897, DOI 10.1007/s00415-006-0470-y; Hansen JJ, 2002, AM J HUM GENET, V70, P1328, DOI 10.1086/339935; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Henneke M, 2008, NEUROLOGY, V70, P748, DOI 10.1212/01.wnl.0000284828.84464.35; Heyrovska N, 1998, BIOL CHEM, V379, P301, DOI 10.1515/bchm.1998.379.3.301; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Inoue K, 2005, NEUROGENETICS, V6, P1, DOI 10.1007/s10048-004-0207-y; Kwong JQ, 2006, J NEUROCHEM, V97, P1659, DOI 10.1111/j.1471-4159.2006.03990.x; Mandemakers W, 2007, J CELL SCI, V120, P1707, DOI 10.1242/jcs.03443; Martin J, 1997, J BIOENERG BIOMEMBR, V29, P35, DOI 10.1023/A:1022407705182; Nielsen KL, 1999, J BACTERIOL, V181, P5871, DOI 10.1128/JB.181.18.5871-5875.1999; OSTERMANN J, 1989, NATURE, V341, P125, DOI 10.1038/341125a0; Pedersen CB, 2003, J BIOL CHEM, V278, P47449, DOI 10.1074/jbc.M309514200; Petrozzi L, 2007, BIOSCIENCE REP, V27, P87, DOI 10.1007/s10540-007-9038-z; Reid E, 2003, J MED GENET, V40, P81, DOI 10.1136/jmg.40.2.81; Richardson A, 2001, J BIOL CHEM, V276, P4981, DOI 10.1074/jbc.M008628200; Rossi A, 2008, AM J NEURORADIOL, V29, P301, DOI 10.3174/ajnr.A0792; Sambrook J, 1989, MOL CLONING LABORATO, V9, P16; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; Schiffmann R, 2001, CURR OPIN NEUROL, V14, P789, DOI 10.1097/00019052-200112000-00018; Silberstein M, 2006, AM J HUM GENET, V78, P922, DOI 10.1086/504158; Soltys BJ, 1996, EXP CELL RES, V222, P16, DOI 10.1006/excr.1996.0003; Uhlenberg B, 2004, AM J HUM GENET, V75, P251, DOI 10.1086/422763; van der Knaap MS, 1999, RADIOLOGY, V213, P121, DOI 10.1148/radiology.213.1.r99se01121; Veereshwarayya V, 2006, J BIOL CHEM, V281, P29468, DOI 10.1074/jbc.M602533200; Vu TH, 1998, NEUROLOGY, V50, P1783, DOI 10.1212/WNL.50.6.1783; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Zuchner S, 2005, J MOL MED-JMM, V83, P935, DOI 10.1007/s00109-005-0694-9	49	158	162	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2008	83	1					30	42		10.1016/j.ajhg.2008.05.016	http://dx.doi.org/10.1016/j.ajhg.2008.05.016			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	328FO	18571143	Bronze, Green Published			2022-12-18	WOS:000257784000005
J	Sharon, D; Sandberg, MA; Rabe, VW; Stillberger, M; Dryja, TP; Berson, EL				Sharon, D; Sandberg, MA; Rabe, VW; Stillberger, M; Dryja, TP; Berson, EL			RP2 and RPGR mutations and clinical correlations in patients with X-linked retinitis pigmentosa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NUCLEOTIDE-EXCHANGE FACTOR; NORTH-AMERICAN COHORT; EXON ORF15; POSITIONAL CLONING; GENE; FAMILIES; LOCUS; IDENTIFICATION; DEGENERATION; DYSTROPHY	We determined the mutation spectrum of the RP2 and RPGR genes in patients with X-linked retinitis pigmentosa (XLRP) and searched for correlations between categories of mutation and severity of disease. We screened 187 unrelated male patients for mutations, including 135 with a prior clinical diagnosis of XLRP, 11 with probable XLRP, 30 isolate cases suspected of having XLRP, and 11 with cone-rod degeneration. Mutation screening was performed by single-strand conformation analysis and by sequencing of all RP2 exons and RPGR exons 1-14, ORF15, and 15a. The refractive error, visual acuity, final dark-adapted threshold, visual field area, and 30-Hz cone electroretinogram (ERG) amplitude were measured in each patient. Among the 187 patients, we found 10 mutations in RP2, 2 of which are novel, and 80 mutations in RPGR, 41 of which are novel; 66% of the RPGR mutations were within ORF15. Among the 135 with a prior clinical diagnosis of XLRP, mutations in the RP2 and RPGR genes were found in 9 of 135 (6.7%) and 98 of 135 (72.6%), respectively, for a total of 79% of patients. Patients with RP2 mutations had, on average, lower visual acuity but similar visual field area, final dark-adapted threshold, and 30-Hz ERG amplitude compared with those with RPGR mutations. Among patients with RPGR mutations, those with ORF15 mutations had, on average, a significantly larger visual field area and a borderline larger ERG amplitude than did patients with RPGR mutations in exons 1-14. Among patients with ORF15 mutations, regression analyses showed that the final dark-adapted threshold became lower (i.e., closer to normal) and that the 30-Hz ERG amplitude increased as the length of the wild-type ORF15 amino acid sequence increased. Furthermore, as the length of the abnormal amino acid sequence following ORF15 frameshift mutations increased, the severity of disease increased.	Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Berman Gund Lab Study Retinal Degenerat, Boston, MA 02114 USA; Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Ocular Mol Genet Inst, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Berson, EL (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Berman Gund Lab Study Retinal Degenerat, 243 Charles St, Boston, MA 02114 USA.		Sharon, Dror/P-4539-2015	Sharon, Dror/0000-0002-1789-5811; Williams, Vivian/0000-0003-0674-6658	NEI NIH HHS [EY08683, R37 EY000169, R01 EY008683, R01 EY000169, EY00169] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY000169, R01EY008683, R37EY000169] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANDREASSON SOL, 1988, AM J OPHTHALMOL, V105, P500, DOI 10.1016/0002-9394(88)90241-3; Ayyagari R, 2002, GENOMICS, V80, P166, DOI 10.1006/geno.2002.6815; Bader I, 2003, INVEST OPHTH VIS SCI, V44, P1458, DOI 10.1167/iovs.02-0605; BERSON EL, 1991, ARCH OPHTHALMOL-CHIC, V109, P92, DOI 10.1001/archopht.1991.01080010094039; BERSON EL, 1980, AM J OPHTHALMOL, V89, P763, DOI 10.1016/0002-9394(80)90163-4; BERSON EL, 1979, AM J OPHTHALMOL, V87, P460, DOI 10.1016/0002-9394(79)90231-9; Breuer DK, 2002, AM J HUM GENET, V70, P1545, DOI 10.1086/340848; Buraczynska M, 1997, AM J HUM GENET, V61, P1287, DOI 10.1086/301646; Fishman GA, 1998, OPHTHALMOLOGY, V105, P2286, DOI 10.1016/S0161-6420(98)91231-3; Gieser L, 1998, AM J HUM GENET, V63, P1439, DOI 10.1086/302121; Guevara-Fujita M, 2001, Hum Mutat, V17, P151, DOI 10.1002/1098-1004(200102)17:2<151::AID-HUMU7>3.3.CO;2-N; Hardcastle AJ, 2000, INVEST OPHTH VIS SCI, V41, P2080; Hardcastle AJ, 1999, AM J HUM GENET, V64, P1210, DOI 10.1086/302325; Hong DH, 2001, J BIOL CHEM, V276, P12091, DOI 10.1074/jbc.M009351200; Hong DH, 2002, INVEST OPHTH VIS SCI, V43, P3373; Mears AJ, 1999, AM J HUM GENET, V64, P897, DOI 10.1086/302298; Meindl A, 1996, NAT GENET, V13, P35, DOI 10.1038/ng0596-35; Miano MG, 1999, EUR J HUM GENET, V7, P687, DOI 10.1038/sj.ejhg.5200352; OTT J, 1990, P NATL ACAD SCI USA, V87, P701, DOI 10.1073/pnas.87.2.701; PAUL SR, 1991, TECHNOMETRICS, V33, P339, DOI 10.2307/1268785; Pusch Carsten M, 2002, Hum Mutat, V20, P405, DOI 10.1002/humu.9072; Roepman R, 1996, HUM MOL GENET, V5, P1035, DOI 10.1093/hmg/5.7.1035; Rosner B., 2000, FUNDAMENTALS BIOSTAT; Rozet JM, 2002, J MED GENET, V39, P284, DOI 10.1136/jmg.39.4.284; SANDBERG MA, 1995, INVEST OPHTH VIS SCI, V36, P1934; Schwahn U, 1998, NAT GENET, V19, P327, DOI 10.1038/1214; Sharon D, 2000, INVEST OPHTH VIS SCI, V41, P2712; Thiselton D L, 2000, Hum Mutat, V15, P580, DOI 10.1002/1098-1004(200006)15:6<580::AID-HUMU15>3.0.CO;2-3; Vervoort R, 2000, NAT GENET, V25, P462, DOI 10.1038/78182; Vervoort R, 2002, HUM MUTAT, V19, P486, DOI 10.1002/humu.10057; Westall Carol A., 2001, Documenta Ophthalmologica, V102, P115, DOI 10.1023/A:1017535207481; Yang ZL, 2002, HUM MOL GENET, V11, P605, DOI 10.1093/hmg/11.5.605; Yesim F, 2002, AM J HUM GENET, V70, P1049, DOI 10.1086/339620; Zhang Q, 2002, HUM MOL GENET, V11, P993, DOI 10.1093/hmg/11.9.993; Zito I, 1999, HUM GENET, V105, P57, DOI 10.1007/s004390051064; Zito I, 2000, HUM MUTAT, V16, DOI 10.1002/1098-1004(200009)16:3<273::AID-HUMU19>3.0.CO;2-W	36	158	164	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2003	73	5					1131	1146		10.1086/379379	http://dx.doi.org/10.1086/379379			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	742AR	14564670	Bronze, Green Published			2022-12-18	WOS:000186493400014
J	Bortolini, MC; Salzano, FM; Thomas, MG; Stuart, S; Nasanen, SPK; Bau, CHD; Hutz, MH; Layrisse, Z; Petzl-Erler, ML; Tsuneto, LT; Hill, K; Hurtado, AM; Castro-de-Guerra, D; Torres, MM; Groot, H; Michalski, R; Nymadawa, P; Bedoya, G; Bradman, N; Labuda, D; Ruiz-Linares, A				Bortolini, MC; Salzano, FM; Thomas, MG; Stuart, S; Nasanen, SPK; Bau, CHD; Hutz, MH; Layrisse, Z; Petzl-Erler, ML; Tsuneto, LT; Hill, K; Hurtado, AM; Castro-de-Guerra, D; Torres, MM; Groot, H; Michalski, R; Nymadawa, P; Bedoya, G; Bradman, N; Labuda, D; Ruiz-Linares, A			Y-chromosome evidence for differing ancient demographic histories in the Americas	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA ANALYSIS; MTDNA HAPLOGROUP X; NATIVE-AMERICAN; NEW-WORLD; MICROSATELLITE; POPULATIONS; DIVERSITY; ORIGIN; POLYMORPHISMS; ENTRY	To scrutinize the male ancestry of extant Native American populations, we examined eight biallelic and six microsatellite polymorphisms from the nonrecombining portion of the Y chromosome, in 438 individuals from 24 Native American populations ( 1 Na Dene and 23 South Amerinds) and in 404 Mongolians. One of the biallelic markers typed is a recently identified mutation ( M242) characterizing a novel founder Native American haplogroup. The distribution, relatedness, and diversity of Y lineages in Native Americans indicate a differentiated male ancestry for populations from North and South America, strongly supporting a diverse demographic history for populations from these areas. These data are consistent with the occurrence of two major male migrations from southern/ central Siberia to the Americas ( with the second migration being restricted to North America) and a shared ancestry in central Asia for some of the initial migrants to Europe and the Americas. The microsatellite diversity and distribution of a Y lineage specific to South America (Q-M19) indicates that certain Amerind populations have been isolated since the initial colonization of the region, suggesting an early onset for tribalization of Native Americans. Age estimates based on Y-chromosome microsatellite diversity place the initial settlement of the American continent at similar to 14,000 years ago, in relative agreement with the age of well-established archaeological evidence.	UCL, Dept Biol, London NW1 2HE, England; Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil; Inst Venezolano Invest Cient, Caracas, Venezuela; Univ Fed Parana, Dept Genet, BR-80060000 Curitiba, Parana, Brazil; Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA; Univ Los Andes, Lab Genet Humana, Bogota, Colombia; Victoria Hosp, Prince Albert, SK, Canada; Mongolian Acad Sci, Ulaanbaatar, Mongolia; Univ Antioquia, Mol Genet Lab, Fac Med, Medellin, Colombia; Univ Montreal, Montreal, PQ, Canada	University of London; University College London; Universidade Federal do Rio Grande do Sul; Venezuelan Institute Science Research; Universidade Federal do Parana; University of New Mexico; Universidad de los Andes (Colombia); University of Victoria; Mongolian Academy of Sciences; Universidad de Antioquia; Universite de Montreal	Ruiz-Linares, A (corresponding author), UCL, Dept Biol, Wolfson House,4 Stephenson Way, London NW1 2HE, England.	a.ruizlin@ucl.ac.uk	Salzano, Francisco M/L-7916-2015; Bau, Claiton Henrique Dotto/C-9980-2013; Hutz, Mara H/I-4070-2012; Nymadawa, Pagbajab/AAE-7344-2019; Petzl-Erler, Maria Luiza/H-8221-2012; Ruiz-Linares, Andres/AAR-1104-2021; Thomas, Mark G/A-2219-2012	Bau, Claiton Henrique Dotto/0000-0001-5644-3845; Nymadawa, Pagbajab/0000-0002-3189-2772; Petzl-Erler, Maria Luiza/0000-0002-0345-5276; Ruiz-Linares, Andres/0000-0001-8372-1011; Thomas, Mark G/0000-0002-2452-981X; Groot, Helena/0000-0002-9152-2175; Hutz, Mara/0000-0002-9146-1229				[Anonymous], PHYLIP PHYLOGENY INF; BANDELT HJ, 1995, GENETICS, V141, P743; Bergen AW, 1999, ANN HUM GENET, V63, P63, DOI 10.1046/j.1469-1809.1999.6310063.x; Bianchi NO, 1997, AM J PHYS ANTHROPOL, V102, P79; Bianchi NO, 1998, AM J HUM GENET, V63, P1862, DOI 10.1086/302141; Bonatto SL, 1997, P NATL ACAD SCI USA, V94, P1866, DOI 10.1073/pnas.94.5.1866; Bonatto SL, 1997, AM J HUM GENET, V61, P1413, DOI 10.1086/301629; Bortolini MC, 2002, ANN HUM GENET, V66, P255, DOI 10.1017/S0003480002001148; Brace CL, 2001, P NATL ACAD SCI USA, V98, P10017, DOI 10.1073/pnas.171305898; Brown MD, 1998, AM J HUM GENET, V63, P1852, DOI 10.1086/302155; Carvajal-Carmona LG, 2000, AM J HUM GENET, V67, P1287, DOI 10.1016/S0002-9297(07)62956-5; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Derenko MV, 2001, AM J HUM GENET, V69, P237, DOI 10.1086/321266; Ellis N, 2002, GENOME RES, V12, P339; Fiedel SJ., 1999, PREHISTORY AM; Forster P, 1996, AM J HUM GENET, V59, P935; GOLDSTEIN DB, 1995, GENETICS, V139, P463; Greenberg JH, 1996, SCIENCE, V274, P1447; GREENBERG JH, 1986, CURR ANTHROPOL, V27, P477, DOI 10.1086/203472; Heyer E, 2001, AM J HUM GENET, V69, P1113, DOI 10.1086/324024; HORAI S, 1993, MOL BIOL EVOL, V10, P23; Jablonski Nina G., 2002, 1 AM PLEISTOCENE COL; Karafet T, 1997, AM J PHYS ANTHROPOL, V102, P301, DOI 10.1002/(SICI)1096-8644(199703)102:3<301::AID-AJPA1>3.0.CO;2-Y; Karafet TM, 1999, AM J HUM GENET, V64, P817, DOI 10.1086/302282; Kayser M, 2000, AM J HUM GENET, V66, P1580, DOI 10.1086/302905; Kolman CJ, 1996, GENETICS, V142, P1321; Lell JT, 1997, HUM GENET, V100, P536, DOI 10.1007/s004390050548; Lell JT, 2002, AM J HUM GENET, V70, P192, DOI 10.1086/338457; Malhi RS, 2002, AM J PHYS ANTHROPOL, V119, P84, DOI 10.1002/ajpa.10106; Malhi RS, 2002, AM J HUM GENET, V70, P905, DOI 10.1086/339690; Merriwether DA, 1996, MOL PHYLOGENET EVOL, V5, P241, DOI 10.1006/mpev.1996.0017; Merriwether DA, 1996, AM J HUM GENET, V59, P204; Mesa NR, 2000, AM J HUM GENET, V67, P1277, DOI 10.1016/S0002-9297(07)62955-3; NEEL JV, 1994, P NATL ACAD SCI USA, V91, P10737, DOI 10.1073/pnas.91.22.10737; Nei M., 1987, MOL EVOLUTIONARY GEN; PENA SDJ, 1995, NAT GENET, V11, P15, DOI 10.1038/ng0995-15; ROHLF J, 2001, NTSYS NUMERICAL TAXO; Roosevelt Anna C., 2002, 1 AM PLEISTOCENE COL, P159; Ruhlen M, 1991, GUIDE WORLDS LANGUAG; Ruiz-Linares A, 1999, P NATL ACAD SCI USA, V96, P6312, DOI 10.1073/pnas.96.11.6312; Santos FR, 1996, GENOME RES, V6, P601, DOI 10.1101/gr.6.7.601; Santos FR, 1999, AM J HUM GENET, V64, P619, DOI 10.1086/302242; Schneider S., 2000, ARLEQUIN VERSION 200; Seielstad M, 2003, AM J HUM GENET, V73, P700, DOI 10.1086/377589; Silva WA, 2002, AM J HUM GENET, V71, P187, DOI 10.1086/341358; SLATKIN M, 1995, GENETICS, V139, P457; Smith DG, 1999, AM J PHYS ANTHROPOL, V110, P271, DOI 10.1002/(SICI)1096-8644(199911)110:3<271::AID-AJPA2>3.0.CO;2-C; Tarazona-Santos E, 2002, AM J HUM GENET, V70, P1377, DOI 10.1086/340388; Thomas MG, 1999, HUM GENET, V105, P577, DOI 10.1007/s004390051148; TORRONI A, 1994, P NATL ACAD SCI USA, V91, P1158, DOI 10.1073/pnas.91.3.1158; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; Underhill PA, 1996, P NATL ACAD SCI USA, V93, P196, DOI 10.1073/pnas.93.1.196; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Weale ME, 2002, MOL BIOL EVOL, V19, P1008, DOI 10.1093/oxfordjournals.molbev.a004160; WEISS KM, 1994, P NATL ACAD SCI USA, V91, P833, DOI 10.1073/pnas.91.3.833; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; Zerjal T, 2002, AM J HUM GENET, V71, P466, DOI 10.1086/342096; [No title captured]	60	158	165	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2003	73	3					524	539		10.1086/377588	http://dx.doi.org/10.1086/377588			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	718FG	12900798	Green Published, Bronze			2022-12-18	WOS:000185134000006
J	Plenge, RM; Stevenson, RA; Lubs, HA; Schwartz, CE; Willard, HF				Plenge, RM; Stevenson, RA; Lubs, HA; Schwartz, CE; Willard, HF			Skewed X-chromosome inactivation is a common feature of X-linked mental retardation disorders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RETT-SYNDROME; XLMR GENES; MUTATIONS; PATTERNS; LOCALIZATION; INHERITANCE; FAMILIES; MECP2	Some deleterious X-linked mutations may result in a growth disadvantage for those cells in which the mutation, when on the active X chromosome, affects cell proliferation or viability. To explore the relationship between skewed X-chromosome inactivation and X-linked mental retardation (XLMR) disorders, we used the androgen receptor X-inactivation assay to determine X-inactivation patterns in 155 female subjects from 24 families segregating 20 distinct XLMR disorders. Among XLMR carriers, similar to50% demonstrate markedly skewed X inactivation (i.e., patterns greater than or equal to80: 20), compared with only similar to10% of female control subjects (P<.001). Thus, skewed Xinactivation is a relatively common feature of XLMR disorders. Of the 20 distinct XLMR disorders, 4 demonstrate a strong association with skewed X inactivation, since all carriers of these mutations demonstrate X-inactivation patterns &GE;80: 20. The XLMR mutations are present on the preferentially inactive X chromosome in all 20 informative female subjects from these families, indicating that skewing is due to selection against those cells in which the XLMR mutation is on the active X chromosome.	Univ Hosp Cleveland, Inst Res, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Ctr Human Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; Greenwood Ctr, JC Self Res Inst, Greenwood, SC USA; Univ Miami, Sch Med, Dept Pediat, Div Genet, Miami, FL USA	University Hospitals of Cleveland; University Hospitals of Cleveland; Case Western Reserve University; University of Miami	Willard, HF (corresponding author), Univ Hosp Cleveland, Inst Res, Lakeside 1400,11100 Euclid Ave, Cleveland, OH 44106 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD026202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045441] Funding Source: NIH RePORTER; NICHD NIH HHS [HD26202, R01 HD026202] Funding Source: Medline; NIGMS NIH HHS [GM45441] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; BELMONT JW, 1995, TRENDS GENET, V11, P112, DOI 10.1016/S0168-9525(00)89012-5; Belmont JW, 1996, AM J HUM GENET, V58, P1101; Cabezas DA, 1999, AM J MED GENET, V85, P202, DOI 10.1002/(SICI)1096-8628(19990730)85:3<202::AID-AJMG2>3.0.CO;2-F; Chelly J, 2001, NAT REV GENET, V2, P669, DOI 10.1038/35088558; Couvert P, 2001, HUM MOL GENET, V10, P941, DOI 10.1093/hmg/10.9.941; D'Adamo P, 1998, NAT GENET, V19, P134, DOI 10.1038/487; GALE RE, 1994, BLOOD, V83, P2899, DOI 10.1182/blood.V83.10.2899.2899; GIBBONS RJ, 1992, AM J HUM GENET, V51, P1136; GORSKI JL, 1991, AM J MED GENET, V40, P332, DOI 10.1002/ajmg.1320400317; Hamel BCJ, 2000, AM J MED GENET, V94, P361, DOI 10.1002/1096-8628(20001023)94:5<361::AID-AJMG2>3.0.CO;2-U; Krepischi ACV, 1998, HUM GENET, V102, P319; Kutsche K, 2000, NAT GENET, V26, P247, DOI 10.1038/80002; Lubs H, 1999, AM J MED GENET, V83, P237, DOI 10.1002/(SICI)1096-8628(19990402)83:4<237::AID-AJMG2>3.3.CO;2-#; Lubs HA, 1996, AM J MED GENET, V64, P169, DOI 10.1002/(SICI)1096-8628(19960712)64:1<169::AID-AJMG29>3.0.CO;2-K; Lyon M. F., 1968, Annual review of genetics. Vol. 2, P31, DOI 10.1146/annurev.ge.02.120168.000335; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; NANCE WE, 1964, COLD SPRING HARB SYM, V29, P415, DOI 10.1101/SQB.1964.029.01.043; Naumova AK, 1996, AM J HUM GENET, V58, P1111; NYHAN WL, 1970, P NATL ACAD SCI USA, V65, P214, DOI 10.1073/pnas.65.1.214; Plenge RM, 1997, NAT GENET, V17, P353, DOI 10.1038/ng1197-353; Plenge RM, 1999, AM J HUM GENET, V64, P759, DOI 10.1086/302286; Puck JM, 1998, NEW ENGL J MED, V338, P325, DOI 10.1056/NEJM199801293380611; Sirianni N, 1998, AM J HUM GENET, V63, P1552, DOI 10.1086/302105; STEVENSON RE, 1999, X LINKED MENTAL RETA; Willard HF, 2000, METABOLIC MOL BASES, P1191; ZOGHBI HY, 1990, BRAIN DEV-JPN, V12, P131, DOI 10.1016/S0387-7604(12)80194-X	29	158	173	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2002	71	1					168	173		10.1086/341123	http://dx.doi.org/10.1086/341123			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	564GY	12068376	Green Published, Bronze			2022-12-18	WOS:000176307700018
J	Duerr, RH; Barmada, MM; Zhang, LL; Pfutzer, R; Weeks, DE				Duerr, RH; Barmada, MM; Zhang, LL; Pfutzer, R; Weeks, DE			High-density genome scan in Crohn disease shows confirmed linkage to chromosome 14q11-12	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; T-CELL RECEPTOR; LARGE EUROPEAN COHORT; SUSCEPTIBILITY LOCI; COMPLEX TRAITS; PROVIDES EVIDENCE; SUPPORTS LINKAGE; GENETIC-ANALYSIS; PA28 COMPLEX; WIDE SEARCH	Epidemiological studies have shown that genetic factors contribute to the pathogenesis of the idiopathic inflammatory bowel diseases (IBD), Crohn disease (CD) and ulcerative colitis (UC). Recent genome scans and replication studies have identified replicated linkage between CD and a locus on chromosome 16 (the IBD1 locus), replicated linkage between IBD (especially UC) and a focus on chromosome 12q (the IBD2 locus), and replicated linkage between IBD (especially CD) and a locus on chromosome 6p (the IBD3 locus). Since the estimated locus-specific lambda(s) values for the regions of replicated linkage do not account for the overall lambda(s) in CD, and since the published genome scans in IBD show at least nominal evidence for linkage to regions on all but two chromosomes, we performed an independent genome scan using 751 microsatellite loci in 127 CD-affected relative pairs from 62 families. Single-point nonparametric linkage analysis using the GENEHUNTER-PLUS program shows evidence for linkage to the adjacent D14S261 and D14S283 loci on chromosome 14q11-12 (LOD = 3.00 and 1.70, respectively), and the maximal multipoint LOD score is observed at D14S261 (LOD = 3.60). In the multipoint analysis, nominal evidence for linkage (P < .05) is observed near D2S117 (LOD = 1.25), near D3S3045 (LOD = 1.31), between D7S40 and D7S648 (LOD = 0.91), and near D18S61 (LOD = 1.15). Our finding of significant linkage to D14S261 and the finding of suggestive linkage to the same locus in an independent study (multipoint LOD = 2.8) satisfies criteria for confirmed linkage, so we propose that the region of interest on chromosome 14q11-12 should be designated the IBD4 locus.	Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA USA; Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA USA; Univ Pittsburgh, Sch Med, Ctr Genom Sci, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Duerr, RH (corresponding author), 656 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	duerr@msx.dept-med.pitt.edu	Weeks, Daniel E/B-2995-2012; Duerr, Richard H/B-4188-2009	Weeks, Daniel E/0000-0001-9410-7228; Duerr, Richard H/0000-0001-6586-3905; Barmada, M Michael/0000-0002-3604-6460				AKOLKAR P, 1998, AM J HUM GENET, V63, pA279; Annese V, 1999, EUR J HUM GENET, V7, P567, DOI 10.1038/sj.ejhg.5200328; BOEHNKE M, 1994, AM J HUM GENET, V55, P379; Brant SR, 1998, GASTROENTEROLOGY, V115, P1056, DOI 10.1016/S0016-5085(98)70073-3; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Calkins BM, 1995, INFLAMM BOWEL DIS, P31; Cavanaugh JA, 1998, ANN HUM GENET, V62, P291, DOI 10.1046/j.1469-1809.1998.6240291.x; CHIEN YH, 1987, NATURE, V327, P677, DOI 10.1038/327677a0; Cho JH, 1998, P NATL ACAD SCI USA, V95, P7502, DOI 10.1073/pnas.95.13.7502; CROCE CM, 1985, SCIENCE, V227, P1044, DOI 10.1126/science.3919442; Curran ME, 1998, GASTROENTEROLOGY, V115, P1066, DOI 10.1016/S0016-5085(98)70075-7; Duerr RH, 1996, INFLAMM BOWEL DIS, V2, P48, DOI 10.1002/ibd.3780020108; Duerr RH, 1998, AM J HUM GENET, V63, P95, DOI 10.1086/301929; Gibson L, 1996, ONCOGENE, V13, P665; Hampe J, 1999, AM J HUM GENET, V64, P808, DOI 10.1086/302294; Hampe J, 1999, AM J HUM GENET, V65, P1647, DOI 10.1086/302677; HANSON RD, 1990, P NATL ACAD SCI USA, V87, P960, DOI 10.1073/pnas.87.3.960; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; Kloetzel PM, 1999, BIOL CHEM, V380, P293, DOI 10.1515/BC.1999.040; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V56, P1212; Kruglyak L, 1996, AM J HUM GENET, V58, P1092; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LASHNER BA, 1995, INFLAMM BOWEL DIS, P344; Ma YH, 1999, INFLAMM BOWEL DIS, V5, P271, DOI 10.1097/00054725-199911000-00005; Mandal DM, 1999, GENET EPIDEMIOL, V17, pS643; McCusker D, 1997, GENOMICS, V45, P362, DOI 10.1006/geno.1997.4948; McCusker D, 1999, IMMUNOGENETICS, V49, P438, DOI 10.1007/s002510050517; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Ohmen JD, 1996, HUM MOL GENET, V5, P1679, DOI 10.1093/hmg/5.10.1679; Parkes M, 1996, LANCET, V348, P1588, DOI 10.1016/S0140-6736(05)66204-6; Roberts SB, 1999, AM J HUM GENET, V65, P876, DOI 10.1086/302528; Satsangi J, 1996, NAT GENET, V14, P199, DOI 10.1038/ng1096-199; Silverberg M, 1999, GASTROENTEROLOGY, V116, pA820; SINGLETON JW, 1995, INFLAMM BOWEL DIS, P335; Somers GR, 1997, GENOMICS, V44, P127, DOI 10.1006/geno.1997.4841; SUAREZ BK, 1994, GENETIC APPROACHES M, P23; Yang H, 1999, GUT, V44, P519, DOI 10.1136/gut.44.4.519; YLUG IG, 1995, GENOMICS, V26, P433, DOI 10.1016/0888-7543(95)80241-D; [No title captured]	41	158	164	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2000	66	6					1857	1862		10.1086/302947	http://dx.doi.org/10.1086/302947			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QU	10747815	Bronze, Green Published			2022-12-18	WOS:000088373800013
J	Helgason, A; Siguroardottir, S; Gulcher, JR; Ward, R; Stefansson, K				Helgason, A; Siguroardottir, S; Gulcher, JR; Ward, R; Stefansson, K			mtDNA and the origin of the Icelanders: Deciphering signals of recent population history	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; CONTROL-REGION SEQUENCES; D-LOOP; EUROPEAN POPULATIONS; GENETIC DIVERSITY; SUBSTITUTION RATE; ADMIXTURE; LINEAGES; TREE; PHENYLKETONURIA	Previous attempts to investigate the origin of the Icelanders have provided estimates of ancestry ranging from a 98%, British Isles contribution to an 86% Scandinavian contribution. We generated mitochondrial sequence data for 401 Icelandic individuals and compared these data with >2,500 other European sequences from published sources, to determine the probable origins of women who contributed to Iceland's settlement. Although the mean number of base-pair differences is high in the Icelandic sequences and they are widely distributed in the overall European mtDNA phylogeny, we find a smaller number of distinct mitochondrial lineages, compared with most other European populations. The frequencies of a number of mtDNA lineages in the Icelanders deviate noticeably from those in neighboring populations, suggesting that founder effects and genetic drift may have had a considerable influence on the Icelandic gene pool. This is in accordance with available demographic evidence about Icelandic population history. A comparison with published mtDNA lineages from European populations indicates that, whereas most founding females probably originated from Scandinavia and the British Isles, lesser contributions from other populations may also have taken place. We present a highly resolved phylogenetic network for the Icelandic data, identifying a number of previously unreported mtDNA lineage clusters and providing a detailed depiction of the evolutionary relationships between European mtDNA clusters. Our findings indicate that European populations contain a large number of closely related mitochondrial lineages, many of which have not vet been sampled in the current comparative data set. Consequently, substantial increases in sample sizes that use mtDNA data will be needed to obtain valid estimates of the diverse ancestral mixtures that ultimately gave rise to contemporary populations.	Univ Oxford, Inst Biol Anthropol, Oxford OX2 6QS, England; deCODE Genet Inc, Reykjavik, Iceland	University of Oxford	Helgason, A (corresponding author), Univ Oxford, Inst Biol Anthropol, 58 Banbury Rd, Oxford OX2 6QS, England.	agnar.helgason@wolfson.ox.ac.uk	Stefansson, Kari/AAE-7187-2019; Helgason, Agnar/K-1522-2015	Helgason, Agnar/0000-0002-8545-3767				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BANDELT HJ, 1995, GENETICS, V141, P743; Bertorelle G, 1998, MOL BIOL EVOL, V15, P1298, DOI 10.1093/oxfordjournals.molbev.a025858; BERTRANPETIT J, 1995, ANN HUM GENET, V59, P63, DOI 10.1111/j.1469-1809.1995.tb01606.x; Brown MD, 1998, AM J HUM GENET, V63, P1852, DOI 10.1086/302155; Calafell F, 1996, ANN HUM GENET, V60, P35, DOI 10.1111/j.1469-1809.1996.tb01170.x; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CHAKRABORTY R, 1986, YEARB PHYS ANTHROPOL, V29, P1; Collins R., 1991, EARLY MEDIEV EUR; Comas D, 1998, AM J HUM GENET, V63, P1824, DOI 10.1086/302133; CorteReal HBSM, 1996, ANN HUM GENET, V60, P331, DOI 10.1111/j.1469-1809.1996.tb01196.x; Delghandi M, 1998, HUM HERED, V48, P108, DOI 10.1159/000022789; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; Eiken HG, 1996, EUR J HUM GENET, V4, P205; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; EXCOFFIER L, 1992, GENETICS, V131, P479; Forster P, 1996, AM J HUM GENET, V59, P935; Francalacci P, 1996, AM J PHYS ANTHROPOL, V100, P443, DOI 10.1002/(SICI)1096-8644(199608)100:4<443::AID-AJPA1>3.0.CO;2-S; Guldberg P, 1997, EUR J HUM GENET, V5, P376, DOI 10.1159/000484795; Handt O, 1998, NUCLEIC ACIDS RES, V26, P126, DOI 10.1093/nar/26.1.126; HANDT O, 1994, SCIENCE, V264, P1775, DOI 10.1126/science.8209259; HASEGAWA M, 1993, J MOL EVOL, V37, P347, DOI 10.1007/BF00178865; Hofmann S, 1997, HUM MOL GENET, V6, P1835, DOI 10.1093/hmg/6.11.1835; Izagirre N, 1999, AM J HUM GENET, V65, P199, DOI 10.1086/302442; Jazin E, 1998, NAT GENET, V18, P109, DOI 10.1038/ng0298-109; Jones Gwyn, 1984, HIST VIKINGS; Kittles RA, 1999, AM J PHYS ANTHROPOL, V108, P381, DOI 10.1002/(SICI)1096-8644(199904)108:4<381::AID-AJPA1>3.0.CO;2-5; Lutz S, 1998, INT J LEGAL MED, V111, P67, DOI 10.1007/s004140050117; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Meyer S, 1999, GENETICS, V152, P1103; Miller KWP, 1996, INT J LEGAL MED, V109, P107, DOI 10.1007/BF01369668; Opdal SH, 1998, ACTA PAEDIATR, V87, P1039, DOI 10.1080/080352598750031347; Orekhov V, 1999, FEBS LETT, V445, P197, DOI 10.1016/S0014-5793(99)00115-5; Parson W, 1998, INT J LEGAL MED, V111, P124, DOI 10.1007/s004140050132; Parsons TJ, 1997, NAT GENET, V15, P363, DOI 10.1038/ng0497-363; Pfeiffer H, 1999, INT J LEGAL MED, V112, P291, DOI 10.1007/s004140050252; PIERCY R, 1993, INT J LEGAL MED, V106, P85, DOI 10.1007/BF01225046; Pinto F, 1996, ANN HUM GENET, V60, P321, DOI 10.1111/j.1469-1809.1996.tb01195.x; PULT I, 1994, BIOL CHEM H-S, V375, P837; Richards M, 1996, AM J HUM GENET, V59, P185; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rohl A., 1997, MATH SEM U HAMB HAMB; Rousselet F, 1998, INT J LEGAL MED, V111, P292, DOI 10.1007/s004140050174; SAJANTILA A, 1995, GENOME RES, V5, P42, DOI 10.1101/gr.5.1.42; Sajantila A, 1996, P NATL ACAD SCI USA, V93, P12035, DOI 10.1073/pnas.93.21.12035; Salas A, 1998, EUR J HUM GENET, V6, P365, DOI 10.1038/sj.ejhg.5200202; Schneider S, 1997, ARLEQUIN 1 1 SOFTWAR; Schurr TG, 1999, AM J PHYS ANTHROPOL, V108, P1, DOI 10.1002/(SICI)1096-8644(199901)108:1<1::AID-AJPA1>3.0.CO;2-1; SMITH KP, 1995, WORLD ARCHAEOL, V26, P319, DOI 10.1080/00438243.1995.9980280; Steffensen J., 1975, MENNING MEINSEMDIR R; Sykes B, 1999, PHILOS T ROY SOC B, V354, P131, DOI 10.1098/rstb.1999.0366; THOMPSON EA, 1973, ANN HUM GENET, V37, P69, DOI 10.1111/j.1469-1809.1973.tb01815.x; TILLS D, 1982, ANN HUM BIOL, V9, P507, DOI 10.1080/03014468200006041; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 1996, GENETICS, V144, P1835; Tyfield LA, 1997, AM J HUM GENET, V60, P388; Vasey DE, 1996, AM ETHNOL, V23, P366, DOI 10.1525/ae.1996.23.2.02a00100; WAKELEY J, 1993, J MOL EVOL, V37, P613; WARD RH, 1993, P NATL ACAD SCI USA, V90, P10663, DOI 10.1073/pnas.90.22.10663; WIJSMAN EM, 1984, HUM GENET, V67, P441, DOI 10.1007/BF00291407; Zschocke J, 1997, HUM GENET, V100, P189, DOI 10.1007/s004390050488	62	158	160	2	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2000	66	3					999	1016		10.1086/302816	http://dx.doi.org/10.1086/302816			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	337QM	10712214	Green Published, Bronze			2022-12-18	WOS:000088373200022
J	Santos, FR; Pandya, A; Tyler-Smith, C; Pena, SDJ; Schanfield, M; Leonard, WR; Osipova, L; Crawford, MH; Mitchell, RJ				Santos, FR; Pandya, A; Tyler-Smith, C; Pena, SDJ; Schanfield, M; Leonard, WR; Osipova, L; Crawford, MH; Mitchell, RJ			The central Siberian origin for Native American Y chromosomes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEW-WORLD; MTDNA VARIATION; DNA ANALYSIS; HAPLOTYPES; POPULATIONS; AMERINDIANS; AFFINITIES; POLYMORPHISMS; MIGRATION; EVOLUTION	Y chromosomal DNA polymorphisms were used to investigate Pleistocene male migrations to the American continent. In a worldwide sample of 306 men, we obtained 32 haplotypes constructed with the variation found in 30 distinct polymorphic sites. The major Y haplotype present in most Native Americans was traced back to recent ancestors common with Siberians, namely, the Kets and Altaians from the Yenissey River Basin and Altai Mountains, respectively. Going further back, the next common ancestor gave rise also to Caucasoid Y chromosomes, probably from the central Eurasian region. This study, therefore, suggests a predominantly central Siberian origin for Native American paternal lineages for those who could have migrated to the Americas during the Upper Pleistocene.	Univ Fed Minas Gerais, Dept Bioquim, Belo Horizonte, MG, Brazil; Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; Analyt Genet Testing Ctr Inc, Denver, CO USA; Univ Florida, Dept Anthropol, Miami, FL USA; Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia; Univ Kansas, Dept Anthropol, Lawrence, KS 66045 USA; La Trobe Univ, Sch Genet & Human Variat, Bundoora, Vic 3083, Australia	Universidade Federal de Minas Gerais; University of Oxford; State University System of Florida; University of Florida; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; University of Kansas; La Trobe University	Santos, FR (corresponding author), UFMG, ICB, Dept Biol Geral, Caixa Postal 486, BR-31270910 Belo Horizonte, MG, Brazil.		Osipova, Ludmila P/O-6480-2014; Santos, Fabrício Rodrigues/H-2370-2011; Leonard, William R./I-5981-2019	Osipova, Ludmila P/0000-0001-7602-1156; Santos, Fabrício Rodrigues/0000-0001-9088-1750; Leonard, William/0000-0002-6233-604X				BANDELT HJ, 1995, GENETICS, V141, P743; Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; Bonatto SL, 1997, P NATL ACAD SCI USA, V94, P1866, DOI 10.1073/pnas.94.5.1866; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CRAWFORD MH, 1998, ORIGINS NATIVE AM EV; EXCOFFIER L, 1992, GENETICS, V131, P479; Felsenstein J, 1993, PHYLOGENY INFERENCE; Forster P, 1996, AM J HUM GENET, V59, P935; FORSYTH J, 1996, HIST PEOPLES SIBERIA; Greenberg JH, 1996, SCIENCE, V274, P1447; GREENBERG JH, 1986, CURR ANTHROPOL, V27, P477, DOI 10.1086/203472; GRIMES BF, 1996, ETHNOLOGUE LANGUAGES; HAMMER MF, 1995, AM J HUM GENET, V56, P951; Jobling MA, 1997, INT J LEGAL MED, V110, P118, DOI 10.1007/s004140050050; JOBLING MA, 1995, TRENDS GENET, V11, P449, DOI 10.1016/S0168-9525(00)89144-1; Karafet T, 1997, AM J PHYS ANTHROPOL, V102, P301, DOI 10.1002/(SICI)1096-8644(199703)102:3<301::AID-AJPA1>3.0.CO;2-Y; Kolman CJ, 1996, GENETICS, V142, P1321; Lahr Marta Mirazon, 1994, Evolutionary Anthropology, V3, P48, DOI 10.1002/evan.1360030206; Lahr MM, 1995, YEARB PHYS ANTHROPOL, V38, P163; Lell JT, 1997, HUM GENET, V100, P536, DOI 10.1007/s004390050548; MATHIAS N, 1994, HUM MOL GENET, V3, P115, DOI 10.1093/hmg/3.1.115; Merriwether DA, 1996, AM J HUM GENET, V59, P204; MERRIWETHER DA, 1995, AM J PHYS ANTHROPOL, V98, P411, DOI 10.1002/ajpa.1330980404; Morell V, 1998, SCIENCE, V280, P520, DOI 10.1126/science.280.5363.520; Morell V, 1998, SCIENCE, V280, P190, DOI 10.1126/science.280.5361.190; NEEL JV, 1994, P NATL ACAD SCI USA, V91, P10737, DOI 10.1073/pnas.91.22.10737; Nei M., 1987, MOL EVOLUTIONARY GEN; NEVES WA, 1991, J HUM EVOL, V21, P261, DOI 10.1016/0047-2484(91)90107-7; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; PENA SDJ, 1995, NAT GENET, V11, P15, DOI 10.1038/ng0995-15; Poloni ES, 1997, AM J HUM GENET, V61, P1015, DOI 10.1086/301602; Rodriguez-Delfin L, 1997, ANN HUM GENET, V61, P439, DOI 10.1046/j.1469-1809.1997.6150439.x; Roosevelt AC, 1996, SCIENCE, V272, P373, DOI 10.1126/science.272.5260.373; Santos FR, 1996, GENOME RES, V6, P601, DOI 10.1101/gr.6.7.601; Santos FR, 1996, BRAZ J GENET, V19, P665, DOI 10.1590/S0100-84551996000400025; Santos FR, 1996, AM J HUM GENET, V58, P1369; SANTOS FR, 1995, GENE, V165, P191, DOI 10.1016/0378-1119(95)00501-V; Santos FR, 1995, BRAZ J GENET, V18, P669; SCHANFIELD MS, 1992, HUM BIOL, V64, P381; TORRONI A, 1993, AM J HUM GENET, V53, P563; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Underhill PA, 1996, P NATL ACAD SCI USA, V93, P196, DOI 10.1073/pnas.93.1.196; WATERS WR, 1997, SCIENCE, V275, P1281; WHITFIELD LS, 1995, NATURE, V378, P379, DOI 10.1038/378379a0; Zerjal T, 1997, AM J HUM GENET, V60, P1174	45	158	160	0	13	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1999	64	2					619	628		10.1086/302242	http://dx.doi.org/10.1086/302242			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	169HA	9973301	Green Published, Bronze			2022-12-18	WOS:000078740600033
J	Cox, A; Camp, NJ; Nicklin, MJH; di Giovine, FS; Duff, GW				Cox, A; Camp, NJ; Nicklin, MJH; di Giovine, FS; Duff, GW			An analysis of linkage disequilibrium in the interleukin-1 gene cluster, using a novel grouping method for multiallelic markers	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RHEUMATOID-ARTHRITIS; POLYMORPHISM; REGION; TRAITS	In population-and family-based association studies, it is useful to have some knowledge of the patterns of linkage disequilibrium that exist between markers in candidate regions. When such studies are carried out with multiallelic markers, it is often convenient to group the alleles into a biallelic system, for analysis. In this study, we specifically examined the interleukin-l (IL-1) gene cluster on chromosome 2, a region containing candidates for many inflammatory and autoimmune disorders. Data were collected on eight markers, four of which were multiallelic. Using these data, we investigated the effect of three allele-grouping strategies, including a novel method, on the detection of linkage disequilibrium. The novel approach, termed the "delta method," measures the deviation from the expected haplotype frequencies under linkage equilibrium, for each allelic combination. This information is then used to group the alleles, in an attempt to avoid the grouping together of alleles at one locus that are in opposite disequilibrium with the same allele at the second locus. The estimate haplotype frequencies (EH) program was used to estimate haplotype frequencies and the disequilibrium measure. In our data it was found that the delta method compared well with the other two strategies. Using this method, we found that there was a reasonable correlation between disequilibrium and physical distance in the region (r = -.540, P = .001, one-tailed). We also identified a common, eight-locus haplotype of the IL-1 gene cluster.	Univ Sheffield, Div Med & Mol Genet, Sheffield S10 2JF, S Yorkshire, England	University of Sheffield	Cox, A (corresponding author), Univ Sheffield, Royal Hallamshire Hosp, Div Med & Mol Genet, Glossop Rd, Sheffield S10 2JF, S Yorkshire, England.			Cox, Angela/0000-0002-5138-1099; Nicklin, Martin/0000-0002-0127-1131				CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; Clay FE, 1996, HUM GENET, V97, P723; COPEMAN JB, 1995, NAT GENET, V9, P80, DOI 10.1038/ng0195-80; Di Giovine F. S., 1992, Human Molecular Genetics, V1, P450; Guasch JF, 1996, CYTOKINE, V8, P598, DOI 10.1006/cyto.1996.0080; HILL WG, 1974, HEREDITY, V33, P229, DOI 10.1038/hdy.1974.89; JORDE LB, 1994, AM J HUM GENET, V54, P884; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; MCDOWELL TL, 1995, ARTHRITIS RHEUM, V38, P221, DOI 10.1002/art.1780380210; NICKLIN MJH, 1994, GENOMICS, V19, P382, DOI 10.1006/geno.1994.1076; Nothwang HG, 1997, GENOMICS, V41, P370, DOI 10.1006/geno.1997.4654; Spur N K, 1996, Cytogenet Cell Genet, V73, P255, DOI 10.1159/000134352; TARLOW JK, 1993, HUM GENET, V91, P403; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI, P188; THOMPSON EA, 1988, AM J HUM GENET, V42, P113; WATKINS WS, 1994, AM J HUM GENET, V55, P348; WEEKS DE, 1995, TRENDS GENET, V11, P513, DOI 10.1016/S0168-9525(00)89163-5; WEIR BS, 1978, GENETICS, V88, P633; WORTHINGTON J, 1994, BRIT J RHEUMATOL, V33, P970	20	158	172	0	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1998	62	5					1180	1188		10.1086/301817	http://dx.doi.org/10.1086/301817			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZL922	9545388	Green Published, Bronze			2022-12-18	WOS:000073487000023
J	Miller, PW; Hamosh, A; Macek, M; Greenberger, PA; MacLean, J; Walden, SM; Slavin, RG; Cutting, GR				Miller, PW; Hamosh, A; Macek, M; Greenberger, PA; MacLean, J; Walden, SM; Slavin, RG; Cutting, GR			Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL BILATERAL ABSENCE; VAS-DEFERENS; FAMILIAL OCCURRENCE; CHRONIC-BRONCHITIS; SWEAT CHLORIDE; MESSENGER-RNA; DIAGNOSIS; IDENTIFICATION; DISEASE; BRONCHIECTASIS	The etiology of allergic bronchopulmonary aspergillosis (ABPA) is not well understood. A clinical phenotype resembling the pulmonary disease seen in cystic fibrosis (CF) patients can occur in some individuals with ABPA. Reports of familial occurrence of ABPA and increased incidence in CF patients suggest a possible genetic basis for the disease. To test this possibility, the entire coding region of the cystic fibrosis transmembrane regulator (CFTR) gene was analyzed in 11 individuals who met strict criteria for the diagnosis of ABPA and had normal sweat electrolytes (less than or equal to 40 mmol/liter). One patient carried two CF mutations (Delta F508/R347H), and five were found to carry one CF mutation (four Delta F508; one R117H). The frequency of the Delta F508 mutation in patients with ABPA was significantly higher than in 53 Caucasian patients with chronic bronchitis (P < .0003) and the general population (P < .003). These results suggest that CFTR plays an etiologic role in a subset of ABPA patients.	JOHNS HOPKINS UNIV,SCH MED,CTR MED GENET,CMSC 1004,BALTIMORE,MD 21287; JOHNS HOPKINS UNIV,SCH MED,DIV PULM & CRIT CARE MED,BALTIMORE,MD 21287; ST LOUIS UNIV,MED CTR,DIV ALLERGY & IMMUNOL,ST LOUIS,MO 63103; MASSACHUSETTS GEN HOSP,GEN MED SERV,CLIN IMMUNOL UNIT,BOSTON,MA 02114; MASSACHUSETTS GEN HOSP,GEN MED SERV,ALLERGY UNIT,BOSTON,MA 02114; NORTHWESTERN UNIV,SCH MED,DIV ALLERGY IMMUNOL,CHICAGO,IL	Johns Hopkins University; Johns Hopkins University; Saint Louis University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Northwestern University			Greenberger, Paul/L-2770-2019	Greenberger, Paul/0000-0003-3882-8498	NIDDK NIH HHS [DK44003, DK09024] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK044003, F32DK009024, R01DK044003] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANGUIANO A, 1992, JAMA-J AM MED ASSOC, V267, P1794, DOI 10.1001/jama.267.13.1794; ARTLICH A, 1995, HUM GENET, V95, P226; BATTEN J. C., 1967, MOD PROBL PAEDIATR, V10, P227; BRUETON MJ, 1980, ARCH DIS CHILD, V55, P348, DOI 10.1136/adc.55.5.348; CHILLON M, 1995, NEW ENGL J MED, V332, P1475, DOI 10.1056/NEJM199506013322204; CHU CS, 1993, NAT GENET, V3, P151, DOI 10.1038/ng0293-151; CHU CS, 1992, J CLIN INVEST, V90, P785, DOI 10.1172/JCI115952; COSTES B, 1995, EUR J HUM GENET, V3, P285; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; CUTTING GR, 1992, AM J HUM GENET, V50, P1185; DAVIS PB, 1980, AM J MED, V69, P643, DOI 10.1016/0002-9343(80)90482-9; DAVIS PB, 1987, THORAX, V42, P120, DOI 10.1136/thx.42.2.120; DAVIS PB, 1984, AM REV RESPIR DIS, V29, P911; ERLICH HA, 1991, SCIENCE, V252, P1643, DOI 10.1126/science.2047872; GABRIEL SE, 1994, SCIENCE, V266, P107, DOI 10.1126/science.7524148; GERVAIS R, 1993, LANCET, V342, P997, DOI 10.1016/0140-6736(93)92046-V; GRAVES TS, 1979, ANN INTERN MED, V91, P378, DOI 10.7326/0003-4819-91-3-378; GREENBERGER PA, 1987, CHEST, V91, pS165, DOI 10.1378/chest.91.6.165S; GREENBERGER PA, 1988, CLIN CHEST MED, V9, P599; GREENBERGER PA, 1982, J LAB CLIN MED, V99, P288; GREGG RG, 1993, AM J HUM GENET, V52, P616; HALWIG JM, 1985, J ALLERGY CLIN IMMUN, V76, P55, DOI 10.1016/0091-6749(85)90804-8; HAMMOND KB, 1991, NEW ENGL J MED, V325, P769, DOI 10.1056/NEJM199109123251104; HIGHSMITH WE, 1994, NEW ENGL J MED, V331, P974, DOI 10.1056/NEJM199410133311503; HUTCHESON PS, 1991, J ALLERGY CLIN IMMUN, V88, P390, DOI 10.1016/0091-6749(91)90102-T; JOSEPH PM, 1993, NEW ENGL J MED, V329, P1484; KAZAZIAN HH, 1990, SEMIN HEMATOL, V27, P209; KEREM BS, 1990, P NATL ACAD SCI USA, V87, P8447, DOI 10.1073/pnas.87.21.8447; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KIESEWETTER S, 1993, NAT GENET, V5, P274, DOI 10.1038/ng1193-274; KNOWLES MR, 1989, ANN INTERN MED, V110, P599, DOI 10.7326/0003-4819-110-8-599; KNOWLES MR, 1995, HUM GENE THER, V6, P445, DOI 10.1089/hum.1995.6.4-445; KRISTIDIS P, 1992, AM J HUM GENET, V50, P1178; LAUFER P, 1984, J ALLERGY CLIN IMMUN, V73, P44, DOI 10.1016/0091-6749(84)90482-2; MACEK M, 1995, PEDIATR PULM, V12, P210; MACEK M, IN PRESS HUM MUTAT; MEARNS M, 1967, LANCET, V1, P53; MURPHY S, 1987, CLIN CHEST MED, V8, P695; NELSON LA, 1979, AM REV RESPIR DIS, V120, P863; OSBORNE LR, 1993, HUM MOL GENET, V2, P1605, DOI 10.1093/hmg/2.10.1605; PIGNATTI PF, 1995, HUM MOL GENET, V4, P635, DOI 10.1093/hmg/4.4.635; POLLER W, 1991, KLIN WOCHENSCHR, V69, P657, DOI 10.1007/BF01649427; RANIERI E, 1991, BRIT MED J, V302, P1237, DOI 10.1136/bmj.302.6787.1237; RAVEHAREL N, 1995, AM J HUM GENET, V56, P1359; ROSENBERG M, 1977, ANN INTERN MED, V86, P405, DOI 10.7326/0003-4819-86-4-405; SHAH A, 1990, ANN ALLERGY, V64, P507; STRONG TV, 1991, NEW ENGL J MED, V325, P1630, DOI 10.1056/NEJM199112053252307; TSUI LC, 1992, TRENDS GENET, V8, P392, DOI 10.1016/0168-9525(92)90301-J; Welsh MJ, 1995, METABOLIC MOL BASES, V3, P3799; ZIELENSKI J, 1991, GENOMICS, V10, P214, DOI 10.1016/0888-7543(91)90503-7; ZIELENSKI J, 1995, AM J HUM GENET, V57, P958; 1987, AM REV RESPIR DIS, V136, P225; 1994, HUM MUTAT, V4, P167	53	158	162	2	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1996	59	1					45	51						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL455	8659542				2022-12-18	WOS:A1996VL45500008
J	LIU, J; FUJIWARA, TM; BUU, NT; SANCHEZ, FO; CELLIER, M; PARADIS, AJ; FRAPPIER, D; SKAMENE, E; GROS, P; MORGAN, K; SCHURR, E				LIU, J; FUJIWARA, TM; BUU, NT; SANCHEZ, FO; CELLIER, M; PARADIS, AJ; FRAPPIER, D; SKAMENE, E; GROS, P; MORGAN, K; SCHURR, E			IDENTIFICATION OF POLYMORPHISMS AND SEQUENCE VARIANTS IN THE HUMAN HOMOLOG OF THE MOUSE NATURAL RESISTANCE-ASSOCIATED MACROPHAGE PROTEIN GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUPERFICIAL BLADDER-CANCER; BACILLUS CALMETTE-GUERIN; BCG; CHROMOSOME-1; GENOME; MICE; MAP	The most common mycobacterial disease in humans is tuberculosis, and there is evidence for genetic factors in susceptibility to tuberculosis. In the mouse, the Beg gene controls macrophage priming for activation and is a major gene for susceptibility to infection with mycobacteria. A candidate gene for Beg was identified by positional cloning and was designated ''natural resistance-associated macrophage protein gene'' (Nramp1), and the human homologue (NRAMP1) has recently been cloned. Here we report on (1) the physical mapping of NRAMP1 close to VIL in chromosome region 2q35 by PCR analysis of somatic cell hybrids and YAC cloning and (2) the identification of nine sequence variants in NRAMP1. Of the four variants in the coding region, there were two missense mutations and two silent substitutions. The missense mutations were a conservative alanine-to-valine substitution at codon 318 in exon 9 and an aspartic acid-to-asparagine substitution at codon 543 in the predicted cytoplasmic tail of the NRAMP1 protein. A microsatellite was located in the immediate 5' region of the gene, three variants were in introns, and one variant was located in the 3' UTR. The allele frequencies of each of the nine variants were determined in DNA samples of 60 Caucasians and 20 Asians. In addition, we have physically linked two highly polymorphic microsatellite markers, D2S104 and D2S173, to NRAMP1 on a 1.5-Mb YAC contig. These molecular markers will be useful to assess the role of NRAMP1 in susceptibility to tuberculosis and other macrophage-mediated diseases.	MCGILL UNIV, MCGILL CTR STUDY HOST RESISTANCE, MONTREAL, PQ, CANADA; MCGILL UNIV, DEPT MED, MONTREAL, PQ, CANADA; MCGILL UNIV, DEPT HUMAN GENET, MONTREAL, PQ, CANADA; MCGILL UNIV, DEPT PEDIAT, MONTREAL, PQ H3A 2T5, CANADA; MCGILL UNIV, DEPT BIOCHEM, MONTREAL, PQ, CANADA; MCGILL UNIV, DEPT EPIDEMIOL & BIOSTAT, MONTREAL, PQ, CANADA	McGill University; McGill University; McGill University; McGill University; McGill University; McGill University					NIAID NIH HHS [R01 AI35237-02] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035237] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BEAUDET AL, 1993, HUM MUTAT, V2, P245, DOI 10.1002/humu.1380020402; BLACKWELL JM, 1989, RES IMMUNOL, V140, P767, DOI 10.1016/0923-2494(89)90029-1; BLACKWELL JM, 1991, IMMUNOL LETT, V30, P241, DOI 10.1016/0165-2478(91)90032-6; BOOTHROUD LJ, 1994, THESIS MCGILL U MONT; BUSCHMAN E, 1989, RES IMMUNOL, V140, P793, DOI 10.1016/0923-2494(89)90035-7; CELLIER M, 1994, J EXP MED, V180, P1741, DOI 10.1084/jem.180.5.1741; COHEN D, 1993, NATURE, V366, P698, DOI 10.1038/366698a0; CORNALL RJ, 1991, NATURE, V353, P262, DOI 10.1038/353262a0; DOSIK JK, 1994, MAMM GENOME, V5, P458, DOI 10.1007/BF00357010; DUBOS R, 1987, WHITE PLAGUE; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GRUENHEID S, IN PRESS GENOMICS; IVANYI J, 1994, PARASITOL TODAY, V10, P416, DOI 10.1016/0169-4758(94)90169-4; JURKA J, 1991, J MOL EVOL, V32, P105, DOI 10.1007/BF02515383; KALLMANN F. J., 1943, American Review of Tuberculosis and Pulmonary Diseases, V47, P549; KUO JL, 1993, GENOMICS, V16, P173, DOI 10.1006/geno.1993.1155; LENZINI L, 1977, CLIN EXP IMMUNOL, V27, P230; LIU J, 1993, J PARASITOL, V79, P463, DOI 10.2307/3283368; LIU J, IN PRESS GENOMICS; Mah M W, 1991, Can J Infect Dis, V2, P133; MALO D, 1993, GENOMICS, V17, P667, DOI 10.1006/geno.1993.1388; MALO D, 1994, GENOMICS, V23, P51, DOI 10.1006/geno.1994.1458; MARCHUK D, 1991, NUCLEIC ACIDS RES, V19, P1154, DOI 10.1093/nar/19.5.1154; MORALES A, 1992, J UROLOGY, V147, P1256, DOI 10.1016/S0022-5347(17)37532-8; NADEAU JH, 1992, MAMM GENOME, V3, P480, DOI 10.1007/BF00778825; Neel JV, 1954, HUMAN HEREDITY; ROUSSEAUMERCK MF, 1988, HUM GENET, V78, P130, DOI 10.1007/BF00278181; Sambrook J., 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHURR E, 1990, GENOMICS, V8, P477, DOI 10.1016/0888-7543(90)90034-R; SCHURR E, 1989, J IMMUNOL, V142, P4507; SCHURR E, 1990, J INFECT DIS, V161, P634, DOI 10.1093/infdis/161.4.634; SEARLE AG, 1994, J MED GENET, V31, P1, DOI 10.1136/jmg.31.1.1; SHAW MA, 1993, ANN HUM GENET, V57, P251, DOI 10.1111/j.1469-1809.1993.tb00899.x; Sifford M, 1991, Semin Respir Infect, V6, P44; SPURR NK, 1994, CYTOGENET CELL GENET, V67, P216, DOI 10.1159/000133857; TORRENCE RJ, 1988, J UROLOGY, V139, P941, DOI 10.1016/S0022-5347(17)42723-6; VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D; VOGEL F, 1986, HUMAN GENETICS; 1994, WHOTB94177	40	158	174	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1995	56	4					845	853						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QP663	7717395				2022-12-18	WOS:A1995QP66300005
J	HASSOLD, TJ; SHERMAN, SL; PETTAY, D; PAGE, DC; JACOBS, PA				HASSOLD, TJ; SHERMAN, SL; PETTAY, D; PAGE, DC; JACOBS, PA			XY-CHROMOSOME NONDISJUNCTION IN MAN IS ASSOCIATED WITH DIMINISHED RECOMBINATION IN THE PSEUDOAUTOSOMAL REGION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ORIGIN; LINKAGE	To assess the possible association between aberrant recombination and XY chromosome nondisjunction, we compared pseudoautosomal region recombination rates in male meiosis resulting in 47,XXY offspring with those resulting in 46,XY and 46,XX offspring. Forty-one paternally derived 47,XXYs and their parents were tested at six polymorphic loci spanning the pseudoautosomal region. We were able to detect crossing-over in only six of 39 cases informative for the telomeric DXYS14/DXYS20 locus. Subsequently, we used the data to generate a genetic linkage map of the pseudoautosomal region and found it to bc significantly shorter than the normal male map of the region. From these analyses we conclude that most paternally derived 47,XXYs result from meiosis in which the X and Y chromosomes did not recombine.	MIT,WHITEHEAD INST BIOMED RES,HOWARD HUGHES RES LABS,CAMBRIDGE,MA 02139; MIT,DEPT BIOL,CAMBRIDGE,MA 02139; WESSEX REG GENET LAB,SALISBURY,ENGLAND	HRL Laboratories; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	HASSOLD, TJ (corresponding author), EMORY UNIV,SCH MED,DEPT PEDIAT,DIV MED GENET,2040 RIDGEWOOD DR,ATLANTA,GA 30322, USA.							Backer L. C., 1987, Aneuploidy. Part A: Incidence and etiology., P219; Boer P. de, 1989, Fertility and chromosome pairing: recent studies in plants and animals., P37; BURGOYNE PS, 1982, HUM GENET, V61, P85, DOI 10.1007/BF00274192; CHAKRAVARTI A, 1989, MOL CYTOGENETIC STUD, P45; GOODFELLOW PJ, 1986, SCIENCE, V234, P740, DOI 10.1126/science.2877492; HASSOLD T, 1988, AM J HUM GENET, V42, P534; HASSOLD TJ, 1984, ANNU REV GENET, V18, P69, DOI 10.1146/annurev.genet.18.1.69; HASSOLD TJ, 1989, MOL CYTOGENETIC STUD, P115; JACOBS PA, 1988, ANN HUM GENET, V52, P93, DOI 10.1111/j.1469-1809.1988.tb01084.x; KIDD KK, 1989, CYTOGENET CELL GENET, V51, P622, DOI 10.1159/000132810; MAY KM, 1990, AM J HUM GENET, V46, P754; MORTON NE, 1990, ANN HUM GENET, V54, P39, DOI 10.1111/j.1469-1809.1990.tb00359.x; MORTON NE, 1989, ANN HUM GENET, V53, P263, DOI 10.1111/j.1469-1809.1989.tb01793.x; PAGE D C, 1987, Genomics, V1, P243, DOI 10.1016/0888-7543(87)90051-6; RAO DC, 1977, HUM HERED, V27, P99, DOI 10.1159/000152856; ROUYER F, 1986, NATURE, V319, P291, DOI 10.1038/319291a0; SHAHAR S, 1986, HUM GENET, V74, P215; SHERMAN SL, 1990, AM J HUM GENET, V47, pA97; SPEED RM, 1989, FERTILITY CHROMOSOME, P2; WALLACE BMN, 1985, ANN HUM GENET, V49, P215, DOI 10.1111/j.1469-1809.1985.tb01695.x; WARREN AC, 1987, SCIENCE, V237, P652, DOI 10.1126/science.2955519	21	158	160	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1991	49	2					253	260						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GA866	1867189				2022-12-18	WOS:A1991GA86600001
J	MCLELLAN, T; JORDE, LB; SKOLNICK, MH				MCLELLAN, T; JORDE, LB; SKOLNICK, MH			GENETIC DISTANCES BETWEEN THE UTAH MORMONS AND RELATED POPULATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV UTAH,SCH MED,DEPT HUMAN GENET,SALT LAKE CITY,UT 84132	Utah System of Higher Education; University of Utah	MCLELLAN, T (corresponding author), UNIV UTAH,SCH MED,DEPT MED,DIV HEMATOL ONCOL,SALT LAKE CITY,UT 84132, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD016109] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA028854] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S07RR005428] Funding Source: NIH RePORTER; NCI NIH HHS [CA-28854] Funding Source: Medline; NCRR NIH HHS [BRSG-SO7-RR05428] Funding Source: Medline; NICHD NIH HHS [HD-16109] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDERTON DL, 1984, SOC BIOL; Arrington Leonard J., 1979, MORMON EXPERIENCE HI; ARVILOMMI M, 1973, VOX SANG, V25, P13; BALAKRISHNAN V, 1968, BIOMETRICS, V24, P859, DOI 10.2307/2528876; BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; BERG K, 1973, HUM HERED, V23, P247, DOI 10.1159/000152581; BJARNASO.O, 1973, ANN HUM GENET, V36, P425, DOI 10.1111/j.1469-1809.1973.tb00606.x; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BROMAN R, 1971, ACTA GENET MED GEMEL, V20, P77; BRONNESTAM R, 1973, HUM HERED, V23, P128, DOI 10.1159/000152564; CAEIRO B, 1982, HUM HERED, V32, P147, DOI 10.1159/000153278; CAMPILLO FL, 1973, HUM HERED, V23, P499, DOI 10.1159/000152616; Cannon L., 1982, CANCER SURV, V1, P47; CARRACEDO A, 1982, HUM HERED, V32, P133, DOI 10.1159/000153273; CARTWRIGHT RA, 1976, HUM GENET, V33, P161; CHAKRABORTY R, 1976, EVOLUTION, V30, P851, DOI [10.2307/2407826, 10.1111/j.1558-5646.1976.tb00970.x]; DADONE MM, 1982, AM J CLIN PATHOL, V78, P196, DOI 10.1093/ajcp/78.2.196; DISSING J, 1971, HUM HERED, V21, P272, DOI 10.1159/000152413; EATON JOSEPH W., 1953, HUMAN BIOL, V25, P206; ERIKSEN B, 1979, HUM HERED, V29, P265, DOI 10.1159/000153056; FRASER GR, 1974, HUM HERED, V24, P435, DOI 10.1159/000152680; GARDNER EJ, 1951, AM J HUM GENET, V3, P167; GOEDDE HW, 1972, HUM HERED, V22, P552, DOI 10.1159/000152537; GOEDDE HW, 1973, HUM HERED, V23, P135, DOI 10.1159/000152565; GOEDDE HW, 1972, HUM HERED, V22, P488, DOI 10.1159/000152528; Gower J.C, 1971, MATH ARCHAEOLOGICAL, P138; HARPENDING HC, 1973, METHODS THEORIES ANT, P177; HASTINGS DW, 1972, POP STUD-J DEMOG, V26, P19, DOI 10.2307/2172798; Hostetler J. A., 1980, AMISH SOC, V3rd; Jorde L., 1980, CURRENT DEV ANTHR GE, V1, P135, DOI DOI 10.1007/978-1-4613-3084-4_7; JORDE LB, 1982, HUM BIOL, V54, P583; JORDE LB, 1984, AM J EPIDEMIOL, V119, P487, DOI 10.1093/oxfordjournals.aje.a113765; JORDE LB, 1982, CURRENT DEV ANTHR GE, V2, P333; JORDE LB, 1984, MIGRATION MOBILITY; KARLIN S, 1979, AM J HUM GENET, V31, P341; KARLSSON S, 1980, HUM HERED, V30, P383, DOI 10.1159/000153163; KARLSSON S, 1980, HUM HERED, V30, P119, DOI 10.1159/000153113; KHAN PM, 1976, HUM GENET, V34, P53; KRAVITZ K, 1979, AM J HUM GENET, V31, P601; KUHNL P, 1977, HUM GENET, V38, P99, DOI 10.1007/BF00295812; KUHNL P, 1978, HUM GENET, V43, P57, DOI 10.1007/BF00396479; KUHNL P, 1972, HUMANGENETIK, V15, P7, DOI 10.1007/BF00273425; KURCZYNSKI TW, 1969, THESIS CASE W RESERV; Lalouel J. M., 1973, Genetic structure of populations. Proceedings of a conference sponsored by the University of Hawaii, 1973., P139; Larson Gustive O., 1971, AM UTAH STATEHOOD; LASKER GW, 1977, HUM BIOL, V49, P489; LOPEZLARREA C, 1981, HUM GENET, V57, P317; LYON JL, 1978, AM J EPIDEMIOL, V108, P357, DOI 10.1093/oxfordjournals.aje.a112632; LYON JL, 1980, J NATL CANCER I, V65, P1055; MARTIN AO, 1970, AM J PHYS ANTHROPOL, V32, P351, DOI 10.1002/ajpa.1330320305; MCKUSICK VA, 1964, COLD SPRING HARB SYM, V29, P99, DOI 10.1101/SQB.1964.029.01.015; MCLELLAN T, 1982, ANAL BIOCHEM, V126, P94, DOI 10.1016/0003-2697(82)90113-0; MCLELLAN T, 1982, AM J HUM GENET, V34, P623; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; MINEAU GP, 1979, POP STUD-J DEMOG, V33, P429, DOI 10.2307/2173890; MORGAN K, 1980, AM J HUM GENET, V32, P246; MORGAN K, 1982, CURRENT DEV ANTHR GE, V2, P429; MORTON N E, 1971, Theoretical Population Biology, V2, P507, DOI 10.1016/0040-5809(71)90038-4; MORTON NE, 1968, AM J HUM GENET, V20, P420; Mourant AE, 1976, DISTRIBUTION HUMAN B; OLAISEN B, 1981, HUM GENET, V57, P351, DOI 10.1007/BF00281682; OLAISEN B, 1976, HUM HERED, V26, P454, DOI 10.1159/000152840; OLSSON KS, 1983, ACTA MED SCAND, V213, P145; PARR CW, 1977, BIOCHEM GENET, V15, P109, DOI 10.1007/BF00484553; PFLUGSHAUPT R, 1973, VOX SANG, V25, P16; PFLUGSHAUPT R, 1978, HUM HERED, V28, P235, DOI 10.1159/000152962; PFLUGSHAUPT R, 1976, HUM HERED, V26, P161, DOI 10.1159/000152799; PIAZZA A, 1981, P NATL ACAD SCI-BIOL, V78, P2638, DOI 10.1073/pnas.78.4.2638; PIAZZA A, 1982, DISTRIBUZIONE ALCUNI; RAY JG, 1974, NIH75545 DHEW PUBL; RITTNER C, 1975, HUM HERED, V25, P152, DOI 10.1159/000152720; ROBERTS DF, 1975, MODERN TRENDS HUMAN, V2, P221; RYDER LP, 1978, HUM HERED, V28, P171, DOI 10.1159/000152958; RYMAN N, 1983, HUM HERED, V33, P93, DOI 10.1159/000153357; SALMON D, 1974, REV FR TRANSFUS IMMU, V17, P295, DOI 10.1016/S0035-2977(74)80042-8; SANGHVI LD, 1972, ASSESSMENT POPULATIO, P26; SCHERZ R, 1981, HUM HERED, V31, P187, DOI 10.1159/000153204; SEGER J, 1977, REV FR TRANSFUS IMMU, V20, P331, DOI 10.1016/S0338-4535(77)80098-6; SEGER J, 1977, REV FR TRANSFUS IMMU, V20, P575, DOI 10.1016/S0338-4535(77)80062-7; SIMON M, 1977, NEW ENGL J MED, V297, P1017, DOI 10.1056/NEJM197711102971901; SKOLNICK M, 1978, POP STUD-J DEMOG, V32, P5, DOI 10.2307/2173837; Skolnick M, 1980, BANDURY CANC INCIDEN, P285; SKOLNICK MH, 1984, CYTOGENET CELL GENET, V37, P210, DOI 10.1159/000132011; Smith Henry, 1957, STORY MENNONITES, V4th; SOKAL RR, 1982, AM NAT, V119, P1, DOI 10.1086/283886; SORENSEN SA, 1976, HUM HERED, V26, P90, DOI 10.1159/000152787; SPICER JC, 1974, SOC BIOL, V21, P70, DOI 10.1080/19485565.1974.9988090; STEINBERG AG, 1967, 3RD P INT C HUM GEN, P267; SVENSSON M, 1982, HUM HERED, V32, P357, DOI 10.1159/000153322; TEISBERG P, 1971, HUM HERED, V21, P154, DOI 10.1159/000152395; Thompson E.A., 1975, HUMAN EVOLUTIONARY T; TILLS D, 1982, ANN HUM BIOL, V9, P507, DOI 10.1080/03014468200006041; VERGNES H, 1980, HUM HERED, V30, P232, DOI 10.1159/000153134; VIRTARANTAKNOWLES K, 1982, HUM HERED, V32, P285, DOI 10.1159/000153308; WAHLQUIST Wayne L., 1978, MORMON ROLE SETTLEME, P107; WARD FE, 1973, HISTOCOMPATIBILITY T, P147; WEITKAMP LR, 1976, TISSUE ANTIGENS, V7, P273; WILLIAMS RR, 1984, GENETIC EPIDEMIOLOGY; WOOLF CM, 1956, AM J HUM GENET, V8, P236	99	158	159	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	4					836	857						22	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TJ077	6591796				2022-12-18	WOS:A1984TJ07700013
J	FRANCKE, U				FRANCKE, U			QUINACRINE MUSTARD FLUORESCENCE OF HUMAN CHROMOSOMES - CHARACTERIZATION OF UNUSUAL TRANSLOCATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ADAMS GL, 1970, ARCH GEN PSYCHIAT, V23, P305; CARREL RE, 1971, J PEDIATR-US, V78, P664, DOI 10.1016/S0022-3476(71)80471-7; CASPERSSON T, 1970, EXP CELL RES, V62, P490, DOI 10.1016/0014-4827(70)90586-0; CASPERSSON T, 1970, SCIENCE, V170, P762, DOI 10.1126/science.170.3959.762; CASPERSSON T, 1969, EXP CELL RES, V58, P141, DOI 10.1016/0014-4827(69)90124-4; CASPERSSON T, 1970, CHROMOSOMA, V30, P215; CASPERSSON T, 1970, Experimental Cell Research, V63, P238, DOI 10.1016/0014-4827(70)90362-9; CASPERSSON T, 1971, HEREDITAS-GENETISK A, V67, P89; CASPERSSON T, 1970, EXP CELL RES, V61, P475, DOI 10.1016/0014-4827(70)90479-9; CRAIG AP, 1971, CHROMOSOMA, V32, P364; CRANDALL B F, 1970, Journal of Medical Genetics, V7, P413, DOI 10.1136/jmg.7.4.413; GEORGE KP, 1970, NATURE, V226, P80, DOI 10.1038/226080a0; GRIPENBE.U, 1965, HEREDITAS-GENETISK A, V54, P1; HSU TC, 1963, EXP CELL RES, P73; LEWIS EB, 1950, ADV GENET, V3, P73, DOI 10.1016/S0065-2660(08)60083-8; MCCLINTOCK B, 1931, 163 U MISS COLL AGR, P1; MILLER DA, 1971, NATURE, V232, P24, DOI 10.1038/232024a0; Muller HJ, 1940, J GENET, V40, P1, DOI 10.1007/BF02982481; NESBITT M, IN PRESS; ORIORDAN ML, 1971, NATURE, V230, P167, DOI 10.1038/230167a0; PEARSON PL, 1970, NATURE, V226, P78, DOI 10.1038/226078a0; RETHORE MO, 1970, ANN GENET-PARIS, V13, P217; SCHMID W., 1963, CYTOGENETICS [BASEL], V2, P175, DOI 10.1159/000129778; SUMNER AT, 1971, NATURE-NEW BIOL, V229, P231, DOI 10.1038/newbio229231a0; UHL CH, 1965, GENETICS, V51, P191; WEBER F, 1971, CLIN RES, V19, P207; 1966, BIRTH DEFECTS OAS, V2	27	158	158	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1972	24	2					189	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M2541	5016511				2022-12-18	WOS:A1972M254100008
J	He, X; Fuller, CK; Song, Y; Meng, QY; Zhang, B; Yang, X; Li, H				He, Xin; Fuller, Chris K.; Song, Yi; Meng, Qingying; Zhang, Bin; Yang, Xia; Li, Hao			Sherlock: Detecting Gene-Disease Associations by Matching Patterns of Expression QTL and GWAS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUSCEPTIBILITY LOCI; MOLECULAR NETWORKS; RECEPTOR; PATHWAYS; METAANALYSIS; LANDSCAPE; TRAITS	Genetic mapping of complex diseases to date depends on variations inside or close to the genes that perturb their activities. A strong body of evidence suggests that changes in gene expression play a key role in complex diseases and that numerous loci perturb gene expression in trans. The information in trans variants, however, has largely been ignored in the current analysis paradigm. Here we present a statistical framework for genetic mapping by utilizing collective information in both cis and trans variants. We reason that for a disease-associated gene, any genetic variation that perturbs its expression is also likely to influence the disease risk. Thus, the expression quantitative trait loci (eQTL) of the gene, which constitute a unique "genetic signature," should overlap significantly with the set of loci associated with the disease. We translate this idea into a computational algorithm (named Sherlock) to search for gene-disease associations from GWASs, taking advantage of independent eQTL data. Application of this strategy to Crohn disease and type 2 diabetes predicts a number of genes with possible disease roles, including several predictions supported by solid experimental evidence. Importantly, predicted genes are often implicated by multiple trans eQTL with moderate associations. These genes are far from any GWAS association signals and thus cannot be identified from the GWAS alone. Our approach allows analysis of association data from a new perspective and is applicable to any complex phenotype. It is readily generalizable to molecular traits other than gene expression, such as metabolites, noncoding RNAs, and epigenetic modifications.	[He, Xin; Fuller, Chris K.; Song, Yi; Li, Hao] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [He, Xin] Carnegie Mellon Univ, Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA; [Meng, Qingying; Yang, Xia] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Zhang, Bin] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA	University of California System; University of California San Francisco; Carnegie Mellon University; University of California System; University of California Los Angeles; Icahn School of Medicine at Mount Sinai	Li, H (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	haoli@genome.ucsf.edu		Song, Yi/0000-0003-0125-6019	National Institutes of Health [R01(GM070808), U19(GM61390)]; NIH Center for Systems and Synthetic Biology [P50 GM081879]; Packard Fellowship in Science and Engineering; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067547, U19GM061390, P50GM081879, R01GM070808, U01GM061390] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Center for Systems and Synthetic Biology; Packard Fellowship in Science and Engineering; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors wish to thank Kathleen Giacomini, Sook Wah Yee, Saunak Sen, Mark Seielstad, Neil Risch, and Jiashun Zheng for helpful discussions and technical support. We would also like to thank the DIAGRAM consortium for providing the T2D GWAS data and Mark McCarthy for valuable comments on the manuscript. This work was supported by National Institutes of Health grants R01(GM070808) and U19(GM61390), the NIH Center for Systems and Synthetic Biology (P50 GM081879), and a Packard Fellowship in Science and Engineering to H.L.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bohm A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034035; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Cheung VG, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000480; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Crowe S, 2009, CELL METAB, V10, P40, DOI 10.1016/j.cmet.2009.06.001; Derry JMJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014319; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Donlin LT, 2005, MOL CELL BIOL, V25, P11035, DOI 10.1128/MCB.25.24.11035-11046.2005; Donlin LT, 2002, J IMMUNOL, V169, P6900, DOI 10.4049/jimmunol.169.12.6900; Duan S, 2008, AM J HUM GENET, V82, P1101, DOI 10.1016/j.ajhg.2008.03.006; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Durbin R, 1998, BIOL SEQUENCE ANAL P; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Galitovskiy V, 2011, J IMMUNOL, V187, P2677, DOI 10.4049/jimmunol.1002711; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Greenawalt DM, 2011, GENOME RES, V21, P1008, DOI 10.1101/gr.112821.110; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Kiezun A, 2012, NAT GENET, V44, P623, DOI 10.1038/ng.2303; Kopf D, 2008, J DIABETES COMPLICAT, V22, P205, DOI 10.1016/j.jdiacomp.2006.12.005; Ku CS, 2010, J HUM GENET, V55, P195, DOI 10.1038/jhg.2010.19; Langberg KA, 2012, J HUM GENET, V57, P57, DOI 10.1038/jhg.2011.133; Lees CW, 2011, GUT, V60, P1739, DOI 10.1136/gut.2009.199679; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; McKusick V.A., 1998, MENDELIAN INHERITANC; Miettinen PJ, 2006, DIABETES, V55, P3299, DOI 10.2337/db06-0413; Montgomery SB, 2011, NAT REV GENET, V12, P277, DOI 10.1038/nrg2969; Moriwaki Y, 2007, LIFE SCI, V80, P2365, DOI 10.1016/j.lfs.2006.12.028; Muraoka M, 2006, ARTHRITIS RHEUM, V54, P3591, DOI 10.1002/art.22172; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000294; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Shen L, 2010, CELL MOL LIFE SCI, V67, P1371, DOI 10.1007/s00018-010-0258-1; Slager SL, 2001, HUM HERED, V52, P149, DOI 10.1159/000053370; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Snoek SA, 2010, BRIT J PHARMACOL, V160, P322, DOI 10.1111/j.1476-5381.2010.00699.x; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wakefield J, 2008, INT J EPIDEMIOL, V37, P641, DOI 10.1093/ije/dym257; Wang K, 2009, AM J HUM GENET, V84, P399, DOI 10.1016/j.ajhg.2009.01.026; Wang Q, 2011, FASEB J, V25, P3949, DOI 10.1096/fj.11-190157; Wittkopp PJ, 2008, NAT GENET, V40, P346, DOI 10.1038/ng.77; Yang X, 2010, GENOME RES, V20, P1020, DOI 10.1101/gr.103341.109; Yang X, 2009, NAT GENET, V41, P415, DOI 10.1038/ng.325; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004; Zhong H, 2010, AM J HUM GENET, V86, P581, DOI 10.1016/j.ajhg.2010.02.020	66	157	158	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 2	2013	92	5					667	680		10.1016/j.ajhg.2013.03.022	http://dx.doi.org/10.1016/j.ajhg.2013.03.022			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	139KY	23643380	Green Published, Bronze			2022-12-18	WOS:000318582800004
J	Bernard, G; Chouery, E; Putorti, ML; Tetreault, M; Takanohashi, A; Carosso, G; Clement, I; Boespflug-Tanguy, O; Rodriguez, D; Delague, V; Abou Ghoch, J; Jalkh, N; Dorboz, I; Fribourg, S; Teichmann, M; Megarbane, A; Schiffmann, R; Vanderver, A; Brais, B				Bernard, Genevieve; Chouery, Eliane; Putorti, Maria Lisa; Tetreault, Martine; Takanohashi, Asako; Carosso, Giovanni; Clement, Isabelle; Boespflug-Tanguy, Odile; Rodriguez, Diana; Delague, Valerie; Abou Ghoch, Joelle; Jalkh, Nadine; Dorboz, Imen; Fribourg, Sebastien; Teichmann, Martin; Megarbane, Andre; Schiffmann, Raphael; Vanderver, Adeline; Brais, Bernard			Mutations of POLR3A Encoding a Catalytic Subunit of RNA Polymerase Pol III Cause a Recessive Hypomyelinating Leukodystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HYPOGONADOTROPIC HYPOGONADISM; CELL-GROWTH; TRANSCRIPTION; HYPODONTIA; YEAST; LEUKOENCEPHALOPATHY; ASSOCIATION; SUBCOMPLEX; DISORDERS	Leukodystrophies are a heterogeneous group of inherited neurodegenerative disorders characterized by abnormal white matter visible by brain imaging. It is estimated that at least 30% to 40% of individuals remain without a precise diagnosis despite extensive investigations. We mapped tremor-ataxia with central hypomyelination (TACH) to 10q22.3-23.1 in French-Canadian families and sequenced candidate genes within this interval. Two missense and one insertion mutations in five individuals with TACH were uncovered in POLR3A, which codes for the largest subunit of RNA polymerase III (Pol III). Because these families were mapped to the same locus as leukodystrophy with oligodontia (LO) and presented clinical and radiological overlap with individuals with hypomyelination, hypodontia and hypogonadotropic hypogonadism (4H) syndrome, we sequenced this gene in nine individuals with 411 and eight with LO. In total, 14 recessive mutations were found in 19 individuals with TACH, 4H, or LO, establishing that these leukodystrophies are allelic. No individual was found to carry two nonsense mutations. Immunoblots on 411 fibroblasts and on the autopsied brain of an individual diagnosed with 414 documented a significant decrease in POLR3A levels, and there was a more significant decrease in the cerebral white matter compared to that in the cortex. Pol III has a wide set of target RNA transcripts, including all nuclear-coded tRNA. We hypothesize that the decrease in POLR3A leads to dysregulation of the expression of certain Pol III targets and thereby perturbs cytoplasmic protein synthesis. This type of broad alteration in protein synthesis is predicted to occur in other leukoencephalopathies such as hypomyelinating leukodystrophy-3, caused by mutations in aminoacyl-tRNA synthetase complex-interacting multifunctional protein I (AIMP1).	[Bernard, Genevieve; Putorti, Maria Lisa; Tetreault, Martine; Clement, Isabelle; Brais, Bernard] McGill Univ, Montreal Neurol Inst, Neurogenet Mot Lab, Montreal, PQ H3A 2B4, Canada; [Bernard, Genevieve] McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Div Pediat Neurol,Dept Pediat, Montreal, PQ H3H 1P3, Canada; [Bernard, Genevieve] McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Div Pediat Neurol,Dept Neurol, Montreal, PQ H3H 1P3, Canada; [Bernard, Genevieve] McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Div Pediat Neurol,Dept Neurosurg, Montreal, PQ H3H 1P3, Canada; [Chouery, Eliane; Abou Ghoch, Joelle; Jalkh, Nadine; Megarbane, Andre] Univ St Joseph, Fac Med, Unite Genet Med & Lab Associe, INSERM,Unite UMR S 910, Beirut 115076, Riad El Solh, Lebanon; [Takanohashi, Asako; Carosso, Giovanni; Vanderver, Adeline] Childrens Natl Med Ctr, Dept Neurol, Washington, DC 20010 USA; [Boespflug-Tanguy, Odile] Hop Robert Debre, APHP, Reference Ctr Leukodystrophies, F-75019 Paris, France; [Boespflug-Tanguy, Odile] Univ Paris Diderot, F-75205 Paris 13, France; [Boespflug-Tanguy, Odile; Dorboz, Imen] INSERM, U931, F-63001 Clermont Ferrand, France; [Boespflug-Tanguy, Odile; Rodriguez, Diana; Dorboz, Imen] INSERM, U676, F-75935 Paris 19, France; [Rodriguez, Diana] Hop Armand Trousseau, AP HP, Serv Neurol Pediat, F-75571 Paris 12, France; [Rodriguez, Diana] Univ Paris 06, UPMC, F-75252 Paris 05, France; [Delague, Valerie] Fac Med Timone, INSERM, UMR S 910, F-13385 Marseille, France; [Fribourg, Sebastien; Teichmann, Martin] Univ Bordeaux, INSERM, IECB, F-33607 Pessac, France; [Megarbane, Andre] Inst Jerome Lejeune, F-75015 Paris, France; [Schiffmann, Raphael] Baylor Res Inst, Inst Metab Dis, Dallas, TX 75226 USA	McGill University; McGill University; McGill University; McGill University; Institut National de la Sante et de la Recherche Medicale (Inserm); Saint Joseph University Beirut; Children's National Health System; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Baylor Scott & White Health; Baylor University Medical Center	Brais, B (corresponding author), McGill Univ, Montreal Neurol Inst, Neurogenet Mot Lab, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	bernard.brais@mcgill.ca	Vanderver, Adeline/CAG-5072-2022; Brais, Bernard/Y-3910-2019; Fribourg, Sebastien/M-7418-2014; Rodriguez, Diana/GVR-7668-2022; Chouery, Eliane/AAC-5957-2021; Bernard, Geneviève/AAU-7569-2020; Megarbane, Andre/ABD-5574-2021; delague, valerie/K-5837-2013; Teichmann, Martin/M-7407-2014	Fribourg, Sebastien/0000-0003-4112-7510; Bernard, Geneviève/0000-0002-9634-2966; Takanohashi, Asako/0000-0003-3292-1595; Vanderver, Adeline/0000-0002-6290-6751; delague, valerie/0000-0003-2652-362X; Carosso, Giovanni/0000-0002-9142-8525; Teichmann, Martin/0000-0002-5257-0510	Fondation sur les Leucodystrophies; European Leukodystrophy Association (ELA); Reseau de Medecine Genetique Appliquee; Fonds de Recherche en Sante du Quebec; Canadian Institute of Health Research; Agence Universitaire de la Francophonie; ELA Foundation; National Human Genome Research Institute; Agence Nationale de Recherche; National Cancer Institute; regional government of Aquitaine; Ligue Contre le Cancer; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS060695] Funding Source: NIH RePORTER	Fondation sur les Leucodystrophies; European Leukodystrophy Association (ELA); Reseau de Medecine Genetique Appliquee; Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Agence Universitaire de la Francophonie; ELA Foundation; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Agence Nationale de Recherche(French National Research Agency (ANR)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); regional government of Aquitaine; Ligue Contre le Cancer(Ligue nationale contre le cancer); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank all participants and the clinicians who referred patients to us, in particular Isabelle Bouchard, Jean-Pierre Bouchard, Rachel Laframboise, Pierre Langevin, Serge Melancon, Sonia Orivoli, Guillaume Sebire, Michel Sylvain, and Michel Vanasse. We would like to thank the Fondation sur les Leucodystrophies and the European Leukodystrophy Association (ELA) for financing this research project. We thank Nouria Hernandez for sharing her hRPC155 POLR3A antibody. G.B. received fellowship scholarships from the Reseau de Medecine Genetique Appliquee and Fonds de Recherche en Sante du Quebec. M.T. is supported by a Canadian Institute of Health Research graduate scholarship. E.C. has received a Ph.D. scholarship from Agence Universitaire de la Francophonie. I.D. received a postdoctoral fellowship scholarship from the ELA Foundation. A.V. contribution is supported in part by the Intramural Research Program of the National Human Genome Research Institute. M.T. has received grants from the Agence Nationale de Recherche, the National Cancer Institute, the regional government of Aquitaine, and the Ligue Contre le Cancer (equipe labellisee). The authors wish to thank all collaborators and patients participating in the Myelin Bioregistry Project.	Armache KJ, 2005, J BIOL CHEM, V280, P7131, DOI 10.1074/jbc.M413038200; Atrouni S, 2003, AM J MED GENET A, V118A, P76, DOI 10.1002/ajmg.a.10019; Bekiesinska-Figatowska M, 2010, BRAIN DEV-JPN, V32, P574, DOI 10.1016/j.braindev.2009.07.008; Bernard G, 2010, NEUROGENETICS, V11, P457, DOI 10.1007/s10048-010-0251-8; Boespflug-Tanguy O, 2011, AM J HUM GENET, V88, P392, DOI 10.1016/j.ajhg.2010.12.015; BOESPFLUGTANGUY O, 2011, AM J HUM GENET, V88, P393; Chouery E, 2011, NEUROGENETICS, V12, P73, DOI 10.1007/s10048-010-0256-3; Cramer P, 2008, ANNU REV BIOPHYS, V37, P337, DOI 10.1146/annurev.biophys.37.032807.130008; Dauwerse JG, 2011, NAT GENET, V43, P20, DOI 10.1038/ng.724; Dieci G, 2007, TRENDS GENET, V23, P614, DOI 10.1016/j.tig.2007.09.001; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Dumay-Odelot H, 2010, CELL CYCLE, V9, P3687, DOI 10.4161/cc.9.18.13203; Feinstein M, 2010, AM J HUM GENET, V87, P820, DOI 10.1016/j.ajhg.2010.10.016; Fernandez-Tornero C, 2007, MOL CELL, V25, P813, DOI 10.1016/j.molcel.2007.02.016; Haurie V, 2010, P NATL ACAD SCI USA, V107, P4176, DOI 10.1073/pnas.0914980107; Jasiak AJ, 2006, MOL CELL, V23, P71, DOI 10.1016/j.molcel.2006.05.013; Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013; Schiffmann R, 2004, CURR OPIN NEUROL, V17, P187, DOI 10.1097/00019052-200404000-00017; Schiffmann R, 2009, NEUROLOGY, V72, P750, DOI 10.1212/01.wnl.0000343049.00540.c8; Sepehri S, 1997, GENOME RES, V7, P1006, DOI 10.1101/gr.7.10.1006; Steenweg ME, 2010, BRAIN, V133, P2971, DOI 10.1093/brain/awq257; TETREAULT M, 2011, CAN J NEURO IN PRESS; Timmons M, 2006, NEUROLOGY, V67, P2066, DOI 10.1212/01.wnl.0000247666.28904.35; Vazquez-Lopez M, 2008, REV NEUROLOGIA, V47, P204, DOI 10.33588/rn.4704.2008163; WERNER M, 1992, MOL CELL BIOL, V12, P1087, DOI 10.1128/MCB.12.3.1087; Werner M, 2009, CURR OPIN STRUC BIOL, V19, P740, DOI 10.1016/j.sbi.2009.10.005; White RJ, 2011, NAT REV GENET, V12, P459, DOI 10.1038/nrg3001; Wolf NI, 2007, NEUROPEDIATRICS, V38, P64, DOI 10.1055/s-2007-985137	28	157	163	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP 9	2011	89	3					415	423		10.1016/j.ajhg.2011.07.014	http://dx.doi.org/10.1016/j.ajhg.2011.07.014			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	820XQ	21855841	Bronze, Green Published			2022-12-18	WOS:000294939800006
J	Derenko, M; Malyarchuk, B; Grzybowski, T; Denisova, G; Dambueva, I; Perkova, M; Dorzhu, C; Luzina, F; Lee, HK; Vanecek, T; Villems, R; Zakharov, I				Derenko, Miroslava; Malyarchuk, Boris; Grzybowski, Tomasz; Denisova, Galina; Dambueva, Irina; Perkova, Maria; Dorzhu, Choduraa; Luzina, Faina; Lee, Hong Kyu; Vanecek, Tomas; Villems, Richard; Zakharov, Ilia			Phylogeographic analysis of mitochondrial DNA in northern Asian Populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MTDNA HAPLOGROUP-H; GENOME VARIATION; GENETIC HISTORY; SIBERIAN POPULATIONS; EVOLUTIONARY HISTORY; REGION SEQUENCES; NEAR-EASTERN; SOUTH; LINEAGES; DIVERSITY	To elucidate the human colonization process of northern Asia and human dispersals to the Americas, a diverse subset of 71 mitochondrial DNA (mtDNA) lineages was chosen for complete genome sequencing from the collection of 1,432 control-region sequences sampled from 18 autochthonous populations of northern, central, eastern, and southwestern Asia. On the basis of complete mtDNA sequencing, we have revised the classification of haplogroups A, D2, G1, M7, and I; identified six new subhaplogroups (I4, N1e, G1c, M7d, M7e, and J1b2a); and fully characterized haplogroups N1a and G1b, which were previously described only by the first hypervariable segment (HVS1) sequencing and coding-region restriction-fragment-length polymorphism analysis. Our findings indicate that the southern Siberian mtDNA pool harbors several lineages associated with the Late Upper Paleolithic and/or early Neolithic dispersals from both eastern Asia and southwestern Asia/southern Caucasus. Moreover, the phylogeography of the D2 lineages suggests that southern Siberia is likely to be a geographical source for the last postglacial maximum spread of this subhaplogroup to northern Siberia and that the expansion of the D2b branch occurred in Beringia similar to 7,000 years ago. In general, a detailed analysis of mtDNA gene pools of northern Asians provides the additional evidence to rule out the existence of a northern Asian route for the initial human colonization of Asia.	Russian Acad Sci, Inst Biol Problems N, Genet Lab, Magadan 685000, Russia; Nicholas Copernicus Univ Torun, Ludwik Rydygier Med Coll, Bydgoszcz, Poland; Russian Acad Sci, Inst Gen & Expt Biol, Ulan Ude, Russia; Tuva State Univ, Kyzyl, Russia; Russian Acad Med Sci, Inst Profess Dis & Hyg Problems, Novokuznetsk, Russia; Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; Charles Univ Prague, Med Fac Hosp, Dept Pathol, Plzen, Czech Republic; Univ Tartu, Estonina Bioctr, Dept Evolutionary Biol, EE-50090 Tartu, Estonia; Russian Acad Sci, NI Vavilov Gen Genet Res Inst, Anim Comparat Genet Lab, Moscow, Russia	Institute of Biological Problems of the North; Russian Academy of Sciences; Nicolaus Copernicus University; Russian Academy of Sciences; Tuvan State University; Russian Academy of Medical Sciences; Seoul National University (SNU); Charles University Prague; Estonian Biocentre; University of Tartu; Russian Academy of Sciences; Vavilov Institute of General Genetics	Derenko, M (corresponding author), Russian Acad Sci, Inst Biol Problems N, Genet Lab, Portovaya St 18, Magadan 685000, Russia.	mderenko@mail.ru	Dorzhu, Choduraa/A-3821-2014; Malyarchuk, Boris/D-5783-2018; Derenko, Miroslava/J-1495-2018; Denisova, Galina/AAZ-4310-2020; Dambueva, Irina/K-3073-2018; Dambueva, Irina/AAZ-4313-2020; Grzybowski, Tomasz/A-1676-2015	Malyarchuk, Boris/0000-0002-0304-0652; Derenko, Miroslava/0000-0002-1849-784X; Grzybowski, Tomasz/0000-0001-6228-6460; Luzina, Faina/0000-0001-9299-4652				Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; ArisBrosou S, 1996, MOL BIOL EVOL, V13, P494, DOI 10.1093/oxfordjournals.molbev.a025610; Bamshad M, 2001, GENOME RES, V11, P994, DOI 10.1101/gr.GR-1733RR; Bandelt HJ, 2005, BIOCHEM BIOPH RES CO, V333, P122, DOI 10.1016/j.bbrc.2005.04.055; Bandelt HJ, 2003, ANN HUM GENET, V67, P512, DOI 10.1046/j.1469-1809.2003.00049.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bermisheva MA, 2002, MOL BIOL+, V36, P802, DOI 10.1023/A:1021677708482; Brown MD, 1998, AM J HUM GENET, V63, P1852, DOI 10.1086/302155; Chaix R, 2007, CURR BIOL, V17, P43, DOI 10.1016/j.cub.2006.10.058; Comas D, 2004, EUR J HUM GENET, V12, P495, DOI 10.1038/sj.ejhg.5201160; Derbeneva OA, 2002, AM J HUM GENET, V71, P415, DOI 10.1086/341720; Derbeneva OA, 2002, AM J HUM GENET, V70, P1009, DOI 10.1086/339524; Derenko M, 2006, HUM GENET, V118, P591, DOI 10.1007/s00439-005-0076-y; Derenko MV, 2003, ANN HUM GENET, V67, P391, DOI 10.1046/j.1469-1809.2003.00035.x; Derenko MV, 2000, HUM BIOL, V72, P945; Derenko MV, 2001, AM J HUM GENET, V69, P237, DOI 10.1086/321266; DERENKO MV, 1998, J MOL BIOL MOSK, V31, P784; EXCOFFIER L, 1992, GENETICS, V131, P479; Fedorova S. A., 2003, Molekulyarnaya Biologiya (Moscow), V37, P643; Finnila S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591; Forster P, 1996, AM J HUM GENET, V59, P935; Fu YX, 1997, GENETICS, V147, P915; Goebel T, 1999, EVOL ANTHROPOL, V8, P208; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; Helgason A, 2006, AM J PHYS ANTHROPOL, V130, P123, DOI 10.1002/ajpa.20313; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Hill C, 2007, AM J HUM GENET, V80, P29, DOI 10.1086/510412; Horai S, 1996, AM J HUM GENET, V59, P579; Ingman M, 2003, GENOME RES, V13, P1600, DOI 10.1101/gr.686603; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Karafet TM, 2002, HUM BIOL, V74, P761, DOI 10.1353/hub.2003.0006; Karafet TM, 1999, AM J HUM GENET, V64, P817, DOI 10.1086/302282; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Kong QP, 2003, AM J HUM GENET, V73, P671, DOI 10.1086/377718; Kong QP, 2003, HUM GENET, V113, P391, DOI 10.1007/s00439-003-1004-7; Lahr Marta Mirazon, 1994, Evolutionary Anthropology, V3, P48, DOI 10.1002/evan.1360030206; Lee H, 2006, INT J LEGAL MED, V120, P5, DOI 10.1007/s00414-005-0005-6; Loogvali EL, 2004, MOL BIOL EVOL, V21, P2012, DOI 10.1093/molbev/msh209; Maca-Meyer N, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-13; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Malyarchuk BA, 2002, ANN HUM GENET, V66, P261, DOI 10.1017/S0003480002001161; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Metspalu M, 2006, NUCL ACID M, V18, P181; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Pakendorf B, 2003, AM J PHYS ANTHROPOL, V120, P211, DOI 10.1002/ajpa.10145; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; Quintana-Murci L, 2004, AM J HUM GENET, V74, P827, DOI 10.1086/383236; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Reidla M, 2003, AM J HUM GENET, V73, P1178, DOI 10.1086/379380; Ricaut FX, 2004, HUM BIOL, V76, P109, DOI 10.1353/hub.2004.0025; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Roessli D, 2000, ARLEQUIN VERSION 2 0; Roostalu U, 2007, MOL BIOL EVOL, V24, P436, DOI 10.1093/molbev/msl173; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Schurr TG, 1999, AM J PHYS ANTHROPOL, V108, P1, DOI 10.1002/(SICI)1096-8644(199901)108:1<1::AID-AJPA1>3.0.CO;2-1; Starikovskaya EB, 2005, ANN HUM GENET, V69, P67, DOI 10.1046/j.1529-8817.2003.00127.x; Starikovskaya YB, 1998, AM J HUM GENET, V63, P1473, DOI 10.1086/302087; Sukernik RI, 1996, GENETIKA+, V32, P432; Sun C, 2006, MOL BIOL EVOL, V23, P683, DOI 10.1093/molbev/msj078; TAJIMA F, 1989, GENETICS, V123, P585; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511; TORRONI A, 1993, AM J HUM GENET, V53, P591; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Trejaut JA, 2005, PLOS BIOL, V3, P1362, DOI 10.1371/journal.pbio.0030247; Vasil'ev SA, 2002, RADIOCARBON, V44, P503, DOI 10.1017/S0033822200031878; VASILEV SA, 1993, CURR ANTHROPOL, V34, P82, DOI 10.1086/204141; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; Zegura SL, 2004, MOL BIOL EVOL, V21, P164, DOI 10.1093/molbev/msh009	72	157	167	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2007	81	5					1025	1041		10.1086/522933	http://dx.doi.org/10.1086/522933			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	224XE	17924343	Green Published, Bronze			2022-12-18	WOS:000250480900013
J	Jaspers, NGJ; Raams, A; Silengo, MC; Wijgers, N; Niedernhofer, LJ; Robinson, AR; Giglia-Mari, G; Hoogstraten, D; Kleijer, WJ; Hoeijmakers, JHJ; Vermeulen, W				Jaspers, Nicolaas G. J.; Raams, Anja; Silengo, Margherita Cirillo; Wijgers, Nils; Niedernhofer, Laura J.; Robinson, Andria Rasile; Giglia-Mari, Giuseppina; Hoogstraten, Deborah; Kleijer, Wim J.; Hoeijmakers, Jan H. J.; Vermeulen, Wim			First reported patient with human ERCC1 deficiency has cerebro-oculo-facio-skeletal syndrome with a mild defect in nucleotide excision repair and severe developmental failure	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PIGMENTOSUM GROUP-F; XERODERMA-PIGMENTOSUM; DNA-REPAIR; COCKAYNE-SYNDROME; GENE ERCC-1; ENDONUCLEASE ERCC1-XPF; NUCLEAR ABNORMALITIES; MICE LACKING; LATE-ONSET; GROUP-A	Nucleotide excision repair (NER) is a genome caretaker mechanism responsible for removing helix-distorting DNA lesions, most notably ultraviolet photodimers. Inherited defects in NER result in profound photosensitivity and the cancer-prone syndrome xeroderma pigmentosum (XP) or two progeroid syndromes: Cockayne and trichothiodystrophy syndromes. The heterodimer ERCC1-XPF is one of two endonucleases required for NER. Mutations in XPF are associated with mild XP and rarely with progeria. Mutations in ERCC1 have not been reported. Here, we describe the first case of human inherited ERCC1 deficiency. Patient cells showed moderate hypersensitivity to ultraviolet rays and mitomycin C, yet the clinical features were very severe and, unexpectedly, were compatible with a diagnosis of cerebro-oculo-facio-skeletal syndrome. This discovery represents a novel complementation group of patients with defective NER. Further, the clinical severity, coupled with a relatively mild repair defect, suggests novel functions for ERCC1.	Erasmus MC, Dept Genet, NL-3000 CA Rotterdam, Netherlands; Erasmus MC, Dept Clin Genet, NL-3000 CA Rotterdam, Netherlands; Univ Turin, Dept Pediat, I-10124 Turin, Italy; Univ Pittsburgh, Inst Canc, Dept Biochem & Mol Genet, Pittsburgh, PA USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Turin; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Jaspers, NGJ (corresponding author), Erasmus MC, Dept Genet, POB 2040, NL-3000 CA Rotterdam, Netherlands.	n.jaspers@erasmusmc.nl	Vermeulen, Wim/W-8708-2019; Hoeijmakers, Jan/AAX-6972-2021; Giglia-Mari, Giuseppina/F-5114-2010	Vermeulen, Wim/0000-0003-3616-734X; Giglia-Mari, Giuseppina/0000-0003-2001-1965; Silengo, Margherita/0000-0002-6255-1532	NATIONAL CANCER INSTITUTE [K22CA111525] Funding Source: NIH RePORTER; NCI NIH HHS [CA111525-01, K22 CA111525] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adair GR, 2000, EMBO J, V19, P5552, DOI 10.1093/emboj/19.20.5552; Bielas S, 2004, ANNU REV CELL DEV BI, V20, P593, DOI 10.1146/annurev.cellbio.20.082503.103047; BIGGERSTAFF M, 1993, EMBO J, V12, P3685, DOI 10.1002/j.1460-2075.1993.tb06043.x; BOOTSMA D, 1997, METABOLIC BASIS INHE, P245; Busch DB, 1997, MUTAT RES-DNA REPAIR, V383, P91, DOI 10.1016/S0921-8777(96)00048-1; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; de Laat WL, 1998, NUCLEIC ACIDS RES, V26, P4146, DOI 10.1093/nar/26.18.4146; DEVRIES A, 1995, NATURE, V377, P169, DOI 10.1038/377169a0; DEWEERDK.EA, 1972, NATURE-NEW BIOL, V238, P80, DOI 10.1038/newbio238080a0; Evans E, 1997, EMBO J, V16, P6559, DOI 10.1093/emboj/16.21.6559; Giglia-Mari G, 2004, NAT GENET, V36, P714, DOI 10.1038/ng1387; Graham JM, 2001, AM J HUM GENET, V69, P291, DOI 10.1086/321295; Hamel BCK, 1996, J MED GENET, V33, P607, DOI 10.1136/jmg.33.7.607; Hayashi T, 1998, MUTAT RES-DNA REPAIR, V407, P269, DOI 10.1016/S0921-8777(98)00013-5; Jaspers NGJ, 2002, DNA REPAIR, V1, P1027, DOI 10.1016/S1568-7864(02)00166-0; JASPERS NGJ, 1982, P NATL ACAD SCI-BIOL, V79, P2641, DOI 10.1073/pnas.79.8.2641; KONDO S, 1989, PHOTODERMATOLOGY, V6, P89; Kuraoka I, 2000, J BIOL CHEM, V275, P26632, DOI 10.1074/jbc.C000337200; MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217; Meira LB, 2000, AM J HUM GENET, V66, P1221, DOI 10.1086/302867; Munoz P, 2005, NAT GENET, V37, P1063, DOI 10.1038/ng1633; Murai M, 2001, P NATL ACAD SCI USA, V98, P13379, DOI 10.1073/pnas.231329598; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Niedernhofer LJ, 2001, EMBO J, V20, P6540, DOI 10.1093/emboj/20.22.6540; Prasher JM, 2005, EMBO J, V24, P861, DOI 10.1038/sj.emboj.7600542; Radford SJ, 2005, GENETICS, V170, P1737, DOI 10.1534/genetics.104.036178; Reed E, 2006, NEW ENGL J MED, V355, P1054, DOI 10.1056/NEJMe068162; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; SCHIESTL RH, 1990, MOL CELL BIOL, V10, P2485, DOI 10.1128/MCB.10.6.2485; SCHLAKE C, 1993, MUTAT RES, V294, P59, DOI 10.1016/0921-8777(93)90058-O; SEKELSKY JJ, 1995, GENETICS, V141, P619; Selfridge J, 2001, NUCLEIC ACIDS RES, V29, P4541, DOI 10.1093/nar/29.22.4541; Sijbers AM, 1998, J INVEST DERMATOL, V110, P832, DOI 10.1046/j.1523-1747.1998.00171.x; Sijbers AM, 1996, NUCLEIC ACIDS RES, V24, P3370, DOI 10.1093/nar/24.17.3370; Sijbers AM, 1996, CELL, V86, P811, DOI 10.1016/S0092-8674(00)80155-5; STEFANINI M, 1993, AM J HUM GENET, V53, P817; Thorel F, 2004, MOL CELL BIOL, V24, P10670, DOI 10.1128/MCB.24.24.10670-10680.2004; Tian M, 2004, MOL CELL BIOL, V24, P1200, DOI 10.1128/MCB.24.3.1200-1205.2004; Tsodikov OV, 2005, P NATL ACAD SCI USA, V102, P11236, DOI 10.1073/pnas.0504341102; vanderSpek PJ, 1996, NUCLEIC ACIDS RES, V24, P2551, DOI 10.1093/nar/24.13.2551; VANDUIN M, 1988, MUTAT RES, V193, P123, DOI 10.1016/0167-8817(88)90042-9; VANDUIN M, 1988, NUCLEIC ACIDS RES, V16, P5305, DOI 10.1093/nar/16.12.5305; VANDUIN M, 1988, CLONING CHARACTERIZA; VANVUUREN AJ, 1993, EMBO J, V12, P3693, DOI 10.1002/j.1460-2075.1993.tb06044.x; VANVUUREN AJ, 1995, MUTAT RES-DNA REPAIR, V337, P25, DOI 10.1016/0921-8777(95)00009-9; Vermeulen W, 2001, NAT GENET, V27, P299, DOI 10.1038/85864; Vermeulen W, 2000, NAT GENET, V26, P307, DOI 10.1038/81603; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Weeda G, 1997, CURR BIOL, V7, P427, DOI 10.1016/S0960-9822(06)00190-4; WEEDA G, 1990, CELL, V62, P777, DOI 10.1016/0092-8674(90)90122-U; WESTERVELD A, 1984, NATURE, V310, P425, DOI 10.1038/310425a0; WOOD RD, 1982, MUTAT RES, V95, P505, DOI 10.1016/0027-5107(82)90281-0; Yagi T, 1997, MUTAGENESIS, V12, P41, DOI 10.1093/mutage/12.1.41; Zafeiriou DI, 2001, PEDIATR RES, V49, P407, DOI 10.1203/00006450-200103000-00016; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7	56	157	167	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2007	80	3					457	466		10.1086/512486	http://dx.doi.org/10.1086/512486			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	139AB	17273966	Green Published, Bronze			2022-12-18	WOS:000244403300006
J	Weale, ME; Depondt, C; Macdonald, SJ; Smith, A; Lai, PS; Shorvon, SD; Wood, NW; Goldstein, DB				Weale, ME; Depondt, C; Macdonald, SJ; Smith, A; Lai, PS; Shorvon, SD; Wood, NW; Goldstein, DB			Selection and evaluation of tagging SNPs in the neuronal-sodium-channel gene SCN1A: Implications for linkage-disequilibrium gene mapping	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FEBRILE SEIZURES PLUS; SEVERE MYOCLONIC EPILEPSY; COMMON DISEASE GENES; GENERALIZED EPILEPSY; BLOCK STRUCTURE; HUMAN GENOME; HUMAN BRAIN; MUTATIONS; COMPLEX; RECOMBINATION	Association studies are widely seen as the most promising approach for finding polymorphisms that influence genetically complex traits, such as common diseases and responses to their treatment. Considerable interest has therefore recently focused on the development of methods that efficiently screen genomic regions or whole genomes for gene variants associated with complex phenotypes. One key element in this search is the use of linkage disequilibrium to gain maximal information from typing a selected subset of highly informative single-nucleotide polymorphism ( SNP) markers, now often called "tagging SNPs" (tSNPs). Probably the most common approach to linkage-disequilibrium gene mapping involves a three-step program: ( 1) characterization of the haplotype structure in candidate genes or genomic regions of interest, ( 2) identification of tSNPs sufficient to represent the most common haplotypes, and ( 3) typing of tSNPs in clinical material. Early definitions of tSNPs focused on the amount of haplotype diversity that they explained. To select tSNPs that would have maximal power in a genetic association study, however, we have developed optimization criteria based on the measure of association and have compared these with other criteria based on the haplotype diversity. To evaluate the full program and to assess how well the selected tags are likely to perform, we have determined the haplotype structure and have assessed tSNPs in the SCN1A gene, an important candidate gene for sporadic epilepsy. We find that as few as four tSNPs are predicted to maintain a consistently high value with all other common SNPs in the gene, indicating that the tags could be used in an association study with only a modest reduction in power relative to direct assays of all common SNPs. This implies that very large case-control studies can be screened for variation in hundreds of candidate genes with manageable experimental effort, once tSNPs are identified. However, our results also show that tSNPs identified in one population may not necessarily perform well in another, indicating that the preliminary study to identify tSNPs and the later case-control study should be performed in the same population. Our results also indicate that tSNPs will not easily identify discrepant SNPs, which lie on importantly discriminating but apparently short genealogical branches. This could significantly complicate tagging approaches for phenotypes influenced by variants that have experienced positive selection.	UCL, Dept Biol, London WC1E 6BT, England; Natl Hosp, Ctr Genet Anthropol, Dept Biol, London WC1N 3BG, England; Natl Hosp, Inst Neurol, London WC1N 3BG, England; Natl Univ Singapore, Dept Paediat, Fac Med, Singapore 117548, Singapore; Natl Inst Neurosci, Singapore, Singapore	University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; National University of Singapore; National Neuroscience Institute (NNI)	Goldstein, DB (corresponding author), UCL, Dept Biol, Gower St, London WC1E 6BT, England.	d.goldstein@ucl.ac.uk	Wood, Nicholas W/C-2505-2009; Shorvon, Simon D/A-2019-2009; Goldstein, David/AAY-8125-2020; Weale, Michael E/F-2587-2010	Wood, Nicholas W/0000-0002-9500-3348; Weale, Michael E/0000-0003-4593-1186; Macdonald, Stuart/0000-0002-9421-002X				Abou-Khalil B, 2001, NEUROLOGY, V57, P2265, DOI 10.1212/WNL.57.12.2265; Catterall W A, 1999, Adv Neurol, V79, P441; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Clayton D., 2002, CHOOSING SET HAPLOTY; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Donahue LM, 2000, BRAIN RES, V887, P335, DOI 10.1016/S0006-8993(00)03033-X; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Escayg A, 2001, AM J HUM GENET, V68, P866, DOI 10.1086/319524; Goldstein DB, 2003, NEW ENGL J MED, V348, P553, DOI 10.1056/NEJMe020173; Goldstein DB, 2001, NAT GENET, V29, P109, DOI 10.1038/ng1001-109; GOLDSTEIN DB, IN PRESS TRENDS GENE; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Kuo CC, 1998, MOL PHARMACOL, V54, P712; Lossin C, 2002, NEURON, V34, P877, DOI 10.1016/S0896-6273(02)00714-6; Plummer NW, 1999, GENOMICS, V57, P323, DOI 10.1006/geno.1998.5735; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Stumpf MPH, 2003, CURR BIOL, V13, P1, DOI 10.1016/S0960-9822(02)01404-5; Sugawara T, 2002, NEUROLOGY, V58, P1122, DOI 10.1212/WNL.58.7.1122; Sugawara T, 2001, NEUROLOGY, V57, P703, DOI 10.1212/WNL.57.4.703; Templeton AR, 2000, GENETICS, V156, P1259; Wallace RH, 2001, AM J HUM GENET, V68, P859, DOI 10.1086/319516; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252; Weiss KM, 2002, TRENDS GENET, V18, P19, DOI 10.1016/S0168-9525(01)02550-1; Whitaker WRJ, 2001, MOL BRAIN RES, V88, P37, DOI 10.1016/S0169-328X(00)00289-8; Zhang K, 2002, AM J HUM GENET, V71, P1386, DOI 10.1086/344780	33	157	165	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2003	73	3					551	565		10.1086/378098	http://dx.doi.org/10.1086/378098			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	718FG	12900796	Bronze, Green Published			2022-12-18	WOS:000185134000008
J	Hwang, SJ; Lozano, G; Amos, CI; Strong, LC				Hwang, SJ; Lozano, G; Amos, CI; Strong, LC			Germline p53 mutations in a cohort with childhood sarcoma: Sex differences in cancer risk	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LI-FRAUMENI-SYNDROME; GAIN-OF-FUNCTION; TUMOR-SUPPRESSOR GENE; MUTANT P53; BREAST-CANCER; SEGREGATION ANALYSIS; TP53 MUTATIONS; CELL-LINES; FAMILIES; TISSUE	To characterize cancer risk in heterozygous p53 mutation carriers, we analyzed cancer incidence in 56 germline p53 mutation carriers and 3,201 noncarriers from 107 kindreds ascertained through patients with childhood soft-tissue sarcoma who were treated at the University of Texas M. D. Anderson Cancer Center. We systematically followed members in these kindreds for cancer incidence for 120 years and evaluated their p53 gene status. We found seven kindreds with germline p53 mutations that include both missense and truncation mutation types. Kaplan-Meier analysis showed similar cancer risks between 21 missense and 35 truncation p53 mutation carriers (log-rank chi(2) = 0.04;). We found a significantly higher cancer risk in female carriers than in male carriers (log- rank chi(2) = 12.1; P < .001), a difference not explained by an excess of sex-specific cancer. The calculated standardized incidence ratio (SIR) showed that mutation carriers had a risk for all types of cancer that was much higher than that for the general population (SIR = 41.1; 95% confidence interval [CI] 29.9-55.0) whereas noncarriers had a risk for all types of cancer that was similar to that in the general population (SIR = 0.9; 95% CI 0.8-1.0). The calculated SIRs showed a >100-fold higher risk of sarcoma, female breast cancer, and hematologic malignancies for the p53 mutation carriers and agreed with the findings of an earlier segregation analysis based on the same cohort. These results quantitatively illustrated the spectrum of cancer risk in germline p53 mutation carriers and will provide valuable reference for the evaluation and treatment of patients with cancer.	Univ Texas, MD Anderson Canc Ctr, Sect Clin Canc Genet, Dept Mol Genet, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Sect Human Genet, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Hwang, SJ (corresponding author), Univ Texas, MD Anderson Canc Ctr, Sect Clin Canc Genet, Dept Mol Genet, Box 209,1515 Holcombe Blvd, Houston, TX 77030 USA.				NCI NIH HHS [CA 34936, P01 CA034936] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA034936] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Birch JM, 1998, ONCOGENE, V17, P1061, DOI 10.1038/sj.onc.1202033; Birch JM, 2001, ONCOGENE, V20, P4621, DOI 10.1038/sj.onc.1204621; Blagosklonny MV, 2000, FASEB J, V14, P1901, DOI 10.1096/fj.99-1078rev; BONDY ML, 1992, GENET EPIDEMIOL, V9, P291, DOI 10.1002/gepi.1370090502; Bougeard G, 2001, J MED GENET, V38, P253, DOI 10.1136/jmg.38.4.253; Cadwell C, 2001, GENE, V277, P15, DOI 10.1016/S0378-1119(01)00696-5; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; DILLER L, 1995, J CLIN INVEST, V95, P1606, DOI 10.1172/JCI117834; DITTMER D, 1993, NAT GENET, V4, P42, DOI 10.1038/ng0593-42; DONEHOWER LA, 1995, MOL CARCINOGEN, V14, P16, DOI 10.1002/mc.2940140105; Evans SC, 1998, HUM GENET, V102, P681, DOI 10.1007/s004390050761; FLAMAN JM, 1995, P NATL ACAD SCI USA, V92, P3963, DOI 10.1073/pnas.92.9.3963; FREBOURG T, 1995, AM J HUM GENET, V56, P608; GRAYSON GH, 1994, AM J PEDIAT HEMATOL, V16, P341; Gualberto A, 1998, P NATL ACAD SCI USA, V95, P5166, DOI 10.1073/pnas.95.9.5166; Guimaraes DP, 2002, BIOCHIMIE, V84, P83, DOI 10.1016/S0300-9084(01)01356-6; Hayes VM, 1999, DIAGN MOL PATHOL, V8, P2, DOI 10.1097/00019606-199903000-00002; Hernandez-Boussard T, 1999, HUM MUTAT, V14, P1; Hisada M, 1998, JNCI-J NATL CANCER I, V90, P606, DOI 10.1093/jnci/90.8.606; Hixon ML, 2000, HISTOL HISTOPATHOL, V15, P551, DOI 10.14670/HH-15.551; HSIAO M, 1994, AM J PATHOL, V145, P702; Hussain SP, 1999, MUTAT RES-FUND MOL M, V428, P23, DOI 10.1016/S1383-5742(99)00028-9; IAVARONE A, 1992, P NATL ACAD SCI USA, V89, P4207, DOI 10.1073/pnas.89.9.4207; Kleihues P, 1997, AM J PATHOL, V150, P1; KYRITSIS AP, 1994, JNCI-J NATL CANCER I, V86, P344, DOI 10.1093/jnci/86.5.344; LAW JC, 1991, CANCER RES, V51, P6385; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lipsitz SR, 1996, BIOMETRICS, V52, P291, DOI 10.2307/2533164; LUSTBADER ED, 1992, AM J HUM GENET, V51, P344; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MALKIN D, 1992, NEW ENGL J MED, V326, P1309, DOI 10.1056/NEJM199205143262002; Martin ACR, 2002, HUM MUTAT, V19, P149, DOI 10.1002/humu.10032; MCINTYRE JF, 1994, J CLIN ONCOL, V12, P925, DOI 10.1200/JCO.1994.12.5.925; Nichols KE, 2001, CANCER EPIDEM BIOMAR, V10, P83; Quesnel S, 1999, ONCOGENE, V18, P3970, DOI 10.1038/sj.onc.1202783; Rapakko K, 2001, BRIT J CANCER, V84, P116, DOI 10.1054/bjoc.2000.1530; Roemer K, 1999, BIOL CHEM, V380, P879, DOI 10.1515/BC.1999.108; Saeki Y, 1997, J MOL MED-JMM, V75, P50, DOI 10.1007/s001090050086; Shete S, 2002, AM J HUM GENET, V70, P813, DOI 10.1086/339370; Sigal A, 2000, CANCER RES, V60, P6788; STRONG LC, 1987, AM J PEDIAT HEMATOL, V9, P99; Sun XF, 1996, ONCOGENE, V13, P407; TOGUCHIDA J, 1992, NEW ENGL J MED, V326, P1301, DOI 10.1056/NEJM199205143262001; van Oijen MGCT, 2000, CLIN CANCER RES, V6, P2138; Varley JM, 1997, CANCER RES, V57, P3245; Wang LH, 1998, ANTICANCER RES, V18, P321	46	157	161	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2003	72	4					975	983		10.1086/374567	http://dx.doi.org/10.1086/374567			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662WT	12610779	Green Published, Bronze			2022-12-18	WOS:000181972600017
J	Rokman, A; Ikonen, T; Seppala, EH; Nupponen, N; Autio, V; Mononen, N; Bailey-Wilson, J; Trent, J; Carpten, J; Matikainen, MP; Koivisto, PA; Tammela, TLJ; Kallioniemi, OP; Schleutker, J				Rokman, A; Ikonen, T; Seppala, EH; Nupponen, N; Autio, V; Mononen, N; Bailey-Wilson, J; Trent, J; Carpten, J; Matikainen, MP; Koivisto, PA; Tammela, TLJ; Kallioniemi, OP; Schleutker, J			Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							2-5A-DEPENDENT RNASE; INTERFERON	The RNASEL gene (2',5'-oligoisoadenylate-synthetase dependent) encodes a ribonuclease that mediates the antiviral and apoptotic activities of interferons. The RNASEL gene maps to the hereditary-prostate-cancer (HPC)-predisposition locus at 1q24-q25 (HPC1) and was recently shown to harbor truncating mutations in two families with linkage to HPC1. Here, we screened for RNASEL germline mutations in 66 Finnish patients with HPC, and we determined the frequency of the changes in the index patients from 116 families with HPC, in 492 patients with unselected prostate cancer (PRCA), in 223 patients with benign prostatic hyperplasia (BPH), and in 566 controls. A truncating mutation, E265X, was found in 5 (4.3%) of the 116 patients from families with HPC. This was significantly higher (odds ratio [OR] = 4.56 P = .04) than the frequency of E265X in controls (1.8%). The highest mutation frequency (9.5%) was found in patients from families with four or more affected members. Possible segregation was detected only in a single family. However, the median age at disease onset for E265X carriers was 11 years less than that for noncarriers in the same families. In addition, of the four missense variants found, R462Q showed an association with HPC (OR = 1.96; P = .07). None of the variants showed any differences between controls and either patients with BPH or patients with PRCA. We conclude that, although RNASEL mutations do not explain disease segregation in Finnish families with HPC, the variants are enriched in families with HPC that include more than two affected members and may also be associated with the age at disease onset. This suggests a possible modifying role in cancer predisposition. The impact that the RNASEL sequence variants have on PRCA burden at the population level seems small but deserves further study.	Univ Tampere, Inst Med Technol, Canc Genet Lab, FIN-33014 Tampere, Finland; Univ Tampere, Tampere Sch Publ Hlth, FIN-33101 Tampere, Finland; Univ Tampere, Sch Med, Dept Urol, FIN-33101 Tampere, Finland; Tampere Univ Hosp, Tampere, Finland; NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; NIH, Ctr Inherited Dis Res, Baltimore, MD USA	Tampere University; Tampere University; Tampere University; Tampere University; Tampere University Hospital; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Rokman, A (corresponding author), Univ Tampere, Inst Med Technol, Canc Genet Lab, FIN-33014 Tampere, Finland.		Kallioniemi, Olli P/H-5111-2011	Kallioniemi, Olli P/0000-0002-3231-0332; Bailey-Wilson, Joan/0000-0002-9153-2920; Schleutker, Johanna/0000-0002-1863-0305	NHGRI NIH HHS [N01-HG-55389] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000107, N01HG055389] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Carpten J, 2002, NAT GENET, V30, P181, DOI 10.1038/ng823; Castelli J, 1998, BIOMED PHARMACOTHER, V52, P386, DOI 10.1016/S0753-3322(99)80006-7; *CYT SOFTW, 1999, STATX 4 VERS 4 0 1; Dong BH, 1999, NUCLEIC ACIDS RES, V27, P439, DOI 10.1093/nar/27.2.439; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; HASSEL BA, 1993, EMBO J, V12, P3297, DOI 10.1002/j.1460-2075.1993.tb05999.x; Ostrander EA, 2000, AM J HUM GENET, V67, P1367, DOI 10.1086/316916; Pentyala SN, 2000, MED ONCOL, V17, P85, DOI 10.1007/BF02796203; Rebbeck TR, 2000, AM J HUM GENET, V67, P1014, DOI 10.1086/303096; Rokman A, 2001, CANCER RES, V61, P6038; Schleutker J, 2000, CLIN CANCER RES, V6, P4810; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; *SPSS, 1999, SPSS 9 0 WIND; Suarez BK, 2001, CANCER RES, V61, P4982; Syvanen A C, 1998, Methods Mol Biol, V98, P291; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; Vesprini D, 2001, AM J HUM GENET, V68, P912, DOI 10.1086/319502; Wang L, 2001, CANCER RES, V61, P6494; Xu JF, 2000, AM J HUM GENET, V66, P945, DOI 10.1086/302807; Xu JF, 2001, AM J HUM GENET, V68, P901, DOI 10.1086/319513; ZHOU AM, 1993, CELL, V72, P753, DOI 10.1016/0092-8674(93)90403-D	21	157	164	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2002	70	5					1299	1304		10.1086/340450	http://dx.doi.org/10.1086/340450			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	541XT	11941539	Green Published, Bronze			2022-12-18	WOS:000175012400019
J	Ohno, K; Engel, AG; Shen, XM; Selcen, D; Brengman, J; Harper, CM; Tsujino, A; Milone, M				Ohno, K; Engel, AG; Shen, XM; Selcen, D; Brengman, J; Harper, CM; Tsujino, A; Milone, M			Rapsyn mutations in humans cause endplate acetylcholine-receptor deficiency and myasthenic syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AGONIST BINDING-AFFINITY; GENE-EXPRESSION; NEUROMUSCULAR-TRANSMISSION; M2 DOMAIN; PROTEIN; AGRIN; TRANSCRIPTS; CLUSTERS; IDENTIFICATION; LOCALIZATION	Congenital myasthenic syndromes (CMSs) stem from genetic defects in endplate (EP)-specific presynaptic, synaptic, and postsynaptic proteins. The postsynaptic CMSs identified to date stem from a deficiency or kinetic abnormality of the acetylcholine receptor (AChR). All CMSs with a kinetic abnormality of AChR, as well as many CMSs with a deficiency of AChR, have been traced to mutations in AChR-subunit genes. However, in a subset of patients with EP AChR deficiency, the genetic defect has remained elusive. Rapsyn, a 43-kDa postsynaptic protein, plays an essential role in the clustering of AChR at the EP. Seven tetratricopeptide repeats (TPRs) of rapsyn subserve self-association, a coiled-coil domain binds to AChR, and a RING-H2 domain associates with beta-dystroglycan and links rapsyn to the subsynaptic cytoskeleton. Rapsyn self-association precedes recruitment of AChR to rapsyn clusters. In four patients with EP AChR deficiency but with no mutations in AChR subunits, we identify three recessive rapsyn mutations: one patient carries L14P in TPR1 and N88K in TPR3; two are homozygous for N88K; and one carries N88K and 553ins5, which frameshifts in TPR5. EP studies in each case show decreased staining for rapsyn and AChR, as well as impaired postsynaptic morphological development. Expression studies in HEK cells indicate that none of the mutations hinders rapsyn self-association but that all three diminish coclustering of AChR with rapsyn.	Mayo Clin & Mayo Fdn, Dept Neurol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Neuromuscular Res Lab, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Engel, AG (corresponding author), Mayo Clin & Mayo Fdn, Dept Neurol, 200 1St St SW, Rochester, MN 55905 USA.	age@mayo.edu	Ohno, Kinji/H-4020-2012	Ohno, Kinji/0000-0002-1529-2750	NINDS NIH HHS [NS 6277, R01 NS006277] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS006277] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams ME, 2000, J CELL BIOL, V150, P1385, DOI 10.1083/jcb.150.6.1385; Altiok N, 1997, EMBO J, V16, P717, DOI 10.1093/emboj/16.4.717; APEL ED, 1995, NEURON, V15, P115, DOI 10.1016/0896-6273(95)90069-1; Apel ED, 1997, NEURON, V18, P623, DOI 10.1016/S0896-6273(00)80303-7; Bartoli M, 2001, J BIOL CHEM, V276, P24911, DOI 10.1074/jbc.M103258200; BARTOLI M, 2001, ABSTR SOC NEUR, V27; Belluardo N, 2001, MOL CELL NEUROSCI, V18, P56, DOI 10.1006/mcne.2001.1001; Buckel A, 1996, GENOMICS, V35, P613, DOI 10.1006/geno.1996.0409; Burgess RW, 1999, NEURON, V23, P33, DOI 10.1016/S0896-6273(00)80751-5; Burns AL, 1997, J NEUROSCI, V17, P5016; Cartaud A, 1998, J BIOL CHEM, V273, P11321, DOI 10.1074/jbc.273.18.11321; Donger C, 1998, AM J HUM GENET, V63, P967, DOI 10.1086/302059; ENGEL AG, 1993, ANN NY ACAD SCI, V681, P425, DOI 10.1111/j.1749-6632.1993.tb22927.x; ENGEL AG, 1993, MUSCLE NERVE, V16, P1284, DOI 10.1002/mus.880161204; ENGEL AG, 1977, NEUROLOGY, V27, P307, DOI 10.1212/WNL.27.4.307; ENGEL AG, 1994, MYOLOGY, P822; ENGEL AG, 1999, CONT NEUROL SERIES, V56, P251; FAMBROUGH DM, 1982, P NATL ACAD SCI-BIOL, V79, P1078, DOI 10.1073/pnas.79.4.1078; FRAIL DE, 1988, J BIOL CHEM, V263, P15602; FRAIL DE, 1987, P NATL ACAD SCI USA, V84, P6302, DOI 10.1073/pnas.84.17.6302; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; FROEHNER SC, 1989, FEBS LETT, V249, P229, DOI 10.1016/0014-5793(89)80629-5; FROEHNER SC, 1990, NEURON, V5, P403, DOI 10.1016/0896-6273(90)90079-U; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Gonzalez M, 1999, NEURON, V24, P567, DOI 10.1016/S0896-6273(00)81113-7; Grady RM, 1997, J CELL BIOL, V136, P871, DOI 10.1083/jcb.136.4.871; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LUTHER MA, 1989, J NEUROSCI, V9, P1082; MAIMONE MM, 1993, NEURON, V11, P53, DOI 10.1016/0896-6273(93)90270-2; Maimone MM, 1999, MOL CELL NEUROSCI, V14, P340, DOI 10.1006/mcne.1999.0779; MARTIN AR, 1994, P ROY SOC B-BIOL SCI, V258, P321, DOI 10.1098/rspb.1994.0180; Milone M, 1997, J NEUROSCI, V17, P5651; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Newey SE, 2001, MOL CELL NEUROSCI, V17, P127, DOI 10.1006/mcne.2000.0918; Ohno K, 1996, NEURON, V17, P157, DOI 10.1016/S0896-6273(00)80289-5; OHNO K, 1995, P NATL ACAD SCI USA, V92, P758, DOI 10.1073/pnas.92.3.758; Ohno K, 1997, HUM MOL GENET, V6, P753, DOI 10.1093/hmg/6.5.753; Ohno K, 1998, P NATL ACAD SCI USA, V95, P9654, DOI 10.1073/pnas.95.16.9654; Ohno K, 2001, P NATL ACAD SCI USA, V98, P2017, DOI 10.1073/pnas.98.4.2017; ONO F, 2001, ABSTR SOC NEUR, V27; PHILLIPS WD, 1991, SCIENCE, V251, P568, DOI 10.1126/science.1703661; Quiram PA, 1999, J CLIN INVEST, V104, P1403, DOI 10.1172/JCI8179; Ramarao MK, 2001, J BIOL CHEM, V276, P7475, DOI 10.1074/jbc.M009888200; Ramarao MK, 1998, P NATL ACAD SCI USA, V95, P4007, DOI 10.1073/pnas.95.7.4007; Ruff RL, 1996, MUSCLE NERVE, V19, P1084; Sandrock AW, 1997, SCIENCE, V276, P599, DOI 10.1126/science.276.5312.599; SCHOEPFER R, 1988, FEBS LETT, V226, P235, DOI 10.1016/0014-5793(88)81430-3; Si JT, 1996, J BIOL CHEM, V271, P19752, DOI 10.1074/jbc.271.33.19752; SINE SM, 1995, NEURON, V15, P229, DOI 10.1016/0896-6273(95)90080-2; Smith CL, 2001, J NEUROSCI, V21, P3151, DOI 10.1523/JNEUROSCI.21-09-03151.2001; TSENG CN, 2001, ABSTR SOC NEUR, V27; UCHITEL O, 1993, MUSCLE NERVE, V16, P1293, DOI 10.1002/mus.880161205; Wood SJ, 1997, J PHYSIOL-LONDON, V500, P165, DOI 10.1113/jphysiol.1997.sp022007	57	157	165	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2002	70	4					875	885		10.1086/339465	http://dx.doi.org/10.1086/339465			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	528PL	11791205	Bronze, Green Published			2022-12-18	WOS:000174252100005
J	Gretarsdottir, S; Sveinbjornsdottir, S; Jonsson, HH; Jakobsson, F; Einarsdottir, E; Agnarsson, U; Shkolny, D; Einarsson, G; Gudjonsdottir, HM; Valdimarsson, EM; Einarsson, OB; Thorgeirsson, G; Hadzic, R; Jonsdottir, S; Reynisdottir, ST; Bjarnadottir, SM; Gudmundsdottir, T; Gudlaugsdottir, GJ; Gill, R; Lindpaintner, K; Sainz, J; Hannesson, HH; Sigurdsson, GT; Frigge, ML; Kong, A; Gudnason, V; Stefansson, K; Gulcher, JR				Gretarsdottir, S; Sveinbjornsdottir, S; Jonsson, HH; Jakobsson, F; Einarsdottir, E; Agnarsson, U; Shkolny, D; Einarsson, G; Gudjonsdottir, HM; Valdimarsson, EM; Einarsson, OB; Thorgeirsson, G; Hadzic, R; Jonsdottir, S; Reynisdottir, ST; Bjarnadottir, SM; Gudmundsdottir, T; Gudlaugsdottir, GJ; Gill, R; Lindpaintner, K; Sainz, J; Hannesson, HH; Sigurdsson, GT; Frigge, ML; Kong, A; Gudnason, V; Stefansson, K; Gulcher, JR			Localization of a susceptibility gene for common forms of stroke to 5q12	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPOINT LINKAGE ANALYSIS; INDEPENDENT RISK FACTOR; CORONARY-ARTERY DISEASE; FAMILY HISTORY; PARENTAL HISTORY; COMPLEX TRAITS; ENCODING KRIT1; MUTATIONS; EPIDEMIOLOGY; HEMORRHAGE	Stroke is one of the most complex diseases, with several subtypes, as well as secondary risk factors, such as hypertension, hyperlipidemia, and diabetes, which, in turn, have genetic and environmental risk factors of their own. Here, we report the results of a genomewide search for susceptibility genes for the common forms of stroke. We cross-matched a population-based list of patients with stroke in Iceland with an extensive computerized genealogy database clustering 476 patients with stroke within 179 extended pedigrees. Linkage to 5q12 was detected, and the LOD score at this locus meets the criteria for genomewide significance (multipoint allele-sharing LOD score of 4.40, P = 3/9 x 10(-6)). A 20-cM region on 5q was physically and genetically mapped to obtain accurate marker order and intermarker distances. This locus on 5q12, which we have designated as "STRK1," does not correspond to known susceptibility loci for stroke or for its risk factors and represents the first mapping of a locus for common stroke.	deCODE Genet, IS-101 Reykjavik, Iceland; Natl Univ Hosp Reykjavik, Reykjavik, Iceland; Iceland Heart Assoc, Heart Prevent Clin, Reykjavik, Iceland; F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland	Landspitali National University Hospital; Icelandic Heart Association; Roche Holding	Stefansson, K (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	kstefans@decode.is; jgulcher@decode.is	Gudnason, Vilmundur/AAE-7126-2019; Einarsdottir, Elisabet/B-4912-2013; Stefansson, Kari/AAE-7187-2019; Gudnason, Vilmundur/K-6885-2015	Gudnason, Vilmundur/0000-0001-5696-0084; Gudnason, Vilmundur/0000-0001-5696-0084; Einarsdottir, Elisabet/0000-0003-3101-2285				ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Agnarsson U, 1999, ANN INTERN MED, V130, P987, DOI 10.7326/0003-4819-130-12-199906150-00006; BONITA R, 1992, LANCET, V339, P342, DOI 10.1016/0140-6736(92)91658-U; CAPLAN LR, 2000, CAPLANS STROKE CLIN, P1; Daw EW, 2000, GENET EPIDEMIOL, V19, P366, DOI 10.1002/1098-2272(200012)19:4<366::AID-GEPI8>3.0.CO;2-F; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Eliasson J H, 1999, Laeknabladid, V85, P517; FRIEDLANDER Y, 1985, BRIT HEART J, V53, P382; Giglio S, 2001, AM J HUM GENET, V68, P874, DOI 10.1086/319506; GRAFFAGNINO C, 1994, STROKE, V25, P1599, DOI 10.1161/01.STR.25.8.1599; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Gulcher J, 1998, CLIN CHEM LAB MED, V36, P523, DOI 10.1515/CCLM.1998.089; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; GUNEL M, 1995, P NATL ACAD SCI USA, V92, P6620, DOI 10.1073/pnas.92.14.6620; Halpern J, 1999, HUM HERED, V49, P194, DOI 10.1159/000022874; HODGE S E, 1984, Genetic Epidemiology, V1, P109, DOI 10.1002/gepi.1370010203; Jonsdottir GM, 2000, AM J HUM GENET, V67, P332; Jousilahti P, 1997, STROKE, V28, P1361, DOI 10.1161/01.STR.28.7.1361; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; KIELY DK, 1993, STROKE, V24, P1366, DOI 10.1161/01.STR.24.9.1366; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Laberge-le Couteulx S, 1999, NAT GENET, V23, P189, DOI 10.1038/13815; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; Liao DP, 1997, STROKE, V28, P1908, DOI 10.1161/01.STR.28.10.1908; LINDENSTROM E, 1993, NEUROEPIDEMIOLOGY, V12, P37, DOI 10.1159/000110297; MOHR JP, 1978, NEUROLOGY, V28, P754, DOI 10.1212/WNL.28.8.754; MYERS RH, 1990, AM HEART J, V120, P963, DOI 10.1016/0002-8703(90)90216-K; NICOLAE DL, 1999, THESIS U CHICAGO CHI, P126; PALSDOTTIR A, 1988, LANCET, V2, P603; Palsson B, 1999, GENOME RES, V9, P1002, DOI 10.1101/gr.9.10.1002; RISCH N, 1990, AM J HUM GENET, V46, P229; Sahoo T, 1999, HUM MOL GENET, V8, P2325, DOI 10.1093/hmg/8.12.2325; SHEA S, 1984, J AM COLL CARDIOL, V4, P793, DOI 10.1016/S0735-1097(84)80408-8; SVEINBJORNSDOTT.S, 1997, LAEKNABLAOIO S, V36, P54; Thompson DW, 1997, NEUROSURG CLIN N AM, V8, P265; THOMPSON EA, 1987, IMA J MATH APPL MED, V4, P93; TOURNIERLASSERVE E, 1993, NAT GENET, V3, P256, DOI 10.1038/ng0393-256; Valdimarsson E M, 1998, Laeknabladid, V84, P921; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185	44	157	175	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2002	70	3					593	603		10.1086/339252	http://dx.doi.org/10.1086/339252			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	522DG	11833004	Green Published, Bronze			2022-12-18	WOS:000173880000004
J	Helgason, A; Hickey, E; Goodacre, S; Bosnes, V; Stefansson, K; Ward, R; Sykes, B				Helgason, A; Hickey, E; Goodacre, S; Bosnes, V; Stefansson, K; Ward, R; Sykes, B			mtDNA and the islands of the north atlantic: Estimating the proportions of Norse and Gaelic ancestry	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA SEQUENCES; CONTROL-REGION SEQUENCES; D-LOOP; EUROPEAN POPULATIONS; GENETIC DIVERSITY; LINEAGES; ORIGIN; ICELANDERS; BOTTLENECK; ADMIXTURE	A total of 1,664 new mtDNA control-region sequences were analyzed in order to estimate Gaelic and Scandinavian matrilineal ancestry in the populations of Iceland, Orkney, the Western Isles, and the Isle of Skye and to investigate other aspects of their genetic history. A relative excess of private lineages in the Icelanders is indicative of isolation, whereas the scarcity of private lineages in Scottish island populations may be explained by recent gene flow and population decline. Differences in the frequencies of lineage clusters are observed between the Scandinavian and the Gaelic source mtDNA pools, and, on a continent-wide basis, such differences between populations seem to be associated with geography. A multidimensional scaling analysis of genetic distances, based on mtDNA lineage-cluster frequencies, groups the North Atlantic islanders with the Gaelic and the Scandinavian populations, whereas populations from the central, southern, and Baltic regions of Europe are arranged in clusters in broad agreement with their geographic locations. This pattern is highly significant, according to a Mantel correlation between genetic and geographic distances (r = .716). Admixture analyses indicate that the ancestral contributions of mtDNA lineages from Scandinavia to the populations of Iceland, Orkney, the Western Isles, and the Isle of Skye are 37.5%, 35.5%, 11.5%, and 12.5%, respectively.	deCODE Genet, IS-101 Reykjavik, Iceland; Univ Oxford, Inst Biol Anthropol, Oxford OX1 2JD, England; Univ Oxford, Inst Mol Med, Oxford OX1 2JD, England; Ulleval Hosp, Dept Immunol & Transfus Med, Oslo, Norway	University of Oxford; University of Oxford; University of Oslo	Helgason, A (corresponding author), deCODE Genet, Lynghals 1, IS-101 Reykjavik, Iceland.		Stefansson, Kari/AAE-7187-2019; Helgason, Agnar/K-1522-2015	Helgason, Agnar/0000-0002-8545-3767; Goodacre, Sara L./0000-0002-0887-6563				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BERRY RJ, 1975, J BIOSOC SCI, V7, P319, DOI 10.1017/S0021932000010191; BERTRANPETIT J, 1995, ANN HUM GENET, V59, P63, DOI 10.1111/j.1469-1809.1995.tb01606.x; BJARNASO.O, 1973, ANN HUM GENET, V36, P425, DOI 10.1111/j.1469-1809.1973.tb00606.x; Bodmer JG, 1996, HUM IMMUNOL, V47, pO265; BOYCE AJ, 1973, GENETIC VARIATION BR; Calafell F, 1996, ANN HUM GENET, V60, P35, DOI 10.1111/j.1469-1809.1996.tb01170.x; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; CLEGG EJ, 1985, ANN HUM BIOL, V12, P345, DOI 10.1080/03014468500007881; CLOVER CJ, 1988, SCAND STUD, V60, P147; Collins R., 1991, EARLY MEDIEV EUR; Comas D, 1996, MOL BIOL EVOL, V13, P1067, DOI 10.1093/oxfordjournals.molbev.a025669; CORRAIN DO, 1999, OXFORD ILLUSTRATED H, P83; CorteReal HBSM, 1996, ANN HUM GENET, V60, P331, DOI 10.1111/j.1469-1809.1996.tb01196.x; Davies Norman, 1999, ISLES HIST; Delghandi M, 1998, HUM HERED, V48, P108, DOI 10.1159/000022789; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; EXCOFFIER L, 1992, GENETICS, V131, P479; Forster P, 1996, AM J HUM GENET, V59, P935; Francalacci P, 1996, AM J PHYS ANTHROPOL, V100, P443, DOI 10.1002/(SICI)1096-8644(199608)100:4<443::AID-AJPA1>3.0.CO;2-S; Graham-Campbell James, 1998, VIKINGS SCOTLAND ARC; Handt O, 1998, NUCLEIC ACIDS RES, V26, P126, DOI 10.1093/nar/26.1.126; HANDT O, 1994, SCIENCE, V264, P1775, DOI 10.1126/science.8209259; Helgason A, 2000, AM J HUM GENET, V67, P697, DOI 10.1086/303046; Helgason A, 2000, AM J HUM GENET, V66, P999, DOI 10.1086/302816; HELGASON A, 2000, ARCHAEOGENETICS DNA; Hofmann S, 1997, HUM MOL GENET, V6, P1835, DOI 10.1093/hmg/6.11.1835; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Johannesson Jon, 1956, ISLENDINGA SAGA; Jones Gwyn, 1984, HIST VIKINGS; Karras R. M., 1988, SLAVERY SOC MEDIEVAL; KEYNES S, 1999, OXFORD ILLUSTRATED H, P48; Kittles RA, 1999, AM J PHYS ANTHROPOL, V108, P381, DOI 10.1002/(SICI)1096-8644(199904)108:4<381::AID-AJPA1>3.0.CO;2-5; Lutz S, 1999, INT J LEGAL MED, V112, P145; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; MAGNUSSON SA, 1977, NO SPHINX; MILLER KWP, 1996, MOL GENETIC ANAL HUM; Opdal SH, 1998, ACTA PAEDIATR, V87, P1039, DOI 10.1080/080352598750031347; Orekhov V, 1999, FEBS LETT, V445, P197, DOI 10.1016/S0014-5793(99)00115-5; Parson W, 1998, INT J LEGAL MED, V111, P124, DOI 10.1007/s004140050132; Pfeiffer H, 1999, INT J LEGAL MED, V112, P291, DOI 10.1007/s004140050252; PIERCY R, 1993, INT J LEGAL MED, V106, P85, DOI 10.1007/BF01225046; Pinto F, 1996, ANN HUM GENET, V60, P321, DOI 10.1111/j.1469-1809.1996.tb01195.x; PULT I, 1994, BIOL CHEM H-S, V375, P837; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; RAFNSON S, 1999, OXFORD ILLUSTRATED H; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 1996, AM J HUM GENET, V59, P185; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; ROBERTS DF, 1985, MAN, V20, P131, DOI 10.2307/2802225; ROBERTS DF, 1990, ANN HUM BIOL, V17, P121, DOI 10.1080/03014469000000872; Rousselet F, 1998, INT J LEGAL MED, V111, P292, DOI 10.1007/s004140050174; SAJANTILA A, 1995, GENOME RES, V5, P42, DOI 10.1101/gr.5.1.42; Sajantila A, 1996, P NATL ACAD SCI USA, V93, P12035, DOI 10.1073/pnas.93.21.12035; Salas A, 1998, EUR J HUM GENET, V6, P365, DOI 10.1038/sj.ejhg.5200202; SAWYER P, 1999, OXFORD ILLUSTRATED H; Schneider S, 1997, ARLEQUIN 1 1 SOFTWAR; Sigurethsson G., 1988, GAELIC INFLUENCE ICE; Simoni L, 2000, AM J HUM GENET, V66, P1177, DOI 10.1086/302790; Simoni L, 2000, AM J HUM GENET, V66, P262, DOI 10.1086/302706; STEFFENSON J, 1975, MENNING MEINSEMDIR R; Stenico M, 1996, AM J HUM GENET, V59, P1363; THOMPSON EA, 1973, ANN HUM GENET, V37, P69, DOI 10.1111/j.1469-1809.1973.tb01815.x; Torroni A, 2000, AM J HUM GENET, V66, P1173, DOI 10.1086/302789; WIJSMAN EM, 1984, HUM GENET, V67, P441, DOI 10.1007/BF00291407	66	157	162	1	15	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2001	68	3					723	737		10.1086/318785	http://dx.doi.org/10.1086/318785			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	402ND	11179019	Green Published, Bronze			2022-12-18	WOS:000166994200016
J	Baulac, S; Gourfinkel-An, I; Picard, F; Rosenberg-Bourgin, M; Prud'homme, JF; Baulac, M; Brice, A; LeGuern, E				Baulac, S; Gourfinkel-An, I; Picard, F; Rosenberg-Bourgin, M; Prud'homme, JF; Baulac, M; Brice, A; LeGuern, E			A second locus for familial generalized epilepsy with febrile seizures plus maps to chromosome 2q21-q33	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SODIUM-CHANNEL GENE; POLYMERASE CHAIN-REACTION; HUMAN BRAIN; LINKAGE ANALYSIS; LOBE EPILEPSY; CONVULSIONS; MUTATION; SUBUNIT	We report a clinical and genetic study of a family with a phenotype resembling generalized epilepsy with febrile seizures plus (GEFS+), described by Berkovic and colleagues. Patients express a very variable phenotype combining febrile seizures, generalized seizures often precipitated by fever at age >6 years, and partial seizures, with a variable degree of severity. Linkage analysis has excluded both the beta 1 subunit gene (SCN1B) of a voltage-gated sodium (Na+) channel responsible for GEFS(+) and the two loci, FEB1 and FEB2, previously implicated in febrile seizures. A genomewide search, under the assumption of incomplete penetrance at 85% and a phenocopy rate of 5%, permitted identification of a new locus on chromosome 2q21-q33. The maximum pairwise LOD score was 3.00 at recombination fraction 0 for marker D2S2330. Haplotype reconstruction defined a large (22-cM) candidate interval flanked by markers D2S156 and D2S2314. Four genes coding for different isoforms of the cu-subunit voltage-gated sodium channels (SCN1A, SCN2A1, SCN2A2, and SCN3A) located in this region are strong candidates for the disease gene.	Hop La Pitie Salpetriere, INSERM, U289, F-75651 Paris 13, France; Hop La Pitie Salpetriere, Ctr Epilepsie, Paris, France; Hop La Pitie Salpetriere, Federat Neurol, Paris, France; Univ Paris 07, INSERM, U155, Paris, France; INSERM, U398, Strasbourg, France; Hop Cantonal Univ Geneva, Dept Neurol, Geneva, Switzerland; Genethon, Evry, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Geneva	LeGuern, E (corresponding author), Hop La Pitie Salpetriere, INSERM, U289, 47 Blvd Hop, F-75651 Paris 13, France.	leguern@ccr.jussieu.fr	Brice, Alexis/A-2170-2009; brice, alexis/AAE-8275-2019; Baulac, Stéphanie/O-2099-2016	brice, alexis/0000-0002-0941-3990; Baulac, Stéphanie/0000-0001-6430-4693				AULD VJ, 1988, NEURON, V1, P449, DOI 10.1016/0896-6273(88)90176-6; CENDES F, 1995, NEUROLOGY, V45, P2058, DOI 10.1212/WNL.45.11.2058; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HAN J, 1991, P NATL ACAD SCI USA, V88, P335, DOI 10.1073/pnas.88.2.335; HAUSER WA, 1985, NEUROLOGY, V35, P1268, DOI 10.1212/WNL.35.9.1268; Hille B., 1992, IONIC CHANNELS EXCIT; Johnson D, 1998, FUTURIST, V32, P7; Johnson WG, 1996, AM J MED GENET, V61, P345; Kugler SL, 1998, AM J MED GENET, V79, P354, DOI 10.1002/(SICI)1096-8628(19981012)79:5<354::AID-AJMG5>3.0.CO;2-J; LOPESCENDES I, 1995, EPILEPSIA S5, V37, P127; LU CM, 1992, FEBS LETT, V303, P53, DOI 10.1016/0014-5793(92)80476-W; Maher J, 1995, BRAIN, V118, P1521, DOI 10.1093/brain/118.6.1521; MALO MS, 1994, P NATL ACAD SCI USA, V91, P2975, DOI 10.1073/pnas.91.8.2975; MALO MS, 1994, CYTOGENET CELL GENET, V67, P178, DOI 10.1159/000133818; RICH SS, 1987, AM J HUM GENET, V41, P249; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Scheffer IE, 1997, BRAIN, V120, P479, DOI 10.1093/brain/120.3.479; Schuster H, 1998, NEPHROL DIAL TRANSPL, V13, P1337, DOI 10.1093/ndt/13.6.1337; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Singh R, 1999, ANN NEUROL, V45, P75, DOI 10.1002/1531-8249(199901)45:1<75::AID-ART13>3.0.CO;2-W; STEINLEIN OK, 1995, NAT GENET, V11, P201, DOI 10.1038/ng1095-201; THOMPSON EA, 1987, IMA J MATH APPL MED, V4, P93; TSUBOI T, 1991, EPILEPSY RES, P119; VERITY CM, 1985, BRIT MED J, V290, P1307, DOI 10.1136/bmj.290.6478.1307; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252; Wallace RH, 1996, J MED GENET, V33, P308, DOI 10.1136/jmg.33.4.308; WEISSENBACH J, 1993, GENE, V135, P275, DOI 10.1016/0378-1119(93)90077-G	29	157	180	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1999	65	4					1078	1085		10.1086/302593	http://dx.doi.org/10.1086/302593			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	241XW	10486327	Green Published, Bronze			2022-12-18	WOS:000082910000017
J	Mehenni, H; Gehrig, C; Nezu, J; Oku, A; Shimane, M; Rossier, C; Guex, N; Blouin, JL; Scott, HS; Antonarakis, SE				Mehenni, H; Gehrig, C; Nezu, J; Oku, A; Shimane, M; Rossier, C; Guex, N; Blouin, JL; Scott, HS; Antonarakis, SE			Loss of LKB1 kinase activity in Peutz-Jeghers syndrome, and evidence for allelic and locus heterogeneity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GIANT PROTEIN-KINASES; DOMAIN; MUTATIONS; CANCER; PROTOONCOGENE; GERMLINE; GENE; 19P	Peutz-Jeghers syndrome (PJS) is an autosomal dominant disease characterized by mucocutaneous pigmentation and hamartomatous polyps. There is an increased risk of benign and malignant tumors in the gastrointestinal tract and in extraintestinal tissues. One PJS locus has been mapped to chromosome 19p13.33 a second locus is suspected on chromosome 19q13.4 in a minority of families. The PJS gene on 19p13.3 has recently been cloned, and it encodes the serine/threonine kinase LKB1. The gene, which is ubiquitously expressed, is composed of 10 exons spanning 23 kb. Several LKB1 mutations have been reported in heterozygosity in PJS patients. In this study, we screened for LKB1 mutations in nine PJS families of American, Spanish, Portuguese, French, Turkish, and Indian origin and detected seven novel mutations. These included two frameshift mutations, one four-amino-acid deletion, two amino-acid substitutions, and two splicing errors. Expression of mutant LKB1 proteins (K78I, D17GN, W308C, and L67P) and assessment of their autophosphorylation activity revealed a loss of the kinase activity in all of these mutants. These results provide direct evidence that the elimination of the kinase activity of LKB1 is probably responsible for the development of the PJS phenotypes. In two Indian families, we failed to detect any LKB1 mutation; in one of these families, we previously had detected linkage to markers on 19q13.3-4, which suggests locus heterogeneity of PJS. The elucidation of the molecular etiology of PJS and the positional cloning of the second potential PJS gene will further elucidate the involvement of kinases/phosphatases in the development of cancer-psedisposing syndromes.	Univ Geneva, Sch Med, Div Med Genet, CH-1211 Geneva 4, Switzerland; Glaxo Wellcome Expt Res, Geneva, Switzerland; Cantonal Hosp Geneva, Geneva, Switzerland; Chugai Res Inst Mol Med, Tokyo, Japan	University of Geneva; GlaxoSmithKline; University of Geneva	Antonarakis, SE (corresponding author), Ctr Med Univ Geneva, Div Genet Med, 1 Rue Michel Servet, CH-1211 Geneva, Switzerland.		Scott, Hamish/B-2122-2009; Antonarakis, Stylianos E/N-8866-2014	Scott, Hamish/0000-0002-5813-631X; Antonarakis, Stylianos E/0000-0001-8907-5823; GUEX, Nicolas/0000-0001-6023-0519				Amos CI, 1997, CANCER RES, V57, P3653; Avizienyte E, 1998, CANCER RES, V58, P2087; Bignell GR, 1998, CANCER RES, V58, P1384; BLUNDELL TL, 1987, NATURE, V326, P347, DOI 10.1038/326347a0; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Cooper DN, 1995, METABOLIC MOL BASES, P259; Eng C, 1997, HUM MUTAT, V9, P97, DOI 10.1002/(SICI)1098-1004(1997)9:2<97::AID-HUMU1>3.3.CO;2-Q; GIARDIELLO FM, 1987, NEW ENGL J MED, V316, P1511, DOI 10.1056/NEJM198706113162404; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Heierhorst J, 1996, NATURE, V380, P636, DOI 10.1038/380636a0; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hemminki A, 1997, NAT GENET, V15, P87, DOI 10.1038/ng0197-87; JEGHERS H, 1949, NEW ENGL J MED, V241, P992; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Kinzler KW, 1998, SCIENCE, V280, P1036, DOI 10.1126/science.280.5366.1036; Kobe B, 1996, EMBO J, V15, P6810, DOI 10.1002/j.1460-2075.1996.tb01072.x; Lawrie AM, 1997, NAT STRUCT BIOL, V4, P796, DOI 10.1038/nsb1097-796; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Mehenni H, 1997, AM J HUM GENET, V61, P1327, DOI 10.1086/301644; Nakagawa H, 1998, HUM GENET, V102, P203, DOI 10.1007/s004390050678; Olschwang S, 1998, J MED GENET, V35, P42, DOI 10.1136/jmg.35.1.42; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.biochem.55.1.1119; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; Peutz JL, 1921, NEDERL MAANDSCHR GEN, V10, P134; PONDER JW, 1987, J MOL BIOL, V193, P775, DOI 10.1016/0022-2836(87)90358-5; Schmidt L, 1997, NAT GENET, V16, P68, DOI 10.1038/ng0597-68; SPIGELMAN AD, 1989, GUT, V30, P1588, DOI 10.1136/gut.30.11.1588; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Su JY, 1996, J BIOL CHEM, V271, P14430, DOI 10.1074/jbc.271.24.14430; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005; Zuo L, 1996, NAT GENET, V12, P97, DOI 10.1038/ng0196-97	32	157	166	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1998	63	6					1641	1650		10.1086/302159	http://dx.doi.org/10.1086/302159			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EL	9837816	Green Published, Bronze			2022-12-18	WOS:000077707700009
J	Mulcahy, B; WaldronLynch, F; McDermott, MF; Adams, C; Amos, CI; Zhu, DK; Ward, RH; Clegg, DO; Shanahan, F; Molloy, MG; OGara, F				Mulcahy, B; WaldronLynch, F; McDermott, MF; Adams, C; Amos, CI; Zhu, DK; Ward, RH; Clegg, DO; Shanahan, F; Molloy, MG; OGara, F			Genetic variability in the tumor necrosis factor-lymphotoxin region influences susceptibility to rheumatoid arthritis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SHARED-EPITOPE HYPOTHESIS; MAJOR HISTOCOMPATIBILITY COMPLEX; DEPENDENT DIABETES-MELLITUS; FACTOR-ALPHA; CEREBRAL MALARIA; HLA COMPONENT; TNF-ALPHA; ASSOCIATION; LOCUS; BETA	The major histocompatibility complex class III tumor necrosis factor-lymphotoxin (TNF-LT) region (6p21.3) was investigated as a possible susceptibility locus for rheumatoid arthritis (RA). Inheritance of five TNF microsatellite markers was determined in 50 multiplex families. Overall, 47 different haplotypes were observed. One of these, the TNF a6, b5, cl, d3, e3 (H1) haplotype, was present in 35.3% of affected, but in only 20.5% of unaffected, individuals (P < .005). This haplotype accounted for 21.5% of the parental haplotypes transmitted to affected offspring and only 7.3% not transmitted to affected offspring (P = .0003). The TNF a6 and TNF cl alleles were individually associated with RA (P = .0005 and .0008, respectively), as were the HLA-DRB1 ''shared epitope'' (SE) (P = .0001) and HLA-DRB1*0401 (P = .0018). Both univariate and bivariate conditional logistic regression analysis showed significant effects of TNF cl and SE in increasing risk to RA (P < .001). Stratification by the presence of SE indicated an independent effect of the TNFc1 allele (P = .0003) and the HLA A1, B8, DR3 extended haplotype (always TNFa2, b3, cl, dl, e3) (P = .0027) in SE heterozygotes, while the H1 haplotype was associated with RA in SE homozygotes (P = .0018). The TNF-LT region appears to influence susceptibility to RA, distinct from HLA-DR.	NATL UNIV IRELAND UNIV COLL CORK,DEPT MICROBIOL,CORK,IRELAND; CORK UNIV HOSP,DEPT MED & RHEUMATOL,CORK,IRELAND; ROYAL LONDON HOSP,MED UNIT,LONDON E1 1BB,ENGLAND; UNIV TEXAS,MD ANDERSON CANC CTR,DEPT EPIDEMIOL,HOUSTON,TX; UNIV UTAH,DEPT MED,SALT LAKE CITY,UT 84112; UNIV OXFORD,INST BIOL ANTHROPOL,OXFORD,ENGLAND	University College Cork; University College Cork; Barts Health NHS Trust; Royal London Hospital; University of Texas System; UTMD Anderson Cancer Center; Utah System of Higher Education; University of Utah; University of Oxford			Shanahan, Fergus/ABF-2390-2020; McDermott, Michael/S-8490-2019; McDermott, Michael Francis/GZM-5330-2022	Shanahan, Fergus/0000-0003-0467-0936; McDermott, Michael/0000-0002-1015-0745; O'Gara, Fergal/0000-0002-2659-0673	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040057] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR40057] Funding Source: Medline; PHS HHS [R01G52607] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALBANI S, 1995, NAT MED, V1, P448, DOI 10.1038/nm0595-448; ARNETT FC, 1993, ARTHRITIS RHEUM, V36, P1681; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; BOKI KA, 1992, ARTHRITIS RHEUM, V35, P749, DOI 10.1002/art.1780350706; BRENNAN FM, 1992, BRIT J RHEUMATOL, V31, P293; DIZIER MH, 1993, AM J HUM GENET, V53, P715; ELLIOTT MJ, 1993, ARTHRITIS RHEUM, V36, P1681, DOI 10.1002/art.23362; FELSON DT, 1992, ARTHRITIS ALLIED CON, P17; FESTENSTEIN H, 1986, NATURE, V322, P64, DOI 10.1038/322064a0; GRAU GE, 1987, SCIENCE, V237, P1210, DOI 10.1126/science.3306918; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; GRIFFITHS RJ, 1995, P NATL ACAD SCI USA, V92, P517, DOI 10.1073/pnas.92.2.517; HARRIS ED, 1990, NEW ENGL J MED, V322, P1277, DOI 10.1056/nejm199005033221805; HASSTEDT SJ, 1994, AM J HUM GENET, V55, P738; JACOB CO, 1988, NATURE, V331, P356, DOI 10.1038/331356a0; JACOB CO, 1990, P NATL ACAD SCI USA, V87, P1233, DOI 10.1073/pnas.87.3.1233; JAWAHEER D, 1993, EUR J IMMUNOGENET, V20, P175, DOI 10.1111/j.1744-313X.1993.tb00108.x; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; KENDALL E, 1990, NUCLEIC ACIDS RES, V18, P7251, DOI 10.1093/nar/18.24.7251; KENNEDY GC, 1995, NAT GENET, V9, P293, DOI 10.1038/ng0395-293; LUCASSEN AM, 1995, HUM MOL GENET, V4, P501, DOI 10.1093/hmg/4.4.501; MCDERMOTT M, 1986, DIS MARKERS, V4, P103; MCDERMOTT M, 1995, ARTHRITIS RHEUM, V38, P91, DOI 10.1002/art.1780380114; MCGUIRE W, 1994, NATURE, V371, P508, DOI 10.1038/371508a0; MOXLEY G, 1992, ARTHRITIS RHEUM, V35, P19, DOI 10.1002/art.1780350104; PLATERZYBERK C, 1995, NAT MED, V1, P781, DOI 10.1038/nm0895-781; Plevy SE, 1996, GASTROENTEROLOGY, V110, P1053, DOI 10.1053/gast.1996.v110.pm8612993; POCIOT F, 1993, EUR J IMMUNOL, V23, P224, DOI 10.1002/eji.1830230135; PUJOLBORRELL R, 1987, NATURE, V326, P304, DOI 10.1038/326304a0; RAINE CS, 1995, NAT MED, V1, P211, DOI 10.1038/nm0395-211; RIGBY AS, 1991, GENET EPIDEMIOL, V8, P153, DOI 10.1002/gepi.1370080303; SAKKAS LI, 1987, J IMMUNOGENET, V14, P189; SAKLATVALA J, 1986, NATURE, V322, P547, DOI 10.1038/322547a0; Sambrook J, 1989, MOL CLONING LAB MANU; SANTAMARIA P, 1989, J IMMUNOL, V143, P913; *SAS I, 1995, LOG REGR EX US SAS S, P119; SELMAJ K, 1991, J IMMUNOL, V147, P1522; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; SPIES T, 1986, P NATL ACAD SCI USA, V83, P8699, DOI 10.1073/pnas.83.22.8699; STASTNY P, 1978, NEW ENGL J MED, V298, P869, DOI 10.1056/NEJM197804202981602; TERASAKI PI, 1964, NATURE, V204, P998, DOI 10.1038/204998b0; THOMSEN M, 1988, IMMUNOGENETICS, V28, P320, DOI 10.1007/BF00364230; UDALOVA IA, 1993, GENOMICS, V16, P180, DOI 10.1006/geno.1993.1156; WEBB GC, 1990, J IMMUNOL, V145, P1278; WEYAND CM, 1992, ANN INTERN MED, V117, P801, DOI 10.7326/0003-4819-117-10-801; WHITE AA, 1982, INT STAT REV, V50, P27, DOI 10.2307/1402457; WILSON AG, 1993, J EXP MED, V23, P3043; WINCHESTER R, 1992, RHEUM DIS CLIN N AM, V18, P761; WORTHINGTON J, 1994, BRIT J RHEUMATOL, V33, P970; YANG SY, 1989, IMMUNOLOGY HLA, P11; ZHENG LX, 1995, NATURE, V377, P348, DOI 10.1038/377348a0	51	157	161	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1996	59	3					676	683						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN625	8751869				2022-12-18	WOS:A1996VN62500022
J	Walkup, JT; LaBuda, MC; Singer, HS; Brown, J; Riddle, MA; Hurko, O				Walkup, JT; LaBuda, MC; Singer, HS; Brown, J; Riddle, MA; Hurko, O			Family study and segregation analysis of Tourette syndrome: Evidence for a mixed model of inheritance	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTOSOMAL-DOMINANT TRANSMISSION; OBSESSIVE-COMPULSIVE DISORDER; VALIDITY; EXPRESSION; CHILDREN; HISTORY; SCALE; TWINS; GENE	To investigate the transmission of Tourette syndrome (TS) and associated disorders within families, complex segregation analysis was performed on family study data obtained from 53 independently ascertained children and adolescents with TS and their 154 first-degree relatives. The results suggest that the susceptibility for TS is conveyed by a major locus in combination with a multifactorial background. Other models of inheritance were definitively rejected, including strictly polygenic models, all single major locus models, and mixed models with dominant and recessive major loci. The frequency of the TS susceptibility allele was estimated to be .01. The major locus accounts for over half of the phenotypic variance for TSI whereas the multifactorial background accounts for similar to 40% of phenotypic variance. Penetrance estimates suggest that all individuals homozygous for the susceptibility allele at the major locus are affected, whereas only 2.2% of males and 0.3% of females heterozygous at the major locus are affected. Of individuals affected with TS, similar to 62% are heterozygous and similar to 38% are homozygous at the major locus. While none of the families had two parents affected with TS, 19% of families had two parents affected with the broader TS phenotype, which includes TS, chronic tic disorder, or obsessive-compulsive disorder.	JOHNS HOPKINS MED INST,DEPT PSYCHIAT & BEHAV SCI,DIV CHILD & ADOLESCENT PSYCHIAT,BALTIMORE,MD 21205; JOHNS HOPKINS MED INST,DIV PEDIAT NEUROL,BALTIMORE,MD 21205; JOHNS HOPKINS MED INST,DEPT NEUROL,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine					NATIONAL INSTITUTE OF MENTAL HEALTH [K20MH001059] Funding Source: NIH RePORTER; NIMH NIH HHS [K20 MH01059] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ACHENBACH TM, 1991, MANUAL CHILD BEHAVIO; ALLEN AJ, 1995, J AM ACAD CHILD PSY, V34, P307, DOI 10.1097/00004583-199503000-00015; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; APTER A, 1993, ARCH GEN PSYCHIAT, V50, P734; BAILEY JN, 1993, GENET EPIDEMIOL, V10, P332; BARON M, 1981, AM J HUM GENET, V33, P767; BERG CJ, 1986, J AM ACAD CHILD PSY, V25, P84, DOI 10.1016/S0002-7138(09)60602-6; BURD L, 1986, J AM ACAD CHILD PSY, V25, P552, DOI 10.1016/S0002-7138(10)60016-7; CAINE ED, 1988, NEUROLOGY, V38, P472, DOI 10.1212/WNL.38.3.472; Comings D E, 1995, Adv Neurol, V65, P293; COMINGS DE, 1984, AM J HUM GENET, V36, P586; Cooper J, 1970, Psychol Med, V1, P48; CURTIS D, 1992, BRIT J PSYCHIAT, V160, P845, DOI 10.1192/bjp.160.6.845; DEVOR EJ, 1984, AM J HUM GENET, V36, P704; EAPEN V, 1993, BRIT J PSYCHIAT, V162, P593, DOI 10.1192/bjp.162.5.593; FLAMENT MF, 1988, J AM ACAD CHILD PSY, V27, P764, DOI 10.1097/00004583-198811000-00018; FRANKEL M, 1986, NEUROLOGY, V36, P378, DOI 10.1212/WNL.36.3.378; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1012; HASSTEDT SJ, 1995, AM J HUM GENET, V57, P682; HASSTEDT SJ, 1995, GENET EPIDEMIOL, V12, P109, DOI 10.1002/gepi.1370120202; HEUTINK P, 1993, HDB TOURETTES SYNDRO, P317; HODGSON RJ, 1977, BEHAV RES THER, V15, P389, DOI 10.1016/0005-7967(77)90042-0; HYDE TM, 1992, NEUROLOGY, V42, P652, DOI 10.1212/WNL.42.3.652; Kidd K K, 1982, Adv Neurol, V35, P243; KURLAN R, 1994, NEUROLOGY, V44, P2336, DOI 10.1212/WNL.44.12.2336; LABUDA MC, 1993, MOL BASIS NEUROLOGY, P199; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; LECKMAN JF, 1987, ARCH GEN PSYCHIAT, V44, P100; LECKMAN JF, 1990, J AM ACAD CHILD PSY, V29, P220, DOI 10.1097/00004583-199003000-00010; Lombroso P J, 1995, Adv Neurol, V65, P305; Morton N. E., 1982, OUTLINE GENETIC EPID; Pato M., 1994, CURRENT INSIGHTS OBS, P77; PAULS DL, 1991, AM J HUM GENET, V48, P154; PAULS DL, 1993, J AM ACAD CHILD PSY, V32, P1044, DOI 10.1097/00004583-199309000-00025; PAULS DL, 1992, ADV NEUROL, V58, P151; PAULS DL, 1986, NEW ENGL J MED, V315, P993, DOI 10.1056/NEJM198610163151604; PAULS DL, 1994, BRIT J PSYCHIAT, V164, P215, DOI 10.1192/bjp.164.2.215; PAULS DL, 1990, J AM ACAD CHILD PSY, V29, P195, DOI 10.1097/00004583-199003000-00007; PAULS DL, 1987, SCHEDULE TOURETTE OT; PRICE RA, 1986, NEUROLOGY, V36, P232, DOI 10.1212/WNL.36.2.232; PRICE RA, 1988, PSYCHIAT RES, V24, P251; Puig-Antich J., 1980, SCHEDULE AFFECTIVE D; RASMUSSEN SA, 1986, AM J PSYCHIAT, V143, P317; ROBINS LN, 1981, ARCH GEN PSYCHIAT, V38, P381; SINGER HS, 1991, MEDICINE, V70, P15, DOI 10.1097/00005792-199101000-00002; Thompson EA, 1986, PEDIGREE ANAL HUMAN; WALKUP JT, 1992, J AM ACAD CHILD PSY, V31, P472, DOI 10.1097/00004583-199205000-00013; 1993, ARCH NEUROL-CHICAGO, V50, P1013	49	157	163	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1996	59	3					684	693						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	VN625	8751870				2022-12-18	WOS:A1996VN62500023
J	SEBASTIO, G; SPERANDEO, MP; PANICO, M; DEFRANCHIS, R; KRAUS, JP; ANDRIA, G				SEBASTIO, G; SPERANDEO, MP; PANICO, M; DEFRANCHIS, R; KRAUS, JP; ANDRIA, G			THE MOLECULAR-BASIS OF HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY IN ITALIAN FAMILIES, AND REPORT OF 4 NOVEL MUTATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VASCULAR-DISEASE; PATIENT; CDNA	Four new mutations in the cystathionine beta-synthase (CBS) gene have been identified in Italian patients with homocystinuria. The first mutation is a G-to-A transition at base 374 in exon 3, causing an arginine-to-glutamic acid substitution at position 125 of the protein (R125Q). This mutation has been found in homozygosity in a patient partially responsive to pyridoxine treatment. The second mutation is a C-to-T transition at base 770 in exon 7, causing a threonine-to-methionine substitution at amino acid 257 of the protein (T257M). This mutation has been observed in homozygosity in a patient nonresponsive to the cofactor treatment. The third mutation, found in heterozygosity in a patient responsive to pyridoxine treatment, is an insertion of 68 bp in exon 8 at base 844, which introduces a premature termination codon. The fourth mutation is C-to-T transition in exon 2 at base 262, causing a proline-to-serine substitution at position 88 of the protein (P88S). This mutation is carried on a single allele in three affected sisters responsive to the cofactor treatment. In addition, six previously reported mutations (A114V, E131D, P145L, I278T, G307S, and A(1224-2)C) have been tested in 14 independent Italian families. Mutations A114V and I278T are carried by three and by seven independent alleles, respectively. The other four mutations-including G307S and A(1224-2)C, common among northern European patients-have not been detected.	FEDERICO UNIV 2,DEPT PEDIAT,I-80131 NAPLES,ITALY; UNIV COLORADO,SCH MED,DEPT PEDIAT,DENVER,CO	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver			Melis, Daniela/AAD-3623-2019; andria, generoso/V-7172-2019	Melis, Daniela/0000-0002-9458-3926; 				ANDRIA G, 1989, RIV ITAL PED, V15, P6; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CLARKE R, 1991, NEW ENGL J MED, V324, P1149, DOI 10.1056/NEJM199104253241701; DEFRANCHIS R, 1994, HUM MOL GENET, V7, P1103; HU FL, 1993, HUM MOL GENET, V2, P1857, DOI 10.1093/hmg/2.11.1857; KERY V, 1994, J BIOL CHEM, V269, P25283; KOCH HG, 1994, 6TH INT C INB ERR ME; KOZICH V, 1993, HUM MOL GENET, V2, P815, DOI 10.1093/hmg/2.6.815; Kozich Viktor, 1992, Human Mutation, V1, P113, DOI 10.1002/humu.1380010206; KRAUS JP, 1993, HUM MOL GENET, V2, P1633, DOI 10.1093/hmg/2.10.1633; KRAUS JP, 1994, J INHERIT METAB DIS, V17, P383, DOI 10.1007/BF00711354; Maniatis T., 1982, MOL CLONING; MARBLE M, 1994, HUM MOL GENET, V3, P1883, DOI 10.1093/hmg/3.10.1883; MUDD SH, 1985, AM J HUM GENET, V37, P1; MUDD SH, 1989, METABOLIC BASIS INHE, P673; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; RUBBA P, 1990, METABOLISM, V39, P1191, DOI 10.1016/0026-0495(90)90093-R; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEBASTIO G, 1993, AM J HUM GENET, V53, pA946; SWAROOP M, 1992, J BIOL CHEM, V267, P11455; WARD P, 1994, 6TH INT C INB ERR ME	21	157	168	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1995	56	6					1324	1333						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA794	7762555				2022-12-18	WOS:A1995RA79400010
J	DEKA, R; JIN, L; SHRIVER, MD; YU, LM; DECROO, S; HUNDRIESER, J; BUNKER, CH; FERRELL, RE; CHAKRABORTY, R				DEKA, R; JIN, L; SHRIVER, MD; YU, LM; DECROO, S; HUNDRIESER, J; BUNKER, CH; FERRELL, RE; CHAKRABORTY, R			POPULATION-GENETICS OF DINUCLEOTIDE (DC-DA)(N)CENTER-DOT(DG-DT)(N) POLYMORPHISMS IN WORLD POPULATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							REPEAT POLYMORPHISM; PHYLOGENETIC TREES; VNTR LOCI; MUTATION; DIFFERENTIATION; DISTRIBUTIONS; PROTEIN; INDIANS; DRIFT	We have characterized eight dinucleotide (dC-dA)(n).(dG-dT)(n) repeat loci located on human chromosome 13q in eight human populations and in a sample of chimpanzees. Even though there is substantial variation in allele frequencies at each locus, at a given locus the most frequent alleles are shared by all human populations. The level of heterozygosity is reduced in isolated or small populations, such as the Pehuenche Indians of Chile, the Dogrib of Canada, and the New Guinea highlanders. On the other hand, larger average heterozygosities are observed in large and cosmopolitan populations, such as the Sokoto population from Nigeria and German Caucasians. Conformity with Hardy-Weinberg equilibrium is generally observed at these loci, unless (a) a population is isolated or small or (b) the repeat motif of the locus is not perfect (e.g., D13S197). Multilocus genotype probabilities at these microsatellite loci do not show departure from the independence rule, unless the loci are closely linked. The allele size distributions at these (CA)(n) loci do not follow a strict single-step stepwise-mutation model. However, this feature does not compromise the ability to detect population affinities, when these loci are used simultaneously. The microsatellite loci examined here are present and, with the exception of the locus D13S197, are polymorphic in the chimpanzees, showing an overlapping distribution of allele sizes with those observed in human populations.	UNIV PITTSBURGH,DEPT EPIDEMIOL,PITTSBURGH,PA 15261; UNIV TEXAS,HLTH SCI CTR,CTR GENET,HOUSTON,TX; HANNOVER MED SCH,HANNOVER,GERMANY	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Health Science Center Houston; Hannover Medical School	DEKA, R (corresponding author), UNIV PITTSBURGH,DEPT HUMAN GENET,A 300 CRABTREE HALL,130 DESOTO ST,PITTSBURGH,PA 15261, USA.		Jin, Li/M-5063-2019; Jin, Li/C-1468-2009	Jin, Li/0000-0002-4546-2415; Shriver, Mark/0000-0003-0006-0479	NHGRI NIH HHS [HG 00094] Funding Source: Medline; NIGMS NIH HHS [GM 45861, GM 41399] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041399, R01GM045861] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; BUDOWLE B, 1991, AM J HUM GENET, V48, P841; CHAKRABORTY R, 1982, GENET RES, V39, P303, DOI 10.1017/S0016672300020978; CHAKRABORTY R, 1980, GENETICS, V94, P1039; CHAKRABORTY R, 1992, HUM BIOL, V64, P141; CHAKRABORTY R, 1991, AM J PHYS ANTHROPOL, V86, P497, DOI 10.1002/ajpa.1330860405; CHAKRABORTY R, 1991, DNA FINGERPRINTING A, P127; DEKA R, 1992, AM J HUM GENET, V51, P1325; DEKA R, 1991, GENOMICS, V11, P83, DOI 10.1016/0888-7543(91)90104-M; DEKA R, 1994, GENOMICS, V22, P226, DOI 10.1006/geno.1994.1369; DIETRICH WF, 1994, NAT GENET, V7, P220, DOI 10.1038/ng0694supp-220; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HONG HK, 1993, HUM MOL GENET, V2, P337, DOI 10.1093/hmg/2.3.337-a; JIN L, 1994, THESIS U TEXAS HOUST; KAMINO K, 1993, HUM MOL GENET, V2, P1751, DOI 10.1093/hmg/2.10.1751; LI CC, 1976, 1ST COURSE POPULATIO; LI WH, 1976, GENETICS, V83, P423; LITT M, 1989, AM J HUM GENET, V44, P397; LONG JC, 1986, AM J PHYS ANTHROPOL, V70, P75, DOI 10.1002/ajpa.1330700113; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; MORTON NE, 1993, P NATL ACAD SCI USA, V90, P1892, DOI 10.1073/pnas.90.5.1892; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; NEI M, 1987, MOL EVOLUTINARY GENE; PENA SDJ, 1994, P NATL ACAD SCI USA, V91, P723, DOI 10.1073/pnas.91.2.723; RISCH NJ, 1992, SCIENCE, V255, P717, DOI 10.1126/science.1738844; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SHRIVER MD, 1993, GENETICS, V134, P983; SZATHMARY EJE, 1983, AM J PHYS ANTHROPOL, V62, P249, DOI 10.1002/ajpa.1330620304; WEBER JL, 1989, AM J HUM GENET, V44, P388; Weir B.S., 1991, GENETIC DATA ANAL	34	157	160	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1995	56	2					461	474						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QF423	7847383				2022-12-18	WOS:A1995QF42300016
J	SYVANEN, AC; SAJANTILA, A; LUKKA, M				SYVANEN, AC; SAJANTILA, A; LUKKA, M			IDENTIFICATION OF INDIVIDUALS BY ANALYSIS OF BIALLELIC DNA MARKERS, USING PCR AND SOLID-PHASE MINISEQUENCING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMERASE CHAIN-REACTION; HUMAN MITOCHONDRIAL-DNA; HUMAN ARYLSULFATASE-B; GENE PS-ALPHA; FINNISH POPULATION; APOLIPOPROTEIN-B; NUCLEOTIDE-SEQUENCE; TANDEM REPEATS; PROTEIN; AMPLIFICATION	We have developed a new method for forensic identification of individuals, in which a panel of biallelic DNA markers are amplified by the PCR, and the variable nucleotides are detected in the amplified DNA fragments by the solid-phase minisequencing method. A panel of 12 common polymorphic nucleotides located on different chromosomes with reported allele frequencies dose to .5 were chosen for the test. The allele frequencies for most of the markers were found to be similar in the Finnish and other Caucasian populations. We also.. introduce a novel approach for rapid determination of the population frequencies of biallelic markers. By this approach we were able to determine the allele frequencies of the markers in the Finnish population, by quantitative analysis of three pooled DNA samples representing 3,000 individuals. The power of discrimination and exclusion of the solid-phase minisequencing typing test with 12 markers was similar to that of three VNTR markers that are routinely used in forensic analyses at our institute. The solid-phase minisequencing method was successfully applied to type paternity and forensic case samples. We also show that the quantitative nature of our method allows typing of mixed samples.	NATL PUBL HLTH INST, DEPT IMMUNOBIOL, SF-00300 HELSINKI, FINLAND	Finland National Institute for Health & Welfare	SYVANEN, AC (corresponding author), NATL PUBL HLTH INST, DEPT HUMAN MOLEC GENET, MANNERHEIMINTIE 166, SF-00300 HELSINKI, FINLAND.		Sajantila, Antti/AAY-9084-2021	Sajantila, Antti/0000-0003-4117-5248				AALTOSETALA K, 1991, J LIPID RES, V32, P1477; ALLEN RC, 1989, BIOTECHNIQUES, V7, P736; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BENGTSTROM M, 1990, NUCLEOS NUCLEOT, V9, P123, DOI 10.1080/07328319008045115; BOWEN DJ, 1991, NUCLEIC ACIDS RES, V19, P3159, DOI 10.1093/nar/19.11.3159-a; BUDOWLE B, 1991, AM J HUM GENET, V48, P137; Cantell K, 1981, Methods Enzymol, V78, P29; CASANOVA JL, 1990, NUCLEIC ACIDS RES, V18, P4028, DOI 10.1093/nar/18.13.4028; CHUMAKOV PM, 1991, NUCLEIC ACIDS RES, V19, P6969, DOI 10.1093/nar/19.24.6969-a; COLLINGE J, 1991, LANCET, V337, P1441, DOI 10.1016/0140-6736(91)93128-V; DEPAGTERHOLTHUIZEN P, 1988, BIOCHIM BIOPHYS ACTA, V950, P282, DOI 10.1016/0167-4781(88)90124-8; DIEPSTRATEN CM, 1991, NUCLEIC ACIDS RES, V19, P5091, DOI 10.1093/nar/19.18.5091; EDWARDS A, 1991, AM J HUM GENET, V49, P746; FISHER KL, 1987, NUCLEIC ACIDS RES, V15, P7657, DOI 10.1093/nar/15.18.7657; GREENBERG BD, 1983, GENE, V21, P33, DOI 10.1016/0378-1119(83)90145-2; GURTLER H, 1956, Acta Med Leg Soc (Liege), V9, P83; HELMINEN P, 1992, MOL CELL PROBE, V6, P21, DOI 10.1016/0890-8508(92)90067-8; HIGUCHI R, 1988, NATURE, V332, P543, DOI 10.1038/332543a0; Higuchi R, 1989, PCR TECHNOLOGY PRINC, P31; HOOG JO, 1986, EUR J BIOCHEM, V159, P215, DOI 10.1111/j.1432-1033.1986.tb09855.x; HORN GT, 1990, CLIN CHEM, V36, P1614; HORN GT, 1989, CYTOGENET CELL GENET, V51, P1015; JALANKO A, 1992, J CELL BIOCH F S, V16, P12; JEFFREYS AJ, 1988, NUCLEIC ACIDS RES, V16, P10953, DOI 10.1093/nar/16.23.10953; JEFFREYS AJ, 1991, NATURE, V354, P204, DOI 10.1038/354204a0; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; JIN WD, 1991, NUCLEIC ACIDS RES, V19, P4305, DOI 10.1093/nar/19.15.4305-a; JONES DA, 1972, J FORENSIC SCI SOC, V12, P355, DOI 10.1016/S0015-7368(72)70695-7; KASAI K, 1990, J FORENSIC SCI, V35, P1196; KNOTT TJ, 1986, NATURE, V323, P734, DOI 10.1038/323734a0; KRETZSCHMAR HA, 1986, DNA-J MOLEC CELL BIO, V5, P315, DOI 10.1089/dna.1986.5.315; LACHANCE Y, 1990, J BIOL CHEM, V265, P20469; LEITERSDORF E, 1988, NUCLEIC ACIDS RES, V16, P7215, DOI 10.1093/nar/16.14.7215; LUKKA M, 1986, HUM HERED, V36, P299, DOI 10.1159/000153646; LUKKA M, 1985, HUM HERED, V35, P95; MANCUSO DJ, 1989, J BIOL CHEM, V264, P19514; MISIURA K, 1990, NUCLEIC ACIDS RES, V18, P4345, DOI 10.1093/nar/18.15.4345; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NEVANLINNA HR, 1972, HEREDITAS-GENETISK A, V71, P195; NEVANLINNA HR, 1980, POPULATION STRUCTURE, P569; NICKERSON DA, 1990, P NATL ACAD SCI USA, V87, P8923, DOI 10.1073/pnas.87.22.8923; OKA K, 1989, NUCLEIC ACIDS RES, V17, P6752, DOI 10.1093/nar/17.16.6752; PETERS C, 1990, J BIOL CHEM, V265, P3374; REYNOLDS R, 1991, CRIME LAB DIGEST, V18, P132; RHEAUME E, 1991, NUCLEIC ACIDS RES, V19, P6060, DOI 10.1093/nar/19.21.6060; SAIKI RK, 1989, P NATL ACAD SCI USA, V86, P6230, DOI 10.1073/pnas.86.16.6230; SAJANTILA A, 1992, BIOTECHNIQUES, V12, P16; SAJANTILA A, 1992, AM J HUM GENET, V50, P816; SORIA LF, 1989, P NATL ACAD SCI USA, V86, P587, DOI 10.1073/pnas.86.2.587; STINISSEN P, 1991, NUCLEIC ACIDS RES, V19, P2516, DOI 10.1093/nar/19.9.2516-a; SULLIVAN KM, 1991, ELECTROPHORESIS, V12, P17, DOI 10.1002/elps.1150120105; SYVANEN AC, 1992, INT J CANCER, V50, P713, DOI 10.1002/ijc.2910500508; SYVANEN AC, 1990, GENOMICS, V8, P684, DOI 10.1016/0888-7543(90)90255-S; TADOKORO K, 1991, NUCLEIC ACIDS RES, V19, P6967, DOI 10.1093/nar/19.24.6967; TANAKA S, 1991, NUCLEIC ACIDS RES, V19, P1964, DOI 10.1093/nar/19.8.1964-a; TSUJIMOTO Y, 1986, P NATL ACAD SCI USA, V83, P5214, DOI 10.1073/pnas.83.14.5214; VANAMSTEL HKP, 1990, BIOCHEMISTRY-US, V29, P7853, DOI 10.1021/bi00486a011; Walsh P S, 1992, PCR Methods Appl, V1, P241, DOI 10.1101/gr.1.4.241; XU Y, 1988, Genomics, V2, P209, DOI 10.1016/0888-7543(88)90004-3	59	157	200	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1993	52	1					46	59						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KK908	8434605				2022-12-18	WOS:A1993KK90800006
J	MOLL, PP; BURNS, TL; LAUER, RM				MOLL, PP; BURNS, TL; LAUER, RM			THE GENETIC AND ENVIRONMENTAL SOURCES OF BODY-MASS INDEX VARIABILITY - THE MUSCATINE PONDEROSITY FAMILY STUDY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CORONARY RISK-FACTORS; WEIGHT-HEIGHT; SEGREGATION ANALYSIS; BIOLOGICAL SIBLINGS; VARIANCE COMPONENTS; EXTREME OVERWEIGHT; PEDIGREE ANALYSIS; BLOOD PRESSURES; RELATIVE WEIGHT; UNIFIED MODEL	The role of genetic and environmental factors in determining the variability in body mass index (BMI; kg/m2) was investigated in 1,302 relatives identified through 284 schoolchildren from Muscatine, IA. BMI levels were first adjusted for variability in age, by gender and by relative type. There was significant familial aggregation of adjusted BMI in the pedigrees, as indicated by inter- and intraclass correlation coefficients significantly different from zero. A mixture of two normal distributions fit the adjusted BMI data better than did a single normal distribution. Genetic and environmental models that could explain both the familial aggregation and the mixture of normal distributions were investigated using complex segregation analysis. There was strong support for a single recessive locus with a major effect that accounted for almost 35% of the adjusted variation in BMI. Polygenic loci accounted for an additional 42% of the variation. Approximately 23% of the adjusted variation was not explained by genetic factors. For spouses living in the same household, their shared environment accounted for 12% of their variation. For siblings living in the same household, their shared environment accounted for 10% of their variation. While shared environments contributed to variation in adjusted BMI, more than 75% of the variation was explained by genetic factors that include a single recessive locus. Approximately 6% of the individuals in the population from which these pedigrees were sampled are predicted to have two copies of the recessive gene, while 37% of the individuals are predicted to have one copy of the gene.	UNIV MICHIGAN,DEPT HUMAN GENET,ANN ARBOR,MI 48109; UNIV IOWA,DEPT PREVENT MED & ENVIRONM HLTH,DIV BIOSTAT,IOWA CITY,IA 52242; UNIV IOWA,DEPT PREVENT MED & ENVIRONM HLTH,DIV EPIDEMIOL,IOWA CITY,IA 52242; UNIV IOWA,DEPT PEDIAT,DIV PEDIAT CARDIOL,IOWA CITY,IA 52242	University of Michigan System; University of Michigan; University of Iowa; University of Iowa; University of Iowa	MOLL, PP (corresponding author), UNIV MICHIGAN,DEPT EPIDEMIOL,109 OBSERV,ANN ARBOR,MI 48109, USA.				NHLBI NIH HHS [HL 14320] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANNEST JL, 1983, AM J EPIDEMIOL, V117, P492, DOI 10.1093/oxfordjournals.aje.a113567; BAILEYWILSON J, 1989, STATISTICAL ANAL GEN; BANDINI LG, 1990, PEDIATR RES, V27, P198, DOI 10.1203/00006450-199002000-00022; BARRETTCONNOR EL, 1985, ANN INTERN MED, V103, P1010, DOI 10.7326/0003-4819-103-6-1010; BAZIN R, 1982, J LIPID RES, V23, P839; BIRON P, 1977, J PEDIATR-US, V91, P555, DOI 10.1016/S0022-3476(77)80501-5; BOEHNKE M, 1984, GENETIC EPIDEMIOLOGY, P173; BOGARDUS C, 1986, NEW ENGL J MED, V315, P96, DOI 10.1056/NEJM198607103150205; BOUCHARD C, 1989, METABOLISM, V38, P364, DOI 10.1016/0026-0495(89)90126-1; BOUCHARD C, 1985, HUM BIOL, V57, P61; BOUCHARD C, 1990, NEW ENGL J MED, V322, P1477, DOI 10.1056/NEJM199005243222101; BOUCHARD C, 1978, AM J PHYS ANTHROPOL, V57, P170; BRAY GA, 1985, ANN INTERN MED, V103, P1052, DOI 10.7326/0003-4819-103-6-1052; BURNS TL, 1989, AM J EPIDEMIOL, V129, P973, DOI 10.1093/oxfordjournals.aje.a115229; BURNS TL, 1989, CIRCULATION S2, V80, P82; CANNINGS C, 1978, ADV APPL PROBAB, V10, P26, DOI 10.2307/1426718; CANNINGS C, 1977, CLIN GENET, V12, P208; CLARKE WR, 1978, CIRCULATION, V58, P626, DOI 10.1161/01.CIR.58.4.626; CLARKE WR, 1986, AM J EPIDEMIOL, V124, P195, DOI 10.1093/oxfordjournals.aje.a114378; COLEMAN DL, 1982, DIABETES, V31, P1; CONOVER WJ, 1971, PRACTICAL NONPARAMET, P302; CRONK CE, 1982, AM J CLIN NUTR, V35, P347, DOI 10.1093/ajcn/35.2.347; DAY NE, 1969, BIOMETRIKA, V56, P463, DOI 10.1093/biomet/56.3.463; DEMENAIS F, 1986, AM J HUM GENET, V38, P228; DESCHENES RJ, 1984, P NATL ACAD SCI-BIOL, V81, P726, DOI 10.1073/pnas.81.3.726; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; FRIEDMAN JM, 1988, MOUSE NEWS LETT, V82, P110; GOODMAN RH, 1980, P NATL ACAD SCI-BIOL, V77, P5869, DOI 10.1073/pnas.77.10.5869; GRAY GA, 1979, NIH79359 US DHEW PUB; HARTZ A, 1977, ANN HUM GENET, V41, P185, DOI 10.1111/j.1469-1809.1977.tb01913.x; HASSTEDT S J, 1985, Genetic Epidemiology, V2, P339, DOI 10.1002/gepi.1370020403; HASSTEDT SJ, 1991, GENET EPIDEMIOL, V8, P113, DOI 10.1002/gepi.1370080205; HASSTEDT SJ, 1979, AM J HUM GENET, V31, pA135; HELLER R, 1984, INT J OBESITY, V8, P399; HOPPER JL, 1982, ANN HUM GENET, V46, P373, DOI 10.1111/j.1469-1809.1982.tb01588.x; HUBERT HB, 1987, AM J EPIDEMIOL, V125, P812, DOI 10.1093/oxfordjournals.aje.a114598; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; HUBERT HB, 1986, ANNU REV PUBL HEALTH, V7, P493, DOI 10.1146/annurev.pu.07.050186.002425; HUNT SC, 1989, AM J EPIDEMIOL, V129, P625, DOI 10.1093/oxfordjournals.aje.a115175; KANNEL WB, 1983, HLTH OBESITY, P1; KEYS A, 1972, J CHRON DIS, V25, P329, DOI 10.1016/0021-9681(72)90027-6; KILLEEN J, 1978, J CHRON DIS, V31, P529, DOI 10.1016/0021-9681(78)90040-1; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; LALOUEL JM, 1979, 13 U UT DEP MED BIOP; LANDSBERG L, 1986, Q J MED, V61, P1081; LANGE K, 1976, ANN HUM GENET, V39, P485, DOI 10.1111/j.1469-1809.1976.tb00156.x; LAVAU M, 1985, INT J OBESITY, V9, P61; LEW EA, 1979, J CHRON DIS, V32, P563, DOI 10.1016/0021-9681(79)90119-X; LONGINI IM, 1984, HUM BIOL, V56, P733; MACLEAN CJ, 1975, AM J HUM GENET, V27, P365; MACLEAN CJ, 1976, BIOMETRICS, V32, P695, DOI 10.2307/2529760; MOLL PP, 1979, ANN HUM GENET, V42, P343, DOI 10.1111/j.1469-1809.1979.tb00668.x; MONTOYE HJ, 1965, AM J CLIN NUTR, V16, P417, DOI 10.1093/ajcn/16.5.417; MUELLER WH, 1983, YEARB PHYS ANTHROPOL, V26, P215; PRICE RA, 1989, AM J EPIDEMIOL, V130, P193, DOI 10.1093/oxfordjournals.aje.a115312; PRICE RA, 1990, HUM BIOL, V62, P747; PROVINCE MA, 1990, AM J HUM GENET S, V47, pA143; RABOUDI SH, 1989, RES COMMUN CHEM PATH, V65, P319; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; ROCHE AF, 1981, AM J CLIN NUTR, V34, P2831, DOI 10.1093/ajcn/34.12.2831; SCHULL WJ, 1990, ANNU REV PUBL HEALTH, V11, P105; SIMOPOULOS AP, 1984, ANN INTERN MED, V100, P285, DOI 10.7326/0003-4819-100-2-285; SIMS EAH, 1979, ENDOCRINOLOGY, V3, P1941; SORENSEN TIA, 1989, BRIT MED J, V298, P87, DOI 10.1136/bmj.298.6666.87; STUNKARD AJ, 1986, JAMA-J AM MED ASSOC, V256, P51, DOI 10.1001/jama.256.1.51; STUNKARD AJ, 1986, NEW ENGL J MED, V314, P193, DOI 10.1056/NEJM198601233140401; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; TOKUYAMA K, 1987, AM J PHYSIOL, V252, pE202, DOI 10.1152/ajpendo.1987.252.2.E202; VANITALLIE TB, 1985, ANN INTERN MED, V103, P983, DOI 10.7326/0003-4819-103-6-983; WHITE JW, 1986, NUCLEIC ACIDS RES, V14, P4719, DOI 10.1093/nar/14.12.4719; YOUNG MR, 1988, AM J HUM GENET, V43, P705; ZANINETTI D, 1989, DIABETOLOGIA, V32, P56; ZUCKER LM, 1961, J HERED, V52, P275, DOI 10.1093/oxfordjournals.jhered.a107093; [No title captured]	74	157	169	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1991	49	6					1243	1255						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GU672	1746554				2022-12-18	WOS:A1991GU67200011
J	DARRAS, BT; BLATTNER, P; HARPER, JF; SPIRO, AJ; ALTER, S; FRANCKE, U				DARRAS, BT; BLATTNER, P; HARPER, JF; SPIRO, AJ; ALTER, S; FRANCKE, U			INTRAGENIC DELETIONS IN 21 DUCHENNE MUSCULAR-DYSTROPHY (DMD) BECKER MUSCULAR-DYSTROPHY (BMD) FAMILIES STUDIED WITH THE DYSTROPHIN CDNA - LOCATION OF BREAKPOINTS ON HINDIII AND BGIII EXON-CONTAINING FRAGMENT MAPS, MEIOTIC AND MITOTIC ORIGIN OF THE MUTATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									YALE UNIV,SCH MED,DEPT HUMAN GENET,333 CEDAR ST,NEW HAVEN,CT 06510; WHITE PLAINS HOSP,MDA CLIN,NEW YORK,NY; YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT NEUROL,BRONX,NY 10461; WESTCHESTER HOSP,MDA CLIN,NEW YORK,NY	Yale University; Yeshiva University; Albert Einstein College of Medicine				Darras, Basil/0000-0002-1536-8145				ANTONARAKIS SE, 1985, NEW ENGL J MED, V313, P842, DOI 10.1056/NEJM198510033131402; BAKKER E, 1987, NATURE, V329, P554, DOI 10.1038/329554a0; BALLABIO A, 1987, P NATL ACAD SCI USA, V84, P4519, DOI 10.1073/pnas.84.13.4519; BARTLETT RJ, 1988, NEUROLOGY, V38, P1; BONIFAS JM, 1987, P NATL ACAD SCI USA, V84, P9248, DOI 10.1073/pnas.84.24.9248; CROSS GS, 1987, EMBO J, V6, P3277, DOI 10.1002/j.1460-2075.1987.tb02646.x; DARRAS BT, 1987, NEW ENGL J MED, V316, P985, DOI 10.1056/NEJM198704163161604; DARRAS BT, 1988, AM J MED GENET, V29, P713, DOI 10.1002/ajmg.1320290341; DARRAS BT, 1987, NATURE, V329, P556, DOI 10.1038/329556a0; DARRAS BT, 1988, AM J HUM GENET, V43, P126; DARRAS BT, 1988, AM J HUM GENET, V43; DENDUNNEN JT, 1987, NATURE, V329, P640, DOI 10.1038/329640a0; FORREST S M, 1988, Genomics, V2, P109, DOI 10.1016/0888-7543(88)90091-2; FORREST SM, 1987, LANCET, V2, P1294; FORREST SM, 1987, NATURE, V329, P638, DOI 10.1038/329638a0; FOX JE, 1988, MOL GENETICS NEUROLO, V48, P71; FRANCKE U, 1987, AM J HUM GENET, V40, P212; GILLARD EF, 1987, NUCLEIC ACIDS RES, V15, P3977, DOI 10.1093/nar/15.10.3977; GITSCHIER J, 1985, NATURE, V315, P427, DOI 10.1038/315427a0; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; KAREL ER, 1986, AM J HUM GENET, V38, P827; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; KOH J, 1987, LANCET, V2, P1154; LANMAN JT, 1987, AM J HUM GENET, V41, P138; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; MONACO AP, 1987, HUM GENET, V75, P221, DOI 10.1007/BF00281063; MOSER H, 1984, HUM GENET, V66, P17, DOI 10.1007/BF00275183; MULLER CR, 1986, HUM GENET, V74, P181, DOI 10.1007/BF00282088; ROBERTSON M, 1987, NATURE, V327, P372, DOI 10.1038/327372a0; RONCUZZI L, 1986, HUM GENET, V74, P456, DOI 10.1007/BF00280507; SMITH TJ, 1987, NUCLEIC ACIDS RES, V15, P9761, DOI 10.1093/nar/15.23.9761; van Ommen G J, 1987, Genomics, V1, P329, DOI 10.1016/0888-7543(87)90032-2; WAPENAAR M C, 1988, Genomics, V2, P101, DOI 10.1016/0888-7543(88)90090-0; WOOD S, 1988, HUM GENET, V78, P282, DOI 10.1007/BF00291677; YANG TP, 1984, NATURE, V310, P412, DOI 10.1038/310412a0; YEN PH, 1987, CELL, V49, P443, DOI 10.1016/0092-8674(87)90447-8; YOUSSOUFIAN H, 1987, P NATL ACAD SCI USA, V84, P3772, DOI 10.1073/pnas.84.11.3772	38	157	157	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1988	43	5					620	629						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q9336	2903663				2022-12-18	WOS:A1988Q933600008
J	WIEACKER, P; DAVIES, KE; COOKE, HJ; PEARSON, PL; WILLIAMSON, R; BHATTACHARYA, S; ZIMMER, J; ROPERS, HH				WIEACKER, P; DAVIES, KE; COOKE, HJ; PEARSON, PL; WILLIAMSON, R; BHATTACHARYA, S; ZIMMER, J; ROPERS, HH			TOWARD A COMPLETE LINKAGE MAP OF THE HUMAN CHROMOSOME-X - REGIONAL ASSIGNMENT OF 16 CLONED SINGLE-COPY DNA-SEQUENCES EMPLOYING A PANEL OF SOMATIC-CELL HYBRIDS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									INST HUMAN GENET, ALBERTSTR 11, D-7800 FREIBURG, FED REP GER; MRC, DEPT ZOOL, MAMMALIAN GENOME UNIT, EDINBURGH, SCOTLAND; INST ANTHROPOGENET, LEIDEN, NETHERLANDS; ST MARYS HOSP, SCH MED, DEPT BIOCHEM, LONDON W2 1PG, ENGLAND	University of Edinburgh; Imperial College London			Bhattacharya, Shom/N-2926-2016	Bhattacharya, Shom/0000-0002-1601-6344				BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BRENNAND J, 1982, P NATL ACAD SCI-BIOL, V79, P1950, DOI 10.1073/pnas.79.6.1950; DAVIDSON RL, 1976, SOMAT CELL GENET, V2, P165, DOI 10.1007/BF01542629; DAVIES KE, 1981, NATURE, V293, P374, DOI 10.1038/293374a0; DAVIES KE, 1983, NUCLEIC ACIDS RES, V11, P2303, DOI 10.1093/nar/11.8.2303; DAVIES KE, 1982, BANBURY REPORT, V14; EMERY AEH, 1969, ANN HUM GENET, V32, P261, DOI 10.1111/j.1469-1809.1969.tb00075.x; FRANCKE U, 1974, AM J HUM GENET, V26, P512; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; HARPER PS, 1983, J MED GENET, V20, P252, DOI 10.1136/jmg.20.4.252; HORN N, 1984, ANN HUM GENET; JEFFREYS AJ, 1979, CELL, V18, P1, DOI 10.1016/0092-8674(79)90348-9; KAN YW, 1978, LANCET, V2, P910; KEATS BJB, 1981, SOURCE BOOK LINKAGE; KINGSTON HM, 1983, J MED GENET, V20, P255, DOI 10.1136/jmg.20.4.255; KRUMLAUF R, 1982, P NATL ACAD SCI-BIOL, V79, P2971, DOI 10.1073/pnas.79.9.2971; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; KUNKEL LM, 1982, NUCLEIC ACIDS RES, V10, P1557, DOI 10.1093/nar/10.5.1557; LANGE K, 1982, AM J HUM GENET, V34, P842; MATTEI MG, 1982, HUM GENET, V61, P295; McKusick V. A., 1982, MENDELIAN INHERITANC; MOHANDAS T, 1979, P NATL ACAD SCI USA, V76, P5779, DOI 10.1073/pnas.76.11.5779; MULLER CR, 1980, HUM GENET, V54, P197, DOI 10.1007/BF00278971; MURRAY JM, 1982, NATURE, V300, P69, DOI 10.1038/300069a0; PAI GS, 1980, P NATL ACAD SCI-BIOL, V77, P2810, DOI 10.1073/pnas.77.5.2810; PEARSON PL, 1982, CYTOGENET CELL GENET, V32, P308; ROPERS HH, 1981, CYTOGENET CELL GENET, V30, P168, DOI 10.1159/000131605; ROPERS HH, 1982, NATURE, V296, P766, DOI 10.1038/296766a0; SINGERSAM J, 1983, P NATL ACAD SCI-BIOL, V80, P802, DOI 10.1073/pnas.80.3.802; SOLARI AJ, 1980, CHROMOSOMA, V81, P315, DOI 10.1007/BF00368145; SOLOMON E, 1979, LANCET, V1, P923; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Summitt R L, 1978, Birth Defects Orig Artic Ser, V14, P219; SZOSTAK JW, 1982, CELL, V29, P245, DOI 10.1016/0092-8674(82)90109-X; TIEPOLO L, 1980, HUM GENET, V54, P205, DOI 10.1007/BF00278973; WIEACKER P, 1983, CYTOGENET CELL GENET, V35, P72, DOI 10.1159/000131841; WIEACKER P, 1983, HUM GENET, V64, P143, DOI 10.1007/BF00327111; WIEACKER P, 1980, ANN GENET-PARIS, V23, P73; WIEACKER P, 1983, HUM GENET, V63, P113, DOI 10.1007/BF00291528; WIEACKER P, 1983, HUM GENET, V64, P139, DOI 10.1007/BF00327110	40	157	158	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1984	36	2					265	276						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	SM324	6324578				2022-12-18	WOS:A1984SM32400001
J	CLONINGER, CR; RICE, J; REICH, T				CLONINGER, CR; RICE, J; REICH, T			MULTIFACTORIAL INHERITANCE WITH CULTURAL TRANSMISSION AND ASSORTATIVE MATING .2. GENERAL-MODEL OF COMBINED POLYGENIC AND CULTURAL INHERITANCE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JEWISH HOSP ST LOUIS,ST LOUIS,MO 63110	Barnes-Jewish Hospital	CLONINGER, CR (corresponding author), WASHINGTON UNIV,SCH MED,DEPT PSYCHIAT,ST LOUIS,MO 63110, USA.		Cloninger, Claude/F-5357-2012	Cloninger, Claude/0000-0003-3096-4807				Burks B., 1928, YB NATL SOC STUDY ED, V27, P219; CATTELL RB, 1967, J PERS SOC PSYCHOL, V7, P351, DOI 10.1037/h0025248; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; CAVALLIS.LL, 1973, AM J HUM GENET, V25, P618; CAVALLISFORZA L, 1973, THEOR POPUL BIOL, V4, P42, DOI 10.1016/0040-5809(73)90005-1; CLONINGER CR, J PSYCHIATR RES; CLONINGER CR, UNPUBLISHED; CLONINGER CR, AM J HUM GENET; EAVES L, 1976, HEREDITY, V37, P41, DOI 10.1038/hdy.1976.64; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; GOLDBERGER AS, 1977, MODELS METHODS IQ DE; HOLYROYD RG, 1975, ANN HUM GENET, V38, P379; Jencks C, 1972, INEQUALITY REASSESSM; LAYZER D, 1974, SCIENCE, V183, P1259, DOI 10.1126/science.183.4131.1259; LEWONTIN R, 1968, EUGEN QUART, V15, P141, DOI 10.1080/19485565.1968.9987764; Li C., 1975, PATH ANAL A PRIMER; LI CC, 1972, POPULATION GENETICS; LI CC, 1978, GENETIC EPIDEMIOLOGY; MORAN PAP, 1973, ANN HUM GENET, V37, P217, DOI 10.1111/j.1469-1809.1973.tb01828.x; MORTON NE, 1974, AM J HUM GENET, V26, P318; MORTON NE, 1978, YEARB PHYS ANTHROPOL, V21, P12; RAO CR, 1973, LINEAR STATISTICAL I, P194; RAO DC, 1976, AM J HUM GENET, V28, P228; RAO DC, 1974, AM J HUM GENET, V26, P331; RAO DC, 1978, GENETIC EPIDEMIOLOGY; RAO DC, GENET RES; RICE J, 1978, AM J HUM GENET, V30, P618; RICE J, UNPUBLISHED; Slater E, 1971, GENETICS MENTAL DISO; WILSON SR, 1973, ANN HUM GENET, V37, P189, DOI 10.1111/j.1469-1809.1973.tb01826.x; Wright S, 1931, J AM STAT ASSOC, V26, P155; Wright S., 1968, EVOLUTION GENETICS P, P373; WRIGHT S, 1978, GENETIC EPIDEMIOLOGY	33	157	157	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1979	31	2					176	198						23	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GZ386	453202				2022-12-18	WOS:A1979GZ38600009
J	REED, TE; SCHULL, WJ				REED, TE; SCHULL, WJ			A GENERAL MAXIMUM LIKELIHOOD ESTIMATION PROGRAM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter																		BALAKRISHNAN V, 1965, ACTA GENET STAT MED, V15, P345; KURCZYNSKI TW, 1967, AM J HUM GENET, V19, P178; MACCLUER JW, 1967, AM J HUM GENET, V19, P189; REED TE, 1968, AM J HUM GENET, V20, P142; REED TE, 1968, VOX SANG, V14, P9, DOI 10.1111/j.1423-0410.1968.tb01698.x; REED TE, IN PRESS	6	157	158	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1968	20	6					579	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	C8180	5703692				2022-12-18	WOS:A1968C818000009
J	HAUSCHKA, TS; SANDBERG, AA; GOLDSTEIN, MN; HASSON, JE; KOEPF, GF				HAUSCHKA, TS; SANDBERG, AA; GOLDSTEIN, MN; HASSON, JE; KOEPF, GF			AN XYY MAN WITH PROGENY INDICATING FAMILIAL TENDENCY TO NON-DISJUNCTION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BLANK CE, 1960, LANCET, V2, P1450; CARR DH, 1961, CAN MED ASSOC J, V84, P131; FERGUSONSMITH MA, 1960, LANCET, V2, P126; FERGUSONSMITH MA, 1960, LANCET, V2, P184; FORD CE, 1959, NATURE, V183, P1030, DOI 10.1038/1831030a0; FORD CE, 1959, LANCET, V1, P711; FRACCARO M, 1960, LANCET, V1, P724; FROTAPESSOA O, 1961, AM NAT, V95, P217, DOI 10.1086/282178; HAUSCHKA TS, 1962, METHODOLOGY HUMAN GE; HIRSCHHORN K, 1960, LANCET, V2, P319; JACOBS PA, 1959, NATURE, V183, P302, DOI 10.1038/183302a0; JACOBS PA, 1959, LANCET, V2, P423; JACOBS PA, 1961, LANCET, V1, P1183; MAKINO S, 1961, AM J HUM GENET, V13, P47; MILLER OJ, 1961, LANCET, V2, P78; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; MULDAL S, 1960, LANCET, V2, P492; PATAU K, 1960, AM J HUM GENET, V12, P250; ROTHFELS KH, 1958, STAIN TECHNOL, V33, P73, DOI 10.3109/10520295809111827; SANDBERG AA, 1960, AM J HUM GENET, V12, P231; SANDBERG AA, 1961, LANCET, V2, P488; THERMAN E, 1961, AM J HUM GENET, V13, P193; WHITE MJD, 1960, AM NAT, V94, P301, DOI 10.1086/282131	23	157	157	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1962	14	1					22	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2966A	13905424				2022-12-18	WOS:A19622966A00006
J	Kochinke, K; Zweier, C; Nijhof, B; Fenckova, M; Cizek, P; Honti, F; Keerthikumar, S; Oortveld, MAW; Kleefstra, T; Kramer, JM; Webber, C; Huynen, MA; Schenck, A				Kochinke, Korinna; Zweier, Christiane; Nijhof, Bonnie; Fenckova, Michaela; Cizek, Pavel; Honti, Frank; Keerthikumar, Shivakumar; Oortveld, Merel A. W.; Kleefstra, Tjitske; Kramer, Jamie M.; Webber, Caleb; Huynen, Martijn A.; Schenck, Annette			Systematic Phenomics Analysis Deconvolutes Genes Mutated in Intellectual Disability into Biologically Coherent Modules	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTISM SPECTRUM DISORDERS; COGNITIVE DISORDERS; TRANSGENIC RNAI; HUMAN-DISEASE; DROSOPHILA; GENETICS; PATHWAYS; EXPRESSION; ONTOLOGY; PROJECT	Intellectual disability (ID) disorders are genetically and phenotypically extremely heterogeneous. Can this complexity be depicted in a comprehensive way as a means of facilitating the understanding of ID disorders and their underlying biology? We provide a curated database of 746 currently known genes, mutations in which cause ID (ID-associated genes [ID-AGs]), classified according to ID manifestation and associated clinical features. Using this integrated resource, we show that ID-AGs are substantially enriched with co-expression, protein-protein interactions, and specific biological functions. Systematic identification of highly enriched functional themes and phenotypes revealed typical phenotype combinations characterizing process-defined groups of ID disorders, such as chromatin-related disorders and deficiencies in DNA repair. Strikingly, phenotype classification efficiently breaks down ID-AGs into subsets with significantly elevated biological coherence and predictive power. Custom-made functional Drosophila datasets revealed further characteristic phenotypes among ID-AGs and specific clinical classes. Our study and resource provide systematic insights into the molecular and clinical landscape of ID disorders, represent a significant step toward overcoming current limitations in ID research, and prove the utility of systematic human and cross-species phenomics analyses in highly heterogeneous genetic disorders.	[Kochinke, Korinna; Nijhof, Bonnie; Fenckova, Michaela; Oortveld, Merel A. W.; Kleefstra, Tjitske; Kramer, Jamie M.; Schenck, Annette] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Zweier, Christiane] Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany; [Cizek, Pavel; Keerthikumar, Shivakumar; Huynen, Martijn A.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Ctr Mol & Biomol Informat, NL-6525 GA Nijmegen, Netherlands; [Honti, Frank; Webber, Caleb] Univ Oxford, Dept Physiol Anat & Genet, Med Res Council Funct Genom Unit, Oxford OX1 3QX, England	Radboud University Nijmegen; University of Erlangen Nuremberg; Radboud University Nijmegen; University of Oxford	Huynen, MA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Ctr Mol & Biomol Informat, NL-6525 GA Nijmegen, Netherlands.	martijn.huijnen@radboudumc.nl; annette.schenck@radboudumc.nl	Fenckova, Michaela/AGY-9276-2022; Zweier, Christiane/F-2202-2015; KEERTHIKUMAR, SHIVAKUMAR/AAP-6850-2020; Kleefstra, Tjitske/G-2619-2012; Huynen, Martijn A/A-1530-2014; Keerthikumar, Shivakumar/B-4673-2011; Fenckova, Michaela/H-8622-2017; Schenck, Annette/E-4514-2012	Fenckova, Michaela/0000-0002-5716-1652; Zweier, Christiane/0000-0001-8002-2020; KEERTHIKUMAR, SHIVAKUMAR/0000-0001-9865-9767; Huynen, Martijn A/0000-0001-6189-5491; Keerthikumar, Shivakumar/0000-0001-9865-9767; Fenckova, Michaela/0000-0002-5716-1652; Schenck, Annette/0000-0002-6918-3314; Kramer, Jamie/0000-0002-0924-1279; Webber, Caleb/0000-0001-8063-7674	European Union [HEALTH-241995]; IZKF (Interdisziplinares Zentrum fur Klinische Forschung) Erlangen; DFG (Deutsche Forschungsgemeinschaft) [ZW184/1-1, ZW184/1-2]; ZonMw grant from NWO (Netherlands Organization for Scientific Research) [907-00-365]; BMBF (German Federal Ministry of Education and Research) [01GS08160]; Vidi from ZonMw; TOP from ZonMw [917-96-346, 912-12-109]; NWO; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER; MRC [MC_UU_12021/4, MC_UP_A320_1004] Funding Source: UKRI; Medical Research Council [MC_UU_12021/4, MC_UP_A320_1004] Funding Source: researchfish	European Union(European Commission); IZKF (Interdisziplinares Zentrum fur Klinische Forschung) Erlangen; DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); ZonMw grant from NWO (Netherlands Organization for Scientific Research); BMBF (German Federal Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF)); Vidi from ZonMw; TOP from ZonMw; NWO(Netherlands Organization for Scientific Research (NWO)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank H.G. Brunner and A. Hoischen for critical reading of the manuscript, J. de Gooyert for input into database design and excellent technical assistance, and I. Kucukkalipci and K. Narci for help with the Drosophila screens. We acknowledge the Vienna Drosophila Resource Center and Bloomington Drosophila Stock Center (NIH P40OD018537) for providing Drosophila strains. This research was supported in part by the European Union's FP7 large-scale integrated network Gencodys (HEALTH-241995 to C.W., M.A.H., and A.S.), by the IZKF (Interdisziplinares Zentrum fur Klinische Forschung) Erlangen and grants (ZW184/1-1 and ZW184/1-2) from the DFG (Deutsche Forschungsgemeinschaft) to C.Z., by a ZonMw grant (907-00-365) from the NWO (Netherlands Organization for Scientific Research) to T.K., by a grant from the BMBF (German Federal Ministry of Education and Research; 01GS08160, funding the German Intellectual Disability Network [MRNET]), and by Vidi and TOP grants (917-96-346 and 912-12-109) from ZonMw and NWO to A.S.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bacon C, 2015, MOL PSYCHIATR, V20, P632, DOI 10.1038/mp.2014.116; Bahi-Buisson N, 2014, BRAIN, V137, P1676, DOI 10.1093/brain/awu082; Basu SN, 2009, NUCLEIC ACIDS RES, V37, pD832, DOI 10.1093/nar/gkn835; Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Bourgeron T, 2015, NAT REV NEUROSCI, V16, P551, DOI 10.1038/nrn3992; Brain Span, 2013, ATL DEV HUM BRAIN; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Deans AR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002033; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Freimer N, 2003, NAT GENET, V34, P15, DOI 10.1038/ng0503-15; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; Grant SGN, 2012, CURR OPIN NEUROBIOL, V22, P522, DOI 10.1016/j.conb.2012.02.002; Grozeva D, 2015, HUM MUTAT, V36, P1197, DOI 10.1002/humu.22901; He XL, 2014, NAT MED, V20, P1035, DOI 10.1038/nm.3666; Honti F, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003815; Houle D, 2010, NAT REV GENET, V11, P855, DOI 10.1038/nrg2897; Inlow JK, 2004, GENETICS, V166, P835, DOI 10.1534/genetics.166.2.835; Kalinka Alex T, 2011, Bioinformatics, V27, P2011, DOI 10.1093/bioinformatics/btr311; Kleefstra T, 2014, NEUROPHARMACOLOGY, V80, P83, DOI 10.1016/j.neuropharm.2013.12.025; Kohler S, 2014, NUCLEIC ACIDS RES, V42, pD966, DOI 10.1093/nar/gkt1026; Kou Y, 2012, AM J MED GENET C, V160C, P130, DOI 10.1002/ajmg.c.31330; Krumm N, 2014, TRENDS NEUROSCI, V37, P95, DOI 10.1016/j.tins.2013.11.005; Lee S, 2005, HUM MOL GENET, V14, P627, DOI 10.1093/hmg/ddi059; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; McGary KL, 2010, P NATL ACAD SCI USA, V107, P6544, DOI 10.1073/pnas.0910200107; Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Neumuller RA, 2011, CELL STEM CELL, V8, P580, DOI 10.1016/j.stem.2011.02.022; Oortveld MAW, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003911; Oti M, 2007, CLIN GENET, V71, P1, DOI 10.1111/j.1399-0004.2006.00708.x; Oti M, 2009, AM J HUM GENET, V85, P801, DOI 10.1016/j.ajhg.2009.10.026; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Pavlowsky A, 2012, MOL PSYCHIATR, V17, P682, DOI 10.1038/mp.2011.139; Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Redin C, 2014, J MED GENET, V51, P724, DOI 10.1136/jmedgenet-2014-102554; Ropers HH, 2010, ANNU REV GENOM HUM G, V11, P161, DOI 10.1146/annurev-genom-082509-141640; Ruan J, 2008, NUCLEIC ACIDS RES, V36, pD735, DOI 10.1093/nar/gkm1005; Sama IE, 2010, BIOINFORMATICS, V26, P2737, DOI 10.1093/bioinformatics/btq474; Schalock R. L., 2021, INTELLECTUAL DISABIL; Schmidt I, 2012, J NEUROSCI, V32, P7466, DOI 10.1523/JNEUROSCI.0349-12.2012; Schnorrer F, 2010, NATURE, V464, P287, DOI 10.1038/nature08799; Sealfon RSG, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-443; Shendure J, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0086-2; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Valente EM, 2014, NAT REV NEUROL, V10, P27, DOI 10.1038/nrneurol.2013.247; van der Voet M, 2014, NEUROSCI BIOBEHAV R, V46, P326, DOI 10.1016/j.neubiorev.2014.01.013; Vulto-van Silfhout AT, 2014, AM J HUM GENET, V94, P649, DOI 10.1016/j.ajhg.2014.03.013; Warnes GR, 2014, GPLOTS VARIOUS R PRO; Yamamoto S, 2014, CELL, V159, P200, DOI 10.1016/j.cell.2014.09.002; Zaghloul NA, 2010, TRENDS GENET, V26, P168, DOI 10.1016/j.tig.2010.01.006; Zenker M, 2011, CURR OPIN PEDIATR, V23, P443, DOI 10.1097/MOP.0b013e32834881dd	58	156	159	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 7	2016	98	1					149	164		10.1016/j.ajhg.2015.11.024	http://dx.doi.org/10.1016/j.ajhg.2015.11.024			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DA8JL	26748517	Green Published, Bronze			2022-12-18	WOS:000368050800011
J	Oji, V; Eckl, KM; Aufenvenne, K; Natebus, M; Tarinski, T; Ackermann, K; Seller, N; Metze, D; Nurnberg, G; Folster-Holst, R; Schafer-Korting, M; Hausser, I; Traupe, H; Hennies, HC				Oji, Vinzenz; Eckl, Katja-Martina; Aufenvenne, Karin; Naetebus, Marc; Tarinski, Tatiana; Ackermann, Katharina; Seller, Natalia; Metze, Dieter; Nuernberg, Gudrun; Foelster-Holst, Regina; Schaefer-Korting, Monika; Hausser, Ingrid; Traupe, Heiko; Hennies, Hans Christian			Loss of Corneodesmosin Leads to Severe Skin Barrier Defect, Pruritus, and Atopy: Unraveling the Peeling Skin Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECONSTRUCTED HUMAN EPIDERMIS; OF-FUNCTION MUTATIONS; PERCUTANEOUS-ABSORPTION; HYPOTRICHOSIS SIMPLEX; ICHTHYOSIS VULGARIS; NETHERTON-SYNDROME; STRATUM-CORNEUM; GENE; FILAGGRIN; DESQUAMATION	Generalized peeling skin disease is an autosomal-recessive ichthyosiform erythroderma characterized by lifelong patchy peeling of the skin. After genome-wide linkage analysis, we have identified a homozygous nonsense mutation in CDSN in a large consanguineous family with generalized peeling skin, pruritus, and food allergies, which leads to a complete loss of corneodesmosin. In contrast to hypotrichosis simplex, which can be associated with specific dominant CDSN mutations, peeling skin disease is characterized by a complete loss of CDSN expression. The skin phenotype is consistent with a recent murine Cdsn knockout model. Using three-dimensional human skin models, we demonstrate that lack of corneodesmosin causes an epidermal barrier defect supposed to account for the predisposition to atopic diseases, and we confirm the role of corneodesmosin as a decisive epidermal adhesion molecule. Therefore, peeling skin disease will represent a new model disorder for atopic diseases, similarly to Netherton syndrome and ichthyosis vulgaris in the recent past.	[Eckl, Katja-Martina; Naetebus, Marc; Nuernberg, Gudrun; Hennies, Hans Christian] Univ Cologne, Div Dermatogenet, Cologne Ctr Genom, D-50931 Cologne, Germany; [Oji, Vinzenz; Aufenvenne, Karin; Tarinski, Tatiana; Seller, Natalia; Metze, Dieter; Traupe, Heiko] Univ Hosp Munster, Dept Dermatol, D-48149 Munster, Germany; [Eckl, Katja-Martina] Univ Cologne, Inst Neurophysiol, Ctr Physiol & Pathophysiol, D-50931 Cologne, Germany; [Ackermann, Katharina; Schaefer-Korting, Monika] Free Univ Berlin, Inst Pharm, D-14195 Berlin, Germany; [Foelster-Holst, Regina] Univ Clin Dermatol, D-24105 Kiel, Germany; [Hausser, Ingrid] Univ Heidelberg Hosp, Dept Dermatol, D-69115 Heidelberg, Germany; [Hennies, Hans Christian] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany	University of Cologne; University of Munster; University of Cologne; Free University of Berlin; University of Kiel; Schleswig Holstein University Hospital; Ruprecht Karls University Heidelberg; University of Cologne	Hennies, HC (corresponding author), Univ Cologne, Div Dermatogenet, Cologne Ctr Genom, D-50931 Cologne, Germany.	h.hennies@uni-koeln.de	Hennies, Hans C/G-9424-2014; Eckl, Katja/C-3581-2014	Hennies, Hans C/0000-0001-7210-2389; Eckl, Katja/0000-0001-8838-3998; Oji, Vinzenz/0000-0003-1380-4828	German Federal Ministry for Education and Research as part of the Network for Rare Diseases (NIRK) [GFGM01143901]; Ministry for Innovation, Science, Research, and Technology of the Land Nordrhein Westfalen; Selbsthilfe Ichthyose e.V.; Interdisciplinary Center of Clinical Research [Lo2/017/07]; Medical Faculty of the University of Munster [OJ120817]	German Federal Ministry for Education and Research as part of the Network for Rare Diseases (NIRK)(Federal Ministry of Education & Research (BMBF)); Ministry for Innovation, Science, Research, and Technology of the Land Nordrhein Westfalen; Selbsthilfe Ichthyose e.V.; Interdisciplinary Center of Clinical Research; Medical Faculty of the University of Munster	We would like to thank our patients and their families, as well as J. Buckmann, P. Wissel, D. Presser, R. Casper, O. Kawaletz, J. Kurtenbach, and B. Willis. Our work is supported by the German Federal Ministry for Education and Research as part of the Network for Rare Diseases (NIRK, GFGM01143901), the Ministry for Innovation, Science, Research, and Technology of the Land Nordrhein Westfalen, the Selbsthilfe Ichthyose e.V. (http://www.ichthyose.de), the Interdisciplinary Center of Clinical Research (Lo2/017/07), and the Medical Faculty (OJ120817) of the University of Munster.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Ackermann K, 2010, SKIN PHARMACOL PHYS, V23, P105, DOI 10.1159/000265681; ALLENHOFFMANN BL, 1984, P NATL ACAD SCI-BIOL, V81, P7802, DOI 10.1073/pnas.81.24.7802; ARAS N, 1994, J AM ACAD DERMATOL, V30, P135, DOI 10.1016/S0190-9622(08)81903-2; Cassidy AJ, 2005, AM J HUM GENET, V77, P909, DOI 10.1086/497707; Caubet C, 2004, J INVEST DERMATOL, V122, P1235, DOI 10.1111/j.0022-202X.2004.22512.x; Chavanas S, 2000, NAT GENET, V25, P141, DOI 10.1038/75977; Davalos NO, 2005, BRIT J DERMATOL, V153, P1216, DOI 10.1111/j.1365-2133.2005.06958.x; DICKEN CH, 1985, J AM ACAD DERMATOL, V13, P158, DOI 10.1016/S0190-9622(85)80339-X; Fallon PG, 2009, NAT GENET, V41, P602, DOI 10.1038/ng.358; Gudbjartsson DF, 2005, NAT GENET, V37, P1015, DOI 10.1038/ng1005-1015; HACHAMZADEH S, 1985, ARCH DERMATOL, V121, P545, DOI 10.1001/archderm.121.4.545; Hausser I, 1996, PEDIATR DERMATOL, V13, P183, DOI 10.1111/j.1442-200X.1996.tb02615.x; Komatsu N, 2006, J INVEST DERMATOL, V126, P2338, DOI 10.1038/sj.jid.5700379; KURBAN AK, 1969, BRIT J DERMATOL, V81, P191, DOI 10.1111/j.1365-2133.1969.tb16005.x; Leclerc EA, 2009, J CELL SCI, V122, P2699, DOI 10.1242/jcs.050302; Leigh I.M., 1994, KERATINOCYTE METHODS; LEVY SB, 1982, J AM ACAD DERMATOL, V7, P606, DOI 10.1016/S0190-9622(82)70140-9; Levy-Nissenbaum E, 2003, NAT GENET, V34, P151, DOI 10.1038/ng1163; LUNDSTROM A, 1994, ARCH DERMATOL RES, V286, P369, DOI 10.1007/BF00371795; Marenholz I, 2006, J ALLERGY CLIN IMMUN, V118, P866, DOI 10.1016/j.jaci.2006.07.026; Matsumoto M, 2008, P NATL ACAD SCI USA, V105, P6720, DOI 10.1073/pnas.0709345105; MEVORAH B, 1987, BRIT J DERMATOL, V116, P117, DOI 10.1111/j.1365-2133.1987.tb05799.x; Mevorah B, 1996, J AM ACAD DERMATOL, V34, P379, DOI 10.1016/S0190-9622(07)80013-2; Mizuno Y, 2006, J DERMATOL, V33, P430, DOI 10.1111/j.1346-8138.2006.00102.x; Moskowitz DG, 2004, J PEDIATR-US, V145, P82, DOI 10.1016/j.jpeds.2004.03.052; Moss GP, 2002, TOXICOL IN VITRO, V16, P299, DOI 10.1016/S0887-2333(02)00003-6; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; Sandilands A, 2007, NAT GENET, V39, P650, DOI 10.1038/ng2020; Schafer-Korting M, 2008, ATLA-ALTERN LAB ANIM, V36, P161, DOI 10.1177/026119290803600207; Schafer-Korting M, 2006, ATLA-ALTERN LAB ANIM, V34, P283, DOI 10.1177/026119290603400312; Simon M, 2001, J BIOL CHEM, V276, P20292, DOI 10.1074/jbc.M100201200; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; Traupe H., 1989, ICHTHYOSES GUIDE CLI; Tsai K, 2006, PEDIATR DERMATOL, V23, P488, DOI 10.1111/j.1525-1470.2006.00290.x; Weidinger S, 2006, J ALLERGY CLIN IMMUN, V118, P214, DOI 10.1016/j.jaci.2006.05.004; Wile UJ, 1924, ARCH DERMATOL SYPH, V10, P487, DOI 10.1001/archderm.1924.02360280081013	39	156	161	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 13	2010	87	2					274	281		10.1016/j.ajhg.2010.07.005	http://dx.doi.org/10.1016/j.ajhg.2010.07.005			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641EG	20691404	Green Published, Bronze			2022-12-18	WOS:000281107000012
J	Ghezzi, D; Sevrioukova, I; Invernizzi, F; Lamperti, C; Mora, M; D'Adamo, P; Novara, F; Zuffardi, O; Uziel, G; Zeviani, M				Ghezzi, Daniele; Sevrioukova, Irina; Invernizzi, Federica; Lamperti, Costanza; Mora, Marina; D'Adamo, Pio; Novara, Francesca; Zuffardi, Orsetta; Uziel, Graziella; Zeviani, Massimo			Severe X-Linked Mitochondrial Encephalomyopathy Associated with a Mutation in Apoptosis-Inducing Factor	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OXIDATIVE-PHOSPHORYLATION; AIF; RELEASE; ATROPHY	We investigated two male infant patients who were given a diagnosis of progressive mitochondrial encephalomyopathy on the basis of clinical, biochemical, and morphological features. These patients were born from monozygotic twin sisters and unrelated fathers, suggesting an X-linked trait. Fibroblasts from both showed reduction of respiratory chain (RC) cIII and cIV, but not of cl activities. We found a disease-segregating mutation in the X-linked AIFM1 gene, encoding the Apoptosis-Inducing Factor (AIF) mitochondrion-associated 1 precursor that deletes arginine 201 (R201 del). Under normal conditions, mature AIF is a FAD-dependent NADH oxidase of unknown function and is targeted to the mitochondrial intermembrane space (this form is called AIF(mit)). Upon apoptogenic stimuli, a soluble form (AIF(sol)) is released by proteolytic cleavage and migrates to the nucleus, where it induces "parthanatos," i.e., caspase-independent fragmentation of chromosomal DNA. In vitro, the AIF(R201) (del) mutation decreases stability of both AIF(mit), and AIF(sol) and increases the AIF(sol) DNA binding affinity, a prerequisite for nuclear apoptosis. In AIF(R201) (del) fibroblasts, staurosporine-induced parthanatos was markedly increased, whereas re-expression of AIF(wt) induced recovery of RC activities. Numerous TUNEL-positive, caspase 3-negative nuclei were visualized in patient #1's muscle, again indicating markedly increased parthanatos in the AIF(R201 del) critical tissues. We conclude that AIF(R201) (del) is an unstable mutant variant associated with increased parthanatos-linked cell death. Our data suggest a role for AIF in RC integrity and mtDNA maintenance, at least in some tissues. Interestingly, riboflavin supplementation was associated with prolonged improvement of patient #1's neurological conditions, as well as correction of RC defects in mutant fibroblasts, suggesting that stabilization of the FAD binding in AIF(mit) is beneficial.	[Ghezzi, Daniele; Invernizzi, Federica; Lamperti, Costanza; Zeviani, Massimo] Ist Ricovero & Cura Carattere Sci, Div Mol Neurogenet, Carlo Besta Neurol Inst Fdn, I-20126 Milan, Italy; [Sevrioukova, Irina] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Mora, Marina] Ist Ricovero & Cura Carattere Sci, Neuromuscular Dis & Neuroimmunol Unit, Carlo Besta Neurol Inst Fdn, I-20126 Milan, Italy; [D'Adamo, Pio] Univ Trieste, Div Med Genet, Ist Ricovero & Cura Carattere Sci, I-34137 Trieste, Italy; [Novara, Francesca; Zuffardi, Orsetta] Univ Pavia, Dept Human End Hereditary Pathol, Med Genet Sect, I-27100 Pavia, Italy; [Uziel, Graziella] Ist Ricovero & Cura Carattere Sci, Div Child Neurol, Carlo Besta Neurol Inst Fdn, I-20133 Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Istituto Neurologico Besta; University of California System; University of California Irvine; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Istituto Neurologico Besta; University of Trieste; University of Pavia; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Istituto Neurologico Besta	Zeviani, M (corresponding author), Ist Ricovero & Cura Carattere Sci, Div Mol Neurogenet, Carlo Besta Neurol Inst Fdn, Via Temolo 4, I-20126 Milan, Italy.	zeviani@istituto-besta.it	d'Adamo, Adamo Pio/G-4064-2011; Zeviani, Massimo/K-2891-2014; Invernizzi, Federica/J-9849-2016; Ghezzi, Daniele/J-7873-2016; lamperti, costanza/J-8801-2016; Zeviani, Massimo/AAU-2632-2021; Mora, Marina/J-2883-2018	d'Adamo, Adamo Pio/0000-0001-9367-4909; Invernizzi, Federica/0000-0001-8072-0152; Ghezzi, Daniele/0000-0002-6564-3766; lamperti, costanza/0000-0002-2280-2253; Zeviani, Massimo/0000-0002-9067-5508; zuffardi, orsetta/0000-0002-1466-4559; Mora, Marina/0000-0002-5765-2320; Novara, Francesca/0000-0003-1216-0231	Pierfranco and Luisa Mariani Foundation Italy; Fondazione Telethon-Italy [GGP07019]; Italian Ministry of Health [RF-INN-2007-634163]	Pierfranco and Luisa Mariani Foundation Italy; Fondazione Telethon-Italy(Fondazione Telethon); Italian Ministry of Health(Ministry of Health, Italy)	We are grateful to Flavia Blasevich for technical support in electron microscopy studies. This work was supported by the Pierfranco and Luisa Mariani Foundation Italy, Fondazione Telethon-Italy grant number GGP07019, and grant RF-INN-2007-634163 of the Italian Ministry of Health.	ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Andrabi SA, 2008, ANN NY ACAD SCI, V1147, P233, DOI 10.1196/annals.1427.014; Arnoult D, 2002, J CELL BIOL, V159, P923, DOI 10.1083/jcb.200207071; Brett CL, 2002, AM J PHYSIOL-CELL PH, V282, pC1031, DOI 10.1152/ajpcell.00420.2001; Cheung ECC, 2006, EMBO J, V25, P4061, DOI 10.1038/sj.emboj.7601276; Churbanova IY, 2008, J BIOL CHEM, V283, P5622, DOI 10.1074/jbc.M709147200; Joza N, 2005, MOL CELL BIOL, V25, P10261, DOI 10.1128/MCB.25.23.10261-10272.2005; Joza N, 2009, ANN NY ACAD SCI, V1171, P2, DOI 10.1111/j.1749-6632.2009.04681.x; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; Mate MJ, 2002, NAT STRUCT BIOL, V9, P442, DOI 10.1038/nsb793; McFarland R, 2009, J INTERN MED, V265, P210, DOI 10.1111/j.1365-2796.2008.02066.x; Modjtahedi N, 2006, TRENDS CELL BIOL, V16, P264, DOI 10.1016/j.tcb.2006.03.008; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200; Regev-Rudzki N, 2007, BIOESSAYS, V29, P772, DOI 10.1002/bies.20609; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; Sevrioukova IF, 2009, J MOL BIOL, V390, P924, DOI 10.1016/j.jmb.2009.05.013; Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Urbano A, 2005, EMBO J, V24, P2815, DOI 10.1038/sj.emboj.7600746; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461; Wang XC, 2002, SCIENCE, V298, P1587, DOI 10.1126/science.1076194; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; Ye H, 2002, NAT STRUCT BIOL, V9, P680, DOI 10.1038/nsb836; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Yu SW, 2009, ASN NEURO, V1, DOI 10.1042/AN20090046; Yuste VJ, 2005, CELL DEATH DIFFER, V12, P1445, DOI 10.1038/sj.cdd.4401687; Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335	28	156	161	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 9	2010	86	4					639	649		10.1016/j.ajhg.2010.03.002	http://dx.doi.org/10.1016/j.ajhg.2010.03.002			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	583YP	20362274	Green Published, Bronze			2022-12-18	WOS:000276716800016
J	Arredi, B; Poloni, ES; Paracchini, S; Zerjal, T; Fathallah, DM; Makrelouf, M; Pascali, VL; Novelletto, A; Tyler-Smith, C				Arredi, B; Poloni, ES; Paracchini, S; Zerjal, T; Fathallah, DM; Makrelouf, M; Pascali, VL; Novelletto, A; Tyler-Smith, C			A predominantly neolithic origin for Y-chromosomal DNA variation in North Africa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HIGH-RESOLUTION ANALYSIS; SHORT TANDEM REPEATS; SPATIAL AUTOCORRELATION; MIGRATORY EVENTS; MICROSATELLITE; DIFFERENTIATION; POLYMORPHISM; POPULATIONS; HAPLOTYPES; DIVERSITY	We have typed 275 men from five populations in Algeria, Tunisia, and Egypt with a set of 119 binary markers and 15 microsatellites from the Y chromosome, and we have analyzed the results together with published data from Moroccan populations. North African Y-chromosomal diversity is geographically structured and fits the pattern expected under an isolation-by-distance model. Autocorrelation analyses reveal an east-west cline of genetic variation that extends into the Middle East and is compatible with a hypothesis of demic expansion. This expansion must have involved relatively small numbers of Y chromosomes to account for the reduction in gene diversity towards the West that accompanied the frequency increase of Y haplogroup E3b2, but gene flow must have been maintained to explain the observed pattern of isolation-by-distance. Since the estimates of the times to the most recent common ancestor (TMRCAs) of the most common haplogroups are quite recent, we suggest that the North African pattern of Y-chromosomal variation is largely of Neolithic origin. Thus, we propose that the Neolithic transition in this part of the world was accompanied by demic diffusion of Afro-Asiatic-speaking pastoralists from the Middle East.	Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; Univ Sacred Heart, Ist Med Legale, I-00168 Rome, Italy; Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; Univ Geneva, Dept Anthropol, CH-1211 Geneva 4, Switzerland; Inst Pasteur Tunis, Tunis, Tunisia; Cent Lab, Chu Bab El Oued, Alger, Algeria; Univ Calabria, Dept Cell Biol, I-87036 Arcavacata Di Rende, Italy	Wellcome Trust Sanger Institute; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Oxford; University of Geneva; Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; University of Calabria	Arredi, B (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, Cambs, England.	b_arredi@libero.it; cts@sanger.ac.uk	zerjal, tatiana/AAO-9473-2020; pascali, vincenzo lorenzo/AAC-8436-2022; Paracchini, Silvia/AAU-6813-2021	Paracchini, Silvia/0000-0001-9934-8602; Novelletto, Andrea/0000-0002-1146-7680; Poloni, Estella S./0000-0002-8465-003X				ARIOTI M, 1997, NOMADIC PEOPLES, V1, P98; Ayub Q, 2000, Nucleic Acids Res, V28, pe8, DOI 10.1093/nar/28.2.e8; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BARBUJANI G, 1994, AM J PHYS ANTHROPOL, V95, P137, DOI 10.1002/ajpa.1330950203; Barker G. W. W., 2003, EXAMINING FARMING LA, P151; BERTORELLE G, 1995, GENETICS, V140, P811; Bosch E, 1997, HUM BIOL, V69, P295; Bosch E, 2001, AM J HUM GENET, V68, P1019, DOI 10.1086/319521; Bosch E, 1999, AM J HUM GENET, V65, P1623, DOI 10.1086/302676; CASANOVA M, 1985, SCIENCE, V230, P1403, DOI 10.1126/science.2999986; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; Cruciani F, 2004, AM J HUM GENET, V74, P1014, DOI 10.1086/386294; Diamond J, 2003, SCIENCE, V300, P597, DOI 10.1126/science.1078208; Ellis N, 2002, GENOME RES, V12, P339; Flores C, 2001, HUM BIOL, V73, P513, DOI 10.1353/hub.2001.0046; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Kayser M, 2000, AM J HUM GENET, V66, P1580, DOI 10.1086/302905; Luis JR, 2004, AM J HUM GENET, V74, P532, DOI 10.1086/382286; Maca-Meyer N, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-15; Manni F, 2002, HUM BIOL, V74, P645, DOI 10.1353/hub.2002.0054; MCEVEDY C, 1980, PENGUIN ATLAS AFRICA; MUZZOLINI A, 1993, ARCHAEOLOGY AFRICA F, P227; Paracchini S, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e27; Repping S, 2003, NAT GENET, V35, P247, DOI 10.1038/ng1250; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Ruhlen M., 1991, GUIDE WORLDS LANGUAG, V1; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295; SLATKIN M, 1995, GENETICS, V139, P457; SOKAL RR, 1978, BIOL J LINN SOC, V10, P199, DOI 10.1111/j.1095-8312.1978.tb00013.x; Thomas MG, 1999, HUM GENET, V105, P577, DOI 10.1007/s004390051148; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Weale ME, 2001, HUM GENET, V109, P659, DOI 10.1007/s00439-001-0627-9; Wilson IJ, 1998, GENETICS, V150, P499; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911	38	156	156	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2004	75	2					338	345		10.1086/423147	http://dx.doi.org/10.1086/423147			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	838GR	15202071	Green Accepted, Green Published, Bronze			2022-12-18	WOS:000222702000019
J	Bastepe, M; Lane, AH; Yuppner, H				Bastepe, M; Lane, AH; Yuppner, H			Paternal uniparental isodisomy of chromosome 20q - and the resulting changes in GNAS1 methylation - as a plausible cause of pseudohypoparathyroidism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE; NEURONATIN; TRANSCRIPT; ANTISENSE; HORMONE; PROTEIN; CLUSTER; DISOMY; MICE; UPD	Heterozygous inactivating mutations in the GNAS1 exons (20q13.3) that encode the alpha -subunit of the stimulatory G protein (Gs alpha) are found in patients with pseudohypoparathyroidism type Ia (PHP-Ia) and in patients with pseudopseudohypoparathyroidism (pPHP). However, because of paternal imprinting, resistance to parathyroid hormone (PTH)-and, sometimes, to other hormones that require Gs alpha signaling-develops only if the defect is inherited from a female carrier of the disease gene. An identical mode of inheritance is observed in kindreds with pseudohypoparathyroidism type Ib (PHP-Ib), which is most likely caused by mutations in regulatory regions of the maternal GNAS1 gene that are predicted to interfere with the parent-specific methylation of this gene. We report a patient with PTH-resistant hypocalcemia and hyperphosphatemia but without evidence for Albright hereditary osteodystrophy who has paternal uniparental isodisomy of chromosome 20q and lacks the maternal-specific methylation pattern within GNAS1. Since studies in the patient's fibroblasts did not reveal any evidence of impaired Gs alpha protein or activity, it appears that the loss of the maternal GNAS1 gene and the resulting epigenetic changes alone can lead to PTH resistance in the proximal renal tubules and thus lead to impaired regulation of mineral-ion homeostasis.	Massachusetts Gen Hosp, Endocrine Unit, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, MassGen Hosp Children, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; SUNY Stony Brook, Stony Brook Sch Med, Dept Pediat, Div Pediat Endocrinol, Stony Brook, NY 11794 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Yuppner, H (corresponding author), Massachusetts Gen Hosp, Endocrine Unit, Dept Med, Wellman 5, Boston, MA 02114 USA.	jueppner@helix.mgh.harvard.edu	Bastepe, Murat/GQQ-3389-2022	Bastepe, Murat/0000-0002-2643-3504	PHS HHS [R01 46718-06] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bastepe M, 2000, ENDOCRIN METAB CLIN, V29, P569, DOI 10.1016/S0889-8529(05)70151-1; Bastepe M, 1999, MOL CELL PROBE, V13, P449, DOI 10.1006/mcpr.1999.0271; Chudoba I, 1999, EUR J HUM GENET, V7, P533, DOI 10.1038/sj.ejhg.5200287; DAVIES SJ, 1993, J MED GENET, V30, P101, DOI 10.1136/jmg.30.2.101; Dou DX, 1996, BRAIN RES, V723, P8, DOI 10.1016/0006-8993(96)00167-9; Farfel Z, 1999, J BONE MINER RES, V14, P1016; Hayward BE, 2000, HUM MOL GENET, V9, P835, DOI 10.1093/hmg/9.5.835; Hayward BE, 1998, P NATL ACAD SCI USA, V95, P15475, DOI 10.1073/pnas.95.26.15475; Hayward BE, 1998, P NATL ACAD SCI USA, V95, P10038, DOI 10.1073/pnas.95.17.10038; Juppner H, 1998, P NATL ACAD SCI USA, V95, P11798, DOI 10.1073/pnas.95.20.11798; Kikyo N, 1997, DEV BIOL, V190, P66, DOI 10.1006/dbio.1997.8681; Kotzot D, 1999, AM J MED GENET, V82, P265, DOI 10.1002/(SICI)1096-8628(19990129)82:3<265::AID-AJMG14>3.3.CO;2-Y; Levine Michael A., 1996, P853; Liu J, 2000, J CLIN INVEST, V106, P1167, DOI 10.1172/JCI10431; Nakamoto JM, 1998, AM J MED GENET, V77, P261; Nicholls RD, 2000, J CLIN INVEST, V105, P413, DOI 10.1172/JCI9460; Peters J, 1999, P NATL ACAD SCI USA, V96, P3830, DOI 10.1073/pnas.96.7.3830; Robinson WP, 2000, BIOESSAYS, V22, P452; Spinner N. B., 1994, American Journal of Human Genetics, V55, pA118; STRAIN L, 1995, NAT GENET, V11, P164, DOI 10.1038/ng1095-164; Tilghman SM, 1999, CELL, V96, P185, DOI 10.1016/S0092-8674(00)80559-0; Weinstein LS, 1998, CONT ENDOCRINOL, V6, P23; WILSON LC, 1994, J MED GENET, V31, P835, DOI 10.1136/jmg.31.11.835; Wroe SF, 2000, P NATL ACAD SCI USA, V97, P3342, DOI 10.1073/pnas.050015397; YAMAMOTO M, 1988, J CLIN ENDOCR METAB, V66, P618, DOI 10.1210/jcem-66-3-618; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715	26	156	163	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2001	68	5					1283	1289		10.1086/320117	http://dx.doi.org/10.1086/320117			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	423HZ	11294659	Green Published, Bronze			2022-12-18	WOS:000168171200022
J	Xu, XP; Rogus, JJ; Terwedow, HA; Yang, JH; Wang, ZX; Chen, CZ; Niu, TH; Wang, BY; Xu, HQ; Weiss, S; Schork, NJ; Fang, ZA				Xu, XP; Rogus, JJ; Terwedow, HA; Yang, JH; Wang, ZX; Chen, CZ; Niu, TH; Wang, BY; Xu, HQ; Weiss, S; Schork, NJ; Fang, ZA			An extreme-sib-pair genome scan for genes regulating blood pressure	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; LINKAGE ANALYSIS; COMPLEX TRAITS; HYPERTENSION; DISEASE; POWER; DETERMINANTS; REGION	Hypertension, a risk factor for many cardiovascular, cerebrovascular, and renal diseases, affects one in four Americans, at an annual cost of >$30 billion. Although genetic mutations have been identified in rare forms of hypertension, including Liddle syndrome and glucocorticoid-remediable aldosteronism, the abundance of plausible candidate genes and potential environmental risk factors has complicated the genetic dissection of more prevalent essential hypertension. To search systematically for chromosomal regions containing genes that regulate blood pressure, we scanned the entire autosomal genome by using 367 polymorphic markers. Our study population, selected from a blood-pressure screen of >200,000 Chinese adults, comprises rare but highly efficient extreme sib pairs (207 discordant, 258 high concordant, and 99 low concordant) and all but a single parent of these sibs. By virtue of the sampling design, the number of sib pairs,:and the availability of genotyped parents, this study represents one of the most powerful of its kind. Although no regions achieved a 5% genomewide significance level, maximum LOD-score values were >2.0 (unadjusted P < .001) for:regions containing five markers (D3S2387, D11S2019, D15S657, D16S3396, and D17S1303), in our primary analysis. Other promising regions identified through:secondary analyses include loci near D4S3248, D7S2195, D10S1423, D20S470, D20S482, D21S2052, PAH, and AGT.	Harvard Univ, Sch Publ Hlth, Program Populat Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Channing Lab, Boston, MA USA; Anhui Med Univ, Inst Biomed, Hefei, Peoples R China; Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Anhui Medical University; Case Western Reserve University	Xu, XP (corresponding author), Harvard Univ, Sch Publ Hlth, Program Populat Genet, FXB-101,665 Huntington Ave, Boston, MA 02115 USA.			Schork, Nicholas/0000-0003-0920-5013	NCRR NIH HHS [RR03655-11] Funding Source: Medline; NHLBI NIH HHS [HL54998-01, HL 94-011] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL054998] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; BUFFONE GJ, 1985, CLIN CHEM, V31, P164; CARDON LR, 1994, AM J HUM GENET, V55, P825; CAREY G, 1991, AM J HUM GENET, V49, P786; CHEN J, 1990, DIET LIFE STYLE MORT, P848; Frossard PM, 1995, CLIN GENET, V48, P284; HOLMANS P, 1993, AM J HUM GENET, V52, P362; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; Julier C, 1997, HUM MOL GENET, V6, P2077, DOI 10.1093/hmg/6.12.2077; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V56, P1212; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lunetta KL, 1998, GENET EPIDEMIOL, V15, P595, DOI 10.1002/(SICI)1098-2272(1998)15:6<595::AID-GEPI4>3.0.CO;2-4; Olson JM, 1997, AM J HUM GENET, V61, pA289; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1995, SCIENCE, V268, P1584, DOI 10.1126/science.7777857; Risch NJ, 1996, AM J HUM GENET, V58, P836; Rogus JJ, 1997, GENET EPIDEMIOL, V14, P879, DOI 10.1002/(SICI)1098-2272(1997)14:6<879::AID-GEPI53>3.0.CO;2-J; ROGUS JJ, IN PRESS GENET EPIDE; Schaid DJ, 1996, GENET EPIDEMIOL, V13, P423, DOI 10.1002/(SICI)1098-2272(1996)13:5<423::AID-GEPI1>3.0.CO;2-3; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; SUAREZ BK, 1979, CLIN GENET, V15, P126; WATT GCM, 1992, J HYPERTENS, V10, P473, DOI 10.1097/00004872-199205000-00011; Xu XP, 1997, ANN EPIDEMIOL, V7, P95, DOI 10.1016/S1047-2797(96)00126-3; Yuan B, 1997, AM J HUM GENET, V60, P459	26	156	169	1	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1999	64	6					1694	1701		10.1086/302405	http://dx.doi.org/10.1086/302405			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	203FA	10330357	Green Published, Bronze			2022-12-18	WOS:000080696200022
J	Parsons, DW; McAndrew, PE; Iannaccone, ST; Mendell, JR; Burghes, AHM; Prior, TW				Parsons, DW; McAndrew, PE; Iannaccone, ST; Mendell, JR; Burghes, AHM; Prior, TW			Intragenic telSMN mutations: Frequency, distribution, evidence of a founder effect, and modification of the spinal muscular atrophy phenotype by cenSMN copy number	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MOTOR-NEURON GENE; SMN GENE; LINKAGE ANALYSIS; MOLECULAR ANALYSIS; CANADIAN FAMILIES; SURVIVAL; REGION; DELETIONS; DISEASE; PROTEIN	The autosomal recessive neuromuscular disorder proximal spinal muscular atrophy (SMA) is caused by the loss or mutation of the survival motor neuron (SMN) gene, which exists in two nearly identical copies, telomeric SMN (telSMN) and centromeric SMN (cenSMN). Exon 7 of the telSMN gene is homozygously absent in similar to 95% of SMA patients, whereas loss of cenSMN does not cause SMA. We searched for other telSMN mutations among 23 SMA compound heterozygotes, using heteroduplex analysis. We identified telSMN mutations in 11 of these unrelated SMA-like individuals who carry a single copy of telSMN: these include two frameshift mutations (800ins11 and 542delGT) and three missense mutations (A2G, S262I, and T2741). The telSMN mutations identified to date cluster at the 3' end, in a region containing sites for SMN oligomerization and binding of Sm proteins. Interestingly, the novel A2G missense mutation occurs outside this conserved carboxy-terminal domain, closely upstream of an SIP1 (SMN-interacting protein 1) binding site. In three patients, the A2G mutation was found to be on the same allele as a rare polymorphism in the 5' UTR, providing evidence for a founder chromosome; Ag1-CA marker data also support evidence of an ancestral origin for the 800ins11 and 542delGT mutations. We note that telSMN missense mutations are associated with milder disease in our patients and that the severe type I SMA phenotype caused by frameshift mutations can be ameliorated by an increase in cenSMN gene copy number.	Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA; Ohio State Univ, Dept Med Biochem, Columbus, OH 43210 USA; Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; Univ Texas, SW Med Ctr, Dept Neurol, Dallas, TX 75235 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Prior, TW (corresponding author), Ohio State Univ, Dept Pathol, 121 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.	prior-1@medctr.osu.edu		Burghes, Arthur/0000-0001-9031-1555; Parsons, Donald/0000-0002-8775-3501				Brahe C, 1996, HUM MOL GENET, V5, P1971, DOI 10.1093/hmg/5.12.1971; BRAHE C, 1994, HUM GENET, V93, P494, DOI 10.1007/BF00202811; BRZUSTOWICZ LM, 1990, NATURE, V344, P540, DOI 10.1038/344540a0; BURGHES AHM, 1994, GENOMICS, V21, P394, DOI 10.1006/geno.1994.1282; Burghes AHM, 1997, AM J HUM GENET, V61, P9, DOI 10.1086/513913; BURGHES AHM, 1994, HUM GENET, V93, P305, DOI 10.1007/BF00212028; Burglen L, 1997, AM J HUM GENET, V60, P72; Burglen L, 1996, GENOMICS, V32, P479, DOI 10.1006/geno.1996.0147; BURGLEN L, 1996, 1 C WORLD MUSCL SOC; BUSSAGLIA E, 1995, NAT GENET, V11, P335, DOI 10.1038/ng1195-335; Campbell L, 1997, AM J HUM GENET, V61, P40, DOI 10.1086/513886; CARPTEN JD, 1994, GENOMICS, V24, P351, DOI 10.1006/geno.1994.1626; Carter TA, 1997, HUM MOL GENET, V6, P229, DOI 10.1093/hmg/6.2.229; CHAKRABARTTY A, 1991, NATURE, V351, P586, DOI 10.1038/351586a0; COBBEN JM, 1995, AM J HUM GENET, V57, P805; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; DANIELS RJ, 1992, GENOMICS, V12, P335, DOI 10.1016/0888-7543(92)90382-3; DIDONATO CJ, 1994, AM J HUM GENET, V55, P1218; DiDonato CJ, 1997, ANN NEUROL, V41, P230, DOI 10.1002/ana.410410214; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; FRANCIS MJ, 1993, HUM MOL GENET, V2, P1161, DOI 10.1093/hmg/2.8.1161; GENNARELLI M, 1995, BIOCHEM BIOPH RES CO, V213, P342, DOI 10.1006/bbrc.1995.2135; HAHNEN E, 1995, HUM MOL GENET, V4, P1927, DOI 10.1093/hmg/4.10.1927; Hahnen E, 1996, AM J HUM GENET, V59, P1057; Hahnen E, 1997, HUM MOL GENET, V6, P821, DOI 10.1093/hmg/6.5.821; JOLLY DJ, 1983, P NATL ACAD SCI-BIOL, V80, P477, DOI 10.1073/pnas.80.2.477; KLEYN PW, 1993, P NATL ACAD SCI USA, V90, P6801, DOI 10.1073/pnas.90.14.6801; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Lorson CL, 1998, NAT GENET, V19, P63, DOI 10.1038/ng0598-63; Lorson CL, 1998, HUM MOL GENET, V7, P1269, DOI 10.1093/hmg/7.8.1269; LYU PC, 1990, SCIENCE, V250, P669, DOI 10.1126/science.2237416; MACKENZIE A, 1993, HUM GENET, V90, P501; Mattaj IW, 1998, CURR BIOL, V8, pR93, DOI 10.1016/S0960-9822(98)70055-7; McAndrew PE, 1997, AM J HUM GENET, V60, P1411, DOI 10.1086/515465; MELKI J, 1990, NATURE, V344, P767, DOI 10.1038/344767a0; MELKI J, 1994, SCIENCE, V264, P1474, DOI 10.1126/science.7910982; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MUNSAT TL, 1992, NEUROMUSCULAR DISORD, V2, P423, DOI 10.1016/S0960-8966(06)80015-5; Parsons DW, 1998, J MED GENET, V35, P674, DOI 10.1136/jmg.35.8.674; Parsons DW, 1996, HUM MOL GENET, V5, P1727, DOI 10.1093/hmg/5.11.1727; PEARN J, 1980, LANCET, V1, P919; Rochat B, 1997, PHARMACOGENETICS, V7, P1, DOI 10.1097/00008571-199702000-00001; RODRIGUES NR, 1995, HUM MOL GENET, V4, P631, DOI 10.1093/hmg/4.4.631; ROY N, 1995, CELL, V80, P167, DOI 10.1016/0092-8674(95)90461-1; Simard LR, 1997, AM J MED GENET, V72, P51, DOI 10.1002/(SICI)1096-8628(19971003)72:1<51::AID-AJMG11>3.0.CO;2-T; SIMARD LR, 1992, GENOMICS, V14, P188, DOI 10.1016/S0888-7543(05)80305-2; Talbot K, 1997, HUM MOL GENET, V6, P497, DOI 10.1093/hmg/6.3.497; THOMPSON TG, 1995, NAT GENET, V9, P56, DOI 10.1038/ng0195-56; vanderSteege G, 1996, AM J HUM GENET, V59, P834; VANDERSTEEGE G, 1995, LANCET, V345, P985, DOI 10.1016/S0140-6736(95)90732-7; Velasco E, 1996, HUM MOL GENET, V5, P257, DOI 10.1093/hmg/5.2.257; WIRTH B, 1994, GENOMICS, V20, P84, DOI 10.1006/geno.1994.1130; WIRTH B, 1995, EUR J HUM GENET, V3, P56	56	156	165	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1998	63	6					1712	1723		10.1086/302160	http://dx.doi.org/10.1086/302160			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EL	9837824	Green Published, Bronze			2022-12-18	WOS:000077707700017
J	Takano, H; Cancel, G; Ikeuchi, T; Lorenzetti, D; Mawad, R; Stevanin, G; Didierjean, O; Durr, A; Oyake, M; Shimohata, T; Sasaki, R; Koide, R; Igarashi, S; Hayashi, S; Takiyama, Y; Nishizawa, M; Tanaka, H; Zoghbi, H; Brice, A; Tsuji, S				Takano, H; Cancel, G; Ikeuchi, T; Lorenzetti, D; Mawad, R; Stevanin, G; Didierjean, O; Durr, A; Oyake, M; Shimohata, T; Sasaki, R; Koide, R; Igarashi, S; Hayashi, S; Takiyama, Y; Nishizawa, M; Tanaka, H; Zoghbi, H; Brice, A; Tsuji, S			Close associations between prevalences of dominantly inherited spinocerebellar ataxias with CAG-repeat expansions and frequencies of large normal CAG alleles in Japanese and Caucasian populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MACHADO-JOSEPH-DISEASE; ALPHA(1A)-VOLTAGE-DEPENDENT CALCIUM-CHANNEL; DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; HUNTINGTONS-DISEASE; LINKAGE DISEQUILIBRIUM; INTERMEDIATE ALLELES; CEREBELLAR-ATAXIA; TRINUCLEOTIDE REPEATS; HAPLOTYPE ANALYSIS; MJD1 GENE	To test the hypothesis that the frequencies of normal alleles (ANs) with a relatively large number of CAG repeats (large ANs) are related to the prevalences of the dominant spinocerebellar ataxias (SCAs)-SCA types 1, 2, 3 (Machado-Joseph disease), 6, and dentatorubral-pallidoluysian atrophy (DRPLA)-we investigated the relative prevalences of these diseases in 202 Japanese and 177 Caucasian families and distributions of the number of CAG repeats of ANs at these disease loci in normal individuals in each population. The relative prevalences of SCA1 and SCA2 were significantly higher in Caucasian pedigrees (15% and 14%, respectively) than in Japanese pedigrees (3% and 5%, respectively), corresponding to the observation that the frequencies of large ANs of SCA1 (alleles >30 repeats) and of SCA2 (alleles >22 repeats) were significantly higher in Caucasians than in Japanese. The relative prevalences of MJD/SCA3, SCA6, and DRPLA were significantly higher in Japanese pedigrees (43%, 11%, and 20%, respectively) than in Caucasian pedigrees (30%, 5%, and 0%, respectively), corresponding to the observation that the frequencies of large ANs of MJD/SCAS (>27 repeats), SCA6 (>13 repeats), and DRPLA (>17 repeats) were significantly higher in Japanese than in Caucasians. The close correlations of the relative prevalences of the dominant SCAs with the distributions of large ANs strongly support the assumption that large ANs contribute to generation of expanded alleles (AEs) and the relative prevalences of the dominant SCAs.	Niigata Univ, Brain Res Inst, Dept Neurol, Niigata 9518585, Japan; Niigata Univ, Brain Res Inst, Dept Pathol, Niigata 9518585, Japan; Hop La Pitie Salpetriere, INSERM U289, Paris, France; Howard Hughes Med Inst, Dept Pediat, Houston, TX 77030 USA; Howard Hughes Med Inst, Dept Neurol, Houston, TX 77030 USA; Howard Hughes Med Inst, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Houston, TX 77030 USA; Jichi Med Sch, Dept Neurol, Tochigi, Japan	Niigata University; Niigata University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Howard Hughes Medical Institute; Howard Hughes Medical Institute; Howard Hughes Medical Institute; Baylor College of Medicine; Jichi Medical University	Tsuji, S (corresponding author), Niigata Univ, Brain Res Inst, Dept Neurol, 1 Asahi Machi, Niigata 9518585, Japan.	tsuji@cc.niigata-u.ac.jp	brice, alexis/AAE-8275-2019; Stevanin, Giovanni/E-5038-2016; Brice, Alexis/A-2170-2009	brice, alexis/0000-0002-0941-3990; Stevanin, Giovanni/0000-0001-9368-8657; Cancel-Tassin, Geraldine/0000-0002-9583-6382; Zoghbi, Huda/0000-0002-0700-3349	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027699] Funding Source: NIH RePORTER; NINDS NIH HHS [NS27699] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BURKE AR, 1994, LANCET, V344, P1711, DOI 10.1016/S0140-6736(94)90497-9; Cancel G, 1997, HUM MOL GENET, V6, P709, DOI 10.1093/hmg/6.5.709; Chong SS, 1997, HUM MOL GENET, V6, P301, DOI 10.1093/hmg/6.2.301; David G, 1997, NAT GENET, V17, P65, DOI 10.1038/ng0997-65; DEKA R, 1995, AM J HUM GENET, V57, P508; Durr A, 1996, ANN NEUROL, V39, P490, DOI 10.1002/ana.410390411; Endo K, 1996, AM J MED GENET, V67, P437, DOI 10.1002/(SICI)1096-8628(19960920)67:5<437::AID-AJMG1>3.0.CO;2-H; Flanigan K, 1996, AM J HUM GENET, V59, P392; Geschwind DH, 1997, AM J HUM GENET, V60, P842; GOLDBERG YP, 1993, NAT GENET, V5, P174, DOI 10.1038/ng1093-174; GOLDBERG YP, 1995, HUM MOL GENET, V4, P1911, DOI 10.1093/hmg/4.10.1911; HARDING AE, 1982, BRAIN, V105, P1, DOI 10.1093/brain/105.1.1; HERNANDEZ A, 1995, GENOMICS, V25, P433, DOI 10.1016/0888-7543(95)80043-L; Ikeuchi T, 1997, ANN NEUROL, V42, P879, DOI 10.1002/ana.410420609; Illarioshkin SN, 1996, J NEUROL, V243, P506, DOI 10.1007/BF00886871; Imbert G, 1996, NAT GENET, V14, P285, DOI 10.1038/ng1196-285; Ishikawa K, 1997, AM J HUM GENET, V61, P336, DOI 10.1086/514867; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; La Spada AR, 1998, HUM MOL GENET, V7, P959, DOI 10.1093/hmg/7.6.959; LEEFLANG EP, 1995, HUM MOL GENET, V4, P1519; Lorenzetti D, 1997, NEUROLOGY, V49, P1009, DOI 10.1212/WNL.49.4.1009; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MYERS RH, 1993, NAT GENET, V5, P168, DOI 10.1038/ng1093-168; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; RANUM LPW, 1995, AM J HUM GENET, V57, P603; RANUM LPW, 1994, NAT GENET, V8, P280, DOI 10.1038/ng1194-280; Riess O, 1997, HUM MOL GENET, V6, P1289, DOI 10.1093/hmg/6.8.1289; RUBINSZTEIN DC, 1994, NAT GENET, V7, P525, DOI 10.1038/ng0894-525; Sanpei K, 1996, NAT GENET, V14, P277, DOI 10.1038/ng1196-277; SCHOLS L, 1995, HUM MOL GENET, V4, P1001, DOI 10.1093/hmg/4.6.1001; Silveira I, 1996, NEUROLOGY, V46, P214, DOI 10.1212/WNL.46.1.214; SQUITIERI F, 1994, HUM MOL GENET, V3, P2103, DOI 10.1093/hmg/3.12.2103; Stevanin G, 1997, NEUROLOGY, V49, P1243, DOI 10.1212/WNL.49.5.1243; Stevanin G, 1997, AM J HUM GENET, V60, P1548; STEVANIN G, 1995, AM J HUM GENET, V57, P1247; TAKIYAMA Y, 1995, HUM MOL GENET, V4, P1137, DOI 10.1093/hmg/4.7.1137; WAKISAKA A, 1995, J MED GENET, V32, P590, DOI 10.1136/jmg.32.8.590; Yanagisawa H, 1996, HUM MOL GENET, V5, P373, DOI 10.1093/hmg/5.3.373; ZHANG L, 1994, NAT GENET, V7, P531, DOI 10.1038/ng0894-531; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	43	156	163	0	11	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1998	63	4					1060	1066		10.1086/302067	http://dx.doi.org/10.1086/302067			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	131LP	9758625	Green Published, Bronze			2022-12-18	WOS:000076577800018
J	Beutler, E				Beutler, E			The significance of the 187G (H63D) mutation in hemochromatosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							HEREDITARY HEMOCHROMATOSIS				Beutler, E (corresponding author), Scripps Res Inst, DEPT MOL & EXPT MED, 10550 N TORREY PINES RD, LA JOLLA, CA 92037 USA.				NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL025552, R37HL025552] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00833] Funding Source: Medline; NHLBI NIH HHS [HL25552] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALLITTO B, 1996, SCI S ADV JEW GEN DI; Beutler E, 1997, MOL MED, V3, P397, DOI 10.1007/BF03401686; Beutler E, 1997, BLOOD CELL MOL DIS, V23, P95, DOI 10.1006/bcmd.1997.0125; Beutler E, 1997, LANCET, V349, P296, DOI 10.1016/S0140-6736(97)22005-2; Beutler E, 1997, BLOOD CELL MOL DIS, V23, pA145, DOI 10.1006/bcmd.1997.0130; Beutler Ernest, 1996, Blood Cells Molecules and Diseases, V22, P187, DOI 10.1006/bcmd.1996.0027; Borot N, 1997, IMMUNOGENETICS, V45, P320, DOI 10.1007/s002510050211; Carella M, 1997, AM J HUM GENET, V60, P828; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; JAZWINSKA EC, 1995, AM J HUM GENET, V56, P428; Jazwinska EC, 1996, NAT GENET, V14, P249, DOI 10.1038/ng1196-249; Jouanolle AM, 1996, NAT GENET, V14, P251, DOI 10.1038/ng1196-251; Roberts AG, 1997, LANCET, V349, P321, DOI 10.1016/S0140-6736(96)09436-6; Rothenberg BE, 1996, P NATL ACAD SCI USA, V93, P1529, DOI 10.1073/pnas.93.4.1529; Santos M, 1996, J EXP MED, V184, P1975, DOI 10.1084/jem.184.5.1975	15	156	160	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1997	61	3					762	764						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XY523	9326341				2022-12-18	WOS:A1997XY52300033
J	Serra, E; Puig, S; Otero, D; Gaona, A; Kruyer, H; Ars, E; Estivill, X; Lazaro, C				Serra, E; Puig, S; Otero, D; Gaona, A; Kruyer, H; Ars, E; Estivill, X; Lazaro, C			Confirmation of a double-hit model for the NF1 gene in benign neurofibromas	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TYPE-1 GENE; VONRECKLINGHAUSEN NEUROFIBROMATOSIS; SCHWANN-CELLS; MUTATIONS; TUMORS; ALLELES; CHROMOSOME-17; DELETIONS; PROTEIN; GAP	Neurofibroma is a benign tumor that arises from small or large nerves. This neoplastic lesion is a common feature of neurofibromatosis type 1 (NF1), one of the most common autosomal dominant disorders, The NF1 gene codes for a protein called ''neurofibromin.'' It possesses a region that shares a high homology with the family of GTPase-activating proteins, which are negative regulators of RAS function and thereby control cell growth and differentiation. The evidence points to the NF1 gene being a tumor-suppressor gene. NF1 patients also have an increased incidence of certain malignant tumors that ape believed to follow the ''two hit'' hypothesis, with one allele constitutionally inactivated and the other somatically mutated. Recently, somatic loss of heterozygosity (LOH) has been described for neurofibromas, and mutations in both copies of the NF1 gene have been reported for a dermal neurofibroma. The aim of our study was the analysis of the NF1 locus in benign neuro-fibromas in NF1 patients. We performed LOH analysis on GO neurofibromas belonging to 17 patients, 9 of them with family history of the disease and 8 of them sporadic, We have analyzed five intragenic NF1 markers and six extragenic markers, and we have found LOH in 25% of the neurofibromas (corresponding to 53% of the patients). In addition, we found that in the neurofibromas of patients from familial cases the deletions occurred in the allele that is not transmitted with the disease, indicating that both copies of the NF1 gene were inactivated in these tumors. Therefore, the recent reports mentioned above, together with our findings, strongly suppers the double inactivation of the NF1 gene in benign neurofibromas.	HOSP DURAN & REYNALS,MED & MOL GENET CTR,IRO,BARCELONA 08907,SPAIN; HOSP CLIN BARCELONA,SERV GENET,BARCELONA,SPAIN; HOSP CLIN BARCELONA,DERMATOL SERV,BARCELONA,SPAIN	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona			GARCIA, CONXI LAZARO/Q-2410-2016; Serra, Eduard/K-1332-2013; Ars, Elisabet/AAM-8454-2021; Puig, Susana/AAB-2091-2020; Estivill, Xavier/A-3125-2013; Estivill, Xavier/E-2957-2012	GARCIA, CONXI LAZARO/0000-0002-7198-5906; Serra, Eduard/0000-0003-2895-9857; Ars, Elisabet/0000-0002-4118-4358; Puig, Susana/0000-0003-1337-9745; Estivill, Xavier/0000-0002-0723-2256; 				ANDERSEN LB, 1993, NAT GENET, V3, P118, DOI 10.1038/ng0293-118; BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; COLMAN SD, 1995, NAT GENET, V11, P90, DOI 10.1038/ng0995-90; DeVitis LR, 1996, HUM GENET, V97, P632; DIB C, 1996, NATURE, V380, pA102; EASTON DF, 1993, AM J HUM GENET, V53, P305; FEARON ER, 1990, CELL, V61, P757; FRIEDMAN TB, 1995, NAT GENET, V9, P86, DOI 10.1038/ng0195-86; GLOVER TW, 1991, GENE CHROMOSOME CANC, V3, P62, DOI 10.1002/gcc.2870030111; Ichii Shigetoshi, 1992, Human Molecular Genetics, V1, P387, DOI 10.1093/hmg/1.6.387; KAMATA Y, 1978, ACTA PATHOL JAPON, V28, P393; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Lazaro C, 1996, HUM GENET, V98, P696, DOI 10.1007/s004390050287; LEGIUS E, 1993, NAT GENET, V3, P122, DOI 10.1038/ng0293-122; Levanat S, 1996, NAT GENET, V12, P85, DOI 10.1038/ng0196-85; LI Y, 1992, CELL, V69, P275, DOI 10.1016/0092-8674(92)90408-5; LI Y, 1995, GENOMICS, V25, P9, DOI 10.1016/0888-7543(95)80104-T; LOTHE RA, 1995, J NEUROPATH EXP NEUR, V54, P65, DOI 10.1097/00005072-199501000-00008; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; MENON AG, 1990, P NATL ACAD SCI USA, V87, P5435, DOI 10.1073/pnas.87.14.5435; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; OTTINI L, 1995, CANCER RES, V55, P5677; Rahman N, 1996, NAT GENET, V13, P461, DOI 10.1038/ng0896-461; Riccardi V. M., 1992, NEUROFIBROMATOSIS PH; ROGERS GR, 1995, AM J HUM GENET, V57, P1123; ROSENBAUM T, 1995, DEVELOPMENT, V121, P3583; Sawada S, 1996, NAT GENET, V14, P110, DOI 10.1038/ng0996-110; SHANNON KM, 1994, NEW ENGL J MED, V330, P597, DOI 10.1056/NEJM199403033300903; Shen MH, 1996, J MED GENET, V33, P2, DOI 10.1136/jmg.33.1.2; SKUSE GR, 1991, AM J HUM GENET, V49, P600; SKUSE GR, 1989, GENE CHROMOSOME CANC, V1, P36, DOI 10.1002/gcc.2870010107; STARK M, 1995, HUM GENET, V96, P619; STEFANSSON K, 1982, AM J PATHOL, V106, P261; THE I, 1993, NAT GENET, V3, P62, DOI 10.1038/ng0193-62; UPADHYAYA M, 1994, HUM MUTAT, V4, P83, DOI 10.1002/humu.1380040202; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; WAGGENER JD, 1966, CANCER-AM CANCER SOC, V19, P699, DOI 10.1002/1097-0142(196605)19:5<699::AID-CNCR2820190516>3.0.CO;2-H; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; Wu Q, 1995, NUCLEIC ACIDS RES, V23, P5087, DOI 10.1093/nar/23.24.5087; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9; XU GF, 1990, CELL, V62, P599, DOI 10.1016/0092-8674(90)90024-9; XU W, 1992, GENE CHROMOSOME CANC, V4, P337, DOI 10.1002/gcc.2870040411	43	156	159	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1997	61	3					512	519		10.1086/515504	http://dx.doi.org/10.1086/515504			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XY523	9326316	Bronze, Green Published			2022-12-18	WOS:A1997XY52300008
J	Tsai, MY; Bignell, M; Schwichtenberg, K; Hanson, NQ				Tsai, MY; Bignell, M; Schwichtenberg, K; Hanson, NQ			High prevalence of a mutation in the cystathionine beta-synthase gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MOLECULAR-BASIS; HOMOCYSTINURIA; DEFICIENCY; HYPERHOMOCYSTEINEMIA; PHENOTYPE; RISK	We found that a mutation preciously described by Sebastio et al., involving a GS-bp insertion in the coding region of exon 8 of the cystathionine-beta-synthase (CBS) gene in a single patient with homocystinuria, is highly prevalent. In our control population, 11.7% (9/77) of the individuals were hetorozygous carriers of this mutation. In contrast to the previous report, which assumed that the 68-bp insertion introduced a premature-termination codon and resulted in a nonfunctional CBS enzyme, we found that the presence of this mutation is not associated with hyperhomocysteinemia. Assay of CBS activity in transformed lymphocytes from individuals who were heterozygous or homozygous for this mutation showed normal activity. Furthermore, reverse-transcription-PCR showed that individuals carrying this mutation have normal size mRNA. Our results suggest that the insertion creates an alternate splicing site, which eliminates not only the inserted intronic sequences but also the T833C mutation associated with this insertion. The net result is the generation of both quantitatively and qualitatively normal mRNA and CBS enzyme. Although the mutation does not seem to affect the activity of the CBS enzyme, the prevalence is somewhat increased in patients with premature coronary-artery disease, although the difference is not statistically significant.	UNIV MINNESOTA,SCH MED,DEPT LAB MED & PATHOL,MINNEAPOLIS,MN 55455	University of Minnesota System; University of Minnesota Twin Cities				Tsai, Michael/0000-0001-7553-3408				ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; BOERS GHJ, 1985, HUM GENET, V69, P164, DOI 10.1007/BF00293290; CHENG J, 1993, MOL CELL BIOL, V13, P1892, DOI 10.1128/MCB.13.3.1892; CLARKE R, 1991, NEW ENGL J MED, V324, P1149, DOI 10.1056/NEJM199104253241701; ENGBERSEN AMT, 1995, AM J HUM GENET, V56, P142; HU FL, 1993, HUM MOL GENET, V2, P1857, DOI 10.1093/hmg/2.11.1857; KLUIJTMANS LAJ, 1995, HUM GENET, V96, P249, DOI 10.1007/BF00207394; KRAUS JP, 1994, J INHERIT METAB DIS, V17, P383, DOI 10.1007/BF00711354; LAVIGUEUR A, 1993, GENE DEV, V7, P2405, DOI 10.1101/gad.7.12a.2405; SEBASTIO G, 1995, AM J HUM GENET, V56, P1324; SELHUB J, 1995, NEW ENGL J MED, V332, P286, DOI 10.1056/NEJM199502023320502; SHIH VE, 1995, AM J HUM GENET, V57, P34; SPERANDEO MP, 1995, J INHERIT METAB DIS, V18, P211, DOI 10.1007/BF00711769; STAMPFER MJ, 1992, JAMA-J AM MED ASSOC, V268, P877, DOI 10.1001/jama.268.7.877; Tsai MY, 1996, ATHEROSCLEROSIS, V122, P69, DOI 10.1016/0021-9150(95)05748-X; TSAI MY, 1996, CLIN BIOCHEM, V28, P473; XU RS, 1993, MOL CELL BIOL, V13, P3660, DOI 10.1128/MCB.13.6.3660	17	156	171	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1996	59	6					1262	1267						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV315	8940271				2022-12-18	WOS:A1996VV31500012
J	BAILLIET, G; ROTHHAMMER, F; CARNESE, FR; BRAVI, CM; BIANCHI, NO				BAILLIET, G; ROTHHAMMER, F; CARNESE, FR; BRAVI, CM; BIANCHI, NO			FOUNDER MITOCHONDRIAL HAPLOTYPES IN AMERINDIAN POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN-EVOLUTION; DNA; MTDNA; MIGRATIONS; AFFINITIES; MUTATIONS; SEQUENCES; LINEAGES; AMERICA; GENOME	It has been proposed that the colonization of the New World took place by three successive migrations from northeastern Asia. The first one gave rise to Amerindians (Paleo-Indians), the second and third ones to Nadene and Aleut-Eskimo, respectively. Variation in mtDNA has been used to infer the demographic structure of the Amerindian ancestors. The study of RFLP all along the mtDNA and the analysis of nucleotide substitutions in the D-loop region of the mitochondrial genome apparently indicate that most or all full-blooded Amerindians cluster in one of four different mitochondrial haplotypes that are considered to represent the founder maternal lineages of Paleo-Indians. We have studied the mtDNA diversity in 109 Amerindians belonging to 3 different tribes, and we have reanalyzed the published data on 482 individuals from 18 other tribes. Our study confirms the existence of four major Amerindian haplotypes. However, we also found evidence supporting the existence of several other potential founder haplotypes or haplotype subsets in addition to the four ancestral lineages reported. Confirmation of a relatively high number of founder haplotypes would indicate that early migration into America was not accompanied by a severe genetic bottleneck.	IMBICE, RA-1900 LA PLATA, ARGENTINA; UNIV CHILE, FAC MED, DEPT BIOL CELULAR & GENET, SANTIAGO 7, CHILE; UNIV BUENOS AIRES, FAC FILOSOFIA & LETRAS, MUSEO ETNOGRAF JUAN B AMBROSETTI, ANTROPOL BIOL SECC, BUENOS AIRES, DF, ARGENTINA	Universidad de Chile; University of Buenos Aires								ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BALLINGER SW, 1992, GENETICS, V130, P139; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CAVALLISFORZA LL, 1988, P NATL ACAD SCI USA, V85, P6002, DOI 10.1073/pnas.85.16.6002; CHAKRABORTY R, 1975, AM J PHYS ANTHROPOL, V42, P507, DOI 10.1002/ajpa.1330420319; CHAKRABORTY R, 1991, AM J PHYS ANTHROPOL, V86, P497, DOI 10.1002/ajpa.1330860405; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; GINTHER C, 1993, EXS, V67, P211; GREENBERG JH, 1986, CURR ANTHROPOL, V27, P477, DOI 10.1086/203472; HERTZBERG M, 1989, AM J HUM GENET, V44, P504; HORAI S, 1993, MOL BIOL EVOL, V10, P23; HORAI S, 1990, AM J HUM GENET, V46, P828; JOHN SWM, 1991, NUCLEIC ACIDS RES, V19, P408, DOI 10.1093/nar/19.2.408; Meltzer David J., 1993, EVOL ANTHROPOL, V1, P157; MERRIWETHER DA, 1993, AM J HUM GENET, V53, P833; REED TE, 1968, AM J HUM GENET, V20, P579; SCHURR TG, 1990, AM J HUM GENET, V46, P613; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; STONE AC, 1993, AM J PHYS ANTHROPOL, V92, P463, DOI 10.1002/ajpa.1330920405; SZATHMARY EJE, 1993, AM J HUM GENET, V53, P793; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; VIGILANT L, 1989, P NATL ACAD SCI USA, V86, P9350, DOI 10.1073/pnas.86.23.9350; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; WRISCHNIK LA, 1987, NUCLEIC ACIDS RES, V15, P529, DOI 10.1093/nar/15.2.529	27	156	166	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1994	55	1					27	33						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NW461	7517626				2022-12-18	WOS:A1994NW46100005
J	KAYES, LM; BURKE, W; RICCARDI, VM; BENNETT, R; EHRLICH, P; RUBENSTEIN, A; STEPHENS, K				KAYES, LM; BURKE, W; RICCARDI, VM; BENNETT, R; EHRLICH, P; RUBENSTEIN, A; STEPHENS, K			DELETIONS SPANNING THE NEUROFIBROMATOSIS-I GENE - IDENTIFICATION AND PHENOTYPE OF 5 PATIENTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VON RECKLINGHAUSEN NEUROFIBROMATOSIS; OLIGODENDROCYTE-MYELIN GLYCOPROTEIN; SOUTH EAST WALES; NOONAN SYNDROME; TYPE-1 GENE; VONRECKLINGHAUSEN NEUROFIBROMATOSIS; GENOMIC STRUCTURE; LINKAGE ANALYSIS; CDNA SEQUENCE; DNA DELETION	Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder characterized by marked variation in clinical severity. To investigate the contribution to variability by genes either contiguous to or contained within the NF1 gene, we screened six NF1 patients with mild facial dysmorphology, mental retardation, and/or learning disabilities, for DNA rearrangement of the NF1 region. Five of the six patients had NF1 gene deletions on the basis of quantitative densitometry, locus hemizygosity, and analysis of somatic cell hybrid lines. Analyses of hybrid lines carrying each of the patient's chromosomes 17, with 15 regional DNA markers, demonstrated that each of the five patients carried a deletion >700 kb in size. Minimally, each of the deletions involved the entire 350-kb NF1 gene; the three genes-EVI2A, EV12B, and OMG-that are contained within an NF1 intron; and considerable flanking DNA. For four of the patients, the deletions mapped to the same interval; the deletion in the fifth patient was larger, extending farther in both directions. The remaining NF1 allele presumably produced functional neurofibromin; no gene rearrangements were detected, and RNA-PCR demonstrated that it was transcribed. These data provide compelling evidence that the NF1 disorder results from haploid insufficiency of neurofibromin. Of the three documented de novo deletion cases, two involved the paternal NF1 allele and one the maternal allele. The parental origin of the single remaining expressed NF1 allele had no dramatic effect on patient phenotype. The deletion patients exhibited a variable number of physical anomalies that were not correlated with the extent of their deletion. All five patients with deletions were remarkable for exhibiting a large number of neurofibromas for their age, suggesting that deletion of an unknown gene in the NF1 region may affect tumor initiation or development.	UNIV WASHINGTON, SCH MED, DEPT MED, DIV MED GENET, SEATTLE, WA 98195 USA; UNIV WASHINGTON, SCH MED, DEPT MED, DIV GEN INTERNAL MED, SEATTLE, WA 98195 USA; NEUROFIBROMATOSIS INST INC, PASADENA, CA USA; CUNY MT SINAI SCH MED, MT SINAI NEUROFIBROMATOSIS CTR, NEW YORK, NY USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai					NINDS NIH HHS [F32-NS09121] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS009121] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABUELO DN, 1988, AM J MED GENET, V29, P937, DOI 10.1002/ajmg.1320290426; AINSWORTH PJ, 1991, AM J HUM GENET, V49, P1098; ALLANSON JE, 1987, J MED GENET, V24, P9, DOI 10.1136/jmg.24.1.9; ALLANSON JE, 1985, AM J MED GENET, V21, P457, DOI 10.1002/ajmg.1320210307; ANDERSEN LB, 1993, NAT GENET, V3, P118, DOI 10.1038/ng0293-118; [Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; [Anonymous], 1992, Science, V258, P67; BARKER D, 1987, SCIENCE, V236, P1100, DOI 10.1126/science.3107130; BUCHBERG AM, 1990, MOL CELL BIOL, V10, P4658, DOI 10.1128/MCB.10.9.4658; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; CAWTHON RM, 1991, GENOMICS, V9, P446, DOI 10.1016/0888-7543(91)90410-G; CLEMENTI M, 1991, HUM GENET, V87, P91, DOI 10.1007/BF01213101; EASTON DF, 1993, AM J HUM GENET, V53, P305; ESTIVILL X, 1991, HUM GENET, V88, P185; FAIN P R, 1987, Genomics, V1, P340, DOI 10.1016/0888-7543(87)90034-6; FAIN PR, 1989, AM J HUM GENET, V45, P721; FUSCOE JC, 1983, MOL CELL BIOL, V3, P1086, DOI 10.1128/MCB.3.6.1086; GOLDGAR DE, 1989, AM J HUM GENET, V44, P6; HUSON SM, 1989, J MED GENET, V26, P704, DOI 10.1136/jmg.26.11.704; HUSON SM, 1989, J MED GENET, V26, P712, DOI 10.1136/jmg.26.11.712; JADAYEL D, 1990, NATURE, V343, P558, DOI 10.1038/343558a0; KAPLAN P, 1985, AM J MED GENET, V21, P463, DOI 10.1002/ajmg.1320210308; KAYES LM, 1992, GENOMICS, V14, P369, DOI 10.1016/S0888-7543(05)80228-9; KAYES LM, 1992, J MED GENET, V29, P686, DOI 10.1136/jmg.29.10.686; LEDBETTER DH, 1989, AM J HUM GENET, V44, P20; LEGIUS E, 1992, GENOMICS, V13, P1316, DOI 10.1016/0888-7543(92)90055-W; LEGIUS E, 1993, NAT GENET, V3, P122, DOI 10.1038/ng0293-122; LI Y, 1992, CELL, V69, P275, DOI 10.1016/0092-8674(92)90408-5; Lyons Jones K., 1988, SMITHS RECOGNIZABLE; MARCHUK DA, 1992, GENOMICS, V13, P672, DOI 10.1016/0888-7543(92)90140-N; MARCHUK DA, 1991, GENOMICS, V11, P931, DOI 10.1016/0888-7543(91)90017-9; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; MEINECKE P, 1987, AM J MED GENET, V26, P741, DOI 10.1002/ajmg.1320260331; MENDEZ HMM, 1985, AM J MED GENET, V21, P471, DOI 10.1002/ajmg.1320210309; MIKOL DD, 1990, J CELL BIOL, V110, P471, DOI 10.1083/jcb.110.2.471; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; OCONNELL P, 1990, GENOMICS, V7, P547, DOI 10.1016/0888-7543(90)90198-4; OPITZ JM, 1985, AM J MED GENET, V21, P477, DOI 10.1002/ajmg.1320210310; PUCK JM, 1989, AM J HUM GENET, V44, P724; QUATTRIN T, 1987, AM J MED GENET, V26, P645, DOI 10.1002/ajmg.1320260320; RASTINEJAD F, 1993, CELL, V72, P903, DOI 10.1016/0092-8674(93)90579-F; Riccardi V. M., 1992, NEUROFIBROMATOSIS PH; RICCARDI VM, 1993, AM J HUM GENET, V53, P301; Riccardi VM., 1993, PLASTIC RECONST SURG, V91, P561, DOI [10.1097/00006534-199303000-00029, DOI 10.1097/00006534-199303000-00029]; SCHMIDT MA, 1987, AM J MED GENET, V28, P771, DOI 10.1002/ajmg.1320280333; SEIZINGER BR, 1987, CELL, V49, P589, DOI 10.1016/0092-8674(87)90534-4; SHEPARD TH, 1986, ACTA ENDOCRINOL-COP, V113, P440; STARK M, 1992, HUM GENET, V90, P356; STEPHENS K, 1987, Genomics, V1, P353, DOI 10.1016/0888-7543(87)90037-1; STEPHENS K, 1992, HUM GENET, V88, P279; STEPHENS K, 1989, AM J HUM GENET, V44, P13; STERN HJ, 1992, J MED GENET, V29, P184, DOI 10.1136/jmg.29.3.184; TASSABEHJI M, 1993, AM J HUM GENET, V53, P90; THE I, 1993, NAT GENET, V3, P62, DOI 10.1038/ng0193-62; TRACY TE, 1992, PCR TECHNIQUE DNA SE, P145; Upadhyaya M., 1992, Human Molecular Genetics, V1, P735; UPADHYAYA M, 1990, J MED GENET, V27, P738, DOI 10.1136/jmg.27.12.738; VISKOCHIL D, 1991, MOL CELL BIOL, V11, P906, DOI 10.1128/MCB.11.2.906; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; VISKOCHIL D, 1993, ANNU REV NEUROSCI, V16, P183, DOI 10.1146/annurev.ne.16.030193.001151; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; WALLACE MR, 1991, NATURE, V353, P864, DOI 10.1038/353864a0; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4640, DOI 10.1093/nar/18.15.4640-a; Weiming Xu, 1992, Human Mutation, V1, P474; WHITE R, 1987, Genomics, V1, P364, DOI 10.1016/0888-7543(87)90040-1; WITT DR, 1987, AM J MED GENET, V27, P841, DOI 10.1002/ajmg.1320270412; XU GF, 1991, NUCLEIC ACIDS RES, V19, P3764, DOI 10.1093/nar/19.13.3764; XU GF, 1990, CELL, V62, P599, DOI 10.1016/0092-8674(90)90024-9	69	156	164	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1994	54	3					424	436						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ158	8116612				2022-12-18	WOS:A1994MZ15800004
J	Tang, SY; Wang, X; Li, WY; Yang, XY; Li, Z; Liu, WJ; Li, CH; Zhu, ZJ; Wang, LX; Wang, JX; Zhang, L; Sun, XL; Zhi, EL; Wang, HY; Li, H; Jin, L; Luo, Y; Wang, J; Yang, SM; Zhang, F				Tang, Shuyan; Wang, Xiong; Li, Weiyu; Yang, Xiaoyu; Li, Zheng; Liu, Wangjie; Li, Caihua; Zhu, Zijue; Wang, Lingxiang; Wang, Jiaxiong; Zhang, Ling; Sun, Xiaoling; Zhi, Erlei; Wang, Hongyan; Li, Hong; Jin, Li; Luo, Yang; Wang, Jian; Yang, Shenmin; Zhang, Feng			Biallelic Mutations in CFAP43 and CFAP44 Cause Male Infertility with Multiple Morphological Abnormalities of the Sperm Flagella	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEOMIC ANALYSIS; HUMAN-SPERMATOZOA; SEQUENCING DATA; FIBROUS SHEATH; GENERATION; VARIANTS; DISEASE; DYNEIN; DNAH1; TRANSCRIPTOME	Sperm motility is vital to human reproduction. Malformations of sperm flagella can cause male infertility. Men with multiple morphological abnormalities of the flagella (MMAF) have abnormal spermatozoa with absent, short, coiled, bent, and/or irregular-caliber flagella, which impair sperm motility. The known human MMAF-associated genes, such as DNAH1, only account for fewer than 45% of affected individuals. Pathogenic mechanisms in the genetically unexplained MMAF remain to be elucidated. Here, we conducted genetic analyses by using whole-exome sequencing and genome-wide comparative genomic hybridization microarrays in a multi-center cohort of 30 Han Chinese men affected by MMAF. Among them, 12 subjects could not be genetically explained by any known MMAF-associated genes. Intriguingly, we identified compound-heterozygous mutations in CFAP43 in three subjects and a homozygous frame-shift mutation in CFAP44 in one subject. All of these recessive mutations were parentally inherited from heterozygous carriers but were absent in 984 individuals from three Han Chinese control populations. CFAP43 and CFAP44, encoding two cilia-and flagella-associated proteins (CFAPs), are specifically or preferentially expressed in the testis. Using CRISPR/ Cas9 technology, we generated two knockout models each deficient in mouse ortholog Cfap43 or Cfap44. Notably, both Cfap43- and Cfap44-deficient male mice presented with MMAF phenotypes, whereas the corresponding female mice were fertile. Our experimental observations on human subjects and animal models strongly suggest that biallelic mutations in either CFAP43 or CFAP44 can cause sperm flagellar abnormalities and impair sperm motility. Further investigations on other CFAP-encoding genes in more genetically unexplained MMAF-affected individuals could uncover novel mechanisms underlying sperm flagellar formation.	[Tang, Shuyan; Li, Weiyu; Liu, Wangjie; Wang, Lingxiang; Zhang, Ling; Wang, Hongyan; Jin, Li; Zhang, Feng] Fudan Univ, Obstet & Gynecol Hosp, State Key Lab Genet Engn, Sch Life Sci,Inst Reprod & Dev, Shanghai 200011, Peoples R China; [Tang, Shuyan; Li, Weiyu; Zhang, Ling; Wang, Hongyan; Jin, Li; Luo, Yang; Zhang, Feng] Fudan Univ, Key Lab Reprod Regulat NPFPC, Collaborat Innovat Ctr Genet & Dev, Shanghai 200032, Peoples R China; [Tang, Shuyan; Li, Weiyu; Zhang, Ling; Wang, Hongyan; Zhang, Feng] Shanghai Key Lab Female Reprod Endocrine Related, Shanghai 200011, Peoples R China; [Wang, Xiong] Shandong Univ, Med Coll, Dept Surg, Jinan 250012, Peoples R China; [Wang, Xiong] Qingdao Univ, Affiliated Yantai Yuhuangding Hosp, Reprod Med Ctr, Yantai 264000, Peoples R China; [Yang, Xiaoyu] Nanjing Med Univ, Affiliated Hosp 1, Ctr Reprod Med, Nanjing 210029, Jiangsu, Peoples R China; [Li, Zheng; Zhu, Zijue; Zhi, Erlei] Shanghai Jiao Tong Univ, Dept Androl, Ctr Mens Hlth, Urol Med Ctr,Shanghai Gen Hosp, Shanghai 200080, Peoples R China; [Li, Zheng; Zhu, Zijue; Zhi, Erlei] Shanghai Jiao Tong Univ, Dept ART, Inst Urol, Urol Med Ctr,Shanghai Gen Hosp, Shanghai 200080, Peoples R China; [Li, Caihua] Genesky Biotechnol Inc, Shanghai 200120, Peoples R China; [Wang, Jiaxiong; Li, Hong; Yang, Shenmin] Nanjing Med Univ, Suzhou Hosp, Ctr Reprod & Genet, Suzhou 215002, Peoples R China; [Sun, Xiaoling] Jinghua Hosp, Shenyang Eastern Med Grp, Shenyang 110005, Peoples R China; [Luo, Yang] China Med Univ, Res Ctr Med Genom, Minist Educ, Key Lab Med Cell Biol,Coll Basic Med Sci, Shenyang 110122, Peoples R China; [Wang, Jian] Shanghai Jiao Tong Univ, Sch Med, Dept Med Genet, Shanghai 200127, Peoples R China; [Wang, Jian] Shanghai Jiao Tong Univ, Sch Med, Mol Diagnost Lab, Shanghai Childrens Med Ctr, Shanghai 200127, Peoples R China	Fudan University; Fudan University; Shandong University; Qingdao University; Nanjing Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Nanjing Medical University; China Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, F (corresponding author), Fudan Univ, Obstet & Gynecol Hosp, State Key Lab Genet Engn, Sch Life Sci,Inst Reprod & Dev, Shanghai 200011, Peoples R China.; Zhang, F (corresponding author), Fudan Univ, Key Lab Reprod Regulat NPFPC, Collaborat Innovat Ctr Genet & Dev, Shanghai 200032, Peoples R China.; Zhang, F (corresponding author), Shanghai Key Lab Female Reprod Endocrine Related, Shanghai 200011, Peoples R China.; Yang, SM (corresponding author), Nanjing Med Univ, Suzhou Hosp, Ctr Reprod & Genet, Suzhou 215002, Peoples R China.	drim2004@126.com; zhangfeng@fudan.edu.cn	杨, 玉/W-7221-2019; Wang, Jiaxiong/AAE-6781-2020; Zhang, Feng/C-7735-2009; Jin, Li/C-1468-2009; Jin, Li/M-5063-2019; Tang, Shuyan/K-9582-2018	Wang, Jiaxiong/0000-0002-2819-165X; Zhang, Feng/0000-0003-4556-8276; Jin, Li/0000-0002-4546-2415; Tang, Shuyan/0000-0003-2701-1976	National Key Research and Development Program of China [2016YFC0905100, 2016YFC1000600]; Maternal and Child Health Research Project of Jiangsu Province [F201521]; National Natural Science Foundation of China [31625015, 31521003, 31571297]	National Key Research and Development Program of China; Maternal and Child Health Research Project of Jiangsu Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We would like to thank Drs. Yufang Zheng and Hexige Saiyin for their critical comments and technical support. This work was supported by the National Key Research and Development Program of China (2016YFC0905100 and 2016YFC1000600), Maternal and Child Health Research Project of Jiangsu Province (F201521), and National Natural Science Foundation of China (31625015, 31521003, and 31571297).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amiri-Yekta A, 2016, HUM REPROD, V31, P2872, DOI 10.1093/humrep/dew262; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Arno G, 2016, AM J HUM GENET, V99, P1305, DOI 10.1016/j.ajhg.2016.10.008; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baccetti B, 2005, HUM REPROD, V20, P2790, DOI 10.1093/humrep/dei126; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Ben Khelifa M, 2014, AM J HUM GENET, V94, P95, DOI 10.1016/j.ajhg.2013.11.017; Blacque OE, 2006, MOL BIOL CELL, V17, P5053, DOI 10.1091/mbc.E06-06-0571; Boivin J, 2007, HUM REPROD, V22, P1506, DOI 10.1093/humrep/dem046; Chemes HE, 2000, J ANDROL, V21, P799; CHEMES HE, 1987, FERTIL STERIL, V48, P664; Chemes HE, 2012, ASIAN J ANDROL, V14, P14, DOI 10.1038/aja.2011.168; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Coutton C, 2015, HUM REPROD UPDATE, V21, P455, DOI 10.1093/humupd/dmv020; Firat-Karalar EN, 2014, J CELL SCI, V127, P4128, DOI 10.1242/jcs.157008; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Imsland F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002775; Jumeau F, 2015, J PROTEOME RES, V14, P3606, DOI 10.1021/acs.jproteome.5b00170; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Knowles MR, 2013, AM J RESP CRIT CARE, V188, P913, DOI 10.1164/rccm.201301-0059CI; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li W, 2015, SCI REP-UK, V5, DOI 10.1038/srep16506; Lizio M, 2017, NUCLEIC ACIDS RES, V45, pD737, DOI 10.1093/nar/gkw995; McClintock TS, 2008, PHYSIOL GENOMICS, V32, P198, DOI 10.1152/physiolgenomics.00128.2007; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Merveille AC, 2011, NAT GENET, V43, P72, DOI 10.1038/ng.726; Neesen J, 2001, HUM MOL GENET, V10, P1117, DOI 10.1093/hmg/10.11.1117; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; San Agustin JT, 2015, MOL BIOL CELL, V26, P4358, DOI 10.1091/mbc.E15-08-0578; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Teves ME, 2016, CYTOSKELETON, V73, P3, DOI 10.1002/cm.21271; Wambergue C, 2016, HUM REPROD, V31, P1164, DOI 10.1093/humrep/dew083; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang X, 2017, CLIN GENET, V91, P313, DOI 10.1111/cge.12857; Wu N, 2015, NEW ENGL J MED, V372, P341, DOI 10.1056/NEJMoa1406829; Yang SM, 2015, ASIAN J ANDROL, V17, P513, DOI 10.4103/1008-682X.146100; Yang Y, 2011, MOL BIOL CELL, V22, P976, DOI 10.1091/mbc.E10-04-0331; Zhang F, 2010, AM J HUM GENET, V86, P892, DOI 10.1016/j.ajhg.2010.05.001; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zhang ZB, 2006, BIOL REPROD, V74, P751, DOI 10.1095/biolreprod.105.049254	48	155	171	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 1	2017	100	6					854	864		10.1016/j.ajhg.2017.04.012	http://dx.doi.org/10.1016/j.ajhg.2017.04.012			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EW7NL	28552195	Green Published, Bronze			2022-12-18	WOS:000402700600003
